Citrus Sinensis ID: 002238
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 948 | 2.2.26 [Sep-21-2011] | |||||||
| P43298 | 942 | Probable receptor protein | yes | no | 0.963 | 0.969 | 0.749 | 0.0 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.810 | 0.636 | 0.290 | 1e-75 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.810 | 0.636 | 0.289 | 2e-74 | |
| Q9LJF3 | 1164 | Receptor-like protein kin | no | no | 0.804 | 0.655 | 0.295 | 8e-74 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.822 | 0.654 | 0.310 | 9e-74 | |
| Q9SYQ8 | 980 | Receptor protein kinase C | no | no | 0.761 | 0.736 | 0.299 | 6e-72 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.386 | 0.516 | 0.403 | 8e-70 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.387 | 0.509 | 0.377 | 4e-69 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.804 | 0.610 | 0.288 | 7e-69 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.389 | 0.484 | 0.410 | 3e-68 |
| >sp|P43298|TMK1_ARATH Probable receptor protein kinase TMK1 OS=Arabidopsis thaliana GN=TMK1 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 1386 bits (3587), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 692/923 (74%), Positives = 793/923 (85%), Gaps = 10/923 (1%)
Query: 30 DGDAAVMLALKKSLNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQ 89
DGD + ML+LKKSLNPP S GWSD DPCKW H+VC KR+TRIQIGH LQGTL +L+
Sbjct: 26 DGDLSAMLSLKKSLNPPSSFGWSDPDPCKWTHIVCTGTKRVTRIQIGHSGLQGTLSPDLR 85
Query: 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149
NL++LERLELQWN+ISGP+PSL+GLASL+V+MLSNN F S+PSD F GL+SLQS+EIDNN
Sbjct: 86 NLSELERLELQWNNISGPVPSLSGLASLQVLMLSNNNFDSIPSDVFQGLTSLQSVEIDNN 145
Query: 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS 209
PF SWEIP+SLRNAS LQNFSANSAN++G +P F GPDEFPGL+ILHLAFN L G LP S
Sbjct: 146 PFKSWEIPESLRNASALQNFSANSANVSGSLPGFLGPDEFPGLSILHLAFNNLEGELPMS 205
Query: 210 FSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLS 269
+GSQ+QSLW+NGQ KL G I V+QNMT LKE+WLHSN FSGPLPDFSG+K+LESLS
Sbjct: 206 LAGSQVQSLWLNGQ----KLTGDITVLQNMTGLKEVWLHSNKFSGPLPDFSGLKELESLS 261
Query: 270 LRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGAC 329
LRDN FTGPVP SL+ LESLK+VN+TNN LQGPVP F SVS+D+ K SN+FCL SPG C
Sbjct: 262 LRDNSFTGPVPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKDSNSFCLSSPGEC 321
Query: 330 DPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE 389
DPR+ +LL + YP R AE+WKGNDPC++WIG+ C+ GNITVI+ +KM LTGTISPE
Sbjct: 322 DPRVKSLLLIASSFDYPPRLAESWKGNDPCTNWIGIACSNGNITVISLEKMELTGTISPE 381
Query: 390 FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGNP 449
F + KSLQR+IL NNL+GMIP+ L+ L LK LDVS+N+L+GK+P F+SN +VNT+GNP
Sbjct: 382 FGAIKSLQRIILGINNLTGMIPQELTTLPNLKTLDVSSNKLFGKVPGFRSNVVVNTNGNP 441
Query: 450 DIGKEKSSSFQGSPSGSPTGTGSG-NASSTENGVKNSSALITVILFCVIGGAFVISLTGV 508
DIGK+KSS S G+GSG N G+K SS I +I+ V+GG I L G+
Sbjct: 442 DIGKDKSSLSSPGSSSPSGGSGSGINGDKDRRGMK-SSTFIGIIVGSVLGGLLSIFLIGL 500
Query: 509 LVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVP-S 567
LVFC KK+QKRFS +S NA+V+HPRHSGS+N ESVKITVAGS+VSVG IS+T+T+P +
Sbjct: 501 LVFCWYKKRQKRFSGSESSNAVVVHPRHSGSDN-ESVKITVAGSSVSVGGISDTYTLPGT 559
Query: 568 SEPGD-IQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRME 626
SE GD IQM+EAGNM+ISIQVLR+VTNNFS +NILG GGFG VYKGELHDGTKIAVKRME
Sbjct: 560 SEVGDNIQMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGTKIAVKRME 619
Query: 627 AGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA 686
GVI+GKG EFKSEIAVLTKVRHRHLV LLG+CLDGNEKLLV+EYMPQGTLSRH+F W+
Sbjct: 620 NGVIAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLSRHLFEWS 679
Query: 687 EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746
EEGLKPL W +RLT+ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV
Sbjct: 680 EEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 739
Query: 747 RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPE 806
RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDV+SFGVILMELITGRK+LDESQPE
Sbjct: 740 RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVYSFGVILMELITGRKSLDESQPE 799
Query: 807 ESMHLVTWFRRIHLSKD-SFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMG 865
ES+HLV+WF+R++++K+ SF KAID TIDL+E LAS+ TVAELAGHCCAREPYQRPDMG
Sbjct: 800 ESIHLVSWFKRMYINKEASFKKAIDTTIDLDEETLASVHTVAELAGHCCAREPYQRPDMG 859
Query: 866 HAVNVLSSLVELWKPTDQNSEDIYGIDLEMSLPQALKKWQAYEGRSYMESSSSSLLPSLD 925
HAVN+LSSLVELWKP+DQN EDIYGIDL+MSLPQALKKWQAYEGRS +ESS+SSLLPSLD
Sbjct: 860 HAVNILSSLVELWKPSDQNPEDIYGIDLDMSLPQALKKWQAYEGRSDLESSTSSLLPSLD 919
Query: 926 NTQTSIPTRPYGFAESFKSADGR 948
NTQ SIPTRPYGFAESF S DGR
Sbjct: 920 NTQMSIPTRPYGFAESFTSVDGR 942
|
Probable receptor. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 285 bits (729), Expect = 1e-75, Method: Compositional matrix adjust.
Identities = 265/911 (29%), Positives = 431/911 (47%), Gaps = 143/911 (15%)
Query: 79 NLQGTLPSNLQNLTK-LERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFT-SVPSDFF 135
+ QG P+ L +L K + L+L +N+ SG +P SL +SLE+V +SNN F+ +P D
Sbjct: 314 DFQGVYPNQLADLCKTVVELDLSYNNFSGMVPESLGECSSLELVDISNNNFSGKLPVDTL 373
Query: 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTIL 195
LS+++++ + N F +P S N L+ +S N+TG IPS D L +L
Sbjct: 374 LKLSNIKTMVLSFNKFVGG-LPDSFSNLPKLETLDMSSNNLTGIIPSGICKDPMNNLKVL 432
Query: 196 HL------------------------AFNQLIGGLPASF-SGSQIQSL--WVNGQNGNAK 228
+L +FN L G +P+S S S+++ L W+N +
Sbjct: 433 YLQNNLFKGPIPDSLSNCSQLVSLDLSFNYLTGSIPSSLGSLSKLKDLILWLN------Q 486
Query: 229 LGGGI-DVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKL 286
L G I + + +L+ + L N +GP+P S +L +SL +N +G +P SL +L
Sbjct: 487 LSGEIPQELMYLQALENLILDFNDLTGPIPASLSNCTKLNWISLSNNQLSGEIPASLGRL 546
Query: 287 ESLKIVNMTNNLLQGPVP-EFDRSVSLDMAKGSNNFCLPSPGACDPRLN--------ALL 337
+L I+ + NN + G +P E SL + NF G+ P L ALL
Sbjct: 547 SNLAILKLGNNSISGNIPAELGNCQSLIWLDLNTNFL---NGSIPPPLFKQSGNIAVALL 603
Query: 338 S--------------------VVKLMGYPQRFAENWKGNDPCS---DWIGVTCT----KG 370
+ +++ G Q + PC+ + G+T G
Sbjct: 604 TGKRYVYIKNDGSKECHGAGNLLEFGGIRQEQLDRISTRHPCNFTRVYRGITQPTFNHNG 663
Query: 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE------------------ 412
++ ++ L G+I E + L L L N+LSGMIP+
Sbjct: 664 SMIFLDLSYNKLEGSIPKELGAMYYLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRF 723
Query: 413 ------GLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGNPDIGKEKSSSFQGSPSGS 466
L+ L L E+D+SNN L G IP D PD + ++S G P
Sbjct: 724 NGTIPNSLTSLTLLGEIDLSNNNLSGMIPESAP-----FDTFPDY-RFANNSLCGYPLPL 777
Query: 467 PTGTG-SGNASSTENGVKNSSALITVILFCVIGGAFVISLTGVLVFCLCKKKQKRFSRVQ 525
P +G +A+ + + ++L + ++ F I G+++ + KK++R
Sbjct: 778 PCSSGPKSDANQHQKSHRRQASLAGSVAMGLLFSLFCI--FGLIIVAIETKKRRRKKEAA 835
Query: 526 SPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISI 585
M H HS + NS + K T A +S+ ++ E ++
Sbjct: 836 LEAYMDGH-SHSATANS-AWKFTSAREALSI---------------NLAAFEKPLRKLTF 878
Query: 586 QVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVL 645
L TN F ++++G GGFG VYK +L DG+ +A+K++ +SG+G EF +E+ +
Sbjct: 879 ADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIH--VSGQGDREFTAEMETI 936
Query: 646 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 705
K++HR+LV LLG+C G E+LLV+EYM G+L + + + G+K L W R IA+
Sbjct: 937 GKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKTGIK-LNWPARRKIAIGA 995
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--APEGKGSIETRIAGT 763
ARG+ +LH IHRD+K SN+LL +++ A+V+DFG+ RL A + S+ T +AGT
Sbjct: 996 ARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVST-LAGT 1054
Query: 764 FGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD 823
GY+ PEY + R +TK DV+S+GV+L+EL+TG++ D + ++ +LV W ++H +K
Sbjct: 1055 PGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDN-NLVGWV-KLH-AKG 1111
Query: 824 SFHKAIDPTIDLNEGILASISTVAEL--AGHCCAREPYQRPDMGHAVNVLSSLVELWKPT 881
D + L E I + L A C ++RP M + V++ E+ +
Sbjct: 1112 KITDVFDREL-LKEDASIEIELLQHLKVACACLDDRHWKRPTM---IQVMAMFKEIQAGS 1167
Query: 882 DQNSEDIYGID 892
+S G D
Sbjct: 1168 GMDSTSTIGAD 1178
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 281 bits (719), Expect = 2e-74, Method: Compositional matrix adjust.
Identities = 264/911 (28%), Positives = 431/911 (47%), Gaps = 143/911 (15%)
Query: 79 NLQGTLPSNLQNLTK-LERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFT-SVPSDFF 135
+ QG P+ L +L K + L+L +N+ SG +P SL +SLE+V +S N F+ +P D
Sbjct: 314 DFQGVYPNQLADLCKTVVELDLSYNNFSGMVPESLGECSSLELVDISYNNFSGKLPVDTL 373
Query: 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTIL 195
+ LS+++++ + N F +P S N L+ +S N+TG IPS D L +L
Sbjct: 374 SKLSNIKTMVLSFNKFVGG-LPDSFSNLLKLETLDMSSNNLTGVIPSGICKDPMNNLKVL 432
Query: 196 HL------------------------AFNQLIGGLPASF-SGSQIQSL--WVNGQNGNAK 228
+L +FN L G +P+S S S+++ L W+N +
Sbjct: 433 YLQNNLFKGPIPDSLSNCSQLVSLDLSFNYLTGSIPSSLGSLSKLKDLILWLN------Q 486
Query: 229 LGGGI-DVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKL 286
L G I + + +L+ + L N +GP+P S +L +SL +N +G +P SL +L
Sbjct: 487 LSGEIPQELMYLQALENLILDFNDLTGPIPASLSNCTKLNWISLSNNQLSGEIPASLGRL 546
Query: 287 ESLKIVNMTNNLLQGPVP-EFDRSVSLDMAKGSNNFCLPSPGACDPRLN--------ALL 337
+L I+ + NN + G +P E SL + NF G+ P L ALL
Sbjct: 547 SNLAILKLGNNSISGNIPAELGNCQSLIWLDLNTNFL---NGSIPPPLFKQSGNIAVALL 603
Query: 338 S--------------------VVKLMGYPQRFAENWKGNDPCS---DWIGVT----CTKG 370
+ +++ G Q + PC+ + G+T G
Sbjct: 604 TGKRYVYIKNDGSKECHGAGNLLEFGGIRQEQLDRISTRHPCNFTRVYRGITQPTFNHNG 663
Query: 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE------------------ 412
++ ++ L G+I E + L L L N+LSGMIP+
Sbjct: 664 SMIFLDLSYNKLEGSIPKELGAMYYLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRF 723
Query: 413 ------GLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGNPDIGKEKSSSFQGSPSGS 466
L+ L L E+D+SNN L G IP D PD + ++S G P
Sbjct: 724 NGTIPNSLTSLTLLGEIDLSNNNLSGMIPESAP-----FDTFPDY-RFANNSLCGYPLPI 777
Query: 467 PTGTG-SGNASSTENGVKNSSALITVILFCVIGGAFVISLTGVLVFCLCKKKQKRFSRVQ 525
P +G +A+ + + ++L + ++ F I G+++ + KK++R
Sbjct: 778 PCSSGPKSDANQHQKSHRRQASLAGSVAMGLLFSLFCI--FGLIIVAIETKKRRRKKEAA 835
Query: 526 SPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISI 585
M H HS + NS + K T A +S+ ++ E ++
Sbjct: 836 LEAYMDGH-SHSATANS-AWKFTSAREALSI---------------NLAAFEKPLRKLTF 878
Query: 586 QVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVL 645
L TN F ++++G GGFG VYK +L DG+ +A+K++ +SG+G EF +E+ +
Sbjct: 879 ADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIH--VSGQGDREFTAEMETI 936
Query: 646 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 705
K++HR+LV LLG+C G E+LLV+EYM G+L + + + G+K L W R IA+
Sbjct: 937 GKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKIGIK-LNWPARRKIAIGA 995
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--APEGKGSIETRIAGT 763
ARG+ +LH IHRD+K SN+LL +++ A+V+DFG+ RL A + S+ T +AGT
Sbjct: 996 ARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVST-LAGT 1054
Query: 764 FGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD 823
GY+ PEY + R +TK DV+S+GV+L+EL+TG++ D + ++ +LV W ++H +K
Sbjct: 1055 PGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDN-NLVGWV-KLH-AKG 1111
Query: 824 SFHKAIDPTIDLNEGILASISTVAEL--AGHCCAREPYQRPDMGHAVNVLSSLVELWKPT 881
D + L E I + L A C ++RP M + V++ E+ +
Sbjct: 1112 KITDVFDREL-LKEDASIEIELLQHLKVACACLDDRHWKRPTM---IQVMAMFKEIQAGS 1167
Query: 882 DQNSEDIYGID 892
+S G D
Sbjct: 1168 GMDSTSTIGAD 1178
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 279 bits (713), Expect = 8e-74, Method: Compositional matrix adjust.
Identities = 258/874 (29%), Positives = 408/874 (46%), Gaps = 111/874 (12%)
Query: 70 ITRIQIGHQNLQGT-LPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQF 127
+ + +G+ L G L + + L+++ L L +N+ISG +P SL ++L V+ LS+N+F
Sbjct: 328 LQSLNLGNNKLSGDFLSTVVSKLSRITNLYLPFNNISGSVPISLTNCSNLRVLDLSSNEF 387
Query: 128 T-SVPSDFFTGLSS--LQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFF 184
T VPS F + SS L+ + I NN + S +P L L+ + +TG IP
Sbjct: 388 TGEVPSGFCSLQSSSVLEKLLIANN-YLSGTVPVELGKCKSLKTIDLSFNALTGLIPKEI 446
Query: 185 GPDEFPGLTILHLAFNQLIGGLPASF--SGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSL 242
P L+ L + N L GG+P S G +++L +N N G + I T++
Sbjct: 447 W--TLPKLSDLVMWANNLTGGIPESICVDGGNLETLILNN---NLLTGSLPESISKCTNM 501
Query: 243 KEIWLHSNAFSGPLPDFSGVKQLESLS---LRDNFFTGPVPDSLVKLESLKIVNMTNNLL 299
I L SN +G +P G+ +LE L+ L +N TG +P L ++L +++ +N L
Sbjct: 502 LWISLSSNLLTGEIP--VGIGKLEKLAILQLGNNSLTGNIPSELGNCKNLIWLDLNSNNL 559
Query: 300 QGPVP-EFDRSVSLDM---AKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 355
G +P E L M G + + G D R +V+ G E++
Sbjct: 560 TGNLPGELASQAGLVMPGSVSGKQFAFVRNEGGTDCR--GAGGLVEFEGIRAERLEHFPM 617
Query: 356 NDPCSD---WIGVTC----------------------------TKGNITVINFQKMNLTG 384
C + G+T G + V+N LTG
Sbjct: 618 VHSCPKTRIYSGMTMYMFSSNGSMIYLDLSYNAVSGSIPLGYGAMGYLQVLNLGHNLLTG 677
Query: 385 TISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVN 444
TI F K++ L L+ N+L G +P L L L +LDVSNN L G IP F
Sbjct: 678 TIPDSFGGLKAIGVLDLSHNDLQGFLPGSLGGLSFLSDLDVSNNNLTGPIP-FGGQLTTF 736
Query: 445 TDGNPDIGKEKSSSFQGSPSGSPTGTGSGNASSTENGVKNS-----SALITVILFCVIGG 499
P +S G P P +GS S + K S SA I C++
Sbjct: 737 ----PLTRYANNSGLCGVPL-PPCSSGSRPTRSHAHPKKQSIATGMSAGIVFSFMCIV-- 789
Query: 500 AFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENS-----ESVKITVAGSNV 554
+L+ L + ++ + Q + P S E + I VA
Sbjct: 790 --------MLIMALYRARKVQKKEKQREKYIESLPTSGSSSWKLSSVHEPLSINVATFEK 841
Query: 555 SVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGEL 614
+ ++ H +LEA TN FS ++++G GGFG VYK +L
Sbjct: 842 PLRKLTFAH-----------LLEA-------------TNGFSADSMIGSGGFGDVYKAKL 877
Query: 615 HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 674
DG+ +A+K++ ++G+G EF +E+ + K++HR+LV LLG+C G E+LLV+EYM
Sbjct: 878 ADGSVVAIKKLIQ--VTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMK 935
Query: 675 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 734
G+L + ++G L+W+ R IA+ ARG+ +LH IHRD+K SN+LL
Sbjct: 936 YGSLETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQ 995
Query: 735 DMRAKVADFGLVRL--APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILME 792
D A+V+DFG+ RL A + S+ T +AGT GY+ PEY + R T K DV+S+GVIL+E
Sbjct: 996 DFVARVSDFGMARLVSALDTHLSVST-LAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLE 1054
Query: 793 LITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGH 852
L++G+K +D + E +LV W ++++ K + +DP + ++ + ++A
Sbjct: 1055 LLSGKKPIDPEEFGEDNNLVGWAKQLYREKRG-AEILDPELVTDKSGDVELLHYLKIASQ 1113
Query: 853 CCAREPYQRPDMGHAVNVLSSLVELWKPTDQNSE 886
C P++RP M + + LV++ D E
Sbjct: 1114 CLDDRPFKRPTMIQVMTMFKELVQVDTENDSLDE 1147
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 279 bits (713), Expect = 9e-74, Method: Compositional matrix adjust.
Identities = 272/877 (31%), Positives = 413/877 (47%), Gaps = 97/877 (11%)
Query: 65 IED-KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSL-NGLASLEVVML 122
IED + + + L G++P L LE ++L N +SG + + +G +SL ++L
Sbjct: 349 IEDCPMLKHLSLASNLLSGSIPRELCGSGSLEAIDLSGNLLSGTIEEVFDGCSSLGELLL 408
Query: 123 SNNQFT-SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIP 181
+NNQ S+P D + L ++++D+N F+ EIP+SL ++ L F+A+ + G +P
Sbjct: 409 TNNQINGSIPEDLWK--LPLMALDLDSNNFTG-EIPKSLWKSTNLMEFTASYNRLEGYLP 465
Query: 182 SFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTS 241
+ G L L L+ NQL G +P ++ SL V N N G + + TS
Sbjct: 466 AEIG--NAASLKRLVLSDNQLTGEIPREIG--KLTSLSVLNLNANMFQGKIPVELGDCTS 521
Query: 242 LKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDS------------LVKLES 288
L + L SN G +PD + + QL+ L L N +G +P L L+
Sbjct: 522 LTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQH 581
Query: 289 LKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMG--- 344
I +++ N L GP+PE + L SNN A RL L +++ L G
Sbjct: 582 HGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNL-TILDLSGNAL 640
Query: 345 ---YPQRFAENWK------------GNDPCSDWIGVTCTKGNIT-----------VINFQ 378
P+ + K G+ P S + + K N+T + N +
Sbjct: 641 TGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLK 700
Query: 379 KM--------NLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
++ NL+G +S E ++ + L L + N +G IP L L L+ LDVS N L
Sbjct: 701 ELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLL 760
Query: 431 YGKIPS----FKSNAIVNTDGNPDIGKEKSSSFQGSPSGSPTGTGSGNASSTENGVKNSS 486
G+IP+ + +N N G+ S PS + SGN V +
Sbjct: 761 SGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALL---SGNKELCGRVVGSDC 817
Query: 487 ALITVILFCV--IGGAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSES 544
+ L I G + V VF ++ RV+ R ES
Sbjct: 818 KIEGTKLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQ--------RDDPERMEES 869
Query: 545 VKITVAGSNVSVGAISETHTVPSSEPG--DIQMLEAGNMVISIQVLRNVTNNFSEENILG 602
N+ + S S EP +I M E + + + + T++FS++NI+G
Sbjct: 870 RLKGFVDQNLYFLSGSR-----SREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIG 924
Query: 603 RGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD 662
GGFGTVYK L +AVK++ G EF +E+ L KV+H +LV+LLG+C
Sbjct: 925 DGGFGTVYKACLPGEKTVAVKKLSEAKTQGN--REFMAEMETLGKVKHPNLVSLLGYCSF 982
Query: 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIH 722
EKLLV+EYM G+L + N L+ L+W++RL IA+ ARG+ +LH IH
Sbjct: 983 SEEKLLVYEYMVNGSLDHWLRNQTGM-LEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIH 1041
Query: 723 RDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVD 782
RD+K SNILL D KVADFGL RL + + T IAGTFGY+ PEY + R TTK D
Sbjct: 1042 RDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGYIPPEYGQSARATTKGD 1101
Query: 783 VFSFGVILMELITGRKALDESQPE-ESMHLVTW-FRRIHLSKDSFHKAIDPTIDLNEGIL 840
V+SFGVIL+EL+TG++ E E +LV W ++I+ K IDP + ++ +
Sbjct: 1102 VYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAV--DVIDPLL-VSVALK 1158
Query: 841 ASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877
S + ++A C A P +RP+M ++VL +L E+
Sbjct: 1159 NSQLRLLQIAMLCLAETPAKRPNM---LDVLKALKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYQ8|CLV1_ARATH Receptor protein kinase CLAVATA1 OS=Arabidopsis thaliana GN=CLV1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 273 bits (697), Expect = 6e-72, Method: Compositional matrix adjust.
Identities = 251/838 (29%), Positives = 391/838 (46%), Gaps = 116/838 (13%)
Query: 68 KRITRIQIGHQN-LQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNN 125
K + + IG+ N G +P LTKLE L++ +++G +P SL+ L L + L N
Sbjct: 216 KNLREMYIGYYNSYTGGVPPEFGGLTKLEILDMASCTLTGEIPTSLSNLKHLHTLFLHIN 275
Query: 126 QFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFG 185
T +GL SL+S+++ N + EIPQS N + + N+ GQIP G
Sbjct: 276 NLTGHIPPELSGLVSLKSLDLSINQLTG-EIPQSFINLGNITLINLFRNNLYGQIPEAIG 334
Query: 186 PDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEI 245
E P L + + N LPA+ G+NGN L ++
Sbjct: 335 --ELPKLEVFEVWENNFTLQLPANL-----------GRNGN---------------LIKL 366
Query: 246 WLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP 304
+ N +G +P D ++LE L L +NFF GP+P+ L K +SL + + NLL G VP
Sbjct: 367 DVSDNHLTGLIPKDLCRGEKLEMLILSNNFFFGPIPEELGKCKSLTKIRIVKNLLNGTVP 426
Query: 305 E--FDRSVSLDMAKGSNNFC--LPSPGACDPRLNALLSVVKLMGYPQRFAENW-KGNDPC 359
F+ + + N F LP + D +L + L + NW G P
Sbjct: 427 AGLFNLPLVTIIELTDNFFSGELPVTMSGD-----VLDQIYL-------SNNWFSGEIPP 474
Query: 360 SDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGA 419
+ IG N+ + + G I E K L R+ + NN++G IP+ +S
Sbjct: 475 A--IG---NFPNLQTLFLDRNRFRGNIPREIFELKHLSRINTSANNITGGIPDSISRCST 529
Query: 420 LKELDVSNNQLYGKIP----SFKSNAIVNTDGNPDIGKEKSSSFQGSPSGSPTGTGSGNA 475
L +D+S N++ G+IP + K+ +N GN G PTG G+ +
Sbjct: 530 LISVDLSRNRINGEIPKGINNVKNLGTLNISGNQLTGS------------IPTGIGNMTS 577
Query: 476 SSTEN-GVKNSSALITVILFCVIGGAFVI----SLTGVLVFCLCKKKQKRFSRVQSPNAM 530
+T + + S + +GG F++ S G CL R S P
Sbjct: 578 LTTLDLSFNDLSGRVP------LGGQFLVFNETSFAGNTYLCL----PHRVSCPTRPGQT 627
Query: 531 VIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNM------VIS 584
H H+ + + ITV + + IS QM + N + +
Sbjct: 628 SDH-NHTALFSPSRIVITVIAAITGLILISVAIR---------QMNKKKNQKSLAWKLTA 677
Query: 585 IQVL----RNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKS 640
Q L +V EENI+G+GG G VY+G + + +A+KR+ G +G+ F +
Sbjct: 678 FQKLDFKSEDVLECLKEENIIGKGGAGIVYRGSMPNNVDVAIKRL-VGRGTGRSDHGFTA 736
Query: 641 EIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT 700
EI L ++RHRH+V LLG+ + + LL++EYMP G+L + + ++ G L+W R
Sbjct: 737 EIQTLGRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGE-LLHGSKGG--HLQWETRHR 793
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS-IETR 759
+A++ A+G+ YLH +HRD+K +NILL D A VADFGL + +G S +
Sbjct: 794 VAVEAAKGLCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGAASECMSS 853
Query: 760 IAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI- 818
IAG++GY+APEYA T +V K DV+SFGV+L+ELI G+K + E E + +V W R
Sbjct: 854 IAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFG--EGVDIVRWVRNTE 911
Query: 819 -HLSKDSFHKAIDPTID--LNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873
+++ S + +D L L S+ V ++A C E RP M V++L++
Sbjct: 912 EEITQPSDAAIVVAIVDPRLTGYPLTSVIHVFKIAMMCVEEEAAARPTMREVVHMLTN 969
|
Involved in the detection of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristem maintenance. Acts with CLV3 as a ligand-receptor pair in a signal transduction pathway coordinating growth between adjacent meristematic regions and controlling the balance between meristem cell proliferation and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 266 bits (679), Expect = 8e-70, Method: Compositional matrix adjust.
Identities = 158/392 (40%), Positives = 225/392 (57%), Gaps = 26/392 (6%)
Query: 491 VILFCVIGGAFVISLTGVLVFCLCKKKQKRFSRVQ----SPNAMVIHPRHSGSENSESVK 546
V+ V V +L G+ V+CL +K++KR S V +P+ M S + S+S
Sbjct: 281 VVGISVAVALVVFTLFGIFVWCL-RKREKRLSAVSGGDVTPSPM------SSTARSDSAF 333
Query: 547 ITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGF 606
+ S+ VGA + + S G L + S + L TN FS+EN+LG GGF
Sbjct: 334 FRMQ-SSAPVGASKRSGSYQSQSGG----LGNSKALFSYEELVKATNGFSQENLLGEGGF 388
Query: 607 GTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666
G VYKG L DG +AVK+++ G G+G EFK+E+ L+++ HRHLV+++GHC+ G+ +
Sbjct: 389 GCVYKGILPDGRVVAVKQLKIG--GGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRR 446
Query: 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLK 726
LL+++Y+ L H+ E+ + L+W R+ IA ARG+ YLH H IHRD+K
Sbjct: 447 LLIYDYVSNNDLYFHLH--GEKSV--LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIK 502
Query: 727 PSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSF 786
SNILL D+ A+V+DFGL RLA + I TR+ GTFGY+APEYA +G++T K DVFSF
Sbjct: 503 SSNILLEDNFDARVSDFGLARLALDCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSF 562
Query: 787 GVILMELITGRKALDESQPEESMHLVTWFRRI---HLSKDSFHKAIDPTIDLNEGILASI 843
GV+L+ELITGRK +D SQP LV W R + + + F DP + N + + +
Sbjct: 563 GVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADPKLGGNY-VESEM 621
Query: 844 STVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875
+ E AG C +RP MG V SL
Sbjct: 622 FRMIEAAGACVRHLATKRPRMGQIVRAFESLA 653
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 263 bits (672), Expect = 4e-69, Method: Compositional matrix adjust.
Identities = 156/413 (37%), Positives = 231/413 (55%), Gaps = 46/413 (11%)
Query: 491 VILFCVIGGAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHS------------- 537
++ + G +++L GV+ L ++K+KR + + + HP S
Sbjct: 246 TMVGMAVAGFAIMALIGVVF--LVRRKKKRNIDSYNHSQYLPHPNFSVKSDGFLYGQDPG 303
Query: 538 --------GS--ENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQV 587
GS NS+ + ++ S + G H + SS D +L +G S +
Sbjct: 304 KGYSSGPNGSMYNNSQQQQSSMGNSYGTAGGGYPHHQMQSSGTPDSAILGSGQTHFSYEE 363
Query: 588 LRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
L +T F+ +NILG GGFG VYKG L DG +AVK+++AG SG+G EFK+E+ ++++
Sbjct: 364 LAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAG--SGQGDREFKAEVEIISR 421
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
V HRHLV+L+G+C+ +LL++EY+ TL H+ +GL LEW++R+ IA+ A+
Sbjct: 422 VHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHG---KGLPVLEWSKRVRIAIGSAK 478
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
G+ YLH H IHRD+K +NILL D+ A+VADFGL RL + + TR+ GTFGYL
Sbjct: 479 GLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRVMGTFGYL 538
Query: 768 APEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827
APEYA +G++T + DVFSFGV+L+EL+TGRK +D++QP LV W R + L K
Sbjct: 539 APEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLL------K 592
Query: 828 AIDPTIDLNEGILASIST---------VAELAGHCCAREPYQRPDMGHAVNVL 871
AI+ T DL+E I + + E A C +RP M V L
Sbjct: 593 AIE-TGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRAL 644
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 263 bits (671), Expect = 7e-69, Method: Compositional matrix adjust.
Identities = 257/891 (28%), Positives = 396/891 (44%), Gaps = 128/891 (14%)
Query: 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS-LNGLASLEVVMLSNNQF 127
+T + + + L+GTL ++ NLT L+ L L N++ G LP ++ L LEV+ L N+F
Sbjct: 385 ELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRF 444
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187
+ +SL+ I++ N F EIP S+ L + G +P+ G
Sbjct: 445 SGEIPQEIGNCTSLKMIDMFGNHFEG-EIPPSIGRLKELNLLHLRQNELVGGLPASLG-- 501
Query: 188 EFPGLTILHLAFNQLIGGLPASF---SGSQIQSLWVNGQNGNA----------------- 227
L IL LA NQL G +P+SF G + L+ N GN
Sbjct: 502 NCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSH 561
Query: 228 -KLGGGI------------DV------------IQNMTSLKEIWLHSNAFSGPLP-DFSG 261
+L G I DV + N +L + L N +G +P
Sbjct: 562 NRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGK 621
Query: 262 VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSL--DMAKGSN 319
+++L L + N TG +P LV + L +++ NN L GP+P + +S ++ SN
Sbjct: 622 IRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSN 681
Query: 320 NFCLPSPGA---CDPRLNALLSVVKLMG-YPQRFAE-------NWKGNDPCSDWIGVTCT 368
F P C L L L G PQ N N
Sbjct: 682 QFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGK 741
Query: 369 KGNITVINFQKMNLTGTISPEFASFKSLQR-LILADNNLSGMIPEGLSVLGALKELDVSN 427
+ + + +LTG I E + LQ L L+ NN +G IP + L L+ LD+S+
Sbjct: 742 LSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSH 801
Query: 428 NQLYGKIP----SFKSNAIVNTDGNPDIGKEKSSSFQGSPSGSPTG-TG-SGNASSTENG 481
NQL G++P KS +N N ++G + F P+ S G TG G+ S N
Sbjct: 802 NQLTGEVPGSVGDMKSLGYLNVSFN-NLGGKLKKQFSRWPADSFLGNTGLCGSPLSRCNR 860
Query: 482 VKNSS-----ALITVILFCVIGGAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRH 536
V++++ + +V++ I I L +++ K++ F +V H
Sbjct: 861 VRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVG----------H 910
Query: 537 SGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFS 596
+ + S + A TH P G A I + + T+N S
Sbjct: 911 GSTAYTSSSSSSQA-----------THK-PLFRNG------ASKSDIRWEDIMEATHNLS 952
Query: 597 EENILGRGGFGTVYKGELHDGTKIAVKRM--EAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
EE ++G GG G VYK EL +G +AVK++ + ++S K F E+ L ++RHRHLV
Sbjct: 953 EEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKS---FSREVKTLGRIRHRHLV 1009
Query: 655 ALLGHCLDGNE--KLLVFEYMPQGTLSRHIFNWA-------EEGLKPLEWNRRLTIALDV 705
L+G+C +E LL++EYM G+ I++W E+ K L+W RL IA+ +
Sbjct: 1010 KLMGYCSSKSEGLNLLIYEYMKNGS----IWDWLHEDKPVLEKKKKLLDWEARLRIAVGL 1065
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG---KGSIETRIAG 762
A+GVEYLH +HRD+K SN+LL +M A + DFGL ++ E T A
Sbjct: 1066 AQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFAC 1125
Query: 763 TFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFR-RIHLS 821
++GY+APEYA + + T K DV+S G++LME++TG+ D E M +V W + ++
Sbjct: 1126 SYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAE-MDMVRWVETHLEVA 1184
Query: 822 KDSFHKAIDPTID-LNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871
+ K IDP + L + V E+A C P +RP A + L
Sbjct: 1185 GSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSL 1235
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 260 bits (665), Expect = 3e-68, Method: Compositional matrix adjust.
Identities = 158/385 (41%), Positives = 217/385 (56%), Gaps = 16/385 (4%)
Query: 497 IGGAFVI-SLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVS 555
IG A V+ +L GV+V CL KK++KR S + M P S S S+S + S
Sbjct: 335 IGVALVLLTLIGVVVCCL-KKRKKRLSTIGGGYVMPT-PMESSSPRSDSALLKTQSSAPL 392
Query: 556 VGAISETHTVPS-SEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGEL 614
VG S T S SEPG + S + L TN FS+EN+LG GGFG VYKG L
Sbjct: 393 VGNRSSNRTYLSQSEPGGFGQ---SRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVL 449
Query: 615 HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 674
D +AVK+++ G G+G EFK+E+ +++V HR+L++++G+C+ N +LL+++Y+P
Sbjct: 450 PDERVVAVKQLKIG--GGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVP 507
Query: 675 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 734
L H+ GL +W R+ IA ARG+ YLH H IHRD+K SNILL +
Sbjct: 508 NNNLYFHLHAAGTPGL---DWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEN 564
Query: 735 DMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELI 794
+ A V+DFGL +LA + I TR+ GTFGY+APEYA +G++T K DVFSFGV+L+ELI
Sbjct: 565 NFHALVSDFGLAKLALDCNTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELI 624
Query: 795 TGRKALDESQPEESMHLVTWFRRI---HLSKDSFHKAIDPTIDLNEGILASISTVAELAG 851
TGRK +D SQP LV W R + + F DP + N + + + E A
Sbjct: 625 TGRKPVDASQPLGDESLVEWARPLLSNATETEEFTALADPKLGRNY-VGVEMFRMIEAAA 683
Query: 852 HCCAREPYQRPDMGHAVNVLSSLVE 876
C +RP M V SL E
Sbjct: 684 ACIRHSATKRPRMSQIVRAFDSLAE 708
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 948 | ||||||
| 224069210 | 945 | predicted protein [Populus trichocarpa] | 0.993 | 0.996 | 0.790 | 0.0 | |
| 224077350 | 946 | predicted protein [Populus trichocarpa] | 0.994 | 0.996 | 0.783 | 0.0 | |
| 255585572 | 951 | receptor protein kinase, putative [Ricin | 0.998 | 0.995 | 0.756 | 0.0 | |
| 449445063 | 953 | PREDICTED: probable receptor protein kin | 0.966 | 0.961 | 0.785 | 0.0 | |
| 359476563 | 889 | PREDICTED: probable receptor protein kin | 0.936 | 0.998 | 0.787 | 0.0 | |
| 351727489 | 941 | NAK-type protein kinase precursor [Glyci | 0.965 | 0.972 | 0.760 | 0.0 | |
| 15218941 | 942 | putative receptor protein kinase TMK1 [A | 0.963 | 0.969 | 0.749 | 0.0 | |
| 29824403 | 942 | putative receptor protein kinase (TMK1) | 0.963 | 0.969 | 0.748 | 0.0 | |
| 224589461 | 942 | leucine-rich repeat receptor-like protei | 0.963 | 0.969 | 0.748 | 0.0 | |
| 297838257 | 937 | hypothetical protein ARALYDRAFT_475717 [ | 0.973 | 0.985 | 0.739 | 0.0 |
| >gi|224069210|ref|XP_002302927.1| predicted protein [Populus trichocarpa] gi|222844653|gb|EEE82200.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1508 bits (3905), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 752/951 (79%), Positives = 837/951 (88%), Gaps = 9/951 (0%)
Query: 1 MKEKTCVGFKLLTLY-VGFCSILFVSASGDDGDAAVMLALKKSLNPPESLGWSDTDPCKW 59
MK ++ KLL ++ VGF SI + S DA VM +LKKSLN P+SLGWSD DPC W
Sbjct: 1 MKRRSHRRTKLLLVFLVGFSSIFHFANSQTSPDAEVMFSLKKSLNVPDSLGWSDPDPCNW 60
Query: 60 NHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEV 119
NHVVC ++KR+TRIQIG QNLQGTLPSNL+NL +LERLELQ+N+ISGPLPSLNGL+SL+V
Sbjct: 61 NHVVCSDEKRVTRIQIGRQNLQGTLPSNLRNLAQLERLELQYNNISGPLPSLNGLSSLQV 120
Query: 120 VMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQ 179
++LS+N+F SVPSDFFTGLSSLQS+EIDNNPFS+W IP+S++NAS LQNFSANSANI+G
Sbjct: 121 ILLSDNKFISVPSDFFTGLSSLQSVEIDNNPFSNWVIPESIKNASALQNFSANSANISGS 180
Query: 180 IPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNM 239
IP FFGPD FPGLTIL LAFN L G LPASFSGSQ+QSLW+NGQ KL GGIDVIQNM
Sbjct: 181 IPGFFGPDSFPGLTILRLAFNDLEGELPASFSGSQVQSLWLNGQ----KLSGGIDVIQNM 236
Query: 240 TSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 299
T L+E+WLHSN FSGPLPDFSG+K LESLSLRDN FTG VP+SLV LESLK VN++NNLL
Sbjct: 237 TLLREVWLHSNGFSGPLPDFSGLKDLESLSLRDNSFTGLVPESLVNLESLKFVNLSNNLL 296
Query: 300 QGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPC 359
QGP+P F SVS+DM K SN FCLP+P CD R+N LLS+VK M YPQR A++WKGNDPC
Sbjct: 297 QGPMPVFKSSVSVDMVKDSNRFCLPTPDLCDSRVNTLLSIVKSMDYPQRLADSWKGNDPC 356
Query: 360 SDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGA 419
+DWIG+TC GNITV+NF+KM LTG+ISP+FAS KSL+RL+LA+NNL+G IP+ ++ L
Sbjct: 357 ADWIGITCNNGNITVVNFEKMGLTGSISPDFASVKSLERLVLANNNLTGSIPQEITTLPG 416
Query: 420 LKELDVSNNQLYGKIPSFKSNAIVNTDGNPDIGKEKS--SSFQGSPSGSPTGTGSGNASS 477
LK LDVSNN LYG++P+F SN IVNT+GNP+IGK+ + +S + + TGSG+ S
Sbjct: 417 LKVLDVSNNHLYGRVPAFTSNVIVNTNGNPNIGKDVNISTSSESPSASPSANTGSGSGGS 476
Query: 478 TENGVKNSSALITVILFCVIGGAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHS 537
+ K SS LI VI+F VIGG F++SL G+LVFCL KKKQKRFSRVQSPN MVIHPRHS
Sbjct: 477 SRKSGKKSSTLIVVIIFSVIGGVFLLSLIGLLVFCLYKKKQKRFSRVQSPNEMVIHPRHS 536
Query: 538 GSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSE 597
GS+N ESVKITVAGS++SVGAISETHT+P+SE GDIQM+EAGNMVISIQVLRNVTNNFSE
Sbjct: 537 GSDN-ESVKITVAGSSISVGAISETHTIPASEQGDIQMVEAGNMVISIQVLRNVTNNFSE 595
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
ENILG GGFG VYKGELHDGTKIAVKRME+GVISGKGLTEFKSEIAVLTKVRHRHLVALL
Sbjct: 596 ENILGWGGFGVVYKGELHDGTKIAVKRMESGVISGKGLTEFKSEIAVLTKVRHRHLVALL 655
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
G+CLDGNEKLLV+EYMPQGTLSRHIFNWAEEGLKPLEW RRLTIALDVARGVEYLHGLAH
Sbjct: 656 GYCLDGNEKLLVYEYMPQGTLSRHIFNWAEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 715
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV 777
QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV
Sbjct: 716 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV 775
Query: 778 TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNE 837
TTKVDVFSFGVILMELITGRKALDE QPEES+HLVTWFRR+HL+KD+F KAIDPTIDLNE
Sbjct: 776 TTKVDVFSFGVILMELITGRKALDERQPEESLHLVTWFRRMHLNKDTFRKAIDPTIDLNE 835
Query: 838 GILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDQNSEDIYGIDLEMSL 897
LASISTVAELAGHCCAREPYQRPDMGH VNVLSSLVELWKPTDQ+SEDIYGIDLEMSL
Sbjct: 836 ETLASISTVAELAGHCCAREPYQRPDMGHTVNVLSSLVELWKPTDQSSEDIYGIDLEMSL 895
Query: 898 PQALKKWQAYEGRSYMESSSSSLLPSLDNTQTSIPTRPYGFAESFKSADGR 948
PQALKKWQAYEGRS M+SSSS L SLDNTQTSIP RPYGFAESF SADGR
Sbjct: 896 PQALKKWQAYEGRSNMDSSSSLLP-SLDNTQTSIPARPYGFAESFTSADGR 945
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224077350|ref|XP_002305223.1| predicted protein [Populus trichocarpa] gi|222848187|gb|EEE85734.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1491 bits (3861), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 745/951 (78%), Positives = 834/951 (87%), Gaps = 8/951 (0%)
Query: 1 MKEKTCVGFKLLTLY-VGFCSILFVSASGDDGDAAVMLALKKSLNPPESLGWSDTDPCKW 59
MK K+ KL ++ VGF SI ++S DA VML+LKKSLN P+SLGWSD DPCKW
Sbjct: 1 MKRKSSQSLKLFLIFLVGFSSIFRYASSQASPDAEVMLSLKKSLNVPDSLGWSDPDPCKW 60
Query: 60 NHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEV 119
NHV C ++KR+TRIQIG QNLQGTLPSNLQNLT+LERLELQ+N+ISG LPSLNGL+SL+V
Sbjct: 61 NHVGCSDEKRVTRIQIGRQNLQGTLPSNLQNLTQLERLELQYNNISGHLPSLNGLSSLQV 120
Query: 120 VMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQ 179
++LS+N+FTSVPSDFF GLSSLQS+EIDNNPFS+W IP+S++NASGLQNFSANSANI+G
Sbjct: 121 ILLSDNKFTSVPSDFFAGLSSLQSVEIDNNPFSNWVIPESIQNASGLQNFSANSANISGS 180
Query: 180 IPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNM 239
IPSFFGPD FP LTIL LAFN L G LPASFSG Q+QSLW+NGQ KL G I VIQNM
Sbjct: 181 IPSFFGPDAFPALTILRLAFNDLEGELPASFSGLQVQSLWLNGQ----KLSGSIYVIQNM 236
Query: 240 TSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 299
T L+E+WL SN FSGPLPDFSG+K LESL+LRDN FTGPVP+SLV LESLK+VN++NNLL
Sbjct: 237 TLLREVWLQSNGFSGPLPDFSGLKDLESLNLRDNSFTGPVPESLVNLESLKVVNLSNNLL 296
Query: 300 QGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPC 359
QGP+P F SVS+D+ K SN FCL +PG CD R+N LLS+VK M YP R A+ WKGNDPC
Sbjct: 297 QGPMPVFKSSVSVDVVKDSNRFCLSTPGPCDSRVNTLLSIVKSMYYPHRLADGWKGNDPC 356
Query: 360 SDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGA 419
+DW G+TC KGNITV+NF+KM LTG+ISP+FAS KSL+RL+LA+NNL+G+IP+ ++ L
Sbjct: 357 ADWFGITCNKGNITVVNFEKMGLTGSISPDFASLKSLERLVLANNNLTGLIPQEITTLPR 416
Query: 420 LKELDVSNNQLYGKIPSFKSNAIVNTDGNPDIGKE--KSSSFQGSPSGSPTGTGSGNASS 477
LK LDVSNNQ+YGK+P+F +N IVNT+GNP IGK+ S+S + TGSG+ +
Sbjct: 417 LKALDVSNNQIYGKVPAFTNNVIVNTNGNPRIGKDVNSSTSPGSPSASPSANTGSGSGGN 476
Query: 478 TENGVKNSSALITVILFCVIGGAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHS 537
+ K SSA I VI+F V+GG F++ L G++VFCL KKKQKRFSRVQSPN MVIHPRHS
Sbjct: 477 SGKSGKKSSAFIGVIVFSVVGGVFLLFLIGLVVFCLYKKKQKRFSRVQSPNEMVIHPRHS 536
Query: 538 GSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSE 597
S+N ESVKITVAGS+VSVGAISETHT+P+SE GDIQM EAGNMVISIQVLRNVTNNFSE
Sbjct: 537 VSDN-ESVKITVAGSSVSVGAISETHTIPTSEQGDIQMGEAGNMVISIQVLRNVTNNFSE 595
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
ENILG+GGFG VYKGELHDGTKIAVKRM +GVIS KGL EFKSEIAVLTKVRHRHLVALL
Sbjct: 596 ENILGQGGFGVVYKGELHDGTKIAVKRMGSGVISSKGLNEFKSEIAVLTKVRHRHLVALL 655
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
G+CLDGNEKLLV+EYMPQGTLSRH+FNWAEEGLKP+EW RRLTIALDVARGVEYLHGLAH
Sbjct: 656 GYCLDGNEKLLVYEYMPQGTLSRHLFNWAEEGLKPMEWTRRLTIALDVARGVEYLHGLAH 715
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV 777
QSFIHRDLKPSNILLGDDMRAKV+DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV
Sbjct: 716 QSFIHRDLKPSNILLGDDMRAKVSDFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV 775
Query: 778 TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNE 837
TTKVDVFSFGVILMELITGRKALD+SQPEESMHLVTWFRR+HL+KD+F KAIDPTIDLNE
Sbjct: 776 TTKVDVFSFGVILMELITGRKALDDSQPEESMHLVTWFRRMHLNKDTFRKAIDPTIDLNE 835
Query: 838 GILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDQNSEDIYGIDLEMSL 897
LASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTD +SEDIYGIDLEMSL
Sbjct: 836 ETLASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDHSSEDIYGIDLEMSL 895
Query: 898 PQALKKWQAYEGRSYMESSSSSLLPSLDNTQTSIPTRPYGFAESFKSADGR 948
PQALKKWQAYEGRS MESSSSSLLPSLDNTQTSIP RPYGFAESF SADGR
Sbjct: 896 PQALKKWQAYEGRSNMESSSSSLLPSLDNTQTSIPARPYGFAESFTSADGR 946
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585572|ref|XP_002533475.1| receptor protein kinase, putative [Ricinus communis] gi|223526668|gb|EEF28907.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1484 bits (3842), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 720/952 (75%), Positives = 824/952 (86%), Gaps = 5/952 (0%)
Query: 1 MKEKTCVGFKLLTLYV-GFCSILF-VSASGDDG-DAAVMLALKKSLNPPESLGWSDTDPC 57
M+++ + FK L +++ GFCS VS G DA VM AL+KSLN P+SLGWSD DPC
Sbjct: 1 MEKRVYIKFKSLLIFLSGFCSFFVNVSCQGSPSEDAPVMFALRKSLNVPDSLGWSDPDPC 60
Query: 58 KWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASL 117
W HV C ++KR+TRIQIG QNL+GTLPSNLQNLT+LERLELQWNSISGPLP+L GLASL
Sbjct: 61 NWKHVTCSDEKRVTRIQIGRQNLEGTLPSNLQNLTQLERLELQWNSISGPLPTLKGLASL 120
Query: 118 EVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANIT 177
VVMLS NQFTS+PSDFFTGLSSLQS+EID+NPFS+W IP+S+++AS LQNFSANSAN++
Sbjct: 121 LVVMLSGNQFTSIPSDFFTGLSSLQSVEIDDNPFSTWVIPESIKDASALQNFSANSANLS 180
Query: 178 GQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQ 237
G IP FFGPD FPGLTILHLA N+L GGLP +FSGSQIQSLW+NGQ KL GGIDVI+
Sbjct: 181 GSIPDFFGPDSFPGLTILHLALNELQGGLPGTFSGSQIQSLWLNGQTSKGKLTGGIDVIK 240
Query: 238 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
NMT LK++WLHSN FSGPLPDFSG+K LE LS+RDN FTGP+P SL L SLK VN++NN
Sbjct: 241 NMTLLKDVWLHSNGFSGPLPDFSGLKDLEVLSIRDNSFTGPIPLSLTALASLKAVNLSNN 300
Query: 298 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 357
L QGP+P F R VS+D+ SN+FCLPSPG CD R+ LL + K +GYPQRFAE+WKGND
Sbjct: 301 LFQGPMPVFKRLVSVDLTADSNSFCLPSPGDCDSRVKTLLLIAKSVGYPQRFAESWKGND 360
Query: 358 PCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVL 417
PC+DW+G+TCT GNITV+NFQKM LTGT++PEFA SLQRL+L +NNL+G IP+ L+ L
Sbjct: 361 PCADWVGITCTGGNITVVNFQKMGLTGTVAPEFAMLLSLQRLVLDNNNLTGSIPQELTTL 420
Query: 418 GALKELDVSNNQLYGKIPSFKSNAIVNTDGNPDIGKE-KSSSFQGSPSGSPTGTGSGNAS 476
ALK+LDVSNNQ+ GKIP+FKSN +VNT+GNPDIGK+ +S+ GSPSG+ +
Sbjct: 421 PALKQLDVSNNQISGKIPTFKSNVMVNTNGNPDIGKDVNTSTTPGSPSGATMAGTGSGSG 480
Query: 477 STENGVKNSSALITVILFCVIGGAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRH 536
++ NG K SS+ I VILF VIGG FVISL G+L+FC+ KKKQKRFS+VQSPNAMVIHPRH
Sbjct: 481 NSGNGGKKSSSNIGVILFSVIGGVFVISLIGLLIFCIYKKKQKRFSKVQSPNAMVIHPRH 540
Query: 537 SGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFS 596
SGS+N ESVKITVAGS+VSVGAISETHT P+SE GDIQM+E+GNMVISIQVLRNVTNNFS
Sbjct: 541 SGSDN-ESVKITVAGSSVSVGAISETHTFPASEQGDIQMVESGNMVISIQVLRNVTNNFS 599
Query: 597 EENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
E+N+LG+GGFG VYKGELHDGTKIAVKRME+GVISGKGL EFKSEIAVL KVRHRHLVAL
Sbjct: 600 EDNLLGQGGFGKVYKGELHDGTKIAVKRMESGVISGKGLAEFKSEIAVLNKVRHRHLVAL 659
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
LG+CLDGNEKLLV+E+MPQG LSRH+F+WA++GLKPLEW RRL IALDVARGVEYLHGLA
Sbjct: 660 LGYCLDGNEKLLVYEFMPQGALSRHLFHWADDGLKPLEWTRRLIIALDVARGVEYLHGLA 719
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR 776
HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP+GKGSIETRIAGTFGYLAPEYAVTGR
Sbjct: 720 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDGKGSIETRIAGTFGYLAPEYAVTGR 779
Query: 777 VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLN 836
VTTKVDVFSFGVILMELITGRKALD+SQPEESMHLVTWFRR+H++KDSF KAIDP ID++
Sbjct: 780 VTTKVDVFSFGVILMELITGRKALDDSQPEESMHLVTWFRRVHINKDSFRKAIDPAIDVD 839
Query: 837 EGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDQNSEDIYGIDLEMS 896
E LAS+STVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKP+DQ ED+YGIDL++S
Sbjct: 840 EETLASVSTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPSDQYPEDVYGIDLDLS 899
Query: 897 LPQALKKWQAYEGRSYMESSSSSLLPSLDNTQTSIPTRPYGFAESFKSADGR 948
LPQ +KKWQA+EG S MES S+ S+DNTQTSIP P GF SF SADGR
Sbjct: 900 LPQVVKKWQAFEGMSNMESPSTFYSRSIDNTQTSIPAVPGGFGASFTSADGR 951
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449445063|ref|XP_004140293.1| PREDICTED: probable receptor protein kinase TMK1-like [Cucumis sativus] gi|449479894|ref|XP_004155738.1| PREDICTED: probable receptor protein kinase TMK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1477 bits (3823), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 724/922 (78%), Positives = 800/922 (86%), Gaps = 6/922 (0%)
Query: 32 DAAVMLALKKSLNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNL 91
DA M ALKKSLNP ESLGWSD +PCKWNHV+C +D R+TRIQIG QNLQG LP NLQNL
Sbjct: 33 DAPAMTALKKSLNPTESLGWSDPNPCKWNHVLCSDDNRVTRIQIGRQNLQGMLPLNLQNL 92
Query: 92 TKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPF 151
T LERLELQWN ISGPLPSL+GL SL+V++LS NQFTS+PSDFF G++SLQ++EID NPF
Sbjct: 93 TALERLELQWNKISGPLPSLSGLTSLQVLLLSGNQFTSIPSDFFAGMTSLQAVEIDENPF 152
Query: 152 SSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFS 211
S+WEIP SLRNAS LQNFSANSAN+TG+IP F G ++ PGLT LHLAFN L GGLP+SFS
Sbjct: 153 SAWEIPASLRNASTLQNFSANSANVTGRIPEFLGGEDIPGLTNLHLAFNNLEGGLPSSFS 212
Query: 212 GSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLR 271
GSQ++SLWVNGQN KL G IDV+QNMTSL E+WLHSN+FSGPLPDFS +K L++LSLR
Sbjct: 213 GSQLESLWVNGQNSADKLSGSIDVLQNMTSLIEVWLHSNSFSGPLPDFSRLKDLQALSLR 272
Query: 272 DNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDP 331
DN FTGPVP SLV SLK+VN+TNNLLQGP+P F V +DM SN+FCL PG CD
Sbjct: 273 DNKFTGPVPSSLVNSPSLKVVNLTNNLLQGPIPLFKTGVVVDMTNDSNSFCLQDPGECDS 332
Query: 332 RLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFA 391
R+N LLS+VK MGYPQRFAENWKGNDPC++WIG++C +IT++NFQKM L+G ISPEFA
Sbjct: 333 RVNTLLSIVKFMGYPQRFAENWKGNDPCAEWIGISCRNQSITIVNFQKMGLSGMISPEFA 392
Query: 392 SFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGNPDI 451
S K L+RL+LADN+L+G IPE L+ L L ELDVSNNQL GKIP F+SN ++ GNPDI
Sbjct: 393 SLKGLERLVLADNHLTGSIPEELTTLPFLTELDVSNNQLSGKIPKFRSNVMMTITGNPDI 452
Query: 452 GKEK--SSSFQGSPSGSPTGTGSGNASSTENGV---KNSSALITVILFCVIGGAFVISLT 506
GKEK SSS SPS S T ++ N K S+++ VI+ V+GG FV+ L
Sbjct: 453 GKEKTDSSSNGASPSASSNDTKEAGSNGGGNSGDGEKKPSSMVGVIVLSVVGGVFVLFLI 512
Query: 507 GVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVP 566
G++V C+ K KQKRFS+VQSPNAMVIHPRHSGS+N ESVKITVAGS+V VGAISET
Sbjct: 513 GLVVLCVYKMKQKRFSQVQSPNAMVIHPRHSGSDN-ESVKITVAGSSVRVGAISETQNGA 571
Query: 567 SSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRME 626
SSE GDIQM+EAGNMVISIQVL+NVTNNFSEENILG+GGFGTVYKGELHDGTKIAVKRME
Sbjct: 572 SSETGDIQMVEAGNMVISIQVLKNVTNNFSEENILGQGGFGTVYKGELHDGTKIAVKRME 631
Query: 627 AGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA 686
+GVI GKGLTEFKSEIAVLTKVRHRHLVALLG+CLDGNEKLLV+EYMPQGTLSRH+FNW
Sbjct: 632 SGVIKGKGLTEFKSEIAVLTKVRHRHLVALLGYCLDGNEKLLVYEYMPQGTLSRHLFNWP 691
Query: 687 EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746
EEGLKPLEW +RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV
Sbjct: 692 EEGLKPLEWTKRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 751
Query: 747 RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPE 806
RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPE
Sbjct: 752 RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPE 811
Query: 807 ESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGH 866
ESMHLVTWFRR+ ++KDSFHKAIDPTIDL E ASI+TVAELAGHCCAREPYQRPDMGH
Sbjct: 812 ESMHLVTWFRRMQINKDSFHKAIDPTIDLTEETFASINTVAELAGHCCAREPYQRPDMGH 871
Query: 867 AVNVLSSLVELWKPTDQNSEDIYGIDLEMSLPQALKKWQAYEGRSYMESSSSSLLPSLDN 926
AVNVLSSLVE WKPTDQNSEDIYGIDLEMSLPQALKKWQAYEGRS MESSSSSLLPS DN
Sbjct: 872 AVNVLSSLVEFWKPTDQNSEDIYGIDLEMSLPQALKKWQAYEGRSQMESSSSSLLPSFDN 931
Query: 927 TQTSIPTRPYGFAESFKSADGR 948
TQTSIPTRPYGFAESF SADGR
Sbjct: 932 TQTSIPTRPYGFAESFTSADGR 953
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359476563|ref|XP_002265087.2| PREDICTED: probable receptor protein kinase TMK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1475 bits (3818), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 720/914 (78%), Positives = 798/914 (87%), Gaps = 26/914 (2%)
Query: 36 MLALKKSLNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLE 95
MLALK SL+ ESLGWS DPC+W HVVC EDKR+TRIQ+G Q LQGTLPS+L NLT+LE
Sbjct: 1 MLALKDSLSNSESLGWSGPDPCEWKHVVCSEDKRVTRIQVGRQGLQGTLPSSLGNLTELE 60
Query: 96 RLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWE 155
RLELQWN+ISGPLPSL GL+SL+V+MLSNNQFT +P DFF+GLSSLQS+EIDNNPFS+WE
Sbjct: 61 RLELQWNNISGPLPSLKGLSSLQVLMLSNNQFTYIPVDFFSGLSSLQSVEIDNNPFSAWE 120
Query: 156 IPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQI 215
IPQSL+NAS LQNFSANSANITG IP F GP FPGL LHLAFN L+GGLP++ SGS I
Sbjct: 121 IPQSLKNASALQNFSANSANITGNIPDFLGPVAFPGLVNLHLAFNALVGGLPSALSGSLI 180
Query: 216 QSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFF 275
+SLWVNGQ KL G IDVIQNMTSLKE+WLHSNAFSGPLPDFSG+K L+SLSLRDN F
Sbjct: 181 ESLWVNGQMSEEKLSGTIDVIQNMTSLKEVWLHSNAFSGPLPDFSGLKDLQSLSLRDNLF 240
Query: 276 TGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNA 335
TG VP SLV L SL+ VN+TNN LQGPVPEF SV++DM N+FCLP PG CDPR+N
Sbjct: 241 TGVVPVSLVNLGSLEAVNLTNNFLQGPVPEFKNSVAVDMTPDGNSFCLPKPGECDPRVNI 300
Query: 336 LLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKS 395
LLS+VK GYP +FA+NWKGNDPC++W G+TC GNITV+NFQKM LTGTIS F+S S
Sbjct: 301 LLSIVKSFGYPTKFAKNWKGNDPCTEWFGITCNNGNITVVNFQKMGLTGTISSNFSSLIS 360
Query: 396 LQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGNPDIGKEK 455
LQ+L+LADNN++G IP+ L+ L AL +LDVSNNQLYGKIPSFK N +VN +G+ D G
Sbjct: 361 LQKLVLADNNITGSIPKELTTLPALTQLDVSNNQLYGKIPSFKGNVLVNANGSQDSG--- 417
Query: 456 SSSFQGSPSGSPTGTGSGNASSTENGVKNSSALITVILFCVIGGAFVISLTGVLVFCLCK 515
S+ NG K SS+LI +I+F VIGG FVI L G+LVFCL K
Sbjct: 418 ---------------------SSMNGGKKSSSLIGIIVFSVIGGVFVIFLIGLLVFCLYK 456
Query: 516 KKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQM 575
+KQKRF+RVQSPNAMVIHPRHSGS+N +SVKITVAGS+VSVGAISETHT PSSEP DIQM
Sbjct: 457 RKQKRFTRVQSPNAMVIHPRHSGSDN-DSVKITVAGSSVSVGAISETHTHPSSEPNDIQM 515
Query: 576 LEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGL 635
+EAGNMVISIQVLRNVTNNFSEENILG+GGFGTVY+GELHDGTKIAVKRME+GVI+GKGL
Sbjct: 516 VEAGNMVISIQVLRNVTNNFSEENILGQGGFGTVYRGELHDGTKIAVKRMESGVITGKGL 575
Query: 636 TEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEW 695
EFKSEIAVLTKVRHRHLVALLG+CLDGNEKLLV+EYMPQGTLSRH+F+W EEG+KPLEW
Sbjct: 576 AEFKSEIAVLTKVRHRHLVALLGYCLDGNEKLLVYEYMPQGTLSRHLFSWPEEGIKPLEW 635
Query: 696 NRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755
RRL IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS
Sbjct: 636 TRRLAIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 695
Query: 756 IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWF 815
IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWF
Sbjct: 696 IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWF 755
Query: 816 RRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875
+R+H++KD+F KAIDPTID++E LASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV
Sbjct: 756 KRMHINKDTFRKAIDPTIDVDEETLASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 815
Query: 876 ELWKPTDQNSEDIYGIDLEMSLPQALKKWQAYEGRSYME-SSSSSLLPSLDNTQTSIPTR 934
ELWKP DQN+EDIYGIDL+MSLPQALKKWQA+EGRS+M+ SSSSS L SLDNTQTSIPTR
Sbjct: 816 ELWKPVDQNTEDIYGIDLDMSLPQALKKWQAFEGRSHMDSSSSSSFLASLDNTQTSIPTR 875
Query: 935 PYGFAESFKSADGR 948
PYGFAESF SADGR
Sbjct: 876 PYGFAESFTSADGR 889
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351727489|ref|NP_001238698.1| NAK-type protein kinase precursor [Glycine max] gi|223452361|gb|ACM89508.1| NAK-type protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1422 bits (3682), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 703/924 (76%), Positives = 794/924 (85%), Gaps = 9/924 (0%)
Query: 29 DDGDAAVMLALKKSLNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNL 88
D DA+VMLALK SLNPP GWSD DPCKW V+C +DKR+TRIQIG NLQGTLP+ L
Sbjct: 23 DYDDASVMLALKNSLNPP---GWSDPDPCKWARVLCSDDKRVTRIQIGRLNLQGTLPTTL 79
Query: 89 QNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148
Q LT LE LELQ+N+ISGPLPSLNGL SL V + SNN+F++VP+DFF G+S LQ++EID+
Sbjct: 80 QKLTHLEHLELQYNNISGPLPSLNGLTSLRVFLASNNRFSAVPADFFAGMSQLQAVEIDS 139
Query: 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPA 208
NPF WEIPQSLRNASGLQNFSANSAN+ G IP FFG D FPGLT+LHLA N L G LP
Sbjct: 140 NPFEPWEIPQSLRNASGLQNFSANSANVGGSIPEFFGSDVFPGLTLLHLAMNNLEGTLPL 199
Query: 209 SFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESL 268
SFSGSQIQSLW+NGQ KLGG ++V+QNMT L ++WL SNAF+GPLPD SG+K L L
Sbjct: 200 SFSGSQIQSLWLNGQKSVNKLGGSVEVLQNMTFLTDVWLQSNAFTGPLPDLSGLKSLRDL 259
Query: 269 SLRDNFFTGPVP-DSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPG 327
SLRDN FTGPVP S V L++LK+VN+TNNL QGP+P F V +D K SN+FCLPSPG
Sbjct: 260 SLRDNRFTGPVPVASFVGLKTLKVVNLTNNLFQGPMPVFGDGVVVDNVKDSNSFCLPSPG 319
Query: 328 ACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTIS 387
CDPR++ LLSVV +MGYP RFAE+WKGNDPC+ WIG+TC+ G ITV+NFQKM L+G IS
Sbjct: 320 DCDPRVDVLLSVVGVMGYPPRFAESWKGNDPCAYWIGITCSNGYITVVNFQKMELSGVIS 379
Query: 388 PEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDG 447
PEFA KSLQR++LADNNL+G IPE L+ L AL +L+V+NNQLYGK+PSF+ N +V+T+G
Sbjct: 380 PEFAKLKSLQRIVLADNNLTGSIPEELATLPALTQLNVANNQLYGKVPSFRKNVVVSTNG 439
Query: 448 NPDIGKEKSS-SFQG-SPSGSPTGTGSGNASSTENGVKNSSALITVILFCVIGGAFVISL 505
N DIGK+KSS S QG P +P G S G K SS+ + VI+F VIG FV+S+
Sbjct: 440 NTDIGKDKSSLSPQGLVPPMAPNAKGDSGGVSGIGG-KKSSSHVGVIVFSVIGAVFVVSM 498
Query: 506 TGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTV 565
G LVFCL + KQK+ SRVQSPNA+VIHPRHSGS+N ESVKITVAGS+VSVGA SET TV
Sbjct: 499 IGFLVFCLFRMKQKKLSRVQSPNALVIHPRHSGSDN-ESVKITVAGSSVSVGAASETRTV 557
Query: 566 PSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRM 625
P SE DIQM+EAGNMVISIQVL+NVT+NFSE+N+LG+GGFGTVY+GELHDGT+IAVKRM
Sbjct: 558 PGSEASDIQMVEAGNMVISIQVLKNVTDNFSEKNVLGQGGFGTVYRGELHDGTRIAVKRM 617
Query: 626 EAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW 685
E G I+GKG EFKSEIAVLTKVRHRHLV+LLG+CLDGNEKLLV+EYMPQGTLSRH+F+W
Sbjct: 618 ECGAIAGKGAAEFKSEIAVLTKVRHRHLVSLLGYCLDGNEKLLVYEYMPQGTLSRHLFDW 677
Query: 686 AEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745
EEGL+PLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL
Sbjct: 678 PEEGLEPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 737
Query: 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQP 805
VRLAPEGK SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDE+QP
Sbjct: 738 VRLAPEGKASIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDETQP 797
Query: 806 EESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMG 865
E+SMHLVTWFRR+ ++KDSF KAID TI+LNE LASI TVAELAGHC AREPYQRPDMG
Sbjct: 798 EDSMHLVTWFRRMSINKDSFRKAIDSTIELNEETLASIHTVAELAGHCGAREPYQRPDMG 857
Query: 866 HAVNVLSSLVELWKPTDQNSEDIYGIDLEMSLPQALKKWQAYEGRSYME-SSSSSLLPSL 924
HAVNVLSSLVELWKP+DQNSEDIYGIDL+MSLPQALKKWQAYEGRS ME S+SSSLLPSL
Sbjct: 858 HAVNVLSSLVELWKPSDQNSEDIYGIDLDMSLPQALKKWQAYEGRSQMESSASSSLLPSL 917
Query: 925 DNTQTSIPTRPYGFAESFKSADGR 948
DNTQTSIPTRPYGFA+SF SADGR
Sbjct: 918 DNTQTSIPTRPYGFADSFTSADGR 941
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15218941|ref|NP_176789.1| putative receptor protein kinase TMK1 [Arabidopsis thaliana] gi|1174718|sp|P43298.1|TMK1_ARATH RecName: Full=Probable receptor protein kinase TMK1; Flags: Precursor gi|12322608|gb|AAG51302.1|AC026480_9 receptor protein kinase (TMK1), putative [Arabidopsis thaliana] gi|166888|gb|AAA32876.1| protein kinase [Arabidopsis thaliana] gi|332196347|gb|AEE34468.1| putative receptor protein kinase TMK1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1386 bits (3587), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 692/923 (74%), Positives = 793/923 (85%), Gaps = 10/923 (1%)
Query: 30 DGDAAVMLALKKSLNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQ 89
DGD + ML+LKKSLNPP S GWSD DPCKW H+VC KR+TRIQIGH LQGTL +L+
Sbjct: 26 DGDLSAMLSLKKSLNPPSSFGWSDPDPCKWTHIVCTGTKRVTRIQIGHSGLQGTLSPDLR 85
Query: 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149
NL++LERLELQWN+ISGP+PSL+GLASL+V+MLSNN F S+PSD F GL+SLQS+EIDNN
Sbjct: 86 NLSELERLELQWNNISGPVPSLSGLASLQVLMLSNNNFDSIPSDVFQGLTSLQSVEIDNN 145
Query: 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS 209
PF SWEIP+SLRNAS LQNFSANSAN++G +P F GPDEFPGL+ILHLAFN L G LP S
Sbjct: 146 PFKSWEIPESLRNASALQNFSANSANVSGSLPGFLGPDEFPGLSILHLAFNNLEGELPMS 205
Query: 210 FSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLS 269
+GSQ+QSLW+NGQ KL G I V+QNMT LKE+WLHSN FSGPLPDFSG+K+LESLS
Sbjct: 206 LAGSQVQSLWLNGQ----KLTGDITVLQNMTGLKEVWLHSNKFSGPLPDFSGLKELESLS 261
Query: 270 LRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGAC 329
LRDN FTGPVP SL+ LESLK+VN+TNN LQGPVP F SVS+D+ K SN+FCL SPG C
Sbjct: 262 LRDNSFTGPVPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKDSNSFCLSSPGEC 321
Query: 330 DPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE 389
DPR+ +LL + YP R AE+WKGNDPC++WIG+ C+ GNITVI+ +KM LTGTISPE
Sbjct: 322 DPRVKSLLLIASSFDYPPRLAESWKGNDPCTNWIGIACSNGNITVISLEKMELTGTISPE 381
Query: 390 FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGNP 449
F + KSLQR+IL NNL+GMIP+ L+ L LK LDVS+N+L+GK+P F+SN +VNT+GNP
Sbjct: 382 FGAIKSLQRIILGINNLTGMIPQELTTLPNLKTLDVSSNKLFGKVPGFRSNVVVNTNGNP 441
Query: 450 DIGKEKSSSFQGSPSGSPTGTGSG-NASSTENGVKNSSALITVILFCVIGGAFVISLTGV 508
DIGK+KSS S G+GSG N G+K SS I +I+ V+GG I L G+
Sbjct: 442 DIGKDKSSLSSPGSSSPSGGSGSGINGDKDRRGMK-SSTFIGIIVGSVLGGLLSIFLIGL 500
Query: 509 LVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVP-S 567
LVFC KK+QKRFS +S NA+V+HPRHSGS+N ESVKITVAGS+VSVG IS+T+T+P +
Sbjct: 501 LVFCWYKKRQKRFSGSESSNAVVVHPRHSGSDN-ESVKITVAGSSVSVGGISDTYTLPGT 559
Query: 568 SEPGD-IQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRME 626
SE GD IQM+EAGNM+ISIQVLR+VTNNFS +NILG GGFG VYKGELHDGTKIAVKRME
Sbjct: 560 SEVGDNIQMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGTKIAVKRME 619
Query: 627 AGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA 686
GVI+GKG EFKSEIAVLTKVRHRHLV LLG+CLDGNEKLLV+EYMPQGTLSRH+F W+
Sbjct: 620 NGVIAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLSRHLFEWS 679
Query: 687 EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746
EEGLKPL W +RLT+ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV
Sbjct: 680 EEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 739
Query: 747 RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPE 806
RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDV+SFGVILMELITGRK+LDESQPE
Sbjct: 740 RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVYSFGVILMELITGRKSLDESQPE 799
Query: 807 ESMHLVTWFRRIHLSKD-SFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMG 865
ES+HLV+WF+R++++K+ SF KAID TIDL+E LAS+ TVAELAGHCCAREPYQRPDMG
Sbjct: 800 ESIHLVSWFKRMYINKEASFKKAIDTTIDLDEETLASVHTVAELAGHCCAREPYQRPDMG 859
Query: 866 HAVNVLSSLVELWKPTDQNSEDIYGIDLEMSLPQALKKWQAYEGRSYMESSSSSLLPSLD 925
HAVN+LSSLVELWKP+DQN EDIYGIDL+MSLPQALKKWQAYEGRS +ESS+SSLLPSLD
Sbjct: 860 HAVNILSSLVELWKPSDQNPEDIYGIDLDMSLPQALKKWQAYEGRSDLESSTSSLLPSLD 919
Query: 926 NTQTSIPTRPYGFAESFKSADGR 948
NTQ SIPTRPYGFAESF S DGR
Sbjct: 920 NTQMSIPTRPYGFAESFTSVDGR 942
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|29824403|gb|AAP04161.1| putative receptor protein kinase (TMK1) [Arabidopsis thaliana] gi|110737237|dbj|BAF00566.1| putative receptor protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1385 bits (3584), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 691/923 (74%), Positives = 793/923 (85%), Gaps = 10/923 (1%)
Query: 30 DGDAAVMLALKKSLNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQ 89
DGD + ML+LKKSLNPP S GWSD DPCKW H+VC KR+TRIQIGH LQGTL +L+
Sbjct: 26 DGDLSAMLSLKKSLNPPSSFGWSDPDPCKWTHIVCTGTKRVTRIQIGHSGLQGTLSPDLR 85
Query: 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149
NL++LERLELQWN+ISGP+PSL+GLASL+V+MLSNN F S+PSD F GL+SLQS+EIDNN
Sbjct: 86 NLSELERLELQWNNISGPVPSLSGLASLQVLMLSNNNFDSIPSDVFQGLTSLQSVEIDNN 145
Query: 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS 209
PF SWEIP+SLRNAS LQNFSANSAN++G +P F GPDEFPGL+ILHLAFN L G LP S
Sbjct: 146 PFKSWEIPESLRNASALQNFSANSANVSGSLPGFLGPDEFPGLSILHLAFNNLEGELPMS 205
Query: 210 FSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLS 269
+GSQ+QSLW+NGQ KL G I V+QNMT LKE+WLHSN FSGPLPDFSG+K+LESLS
Sbjct: 206 LAGSQVQSLWLNGQ----KLTGDITVLQNMTGLKEVWLHSNKFSGPLPDFSGLKELESLS 261
Query: 270 LRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGAC 329
LRDN FTGPVP SL+ LESLK+VN+TNN LQGPVP F SVS+D+ K SN+FCL SPG C
Sbjct: 262 LRDNSFTGPVPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKDSNSFCLSSPGEC 321
Query: 330 DPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE 389
DPR+ +LL + YP R AE+WKGNDPC++WIG+ C+ GNITVI+ +KM LTGTISPE
Sbjct: 322 DPRVKSLLLIASSFDYPPRLAESWKGNDPCTNWIGIACSNGNITVISLEKMELTGTISPE 381
Query: 390 FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGNP 449
F + KSLQR+IL NNL+GMIP+ L+ L LK LDVS+N+L+GK+P F+SN +VNT+GNP
Sbjct: 382 FGAIKSLQRIILGINNLTGMIPQELTTLPNLKTLDVSSNKLFGKVPGFRSNVVVNTNGNP 441
Query: 450 DIGKEKSSSFQGSPSGSPTGTGSG-NASSTENGVKNSSALITVILFCVIGGAFVISLTGV 508
DIGK+KSS S G+GSG N G+K SS I +I+ V+GG I L G+
Sbjct: 442 DIGKDKSSLSSPGSSSPSGGSGSGINGDKDRRGMK-SSTFIGIIVGSVLGGLLSIFLIGL 500
Query: 509 LVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVP-S 567
LVFC KK+QKRFS +S NA+V+HPRHSGS+N ESVKITVAGS+VSVG IS+T+T+P +
Sbjct: 501 LVFCWYKKRQKRFSGSESSNAVVVHPRHSGSDN-ESVKITVAGSSVSVGGISDTYTLPGT 559
Query: 568 SEPGD-IQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRME 626
SE GD IQM+EAGNM+ISIQVLR+VTNNFS +NILG GGFG VYKGELHDGTKIAVKRME
Sbjct: 560 SEVGDNIQMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGTKIAVKRME 619
Query: 627 AGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA 686
GVI+GKG EFKSEIAVLTKVRHRHLV LLG+CLDGNEKLLV+EYMPQGTLSRH+F W+
Sbjct: 620 NGVIAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLSRHLFEWS 679
Query: 687 EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746
EEGLKPL W +RLT+ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV
Sbjct: 680 EEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 739
Query: 747 RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPE 806
RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDV+SFGVILMELITGRK+LDESQPE
Sbjct: 740 RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVYSFGVILMELITGRKSLDESQPE 799
Query: 807 ESMHLVTWFRRIHLSKD-SFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMG 865
ES+HLV+WF+R++++K+ SF KAID TIDL+E LAS+ TVAELAGHCC+REPYQRPDMG
Sbjct: 800 ESIHLVSWFKRMYINKEASFKKAIDTTIDLDEETLASVHTVAELAGHCCSREPYQRPDMG 859
Query: 866 HAVNVLSSLVELWKPTDQNSEDIYGIDLEMSLPQALKKWQAYEGRSYMESSSSSLLPSLD 925
HAVN+LSSLVELWKP+DQN EDIYGIDL+MSLPQALKKWQAYEGRS +ESS+SSLLPSLD
Sbjct: 860 HAVNILSSLVELWKPSDQNPEDIYGIDLDMSLPQALKKWQAYEGRSDLESSTSSLLPSLD 919
Query: 926 NTQTSIPTRPYGFAESFKSADGR 948
NTQ SIPTRPYGFAESF S DGR
Sbjct: 920 NTQMSIPTRPYGFAESFTSVDGR 942
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224589461|gb|ACN59264.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1384 bits (3583), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 691/923 (74%), Positives = 792/923 (85%), Gaps = 10/923 (1%)
Query: 30 DGDAAVMLALKKSLNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQ 89
DGD + ML+LKKSLNPP S GWSD DPCKW H+VC KR+TRIQIGH LQGTL +L+
Sbjct: 26 DGDLSAMLSLKKSLNPPSSFGWSDPDPCKWTHIVCTGTKRVTRIQIGHSGLQGTLSPDLR 85
Query: 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149
NL++LERLELQWN+ISGP+PSL+GLASL+V+MLSNN F S+PSD F GL+SLQS+EIDNN
Sbjct: 86 NLSELERLELQWNNISGPVPSLSGLASLQVLMLSNNNFDSIPSDVFQGLTSLQSVEIDNN 145
Query: 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS 209
PF SWEIP+SLRNAS LQNFSANSAN++G +P F GPDEFPGL+ILHLAFN L G LP S
Sbjct: 146 PFKSWEIPESLRNASALQNFSANSANVSGSLPGFLGPDEFPGLSILHLAFNNLEGELPMS 205
Query: 210 FSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLS 269
+GSQ+QSLW+NGQ KL G I V+QNMT LKE+WLHSN FSGPLPDFSG+K+LESLS
Sbjct: 206 LAGSQVQSLWLNGQ----KLTGDITVLQNMTGLKEVWLHSNKFSGPLPDFSGLKELESLS 261
Query: 270 LRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGAC 329
LRDN FTGPVP SL+ LESLK+VN+TNN LQGPVP F SVS+D+ K SN+FCL SPG C
Sbjct: 262 LRDNSFTGPVPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKDSNSFCLSSPGEC 321
Query: 330 DPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE 389
DPR+ +LL + YP R AE+WKGNDPC++WIG+ C+ GNITVI+ +KM LTGTISPE
Sbjct: 322 DPRVKSLLLIASSFDYPPRLAESWKGNDPCTNWIGIACSNGNITVISLEKMELTGTISPE 381
Query: 390 FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGNP 449
F + KSLQR+IL NNL+GMIP+ L+ L LK LDVS+N+L+GK+P F+SN +VNT+GNP
Sbjct: 382 FGAIKSLQRIILGINNLTGMIPQELTTLPNLKTLDVSSNKLFGKVPGFRSNVVVNTNGNP 441
Query: 450 DIGKEKSSSFQGSPSGSPTGTGSG-NASSTENGVKNSSALITVILFCVIGGAFVISLTGV 508
DIGK+KSS S G+GSG N G+K SS I +I+ V+GG I L G+
Sbjct: 442 DIGKDKSSLSSPGSSSPSGGSGSGINGDKDRRGMK-SSTFIGIIVGSVLGGLLSIFLIGL 500
Query: 509 LVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVP-S 567
LVFC KK+QKRFS +S NA+V+HPRHSGS+N ESVKITVAGS+VSVG IS+T+T+P +
Sbjct: 501 LVFCWYKKRQKRFSGSESSNAVVVHPRHSGSDN-ESVKITVAGSSVSVGGISDTYTLPGT 559
Query: 568 SEPGD-IQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRME 626
SE GD IQM+EAGNM+ISIQVLR+VTNNFS +NILG GGFG VYKGELHDGTKIAVKRME
Sbjct: 560 SEVGDNIQMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGTKIAVKRME 619
Query: 627 AGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA 686
GVI+GKG EFKSEIAVLTKVRHRHLV LLG+CLDGNEKLLV+EYMPQGTLSRH+F W+
Sbjct: 620 NGVIAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLSRHLFEWS 679
Query: 687 EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746
EEGLKPL W +RLT+ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV
Sbjct: 680 EEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 739
Query: 747 RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPE 806
RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDV+SFGVILMELITGRK+LDESQPE
Sbjct: 740 RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVYSFGVILMELITGRKSLDESQPE 799
Query: 807 ESMHLVTWFRRIHLSKD-SFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMG 865
ES+HLV+WF+R++++K+ SF KAID TIDL+E LAS+ TVAELAGHCCAREPYQRPDMG
Sbjct: 800 ESIHLVSWFKRMYINKEASFKKAIDTTIDLDEETLASVHTVAELAGHCCAREPYQRPDMG 859
Query: 866 HAVNVLSSLVELWKPTDQNSEDIYGIDLEMSLPQALKKWQAYEGRSYMESSSSSLLPSLD 925
HAVN+LSSLVELWKP+DQN EDIYGIDL+MSLPQALKKWQAYEGR +ESS+SSLLPSLD
Sbjct: 860 HAVNILSSLVELWKPSDQNPEDIYGIDLDMSLPQALKKWQAYEGRGDLESSTSSLLPSLD 919
Query: 926 NTQTSIPTRPYGFAESFKSADGR 948
NTQ SIPTRPYGFAESF S DGR
Sbjct: 920 NTQMSIPTRPYGFAESFTSVDGR 942
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297838257|ref|XP_002887010.1| hypothetical protein ARALYDRAFT_475717 [Arabidopsis lyrata subsp. lyrata] gi|297332851|gb|EFH63269.1| hypothetical protein ARALYDRAFT_475717 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1382 bits (3576), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 690/933 (73%), Positives = 798/933 (85%), Gaps = 10/933 (1%)
Query: 20 SILFVSASGDDGDAAVMLALKKSLNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQN 79
S F+ S DGD + M++LKKSLNPP S GWSD DPCKW H+VC KR+TRIQIGH
Sbjct: 11 SFTFLLKSDSDGDLSAMISLKKSLNPPSSFGWSDPDPCKWTHIVCTGTKRVTRIQIGHSG 70
Query: 80 LQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLS 139
LQGTL +L+NL++LERLELQWN+ISGP+PSL+GLASL+V+MLSNN F S+PSD F GL+
Sbjct: 71 LQGTLSPDLRNLSELERLELQWNNISGPVPSLSGLASLQVLMLSNNNFDSIPSDVFEGLT 130
Query: 140 SLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAF 199
SLQS+EIDNNPF +WEIP+SLRNAS LQNFSANSAN++G++P FFGPDEFPGL+ILHLAF
Sbjct: 131 SLQSVEIDNNPFKAWEIPESLRNASALQNFSANSANVSGKLPGFFGPDEFPGLSILHLAF 190
Query: 200 NQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDF 259
N L G LP S +GSQ+QSLW+NGQ KL G I+V+QNMT LKE+WLHSN FSGPLPDF
Sbjct: 191 NSLGGELPLSLAGSQVQSLWLNGQ----KLTGEINVLQNMTGLKEVWLHSNVFSGPLPDF 246
Query: 260 SGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSN 319
SG+K+LESLSLRDN FTGPVP SL+ LESLK++N+TNN LQGPVP F SVS+D+ K SN
Sbjct: 247 SGLKELESLSLRDNAFTGPVPTSLLSLESLKVLNLTNNHLQGPVPVFKSSVSVDLDKDSN 306
Query: 320 NFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQK 379
+FCLPSP CD R+ +LL + YPQR AE+WKGNDPC++WIG+ C+ GNITVIN +K
Sbjct: 307 SFCLPSPDECDSRVKSLLLIASSFDYPQRLAESWKGNDPCTNWIGIACSNGNITVINLEK 366
Query: 380 MNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS 439
M LTGTISPEF S KSLQR+IL NNL+G IP+ L+ L LK LDVS+N+L+GK+P F+S
Sbjct: 367 MGLTGTISPEFGSIKSLQRIILGINNLTGTIPQELTTLPNLKTLDVSSNKLFGKVPGFRS 426
Query: 440 NAIVNTDGNPDIGKEKSSSFQGSPSGSPTGTGSG-NASSTENGVKNSSALITVILFCVIG 498
N +V+T+GNPDIGK+KSS S G+GSG N G+K SS I +++ V+G
Sbjct: 427 NVVVSTNGNPDIGKDKSSLPSPGSSSPSGGSGSGINGDKDRRGMK-SSTFIGIVVGSVLG 485
Query: 499 GAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGA 558
G I + G+LVFC KK+QK +R +S NA+V+HPRHSGS+N ESVKITVAGS+VSVG
Sbjct: 486 GLLSIFMIGLLVFCWYKKRQKCNTRGESSNAVVVHPRHSGSDN-ESVKITVAGSSVSVGG 544
Query: 559 ISETHTVP-SSEPGD-IQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHD 616
IS+T+T+P +SE GD IQM+EAGNM+ISIQVLR+VTNNFS +NILG GGFG VYKGELHD
Sbjct: 545 ISDTYTLPGTSEVGDNIQMVEAGNMLISIQVLRSVTNNFSADNILGSGGFGVVYKGELHD 604
Query: 617 GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676
GTKIAVKRME GVI GKG EFKSEIAVLTKVRHRHLV LLG+CLDGNEKLLV+EYMPQG
Sbjct: 605 GTKIAVKRMENGVIVGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQG 664
Query: 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 736
TLSRH+F W+EEGLKPL W +RLT+ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM
Sbjct: 665 TLSRHLFEWSEEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 724
Query: 737 RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG 796
RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDV+SFGVILMELITG
Sbjct: 725 RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVYSFGVILMELITG 784
Query: 797 RKALDESQPEESMHLVTWFRRIHLSKD-SFHKAIDPTIDLNEGILASISTVAELAGHCCA 855
RK+LDESQPEES+HLV+WF+R++++K+ SF KAIDPTIDL+E LAS+ TVAELAGHCCA
Sbjct: 785 RKSLDESQPEESIHLVSWFKRMYINKESSFKKAIDPTIDLDEETLASVHTVAELAGHCCA 844
Query: 856 REPYQRPDMGHAVNVLSSLVELWKPTDQNSEDIYGIDLEMSLPQALKKWQAYEGRSYMES 915
REPYQRPDMGHAVN+LSSLVELWKP+DQN EDIYGIDL+MSLPQALKKWQAYEGRS +ES
Sbjct: 845 REPYQRPDMGHAVNILSSLVELWKPSDQNPEDIYGIDLDMSLPQALKKWQAYEGRSDLES 904
Query: 916 SSSSLLPSLDNTQTSIPTRPYGFAESFKSADGR 948
S+SSLLPSLDNTQ SIPTRPYGFAESF S DGR
Sbjct: 905 STSSLLPSLDNTQMSIPTRPYGFAESFTSVDGR 937
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 948 | ||||||
| TAIR|locus:2013825 | 942 | TMK1 "transmembrane kinase 1" | 0.976 | 0.983 | 0.723 | 0.0 | |
| TAIR|locus:2059703 | 943 | AT2G01820 [Arabidopsis thalian | 0.956 | 0.961 | 0.587 | 2.9e-286 | |
| TAIR|locus:2024016 | 886 | AT1G24650 [Arabidopsis thalian | 0.449 | 0.480 | 0.626 | 2.3e-251 | |
| TAIR|locus:2095188 | 928 | AT3G23750 [Arabidopsis thalian | 0.963 | 0.983 | 0.472 | 7.3e-217 | |
| TAIR|locus:2156992 | 946 | AT5G49770 [Arabidopsis thalian | 0.304 | 0.305 | 0.409 | 1.3e-81 | |
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.301 | 0.285 | 0.400 | 1.6e-80 | |
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.303 | 0.302 | 0.407 | 2.5e-79 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.319 | 0.289 | 0.408 | 3.7e-79 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.318 | 0.233 | 0.387 | 8.5e-79 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.304 | 0.288 | 0.393 | 1.1e-78 |
| TAIR|locus:2013825 TMK1 "transmembrane kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3543 (1252.3 bits), Expect = 0., P = 0.
Identities = 676/934 (72%), Positives = 777/934 (83%)
Query: 18 FCSILFVSASGDDGDAAVMLALKKSLNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGH 77
F +L +S + DGD + ML+LKKSLNPP S GWSD DPCKW H+VC KR+TRIQIGH
Sbjct: 14 FLLLLSLSKADSDGDLSAMLSLKKSLNPPSSFGWSDPDPCKWTHIVCTGTKRVTRIQIGH 73
Query: 78 QNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTG 137
LQGTL +L+NL++LERLELQWN+ISGP+PSL+GLASL+V+MLSNN F S+PSD F G
Sbjct: 74 SGLQGTLSPDLRNLSELERLELQWNNISGPVPSLSGLASLQVLMLSNNNFDSIPSDVFQG 133
Query: 138 LSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHL 197
L+SLQS+EIDNNPF SWEIP+SLRNAS LQNFSANSAN++G +P F GPDEFPGL+ILHL
Sbjct: 134 LTSLQSVEIDNNPFKSWEIPESLRNASALQNFSANSANVSGSLPGFLGPDEFPGLSILHL 193
Query: 198 AFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP 257
AFN L G LP S +GSQ+QSLW+NGQ KL G I V+QNMT LKE+WLHSN FSGPLP
Sbjct: 194 AFNNLEGELPMSLAGSQVQSLWLNGQ----KLTGDITVLQNMTGLKEVWLHSNKFSGPLP 249
Query: 258 DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKG 317
DFSG+K+LESLSLRDN FTGPVP SL+ LESLK+VN+TNN LQGPVP F SVS+D+ K
Sbjct: 250 DFSGLKELESLSLRDNSFTGPVPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKD 309
Query: 318 SNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINF 377
SN+FCL SPG CDPR+ +LL + YP R AE+WKGNDPC++WIG+ C+ GNITVI+
Sbjct: 310 SNSFCLSSPGECDPRVKSLLLIASSFDYPPRLAESWKGNDPCTNWIGIACSNGNITVISL 369
Query: 378 QKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSF 437
+KM LTGTISPEF + KSLQR+IL NNL+GMIP+ L+ L LK LDVS+N+L+GK+P F
Sbjct: 370 EKMELTGTISPEFGAIKSLQRIILGINNLTGMIPQELTTLPNLKTLDVSSNKLFGKVPGF 429
Query: 438 KSNAIVNTDGNPDIGKEKXXXXXXXXXXXXXXXXXXXXXXXXXXVKNSSALITVILFCVI 497
+SN +VNT+GNPDIGK+K SS I +I+ V+
Sbjct: 430 RSNVVVNTNGNPDIGKDKSSLSSPGSSSPSGGSGSGINGDKDRRGMKSSTFIGIIVGSVL 489
Query: 498 GGAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVG 557
GG I L G+LVFC KK+QKRFS +S NA+V+HPRHSGS+N ESVKITVAGS+VSVG
Sbjct: 490 GGLLSIFLIGLLVFCWYKKRQKRFSGSESSNAVVVHPRHSGSDN-ESVKITVAGSSVSVG 548
Query: 558 AISETHTVP-SSEPGD-IQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELH 615
IS+T+T+P +SE GD IQM+EAGNM+ISIQVLR+VTNNFS +NILG GGFG VYKGELH
Sbjct: 549 GISDTYTLPGTSEVGDNIQMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELH 608
Query: 616 DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675
DGTKIAVKRME GVI+GKG EFKSEIAVLTKVRHRHLV LLG+CLDGNEKLLV+EYMPQ
Sbjct: 609 DGTKIAVKRMENGVIAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQ 668
Query: 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 735
GTLSRH+F W+EEGLKPL W +RLT+ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD
Sbjct: 669 GTLSRHLFEWSEEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 728
Query: 736 MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDV+SFGVILMELIT
Sbjct: 729 MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVYSFGVILMELIT 788
Query: 796 GRKALDESQPEESMHLVTWFRRIHLSKD-SFHKAIDPTIDLNEGILASISTVAELAGHCC 854
GRK+LDESQPEES+HLV+WF+R++++K+ SF KAID TIDL+E LAS+ TVAELAGHCC
Sbjct: 789 GRKSLDESQPEESIHLVSWFKRMYINKEASFKKAIDTTIDLDEETLASVHTVAELAGHCC 848
Query: 855 AREPYQRPDMGHAVNVLSSLVELWKPTDQNSEDIYGIDLEMSLPQALKKWQAYEGRSYME 914
AREPYQRPDMGHAVN+LSSLVELWKP+DQN EDIYGIDL+MSLPQALKKWQAYEGRS +E
Sbjct: 849 AREPYQRPDMGHAVNILSSLVELWKPSDQNPEDIYGIDLDMSLPQALKKWQAYEGRSDLE 908
Query: 915 XXXXXXXXXXDNTQTSIPTRPYGFAESFKSADGR 948
DNTQ SIPTRPYGFAESF S DGR
Sbjct: 909 SSTSSLLPSLDNTQMSIPTRPYGFAESFTSVDGR 942
|
|
| TAIR|locus:2059703 AT2G01820 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2750 (973.1 bits), Expect = 2.9e-286, P = 2.9e-286
Identities = 543/925 (58%), Positives = 674/925 (72%)
Query: 32 DAAVMLALKKSLNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNL 91
D + M +LK SLN + WS+ +PCKW V C R+T+IQ+ + ++GTLP+NLQ+L
Sbjct: 29 DDSTMQSLKSSLNLTSDVDWSNPNPCKWQSVQCDGSNRVTKIQLKQKGIRGTLPTNLQSL 88
Query: 92 TKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPF 151
++L LEL N ISGP+P L+GL+ L+ + L +N FTSVP + F+G+SSLQ + ++NNPF
Sbjct: 89 SELVILELFLNRISGPIPDLSGLSRLQTLNLHDNLFTSVPKNLFSGMSSLQEMYLENNPF 148
Query: 152 SSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFS 211
W IP +++ A+ LQN + ++ +I G+IP FFG P LT L L+ N L G LP SF+
Sbjct: 149 DPWVIPDTVKEATSLQNLTLSNCSIIGKIPDFFGSQSLPSLTNLKLSQNGLEGELPMSFA 208
Query: 212 GSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLR 271
G+ IQSL++NGQ KL G I V+ NMTSL E+ L N FSGP+PD SG+ L ++R
Sbjct: 209 GTSIQSLFLNGQ----KLNGSISVLGNMTSLVEVSLQGNQFSGPIPDLSGLVSLRVFNVR 264
Query: 272 DNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPG-ACD 330
+N TG VP SLV L SL VN+TNN LQGP P F +SV +D+ N+FC G ACD
Sbjct: 265 ENQLTGVVPQSLVSLSSLTTVNLTNNYLQGPTPLFGKSVGVDIVNNMNSFCTNVAGEACD 324
Query: 331 PRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEF 390
PR++ L+SV + GYP + AE+WKGN+PC +W+G+TC+ GNITV+N +K +L+GTISP
Sbjct: 325 PRVDTLVSVAESFGYPVKLAESWKGNNPCVNWVGITCSGGNITVVNMRKQDLSGTISPSL 384
Query: 391 ASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGNPD 450
A SL+ + LADN LSG IP+ L+ L L+ LDVSNN YG P F+ + T+GN +
Sbjct: 385 AKLTSLETINLADNKLSGHIPDELTTLSKLRLLDVSNNDFYGIPPKFRDTVTLVTEGNAN 444
Query: 451 IGKEKXXXXXXXXXXXXXXXXXXXXXXXXXXVKNSSALITVILFCVIGGAF-VISLTGVL 509
+GK K+S+ I V V+GG + L G+
Sbjct: 445 MGKNGPNKTSDAPGASPGSKPSGGSDGSETSKKSSNVKIIVP---VVGGVVGALCLVGLG 501
Query: 510 VFCLCKKKQKRFSRVQSPNA-MVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSS 568
V CL KK+KR +RVQSP++ MVIHP HSG +++ +K+TVA S+++ G S++++ S
Sbjct: 502 V-CLYAKKRKRPARVQSPSSNMVIHPHHSG--DNDDIKLTVAASSLNSGGGSDSYSHSGS 558
Query: 569 EPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAG 628
DI ++EAGN+VISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRME+
Sbjct: 559 AASDIHVVEAGNLVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMESS 618
Query: 629 VISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE 688
V+S KGLTEFKSEI VLTK+RHRHLVALLG+CLDGNE+LLV+EYMPQGTLS+H+F+W EE
Sbjct: 619 VVSDKGLTEFKSEITVLTKMRHRHLVALLGYCLDGNERLLVYEYMPQGTLSQHLFHWKEE 678
Query: 689 GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748
G KPL+W RRL IALDVARGVEYLH LAHQSFIHRDLKPSNILLGDDMRAKV+DFGLVRL
Sbjct: 679 GRKPLDWTRRLAIALDVARGVEYLHTLAHQSFIHRDLKPSNILLGDDMRAKVSDFGLVRL 738
Query: 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEES 808
AP+GK SIETR+AGTFGYLAPEYAVTGRVTTKVD+FS GVILMELITGRKALDE+QPE+S
Sbjct: 739 APDGKYSIETRVAGTFGYLAPEYAVTGRVTTKVDIFSLGVILMELITGRKALDETQPEDS 798
Query: 809 MHLVTWFRRIHLSKD--SFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGH 866
+HLVTWFRR+ SKD +F AIDP I L++ +ASI V ELAGHCCAREPYQRPDM H
Sbjct: 799 VHLVTWFRRVAASKDENAFKNAIDPNISLDDDTVASIEKVWELAGHCCAREPYQRPDMAH 858
Query: 867 AVNVLSSLVELWKPTDQNSEDIYGIDLEMSLPQALKKWQAYEGRSYM---EXXXXXXXXX 923
VNVLSSL WKPT+ + +D+YGID +M LPQ LKKWQA+EG S
Sbjct: 859 IVNVLSSLTVQWKPTETDPDDVYGIDYDMPLPQVLKKWQAFEGLSQTADDSGSSSSAYGS 918
Query: 924 XDNTQTSIPTRPYGFAESFKSADGR 948
DNTQTSIPTRP GFA+SF S DGR
Sbjct: 919 KDNTQTSIPTRPSGFADSFTSVDGR 943
|
|
| TAIR|locus:2024016 AT1G24650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1338 (476.1 bits), Expect = 2.3e-251, Sum P(2) = 2.3e-251
Identities = 283/452 (62%), Positives = 332/452 (73%)
Query: 499 GAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGA 558
G V S+ G+L+ L F + +HP+ S+ ++ KIT+ N+ G
Sbjct: 459 GKIVGSVIGILLALLLIGVAIFFLVKKKMQYHKMHPQQQSSDQ-DAFKITI--ENLCTG- 514
Query: 559 ISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGT 618
+SE+ D + EAGN+VISIQVLR+ T NF E+NILGRGGFG VYKGELHDGT
Sbjct: 515 VSES----GFSGNDAHLGEAGNIVISIQVLRDATYNFDEKNILGRGGFGIVYKGELHDGT 570
Query: 619 KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 678
KIAVKRME+ +ISGKGL EFKSEIAVLT+VRHR+LV L G+CL+GNE+LLV++YMPQGTL
Sbjct: 571 KIAVKRMESSIISGKGLDEFKSEIAVLTRVRHRNLVVLHGYCLEGNERLLVYQYMPQGTL 630
Query: 679 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 738
SRHIF W EEGL+PLEW RRL IALDVARGVEYLH LAHQSFIHRDLKPSNILLGDDM A
Sbjct: 631 SRHIFYWKEEGLRPLEWTRRLIIALDVARGVEYLHTLAHQSFIHRDLKPSNILLGDDMHA 690
Query: 739 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRK 798
KVADFGLVRLAPEG SIET+IAGTFGYLAPEYAVTGRVTTKVDV+SFGVILMEL+TGRK
Sbjct: 691 KVADFGLVRLAPEGTQSIETKIAGTFGYLAPEYAVTGRVTTKVDVYSFGVILMELLTGRK 750
Query: 799 ALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREP 858
ALD ++ EE +HL TWFRR+ ++K SF KAID +++NE L SI+ VAELA C +REP
Sbjct: 751 ALDVARSEEEVHLATWFRRMFINKGSFPKAIDEAMEVNEETLRSINIVAELANQCSSREP 810
Query: 859 YQRPDMGHAVNVLSSLVELWKPTDQNS--EDIYGIDLEMSLPQALKKWQAYEGRSYMEXX 916
RPDM H VNVL SLV WKPT+++S EDIYGID + LPQ + + G
Sbjct: 811 RDRPDMNHVVNVLVSLVVQWKPTERSSDSEDIYGIDYDTPLPQLILD-SCFFG------- 862
Query: 917 XXXXXXXXDNTQTSIPTRPYGFAESFKSADGR 948
DNT TSIP+RP +FKS GR
Sbjct: 863 --------DNTLTSIPSRPSELESTFKSGQGR 886
|
|
| TAIR|locus:2095188 AT3G23750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2095 (742.5 bits), Expect = 7.3e-217, P = 7.3e-217
Identities = 447/946 (47%), Positives = 594/946 (62%)
Query: 12 LTLYVGFCSILFVSASGDDGDAAVMLALKKSLNPPESLGWSDT-DPCKWNHVVCIEDKRI 70
L L V +I F + S D D MLAL KS NPP S WS T D CKW+ V C R+
Sbjct: 7 LLLLVLLTTITFFTTSVAD-DQTAMLALAKSFNPPPS-DWSSTTDFCKWSGVRCTGG-RV 63
Query: 71 TRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSV 130
T I + ++L G + + L++L+ + +Q N +SG +PS L+SL+ + + N F V
Sbjct: 64 TTISLADKSLTGFIAPEISTLSELKSVSIQRNKLSGTIPSFAKLSSLQEIYMDENNFVGV 123
Query: 131 PSDFFTGLSSLQSIEI-DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEF 189
+ F GL+SLQ + + DNN ++W P L +++ L ++ NI G +P F D
Sbjct: 124 ETGAFAGLTSLQILSLSDNNNITTWSFPSELVDSTSLTTIYLDNTNIAGVLPDIF--DSL 181
Query: 190 PGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHS 249
L L L++N + G LP S S IQ+LW+N Q+ + G I+V+ +MTSL + WLH
Sbjct: 182 ASLQNLRLSYNNITGVLPPSLGKSSIQNLWINNQD--LGMSGTIEVLSSMTSLSQAWLHK 239
Query: 250 NAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRS 309
N F GP+PD S + L L LRDN TG VP +L+ L SLK +++ NN QGP+P F
Sbjct: 240 NHFFGPIPDLSKSENLFDLQLRDNDLTGIVPPTLLTLASLKNISLDNNKFQGPLPLFSPE 299
Query: 310 VSLDMAKGSNNFCLPSPG-ACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCT 368
V + + N FC G +C P++ LL+V +GYP AE+W+G+D CS W V+C
Sbjct: 300 VKVTI--DHNVFCTTKAGQSCSPQVMTLLAVAGGLGYPSMLAESWQGDDACSGWAYVSCD 357
Query: 369 KG--NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVS 426
N+ +N K TG ISP A+ SL+ L L N+L+G+IP+ L+ + +L+ +DVS
Sbjct: 358 SAGKNVVTLNLGKHGFTGFISPAIANLTSLKSLYLNGNDLTGVIPKELTFMTSLQLIDVS 417
Query: 427 NNQLYGKIPSFKSNAIVN-TDGNPDIGKEKXXXXXXXXXXXXXXXXXXXXXXXXXXVKNS 485
NN L G+IP F + + GN +G
Sbjct: 418 NNNLRGEIPKFPATVKFSYKPGNALLGTNGGDGSSPGTGGASGGPGGSSGGGGSKVGVIV 477
Query: 486 SALITVILFCVIGGAFVISLTGVLVFCLCKKKQKRFSRV--QSPNAMVIHPRHSGSENSE 543
++ V++F I G FV V F + K+K RF+R + +++ S +
Sbjct: 478 GVIVAVLVFLAILG-FV-----VYKFVM-KRKYGRFNRTDPEKVGKILVSDAVSNGGSGN 530
Query: 544 SVKITVAGSNVSVGAISETHTVPSS-EPGDIQMLEAGNMVISIQVLRNVTNNFSEENILG 602
G+N + A++ PSS + D +LE G++ I ++VLR VTNNFSE+NILG
Sbjct: 531 GGYANGHGAN-NFNALNS----PSSGDNSDRFLLEGGSVTIPMEVLRQVTNNFSEDNILG 585
Query: 603 RGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD 662
RGGFG VY GELHDGTK AVKRME + KG++EF++EIAVLTKVRHRHLVALLG+C++
Sbjct: 586 RGGFGVVYAGELHDGTKTAVKRMECAAMGNKGMSEFQAEIAVLTKVRHRHLVALLGYCVN 645
Query: 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIH 722
GNE+LLV+EYMPQG L +H+F W+E G PL W +R++IALDVARGVEYLH LA QSFIH
Sbjct: 646 GNERLLVYEYMPQGNLGQHLFEWSELGYSPLTWKQRVSIALDVARGVEYLHSLAQQSFIH 705
Query: 723 RDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVD 782
RDLKPSNILLGDDMRAKVADFGLV+ AP+GK S+ETR+AGTFGYLAPEYA TGRVTTKVD
Sbjct: 706 RDLKPSNILLGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKVD 765
Query: 783 VFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILAS 842
V++FGV+LME++TGRKALD+S P+E HLVTWFRRI ++K++ KA+D T++ +E + S
Sbjct: 766 VYAFGVVLMEILTGRKALDDSLPDERSHLVTWFRRILINKENIPKALDQTLEADEETMES 825
Query: 843 ISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDQNSEDIYGIDLEMSLPQALK 902
I VAELAGHC AREP QRPDMGHAVNVL LVE WKP+ Q E+ +GID+ MSLPQAL+
Sbjct: 826 IYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEKWKPSCQEEEESFGIDVNMSLPQALQ 885
Query: 903 KWQAYEGRSYMEXXXXXXXXXXDNTQTSIPTRPYGFAESFKSADGR 948
+WQ EG S TQ+SIP + GF +F SADGR
Sbjct: 886 RWQN-EGTS--SSTMFHGDFSYSQTQSSIPPKASGFPNTFDSADGR 928
|
|
| TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 559 (201.8 bits), Expect = 1.3e-81, Sum P(2) = 1.3e-81
Identities = 124/303 (40%), Positives = 179/303 (59%)
Query: 579 GNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEF 638
G + + L TNNFS+ N +G GG+G VYKG L +G IA+KR + G S +G EF
Sbjct: 618 GTKAFTFEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIAIKRAQQG--SMQGAFEF 675
Query: 639 KSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRR 698
K+EI +L++V H+++V LLG C D E++LV+EY+P G+L + + G+K L+W RR
Sbjct: 676 KTEIELLSRVHHKNVVKLLGFCFDQKEQMLVYEYIPNGSLRDGLSG--KNGVK-LDWTRR 732
Query: 699 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA--PEGKGSI 756
L IAL +G+ YLH LA IHRD+K +NILL + + AKVADFGL +L PE K +
Sbjct: 733 LKIALGSGKGLAYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGLSKLVGDPE-KAHV 791
Query: 757 ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQ--PEESMHLVTW 814
T++ GT GYL PEY +T ++T K DV+ FGV+++EL+TG+ +D +E +
Sbjct: 792 TTQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVMLELLTGKSPIDRGSYVVKEVKKKMDK 851
Query: 815 FRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874
R ++ + +D TI N G L ++A C E RP M V L S+
Sbjct: 852 SRNLY----DLQELLDTTIIQNSGNLKGFEKYVDVALQCVEPEGVNRPTMSEVVQELESI 907
Query: 875 VEL 877
+ L
Sbjct: 908 LRL 910
|
|
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 519 (187.8 bits), Expect = 1.6e-80, Sum P(2) = 1.6e-80
Identities = 119/297 (40%), Positives = 176/297 (59%)
Query: 590 NVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKV 648
+V ++ E+NI+G+GG G VYKG + +G +AVKR+ A + G F +EI L ++
Sbjct: 689 DVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRL-AAMSRGSSHDHGFNAEIQTLGRI 747
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
RHRH+V LLG C + LLV+EYMP G+L + + + G L W+ R IAL+ A+G
Sbjct: 748 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGE-VLHGKKGG--HLHWDTRYKIALEAAKG 804
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYL 767
+ YLH +HRD+K +NILL + A VADFGL + L G + IAG++GY+
Sbjct: 805 LCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI 864
Query: 768 APEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS-KDSFH 826
APEYA T +V K DV+SFGV+L+EL+TGRK + E + + +V W R++ S KDS
Sbjct: 865 APEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFG--DGVDIVQWVRKMTDSNKDSVL 922
Query: 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDQ 883
K +DP L+ + ++ V +A C + +RP M V +L+ + +L DQ
Sbjct: 923 KVLDPR--LSSIPIHEVTHVFYVAMLCVEEQAVERPTMREVVQILTEIPKLPPSKDQ 977
|
|
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 564 (203.6 bits), Expect = 2.5e-79, Sum P(2) = 2.5e-79
Identities = 124/304 (40%), Positives = 188/304 (61%)
Query: 579 GNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEF 638
G + + L+ T+NFSE N +G GG+G VY+G L +G IA+KR + G + G GL EF
Sbjct: 615 GAKAFTFEELKKCTDNFSEANDVGGGGYGKVYRGILPNGQLIAIKRAQQGSLQG-GL-EF 672
Query: 639 KSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRR 698
K+EI +L++V H+++V LLG C D NE++LV+EY+ G+L + + G++ L+W RR
Sbjct: 673 KTEIELLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSLSG--KSGIR-LDWTRR 729
Query: 699 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA--PEGKGSI 756
L IAL +G+ YLH LA IHRD+K +NILL +++ AKVADFGL +L PE K +
Sbjct: 730 LKIALGSGKGLAYLHELADPPIIHRDIKSNNILLDENLTAKVADFGLSKLVGDPE-KTHV 788
Query: 757 ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFR 816
T++ GT GYL PEY +T ++T K DV+ FGV+L+EL+TGR + E ++V +
Sbjct: 789 TTQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVLLELLTGRSPI-----ERGKYVVREVK 843
Query: 817 -RIHLSKDSF--HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873
+++ S+ + + +D TI + G L +LA C E RP MG V + +
Sbjct: 844 TKMNKSRSLYDLQELLDTTIIASSGNLKGFEKYVDLALRCVEEEGVNRPSMGEVVKEIEN 903
Query: 874 LVEL 877
+++L
Sbjct: 904 IMQL 907
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 586 (211.3 bits), Expect = 3.7e-79, Sum P(2) = 3.7e-79
Identities = 128/313 (40%), Positives = 189/313 (60%)
Query: 566 PSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRM 625
P ++ +I ++ + L+N T +F N LG GGFG VYKG L+DG ++AVK++
Sbjct: 681 PYTDDEEILSMDVKPYTFTYSELKNATQDFDLSNKLGEGGFGAVYKGNLNDGREVAVKQL 740
Query: 626 EAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW 685
G GKG +F +EI ++ V HR+LV L G C +G+ +LLV+EY+P G+L + +F
Sbjct: 741 SIGSRQGKG--QFVAEIIAISSVLHRNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFG- 797
Query: 686 AEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745
++ L L+W+ R I L VARG+ YLH A IHRD+K SNILL ++ KV+DFGL
Sbjct: 798 -DKSLH-LDWSTRYEICLGVARGLVYLHEEASVRIIHRDVKASNILLDSELVPKVSDFGL 855
Query: 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQP 805
+L + K I TR+AGT GYLAPEYA+ G +T K DV++FGV+ +EL++GRK DE+
Sbjct: 856 AKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRKNSDENLE 915
Query: 806 EESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQ-RPDM 864
E +L+ W +H K+ + ID +L+E + + + +A C + Y RP M
Sbjct: 916 EGKKYLLEWAWNLH-EKNRDVELIDD--ELSEYNMEEVKRMIGIA-LLCTQSSYALRPPM 971
Query: 865 GHAVNVLSSLVEL 877
V +LS E+
Sbjct: 972 SRVVAMLSGDAEV 984
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 548 (198.0 bits), Expect = 8.5e-79, Sum P(2) = 8.5e-79
Identities = 119/307 (38%), Positives = 184/307 (59%)
Query: 567 SSEPGDIQM--LEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKR 624
S EP I + E + ++ + T NFS+ +I+G GGFGTVYK L +G ++A+KR
Sbjct: 972 SREPLSINLATFEHALLRVTADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKR 1031
Query: 625 MEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFN 684
+ G +G EF +E+ + KV+H +LV LLG+C+ G+E+ L++EYM G+L + N
Sbjct: 1032 LHGGH-QFQGDREFLAEMETIGKVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLRN 1090
Query: 685 WAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744
A+ L+ L W RL I L ARG+ +LH IHRD+K SNILL ++ +V+DFG
Sbjct: 1091 RAD-ALEALGWPDRLKICLGSARGLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFG 1149
Query: 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQ 804
L R+ + + T IAGTFGY+ PEY +T + TTK DV+SFGV+++EL+TGR + +
Sbjct: 1150 LARIISACETHVSTDIAGTFGYIPPEYGLTMKSTTKGDVYSFGVVMLELLTGRPPTGQEE 1209
Query: 805 PEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDM 864
+ +LV W R + +++ ++ DP + ++ ++ V +A C A EP++RP M
Sbjct: 1210 VQGGGNLVGWVRWM-IARGKQNELFDPCLPVSSVWREQMARVLAIARDCTADEPFKRPTM 1268
Query: 865 GHAVNVL 871
V L
Sbjct: 1269 LEVVKGL 1275
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 501 (181.4 bits), Expect = 1.1e-78, Sum P(2) = 1.1e-78
Identities = 118/300 (39%), Positives = 174/300 (58%)
Query: 590 NVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKV 648
+V ++ E+NI+G+GG G VYKG + G +AVKR+ A + G F +EI L ++
Sbjct: 685 DVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRL-ATMSHGSSHDHGFNAEIQTLGRI 743
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
RHRH+V LLG C + LLV+EYMP G+L + + + G L WN R IAL+ A+G
Sbjct: 744 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGE-VLHGKKGG--HLHWNTRYKIALEAAKG 800
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYL 767
+ YLH +HRD+K +NILL + A VADFGL + L G + IAG++GY+
Sbjct: 801 LCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI 860
Query: 768 APEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS-KDSFH 826
APEYA T +V K DV+SFGV+L+ELITG+K + E + + +V W R + S KD
Sbjct: 861 APEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFG--DGVDIVQWVRSMTDSNKDCVL 918
Query: 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDQNSE 886
K ID + L+ + ++ V +A C + +RP M V +L+ + ++ Q +E
Sbjct: 919 KVID--LRLSSVPVHEVTHVFYVALLCVEEQAVERPTMREVVQILTEIPKIPLSKQQAAE 976
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P43298 | TMK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7497 | 0.9630 | 0.9692 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 948 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-49 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-45 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-43 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-37 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-33 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-32 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-32 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-31 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-31 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-30 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-29 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-28 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-28 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-28 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-27 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-27 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-27 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-26 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-26 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-26 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-26 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-25 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-24 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-24 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-24 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-24 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-24 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-24 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-23 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-23 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-21 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-21 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-21 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-21 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-20 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-20 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-20 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-20 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-20 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-17 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-16 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-15 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-15 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-15 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-15 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-14 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-05 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 7e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-04 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 2e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 5e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-04 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 8e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 8e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 9e-53
Identities = 87/272 (31%), Positives = 124/272 (45%), Gaps = 23/272 (8%)
Query: 600 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
LG G FGTVYK + G +AVK ++ K + EI +L ++ H ++V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
D + LV EY G L ++ PL + IAL + RG+EYLH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSR-----GGPLSEDEAKKIALQILRGLEYLHS---N 117
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR-V 777
IHRDLKP NILL ++ K+ADFGL + + S+ T GT Y+APE + G
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGY 176
Query: 778 TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNE 837
KVDV+S GVIL EL+TG+ + + L RRI F + +
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQL---IRRILGPPLEFDEPKWSSGS--- 230
Query: 838 GILASISTVAELAGHCCAREPYQRPDMGHAVN 869
+L C ++P +RP +
Sbjct: 231 ------EEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 3e-51
Identities = 79/196 (40%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
LG GGFGTVY G K+A+K ++ S L E EI +L K+ H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED-SSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 719
D N LV EY G+L + L + L I L + G+EYLH
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENE----GKLSEDEILRILLQILEGLEYLH---SNG 112
Query: 720 FIHRDLKPSNILLG-DDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE-YAVTGRV 777
IHRDLKP NILL D+ + K+ADFGL +L K S+ I GT Y+APE G
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK-SLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 778 TTKVDVFSFGVILMEL 793
+ K D++S GVIL EL
Sbjct: 172 SEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 4e-49
Identities = 74/271 (27%), Positives = 109/271 (40%), Gaps = 31/271 (11%)
Query: 595 FSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
+ LG G FG VY + G +A+K ++ I EI +L K++H ++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD-RERILREIKILKKLKHPNI 59
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
V L D ++ LV EY G L + L + + +EYLH
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR-----GRLSEDEARFYLRQILSALEYLH 114
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV 773
+ +HRDLKP NILL +D K+ADFGL R G+ T GT Y+APE +
Sbjct: 115 S---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPEVLL 169
Query: 774 TGRVTTKVDVFSFGVILMELITGRKAL--DESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831
VD++S GVIL EL+TG+ + Q E + + I P
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGK-PPFPGDDQLLELFKKI---GKPKPPFPPPEWDISP 225
Query: 832 TIDLNEGILASISTVAELAGHCCAREPYQRP 862
+L ++P +R
Sbjct: 226 -------------EAKDLIRKLLVKDPEKRL 243
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-45
Identities = 84/286 (29%), Positives = 129/286 (45%), Gaps = 43/286 (15%)
Query: 598 ENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
LG G FG VYKG L ++AVK ++ S + + EF E ++ K+ H +
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA-SEQQIEEFLREARIMRKLDHPN 62
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+V LLG C + ++V EYMP G L ++ + K L + L+ AL +ARG+EYL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL---RKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT---FGYLAP 769
++FIHRDL N L+G+++ K++DFGL R + ++ G ++AP
Sbjct: 120 E---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYKVKGGKLPIRWMAP 173
Query: 770 EYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829
E G+ T+K DV+SFGV+L E+ T +P M +
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFT-----LGEEPYPGMSNAEVLEYL----------- 217
Query: 830 DPTIDLNEGILASIST----VAELAGHCCAREPYQRPDMGHAVNVL 871
L + +L C A +P RP V +L
Sbjct: 218 -----KKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 3e-45
Identities = 72/206 (34%), Positives = 109/206 (52%), Gaps = 19/206 (9%)
Query: 598 ENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
LG G FG VYKG+L ++AVK ++ S + + EF E ++ K+ H +
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLREARIMRKLDHPN 62
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+V LLG C + +V EYM G L ++ + L + L+ AL +ARG+EYL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL----RKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT---FGYLAP 769
++FIHRDL N L+G+++ K++DFGL R + R G ++AP
Sbjct: 119 E---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYRKRGGKLPIRWMAP 172
Query: 770 EYAVTGRVTTKVDVFSFGVILMELIT 795
E G+ T+K DV+SFGV+L E+ T
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 3e-45
Identities = 72/208 (34%), Positives = 105/208 (50%), Gaps = 17/208 (8%)
Query: 599 NILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
LG G FG VYKG+L T++AVK ++ + +F E V+ K+ H ++V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE-RKDFLKEARVMKKLGHPNVV 59
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTL------SRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
LLG C + LV EYM G L SR +F L L+ A+ +A+G
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFP--SPEKSTLSLKDLLSFAIQIAKG 117
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT-FGYL 767
+EYL + F+HRDL N L+G+D+ K++DFGL R + + ++
Sbjct: 118 MEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174
Query: 768 APEYAVTGRVTTKVDVFSFGVILMELIT 795
APE G T+K DV+SFGV+L E+ T
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 3e-44
Identities = 77/272 (28%), Positives = 119/272 (43%), Gaps = 36/272 (13%)
Query: 599 NILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+LGRG FG+VY D G +AVK +E S + L + EI +L+ ++H ++V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 658 GHCLDGNEK-LLVF-EYMPQGTLSRHIFNWAEEGLKPLEWN--RRLTIALDVARGVEYLH 713
G D + L +F EY+ G+LS + + L R+ T + G+ YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL-----KKFGKLPEPVIRKYTR--QILEGLAYLH 118
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETRIAGTFGYLAPEYA 772
+HRD+K +NIL+ D K+ADFG RL G + GT ++APE
Sbjct: 119 S---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 773 VTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832
D++S G ++E+ TG+ E M + +I S + P
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPWSEL--GNPMAALY---KIGSSGEP------PE 224
Query: 833 I--DLNEGILASISTVAELAGHCCAREPYQRP 862
I L+E + C R+P +RP
Sbjct: 225 IPEHLSEEAKDFLR-------KCLRRDPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 7e-43
Identities = 75/210 (35%), Positives = 110/210 (52%), Gaps = 30/210 (14%)
Query: 601 LGRGGFGTVYKGELHD-----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA 655
LG G FG VYKG L TK+AVK ++ G S + EF E +++ K+ H ++V
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA-SEEEREEFLEEASIMKKLSHPNIVR 65
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
LLG C G +V EYMP G L + + + L L +AL +A+G+EYL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL----RKHGEKLTLKDLLQMALQIAKGMEYLES- 120
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL---------APEGKGSIETRIAGTFGY 766
++F+HRDL N L+ +++ K++DFGL R GK I+ +
Sbjct: 121 --KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK--------W 170
Query: 767 LAPEYAVTGRVTTKVDVFSFGVILMELITG 796
+APE G+ T+K DV+SFGV+L E+ T
Sbjct: 171 MAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 5e-37
Identities = 125/415 (30%), Positives = 203/415 (48%), Gaps = 38/415 (9%)
Query: 35 VMLALKKSLNPPESL--GWSDT-DPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNL 91
++L+ K S+N P W+ + D C W + C R+ I + +N+ G + S + L
Sbjct: 33 LLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRL 92
Query: 92 TKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQFT-SVPSDFFTGLSSLQSIEIDN 148
++ + L N +SGP+P +SL + LSNN FT S+P + +L+++++ N
Sbjct: 93 PYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGS---IPNLETLDLSN 149
Query: 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPA 208
N S EIP + + S L+ + G+IP+ L L LA NQL+G +P
Sbjct: 150 NMLSG-EIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT--NLTSLEFLTLASNQLVGQIPR 206
Query: 209 SFSGSQIQSL-WVNGQNGNAKLGGGIDV-IQNMTSLKEIWLHSNAFSGPLP-DFSGVKQL 265
Q++SL W+ G L G I I +TSL + L N +GP+P +K L
Sbjct: 207 EL--GQMKSLKWI--YLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNL 262
Query: 266 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSV-SLDMAK-GSNNFCL 323
+ L L N +GP+P S+ L+ L +++++N L G +PE + +L++ SNNF
Sbjct: 263 QYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTG 322
Query: 324 PSPGACD--PRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMN 381
P A PRL L Q ++ + G P + +G N+TV++ N
Sbjct: 323 KIPVALTSLPRLQVL----------QLWSNKFSGEIPKN--LG---KHNNLTVLDLSTNN 367
Query: 382 LTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 436
LTG I S +L +LIL N+L G IP+ L +L+ + + +N G++PS
Sbjct: 368 LTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422
|
Length = 968 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 75/205 (36%), Positives = 113/205 (55%), Gaps = 29/205 (14%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
+G+G FG V G+ G K+AVK ++ F +E +V+T +RH +LV LLG
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKD---DSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 661 LDGNEKLLVFEYMPQGTL-------SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
L GN +V EYM +G+L R + A+ +L ALDV G+EYL
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQ----------QLGFALDVCEGMEYLE 119
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV 773
++F+HRDL N+L+ +D+ AKV+DFGL + A +G+ S + + T APE
Sbjct: 120 E---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALR 172
Query: 774 TGRVTTKVDVFSFGVILMELIT-GR 797
+ +TK DV+SFG++L E+ + GR
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 77/214 (35%), Positives = 112/214 (52%), Gaps = 22/214 (10%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
LG G FG V+ G + TK+AVK ++ G +S F E ++ K+RH LV L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 661 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 720
+ +V EYM +G+L + + EG K L + + +A +A G+ YL +++
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKS--GEG-KKLRLPQLVDMAAQIAEGMAYLE---SRNY 124
Query: 721 IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT---FGYLAPEYAVTGRV 777
IHRDL NIL+G+++ K+ADFGL RL + T G + APE A GR
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLI---EDDEYTAREGAKFPIKWTAPEAANYGRF 181
Query: 778 TTKVDVFSFGVILMELIT-GRKALDESQPEESMH 810
T K DV+SFG++L E++T GR P M
Sbjct: 182 TIKSDVWSFGILLTEIVTYGR------VPYPGMT 209
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 26/220 (11%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
+G+GGFG VYK G ++A+K ++ + S + + +EI +L K +H ++V G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIK--LESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVARGVEYLH 713
L +E +V E+ G+L + + N+ LT + ++ +G+EYLH
Sbjct: 66 YLKKDELWIVMEFCSGGSL-KDLLK---------STNQTLTESQIAYVCKELLKGLEYLH 115
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETRIAGTFGYLAPEYA 772
IHRD+K +NILL D K+ DFGL +L+ + GT ++APE
Sbjct: 116 S---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS---DTKARNTMVGTPYWMAPEVI 169
Query: 773 VTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLV 812
K D++S G+ +EL G+ E P +++ +
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI 209
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 70/201 (34%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 601 LGRGGFGTVYK-GELHDGTKIAVKRMEAGVISGKGLTEF-KSEIAVLTKVRHRHLVALLG 658
LG+G FG V + G A+K ++ I + E +E +L+++ H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 659 HC-LDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
H EKL LV EY P G L H+ ++EG E R A ++ +EYLH
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARF--YAAEIVLALEYLHS-- 111
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR 776
I+RDLKP NILL D K+ DFGL + T GT YLAPE +
Sbjct: 112 -LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKG 169
Query: 777 VTTKVDVFSFGVILMELITGR 797
VD +S GV+L E++TG+
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 4e-32
Identities = 73/237 (30%), Positives = 112/237 (47%), Gaps = 35/237 (14%)
Query: 601 LGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
LG G FG V+ GE +D +AVK ++ S +F+ E +LT +H ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAELLTNFQHENIV 71
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSR-------HIFNWAEEGLKPLEWNRR--LTIALDV 705
G C +G+ ++VFEYM G L++ E L IA+ +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET----RIA 761
A G+ Y LA Q F+HRDL N L+G D+ K+ DFG+ R + T R+
Sbjct: 132 ASGMVY---LASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-------DVYTTDYYRVG 181
Query: 762 GT----FGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVT 813
G ++ PE + + TT+ DV+SFGV+L E+ T G++ EE + +T
Sbjct: 182 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 72/202 (35%), Positives = 111/202 (54%), Gaps = 11/202 (5%)
Query: 595 FSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
F+ E LG G FG V++G + ++A+K +++ +F+ E+ L ++RH+HL+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLI 65
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
+L C G ++ E M +G+L F + EG + L + +A VA G+ YL
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSL--LAFLRSPEG-QVLPVASLIDMACQVAEGMAYLE- 121
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE-TRIAGTFGYLAPEYAV 773
Q+ IHRDL NIL+G+D+ KVADFGL RL E +I + + APE A
Sbjct: 122 --EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEAAS 177
Query: 774 TGRVTTKVDVFSFGVILMELIT 795
G +TK DV+SFG++L E+ T
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 75/217 (34%), Positives = 115/217 (52%), Gaps = 24/217 (11%)
Query: 584 SIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIA 643
SIQ+LR LG G FG V++G ++ T +AVK ++ G + K +F +E
Sbjct: 7 SIQLLRK----------LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---DFLAEAQ 53
Query: 644 VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 703
++ K+RH L+ L C +V E M G+L ++ + L+ + + +A
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG---GAGRALKLPQLIDMAA 110
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT 763
VA G+ YL Q++IHRDL N+L+G++ KVADFGL R+ E E R
Sbjct: 111 QVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI--YEAREGAK 165
Query: 764 F--GYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GR 797
F + APE A+ R + K DV+SFG++L E++T GR
Sbjct: 166 FPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 6e-31
Identities = 105/371 (28%), Positives = 171/371 (46%), Gaps = 31/371 (8%)
Query: 73 IQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFT-SV 130
I +G+ NL G +P + LT L L+L +N+++GP+P SL L +L+ + L N+ + +
Sbjct: 217 IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI 276
Query: 131 PSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFP 190
P F L L S+++ +N S EIP+ + L+ S N TG+IP P
Sbjct: 277 PPSIF-SLQKLISLDLSDN-SLSGEIPELVIQLQNLEILHLFSNNFTGKIPV--ALTSLP 332
Query: 191 GLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250
L +L L N+ G +P + G +L V + N G + + + +L ++ L SN
Sbjct: 333 RLQVLQLWSNKFSGEIPKNL-GKH-NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSN 390
Query: 251 AFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP----E 305
+ G +P + L + L+DN F+G +P KL + ++++NN LQG + +
Sbjct: 391 SLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWD 450
Query: 306 FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMG-YPQRFAENWKGNDPCSDWIG 364
L +A+ LP N LS + G P++
Sbjct: 451 MPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLG-------------- 496
Query: 365 VTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELD 424
+ + + + L+G I E +S K L L L+ N LSG IP S + L +LD
Sbjct: 497 ---SLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLD 553
Query: 425 VSNNQLYGKIP 435
+S NQL G+IP
Sbjct: 554 LSQNQLSGEIP 564
|
Length = 968 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 594 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
N+ +++GRG FG VYKG L G +A+K++ I + L EI +L ++H +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHI--FNWAEEGLKPLEWNRRLTIALDVA---R 707
+V +G + ++ EY G+L + I F E L +A+ V +
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL----------VAVYVYQVLQ 110
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETRIAGTFGY 766
G+ YLH Q IHRD+K +NIL D K+ADFG+ +L K + + GT +
Sbjct: 111 GLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYW 165
Query: 767 LAPEYAVTGRVTTKVDVFSFGVILMELITGR 797
+APE +T D++S G ++EL+TG
Sbjct: 166 MAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 5e-30
Identities = 85/371 (22%), Positives = 130/371 (35%), Gaps = 37/371 (9%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRH-RHLVALLG 658
LG G FG VY D +A+K + + S E F EI +L + H ++V L
Sbjct: 8 LGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
D LV EY+ G+L + PL + L I + +EYLH +
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKK--IGRKGPLSESEALFILAQILSALEYLH---SK 120
Query: 719 SFIHRDLKPSNILLG-DDMRAKVADFGLVRLAPEGKGSIETR-----IAGTFGYLAPEYA 772
IHRD+KP NILL D K+ DFGL +L P+ + GT GY+APE
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 773 ---VTGRVTTKVDVFSFGVILMELITGRKALDESQPEESM--------HLVTWFRRIHLS 821
++ D++S G+ L EL+TG + + + L T LS
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240
Query: 822 KDSFHKAIDPTIDLNEGILAS-----ISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876
+ DL + +LA +S+ ++L+ ++ L
Sbjct: 241 PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS------HDLLAHLKLKESDLSDLLKP 294
Query: 877 LWKPTDQNSEDIYGIDLEMSLPQALKKWQAYEGRSYMESSSSSLLPSLDNTQTSIPTRPY 936
+ S L SL + S + + S
Sbjct: 295 DDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLS 354
Query: 937 GFAESFKSADG 947
+ S
Sbjct: 355 TASSKRSSLPK 365
|
Length = 384 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 67/208 (32%), Positives = 108/208 (51%), Gaps = 15/208 (7%)
Query: 600 ILGRGGFGTVYKGELH--DGT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA 655
ILG G FG+V +G+L DG+ K+AVK M+ + + + EF SE A + H +++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 656 LLGHCLDGNEK------LLVFEYMPQGTLSRHIF-NWAEEGLKPLEWNRRLTIALDVARG 708
L+G C + + +++ +M G L + + + L L +D+A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT-FGYL 767
+EYL ++++FIHRDL N +L +DM VADFGL + G + RIA ++
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 768 APEYAVTGRVTTKVDVFSFGVILMELIT 795
A E T+K DV++FGV + E+ T
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 72/226 (31%), Positives = 111/226 (49%), Gaps = 24/226 (10%)
Query: 599 NILGRGGFGTVYKGE---LHDGT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
LG G FG V L D T ++AVK + + ++F+ EI +L + H ++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG-EEQHRSDFEREIEILRTLDHENI 68
Query: 654 VALLGHCLD--GNEKLLVFEYMPQGTLSRHI-FNWAEEGLKPLEWNRRLTIALDVARGVE 710
V G C G L+ EY+P G+L ++ + + LK L L + + +G++
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRL-----LLFSSQICKGMD 123
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG---TFGYL 767
YL Q +IHRDL NIL+ + K++DFGL ++ PE K + G F Y
Sbjct: 124 YLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179
Query: 768 APEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLV 812
APE T + ++ DV+SFGV L EL T G +S P E + ++
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFTYGDP--SQSPPAEFLRMI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 72/225 (32%), Positives = 111/225 (49%), Gaps = 40/225 (17%)
Query: 595 FSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
F EE LG G FG VYKGEL T +A+K ++ K EF+ E +++ +
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDL 65
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIF-------------NWAEEGLKPLEW 695
+H ++V LLG C ++FEY+ G L H F + E L+
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDL--HEFLVRNSPHSDVGAESGDETVKSSLDC 123
Query: 696 NRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA------ 749
+ L IA+ +A G+EY L+ F+HRDL N L+G+ + K++DFGL R
Sbjct: 124 SDFLHIAIQIAAGMEY---LSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180
Query: 750 -PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMEL 793
+ K + R ++ PE + G+ TT+ D++SFGV+L E+
Sbjct: 181 RVQSKSLLPVR------WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 78/263 (29%), Positives = 123/263 (46%), Gaps = 29/263 (11%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
+G G FG V+ G + K+A+K + G +S + +F E V+ K+ H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 661 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 720
+ + LVFE+M G LS ++ A+ G L + LDV G+ YL +
Sbjct: 69 TERSPICLVFEFMEHGCLSDYL--RAQRGK--FSQETLLGMCLDVCEGMAYLE---SSNV 121
Query: 721 IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTK 780
IHRDL N L+G++ KV+DFG+ R + + + T + +PE + ++K
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181
Query: 781 VDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGI 839
DV+SFGV++ E+ + G+ + E + + R++ +
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPR----------------- 224
Query: 840 LASISTVAELAGHCCAREPYQRP 862
LAS S V EL HC P RP
Sbjct: 225 LASQS-VYELMQHCWKERPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 86/264 (32%), Positives = 133/264 (50%), Gaps = 31/264 (11%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
LG G FG V+ G + TK+AVK ++ G +S + E E ++ K+RH LV L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE---EAQIMKKLRHDKLVQL--YA 68
Query: 661 LDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 719
+ E + +V EYM +G+L F EG + L+ + +A VA G+ Y+ + +
Sbjct: 69 VVSEEPIYIVTEYMSKGSLL--DFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERM---N 122
Query: 720 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTT 779
+IHRDL+ +NIL+GD + K+ADFGL RL + + + + APE A+ GR T
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 780 KVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEG 838
K DV+SFG++L EL+T GR E + V R+ +D P
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDC------PI------ 230
Query: 839 ILASISTVAELAGHCCAREPYQRP 862
++ EL C ++P +RP
Sbjct: 231 ------SLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 3e-28
Identities = 80/279 (28%), Positives = 123/279 (44%), Gaps = 41/279 (14%)
Query: 601 LGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
LG G FG V+ E H D +AVK ++ S + +F+ E +LT ++H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR--QDFQREAELLTVLQHQHIV 70
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSR---------HIFNWAE-EGLKPLEWNRRLTIALD 704
G C +G L+VFEYM G L+R I E L + L IA
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 705 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGT 763
+A G+ YL L F+HRDL N L+G + K+ DFG+ R + + R
Sbjct: 131 IASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 764 FGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSK 822
++ PE + + TT+ D++SFGV+L E+ T G++ + E++ +T R + +
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPR 247
Query: 823 DSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQR 861
V + C REP QR
Sbjct: 248 ------------------TCPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 29/226 (12%)
Query: 594 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+ +G+G FG VY DG +K ++ +S K + +E+ +L K+ H +
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKP-----LEWNRRLTIALDVAR 707
++ + + +V EY G LS+ I +EG L+W +L +AL
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK--- 117
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
YLH + +HRD+KP NI L + K+ DFG+ ++ +T + GT YL
Sbjct: 118 ---YLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYL 170
Query: 768 APE------YAVTGRVTTKVDVFSFGVILMELITGRKALD-ESQPE 806
+PE Y K D++S G +L EL T + + E+ E
Sbjct: 171 SPELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFEGENLLE 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 2e-27
Identities = 73/199 (36%), Positives = 115/199 (57%), Gaps = 13/199 (6%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
LG+G FG V+ G + T++A+K ++ G +S + F E V+ K+RH LV L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL--YA 68
Query: 661 LDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 719
+ E + +V EYM +G+L F E G K L + + +A +A G+ Y+ + +
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLD--FLKGEMG-KYLRLPQLVDMAAQIASGMAYVERM---N 122
Query: 720 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTT 779
++HRDL+ +NIL+G+++ KVADFGL RL + + + + APE A+ GR T
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 780 KVDVFSFGVILMELIT-GR 797
K DV+SFG++L EL T GR
Sbjct: 183 KSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 74/199 (37%), Positives = 109/199 (54%), Gaps = 17/199 (8%)
Query: 600 ILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
I+G G FG V +GE + G K+AVK ++ V + F E AV+TK+ H++LV LLG
Sbjct: 13 IIGEGEFGAVLQGE-YTGQKVAVKNIKCDVTA----QAFLEETAVMTKLHHKNLVRLLGV 67
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 719
L N +V E M +G L + G + + L +LDVA G+EYL +
Sbjct: 68 ILH-NGLYIVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLES---KK 120
Query: 720 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTT 779
+HRDL NIL+ +D AKV+DFGL R+ G + + + T APE + ++
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSS 176
Query: 780 KVDVFSFGVILMELIT-GR 797
K DV+S+GV+L E+ + GR
Sbjct: 177 KSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 68/200 (34%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
LG G FG V+ G+ +A+K + G +S +F E V+ K+ H +LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 661 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 720
+V EYM G L + +G EW L + DV +EYL F
Sbjct: 69 TKQRPIFIVTEYMANGCLLN--YLRERKGKLGTEW--LLDMCSDVCEAMEYLE---SNGF 121
Query: 721 IHRDLKPSNILLGDDMRAKVADFGLVR--LAPEGKGSIETRIAGTFGYLAPEYAVTGRVT 778
IHRDL N L+G+D KV+DFGL R L + S T+ + PE R +
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP--VKWAPPEVFDYSRFS 179
Query: 779 TKVDVFSFGVILMELITGRK 798
+K DV+SFGV++ E+ + K
Sbjct: 180 SKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 83/296 (28%), Positives = 139/296 (46%), Gaps = 48/296 (16%)
Query: 601 LGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
LG G FG V+ E + D +AVK ++ ++ + +F+ E +LT ++H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHIV 70
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL-----KPLEWN------RRLTIAL 703
G C DG+ ++VFEYM G L++ + + + +P + + L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG- 762
+A G+ Y LA Q F+HRDL N L+G ++ K+ DFG+ R + + R+ G
Sbjct: 131 QIASGMVY---LASQHFVHRDLATRNCLVGANLLVKIGDFGMSR---DVYSTDYYRVGGH 184
Query: 763 ---TFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRI 818
++ PE + + TT+ DV+SFGVIL E+ T G++ + E + +T R +
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL 244
Query: 819 HLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874
P + E V ++ C REP QR ++ +L +L
Sbjct: 245 E----------RPRVCPKE--------VYDIMLGCWQREPQQRLNIKEIYKILHAL 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 71/200 (35%), Positives = 118/200 (59%), Gaps = 15/200 (7%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
LG+G FG V+ G + TK+A+K ++ G + + F E ++ K+RH LV L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPL--YA 68
Query: 661 LDGNEKL-LVFEYMPQGTLSRHIFNWAEEGL-KPLEWNRRLTIALDVARGVEYLHGLAHQ 718
+ E + +V E+M +G+L ++ +EG K L+ + + +A +A G+ Y+ +
Sbjct: 69 VVSEEPIYIVTEFMGKGSL----LDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM--- 121
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVT 778
++IHRDL+ +NIL+GD++ K+ADFGL RL + + + + APE A+ GR T
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 779 TKVDVFSFGVILMELIT-GR 797
K DV+SFG++L EL+T GR
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 69/213 (32%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 601 LGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
LG+G FG VY+G T++A+K + + + EF +E +V+ + H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNEASVMKEFNCHHVV 72
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
LLG G L+V E M +G L SR GL P + + +A ++A G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-------PEGKGSIETRIAG 762
YL F+HRDL N ++ +D+ K+ DFG+ R GKG + R
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 763 TFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
++APE G TTK DV+SFGV+L E+ T
Sbjct: 187 ---WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 69/202 (34%), Positives = 111/202 (54%), Gaps = 17/202 (8%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+G+G FG V G+ + G K+AVK ++ + F +E +V+T++RH +LV LL
Sbjct: 11 LQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA----QAFLAEASVMTQLRHSNLVQLL 65
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
G ++ L +V EYM +G+L ++ G L + L +LDV +EYL
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEA-- 120
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR 776
+F+HRDL N+L+ +D AKV+DFGL + A + + + + T APE +
Sbjct: 121 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKK 175
Query: 777 VTTKVDVFSFGVILMELIT-GR 797
+TK DV+SFG++L E+ + GR
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 38/212 (17%)
Query: 601 LGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTEFKSEIAV----LTKVRHRHLV 654
LG+G G VYK H T A+K I G EF+ ++ L ++V
Sbjct: 9 LGQGSSGVVYKV-RHKPTGKIYALK-----KIHVDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLS---RHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
G E +V EYM G+L+ + + E L IA + +G++Y
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA--------YIARQILKGLDY 114
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA------GTFG 765
LH H IHRD+KPSN+L+ K+ADFG+ +E + GT
Sbjct: 115 LHTKRHI--IHRDIKPSNLLINSKGEVKIADFGI-------SKVLENTLDQCNTFVGTVT 165
Query: 766 YLAPEYAVTGRVTTKVDVFSFGVILMELITGR 797
Y++PE + D++S G+ L+E G+
Sbjct: 166 YMSPERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 5e-26
Identities = 66/203 (32%), Positives = 106/203 (52%), Gaps = 18/203 (8%)
Query: 598 ENILGRGGFGTVYKG--ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA 655
++ LG G +G VY+G + + T +AVK ++ + + EF E AV+ +++H +LV
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLT-VAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQ 66
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
LLG C ++ E+M G L ++ + + + L +A ++ +EYL
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE-- 121
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT---FGYLAPEYA 772
++FIHRDL N L+G++ KVADFGL RL G T AG + APE
Sbjct: 122 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESL 177
Query: 773 VTGRVTTKVDVFSFGVILMELIT 795
+ + K DV++FGV+L E+ T
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 5e-26
Identities = 75/218 (34%), Positives = 108/218 (49%), Gaps = 31/218 (14%)
Query: 599 NILGRGGFGTVYKG----ELHDGT---KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
N LG G FG VY+G L G+ ++AVK + G + EF E +++ H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLKEAHLMSNFNHP 59
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKP--LEWNRRLTIALDVARGV 709
++V LLG CL + ++ E M G L ++ + E P L L I LDVA+G
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 710 EYLHGLAHQSFIHRDLKPSNILL----GDDMR-AKVADFGLVR-------LAPEGKGSIE 757
YL + FIHRDL N L+ D R K+ DFGL R EG+G +
Sbjct: 120 VYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 758 TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
R ++APE + G+ TT+ DV+SFGV++ E++T
Sbjct: 177 VR------WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 22/228 (9%)
Query: 592 TNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 650
+ +G G G VYK + G ++A+K+M + + +EI ++ +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKH 74
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTL----SRHIFNWAEEGLKPLEWNRRLTIALDVA 706
++V L G+E +V EYM G+L +++ E + + +V
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA--------YVCREVL 126
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETRIAGTFG 765
+G+EYLH Q+ IHRD+K NILL D K+ADFG +L E S + GT
Sbjct: 127 QGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE--KSKRNSVVGTPY 181
Query: 766 YLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVT 813
++APE KVD++S G++ +E+ G P ++ L+T
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT 229
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 84/292 (28%), Positives = 134/292 (45%), Gaps = 41/292 (14%)
Query: 601 LGRGGFGTVYK---GELHDGTK--IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA 655
LG+G FG+V L D T +AVK+++ + + L +F+ EI +L ++H ++V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVK 69
Query: 656 LLGHCLD-GNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
G C G L LV EY+P G+L ++ E L+ + L A + +G+EYL
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER----LDHRKLLLYASQICKGMEYL- 124
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG---TFGYLAPE 770
+ ++HRDL NIL+ + R K+ DFGL ++ P+ K + R G F Y APE
Sbjct: 125 --GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APE 181
Query: 771 YAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLV--------TWFRRIHLSK 822
+ + DV+SFGV+L EL T S P E M ++ + I L K
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT-YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240
Query: 823 DSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRP---DMGHAVNVL 871
++ P + + + C +P QRP ++ V +
Sbjct: 241 NNGRLPAPP---------GCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 19/202 (9%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVK--RMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
+G+G FG VYKG L T++AVK R + +F E +L + H ++V L+G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRST---LPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
C+ +V E +P G+L + L + L ++LD A G+EYL +
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNR----LTVKKLLQMSLDAAAGMEYLES---K 112
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT----FGYLAPEYAVT 774
+ IHRDL N L+G++ K++DFG+ R E +G I T G + APE
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNY 169
Query: 775 GRVTTKVDVFSFGVILMELITG 796
GR T++ DV+S+G++L E +
Sbjct: 170 GRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 595 FSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS----EIAVLTKVR 649
+ + LG G +G VYK + G +A+K++ S EI++L +++
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR----LDNEEEGIPSTALREISLLKELK 56
Query: 650 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
H ++V LL + LVFEY L +++ ++ PL N +I + RG+
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL----DKRPGPLSPNLIKSIMYQLLRGL 111
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
Y H +HRDLKP NIL+ D K+ADFGL R + + T Y AP
Sbjct: 112 AYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAP 167
Query: 770 E-------YAVTGRVTTKVDVFSFGVILMELITGR 797
E Y +T VD++S G I E+ITG+
Sbjct: 168 EILLGSKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 8e-25
Identities = 82/295 (27%), Positives = 139/295 (47%), Gaps = 45/295 (15%)
Query: 601 LGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
LG G FG V+ E + D +AVK ++ S +F E +LT ++H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIV 70
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA------EEGLKPLEW--NRRLTIALDVA 706
G C++G+ ++VFEYM G L++ + EG +P E ++ L IA +A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG---- 762
G+ Y LA Q F+HRDL N L+G+++ K+ DFG+ R + + R+ G
Sbjct: 131 AGMVY---LASQHFVHRDLATRNCLVGENLLVKIGDFGMSR---DVYSTDYYRVGGHTML 184
Query: 763 TFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLS 821
++ PE + + TT+ DV+S GV+L E+ T G++ + E + +T R +
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRP 244
Query: 822 KDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876
+ + V +L C REP+ R ++ ++L +L +
Sbjct: 245 RTCPKE------------------VYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 63/199 (31%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 601 LGRGGFGTVYK-GELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
+G G G V+K + G +A+K++ + G + EI L +H ++V LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 719
G+ +LV EYMP LS + + E L + + L +GV Y+H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRD-EERPLPEAQ-VKSYMRML--LKGVAYMHAN---G 119
Query: 720 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR-VT 778
+HRDLKP+N+L+ D K+ADFGL RL E + + + T Y APE R
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 779 TKVDVFSFGVILMELITGR 797
VD+++ G I EL+ G
Sbjct: 180 PGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 63/219 (28%), Positives = 90/219 (41%), Gaps = 44/219 (20%)
Query: 599 NILGRGGFGTVYKGE-LHDGTKIAVKRM------EAGVISGKGLTEFKSEIAVLTKVRHR 651
+G G +G VYK G +A+K++ E I+ EI +L K+RH
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPIT------AIREIKLLQKLRHP 58
Query: 652 HLVALLGHCLD--GNEKLLVFEYMP---QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 706
++V L +VFEYM G L + E +K +
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIK--------CYMKQLL 110
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFG 765
G++YLH +HRD+K SNIL+ +D K+ADFGL R R+ T
Sbjct: 111 EGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLW 166
Query: 766 YLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 797
Y PE Y +VD++S G IL EL G+
Sbjct: 167 YRPPELLLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 93/286 (32%), Positives = 132/286 (46%), Gaps = 75/286 (26%)
Query: 595 FSEENILGRGGFGTVYKG-ELHDGTKIAVKRM-----EAGV-ISGKGLTEFKSEIAVLTK 647
+ E +G G +GTVYK +L+ G +A+K++ E G+ +S EIA+L +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS------TLREIALLKQ 54
Query: 648 VR---HRHLVALL----GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL 699
+ H ++V LL G D KL LVFE++ Q L+ ++ + GL P E + L
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPP-ETIKDL 112
Query: 700 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE-- 757
L RGV++LH +H +HRDLKP NIL+ D + K+ADFGL R+ S E
Sbjct: 113 MRQL--LRGVDFLH--SH-RIVHRDLKPQNILVTSDGQVKIADFGLARIY-----SFEMA 162
Query: 758 -TRIAGTFGYLAPE------YAVTGRVTTKVDVFSFGVILMELITGRKAL----DESQ-- 804
T + T Y APE YA T VD++S G I EL R+ L E+
Sbjct: 163 LTSVVVTLWYRAPEVLLQSSYA------TPVDMWSVGCIFAELFR-RRPLFRGTSEADQL 215
Query: 805 ---------PEESMHLVTWFRRIHLSKDSFH-------KAIDPTID 834
P E W R + L + SF K+ P I
Sbjct: 216 DKIFDVIGLPSEE----EWPRNVSLPRSSFPSYTPRSFKSFVPEIC 257
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 8/205 (3%)
Query: 594 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+F LG+G +G+VYK + L D A+K ++ G +S K + +EI +L V H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+++ LDGN+ +V EY P G LS+ I ++ K + I + + RG++ L
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKR-KLIPEQEIWRIFIQLLRGLQAL 119
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
H Q +HRDLK +NILL + K+ D G+ ++ K +T+I GT Y+APE
Sbjct: 120 H---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK--KNMAKTQI-GTPHYMAPEVW 173
Query: 773 VTGRVTTKVDVFSFGVILMELITGR 797
+ K D++S G +L E+ T
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 66/199 (33%), Positives = 112/199 (56%), Gaps = 13/199 (6%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
LG G FG V+ G + TK+A+K ++ G +S + F +E ++ +++H LV L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA---FLAEANLMKQLQHPRLVRL--YA 68
Query: 661 LDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 719
+ E + ++ EYM G+L F EG+K L N+ + +A +A G+ ++ ++
Sbjct: 69 VVTQEPIYIITEYMENGSLVD--FLKTPEGIK-LTINKLIDMAAQIAEGMAFIE---RKN 122
Query: 720 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTT 779
+IHRDL+ +NIL+ + + K+ADFGL RL + + + + APE G T
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 780 KVDVFSFGVILMELIT-GR 797
K DV+SFG++L E++T GR
Sbjct: 183 KSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-24
Identities = 72/213 (33%), Positives = 111/213 (52%), Gaps = 12/213 (5%)
Query: 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRH 652
F + +LG+GGFG V ++ G A K++E I KG + +E +L KV R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 653 LVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
+V+L + + + L LV M G L HI++ E G E R + A ++ G+E
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF---EEGRAVFYAAEICCGLED 117
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
LH + ++RDLKP NILL D +++D GL PEG+ +I+ R+ GT GY+APE
Sbjct: 118 LH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRV-GTVGYMAPEV 172
Query: 772 AVTGRVTTKVDVFSFGVILMELITGRKALDESQ 804
R T D ++ G +L E+I G+ + +
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 74/229 (32%), Positives = 109/229 (47%), Gaps = 32/229 (13%)
Query: 593 NNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLT 646
NN +G+G FG V++ T +AVK ++ S +F+ E A++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMA 63
Query: 647 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLS---RHIFNWAEEGLK------------ 691
+ H ++V LLG C G L+FEYM G L+ RH A+ L
Sbjct: 64 EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 692 --PLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-- 747
PL +L IA VA G+ YL + + F+HRDL N L+G++M K+ADFGL R
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 180
Query: 748 -LAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
A K S I ++ PE R TT+ DV+++GV+L E+ +
Sbjct: 181 YSADYYKASENDAIP--IRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 73/206 (35%), Positives = 106/206 (51%), Gaps = 12/206 (5%)
Query: 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRH 652
F + +LG+GGFG V ++ G A KR+E I KG + +E +L KV +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 653 LVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
+V L + + + L LV M G L HI+N G E R L A ++ G+E
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF---EEERALFYAAEILCGLED 117
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
LH ++ ++RDLKP NILL D +++D GL PEG+ SI R+ GT GY+APE
Sbjct: 118 LH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIRGRV-GTVGYMAPEV 172
Query: 772 AVTGRVTTKVDVFSFGVILMELITGR 797
R T D + G ++ E+I G+
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 63/201 (31%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 601 LGRGGFGTVYKGELHDGT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
LG G FG V +GE +AVK +++ +S + +F E A++ + H +L+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRL 61
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
G L + V E P G+L ++ L + A+ +A G+ YL
Sbjct: 62 YGVVLTHPLMM-VTELAPLGSLLD---RLRKDALGHFLISTLCDYAVQIANGMRYLE--- 114
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG--SIETRIAGTFGYLAPEYAVT 774
+ FIHRDL NILL D + K+ DFGL+R P+ + +E + F + APE T
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 775 GRVTTKVDVFSFGVILMELIT 795
+ DV+ FGV L E+ T
Sbjct: 175 RTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 69/206 (33%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 599 NILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
++G+G FG VY G L D AVK + + + + +F E ++ H +++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR-ITDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 655 ALLGHCLDGN-EKLLVFEYMPQGTLSRHIFNWAEE-GLKPLEWNRRLTIALDVARGVEYL 712
+LLG CL L+V YM G L I + +K L + L VA+G+EYL
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGMEYL 114
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK-GSIETRIAGTF--GYLAP 769
A + F+HRDL N +L + KVADFGL R + + S+ ++A
Sbjct: 115 ---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 770 EYAVTGRVTTKVDVFSFGVILMELIT 795
E T + TTK DV+SFGV+L EL+T
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 71/218 (32%), Positives = 101/218 (46%), Gaps = 40/218 (18%)
Query: 600 ILGRGGFGTVYKG---ELHDGTKI--AVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
+LG G FGTVYKG + KI A+K + S K E E V+ V H H+V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVV 72
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE--GLKPLEWNRRLTIALDVARGVEYL 712
LLG CL ++ L+ + MP G L ++ N + L W + +A+G+ YL
Sbjct: 73 RLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL 125
Query: 713 --HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL---------APEGKGSIETRIA 761
L +HRDL N+L+ K+ DFGL +L A GK I+
Sbjct: 126 EEKRL-----VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK---- 176
Query: 762 GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRK 798
++A E + T K DV+S+GV + EL+T G K
Sbjct: 177 ----WMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 68/200 (34%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 601 LGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGK-GLTEFKSEIAVLTKVRHRHLVALLG 658
LG+GGFG V ++ K+ A K+++ + + G +E +L KV R +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 659 HCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
+ + + L LV M G L HI+N E G R + A + G+E+LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPE---ARAIFYAAQIICGLEHLH---Q 113
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV 777
+ ++RDLKP N+LL D +++D GL GK I+ R AGT GY+APE
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-KIKGR-AGTPGYMAPEVLQGEVY 171
Query: 778 TTKVDVFSFGVILMELITGR 797
VD F+ G L E+I GR
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 73/210 (34%), Positives = 101/210 (48%), Gaps = 31/210 (14%)
Query: 601 LGRGGFGTV--YKGE-LHDGTK--IAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLV 654
LG G FG V Y + +DGT +AVK ++ G+ T +K EI +L + H ++V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILKTLYHENIV 69
Query: 655 ALLGHCLDGNEK--LLVFEYMPQGTL----SRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
G C + K L+ EY+P G+L +H N A+ L A + G
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQ----------LLLFAQQICEG 119
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG---TFG 765
+ YLH Q +IHRDL N+LL +D K+ DFGL + PEG R G F
Sbjct: 120 MAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 766 YLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
Y A E + + DV+SFGV L EL+T
Sbjct: 177 Y-AVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 68/212 (32%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 599 NILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
N +G G FG VY L G +AVK + K + E E+ VL ++H +LV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 658 G---HCLDGNEKLLVF-EYMPQGTLSRHIFNWAEEG-LKPLEWNRRLTIALDVARGVEYL 712
G H EK+ +F EY GTL E G + R T+ L G+ YL
Sbjct: 66 GVEVH----REKVYIFMEYCSGGTLEE----LLEHGRILDEHVIRVYTLQL--LEGLAYL 115
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGK--GSIETRIAGTFGYLAP 769
H +HRD+KP+NI L + K+ DFG V+L G +AGT Y+AP
Sbjct: 116 H---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
Query: 770 EYAVTGRVTTK---VDVFSFGVILMELITGRK 798
E G+ D++S G +++E+ TG++
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 92/306 (30%), Positives = 137/306 (44%), Gaps = 52/306 (16%)
Query: 593 NNFSEENILGRGGFGTVYKGELH-DGTKI--AVKRMEAGVISGKGLTEFKSEIAVLTKV- 648
N+ ++++G G FG V K + DG ++ A+KRM+ S +F E+ VL K+
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLG 65
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTL------SRHI-----FNWAEEGLKPLEWNR 697
H +++ LLG C L EY P G L SR + F A L +
Sbjct: 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE 757
L A DVARG++YL + + FIHRDL NIL+G++ AK+ADFGL R G+ E
Sbjct: 126 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQ---E 175
Query: 758 TRIAGTFG-----YLAPEYAVTGRVTTKVDVFSFGVILMELIT--GRKALDESQPEESMH 810
+ T G ++A E TT DV+S+GV+L E+++ G + E
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 235
Query: 811 LVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870
L +R E L V +L C +PY+RP +
Sbjct: 236 LPQGYRL-------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276
Query: 871 LSSLVE 876
L+ ++E
Sbjct: 277 LNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 6e-23
Identities = 66/207 (31%), Positives = 106/207 (51%), Gaps = 16/207 (7%)
Query: 601 LGRGGFGTVYKGELHDGT---KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
LG G FG+V +G+L+ K+AVK M+ + + + +F SE + + H +++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 658 GHCLDGNEK------LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL--DVARGV 709
G CL E +++ +M G L + ++ G P ++ + D+A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT-FGYLA 768
EYL + +SFIHRDL N +L ++M VADFGL + G + RIA ++A
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 769 PEYAVTGRVTTKVDVFSFGVILMELIT 795
E TTK DV+SFGV + E+ T
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 9e-23
Identities = 60/195 (30%), Positives = 105/195 (53%), Gaps = 9/195 (4%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
LG G FG V+ G ++ TK+AVK ++ G +S + F E ++ ++H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 661 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 720
++ EYM +G+L F ++EG K + + + + +A G+ Y+ +++
Sbjct: 71 TKEEPIYIITEYMAKGSLLD--FLKSDEGGK-VLLPKLIDFSAQIAEGMAYIE---RKNY 124
Query: 721 IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTK 780
IHRDL+ +N+L+ + + K+ADFGL R+ + + + + APE G T K
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 781 VDVFSFGVILMELIT 795
DV+SFG++L E++T
Sbjct: 185 SDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 61/236 (25%), Positives = 94/236 (39%), Gaps = 48/236 (20%)
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKV-R 649
++F I+G G F TV E + A+K ++ +I K + K E VLT++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 650 HRHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR- 707
H ++ L D E L V EY P G L ++I + ++ R
Sbjct: 61 HPGIIKLYYTFQD-EENLYFVLEYAPNGELLQYI-------------RKYGSLDEKCTRF 106
Query: 708 -------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRI 760
+EYLH IHRDLKP NILL DM K+ DFG ++ +
Sbjct: 107 YAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163
Query: 761 A-------------------GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 797
GT Y++PE D+++ G I+ +++TG+
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 72/232 (31%), Positives = 113/232 (48%), Gaps = 18/232 (7%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
LG G FG V G+ +A+K ++ G +S EF E V+ K+ H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 661 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 720
+V EYM G L N+ E K + ++ L + DV G+ YL + Q F
Sbjct: 69 TKQRPIYIVTEYMSNGCL----LNYLREHGKRFQPSQLLEMCKDVCEGMAYLE--SKQ-F 121
Query: 721 IHRDLKPSNILLGDDMRAKVADFGLVR--LAPEGKGSIETRIAGTFGYLAPEYAVTGRVT 778
IHRDL N L+ D KV+DFGL R L E S+ ++ + PE + + +
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLLYSKFS 179
Query: 779 TKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRI---HLSKDSFH 826
+K DV++FGV++ E+ + G+ + E++ V+ R+ HL+ + +
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVY 231
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 69/231 (29%), Positives = 103/231 (44%), Gaps = 23/231 (9%)
Query: 599 NILGRGGFGTVYKGEL----HDGTKIAVK-RMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
LG G FG VY+G D ++ V + S + ++F E +++K H+++
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLS---RHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
V L+G + + ++ E M G L R E L L A DVA+G +
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERP-SSLTMKDLLFCARDVAKGCK 130
Query: 711 YLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIAGT---- 763
YL FIHRD+ N LL G AK+ADFG+ R + + R G
Sbjct: 131 YLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR---DIYRASYYRKGGRAMLP 184
Query: 764 FGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVT 813
++ PE + G T+K DV+SFGV+L E+ + G +E M VT
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 12/207 (5%)
Query: 594 NFSEENILGRGGFGTVYKGELHDGTKI-AVKRM-EAGVISGKGLTEFKSEIAVLTKVRHR 651
+F ++G+G FG V + D K+ A+K M + + + +E +L ++ H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
LV L D LV + + G L H+ + +K E + I ++ +EY
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHL----SQKVKFSEEQVKFWIC-EIVLALEY 115
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
LH + IHRD+KP NILL + + DF + + T +GT GY+APE
Sbjct: 116 LH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST--SGTPGYMAPEV 170
Query: 772 AVTGRVTTKVDVFSFGVILMELITGRK 798
+ VD +S GV E + G++
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 23/226 (10%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
LG G FG V+ G+ K+A+K + G +S + +F E V+ K+ H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 661 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 720
+V E+M G L N+ + L + L++ DV G+EYL SF
Sbjct: 69 TQQKPLYIVTEFMENGCL----LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSF 121
Query: 721 IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFG------YLAPEYAVT 774
IHRDL N L+ KV+DFG+ R ++ + G + PE
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYV------LDDEYTSSSGAKFPVKWSPPEVFNF 175
Query: 775 GRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIH 819
+ ++K DV+SFGV++ E+ T G+ ++ E + +++ R++
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 71/205 (34%), Positives = 104/205 (50%), Gaps = 24/205 (11%)
Query: 601 LGRGGFGTVYKG--ELHDGTKI--AVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
LG G FG+V KG + G ++ AVK ++ I+ G EF E +V+ ++ H +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA-GKKEFLREASVMAQLDHPCIVRL 61
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAE-EGLKPLEWNRRLTIALDVARGVEYLHGL 715
+G C G +LV E P G L +++ E E A VA G+ YL
Sbjct: 62 IGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLES- 113
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFG-----YLAPE 770
+ F+HRDL N+LL + +AK++DFG+ R G GS R A T G + APE
Sbjct: 114 --KHFVHRDLAARNVLLVNRHQAKISDFGMSRAL--GAGSDYYR-ATTAGRWPLKWYAPE 168
Query: 771 YAVTGRVTTKVDVFSFGVILMELIT 795
G+ ++K DV+S+GV L E +
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 6e-22
Identities = 62/193 (32%), Positives = 100/193 (51%), Gaps = 8/193 (4%)
Query: 600 ILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
+LG+G FG V+KG L D T +AVK + + + +F SE +L + H ++V L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI-KFLSEARILKQYDHPNIVKLIGV 60
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 719
C +V E +P G + +E L+ + + ALD A G+ YL ++
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDE----LKTKQLVKFALDAAAGMAYLES---KN 113
Query: 720 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTT 779
IHRDL N L+G++ K++DFG+ R +G S + APE GR ++
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 780 KVDVFSFGVILME 792
+ DV+S+G++L E
Sbjct: 174 ESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 68/287 (23%), Positives = 127/287 (44%), Gaps = 34/287 (11%)
Query: 592 TNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEA-GVISGKGLTEFKSEIAVLTKVR 649
NF E +G+G F VYK L DG +A+K+++ ++ K + EI +L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 650 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
H +++ L ++ NE +V E G LSR I ++ ++ + + + + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQK-RLIPERTIWKYFVQLCSAL 119
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
E++H + +HRD+KP+N+ + K+ D GL R K + + GT Y++P
Sbjct: 120 EHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSP 175
Query: 770 EYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH------LSKD 823
E K D++S G +L E+ AL + M+L + ++I L D
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKKIEKCDYPPLPAD 231
Query: 824 SFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870
+ + + +L C +P +RPD+ + + V
Sbjct: 232 HYSEEL-----------------RDLVSRCINPDPEKRPDISYVLQV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 67/218 (30%), Positives = 98/218 (44%), Gaps = 46/218 (21%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISG--KGL--TEFKSEIAVLTKVRHRHLVA 655
LG G + VYK G +A+K+++ G G+ T + EI +L +++H +++
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNIIG 66
Query: 656 LL---GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVA 706
LL GH N LVFE+M L + I + + LT L
Sbjct: 67 LLDVFGH--KSNIN-LVFEFME-TDLEKVIKD----------KSIVLTPADIKSYMLMTL 112
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY 766
RG+EYLH +HRDLKP+N+L+ D K+ADFGL R + ++ T Y
Sbjct: 113 RGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWY 168
Query: 767 LAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 797
APE Y V VD++S G I EL+
Sbjct: 169 RAPELLFGARHYGVG------VDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 51/219 (23%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS--------EIAVLTKV-RH 650
LG G FG+VY G +A+K+M+ +F S E+ L K+ H
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK---------KKFYSWEECMNLREVKSLRKLNEH 57
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
++V L + +E VFEYM +G L + + + KP + +I + +G+
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYM-EGNLYQLM---KDRKGKPFSESVIRSIIYQILQGLA 113
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE-----TRIAGTFG 765
++H F HRDLKP N+L+ K+ADFGL R I T T
Sbjct: 114 HIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTRW 163
Query: 766 YLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 797
Y APE Y ++ VD+++ G I+ EL T R
Sbjct: 164 YRAPEILLRSTSY------SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 28/213 (13%)
Query: 601 LGRGGFGTVY----KGELHDG--TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
LG+G FG VY KG + D T++A+K + S + EF +E +V+ + H+V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVV 72
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE-----GLKPLEWNRRLTIALDVARGV 709
LLG G L++ E M +G L ++ + E P + + +A ++A G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE-------GKGSIETRIAG 762
YL+ F+HRDL N ++ +D K+ DFG+ R E GKG + R
Sbjct: 133 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 763 TFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
+++PE G TT DV+SFGV+L E+ T
Sbjct: 187 ---WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 74/220 (33%), Positives = 103/220 (46%), Gaps = 33/220 (15%)
Query: 600 ILGRGGFGTVYKGEL-----HDGT-KIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRH 652
LG G FG V K E + T +AVK M + K L++ SE+ ++ + +H++
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVK-MLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLT------I 701
++ LLG C +V EY G L +R P LT
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA 761
A VARG+E+L A + IHRDL N+L+ +D K+ADFGL R I+
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYRK 190
Query: 762 GTFGYL-----APEYAVTGRV-TTKVDVFSFGVILMELIT 795
T G L APE A+ RV T + DV+SFGV+L E+ T
Sbjct: 191 TTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-21
Identities = 86/281 (30%), Positives = 134/281 (47%), Gaps = 28/281 (9%)
Query: 597 EENILGRGGFGTVYKGE-LHDGTKIAVKRM-EAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
EEN++ RG G YKG+ + +G + VK + + I SEIA + K++H ++V
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-------SSEIADMGKLQHPNIV 746
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
L+G C L+ EY+ LS E L+ L W RR IA+ +A+ + +LH
Sbjct: 747 KLIGLCRSEKGAYLIHEYIEGKNLS--------EVLRNLSWERRRKIAIGIAKALRFLHC 798
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT 774
+ + +L P I++ D +RL+ G +T+ + Y+APE T
Sbjct: 799 RCSPAVVVGNLSPEKIII------DGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRET 852
Query: 775 GRVTTKVDVFSFGVILMELITGRKALD-ESQPEESMHLVTWFRRIHLSKDSFHKAIDPTI 833
+T K D++ FG+IL+EL+TG+ D E S +V W R + S IDP+I
Sbjct: 853 KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS--IVEWARYCY-SDCHLDMWIDPSI 909
Query: 834 DLNEGILAS-ISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873
+ + + I V LA HC A +P RP + L S
Sbjct: 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 70/206 (33%), Positives = 105/206 (50%), Gaps = 12/206 (5%)
Query: 595 FSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRH 652
F +LG+GGFG V ++ K+ A K++E I KG +E +L KV R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 653 LVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
+V+L + + + L LV M G L HI+N G + R + A ++ G+E
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGF---DEERAVFYAAEITCGLED 117
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
LH + ++RDLKP NILL D +++D GL PEG+ +I R+ GT GY+APE
Sbjct: 118 LH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TIRGRV-GTVGYMAPEV 172
Query: 772 AVTGRVTTKVDVFSFGVILMELITGR 797
R T D + G ++ E+I G+
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 3e-21
Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 601 LGRGGFGTV------YKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
LG+GGFG V G+++ K+ KR++ SG+ + + EI L KV +V
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK--SGEKMALLEKEI--LEKVNSPFIV 56
Query: 655 ALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
L + + L LV M G L HI+N E GL E R + + + G+ +LH
Sbjct: 57 NL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL---EMERVIHYSAQITCGILHLH 112
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV 773
+ ++RD+KP N+LL D +++D GL +GK T+ AGT GY+APE
Sbjct: 113 SM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI--TQRAGTNGYMAPEILK 167
Query: 774 TGRVTTKVDVFSFGVILMELITGR 797
+ VD F+ G + E++ GR
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 599 NILGRGGFGTVYK-GELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+G+G FGTV K DG + K ++ G ++ K + SE+ +L +++H ++V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 658 GHCLD-GNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLE----WN--RRLTIALDVARGV 709
+D N+ L +V EY G L++ I +E K +E W +L +AL
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER-KYIEEEFIWRILTQLLLALY----- 119
Query: 710 EYLHGLAH--QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
H + + +HRDLKP+NI L + K+ DFGL ++ S GT Y+
Sbjct: 120 -ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS-SFAKTYVGTPYYM 177
Query: 768 APEYAVTGRVTTKVDVFSFGVILMELITGR 797
+PE K D++S G ++ EL
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 56/207 (27%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 598 ENILGRGGFGTVYKGELHDGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
E ++G G FG V +G L K +A+K ++AG S K +F +E +++ + H ++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNI 67
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
+ L G +++ EYM G+L + + + + + + +A G++YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMKYL- 122
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR-----IAGTFGYLA 768
+ +++HRDL NIL+ ++ KV+DFGL R + + + T+ I T A
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----A 176
Query: 769 PEYAVTGRVTTKVDVFSFGVILMELIT 795
PE + T+ DV+SFG+++ E+++
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 601 LGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALL 657
+ +G +G V+ + T A+K ++ + K + +E +L++ + ++V L
Sbjct: 1 ISKGAYGRVFLAK-KKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSR--HIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
+ G + L LV EY+P G L+ +E + R+ IA ++ +EYLH
Sbjct: 60 -YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA------RIYIA-EIVLALEYLHS 111
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLV------RLAPEGKGSIET-RIAGTFGYL 767
IHRDLKP NIL+ + K+ DFGL R E RI GT Y+
Sbjct: 112 N---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 768 APEYAVTGRVTTK-VDVFSFGVILMELITGRKALDESQPEE 807
APE + G+ +K VD +S G IL E + G PEE
Sbjct: 169 APE-VILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 5e-21
Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 42/228 (18%)
Query: 600 ILGRGGFGTVYKGE------LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
LG G FG V K T +AVK ++ S + L + SE +L +V H H+
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE-LRDLLSEFNLLKQVNHPHV 65
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTL-------------------SRHIFNWAEEGLKPLE 694
+ L G C LL+ EY G+L +R+ + L
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 695 WNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE--- 751
++ A ++RG++YL A +HRDL N+L+ + + K++DFGL R E
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 752 ----GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
KG I + ++A E TT+ DV+SFGV+L E++T
Sbjct: 183 YVKRSKGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 6e-21
Identities = 60/218 (27%), Positives = 109/218 (50%), Gaps = 22/218 (10%)
Query: 595 FSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 650
F EE LG FG +YKG L+ D ++ + + + + EF+ E +++ ++ H
Sbjct: 9 FMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHH 66
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA----------EEGL--KPLEWNRR 698
++V LLG ++FEY+ QG L + + E+G L+
Sbjct: 67 PNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 699 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIE 757
L IA+ +A G+EYL + F+H+DL NIL+G+ + K++D GL R + ++
Sbjct: 127 LHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 758 TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
+ ++ PE + G+ ++ D++SFGV+L E+ +
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 29/208 (13%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRM----EAGVISGKGLTEFKSEIAVLTKVRHRHLVA 655
+G G +G VYK + G +A+K++ E+ I L E K L ++ H +++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKL----LKELNHPNIIK 62
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY--LH 713
LL + LVFE+M + L L +R+ + + + Y L
Sbjct: 63 LLDVFRHKGDLYLVFEFM-------------DTDLYKLIKDRQRGLPESLIKSYLYQLLQ 109
Query: 714 GLAH---QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
GLA +HRDLKP N+L+ + K+ADFGL R T T Y APE
Sbjct: 110 GLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVVTRWYRAPE 168
Query: 771 YAVTGRV-TTKVDVFSFGVILMELITGR 797
+ + +T VD++S G I EL++ R
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 15/220 (6%)
Query: 595 FSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
F LG G +G+VYK +H G +A+K + + L E EI++L + +
Sbjct: 5 FDILEKLGEGSYGSVYKA-IHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDSPY 59
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+V G + +V EY G++S I + L E I +G+EYL
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVS-DIMKITNKTLTEEEIA---AILYQTLKGLEYL 115
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
H IHRD+K NILL ++ +AK+ADFG+ + T I GT ++APE
Sbjct: 116 H---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVI 171
Query: 773 VTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLV 812
K D++S G+ +E+ G+ + P ++ ++
Sbjct: 172 QEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI 211
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 8e-21
Identities = 67/225 (29%), Positives = 106/225 (47%), Gaps = 39/225 (17%)
Query: 595 FSEENILGRGGFGTVYKG---ELHDGTKIAVKRMEAGVISGKGLTEFKS---EIAVLTKV 648
+ E +GRG +G VYK DG + A+K+ + G+++ S EIA+L ++
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQ--SACREIALLREL 59
Query: 649 RHRHLVALLGHCLDGNEKL--LVFEYMPQGTLSRHIFNWAEEG---------LKPLEWNR 697
+H ++V+L+ L+ +K L+F+Y I + + +K L W
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEHDLW--QIIKFHRQAKRVSIPPSMVKSLLWQ- 116
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDM---RAKVADFGLVRL--APE 751
+ GV YLH +HRDLKP+NIL+ G+ K+ D GL RL AP
Sbjct: 117 -------ILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
Query: 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTK-VDVFSFGVILMELIT 795
+ + T Y APE + R TK +D+++ G I EL+T
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 8e-21
Identities = 68/240 (28%), Positives = 106/240 (44%), Gaps = 34/240 (14%)
Query: 594 NFSEENILGRGGFGTVYKGELHDGTKI-----------------AVKRMEAGVISGKGLT 636
NF E+ LG G FG V+ E AVK +
Sbjct: 8 NFVEK--LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDN-ARE 64
Query: 637 EFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL----SRHIF--NWAEEGL 690
+F E+ +L+++ ++ LLG C ++ EYM G L +H+ +
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750
K L ++ L +A +A G+ YL L +F+HRDL N L+G + K+ADFG+ R
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 751 EGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESM 809
++ R ++A E + G+ TTK DV++FGV L E++T L QP E +
Sbjct: 182 SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT----LCREQPYEHL 237
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 9e-21
Identities = 71/217 (32%), Positives = 107/217 (49%), Gaps = 29/217 (13%)
Query: 598 ENILGRGGFGTVYKGELH-DGTKI-AVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLV 654
E+++G G FG V + + DG K+ A +M S +F E+ VL K+ H +++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTL------SRHI-----FNWAEEGLKPLEWNRRLTIAL 703
LLG C + + EY P G L SR + F L + L A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT 763
DVA G++YL + + FIHRDL N+L+G+++ +K+ADFGL R E + T
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR-------GEEVYVKKT 176
Query: 764 FG-----YLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
G ++A E TTK DV+SFGV+L E+++
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 68/203 (33%), Positives = 112/203 (55%), Gaps = 15/203 (7%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
E LG G FG V+ + TK+AVK M+ G +S + F +E V+ ++H LV L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKL- 66
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLK-PLEWNRRLTIALDVARGVEYLHGL 715
H + E + ++ E+M +G+L F ++EG K PL + + + +A G+ ++
Sbjct: 67 -HAVVTKEPIYIITEFMAKGSLLD--FLKSDEGSKQPLP--KLIDFSAQIAEGMAFIE-- 119
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG 775
+++IHRDL+ +NIL+ + K+ADFGL R+ + + + + APE G
Sbjct: 120 -QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 178
Query: 776 RVTTKVDVFSFGVILMELIT-GR 797
T K DV+SFG++LME++T GR
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 73/221 (33%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 587 VLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK--RM--EAGVISGKGLTEFKSE 641
R+VT F + N +G G +G VY+ + G +A+K RM E I L E
Sbjct: 2 RCRSVTE-FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL----RE 56
Query: 642 IAVLTKVRHRHLVALL----GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNR 697
I +L +RH ++V L G LD LV EY Q L+ + N P ++
Sbjct: 57 ITLLLNLRHPNIVELKEVVVGKHLD--SIFLVMEYCEQ-DLASLLDNMP----TPFSESQ 109
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE 757
+ L + RG++YLH IHRDLK SN+LL D K+ADFGL R +
Sbjct: 110 VKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT 166
Query: 758 TRIAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGR 797
++ T Y APE + TT +D+++ G IL EL+ +
Sbjct: 167 PKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 75/296 (25%), Positives = 138/296 (46%), Gaps = 45/296 (15%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
++ +++ ++G G FG V++G L + +A+K ++ G + K +F SE +++ +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQF 63
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
H +++ L G +++ EYM G L +++ + E + L +A G
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGE-FSSYQLVGMLR---GIAAG 119
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA---PEGK-----GSIETRI 760
++YL + +++HRDL NIL+ ++ KV+DFGL R+ PEG G I R
Sbjct: 120 MKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR- 175
Query: 761 AGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIH 819
+ APE + T+ DV+SFG+++ E+++ G + + E M
Sbjct: 176 -----WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM---------- 220
Query: 820 LSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875
KAI+ L + S V +L C ++ +RP VN+L L+
Sbjct: 221 -------KAINDGFRL-PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 73/274 (26%), Positives = 123/274 (44%), Gaps = 32/274 (11%)
Query: 599 NILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
++G G VY L + K+A+KR++ + E + E+ +++ H ++V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 658 GHCLDGNEKLLVFEYMPQGTLS---RHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
+ G+E LV Y+ G+L + + L+ T+ +V +G+EYLH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPR-----GGLDEAIIATVLKEVLKGLEYLHS 120
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETR--IAGTFGYLAPE- 770
IHRD+K NILLG+D K+ADFG+ LA G + + R GT ++APE
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 771 -YAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829
V G K D++SFG+ +EL TG + P + + L L D
Sbjct: 178 MEQVHG-YDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT-------LQNDP----- 224
Query: 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPD 863
P+++ + ++ C ++P +RP
Sbjct: 225 -PSLETGADYKKYSKSFRKMISLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 18/211 (8%)
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRM----EAGVISGKGLTEFKSEIAVLTK 647
N + ++G G +G V K G +A+K+ + + L E+ VL +
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL----REVKVLRQ 56
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+RH ++V L LVFEY+ + L + + GL P + R L +
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLL--ELLEASPGGLPP-DAVRSYIWQL--LQ 111
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
+ Y H + IHRD+KP NIL+ + K+ DFG R S T T Y
Sbjct: 112 AIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYR 168
Query: 768 APEYAVTGRVTTK-VDVFSFGVILMELITGR 797
APE V K VDV++ G I+ EL+ G
Sbjct: 169 APELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 28/213 (13%)
Query: 601 LGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
LG+G FG VY+G D T++AVK + S + EF +E +V+ H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVV 72
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE-----GLKPLEWNRRLTIALDVARGV 709
LLG G L+V E M G L ++ + E G P + +A ++A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE-------GKGSIETRIAG 762
YL+ + F+HRDL N ++ D K+ DFG+ R E GKG + R
Sbjct: 133 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 763 TFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
++APE G TT D++SFGV+L E+ +
Sbjct: 187 ---WMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRH 652
F +LG+GGFG V ++ G A K++E I KG +E +L KV R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 653 LVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
+V+L + + + L LV M G L HI+N G + R + A ++ G+E
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF---DEQRAIFYAAELCCGLED 117
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
L + ++RDLKP NILL D +++D GL PEG+ ++ R+ GT GY+APE
Sbjct: 118 LQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TVRGRV-GTVGYMAPEV 172
Query: 772 AVTGRVTTKVDVFSFGVILMELITGR 797
+ T D + G ++ E+I G+
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 30/205 (14%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVRHRHLVAL 656
+G G +G VYK ++ G +A+K VI G + EI++L + RH ++VA
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIK-----VIKLEPGDDFEIIQQEISMLKECRHPNIVAY 65
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL---DVARGVEYLH 713
G L ++ +V EY G+L I+ PL L IA + +G+ YLH
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQ-DIYQ---VTRGPLS---ELQIAYVCRETLKGLAYLH 118
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFGYLAPEY 771
IHRD+K +NILL +D K+ADFG ++ + +I R GT ++APE
Sbjct: 119 ---ETGKIHRDIKGANILLTEDGDVKLADFG---VSAQLTATIAKRKSFIGTPYWMAPEV 172
Query: 772 A---VTGRVTTKVDVFSFGVILMEL 793
A G K D+++ G+ +EL
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 5e-20
Identities = 69/205 (33%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 601 LGRGGFGTVY------KGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
LG+GGFG V G+L+ K+ KR++ KG E +L KV R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK----KRKGYEGAMVEKRILAKVHSRFIV 56
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
+L + LV M G L HI+N EE R + G+E+LH
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEEN-PGFPEPRACFYTAQIISGLEHLH- 114
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETR-IAGTFGYLAPEYA 772
+ I+RDLKP N+LL +D +++D GL V L G +T+ AGT G++APE
Sbjct: 115 --QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELK---DGQSKTKGYAGTPGFMAPELL 169
Query: 773 VTGRVTTKVDVFSFGVILMELITGR 797
VD F+ GV L E+I R
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-20
Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 14/208 (6%)
Query: 594 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
NF + LG G + TVYKG G +A+K + G T + EI+++ +++H +
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHEN 59
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+V L N+ +LVFEYM + L +++ G L+ N + + +G+ +
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRG--ALDPNTVKSFTYQLLKGIAFC 116
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--APEGKGSIETRIAGTFGYLAPE 770
H +HRDLKP N+L+ K+ADFGL R P S E T Y AP+
Sbjct: 117 H---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV---TLWYRAPD 170
Query: 771 YAVTGRV-TTKVDVFSFGVILMELITGR 797
+ R +T +D++S G I+ E+ITGR
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 6e-20
Identities = 67/218 (30%), Positives = 109/218 (50%), Gaps = 25/218 (11%)
Query: 595 FSEENILGRGGFGTVYKGEL--HDGT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 650
F+ +LG+G FG+V + +L DG+ K+AVK ++A + S + EF E A + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 651 RHLVALLGHCLDGNEK------LLVFEYMPQGTLSRHIFNWAEE-GLKPLEWNRRLTI-- 701
+++ L+G L K +++ +M G L H F G +P + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDL--HTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG----KGSIE 757
+D+A G+EYL + ++FIHRDL N +L ++M VADFGL + G +G
Sbjct: 119 MIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 758 TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
+LA E TT DV++FGV + E++T
Sbjct: 176 KL---PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 66/241 (27%), Positives = 104/241 (43%), Gaps = 17/241 (7%)
Query: 603 RGGFGTVYKGELH-DGTKIAVKRM-EAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
+G FG+VY + G A+K + ++ +I+ +T K+E A++ VA L +
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 661 LDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 719
+ L LV EY+ G + I G P +W + +V GVE LH +
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAK--QYIAEVVLGVEDLHQ---RG 117
Query: 720 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTT 779
IHRD+KP N+L+ K+ DFGL R G + GT YLAPE +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGDDK 172
Query: 780 KVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGI 839
D +S G ++ E + G P+ + RRI+ ++ +DL +
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL-SRRINWPEEVKEFCSPEAVDLINRL 231
Query: 840 L 840
L
Sbjct: 232 L 232
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 62/202 (30%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 601 LGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFK---SEIAVLTKVRHRHLVA 655
LG G G V K LH G +AVK + + K E+ +L K ++V
Sbjct: 9 LGAGNSGVVSKV-LHRPTGKIMAVKTIRLEINE----AIQKQILRELDILHKCNSPYIVG 63
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
G + + + EYM G+L + I + + P ++ +A V +G+ YLH
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDK-ILKEVQGRI-PERILGKIAVA--VLKGLTYLHEK 119
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG 775
IHRD+KPSNIL+ + K+ DFG+ + S+ GT Y+APE
Sbjct: 120 HK--IIHRDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTFVGTSSYMAPERIQGN 174
Query: 776 RVTTKVDVFSFGVILMELITGR 797
+ K D++S G+ L+EL TGR
Sbjct: 175 DYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 64/209 (30%), Positives = 110/209 (52%), Gaps = 29/209 (13%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKG---LTEFKSEIAVLTKVRHRHLVAL 656
LG G FG+VY+G L DG AVK + G + + + EIA+L+K++H ++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 657 LGHCLDGNEKLLVF-EYMPQGTLSRHI--FNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
LG + + L +F E +P G+L++ + + E + L + R++ + G+EYLH
Sbjct: 68 LGTEREE-DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL-YTRQILL------GLEYLH 119
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA----GTFGYLAP 769
++ +HRD+K +NIL+ + K+ADFG+ K +E A G+ ++AP
Sbjct: 120 D---RNTVHRDIKGANILVDTNGVVKLADFGM------AKQVVEFSFAKSFKGSPYWMAP 170
Query: 770 EYAV-TGRVTTKVDVFSFGVILMELITGR 797
E G D++S G ++E+ TG+
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 73/263 (27%), Positives = 111/263 (42%), Gaps = 45/263 (17%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 650
++F LG G FG V K A+K + A ++ K + +E +L +RH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--- 707
LV L G D + LV EY+P G L F+ L + R VAR
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGEL----FSH-------LRKSGRFP--EPVARFYA 107
Query: 708 -----GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--- 759
+EYLH ++RDLKP N+LL D K+ DFG + ++ R
Sbjct: 108 AQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKR-------VKGRTYT 157
Query: 760 IAGTFGYLAPEYAVTGRVTTK-VDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI 818
+ GT YLAPE + + K VD ++ G+++ E++ G + P + + + +I
Sbjct: 158 LCGTPEYLAPE-IILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---IQI---YEKI 210
Query: 819 HLSKDSFHKAIDPTI-DLNEGIL 840
K F P DL +L
Sbjct: 211 LEGKVRFPSFFSPDAKDLIRNLL 233
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 4e-19
Identities = 65/220 (29%), Positives = 109/220 (49%), Gaps = 17/220 (7%)
Query: 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAG----VISGKGLTEFKSEIAVLTKVRHRHLV 654
+LG+G +GTVY G + G IAVK++E + + K + + E+ +L ++H ++V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
LG CLD N + E++P G++S + + G P + T + GV YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRF---GPLPEPVFCKYT--KQILDGVAYLH- 119
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLV-RLAPEG----KGSIETRIAGTFGYLAP 769
+ +HRD+K +N++L + K+ DFG RLA G ++ + GT ++AP
Sbjct: 120 --NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 770 EYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESM 809
E K D++S G + E+ TG+ L +M
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM 217
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 8e-19
Identities = 68/236 (28%), Positives = 115/236 (48%), Gaps = 38/236 (16%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGL----------------TEFKSEIAV 644
LG G FG V+ E+ + + + V G+ L +F E+ +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 645 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEG---------L 690
L++++ +++ LLG C+D + ++ EYM G L S H+ + E G L
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LA 749
+ ++ L +AL +A G++YL L +F+HRDL N L+G+++ K+ADFG+ R L
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQP 805
I+ R ++A E + G+ TT DV++FGV L E++ L + QP
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM----LCKEQP 241
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 8e-19
Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 33/202 (16%)
Query: 617 GTKIAVKRMEAGVISGKGL-TEFKSEIAVLTKVRHRHLVALL--GHCLDGNEKLL--VFE 671
G ++A+K + + F+ E A+ ++ H ++VALL G G LL VFE
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG---LLFAVFE 59
Query: 672 YMPQGTLSRHIFNWAEEG-LKPLEWNRRLTIALDVARGVEYLHGLAH---QSFIHRDLKP 727
Y+P TL + A +G L E R + LD LA Q +HRDLKP
Sbjct: 60 YVPGRTLREVL---AADGALPAGETGRLMLQVLD---------ALACAHNQGIVHRDLKP 107
Query: 728 SNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIA------GTFGYLAPEYAVTGRVT 778
NI++ G AKV DFG+ L P + + + GT Y APE VT
Sbjct: 108 QNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT 167
Query: 779 TKVDVFSFGVILMELITGRKAL 800
D++++G+I +E +TG++ +
Sbjct: 168 PNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 600 ILGRGGFG--TVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+LG+G FG T+Y+ D + + K + +S K + +EI +L+ ++H +++A
Sbjct: 7 VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
H +D N L+ EY GTL I + + E L + V Y+H
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYLFQIVSAVSYIH---K 119
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV 777
+HRD+K NI L K+ DFG+ ++ ET + GT Y++PE +
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKY 178
Query: 778 TTKVDVFSFGVILMELITGRKALDESQP 805
K D+++ G +L EL+T ++ D + P
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFDATNP 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-18
Identities = 67/244 (27%), Positives = 121/244 (49%), Gaps = 20/244 (8%)
Query: 572 DIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI 630
D ++LE ++S+ + ++ +G+G GTVY ++ G ++A+K+M
Sbjct: 1 DEEILEKLRTIVSVG---DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ 57
Query: 631 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA-EEG 689
K L +EI V+ + +H ++V L L G+E +V EY+ G+L+ + +EG
Sbjct: 58 PKKEL--IINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG 115
Query: 690 LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRL 748
+ + + + +E+LH IHRD+K NILLG D K+ DFG ++
Sbjct: 116 -------QIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165
Query: 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEES 808
PE S + + GT ++APE KVD++S G++ +E++ G P +
Sbjct: 166 TPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223
Query: 809 MHLV 812
++L+
Sbjct: 224 LYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-18
Identities = 72/216 (33%), Positives = 104/216 (48%), Gaps = 29/216 (13%)
Query: 599 NILGRGGFGTVYKGELH-DGTKI-AVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVA 655
+++G G FG V K + DG ++ A + S +F E+ VL K+ H +++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 656 LLGHCLDGNEKLLVFEYMPQGTL------SRHI-----FNWAEEGLKPLEWNRRLTIALD 704
LLG C L EY P G L SR + F A L + L A D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 705 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF 764
VARG++YL + + FIHRDL NIL+G++ AK+ADFGL R E + T
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTM 170
Query: 765 G-----YLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
G ++A E TT DV+S+GV+L E+++
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 18/217 (8%)
Query: 600 ILGRGGFGTVYKG---ELHDGTKIAVKRMEAGVISGK-GLTEFKSEIAVLTKVRHRHLVA 655
+LG G FGTV+KG D KI V SG+ E + + + H ++V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
LLG C G LV + P G+L H+ + L P R L + +A+G+ YL
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHV-RQHRDSLDP---QRLLNWCVQIAKGMYYLE-- 126
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEGKGSIETRIAGTFGYLAPEYAVT 774
+HR+L NILL D ++ADFG+ L P+ K + ++A E +
Sbjct: 127 -EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF 185
Query: 775 GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHL 811
GR T + DV+S+GV + E+++ ++P M
Sbjct: 186 GRYTHQSDVWSYGVTVWEMMSY-----GAEPYAGMRP 217
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-18
Identities = 74/241 (30%), Positives = 114/241 (47%), Gaps = 29/241 (12%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEA-GVISGKGLTEFKSEIAVLT 646
R V F +G G +G VYK D G +A+K++ G +T + EI +L
Sbjct: 4 RCVDK-FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILR 61
Query: 647 KVRHRHLVALLGHCLDGNEKL----------LVFEYMPQ---GTLSRHIFNWAEEGLKPL 693
++ HR++V L D + L LVFEYM G L + +++E+ +K
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF 121
Query: 694 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753
++L L+ G+ Y H ++F+HRD+K SNILL + + K+ADFGL RL +
Sbjct: 122 M--KQL---LE---GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170
Query: 754 GSIETRIAGTFGYLAPEYAV-TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLV 812
T T Y PE + R +DV+S G IL EL T + +Q + L+
Sbjct: 171 SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230
Query: 813 T 813
+
Sbjct: 231 S 231
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 36/215 (16%)
Query: 595 FSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI----SGKGLTEFKSEIAVLTKVR 649
F+ +G+G FG VYK + +A+K VI + + + + EI L++ R
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIK-----VIDLEEAEDEIEDIQQEIQFLSQCR 57
Query: 650 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKP--LEWNRRLTIALDVAR 707
++ G L G++ ++ EY G+ + LKP L+ I +V
Sbjct: 58 SPYITKYYGSFLKGSKLWIIMEYCGGGSCL--------DLLKPGKLDETYIAFILREVLL 109
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRI------A 761
G+EYLH + IHRD+K +NILL ++ K+ADFG+ G + + +
Sbjct: 110 GLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGV-------SGQLTSTMSKRNTFV 159
Query: 762 GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG 796
GT ++APE K D++S G+ +EL G
Sbjct: 160 GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 66/235 (28%), Positives = 110/235 (46%), Gaps = 23/235 (9%)
Query: 592 TNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 650
+ E +LG+G +G VY +L +IA+K + + + EIA+ + ++H
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIP--ERDSRYVQPLHEEIALHSYLKH 64
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFN-WAEEGLKPLEWNRRLTIAL---DVA 706
R++V LG + + E +P G+LS + + W PL+ N + TI +
Sbjct: 65 RNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWG-----PLKDNEQ-TIIFYTKQIL 118
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLV-RLAPEGKGSIETRIAGTF 764
G++YLH +HRD+K N+L+ K++DFG RLA G GT
Sbjct: 119 EGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA--GINPCTETFTGTL 173
Query: 765 GYLAPEYAVTGR--VTTKVDVFSFGVILMELITGRKALDE-SQPEESMHLVTWFR 816
Y+APE G D++S G ++E+ TG+ E +P+ +M V F+
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK 228
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 61/239 (25%), Positives = 102/239 (42%), Gaps = 40/239 (16%)
Query: 594 NFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
N E LGRG FG V+ + T + VK ++ +EF+ E+ + K
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK-TKDENLQSEFRRELDMFRK 64
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRH--IFNWAEEGLK--PLEWNRRLTIAL 703
+ H+++V LLG C + ++ EY G L + +E LK PL +++ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-------------LAP 750
+A G+++ L++ F+HRDL N L+ KV+ L + L P
Sbjct: 125 QIALGMDH---LSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP 181
Query: 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESM 809
+LAPE +TK DV+SFGV++ E+ T + +E +
Sbjct: 182 -------------LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV 227
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 4e-18
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 19/205 (9%)
Query: 601 LGRGGFGTV----YKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA 655
LG G FG V Y E + G ++AVK ++ G + + K EI +L + H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVK 70
Query: 656 LLGHCLD--GNEKLLVFEYMPQGTLSRHI-FNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
G C + GN L+ E++P G+L ++ N + LK L A+ + +G++YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQ-----LKYAVQICKGMDYL 125
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG--SIETRIAGTFGYLAPE 770
+ ++HRDL N+L+ + + K+ DFGL + K +++ + + APE
Sbjct: 126 ---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182
Query: 771 YAVTGRVTTKVDVFSFGVILMELIT 795
+ + DV+SFGV L EL+T
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 16/220 (7%)
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKV 648
N+ +LG+G FG VY ++ G ++AVK++ S K + + EI +L +
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 649 RHRHLVALLGHCLDGNEKLLVF-EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+H +V G CL +E L +F EYMP G++ + + L +
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG-----ALTETVTRKYTRQILE 115
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV-RL-APEGKGSIETRIAGTFG 765
GVEYLH +HRD+K +NIL K+ DFG RL G+ + GT
Sbjct: 116 GVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY 172
Query: 766 YLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQP 805
+++PE K DV+S G ++E++T + E +
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 601 LGRGGFGTVYKGELHDGTKIA---VKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+G G FG V GE H G A VK + A + L F E+ ++ H +++ L
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL-FLQEVQPYRELNHPNVLQCL 61
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
G C++ LLV E+ P G L ++ + + + + +A +VA G+ +LH
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-- 119
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEGKGSIETRIAGTFGYLAPEYA---- 772
FIH DL N L D+ K+ D+GL PE + A +LAPE
Sbjct: 120 -DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 773 ---VTGRVTTKVDVFSFGVILMELIT 795
+ T K +++S GV + EL T
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 26/214 (12%)
Query: 600 ILGRGGFGTVYKG-ELHDGTKIAVKRME-AGVISG------KGLTE-FKSEIAVLTKVRH 650
++G+G +G VY + G +AVK++E I+G K + + +SEI L + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 651 RHLVALLGHCLDGNEKLLVF-EYMPQGTLSRHIFNWA--EEGLKPLEWNRRLTIALDVAR 707
++V LG E L +F EY+P G++ + + EE L R T V
Sbjct: 68 LNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLV-----RFFT--EQVLE 119
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE-TRIAGTFGY 766
G+ YLH + +HRDLK N+L+ D K++DFG+ + + + + + + G+ +
Sbjct: 120 GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 767 LAPEYAVTGR--VTTKVDVFSFGVILMELITGRK 798
+APE + + KVD++S G +++E+ GR+
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 8e-18
Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 25/213 (11%)
Query: 600 ILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKG-------LTEFKSEIAVLTKVRHR 651
++G G FG+VY G G +AVK++E +S L EIA+L +++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA--EEGLKPLEWNRRLTIALDVARGV 709
++V LG LD + + EY+P G+++ + N+ EE L + +G+
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-------NFVRQILKGL 119
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-----LAPEGKGSIETRIAGTF 764
YLH ++ IHRD+K +NIL+ + K++DFG+ + + G+
Sbjct: 120 NYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 765 GYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 797
++APE T K D++S G +++E++TG+
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 69/234 (29%), Positives = 104/234 (44%), Gaps = 56/234 (23%)
Query: 595 FSEENILGRGGFGTVYKG-ELHDGTKI----AVKRMEAGVISGKGLTEFKSEIAVLTKVR 649
F + +LG G FGTVYKG + +G K+ A+K + S K E E V+ V
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVD 67
Query: 650 HRHLVALLGHCLDGNEKLLVFEYMPQGTL------------SRHIFNWAEEGLKPLEWNR 697
+ H+ LLG CL +L+ + MP G L S+++ NW
Sbjct: 68 NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWC----------- 115
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--------- 748
+ +A+G+ YL + +HRDL N+L+ K+ DFGL +L
Sbjct: 116 -----VQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH 167
Query: 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALD 801
A GK I+ ++A E + T + DV+S+GV + EL+T G K D
Sbjct: 168 AEGGKVPIK--------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-17
Identities = 65/243 (26%), Positives = 120/243 (49%), Gaps = 18/243 (7%)
Query: 572 DIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI 630
D ++LE ++S+ + F + +G+G GTVY ++ G ++A+++M
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58
Query: 631 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL 690
K L +EI V+ + ++ ++V L L G+E +V EY+ G+L+ +
Sbjct: 59 PKKEL--IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---- 112
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLA 749
++ + + + + +E+LH IHRD+K NILLG D K+ DFG ++
Sbjct: 113 --MDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
Query: 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESM 809
PE S + + GT ++APE KVD++S G++ +E+I G P ++
Sbjct: 168 PE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225
Query: 810 HLV 812
+L+
Sbjct: 226 YLI 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 12/205 (5%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
LG G G+V K + + GT +A K + G S + E+ ++ + R ++V+ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS-SVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 719
L+ N + E+M G+L R I+ + P+ IA+ V G+ YL+ +
Sbjct: 72 FLNENNICMCMEFMDCGSLDR-IY----KKGGPIPVEILGKIAVAVVEGLTYLYNVHR-- 124
Query: 720 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTT 779
+HRD+KPSNIL+ + K+ DFG+ + E SI GT Y++PE G+ T
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGV---SGELINSIADTFVGTSTYMSPERIQGGKYTV 181
Query: 780 KVDVFSFGVILMELITGRKALDESQ 804
K DV+S G+ ++EL G+ S
Sbjct: 182 KSDVWSLGISIIELALGKFPFAFSN 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 65/201 (32%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 601 LGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 658
LG GGFG V ++ A+K ++ I G E SE +L + H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 659 HCLDGNEKLLVF--EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
+ ++K + EY G L I + GL E+ R IA V EYLH
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGEL-WTILR--DRGLFD-EYTARFYIAC-VVLAFEYLH--- 110
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR 776
++ I+RDLKP N+LL + K+ DFG + G GT Y+APE +
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL--KSGQKTWTFCGTPEYVAPEIILNKG 168
Query: 777 VTTKVDVFSFGVILMELITGR 797
VD +S G++L EL+TGR
Sbjct: 169 YDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 66/228 (28%), Positives = 108/228 (47%), Gaps = 31/228 (13%)
Query: 601 LGRGGFGTVYKGEL---------------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVL 645
LG G FG V+ E +AVK + A V +F EI ++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK-TARNDFLKEIKIM 71
Query: 646 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLS-----RHIFNW--AEEGLKPLEWNRR 698
+++++ +++ LLG C+ + ++ EYM G L+ R I + + +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 699 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIE 757
L +A+ +A G++YL L +F+HRDL N L+G+ K+ADFG+ R L I+
Sbjct: 132 LYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 758 TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQP 805
R ++A E + G+ TT DV++FGV L E+ T L + QP
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT----LCKEQP 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 23/210 (10%)
Query: 600 ILGRGGFGTVYKG-ELHDGTKIAVKRM----EAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
LG G F + Y+ ++ GT +AVK++ + + + EI ++ ++ H H++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 655 ALLGH-CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
+LG C D + L V E+M G++S + + + + + RG+ YLH
Sbjct: 67 RMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLH 120
Query: 714 GLAHQSFIHRDLKPSNILL---GDDMRAKVADFG-LVRLAPE--GKGSIETRIAGTFGYL 767
IHRD+K +N+L+ G +R +ADFG RLA + G G + ++ GT ++
Sbjct: 121 ---ENQIIHRDVKGANLLIDSTGQRLR--IADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 768 APEYAVTGRVTTKVDVFSFGVILMELITGR 797
APE + DV+S G +++E+ T +
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-17
Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 29/218 (13%)
Query: 601 LGRGGFGTVYKGEL--------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHR 651
LG G FG V E + TK+AVK +++ + K L++ SE+ ++ + +H+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHK 84
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHI-----------FNWAEEGLKPLEWNRRLT 700
+++ LLG C ++ EY +G L ++ +N + + L + ++
Sbjct: 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE---GKGSIE 757
A VARG+EYL A + IHRDL N+L+ +D K+ADFGL R K +
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 758 TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
R+ ++APE T + DV+SFGV+L E+ T
Sbjct: 202 GRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 69/214 (32%), Positives = 108/214 (50%), Gaps = 21/214 (9%)
Query: 594 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRME-----AGVISGKGLTEFKSEIAVLTK 647
NF + +G G +G VYK G +A+K++ GV S T + EI++L +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS----TAIR-EISLLKE 55
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+ H ++V LL N+ LVFE++ Q L + + G+ PL + L +
Sbjct: 56 LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGI-PLPLIKSYLFQL--LQ 111
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
G+ + H +H+ +HRDLKP N+L+ + K+ADFGL R A T T Y
Sbjct: 112 GLAFCH--SHR-VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYR 167
Query: 768 APEYAVTGRV-TTKVDVFSFGVILMELITGRKAL 800
APE + + +T VD++S G I E++T R+AL
Sbjct: 168 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 9/213 (4%)
Query: 594 NFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+F N +G+G FG V+K D A+K+++ ++ + E E VL K+ +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
++ LD + +V EY G L H + G +PL ++ + + G+ +L
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDL--HKLLKMQRG-RPLPEDQVWRFFIQILLGLAHL 117
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
H + +HRD+K N+ L K+ D G+ +L + T I GT YL+PE
Sbjct: 118 HS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELC 173
Query: 773 VTGRVTTKVDVFSFGVILMELITGRKALD-ESQ 804
K DV++ GV+L E TG+ D +Q
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ 206
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 72/295 (24%), Positives = 126/295 (42%), Gaps = 44/295 (14%)
Query: 574 QMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISG 632
Q A +V+ R+ +NF + +G G G V + G ++AVK+M+
Sbjct: 3 QFRAALQLVVDPGDPRSYLDNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR 59
Query: 633 KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI--FNWAEEGL 690
+ L +E+ ++ +H ++V + L G+E +V E++ G L+ + EE +
Sbjct: 60 REL--LFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI 117
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750
T+ L V + + +LH Q IHRD+K +ILL D R K++DFG
Sbjct: 118 A--------TVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFC---- 162
Query: 751 EGKGSIET----RIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPE 806
+ S E + GT ++APE T+VD++S G++++E++ G P
Sbjct: 163 -AQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL 221
Query: 807 ESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQR 861
++M +RI + L S + R+P QR
Sbjct: 222 QAM------KRIRDNLPPK---------LKNLHKVS-PRLRSFLDRMLVRDPAQR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 5e-17
Identities = 64/243 (26%), Positives = 120/243 (49%), Gaps = 18/243 (7%)
Query: 572 DIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI 630
D ++LE ++S+ + F + +G+G GTVY ++ G ++A+K+M
Sbjct: 1 DEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQ 57
Query: 631 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL 690
K L +EI V+ + ++ ++V L L G+E +V EY+ G+L+ +
Sbjct: 58 PKKEL--IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---- 111
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLA 749
++ + + + + +++LH IHRD+K NILLG D K+ DFG ++
Sbjct: 112 --MDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166
Query: 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESM 809
PE S + + GT ++APE KVD++S G++ +E++ G P ++
Sbjct: 167 PE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224
Query: 810 HLV 812
+L+
Sbjct: 225 YLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 38/225 (16%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKR--MEAGVISGKGLTEFKSEIAVL 645
R+V + + + N + G +G VY+ + G +A+K+ ME G +T + EI +L
Sbjct: 2 RSV-DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK-EKEGFPITSLR-EINIL 58
Query: 646 TKVRHRHLVAL----LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPL--EWNRRL 699
K++H ++V + +G LD + +V EY+ E LK L +
Sbjct: 59 LKLQHPNIVTVKEVVVGSNLD--KIYMVMEYV-------------EHDLKSLMETMKQPF 103
Query: 700 TIA------LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753
+ L + GV +LH +HRDLK SN+LL + K+ DFGL R
Sbjct: 104 LQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160
Query: 754 GSIETRIAGTFGYLAPEYAV-TGRVTTKVDVFSFGVILMELITGR 797
T++ T Y APE + +T +D++S G I EL+T +
Sbjct: 161 KPY-TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 6e-17
Identities = 65/221 (29%), Positives = 109/221 (49%), Gaps = 35/221 (15%)
Query: 601 LGRGGFGTVYKGEL--------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHR 651
LG G FG V E + +AVK ++ + K L++ SE+ ++ + +H+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHK 81
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHI-----------FNWAEEGLKPLEWNRRLT 700
+++ LLG C ++ EY +G L ++ ++ A + + + ++
Sbjct: 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRI 760
VARG+EYL A Q IHRDL N+L+ ++ K+ADFGL R +I+
Sbjct: 142 CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DVNNIDYYK 194
Query: 761 AGTFG-----YLAPEYAVTGRVTT-KVDVFSFGVILMELIT 795
T G ++APE A+ RV T + DV+SFGV++ E+ T
Sbjct: 195 KTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 16/221 (7%)
Query: 595 FSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
F++ +G+G FG VYKG + +A+K ++ + + + + EI VL++ ++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYI 64
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKP--LEWNRRLTIALDVARGVEY 711
G L G + ++ EY+ G+ A + LKP LE TI ++ +G++Y
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGS--------ALDLLKPGPLEETYIATILREILKGLDY 116
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
LH + IHRD+K +N+LL + K+ADFG+ + + T + F ++APE
Sbjct: 117 LHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEV 172
Query: 772 AVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLV 812
K D++S G+ +EL G + P + L+
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 8e-17
Identities = 71/278 (25%), Positives = 119/278 (42%), Gaps = 39/278 (14%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVIS---GKGLTE-------FKSEIAVLTK-VR 649
LG G FG VYK + + + E V + GK E SE+ ++ + +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 650 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLE---WNRRLTIALDVA 706
H ++V L+ + +V + + L H + E+ + E WN + + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL--- 124
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY 766
+ YLH + +HRDL P+NI+LG+D + + DFGL + + S T + GT Y
Sbjct: 125 -ALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILY 179
Query: 767 LAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826
PE K DV++FG IL ++ T P S ++++ +I
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLATKI------VE 227
Query: 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDM 864
+P L EG+ + V ++ C + RPD+
Sbjct: 228 AVYEP---LPEGMYS--EDVTDVITSCLTPDAEARPDI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 9e-17
Identities = 63/201 (31%), Positives = 91/201 (45%), Gaps = 24/201 (11%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE----FKSEIAVLTKVRHRHLVA 655
+G G FG VY ++ +A+K+M SGK E E+ L ++RH + +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMS---YSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
G L + LV EY G+ S + E KPL+ I +G+ YLH
Sbjct: 80 YKGCYLREHTAWLVMEYC-LGSASDIL----EVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT- 774
IHRD+K NILL + K+ADFG L + GT ++APE +
Sbjct: 135 ER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAM 186
Query: 775 --GRVTTKVDVFSFGVILMEL 793
G+ KVDV+S G+ +EL
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 9e-17
Identities = 68/219 (31%), Positives = 109/219 (49%), Gaps = 31/219 (14%)
Query: 601 LGRGGFGTVYKGEL--------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHR 651
LG G FG V E + +AVK ++ + K L++ SE+ ++ + +H+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHK 78
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHI-----------FNWAEEGLKPLEWNRRLT 700
+++ LLG C ++ EY +G L ++ F+ + + L + ++
Sbjct: 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE---GKGSIE 757
A VARG+EYL A Q IHRDL N+L+ +D K+ADFGL R K +
Sbjct: 139 CAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 758 TRIAGTFGYLAPEYAVTGRVTT-KVDVFSFGVILMELIT 795
R+ ++APE A+ RV T + DV+SFGV+L E+ T
Sbjct: 196 GRLP--VKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 44/229 (19%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRM---EAGVISGKGLTEFKSEIAVL 645
+V + + +G G +G V G K+A+K++ E + L E K +L
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----IL 57
Query: 646 TKVRHRHLVALL-----GHCLDGNEKLLVFEYMP---------QGTLSRHIFNWAEEGLK 691
+ +H +++ +L N+ +V E M Q + HI + + L
Sbjct: 58 RRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQIL- 116
Query: 692 PLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-P 750
RG++Y+H + +HRDLKPSN+LL + K+ DFGL R+A P
Sbjct: 117 ---------------RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158
Query: 751 EGKGSIE-TRIAGTFGYLAPEYAVTGRVTTK-VDVFSFGVILMELITGR 797
E + T T Y APE + + TK +D++S G IL E+++ R
Sbjct: 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-16
Identities = 66/221 (29%), Positives = 109/221 (49%), Gaps = 35/221 (15%)
Query: 601 LGRGGFGTVYKGELHDGTK--------IAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHR 651
LG G FG V + E + K +AVK ++ + K L + SE+ ++ + +H+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHK 78
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHI-----------FNWAEEGLKPLEWNRRLT 700
+++ LLG C ++ EY +G L + F+ + + L + ++
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRI 760
A VARG+EYL + IHRDL N+L+ +D K+ADFGL R G I+
Sbjct: 139 CAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDIDYYK 191
Query: 761 AGTFG-----YLAPEYAVTGRVTT-KVDVFSFGVILMELIT 795
+ G ++APE A+ RV T + DV+SFG+++ E+ T
Sbjct: 192 KTSNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 69/246 (28%), Positives = 118/246 (47%), Gaps = 28/246 (11%)
Query: 574 QMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISG 632
Q A +V+S R ++F + +G G G V E H G ++AVK+M+
Sbjct: 6 QFRAALQLVVSPGDPREYLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR 62
Query: 633 KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFN--WAEEGL 690
+ L +E+ ++ H ++V + L G+E +V E++ G L+ + + EE +
Sbjct: 63 REL--LFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI 120
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV---- 746
T+ L V R + YLH +Q IHRD+K +ILL D R K++DFG
Sbjct: 121 A--------TVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169
Query: 747 RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPE 806
+ P+ K + GT ++APE T+VD++S G++++E+I G P
Sbjct: 170 KEVPKRKS-----LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL 224
Query: 807 ESMHLV 812
++M +
Sbjct: 225 QAMRRI 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 593 NNFSEENILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLT 646
NN S LG G FG V + + K+AVK ++ S + SE+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER-EALMSELKIMS 93
Query: 647 KV-RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 705
+ H ++V LLG C G L++ EY G L + E L L+ + V
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQV 150
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG-----KGSIETRI 760
A+G+ +L A ++ IHRDL N+LL K+ DFGL R KG+ R+
Sbjct: 151 AKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGN--ARL 205
Query: 761 AGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
++APE T + DV+S+G++L E+ +
Sbjct: 206 P--VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 65/205 (31%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 600 ILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTE-FKSEIAVL---TKVRHRHLV 654
+LGRG FG V E G A+K ++ G I + E E + RH LV
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 655 ALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
L C + + V EY G L HI + +P R + A V G++YLH
Sbjct: 66 NLFA-CFQTEDHVCFVMEYAAGGDLMMHIH--TDVFSEP----RAVFYAACVVLGLQYLH 118
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET--RIAGTFGYLAPEY 771
++RDLK N+LL + K+ADFGL + EG G + GT +LAPE
Sbjct: 119 ---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEFLAPEV 172
Query: 772 AVTGRVTTKVDVFSFGVILMELITG 796
T VD + GV++ E++ G
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 67/212 (31%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 601 LGRGGFGTVYKGELHDGT---KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+GRG +G VYK + DG + A+K++E IS EIA+L +++H +++AL
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC----REIALLRELKHPNVIALQ 64
Query: 658 GHCLDGNEK--LLVFEYMPQGTLSRHIFNW---AEEGLKPLEWNRRLTIAL--DVARGVE 710
L +++ L+F+Y HI + ++ KP++ R + +L + G+
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLW--HIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 711 YLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRL--APEGKGSIETRIAGTF 764
YLH +HRDLKP+NIL+ + R K+AD G RL +P + + TF
Sbjct: 123 YLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 765 GYLAPEYAVTGRVTTK-VDVFSFGVILMELIT 795
Y APE + R TK +D+++ G I EL+T
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 66/268 (24%), Positives = 119/268 (44%), Gaps = 28/268 (10%)
Query: 595 FSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
F++ +G+G FG V+KG + K+ ++ + + + + EI VL++ ++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
G L + ++ EY+ G+ + E G PL+ + TI ++ +G++YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPG--PLDETQIATILREILKGLDYLHS 119
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT 774
+ IHRD+K +N+LL + K+ADFG+ + + GT ++APE
Sbjct: 120 ---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQ 175
Query: 775 GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTID 834
+K D++S G+ +EL G E P + + L+ K PT++
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-------------KNNPPTLE 222
Query: 835 LNEGILASISTVAELAGHCCAREPYQRP 862
N + E C +EP RP
Sbjct: 223 GNYS-----KPLKEFVEACLNKEPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 70/290 (24%), Positives = 127/290 (43%), Gaps = 36/290 (12%)
Query: 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEA-GVISGKGLTEFKSEIAVLTKVRHR 651
NF E +GRG F VY+ D +A+K+++ ++ K + EI +L ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL-TIALDVARGVE 710
+++ L ++ NE +V E G LS+ I + ++ K L R + + + VE
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQ--KRLIPERTVWKYFVQLCSAVE 120
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
++H + +HRD+KP+N+ + K+ D GL R K + + GT Y++PE
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPE 176
Query: 771 YAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH------LSKDS 824
K D++S G +L E+ AL + M+L + ++I L +
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEH 232
Query: 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874
+ + + EL C +P QRPD+G+ + +
Sbjct: 233 YSEKL-----------------RELVSMCIYPDPDQRPDIGYVHQIAKQM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 32/210 (15%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVK--RMEA---GVISGKGLTEFKSEIAVLTKVRHRHLV 654
+G G +G VYK + G +A+K R+E GV S T + EI++L ++ H ++V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPS----TAIR-EISLLKELNHPNIV 61
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL--TIALDVARGVEYL 712
LL N+ LVFE++ L +++ + GL + L + + +G+ Y
Sbjct: 62 RLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGL-----DPPLIKSYLYQLLQGIAYC 115
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG----TFGYLA 768
H H+ +HRDLKP N+L+ + K+ADFGL R + R T Y A
Sbjct: 116 HS--HR-VLHRDLKPQNLLIDREGALKLADFGLARAF-----GVPVRTYTHEVVTLWYRA 167
Query: 769 PEYAVTGR-VTTKVDVFSFGVILMELITGR 797
PE + R +T VD++S G I E++ R
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 61/220 (27%), Positives = 92/220 (41%), Gaps = 35/220 (15%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKS----EIAVLTKV 648
E + LG G G+V K L + I + I+ + + E+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALK----TITTDPNPDLQKQILRELEINKSC 56
Query: 649 RHRHLVALLGHCLDGNEKLL--VFEYMPQGTLSRHIF-----NWAEEGLKPLEWNRRLTI 701
+ ++V G LD + + EY G+L I+ G K L I
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVL-----GKI 110
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA 761
A V +G+ YLH + IHRD+KPSNILL + K+ DFG+ G + +A
Sbjct: 111 AESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGV-------SGELVNSLA 160
Query: 762 GTFG----YLAPEYAVTGRVTTKVDVFSFGVILMELITGR 797
GTF Y+APE + DV+S G+ L+E+ R
Sbjct: 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 601 LGRGGFGTVYKGELHDGTKI--AVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
LG G FG VYK + H T + A K ++ S + L +F EI +L++ +H ++V L
Sbjct: 13 LGDGAFGKVYKAQ-HKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
N+ ++ E+ G L + E + L + + + + +LH
Sbjct: 70 AYFYENKLWILIEFCDGGALD----SIMLELERGLTEPQIRYVCRQMLEALNFLH---SH 122
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFGYLAPEYAVTGR 776
IHRDLK NILL D K+ADFG ++ + K +++ R GT ++APE
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFG---VSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179
Query: 777 VTT-----KVDVFSFGVILMELITGR 797
K D++S G+ L+EL
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 5e-16
Identities = 61/243 (25%), Positives = 121/243 (49%), Gaps = 18/243 (7%)
Query: 572 DIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI 630
D +++E ++SI + ++ +G+G GTV+ ++ G ++A+K++
Sbjct: 1 DEEIMEKLRTIVSIG---DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ 57
Query: 631 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL 690
K L +EI V+ ++++ ++V L L G+E +V EY+ G+L+ +
Sbjct: 58 PKKEL--IINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC---- 111
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLA 749
++ + + + + +E+LH IHRD+K N+LLG D K+ DFG ++
Sbjct: 112 --MDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166
Query: 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESM 809
PE S + + GT ++APE KVD++S G++ +E++ G P ++
Sbjct: 167 PEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224
Query: 810 HLV 812
+L+
Sbjct: 225 YLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-16
Identities = 69/209 (33%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 600 ILGRGGFGTVYKG---ELHDGTKIAVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRHLVA 655
+LG G FGTVYKG + KI V +G K EF E ++ + H HLV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
LLG CL +L V + MP G L ++ E + L + +A+G+ YL
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCL----LDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE-- 126
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF--GYLAPEYAV 773
+ +HRDL N+L+ K+ DFGL RL EG G ++A E
Sbjct: 127 -ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL-EGDEKEYNADGGKMPIKWMALECIH 184
Query: 774 TGRVTTKVDVFSFGVILMELIT-GRKALD 801
+ T + DV+S+GV + EL+T G K D
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-16
Identities = 70/223 (31%), Positives = 101/223 (45%), Gaps = 32/223 (14%)
Query: 600 ILGRGGFGTVYKG-ELHDGTKI----AVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
+LG G FGTVYKG + DG + A+K + S K E E V+ V ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVC 72
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
LLG CL +L V + MP G L ++ E + L + +A+G+ YL
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYV----RENKDRIGSQDLLNWCVQIAKGMSYLEE 127
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL---------APEGKGSIETRIAGTFG 765
+ +HRDL N+L+ K+ DFGL RL A GK I+
Sbjct: 128 V---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK-------- 176
Query: 766 YLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEE 807
++A E + R T + DV+S+GV + EL+T G K D E
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 7e-16
Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 29/216 (13%)
Query: 591 VTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRM----EAGVISGKGLTEFKSEIAVL 645
+TN + + +G G FG V + G +A+K++ V++ + E K +L
Sbjct: 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK----LL 63
Query: 646 TKVRHRHLVALLGHCLDGNEKL-LVFEYMPQGT-LSRHIFNWAEEGLKPLEWNRRLTIAL 703
+RH ++++L + E + V E + GT L R + + +PLE
Sbjct: 64 KHLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTS------RPLEKQFIQYFLY 115
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEGKGSIETRIAG 762
+ RG++Y+H +HRDLKPSNIL+ ++ K+ DFGL R+ P+ G + TR
Sbjct: 116 QILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-- 170
Query: 763 TFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGR 797
Y APE +T + +VD++S G I E++ G+
Sbjct: 171 ---YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 7e-16
Identities = 64/235 (27%), Positives = 111/235 (47%), Gaps = 34/235 (14%)
Query: 595 FSEENILGRGGFGTVYKGE---LHDGTK--------------IAVKRMEAGVISGKGLTE 637
F E+ LG G FG V+ E + +AVK + + +
Sbjct: 9 FKEK--LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARND 65
Query: 638 FKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL----SRHIF--NWAEEGLK 691
F EI ++++++ +++ LL C+ + ++ EYM G L SRH + +
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 692 PLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751
+ ++ + +A +A G++YL L +F+HRDL N L+G + K+ADFG+ R
Sbjct: 126 TISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 752 GK-GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQP 805
G I+ R +++ E + G+ TT DV++FGV L E++T L + QP
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT----LCKEQP 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 7e-16
Identities = 66/234 (28%), Positives = 99/234 (42%), Gaps = 38/234 (16%)
Query: 592 TNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKR-MEAGVISGKGLTEFKSEIAVLTKVR 649
++ LG G FG VYK ++ G +A+K+ + G +T + EI +L K++
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLK 65
Query: 650 HRHLVALL--------GHCLDGNEKLLVFEYMPQ---GTLSRHIFNWAEEGLKPLEWNRR 698
H ++V L+ +V YM G L E +K
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK------- 118
Query: 699 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL------APEG 752
L + G+ YLH +HRD+K +NIL+ + K+ADFGL R P+G
Sbjct: 119 -CYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 753 KGSIETR----IAGTFGYLAPEYAVTG--RVTTKVDVFSFGVILMELITGRKAL 800
G TR + T Y PE + G R TT VD++ G + E+ T R L
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPEL-LLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 8e-16
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 600 ILGRGGFGTVYKGELHDGT---KI-AVKRMEAGVI--SGKGLTEFKSEIAVLTKVRHRHL 653
+LG+GG+G V++ G KI A+K ++ I + K K+E +L V+H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
V L+ G + L+ EY+ G L H+ EG+ +E ++ +++ +E+LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIF-MEDTACFYLS-EISLALEHLH 117
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV 773
Q I+RDLKP NILL K+ DFGL + + G++ GT Y+APE +
Sbjct: 118 ---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-GTVTHTFCGTIEYMAPEILM 173
Query: 774 TGRVTTKVDVFSFGVILMELITG 796
VD +S G ++ +++TG
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 9e-16
Identities = 53/213 (24%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 594 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+ + ++GRG FG V+ D + +K++ ++ ++E VL + H +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKP---LEWNRRLTIALDVARGV 709
++ + L+ ++V EY P GTL+ +I L L + ++ +A
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------- 113
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 768
LH + + +HRDLK NILL M K+ DFG+ ++ S + GT Y++
Sbjct: 114 --LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYIS 169
Query: 769 PEYAVTGRVTTKVDVFSFGVILMELITGRKALD 801
PE K D+++ G +L EL + ++A +
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 9e-16
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 27/207 (13%)
Query: 600 ILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKS----EIAVLTKVRHRHLV 654
++G G +G V K + + G +A+K+ + + K EI +L ++RH +LV
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF----LESEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
L+ LVFE++ + + E+ L+ +R + RG+E+ H
Sbjct: 64 NLIEVFRRKKRLYLVFEFV-----DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH- 117
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYLAPEYAV 773
+ IHRD+KP NIL+ K+ DFG R LA G + T T Y APE V
Sbjct: 118 --SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA--APGEVYTDYVATRWYRAPELLV 173
Query: 774 T----GRVTTKVDVFSFGVILMELITG 796
GR VD+++ G ++ E++TG
Sbjct: 174 GDTKYGR---AVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-16
Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 26/221 (11%)
Query: 601 LGRGGFGTVYKG--ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
LG G + TVYKG +L D +A+K + G T + E+++L ++H ++V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL-- 69
Query: 659 HCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
H + EK LVFEY L + + + ++ + + + RG+ Y H
Sbjct: 70 HDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH--- 121
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG----TFGYLAPEYA 772
+ +HRDLKP N+L+ + K+ADFGL R SI T+ T Y P+
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAK-----SIPTKTYSNEVVTLWYRPPDIL 176
Query: 773 V-TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLV 812
+ + +T++D++ G I E+ TGR S EE +H +
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 70/286 (24%), Positives = 130/286 (45%), Gaps = 36/286 (12%)
Query: 594 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEA-GVISGKGLTEFKSEIAVLTKVRHR 651
NF E +GRG F VY+ L DG +A+K+++ ++ K + EI +L ++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEG-LKPLEWNRRLTIALDVARGVE 710
+++ ++ NE +V E G LSR I ++ ++ L P + + + L A +E
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--LE 120
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
++H + +HRD+KP+N+ + K+ D GL R K + + GT Y++PE
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPE 176
Query: 771 YAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH------LSKDS 824
K D++S G +L E+ AL + M+L + ++I L D
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH 232
Query: 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870
+ + + +++ C +P +RPD+ + +V
Sbjct: 233 YSEELRQLVNM-----------------CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 61/225 (27%), Positives = 96/225 (42%), Gaps = 42/225 (18%)
Query: 591 VTNNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKS--------- 640
V + + + +G G +G V G K+A+K++ F+S
Sbjct: 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL---------SRPFQSAIHAKRTYR 63
Query: 641 EIAVLTKVRHRHLVALLG--HCLDGNEKL----LVFEYMPQGTLSRHIFNWAEEGLKPLE 694
E+ +L + H +++ LL E LV M L+ + + L
Sbjct: 64 ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIV------KCQKLS 116
Query: 695 WNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP-EGK 753
+ + + RG++Y+H A IHRDLKPSNI + +D K+ DFGL R E
Sbjct: 117 DDHIQFLVYQILRGLKYIHS-AG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT 173
Query: 754 GSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGR 797
G + TR Y APE + VD++S G I+ EL+TG+
Sbjct: 174 GYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 60/239 (25%), Positives = 108/239 (45%), Gaps = 24/239 (10%)
Query: 600 ILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTEFKSEIAVLTKVRH---RHLV 654
++GRG +G VY+G H T +A+K + +++ + E+A+L+++R ++
Sbjct: 8 LIGRGAYGAVYRG-KHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQPPNIT 65
Query: 655 ALLGHCLDGNEKLLVFEYMPQG---TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
G L G ++ EY G TL + P+ I +V ++Y
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMK---------AGPIAEKYISVIIREVLVALKY 116
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
+H IHRD+K +NIL+ + K+ DFG+ L + T GT ++APE
Sbjct: 117 IH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEV 172
Query: 772 AVTGRV-TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829
G+ TK D++S G+ + E+ TG + +M L+ + L + + K +
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLL 231
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 15/217 (6%)
Query: 601 LGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKG-LTEFKSEIAVLTKVRHRHLVALLG 658
+G+GG+G V+ + D +I A+KRM+ ++ + +E +LT + LV LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
D L EY+P G R + N L E + R +A V+ LH L
Sbjct: 69 AFQDDEYLYLAMEYVPGGDF-RTLLN-NLGVLS--EDHARFYMAEMFE-AVDALHELG-- 121
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVT 778
+IHRDLKP N L+ K+ DFGL + G + + G+ Y+APE
Sbjct: 122 -YIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRGKGYD 176
Query: 779 TKVDVFSFGVILMELITGRKALDESQPEESM-HLVTW 814
VD +S G +L E + G S P E+ +L W
Sbjct: 177 FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 65/243 (26%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 574 QMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISG 632
Q A MV+ R++ N+ + +G G G V E H G ++AVK M+
Sbjct: 5 QFKAALRMVVDQGDPRSLLENYIK---IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR 61
Query: 633 KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI--FNWAEEGL 690
+ L +E+ ++ +H+++V + L G E ++ E++ G L+ + EE +
Sbjct: 62 REL--LFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQI 119
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LV 746
T+ V + + YLH Q IHRD+K +ILL D R K++DFG +
Sbjct: 120 A--------TVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168
Query: 747 RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPE 806
+ P+ K + GT ++APE T+VD++S G++++E++ G P
Sbjct: 169 KDVPKRKS-----LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV 223
Query: 807 ESM 809
++M
Sbjct: 224 QAM 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 2e-15
Identities = 65/228 (28%), Positives = 97/228 (42%), Gaps = 58/228 (25%)
Query: 599 NILGRGGFGTVYKGE-LHDGTKIAVKRME---AGVISGKGLTEFKSEIAVLTKVRHRHLV 654
+G G +G V G K+A+K++ +I K + EI +L +RH +++
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR---EIKLLRHLRHENII 62
Query: 655 ALL-----GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IAL 703
LL D N+ +V E M + L + I + + LT
Sbjct: 63 GLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKS-----------PQPLTDDHIQYFLY 110
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEGKGSIE----- 757
+ RG++YLH A+ IHRDLKPSNIL+ + K+ DFGL R P+
Sbjct: 111 QILRGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167
Query: 758 -TRIAGTFGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 797
TR Y APE Y T +D++S G I EL+T +
Sbjct: 168 VTRW-----YRAPELLLSSSRY------TKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 66/212 (31%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 601 LGRGGFGTVYKGELHDGTK---IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+GRG +G VYK + DG A+K++E IS EIA+L +++H ++++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC----REIALLRELKHPNVISLQ 64
Query: 658 GHCLDGNEK--LLVFEYMPQGTLSRHIFNW---AEEGLKPLEWNRRLTIAL--DVARGVE 710
L ++ L+F+Y HI + ++ KP++ R + +L + G+
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLW--HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 711 YLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRL--APEGKGSIETRIAGTF 764
YLH +HRDLKP+NIL+ + R K+AD G RL +P + + TF
Sbjct: 123 YLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 765 GYLAPEYAVTGRVTTK-VDVFSFGVILMELIT 795
Y APE + R TK +D+++ G I EL+T
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 68/228 (29%), Positives = 101/228 (44%), Gaps = 53/228 (23%)
Query: 594 NFSE---ENILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKG----LTEFKSEIAV 644
+ SE N +G G GTVYK +H T A+K VI G + EI +
Sbjct: 72 SLSELERVNRIGSGAGGTVYK-VIHRPTGRLYALK-----VIYGNHEDTVRRQICREIEI 125
Query: 645 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLS-RHIFNWAEEGLKPLEWNRRLTIAL 703
L V H ++V E ++ E+M G+L HI E+ L
Sbjct: 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI--ADEQFLA------------ 171
Query: 704 DVAR----GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR 759
DVAR G+ YLH + +HRD+KPSN+L+ K+ADFG+ R+ + +
Sbjct: 172 DVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS 228
Query: 760 IAGTFGYLAPEYAVTGRVTTKV----------DVFSFGVILMELITGR 797
+ GT Y++PE R+ T + D++S GV ++E GR
Sbjct: 229 V-GTIAYMSPE-----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 3e-15
Identities = 65/250 (26%), Positives = 99/250 (39%), Gaps = 43/250 (17%)
Query: 600 ILGRGGFGTVYKG-ELHDGTKIAVKRM-EAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
++GRG FG V+ + G A+K + ++ +I + ++E +L +V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
D LV EYMP G L + + + P E R L +A ++ +H L
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIR---KDVFPEETARFYIAELVLA--LDSVHKLG- 121
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGL------------------VRLAPEGKGSIETR 759
FIHRD+KP NIL+ D K+ADFGL L +
Sbjct: 122 --FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 760 ----------IAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESM 809
GT Y+APE + D +S GVIL E++ G +E
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE-- 237
Query: 810 HLVTWFRRIH 819
T+ + I+
Sbjct: 238 ---TYNKIIN 244
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 69/240 (28%), Positives = 110/240 (45%), Gaps = 33/240 (13%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
+LG+G FG V EL + A+K ++ V+ L + E ++ R ++AL
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVV----LEDDDVECTMV----ERRVLALAW 53
Query: 659 HC---------LDGNEKLL-VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
E L V EY+ G L HI + + R A ++ G
Sbjct: 54 EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHI-----QSSGRFDEARARFYAAEIICG 108
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 768
+++LH + I+RDLK N+LL D K+ADFG+ + G+G T GT Y+A
Sbjct: 109 LQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIA 164
Query: 769 PEYAVTGRVTTKVDVFSFGVILMELITGRKAL---DESQPEESM-HLVTWFRRIHLSKDS 824
PE + VD +SFGV+L E++ G+ DE + +S+ + F R +SK++
Sbjct: 165 PEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR-WISKEA 223
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 11/198 (5%)
Query: 600 ILGRGGFGTVYKGELHD--GTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVAL 656
+G G FG VY+G KIAV + + E F E ++ + H H+V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
+G + N +V E P G L ++ L+ + + ++ + YL
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYLQVNKYS----LDLASLILYSYQLSTALAYLES-- 125
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR 776
+ F+HRD+ N+L+ K+ DFGL R + ++ ++APE R
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 777 VTTKVDVFSFGVILMELI 794
T+ DV+ FGV + E++
Sbjct: 185 FTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 4e-15
Identities = 61/236 (25%), Positives = 99/236 (41%), Gaps = 51/236 (21%)
Query: 599 NILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKS-------------EIAV 644
LG G +G V K G +A+K+++ IS +T+ + E+ +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEIS-NDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 645 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT---- 700
+ +++H +++ L+ ++G+ LV + M L K ++ RLT
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLK-----------KVVDRKIRLTESQV 121
Query: 701 --IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR--LAPEGKGSI 756
I L + G+ LH F+HRDL P+NI + K+ADFGL R P ++
Sbjct: 122 KCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178
Query: 757 ETRIAG-----------TFGYLAPEYAV-TGRVTTKVDVFSFGVILMELITGRKAL 800
T Y APE + + VD++S G I EL+TG K L
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPL 233
|
Length = 335 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 63/239 (26%), Positives = 101/239 (42%), Gaps = 32/239 (13%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
+G G FG V+ + A+K M VI K +E VL +V H ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVARGVEYL 712
D ++ EY+P G L F++ L + R + A ++ +EYL
Sbjct: 69 TEHDQRFLYMLMEYVPGGEL----FSY-------LRNSGRFSNSTGLFYASEIVCALEYL 117
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
H ++RDLKP NILL + K+ DFG A + + T + GT YLAPE
Sbjct: 118 HSK---EIVYRDLKPENILLDKEGHIKLTDFG---FAKKLRDRTWT-LCGTPEYLAPEVI 170
Query: 773 VTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831
+ VD ++ G+++ E++ G + P + +I K F + +D
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI------YEKILAGKLEFPRHLDL 223
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 59/245 (24%), Positives = 118/245 (48%), Gaps = 17/245 (6%)
Query: 595 FSEENILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
F++ +G+G FG V+KG + + T+ +A+K ++ + + + + EI VL++ +
Sbjct: 6 FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPY 63
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+ G L G + ++ EY+ G+ + G P + + T+ ++ +G++YL
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAG--PFDEFQIATMLKEILKGLDYL 117
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
H + IHRD+K +N+LL + K+ADFG+ + + T + F ++APE
Sbjct: 118 HS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVI 173
Query: 773 VTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD---SFHKAI 829
+K D++S G+ +EL G + P + L+ L+ + F + I
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFI 233
Query: 830 DPTID 834
D ++
Sbjct: 234 DACLN 238
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 6e-15
Identities = 69/238 (28%), Positives = 108/238 (45%), Gaps = 23/238 (9%)
Query: 588 LRNVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLT 646
LR+ F ++G G +G VYKG + G A+K M+ ++G E K EI +L
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLK 57
Query: 647 KV-RHRHLVALLGHCLDGN------EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL 699
K HR++ G + N + LV E+ G+++ I N LK EW
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE-EW--IA 114
Query: 700 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR 759
I ++ RG+ +LH IHRD+K N+LL ++ K+ DFG+ G T
Sbjct: 115 YICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 171
Query: 760 IAGTFGYLAPEYAVT-----GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLV 812
I GT ++APE K D++S G+ +E+ G L + P ++ L+
Sbjct: 172 I-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 6e-15
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 28/217 (12%)
Query: 597 EENILGRGGFGTVYKG-ELHDGTKIAVKRM----EAGVISGKGLTEFKSEIAVLTKVRHR 651
ENI G G +G V + G K+A+K++ + ++ + L E K +L +H
Sbjct: 10 IENI-GSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILRHFKHD 64
Query: 652 HLVALLGHCL----DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+++A+ D + +V + M + L I +PL + R
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIH-----SDQPLTEEHIRYFLYQLLR 118
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA---PEGKGSIETRIAGTF 764
G++Y+H + IHRDLKPSN+L+ +D ++ DFG+ R P T T
Sbjct: 119 GLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 765 GYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKAL 800
Y APE ++ TT +D++S G I E++ GR+ L
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 68/229 (29%), Positives = 107/229 (46%), Gaps = 41/229 (17%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVK--RMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
LG G + TVYKG G +A+K R+E G T + E ++L ++H ++V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIR-EASLLKDLKHANIVTL- 68
Query: 658 GHCLDGNEKLL--VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
H + +K L VFEY+ L +++ + GL N RL + + RG+ Y H
Sbjct: 69 -HDIIHTKKTLTLVFEYL-DTDLKQYM-DDCGGGLSMH--NVRLFL-FQLLRGLAYCH-- 120
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG----TFGYLAP-- 769
+ +HRDLKP N+L+ + K+ADFGL R S+ ++ T Y P
Sbjct: 121 -QRRVLHRDLKPQNLLISERGELKLADFGLARAK-----SVPSKTYSNEVVTLWYRPPDV 174
Query: 770 -----EYAVTGRVTTKVDVFSFGVILMELITGRKAL-DESQPEESMHLV 812
EY +T +D++ G I E+ TGR + E+ +H +
Sbjct: 175 LLGSTEY------STSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 6e-15
Identities = 41/96 (42%), Positives = 56/96 (58%), Gaps = 8/96 (8%)
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE----TRIAG 762
+ ++Y+H + IHRDLKPSNILL D R K+ADFGL R E + + E T
Sbjct: 118 KALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 763 TFGYLAPEYAV-TGRVTTKVDVFSFGVILMELITGR 797
T Y APE + + R T VD++S G IL E++ G+
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 7e-15
Identities = 73/290 (25%), Positives = 130/290 (44%), Gaps = 43/290 (14%)
Query: 598 ENILGRGGFGTVYKGELHDGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
E ++G G FG V G L K +A+K ++AG + K +F SE +++ + H ++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNI 67
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL-----DVARG 708
+ L G ++V EYM G+L F +G + I L +A G
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDA--FLRKHDG-------QFTVIQLVGMLRGIASG 118
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFG--Y 766
++YL + ++HRDL NIL+ ++ KV+DFGL R+ + + T G +
Sbjct: 119 MKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 175
Query: 767 LAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSF 825
APE + T+ DV+S+G+++ E+++ G + W +S
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY-------------W----EMSNQDV 218
Query: 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875
KAI+ L + + + +L C ++ +RP V++L L+
Sbjct: 219 IKAIEEGYRLPAPMDCPAA-LHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-15
Identities = 64/214 (29%), Positives = 95/214 (44%), Gaps = 12/214 (5%)
Query: 600 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKS-EIAVLTKVRHRHLVALL 657
+LG+G FG V+ EL A+K ++ V+ E E VL+ + L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 658 GHCLDGNEKLL-VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
E L V EY+ G L HI + + R A ++ G+++LH
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHI-----QSCHKFDLPRATFYAAEIICGLQFLHS-- 114
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR 776
+ ++RDLK NILL D K+ADFG+ + G T GT Y+APE + +
Sbjct: 115 -KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQK 172
Query: 777 VTTKVDVFSFGVILMELITGRKALDESQPEESMH 810
T VD +SFGV+L E++ G+ EE
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 8e-15
Identities = 55/213 (25%), Positives = 105/213 (49%), Gaps = 30/213 (14%)
Query: 598 ENILGRGGFGTVYKGEL-HDGTK---IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
E ++G G FG V +G L G + +A+K +++G + K +F SE +++ + H ++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNI 67
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEG-LKPLEWNRRLTIALDVARGVEYL 712
+ L G +++ E+M G L F +G ++ + + +A G++YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDS--FLRQNDGQFTVIQL---VGMLRGIAAGMKYL 122
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK----------GSIETRIAG 762
+ +++HRDL NIL+ ++ KV+DFGL R + G I R
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR--- 176
Query: 763 TFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
+ APE + T+ DV+S+G+++ E+++
Sbjct: 177 ---WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-15
Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 18/220 (8%)
Query: 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
LG G + TV+KG +A+K + G T + E+++L ++H ++V L H
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTL--H 69
Query: 660 CLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
+ E+ LVFEY+ L +++ N + + + RG+ Y H
Sbjct: 70 DIIHTERCLTLVFEYL-DSDLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCH---K 121
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV-TGR 776
+ +HRDLKP N+L+ + K+ADFGL R + + T Y P+ + +
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTE 180
Query: 777 VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFR 816
+T +D++ G IL E+ TGR S +E +HL+ FR
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI--FR 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 8e-15
Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 591 VTNNFSEENILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 649
V + + + +G G +GTV + G K+A+K++ S E+ +L ++
Sbjct: 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK 72
Query: 650 HRHLVALLG-----HCLDG-NEKLLVFEYMPQ--GTLSRHIFNWAEEGLKPLEWNRRLTI 701
H +++ LL LD ++ LV +M G L +H + L +R +
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH---------EKLSEDRIQFL 123
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEGKGSIETRI 760
+ +G++Y+H IHRDLKP N+ + +D K+ DFGL R E G + TR
Sbjct: 124 VYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR- 179
Query: 761 AGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGR 797
Y APE + T VD++S G I+ E++TG+
Sbjct: 180 ----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRM-----EAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
+G G +G VYKG G +A+K++ E GV S T + EI++L +++H ++V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPS----TAIR-EISLLKELQHPNIV 62
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
L + + L+FE++ L +++ + + E + + +G+ + H
Sbjct: 63 CLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYL--YQILQGILFCH- 118
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRI----AGTFGYLAPE 770
+ +HRDLKP N+L+ + K+ADFGL R I R+ T Y APE
Sbjct: 119 --SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-----GIPVRVYTHEVVTLWYRAPE 171
Query: 771 YAVTG-RVTTKVDVFSFGVILMELITGR 797
+ R +T VD++S G I E+ T +
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRM-----EAGVISGKGLTEFKSEIAVLT 646
+ + + +G G +G VYK + + G +A+K+ E G+ T + EI++L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPP----TALR-EISLLQ 55
Query: 647 KVRHR-HLVALLG--HCLDGNEKL---LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT 700
+ ++V LL H + N K LVFEY+ L + + + +PL +
Sbjct: 56 MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKS 114
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGLVRLAPEGKGSIETR 759
+ +GV + H +HRDLKP N+L+ K+AD GL R S
Sbjct: 115 FMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHE 171
Query: 760 IAGTFGYLAPEYAVTGR-VTTKVDVFSFGVILMELITG 796
I T Y APE + +T VD++S G I E+
Sbjct: 172 IV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 598 ENILGRGGFGTVYKGELHDGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
E ILG G FG + +G L +K +A+ + AG S K F +E L + H ++
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNI 68
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
V L G GN ++V EYM G L F EG L + + + +A G++Y
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNGALDS--FLRKHEG--QLVAGQLMGMLPGLASGMKY-- 122
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL--APEY 771
L+ ++H+ L +L+ D+ K++ F RL + +I T ++G L APE
Sbjct: 123 -LSEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEA 179
Query: 772 AVTGRVTTKVDVFSFGVILMELIT 795
++ DV+SFG+++ E+++
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 601 LGRGGFGTVYKG-ELHDGTK-IAVKRMEAGVIS-GKGLTEFKSEIAVLTKVR---HRHLV 654
+G G +G V+K +L +G + +A+KR+ G L+ + E+AVL + H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 67
Query: 655 ALLGHCL----DGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
L C D KL LVFE++ Q L+ ++ E G+ P E + + L RG+
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV-PTETIKDMMFQL--LRGL 123
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
++LH +H+ +HRDLKP NIL+ + K+ADFGL R+ T + T Y AP
Sbjct: 124 DFLH--SHR-VVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAP 178
Query: 770 EYAVTGRVTTKVDVFSFGVILMELITGR 797
E + T VD++S G I E+ +
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 3e-14
Identities = 52/182 (28%), Positives = 79/182 (43%), Gaps = 30/182 (16%)
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL-- 748
+PL ++ L I + G+ YLH Q IHRD+K NI + D + + D G +
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208
Query: 749 -APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDE---SQ 804
AP G +AGT APE + +K D++S G++L E++ + E S
Sbjct: 209 VAPAFLG-----LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPST 263
Query: 805 PEES-----MHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPY 859
PEE HL+ + + + F + DP L G + E A R+PY
Sbjct: 264 PEEYVKSCHSHLLKIISTLKVHPEEFPR--DPGSRLVRGFI-------EYAS--LERQPY 312
Query: 860 QR 861
R
Sbjct: 313 TR 314
|
Length = 357 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-14
Identities = 65/250 (26%), Positives = 106/250 (42%), Gaps = 50/250 (20%)
Query: 600 ILGRGGFGTVYKGELHD---GTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVA 655
++G+GG G VY +D ++A+K++ + L + F E + + H +V
Sbjct: 9 LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 656 LLGHCLDGNEKLLVFEYMP--QGTLSRHIFN--WAEEGL-KPLEWNRR----LTIALDVA 706
+ C DG+ V+ MP +G + + W +E L K L L+I +
Sbjct: 67 VYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL---VRLAPEGKGSIET----- 758
+EY+H + +HRDLKP NILLG + D+G +L E I+
Sbjct: 124 ATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 759 ---------RIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT---------GRKAL 800
+I GT Y+APE + + D+++ GVIL +++T GRK
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240
Query: 801 DESQ---PEE 807
P E
Sbjct: 241 YRDVILSPIE 250
|
Length = 932 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 64/207 (30%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 601 LGRGGFGTVYKGELHD-GTKIAVKRM----EAGVISGKGLTEFKSEIAVLTKVRHRHLVA 655
+G G +G V+K + G +A+K+ + VI L EI +L +++H +LV
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL----REIRMLKQLKHPNLVN 64
Query: 656 LLGHCLDGNEKL-LVFEYMPQ---GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
L+ KL LVFEY L ++ E +K + W + V +
Sbjct: 65 LI-EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQ--------TLQAVNF 115
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
H H IHRD+KP NIL+ + K+ DFG R+ G G T T Y APE
Sbjct: 116 CH--KHNC-IHRDVKPENILITKQGQIKLCDFGFARIL-TGPGDDYTDYVATRWYRAPEL 171
Query: 772 AVTGRVT--TKVDVFSFGVILMELITG 796
V G VDV++ G + EL+TG
Sbjct: 172 LV-GDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 70/211 (33%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVK--RMEAGVISGKGLTEFKSEIAVLTKVR---HRHLV 654
+G G +GTVYK + H G +A+K R++ G L+ + E+A+L ++ H ++V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVR-EVALLKRLEAFDHPNIV 65
Query: 655 ALLGHC----LDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
L+ C D K+ LVFE++ Q L ++ GL P E + L RG+
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGL-PAETIKDLMRQF--LRGL 121
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
++LH +HRDLKP NIL+ + K+ADFGL R+ T + T Y AP
Sbjct: 122 DFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL--TPVVVTLWYRAP 176
Query: 770 EYAVTGRVTTKVDVFSFGVILMELITGRKAL 800
E + T VD++S G I E+ RK L
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-14
Identities = 62/201 (30%), Positives = 92/201 (45%), Gaps = 17/201 (8%)
Query: 598 ENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
+ ILG G GTVYK L +AVK + I+ + + SE+ +L K +++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
G N + E+M G+L + P R IA+ V +G+ YL L
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVY-------RKIPEHVLGR--IAVAVVKGLTYLWSL- 114
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR 776
+HRD+KPSN+L+ + K+ DFG+ + SI GT Y+APE +
Sbjct: 115 --KILHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISGEQ 169
Query: 777 VTTKVDVFSFGVILMELITGR 797
DV+S G+ MEL GR
Sbjct: 170 YGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 65/244 (26%), Positives = 104/244 (42%), Gaps = 33/244 (13%)
Query: 588 LRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLT 646
L + T F ++G G +G VYK G +A+K M+ I E K E +L
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEEIKEEYNILR 57
Query: 647 KV-RHRHLVALLG------HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL 699
K H ++ G + ++ LV E G+++ + +GL+ +RL
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKK--GKRL 110
Query: 700 T------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753
I + RG+ YLH ++ IHRD+K NILL + K+ DFG+
Sbjct: 111 KEEWIAYILRETLRGLAYLH--ENK-VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL 167
Query: 754 GSIETRIAGTFGYLAPE-----YAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEES 808
G T I GT ++APE + DV+S G+ +EL G+ L + P +
Sbjct: 168 GRRNTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA 226
Query: 809 MHLV 812
+ +
Sbjct: 227 LFKI 230
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 5e-14
Identities = 80/255 (31%), Positives = 117/255 (45%), Gaps = 22/255 (8%)
Query: 600 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKS-EIAVLTKVRHRHLVALL 657
+LG+G FG V EL G AVK ++ V+ E E VL + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 658 GHCLDGNEKLL-VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
E L V E++ G L HI ++G + R A ++ G+++LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHI---QDKG--RFDLYRATFYAAEIVCGLQFLHS-- 114
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR 776
+ I+RDLK N++L D K+ADFG+ + G T GT Y+APE +
Sbjct: 115 -KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLK 172
Query: 777 VTTKVDVFSFGVILMELITGRKAL---DESQPEESMHLVT--WFRRIHL-SKDSFHKAI- 829
T VD +SFGV+L E++ G+ DE + ES+ + T + R I SKD K
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFE 232
Query: 830 -DPTIDLNEGILASI 843
DPT L G++ +I
Sbjct: 233 RDPTRRL--GVVGNI 245
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 70/250 (28%), Positives = 109/250 (43%), Gaps = 25/250 (10%)
Query: 594 NFSEENILGRGGFGTVY----KGELHDGTKIAVKRMEAGVISGKGLT--EFKSEIAVLTK 647
NF +LG G +G V+ G G A+K ++ I K T ++E VL
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 648 VRHRHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIF---NWAEEGLKPLEWNRRLTIAL 703
VR + L + + KL L+ +Y+ G L H++ ++ E + R+ IA
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEV-------RVYIA- 112
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT 763
++ +++LH L I+RD+K NILL + + DFGL + + GT
Sbjct: 113 EIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGT 169
Query: 764 FGYLAPEYAVTGRV--TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS 821
Y+APE G VD +S GV+ EL+TG + S ++ RRI S
Sbjct: 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS--RRILKS 227
Query: 822 KDSFHKAIDP 831
K F K +
Sbjct: 228 KPPFPKTMSA 237
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-14
Identities = 75/270 (27%), Positives = 115/270 (42%), Gaps = 41/270 (15%)
Query: 601 LGRGGFGTVY-KGELHDGTKIAVKRMEAGVISGKGLTE----FKSEIAVLTKVRHRHLVA 655
+G G FG VY H +AVK+M SGK E E+ L +++H + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMS---YSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
G L + LV EY G+ S + E KPL+ I +G+ YLH
Sbjct: 86 YKGCYLKEHTAWLVMEYC-LGSAS----DLLEVHKKPLQEVEIAAITHGALQGLAYLHS- 139
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT- 774
+ IHRD+K NILL + + K+ADFG K S GT ++APE +
Sbjct: 140 --HNMIHRDIKAGNILLTEPGQVKLADFG-----SASKSSPANSFVGTPYWMAPEVILAM 192
Query: 775 --GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832
G+ KVDV+S G+ +EL + L +++ H++++ PT
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--------HIAQND-----SPT 239
Query: 833 IDLNEGILASISTVAELAGHCCAREPYQRP 862
+ NE + +C + P +RP
Sbjct: 240 LQSNEW----TDSFRGFVDYCLQKIPQERP 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 6e-14
Identities = 41/109 (37%), Positives = 63/109 (57%), Gaps = 6/109 (5%)
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY 766
RG++YLH A +HRD+KP N+L+ + K+ DFGL R+ + T+ T Y
Sbjct: 114 RGLKYLHS-AG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 767 LAPEYAVTGR-VTTKVDVFSFGVILMELITGRKALDESQ-PEESMHLVT 813
APE + R T+ VD++S G I EL+ GR+ L ++Q P + + L+T
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELL-GRRILFQAQSPIQQLDLIT 218
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 57/194 (29%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
+GRG FG V+ G L D T +AVK + +F E +L + H ++V L+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRE-TLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 719
C +V E + G + EG + L+ + + + A G+EYL +
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRT---EGPR-LKVKELIQMVENAAAGMEYLES---KH 114
Query: 720 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT-FGYLAPEYAVTGRVT 778
IHRDL N L+ + K++DFG+ R +G + + + APE GR +
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 779 TKVDVFSFGVILME 792
++ DV+SFG++L E
Sbjct: 175 SESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 7e-14
Identities = 71/210 (33%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 601 LGRGGFGTVYKGELHDGTKI-AVKRM-EAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
+G+G FG V + D +I A+K + +A ++S +T +E VL +V +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 659 HCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
EKL LV ++ G L H+ EG L R T L A +E LH
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYTAELLCA--LENLHKF-- 112
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV 777
+ I+RDLKP NILL + DFGL +L + T GT YLAPE +
Sbjct: 113 -NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHGY 170
Query: 778 TTKVDVFSFGVILMELITGRKAL-DESQPE 806
T VD ++ GV+L E++TG DE+ E
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPPFYDENVNE 200
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 14/215 (6%)
Query: 601 LGRGGFGTVYKG--ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
LG G + TV+KG +L + +A+K + G T + E+++L ++H ++V L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
LVFEY L + + + ++ + + + RG+ Y H +
Sbjct: 72 IVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RR 123
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV-TGRV 777
+HRDLKP N+L+ + K+ADFGL R + + T Y P+ + +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEY 182
Query: 778 TTKVDVFSFGVILMELITGRKALDESQPEESMHLV 812
+T++D++ G I E+ +GR S E+ +HL+
Sbjct: 183 STQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 9e-14
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 598 ENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
+ ++G+G +G V + H G K+A+K++ T EI +L +RH +V +
Sbjct: 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 64
Query: 657 LGHCL-----DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
L + + +VFE M H A + L P L L R ++Y
Sbjct: 65 KHIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTPEHHQFFLYQLL---RALKY 118
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEGKGSI-ETRIAGTFGYLAP 769
+H + HRDLKP NIL D + K+ DFGL R+A + +I T T Y AP
Sbjct: 119 IHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 770 EY--AVTGRVTTKVDVFSFGVILMELITGR 797
E + + T +D++S G I E++TG+
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 595 FSEENILGRGGFGTVY-KGELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKVRHRH 652
F++ +G G FG VY ++ +A+K+M +G S + + E+ L +++H +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+ G L + LV EY G+ S + E KPL+ I +G+ YL
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC-LGSAS----DLLEVHKKPLQEVEIAAITHGALQGLAYL 141
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
H + IHRD+K NILL + + K+ADFG +A S GT ++APE
Sbjct: 142 HS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIA-----SPANSFVGTPYWMAPEVI 193
Query: 773 VT---GRVTTKVDVFSFGVILMEL 793
+ G+ KVDV+S G+ +EL
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 30/206 (14%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKG---LTEFKSEIAVLTKVRHRHLVALL 657
LG G FG VYK + + +A A VI K L ++ EI +L H ++V LL
Sbjct: 20 LGDGAFGKVYKAKNKETGALAA----AKVIETKSEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT---IALDVARGVEYLHG 714
G + ++ E+ P G + + LE +R LT I + + +E L
Sbjct: 76 GAFYWDGKLWIMIEFCPGGAVDAIM----------LELDRGLTEPQIQVICRQMLEALQY 125
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFGYLAPEYA 772
L IHRDLK N+LL D K+ADFG ++ + +++ R GT ++APE
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGDIKLADFG---VSAKNVKTLQRRDSFIGTPYWMAPEVV 182
Query: 773 VTGRVTT-----KVDVFSFGVILMEL 793
+ + K D++S G+ L+E+
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 63/204 (30%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEF-KSEIAVLTKV-RHRHLVAL 656
+LG+G FG V EL ++ AVK ++ VI E +E VL +H L L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 657 LGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
C ++L V EY+ G L HI + + R A ++ G+++LH
Sbjct: 62 HS-CFQTKDRLFFVMEYVNGGDLMFHI-----QRSGRFDEPRARFYAAEIVLGLQFLH-- 113
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG--KGSIETRIAGTFGYLAPEYAV 773
+ I+RDLK N+LL + K+ADFG+ + EG G + GT Y+APE
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTPDYIAPEILS 169
Query: 774 TGRVTTKVDVFSFGVILMELITGR 797
VD ++ GV+L E++ G+
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 594 NFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLT--EFKS--------EIA 643
+F + LG G G V K V +G+I + L E K E+
Sbjct: 2 DFEKLGELGAGNGGVVTK----------VLHRPSGLIMARKLIHLEIKPAIRNQIIRELK 51
Query: 644 VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 703
VL + ++V G E + E+M G+L + + + G P +++IA
Sbjct: 52 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIA- 107
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT 763
V RG+ YL +HRD+KPSNIL+ K+ DFG ++ + S+ GT
Sbjct: 108 -VLRGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFG---VSGQLIDSMANSFVGT 161
Query: 764 FGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 797
Y++PE T + D++S G+ L+E+ GR
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 66/203 (32%), Positives = 93/203 (45%), Gaps = 18/203 (8%)
Query: 600 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFK---SEIAVLTK-VRHRHLV 654
++G+G FG V + DG AVK ++ I K E K +E VL K V+H LV
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK--KEQKHIMAERNVLLKNVKHPFLV 59
Query: 655 ALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
L + +KL V +Y+ G L H+ + + R A ++A + YLH
Sbjct: 60 GL-HYSFQTADKLYFVLDYVNGGELFFHL-----QRERSFPEPRARFYAAEIASALGYLH 113
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV 773
L + I+RDLKP NILL + DFGL + E + T GT YLAPE
Sbjct: 114 SL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEVLR 169
Query: 774 TGRVTTKVDVFSFGVILMELITG 796
VD + G +L E++ G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 11/205 (5%)
Query: 594 NFSEENILGRGGFGTVY--KGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
+ +G G FG +Y K + D +K ++ + K K E+ +L K++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
++V + +V EY G L + I + G+ ++ L+ + ++ G+++
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINR--QRGVL-FSEDQILSWFVQISLGLKH 116
Query: 712 LHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+H + +HRD+K NI L + M AK+ DFG+ R + T GT YL+PE
Sbjct: 117 IH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPE 172
Query: 771 YAVTGRVTTKVDVFSFGVILMELIT 795
K D++S G +L EL T
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 595 FSEENILGRGGFGTVYKG-ELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKVRHRH 652
FS+ +G G FG VY ++ + +A+K+M +G S + + E+ L K+RH +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+ G L + LV EY G+ S + E KPL+ + +G+ YL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC-LGSAS----DLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
H + IHRD+K NILL + K+ DFG + + GT ++APE
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANXFVGTPYWMAPEVI 183
Query: 773 VT---GRVTTKVDVFSFGVILMEL 793
+ G+ KVDV+S G+ +EL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 67/201 (33%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 600 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTK-VRHRHLVAL 656
++G+G FG V + DG+ AVK ++ I K +E VL K ++H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 657 LGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
+ EKL V +Y+ G L H+ L+P R A +VA + YLH L
Sbjct: 62 -HYSFQTAEKLYFVLDYVNGGELFFHL-QRERCFLEP----RARFYAAEVASAIGYLHSL 115
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG 775
+ I+RDLKP NILL + DFGL + E + + T GT YLAPE
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKE 171
Query: 776 RVTTKVDVFSFGVILMELITG 796
VD + G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 69/248 (27%), Positives = 110/248 (44%), Gaps = 21/248 (8%)
Query: 594 NFSEENILGRGGFGTVY---KGELHDGTKI-AVKRMEAGVISGKGLT--EFKSEIAVLTK 647
NF +LG G +G V+ K HD K+ A+K ++ I K T ++E VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 648 VRHRHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL-DV 705
+R + L + + KL L+ +Y+ G L H+ E K E + I ++
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ--RERFKEQE----VQIYSGEI 114
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFG 765
+E+LH L I+RD+K NILL + + DFGL + E + GT
Sbjct: 115 VLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIE 171
Query: 766 YLAPEYAVTGRV--TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD 823
Y+AP+ G VD +S GV++ EL+TG + S ++ RRI S+
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS--RRILKSEP 229
Query: 824 SFHKAIDP 831
+ + +
Sbjct: 230 PYPQEMSA 237
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 67/234 (28%), Positives = 101/234 (43%), Gaps = 55/234 (23%)
Query: 591 VTNNFSEENILGRGGFGTVYKGELHD--GTKIAVKRMEAGVISGKGLTEFKSEIAVLTK- 647
+ + +GRG FGTV K LH GT +AVKR+ + V K ++ V+ +
Sbjct: 2 TAEDLKDLGEIGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVD-EKEQKRLLMDLDVVMRS 59
Query: 648 ------VRHRHLVALLGHC------LDGN-EKLLVFEYMPQGTLSRHIFNWAEEGLKPLE 694
V+ + G C +D + +K + Y + + EE L
Sbjct: 60 SDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL----KSVIP--EEILG--- 110
Query: 695 WNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK- 753
IA+ + + YL IHRD+KPSNILL + K+ DFG+ G+
Sbjct: 111 -----KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGI-----SGQL 158
Query: 754 -GSI-ETRIAGTFGYLAPEYAVTGRVTT--------KVDVFSFGVILMELITGR 797
SI +TR AG Y+APE R+ + DV+S G+ L E+ TG+
Sbjct: 159 VDSIAKTRDAGCRPYMAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-13
Identities = 67/233 (28%), Positives = 100/233 (42%), Gaps = 39/233 (16%)
Query: 582 VISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEF--- 638
I LR +F ++GRG FG V ++ + V + K L++F
Sbjct: 32 AEKITKLRMKAEDFDVIKVIGRGAFGEV---------QLVRHKSSKQVYAMKLLSKFEMI 82
Query: 639 -KSEIAVLTKVRH-------RHLVALLGHCLDGNEKLL--VFEYMPQGTLSRHIFNWAEE 688
+S+ A + R +V L H ++K L V EYMP G L + N+
Sbjct: 83 KRSDSAFFWEERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-- 138
Query: 689 GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VR 747
P +W R T A V L + FIHRD+KP N+LL K+ADFG ++
Sbjct: 139 --IPEKWARFYT-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191
Query: 748 LAPEGKGSIETRIAGTFGYLAPEY----AVTGRVTTKVDVFSFGVILMELITG 796
+ G +T + GT Y++PE G + D +S GV L E++ G
Sbjct: 192 MDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 47/220 (21%)
Query: 601 LGRGGFGTVYKGELHD-GTKIAVKRM-----EAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
+G G +GTV+K + + +A+KR+ + GV S EI +L +++H+++V
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA-----LREICLLKELKHKNIV 62
Query: 655 ALLGHCLDGNEKL-LVFEYMPQ----------GTLSRHIFNWAEEGLKPLEWNRRLTIAL 703
L L ++KL LVFEY Q G + I +
Sbjct: 63 RLY-DVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK---------------SFMF 106
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--APEGKGSIETRIA 761
+ +G+ + H + +HRDLKP N+L+ + K+ADFGL R P S E
Sbjct: 107 QLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-- 161
Query: 762 GTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKAL 800
T Y P+ ++ +T +D++S G I EL + L
Sbjct: 162 -TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 25/223 (11%)
Query: 600 ILGRGGFGTVY-----KGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
+LG+G FG V+ G G A+K ++ + + K E +L +V H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGP-DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 655 ALLGHCLDGNEKL-LVFEYMPQGT----LSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
L + KL L+ +++ G LS+ + + EE +K + L +ALD
Sbjct: 62 KL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVM-FTEEDVK--FYLAELALALD----- 112
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
+LH L I+RDLKP NILL ++ K+ DFGL + + + + + GT Y+AP
Sbjct: 113 -HLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAP 167
Query: 770 EYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLV 812
E T D +SFGV++ E++TG +E+M ++
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 73/268 (27%), Positives = 109/268 (40%), Gaps = 79/268 (29%)
Query: 598 ENILGRGGFGTVYKGELHDGTK------IAVKRMEAGVISGKGLTEFK---SEIAVLTKV 648
LGRG FG V + K +AVK ++ G + +E+K +E+ +L +
Sbjct: 12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA----SEYKALMTELKILIHI 67
Query: 649 -RHRHLVALLGHCLDGNEKLLVF-EYMPQGTLS------RHIF----------------- 683
H ++V LLG C L+V EY G LS R F
Sbjct: 68 GHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKE 127
Query: 684 ------------------NWAEE-GLKPLE--------WNRRLTI------ALDVARGVE 710
+ E+ L +E + LT+ + VARG+E
Sbjct: 128 GKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGME 187
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR---LAPEGKGSIETRIAGTFGYL 767
+L A + IHRDL NILL ++ K+ DFGL R P+ + R+ ++
Sbjct: 188 FL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP--LKWM 242
Query: 768 APEYAVTGRVTTKVDVFSFGVILMELIT 795
APE TT+ DV+SFGV+L E+ +
Sbjct: 243 APESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 67/243 (27%), Positives = 112/243 (46%), Gaps = 23/243 (9%)
Query: 583 ISIQVLRNVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSE 641
I + LR+ F ++G G +G VYKG + G A+K M+ ++ E K E
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKLE 62
Query: 642 IAVLTKV-RHRHLVALLGHCL------DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLE 694
I +L K HR++ G + ++ LV E+ G+++ + N LK +
Sbjct: 63 INMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE-D 121
Query: 695 WNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 754
W I ++ RG+ +LH AH+ IHRD+K N+LL ++ K+ DFG+ G
Sbjct: 122 W--IAYICREILRGLAHLH--AHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 176
Query: 755 SIETRIAGTFGYLAPEYAVT-----GRVTTKVDVFSFGVILMELITGRKALDESQPEESM 809
T I GT ++APE + D++S G+ +E+ G L + P ++
Sbjct: 177 RRNTFI-GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235
Query: 810 HLV 812
L+
Sbjct: 236 FLI 238
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 69/215 (32%), Positives = 106/215 (49%), Gaps = 41/215 (19%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRM-----EAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
+G G +G VYK + IA+K++ + GV S T + EI++L +++H ++V
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPS----TAIR-EISLLKEMQHGNIV 64
Query: 655 ALLGHCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL--TIALDVARGVE 710
L + +EK LVFEY+ L +H+ + + N RL T + RG+
Sbjct: 65 RL--QDVVHSEKRLYLVFEYLDL-DLKKHMDSSPD-----FAKNPRLIKTYLYQILRGIA 116
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRA---KVADFGLVRLAPEGKGSIETRI----AGT 763
Y H +H+ +HRDLKP N+L+ D R K+ADFGL R I R T
Sbjct: 117 YCH--SHR-VLHRDLKPQNLLI--DRRTNALKLADFGLARAF-----GIPVRTFTHEVVT 166
Query: 764 FGYLAPEYAVTGR-VTTKVDVFSFGVILMELITGR 797
Y APE + R +T VD++S G I E++ +
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 57/228 (25%), Positives = 102/228 (44%), Gaps = 36/228 (15%)
Query: 592 TNNFSEENILGRGGFGTVYKGELHDGT------KIAVKRMEAGVISGKGLTEFKSEIAVL 645
T F EE LG FG VYKG L +A+K ++ G EFK E +
Sbjct: 6 TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMR 62
Query: 646 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIF--------------NWAEEGLK 691
++++H ++V LLG ++F Y L + + L+
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 692 PLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751
P ++ + I +A G+E+L + +H+DL N+L+ D + K++D GL R E
Sbjct: 123 PADF---VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR---E 173
Query: 752 GKGSIETRIAGT----FGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
+ ++ G +++PE + G+ + D++S+GV+L E+ +
Sbjct: 174 VYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 8e-13
Identities = 42/95 (44%), Positives = 54/95 (56%), Gaps = 6/95 (6%)
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY 766
RG++Y+H + +HRDLKPSN+LL + K+ DFGL R E KG T T Y
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-KGDFMTEYVVTRWY 174
Query: 767 LAPEYAVT-GRVTTKVDVFSFGVILMELITGRKAL 800
APE + TT +DV+S G I EL+ GRK L
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 60/231 (25%), Positives = 114/231 (49%), Gaps = 19/231 (8%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
RN +F +G G +G VYK ++ G A+K ++ + G+ + EI ++
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKD 62
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+H ++VA G L ++ + E+ G+L + I++ PL ++ ++ + +
Sbjct: 63 CKHSNIVAYFGSYLRRDKLWICMEFCGGGSL-QDIYHVT----GPLSESQIAYVSRETLQ 117
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFG 765
G+ YLH + +HRD+K +NILL D+ K+ADFG ++ + +I R GT
Sbjct: 118 GLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFG---VSAQITATIAKRKSFIGTPY 171
Query: 766 YLAPEYAVTGR---VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVT 813
++APE A R D+++ G+ +EL + + + P ++ L+T
Sbjct: 172 WMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 594 NFSEENILGRGGFGTVYKG-ELHDGTKIAVKRME---AGVISGKGLTEFKSEIAVLTKVR 649
N+ +LGRG FG VY + G ++AVK++ + K + + EI +L +R
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 650 HRHLVALLGHCLDGNE--KLLVF-EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 706
H +V G CL E KL +F EYMP G++ + + G RR T +
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAY---GALTENVTRRYT--RQIL 116
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR----LAPEGKGSIETRIAG 762
+GV YLH +HRD+K +NIL K+ DFG + + G G I++ + G
Sbjct: 117 QGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG-IKS-VTG 171
Query: 763 TFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
T +++PE K DV+S ++E++T
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-13
Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
LG G + TVYKG+ +G +A+K + G T + E ++L ++H ++V LL
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIV-LLHD 70
Query: 660 CLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
+ E L LVFEY+ L +++ + GL P N +L + + RG+ Y+H +
Sbjct: 71 IIHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPE--NVKLFL-FQLLRGLSYIH---QR 122
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV-TGRV 777
+HRDLKP N+L+ D K+ADFGL R + + T Y P+ + +
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 778 TTKVDVFSFGVILMELITGRKAL 800
+T +D++ G I +E+I G A
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 63/246 (25%), Positives = 112/246 (45%), Gaps = 28/246 (11%)
Query: 574 QMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISG 632
Q A MV+ R +NF + +G G G V + G +AVK+M+
Sbjct: 4 QFRAALQMVVDPGDPRTYLDNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQR 60
Query: 633 KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFN--WAEEGL 690
+ L +E+ ++ +H ++V + L G+E +V E++ G L+ + + EE +
Sbjct: 61 REL--LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI 118
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV---- 746
+ L V + + LH Q IHRD+K +ILL D R K++DFG
Sbjct: 119 A--------AVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 167
Query: 747 RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPE 806
+ P K + GT ++APE +VD++S G++++E++ G P
Sbjct: 168 KEVPRRKS-----LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL 222
Query: 807 ESMHLV 812
++M ++
Sbjct: 223 KAMKMI 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
LG G + TVYKG +G +A+K + G T + E ++L ++H ++V LL
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIV-LLHD 70
Query: 660 CLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
+ E L VFEYM L++++ GL P +N RL + + RG+ Y+H Q
Sbjct: 71 IIHTKETLTFVFEYM-HTDLAQYMIQ-HPGGLHP--YNVRLFM-FQLLRGLAYIH---GQ 122
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV- 777
+HRDLKP N+L+ K+ADFGL R + + + T Y P+ + G
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPD-VLLGATD 180
Query: 778 -TTKVDVFSFGVILMELITGRKAL 800
++ +D++ G I +E++ G+ A
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 594 NFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVR 649
N+ +LG+G FG VY ++ G ++A K+++ S K ++ + EI +L ++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 650 HRHLVALLGHCLDGNEKLLV--FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
H +V G D EK L EYMP G++ + + G R+ T +
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY---GALTESVTRKYT--RQILE 117
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPEGKGSIETRIAGT 763
G+ YLH +HRD+K +NIL K+ DFG L + G G + GT
Sbjct: 118 GMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI--RSVTGT 172
Query: 764 FGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 797
+++PE K DV+S G ++E++T +
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 26/203 (12%)
Query: 601 LGRGGFGTVYKG--ELHDGTK-IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
LG G FGTV KG ++ K +AVK ++ E E V+ ++ + ++V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVARGVEY 711
G C + +LV E G L+ K L+ N+ +T + V+ G++Y
Sbjct: 63 GIC-EAESWMLVMELAELGPLN-----------KFLQKNKHVTEKNITELVHQVSMGMKY 110
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF--GYLAP 769
L +F+HRDL N+LL AK++DFGL + + + + G + + AP
Sbjct: 111 LE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP 167
Query: 770 EYAVTGRVTTKVDVFSFGVILME 792
E + ++K DV+SFGV++ E
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
+G G +G+V + G ++AVK++ S E+ +L ++H +++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 82
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVARGVEYLH 713
D E L H+ L + ++LT + + RG++Y+H
Sbjct: 83 --DVFTPARSLEEFNDVYLVTHLMG---ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 137
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYLAPEYA 772
IHRDLKPSN+ + +D K+ DFGL R E G + TR Y APE
Sbjct: 138 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 189
Query: 773 VTG-RVTTKVDVFSFGVILMELITGR 797
+ VD++S G I+ EL+TGR
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-12
Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 14/221 (6%)
Query: 600 ILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL-- 656
+LG G GTV + DG AVK ++ +S ++E+ L +V
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 657 -LGHCLDGNEKL-----LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
N + LV +Y G L + I + A+ + + + + V V
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTN-RTFREHEAGLLFIQVLLAVH 157
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL-APEGKGSIETRIAGTFGYLAP 769
++H + IHRD+K +NILL + K+ DFG ++ A + GT Y+AP
Sbjct: 158 HVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP 214
Query: 770 EYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMH 810
E + K D+FS GV+L EL+T ++ D EE MH
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH 255
|
Length = 496 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 57/232 (24%), Positives = 104/232 (44%), Gaps = 33/232 (14%)
Query: 601 LGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
LG G G V+ D ++AVK++ + + + EI ++ ++ H ++V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIV--LTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 660 CLDGNEKL--------------LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 705
L +V EYM + L+ + E+G E R L
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL----EQGPLSEEHARLFMYQL-- 123
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLAP---EGKGSIETRIA 761
RG++Y+H + +HRDLKP+N+ + +D+ K+ DFGL R+ KG + +
Sbjct: 124 LRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 762 GTFGYLAPEYAVTGRVTTK-VDVFSFGVILMELITGRKALDESQPEESMHLV 812
+ Y +P ++ TK +D+++ G I E++TG+ + E M L+
Sbjct: 181 TKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-12
Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 17/215 (7%)
Query: 600 ILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFK-SEIAVLTKVRHRHLVALL 657
+LG+G FG V L G AVK ++ VI E +E +L+ R+ + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 658 GHCLDGNEKLL-VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
C ++L V E++ G L HI + + + R A ++ + +LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHI-----QKSRRFDEARARFYAAEITSALMFLH--- 113
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG--KGSIETRIAGTFGYLAPEYAVT 774
+ I+RDLK N+LL + K+ADFG+ + EG G + GT Y+APE
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPEILQE 170
Query: 775 GRVTTKVDVFSFGVILMELITGRKALDESQPEESM 809
VD ++ GV+L E++ G E++ E+ +
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPF-EAENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 29/206 (14%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLG 658
+G G F V K G A+K M+ S + + EI L ++ H +++ L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRLIE 65
Query: 659 HCLD-GNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
D +L LVFE M +++ + +PL R + + + ++++H
Sbjct: 66 VLFDRKTGRLALVFELMDM-----NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR-- 118
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR------IAGTFGYLAPE 770
+ F HRD+KP NIL+ DD K+ADFG R I ++ I+ T Y APE
Sbjct: 119 NGIF-HRDIKPENILIKDD-ILKLADFGSCR-------GIYSKPPYTEYIS-TRWYRAPE 168
Query: 771 YAVT-GRVTTKVDVFSFGVILMELIT 795
+T G K+D+++ G + E+++
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 58/225 (25%), Positives = 112/225 (49%), Gaps = 17/225 (7%)
Query: 601 LGRGGFGTVYKGELHDGTK---IAVKRMEAGVISGKGLT-EFKSEIAVLTKVRHRHLVAL 656
LG G FG V KG K +A+K ++ + K + E E ++ ++ + ++V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
+G C + +LV E G L++ + +E + + + + V+ G++YL G
Sbjct: 61 IGVC-EAEALMLVMEMASGGPLNKFLSGKKDE----ITVSNVVELMHQVSMGMKYLEG-- 113
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF--GYLAPEYAVT 774
++F+HRDL N+LL + AK++DFGL + + R AG + + APE
Sbjct: 114 -KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 775 GRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRI 818
+ +++ DV+S+G+ + E + G+K + + E M + +R+
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL 217
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 60/201 (29%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 600 ILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISGKG-LTEFKSEIAVLTKVRHRHLVALL 657
+LG+G FG V E G A+K + VI K + +E VL RH L AL
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
+ +++L V EY G L F+ + E + R ++ +EYLH
Sbjct: 61 KYAFQTHDRLCFVMEYANGGEL---FFHLSRE--RVFTEERARFYGAEIVSALEYLHS-- 113
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR 776
+ ++RD+K N++L D K+ DFGL + +++T GT YLAPE
Sbjct: 114 -RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDND 171
Query: 777 VTTKVDVFSFGVILMELITGR 797
VD + GV++ E++ GR
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 66/244 (27%), Positives = 115/244 (47%), Gaps = 27/244 (11%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
RN +++ +G G +G VYK LH G AVK ++ + G + + EI ++ +
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKE 62
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+H ++VA G L + + EY G+L + I++ PL + + + +
Sbjct: 63 CKHCNIVAYFGSYLSREKLWICMEYCGGGSL-QDIYHVT----GPLSELQIAYVCRETLQ 117
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFG 765
G+ YLH +HRD+K +NILL D+ K+ADFG +A + +I R GT
Sbjct: 118 GLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFG---VAAKITATIAKRKSFIGTPY 171
Query: 766 YLAPEYAV---TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK 822
++APE A G D+++ G+ +EL + + + P ++ L +SK
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL--------MSK 223
Query: 823 DSFH 826
+F
Sbjct: 224 SNFQ 227
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 594 NFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVR 649
N+ +LG+G FG VY + G ++AVK+++ S K + + EI +L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 650 HRHLVALLGHCLDGNEKLL--VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
H +V G D E+ L E+MP G++ + ++ G R+ T +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY---GALTENVTRKYT--RQILE 117
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPEGKGSIETRIAGT 763
GV YLH +HRD+K +NIL K+ DFG L + G G + GT
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGT 172
Query: 764 FGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 797
+++PE K D++S G ++E++T +
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 12/216 (5%)
Query: 600 ILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISGKG-LTEFKSEIAVLTKVRHRHLVALL 657
+LG+G FG V E G A+K ++ VI K + +E VL RH L AL
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL- 60
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
+ +++L V EY G L F+ + E + +R ++ ++YLH +
Sbjct: 61 KYSFQTHDRLCFVMEYANGGEL---FFHLSRE--RVFSEDRARFYGAEIVSALDYLH--S 113
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR 776
++ ++RDLK N++L D K+ DFGL + + +++T GT YLAPE
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDND 172
Query: 777 VTTKVDVFSFGVILMELITGRKALDESQPEESMHLV 812
VD + GV++ E++ GR E+ L+
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 6e-12
Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEFK-SEIAVLTKVRHRHLVALL 657
+LG+G FG V EL ++ A+K ++ VI + +E +L + L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 658 GHCLDGNEKLL-VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
C ++L V EY+ G L I + + + R A +V + +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQI-----QRSRKFDEPRSRFYAAEVTLALMFLH--- 113
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG--KGSIETRIAGTFGYLAPEYAVT 774
I+RDLK NILL + K+ADFG+ + EG G T GT Y+APE
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQE 170
Query: 775 GRVTTKVDVFSFGVILMELITGR 797
VD ++ GV++ E++ G+
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 8e-12
Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 11/215 (5%)
Query: 600 ILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISGKG-LTEFKSEIAVLTKVRHRHLVALL 657
+LG+G FG V E G A+K ++ VI K + +E VL RH L +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
+ V EY+ G L F+ + E + +R ++ ++YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGEL---FFHLSRE--RVFSEDRTRFYGAEIVSALDYLHS--- 113
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV 777
++RDLK N++L D K+ DFGL + +++T GT YLAPE
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDY 172
Query: 778 TTKVDVFSFGVILMELITGRKALDESQPEESMHLV 812
VD + GV++ E++ GR E+ L+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 71/274 (25%), Positives = 110/274 (40%), Gaps = 24/274 (8%)
Query: 593 NNFSEENILGRGGFGTVY-KGELHDGTKIAVKRMEAGVISGKGLTEF-KSEIAVLTKVRH 650
+F ++++GRG FG V E G A+K M+ V+ + F + E +L+
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTL----SRHIFNWAEEGLKPLEWNRRLTIALDVA 706
+ L D + LV EY P G L +R+ + E+ +A
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDED-----------MAQFYLA 109
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY 766
V +H + ++HRD+KP N+L+ K+ADFG K GT Y
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169
Query: 767 LAPEYAVT------GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL 820
+APE T G + D +S GVI E+I GR E ++ + + F+R L
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF-L 228
Query: 821 SKDSFHKAIDPTIDLNEGILASISTVAELAGHCC 854
K +DL + +L G CC
Sbjct: 229 KFPEDPKVSSDFLDLIQSLLCGQKERLGYEGLCC 262
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 601 LGRGGFGTVYKGELHDG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+G G FG V GE++ G ++ VK + S + +F E ++H +L+ L
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
G C + LLV E+ P G L ++ + E + P + +A ++A G+ +LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP-DPTTLQRMACEIALGLLHLH--- 117
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEGKGSIETRIAGTFGYLAPEYA--V 773
+FIH DL N LL D+ K+ D+GL E ++ ++APE V
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 774 TGRV-----TTKVDVFSFGVILMEL 793
G + T + +V+S GV + EL
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-11
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 17/219 (7%)
Query: 585 IQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAG--VISGKGLTEFKSEI 642
I+ LR ++ ++GRG FG V K+ ++ + +I F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 643 AVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIA 702
++ +V L D +V EYMP G L + N+ P +W R T
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAE 150
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETRIA 761
+ +A L + FIHRD+KP N+LL K+ADFG +++ EG +T +
Sbjct: 151 VVLA-----LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV- 204
Query: 762 GTFGYLAPEYAVT----GRVTTKVDVFSFGVILMELITG 796
GT Y++PE + G + D +S GV L E++ G
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 37/226 (16%)
Query: 594 NFSEENILGRGGFGTV----YKGELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKV 648
+F+ LG G FG V YK E D +A+KR E + +I K + SE +L +
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNE--DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI 88
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IA 702
H V L G D + LV E++ G E L N+R A
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGG-----------EFFTFLRRNKRFPNDVGCFYA 137
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--- 759
+ EYL L + ++RDLKP N+LL D K+ DFG ++ ++TR
Sbjct: 138 AQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV-------VDTRTYT 187
Query: 760 IAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQP 805
+ GT Y+APE + D ++ G+ + E++ G ++P
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 594 NFSEENILGRGGFGTVY---KGELHDGTKI---AVKRMEAGVISGKGLTEFKSEIAVLTK 647
NF +LG G +G V+ K HD K+ V + A V K + ++E VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 648 VRHRHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIF---NWAEEGLKPLEWNRRLTIAL 703
VR + L + KL L+ +Y+ G + H++ N++E+ ++ ++ + +AL
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRF--YSGEIILAL 118
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT 763
E+LH L ++RD+K NILL + + DFGL + + GT
Sbjct: 119 ------EHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGT 169
Query: 764 FGYLAPEYAVTGRVTTK-VDVFSFGVILMELITG 796
Y+APE K VD +S G+++ EL+TG
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-11
Identities = 50/175 (28%), Positives = 76/175 (43%), Gaps = 29/175 (16%)
Query: 68 KRITRIQIGHQNLQGTLPS----------------NLQ--------NLTKLERLELQWNS 103
+ + R+++ + G LPS NLQ ++ L+ L L N
Sbjct: 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNK 463
Query: 104 ISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNA 163
G LP G LE + LS NQF+ LS L +++ N S EIP L +
Sbjct: 464 FFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSG-EIPDELSSC 522
Query: 164 SGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSL 218
L + + ++GQIP+ F E P L+ L L+ NQL G +P + ++SL
Sbjct: 523 KKLVSLDLSHNQLSGQIPASFS--EMPVLSQLDLSQNQLSGEIPKNLGN--VESL 573
|
Length = 968 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 28/213 (13%)
Query: 601 LGRGGFGTVYKG---ELHDGTKIAVKRMEAGVISGKGLTEFK-SEIAVLTKVR-HRHLVA 655
LG+G +G V E + +A+K++ V S K L + E+ +L R H+++
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKI-TNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 656 LLGHCLDG------NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
L +D NE L E M + L + I +PL + + G+
Sbjct: 67 LYD--MDIVFPGNFNELYLYEELM-EADLHQII-----RSGQPLTDAHFQSFIYQILCGL 118
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG---TFGY 766
+Y+H + +HRDLKP N+L+ D K+ DFGL R E G + T Y
Sbjct: 119 KYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 767 LAPEYAVTGRVTTK-VDVFSFGVILMELITGRK 798
APE ++ + TK +DV+S G IL EL+ GRK
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELL-GRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 14/218 (6%)
Query: 594 NFSEENILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTEFK-SEIAVLTKVRH 650
+F+ +LG+G FG V E GT A+K ++ VI E E VL
Sbjct: 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK 59
Query: 651 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
+ L C ++L V EY+ G L HI + + + + A ++A G+
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPHAVFYAAEIAIGL 114
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
+LH + I+RDLK N++L + K+ADFG+ + G + T GT Y+AP
Sbjct: 115 FFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTPDYIAP 170
Query: 770 EYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEE 807
E VD ++FGV+L E++ G+ D +E
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 601 LGRGGFGTVYKGELHDGTKIA---VKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+G G FG V E++ T +A VK ++A S K EF + ++H +++ L
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFN--WAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
G C++ LLVFEY G L ++ W + L R +A ++A GV ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTHMHKH 118
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETRIAGTFGYLAPEYA-- 772
+F+H DL N L D+ KV D+G+ E E +LAPE
Sbjct: 119 ---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175
Query: 773 -----VTGRVTTKVDVFSFGVILMEL 793
+T T +V++ GV L EL
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 36/90 (40%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
G+++LH IHRDLKPSNI++ D K+ DFGL R A G + T T Y
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 184
Query: 768 APEYAVTGRVTTKVDVFSFGVILMELITGR 797
APE + VD++S G I+ E+I G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 64/229 (27%), Positives = 101/229 (44%), Gaps = 16/229 (6%)
Query: 601 LGRGGFGTVYKGELHDGTKI-AVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRH---LVA 655
+G+G FG VY+ D +I A+K + I + K + E +L + +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
L ++ LV +YM G L H+ +EG E + IA ++ +E+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL---QKEGRFS-EDRAKFYIA-ELVLALEHLH-- 113
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG 775
++RDLKP NILL + DFGL + A GT YLAPE +
Sbjct: 114 -KYDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDE 171
Query: 776 RVTTK-VDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD 823
+ TK VD +S GV++ E+ G ++ M+ F ++ K+
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-MYRNIAFGKVRFPKN 219
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 601 LGRGGFGTVY-----KGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA 655
LG+G FGTVY K + K+ +K + G ++ + E +L+K+ H +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKV-LKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
L+ + ++ EY L + G K L N+ + + GV Y+H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTG-KTLSENQVCEWFIQLLLGVHYMH-- 123
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG 775
+ +HRDLK NI L +++ K+ DFG+ RL G + T GT Y++PE
Sbjct: 124 -QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEALKHQ 180
Query: 776 RVTTKVDVFSFGVILMEL 793
+K D++S G IL E+
Sbjct: 181 GYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 599 NILGRGGFGTVYKGELHDGT-----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
++L G FG ++ G L D ++ VK ++ S +T E +L + H+++
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNI 70
Query: 654 VALLGHCLDGNEKLLV-FEYMPQGTL------SRHIFNWAEEGLKPLEWNRRLTIALDVA 706
+ +L C++ E V + YM G L R + L + + +A+ +A
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLG---EANNPQALSTQQLVHMAIQIA 127
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGK---GSIETRIAG 762
G+ YLH IH+D+ N ++ ++++ K+ D L R L P G E R
Sbjct: 128 CGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR--- 181
Query: 763 TFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEE 807
++A E V ++ DV+SFGV+L EL+T G+ E P E
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE 227
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 64/217 (29%), Positives = 93/217 (42%), Gaps = 38/217 (17%)
Query: 594 NFSEENILGRGGFGTVYKGELHDGT------KIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
+F LG G FG V + H GT K KR ++ K + E ++L +
Sbjct: 19 DFEMGETLGTGSFGRVRIAK-HKGTGEYYAIKCLKKRE---ILKMKQVQHVAQEKSILME 74
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+ H +V ++ D N + E++ G L H+ + G P N DVA+
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL---RKAGRFP---N-------DVAK 121
Query: 708 --------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR 759
EYLH I+RDLKP N+LL + KV DFG + P+ +
Sbjct: 122 FYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT---- 174
Query: 760 IAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG 796
+ GT YLAPE + VD ++ GV+L E I G
Sbjct: 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 63/200 (31%), Positives = 90/200 (45%), Gaps = 12/200 (6%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEA-GVISGKGLTEFKSEIAVLTK-VRHRHLVAL 656
++G+G FG V K AVK ++ ++ K SE VL K V+H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
++ V +Y+ G L H+ L+P R A ++A + YLH L
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHL-QRERCFLEP----RARFYAAEIASALGYLHSL- 115
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR 776
+ ++RDLKP NILL + DFGL + E G+ T GT YLAPE
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQP 172
Query: 777 VTTKVDVFSFGVILMELITG 796
VD + G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 30/206 (14%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKG---LTEFKSEIAVLTKVRHRHLVALL 657
LG G FG VYK + + +A A VI K L ++ EI +L H ++V LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAA----AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT---IALDVARGVEYLHG 714
N ++ E+ G + + LE R LT I + + +E L+
Sbjct: 69 DAFYYENNLWILIEFCAGGAVDAVM----------LELERPLTEPQIRVVCKQTLEALNY 118
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFGYLAPEYA 772
L IHRDLK NIL D K+ADFG ++ + +I+ R GT ++APE
Sbjct: 119 LHENKIIHRDLKAGNILFTLDGDIKLADFG---VSAKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 773 V--TGR---VTTKVDVFSFGVILMEL 793
+ T + K DV+S G+ L+E+
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 25/209 (11%)
Query: 601 LGRGGFGTVYKGELHDGTKI--AVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
LG+G +G+VYK LH T + A+K + + K + E+ +L K ++V G
Sbjct: 9 LGKGNYGSVYKV-LHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFYG 66
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
+ EYM G+L + P + RR+T A V +G+++L
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYA--VVKGLKFLK--EEH 122
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA----GTFGYLAPEY--- 771
+ IHRD+KP+N+L+ + + K+ DFG+ G++ +A G Y+APE
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGV-------SGNLVASLAKTNIGCQSYMAPERIKS 175
Query: 772 -AVTGRVTTKV--DVFSFGVILMELITGR 797
T V DV+S G+ ++E+ GR
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 64/207 (30%), Positives = 93/207 (44%), Gaps = 25/207 (12%)
Query: 600 ILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISGKG-----LTEFKSEIAVLTKVRHRHL 653
+LG+G FG V E G A+K ++ VI K LTE + VL RH L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESR----VLQNTRHPFL 57
Query: 654 VALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
AL + +++L V EY G L H+ + E + +R ++ + YL
Sbjct: 58 TAL-KYSFQTHDRLCFVMEYANGGELFFHL---SRERV--FSEDRARFYGAEIVSALGYL 111
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG--KGSIETRIAGTFGYLAPE 770
H ++RDLK N++L D K+ DFGL + EG G+ GT YLAPE
Sbjct: 112 H---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPE 165
Query: 771 YAVTGRVTTKVDVFSFGVILMELITGR 797
VD + GV++ E++ GR
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-11
Identities = 67/270 (24%), Positives = 106/270 (39%), Gaps = 63/270 (23%)
Query: 601 LGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
+G G FG V D + A+K + A V+ K+E +L + + +V L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 659 HCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
D + V +Y+P G + IF EE L R IA ++ +E +H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIF---EEDLA------RFYIA-ELTCAIESVH 118
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV--------------------------- 746
+ FIHRD+KP NIL+ D K+ DFGL
Sbjct: 119 KMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 747 RLAPEGKG---SIETR------------IAGTFGYLAPEYAVTGRVTTKVDVFSFGVILM 791
+ + +E R + GT Y+APE + T D +S GVIL
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235
Query: 792 ELITGRKA-LDESQPEESMHLVTWFRRIHL 820
E++ G+ L ++ E + ++ W +H+
Sbjct: 236 EMLVGQPPFLADTPAETQLKVINWETTLHI 265
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 73/269 (27%), Positives = 113/269 (42%), Gaps = 35/269 (13%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
LG G G V K + I +++ I + E+ VL + ++V G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 661 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 720
E + E+M G+L + + E P E +++IA V RG+ YL HQ
Sbjct: 73 YSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIA--VLRGLAYLRE-KHQ-I 125
Query: 721 IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTK 780
+HRD+KPSNIL+ K+ DFG ++ + S+ GT Y++PE + +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFG---VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 182
Query: 781 VDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGIL 840
D++S G+ L+EL GR + P ++ L F R P +D EG
Sbjct: 183 SDIWSMGLSLVELAIGRYPI---PPPDAKELEAIFGR-------------PVVDGEEGEP 226
Query: 841 ASISTVAELAGHCCAREPYQRPDMGHAVN 869
SIS P RP GH ++
Sbjct: 227 HSISPRP---------RPPGRPVSGHGMD 246
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 17/214 (7%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGK-GLTEFKSEIAVLTKVRHRH--LVA 655
I+GRGGFG VY D K+ A+K ++ I K G T +E +L+ V +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 656 LLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
+ + +KL + + M G L H+ K + + A ++ G+E++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-----YATEIILGLEHMH- 114
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT 774
++ ++RDLKP+NILL + +++D GL + K GT GY+APE
Sbjct: 115 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 169
Query: 775 GRV-TTKVDVFSFGVILMELITGRKALDESQPEE 807
G + D FS G +L +L+ G + + ++
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 42/112 (37%), Positives = 60/112 (53%), Gaps = 30/112 (26%)
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LV-RLAPEGKGS 755
IA+ + + +EYLH + S IHRD+KPSN+L+ + + K+ DFG LV +A
Sbjct: 108 IAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA------ 159
Query: 756 IETRIAGTFGYLAPE----------YAVTGRVTTKVDVFSFGVILMELITGR 797
+T AG Y+APE Y V K DV+S G+ ++EL TGR
Sbjct: 160 -KTIDAGCKPYMAPERINPELNQKGYDV------KSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 8e-11
Identities = 65/234 (27%), Positives = 115/234 (49%), Gaps = 40/234 (17%)
Query: 582 VISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGT-KIAVKRMEAGVISGKGLTEFKS 640
+I + R+ ++ NI+G G FG VY+ D + K+A+K++ ++K+
Sbjct: 55 MIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-------PQYKN 107
Query: 641 -EIAVLTKVRHRHLVALLGH----CLDGNEKLL----VFEYMPQGTLSRHIFNWAEEGLK 691
E+ ++ + H +++ L + C NEK + V E++PQ T+ +++ ++A
Sbjct: 108 RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARN--- 163
Query: 692 PLEWNRRLTIAL------DVARGVEYLHGLAHQSFI-HRDLKPSNILLGDDMRA-KVADF 743
N L + L + R + Y+H FI HRDLKP N+L+ + K+ DF
Sbjct: 164 ----NHALPLFLVKLYSYQLCRALAYIH----SKFICHRDLKPQNLLIDPNTHTLKLCDF 215
Query: 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAV-TGRVTTKVDVFSFGVILMELITG 796
G + G+ S+ + I F Y APE + TT +D++S G I+ E+I G
Sbjct: 216 GSAKNLLAGQRSV-SYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 9e-11
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 17/203 (8%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGK-GLTEFKSEIAVLTKVRHRH--LVA 655
I+GRGGFG VY D K+ A+K ++ I K G T +E +L+ V +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 656 LLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
+ + +KL + + M G L H+ ++ G+ E R A ++ G+E++H
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFS-EAEMRF-YAAEIILGLEHMH- 114
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT 774
++ ++RDLKP+NILL + +++D GL + K GT GY+APE
Sbjct: 115 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 169
Query: 775 GRV-TTKVDVFSFGVILMELITG 796
G + D FS G +L +L+ G
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 65/203 (32%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 600 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTK-VRHRHLVAL 656
++G+G FG V + DG AVK ++ ++ + K +E VL K V+H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 657 LGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
+ EKL V +++ G L F+ E P E R A ++A + YLH +
Sbjct: 62 -HYSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFP-EPRARFYAA-EIASALGYLHSI 115
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG--KGSIETRIAGTFGYLAPEYAV 773
+ ++RDLKP NILL + DFGL + EG + T GT YLAPE
Sbjct: 116 ---NIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIR 169
Query: 774 TGRVTTKVDVFSFGVILMELITG 796
VD + G +L E++ G
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 601 LGRGGFG-TVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
+G G FG + DG + +K + +S K E + E+AVL+ ++H ++V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFN-----WAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
+ +V +Y G L + I + E+ + L+W ++ +AL +++H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI--LDWFVQICLAL------KHVH- 118
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT 774
+ +HRD+K NI L D K+ DFG+ R+ T I GT YL+PE
Sbjct: 119 --DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICEN 175
Query: 775 GRVTTKVDVFSFGVILMELITGRKALD 801
K D+++ G +L E+ T + A +
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 57/222 (25%), Positives = 91/222 (40%), Gaps = 41/222 (18%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTEFKS----EIAVLT 646
N F ++G G +G V K H TK +A+K+ + + E K E+ +L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCR-HKETKEIVAIKKFK----DSEENEEVKETTLRELKMLR 55
Query: 647 KVRHRHLVALLGHCLDGNEKLLVFEY-----------MPQGTLSRHIFNWAEEGLKPLEW 695
++ ++V L + LVFEY MP G + ++ + +K + W
Sbjct: 56 TLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 696 NRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755
+ I +HRD+KP N+L+ + K+ DFG R EG +
Sbjct: 116 CHKNDI-------------------VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156
Query: 756 IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 797
T T Y +PE + VD++S G IL EL G+
Sbjct: 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 27/207 (13%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL-- 657
+G G +G+V + G K+A+K++ S E+ +L ++H +++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 658 ---GHCLDGNEKL-LVFEYMPQGTLSRHI-FNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
D + LV YM Q L + + +E+ ++ L + + G++Y+
Sbjct: 83 FTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHPLSEDKVQYLVYQ--------MLCGLKYI 133
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEGKGSIETRIAGTFGYLAPEY 771
H IHRDLKP N+ + +D K+ DFGL R A E G + TR Y APE
Sbjct: 134 HS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEV 185
Query: 772 AVTG-RVTTKVDVFSFGVILMELITGR 797
+ VD++S G I+ E++TG+
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 42/133 (31%), Positives = 66/133 (49%), Gaps = 13/133 (9%)
Query: 39 LKKSLNPPESLGWSDTDPC-----KWNHVVCIEDKRITR-----IQIGHQNLQGTLPSNL 88
LK SL P GW + DPC W+ C D + + + +Q L+G +P+++
Sbjct: 380 LKSSLGLPLRFGW-NGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDI 438
Query: 89 QNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147
L L+ + L NSI G +P SL + SLEV+ LS N F + L+SL+ + ++
Sbjct: 439 SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498
Query: 148 NNPFSSWEIPQSL 160
N S +P +L
Sbjct: 499 GN-SLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 33/84 (39%), Positives = 45/84 (53%), Gaps = 6/84 (7%)
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY----AV 773
IHRD+KPSNILL K+ DFG+ + K +TR AG Y+APE
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA--KTRSAGCAAYMAPERIDPPDP 191
Query: 774 TGRVTTKVDVFSFGVILMELITGR 797
+ + DV+S G+ L+EL TG+
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 4e-10
Identities = 60/236 (25%), Positives = 92/236 (38%), Gaps = 54/236 (22%)
Query: 601 LGRGGFGTVYKGELHD-GTKIAVKRME-AGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
LG+G G V+ L G A+K ++ +I + +E +L + H L L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVE 710
LV +Y P G L R L + + L+ +VAR +E
Sbjct: 69 SFQTETYLCLVMDYCPGGELFR---------LLQRQPGKCLSE--EVARFYAAEVLLALE 117
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEG----------------- 752
YLH L ++RDLKP NILL + ++DF L + E
Sbjct: 118 YLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 753 KGSIETRIA----------GTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGR 797
ET GT Y+APE ++G + VD ++ G++L E++ G
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 57/217 (26%), Positives = 98/217 (45%), Gaps = 12/217 (5%)
Query: 594 NFSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEFKS-EIAVLTKVRHR 651
+F+ +LG+G FG V E ++ A+K ++ V+ E E VL
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 652 HLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
+ L C ++L V EY+ G L HI + + + + + A +++ G+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPQAVFYAAEISVGLF 115
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+LH + I+RDLK N++L + K+ADFG+ + G GT Y+APE
Sbjct: 116 FLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-EHMVDGVTTRTFCGTPDYIAPE 171
Query: 771 YAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEE 807
VD +++GV+L E++ G+ D +E
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 25/212 (11%)
Query: 599 NILGRGGFGTVYKG-ELHDGTKIAVKR--MEAGVISGKGLTEFKSEIAVLTKVRHRHLVA 655
+G+G FG V+K +A+K+ ME G +T + EI +L ++H ++V
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALR-EIKILQLLKHENVVN 75
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR-------- 707
L+ C + Y L +F + E L L N+ + L +
Sbjct: 76 LIEIC--RTKATPYNRYKGSFYL---VFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR---LAPEGKGSIETRIAGTF 764
G+ Y+H +HRD+K +NIL+ D K+ADFGL R L+ K + T T
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 765 GYLAPEYAVTGR-VTTKVDVFSFGVILMELIT 795
Y PE + R +D++ G I+ E+ T
Sbjct: 188 WYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 5e-10
Identities = 65/248 (26%), Positives = 100/248 (40%), Gaps = 57/248 (22%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKVRH 650
++F ++GRG FG V + D I A+K++ + K ++E +L + +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQG---TL--SRHIFNWAEEGLKPLEWNRRLTIALDV 705
+V L D N L+ EY+P G TL + F EE R IA +
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTF--TEEE-------TRFYIA-ET 110
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-------------------- 745
++ +H L +IHRD+KP N+LL K++DFGL
Sbjct: 111 ILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHAL 167
Query: 746 -------VRLAPEGKGSIET----RIA------GTFGYLAPEYAVTGRVTTKVDVFSFGV 788
+ K ET R A GT Y+APE + + D +S GV
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227
Query: 789 ILMELITG 796
I+ E++ G
Sbjct: 228 IMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-09
Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 2/106 (1%)
Query: 333 LNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGN-ITVINFQKMNLTGTISPEFA 391
L LLS + P ++ NW + W G+TC + + I+ N++G IS
Sbjct: 31 LELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIF 90
Query: 392 SFKSLQRLILADNNLSGMIPEGLSVLG-ALKELDVSNNQLYGKIPS 436
+Q + L++N LSG IP+ + +L+ L++SNN G IP
Sbjct: 91 RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR 136
|
Length = 968 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 12/205 (5%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALL 657
++GRG + V L +I A+K ++ ++ + + ++E V + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
C +L LV EY+ G L +F+ + P E R A ++ + +LH
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHAR--FYAAEICIALNFLH--- 113
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR 776
+ I+RDLK N+LL D K+ D+G+ + G G + GT Y+APE
Sbjct: 114 ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL-GPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 777 VTTKVDVFSFGVILMELITGRKALD 801
VD ++ GV++ E++ GR D
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRHLVALL 657
++GRG + V L +I A+K ++ +++ + + ++E V + + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 658 GHCLDGNEKLL-VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
C +L V EY+ G L +F+ + P E R + + +A + YLH
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLA--LNYLH--- 113
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR--LAPEGKGSIETRIAGTFGYLAPEYAVT 774
+ I+RDLK N+LL + K+ D+G+ + L P G + GT Y+APE
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP---GDTTSTFCGTPNYIAPEILRG 170
Query: 775 GRVTTKVDVFSFGVILMELITGRKALD 801
VD ++ GV++ E++ GR D
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 55/189 (29%), Positives = 84/189 (44%), Gaps = 24/189 (12%)
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR--- 747
K L + + VA+G+E+L A + IHRDL NILL ++ K+ DFGL R
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 230
Query: 748 LAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEE 807
P+ + R+ ++APE T + DV+SFGV+L E+ + L S P
Sbjct: 231 KDPDYVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGAS-PYP 283
Query: 808 SMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHA 867
+ + F R L + + +A D T + + C EP QRP
Sbjct: 284 GVKIDEEFCR-RLKEGTRMRAPDYTT----------PEMYQTMLDCWHGEPSQRPTFSEL 332
Query: 868 VNVLSSLVE 876
V L +L++
Sbjct: 333 VEHLGNLLQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 36/93 (38%), Positives = 51/93 (54%), Gaps = 10/93 (10%)
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEGKGSIETRIAGTFG 765
RG++Y+H IHRDLKPSN+ + +D ++ DFGL R A E G + TR
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 766 YLAPEYAVTG-RVTTKVDVFSFGVILMELITGR 797
Y APE + VD++S G I+ EL+ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 45/158 (28%), Positives = 65/158 (41%), Gaps = 21/158 (13%)
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA---EEGLKPLEWNRRLTIALDVARG 708
++V L + + + LV ++ G L HI + EE +K W + +ALD
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK--RWAAEMVVALD---- 99
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG-LVRLAPEGKGSIETRIAGTFGYL 767
L + + RDL P+NILL D ++ F + G + Y
Sbjct: 100 -----ALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YC 149
Query: 768 APEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQP 805
APE T D +S G IL EL+TG K L E P
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTG-KTLVECHP 186
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-09
Identities = 66/246 (26%), Positives = 113/246 (45%), Gaps = 32/246 (13%)
Query: 594 NFSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKVRHR 651
+F ++GRG FG V +L + K+ A+K + + + T F+ E VL ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNR----RLTIALDVAR 707
+ L D N LV +Y G L + + E P + R + IA+D
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAID--- 116
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG-LVRLAPEGKGSIETRIA-GTFG 765
V LH ++HRD+KP NIL+ + ++ADFG ++L + G++++ +A GT
Sbjct: 117 SVHQLH------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED--GTVQSSVAVGTPD 168
Query: 766 YLAPEYAVT-----GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL 820
Y++PE G+ + D +S GV + E++ G P + LV + +I
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE------TPFYAESLVETYGKIMN 222
Query: 821 SKDSFH 826
K+ F
Sbjct: 223 HKERFQ 228
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 61/233 (26%), Positives = 103/233 (44%), Gaps = 39/233 (16%)
Query: 638 FKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNR 697
F +++++V H HL + G C+ G+E ++V E++ G L + E+G P+ W
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD--VCLRKEKGRVPVAW-- 118
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL--VRLAPEGKG- 754
++T+A +A + YL ++ +H ++ NILL R +A+ ++L+ G
Sbjct: 119 KITVAQQLASALSYLE---DKNLVHGNVCAKNILLA---RLGLAEGTSPFIKLSDPGVSF 172
Query: 755 ---SIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMEL-ITGRKALDESQPEESM 809
S E R+ ++APE G ++T D +SFG L+E+ G L E P E
Sbjct: 173 TALSREERVE-RIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231
Query: 810 HLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRP 862
+ H+ +P S +A L C EP QRP
Sbjct: 232 RFY----------EKKHRLPEP----------SCKELATLISQCLTYEPTQRP 264
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
++F + + LG G G V+K I +++ I + E+ VL + +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+V G E + E+M G+L + + + G P + +++IA V +G+ YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIA--VIKGLTYL 119
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
+HRD+KPSNIL+ K+ DFG ++ + S+ GT Y++PE
Sbjct: 120 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFG---VSGQLIDSMANSFVGTRSYMSPERL 174
Query: 773 VTGRVTTKVDVFSFGVILMELITGR 797
+ + D++S G+ L+E+ GR
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 41/111 (36%), Positives = 58/111 (52%), Gaps = 12/111 (10%)
Query: 690 LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-- 747
PL + + VARG+E+L A + IHRDL NILL ++ K+ DFGL R
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI 224
Query: 748 -LAPE--GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
P+ KGS + ++APE TT+ DV+SFGV+L E+ +
Sbjct: 225 YKDPDYVRKGSARLPLK----WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 68/275 (24%), Positives = 105/275 (38%), Gaps = 57/275 (20%)
Query: 595 FSEENILGRGGFGTVYKGELHD-GTKIAVKRM-EAGVISGKGLTEFKSEIAVLTKVRHRH 652
F + LG G FG V D A+K + + V+ + K+E +L + +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+V L D + V +Y+P G + + G+ P + R L A VE +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM---GIFPEDLARFYIAELTCA--VESV 117
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV-------------------------- 746
H + FIHRD+KP NIL+ D K+ DFGL
Sbjct: 118 HKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS 174
Query: 747 -------------RLAP-------EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSF 786
RL P + + + + GT Y+APE + T D +S
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234
Query: 787 GVILMELITGRKALDESQP-EESMHLVTWFRRIHL 820
GVIL E++ G+ P E M ++ W +H+
Sbjct: 235 GVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHI 269
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 12/211 (5%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEFKS-EIAVLTKVRHRHLVALL 657
+LG+G FG V E ++ A+K ++ V+ E E VL + L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
C ++L V EY+ G L I + + + + A ++A G+ +LH
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQI-----QQVGRFKEPHAVFYAAEIAIGLFFLHS-- 119
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR 776
+ I+RDLK N++L + K+ADFG+ + G GT Y+APE
Sbjct: 120 -KGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAPEIIAYQP 177
Query: 777 VTTKVDVFSFGVILMELITGRKALDESQPEE 807
VD ++FGV+L E++ G+ + +E
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-09
Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 17/223 (7%)
Query: 581 MVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAG--VISGKGLTEF 638
+V I+ L+ ++ ++GRG FG V K+ ++ + +I F
Sbjct: 31 IVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 639 KSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRR 698
E ++ +V L D +V EYMP G L + N+ P +W +
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD----VPEKWAKF 146
Query: 699 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIE 757
T +V ++ +H + IHRD+KP N+LL K+ADFG +++ G +
Sbjct: 147 YTA--EVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201
Query: 758 TRIAGTFGYLAPEYAVT----GRVTTKVDVFSFGVILMELITG 796
T + GT Y++PE + G + D +S GV L E++ G
Sbjct: 202 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 35/89 (39%), Positives = 47/89 (52%), Gaps = 5/89 (5%)
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
G+++LH IHRDLKPSNI++ D K+ DFGL R A + T T Y
Sbjct: 135 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--CTNFMMTPYVVTRYYR 189
Query: 768 APEYAVTGRVTTKVDVFSFGVILMELITG 796
APE + VD++S G I+ EL+ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 6e-09
Identities = 50/177 (28%), Positives = 79/177 (44%), Gaps = 5/177 (2%)
Query: 639 KSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRR 698
+SE+ L H +V ++ LL+ EY G L++ I +E L E+
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 699 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG-SIE 757
L + + ++ +H + +HRDLK +NI L K+ DFG + + +
Sbjct: 173 L-LFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 758 TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTW 814
+ GT YLAPE R + K D++S GVIL EL+T + E M V +
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY 285
|
Length = 478 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 36/90 (40%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
G+++LH IHRDLKPSNI++ D K+ DFGL R A G + T T Y
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 192
Query: 768 APEYAVTGRVTTKVDVFSFGVILMELITGR 797
APE + VD++S G I+ E+I G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-08
Identities = 42/128 (32%), Positives = 59/128 (46%), Gaps = 17/128 (13%)
Query: 335 ALLSVVKLMGYPQRFAENWKGNDPCSD----WIGVTC----TKGN--ITVINFQKMNLTG 384
AL ++ +G P RF W G DPC W G C TKG I + L G
Sbjct: 376 ALQTLKSSLGLPLRFG--WNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRG 432
Query: 385 TISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS----FKSN 440
I + + + LQ + L+ N++ G IP L + +L+ LD+S N G IP S
Sbjct: 433 FIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSL 492
Query: 441 AIVNTDGN 448
I+N +GN
Sbjct: 493 RILNLNGN 500
|
Length = 623 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-08
Identities = 37/101 (36%), Positives = 52/101 (51%), Gaps = 11/101 (10%)
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
G+++LH IHRDLKPSNI++ D K+ DFGL R A G + T T Y
Sbjct: 131 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 185
Query: 768 APEYAVTGRVTTKVDVFSFGVILMELI------TGRKALDE 802
APE + VD++S G I+ E++ GR +D+
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 11/205 (5%)
Query: 600 ILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
++G+G +G V DG + +K++ S + + E +L++++H ++VA
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY-R 65
Query: 659 HCLDGNEKLL--VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
+G + LL V + G L + E+ K L N+ + + +A ++YLH
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKL---KEQKGKLLPENQVVEWFVQIAMALQYLH--- 119
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR 776
+ +HRDLK N+ L KV D G+ R+ E + + + + GT Y++PE
Sbjct: 120 EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIGTPYYMSPELFSNKP 178
Query: 777 VTTKVDVFSFGVILMELITGRKALD 801
K DV++ G + E+ T + A +
Sbjct: 179 YNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 49/157 (31%), Positives = 71/157 (45%), Gaps = 28/157 (17%)
Query: 668 LVFEYMPQG---TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRD 724
+V EY+ G TL ++I G P++ R + A V +EYLH +HRD
Sbjct: 78 MVMEYVEGGDCATLLKNI------GALPVDMAR-MYFAETVL-ALEYLHNYG---IVHRD 126
Query: 725 LKPSNILLGDDMRAKVADFGLVRLA--------PEGKGSIETR------IAGTFGYLAPE 770
LKP N+L+ K+ DFGL ++ EG +TR + GT Y+APE
Sbjct: 127 LKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186
Query: 771 YAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEE 807
+ VD ++ G+IL E + G PEE
Sbjct: 187 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 51/193 (26%), Positives = 85/193 (44%), Gaps = 24/193 (12%)
Query: 686 AEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745
+++G + L L+ VARG+E+L A ++ +HRDL N+LL K+ DFGL
Sbjct: 227 SDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGL 283
Query: 746 VRLAPEGKGSIETRIAGTF---GYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDE 802
R + TF ++APE TT DV+S+G++L E+ +
Sbjct: 284 ARDIMHDSNYVSK--GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYP 341
Query: 803 SQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRP 862
+S T++ +I S ++ P E V ++ C EP +RP
Sbjct: 342 GMIVDS----TFYNKI----KSGYRMAKPDHATQE--------VYDIMVKCWNSEPEKRP 385
Query: 863 DMGHAVNVLSSLV 875
H +++ SL+
Sbjct: 386 SFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 16/212 (7%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKVRH 650
++F ++GRG FG V ++ +I A+K + + + T F+ E VL
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
+ + L D N LV +Y G L + + E P + R +A V
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKF--EDRLPEDMAR-----FYIAEMVL 113
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA-GTFGYLAP 769
+H + ++HRD+KP N+LL + ++ADFG L G++++ +A GT Y++P
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC-LKMNQDGTVQSSVAVGTPDYISP 172
Query: 770 EYAVT-----GRVTTKVDVFSFGVILMELITG 796
E G+ + D +S GV + E++ G
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVIS-GKGLTEFKSEIAVL-TKVRHRHLVAL 656
++GRG + V EL +I A+K ++ +++ + + ++E V T H LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 657 LGH-CLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
H C +L V E++ G L +F+ + P E R + + +A L+
Sbjct: 62 --HSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLA-----LNF 111
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG--KGSIETRIAGTFGYLAPEYA 772
L + I+RDLK N+LL + K+ D+G+ + EG G + GT Y+APE
Sbjct: 112 LHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 773 VTGRVTTKVDVFSFGVILMELITGRKALD 801
VD ++ GV++ E++ GR D
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-08
Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 603 RGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLGHC 660
RG FG VY G + +K+ AVK ++ + K + ++E L + +V L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 661 LDGNEKLLVFEYMPQGTLSR--HIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
N LV EY+ G + HI+ + +E + I+ +VA ++YLH
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA------VKYIS-EVALALDYLH---RH 123
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRL 748
IHRDLKP N+L+ ++ K+ DFGL ++
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 34/147 (23%), Positives = 62/147 (42%), Gaps = 13/147 (8%)
Query: 600 ILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
+ K + T +AVK++ S + L + EI +++H +++ +
Sbjct: 9 CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL---DVARGVEYLHGLA 716
+ +E +V M G+ + EGL L IA DV ++Y+H
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP------ELAIAFILKDVLNALDYIH--- 118
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADF 743
+ FIHR +K S+ILL D + ++
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALL 657
++GRG FG V ++ + ++ A+K + + + T F+ E VL R + L
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
D N LV +Y G L + + E+ L P + R +A V + +
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKF-EDRL-PEDMAR-----FYLAEMVLAIDSVHQ 120
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFG-LVRLAPEGKGSIETRIA-GTFGYLAPEY--AV 773
++HRD+KP N+LL + ++ADFG +RL + G++++ +A GT Y++PE A+
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD--GTVQSNVAVGTPDYISPEILQAM 178
Query: 774 ---TGRVTTKVDVFSFGVILMELITG 796
GR + D +S GV + E++ G
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-08
Identities = 47/163 (28%), Positives = 71/163 (43%), Gaps = 26/163 (15%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKG-LTEFKSEIAVLTKVRH 650
+F ++G+G FG V + D KI A+K + + K L K+E VL +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--- 707
+V+L D L+ E++P G L + + T + DV R
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD-------------TFSEDVTRFYM 107
Query: 708 -----GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745
+E +H L FIHRD+KP NIL+ K++DFGL
Sbjct: 108 AECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 600 ILGRGGFGT--VYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
++G G FG + + D K A+K + S + + + E +L K++H ++VA
Sbjct: 7 VVGEGSFGRALLVQHVNSD-QKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAF- 63
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFN-----WAEEGLKPLEWNRRLTIALDVARGVEY 711
+ + L +V EY G L + I + E+ + L+W ++ + GV++
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI--LQWFVQMCL------GVQH 115
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
+H + +HRD+K NI L + + K+ DFG RL G+ GT Y+ PE
Sbjct: 116 IH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS-PGAYACTYVGTPYYVPPEI 171
Query: 772 AVTGRVTTKVDVFSFGVILMELIT 795
K D++S G IL EL T
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 63/275 (22%), Positives = 107/275 (38%), Gaps = 57/275 (20%)
Query: 595 FSEENILGRGGFGTV-YKGELHDGTKIAVKRM-EAGVISGKGLTEFKSEIAVLTKVRHRH 652
F + LG G FG V ++ A+K + + V++ + K+E +L + +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+V L D + V +Y+P G + + + P E R IA ++ +E +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM---EVFP-EVLARFYIA-ELTLAIESV 117
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV-------------------------- 746
H + FIHRD+KP NIL+ D K+ DFGL
Sbjct: 118 HKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPS 174
Query: 747 --------------------RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSF 786
R + + + + GT Y+APE + T D +S
Sbjct: 175 DLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234
Query: 787 GVILMELITGRKALDESQPEES-MHLVTWFRRIHL 820
GVIL E++ G+ P E+ + ++ W +H+
Sbjct: 235 GVILFEMLVGQPPFLAPTPTETQLKVINWENTLHI 269
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 7e-08
Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 45/231 (19%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEA----GVISGKGLTEFKS-----EIAVLTKVRHR 651
+G G FG V+ + KR + IS +GL E + E+ V+ +++H+
Sbjct: 21 IGNGRFGEVFL--------VKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 652 HLVALLGHCLD-GNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
++V + L+ N+KL ++ E+ G LSR+I + +E + + I + +
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI-QKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 710 EYLHGLAH----QSFIHRDLKPSNILLGDDMR-----------------AKVADFGLVRL 748
Y H L + +HRDLKP NI L +R AK+ DFGL +
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191
Query: 749 APEGKGSIETRIAGTFGYLAPEYAV--TGRVTTKVDVFSFGVILMELITGR 797
G S+ GT Y +PE + T K D+++ G I+ EL +G+
Sbjct: 192 I--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 53/214 (24%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 601 LGRGGFGTVYKG---ELHDG-----TKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHR 651
LG+G F ++KG E+ D T++ +K ++ S + +E F ++++++ H+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK---SHRNYSESFFEAASMMSQLSHK 59
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
HLV G C+ G+E ++V EY+ G+L ++ + L + W L+VA+ + +
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK--NKNLINISWK------LEVAKQLAW 111
Query: 712 -LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG-------KGSIETRIAGT 763
LH L + H ++ N+LL + K + ++L+ G K + RI
Sbjct: 112 ALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP-- 169
Query: 764 FGYLAPEYAVTGR-VTTKVDVFSFGVILMELITG 796
++ PE + ++ D +SFG L E+ +G
Sbjct: 170 --WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-07
Identities = 63/250 (25%), Positives = 104/250 (41%), Gaps = 14/250 (5%)
Query: 54 TDPCKWNHV---VCIEDKRITRIQIGHQNLQGTL-PSNLQNLTKLERLELQWNSISGPLP 109
T P N +E + R+ + + L PS+L L L+ L S
Sbjct: 28 TTPQSINLNFPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSE 87
Query: 110 SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNF 169
+L L L + L+ N+ S S L++L S+++DNN + P S L+
Sbjct: 88 NLLNLLPLPSLDLNLNRLRSNIS-ELLELTNLTSLDLDNNNITDIP-PLIGLLKSNLKEL 145
Query: 170 SANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKL 229
+ I +PS P L L L+FN L LP S S N K+
Sbjct: 146 DLSDNKIE-SLPS--PLRNLPNLKNLDLSFNDLSD-LPKLLSNL---SNLNNLDLSGNKI 198
Query: 230 GGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESL 289
I+ +++L+E+ L +N+ L S +K L L L +N P+S+ L +L
Sbjct: 199 SDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDL-PESIGNLSNL 257
Query: 290 KIVNMTNNLL 299
+ ++++NN +
Sbjct: 258 ETLDLSNNQI 267
|
Length = 394 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 35/115 (30%), Positives = 59/115 (51%), Gaps = 16/115 (13%)
Query: 688 EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
E PL+ + L + VA+G+++L A ++ IHRD+ N+LL D AK+ DFGL R
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 748 -------LAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
+G + + ++APE T + DV+S+G++L E+ +
Sbjct: 261 DIMNDSNYVVKGNARLPVK------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 35/106 (33%), Positives = 53/106 (50%), Gaps = 8/106 (7%)
Query: 693 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752
L + + + VA G+E+L A ++ +HRDL N+L+ + K+ DFGL R
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292
Query: 753 KGSIETRIAGTF---GYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
I TF ++APE TT DV+SFG++L E+ T
Sbjct: 293 SNYISK--GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 58/260 (22%), Positives = 104/260 (40%), Gaps = 44/260 (16%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRM--EAGVISGKGLTEFKSEIAVLTKVRH 650
++F ++GRG FG V + D I ++ +A ++ + + ++E +L +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
+V + D L+ E++P G + + ++ L E + IA + ++
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK--KDTLS--EEATQFYIA-ETVLAID 115
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV------------------------ 746
+H L FIHRD+KP N+LL K++DFGL
Sbjct: 116 AIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 747 -------RLAPEGKGS---IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG 796
R A K + + GT Y+APE + D +S GVI+ E++ G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 797 RKALDESQPEESMHLVTWFR 816
P+E+ V ++
Sbjct: 233 YPPFCSETPQETYRKVMNWK 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 63/248 (25%), Positives = 112/248 (45%), Gaps = 34/248 (13%)
Query: 581 MVISIQVLRNVTNNFSEENILGRGGFGTVYK-GELHDGTKIAVKRMEAGVISGKGLTEFK 639
++ ++ L + T+ + +G+G +G VYK DG+ AVK ++ IS E +
Sbjct: 10 SMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP--ISDVD-EEIE 66
Query: 640 SEIAVLTKV-RHRHLVALLG------HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKP 692
+E +L + H ++V G + G + LV E G+++ + +GL
Sbjct: 67 AEYNILQSLPNHPNVVKFYGMFYKADKLV-GGQLWLVLELCNGGSVTELV-----KGL-- 118
Query: 693 LEWNRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746
L +RL I G+++LH + IHRD+K +NILL + K+ DFG+
Sbjct: 119 LICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175
Query: 747 RLAPEGKGSIETRIAGTFGYLAPEYAVTGR-----VTTKVDVFSFGVILMELITGRKALD 801
+ T + GT ++APE + + DV+S G+ +EL G L
Sbjct: 176 AQLTSTRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234
Query: 802 ESQPEESM 809
+ P +++
Sbjct: 235 DMHPVKTL 242
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 59/259 (22%), Positives = 104/259 (40%), Gaps = 44/259 (16%)
Query: 594 NFSEENILGRGGFGTVYKGELHD-GTKIAVKRM-EAGVISGKGLTEFKSEIAVLTKVRHR 651
+F ++GRG FG V + D G A+K + +A ++ + + ++E +L +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
+V + D L+ E++P G + + ++ L E + IA + ++
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK--KDTLT--EEETQFYIA-ETVLAIDS 116
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV------------------------- 746
+H L FIHRD+KP N+LL K++DFGL
Sbjct: 117 IHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 747 -RLAPEGKGSIETR--------IAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 797
+ + K R GT Y+APE + D +S GVI+ E++ G
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 798 KALDESQPEESMHLVTWFR 816
P+E+ V ++
Sbjct: 234 PPFCSETPQETYKKVMNWK 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 40/146 (27%), Positives = 59/146 (40%), Gaps = 14/146 (9%)
Query: 699 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET 758
L I V R ++YLH IHRD+K NI + + DFG + +
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 759 RIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDES-------QPEESMHL 811
AGT APE VD++S G++L E+ T +L E + + L
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL 301
Query: 812 VTWFRRIHLSKDSFHKAIDPTIDLNE 837
+ RR + F ID +L+E
Sbjct: 302 I--IRRSGTHPNEF--PIDAQANLDE 323
|
Length = 391 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 31/81 (38%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 226 NAKLGGGI-DVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSL 283
N L G I + I + L+ I L N+ G +P + LE L L N F G +P+SL
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 284 VKLESLKIVNMTNNLLQGPVP 304
+L SL+I+N+ N L G VP
Sbjct: 487 GQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 4/98 (4%)
Query: 699 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIE 757
L+ + VA+G+ +L A ++ IHRDL NILL K+ DFGL R + + ++
Sbjct: 217 LSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273
Query: 758 TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
++APE T + DV+S+G++L E+ +
Sbjct: 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 67/282 (23%), Positives = 116/282 (41%), Gaps = 55/282 (19%)
Query: 601 LGRGGFGTVYKGELHD--GTKIAVKRMEAGVI------SGKGLTEFKSEIAVLTKVRHRH 652
LG+G F +YKG L I E V+ + F ++++++ H+H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
LV L G C+ +E ++V EY+ G L +F E+ L W +L +A +A + YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLD--VFLHREKNNVSLHW--KLDVAKQLASALHYL 117
Query: 713 HGLAHQSFIHRDLKPSNILL---GDDMR----AKVADFGLVRLAPEGKGSIETRIAGTFG 765
+ +H ++ NIL+ G + K++D G + + + RI
Sbjct: 118 E---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG-IPITVLSREERVERIP---- 169
Query: 766 YLAPEYAVTGRV--TTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSK 822
++APE G+ T D +SFG L+E+ + G + L E K
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--------------K 215
Query: 823 DSFHKAIDPTIDLNEGILA--SISTVAELAGHCCAREPYQRP 862
+ F++ + L + +A L C +P +RP
Sbjct: 216 ERFYQD--------QHRLPMPDCAELANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 48/226 (21%), Positives = 89/226 (39%), Gaps = 35/226 (15%)
Query: 67 DKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQ 126
+ + + ++ +LPS L+NL L+ L+L +N +S L+ L++L + LS N+
Sbjct: 139 KSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNK 197
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGP 186
+ +P LS+L+ +++ NN + SL N L ++ + +P G
Sbjct: 198 ISDLP-PEIELLSALEELDLSNNSIIE--LLSSLSNLKNLSGLELSNNKLE-DLPESIGN 253
Query: 187 DEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIW 246
L L S +QI S I + ++T+L+E+
Sbjct: 254 L--SNLETL-------------DLSNNQISS---------------ISSLGSLTNLRELD 283
Query: 247 LHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 292
L N+ S LP + + L L L + L + +
Sbjct: 284 LSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNI 329
|
Length = 394 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 17/157 (10%)
Query: 641 EIAVLTKVRHRHLVALLG-HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL 699
E +L ++ H ++ALL + G L++ +Y ++ + L+PL +
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSD------LYTYLGARLRPLGLAQVT 263
Query: 700 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR 759
+A + ++Y+HG + IHRD+K N+L+ + DFG A +GS T
Sbjct: 264 AVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFA---RGSWSTP 317
Query: 760 ----IAGTFGYLAPEYAVTGRVTTKVDVFSFGVILME 792
IAGT APE T VD++S G+++ E
Sbjct: 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 1e-05
Identities = 21/61 (34%), Positives = 37/61 (60%), Gaps = 3/61 (4%)
Query: 93 KLERLELQWNSISGPLP--SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNP 150
L+ L+L N ++ +P + GL +L+V+ LS N TS+ + F+GL SL+S+++ N
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 151 F 151
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 49/199 (24%), Positives = 81/199 (40%), Gaps = 23/199 (11%)
Query: 616 DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675
K+ VK ++G EI +L + HR ++ L+ + +V MP+
Sbjct: 118 QRKKVIVK-----AVTGGKTPG--REIDILKTISHRAIINLIHAYRWKSTVCMV---MPK 167
Query: 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 735
+F + + PL + +TI + + YLHG + IHRD+K NI L +
Sbjct: 168 YKCD--LFTYVD-RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEP 221
Query: 736 MRAKVADFGLVRLAPEGKGSIETR----IAGTFGYLAPEYAVTGRVTTKVDVFSFGVILM 791
A + DFG A + +T +GT +PE K D++S G++L
Sbjct: 222 ENAVLGDFG---AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLF 278
Query: 792 ELITGRKALDESQPEESMH 810
E+ L Q + S
Sbjct: 279 EMSVKNVTLFGKQVKSSSS 297
|
Length = 392 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 5e-05
Identities = 21/61 (34%), Positives = 32/61 (52%), Gaps = 2/61 (3%)
Query: 371 NITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQ 429
N+ ++ LT I F +L+ L L+ NNL+ + PE S L +L+ LD+S N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 430 L 430
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 20/221 (9%)
Query: 601 LGRGGFGTVYK-GELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLG 658
+G+G +G V+K +G+K AVK ++ + E ++E +L + H ++V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE---EIEAEYNILKALSDHPNVVKFYG 82
Query: 659 -----HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
+G++ LV E G+++ + + LK E IA + + L
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVT----DLVKGFLKRGERMEEPIIAYILHEALMGLQ 138
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY-- 771
L IHRD+K +NILL + K+ DFG+ + T + GT ++APE
Sbjct: 139 HLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIA 197
Query: 772 ---AVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESM 809
+ + DV+S G+ +EL G L + P ++
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL 238
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 7e-05
Identities = 31/113 (27%), Positives = 53/113 (46%), Gaps = 7/113 (6%)
Query: 683 FNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742
F+W + +PL R I + VEY+H + IHRD+K NI L D + + D
Sbjct: 258 FDWKD---RPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGD 310
Query: 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
FG + + + + GT +PE D++S G+IL+++++
Sbjct: 311 FGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 7e-05
Identities = 16/41 (39%), Positives = 19/41 (46%), Gaps = 5/41 (12%)
Query: 29 DDGDAAVMLALKKSLNPPES---LGW--SDTDPCKWNHVVC 64
+ D +LA K SLN S W S +DPC W V C
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-04
Identities = 32/116 (27%), Positives = 59/116 (50%), Gaps = 2/116 (1%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS-LNGLASLEVVMLSNNQ 126
KR+ + + G +P L +L++L +L+L N +SG +P L+ L + LS+NQ
Sbjct: 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ 534
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPS 182
+ F+ + L +++ N S EIP++L N L + + ++ G +PS
Sbjct: 535 LSGQIPASFSEMPVLSQLDLSQNQLSG-EIPKNLGNVESLVQVNISHNHLHGSLPS 589
|
Length = 968 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 21/105 (20%), Positives = 31/105 (29%), Gaps = 9/105 (8%)
Query: 650 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
R L L H + L + L R + + +R + +
Sbjct: 99 ARLLARL--HSVPPEALPLARRLRRRLKLLRQLAAALRRLVAAELLDRLAELWERLLA-- 154
Query: 710 EYLHGLAHQS---FIHRDLKPSNILLGDDMR-AKVADFGLVRLAP 750
L L +H DL P N+L+ R V DF L
Sbjct: 155 -ALLALLPALPLVLVHGDLHPGNLLVDPGGRVTGVIDFEDAGLGD 198
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 42/177 (23%), Positives = 61/177 (34%), Gaps = 28/177 (15%)
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRI 760
+ L + LH A K NILL D K+ G V E
Sbjct: 22 VCLQCLGALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTP-----EQSR 65
Query: 761 AGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL 820
+ ++APE T K D++S G+ L +ALD P + I
Sbjct: 66 PDPY-FMAPEVIQGQSYTEKADIYSLGITL------YEALDYELPYNEEREL---SAILE 115
Query: 821 SKDSFHKAIDPTIDLN-EGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876
+ A DP N EG+ A+ S + C +R P +R H + +L
Sbjct: 116 ILLNGMPADDPRDRSNLEGVSAARS-FEDFMRLCASRLPQRREAANHYLAHCRALFA 171
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 4e-04
Identities = 41/169 (24%), Positives = 67/169 (39%), Gaps = 39/169 (23%)
Query: 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVARGVEYLHGLAH 717
+L+ +Y+ G L F+ L+ +L+ I + + LH H
Sbjct: 82 KGHVLIMDYIKDGDL----FDL-------LKKEGKLSEAEVKKIIRQLVEALNDLH--KH 128
Query: 718 QSFIHRDLKPSNILLGDDM-RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE------ 770
IH D+K N+L R + D+GL + G S GT Y +PE
Sbjct: 129 N-IIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIGTPSCYD---GTLDYFSPEKIKGHN 182
Query: 771 YAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH 819
Y V+ D ++ GV+ EL+TG+ E +E + L + +R
Sbjct: 183 YDVS------FDWWAVGVLTYELLTGKHPFKED-EDEELDLESLLKRQQ 224
|
Length = 267 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 5e-04
Identities = 22/84 (26%), Positives = 34/84 (40%), Gaps = 16/84 (19%)
Query: 662 DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFI 721
D + K +V EY+ L + ++ I V + LH +
Sbjct: 68 DPDNKTIVMEYIEGKPLK--------DVIEEGNDELLREIGRLVGK----LHKA---GIV 112
Query: 722 HRDLKPSNILLGDDMRAKVADFGL 745
H DL SNI++ DD + + DFGL
Sbjct: 113 HGDLTTSNIIVRDD-KLYLIDFGL 135
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 7e-04
Identities = 25/66 (37%), Positives = 36/66 (54%), Gaps = 2/66 (3%)
Query: 375 INFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKI 434
+N N TG+I +L+ L L++N LSG IP + +LK LD+ N L GKI
Sbjct: 123 LNLSNNNFTGSIPRGSIP--NLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180
Query: 435 PSFKSN 440
P+ +N
Sbjct: 181 PNSLTN 186
|
Length = 968 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 8e-04
Identities = 17/41 (41%), Positives = 24/41 (58%), Gaps = 1/41 (2%)
Query: 92 TKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPS 132
T LE L+L N I+ LP L+ L +LE + LS N+ T +
Sbjct: 1 TNLETLDLSNNQITD-LPPLSNLPNLETLDLSGNKITDLSP 40
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 8e-04
Identities = 38/124 (30%), Positives = 52/124 (41%), Gaps = 14/124 (11%)
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILL--GDDM------RAKVADFGLVRLAPEG 752
I ++Y H H +H DLKP NIL+ D + RA D VR+ G
Sbjct: 236 IIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG 293
Query: 753 KGSIE----TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEES 808
E T I T Y +PE + D++S G I+ EL TG+ D E
Sbjct: 294 GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353
Query: 809 MHLV 812
+HL+
Sbjct: 354 LHLM 357
|
Length = 467 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 19/61 (31%), Positives = 33/61 (54%), Gaps = 3/61 (4%)
Query: 241 SLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 298
+LK + L +N + +PD F G+ L+ L L N T P++ L SL+ ++++ N
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 299 L 299
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 13/38 (34%), Positives = 24/38 (63%)
Query: 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSS 153
+L+ + LSNN+ T +P F GL +L+ +++ N +S
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTS 38
|
Length = 60 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.002
Identities = 27/84 (32%), Positives = 34/84 (40%), Gaps = 16/84 (19%)
Query: 662 DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFI 721
D + L+V EY+ G L LK R + +V R V LH +
Sbjct: 70 DPDNGLIVMEYIE-GEL-----------LKDALEEARPDLLREVGRLVGKLH---KAGIV 114
Query: 722 HRDLKPSNILLGDDMRAKVADFGL 745
H DL SNI+L R DFGL
Sbjct: 115 HGDLTTSNIILSGG-RIYFIDFGL 137
|
Length = 204 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 948 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.94 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.93 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.86 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.8 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.34 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.31 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.28 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.28 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.25 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.21 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.21 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.15 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.05 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.04 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.03 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.03 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.03 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.99 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.99 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.98 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.97 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.95 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.93 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.87 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.85 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.84 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.8 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.75 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.74 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.73 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.65 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.59 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.52 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.52 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.49 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.49 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.47 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.41 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.39 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.35 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.31 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-84 Score=816.19 Aligned_cols=775 Identities=28% Similarity=0.444 Sum_probs=464.4
Q ss_pred ChHHHHHHHHHHHhcCCCCCC--CCC-CCCCCCccceEEeCCCCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCC
Q 002238 29 DDGDAAVMLALKKSLNPPESL--GWS-DTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSIS 105 (948)
Q Consensus 29 ~~~d~~~l~~~k~~~~~~~~~--~w~-~~~~C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~ 105 (948)
++.|++||++||+++.++... +|. ..+||.|.||+|+..++|+.|+|++|+++|.++..|..+++|+.|+|++|++.
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~ 106 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLS 106 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccC
Confidence 678999999999999766543 895 46899999999988889999999999999999988989999999999999888
Q ss_pred CCCC-C-cCCCCCCcEEEcccccccCC----------------------CCccccCCCCCCEEEccCCCCCCCCCCcccc
Q 002238 106 GPLP-S-LNGLASLEVVMLSNNQFTSV----------------------PSDFFTGLSSLQSIEIDNNPFSSWEIPQSLR 161 (948)
Q Consensus 106 ~~~p-~-~~~l~~L~~L~L~~N~l~~~----------------------~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~ 161 (948)
+.+| . +.++++|++|+|++|.+++. .|..|+++++|++|+|++|.+.+ .+|..+.
T Consensus 107 ~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~ 185 (968)
T PLN00113 107 GPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG-KIPNSLT 185 (968)
T ss_pred CcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccc-cCChhhh
Confidence 7666 3 33566666666666665543 34444555555555555555544 4455555
Q ss_pred CCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCccc-ccccceeccCCCCCCccCCCccccccCC
Q 002238 162 NASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMT 240 (948)
Q Consensus 162 ~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~~~~~~~~~~~~~~~~~l~~l~ 240 (948)
++++|++|+|++|++++.+|..++ .+++|++|+|++|++++.+|..+.. .+|+.|++.+ |...+..+..|.+++
T Consensus 186 ~l~~L~~L~L~~n~l~~~~p~~l~--~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~---n~l~~~~p~~l~~l~ 260 (968)
T PLN00113 186 NLTSLEFLTLASNQLVGQIPRELG--QMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVY---NNLTGPIPSSLGNLK 260 (968)
T ss_pred hCcCCCeeeccCCCCcCcCChHHc--CcCCccEEECcCCccCCcCChhHhcCCCCCEEECcC---ceeccccChhHhCCC
Confidence 555555555555555555554444 4455555555555555444444432 2233333322 222222233333333
Q ss_pred C------------------------ccEEEccCCcccccCCC-CCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcc
Q 002238 241 S------------------------LKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 295 (948)
Q Consensus 241 ~------------------------L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 295 (948)
+ |+.|+|++|.+.+.+|. +.++++|+.|++++|.+++.+|..+..+++|+.|+|+
T Consensus 261 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~ 340 (968)
T PLN00113 261 NLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLW 340 (968)
T ss_pred CCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECc
Confidence 3 33333333333333332 3334444444444444444444444444444444444
Q ss_pred cCcccccCCC-CCCccccccccccCCCCCC-CCCC-C-------------------chhhhhhHHHHHhh--C------C
Q 002238 296 NNLLQGPVPE-FDRSVSLDMAKGSNNFCLP-SPGA-C-------------------DPRLNALLSVVKLM--G------Y 345 (948)
Q Consensus 296 ~N~l~g~~p~-~~~~~~l~~~~~~~~~~~~-~~~~-~-------------------~~~~~~l~~~~~~~--~------~ 345 (948)
+|++++.+|. +..+.+|..++..+|.... .|.. + +..+..+..+..+. . .
T Consensus 341 ~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~ 420 (968)
T PLN00113 341 SNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420 (968)
T ss_pred CCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeEC
Confidence 4444444442 2233333333333332210 0000 0 00000000000000 0 0
Q ss_pred cchh------------------------------------------------------ccccCCCCCCCCccceeecCCc
Q 002238 346 PQRF------------------------------------------------------AENWKGNDPCSDWIGVTCTKGN 371 (948)
Q Consensus 346 ~~~~------------------------------------------------------~~~~~~~~~~~~~~~~~~~~~~ 371 (948)
+..+ ..+..++.........+..+++
T Consensus 421 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~ 500 (968)
T PLN00113 421 PSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSE 500 (968)
T ss_pred ChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhc
Confidence 0000 0000000000011112334556
Q ss_pred eEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCCC----CCcccccccCC
Q 002238 372 ITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDG 447 (948)
Q Consensus 372 L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~----~~~~~~~~~~g 447 (948)
|+.|+|++|++.+.+|..|+++++|++|+|++|+++|.+|..+..+++|+.|||++|+++|.+|. +.....+++++
T Consensus 501 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~ 580 (968)
T PLN00113 501 LMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISH 580 (968)
T ss_pred cCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccC
Confidence 77777777888888888888888888888888888888888888888888888888888888875 34466778888
Q ss_pred CCCCCCccCC---------CCCCCCCCCCCCCCCCCCCCCCCCCcCCccceeehhhHhHhHHHHHHHHHHhhhhhhhccc
Q 002238 448 NPDIGKEKSS---------SFQGSPSGSPTGTGSGNASSTENGVKNSSALITVILFCVIGGAFVISLTGVLVFCLCKKKQ 518 (948)
Q Consensus 448 np~~~~~~~~---------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~l~~~~~~~~~ 518 (948)
|+..+..|.. ++.++|..+...... ..+.....+. .....++++++++++++++++++++++++++++
T Consensus 581 N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~--~~~~c~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (968)
T PLN00113 581 NHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTS--GLPPCKRVRK-TPSWWFYITCTLGAFLVLALVAFGFVFIRGRNN 657 (968)
T ss_pred CcceeeCCCcchhcccChhhhcCCccccCCcccc--CCCCCccccc-cceeeeehhHHHHHHHHHHHHHHHHHHHHhhhc
Confidence 8887766543 122222111100000 0001111111 111222333333333333333333332222221
Q ss_pred ccccccCCCCccccccCCCCCCCCcceeeeecCCccccccccccccCCCCCCcchhhhccCcceeeHHHHHHhhcCCccc
Q 002238 519 KRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEE 598 (948)
Q Consensus 519 kr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 598 (948)
++..+.... .+. . ... .... . ....+.+ ......|+..
T Consensus 658 ~~~~~~~~~---------~~~--~---~~~---------------~~~~-~---------~~~~~~~---~~~~~~~~~~ 695 (968)
T PLN00113 658 LELKRVENE---------DGT--W---ELQ---------------FFDS-K---------VSKSITI---NDILSSLKEE 695 (968)
T ss_pred ccccccccc---------ccc--c---ccc---------------cccc-c---------cchhhhH---HHHHhhCCcc
Confidence 111110000 000 0 000 0000 0 0001122 2334567888
Q ss_pred ceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCCC
Q 002238 599 NILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGT 677 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 677 (948)
++||+|+||.||+|+. .++..||||++.... . ...+|++++++++|||||+++++|.+++..++||||+++|+
T Consensus 696 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~ 769 (968)
T PLN00113 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVN--S----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN 769 (968)
T ss_pred cEEccCCCeeEEEEEECCCCcEEEEEEccCCc--c----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCc
Confidence 9999999999999987 478999999886431 1 12356889999999999999999999999999999999999
Q ss_pred hhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCcee
Q 002238 678 LSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE 757 (948)
Q Consensus 678 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 757 (948)
|.++++ .++|.++.+|+.|+|+|++|||+.++++|+||||||+||+++.++.+++. ||.+......
T Consensus 770 L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----- 835 (968)
T PLN00113 770 LSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----- 835 (968)
T ss_pred HHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----
Confidence 999983 48899999999999999999997656899999999999999999888875 6655433221
Q ss_pred eeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCc-
Q 002238 758 TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLN- 836 (948)
Q Consensus 758 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 836 (948)
....||+.|+|||++.+..++.++|||||||++|||+||+.||+.... .....++|.+... ........+|+.+...
T Consensus 836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCY-SDCHLDMWIDPSIRGDV 913 (968)
T ss_pred CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhc-CccchhheeCccccCCC
Confidence 223688999999999999999999999999999999999999965432 2334555655432 2223444555554321
Q ss_pred cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 837 EGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 837 ~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
.....+..++.+++.+|++.+|++||+|+||++.|+++.+
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 2233456678899999999999999999999999998764
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-52 Score=459.04 Aligned_cols=290 Identities=48% Similarity=0.832 Sum_probs=251.3
Q ss_pred CcceeeHHHHHHhhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEe
Q 002238 579 GNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658 (948)
Q Consensus 579 ~~~~~~~~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 658 (948)
....|++.+++.+|++|...++||+|+||.||+|.+++|..||||++....... ..+|..|++++.+++|||+|+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence 456799999999999999999999999999999999989999999887642221 466999999999999999999999
Q ss_pred EEEeCC-ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCC
Q 002238 659 HCLDGN-EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 737 (948)
Q Consensus 659 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~ 737 (948)
||.+++ +.+||||||++|+|.++++... .. +++|.+|++||.++|+||+|||+.++++||||||||+|||||++++
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~--~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKK--GE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCC--CC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence 999998 5999999999999999997622 11 8899999999999999999999988789999999999999999999
Q ss_pred eEEeecCCceecCC-CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH
Q 002238 738 AKVADFGLVRLAPE-GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFR 816 (948)
Q Consensus 738 ~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~ 816 (948)
+||+|||+|+..+. ..... +...||.+|+|||++..+..+.|+|||||||+|+|++||+.|.+...+.....++.|..
T Consensus 216 aKlsDFGLa~~~~~~~~~~~-~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDTSVS-TTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred EEccCccCcccCCcccccee-eecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 99999999976654 32211 11179999999999999999999999999999999999999998776555666889986
Q ss_pred HhhcCccccccccCcccCCccchH-HHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhh
Q 002238 817 RIHLSKDSFHKAIDPTIDLNEGIL-ASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875 (948)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~ 875 (948)
.... +..+.+++|+.+....... .+..++.+++.+|++.+|.+||+|.||+++|+.+.
T Consensus 295 ~~~~-~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 295 PLLE-EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHH-CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 6554 4488999999986433332 67788999999999999999999999999996654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=405.63 Aligned_cols=259 Identities=36% Similarity=0.587 Sum_probs=215.4
Q ss_pred cccceecccCceEEEEEEEcCCcE-EEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-ceEEEEEec
Q 002238 596 SEENILGRGGFGTVYKGELHDGTK-IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-EKLLVFEYM 673 (948)
Q Consensus 596 ~~~~~lg~G~fg~Vy~~~~~~g~~-vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~ 673 (948)
...+.||+|+||+||+|.++ |+. ||||++..........++|.+|+.+|.+++|||||+++|+|.+.. ..++||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~-g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWR-GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhcccCCceeEEEEEeC-CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 34556999999999999998 555 999999876555555789999999999999999999999999887 789999999
Q ss_pred CCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCC-eeecCCCCccEEEcCCC-CeEEeecCCceecCC
Q 002238 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS-FIHRDLKPSNILLGDDM-RAKVADFGLVRLAPE 751 (948)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivHrDik~~Nill~~~~-~~kl~DfGla~~~~~ 751 (948)
++|+|.++++.. ....+++..++++|.|||+||+|||+ .+ ||||||||+|||++.++ .+||+|||+++....
T Consensus 123 ~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 123 PGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred CCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 999999999653 34789999999999999999999998 55 99999999999999997 999999999996654
Q ss_pred CCCceeeeecccccccCceecc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAV--TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
.. ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||.+..+.+....+ .. ...
T Consensus 197 ~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v---~~---------~~~ 263 (362)
T KOG0192|consen 197 SK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV---VV---------GGL 263 (362)
T ss_pred cc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH---Hh---------cCC
Confidence 32 2234467999999999999 669999999999999999999999999987763322111 10 111
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhC
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWK 879 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~ 879 (948)
.+.++ ...+..+..++.+||+.||.+||++.+++..|+.+.....
T Consensus 264 Rp~~p-----~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 264 RPPIP-----KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCCCC-----ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 11111 1144568899999999999999999999999999876543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=378.10 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=208.6
Q ss_pred cccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-ceEEEEEec
Q 002238 596 SEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-EKLLVFEYM 673 (948)
Q Consensus 596 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~ 673 (948)
+..+.||+|..|+||++.++ +++-+|+|++... ......+++.+|+++++.++||+||+++|+|.... +..++||||
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 34678999999999999986 7889999999543 35666789999999999999999999999999988 599999999
Q ss_pred CCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCC
Q 002238 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (948)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~ 753 (948)
++|+|++++.. .+.+++...-+|+.+|++||.|||+ .++||||||||+|||++..|+|||||||.++.....
T Consensus 161 DgGSLd~~~k~-----~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 161 DGGSLDDILKR-----VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred CCCCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999998843 2678999999999999999999996 489999999999999999999999999999866543
Q ss_pred CceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hhhhhHHHHHHHhhcCccccccccCc
Q 002238 754 GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQP--EESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 754 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
....++||..|||||.+.+..|+.++||||||+.++|+.+|+.||....+ .....+..++ .. ...|
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---v~-------~ppP 300 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---VD-------EPPP 300 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH---hc-------CCCC
Confidence 55678899999999999999999999999999999999999999987521 1222222211 11 1112
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.++.. ....++.+++..|++.||.+||+++|++++
T Consensus 301 ~lP~~----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 RLPEG----EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCcc----cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 22211 234569999999999999999999999874
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=377.44 Aligned_cols=209 Identities=33% Similarity=0.530 Sum_probs=188.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
..+|...+.||+|+||+||+|+++ ++..||||.+.+.....+..+.+..|+.+|+.++|||||++++++..++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 457888888999999999999875 6899999999887666777788999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC------CCeEEeecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD------MRAKVADFG 744 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~------~~~kl~DfG 744 (948)
|||.||+|.++++. .+.+++.++..++.|+|.||++||+ ++||||||||+|||++.. -.+||+|||
T Consensus 89 EyC~gGDLs~yi~~-----~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR-----RGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 99999999999965 2478999999999999999999997 899999999999999864 468999999
Q ss_pred CceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhh
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMH 810 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~ 810 (948)
+|+....+ ......+|++-|||||++...+|+.|+|+||.|+++||+++|+.||+...+.+...
T Consensus 161 fAR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~ 224 (429)
T KOG0595|consen 161 FARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL 224 (429)
T ss_pred hhhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 99987653 35566899999999999999999999999999999999999999999877665544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=364.33 Aligned_cols=262 Identities=26% Similarity=0.413 Sum_probs=214.4
Q ss_pred cCCcccceecccCceEEEEEE-EcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEe-EEEeCCc-eEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG-HCLDGNE-KLLV 669 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~-~~~~~~~-~~lv 669 (948)
.+|++.++||+|.||+||++. ..+|..||.|.+.-...+.+..++...|+.+|++++|||||++++ -+.++.+ .++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 357778899999999999996 568999999999877778888999999999999999999999998 4444555 7899
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCC-eeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS-FIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
|||+.+|+|.+.++.+.+ ..+.+++.++|+++.|++.||.++|+..+++ |+||||||.||+++.+|.|||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999987654 4578999999999999999999999854333 78999999999999999999999999997
Q ss_pred cCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
..... ......+|||.||+||.+....|+.|+||||+||++|||+.-++||.+..- .+...++.. +++..+
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------~~L~~KI~q--gd~~~~ 248 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------LSLCKKIEQ--GDYPPL 248 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH------HHHHHHHHc--CCCCCC
Confidence 76543 345567899999999999999999999999999999999999999987632 222222221 111111
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHh
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~ 873 (948)
. .......+..+|..|+..||+.||+...++..+..
T Consensus 249 p---------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 249 P---------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred c---------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1 12334568899999999999999986555544433
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=391.16 Aligned_cols=254 Identities=33% Similarity=0.506 Sum_probs=214.2
Q ss_pred cccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCC
Q 002238 596 SEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (948)
Q Consensus 596 ~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 675 (948)
+..+.||+|-||.||.|.++....||||.++.. ....++|.+|+++|++++|+|||+++|+|..++..+||||||+.
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 346779999999999999997779999999864 33347889999999999999999999999998999999999999
Q ss_pred CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc
Q 002238 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (948)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 755 (948)
|+|.++|+. .....+...+.+.++.|||+|++||++ +++|||||.++||||+++..+||+|||||+...++...
T Consensus 286 GsLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 286 GSLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred CcHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 999999965 445778999999999999999999998 89999999999999999999999999999965554443
Q ss_pred eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccC
Q 002238 756 IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTID 834 (948)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (948)
......-+..|+|||.+..+.++.|+|||||||+|||++| |+.|+......+....++...+ ++
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR---------------lp 424 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR---------------LP 424 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc---------------CC
Confidence 3333344679999999999999999999999999999999 8889887765554333321111 11
Q ss_pred CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 835 LNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 835 ~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
. +..++.++.+++..||+.+|++|||++.+...++++..
T Consensus 425 ~---P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 425 R---PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred C---CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 1 12355679999999999999999999999999888754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=387.97 Aligned_cols=250 Identities=25% Similarity=0.444 Sum_probs=215.8
Q ss_pred cCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.+|...+.||+|||+.||+++. .+|+.||+|++.+... .....+.+.+||++.++|+|||||+++++|++.+.+|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999987 7899999999987543 3455678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
|+|+.++|..+++ ..+++++.++..+.+||+.||.|||+ .+|+|||||..|+|++++.++||+|||||....
T Consensus 98 ELC~~~sL~el~K-----rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-----RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHHH-----hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeec
Confidence 9999999998873 34789999999999999999999997 899999999999999999999999999999776
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
.+. ....+.+|||-|.|||++.....+..+||||+||++|-|+.|++||+...-.+....+. ..+..+..
T Consensus 170 ~~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik------~~~Y~~P~--- 239 (592)
T KOG0575|consen 170 YDG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK------LNEYSMPS--- 239 (592)
T ss_pred Ccc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH------hcCccccc---
Confidence 543 24566899999999999999999999999999999999999999998765544433332 22222211
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
....+..+||.++++.+|.+||++++|+..
T Consensus 240 ----------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 240 ----------HLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ----------ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 122357899999999999999999999874
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=370.91 Aligned_cols=256 Identities=28% Similarity=0.435 Sum_probs=206.8
Q ss_pred hhcCCcccceecccCceEEEEEE-EcCCcEEEEEEeecCcCChh-----hHHHHHHHHHHHHhcCCCceeeEEeEEEeCC
Q 002238 591 VTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGK-----GLTEFKSEIAVLTKVRHRHLVALLGHCLDGN 664 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 664 (948)
..+.|.+.+.||+|+||.|-+|. .++|+.||||++++...... ......+|+++|++++|||||++.+++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45678889999999999999996 46899999999977543321 1234579999999999999999999999999
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC---CCeEEe
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAKVA 741 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~---~~~kl~ 741 (948)
..||||||++||+|.+++.. .+.+.+.....+++|++.|+.|||+ .||+||||||+|||+..+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~-----nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA-----NKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHh-----ccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEec
Confidence 99999999999999998843 2566677778899999999999997 899999999999999766 679999
Q ss_pred ecCCceecCCCCCceeeeecccccccCceecccCCC---CchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh
Q 002238 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV---TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI 818 (948)
Q Consensus 742 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 818 (948)
|||+|+.... .....+.+|||.|.|||++.++.+ ..|+|+||+||+||-+++|.+||.+..... .+. .++
T Consensus 322 DFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~---eQI 394 (475)
T KOG0615|consen 322 DFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLK---EQI 394 (475)
T ss_pred ccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHH---HHH
Confidence 9999998763 446677899999999999987653 358899999999999999999998754322 111 122
Q ss_pred hcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 819 HLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
......+.. ..+.....+..++|.+|+..||++||++.|++++
T Consensus 395 ~~G~y~f~p---------~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 395 LKGRYAFGP---------LQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hcCcccccC---------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 222222211 2223334568899999999999999999999873
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=400.18 Aligned_cols=262 Identities=28% Similarity=0.494 Sum_probs=216.9
Q ss_pred cCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCce
Q 002238 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 666 (948)
.+....+.||+|+||+||+|+.. +.+.||||.++.. ...+..++|++|++++..++|||||+++|+|.+++..
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 34455678999999999999753 3567999999875 3555789999999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHhhhhc-----C----CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCC
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEE-----G----LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 737 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~-----~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~ 737 (948)
+||+|||..|||.++|+..... + ..+++..+.+.||.|||.|++||-+ +.+||||+..+|+|+.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceE
Confidence 9999999999999999753211 1 2348999999999999999999997 89999999999999999999
Q ss_pred eEEeecCCcee-cCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHH
Q 002238 738 AKVADFGLVRL-APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWF 815 (948)
Q Consensus 738 ~kl~DfGla~~-~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 815 (948)
|||+||||+|. +..++.....+..=+.+|||||.+..+++|.++|||||||||||+++ |+.||.+....+....+.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~-- 719 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR-- 719 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH--
Confidence 99999999993 33333333323344789999999999999999999999999999999 999998877665543332
Q ss_pred HHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 816 RRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
.+.+ ......++.++..|+..||+.+|.+||+++||-..|+...+
T Consensus 720 ------~g~l----------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 720 ------AGQL----------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred ------cCCc----------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 1111 12233566779999999999999999999999999988764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=357.08 Aligned_cols=244 Identities=27% Similarity=0.436 Sum_probs=205.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|++.++||+|+||+||.++.+ +++-+|+|++++.... ..+.+....|..++.+++||+||+++-.|++.+..|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467999999999999999999754 6899999999876543 44678899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
+||+.||.|..+|.. ...+++.++.-++..|+.||.|||+ ++|||||+||+|||+|.+|.++|+|||+++..
T Consensus 104 ld~~~GGeLf~hL~~-----eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR-----EGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EeccCCccHHHHHHh-----cCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 999999999999943 3678899899999999999999997 89999999999999999999999999999955
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
.... .....++||+.|||||++.+..|+.++|.||+|+++|||++|.+||...+.... ...+...+. ..
T Consensus 176 ~~~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~------~~~I~~~k~----~~ 244 (357)
T KOG0598|consen 176 LKDG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM------YDKILKGKL----PL 244 (357)
T ss_pred ccCC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH------HHHHhcCcC----CC
Confidence 4432 234558999999999999999999999999999999999999999987654332 222222110 00
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCC
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRP 862 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RP 862 (948)
.+. -...+..+++.+++..||++|.
T Consensus 245 ~p~--------~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 245 PPG--------YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCc--------cCCHHHHHHHHHHhccCHHHhc
Confidence 010 0123478999999999999996
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=360.43 Aligned_cols=268 Identities=25% Similarity=0.347 Sum_probs=216.0
Q ss_pred cCCcccceecccCceEEEEEE-EcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CceEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKLLV 669 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv 669 (948)
+.|+..++||+|+||.||+|+ ..+|+.||+|+++.+........-..+||.+|++++||||+++.+...+. ...|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 457778889999999999997 46899999999987755555567788999999999999999999988876 689999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
+|||+. +|.-++. ...-.++..++..++.|++.||+|+|+ ++|+|||||.+|||+|.+|.+||+|||||+++
T Consensus 197 FeYMdh-DL~GLl~----~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLS----SPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred Eecccc-hhhhhhc----CCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeec
Confidence 999976 7877663 344679999999999999999999997 89999999999999999999999999999988
Q ss_pred CCCCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc--
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH-- 826 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 826 (948)
........+..+-|.+|.|||.+.+. .|+.+.|+||.||||.||++|++.|.+..+.+..+.+--+-....... +.
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~-W~~~ 347 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY-WPVS 347 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc-cccc
Confidence 77666666777889999999999875 699999999999999999999999999887666555532222111111 11
Q ss_pred -----cccCcccC----CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 827 -----KAIDPTID----LNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 827 -----~~~~~~~~----~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..+.+.-. +.+.....+....+|+..++..||++|.|+.++++
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111111 01111223456779999999999999999998876
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=342.07 Aligned_cols=268 Identities=23% Similarity=0.330 Sum_probs=212.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|+...++|+|+||.||+++.+ +|+.||||++.....++.-.+-..+|++++++++|||+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46788889999999999999976 69999999997654444455667899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|++.--| +-+. .....++...+.++++|++.|+.|+|+ +++|||||||+|||++.+|.+||||||+|+....
T Consensus 82 ~~dhTvL-~eLe----~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVL-HELE----RYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHH-HHHH----hccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 9977333 3332 223457888899999999999999996 8999999999999999999999999999997654
Q ss_pred CCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHH--------HHHHhhcCc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVT--------WFRRIHLSK 822 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~~ 822 (948)
.+...+..+.|.+|.|||.+.+ -+|+..+||||.||++.||++|.+-|.+..+-+..+.+. .-..+....
T Consensus 154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 2334566788999999999988 679999999999999999999999999887766554442 112222223
Q ss_pred cccccccCcccCC----ccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 823 DSFHKAIDPTIDL----NEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 823 ~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..+..+.-|...- +........-++++++.|++.||++|++-++++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 3333333332221 1111222345789999999999999999999876
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=346.32 Aligned_cols=263 Identities=22% Similarity=0.387 Sum_probs=213.5
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.+.|++..+||.|..++||+|+. ..++.||||++..+.+... .+.+.+|+..|+.++||||++++..|..+...|+||
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 45789999999999999999974 5789999999988765444 789999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
.||.+|++.++++.+... .+++..+..|.+++++||.|||. +|.||||||+.|||++.+|.|||+|||.+....
T Consensus 104 pfMa~GS~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD---GLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred hhhcCCcHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 999999999999875544 38889999999999999999996 899999999999999999999999999876443
Q ss_pred CCCCcee---eeecccccccCceeccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 751 EGKGSIE---TRIAGTFGYLAPEYAVT--GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 751 ~~~~~~~---~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
+...... ..++||+.|||||+++. ..|+.|+||||||+...||.+|..||....+.....+. . ++..
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t-----L---qn~p 249 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT-----L---QNDP 249 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH-----h---cCCC
Confidence 3322222 44689999999999654 46999999999999999999999999988765432211 0 1111
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
....-..++ .+........+.+++..|++.||.+|||++++++.
T Consensus 250 p~~~t~~~~-~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 250 PTLLTSGLD-KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CCcccccCC-hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 111111111 22223334578999999999999999999999873
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=376.23 Aligned_cols=259 Identities=24% Similarity=0.457 Sum_probs=220.2
Q ss_pred hcCCcccceecccCceEEEEEEEc----CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
.....+.++||.|.||+||+|+++ ....||||.++.. ..++...+|..|+.||.++.||||+++.|+.......+
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 345678899999999999999876 2457999999875 36677889999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+|+|||++|+|+.+|+. ....+++.+..-++++||.|++||-+ .++|||||.++|||++.+-.+|++|||++|
T Consensus 707 IiTEyMENGsLDsFLR~----~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred EEhhhhhCCcHHHHHhh----cCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEecccccee
Confidence 99999999999999954 33569999999999999999999997 899999999999999999999999999999
Q ss_pred ecCCCCCceeeeecc--cccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 748 LAPEGKGSIETRIAG--TFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 748 ~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
...++.....+..-| +.+|.|||.+...+++.++||||||+||||.++ |.+||.+....+...-++. ...
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~-------gyR 852 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ-------GYR 852 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh-------ccC
Confidence 776655333222222 469999999999999999999999999999998 9999988765554333321 111
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
....++++..+.+|+..||+.|=.+||.+.+|+..|.+++.
T Consensus 853 -----------LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 853 -----------LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred -----------CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 12234567789999999999999999999999999999875
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=362.47 Aligned_cols=268 Identities=26% Similarity=0.477 Sum_probs=218.4
Q ss_pred HHHHHhhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc
Q 002238 586 QVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (948)
Q Consensus 586 ~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 665 (948)
++-+...+.+.+.+.||+|.||+||||.|. ..||||++.....++...+.|+.|+.++++-||.||+=+.|||..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 333444556677899999999999999997 479999999887788889999999999999999999999999998877
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGl 745 (948)
.+|+.||+|-+|..++|.. ...++..+.+.||.|||+|+.|||. ++|||||+|..||++.+++.|||+|||+
T Consensus 463 -AIiTqwCeGsSLY~hlHv~----etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQ----ETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred -eeeehhccCchhhhhccch----hhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccc
Confidence 9999999999999999753 2578999999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCCc-eeeeecccccccCceecccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcC
Q 002238 746 VRLAPEGKGS-IETRIAGTFGYLAPEYAVTG---RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS 821 (948)
Q Consensus 746 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 821 (948)
+.......+. ......|...|||||++... .|+..+||||||+|+|||+||..||.....+.....+ .
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV--------G 606 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV--------G 606 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe--------c
Confidence 8854433221 12234578899999999754 5899999999999999999999999955444322111 1
Q ss_pred ccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 822 KDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
.+.+. . +.......++.++.+|+..||..++++||.+.+|+..|+.+...
T Consensus 607 rG~l~--p----d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 607 RGYLM--P----DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ccccC--c----cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 11111 1 11222334556799999999999999999999999999988653
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=323.90 Aligned_cols=267 Identities=26% Similarity=0.374 Sum_probs=211.7
Q ss_pred cCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.+|...++||+|.||.||+|+. ++|+.||||+++.....+.......+|++.++.++|+||+.+++++...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677889999999999999974 589999999998765444445678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
||+. +|+..+++ ....++-.++..++.++++|++|||+ +.|+||||||.|+|++.+|.+||+|||+|+.+..
T Consensus 82 fm~t-dLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred eccc-cHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 9965 99888843 44688999999999999999999997 8999999999999999999999999999998765
Q ss_pred CCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcc-cccc--
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD-SFHK-- 827 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-- 827 (948)
.... .+..+-|.+|.|||.+.+. .|+...||||.||++.||+-|.+-|.+..+-+....+ ++..-.+.. .+.+
T Consensus 154 p~~~-~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~I--f~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 154 PNRI-QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKI--FRALGTPTPDQWPEMT 230 (318)
T ss_pred CCcc-cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHH--HHHcCCCCcccCcccc
Confidence 5432 3333679999999999874 6999999999999999999999888887765544333 221111111 0000
Q ss_pred -cc-------CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 828 -AI-------DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 828 -~~-------~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.. -|.......-........+++..++..||.+|++++|++++
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 00 01111111223344567899999999999999999999874
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=354.15 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=211.2
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 667 (948)
-.++|..++.||+|+|++||+|+. ++++.||||++.+... .+...+.+.+|-.+|.+| .||.|++++-.|.++...|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 356899999999999999999975 4799999999976543 234456788899999999 8999999999999999999
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+|+||+++|+|.++++.+ +.+++.-...+|.+|+.||+|||+ +|||||||||+|||+|++++++|+|||-|+
T Consensus 151 FvLe~A~nGdll~~i~K~-----Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY-----GSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred EEEEecCCCcHHHHHHHh-----CcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999653 578888888999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCC------------ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHH
Q 002238 748 LAPEGKG------------SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWF 815 (948)
Q Consensus 748 ~~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~ 815 (948)
.+..... .....++||..|.+||++..+..+..+|+|+|||++|+|+.|++||...++.-...
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq----- 297 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ----- 297 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH-----
Confidence 6543221 11245899999999999999999999999999999999999999999876543322
Q ss_pred HHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 816 RRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
++......+.+-+. ..+.+|+.+.+..||.+|++..+|.++
T Consensus 298 -kI~~l~y~fp~~fp-------------~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 298 -KIQALDYEFPEGFP-------------EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -HHHHhcccCCCCCC-------------HHHHHHHHHHHccCccccccHHHHhhC
Confidence 22222222222222 347799999999999999999888764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=354.94 Aligned_cols=268 Identities=25% Similarity=0.334 Sum_probs=212.1
Q ss_pred HhhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCC-ce
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGN-EK 666 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~ 666 (948)
...++|...++||.|+||.||+|+. .+|+.||||++++....-+ .-.=.||+..|++++ |||||++.+++.+.+ ..
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 3457899999999999999999975 4799999999988654432 233468999999998 999999999999888 89
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCc
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla 746 (948)
++|||||+ .+|.+++++ ..+.+++..+..|+.||++||+|+|. +|+.|||+||+|||+.....+||+|||+|
T Consensus 86 ~fVfE~Md-~NLYqLmK~----R~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLA 157 (538)
T KOG0661|consen 86 YFVFEFMD-CNLYQLMKD----RNRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLA 157 (538)
T ss_pred eeeHHhhh-hhHHHHHhh----cCCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccc
Confidence 99999995 599999854 35789999999999999999999995 99999999999999999999999999999
Q ss_pred eecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc---
Q 002238 747 RLAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK--- 822 (948)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 822 (948)
|...... ..+..+.|.+|+|||++.. +-|+.+.||||+||+++|+.+-++-|.+..+.+....+-.+-.-...+
T Consensus 158 Rev~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 158 REVRSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred cccccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 9665433 3456778999999998855 678999999999999999999999998877654433321111100000
Q ss_pred ----------cccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 823 ----------DSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 823 ----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
..+.+... .....-......+.++++.+|+++||.+|||++|++++
T Consensus 236 eg~~La~~mnf~~P~~~~--~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKP--SPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hHHHHHHHhccCCCcCCC--CChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 01111111 11122223355678999999999999999999999885
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=326.24 Aligned_cols=238 Identities=27% Similarity=0.413 Sum_probs=205.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCc-CChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|+..+.||.|+||.|..++.+ +|..+|+|++.+.. ..-.+.+....|..+|+.+.||+++++++.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46778899999999999999865 68999999997653 33455677889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||++||.|..+++. .++++...+.-+|.||+.||+|||+ .+|++||+||+|||+|.+|.+||+|||.|+...
T Consensus 124 eyv~GGElFS~Lrk-----~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK-----SGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eccCCccHHHHHHh-----cCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 99999999999953 3679999999999999999999997 899999999999999999999999999999775
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
.. ..+.+|||.|+|||++..+.|..++|.|||||++|||+.|.+||...++... ...+...+-.+...+.
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i------Y~KI~~~~v~fP~~fs 265 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI------YEKILEGKVKFPSYFS 265 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH------HHHHHhCcccCCcccC
Confidence 42 5678999999999999999999999999999999999999999998876443 2233333333333332
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCC
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQR 861 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~R 861 (948)
.++.+|+.+.++.|=.+|
T Consensus 266 -------------~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 266 -------------SDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -------------HHHHHHHHHHHhhhhHhh
Confidence 247799999999999888
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=348.63 Aligned_cols=255 Identities=29% Similarity=0.462 Sum_probs=202.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC--ceEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN--EKLLV 669 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lv 669 (948)
.+|...+.||+|+||.||++... +|+..|||.+... .....+.+.+|+.+|++++|||||+++|...... .+++.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 45777899999999999999875 4899999998765 2222677999999999999999999999855544 58999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC-CCCeEEeecCCcee
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRL 748 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~-~~~~kl~DfGla~~ 748 (948)
|||+++|+|.+++.. .+. .+++..+.+++.||++||+|||+ +|||||||||+|||++. ++.+||+|||+++.
T Consensus 95 mEy~~~GsL~~~~~~---~g~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKR---YGG-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeccCCCcHHHHHHH---cCC-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 999999999999954 222 79999999999999999999997 89999999999999999 79999999999986
Q ss_pred cCC--CCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-CchhhhhHHHHHHHhhcCccc
Q 002238 749 APE--GKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDES-QPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 749 ~~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~ 824 (948)
... ........+.||+.|||||++..+ ....++||||+||++.||+||++||.+. ...+ +.-.+.... .
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~------~~~~ig~~~-~ 240 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAE------ALLLIGRED-S 240 (313)
T ss_pred cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHH------HHHHHhccC-C
Confidence 653 222234457899999999999864 3445999999999999999999999874 1111 111111111 1
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHh
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~ 873 (948)
.. .++ .....+..+++.+|+..+|++|||+++++++-..
T Consensus 241 ~P-----~ip-----~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 241 LP-----EIP-----DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred CC-----CCC-----cccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 11 111 1123457899999999999999999999986544
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.34 Aligned_cols=268 Identities=26% Similarity=0.396 Sum_probs=216.7
Q ss_pred HHhhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEE
Q 002238 589 RNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 589 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
+-..+...+.++||+|-||.|..++...+..||||.++... ......+|.+|+++|.+++|||||+++|+|..++..++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 33456778889999999999999999878999999998753 45557899999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
|+|||++|+|.+++..... ..+.-...++|+.|||.|++||.+ .++||||+.++|+|++.++++||+|||++|.
T Consensus 613 I~EYmEnGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred HHHHHhcCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccc
Confidence 9999999999999965221 224556677899999999999998 8999999999999999999999999999994
Q ss_pred c-CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 749 A-PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT--GRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 749 ~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
. ..+......+.+-+.+|||||.+..++++.++|||+||+.+||+++ ...||.+..+++. ++.........+.
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~- 762 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGR- 762 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCc-
Confidence 3 3333344455666789999999999999999999999999999976 7789887765443 2222222111111
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
+.+ ..-...++..+.+++.+||..+-.+||+++++...|.+.
T Consensus 763 -~~~------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 763 -QVV------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -cee------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111 112234556789999999999999999999999988764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=350.77 Aligned_cols=249 Identities=27% Similarity=0.407 Sum_probs=213.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+.....++.+.+.+|+++++.++|||||.++++|....+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 56777888999999999999765 68999999998877677888899999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+.| +|.+++.. ...+++..+..|+.+++.||.|||+ .+|+|||+||+|||++..+.+|+||||+|+.+..
T Consensus 82 ~a~g-~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred hhhh-hHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 9976 99999843 3678999999999999999999997 8999999999999999999999999999998766
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
++ ...+.+.|||-|||||+..+..|+..+|+||+||++||+++|++||.... ...+++ .+.. +.+.+
T Consensus 153 ~t-~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---i~~Lv~---~I~~------d~v~~ 219 (808)
T KOG0597|consen 153 NT-SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---ITQLVK---SILK------DPVKP 219 (808)
T ss_pred Cc-eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---HHHHHH---HHhc------CCCCC
Confidence 43 56777889999999999999999999999999999999999999997532 223332 2211 11111
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.......+..++...+..||.+|.+-.+++.+
T Consensus 220 -------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 220 -------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -------cccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 11334568899999999999999999888764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=357.57 Aligned_cols=251 Identities=24% Similarity=0.437 Sum_probs=212.6
Q ss_pred hcCCcccceecccCceEEEEEE-EcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
...|..-.+||+|+.|.||.|. ..+++.||||++... .....+-+..|+.+|+..+|+|||.+++.+..+++.|.||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~--~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR--KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEec--cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 3568888899999999999996 457899999999865 3344567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
|||+||+|.+.+.. ..+++.++..|++++++||+|||. .+|+|||||.+|||++.+|.+||+|||++....
T Consensus 350 Eym~ggsLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTK------TRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred eecCCCchhhhhhc------ccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 99999999998843 458999999999999999999997 899999999999999999999999999998765
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
.... .....+|||.|||||+.....|++|.||||||++++||+-|++||-...+....+++.- . -.
T Consensus 421 ~~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-------n------g~ 486 (550)
T KOG0578|consen 421 EEQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-------N------GT 486 (550)
T ss_pred cccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-------c------CC
Confidence 5443 56678899999999999999999999999999999999999999987666554444321 1 11
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+.+. ........+.+++.+|+..|+++||++.|++++
T Consensus 487 P~lk---~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 487 PKLK---NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCcC---CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 2221 112233468999999999999999999999874
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.01 Aligned_cols=274 Identities=24% Similarity=0.391 Sum_probs=221.0
Q ss_pred eHHHHHHhhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc--CCCceeeEEeEEE
Q 002238 584 SIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV--RHRHLVALLGHCL 661 (948)
Q Consensus 584 ~~~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~ 661 (948)
++-..+.+.++..+.+.||+|.||+||+|.|+ |+.||||++.. .+.+.+.+|.++++.. ||+||+.+++...
T Consensus 202 plLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~ 275 (513)
T KOG2052|consen 202 PLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAADN 275 (513)
T ss_pred hhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence 34556778888999999999999999999999 99999999864 3446788888888875 9999999998876
Q ss_pred eCC----ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-----hccCCCeeecCCCCccEEE
Q 002238 662 DGN----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH-----GLAHQSFIHRDLKPSNILL 732 (948)
Q Consensus 662 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~ivHrDik~~Nill 732 (948)
.+. +.|||++|.+.|+|.|+|.. ..++....++++..+|.||+||| ++.++.|.|||||+.|||+
T Consensus 276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV 349 (513)
T KOG2052|consen 276 KDNGSWTQLWLVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 349 (513)
T ss_pred cCCCceEEEEEeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE
Confidence 543 56999999999999999943 57899999999999999999999 3468899999999999999
Q ss_pred cCCCCeEEeecCCceecCCCCCce---eeeecccccccCceecccCC------CCchhhHHHHHHHHHHHHhC-------
Q 002238 733 GDDMRAKVADFGLVRLAPEGKGSI---ETRIAGTFGYLAPEYAVTGR------VTTKVDVFSFGVILMELITG------- 796 (948)
Q Consensus 733 ~~~~~~kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~Gv~l~elltg------- 796 (948)
.+++.+.|+|+|||.......... ....+||.+|||||++...- .-..+||||||.|+||+..+
T Consensus 350 Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ 429 (513)
T KOG2052|consen 350 KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIV 429 (513)
T ss_pred ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEe
Confidence 999999999999999776654332 34578999999999986532 22469999999999999873
Q ss_pred ---CCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHh
Q 002238 797 ---RKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873 (948)
Q Consensus 797 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~ 873 (948)
+.||.+.-+.+.. . +..+ +--..+-+.|.++......+....+.++++.||..+|.-|-|+-.|.+.|.+
T Consensus 430 eey~~Pyyd~Vp~DPs-~-eeMr-----kVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~ 502 (513)
T KOG2052|consen 430 EEYQLPYYDVVPSDPS-F-EEMR-----KVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAK 502 (513)
T ss_pred hhhcCCcccCCCCCCC-H-HHHh-----cceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence 5677665443221 0 0011 1112344556666667777888899999999999999999999999999888
Q ss_pred hhh
Q 002238 874 LVE 876 (948)
Q Consensus 874 ~~~ 876 (948)
+.+
T Consensus 503 l~~ 505 (513)
T KOG2052|consen 503 LSN 505 (513)
T ss_pred Hhc
Confidence 763
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=360.77 Aligned_cols=262 Identities=28% Similarity=0.440 Sum_probs=211.9
Q ss_pred CCcccceecccCceEEEEEEEcC--C---cEEEEEEeecC-cCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 594 NFSEENILGRGGFGTVYKGELHD--G---TKIAVKRMEAG-VISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~~--g---~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
+....++||+|+||.||+|+++. + ..||||..+.+ ........+|.+|+++|++++|||||+++|++......+
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 34455899999999999998752 2 23899998853 356777899999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+|||+|.||+|.++|+. ....++..+++.++.++|+||+|||+ +++|||||.++|+|++.++.+||+||||++
T Consensus 238 ivmEl~~gGsL~~~L~k----~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKK----NKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred EEEEecCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 99999999999999954 22369999999999999999999997 899999999999999999999999999988
Q ss_pred ecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 748 LAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
.-...... .....-+.+|+|||.+..+.|+.++|||||||++||+++ |..||.+....+....+. . .+ +.
T Consensus 311 ~~~~~~~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~------~-~~-~r 381 (474)
T KOG0194|consen 311 AGSQYVMK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV------K-NG-YR 381 (474)
T ss_pred CCcceeec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH------h-cC-cc
Confidence 54311111 111124679999999999999999999999999999999 888999877654322221 1 00 11
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCC
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKP 880 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~ 880 (948)
... . ...+..+..++.+||..+|++||+|.++.+.++.+......
T Consensus 382 ~~~------~---~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 382 MPI------P---SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCC------C---CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 111 1 13345688899999999999999999999999999765443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=338.34 Aligned_cols=267 Identities=27% Similarity=0.450 Sum_probs=206.3
Q ss_pred cccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc--CCCceeeEEeEEEeCC----ceEEE
Q 002238 596 SEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV--RHRHLVALLGHCLDGN----EKLLV 669 (948)
Q Consensus 596 ~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~~----~~~lv 669 (948)
+..++||+|.||.||+|.++ ++.||||++. .++.+.|..|-++.+.. +|+||++++++-..+. +++||
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 34567999999999999998 6999999874 45678899888887765 8999999999877655 88999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc------cCCCeeecCCCCccEEEcCCCCeEEeec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL------AHQSFIHRDLKPSNILLGDDMRAKVADF 743 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~~ivHrDik~~Nill~~~~~~kl~Df 743 (948)
+||.+.|+|.++|.. ..++|....+|+..+++||+|||+. .|++|+|||||++|||+.+|+++.|+||
T Consensus 287 t~fh~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred eeeccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 999999999999954 5799999999999999999999964 3678999999999999999999999999
Q ss_pred CCceecCCCCCce-eeeecccccccCceecccCC-CC-----chhhHHHHHHHHHHHHhCCCCCCC-CCchhhhh-----
Q 002238 744 GLVRLAPEGKGSI-ETRIAGTFGYLAPEYAVTGR-VT-----TKVDVFSFGVILMELITGRKALDE-SQPEESMH----- 810 (948)
Q Consensus 744 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dv~s~Gv~l~elltg~~p~~~-~~~~~~~~----- 810 (948)
|+|..+..+.... .-..+||.+|||||++.+.. +. .+.||||+|.|||||+++...++. ..++-..-
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9999776554332 23478999999999997642 22 368999999999999998665531 11110000
Q ss_pred ----HHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhC
Q 002238 811 ----LVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWK 879 (948)
Q Consensus 811 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~ 879 (948)
..+..+... +.+-..|.++........+..+.+.+..||+.||+.|.|+.=|-+.+.++...+.
T Consensus 441 G~hPt~e~mq~~V-----V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 441 GNHPTLEEMQELV-----VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred cCCCCHHHHHHHH-----HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 001111111 1222233443333334556678899999999999999999999999998875554
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=354.70 Aligned_cols=252 Identities=27% Similarity=0.412 Sum_probs=208.4
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCC---hhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCc
Q 002238 591 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNE 665 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~ 665 (948)
..++|...+.||+|+||.||.|.. .+|+.||||++...... ....+.+.+|+.+++.++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 457899999999999999999975 47899999977664222 123566779999999998 9999999999999999
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC-CCeEEeecC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFG 744 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~-~~~kl~DfG 744 (948)
.++||||+.||+|.+++.. .+++.+..+.+++.|++.|++|||+ ++|+||||||+|||++.+ +++||+|||
T Consensus 95 ~~ivmEy~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred EEEEEEecCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 9999999999999999843 3678889999999999999999997 899999999999999999 999999999
Q ss_pred CceecCCCCCceeeeecccccccCceecccCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR-VT-TKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK 822 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 822 (948)
++.... .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||++........ .+...+
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~------ki~~~~ 239 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR------KIRKGE 239 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH------HHhcCC
Confidence 999774 2223455678999999999999877 75 78999999999999999999999854332211 122222
Q ss_pred cccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 823 DSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..+...++ ..++..++.+|+..+|.+|+++.+|++
T Consensus 240 ~~~p~~~~------------S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 240 FKIPSYLL------------SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ccCCCCcC------------CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 22222221 235889999999999999999999983
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=382.50 Aligned_cols=269 Identities=29% Similarity=0.453 Sum_probs=218.0
Q ss_pred cCCcccceecccCceEEEEEEEc--CCc----EEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCce
Q 002238 593 NNFSEENILGRGGFGTVYKGELH--DGT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~--~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 666 (948)
.+.+..+.||+|+||.||+|... +|. .||||.++.. .+.++..+|.+|..+|+.++|||||+++|+|.+....
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 34566788999999999999865 343 4899988764 3677789999999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEE--GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
++++|||++|+|..+|++..-. ....++....+.++.|||+|+.||++ +++|||||.++|+||+....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999653111 13568999999999999999999997 899999999999999999999999999
Q ss_pred Ccee-cCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCc
Q 002238 745 LVRL-APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSK 822 (948)
Q Consensus 745 la~~-~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 822 (948)
||+. +............=..+|||||.+..+.++.|+|||||||+|||++| |..||......+....+. . .
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~--~-----g 920 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL--E-----G 920 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH--h-----C
Confidence 9993 33322222222223569999999999999999999999999999999 899998877655433221 0 1
Q ss_pred cccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCCCCC
Q 002238 823 DSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDQ 883 (948)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~~~~ 883 (948)
+ +++.. ..++..+.++|..||+.+|++||++..+++.+..+.....+.+-
T Consensus 921 g--------RL~~P---~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~ 970 (1025)
T KOG1095|consen 921 G--------RLDPP---SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIY 970 (1025)
T ss_pred C--------ccCCC---CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcc
Confidence 1 22222 23455688999999999999999999999999988876555443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=357.33 Aligned_cols=264 Identities=27% Similarity=0.444 Sum_probs=206.2
Q ss_pred hcCCcccceecccCceEEEEEEE------cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeC-
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG- 663 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~- 663 (948)
.++|++.++||+|+||.||+|.+ .+++.||||++... ........+.+|+.++..+ +||||++++++|...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 46789999999999999999974 23568999998753 2334456799999999999 899999999988764
Q ss_pred CceEEEEEecCCCChhHHHHhhhhc-------------------------------------------------------
Q 002238 664 NEKLLVFEYMPQGTLSRHIFNWAEE------------------------------------------------------- 688 (948)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 688 (948)
...++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4578999999999999988642110
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc-eeeeeccccc
Q 002238 689 --GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFG 765 (948)
Q Consensus 689 --~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~ 765 (948)
...++++.++.+++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++........ ......+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 01358889999999999999999997 89999999999999999999999999999855332221 1223346789
Q ss_pred ccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHH
Q 002238 766 YLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASIS 844 (948)
Q Consensus 766 y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (948)
|+|||++.+..++.++|||||||++|||++ |..||......+.. .. ... .+.. ... ......
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~--~~---~~~--~~~~-----~~~-----~~~~~~ 304 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF--CQ---RLK--DGTR-----MRA-----PENATP 304 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH--HH---HHh--cCCC-----CCC-----CCCCCH
Confidence 999999999999999999999999999997 99999865432211 11 111 1100 000 011234
Q ss_pred HHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 845 TVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 845 ~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
.+.+++.+|++.||++||++.++++.|+++.+
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 58899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=344.32 Aligned_cols=249 Identities=26% Similarity=0.435 Sum_probs=210.8
Q ss_pred cCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
..|+..+.||+|+||.||+|.. ++++.||+|++..+. ...+.+++++|+.++.+++++||.++++.+..+...+++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 4577778999999999999975 478999999998753 45567889999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+.||++.+.+.. ...+++..+.-|+.++..|+.|||+ .+.+|||||+.|||+..+|.+|++|||.+.....
T Consensus 92 y~~gGsv~~lL~~-----~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 92 YCGGGSVLDLLKS-----GNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HhcCcchhhhhcc-----CCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeec
Confidence 9999999998832 2444777777899999999999997 7999999999999999999999999999987766
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
.... ...++||+.|||||++....|+.|+||||+|++.+||.+|.+|+....+.....+ ..+...|
T Consensus 164 ~~~r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-------------Ipk~~PP 229 (467)
T KOG0201|consen 164 TVKR-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-------------IPKSAPP 229 (467)
T ss_pred hhhc-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------------ccCCCCC
Confidence 5433 3668899999999999988999999999999999999999999998776432211 2233333
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.++. .....+.+++..|++.+|+.||++.++++
T Consensus 230 ~L~~-----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 230 RLDG-----DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cccc-----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 3331 23345889999999999999999999887
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=351.62 Aligned_cols=250 Identities=25% Similarity=0.365 Sum_probs=211.6
Q ss_pred cCCcccceecccCceEEEEEEE-cCCcEEEEEEeecC-cCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAG-VISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.-|+.++-||+|+.|.|-.|++ .+|+.+|||++.+. .........+.+|+-+|+.+.|||++++++++.+..+.|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3478889999999999999986 58999999999775 334555678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|.|.+++.. .+++.+.++.+++.||+.|+.|+|. .+|+|||+||+|+|+|..+++||+|||||....
T Consensus 92 Eyv~gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EecCCchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 99999999999843 3689999999999999999999997 899999999999999999999999999999766
Q ss_pred CCCCceeeeecccccccCceecccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
.++ ...+-+|+|.|.|||++.+..| +.++||||.||+||.|+||+.||++.+-... .. ++......+..
T Consensus 164 ~gk--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~L---Ll---KV~~G~f~MPs-- 233 (786)
T KOG0588|consen 164 PGK--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVL---LL---KVQRGVFEMPS-- 233 (786)
T ss_pred CCc--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHH---HH---HHHcCcccCCC--
Confidence 554 4556689999999999999988 5799999999999999999999996543322 21 12222222211
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
....+..+|+.+|+..||++|.|++||.++-
T Consensus 234 -----------~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 234 -----------NISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred -----------cCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 1224588999999999999999999999864
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=346.98 Aligned_cols=241 Identities=29% Similarity=0.500 Sum_probs=201.8
Q ss_pred ccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCC
Q 002238 597 EENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676 (948)
Q Consensus 597 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 676 (948)
..+.||.|+.|.||+|+++ ++.||||+++. .-..+|+.|++|+||||+.+.|+|....-++||||||..|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 3578999999999999998 89999998752 2246788999999999999999999999999999999999
Q ss_pred ChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCce
Q 002238 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI 756 (948)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 756 (948)
-|...|+. ..++.-.....|..+||.|+.|||. +.|||||+|.-|||+..+..|||+|||-++...+. ..
T Consensus 198 qL~~VLka-----~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--ST 267 (904)
T KOG4721|consen 198 QLYEVLKA-----GRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--ST 267 (904)
T ss_pred cHHHHHhc-----cCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh--hh
Confidence 99999943 3677888889999999999999997 88999999999999999999999999998866543 23
Q ss_pred eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCc
Q 002238 757 ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLN 836 (948)
Q Consensus 757 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (948)
...++||..|||||++.+...++|+||||||||||||+||..||.+....... | -.....++-.+
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----w----GVGsNsL~Lpv------- 332 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----W----GVGSNSLHLPV------- 332 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE----E----eccCCcccccC-------
Confidence 44578999999999999999999999999999999999999999876543211 0 11122222111
Q ss_pred cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 837 EGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 837 ~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
...++..+.-|+++||+..|..||++.+|+.+|+-.
T Consensus 333 --PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 333 --PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred --cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 223456688999999999999999999999998543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=353.39 Aligned_cols=244 Identities=27% Similarity=0.409 Sum_probs=207.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 668 (948)
.++|...++||+|+||+|+.|..+ +++.+|||++++... ..++.+..+.|.+++... +||.++.++.++++.++.|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 467999999999999999999876 688999999988754 466778899999998888 59999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||||+.||++..+.+ ...+++.++.-+|..|+.||+|||+ ++||+||||.+|||||.+|.+||+||||++.
T Consensus 447 vmey~~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEecCCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccc
Confidence 999999999654442 2679999999999999999999997 9999999999999999999999999999995
Q ss_pred cCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
-.. .+....+++|||.|||||++.+..|+.++|.|||||+||||+.|..||.+.++++..+-+. ..+ .
T Consensus 518 ~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~------~d~-----~ 585 (694)
T KOG0694|consen 518 GMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV------NDE-----V 585 (694)
T ss_pred cCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh------cCC-----C
Confidence 432 2335677999999999999999999999999999999999999999999877665433221 111 1
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCCh
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDM 864 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~ 864 (948)
.++.....+.+.++++++..+|++|.-+
T Consensus 586 --------~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 --------RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --------CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1122234568899999999999999976
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=345.34 Aligned_cols=266 Identities=26% Similarity=0.438 Sum_probs=204.9
Q ss_pred hcCCcccceecccCceEEEEEEEcC-----------------CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCcee
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHD-----------------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 654 (948)
.++|++.+.||+|+||.||+|.+++ +..||+|++.... ......+|.+|++++.+++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 3578889999999999999997532 3469999987542 344467899999999999999999
Q ss_pred eEEeEEEeCCceEEEEEecCCCChhHHHHhhhh--------------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCe
Q 002238 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAE--------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 720 (948)
Q Consensus 655 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 720 (948)
++++++.+.+..++||||+++|+|.+++..... .....++|.++++++.|++.||+|||+ .+|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCc
Confidence 999999999999999999999999998854211 112357889999999999999999997 899
Q ss_pred eecCCCCccEEEcCCCCeEEeecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh--CC
Q 002238 721 IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT--GR 797 (948)
Q Consensus 721 vHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt--g~ 797 (948)
+||||||+|||++.++.+||+|||+++....... .......++..|+|||++.++.++.++||||||+++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999986543322 11223446789999999998899999999999999999987 56
Q ss_pred CCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 798 KALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 798 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
.||......+.. .................. ....+..+.+++.+||+.+|++||++.+|.+.|+
T Consensus 240 ~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 QPYGELTDEQVI---ENAGEFFRDQGRQVYLFR--------PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCcCCHHHHH---HHHHHHhhhccccccccC--------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 677765433221 111111111100000000 1122346889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.04 Aligned_cols=248 Identities=22% Similarity=0.393 Sum_probs=205.5
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
-.++|+.+++||+|+||.||.|+-+ +|+.+|+|++++... ...+.+.+..|-.+|....+|.||+++-.|++.+..||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999754 799999999987643 34556788999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||||++||++..+|.. ...+++..+..++.+++.|++-+|. .|+|||||||+|+|+|..|++||+||||+.-
T Consensus 219 iMEylPGGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEecCCccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccch
Confidence 9999999999999943 3678888889999999999999996 8999999999999999999999999999851
Q ss_pred cCC-----------------------CCCc-----------------------eeeeecccccccCceecccCCCCchhh
Q 002238 749 APE-----------------------GKGS-----------------------IETRIAGTFGYLAPEYAVTGRVTTKVD 782 (948)
Q Consensus 749 ~~~-----------------------~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D 782 (948)
... .... .....+|||.|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 110 0000 012357999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCchhhh-hHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCC
Q 002238 783 VFSFGVILMELITGRKALDESQPEESM-HLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQR 861 (948)
Q Consensus 783 v~s~Gv~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~R 861 (948)
.||+||++|||+.|-+||....+.+.. .++.|......+.+. ....+..++|.+|+. ||++|
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~----------------~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEV----------------DLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcC----------------cccHHHHHHHHHHhc-CHHHh
Confidence 999999999999999999998886653 344444433332211 111457899999999 99999
Q ss_pred CC
Q 002238 862 PD 863 (948)
Q Consensus 862 Pt 863 (948)
--
T Consensus 434 LG 435 (550)
T KOG0605|consen 434 LG 435 (550)
T ss_pred cC
Confidence 85
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=339.17 Aligned_cols=250 Identities=18% Similarity=0.314 Sum_probs=201.6
Q ss_pred cceecccCceEEEEEEEcCCcEEEEEEeecCcCChhh-HHHHHHHHHHHHhcCCCceeeEEeEEEe----CCceEEEEEe
Q 002238 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKG-LTEFKSEIAVLTKVRHRHLVALLGHCLD----GNEKLLVFEY 672 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~ 672 (948)
...||+|++|.||+|.+. |+.||||+++........ .+.+.+|++++++++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 367999999999999984 899999998765322222 4678899999999999999999999877 3467899999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++|+|.+++.. .+.++|..+++++.+++.|++|||+ ..+++||||||+||++++++.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 104 CTRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCCcHHHHHhh-----CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 999999999843 2468999999999999999999996 248889999999999999999999999998865332
Q ss_pred CCceeeeecccccccCceeccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 753 KGSIETRIAGTFGYLAPEYAVT--GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
. ....||..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+ ......
T Consensus 177 ~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i------~~~~~~------ 240 (283)
T PHA02988 177 P----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI------INKNNS------ 240 (283)
T ss_pred c----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HhcCCC------
Confidence 1 23458899999999976 68999999999999999999999999876543321111 100100
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
+.++ ...+..+.+++.+||+.||++||+++++++.|+.+..
T Consensus 241 ~~~~-----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 241 LKLP-----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCC-----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1111 1234468899999999999999999999999988753
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=310.88 Aligned_cols=251 Identities=27% Similarity=0.451 Sum_probs=211.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|++++.||+|-||.||.|+.+ ++-.||+|++.+.... ....+++.+|+++-..++||||+++++++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 467999999999999999999754 6788999999775432 33357899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
+||.++|++...|+. .....++......++.|+|.|+.|+|. ++||||||||+|+|++.++..|++|||.+...
T Consensus 101 lEya~~gel~k~L~~---~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQE---GRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEecCCchHHHHHHh---cccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 999999999999854 234678888999999999999999996 89999999999999999999999999998866
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
+.+ .....+||..|.|||...+..++...|+|++|++.||++.|.+||......+....+ ... + ..
T Consensus 175 p~~---kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI---~k~---~-----~~ 240 (281)
T KOG0580|consen 175 PSN---KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI---RKV---D-----LK 240 (281)
T ss_pred CCC---CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH---HHc---c-----cc
Confidence 533 456788999999999999999999999999999999999999999876644332222 221 1 11
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+|. ....+..++|.+|+..+|.+|....|+++.
T Consensus 241 ~p~--------~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 241 FPS--------TISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred CCc--------ccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 111 122358899999999999999999998875
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=344.40 Aligned_cols=269 Identities=21% Similarity=0.309 Sum_probs=206.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|++.+.||+|+||.||+|+.+ +++.||||++..........+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999875 68899999997654444456778899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|++++.+..+. .....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~~~~l~~~~-----~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLE-----EMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 99987775443 122468899999999999999999997 8999999999999999999999999999986644
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH--------hhcCcc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRR--------IHLSKD 823 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~ 823 (948)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..... ......
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 333333445789999999999998999999999999999999999999987554332221111100 000000
Q ss_pred ccccccCcccCCcc-----chHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 824 SFHKAIDPTIDLNE-----GILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 824 ~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.......+...... ........+.+++.+|++.||++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111111110000 00112346899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=337.25 Aligned_cols=257 Identities=23% Similarity=0.382 Sum_probs=205.8
Q ss_pred hcCCcccceecccCceEEEEEEEc----CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
.++|++.+.||+|+||.||+|.++ .+..||+|.++... .......+.+|+.++++++||||+++++++..++..+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 356888999999999999999763 35789999987642 3344567999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.++++|||.+.
T Consensus 83 lv~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 83 IVTEYMSNGALDSFLRK----HEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred EEEEeCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 99999999999998843 22468999999999999999999997 899999999999999999999999999876
Q ss_pred ecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 748 LAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
..............++..|+|||++.+..++.++|||||||++||+++ |+.||......+.... +. .. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~---~~-----~~-~~ 226 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA---VE-----DG-FR 226 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH---HH-----CC-CC
Confidence 433222111122345678999999999999999999999999999875 9999987654332111 11 00 00
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
... ....+..+.+++.+||+.+|.+||++.+|.+.|.++
T Consensus 227 ----~~~-----~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 ----LPA-----PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCC-----CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 000 112344688999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=340.23 Aligned_cols=252 Identities=28% Similarity=0.421 Sum_probs=201.2
Q ss_pred CcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 595 FSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
|+..+.||+|+||.||+|.. .+|+.||||.+...... ......+.+|++++++++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67789999999999999986 47999999998754322 23345678999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++|+|.+++.. .....+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.++|+|||++......
T Consensus 82 ~~~g~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 82 MNGGDLKFHIYN---MGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred cCCCcHHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 999999887743 223468999999999999999999997 89999999999999999999999999999875433
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (948)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. ....... ....
T Consensus 156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~--~~~~~~~----~~~~-- 225 (285)
T cd05631 156 E--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD--RRVKEDQ----EEYS-- 225 (285)
T ss_pred C--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH--HHhhccc----ccCC--
Confidence 2 2234569999999999999999999999999999999999999998755322111111 1110000 0001
Q ss_pred cCCccchHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 002238 833 IDLNEGILASISTVAELAGHCCAREPYQRPD-----MGHAVN 869 (948)
Q Consensus 833 ~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt-----~~ev~~ 869 (948)
.....++.+++.+|++.||.+||+ ++++++
T Consensus 226 -------~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 226 -------EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -------ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 112245889999999999999997 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.81 Aligned_cols=260 Identities=28% Similarity=0.409 Sum_probs=205.7
Q ss_pred HHhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCCh------------hhHHHHHHHHHHHHhcCCCceee
Q 002238 589 RNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG------------KGLTEFKSEIAVLTKVRHRHLVA 655 (948)
Q Consensus 589 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~H~niv~ 655 (948)
+...++|++.+.||+|.||.|-+|... +++.||||++.+..... ...+...+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345688999999999999999999754 78999999996542211 12357899999999999999999
Q ss_pred EEeEEEe--CCceEEEEEecCCCChhHHHHhhhhcCCCC-CCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE
Q 002238 656 LLGHCLD--GNEKLLVFEYMPQGTLSRHIFNWAEEGLKP-LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732 (948)
Q Consensus 656 l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill 732 (948)
++++..+ .+..|||+|||..|.+...- . .++ ++..++++++.+++.||+|||. ++||||||||+|+|+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~-d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl 243 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP-----P-DKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLL 243 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC-----C-CcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEE
Confidence 9999876 46789999999998874321 2 234 8999999999999999999997 899999999999999
Q ss_pred cCCCCeEEeecCCceecCCCCC----ceeeeecccccccCceecccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 002238 733 GDDMRAKVADFGLVRLAPEGKG----SIETRIAGTFGYLAPEYAVTGR----VTTKVDVFSFGVILMELITGRKALDESQ 804 (948)
Q Consensus 733 ~~~~~~kl~DfGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~Gv~l~elltg~~p~~~~~ 804 (948)
+++|+|||+|||.+..+..+.. ......+|||.|+|||...++. .+.+.||||+||.||.|+.|+.||.+..
T Consensus 244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 9999999999999886643321 1223478999999999987743 4678999999999999999999998765
Q ss_pred chhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 805 PEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 805 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
..+..+ +++...+...... +...++.+||++++..||++|.+..+|..+.+--
T Consensus 324 ~~~l~~----------------KIvn~pL~fP~~p-e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 324 ELELFD----------------KIVNDPLEFPENP-EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred HHHHHH----------------HHhcCcccCCCcc-cccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 443322 2222222222211 2334688999999999999999999998876544
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=350.82 Aligned_cols=262 Identities=26% Similarity=0.438 Sum_probs=205.9
Q ss_pred hcCCcccceecccCceEEEEEEE------cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCC
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 664 (948)
.++|+..+.||+|+||.||+|++ .++..||||+++... .....+.+.+|+++++.+ +||||++++++|.+++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 45788899999999999999964 245689999987542 234456789999999999 8999999999999999
Q ss_pred ceEEEEEecCCCChhHHHHhhhh---------------------------------------------------------
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAE--------------------------------------------------------- 687 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 687 (948)
..++||||+++|+|.++++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999998854210
Q ss_pred -------------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCC
Q 002238 688 -------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 754 (948)
Q Consensus 688 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~ 754 (948)
.....++|..+++++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 112357899999999999999999997 8999999999999999999999999999986543322
Q ss_pred c-eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcc
Q 002238 755 S-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832 (948)
Q Consensus 755 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (948)
. ......++..|+|||++.+..++.++|||||||++|||++ |..||........ ....... + ... ..+.
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~~~~~-----~-~~~-~~~~ 340 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYKMIKE-----G-YRM-LSPE 340 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHHHHHh-----C-ccC-CCCC
Confidence 1 1122345678999999999999999999999999999998 8889876543221 1111111 0 000 0010
Q ss_pred cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 833 IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 833 ~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
..+.++.+++.+|++.||++||++.+|++.|++.
T Consensus 341 --------~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 --------CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1134688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=350.49 Aligned_cols=263 Identities=26% Similarity=0.460 Sum_probs=206.4
Q ss_pred hcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCC
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 664 (948)
.++|++.+.||+|+||.||+|... ++..||||+++... .......+.+|+++++.+ +||||++++++|.+.+
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 357889999999999999999742 34579999987542 333456788999999999 8999999999999999
Q ss_pred ceEEEEEecCCCChhHHHHhhhh---------------------------------------------------------
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAE--------------------------------------------------------- 687 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 687 (948)
..++||||+++|+|.++++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999998854211
Q ss_pred --------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc-eee
Q 002238 688 --------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS-IET 758 (948)
Q Consensus 688 --------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~ 758 (948)
....++++.++++++.||+.||+|||+ ++|+||||||+|||+++++.++|+|||+++........ ...
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 011357889999999999999999997 89999999999999999999999999999865433221 112
Q ss_pred eecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCcc
Q 002238 759 RIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNE 837 (948)
Q Consensus 759 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (948)
...++..|+|||++.+..++.++|||||||++|||++ |+.||......... ..... . ... ...+.
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~--~~~~~-----~-~~~-~~~~~----- 338 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF--YKMVK-----R-GYQ-MSRPD----- 338 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH--HHHHH-----c-ccC-ccCCC-----
Confidence 2335678999999999999999999999999999997 99999765432211 11000 0 000 00010
Q ss_pred chHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhh
Q 002238 838 GILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875 (948)
Q Consensus 838 ~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~ 875 (948)
..+.++.+++.+|++.+|++||++.+|++.|+++.
T Consensus 339 ---~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 ---FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 11346889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=318.06 Aligned_cols=263 Identities=25% Similarity=0.338 Sum_probs=203.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCceEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNEKLLV 669 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv 669 (948)
+.|+..+.|++|+||.||+|+.+ +++.||+|+++-+.....-.-.-.+||.++.+++|||||.+-.+... -+..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 34677889999999999999864 78999999997653222112345799999999999999999887764 3568999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
||||+. +|...+.. -.+++...++..+..|+++|++|||. +.|+|||+|++|+|+.+.|.+||+|||+||.+
T Consensus 156 Me~~Eh-DLksl~d~----m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMET----MKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred HHHHHh-hHHHHHHh----ccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhh
Confidence 999976 88888854 23688999999999999999999997 89999999999999999999999999999988
Q ss_pred CCCCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
.+..- ..+..+-|.+|.|||.+.+. .|+++.|+||+||++.||+++++-|.+....+..+.+ +...-.+. +.
T Consensus 228 gsp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~I--f~llGtPt----e~ 300 (419)
T KOG0663|consen 228 GSPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKI--FKLLGTPS----EA 300 (419)
T ss_pred cCCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHH--HHHhCCCc----cc
Confidence 77532 35567789999999998874 6999999999999999999999999887655443333 22221111 11
Q ss_pred cCcccC---------Cccch----------HHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 829 IDPTID---------LNEGI----------LASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 829 ~~~~~~---------~~~~~----------~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+.|.+. ..... ......-.+++..++..||.+|-|+.|.++.
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 111110 00000 0012456789999999999999999998763
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=330.88 Aligned_cols=256 Identities=25% Similarity=0.469 Sum_probs=208.8
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.++|++.++||+|+||.||+|...+++.||+|.+... ....+.+.+|+.+++.++|+||+++++++.+++..++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 3578899999999999999999888899999987653 2335788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++|+|.++++. .....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++....
T Consensus 82 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 82 YMAKGSLLDFLKS---DEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cCCCCcHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 9999999998854 223568899999999999999999997 8999999999999999999999999999987654
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
..........++..|+|||++.+..++.++|||||||++|||++ |+.||......+.. ..+.. . .. .
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~~~-----~-~~---~ 223 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM---SALQR-----G-YR---M 223 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH---HHHHc-----C-CC---C
Confidence 33222233446778999999988889999999999999999998 99999765433221 11111 0 00 0
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
+.. ...+.++.+++.+|++.+|++||+++++.+.|+++
T Consensus 224 ~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 PRM------ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCC------CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 000 11234588999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=312.39 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=209.6
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.+.|++.+.||+|.|+.||++.. .+|+.+|+|.+........+.+++.+|+++.+.++|||||++.+.+.+....|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45677888999999999999965 47999999999877777778899999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC---CCCeEEeecCCce
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVADFGLVR 747 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~---~~~~kl~DfGla~ 747 (948)
|+|.|++|..-+-.. ..+++..+-..+.||+++|.|+|+ ++|||||+||.|+++.. ..-+||+|||+|.
T Consensus 90 e~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred ecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEE
Confidence 999999997555321 346677788899999999999997 89999999999999963 3369999999999
Q ss_pred ecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 748 LAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
... .+.....++|||+|||||++....|+..+|||+-||+||-|+.|.+||.+...... ..++.....++..
T Consensus 162 ~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl------ye~I~~g~yd~~~ 233 (355)
T KOG0033|consen 162 EVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------YEQIKAGAYDYPS 233 (355)
T ss_pred EeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH------HHHHhccccCCCC
Confidence 877 34466678899999999999999999999999999999999999999987543322 2222222222221
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
..+.....+..+|+++|+..||.+|.|+.|.+++
T Consensus 234 ---------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 234 ---------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ---------cccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 1122233457899999999999999999998774
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=344.29 Aligned_cols=265 Identities=23% Similarity=0.344 Sum_probs=206.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|++.+.||+|+||.||+|+.+ +|..||+|++.... .......+.+|++++++++||||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 368999999999999999999875 68899999987642 3344577999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ +.+|+||||||+||+++.++.++|+|||+++...
T Consensus 83 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 83 EHMDGGSLDQVLKE-----AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 99999999998843 2468899999999999999999997 3579999999999999999999999999987553
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcC-ccccc---
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS-KDSFH--- 826 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~--- 826 (948)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... ....... .....
T Consensus 156 ~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 229 (331)
T cd06649 156 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI---FGRPVVDGEEGEPHSI 229 (331)
T ss_pred cc---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---hcccccccccCCcccc
Confidence 32 22345699999999999999999999999999999999999999976543322111 1000000 00000
Q ss_pred ----------------------------cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 827 ----------------------------KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 827 ----------------------------~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+.+...............++.+++.+|++.||++||++.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 230 SPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred CcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000001133568999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=330.05 Aligned_cols=251 Identities=29% Similarity=0.458 Sum_probs=203.4
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
++|+..+.||+|+||.||+|.++++..+|+|.+.... ....++.+|++++++++||||+++++++.+++..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 4578889999999999999998888899999876532 2346789999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++|+|.++++. ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++.....
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 81 MENGCLLNYLRQ----RQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred CCCCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 999999988853 12468899999999999999999997 89999999999999999999999999998865433
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
.........++..|+|||++.+..++.++||||||+++|||++ |+.||......+. ...+.. .. ....+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~i~~---~~----~~~~~ 223 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEMISR---GF----RLYRP 223 (256)
T ss_pred ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHC---CC----CCCCC
Confidence 2222223345678999999988889999999999999999999 8999976543322 111111 00 00111
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
.. ....+.+++.+|++.+|++||+++++++.|
T Consensus 224 ~~--------~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 KL--------ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CC--------CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11 123588999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=341.01 Aligned_cols=246 Identities=24% Similarity=0.330 Sum_probs=201.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|++.+.||+|+||.||+|..+ +|+.||+|++..... .....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999875 689999999875322 2234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRN-----SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 99999999998843 2468899999999999999999997 899999999999999999999999999988654
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+......+.
T Consensus 153 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~------~i~~~~~~~~---- 218 (291)
T cd05612 153 DR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE------KILAGKLEFP---- 218 (291)
T ss_pred CC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhCCcCCC----
Confidence 32 223569999999999999899999999999999999999999998765433211 1111111111
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPD-----MGHAVN 869 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt-----~~ev~~ 869 (948)
. .....+.+++.+|++.||.+||+ +.++++
T Consensus 219 ~---------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 219 R---------HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred c---------cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 0 11235789999999999999995 666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=345.51 Aligned_cols=246 Identities=25% Similarity=0.386 Sum_probs=201.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|++.+.||+|+||.||+|+.+ +++.||||++..... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57888999999999999999875 689999999875422 2234567899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 98 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 98 EFVVGGELFTHLRK-----AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred cCCCCChHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 99999999998843 2467888899999999999999997 899999999999999999999999999998664
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+..+.+... .+......+..
T Consensus 170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~------~i~~~~~~~p~--- 236 (329)
T PTZ00263 170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE------KILAGRLKFPN--- 236 (329)
T ss_pred CCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHH------HHhcCCcCCCC---
Confidence 422 23579999999999999999999999999999999999999997755432211 11111111110
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPD-----MGHAVN 869 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt-----~~ev~~ 869 (948)
.....+.+++.+|++.||.+||+ +++++.
T Consensus 237 ----------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 237 ----------WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ----------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 01235789999999999999997 456554
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=347.02 Aligned_cols=255 Identities=25% Similarity=0.384 Sum_probs=206.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|++.+.||+|+||.||+|+.. +++.||||+++..... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999876 5899999999764322 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 99999999998843 2468899999999999999999997 899999999999999999999999999988554
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. .. ...+. .
T Consensus 153 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~---~~---~~~~~---~ 219 (333)
T cd05600 153 T----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK---YW---KETLQ---R 219 (333)
T ss_pred c----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH---hc---ccccc---C
Confidence 3 2234569999999999999999999999999999999999999998765543322111 00 00000 0
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+... ........++.+++.+|++.+|.+||++.+++++
T Consensus 220 ~~~~--~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 PVYD--DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCC--ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1000 0001223468899999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=333.86 Aligned_cols=259 Identities=29% Similarity=0.510 Sum_probs=207.6
Q ss_pred cCCcccceecccCceEEEEEEEcC------CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCce
Q 002238 593 NNFSEENILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 666 (948)
++|+..+.||+|+||.||+|.... ...||+|.+.... ......++.+|++++++++||||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 468888999999999999997642 2579999887542 334456799999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHhhhhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEG-----------LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 735 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~ 735 (948)
+++|||+++|+|.+++....... ...+++.+++.++.|++.||+|||+ .+++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCC
Confidence 99999999999999986532111 1468899999999999999999997 899999999999999999
Q ss_pred CCeEEeecCCceecCCCC-CceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHH
Q 002238 736 MRAKVADFGLVRLAPEGK-GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVT 813 (948)
Q Consensus 736 ~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~ 813 (948)
+.++|+|||+++...... ........+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~-- 238 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM-- 238 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--
Confidence 999999999998553322 122334457889999999998899999999999999999998 9999987654332111
Q ss_pred HHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHh
Q 002238 814 WFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873 (948)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~ 873 (948)
+.. ..... .....+.++.+++.+||+.+|.+||++++|++.|+.
T Consensus 239 -i~~-----~~~~~----------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 -IRS-----RQLLP----------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHc-----CCcCC----------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 110 00000 011234568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=321.67 Aligned_cols=253 Identities=25% Similarity=0.421 Sum_probs=214.2
Q ss_pred HhhcCCcccceecccCceEEEEEE-EcCCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
....+|++.+.||+|.||.|-+|. ...|+.||||.++++.. +.++.-.+.+|+++|..++||||+.++.+|...+...
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 345688899999999999999996 46899999999987644 4566778999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+||||..+|.|.+++.. .+.+++.++..++.||+.|+.|+|. ++++|||+|.+|||+|.++++||+|||++.
T Consensus 130 ivMEYaS~GeLYDYiSe-----r~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSN 201 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISE-----RGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSN 201 (668)
T ss_pred EEEEecCCccHHHHHHH-----hccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhh
Confidence 99999999999999933 3679999999999999999999994 999999999999999999999999999998
Q ss_pred ecCCCCCceeeeecccccccCceecccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 748 LAPEGKGSIETRIAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
.+.+.+ ..+.++|++-|.+||++.+..| ++.+|-||+||+||-|+.|..||++.+-. .++. ++. .+.+.
T Consensus 202 ly~~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lvr---QIs--~GaYr 271 (668)
T KOG0611|consen 202 LYADKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLVR---QIS--RGAYR 271 (668)
T ss_pred hhcccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHHH---Hhh--ccccc
Confidence 876654 4567899999999999999888 47899999999999999999999986532 2222 221 12111
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
.| ..++...-||++|+..+|++|.|+.+|..+-+
T Consensus 272 ---EP---------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 272 ---EP---------ETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ---CC---------CCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 11 22334668999999999999999999987653
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=334.45 Aligned_cols=267 Identities=24% Similarity=0.345 Sum_probs=201.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|+..+.||+|+||.||+|..+ +++.||+|+++... .......+.+|++++++++||||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 56889999999999999999865 68999999987542 22234567899999999999999999999999989999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++ +|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~~-~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 84 YLDS-DLKQYLDN----CGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred CCCc-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 9975 88887743 22457889999999999999999997 8999999999999999999999999999985443
Q ss_pred CCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc--------Cc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL--------SK 822 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~ 822 (948)
... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+....+........ ..
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 156 PTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred CCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 222 2233468999999998865 5689999999999999999999999987654443222211100000 00
Q ss_pred cccccccCcccCCc---cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 823 DSFHKAIDPTIDLN---EGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 823 ~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..+.....+..... ........++.+++.+|++.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00111111110000 000112345789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=342.62 Aligned_cols=243 Identities=26% Similarity=0.374 Sum_probs=197.4
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCC
Q 002238 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 676 (948)
+.||+|+||.||+|+.+ +|+.||||+++.... .......+.+|++++++++||||+++++++.+++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 789999999976432 2334567889999999999999999999999999999999999999
Q ss_pred ChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCce
Q 002238 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI 756 (948)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 756 (948)
+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~ 151 (323)
T cd05571 81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-AT 151 (323)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cc
Confidence 99888743 2568999999999999999999997 899999999999999999999999999987533222 22
Q ss_pred eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCc
Q 002238 757 ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLN 836 (948)
Q Consensus 757 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (948)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........... +......+ +
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~------~~~~~~~~--------p-- 215 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL------ILMEEIRF--------P-- 215 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH------HHcCCCCC--------C--
Confidence 3346799999999999999999999999999999999999999976543322111 11111001 0
Q ss_pred cchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 002238 837 EGILASISTVAELAGHCCAREPYQRP-----DMGHAVN 869 (948)
Q Consensus 837 ~~~~~~~~~l~~li~~c~~~~P~~RP-----t~~ev~~ 869 (948)
.....++.+++.+|++.||++|| ++.++++
T Consensus 216 ---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 ---RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred ---CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 11234588999999999999999 7887765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=334.50 Aligned_cols=267 Identities=23% Similarity=0.325 Sum_probs=199.3
Q ss_pred cCCcccceecccCceEEEEEEEc--CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc---CCCceeeEEeEEEe-----
Q 002238 593 NNFSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV---RHRHLVALLGHCLD----- 662 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~----- 662 (948)
++|++.+.||+|+||.||+|+.. +++.||||+++...........+.+|+++++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 46889999999999999999863 468899999876543333345667788877766 69999999999853
Q ss_pred CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEee
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~D 742 (948)
....++||||++ ++|.+++.. .....+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEcc
Confidence 345799999996 689888743 223458999999999999999999997 8999999999999999999999999
Q ss_pred cCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc
Q 002238 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK 822 (948)
Q Consensus 743 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 822 (948)
||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|++||......+....+........ .
T Consensus 154 fg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~-~ 230 (290)
T cd07862 154 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG-E 230 (290)
T ss_pred ccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC-h
Confidence 9999865433 223445689999999999888999999999999999999999999987665433221111000000 0
Q ss_pred ccccc-------ccCccc--CCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 823 DSFHK-------AIDPTI--DLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 823 ~~~~~-------~~~~~~--~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..+.. .+.+.. ............+.+++.+|++.||++||++.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 000000 000011122345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=344.15 Aligned_cols=264 Identities=26% Similarity=0.408 Sum_probs=208.0
Q ss_pred hcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCC
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGN 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 664 (948)
.++|.+.++||+|+||.||+|+.. .+..||||++.... .....+.+.+|+++++++. ||||++++++|.+..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 567889999999999999999753 23479999986542 3344578999999999995 999999999999999
Q ss_pred ceEEEEEecCCCChhHHHHhhhh---------------------------------------------------------
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAE--------------------------------------------------------- 687 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 687 (948)
..++||||+++|+|.++++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999998864211
Q ss_pred ----------------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEc
Q 002238 688 ----------------------------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 733 (948)
Q Consensus 688 ----------------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~ 733 (948)
.....+++.+++.++.|+++||+|||+ .+|+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence 012357889999999999999999997 8999999999999999
Q ss_pred CCCCeEEeecCCceecCCCCCc-eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhH
Q 002238 734 DDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHL 811 (948)
Q Consensus 734 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~ 811 (948)
.++.+||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||.........
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~-- 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF-- 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--
Confidence 9999999999999865432221 1223457789999999999999999999999999999997 99998764332211
Q ss_pred HHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 812 VTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
...+ .. . .. ... ....+..+.+++.+||+.+|++||++.+|.++|+++.+
T Consensus 350 ~~~~---~~-~--~~----~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 YNKI---KS-G--YR----MAK-----PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHH---hc-C--CC----CCC-----CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1100 00 0 00 000 01223568899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=320.89 Aligned_cols=272 Identities=25% Similarity=0.374 Sum_probs=209.9
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe-----C
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-----G 663 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~ 663 (948)
.+..+|...+.||+|+||.|..|..+ +|+.||||++..........++..+|+++++.++|+||+.+.+.+.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34566777899999999999999764 79999999998655566677889999999999999999999998765 3
Q ss_pred CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeec
Q 002238 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (948)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~Df 743 (948)
...|+|+|+| +-+|.+.++. .+.++...+..+++|+++||+|+|+ .+|+|||+||+|++++.+...||+||
T Consensus 99 ~DvYiV~elM-etDL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHc-----CccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccc
Confidence 4679999999 5688888843 2458899999999999999999998 89999999999999999999999999
Q ss_pred CCceecCCC-CCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh--
Q 002238 744 GLVRLAPEG-KGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH-- 819 (948)
Q Consensus 744 Gla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-- 819 (948)
|+|+..... .....+..+.|.+|.|||++.. ..|+.+.||||.||++.||++|++-|.+.+..+...++...-...
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 999976432 2223466788999999998865 579999999999999999999999998876544333332111000
Q ss_pred -----cCcccccccc-----CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 820 -----LSKDSFHKAI-----DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 820 -----~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.........+ .+..+...-.........+|+.+|+..||.+|+|++|++++
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000000 11111122222334568899999999999999999998874
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=336.47 Aligned_cols=258 Identities=28% Similarity=0.436 Sum_probs=216.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
..+....++||-|.||.||.|.|+ -.-.||||.++. +..+.++|.+|+.+|+.++|||+|+++|+|..+..+|||+
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE---DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT 342 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT 342 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhh---cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence 345566789999999999999987 357899999876 4556789999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
|||..|+|.++|+...+ ..++-...+.+|.||+.|++||.. +++||||+.++|+|+.++..|||+|||+++.+.
T Consensus 343 EfM~yGNLLdYLRecnr---~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNR---SEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred ecccCccHHHHHHHhch---hhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 99999999999976433 456666788999999999999995 899999999999999999999999999999887
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
.+........--.+.|.|||-+....++.|+|||+|||+|||+.| |..||.+.+-.+.+.+.+-..+
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR------------ 484 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR------------ 484 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc------------
Confidence 665433333334678999999999999999999999999999999 8889988765554444331111
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
++ ....++..+.+|++.||+++|.+||+++|+-+.++.+..
T Consensus 485 ---M~---~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 485 ---MD---GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred ---cc---CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 11 123455678999999999999999999999999988764
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.23 Aligned_cols=256 Identities=29% Similarity=0.453 Sum_probs=207.4
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.++|++.+.||+|+||.||+|...+++.||||.++... ...+++.+|+.++++++||||+++++++...+..++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 45788999999999999999998778899999987532 235678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.+++.. .....+++.++..++.|++.|++|||+ .+++||||||+||++++++.++|+|||+++....
T Consensus 82 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 82 LMKYGSLLEYLQG---GAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred cccCCcHHHHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999998854 123568999999999999999999997 8999999999999999999999999999986653
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
...........+..|+|||++.+..++.++||||||+++|||++ |+.||...........+ .. .... ..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~---~~----~~~~--~~- 225 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV---DQ----GYRM--PC- 225 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---Hc----CCCC--CC-
Confidence 32211222223468999999998899999999999999999999 99999765533221111 00 0000 00
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
.......+.+++.+|++.+|.+||++.++++.|+++
T Consensus 226 --------~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 226 --------PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred --------CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 011234688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=350.99 Aligned_cols=262 Identities=25% Similarity=0.360 Sum_probs=210.5
Q ss_pred hcCCcccceecccCceEEEEEEEcCC-cEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCceeeEEe-EEEe------
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDG-TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLG-HCLD------ 662 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~-~~~~------ 662 (948)
..++++.++|.+|||+.||.|....+ ..||+|++... +......+.+||++|++|+ |||||.+++ ....
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 35677889999999999999987655 99999999765 6777899999999999996 999999999 3321
Q ss_pred CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEee
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~D 742 (948)
..+++|.||||.||.|-+++..+.. ..|++.++++|+.++++|+++||.+ +.+|||||||.+|||++.++..||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 2467899999999999999976443 3499999999999999999999985 67899999999999999999999999
Q ss_pred cCCceecCCCC-Cce-------eeeecccccccCceec---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhH
Q 002238 743 FGLVRLAPEGK-GSI-------ETRIAGTFGYLAPEYA---VTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHL 811 (948)
Q Consensus 743 fGla~~~~~~~-~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~ 811 (948)
||.|.-..... ... .-....|+.|+|||++ .+...++|+||||+||+||-|+....||++......
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI--- 266 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI--- 266 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE---
Confidence 99987222111 100 1123579999999987 456789999999999999999999999987643221
Q ss_pred HHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCC
Q 002238 812 VTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKP 880 (948)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~ 880 (948)
+.....+.. .......|.+||+.|++++|.+||++.+|++.+.++.....+
T Consensus 267 -----------------lng~Y~~P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 267 -----------------LNGNYSFPP-FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred -----------------EeccccCCC-CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 111111111 124556799999999999999999999999999998765433
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=303.49 Aligned_cols=264 Identities=25% Similarity=0.365 Sum_probs=209.2
Q ss_pred hcCCcccceecccCceEEEEEE-EcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-----c
Q 002238 592 TNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-----E 665 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~ 665 (948)
.++|++.+.||+|||+-||.++ ..++..||+|++... ..++.+...+|++..++++|||++++++++..+. +
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 4689999999999999999997 567899999999765 3566788999999999999999999998876433 4
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGl 745 (948)
.|++++|...|+|.+.+... +.++..+++.+.++|+.+|++||++||+.. .+++||||||.|||+++++.+++.|||.
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~-k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERL-KIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred EEEEeehhccccHHHHHHHH-hhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence 89999999999999998664 334467999999999999999999999842 4699999999999999999999999998
Q ss_pred ceecCC---CCC-----ceeeeecccccccCceeccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHH
Q 002238 746 VRLAPE---GKG-----SIETRIAGTFGYLAPEYAVT---GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTW 814 (948)
Q Consensus 746 a~~~~~---~~~-----~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~ 814 (948)
++..+- +.. +.......|..|.|||.+.- ...++++|||||||+||+|+.|..||+.....
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-------- 247 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-------- 247 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc--------
Confidence 874431 111 11223457999999998853 45789999999999999999999999753221
Q ss_pred HHHhhcCcccccc-ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhh
Q 002238 815 FRRIHLSKDSFHK-AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875 (948)
Q Consensus 815 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~ 875 (948)
.+++.- ...+.+...... .....+.++++.|++.||.+||++.+++..+..+.
T Consensus 248 -------GgSlaLAv~n~q~s~P~~~-~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 -------GGSLALAVQNAQISIPNSS-RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -------CCeEEEeeeccccccCCCC-CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111211 111122211111 14567999999999999999999999999987764
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=327.86 Aligned_cols=250 Identities=33% Similarity=0.578 Sum_probs=195.0
Q ss_pred ccceecccCceEEEEEEEc-----CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 597 EENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 597 ~~~~lg~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
..+.||+|.||.||+|.++ .+..|+||.++.. ......+.|.+|++.+++++||||++++|++...+..++|||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccccccccccc
Confidence 4578999999999999876 3578999999552 344557899999999999999999999999998888999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++|+|.+++... ....+++.+++.|+.||++||+|||+ .+++|+||+++||++++++.+||+|||+++....
T Consensus 82 ~~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp --TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999999652 24678999999999999999999997 7899999999999999999999999999987632
Q ss_pred CCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 752 GKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 752 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
... .......+...|+|||.+....++.++||||||+++||+++ |+.||.+....+. .. .... .... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~---~~---~~~~-~~~~--~~ 226 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI---IE---KLKQ-GQRL--PI 226 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH---HH---HHHT-TEET--TS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc---cccc-cccc--ee
Confidence 221 12223456789999999999999999999999999999999 7899877644332 11 1111 1100 00
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
. ...+..+.+++..||+.+|++||++.++++.|
T Consensus 227 ~---------~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 P---------DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp B---------TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred c---------cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1 11234588999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.54 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=206.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.+|+..+.||+|+||.||+|..+ +++.||+|++... .....++.+|+++++.++||||+++++++..+...++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 45778899999999999999865 5889999998653 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.+++.. .....+++..++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~~~~L~~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 83 FMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred eCCCCcHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999998843 223568999999999999999999997 8999999999999999999999999999986654
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
..........++..|+|||++.+..++.++||||||+++|||++ |..||......+.... ... . . .
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~------~~~-~--~----~ 223 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL------LEK-G--Y----R 223 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH------HHC-C--C----C
Confidence 33222222334678999999999999999999999999999998 9999876543322111 110 0 0 0
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
+.. ....+..+.+++.+|++.+|++||++.++.+.|+.+
T Consensus 224 ~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MER-----PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCC-----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 011 112235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=354.41 Aligned_cols=259 Identities=24% Similarity=0.368 Sum_probs=208.7
Q ss_pred HhhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC----
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN---- 664 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 664 (948)
...++|++.+.||+|+||.||+|+. .+|+.||||++............+.+|+.++..++|+|++++.+.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457899999999999999999975 47999999999876556666778899999999999999999988765432
Q ss_pred ----ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEE
Q 002238 665 ----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 740 (948)
Q Consensus 665 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl 740 (948)
..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEE
Confidence 25799999999999999865332 23578999999999999999999997 89999999999999999999999
Q ss_pred eecCCceecCCCC-CceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh
Q 002238 741 ADFGLVRLAPEGK-GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH 819 (948)
Q Consensus 741 ~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 819 (948)
+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~------~~~~ 258 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM------HKTL 258 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHh
Confidence 9999998654322 12233467999999999999999999999999999999999999999865433221 1111
Q ss_pred cCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 820 LSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
... . ..+. .....++.+++.+|++.+|.+||++.+++++
T Consensus 259 ~~~--~-~~~~---------~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGR--Y-DPLP---------PSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCC--C-CCCC---------CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 100 0 0011 1123468899999999999999999999874
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.74 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=216.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc-eEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE-KLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lv~ 670 (948)
++|...+++|+|+||.++.++++ ++..||+|.+.....+....+....|+.++++++|||||.+.+.+.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999765 67899999998877677777788999999999999999999999999888 89999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
+|++||++.+.+... .+..+++.++++++.|++.|+.|||+ ..|+|||||+.||++++++.|+|+|||+|+...
T Consensus 84 ~Y~eGg~l~~~i~~~---k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ---KGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eecCCCCHHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 999999999999652 24678999999999999999999996 899999999999999999999999999999876
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
... .....++||+.||.||.+.+..|..|+||||+||++|||++-+++|...+.......+ -+ ....
T Consensus 158 ~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki---~~---------~~~~ 224 (426)
T KOG0589|consen 158 PED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKI---NR---------GLYS 224 (426)
T ss_pred Cch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHH---hh---------ccCC
Confidence 654 2455678999999999999999999999999999999999999999876644321111 11 1111
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
| .......++..+++.|++.+|+.||++.+++.+
T Consensus 225 P------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 P------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred C------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1 112334568899999999999999999999987
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=342.08 Aligned_cols=268 Identities=25% Similarity=0.384 Sum_probs=199.1
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-----ceE
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-----EKL 667 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 667 (948)
+|++.+.||+|+||.||+|... +|+.||||++............+.+|+++++.++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999864 7899999998754333444567899999999999999999999886432 479
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+||||++ ++|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELME-SDLHQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecCC-CCHHHHHHh-----cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 9999995 688887732 2468999999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCC--ceeeeecccccccCceeccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHH--------
Q 002238 748 LAPEGKG--SIETRIAGTFGYLAPEYAVT--GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWF-------- 815 (948)
Q Consensus 748 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~-------- 815 (948)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+...
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 5432221 12234579999999999866 67899999999999999999999999765432221111000
Q ss_pred -HHhhcC-ccccccccCcc--cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 816 -RRIHLS-KDSFHKAIDPT--IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 816 -~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
..+... ...+...+... .............+.+++.+|++.+|++||+++|+++.
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000 00000000000 00001111223457899999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=321.41 Aligned_cols=261 Identities=25% Similarity=0.391 Sum_probs=199.5
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC---c--eE
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN---E--KL 667 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---~--~~ 667 (948)
.|+..+++|.|+||.||+|... +++.||||++-.+. +.-.+|+++|+.+.|||||++.-++.... + ..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 4667899999999999999865 57999999875431 22357999999999999999998886432 2 25
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC-CCeEEeecCCc
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGLV 746 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~-~~~kl~DfGla 746 (948)
+|||||+. +|.+.++.+... ...++...+.-+..||.+||+|||+ .+|+||||||+|+|+|.+ |.+||||||.|
T Consensus 99 lVleymP~-tL~~~~r~~~~~-~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRA-NQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhc-CCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 89999976 999998765433 3566777788899999999999997 899999999999999965 89999999999
Q ss_pred eecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 747 RLAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
+....+... .....|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+....+. ++..+.-.-.+....
T Consensus 174 K~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 174 KVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEIIKVLGTPTRED 249 (364)
T ss_pred eeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHHHHhCCCCHHH
Confidence 987766543 44557899999999987 4799999999999999999999999988665443 232222222211111
Q ss_pred cccc--------CcccCCc----cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 826 HKAI--------DPTIDLN----EGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 826 ~~~~--------~~~~~~~----~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
...+ .|.+... ........+..+++.+++..+|.+|.++.|++.
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1111 1111111 122344567899999999999999999988875
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=344.58 Aligned_cols=261 Identities=20% Similarity=0.252 Sum_probs=198.3
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|++.+.||+|+||.||+|... +++.||+|+... ..+.+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 467999999999999999999864 789999996432 35688999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
|++. ++|.+++.. ...+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 163 e~~~-~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 163 PRYK-TDLYCYLAA-----KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred ecCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 9995 688777732 2468899999999999999999997 799999999999999999999999999997543
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh-----hhhHHHHHHHhhcCcccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEE-----SMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 825 (948)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+...+.........+
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 333223345679999999999999999999999999999999999998875432111 011111111100000000
Q ss_pred --------ccc---------cCcc-cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 826 --------HKA---------IDPT-IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 826 --------~~~---------~~~~-~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
... ..+. ..........+.++.+++.+|++.||.+|||+.|+++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 0000 0000111123457889999999999999999999986
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=338.12 Aligned_cols=242 Identities=26% Similarity=0.367 Sum_probs=195.0
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEeecCc-CChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCCCh
Q 002238 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 678 (948)
Q Consensus 601 lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 678 (948)
||+|+||.||+|... +++.||+|++.... ........+.+|+.++++++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999875 68899999987542 2334456788999999999999999999999999999999999999999
Q ss_pred hHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCceee
Q 002238 679 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET 758 (948)
Q Consensus 679 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 758 (948)
.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||+++...... ....
T Consensus 81 ~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 151 (312)
T cd05585 81 FHHLQR-----EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTN 151 (312)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccc
Confidence 988843 2468999999999999999999997 899999999999999999999999999988543322 2234
Q ss_pred eecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccc
Q 002238 759 RIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEG 838 (948)
Q Consensus 759 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (948)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ..........+. .
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~------~~~~~~~~~~~~----~------- 214 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM------YRKILQEPLRFP----D------- 214 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH------HHHHHcCCCCCC----C-------
Confidence 45799999999999999999999999999999999999999986543321 111111111111 1
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 839 ILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 839 ~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.....+.+++.+|++.||.+||++..+.+.
T Consensus 215 --~~~~~~~~li~~~L~~dp~~R~~~~~~~e~ 244 (312)
T cd05585 215 --GFDRDAKDLLIGLLSRDPTRRLGYNGAQEI 244 (312)
T ss_pred --cCCHHHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence 122457899999999999999875444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=333.95 Aligned_cols=259 Identities=25% Similarity=0.442 Sum_probs=215.2
Q ss_pred hhcCCcccceecccCceEEEEEEEc---CCc--EEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH---DGT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~---~g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 665 (948)
.++.....++||+|-||.||+|... .|+ .||||..+.+. .....+.|..|+.+|++++|||||+++|+|.+ ..
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 3455566788999999999999753 343 58889887653 45557899999999999999999999999975 57
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGl 745 (948)
.|+|||.++-|.|..+++. ....++..+...++.||+.||+|||+ ..+|||||.++|||+....-||++|||+
T Consensus 465 ~WivmEL~~~GELr~yLq~----nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQ----NKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred eeEEEecccchhHHHHHHh----ccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccch
Confidence 8999999999999999943 44678899999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
+|...+...+..+...-+..|||||.+.-.+++.++|||-|||++||++. |..||.+....+....++ ++
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE--------nG- 608 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE--------NG- 608 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec--------CC-
Confidence 99887766555554445779999999999999999999999999999988 999999876544321111 11
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
.+ ......++..+..++.+||+.+|.+||.+.++...|.++.+
T Consensus 609 ------eR---lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 609 ------ER---LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ------CC---CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 11 11223456778999999999999999999999999998875
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=341.59 Aligned_cols=247 Identities=23% Similarity=0.303 Sum_probs=200.8
Q ss_pred hcCCcccceecccCceEEEEEEEcC--CcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHD--GTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~--g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
.++|++.+.||+|+||.||+|.++. +..||+|++..... .....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568899999999999999998643 36899999865422 23345678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 109 v~Ey~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR-----NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 9999999999998843 2468899999999999999999997 8999999999999999999999999999986
Q ss_pred cCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+...... +......
T Consensus 181 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~------i~~~~~~---- 246 (340)
T PTZ00426 181 VDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK------ILEGIIY---- 246 (340)
T ss_pred cCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH------HhcCCCC----
Confidence 5432 2345799999999999998899999999999999999999999987654322111 1111100
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRP-----DMGHAVN 869 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RP-----t~~ev~~ 869 (948)
+.+. ....+.+++.+|++.+|++|+ +++++++
T Consensus 247 ~p~~---------~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 247 FPKF---------LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred CCCC---------CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 1111 123477999999999999995 7777765
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=342.78 Aligned_cols=248 Identities=25% Similarity=0.368 Sum_probs=193.7
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
+|+..+.||+|+||.||+|+.. +++.||||++.... .......+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 4556788999999999999865 68999999986532 334456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++|+|.+. ....+..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 154 ~~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 154 MDGGSLEGT---------HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred CCCCccccc---------ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 999998643 234567788999999999999997 89999999999999999999999999999865432
Q ss_pred CCceeeeecccccccCceeccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVT-----GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
.. ......||..|+|||++.. ...+.++|||||||++|||++|+.||......+.......+. ...
T Consensus 222 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~---~~~----- 292 (353)
T PLN00034 222 MD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC---MSQ----- 292 (353)
T ss_pred cc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---ccC-----
Confidence 21 2234569999999998743 234568999999999999999999997433222211111110 000
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.+. .......++.+++.+||+.+|++||++.|++++
T Consensus 293 --~~~-----~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 --PPE-----APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --CCC-----CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 011223458899999999999999999999873
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=325.30 Aligned_cols=257 Identities=24% Similarity=0.461 Sum_probs=206.9
Q ss_pred hcCCcccceecccCceEEEEEEEc----CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
.++|+..+.||+|+||.||+|.++ +...||||+++... ......+|.+|+.++++++||||+++++++.+.+..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 357889999999999999999874 24579999887542 3445677899999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+||||+++++|.+++.. ....+++.++++++.|++.|++|||+ .+|+||||||+||++++++.++|+|||+++
T Consensus 82 iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~ 154 (266)
T cd05033 82 IITEYMENGSLDKFLRE----NDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (266)
T ss_pred EEEEcCCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhh
Confidence 99999999999998843 22478999999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCc-eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 748 LAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 748 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+. ...+.. ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~---~~~~~~----~~~~ 227 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV---IKAVED----GYRL 227 (266)
T ss_pred cccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH---HHHHHc----CCCC
Confidence 76422221 1122335678999999998899999999999999999998 9999976543322 111110 0000
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
+. ....+..+.+++.+|++.+|++||++.+|++.|.++
T Consensus 228 -----~~------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 -----PP------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 011234588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=337.26 Aligned_cols=244 Identities=26% Similarity=0.373 Sum_probs=196.9
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCC
Q 002238 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 676 (948)
+.||+|+||.||+|..+ +|+.||+|+++.... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999864 689999999976432 2334567788999999999999999999999999999999999999
Q ss_pred ChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCce
Q 002238 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI 756 (948)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 756 (948)
+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 151 (323)
T cd05595 81 ELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-T 151 (323)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-c
Confidence 99887743 2468999999999999999999997 8999999999999999999999999999875322221 2
Q ss_pred eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCc
Q 002238 757 ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLN 836 (948)
Q Consensus 757 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (948)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ......+.
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~------~~~~~~~p---------- 215 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------LMEEIRFP---------- 215 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------hcCCCCCC----------
Confidence 23456999999999999999999999999999999999999999765543221111 11111110
Q ss_pred cchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHHH
Q 002238 837 EGILASISTVAELAGHCCAREPYQRP-----DMGHAVNV 870 (948)
Q Consensus 837 ~~~~~~~~~l~~li~~c~~~~P~~RP-----t~~ev~~~ 870 (948)
.....++.+++.+|++.||++|| ++.++++.
T Consensus 216 ---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 216 ---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred ---CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 11224578999999999999998 77777653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=338.41 Aligned_cols=202 Identities=24% Similarity=0.402 Sum_probs=176.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|++.+.||+|+||.||+|..+ ++..+|+|++.... .......+.+|++++++++||||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 368999999999999999999876 68899999887642 3344577999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ..+|+||||||+||+++.++.+||+|||++....
T Consensus 83 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 83 EHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 99999999998843 2468889999999999999999997 3579999999999999999999999999987543
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQ 804 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~ 804 (948)
.. ......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 156 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 156 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred hh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 32 1233568999999999998899999999999999999999999997644
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=325.73 Aligned_cols=252 Identities=27% Similarity=0.429 Sum_probs=203.0
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
++|+..+.||+|+||.||+|+++++..||||.+.... ....++.+|+.++++++||||+++++++.+....++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 4578889999999999999998777789999887532 2246789999999999999999999999988899999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++|+|.+++.. ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||.++.....
T Consensus 81 ~~~~~l~~~i~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 81 MSNGCLLNYLRE----HGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred CCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 999999998843 22368999999999999999999997 89999999999999999999999999998865443
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
.........++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+ .. .... ..+
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~------~~-~~~~---~~~ 223 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV------SQ-GLRL---YRP 223 (256)
T ss_pred ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH------hc-CCCC---CCC
Confidence 2222222345678999999988889999999999999999999 99999765543221111 11 0000 000
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
. .....+.+++.+||+.+|.+||++.++++.|+
T Consensus 224 ~--------~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 H--------LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred C--------CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0 11346889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=387.90 Aligned_cols=372 Identities=26% Similarity=0.407 Sum_probs=263.3
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (948)
.+++.|+|++|++++.+|..++++++|++|+|++|.+.+.+| .+.++++|++|+|++|.+++..|..+.++++|+.|+|
T Consensus 212 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 291 (968)
T PLN00113 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDL 291 (968)
T ss_pred CCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEEC
Confidence 478888888888888888888888888888888888887766 6888888888888888888877777888888888888
Q ss_pred cCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCccc-ccccceeccCCC-
Q 002238 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQN- 224 (948)
Q Consensus 147 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~~~~~~- 224 (948)
++|.+.+ .+|..+.++++|+.|++++|.+++.+|..+. .+++|+.|+|++|++.+.+|..+.. .+|+.|++.++.
T Consensus 292 s~n~l~~-~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~--~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l 368 (968)
T PLN00113 292 SDNSLSG-EIPELVIQLQNLEILHLFSNNFTGKIPVALT--SLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNL 368 (968)
T ss_pred cCCeecc-CCChhHcCCCCCcEEECCCCccCCcCChhHh--cCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCee
Confidence 8888876 6777777888888888888888877777776 6777777777777777777766543 334444443322
Q ss_pred --------------------CCCccCCCccccccCCCccEEEccCCcccccCC-CCCCCCCCcEEeccCCccccccchhh
Q 002238 225 --------------------GNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSL 283 (948)
Q Consensus 225 --------------------~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l 283 (948)
.|...+..+..+.++++|+.|+|++|++++.+| .+..+++|+.|+|++|.+++.+|..+
T Consensus 369 ~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 448 (968)
T PLN00113 369 TGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRK 448 (968)
T ss_pred EeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhh
Confidence 122223334445556666666666666665554 35556666666666666666666666
Q ss_pred hCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCcc
Q 002238 284 VKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWI 363 (948)
Q Consensus 284 ~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (948)
..+++|+.|+|++|++.|.+|......+|..+++.+|............+..+ ...+..++.......
T Consensus 449 ~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L------------~~L~Ls~N~l~~~~p 516 (968)
T PLN00113 449 WDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSEL------------MQLKLSENKLSGEIP 516 (968)
T ss_pred ccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhcc------------CEEECcCCcceeeCC
Confidence 66666666666666666666665555556566655554432221111111111 111222222111122
Q ss_pred ceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCCCC---Ccc
Q 002238 364 GVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSF---KSN 440 (948)
Q Consensus 364 ~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~~---~~~ 440 (948)
..+..+++|+.|+|++|.++|.+|..|+++++|+.|+|++|+++|.+|..+..+++|+.|++++|+++|.+|.. ...
T Consensus 517 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~ 596 (968)
T PLN00113 517 DELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAI 596 (968)
T ss_pred hHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhccc
Confidence 34556789999999999999999999999999999999999999999999999999999999999999999963 334
Q ss_pred cccccCCCCCCCCc
Q 002238 441 AIVNTDGNPDIGKE 454 (948)
Q Consensus 441 ~~~~~~gnp~~~~~ 454 (948)
....+.|||..|..
T Consensus 597 ~~~~~~~n~~lc~~ 610 (968)
T PLN00113 597 NASAVAGNIDLCGG 610 (968)
T ss_pred ChhhhcCCccccCC
Confidence 45567899999864
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=333.08 Aligned_cols=266 Identities=23% Similarity=0.345 Sum_probs=199.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|++.+.||+|+||.||+|+.+ +++.||||++.... .......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE-EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccc-ccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 468999999999999999999875 68999999987542 2223356788999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||++ ++|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 83 EYVH-TDLCQYMDK----HPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred ECCC-cCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 9995 677777632 23568889999999999999999997 899999999999999999999999999987543
Q ss_pred CCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcC--cccccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS--KDSFHK 827 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 827 (948)
.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..+... ....+...... ...+..
T Consensus 155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 155 VPSH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred CCCc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccc
Confidence 3221 2233568999999999865 4588999999999999999999999987543211 11111111000 000000
Q ss_pred -----ccCcc-cC--Cccc------hHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 828 -----AIDPT-ID--LNEG------ILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 828 -----~~~~~-~~--~~~~------~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..++. .. .... .......+.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 00 0000 0011245779999999999999999999976
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=352.39 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=203.6
Q ss_pred CCcccceecccCceEEEEEEEc-C-CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 594 NFSEENILGRGGFGTVYKGELH-D-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.|.+.+.||+|+||.||+|... + ++.||+|.+... .......+.+|+++++.++|||||++++++..++..++|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 3888999999999999999754 4 678899976543 33445678889999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++|+|.++++.... ...++++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 146 ~~~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred CCCCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 9999999998865322 23578999999999999999999997 8999999999999999999999999999986644
Q ss_pred CCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 752 GKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ...... . +
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~------~~~~~~--~----~ 289 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ------QVLYGK--Y----D 289 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhCC--C----C
Confidence 322 22344679999999999999999999999999999999999999997654332211 111100 0 0
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+ . .......+.+++.+|++.+|++||++.+++.
T Consensus 290 ~-~-----~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 P-F-----PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred C-C-----CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0 0 0112245889999999999999999999875
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=325.29 Aligned_cols=263 Identities=24% Similarity=0.393 Sum_probs=210.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCc-CChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|++.+.||+|+||.||+|+.. +++.||||.+.... ........+.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999864 78999999886532 23444567899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++..... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 99999999988854322 23568889999999999999999997 899999999999999999999999999988654
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
.... ......|++.|+|||++.+..++.++||||||+++|||++|+.||....... .... ..... ...
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~---~~~~~-------~~~ 225 (267)
T cd08228 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLC---QKIEQ-------CDY 225 (267)
T ss_pred chhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHH---HHHhc-------CCC
Confidence 4321 1223458899999999988889999999999999999999999996543211 1111 11111 001
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~ 875 (948)
+... .......+.+++.+||+.+|++||++.+|++.++++.
T Consensus 226 ~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 PPLP----TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCC----hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1111 1122356889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=323.67 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=202.3
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
.+|++.+.||+|+||.||+|.++++..+|+|.+.... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 3577889999999999999998877899999986532 2335788999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++++|.+++.. ....+++..++.++.|++.|++|||+ .+++||||||+||++++++.+||+|||+++...+.
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 81 MANGCLLNYLRE----RKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred CCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 999999998853 12468999999999999999999997 89999999999999999999999999998865433
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
.........++..|+|||++.+..++.++||||||+++||+++ |+.||....+.+.... ... ....
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~------~~~-------~~~~ 220 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES------VSA-------GYRL 220 (256)
T ss_pred cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH------HHc-------CCcC
Confidence 2221222234568999999999999999999999999999999 8999976544322111 110 0000
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
... ...+.++.+++.+|++.+|++||++.++++.|
T Consensus 221 ~~~-----~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 YRP-----KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCC-----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 000 11344689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=337.15 Aligned_cols=244 Identities=25% Similarity=0.364 Sum_probs=197.8
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCC
Q 002238 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 676 (948)
+.||+|+||.||++..+ +|+.||||++..... .......+.+|+++++.++||||+++++++.+++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 689999999976432 2344567889999999999999999999999999999999999999
Q ss_pred ChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCce
Q 002238 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI 756 (948)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 756 (948)
+|.+++.. ...+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 151 (328)
T cd05593 81 ELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-AT 151 (328)
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cc
Confidence 99887743 2468999999999999999999997 899999999999999999999999999987543222 12
Q ss_pred eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCc
Q 002238 757 ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLN 836 (948)
Q Consensus 757 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (948)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ........ +..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~------~~~~~~~~----~p~----- 216 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE------LILMEDIK----FPR----- 216 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHH------HhccCCcc----CCC-----
Confidence 234579999999999999999999999999999999999999997654332211 11111100 111
Q ss_pred cchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHHH
Q 002238 837 EGILASISTVAELAGHCCAREPYQRP-----DMGHAVNV 870 (948)
Q Consensus 837 ~~~~~~~~~l~~li~~c~~~~P~~RP-----t~~ev~~~ 870 (948)
....++.+++.+|++.||.+|| ++.+++++
T Consensus 217 ----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 ----TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1224578999999999999997 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=324.79 Aligned_cols=259 Identities=27% Similarity=0.433 Sum_probs=202.0
Q ss_pred CcccceecccCceEEEEEEEcC-Cc--EEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC------Cc
Q 002238 595 FSEENILGRGGFGTVYKGELHD-GT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------NE 665 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~ 665 (948)
|.+.+.||+|+||.||+|.+.+ ++ .||||.++.........+.+.+|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999998753 33 699999876544556678899999999999999999999987532 24
Q ss_pred eEEEEEecCCCChhHHHHhhh-hcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWA-EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
.++||||+++|+|.+++.... ......+++.++..++.|++.||+|||+ ++|+||||||+||++++++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874321 1223458999999999999999999997 899999999999999999999999999
Q ss_pred CceecCCCCCce-eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCc
Q 002238 745 LVRLAPEGKGSI-ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSK 822 (948)
Q Consensus 745 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 822 (948)
+++......... .....+++.|+|||+..+..++.++||||||+++|||++ |+.||......+.. . .... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~---~~~~-~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY---D---YLRQ-G 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H---HHHc-C
Confidence 998654432211 122346778999999999999999999999999999999 88999765432211 1 1111 0
Q ss_pred cccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 823 DSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
... . . .......+.+++.+|++.+|++||++.++++.|+++
T Consensus 231 ~~~-~-~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRL-K-Q---------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC-C-C---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 0 0 012234588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.42 Aligned_cols=270 Identities=24% Similarity=0.333 Sum_probs=204.9
Q ss_pred cCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCc-eeeEEeEEEeCC------
Q 002238 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH-LVALLGHCLDGN------ 664 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~------ 664 (948)
..|...++||+|+||+||+|+. .+|+.||+|++......+.......+|+.+++.++|+| ||++.+++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4466677799999999999975 47899999999875433233456789999999999999 999999998877
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
..++|+||++ -+|.+++....... ..++...+..++.|+++||+|||+ ++|+||||||+|||++++|.+||+|||
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccc
Confidence 6789999995 49998885533221 356668899999999999999997 899999999999999999999999999
Q ss_pred CceecCCCCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc-
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK- 822 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 822 (948)
+|+...-... ..+..++|..|.|||++.+. .|+...||||+||+++||++++.-|.+..+.+....+ .+-.-.+.
T Consensus 166 lAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~I--f~~lGtP~e 242 (323)
T KOG0594|consen 166 LARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRI--FRLLGTPNE 242 (323)
T ss_pred hHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHH--HHHcCCCCc
Confidence 9996543332 24556789999999999887 7999999999999999999999999887764433222 22211111
Q ss_pred ccccccc---CcccCC--c----cchH---HHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 823 DSFHKAI---DPTIDL--N----EGIL---ASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 823 ~~~~~~~---~~~~~~--~----~~~~---~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
..+.... +-.... . .... .......+++.+|++.+|.+|.+++.++++
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111111 111000 0 0001 111357899999999999999999998875
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=334.05 Aligned_cols=257 Identities=27% Similarity=0.433 Sum_probs=203.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCc----EEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
.+|+..+.||+|+||.||+|++. +++ .||||+++.. ......+++.+|+.+++.++||||++++|+|... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 46899999999999999999864 344 3899998643 2344567899999999999999999999999764 568
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+|+||+++|+|.+++.. ....+++..++.++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++
T Consensus 85 ~v~e~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 85 LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeeecCCCCCHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccc
Confidence 99999999999998853 22468899999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCcee-eeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 748 LAPEGKGSIE-TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 748 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
.......... ....++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+.... .. . ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~---~~---~-~~~~ 230 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LE---K-GERL 230 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---Hh---C-CCCC
Confidence 6654332211 12234678999999999999999999999999999998 9999986543322111 11 0 1000
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
..+ ......+.+++.+|++.+|++||++.+++..+..+..
T Consensus 231 ---~~~--------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 231 ---PQP--------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred ---CCC--------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 000 1122458899999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=327.40 Aligned_cols=262 Identities=29% Similarity=0.491 Sum_probs=208.4
Q ss_pred hcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 665 (948)
.++|.+.+.||+|+||.||++... ++..+|+|.+... .......+.+|++++++++||||+++++++...+.
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 357888999999999999999742 3456899988653 34456789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHhhhh--------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAE--------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 737 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~ 737 (948)
.++||||+++++|.+++..... .....+++.+++.++.|++.||+|||+ ++++||||||+||++++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 9999999999999999864221 112358999999999999999999997 89999999999999999999
Q ss_pred eEEeecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHH
Q 002238 738 AKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWF 815 (948)
Q Consensus 738 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 815 (948)
++|+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||......+....
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~---- 234 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC---- 234 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----
Confidence 99999999885433221 11223345788999999998899999999999999999998 9999977654332111
Q ss_pred HHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 816 RRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
... +.... .. .....++.+++.+|++.+|.+||++.++.+.|+.+.+
T Consensus 235 --i~~--~~~~~-----~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 235 --ITQ--GRVLQ-----RP-----RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred --HHc--CCcCC-----CC-----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 111 11000 00 0122458999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=324.05 Aligned_cols=255 Identities=31% Similarity=0.501 Sum_probs=204.8
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.++|++.+.||+|+||.||+|++++...||+|+++.... ..+++.+|++++++++||||+++++++. ....++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 80 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence 356899999999999999999887777899999875322 3457899999999999999999998874 456799999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++|+|.+++.. .....+++..++.++.|+++||+|||+ .+++||||||+||++++++.++|+|||.++....
T Consensus 81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 81 YMSKGSLLDFLKG---EMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred cCCCCcHHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 9999999999853 223467999999999999999999997 8999999999999999999999999999986644
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
..........++..|+|||+..+..++.++||||||+++|||++ |..||......+..... .. . .....
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~------~~-~--~~~~~- 224 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV------ER-G--YRMPC- 224 (262)
T ss_pred cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH------hc-C--CCCCC-
Confidence 33222223446778999999988899999999999999999999 88888765443221111 00 0 00000
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
....+..+.+++.+|++.+|++||+++++.+.|++.
T Consensus 225 --------~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 225 --------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --------ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 112334688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=327.11 Aligned_cols=257 Identities=30% Similarity=0.488 Sum_probs=210.0
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
...+|+..+.||+|+||.||+|..++++.+|+|++... ......++.+|+.+++.++||||+++++++.+.+..++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 34578889999999999999999888999999998764 3334567899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++++|.+++.. .....+++.+++.++.|++.|++|||+ .+++||||||+||++++++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 82 ELMEKGSLLAFLRS---PEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred eecccCCHHHHHhc---CCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 99999999999854 223568999999999999999999997 899999999999999999999999999998654
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
..... .....++..|+|||++.+..++.++||||||+++|+|++ |+.||......+..... .. . ..
T Consensus 156 ~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~---~~----~--~~--- 222 (261)
T cd05148 156 EDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI---TA----G--YR--- 222 (261)
T ss_pred Ccccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH---Hh----C--Cc---
Confidence 43221 223346778999999988899999999999999999998 89999765533322111 10 0 00
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
... ....+..+.+++.+|++.+|.+||+++++++.|+.+
T Consensus 223 -~~~-----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 -MPC-----PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -CCC-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 000 112234588999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=321.52 Aligned_cols=254 Identities=28% Similarity=0.458 Sum_probs=205.8
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.++|++.++||+|+||.||+|..++++.||+|.+.... ....++.+|+.++++++|||++++++++ ..+..++|||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITE 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEE
Confidence 46788999999999999999998889999999987543 2346789999999999999999999886 4567899999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.+++.. .....+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 81 YMENGSLVDFLKT---PEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cCCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 9999999998843 233578999999999999999999996 8999999999999999999999999999986653
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
..........++..|+|||++.+..++.++||||||+++||+++ |+.||......+.... ... . ..
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~~~-----~-~~---- 221 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN---LER-----G-YR---- 221 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH---HHc-----C-CC----
Confidence 32222223446788999999998899999999999999999999 9999986554322111 110 0 00
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~ 873 (948)
... . ...+.++.+++.+|++.+|++||+++++.+.|+.
T Consensus 222 ~~~--~---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 MPR--P---DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCC--C---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 000 0 1123468999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=328.14 Aligned_cols=254 Identities=28% Similarity=0.422 Sum_probs=201.4
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.|+..+.||+|+||.||++... +++.||||++...... ......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999864 6899999998754322 2234567889999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++|+|.+++.. .....+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++....
T Consensus 81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYN---MGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 9999999988743 223568999999999999999999997 8999999999999999999999999999986543
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
... .....|++.|+|||++.+..++.++||||+||++|||++|+.||...........+. ....... ..+
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~--~~~~~~~----~~~-- 224 (285)
T cd05605 155 GET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE--RRVKEDQ----EEY-- 224 (285)
T ss_pred CCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH--HHhhhcc----ccc--
Confidence 321 233468999999999998899999999999999999999999998654322211111 1110000 000
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHHH
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRP-----DMGHAVNV 870 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RP-----t~~ev~~~ 870 (948)
.......+.+++.+|++.||++|| ++++++++
T Consensus 225 -------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 225 -------SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -------CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111234588999999999999999 66676553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=321.82 Aligned_cols=254 Identities=31% Similarity=0.500 Sum_probs=203.9
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.++|++.+.||+|+||.||+|..+++..||+|.+..... ..+.+.+|+.++++++|+|++++++++. ....++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 357888999999999999999988888999999876432 2467899999999999999999999875 456899999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.++++. .....+++.+++.++.|++.||+|||+ .+++||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 81 YMSKGSLLDFLKD---GEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred ecCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 9999999998854 223468999999999999999999997 8999999999999999999999999999986544
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
..........++..|+|||++.+..++.++||||||+++|||++ |..||.+....+.. ..... .. .
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~---~~~~~----~~------~ 221 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL---EQVER----GY------R 221 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHHc----CC------C
Confidence 32222222345678999999988899999999999999999999 89999765433221 11110 00 0
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~ 873 (948)
... .......+.+++.+|++.+|++||++.++.+.|++
T Consensus 222 ~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPC-----PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCC-----CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 000 11223468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=325.83 Aligned_cols=261 Identities=26% Similarity=0.434 Sum_probs=205.3
Q ss_pred hhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN 664 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 664 (948)
+.++|+..+.||+|+||.||+|.++ ++..||||++.... ......++.+|+.+++.++||||+++++++.++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4678999999999999999999753 25679999886432 2344567899999999999999999999999999
Q ss_pred ceEEEEEecCCCChhHHHHhhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeE
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEE-----GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 739 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~k 739 (948)
..++||||+++|+|.+++...... ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEE
Confidence 999999999999999998642111 12346889999999999999999997 8999999999999999999999
Q ss_pred EeecCCceecCCCCCce-eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHH
Q 002238 740 VADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRR 817 (948)
Q Consensus 740 l~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 817 (948)
|+|||+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~----- 234 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV----- 234 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-----
Confidence 99999987543322211 112345788999999998899999999999999999999 78898765543221111
Q ss_pred hhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHh
Q 002238 818 IHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873 (948)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~ 873 (948)
. ...... . . ...+..+.+++.+|++.+|++||++.|+++.|++
T Consensus 235 -~--~~~~~~-----~--~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 -M--EGGLLD-----K--P---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -H--cCCcCC-----C--C---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 0 110000 0 0 1123468899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=342.16 Aligned_cols=254 Identities=25% Similarity=0.369 Sum_probs=198.6
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.|+..+.||+|+||+||+|+.. +++.||||++..... .......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999764 689999999976432 23445778999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 82 YIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred cCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 9999999998843 2468888999999999999999997 8999999999999999999999999999753211
Q ss_pred CCC----------------------------------------------ceeeeecccccccCceecccCCCCchhhHHH
Q 002238 752 GKG----------------------------------------------SIETRIAGTFGYLAPEYAVTGRVTTKVDVFS 785 (948)
Q Consensus 752 ~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 785 (948)
... .......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 000 0012357999999999999989999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHH--hcccCCCCCCC
Q 002238 786 FGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGH--CCAREPYQRPD 863 (948)
Q Consensus 786 ~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--c~~~~P~~RPt 863 (948)
|||++|||++|+.||....+.+....+ ........ +.+. .....++.+++.+ |...+|..||+
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i------~~~~~~~~--~~~~-------~~~s~~~~dli~~ll~~~~~~~~R~~ 298 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKV------INWENTLH--IPPQ-------VKLSPEAVDLITKLCCSAEERLGRNG 298 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHH------HccccccC--CCCC-------CCCCHHHHHHHHHHccCcccccCCCC
Confidence 999999999999999876543321111 00000000 0000 0112357788887 55566667999
Q ss_pred hHHHHHH
Q 002238 864 MGHAVNV 870 (948)
Q Consensus 864 ~~ev~~~ 870 (948)
+.+++++
T Consensus 299 ~~~~l~h 305 (381)
T cd05626 299 ADDIKAH 305 (381)
T ss_pred HHHHhcC
Confidence 9999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=342.29 Aligned_cols=254 Identities=24% Similarity=0.331 Sum_probs=203.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|++.+.||+|+||.||+|+.+ +|+.||||+++.... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999865 789999999986532 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 81 EYQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 999999999988542 2468999999999999999999997 899999999999999999999999999998765
Q ss_pred CCCCceeeeecccccccCceecc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAV------TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
...........||+.|+|||++. ...++.++|||||||++|||++|+.||.......... .+.....
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~------~i~~~~~- 226 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN------NIMNFQR- 226 (330)
T ss_pred CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH------HHHcCCC-
Confidence 54433334457999999999986 4567899999999999999999999998765433211 1111000
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.....+ .......+.+++..|++ +|.+||++.+++.
T Consensus 227 ~~~~~~--------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 FLKFPE--------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ccCCCC--------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 000000 01123457899999998 9999999998865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.70 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=198.5
Q ss_pred CCcccceecccCceEEEEEEE----cCCcEEEEEEeecCcC--ChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCce
Q 002238 594 NFSEENILGRGGFGTVYKGEL----HDGTKIAVKRMEAGVI--SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 666 (948)
+|++.+.||+|+||.||+++. .+++.||+|++..... .....+.+..|+.+++.+ +||||+++++++.+++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999975 3588999999875322 123345688999999999 599999999999999999
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCc
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla 746 (948)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 81 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 999999999999988843 2468899999999999999999997 89999999999999999999999999999
Q ss_pred eecCCCCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 747 RLAPEGKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
+..............||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+ .......
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~~~---- 226 (332)
T cd05614 153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRILKC---- 226 (332)
T ss_pred ccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHhcC----
Confidence 86544333333456799999999998765 4789999999999999999999999754322211111 1111110
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRP-----DMGHAVN 869 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RP-----t~~ev~~ 869 (948)
++.+. ......+.+++.+|++.||++|| +++++++
T Consensus 227 ----~~~~~-----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 ----DPPFP-----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ----CCCCC-----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11111 11224578999999999999999 5556655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=326.51 Aligned_cols=258 Identities=29% Similarity=0.506 Sum_probs=206.5
Q ss_pred cCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCce
Q 002238 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 666 (948)
++|.+.+.||+|+||.||+|... +++.||||.++... .....+.+.+|+++++.++||||+++++++..+...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 46788899999999999999764 24789999987542 233457899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHhhh---------hcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCC
Q 002238 667 LLVFEYMPQGTLSRHIFNWA---------EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 737 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~ 737 (948)
++||||+++++|.+++.... ......+++.++..++.|++.|++|||+ .+++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 99999999999999986531 1123458899999999999999999997 89999999999999999999
Q ss_pred eEEeecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHH
Q 002238 738 AKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWF 815 (948)
Q Consensus 738 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 815 (948)
++|+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||......+. ...+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH
Confidence 99999999875432221 11233446789999999999999999999999999999999 9999976554332 1111
Q ss_pred HHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 816 RRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
. .+... ... ...+..+.+++.+||+.+|++||++.||++.|+
T Consensus 238 ~-----~~~~~-~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 T-----QGRLL-QRP---------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H-----cCCcC-CCC---------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 11110 000 122346889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=340.64 Aligned_cols=260 Identities=22% Similarity=0.277 Sum_probs=202.3
Q ss_pred HHHHhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC
Q 002238 587 VLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN 664 (948)
Q Consensus 587 ~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 664 (948)
.+....++|++.+.||+|+||.||+|+.+ +++.||+|++.+... .......+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34444678999999999999999999875 688999999865321 2334456889999999999999999999999999
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG 187 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFG 187 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecc
Confidence 99999999999999998843 357888899999999999999997 899999999999999999999999999
Q ss_pred CceecCCCCCceeeeecccccccCceecccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVTG----RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL 820 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 820 (948)
+++..............||+.|+|||++.+. .++.++||||+||++|||++|+.||......... ..+..
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~------~~i~~ 261 (370)
T cd05621 188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY------SKIMD 261 (370)
T ss_pred cceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH------HHHHh
Confidence 9986643332223356799999999998754 3788999999999999999999999875543221 11111
Q ss_pred CccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCC--CCChHHHHHH
Q 002238 821 SKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQ--RPDMGHAVNV 870 (948)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~--RPt~~ev~~~ 870 (948)
....+. +... ......+.+++..|++.++.+ ||++.+++++
T Consensus 262 ~~~~~~--~p~~-------~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 262 HKNSLN--FPED-------VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCcccC--CCCc-------ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 111000 0000 111234778899999765544 8899888774
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=322.59 Aligned_cols=259 Identities=28% Similarity=0.457 Sum_probs=205.5
Q ss_pred CcccceecccCceEEEEEEEc-C---CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc-----
Q 002238 595 FSEENILGRGGFGTVYKGELH-D---GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE----- 665 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 665 (948)
|++.+.||+|+||.||+|.+. + +..||||+++...........+.+|+++++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999864 2 3689999988654455556789999999999999999999998876554
Q ss_pred -eEEEEEecCCCChhHHHHhhhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeec
Q 002238 666 -KLLVFEYMPQGTLSRHIFNWAE-EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (948)
Q Consensus 666 -~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~Df 743 (948)
.++||||+++|+|.+++..... .....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 6999999999999998865321 123468999999999999999999997 89999999999999999999999999
Q ss_pred CCceecCCCCCce-eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcC
Q 002238 744 GLVRLAPEGKGSI-ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLS 821 (948)
Q Consensus 744 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 821 (948)
|+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.+....+. ......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~---~~~~~~---- 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI---YDYLRH---- 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHc----
Confidence 9998654332211 112335678999999988899999999999999999999 8899976543322 111111
Q ss_pred ccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 822 KDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
... ... .......+.+++.+|++.||.+||++.++++.|+++
T Consensus 231 -~~~-----~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 -GNR-----LKQ-----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -CCC-----CCC-----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 000 112334688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=334.57 Aligned_cols=264 Identities=27% Similarity=0.457 Sum_probs=205.6
Q ss_pred hcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeC-
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG- 663 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~- 663 (948)
.++|++.+.||+|+||.||+|... +++.||+|+++... .....+.+.+|+.++.++ +||||++++++|...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 357899999999999999999642 35789999987532 334456788999999999 899999999988654
Q ss_pred CceEEEEEecCCCChhHHHHhhhhc-------------------------------------------------------
Q 002238 664 NEKLLVFEYMPQGTLSRHIFNWAEE------------------------------------------------------- 688 (948)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 688 (948)
...+++|||+++++|.+++......
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5678999999999999888532110
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCce-eeeecccccc
Q 002238 689 -GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI-ETRIAGTFGY 766 (948)
Q Consensus 689 -~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y 766 (948)
....++|..+.+++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||+++......... .....++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 01368999999999999999999997 899999999999999999999999999998654322211 2234467789
Q ss_pred cCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHH
Q 002238 767 LAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASIST 845 (948)
Q Consensus 767 ~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (948)
+|||++.+..++.++|||||||++|||++ |..||......+. ...... .. .....+ .....+
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~~~~-----~~-~~~~~~---------~~~~~~ 304 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCRRLK-----EG-TRMRAP---------EYATPE 304 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHHHHh-----cc-CCCCCC---------ccCCHH
Confidence 99999999999999999999999999998 9999976443221 111110 00 000000 112245
Q ss_pred HHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 846 VAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 846 l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
+.+++.+|++.+|++||++.|++++|+++.+
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=325.66 Aligned_cols=261 Identities=28% Similarity=0.448 Sum_probs=206.7
Q ss_pred CCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 594 NFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
+|++.+.||+|+||.||+|... ....+|+|.+.... ......++.+|+.+++.++||||+++++++..++..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 4778899999999999999753 23578999886542 3344578999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHHhhhh-------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCc
Q 002238 668 LVFEYMPQGTLSRHIFNWAE-------------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 728 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~ 728 (948)
+||||+.+|+|.+++..... .....+++.+++.++.|++.||+|||+ .+++||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhh
Confidence 99999999999998854211 112458899999999999999999997 89999999999
Q ss_pred cEEEcCCCCeEEeecCCceecCCCCCc-eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCch
Q 002238 729 NILLGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPE 806 (948)
Q Consensus 729 Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~ 806 (948)
||++++++.++|+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||....+.
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999998854332221 1222345778999999988899999999999999999999 99999766543
Q ss_pred hhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 807 ESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 807 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
+..... .. . . ....+ .....++.+++.+|++.+|.+||+++++++.|+++..
T Consensus 237 ~~~~~~---~~-----~-~----~~~~~-----~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 RLFNLL---KT-----G-Y----RMERP-----ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHH---hC-----C-C----CCCCC-----CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 322111 10 0 0 00000 1122458899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=344.49 Aligned_cols=256 Identities=22% Similarity=0.282 Sum_probs=202.7
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
..++|++.+.||+|+||.||+|+.+ +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3567999999999999999999875 689999999875322 22334567899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||||+++|+|.+++.. ..++...+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 121 v~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 121 VMEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 9999999999998843 347778888999999999999997 8999999999999999999999999999986
Q ss_pred cCCCCCceeeeecccccccCceecccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYAVTG----RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
.............||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... .+......
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~------~i~~~~~~ 265 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS------KIMDHKNS 265 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHH------HHHcCCCc
Confidence 543322223345799999999998653 47899999999999999999999998755432211 11111110
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCC--CCChHHHHHH
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQ--RPDMGHAVNV 870 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~--RPt~~ev~~~ 870 (948)
+. +.. ......++.+++.+|++.+|.+ ||++.+++++
T Consensus 266 ~~--~~~-------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 LT--FPD-------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CC--CCC-------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00 000 0112345889999999999988 9999998775
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=342.18 Aligned_cols=254 Identities=25% Similarity=0.373 Sum_probs=205.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|++.+.||+|+||.||+|+.. +|+.||||++...... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47889999999999999999875 7899999999764322 244567899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 81 EYMPGGDLMNLLIR-----KDVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred cCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 99999999998853 1578899999999999999999997 899999999999999999999999999998654
Q ss_pred CCC----------------------------CceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 002238 751 EGK----------------------------GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDE 802 (948)
Q Consensus 751 ~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~ 802 (948)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 432 1122345699999999999999999999999999999999999999987
Q ss_pred CCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCC-hHHHHHH
Q 002238 803 SQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPD-MGHAVNV 870 (948)
Q Consensus 803 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt-~~ev~~~ 870 (948)
....+....+ ........ + +. . ......+.+++.+|+. +|.+||+ +.++++.
T Consensus 233 ~~~~~~~~~i------~~~~~~~~--~-p~---~---~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 233 DTLQETYNKI------INWKESLR--F-PP---D---PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCHHHHHHHH------hccCCccc--C-CC---C---CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 6643321111 11000000 0 00 0 0023458899999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=338.90 Aligned_cols=207 Identities=24% Similarity=0.422 Sum_probs=177.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|+..+.||+|+||+||+|... +++.||||++..... .......+.+|+.++..++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999865 689999999975422 2333467889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999998843 2578999999999999999999997 899999999999999999999999999987442
Q ss_pred CCCC----------------------------------ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhC
Q 002238 751 EGKG----------------------------------SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG 796 (948)
Q Consensus 751 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg 796 (948)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 2110 011235799999999999999999999999999999999999
Q ss_pred CCCCCCCCchh
Q 002238 797 RKALDESQPEE 807 (948)
Q Consensus 797 ~~p~~~~~~~~ 807 (948)
+.||....+.+
T Consensus 233 ~~Pf~~~~~~~ 243 (363)
T cd05628 233 YPPFCSETPQE 243 (363)
T ss_pred CCCCCCCCHHH
Confidence 99998765443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=325.99 Aligned_cols=259 Identities=26% Similarity=0.471 Sum_probs=204.6
Q ss_pred cCCcccceecccCceEEEEEEE-----cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 593 NNFSEENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
++|++.+.||+|+||.||+|.+ .++..||+|.+.... .......+.+|+++++.++||||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 4577889999999999999974 246789999987532 3444578999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHHhhhh------------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC
Q 002238 668 LVFEYMPQGTLSRHIFNWAE------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 735 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~ 735 (948)
+||||+++++|.+++..... .....+++.+++.++.|++.||+|||+ ++++||||||+||+++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCC
Confidence 99999999999998853110 112357899999999999999999997 899999999999999999
Q ss_pred CCeEEeecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHH
Q 002238 736 MRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVT 813 (948)
Q Consensus 736 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~ 813 (948)
+.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||.+..+......+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~- 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV- 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-
Confidence 9999999999985533221 12233446778999999988889999999999999999998 99999765433221111
Q ss_pred HHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHh
Q 002238 814 WFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873 (948)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~ 873 (948)
.. .. .. . .....+..+.+++.+|++.+|++||++.+|.++|..
T Consensus 240 --~~----~~-~~-------~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 --RK----RQ-LL-------P---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --Hc----CC-cC-------C---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11 00 00 0 001123468899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=341.78 Aligned_cols=254 Identities=22% Similarity=0.396 Sum_probs=200.8
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|++.+.||+|+||.||+|+.. +|+.||||++..... .......+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999875 689999999975422 2334466889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++|+|||+++...
T Consensus 81 E~~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMK-----KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999998843 2468999999999999999999997 899999999999999999999999999987543
Q ss_pred CCCCc-------------------------------------eeeeecccccccCceecccCCCCchhhHHHHHHHHHHH
Q 002238 751 EGKGS-------------------------------------IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMEL 793 (948)
Q Consensus 751 ~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el 793 (948)
..... .....+||+.|+|||++.+..++.++|||||||++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 21100 01124699999999999999999999999999999999
Q ss_pred HhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCC---hHHHHHH
Q 002238 794 ITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPD---MGHAVNV 870 (948)
Q Consensus 794 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt---~~ev~~~ 870 (948)
++|..||....+.+.... +......+. +... ......+.+++.+|+. +|.+|++ +.+++++
T Consensus 233 ~~G~~Pf~~~~~~~~~~~------i~~~~~~~~--~~~~-------~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 233 LVGYPPFCSDNPQETYRK------IINWKETLQ--FPDE-------VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred hcCCCCCCCCCHHHHHHH------HHcCCCccC--CCCC-------CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999999987654332111 111011000 0000 0112357789999996 9999998 7777663
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=347.34 Aligned_cols=254 Identities=24% Similarity=0.350 Sum_probs=197.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|++.+.||+|+||.||+|+.. +++.||||++..... .......+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999864 689999999865322 2233567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.++|+|||++....
T Consensus 81 E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 81 DYIPGGDMMSLLIR-----LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence 99999999999843 2467888889999999999999997 899999999999999999999999999975221
Q ss_pred CCC------------------------------------------CceeeeecccccccCceecccCCCCchhhHHHHHH
Q 002238 751 EGK------------------------------------------GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGV 788 (948)
Q Consensus 751 ~~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv 788 (948)
... ........||+.|+|||++.+..++.++|||||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 232 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence 000 00012357999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCC---ChH
Q 002238 789 ILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRP---DMG 865 (948)
Q Consensus 789 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RP---t~~ 865 (948)
++|||++|+.||....+.+....+ ........ + +. ......++.+++.+|+ .+|.+|+ ++.
T Consensus 233 ilyell~G~~Pf~~~~~~~~~~~i------~~~~~~~~--~-~~------~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ 296 (376)
T cd05598 233 ILYEMLVGQPPFLADTPAETQLKV------INWETTLH--I-PS------QAKLSREASDLILRLC-CGAEDRLGKNGAD 296 (376)
T ss_pred eeeehhhCCCCCCCCCHHHHHHHH------hccCcccc--C-CC------CCCCCHHHHHHHHHHh-cCHhhcCCCCCHH
Confidence 999999999999876654322111 10000000 0 00 0012234677888876 5999999 778
Q ss_pred HHHHH
Q 002238 866 HAVNV 870 (948)
Q Consensus 866 ev~~~ 870 (948)
++++.
T Consensus 297 ell~h 301 (376)
T cd05598 297 EIKAH 301 (376)
T ss_pred HHhCC
Confidence 88764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=334.00 Aligned_cols=242 Identities=28% Similarity=0.401 Sum_probs=193.0
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHH---HhcCCCceeeEEeEEEeCCceEEE
Q 002238 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVL---TKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
|++.+.||+|+||.||+|..+ +++.||||+++.... .....+.+.+|++++ +.++||||+++++++.+++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 667889999999999999865 689999999976432 223345677776665 466899999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++|+|..++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999877632 468999999999999999999997 89999999999999999999999999998743
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +......+
T Consensus 152 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~------i~~~~~~~---- 220 (324)
T cd05589 152 MGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS------IVNDEVRY---- 220 (324)
T ss_pred CCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhCCCCC----
Confidence 3222 223446799999999999999999999999999999999999999987654332111 11111100
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMG 865 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ 865 (948)
.. .....+.+++.+|++.||.+||+++
T Consensus 221 p~---------~~~~~~~~li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 221 PR---------FLSREAISIMRRLLRRNPERRLGSG 247 (324)
T ss_pred CC---------CCCHHHHHHHHHHhhcCHhHcCCCC
Confidence 01 1224578999999999999999543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=331.71 Aligned_cols=240 Identities=27% Similarity=0.416 Sum_probs=191.6
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEEEEEecCC
Q 002238 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 675 (948)
+.||+|+||.||+|+.+ +++.||||+++.... .....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 678999999976432 223345566777777654 899999999999999999999999999
Q ss_pred CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc
Q 002238 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (948)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 755 (948)
|+|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~ 151 (316)
T cd05592 81 GDLMFHIQS-----SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-G 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-C
Confidence 999888743 2468889999999999999999997 899999999999999999999999999998543322 2
Q ss_pred eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCC
Q 002238 756 IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDL 835 (948)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (948)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +...... ++.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~------i~~~~~~----~~~---- 217 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS------ILNDRPH----FPR---- 217 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH------HHcCCCC----CCC----
Confidence 33446799999999999999999999999999999999999999987654332111 1110100 111
Q ss_pred ccchHHHHHHHHHHHHHhcccCCCCCCChHH
Q 002238 836 NEGILASISTVAELAGHCCAREPYQRPDMGH 866 (948)
Q Consensus 836 ~~~~~~~~~~l~~li~~c~~~~P~~RPt~~e 866 (948)
....++.+++.+|++.+|.+||++.+
T Consensus 218 -----~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 218 -----WISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred -----CCCHHHHHHHHHHccCCHHHcCCChH
Confidence 12235789999999999999999853
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=325.80 Aligned_cols=261 Identities=29% Similarity=0.480 Sum_probs=208.3
Q ss_pred cCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCce
Q 002238 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 666 (948)
.+|...+.||+|+||.||+|+.. ++..+++|.+... .....+.+.+|++++++++||||+++++++..++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 45778899999999999999742 3456899987643 334456789999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHhhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC
Q 002238 667 LLVFEYMPQGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 735 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~ 735 (948)
++||||+++++|.+++..... .....+++..++.++.|++.|++|||+ ++++||||||+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccC
Confidence 999999999999999864211 112458999999999999999999997 899999999999999999
Q ss_pred CCeEEeecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHH
Q 002238 736 MRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVT 813 (948)
Q Consensus 736 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~ 813 (948)
+.++|+|||+++....... .......++..|+|||++.+..++.++||||||+++|||+| |+.||......+.. .
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~ 236 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI---E 236 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H
Confidence 9999999999875433221 12233456789999999999999999999999999999999 99999776543321 1
Q ss_pred HHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 814 WFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
.. . ....... ....+..+.+++.+|++.+|.+||++.+|++.|+++.+
T Consensus 237 ~~---~--~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 CI---T--QGRVLER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HH---h--CCCCCCC----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11 0 1111000 01123468899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=333.47 Aligned_cols=243 Identities=26% Similarity=0.436 Sum_probs=195.3
Q ss_pred ceecccCceEEEEEEE----cCCcEEEEEEeecCcC--ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 599 NILGRGGFGTVYKGEL----HDGTKIAVKRMEAGVI--SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
+.||+|+||.||+++. .+++.||||+++.... .......+..|+++++.++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 3578999999875421 223345678999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++|+|.+++.. ...+.+..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 999999988843 2467888889999999999999997 89999999999999999999999999998754332
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (948)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+...... +.+.
T Consensus 154 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~------~~~~~~~~~----~~~~ 222 (323)
T cd05584 154 G-TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI------DKILKGKLN----LPPY 222 (323)
T ss_pred C-CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH------HHHHcCCCC----CCCC
Confidence 2 1233456999999999999888999999999999999999999999875543211 111111111 1111
Q ss_pred cCCccchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 002238 833 IDLNEGILASISTVAELAGHCCAREPYQRP-----DMGHAVN 869 (948)
Q Consensus 833 ~~~~~~~~~~~~~l~~li~~c~~~~P~~RP-----t~~ev~~ 869 (948)
....+.+++.+|++.+|++|| ++.++++
T Consensus 223 ---------~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 223 ---------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ---------CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 123578999999999999999 7777766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=299.70 Aligned_cols=256 Identities=29% Similarity=0.409 Sum_probs=208.2
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChh------hHHHHHHHHHHHHhc-CCCceeeEEeEEE
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGK------GLTEFKSEIAVLTKV-RHRHLVALLGHCL 661 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l-~H~niv~l~~~~~ 661 (948)
..-++|...+.||.|..+.|.++..+ +|.++|+|++........ -.+.-.+|+.+++++ .||+|+++.+++.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34467888899999999999999764 789999999865432211 124456799999999 7999999999999
Q ss_pred eCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEe
Q 002238 662 DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 741 (948)
Q Consensus 662 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~ 741 (948)
.+...++|+|.|+.|.|.+++.. .-.+++++..+|+.|+.+|++|||. .+|||||+||+|||++++.+++|+
T Consensus 94 s~sF~FlVFdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEe
Confidence 99999999999999999999943 3578999999999999999999997 899999999999999999999999
Q ss_pred ecCCceecCCCCCceeeeecccccccCceeccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHH
Q 002238 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT------GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWF 815 (948)
Q Consensus 742 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~ 815 (948)
|||+|+....+. .....+|||+|+|||.+.- ..|+...|+||.||++|-|+.|.+||..... .-..
T Consensus 166 DFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ------mlML 237 (411)
T KOG0599|consen 166 DFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ------MLML 237 (411)
T ss_pred ccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH------HHHH
Confidence 999999877654 4566899999999999853 4688999999999999999999999975321 1122
Q ss_pred HHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 816 RRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+.+...+..+. ...+.+...+..+||.+|++.||.+|.|++|++.+
T Consensus 238 R~ImeGkyqF~---------speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 238 RMIMEGKYQFR---------SPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHhcccccC---------CcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 23333333221 12233344568899999999999999999999874
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=339.62 Aligned_cols=265 Identities=24% Similarity=0.352 Sum_probs=201.6
Q ss_pred CCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-----ceE
Q 002238 594 NFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-----EKL 667 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 667 (948)
+|++.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999986 47899999998654333445577899999999999999999999998776 789
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+||||+. ++|.+.+.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEecccccee
Confidence 9999996 577776632 3578999999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHH-----------
Q 002238 748 LAPEGKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWF----------- 815 (948)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~----------- 815 (948)
..............+|+.|+|||++.+. .++.++|||||||++|||++|+.||....+.+....+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 6544333333445689999999998774 4799999999999999999999999876654332222110
Q ss_pred -----HHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 816 -----RRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 816 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.................. ........++.+++.+|++.||++||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLY---TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhc---ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000000000000 0001123468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.44 Aligned_cols=253 Identities=30% Similarity=0.499 Sum_probs=203.1
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
++|.+.+.||+|+||.||+|..+++..||+|.+.... ...+.+.+|++++++++|||++++++++. .+..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 4688889999999999999998877789999876532 23467889999999999999999998875 4567999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++++|.++++. .....+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++.....
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 82 MGKGSLLDFLKE---GDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred CCCCCHHHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 999999998854 223458999999999999999999997 89999999999999999999999999999865443
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
.........++..|+|||+..+..++.++||||||+++|||++ |+.||.+..+.+.. .+... . .. .
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~~~----~--~~----~ 222 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL---EQVER----G--YR----M 222 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHc----C--CC----C
Confidence 3222223346788999999998899999999999999999999 89999875543221 11110 0 00 0
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHh
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~ 873 (948)
.. ....+..+.+++.+|++.+|++||++.++++.|++
T Consensus 223 ~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PC-----PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CC-----CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00 01223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=319.55 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=198.2
Q ss_pred eecccCceEEEEEEEc---CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCC
Q 002238 600 ILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676 (948)
Q Consensus 600 ~lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 676 (948)
.||+|+||.||+|.++ ++..+|+|+++.........+++..|+.+++.++||||+++++++. ++..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 5789999998765444455678999999999999999999999875 45678999999999
Q ss_pred ChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCce
Q 002238 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI 756 (948)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 756 (948)
+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||++++++.++|+|||+++.........
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQK-----NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 99998843 2468899999999999999999997 899999999999999999999999999998654433211
Q ss_pred --eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCccc
Q 002238 757 --ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTI 833 (948)
Q Consensus 757 --~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (948)
.....++..|+|||.+....++.++||||||+++|||++ |+.||......+....+ .. ... +..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i---~~-----~~~-----~~~ 219 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI---ES-----GER-----MEC 219 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HC-----CCC-----CCC
Confidence 112234678999999988889999999999999999998 99999875543321111 11 000 001
Q ss_pred CCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 834 DLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 834 ~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
+ ...+.++.+++.+|++.+|++||++.+|++.|+..
T Consensus 220 ~-----~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 220 P-----QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred C-----CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 0 11234688999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=325.59 Aligned_cols=249 Identities=27% Similarity=0.383 Sum_probs=195.7
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCCCh
Q 002238 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 678 (948)
Q Consensus 601 lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 678 (948)
||+|+||+||++..+ +|+.||||++...... ....+.+..|+++++.++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 7899999998754322 22346678899999999999999999999999999999999999999
Q ss_pred hHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCceee
Q 002238 679 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET 758 (948)
Q Consensus 679 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 758 (948)
.+++.... .....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 155 (280)
T cd05608 81 RYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTK 155 (280)
T ss_pred HHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccc
Confidence 88875422 223568999999999999999999997 8999999999999999999999999999986544332 223
Q ss_pred eecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccc
Q 002238 759 RIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEG 838 (948)
Q Consensus 759 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (948)
...||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ....... ..... .
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~----------~~~~~---~ 220 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRIL----------NDSVT---Y 220 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HHHHhhc----------ccCCC---C
Confidence 4568999999999999999999999999999999999999997643221110 1011110 00000 0
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 002238 839 ILASISTVAELAGHCCAREPYQRP-----DMGHAVN 869 (948)
Q Consensus 839 ~~~~~~~l~~li~~c~~~~P~~RP-----t~~ev~~ 869 (948)
.......+.+++.+|++.||++|| +++++++
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 112234588999999999999999 5555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=333.56 Aligned_cols=247 Identities=27% Similarity=0.418 Sum_probs=202.6
Q ss_pred CCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 594 NFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.|...+.||.|+||.||-|+. ++.+.||||++.-... +.....++.+|+.++++++|||+|.+-|||..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 355667799999999999975 4789999999975432 23346789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
||- |+-.+++. .-.+++...++..|..+.+.||+|||+ .+.||||||+.|||+++.|.|||+|||.|.....
T Consensus 107 YCl-GSAsDlle----VhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 107 YCL-GSASDLLE----VHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHh-ccHHHHHH----HHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 994 57777773 234788999999999999999999998 8999999999999999999999999999886644
Q ss_pred CCCceeeeecccccccCceecc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAV---TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
...++|||.|||||++. .+.|+-|+||||+|+.+.||.-+++|+...+.....+-+. ..
T Consensus 179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA-------------QN 240 (948)
T KOG0577|consen 179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-------------QN 240 (948)
T ss_pred -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH-------------hc
Confidence 34578999999999985 4789999999999999999999999998776543322221 11
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
-.|.+. ..+....+.+++..|++.-|.+|||.+++++.
T Consensus 241 esPtLq----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 241 ESPTLQ----SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCCC----CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 123333 11233468899999999999999999988763
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=323.17 Aligned_cols=257 Identities=27% Similarity=0.454 Sum_probs=202.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCc----EEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
++|++.+.||+|+||.||+|.+. +++ .|++|.+... .......++..|+.++++++||||+++++++. +...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 46788899999999999999864 454 4777776532 12334567888999999999999999999875 45678
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+|+||+++|+|.+++.. ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++
T Consensus 85 ~i~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQ----HRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred EEEEeCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccce
Confidence 99999999999999853 23568999999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCc-eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 748 LAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 748 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
........ ......++..|+|||++.++.++.++||||||+++||+++ |+.||.+..+......+ . .+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~---~-----~~~- 228 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL---E-----KGE- 228 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---H-----CCC-
Confidence 65433221 2233457789999999998999999999999999999998 99999876543321111 1 110
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
....+.. ....+.+++.+|+..+|++||++.|+.+.|..+.+
T Consensus 229 -~~~~~~~--------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 229 -RLAQPQI--------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -cCCCCCC--------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0011111 12357889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=311.42 Aligned_cols=273 Identities=22% Similarity=0.322 Sum_probs=225.6
Q ss_pred eeHHHHHHhhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeE
Q 002238 583 ISIQVLRNVTNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656 (948)
Q Consensus 583 ~~~~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 656 (948)
...+++....++++...++-+|.||.||+|.|. +.+.|-||.++.. .++.+...+..|..++..+.|||+..+
T Consensus 274 ~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 274 RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred hhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccce
Confidence 345677777888999999999999999999764 3456788887653 356667889999999999999999999
Q ss_pred EeEEEeC-CceEEEEEecCCCChhHHHHhhh---hcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE
Q 002238 657 LGHCLDG-NEKLLVFEYMPQGTLSRHIFNWA---EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732 (948)
Q Consensus 657 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill 732 (948)
.+++.++ +..+.+|.++.-|+|..++.... ....+.++-.+...+|.|++.|++|||. ++|||.||.++|+++
T Consensus 353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvI 429 (563)
T KOG1024|consen 353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVI 429 (563)
T ss_pred eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhccee
Confidence 9998754 56789999999999999997322 1223567788889999999999999996 899999999999999
Q ss_pred cCCCCeEEeecCCce-ecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhh
Q 002238 733 GDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMH 810 (948)
Q Consensus 733 ~~~~~~kl~DfGla~-~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~ 810 (948)
|+.-++||+|-.++| .++.+..........+..||+||.+.+..|+.++|||||||+||||+| |+.|+.+.+|.+..+
T Consensus 430 dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ 509 (563)
T KOG1024|consen 430 DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH 509 (563)
T ss_pred hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH
Confidence 999999999999999 444444444445556789999999999999999999999999999999 999999999887765
Q ss_pred HHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 811 LVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
..+-..+. ..+.+++.++..++.-||+..|++||++++++..|.+.-.+
T Consensus 510 ylkdGyRl------------------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 510 YLKDGYRL------------------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred HHhcccee------------------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 55422211 11234667899999999999999999999999999887543
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=325.15 Aligned_cols=255 Identities=27% Similarity=0.379 Sum_probs=214.0
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCce
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEK 666 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 666 (948)
.....|+..+.||+|.||.||+++.+ +|+.+|+|++.+.... ......+.+|+.+|+++. |||||.+.+++.+....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34567888999999999999999876 5999999999776433 334678999999999998 99999999999999999
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC----CCeEEee
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD----MRAKVAD 742 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~----~~~kl~D 742 (948)
++|||++.||.|.+.+... .+++..+..++.|++.+++|||+ .||+|||+||+|+|+... +.+|++|
T Consensus 112 ~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEee
Confidence 9999999999999998542 38999999999999999999997 899999999999999633 4799999
Q ss_pred cCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc
Q 002238 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK 822 (948)
Q Consensus 743 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 822 (948)
||++..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||........... +...+
T Consensus 183 FGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~------i~~~~ 254 (382)
T KOG0032|consen 183 FGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA------ILRGD 254 (382)
T ss_pred CCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH------HHcCC
Confidence 999998776 4456778999999999999999999999999999999999999999998775443221 11111
Q ss_pred cccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 823 DSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
..+. ...+......+.+++..|+..||.+|+++.+++++
T Consensus 255 ~~f~---------~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 255 FDFT---------SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCCC---------CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1111 11222334568899999999999999999999983
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=338.54 Aligned_cols=263 Identities=25% Similarity=0.415 Sum_probs=206.2
Q ss_pred hcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCC
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGN 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 664 (948)
.++|.+.+.||+|+||.||+|+++ .+..||||+++... .....+.+.+|++++.++. ||||+++++++...+
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 345778899999999999999864 24689999997642 2333467899999999997 999999999999999
Q ss_pred ceEEEEEecCCCChhHHHHhhhh---------------------------------------------------------
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAE--------------------------------------------------------- 687 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 687 (948)
..++||||+++|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999864211
Q ss_pred ------------------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEE
Q 002238 688 ------------------------------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (948)
Q Consensus 688 ------------------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nil 731 (948)
.....+++.++++++.|++.||+|||+ .+++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEE
Confidence 011347888899999999999999997 89999999999999
Q ss_pred EcCCCCeEEeecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhh
Q 002238 732 LGDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESM 809 (948)
Q Consensus 732 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~ 809 (948)
+++++.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||......+..
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 99999999999999985433221 11223457889999999998889999999999999999998 88998765432211
Q ss_pred hHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhh
Q 002238 810 HLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875 (948)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~ 875 (948)
. . ... .+ .. +.. ......++.+++.+||+.+|.+||++++|++.|+.++
T Consensus 352 ~--~----~~~-~~-~~----~~~-----p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 Y--N----AIK-RG-YR----MAK-----PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H--H----HHH-cC-CC----CCC-----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 0 000 00 00 000 0112346889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=337.00 Aligned_cols=240 Identities=25% Similarity=0.369 Sum_probs=195.7
Q ss_pred ceecccCceEEEEEEE----cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecC
Q 002238 599 NILGRGGFGTVYKGEL----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 674 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 674 (948)
+.||+|+||.||+++. .+|+.||+|++............+..|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 368999999998654333445667889999999999999999999999999999999999
Q ss_pred CCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCC
Q 002238 675 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 754 (948)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~ 754 (948)
+|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 152 (318)
T cd05582 82 GGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE- 152 (318)
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-
Confidence 9999988843 2468999999999999999999997 899999999999999999999999999988654332
Q ss_pred ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccC
Q 002238 755 SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTID 834 (948)
Q Consensus 755 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (948)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+......+ ..
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~------~i~~~~~~~----p~--- 219 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT------MILKAKLGM----PQ--- 219 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH------HHHcCCCCC----CC---
Confidence 22344679999999999998889999999999999999999999998755432211 111111111 11
Q ss_pred CccchHHHHHHHHHHHHHhcccCCCCCCChHH
Q 002238 835 LNEGILASISTVAELAGHCCAREPYQRPDMGH 866 (948)
Q Consensus 835 ~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~e 866 (948)
.....+.+++.+|++.||++||++.+
T Consensus 220 ------~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 ------FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ------CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11235789999999999999999766
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.78 Aligned_cols=252 Identities=26% Similarity=0.430 Sum_probs=207.6
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
+|+..+.||+|+||.||+|..+ +++.|++|.+...........++.+|+++++.++|||++++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777899999999999999875 689999999876554566678899999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++++|.+++... ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999998642 23578999999999999999999997 89999999999999999999999999998866543
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (948)
.. ......|++.|+|||+..+..++.++||||||+++|||++|+.||........ .. ... .... +.
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~---~~~--~~~~-----~~ 220 (256)
T cd08529 155 TN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL---IL---KII--RGVF-----PP 220 (256)
T ss_pred cc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HH---HHH--cCCC-----CC
Confidence 32 22345688999999999999999999999999999999999999976553221 11 111 0100 00
Q ss_pred cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 833 IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 833 ~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+. ......+.+++.+|++.+|++||++.++++.
T Consensus 221 ~~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 VS-----QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred Cc-----cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11 1223468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=336.33 Aligned_cols=245 Identities=26% Similarity=0.377 Sum_probs=197.7
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCC
Q 002238 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 676 (948)
+.||+|+||.||+|..+ +|+.||+|++..... .......+..|+++++.++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 789999999976432 2334567788999999999999999999999999999999999999
Q ss_pred ChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCce
Q 002238 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI 756 (948)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 756 (948)
+|.+++.. ...+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 99887732 2468999999999999999999995 36999999999999999999999999999875433221 2
Q ss_pred eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCc
Q 002238 757 ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLN 836 (948)
Q Consensus 757 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (948)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ......+. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i------~~~~~~~p----~----- 217 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LMEEIRFP----R----- 217 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH------hcCCCCCC----C-----
Confidence 23456999999999999999999999999999999999999999775543322111 11111111 0
Q ss_pred cchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHHH
Q 002238 837 EGILASISTVAELAGHCCAREPYQRP-----DMGHAVNV 870 (948)
Q Consensus 837 ~~~~~~~~~l~~li~~c~~~~P~~RP-----t~~ev~~~ 870 (948)
....++.+++.+|++.||++|+ ++.+++++
T Consensus 218 ----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 ----TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ----CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1223588999999999999997 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=331.26 Aligned_cols=243 Identities=26% Similarity=0.371 Sum_probs=195.6
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCC-ceeeEEeEEEeCCceEEEE
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHR-HLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lv~ 670 (948)
+|++.+.||+|+||.||+|+.+ +++.||||++..... .....+.+..|++++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999865 578999999976432 234456788999999999765 5888989999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 81 EYVNGGDLMYHIQQ-----VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 99999999888743 2468899999999999999999997 899999999999999999999999999987533
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.... +......+.
T Consensus 153 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~------i~~~~~~~~---- 221 (324)
T cd05587 153 FGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS------IMEHNVSYP---- 221 (324)
T ss_pred CCC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH------HHcCCCCCC----
Confidence 222 123345799999999999999999999999999999999999999987654332111 111111111
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCCh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDM 864 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~ 864 (948)
. ....++.+++.+|++.+|.+|++.
T Consensus 222 ~---------~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 222 K---------SLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred C---------CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0 122357899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.71 Aligned_cols=263 Identities=24% Similarity=0.412 Sum_probs=211.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|+..+.||+|+||.||+|... +|+.||+|.++.... .....+.+.+|++++++++|+|++++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999876 799999998865322 3334678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.... .....+++.+++.++.+++.||+|||+ .+++||||||+||+++.++.++|+|||+++...
T Consensus 82 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 9999999999886532 223568999999999999999999997 899999999999999999999999999988654
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
.... ......|++.|+|||++.+..++.++|||||||++|||++|+.||...... .......... ...
T Consensus 158 ~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~--~~~----- 225 (267)
T cd08224 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEK--CDY----- 225 (267)
T ss_pred CCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhhhhc--CCC-----
Confidence 4322 223356899999999999888999999999999999999999999654321 1111111110 000
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~ 875 (948)
+... .......+.+++.+|++.+|++||++.+|+++|+++.
T Consensus 226 ~~~~----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 PPLP----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCC----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1111 1123346889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=315.31 Aligned_cols=248 Identities=28% Similarity=0.471 Sum_probs=199.7
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCCCh
Q 002238 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 678 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 678 (948)
++||+|+||.||+|..+++..||+|++.... .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3689999999999998888999999887542 334445788999999999999999999999999999999999999999
Q ss_pred hHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCceee
Q 002238 679 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET 758 (948)
Q Consensus 679 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 758 (948)
.+++.. ....+++.+++.++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++............
T Consensus 80 ~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 80 LSFLRK----KKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred HHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 988743 22468899999999999999999997 89999999999999999999999999998754433222222
Q ss_pred eecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCcc
Q 002238 759 RIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNE 837 (948)
Q Consensus 759 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (948)
...+++.|+|||++.+..++.++||||||+++||+++ |..||...........+ .. . ......
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~---~~-----~-~~~~~~------- 216 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV---EK-----G-YRMSCP------- 216 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH---Hc-----C-CCCCCC-------
Confidence 2345678999999998899999999999999999998 99999765443221111 10 0 000000
Q ss_pred chHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 838 GILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 838 ~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 217 --~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 --QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred --CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 112346889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=317.50 Aligned_cols=248 Identities=26% Similarity=0.413 Sum_probs=197.5
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCCC
Q 002238 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGT 677 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 677 (948)
+.||+|+||.||+|+.+ +++.||+|.+... ........+.+|++++++++||||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 36999999999999874 7899999987643 234455779999999999999999999999999999999999999999
Q ss_pred hhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCce-
Q 002238 678 LSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI- 756 (948)
Q Consensus 678 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~- 756 (948)
|.+++.. ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++..........
T Consensus 80 L~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 80 FLTFLRT----EGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 9998843 22468899999999999999999997 899999999999999999999999999987543321111
Q ss_pred eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCC
Q 002238 757 ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDL 835 (948)
Q Consensus 757 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (948)
.....++..|+|||.+.++.++.++||||||+++|||++ |..||............. . . .. ...
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~---~----~--~~----~~~-- 217 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE---Q----G--VR----LPC-- 217 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH---c----C--CC----CCC--
Confidence 111123467999999999899999999999999999998 888887654432211111 0 0 00 000
Q ss_pred ccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 836 NEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 836 ~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
....+..+.+++.+|++.+|++||++.++.++|.
T Consensus 218 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 ---PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ---cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 0112346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=337.33 Aligned_cols=263 Identities=22% Similarity=0.269 Sum_probs=203.4
Q ss_pred HHHHHHhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe
Q 002238 585 IQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD 662 (948)
Q Consensus 585 ~~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 662 (948)
+.+.+...++|++.+.||+|+||.||+|+.+ +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3444555689999999999999999999875 688999999865321 23334568899999999999999999999999
Q ss_pred CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEee
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~D 742 (948)
+...++||||+++|+|.+++.. ..++...+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~D 185 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 185 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEe
Confidence 9999999999999999988843 347788888999999999999997 8999999999999999999999999
Q ss_pred cCCceecCCCCCceeeeecccccccCceecccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh
Q 002238 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG----RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI 818 (948)
Q Consensus 743 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 818 (948)
||+++..............||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ..+
T Consensus 186 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i 259 (371)
T cd05622 186 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKI 259 (371)
T ss_pred CCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH------HHH
Confidence 999986644332223456799999999998754 3789999999999999999999999875543221 111
Q ss_pred hcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCC--CCChHHHHHHH
Q 002238 819 HLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQ--RPDMGHAVNVL 871 (948)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~--RPt~~ev~~~L 871 (948)
........ ++. .......+.+++..|+..++.+ ||++.+++++.
T Consensus 260 ~~~~~~~~------~~~---~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 260 MNHKNSLT------FPD---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HcCCCccc------CCC---cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11111100 000 0112345788999999844433 77888887753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=343.55 Aligned_cols=254 Identities=22% Similarity=0.336 Sum_probs=198.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|++.+.||+|+||.||+|... +++.||||++..... .....+.+.+|+++++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46889999999999999999764 789999999865422 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 81 EFLPGGDLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 99999999998843 2468888999999999999999997 899999999999999999999999999986332
Q ss_pred CCCCc----------------------------------------------eeeeecccccccCceecccCCCCchhhHH
Q 002238 751 EGKGS----------------------------------------------IETRIAGTFGYLAPEYAVTGRVTTKVDVF 784 (948)
Q Consensus 751 ~~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 784 (948)
..... ......||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 11000 00124699999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCC---
Q 002238 785 SFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQR--- 861 (948)
Q Consensus 785 s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~R--- 861 (948)
||||++|||++|+.||......+....+ ......+. + +. ......++.+++.+|+. +|.+|
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~~~~i------~~~~~~~~--~-p~------~~~~s~~~~dli~~lL~-~~~~r~~r 296 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENSHETYRKI------INWRETLY--F-PD------DIHLSVEAEDLIRRLIT-NAENRLGR 296 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCHHHHHHHH------HccCCccC--C-CC------CCCCCHHHHHHHHHHhc-CHhhcCCC
Confidence 9999999999999999876543321111 10000000 0 00 00112357899999997 66665
Q ss_pred CChHHHHHH
Q 002238 862 PDMGHAVNV 870 (948)
Q Consensus 862 Pt~~ev~~~ 870 (948)
+++.+++++
T Consensus 297 ~~~~~~l~h 305 (377)
T cd05629 297 GGAHEIKSH 305 (377)
T ss_pred CCHHHHhcC
Confidence 588888764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=321.39 Aligned_cols=263 Identities=23% Similarity=0.395 Sum_probs=210.7
Q ss_pred cCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|++.+.||+|+||.||+|.. .+++.||||.+..... ......++.+|+.+++.++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999985 4789999998865322 3344568899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++++|.+++.... .....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFK-KQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 9999999999886432 233578999999999999999999997 899999999999999999999999999988654
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
.... ......|+..|+|||++.+..++.++||||||+++|||++|..||....... .... .... ....
T Consensus 158 ~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~---~~~~-------~~~~ 225 (267)
T cd08229 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLC---KKIE-------QCDY 225 (267)
T ss_pred cCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHh---hhhh-------cCCC
Confidence 4322 1233468999999999988889999999999999999999999997543221 1111 1111 1111
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~ 875 (948)
+... .......+.+++.+|++.+|.+||||.+|+++++++.
T Consensus 226 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 226 PPLP----SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCC----cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1111 1123346889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=323.70 Aligned_cols=268 Identities=25% Similarity=0.403 Sum_probs=202.2
Q ss_pred CcccceecccCceEEEEEEE-----cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CceE
Q 002238 595 FSEENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKL 667 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 667 (948)
|+..+.||+|+||+||++.. .+++.||+|.++... .......+.+|++++++++||||+++++++... ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 48889999999999988653 357899999987542 334457788999999999999999999988754 3578
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+||||+++++|.+++.. ..+++.+++.++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++
T Consensus 85 lv~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeeccccc
Confidence 99999999999998843 358999999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCce--eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 748 LAPEGKGSI--ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 748 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
......... .....++..|+|||.+.+..++.++||||||+++|||++|+.||........ ........ ......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~-~~~~~~~ 233 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQG-QMTVVRL 233 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhccccc-ccchhhh
Confidence 654432211 1223356779999999888999999999999999999999999865432110 00000000 0000001
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhh
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~ 875 (948)
.+..+.... .......+.++.+++.+|++.+|++||+++++++.|+++.
T Consensus 234 ~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 234 IELLERGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111111110 0011223457999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=331.37 Aligned_cols=240 Identities=25% Similarity=0.381 Sum_probs=193.4
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEEEEEecCC
Q 002238 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 675 (948)
+.||+|+||.||+|+.+ +++.||||++..... .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 688999999876422 233456778888888877 799999999999999999999999999
Q ss_pred CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc
Q 002238 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (948)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 755 (948)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.++|+|||+++...... .
T Consensus 81 g~L~~~i~~-----~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~ 151 (320)
T cd05590 81 GDLMFHIQK-----SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-K 151 (320)
T ss_pred chHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-C
Confidence 999888743 2468899999999999999999997 899999999999999999999999999987543222 2
Q ss_pred eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCC
Q 002238 756 IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDL 835 (948)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (948)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+....... +.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~------~i~~~~~~~-----~~--- 217 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE------AILNDEVVY-----PT--- 217 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH------HHhcCCCCC-----CC---
Confidence 2344579999999999999999999999999999999999999998765433211 111111000 10
Q ss_pred ccchHHHHHHHHHHHHHhcccCCCCCCChHH
Q 002238 836 NEGILASISTVAELAGHCCAREPYQRPDMGH 866 (948)
Q Consensus 836 ~~~~~~~~~~l~~li~~c~~~~P~~RPt~~e 866 (948)
....++.+++.+|++.||++||++.+
T Consensus 218 -----~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 218 -----WLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred -----CCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 12235789999999999999999844
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=317.37 Aligned_cols=255 Identities=31% Similarity=0.518 Sum_probs=207.4
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.++|++.+.||+|+||.||+|..+++..||||.+.... ...+++.+|+.++++++||||+++++++......++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 46789999999999999999998878899999987532 334678999999999999999999999998889999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.+++.. .....+++.++..++.|++.|++|||+ .+++||||||+||++++++.++|+|||+++....
T Consensus 82 ~~~~~~L~~~i~~---~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 82 YMSKGSLLDFLKS---GEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred ccCCCCHHHHHhc---cccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999998854 223568999999999999999999997 7999999999999999999999999999886654
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
..........++..|+|||.+.+..++.++||||||+++||+++ |+.||......... ..... . ......
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~---~~~~~----~--~~~~~~ 226 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL---EQVER----G--YRMPRP 226 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHc----C--CCCCCC
Confidence 32222223335678999999998899999999999999999999 99999765433211 11110 0 000000
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~ 873 (948)
...+.++.+++.+|++.+|++||+++++.+.|+.
T Consensus 227 ---------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 ---------PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1113468899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.94 Aligned_cols=256 Identities=26% Similarity=0.396 Sum_probs=194.7
Q ss_pred ceecccCceEEEEEEEcC---CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCC
Q 002238 599 NILGRGGFGTVYKGELHD---GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 675 (948)
+.||+|+||.||+|.+.+ +..+|+|.++... .......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 358999999999998653 4579999887543 233446789999999999999999999999999999999999999
Q ss_pred CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc
Q 002238 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (948)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 755 (948)
|+|.+++...........++..+..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 999999865332233456788888999999999999997 89999999999999999999999999998754332211
Q ss_pred e-eeeecccccccCceecccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 756 I-ETRIAGTFGYLAPEYAVTG-------RVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 756 ~-~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
. .....|+..|+|||++.+. .++.++||||||+++|||++ |+.||......+..... .. ....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~-----~~---~~~~ 228 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT-----VR---EQQL 228 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-----hh---cccC
Confidence 1 1234578899999998642 35789999999999999996 99999765543321110 00 0001
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
...++.+. ......+.+++..|+ .+|++||++++|+..|+
T Consensus 229 ~~~~~~~~-----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLK-----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccC-----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11122211 112234778999998 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=332.21 Aligned_cols=243 Identities=25% Similarity=0.360 Sum_probs=194.9
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEEEEEecCC
Q 002238 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 675 (948)
++||+|+||.||+|+.+ +++.||||++..... .....+.+..|.+++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 578999999876432 234456678899998876 899999999999999999999999999
Q ss_pred CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc
Q 002238 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (948)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 755 (948)
|+|...+.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 151 (321)
T cd05591 81 GDLMFQIQR-----SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-V 151 (321)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC-c
Confidence 999888743 2468899999999999999999997 899999999999999999999999999988543322 2
Q ss_pred eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCC
Q 002238 756 IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDL 835 (948)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (948)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+...... .+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~------~i~~~~~~-----~p~--- 217 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE------SILHDDVL-----YPV--- 217 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHH------HHHcCCCC-----CCC---
Confidence 2334569999999999999999999999999999999999999998765433211 11111100 010
Q ss_pred ccchHHHHHHHHHHHHHhcccCCCCCC-------ChHHHHH
Q 002238 836 NEGILASISTVAELAGHCCAREPYQRP-------DMGHAVN 869 (948)
Q Consensus 836 ~~~~~~~~~~l~~li~~c~~~~P~~RP-------t~~ev~~ 869 (948)
....++.+++.+|++.+|++|| ++.++++
T Consensus 218 -----~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 218 -----WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred -----CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 1124588999999999999999 5666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=325.72 Aligned_cols=266 Identities=25% Similarity=0.395 Sum_probs=206.5
Q ss_pred hcCCcccceecccCceEEEEEEEcC-----------------CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCcee
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHD-----------------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 654 (948)
.++|++.+.||+|+||.||+|...+ +..||+|++.... .....+++.+|++++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 4678999999999999999997642 2468999987542 334567899999999999999999
Q ss_pred eEEeEEEeCCceEEEEEecCCCChhHHHHhhhh------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCc
Q 002238 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAE------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 728 (948)
Q Consensus 655 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~ 728 (948)
++++++..++..++||||+++++|.+++..... .....+++..++.++.|++.||+|||+ .+++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchh
Confidence 999999999999999999999999999865331 112368999999999999999999997 89999999999
Q ss_pred cEEEcCCCCeEEeecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCc
Q 002238 729 NILLGDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT--GRKALDESQP 805 (948)
Q Consensus 729 Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt--g~~p~~~~~~ 805 (948)
||+++.++.++|+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999885433221 12233456789999999988899999999999999999998 6778865543
Q ss_pred hhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 806 EESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 806 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
.+. ........... ...... . .....+.++.+++.+|++.+|.+||++.+|++.|+
T Consensus 240 ~~~---~~~~~~~~~~~-~~~~~~----~---~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 QQV---IENAGHFFRDD-GRQIYL----P---RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHH---HHHHHhccccc-cccccC----C---CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 222 11111110000 000000 0 01122346899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=325.85 Aligned_cols=266 Identities=26% Similarity=0.429 Sum_probs=203.8
Q ss_pred hcCCcccceecccCceEEEEEEEcC---------------CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHD---------------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~---------------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 656 (948)
.++|++.+.||+|+||.||++.... ...||||.++.. ........+.+|++++++++|||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 3578999999999999999987542 235899998754 234455679999999999999999999
Q ss_pred EeEEEeCCceEEEEEecCCCChhHHHHhhhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCcc
Q 002238 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE-------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSN 729 (948)
Q Consensus 657 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~N 729 (948)
++++......++||||+++++|.+++...... ....+++..++.++.|+++||+|||+ .+++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhh
Confidence 99999999999999999999999988542110 11247899999999999999999997 899999999999
Q ss_pred EEEcCCCCeEEeecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCch
Q 002238 730 ILLGDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT--GRKALDESQPE 806 (948)
Q Consensus 730 ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt--g~~p~~~~~~~ 806 (948)
|++++++.+||+|||+++....... .......++..|+|||++.++.++.++|||||||++|||++ |..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999875443321 11223345779999999998999999999999999999998 66777765443
Q ss_pred hhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 807 ESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 807 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
+..... ......... ..... .....+..+.+++.+|++.+|++||++.+|++.|.
T Consensus 240 ~~~~~~---~~~~~~~~~--~~~~~------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 QVIENT---GEFFRNQGR--QIYLS------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHH---HHhhhhccc--cccCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 321111 111100000 00000 00112346899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=331.94 Aligned_cols=239 Identities=26% Similarity=0.368 Sum_probs=188.6
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHH-HHHhcCCCceeeEEeEEEeCCceEEEEEecCC
Q 002238 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIA-VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 675 (948)
++||+|+||.||+|+.. +++.||+|++..... .......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 688999999875422 2223345555654 67889999999999999999999999999999
Q ss_pred CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc
Q 002238 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (948)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 755 (948)
|+|..++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 151 (321)
T cd05603 81 GELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-E 151 (321)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-C
Confidence 999887732 2467888899999999999999997 899999999999999999999999999987532222 1
Q ss_pred eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCC
Q 002238 756 IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDL 835 (948)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (948)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+.... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------~~i~~~~----------~~~ 215 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY------DNILHKP----------LQL 215 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH------HHHhcCC----------CCC
Confidence 234457999999999999889999999999999999999999999875432211 1111100 000
Q ss_pred ccchHHHHHHHHHHHHHhcccCCCCCCChH
Q 002238 836 NEGILASISTVAELAGHCCAREPYQRPDMG 865 (948)
Q Consensus 836 ~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ 865 (948)
. ......+.+++.+|++.+|.+||+..
T Consensus 216 ~---~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 P---GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred C---CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0 11223588999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.92 Aligned_cols=249 Identities=27% Similarity=0.392 Sum_probs=196.0
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCCCh
Q 002238 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 678 (948)
Q Consensus 601 lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 678 (948)
||+|+||.||+++.+ +|+.||+|++...... ......+..|++++++++||||+++++++.++.+.++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 6899999998654322 22234566799999999999999999999999999999999999999
Q ss_pred hHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCceee
Q 002238 679 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET 758 (948)
Q Consensus 679 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 758 (948)
.+++.. .....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~ 152 (277)
T cd05607 81 KYHIYN---VGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TIT 152 (277)
T ss_pred HHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eee
Confidence 888753 233468899999999999999999997 899999999999999999999999999988664432 223
Q ss_pred eecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccc
Q 002238 759 RIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEG 838 (948)
Q Consensus 759 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (948)
...||..|+|||++.+..++.++||||+||++|||++|+.||......... ......... .. +.. .
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~--~~----~~~----~-- 218 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTLE--DE----VKF----E-- 218 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhhc--cc----ccc----c--
Confidence 456899999999999988999999999999999999999999764332111 111111110 00 000 0
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 839 ILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 839 ~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
......++.+++.+|++.||++||+++|+++.+
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 011234588999999999999999998876433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=352.16 Aligned_cols=265 Identities=22% Similarity=0.326 Sum_probs=207.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|++.++||+|+||.||+|... +|+.||||++...... ....+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999865 6899999998764322 233567999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhh------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 671 EYMPQGTLSRHIFNWAE------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
||++||+|.+++..... ......++..+++++.||++||+|||+ .+|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 112346778889999999999999997 799999999999999999999999999
Q ss_pred CceecCCCCC-----------------ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q 002238 745 LVRLAPEGKG-----------------SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEE 807 (948)
Q Consensus 745 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~ 807 (948)
+++....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521100 01123569999999999999999999999999999999999999997643322
Q ss_pred hhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCC-ChHHHHHHHHhhhh
Q 002238 808 SMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRP-DMGHAVNVLSSLVE 876 (948)
Q Consensus 808 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RP-t~~ev~~~L~~~~~ 876 (948)
.... ... .++. . .......+..+.+++.+|++.||++|| +++++.+.|+...+
T Consensus 239 i~~~----~~i----------~~P~-~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISYR----DVI----------LSPI-E-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhh----hhc----------cChh-h-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1100 000 0000 0 000112234588999999999999996 67778787877654
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=316.41 Aligned_cols=253 Identities=24% Similarity=0.375 Sum_probs=202.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC---hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
++|+..+.||+|+||.||+|... +++.||+|.+...... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999864 6899999998754322 2234678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||||+++++|.+++.. ...+++..+.+++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++.
T Consensus 82 v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLKA-----YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 9999999999988843 2467888999999999999999997 8999999999999999999999999999885
Q ss_pred cCCCCCcee--eeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 749 APEGKGSIE--TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 749 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
......... ....|+..|+|||++.+..++.++||||||+++||+++|+.||.......... ...... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~~~--~~ 225 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF------KIATQP--TN 225 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH------HHhccC--CC
Confidence 543221111 23457889999999999899999999999999999999999997654322111 110000 00
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+.++ ......+.+++.+|++.+|.+||++.++++.
T Consensus 226 ----~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 ----PQLP-----SHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----CCCC-----ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0111 1123458899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=320.71 Aligned_cols=255 Identities=26% Similarity=0.423 Sum_probs=202.0
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|++.+.||+|+||.||+|+. .+++.||+|++... .......+.+|+.++++++||||+++++++..++..++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC--ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 35789999999999999999986 46889999998754 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++++|.++++. ...+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.++|+|||+++...
T Consensus 86 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 86 EYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 99999999988843 2468899999999999999999997 899999999999999999999999999998654
Q ss_pred CCCCceeeeecccccccCceecc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAV---TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
.... ......|++.|+|||.+. ...++.++|||||||++|||++|+.||....+.+..... ....+
T Consensus 158 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--------~~~~~-- 226 (267)
T cd06646 158 ATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--------SKSNF-- 226 (267)
T ss_pred cccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--------ecCCC--
Confidence 3221 123346889999999874 345788999999999999999999999655432211000 00000
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
..+... ........+.+++.+|++.+|++||+++++++.+
T Consensus 227 -~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 -QPPKLK---DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -CCCCCc---cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 001110 1112234688999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=332.89 Aligned_cols=245 Identities=21% Similarity=0.359 Sum_probs=192.2
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEEEEEecCC
Q 002238 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 675 (948)
++||+|+||.||+|+.+ +++.||||+++..... ......+.+|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999865 6899999999865332 33456688999999998 799999999999999999999999999
Q ss_pred CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc
Q 002238 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (948)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 755 (948)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~ 151 (329)
T cd05588 81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-D 151 (329)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC-C
Confidence 999887742 2578999999999999999999997 899999999999999999999999999987432211 1
Q ss_pred eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh--hhhHHHHHHHhhcCccccccccCccc
Q 002238 756 IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEE--SMHLVTWFRRIHLSKDSFHKAIDPTI 833 (948)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (948)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ......+........ ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---------~~ 222 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK---------QI 222 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC---------CC
Confidence 2334679999999999999999999999999999999999999997432211 111111111111100 00
Q ss_pred CCccchHHHHHHHHHHHHHhcccCCCCCCCh
Q 002238 834 DLNEGILASISTVAELAGHCCAREPYQRPDM 864 (948)
Q Consensus 834 ~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~ 864 (948)
... .....++.+++.+|++.||.+||++
T Consensus 223 ~~p---~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 223 RIP---RSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred CCC---CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 000 0122357899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=329.03 Aligned_cols=242 Identities=27% Similarity=0.434 Sum_probs=193.3
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEEEEEecCC
Q 002238 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 675 (948)
+.||+|+||.||+|... +++.||||+++.... .......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 578999999976432 123345667788888764 999999999999999999999999999
Q ss_pred CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc
Q 002238 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (948)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 755 (948)
|+|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 151 (316)
T cd05619 81 GDLMFHIQS-----CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-A 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-C
Confidence 999988843 2468899999999999999999997 899999999999999999999999999987543222 1
Q ss_pred eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCC
Q 002238 756 IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDL 835 (948)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (948)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ...... +..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i------~~~~~~----~~~---- 217 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI------RMDNPC----YPR---- 217 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCCC----CCc----
Confidence 234467999999999999999999999999999999999999999876543322111 110100 001
Q ss_pred ccchHHHHHHHHHHHHHhcccCCCCCCChH-HHH
Q 002238 836 NEGILASISTVAELAGHCCAREPYQRPDMG-HAV 868 (948)
Q Consensus 836 ~~~~~~~~~~l~~li~~c~~~~P~~RPt~~-ev~ 868 (948)
....++.+++.+|++.+|++||++. ++.
T Consensus 218 -----~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 218 -----WLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred -----cCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 1123578999999999999999997 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=330.32 Aligned_cols=257 Identities=20% Similarity=0.282 Sum_probs=198.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCc-CChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|++.+.||+|+||.||+++.+ +++.||+|++.... ........+.+|+.++..++|+||+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999875 67899999987532 12333456888999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 Ey~~gg~L~~~l~~----~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLSK----FEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999853 12468889999999999999999997 899999999999999999999999999998665
Q ss_pred CCCCceeeeecccccccCceeccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVT-----GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
...........||+.|+|||++.+ +.++.++|||||||++|||++|+.||......+... .+.......
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~------~i~~~~~~~ 227 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHEERF 227 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH------HHHcCCCcc
Confidence 433323334569999999999875 467899999999999999999999997655432211 111111000
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCC--CCChHHHHHH
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQ--RPDMGHAVNV 870 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~--RPt~~ev~~~ 870 (948)
.+.+ .......++.+++.+|+..++.+ |++++++.++
T Consensus 228 --~~p~------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 --QFPS------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred --cCCC------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0111 11112345788999998866544 4577776653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=320.53 Aligned_cols=254 Identities=31% Similarity=0.515 Sum_probs=203.6
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEec
Q 002238 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 673 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 673 (948)
|+..+.||+|+||+||+|+.. +++.||+|++..............+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567899999999999999876 5678999999876433333344566999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCC
Q 002238 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (948)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~ 753 (948)
++++|.+++. ....+++..++.++.|+++||+|||+ .+++||||||+||++++++.++|+|||.+..... .
T Consensus 81 ~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQ-----KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-N 151 (260)
T ss_dssp TTEBHHHHHH-----HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-T
T ss_pred cccccccccc-----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-c
Confidence 9999999985 12578999999999999999999997 8999999999999999999999999999886422 2
Q ss_pred CceeeeecccccccCceecc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcc
Q 002238 754 GSIETRIAGTFGYLAPEYAV-TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832 (948)
Q Consensus 754 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (948)
........++..|+|||++. +..++.++||||+|+++|+|++|..||.................... ...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-----~~~---- 222 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPL-----PSS---- 222 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHH-----HHH----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccc-----ccc----
Confidence 22344567899999999998 88899999999999999999999999987633332222221111000 000
Q ss_pred cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 833 IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 833 ~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
. ........++.+++.+|++.+|++||++.++++
T Consensus 223 ~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 223 S---QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp T---TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred c---cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000011256999999999999999999999976
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.48 Aligned_cols=257 Identities=26% Similarity=0.476 Sum_probs=205.3
Q ss_pred hcCCcccceecccCceEEEEEEEc-CC---cEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
.++|+..+.||+|+||.||+|+.+ ++ ..+|||.+.... .....+++..|++++++++|||++++.+++.+.+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 356788899999999999999875 33 379999886542 3344678999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+||||+++++|.+++.. ....+++.++..++.|++.|++|||+ .+++||||||+||+++.++.++++|||++.
T Consensus 83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 83 IITEYMENGALDKYLRD----HDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred EEEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccce
Confidence 99999999999998843 22568999999999999999999997 899999999999999999999999999988
Q ss_pred ecCCCCCceee--eecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 748 LAPEGKGSIET--RIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 748 ~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
........... ....++.|+|||++.+..++.++|||||||++||+++ |+.||......+... .+.. ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~------~i~~-~~~ 228 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMK------AIND-GFR 228 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHH------HHhc-CCC
Confidence 65433221111 1223467999999998899999999999999999998 999997654332211 1111 000
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
. + .....+.++.+++.+|++.+|++||++.+|++.|+++
T Consensus 229 ~-----~------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 L-----P------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred C-----C------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0 0112335688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=310.16 Aligned_cols=248 Identities=26% Similarity=0.422 Sum_probs=208.5
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEec
Q 002238 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 673 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 673 (948)
|.+..+||+|+||.||+|.++ .|+.+|||.+.. ..+.+++.+|+.+|+++..|++|+++|.+......|+|||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 556788999999999999865 799999998864 346789999999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCC
Q 002238 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (948)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~ 753 (948)
..|++.+.++. ..+++++.++..|+...++||+|||. ..-||||||+.|||++.+|.+||+|||.|-...+.-
T Consensus 111 GAGSiSDI~R~----R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 111 GAGSISDIMRA----RRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred CCCcHHHHHHH----hcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 99999999853 34789999999999999999999997 567999999999999999999999999988665432
Q ss_pred CceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCccc
Q 002238 754 GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTI 833 (948)
Q Consensus 754 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (948)
.....+.|||.|||||++..-.|..++||||+|+...||.-|++||.+..+...... ..-...|.+
T Consensus 184 -AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-------------IPT~PPPTF 249 (502)
T KOG0574|consen 184 -AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-------------IPTKPPPTF 249 (502)
T ss_pred -HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-------------ccCCCCCCC
Confidence 234557899999999999999999999999999999999999999988765432111 111122222
Q ss_pred CCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 834 DLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 834 ~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
. .......++-++++.|+-..|++|-|+.++.++
T Consensus 250 ~---KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 K---KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred C---ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 2 222344578999999999999999999888763
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=323.16 Aligned_cols=264 Identities=30% Similarity=0.461 Sum_probs=206.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCc--EEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 668 (948)
++|++.+.||+|+||.||+|..+ ++. .+++|.++.. ......+.+.+|++++.++ +||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 57889999999999999999875 343 4788887642 2344457789999999999 79999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCC
Q 002238 669 VFEYMPQGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 737 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~ 737 (948)
||||+++|+|.++++.... .....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCe
Confidence 9999999999999854211 011358899999999999999999997 89999999999999999999
Q ss_pred eEEeecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHH
Q 002238 738 AKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFR 816 (948)
Q Consensus 738 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 816 (948)
+||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||......+...
T Consensus 158 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~------ 229 (297)
T cd05089 158 SKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE------ 229 (297)
T ss_pred EEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH------
Confidence 9999999986432111 1111223567999999998899999999999999999998 999997765433211
Q ss_pred HhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCC
Q 002238 817 RIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKP 880 (948)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~ 880 (948)
... .. . ..... ......+.+++.+|++.+|.+||+++++++.|+.+...+..
T Consensus 230 ~~~--~~-~----~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 230 KLP--QG-Y----RMEKP-----RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred HHh--cC-C----CCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 110 00 0 00000 11234588999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=325.98 Aligned_cols=263 Identities=28% Similarity=0.422 Sum_probs=209.0
Q ss_pred hhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeC
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG 663 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 663 (948)
..++|+..+.||+|+||.||+|... +...+|+|.+.... ......++.+|+++++++ +||||+++++++..+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 3467888999999999999999864 23679999987542 344556789999999999 899999999999999
Q ss_pred CceEEEEEecCCCChhHHHHhhh-----------hcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE
Q 002238 664 NEKLLVFEYMPQGTLSRHIFNWA-----------EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732 (948)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill 732 (948)
+..++||||+++|+|.+++.... ......+++..+++++.|++.||+|||+ .+|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEE
Confidence 99999999999999999986421 0233578999999999999999999997 899999999999999
Q ss_pred cCCCCeEEeecCCceecCCCCCc-eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhh
Q 002238 733 GDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMH 810 (948)
Q Consensus 733 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~ 810 (948)
+.++.++|+|||+++........ ......++..|+|||++.+..++.++|||||||++||+++ |..||......+...
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 99999999999999865433211 1122335678999999988899999999999999999998 999987655433211
Q ss_pred HHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhh
Q 002238 811 LVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875 (948)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~ 875 (948)
... . ... ... .......+.+++.+|++.+|.+||++.++++.|+.++
T Consensus 246 ~~~------~-~~~------~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 LLK------E-GYR------MEK-----PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHH------c-CCc------CCC-----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 110 0 000 000 1112346889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=329.16 Aligned_cols=242 Identities=27% Similarity=0.421 Sum_probs=193.0
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEEEEEecCC
Q 002238 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 675 (948)
+.||+|+||.||+|+.+ +|+.||||+++.... .......+..|..++... +||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999875 688999999976432 123345677788888765 899999999999999999999999999
Q ss_pred CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc
Q 002238 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (948)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 755 (948)
|+|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.++|+|||+++...... .
T Consensus 81 g~L~~~i~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 151 (316)
T cd05620 81 GDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-N 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-C
Confidence 999888743 2468899999999999999999997 899999999999999999999999999987543222 2
Q ss_pred eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCC
Q 002238 756 IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDL 835 (948)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (948)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ...... +.++
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~------~~~~~~--------~~~~- 216 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE------SIRVDT--------PHYP- 216 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH------HHHhCC--------CCCC-
Confidence 2345679999999999999999999999999999999999999998655432211 111111 1111
Q ss_pred ccchHHHHHHHHHHHHHhcccCCCCCCChH-HHH
Q 002238 836 NEGILASISTVAELAGHCCAREPYQRPDMG-HAV 868 (948)
Q Consensus 836 ~~~~~~~~~~l~~li~~c~~~~P~~RPt~~-ev~ 868 (948)
.....++.+++.+|++.||++||++. ++.
T Consensus 217 ----~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 ----RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ----CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 01223578999999999999999984 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=327.16 Aligned_cols=264 Identities=28% Similarity=0.420 Sum_probs=207.8
Q ss_pred hcCCcccceecccCceEEEEEEEc--------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEe
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH--------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD 662 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 662 (948)
.++|.+.+.||+|+||.||+|... ++..+|+|.+.... ......++.+|+++++.+ +||||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 357899999999999999999752 23579999987542 344456788999999999 89999999999999
Q ss_pred CCceEEEEEecCCCChhHHHHhhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEE
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nil 731 (948)
.+..++||||+++|+|.+++...... ....+++.++++++.|++.||+|||+ .+++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheE
Confidence 99999999999999999998653211 12358999999999999999999997 89999999999999
Q ss_pred EcCCCCeEEeecCCceecCCCCCce-eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhh
Q 002238 732 LGDDMRAKVADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESM 809 (948)
Q Consensus 732 l~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~ 809 (948)
++.++.++|+|||+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||......+..
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~ 252 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 9999999999999987554322111 112234578999999998899999999999999999998 88898765433221
Q ss_pred hHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 810 HLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
..+. . ... .. .......++.+++.+|++.+|++||++.+|++.|+++.+.
T Consensus 253 ~~~~------~--~~~-----~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 253 KLLK------E--GHR-----MD-----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHH------c--CCC-----CC-----CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1111 0 000 00 0111234688999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=323.89 Aligned_cols=267 Identities=24% Similarity=0.424 Sum_probs=204.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-----------------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCcee
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-----------------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-----------------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 654 (948)
.++|++.+.||+|+||.||++... ++..||+|++.... ......++.+|+++++.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 357999999999999999998542 23468999987542 344457899999999999999999
Q ss_pred eEEeEEEeCCceEEEEEecCCCChhHHHHhhhhc------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCc
Q 002238 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 728 (948)
Q Consensus 655 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~ 728 (948)
++++++..++..++||||+++|+|.+++...... ....+++.+++.++.|++.||+|||+ .+++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChh
Confidence 9999999999999999999999999998652211 12357889999999999999999997 89999999999
Q ss_pred cEEEcCCCCeEEeecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCc
Q 002238 729 NILLGDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT--GRKALDESQP 805 (948)
Q Consensus 729 Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt--g~~p~~~~~~ 805 (948)
||+++.++.++|+|||+++....... .......+++.|+|||+..++.++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999999885533221 11222345678999999888899999999999999999998 7788876544
Q ss_pred hhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHh
Q 002238 806 EESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873 (948)
Q Consensus 806 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~ 873 (948)
.+...... ....... .....+. ....+..+.+++.+|++.+|.+||++.+|++.|++
T Consensus 240 ~~~~~~~~---~~~~~~~--~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQVIENTG---EFFRDQG--RQVYLPK------PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHH---HHHhhcc--ccccCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 33221111 1000000 0000000 01123568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=330.71 Aligned_cols=245 Identities=22% Similarity=0.364 Sum_probs=191.3
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEEEEEecCC
Q 002238 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 675 (948)
+.||+|+||.||+|..+ +++.||+|+++.... .......+..|+.++.++ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 688999999986532 233456688899988877 899999999999999999999999999
Q ss_pred CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc
Q 002238 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (948)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 755 (948)
|+|..++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~ 151 (329)
T cd05618 81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-D 151 (329)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-C
Confidence 999887732 2568999999999999999999997 899999999999999999999999999987532221 1
Q ss_pred eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh--hhhHHHHHHHhhcCccccccccCccc
Q 002238 756 IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEE--SMHLVTWFRRIHLSKDSFHKAIDPTI 833 (948)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (948)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+......... ..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-------~~~ 224 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------IRI 224 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-------CCC
Confidence 2334579999999999999999999999999999999999999996422111 1111111111111000 001
Q ss_pred CCccchHHHHHHHHHHHHHhcccCCCCCCCh
Q 002238 834 DLNEGILASISTVAELAGHCCAREPYQRPDM 864 (948)
Q Consensus 834 ~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~ 864 (948)
+ .....++.+++.+|++.||++||++
T Consensus 225 p-----~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 P-----RSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred C-----CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1 1122457899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=320.25 Aligned_cols=260 Identities=27% Similarity=0.393 Sum_probs=205.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCc----EEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCce
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 666 (948)
.++|+..++||+|+||.||+|++. +|+ .||+|++.... ......++.+|+.+++.+.||||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 356888999999999999999854 454 48999886542 34446788999999999999999999999875 457
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCc
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla 746 (948)
+++|||+++|+|.++++. ....+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++
T Consensus 84 ~l~~~~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRE----NKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred EEEEEcCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCce
Confidence 899999999999988843 23568999999999999999999997 89999999999999999999999999999
Q ss_pred eecCCCCCce-eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 747 RLAPEGKGSI-ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 747 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
+......... .....+++.|+|||...+..++.++|||||||++|||++ |..||........ ..++... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~~----~~ 229 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI---PDLLEKG----ER 229 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHCC----Cc
Confidence 8664332211 112235678999999998999999999999999999998 8999976543322 1111110 00
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhh
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELW 878 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 878 (948)
.. . .......+.+++.+|++.||++||++.++++.|+.+...+
T Consensus 230 ~~------~-----~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 230 LP------Q-----PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred CC------C-----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 00 0 0112345889999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.00 Aligned_cols=263 Identities=23% Similarity=0.407 Sum_probs=209.9
Q ss_pred hcCCcccceecccCceEEEEEEEcC-----CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe-CCc
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHD-----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-GNE 665 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~ 665 (948)
.++|++.+.||+|+||.||+|.+.+ +..||+|++... ........+.+|+.++++++||||+++++++.. +..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4678899999999999999998765 688999988643 345556788999999999999999999998876 467
Q ss_pred eEEEEEecCCCChhHHHHhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEee
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEE---GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~D 742 (948)
.++++||+++|+|.+++...... ....+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999988542111 12568999999999999999999997 8999999999999999999999999
Q ss_pred cCCceecCCCCCc-eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhc
Q 002238 743 FGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHL 820 (948)
Q Consensus 743 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 820 (948)
||+++........ ......++..|+|||++.+..++.++||||||+++||+++ |+.||....+.+. ..+...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~~--- 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM---AAYLKD--- 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH---HHHHHc---
Confidence 9999855432221 1122346778999999998889999999999999999999 9999987554332 111111
Q ss_pred CccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 821 SKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
..... . ....+..+.+++.+|++.+|++||++.++++.|+.+.+
T Consensus 235 -~~~~~------~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 -GYRLA------Q-----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -CCCCC------C-----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00000 0 01123468899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=324.14 Aligned_cols=258 Identities=23% Similarity=0.373 Sum_probs=203.1
Q ss_pred CCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 594 NFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
+|++.+.||+|+||.||+|... +++.||||+++... .....+.+.+|+.++..++||||+++++++.+....+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4667788999999999999753 25789999987542 2333567899999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHHhhh-----------hcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC
Q 002238 668 LVFEYMPQGTLSRHIFNWA-----------EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 736 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~ 736 (948)
+++||+++++|.+++.... ......+++..+++++.|++.||+|||+ ++|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence 9999999999999885311 0112358899999999999999999997 8999999999999999999
Q ss_pred CeEEeecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHH
Q 002238 737 RAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTW 814 (948)
Q Consensus 737 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~ 814 (948)
.+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |..||.+....+.. .
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~---~- 237 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI---E- 237 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H-
Confidence 999999999885543221 11223446789999999988899999999999999999998 88888765443221 1
Q ss_pred HHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHh
Q 002238 815 FRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873 (948)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~ 873 (948)
.+.... .. ......+..+.+++.+|++.+|.+||++++|+..|+.
T Consensus 238 --~i~~~~--~~----------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 --MIRNRQ--VL----------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --HHHcCC--cC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111 00 0011233458899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=318.36 Aligned_cols=256 Identities=25% Similarity=0.451 Sum_probs=205.2
Q ss_pred cCCcccceecccCceEEEEEEEc-C---CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-D---GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
++|++.+.||+|+||.||+|.+. + +..+|+|.++... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57888999999999999999764 2 3479999886542 34456789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||||+++++|.+++.. ....+++.+++.++.|++.|++|||+ .+++||||||+||+++.++.++++|||+++.
T Consensus 83 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 83 VTEYMENGSLDAFLRK----HDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 9999999999998843 22468999999999999999999997 8999999999999999999999999999986
Q ss_pred cCCCCCceee--eecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 749 APEGKGSIET--RIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 749 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
.........+ ...++..|+|||++.+..++.++||||||+++||+++ |..||......+. ...+.. ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~~----~~~~ 228 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAIEE----GYRL 228 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHHhC----CCcC
Confidence 5543322221 1223568999999998899999999999999999887 9999977654322 111110 0000
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
+ . ....+..+.+++.+|++.+|.+||+|.++++.|.++
T Consensus 229 -----~-~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 -----P-A-----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -----C-C-----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 0 011234588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=313.85 Aligned_cols=247 Identities=22% Similarity=0.399 Sum_probs=195.7
Q ss_pred ecccCceEEEEEEEc---CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCCC
Q 002238 601 LGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGT 677 (948)
Q Consensus 601 lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 677 (948)
||+|+||.||+|.+. ++..||+|++.... .....+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 899999999999764 35579999986542 3344567999999999999999999999875 457899999999999
Q ss_pred hhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCcee
Q 002238 678 LSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE 757 (948)
Q Consensus 678 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 757 (948)
|.+++.. ....+++.++++++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..........
T Consensus 81 L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 81 LNKFLSG----KKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred HHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 9988843 23578999999999999999999997 8999999999999999999999999999885543322211
Q ss_pred e--eecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccC
Q 002238 758 T--RIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTID 834 (948)
Q Consensus 758 ~--~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (948)
. ...++..|+|||++.+..++.++||||||+++||+++ |..||......+....+ . . .. ....+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~---~--~~-~~~~~---- 220 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI---E---Q--GK-RLDCP---- 220 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH---H---C--CC-CCCCC----
Confidence 1 1223578999999988889999999999999999996 99999876543321111 1 1 00 00011
Q ss_pred CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 835 LNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 835 ~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
.....++.+++.+||+.+|++||++.+|.+.|+..
T Consensus 221 -----~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 -----AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 12235688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.37 Aligned_cols=259 Identities=24% Similarity=0.417 Sum_probs=205.9
Q ss_pred hcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCC
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 664 (948)
.++|...+.||+|+||.||+|... ++..||||+++... .....+.+.+|+++++++ +||||+++++++...+
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 357889999999999999999742 35589999887542 234456789999999999 7999999999999999
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
..++||||+++|+|.++++. .....+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.++++|||
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRR---KRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCc
Confidence 99999999999999998853 122348999999999999999999997 799999999999999999999999999
Q ss_pred CceecCCCCCc-eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCc
Q 002238 745 LVRLAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSK 822 (948)
Q Consensus 745 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 822 (948)
+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......+.. ..... .
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~~~~~-----~ 259 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--YKLIK-----E 259 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--HHHHH-----c
Confidence 99855433221 1222346788999999999999999999999999999998 99999765543221 11110 0
Q ss_pred cccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 823 DSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
. .. ... ......++.+++.+|++.+|++||++.++++.|+++
T Consensus 260 ~-~~----~~~-----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 G-YR----MAQ-----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred C-Cc----CCC-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 00 000 011234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=342.52 Aligned_cols=265 Identities=21% Similarity=0.332 Sum_probs=195.6
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC------
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------ 663 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 663 (948)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 3467999999999999999999864 68999999886431 2345799999999999999999876432
Q ss_pred --CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC-CeEE
Q 002238 664 --NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKV 740 (948)
Q Consensus 664 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~-~~kl 740 (948)
...++||||+++ +|.+++..+.. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceee
Confidence 135689999974 77777654322 33578999999999999999999997 8999999999999999665 7999
Q ss_pred eecCCceecCCCCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh
Q 002238 741 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH 819 (948)
Q Consensus 741 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 819 (948)
+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+....+....+ +....
T Consensus 213 ~DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i--~~~~~ 288 (440)
T PTZ00036 213 CDFGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI--IQVLG 288 (440)
T ss_pred eccccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--HHHhC
Confidence 9999998654432 22345689999999998764 6899999999999999999999999876543322211 11100
Q ss_pred cCc--------cccccccCcccCCcc----chHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 820 LSK--------DSFHKAIDPTIDLNE----GILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 820 ~~~--------~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
... ..+....-+.+.... .....+.++.+++.+|++.+|.+||++.|++++
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000 000000000000000 001123568899999999999999999999864
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.61 Aligned_cols=261 Identities=31% Similarity=0.481 Sum_probs=204.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCc--EEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 667 (948)
.++|++.+.||+|+||.||+|.++ ++. .+|+|.++.. ........+.+|++++.++ +||||+++++++.+++..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 357888999999999999999865 454 4577776542 2344567889999999999 8999999999999999999
Q ss_pred EEEEecCCCChhHHHHhhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC
Q 002238 668 LVFEYMPQGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 736 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~ 736 (948)
+||||+++|+|.++++.... .....+++.+++.++.|++.|++|||+ .+++||||||+|||+++++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCC
Confidence 99999999999999864221 112468899999999999999999997 8999999999999999999
Q ss_pred CeEEeecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHH
Q 002238 737 RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWF 815 (948)
Q Consensus 737 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 815 (948)
.++|+|||+++...... ......++..|+|||++.+..++.++|||||||++|||+| |..||......+...
T Consensus 162 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----- 234 (303)
T cd05088 162 VAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----- 234 (303)
T ss_pred cEEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH-----
Confidence 99999999986332111 1112234678999999988889999999999999999998 999997654332211
Q ss_pred HHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 816 RRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
.... . ..... .......+.+++.+|++.+|++||++.++++.|+.+..
T Consensus 235 -~~~~--~-----~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 235 -KLPQ--G-----YRLEK-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred -HHhc--C-----CcCCC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1100 0 00000 01123458899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=315.18 Aligned_cols=254 Identities=26% Similarity=0.459 Sum_probs=205.8
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.++|++.+.||+|+||.||+|...++..+|+|.+... ....+.+.+|++++++++|+||+++.+++.+ ...++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 4678999999999999999999877888999987653 3345678999999999999999999999877 77899999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.+++.. .....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||.+.....
T Consensus 81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 81 FMAKGSLLDFLKS---DEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eCCCCcHHHHHHh---CCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 9999999999854 223568899999999999999999997 8999999999999999999999999999986544
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
..........++..|+|||++....++.++|||||||++||+++ |+.||......+.. .+... . ..
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~~~-----~-~~---- 221 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RALER-----G-YR---- 221 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHhC-----C-CC----
Confidence 33222333446778999999998889999999999999999999 99999765433221 11110 0 00
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~ 873 (948)
.. .....+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus 222 --~~---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 --MP---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CC---CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00 001223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=338.84 Aligned_cols=252 Identities=26% Similarity=0.371 Sum_probs=195.2
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
+|+..+.||+|+||.||+|+.. +++.||||++..... .......+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999864 688999999875422 23345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 82 YIPGGDMMSLLIR-----MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred CCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 9999999988843 2467888899999999999999997 8999999999999999999999999999753210
Q ss_pred CC----------------------------------------------CceeeeecccccccCceecccCCCCchhhHHH
Q 002238 752 GK----------------------------------------------GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFS 785 (948)
Q Consensus 752 ~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 785 (948)
.. ........||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 00 00012346999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCC--
Q 002238 786 FGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPD-- 863 (948)
Q Consensus 786 ~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt-- 863 (948)
+||++|||++|+.||....+.+....+ ........ + +. . .....++.+++.+|+ .+|.+|++
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i------~~~~~~~~--~-p~---~---~~~s~~~~~li~~l~-~~p~~R~~~~ 297 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKV------INWQTSLH--I-PP---Q---AKLSPEASDLIIKLC-RGPEDRLGKN 297 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHH------HccCCCcC--C-CC---c---ccCCHHHHHHHHHHc-cCHhHcCCCC
Confidence 999999999999999876543321111 00000000 0 00 0 011234667777765 59999997
Q ss_pred -hHHHHH
Q 002238 864 -MGHAVN 869 (948)
Q Consensus 864 -~~ev~~ 869 (948)
+.++++
T Consensus 298 ~~~ei~~ 304 (382)
T cd05625 298 GADEIKA 304 (382)
T ss_pred CHHHHhc
Confidence 666654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=321.94 Aligned_cols=264 Identities=28% Similarity=0.438 Sum_probs=206.5
Q ss_pred hhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN 664 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 664 (948)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4578999999999999999999653 24589999876532 2334456889999999999999999999999999
Q ss_pred ceEEEEEecCCCChhHHHHhhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeE
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEE-----GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 739 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~k 739 (948)
..++||||+++|+|.+++...... +....++..+..++.|++.||+|||+ ++|+||||||+||+++.++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEE
Confidence 999999999999999999653211 12456788899999999999999997 8999999999999999999999
Q ss_pred EeecCCceecCCCCCc-eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHH
Q 002238 740 VADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRR 817 (948)
Q Consensus 740 l~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 817 (948)
|+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||......+....
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~------ 233 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------ 233 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------
Confidence 9999998854332211 1122345778999999998899999999999999999999 7889876544322111
Q ss_pred hhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 818 IHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
... .. .. .. . ......+.+++.+|++.+|++||++.++++.|.+...
T Consensus 234 ~~~-~~-~~-----~~--~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 234 VMD-GG-YL-----DQ--P---DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred HHc-CC-CC-----CC--C---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 110 00 00 00 0 1123468899999999999999999999999888653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=324.44 Aligned_cols=264 Identities=26% Similarity=0.421 Sum_probs=208.8
Q ss_pred hcCCcccceecccCceEEEEEEEc--------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEe
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH--------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD 662 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 662 (948)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+... ......+++.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 457888999999999999999641 3457999988653 2344567899999999999 89999999999999
Q ss_pred CCceEEEEEecCCCChhHHHHhhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEE
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nil 731 (948)
....++||||+++|+|.+++...... ....+++.+++.++.|+++||+|||+ .+++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEE
Confidence 99999999999999999998652111 12458899999999999999999997 89999999999999
Q ss_pred EcCCCCeEEeecCCceecCCCCCce-eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhh
Q 002238 732 LGDDMRAKVADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESM 809 (948)
Q Consensus 732 l~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~ 809 (948)
++.++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++||+++ |..||......+..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 9999999999999998664432211 222345678999999998889999999999999999998 78888765433321
Q ss_pred hHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 810 HLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
..+ .. .... .. .......+.+++.+|++.+|++||++.++++.|.++...
T Consensus 250 ~~~------~~-~~~~------~~-----~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 250 KLL------KE-GHRM------DK-----PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHH------Hc-CCcC------CC-----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 111 11 0000 00 012234688999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=332.74 Aligned_cols=267 Identities=25% Similarity=0.327 Sum_probs=200.2
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-----
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----- 664 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 664 (948)
+.++|++.+.||+|+||.||+|... +|+.||||++............+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999864 6899999999765444455677889999999999999999999886543
Q ss_pred -ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeec
Q 002238 665 -EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (948)
Q Consensus 665 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~Df 743 (948)
..++||||+++ +|.+.++ ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-------ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecC
Confidence 46999999965 5655552 247888899999999999999997 89999999999999999999999999
Q ss_pred CCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHH-----------
Q 002238 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLV----------- 812 (948)
Q Consensus 744 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~----------- 812 (948)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.....
T Consensus 168 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 168 GLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred CCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 9997543321 233456899999999999999999999999999999999999999865432211000
Q ss_pred -----HHHHHhhcCccc-----cccccCcc-cCC-ccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 813 -----TWFRRIHLSKDS-----FHKAIDPT-IDL-NEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 813 -----~~~~~~~~~~~~-----~~~~~~~~-~~~-~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
............ +.+.+..- .+. ..........+.+++.+|++.||++||++.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000000 00000000 000 00001123457899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=320.05 Aligned_cols=259 Identities=27% Similarity=0.425 Sum_probs=202.8
Q ss_pred hcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 665 (948)
+++|++.+.||+|+||.||+|.+. .+..||+|.+.... .......|.+|+.+++.++|+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 467899999999999999999875 35678999876432 33345678999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC---CeEE
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAE--EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKV 740 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~---~~kl 740 (948)
.++||||+++++|.+++..... .....++|..+++++.||+.||+|||+ .+++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999865321 112358999999999999999999997 7999999999999998654 5999
Q ss_pred eecCCceecCCCCCc-eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHh
Q 002238 741 ADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRI 818 (948)
Q Consensus 741 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 818 (948)
+|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |+.||......+....+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~------ 234 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV------ 234 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------
Confidence 999999865322111 1112234568999999999999999999999999999997 99999875543321111
Q ss_pred hcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 819 HLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
.. .... .. ....+..+.+++.+|++.+|++||++.+|++.|.
T Consensus 235 ~~-~~~~------~~-----~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TG-GGRL------DP-----PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred Hc-CCcC------CC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 10 0000 00 1112346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=329.86 Aligned_cols=257 Identities=22% Similarity=0.322 Sum_probs=198.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCc-CChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|++.+.||+|+||.||+++.. +++.||||++.+.. ......+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999865 68999999987532 12334566889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 99999999998843 22468899999999999999999997 899999999999999999999999999988654
Q ss_pred CCCCceeeeecccccccCceeccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVT-----GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
...........||+.|+|||++.. ..++.++|||||||++|||++|+.||......+... .+......+
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~------~i~~~~~~~ 227 (331)
T cd05597 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHKEHF 227 (331)
T ss_pred CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH------HHHcCCCcc
Confidence 433323334569999999999863 457889999999999999999999997654332211 111111100
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCC--CCCChHHHHHH
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPY--QRPDMGHAVNV 870 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~--~RPt~~ev~~~ 870 (948)
. +.+ ........+.+++.+|+..+++ .||++.++++.
T Consensus 228 ~--~~~------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 Q--FPP------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred c--CCC------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 001 1111234577888887765443 37888888775
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=329.12 Aligned_cols=243 Identities=23% Similarity=0.351 Sum_probs=195.5
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEEEE
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 670 (948)
+|++.+.||+|+||.||+|..+ +++.||||++..... .......+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999865 578999999876432 223345677788888887 5899999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+.+.. ...+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 99999999888743 2468899999999999999999997 899999999999999999999999999988543
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ......+ .
T Consensus 153 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i------~~~~~~~----p 221 (323)
T cd05616 153 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------MEHNVAY----P 221 (323)
T ss_pred CCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCCCC----C
Confidence 222 1233457999999999999999999999999999999999999999876543322111 1111000 0
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCCh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDM 864 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~ 864 (948)
. ....++.+++.+|++.+|.+|++.
T Consensus 222 ~---------~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 222 K---------SMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred C---------cCCHHHHHHHHHHcccCHHhcCCC
Confidence 1 122457899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.81 Aligned_cols=243 Identities=26% Similarity=0.373 Sum_probs=195.4
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEEEEEecCC
Q 002238 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 675 (948)
+.||+|+||.||+|..+ +++.||||+++.... .......+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 578999999986432 233456778899999888 799999999999999999999999999
Q ss_pred CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc
Q 002238 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (948)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 755 (948)
|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++.......
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 151 (318)
T cd05570 81 GDLMFHIQR-----SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV- 151 (318)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-
Confidence 999888743 2468999999999999999999997 8999999999999999999999999999875332221
Q ss_pred eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCC
Q 002238 756 IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDL 835 (948)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (948)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ........ +.
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~------~i~~~~~~----~~----- 216 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ------SILEDEVR----YP----- 216 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH------HHHcCCCC----CC-----
Confidence 2234569999999999999999999999999999999999999997655332211 11110100 00
Q ss_pred ccchHHHHHHHHHHHHHhcccCCCCCCCh-----HHHHH
Q 002238 836 NEGILASISTVAELAGHCCAREPYQRPDM-----GHAVN 869 (948)
Q Consensus 836 ~~~~~~~~~~l~~li~~c~~~~P~~RPt~-----~ev~~ 869 (948)
......+.+++.+|++.||.+||++ .++++
T Consensus 217 ----~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 ----RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred ----CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1122458899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=309.23 Aligned_cols=254 Identities=28% Similarity=0.377 Sum_probs=207.1
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
+.|+..+.||.|.-|+||.++++ ++..+|+|++.+.... .....+.+.|-+||+.++||.++.+++.+..++..++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 35667788999999999999987 3589999999876443 455677889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
|||+||+|...++. +..+.++...+.-+|..|+.||+|||- .|||.||+||+|||+.++|++-|+||.|+....
T Consensus 157 eyCpGGdL~~Lrqk---Qp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK---QPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred ecCCCccHHHHHhh---CCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999988864 455789999999999999999999997 899999999999999999999999999865211
Q ss_pred C---------------------------------C-C---------------------CceeeeecccccccCceecccC
Q 002238 751 E---------------------------------G-K---------------------GSIETRIAGTFGYLAPEYAVTG 775 (948)
Q Consensus 751 ~---------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~ 775 (948)
. . + +.....++||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 0 0011236799999999999999
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcc
Q 002238 776 RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCA 855 (948)
Q Consensus 776 ~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~ 855 (948)
..+.++|.|+|||++|||+.|.-||.+....+....+ .. ..+...+.. .....+.+||++.+.
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI------v~----------~~l~Fp~~~-~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI------VG----------QPLKFPEEP-EVSSAAKDLIRKLLV 373 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH------hc----------CCCcCCCCC-cchhHHHHHHHHHhc
Confidence 9999999999999999999999999987765542221 11 111111111 334568899999999
Q ss_pred cCCCCCCC----hHHHHH
Q 002238 856 REPYQRPD----MGHAVN 869 (948)
Q Consensus 856 ~~P~~RPt----~~ev~~ 869 (948)
.||.+|-. ++||.+
T Consensus 374 KdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred cChhhhhccccchHHhhc
Confidence 99999997 666655
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=329.63 Aligned_cols=250 Identities=26% Similarity=0.431 Sum_probs=206.6
Q ss_pred cccceecccCceEEEEEEEc--CC--cEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 596 SEENILGRGGFGTVYKGELH--DG--TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 596 ~~~~~lg~G~fg~Vy~~~~~--~g--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
...++||+|.||.|++|.|. .| -.||||.++..... ....+|.+|+.+|.+|+|||+++++|+..+ ....||||
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 34578999999999999886 34 46899999876433 367899999999999999999999999987 67899999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
+++.|+|.+.|++ .....+-......++.|||.|+.||.+ +++||||+.++|+|+.....|||+||||.+....
T Consensus 191 LaplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hcccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 9999999999965 233567888899999999999999997 8999999999999999999999999999997665
Q ss_pred CCCcee--eeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 752 GKGSIE--TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 752 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
+..... ...--.+.|+|||.+....++.++|||+|||.+|||+| |+.||.+.........++..
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~------------- 331 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG------------- 331 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc-------------
Confidence 543321 12224678999999999999999999999999999999 88999988776554443310
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
..+ .....+..++.++++.||..+|++||++..|.+.+
T Consensus 332 --erL---pRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 332 --ERL---PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred --ccC---CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 011 12234566799999999999999999999998544
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=326.08 Aligned_cols=267 Identities=24% Similarity=0.355 Sum_probs=200.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|...+.||+|+||.||+|+.+ +++.||+|+++... .......+.+|++++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccc-cCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 56889999999999999999865 67899999987543 22233567889999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++ +|.+++.. ....+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 85 YLDK-DLKQYMDD----CGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred CCCC-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 9975 88777643 23457899999999999999999997 8999999999999999999999999999875433
Q ss_pred CCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc--------Cc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL--------SK 822 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~ 822 (948)
... ......+|+.|+|||++.+ ..++.++|||||||++|||+||++||......+....+........ ..
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 157 PTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred Ccc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence 221 2233467999999998865 4689999999999999999999999987665433222211100000 00
Q ss_pred cccccccCcccC---CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 823 DSFHKAIDPTID---LNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 823 ~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..+...-.+... ..........++.+++.+|++.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000000 00000112345789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=319.74 Aligned_cols=248 Identities=30% Similarity=0.433 Sum_probs=197.7
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
|+..+.||+|+||+||+|... +++.||+|.+...... ......+.+|+++++.++|+|++++.+++.+++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999864 7899999998764322 22345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++++|.+++.. .....+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 82 MNGGDLKFHIYN---MGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred ccCccHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 999999988753 223469999999999999999999997 89999999999999999999999999998765432
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (948)
. ......|+..|+|||++.+..++.++|+||||+++|||++|+.||...........+ ......... .+.
T Consensus 156 ~--~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~--~~~~~~~~~----~~~-- 225 (285)
T cd05632 156 E--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV--DRRVLETEE----VYS-- 225 (285)
T ss_pred C--cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhhhcccc----ccC--
Confidence 2 123346899999999999899999999999999999999999999865443221111 111111010 111
Q ss_pred cCCccchHHHHHHHHHHHHHhcccCCCCCCChH
Q 002238 833 IDLNEGILASISTVAELAGHCCAREPYQRPDMG 865 (948)
Q Consensus 833 ~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ 865 (948)
.....++.+++..|++.+|++||++.
T Consensus 226 -------~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 226 -------AKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred -------ccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 11223578999999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=329.09 Aligned_cols=239 Identities=26% Similarity=0.378 Sum_probs=189.9
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHH-HHHhcCCCceeeEEeEEEeCCceEEEEEecCC
Q 002238 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIA-VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 675 (948)
+.||+|+||.||+|..+ +|+.||||++..... ......++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999875 789999999875422 1223344555554 56789999999999999999999999999999
Q ss_pred CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc
Q 002238 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (948)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 755 (948)
|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 151 (323)
T cd05575 81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-K 151 (323)
T ss_pred CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-C
Confidence 999888743 2468899999999999999999997 899999999999999999999999999987543222 1
Q ss_pred eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCC
Q 002238 756 IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDL 835 (948)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (948)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+...... +.+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~------~~i~~~~~~----~~~~--- 218 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY------DNILNKPLR----LKPN--- 218 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH------HHHHcCCCC----CCCC---
Confidence 233457999999999999999999999999999999999999999875433221 111111100 1111
Q ss_pred ccchHHHHHHHHHHHHHhcccCCCCCCChH
Q 002238 836 NEGILASISTVAELAGHCCAREPYQRPDMG 865 (948)
Q Consensus 836 ~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ 865 (948)
....+.+++.+|++.+|.+||++.
T Consensus 219 ------~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 ------ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ------CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 134588999999999999999986
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=329.33 Aligned_cols=246 Identities=22% Similarity=0.358 Sum_probs=193.4
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEEEEEecCC
Q 002238 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 675 (948)
+.||+|+||.||+|..+ +++.||||+++..... ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 6789999999865322 33456788999999888 699999999999999999999999999
Q ss_pred CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc
Q 002238 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (948)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 755 (948)
|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~ 151 (327)
T cd05617 81 GDLMFHMQR-----QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-D 151 (327)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-C
Confidence 999887742 2468999999999999999999997 899999999999999999999999999987532221 1
Q ss_pred eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCC
Q 002238 756 IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDL 835 (948)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (948)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.............+........ ....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 222 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK---------PIRI 222 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC---------CCCC
Confidence 2344679999999999999999999999999999999999999997543222111111111111110 0000
Q ss_pred ccchHHHHHHHHHHHHHhcccCCCCCCChH
Q 002238 836 NEGILASISTVAELAGHCCAREPYQRPDMG 865 (948)
Q Consensus 836 ~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ 865 (948)
. ......+.+++.+|++.||.+||++.
T Consensus 223 p---~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 223 P---RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred C---CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 0 01123478999999999999999854
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=320.34 Aligned_cols=252 Identities=29% Similarity=0.431 Sum_probs=199.9
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
|+..+.||+|+||.||+|... +++.||||.+...... ......+..|+.++++++|++++++++++.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677889999999999999865 6899999998754322 22345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++++|.+++.. .....+++.++..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++......
T Consensus 82 ~~g~~L~~~l~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 82 MNGGDLKFHIYH---MGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred cCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999988854 222468899999999999999999997 89999999999999999999999999998765433
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (948)
.. .....||..|+|||++.+..++.++||||||+++|||++|+.||................. ......
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~------~~~~~~--- 224 (285)
T cd05630 156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK------EVQEEY--- 224 (285)
T ss_pred cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh------hhhhhc---
Confidence 22 2234689999999999999999999999999999999999999986543211111110000 000000
Q ss_pred cCCccchHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 002238 833 IDLNEGILASISTVAELAGHCCAREPYQRPD-----MGHAVN 869 (948)
Q Consensus 833 ~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt-----~~ev~~ 869 (948)
.......+.+++.+|++.||++||+ +.|+++
T Consensus 225 ------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 ------SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ------CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0112235789999999999999999 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=318.30 Aligned_cols=254 Identities=26% Similarity=0.394 Sum_probs=190.7
Q ss_pred eecccCceEEEEEEEcC---CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCC
Q 002238 600 ILGRGGFGTVYKGELHD---GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676 (948)
Q Consensus 600 ~lg~G~fg~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 676 (948)
.||+|+||.||+|...+ ...+|+|.+.... .......+.+|+++++.++||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999997543 3578888775432 3344567889999999999999999999999999999999999999
Q ss_pred ChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc-
Q 002238 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS- 755 (948)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~- 755 (948)
+|.+++...........++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865332222445788889999999999999997 89999999999999999999999999998754322111
Q ss_pred eeeeecccccccCceeccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 756 IETRIAGTFGYLAPEYAVT-------GRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
......+++.|+|||+... ..++.++|||||||++|||++ |..||....+.+..... .. .. ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-----~~--~~-~~~ 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV-----VR--EQ-DIK 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH-----hh--cc-Ccc
Confidence 1223346778999998743 356889999999999999999 78888765433211110 00 00 011
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
..++.+. ......+.+++..|+ .||++||++++|++.|
T Consensus 230 ~~~~~~~-----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 230 LPKPQLD-----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCCCccc-----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 1111111 122345677888888 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.24 Aligned_cols=259 Identities=29% Similarity=0.467 Sum_probs=206.2
Q ss_pred hcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 665 (948)
.++|++.+.||+|+||.||+|..+ ++..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 467889999999999999999864 23689999986542 33445678999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHhhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEE
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEE-----GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 740 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl 740 (948)
.++||||+++|+|.+++...... ....++|..++.++.|++.||+|||+ .+++||||||+||+++.++.++|
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEE
Confidence 99999999999999998653211 12357899999999999999999997 89999999999999999999999
Q ss_pred eecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHh
Q 002238 741 ADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRI 818 (948)
Q Consensus 741 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 818 (948)
+|||+++....... .......++..|+|||.+.+..++.++|||||||++||+++ |..||......+... ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~---~~~-- 235 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK---FVI-- 235 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH---HHh--
Confidence 99999875433221 12233456789999999988889999999999999999998 999997655433211 111
Q ss_pred hcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 819 HLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
..... ..+ ...+..+.+++.+|++.+|++|||+.++++.|+
T Consensus 236 ---~~~~~-----~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 ---DGGHL-----DLP-----ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ---cCCCC-----CCC-----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11000 011 112356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=321.14 Aligned_cols=260 Identities=29% Similarity=0.458 Sum_probs=205.6
Q ss_pred hcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 665 (948)
.++|+..+.||+|+||.||+|..+ ++..||+|++.... ......++.+|+.++++++||||+++++++.++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 467899999999999999999863 46889999987542 33445779999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHhhhh-----------------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCc
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAE-----------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 728 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~ 728 (948)
.++||||+++|+|.+++..... .....+++.+++.++.|++.||+|||+ .+++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHh
Confidence 9999999999999999864211 112357889999999999999999997 89999999999
Q ss_pred cEEEcCCCCeEEeecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCch
Q 002238 729 NILLGDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPE 806 (948)
Q Consensus 729 Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~ 806 (948)
||+++.++.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999875433221 11122335678999999998999999999999999999998 88888765443
Q ss_pred hhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHh
Q 002238 807 ESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873 (948)
Q Consensus 807 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~ 873 (948)
+... ... ...... . ....+.++.+++.+|++.+|++||++.|+++.|++
T Consensus 240 ~~~~------~~~--~~~~~~-----~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 EVIY------YVR--DGNVLS-----C-----PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHH------HHh--cCCCCC-----C-----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 3211 111 111000 0 01123568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=320.97 Aligned_cols=265 Identities=25% Similarity=0.358 Sum_probs=196.2
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc---CCCceeeEEeEEEe-----CC
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV---RHRHLVALLGHCLD-----GN 664 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~-----~~ 664 (948)
+|++.+.||+|+||.||+|..+ +++.||+|.++...........+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999865 689999999876433333334566777777665 79999999998864 24
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
..++||||++ ++|.+++.. .....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDK---VPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEcccc-cCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccC
Confidence 5789999997 488887743 222458999999999999999999997 899999999999999999999999999
Q ss_pred CceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcC-cc
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS-KD 823 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~ 823 (948)
+++...... ......||..|+|||++.+..++.++||||+||++|||++|++||......+....+ ....... ..
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~--~~~~~~~~~~ 229 (288)
T cd07863 154 LARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI--FDLIGLPPED 229 (288)
T ss_pred ccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHH--HHHhCCCChh
Confidence 998654322 223456899999999999889999999999999999999999999765543322111 1110000 00
Q ss_pred cccc-------ccCcccC--CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 824 SFHK-------AIDPTID--LNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 824 ~~~~-------~~~~~~~--~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.+.. .+.+... ..........++.+++.+|++.||++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 0000000 00111123346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=316.66 Aligned_cols=251 Identities=25% Similarity=0.379 Sum_probs=199.1
Q ss_pred cCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|+..++||+|+||.||+|.. .+++.||+|++.... ......++.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 3677889999999999999986 478999999987542 33445678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|..+ ..+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 80 FMDGGSLDVY---------RKIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred cCCCCChHHh---------hcCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 9999998643 246788889999999999999997 8999999999999999999999999999885543
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhh-hHHHHHHHhhcCccccccccC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESM-HLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 830 (948)
. ......||..|+|||++.+..++.++||||||+++|||++|+.||......... ........... . ..
T Consensus 148 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~------~~ 217 (279)
T cd06619 148 S---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-E------DP 217 (279)
T ss_pred c---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-c------CC
Confidence 2 223457899999999999999999999999999999999999999764322211 00111111000 0 01
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+.+. ......++.+++.+|++.+|++||+++++++.
T Consensus 218 ~~~~----~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 218 PVLP----VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCC----CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1111 01122458899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=321.12 Aligned_cols=250 Identities=23% Similarity=0.398 Sum_probs=202.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
..+|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++|||++++++++..+...++||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 457889999999999999999864 68999999987643 233467889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++++|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++....
T Consensus 97 e~~~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 97 EYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred cccCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 99999999998742 357899999999999999999997 899999999999999999999999999987543
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
.... ......|++.|+|||.+.+..++.++|||||||++|||++|+.||....+..... .+. . .. .
T Consensus 168 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~--~~~----~-~~------~ 233 (296)
T cd06654 168 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY--LIA----T-NG------T 233 (296)
T ss_pred cccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH--HHh----c-CC------C
Confidence 3221 1233468999999999998889999999999999999999999997655422111 100 0 00 0
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+.+. ........+.+++.+|+..+|++||++.++++
T Consensus 234 ~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 234 PELQ---NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCC---CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 0010 01122345889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=320.51 Aligned_cols=271 Identities=25% Similarity=0.423 Sum_probs=200.7
Q ss_pred cCCcccceecccCceEEEEEEEc-----CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCc
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNE 665 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~ 665 (948)
++|++.+.||+|+||.||+|..+ +++.||+|++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 46888999999999999999742 5789999998654 44556789999999999999999999998754 346
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGl 745 (948)
.++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.++|+|||+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQK----HRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred eEEEEEecCCCCHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcc
Confidence 7899999999999998843 22468999999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCcee--eeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcc
Q 002238 746 VRLAPEGKGSIE--TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD 823 (948)
Q Consensus 746 a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 823 (948)
++.......... ....++..|+|||++.+..++.++||||||+++|||++|..|+........ ..............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM-RMMGNDKQGQMIVY 233 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhh-hhcccccccccchH
Confidence 986644332111 112234569999999988999999999999999999998877643221100 00000000000000
Q ss_pred ccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 824 SFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
.+.+.+..... .......+..+.+++.+|++.+|++|||+.+|++.|+.+
T Consensus 234 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGR-LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000000000 000112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=340.27 Aligned_cols=269 Identities=22% Similarity=0.265 Sum_probs=196.5
Q ss_pred HHHHHhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCC------ceeeEEe
Q 002238 586 QVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR------HLVALLG 658 (948)
Q Consensus 586 ~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~------niv~l~~ 658 (948)
+++....++|++.++||+|+||.||+|... +++.||||+++.. .....++..|+++++.++|. +++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 344455789999999999999999999864 6789999998642 22234566788888777654 5888988
Q ss_pred EEEeC-CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC-
Q 002238 659 HCLDG-NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM- 736 (948)
Q Consensus 659 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~- 736 (948)
++..+ .+.++|||++ +++|.+++.. ...+++..+..|+.||+.||+|||+ +.+||||||||+|||++.++
T Consensus 199 ~~~~~~~~~~iv~~~~-g~~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~ 270 (467)
T PTZ00284 199 YFQNETGHMCIVMPKY-GPCLLDWIMK-----HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDT 270 (467)
T ss_pred EEEcCCceEEEEEecc-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCc
Confidence 88754 5678999988 7788887743 2468999999999999999999996 25999999999999998765
Q ss_pred ---------------CeEEeecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 002238 737 ---------------RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALD 801 (948)
Q Consensus 737 ---------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~ 801 (948)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 271 VVDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred ccccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 499999998764322 2345679999999999999999999999999999999999999998
Q ss_pred CCCchhhhhHHHHHHH-----------------hhcCccccccccCcc-c---CCc--cchHHHHHHHHHHHHHhcccCC
Q 002238 802 ESQPEESMHLVTWFRR-----------------IHLSKDSFHKAIDPT-I---DLN--EGILASISTVAELAGHCCAREP 858 (948)
Q Consensus 802 ~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~-~---~~~--~~~~~~~~~l~~li~~c~~~~P 858 (948)
.....+....+..... .......+....++. + ... .........+.+|+.+|++.||
T Consensus 347 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 426 (467)
T PTZ00284 347 THDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR 426 (467)
T ss_pred CCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence 7664433322211100 000000000000000 0 000 0000112457799999999999
Q ss_pred CCCCChHHHHH
Q 002238 859 YQRPDMGHAVN 869 (948)
Q Consensus 859 ~~RPt~~ev~~ 869 (948)
++||+++|+++
T Consensus 427 ~~R~ta~e~L~ 437 (467)
T PTZ00284 427 QKRLNARQMTT 437 (467)
T ss_pred hhCCCHHHHhc
Confidence 99999999987
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=331.77 Aligned_cols=268 Identities=23% Similarity=0.306 Sum_probs=201.1
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG----- 663 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 663 (948)
...++|+..+.||+|+||.||+|... .++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34678999999999999999999764 689999999876544445567788999999999999999999988643
Q ss_pred -CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEee
Q 002238 664 -NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (948)
Q Consensus 664 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~D 742 (948)
...++||||+++ ++.+.+. ..+++.++..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEee
Confidence 346999999965 6666552 247888999999999999999997 8999999999999999999999999
Q ss_pred cCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHH-H--------
Q 002238 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLV-T-------- 813 (948)
Q Consensus 743 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~-~-------- 813 (948)
||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... .
T Consensus 163 fg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 163 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_pred CcccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99998653321 223456899999999999999999999999999999999999999875532221110 0
Q ss_pred -------HHHHhhcCccccc-----cccC-cccCCc-cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 814 -------WFRRIHLSKDSFH-----KAID-PTIDLN-EGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 814 -------~~~~~~~~~~~~~-----~~~~-~~~~~~-~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
............. .... ...+.. .........+.+++.+|++.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000000000 0000 000000 0011123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=311.59 Aligned_cols=249 Identities=32% Similarity=0.538 Sum_probs=204.8
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
++|+..+.||+|+||.||+|... |+.||||.+.... ...+++.+|+.+++.++|+||+++++++.+....++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccch---hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 56888999999999999999876 8999999987642 2467899999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++++|.+++.. .....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||.++.....
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 82 MAKGSLVDYLRS---RGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred cCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 999999998854 222468999999999999999999997 89999999999999999999999999999866332
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
.. ...++..|+|||++.+..++.++||||||+++||+++ |+.||......+....+ . .. .. .
T Consensus 156 ~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~-----~~-~~----~ 218 (256)
T cd05039 156 QD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV---E-----KG-YR----M 218 (256)
T ss_pred cc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---h-----cC-CC----C
Confidence 21 2335678999999998899999999999999999997 99999765443321111 1 00 00 0
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHh
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~ 873 (948)
.. ....+..+.+++.+|+..+|++||++.+++++|+.
T Consensus 219 ~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 EA-----PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CC-----ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 00 01123568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=317.25 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=200.0
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeC----
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG---- 663 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~---- 663 (948)
.+.+.|+..+.||+|+||.||+|... +++.||+|++... ......+..|+.+++++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC---CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 35677888999999999999999865 6889999998653 23446788999999999 799999999998753
Q ss_pred --CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEe
Q 002238 664 --NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 741 (948)
Q Consensus 664 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~ 741 (948)
...++||||+++++|.+++.. .....+++..+..++.|++.|++|||+ .+|+||||||+||++++++.++|+
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~---~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKN---TKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEc
Confidence 357899999999999998853 223568899999999999999999997 799999999999999999999999
Q ss_pred ecCCceecCCCCCceeeeecccccccCceecc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH
Q 002238 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFR 816 (948)
Q Consensus 742 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~ 816 (948)
|||+++....... ......|+..|+|||++. +..++.++|||||||++|||++|+.||....+........
T Consensus 154 Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~--- 229 (272)
T cd06637 154 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--- 229 (272)
T ss_pred cCCCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh---
Confidence 9999886543222 233456899999999986 3458889999999999999999999997654322211110
Q ss_pred HhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 817 RIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
........+. .....+.+++.+|++.+|.+||++.++++
T Consensus 230 -----~~~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 -----RNPAPRLKSK---------KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -----cCCCCCCCCC---------CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000111111 12245889999999999999999999876
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=312.53 Aligned_cols=249 Identities=29% Similarity=0.474 Sum_probs=200.3
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEE-eCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCL-DGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e 671 (948)
++|++.+.||+|+||.||+|..+ |..||+|.++.. ...+.+.+|+.++++++|+|++++++++. ++...++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 46888999999999999999876 889999988643 23467899999999999999999999765 4566899999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.+++.. .....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++....
T Consensus 81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 81 YMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 9999999998853 223458899999999999999999997 8999999999999999999999999999885433
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
.. ....++..|+|||++.+..++.++||||||+++|||++ |+.||......+. ...+.. . ..
T Consensus 155 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~---~~~~~~-----~-~~---- 217 (256)
T cd05082 155 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVEK-----G-YK---- 217 (256)
T ss_pred cC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHhc-----C-CC----
Confidence 22 22335678999999998899999999999999999998 9999876443221 111111 0 00
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
+.. ....+..+.+++.+|++.+|++||++.++++.|+++
T Consensus 218 ~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 MDA-----PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCC-----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 000 012234688999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=312.31 Aligned_cols=251 Identities=29% Similarity=0.517 Sum_probs=202.6
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
.+|+..+.||+|+||.||+|.+.++..+|+|.+..... ...++.+|++++++++|||++++++++......++||||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 46778899999999999999887788999998875422 245789999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++++|.+++.. ....+++..++.++.|++.|++|||+ .+++||||||+||+++.++.++|+|||+++.....
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 81 MEHGCLSDYLRA----QRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred CCCCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 999999988843 22467899999999999999999997 79999999999999999999999999998865433
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
.........++.+|+|||++.++.++.++||||||+++|||++ |+.||......+. .. .... . .....+
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~---~~~~--~--~~~~~~ 223 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV---VE---TINA--G--FRLYKP 223 (256)
T ss_pred cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH---HH---HHhC--C--CCCCCC
Confidence 2222222335678999999998899999999999999999998 9999976543221 11 1110 0 011111
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
.. ...++.+++.+|++.+|++||++.++++.|
T Consensus 224 ~~--------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 RL--------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CC--------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 11 124688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=316.42 Aligned_cols=256 Identities=23% Similarity=0.462 Sum_probs=203.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CC---cEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
.+|++.+.||+|+||.||+|..+ ++ ..||||++.... ......+|..|+.+++.++||||+++++++.++...++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 35778899999999999999865 33 369999987542 34456789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||||+++++|.+++.. ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++.
T Consensus 83 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 83 ITEFMENGALDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred EEecCCCCcHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccc
Confidence 9999999999988843 23468999999999999999999997 8999999999999999999999999999875
Q ss_pred cCCCCCcee--eeec--ccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCcc
Q 002238 749 APEGKGSIE--TRIA--GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKD 823 (948)
Q Consensus 749 ~~~~~~~~~--~~~~--gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 823 (948)
......... .... .+..|+|||++.+..++.++|||||||++||+++ |..||......+. ..++.. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~---~~~i~~----~~ 228 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---INAIEQ----DY 228 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH---HHHHHc----CC
Confidence 543222111 1111 2457999999999999999999999999999987 9999976554322 221111 00
Q ss_pred ccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 824 SFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
. ++.. ...+..+.+++.+|++.+|++||++.+|+..|+.+
T Consensus 229 ~--------~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 R--------LPPP---MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred c--------CCCc---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0000 12234588999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.51 Aligned_cols=257 Identities=30% Similarity=0.488 Sum_probs=203.6
Q ss_pred cCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCce
Q 002238 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 666 (948)
++|...+.||+|+||.||+|... ++..+|+|.+... .......+.+|+++++.++|+||+++++++.++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 46778899999999999999642 3568999987653 445567899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHhhhh----------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC
Q 002238 667 LLVFEYMPQGTLSRHIFNWAE----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 736 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~ 736 (948)
++||||+++++|.+++..... .....+++.+++.++.|++.|++|||+ .+++||||||+||++++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCC
Confidence 999999999999999864211 011358899999999999999999997 8999999999999999999
Q ss_pred CeEEeecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHH
Q 002238 737 RAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTW 814 (948)
Q Consensus 737 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~ 814 (948)
.++|+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |++||......+.....
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-- 237 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI-- 237 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH--
Confidence 999999999875533221 11222345788999999999999999999999999999998 99999765443321111
Q ss_pred HHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 815 FRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
..... ... ....+..+.+++.+|++.+|.+||++.+|.+.|+
T Consensus 238 ----~~~~~-------~~~-----~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 ----TQGRE-------LER-----PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ----HcCcc-------CCC-----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 10000 000 0112345889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=322.49 Aligned_cols=264 Identities=23% Similarity=0.340 Sum_probs=203.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|++.+.||+|+||.||+|... ++..||+|.+.... ......++.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 36889999999999999999865 68889999886542 33445678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.+++.. ...+++..+..++.|+++||+|||+ +.+++||||||+||+++.++.++|+|||++.....
T Consensus 80 y~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 80 HMDGGSLDQVLKK-----AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred ccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 9999999999843 2568899999999999999999997 35899999999999999999999999999875433
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccc-------
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDS------- 824 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 824 (948)
. ......|+..|+|||++.+..++.++||||||+++|||++|+.||........................
T Consensus 153 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 153 S---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred c---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 2 123456899999999998888999999999999999999999999654422211111000000000000
Q ss_pred -------------c---ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 825 -------------F---HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 825 -------------~---~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
. .....+.++ ......++.+++.+|++.+|++||++.++++.-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLP----SGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCc----CcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0 000000000 001234688999999999999999999998853
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=327.01 Aligned_cols=264 Identities=27% Similarity=0.433 Sum_probs=203.8
Q ss_pred hcCCcccceecccCceEEEEEEE------cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeC-
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG- 663 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~- 663 (948)
.++|++.+.||+|+||.||+|.+ .+++.||||+++... .......+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 35799999999999999999973 357899999987542 334456788999999999 689999999988654
Q ss_pred CceEEEEEecCCCChhHHHHhhhhc-------------------------------------------------------
Q 002238 664 NEKLLVFEYMPQGTLSRHIFNWAEE------------------------------------------------------- 688 (948)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 688 (948)
...++||||+++|+|.++++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 4578999999999999988642100
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc-eeeee
Q 002238 689 -------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS-IETRI 760 (948)
Q Consensus 689 -------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~ 760 (948)
....+++.++.+++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++........ .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 01347889999999999999999997 89999999999999999999999999998865332211 11223
Q ss_pred cccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccch
Q 002238 761 AGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGI 839 (948)
Q Consensus 761 ~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (948)
.+++.|+|||++.+..++.++||||||+++|||++ |..||........ ... ... .... ...+ .
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~---~~~--~~~~-----~~~~--~-- 305 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR---RLK--EGTR-----MRAP--D-- 305 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHH---HHh--ccCC-----CCCC--C--
Confidence 45678999999999999999999999999999997 9999876433211 111 000 0000 0000 0
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 840 LASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 840 ~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
....++.+++.+|++.+|++||++.+|++.|+.+.+
T Consensus 306 -~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 306 -YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred -CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 112358899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=328.35 Aligned_cols=257 Identities=21% Similarity=0.296 Sum_probs=198.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|++.+.||+|+||.||+++.+ +++.||+|++.+... .......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46889999999999999999875 578899999865321 2233456888999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ey~~~g~L~~~l~~----~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 99999999999853 22468899999999999999999997 899999999999999999999999999987554
Q ss_pred CCCCceeeeecccccccCceecc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
...........||+.|+|||++. ...++.++|||||||++|||++|+.||......+... .+.......
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~------~i~~~~~~~ 227 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHKERF 227 (332)
T ss_pred cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH------HHhCCCccc
Confidence 33332333457999999999986 3468899999999999999999999998654333211 111111000
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCC--CCChHHHHHH
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQ--RPDMGHAVNV 870 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~--RPt~~ev~~~ 870 (948)
...........++.+++.+|+..++.+ |+++.+++++
T Consensus 228 --------~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 --------QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --------cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 001111122345788999988665544 6788888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=322.44 Aligned_cols=263 Identities=27% Similarity=0.428 Sum_probs=207.1
Q ss_pred hcCCcccceecccCceEEEEEEEc--------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEe
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH--------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD 662 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 662 (948)
.++|.+.+.||+|+||.||+|+.. ....||+|.++... ......++.+|+++++++ +||||+++++++.+
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 357888999999999999999742 24579999887542 344567789999999999 69999999999999
Q ss_pred CCceEEEEEecCCCChhHHHHhhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEE
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nil 731 (948)
.+..++||||+++|+|.+++..... .....++|.++.+++.|++.||+|||+ ++++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEE
Confidence 9999999999999999999865321 112468999999999999999999997 89999999999999
Q ss_pred EcCCCCeEEeecCCceecCCCCCc-eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhh
Q 002238 732 LGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESM 809 (948)
Q Consensus 732 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~ 809 (948)
++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||......+..
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999999855432211 1112234568999999998899999999999999999999 88999765443322
Q ss_pred hHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 810 HLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
... . . ... . .. ....+.++.+++.+|++.+|++||++.++++.|.++..
T Consensus 247 ~~~---~---~-~~~-~-----~~-----~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 247 KLL---R---E-GHR-M-----DK-----PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHH---H---c-CCC-C-----CC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 111 1 0 000 0 00 11123458899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=351.86 Aligned_cols=259 Identities=21% Similarity=0.373 Sum_probs=202.8
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--Cce
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEK 666 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 666 (948)
...++|++.+.||+|+||.||+|... +++.||+|++............+..|+.++++++|||||++++++.+. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 44578999999999999999999865 578899999876555555667899999999999999999999988653 468
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcc----CCCeeecCCCCccEEEcCC-------
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA----HQSFIHRDLKPSNILLGDD------- 735 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----~~~ivHrDik~~Nill~~~------- 735 (948)
|+||||+++|+|.+++..... ....+++..++.|+.||+.||+|||+.. ..+||||||||+|||++.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 999999999999999865322 2357899999999999999999999732 1459999999999999642
Q ss_pred ----------CCeEEeecCCceecCCCCCceeeeecccccccCceeccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 002238 736 ----------MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT--GRVTTKVDVFSFGVILMELITGRKALDES 803 (948)
Q Consensus 736 ----------~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~elltg~~p~~~~ 803 (948)
+.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 348999999998654322 2234579999999999864 45889999999999999999999999764
Q ss_pred CchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 804 QPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 804 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..... +.. .+.. . +.+... .....+.+||..||+.+|.+||++.+++.
T Consensus 247 ~~~~q--li~---~lk~-~--------p~lpi~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNFSQ--LIS---ELKR-G--------PDLPIK----GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcHHH--HHH---HHhc-C--------CCCCcC----CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 43221 111 1110 0 111101 12345889999999999999999999985
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=330.42 Aligned_cols=267 Identities=24% Similarity=0.309 Sum_probs=200.6
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC------
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------ 663 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 663 (948)
..++|+..+.||+|+||.||+|... .++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999864 688999999876544445567788999999999999999999987543
Q ss_pred CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeec
Q 002238 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (948)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~Df 743 (948)
...++||||+++ +|.+.+. ..+++.++..++.|+++||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-------hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeC
Confidence 356999999965 6766652 247888999999999999999997 89999999999999999999999999
Q ss_pred CCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHH---------
Q 002238 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTW--------- 814 (948)
Q Consensus 744 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~--------- 814 (948)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..
T Consensus 171 G~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 171 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9998653322 22345689999999999999999999999999999999999999987654332111100
Q ss_pred -------HHHhhcCccc-----cccccCccc-CC-ccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 815 -------FRRIHLSKDS-----FHKAIDPTI-DL-NEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 815 -------~~~~~~~~~~-----~~~~~~~~~-~~-~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.......... +.+.+.... +. ..........+.+++.+|++.||.+|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000 000000000 00 00001122467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=315.73 Aligned_cols=258 Identities=24% Similarity=0.395 Sum_probs=204.9
Q ss_pred hcCCcccceecccCceEEEEEEEcC----CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
.++|.+.+.||+|+||.||+|.+.+ ...||||...... .....+.+.+|+.++++++||||+++++++.+ ...+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 3468888999999999999998643 2468999876542 24456789999999999999999999998865 5678
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++
T Consensus 83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~ 155 (270)
T cd05056 83 IVMELAPLGELRSYLQV----NKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155 (270)
T ss_pred EEEEcCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceee
Confidence 99999999999999843 22458999999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 748 LAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
..............++..|+|||.+....++.++||||||+++||+++ |..||......+.. .... ... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~~---~~~-~~- 227 (270)
T cd05056 156 YLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GRIE---NGE-RL- 227 (270)
T ss_pred ecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHH---cCC-cC-
Confidence 655443222223335578999999988889999999999999999986 99999776543221 1111 000 00
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
.. ....+..+.+++.+|+..+|++||++.++++.|+.+..
T Consensus 228 -~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 -PM---------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -CC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00 01123468899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=311.25 Aligned_cols=251 Identities=23% Similarity=0.350 Sum_probs=203.6
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
+|++.+.||+|+||.||++... +++.||+|.++... .....+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 4788899999999999999865 68999999986532 334567888999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++|+|.+++.. .....+++..++.++.|++.||+|||+ .+++|+||||+||++++++.++++|||+++.....
T Consensus 80 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 80 CDGGDLMQKIKL---QRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred CCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 999999888743 223567899999999999999999997 89999999999999999999999999998865432
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (948)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.......... ... ..... .+..
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~------~~~--~~~~~-~~~~- 222 (255)
T cd08219 154 GA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL------KVC--QGSYK-PLPS- 222 (255)
T ss_pred cc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH------HHh--cCCCC-CCCc-
Confidence 21 2234568999999999998899999999999999999999999998654322111 111 11110 0111
Q ss_pred cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 833 IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 833 ~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.....+.+++.+|++.+|++||++.+++..
T Consensus 223 --------~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 --------HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --------ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 122357899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=311.66 Aligned_cols=248 Identities=28% Similarity=0.462 Sum_probs=197.4
Q ss_pred ceecccCceEEEEEEEc--C--CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecC
Q 002238 599 NILGRGGFGTVYKGELH--D--GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 674 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~--~--g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 674 (948)
+.||+|+||.||+|.+. + +..||+|.+...... ...+++.+|+.+++++.||||+++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 46999999999999753 2 268999998765332 45578999999999999999999999875 556899999999
Q ss_pred CCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCC
Q 002238 675 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 754 (948)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~ 754 (948)
+|+|.+++.. ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 79 LGPLLKYLKK-----RREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 9999999853 1368999999999999999999997 7999999999999999999999999999986544332
Q ss_pred ceee--eecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 755 SIET--RIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 755 ~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
.... ...++..|+|||.+.+..++.++||||||+++||+++ |..||......+. ..++... ... .
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~---~~~~~~~----~~~--~--- 218 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV---IAMLESG----ERL--P--- 218 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHHHcC----CcC--C---
Confidence 2211 1224568999999998899999999999999999998 9999977654322 2222111 000 0
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
.....+..+.+++.+|+..+|++||++.++.+.|+.+
T Consensus 219 ------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 ------RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 0011234588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=317.58 Aligned_cols=268 Identities=23% Similarity=0.330 Sum_probs=202.8
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|+..+.||+|+||.||+|+.+ +|+.||+|++..........+.+.+|+.++++++|||++++++++.++...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999876 68999999987543233334668899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|++++.|..++. ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEK-----NPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 999988877652 22468999999999999999999997 8999999999999999999999999999986544
Q ss_pred CCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHH-HHHHhh------cCcc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVT-WFRRIH------LSKD 823 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~-~~~~~~------~~~~ 823 (948)
... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||.+....+...... ...... ....
T Consensus 153 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 153 PGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred Ccc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 321 1223457889999999876 457899999999999999999999998765433221111 000000 0000
Q ss_pred cc-ccccCcccC----CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 824 SF-HKAIDPTID----LNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 824 ~~-~~~~~~~~~----~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.+ .....+... ...........+.+++.+|++.+|++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 000000000 00001122356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=317.42 Aligned_cols=251 Identities=26% Similarity=0.381 Sum_probs=200.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
+.|++.+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|+.+++.++|||++++++++..+...++|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 56888999999999999999875 5899999998754 44556788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|..++.. ....+++..+..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 90 ~~~~~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 90 FCPGGAVDAIMLE----LDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred cCCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 9999999887743 22468999999999999999999996 8999999999999999999999999999875433
Q ss_pred CCCceeeeecccccccCceecc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
... ......+++.|+|||++. ...++.++|||||||++|||++|+.||....+.... . .....
T Consensus 163 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--~----~~~~~----- 230 (292)
T cd06644 163 TLQ-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL--L----KIAKS----- 230 (292)
T ss_pred ccc-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH--H----HHhcC-----
Confidence 221 223456889999999985 345688999999999999999999999765432211 1 11100
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..+.... ......++.+++.+|++.+|++||++.++++
T Consensus 231 --~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 231 --EPPTLSQ---PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred --CCccCCC---CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0011110 0112235789999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=325.32 Aligned_cols=244 Identities=24% Similarity=0.364 Sum_probs=194.9
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCceEEEE
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 670 (948)
+|+..+.||+|+||.||+|..+ +|+.||||++..... .....+.+..|..++..+. |++|+++.+++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999865 689999999876432 2334566788999998885 577888999999989999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.++|+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 99999999988743 2468999999999999999999997 899999999999999999999999999987543
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........... +......+.
T Consensus 153 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~------i~~~~~~~p---- 221 (323)
T cd05615 153 VDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS------IMEHNVSYP---- 221 (323)
T ss_pred CCC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH------HHhCCCCCC----
Confidence 222 123345699999999999999999999999999999999999999987654322111 111010000
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChH
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMG 865 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ 865 (948)
.....++.+++.+|++.+|.+|++..
T Consensus 222 ---------~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 222 ---------KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ---------ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 11123578999999999999999854
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=327.42 Aligned_cols=243 Identities=26% Similarity=0.351 Sum_probs=190.6
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHH-HHHhcCCCceeeEEeEEEeCCceEEEEEecCC
Q 002238 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIA-VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 675 (948)
+.||+|+||.||+|+.+ +++.||+|++...... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 6788999998754221 222334445544 56888999999999999999999999999999
Q ss_pred CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc
Q 002238 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (948)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 755 (948)
|+|.+++.. ...+.+..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~- 151 (325)
T cd05602 81 GELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG- 151 (325)
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-
Confidence 999988843 2457788888999999999999997 8999999999999999999999999999875433221
Q ss_pred eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCC
Q 002238 756 IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDL 835 (948)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (948)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .. ...... .+.+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~---i~~~~~----~~~~~--- 218 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY---DN---ILNKPL----QLKPN--- 218 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH---HH---HHhCCc----CCCCC---
Confidence 234457999999999999999999999999999999999999999875543321 11 111000 01111
Q ss_pred ccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 836 NEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 836 ~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
....+.+++.+|++.+|.+||++.+.+.
T Consensus 219 ------~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 219 ------ITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred ------CCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 2235789999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=328.70 Aligned_cols=244 Identities=25% Similarity=0.356 Sum_probs=192.2
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHH-HHHhcCCCceeeEEeEEEeCCceEEEEEecCC
Q 002238 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIA-VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 675 (948)
+.||+|+||.||+|+.+ +|+.||||++..... .......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999864 789999999875422 2233455566655 56778999999999999999999999999999
Q ss_pred CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc
Q 002238 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (948)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 755 (948)
|+|..++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~ 151 (325)
T cd05604 81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-D 151 (325)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-C
Confidence 999887732 2568999999999999999999997 899999999999999999999999999987533222 1
Q ss_pred eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCC
Q 002238 756 IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDL 835 (948)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (948)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ...... ..+.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~------~~~~~~----~~~~~---- 217 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD------NILHKP----LVLRP---- 217 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH------HHHcCC----ccCCC----
Confidence 2334579999999999999999999999999999999999999998755432211 111100 00111
Q ss_pred ccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 836 NEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 836 ~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.....+.+++.+|++.+|.+||++.+.++.
T Consensus 218 -----~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 218 -----GASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred -----CCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 122357799999999999999998654433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=334.03 Aligned_cols=262 Identities=22% Similarity=0.294 Sum_probs=196.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
...|.+.+.||+|+||.||+|... +++.||||.... ..+.+|++++++++|||||++++++..++..++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 447999999999999999999875 578999996432 34578999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
|++. ++|.+++.. ....++|.+++.|+.|+++||+|||+ .+||||||||+|||++.++.++|+|||+++...
T Consensus 240 e~~~-~~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 240 PKYR-SDLYTYLGA----RLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred EccC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 9995 688877743 23479999999999999999999997 899999999999999999999999999998654
Q ss_pred CCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----hhhhHHHHHHHhhcCccc
Q 002238 751 EGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPE-----ESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 751 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~ 824 (948)
.... .......||+.|+|||++.+..++.++|||||||++|||++|..|+...... ....+...+.........
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 3221 1223457999999999999999999999999999999999988765432211 011122222221111011
Q ss_pred ccccc----------------CcccCCccch---HHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 825 FHKAI----------------DPTIDLNEGI---LASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 825 ~~~~~----------------~~~~~~~~~~---~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+.... .+... ...+ ......+.+++.+|++.||.+||++.|+++.
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYT-RPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccC-CcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 10000 00000 0000 0112357899999999999999999999874
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=317.24 Aligned_cols=262 Identities=24% Similarity=0.447 Sum_probs=202.2
Q ss_pred cCCcccceecccCceEEEEEEE-----cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--Cc
Q 002238 593 NNFSEENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NE 665 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~ 665 (948)
+.|++.+.||+|+||.||+|+. .++..||+|.++... .......+.+|+++++.++|||++++.+++.+. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3578889999999999999974 357899999986542 344457899999999999999999999998775 56
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGl 745 (948)
.++||||+++++|.+++.. ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+
T Consensus 83 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPR----NKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred eEEEEEccCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcc
Confidence 7899999999999998843 22468999999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCc--eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---------hhhhHHHH
Q 002238 746 VRLAPEGKGS--IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPE---------ESMHLVTW 814 (948)
Q Consensus 746 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~---------~~~~~~~~ 814 (948)
++........ ......++..|+|||++.+..++.++||||||+++|||++++.|....... .......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 9865433221 122345677899999998888999999999999999999987765332110 00000111
Q ss_pred HHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 815 FRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
...... .. ..+ ........+.+++.+|++.+|++||++.++++.++.+
T Consensus 236 ~~~~~~--~~-------~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 VRVLEE--GK-------RLP---RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHc--Cc-------cCC---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111100 00 000 0112335689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=323.13 Aligned_cols=264 Identities=28% Similarity=0.407 Sum_probs=208.0
Q ss_pred cCCcccceecccCceEEEEEEEc--------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeC
Q 002238 593 NNFSEENILGRGGFGTVYKGELH--------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG 663 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 663 (948)
.+|++.+.||+|+||.||+|... .+..||+|.++.. ......+++.+|+++++++ +||||+++++++..+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 46889999999999999999742 1236899987753 2344567899999999999 899999999999999
Q ss_pred CceEEEEEecCCCChhHHHHhhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE
Q 002238 664 NEKLLVFEYMPQGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732 (948)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill 732 (948)
+..++||||+++|+|.+++..... .....++|.+++.++.|++.||+|||+ ++++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEE
Confidence 999999999999999999864211 112458899999999999999999997 899999999999999
Q ss_pred cCCCCeEEeecCCceecCCCCCce-eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhh
Q 002238 733 GDDMRAKVADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMH 810 (948)
Q Consensus 733 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~ 810 (948)
+.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......+...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 999999999999998654322111 122234578999999999999999999999999999998 888987655433211
Q ss_pred HHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhh
Q 002238 811 LVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELW 878 (948)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 878 (948)
.+ .. ... ... ......++.+++.+|++.+|++||++.++++.|+.+....
T Consensus 248 ~~------~~-~~~------~~~-----~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 248 LL------KE-GHR------MDK-----PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HH------Hc-CCC------CCC-----CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11 11 000 000 0122346889999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.40 Aligned_cols=252 Identities=22% Similarity=0.359 Sum_probs=203.2
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-CceEEEEE
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-NEKLLVFE 671 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e 671 (948)
+|++.+.||+|++|.||++..+ +++.||+|++..........+.+.+|++++++++|||++++++.+... ...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999865 578999999876544555567789999999999999999999887643 45789999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.+++.. .....+++.+++.++.+++.|++|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~l~~---~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKE---QKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 9999999998854 223568999999999999999999997 8999999999999999999999999999986643
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
.. .......|++.|+|||++.+..++.++||||||+++|||++|+.||......... .... .... +
T Consensus 155 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~------~~~~--~~~~-----~ 220 (257)
T cd08223 155 QC-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV------YRII--EGKL-----P 220 (257)
T ss_pred cC-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH------HHHH--hcCC-----C
Confidence 32 2233456899999999999999999999999999999999999999765432211 1111 0101 0
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.. .......+.+++.+|++.+|++||++.+++++
T Consensus 221 ~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 PM-----PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CC-----ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 01 11223468899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=313.64 Aligned_cols=253 Identities=32% Similarity=0.491 Sum_probs=196.9
Q ss_pred ceecccCceEEEEEEEc-CCc--EEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEEEEEecC
Q 002238 599 NILGRGGFGTVYKGELH-DGT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMP 674 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 674 (948)
+.||+|+||.||+|.++ ++. .+|+|.++.. ........+.+|++++.++ +||||+++++++......++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 36899999999999875 343 4688887642 2344556889999999999 89999999999999999999999999
Q ss_pred CCChhHHHHhhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeec
Q 002238 675 QGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (948)
Q Consensus 675 ~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~Df 743 (948)
+|+|.+++..... .....+++.+++.++.|++.|++|||+ .+++||||||+||++++++.+|++||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCC
Confidence 9999999864221 112357899999999999999999997 89999999999999999999999999
Q ss_pred CCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCc
Q 002238 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSK 822 (948)
Q Consensus 744 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 822 (948)
|++....... .......+..|+|||++....++.++||||||+++|||++ |..||......+... .... .
T Consensus 157 gl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~------~~~~-~ 227 (270)
T cd05047 157 GLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE------KLPQ-G 227 (270)
T ss_pred CCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHH------HHhC-C
Confidence 9986322111 1111224668999999988889999999999999999997 999997654322111 1100 0
Q ss_pred cccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhh
Q 002238 823 DSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875 (948)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~ 875 (948)
... .. .......+.+++.+|++.+|.+||++.+++..|.++.
T Consensus 228 ~~~------~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 YRL------EK-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC------CC-----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000 00 0112345889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=312.91 Aligned_cols=239 Identities=23% Similarity=0.390 Sum_probs=187.7
Q ss_pred ceecccCceEEEEEEEcC-------------CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc
Q 002238 599 NILGRGGFGTVYKGELHD-------------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 665 (948)
+.||+|+||.||+|.+.+ ...||+|++... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 358999999999998542 235888987653 23344678899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCC-------e
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR-------A 738 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~-------~ 738 (948)
.++||||+++|+|..++.. ....+++..+++++.||++||+|||+ .+|+||||||+|||++.++. +
T Consensus 79 ~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHR----KSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred CEEEEecccCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCcee
Confidence 9999999999999887742 23468999999999999999999997 89999999999999987664 8
Q ss_pred EEeecCCceecCCCCCceeeeecccccccCceecc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCchhhhhHHHHHH
Q 002238 739 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV-TGRVTTKVDVFSFGVILMELI-TGRKALDESQPEESMHLVTWFR 816 (948)
Q Consensus 739 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gv~l~ell-tg~~p~~~~~~~~~~~~~~~~~ 816 (948)
+++|||++...... ....++..|+|||++. +..++.++|||||||++|||+ +|+.|+......+....
T Consensus 152 ~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~----- 221 (262)
T cd05077 152 KLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF----- 221 (262)
T ss_pred EeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-----
Confidence 99999998754322 2245788999999886 466899999999999999998 58888875443221110
Q ss_pred HhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 817 RIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
. .... ... ......+.+++.+||+.||.+||++.+|++.+
T Consensus 222 --~--~~~~-~~~----------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 222 --Y--EGQC-MLV----------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred --H--hcCc-cCC----------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 0000 000 01124588999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=317.59 Aligned_cols=267 Identities=22% Similarity=0.354 Sum_probs=200.5
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
+|++.+.||+|+||.||+|+.+ +++.||||++............+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999875 689999999876433333456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
++ ++|.+++... .....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 81 LS-MDLKKYLDSL--PKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred CC-CCHHHHHhcC--CCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 97 6888877432 222568999999999999999999997 89999999999999999999999999998754332
Q ss_pred CCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc---------
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK--------- 822 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 822 (948)
. .......+++.|+|||++.+. .++.++||||||+++|||+||+.||.......... ..........
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 155 V-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF--RIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred c-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHHHHhCCCChhhhhcchh
Confidence 2 122334578999999988654 57899999999999999999999998654332211 1111000000
Q ss_pred -cccccccCcccC--CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 823 -DSFHKAIDPTID--LNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 823 -~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..+...++.... ..........++.+++.+|++.||++||++.+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000 00001112346789999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=332.15 Aligned_cols=248 Identities=23% Similarity=0.394 Sum_probs=195.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|+..+.||+|+||.||+|..+ +++.||||++..... .......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999865 689999999975322 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++|+|||+++...
T Consensus 81 E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMK-----KDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999998843 2468899999999999999999997 899999999999999999999999999987432
Q ss_pred CCCC----------------------------------ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhC
Q 002238 751 EGKG----------------------------------SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG 796 (948)
Q Consensus 751 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg 796 (948)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 2110 011235799999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCCh
Q 002238 797 RKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDM 864 (948)
Q Consensus 797 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~ 864 (948)
+.||....+......+ ....... .+.+... ...++.+++.+|+ .+|.+|++.
T Consensus 233 ~~Pf~~~~~~~~~~~i------~~~~~~~--~~p~~~~-------~s~~~~~li~~l~-~~p~~R~~~ 284 (360)
T cd05627 233 YPPFCSETPQETYRKV------MNWKETL--VFPPEVP-------ISEKAKDLILRFC-TDSENRIGS 284 (360)
T ss_pred CCCCCCCCHHHHHHHH------HcCCCce--ecCCCCC-------CCHHHHHHHHHhc-cChhhcCCC
Confidence 9999876654322111 1100000 0111111 1234778888876 499999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=317.56 Aligned_cols=250 Identities=25% Similarity=0.369 Sum_probs=198.7
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
.|++.+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+++++.++|||++++++++..+...++||||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 3667788999999999999875 5788899988643 345567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++++|..++.. ...++++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~l~~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 156 (282)
T cd06643 84 CAGGAVDAVMLE----LERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 156 (282)
T ss_pred cCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccc
Confidence 999999887743 23578999999999999999999997 89999999999999999999999999998754332
Q ss_pred CCceeeeecccccccCceecc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 753 KGSIETRIAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
.. ......|++.|+|||++. +..++.++|||||||++|||++|++||....+.+.. ..... ..
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~~~----~~----- 224 (282)
T cd06643 157 IQ-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL--LKIAK----SE----- 224 (282)
T ss_pred cc-ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH--HHHhh----cC-----
Confidence 21 223356899999999974 445788999999999999999999999765432221 11100 00
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.+.+... ......+.+++.+|++.+|.+||++.++++
T Consensus 225 --~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 225 --PPTLAQP---SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred --CCCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 112345889999999999999999998876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=292.74 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=201.3
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv 669 (948)
.++.+....||.|+.|.||+++.+ +|..+|||.+.... ...+.+++...++++.... +|.||+.+|||..+..+++.
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 344555677999999999999875 68999999998753 5566788888998887774 99999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
||.|. .-++.+++ ...+++++..+-++...++.||.||.+ +++|+|||+||+|||+|+.|++|+||||++-+.
T Consensus 170 MelMs-~C~ekLlk----rik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 170 MELMS-TCAEKLLK----RIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred HHHHH-HHHHHHHH----HhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeeccccccee
Confidence 99983 23444442 334678888888999999999999998 799999999999999999999999999999877
Q ss_pred CCCCCceeeeecccccccCceeccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-hhhhHHHHHHHhhcCcccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVT---GRVTTKVDVFSFGVILMELITGRKALDESQPE-ESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~ 825 (948)
.+.. ..++.+|-+.|||||.+.- ..|+.++||||||+.++||.||+.||.....+ +....+ ..
T Consensus 243 vdSk--AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv------ln----- 309 (391)
T KOG0983|consen 243 VDSK--AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV------LN----- 309 (391)
T ss_pred eccc--ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH------Hh-----
Confidence 6654 3456679999999999864 46899999999999999999999999875432 221111 10
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
...|.++.... ....+.+++..|++.|+.+||.+.+++++
T Consensus 310 --~ePP~L~~~~g---FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 310 --EEPPLLPGHMG---FSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --cCCCCCCcccC---cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11133332221 34568999999999999999999998874
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=309.08 Aligned_cols=252 Identities=24% Similarity=0.406 Sum_probs=207.5
Q ss_pred CCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
+|+..+.||+|+||.||.++. ++++.+++|.+...........++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999975 4689999999876655566677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++++|.+++.. .....+++.++..++.|++.|++|||+ .+++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVR---QKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 999999998853 113568999999999999999999997 79999999999999999999999999999866443
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (948)
.. ......|++.|+|||+..+..++.++||||||+++|||++|+.||......+... .... ......
T Consensus 155 ~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~------~~~~--~~~~~~---- 221 (256)
T cd08221 155 YS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV------KIVQ--GNYTPV---- 221 (256)
T ss_pred cc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHHc--CCCCCC----
Confidence 32 2334568999999999988889999999999999999999999997654432211 1111 111100
Q ss_pred cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 833 IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 833 ~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
......++.+++.+|++.+|.+||++.++++.
T Consensus 222 ------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 ------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ------ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 01223458899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=318.25 Aligned_cols=265 Identities=22% Similarity=0.352 Sum_probs=204.9
Q ss_pred eeHHHHHHhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEE
Q 002238 583 ISIQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHC 660 (948)
Q Consensus 583 ~~~~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~ 660 (948)
+.++.+..+.++|++.+.||+|+||.||+|... +++.+|+|++... .....++..|+.+++.+ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 344555667889999999999999999999864 6889999987542 22235688899999999 799999999988
Q ss_pred E-----eCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC
Q 002238 661 L-----DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 735 (948)
Q Consensus 661 ~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~ 735 (948)
. .++..++||||+++++|.+++..... ....+++..+..++.|+++||.|||+ .+++||||||+||+++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~ 160 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTE 160 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCC
Confidence 4 34568999999999999998764322 23568899999999999999999997 899999999999999999
Q ss_pred CCeEEeecCCceecCCCCCceeeeecccccccCceeccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhh
Q 002238 736 MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT-----GRVTTKVDVFSFGVILMELITGRKALDESQPEESMH 810 (948)
Q Consensus 736 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~ 810 (948)
+.++|+|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.||....+.....
T Consensus 161 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~ 239 (286)
T cd06638 161 GGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF 239 (286)
T ss_pred CCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh
Confidence 9999999999886543221 2233468999999998753 457889999999999999999999997654322110
Q ss_pred HHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 811 LVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
. .. ........++. .....+.+++.+|++.+|++||++.|+++..
T Consensus 240 --~----~~--~~~~~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 240 --K----IP--RNPPPTLHQPE--------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred --h----cc--ccCCCcccCCC--------CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 00 00000111111 1123588999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=317.58 Aligned_cols=250 Identities=23% Similarity=0.407 Sum_probs=203.4
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 46899999999999999999986 479999999987542 233467889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++++|.+++.. ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 96 e~~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 96 EYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred cccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 99999999998743 457889999999999999999997 899999999999999999999999999988654
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
.... ......|++.|+|||.+.+..++.++|||||||++|++++|+.||....+....... .....
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-------------~~~~~ 232 (297)
T cd06656 167 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------ATNGT 232 (297)
T ss_pred CCcc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-------------ccCCC
Confidence 3322 223346889999999999888999999999999999999999999765432211000 00000
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+... ........+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 233 PELQ---NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1110 11122345789999999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=311.32 Aligned_cols=249 Identities=26% Similarity=0.443 Sum_probs=203.9
Q ss_pred cCCcccceecccCceEEEEEEEcC-CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|+..+.||+|+||.||+|..++ ++.||+|.+... ...+++.+|++++++++||||+++++++.++...+++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 578889999999999999998764 789999998653 126789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.+++.. ....+++..+..++.|++.|++|||+ .+++||||+|+||+++.++.++|+|||++.....
T Consensus 79 ~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 79 YCGAGSVSDIMKI----TNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred cCCCCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 9999999998843 23578999999999999999999997 7999999999999999999999999999886544
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
... ......|+..|+|||++.+..++.++||||||+++|||++|+.||....+....... . ....+
T Consensus 152 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~---------~----~~~~~ 217 (256)
T cd06612 152 TMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI---------P----NKPPP 217 (256)
T ss_pred Ccc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh---------c----cCCCC
Confidence 321 223355889999999999889999999999999999999999999865443211100 0 00001
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.+. ........+.+++.+|++.+|++||++.++++
T Consensus 218 ~~~---~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 TLS---DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCC---chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 111 11122345889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=329.04 Aligned_cols=266 Identities=23% Similarity=0.344 Sum_probs=200.0
Q ss_pred HHhhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC----
Q 002238 589 RNVTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG---- 663 (948)
Q Consensus 589 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~---- 663 (948)
..+.++|++.+.||+|+||.||+|.. .+++.||||++............+.+|++++++++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 34578899999999999999999986 4688999999876433334456788999999999999999999887543
Q ss_pred --CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEe
Q 002238 664 --NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 741 (948)
Q Consensus 664 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~ 741 (948)
...++++|++ +++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEc
Confidence 3468999988 7789877632 468999999999999999999997 899999999999999999999999
Q ss_pred ecCCceecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc
Q 002238 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL 820 (948)
Q Consensus 742 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 820 (948)
|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+ ......
T Consensus 161 Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~ 234 (343)
T cd07878 161 DFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI--MEVVGT 234 (343)
T ss_pred CCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH--HHHhCC
Confidence 99999865432 234568999999999877 56899999999999999999999999765433221111 100000
Q ss_pred Cccccc---------cccC--cccCC---ccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 821 SKDSFH---------KAID--PTIDL---NEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 821 ~~~~~~---------~~~~--~~~~~---~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
...... .... +.... ..........+.+++.+|++.||.+||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0000 00000 00000112347799999999999999999999874
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=317.80 Aligned_cols=250 Identities=22% Similarity=0.414 Sum_probs=203.6
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
..+|+..+.||.|+||.||+|.. .+++.||+|.+... .......+.+|+.+++.++|||++++++++..++..++||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ--KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc--cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 35689999999999999999975 47899999998754 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++++|.+++.. ..+++.++..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 96 e~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 96 EYLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred EecCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 99999999988742 358999999999999999999997 899999999999999999999999999987544
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
.... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||....+........ .. . .
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~---~~---~--~----- 232 (296)
T cd06655 167 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TN---G--T----- 232 (296)
T ss_pred cccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hc---C--C-----
Confidence 3321 2233468899999999998889999999999999999999999998765433221110 00 0 0
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+.+. ........+.+++.+|+..+|.+||++.++++
T Consensus 233 ~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 233 PELQ---NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cccC---CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000 01112345889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=327.17 Aligned_cols=261 Identities=21% Similarity=0.305 Sum_probs=193.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
..+|++.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++||||+++++++.++...++||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 457999999999999999999875 5788999975432 2356999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+. ++|.+++.. ....+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++.++|+|||+++...
T Consensus 137 e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 137 PHYS-SDLYTYLTK----RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EccC-CcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 9995 688877743 33578999999999999999999997 899999999999999999999999999987533
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh--------hhhHHHHHHHhhcCc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEE--------SMHLVTWFRRIHLSK 822 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~--------~~~~~~~~~~~~~~~ 822 (948)
... ......||+.|+|||++.+..++.++|||||||++|||+++..|+....+.. ...+...+.......
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 286 (357)
T PHA03209 209 VAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP 286 (357)
T ss_pred cCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh
Confidence 221 2234569999999999999999999999999999999999666553332211 011111111111101
Q ss_pred ccccc---------ccC------cccCCc--cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 823 DSFHK---------AID------PTIDLN--EGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 823 ~~~~~---------~~~------~~~~~~--~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
..+.. .++ ...... .........+.+++.+|++.||.+|||+.|++++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 287 EEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred hhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 11100 000 000000 0000112345679999999999999999999863
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=316.61 Aligned_cols=257 Identities=25% Similarity=0.397 Sum_probs=205.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|++.+.||+|+||+||+|... +|+.||+|++.... .......+.+|+++++.++||||+++++++......++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 46778899999999999999865 68899999886542 33445789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.+++.. .+.+++..+..++.+++.||.|||+ ..+++||||||+||++++++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 84 FMDCGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred cCCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 9999999888743 2468999999999999999999996 36899999999999999999999999999875432
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh-----hhhHHHHHHHhhcCccccc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEE-----SMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 826 (948)
.. .....|+..|+|||++.+..++.++|||||||++||+++|+.||....+.+ ......+.......
T Consensus 157 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 228 (284)
T cd06620 157 SI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE----- 228 (284)
T ss_pred hc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-----
Confidence 21 223568999999999988899999999999999999999999998654321 11111222211110
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
..+.+. ....+..+.+++.+|++.+|++||++.|++++.
T Consensus 229 --~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 229 --PPPRLP----SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --cCCCCC----chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 011111 011334688999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=317.99 Aligned_cols=265 Identities=22% Similarity=0.292 Sum_probs=198.1
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
+|+..+.||+|+||.||+|... +|+.||+|+++...........+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999875 689999999876433333446788899999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
++ ++|.+++.. ....+++..++.++.||++||+|||+ .+++||||||+||+++.++.++|+|||+++.....
T Consensus 81 ~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 81 CD-QDLKKYFDS----CNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 96 578777642 23568999999999999999999997 89999999999999999999999999998855433
Q ss_pred CCceeeeecccccccCceecccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc-----------
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGR-VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL----------- 820 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------- 820 (948)
.. ......+++.|+|||++.+.. ++.++|||||||++|||++|+.|+........ ....+.....
T Consensus 153 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 153 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred CC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHHhHHhh
Confidence 22 122345789999999987654 78999999999999999999988654332211 1111100000
Q ss_pred --CccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 821 --SKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 821 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
........................++.+++.+|++.||.+|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000000000000111122356789999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=331.81 Aligned_cols=263 Identities=22% Similarity=0.281 Sum_probs=199.5
Q ss_pred hcCCcccceecccCceEEEEEEEc---CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
..+|++.+.||+|+||.||+|... .+..||||.+... ....+|++++++++||||+++++++......++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 457999999999999999999753 3578999987643 245689999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
|||++. ++|.+++. ....+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.++|+|||+++.
T Consensus 164 v~e~~~-~~l~~~l~-----~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 164 VMPKYK-CDLFTYVD-----RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred EehhcC-CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 999995 68877772 23578999999999999999999997 8999999999999999999999999999975
Q ss_pred cCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhh-HHHHHHHhhcCccccc
Q 002238 749 APEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMH-LVTWFRRIHLSKDSFH 826 (948)
Q Consensus 749 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 826 (948)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+........ +.............+.
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 543322 22234679999999999999999999999999999999999999997654322111 1111111100000000
Q ss_pred ---------------cccCcccCCccc--hHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 827 ---------------KAIDPTIDLNEG--ILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 827 ---------------~~~~~~~~~~~~--~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
....+....... ......++.+++.+|++.||++||++.|++.+
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000 01123457889999999999999999999875
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=312.54 Aligned_cols=252 Identities=27% Similarity=0.463 Sum_probs=201.5
Q ss_pred CCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCC----hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 594 NFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS----GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
+|+..+.||+|+||.||+|...+|+.+|||.+...... ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47888999999999999998888999999988654221 23346688999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNR-----FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 999999999998843 1467899999999999999999997 78999999999999999999999999998754
Q ss_pred CCC-----CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 750 PEG-----KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 750 ~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
... .........|+..|+|||++.+..++.++||||||+++|||++|+.||........... .......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~------~~~~~~~ 226 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY------IGAHRGL 226 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH------hhhccCC
Confidence 221 11122345689999999999988899999999999999999999999976543221110 0000000
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.+.++ .....++.+++.+|++.+|.+||++.++++
T Consensus 227 -----~~~~~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 -----MPRLP-----DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -----CCCCC-----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11111 112345889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=310.43 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=212.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
..-|...+.||+|.|+.|-.|++- +|+.||||++.+...+......+..|++.|+.++|||||++|++.......|||.
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 345777889999999999999753 7999999999988777777788999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE-cCCCCeEEeecCCceec
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLA 749 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill-~~~~~~kl~DfGla~~~ 749 (948)
|.=++|+|.+++.... ..+.+.-+.+++.||+.|+.|+|. ..+||||+||+||.+ .+-|-|||.|||++..+
T Consensus 97 ELGD~GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EecCCchHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 9999999999985422 457788889999999999999996 899999999999776 56789999999999877
Q ss_pred CCCCCceeeeecccccccCceecccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVT-TKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
..++ ..+..+|+..|-|||++.+..|+ +++||||+||+||-|++|++||+..++.+....+
T Consensus 170 ~PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI---------------- 231 (864)
T KOG4717|consen 170 QPGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI---------------- 231 (864)
T ss_pred CCcc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh----------------
Confidence 6654 45667899999999999999986 5899999999999999999999988776653322
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+|.... .+.....+..+||..|+..||.+|.+.+||+..
T Consensus 232 mDCKYt---vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 232 MDCKYT---VPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hccccc---CchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 222221 112334568899999999999999999998763
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.47 Aligned_cols=258 Identities=25% Similarity=0.439 Sum_probs=206.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|++.+.||.|+||.||+|... ++..+|+|++....... ..+.+.+|+++++.++|+|++++++.+..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 47889999999999999999864 68899999987543333 56789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.+++... .....+++..+..++.|++.|++|||+ .+++||||||+||++++++.++|+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 80 YLSGGSLLDIMKSS--YPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred ccCCCcHHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 99999999998542 112468999999999999999999997 8999999999999999999999999999875544
Q ss_pred CCCc---eeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 752 GKGS---IETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 752 ~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
.... ......|+..|+|||++... .++.++|||||||++|||++|+.||........ ...... .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~----~------ 222 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQ----N------ 222 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhc----C------
Confidence 3322 22345689999999998877 789999999999999999999999976544321 111110 0
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..+.+............+.+++.+|++.+|++||++.++++
T Consensus 223 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 223 -DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 01111111111223456889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=321.51 Aligned_cols=266 Identities=17% Similarity=0.263 Sum_probs=196.3
Q ss_pred ccceeccc--CceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEec
Q 002238 597 EENILGRG--GFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 673 (948)
Q Consensus 597 ~~~~lg~G--~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 673 (948)
+.++||+| +||+||++..+ +|+.||||++............+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35779999 78999999764 7899999999765444445567888999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCC
Q 002238 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (948)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~ 753 (948)
++|+|.+++... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++++|||.+.......
T Consensus 82 ~~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTH---FMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 999999988532 22458999999999999999999997 899999999999999999999999998654322111
Q ss_pred C------ceeeeecccccccCceeccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc---C-
Q 002238 754 G------SIETRIAGTFGYLAPEYAVT--GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL---S- 821 (948)
Q Consensus 754 ~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~- 821 (948)
. .......++..|+|||++.+ ..++.++|||||||++|||++|+.||......... ......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~ 233 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLDT 233 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHhcCCccccccc
Confidence 0 01122346788999999876 45899999999999999999999999764432211 000000000 0
Q ss_pred ----cccc-----ccccCccc----------------CCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 822 ----KDSF-----HKAIDPTI----------------DLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 822 ----~~~~-----~~~~~~~~----------------~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.... ....+... ............+.+++.+|++.||++|||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0000 00000000 0000111223468899999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=312.55 Aligned_cols=249 Identities=29% Similarity=0.498 Sum_probs=199.5
Q ss_pred ceecccCceEEEEEEEcC--C--cEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecC
Q 002238 599 NILGRGGFGTVYKGELHD--G--TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 674 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~~--g--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 674 (948)
+.||+|++|.||+|.+.+ + ..||||.+...... ...+.+.+|+.++++++||||+++++++.+ ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999998743 3 36999998875433 556789999999999999999999999988 88899999999
Q ss_pred CCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCC
Q 002238 675 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 754 (948)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~ 754 (948)
+++|.+++.... ...++|..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 79 LGSLLDRLRKDA---LGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CCcHHHHHHhcc---cccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccc
Confidence 999999985421 1468999999999999999999997 8999999999999999999999999999986544222
Q ss_pred c--eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 755 S--IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 755 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
. ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+. . ....
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---~---~~~~------- 219 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID---K---EGER------- 219 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---h---cCCc-------
Confidence 1 1123457889999999998899999999999999999999 999997665443221111 0 0000
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
.. .....+..+.+++.+|++.+|++||++.++++.|.
T Consensus 220 -~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 -LE---RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CC---CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00 00112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.85 Aligned_cols=248 Identities=28% Similarity=0.470 Sum_probs=199.6
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCCCh
Q 002238 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 678 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 678 (948)
++||+|+||.||+|...+++.||+|.+..... ......+.+|++++++++||||+++++++.+....++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP-PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 46999999999999987799999998876432 24567899999999999999999999999999999999999999999
Q ss_pred hHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCcee-
Q 002238 679 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE- 757 (948)
Q Consensus 679 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~- 757 (948)
.+++.. ....+++..++.++.+++.|++|||+ .+++||||||+||+++.++.++|+|||+++..........
T Consensus 80 ~~~l~~----~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 80 LTFLRK----KKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 998843 22467899999999999999999997 8999999999999999999999999999886543221111
Q ss_pred eeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCc
Q 002238 758 TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLN 836 (948)
Q Consensus 758 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (948)
....++..|+|||++.++.++.++||||||+++|||+| |..||...........+. . .. . ..
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~------~-~~---~-----~~-- 215 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE------S-GY---R-----MP-- 215 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh------c-CC---C-----CC--
Confidence 12234667999999988899999999999999999999 888887665432211111 0 00 0 00
Q ss_pred cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 837 EGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 837 ~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
.....+.++.+++.+|+..+|.+||++.|+++.|.
T Consensus 216 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 216 -APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 00112346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=314.05 Aligned_cols=253 Identities=24% Similarity=0.429 Sum_probs=200.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|+..+.||+|+||.||+|... +++.||+|+++.. .......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 346788889999999999999864 6899999998754 3334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++++|.+++.. ...+++.+++.++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 86 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 86 EFCGGGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred eccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 99999999998743 2468899999999999999999997 799999999999999999999999999987554
Q ss_pred CCCCceeeeecccccccCceecc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAV---TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
.... ......|+..|+|||++. ...++.++|||||||++|||++|+.||....+........ .....
T Consensus 158 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~--------~~~~~- 227 (267)
T cd06645 158 ATIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT--------KSNFQ- 227 (267)
T ss_pred Cccc-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh--------ccCCC-
Confidence 3221 223456899999999874 4568899999999999999999999997654332211110 00000
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.+... ........+.+++.+|++.+|++||+++++++
T Consensus 228 --~~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 228 --PPKLK---DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --CCccc---ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00000 00012235789999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.45 Aligned_cols=267 Identities=27% Similarity=0.417 Sum_probs=204.8
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
+|++.+.||+|+||.||+|... +|+.||||++............+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999864 689999999987544444567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+ +++|.+++.. ....+++.+++.++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~-~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRD----EERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 9999998853 22578999999999999999999997 89999999999999999999999999998866543
Q ss_pred CCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcc--------
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD-------- 823 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 823 (948)
.........|+..|+|||++.+. .++.++||||+|+++|||++|.+||....+......+ .........
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV--FRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHH--HHHcCCCChHHHhhccC
Confidence 32223345689999999998654 4689999999999999999998888765432221111 100000000
Q ss_pred --ccccccCcc---cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 824 --SFHKAIDPT---IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 824 --~~~~~~~~~---~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.......+. ............++.+++.+|++.+|.+||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 00000011223678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=310.94 Aligned_cols=249 Identities=24% Similarity=0.438 Sum_probs=204.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
..|+..+.||+|+||.||+|..+ +++.||+|++.... .......+.+|+.++++++||||+++++++.++...++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 35777888999999999999875 58899999987542 23456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++|+|.+++.. .++++.++..++.|++.|++|||+ .+++|+||+|+||+++.++.++++|||++.....
T Consensus 83 ~~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 83 YLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred cCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 9999999988742 468889999999999999999997 8999999999999999999999999999976544
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
... ......++..|+|||++.+..++.++|||||||++|||++|+.||....+....... . ... .+
T Consensus 154 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------~--~~~-----~~ 219 (277)
T cd06640 154 TQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI------P--KNN-----PP 219 (277)
T ss_pred Ccc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh------h--cCC-----CC
Confidence 321 223346888999999999888999999999999999999999999865543221111 0 000 01
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
......+..+.+++.+|++.+|++||++.++++.
T Consensus 220 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 -----TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -----CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1112345568899999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=313.53 Aligned_cols=238 Identities=25% Similarity=0.430 Sum_probs=186.5
Q ss_pred eecccCceEEEEEEEcC-------------------------CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCcee
Q 002238 600 ILGRGGFGTVYKGELHD-------------------------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654 (948)
Q Consensus 600 ~lg~G~fg~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 654 (948)
.||+|+||.||+|.+.. ...||+|++... ......++.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 59999999999997521 135888987643 223346788899999999999999
Q ss_pred eEEeEEEeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC
Q 002238 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 734 (948)
Q Consensus 655 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~ 734 (948)
+++++|.++...++||||+++|+|..++.. ....+++..+.+++.|+++||+|||+ .+|+||||||+||++++
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~ 152 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRK----EKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLAR 152 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEec
Confidence 999999999999999999999999888743 23568899999999999999999997 89999999999999976
Q ss_pred CC-------CeEEeecCCceecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCCc
Q 002238 735 DM-------RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELI-TGRKALDESQP 805 (948)
Q Consensus 735 ~~-------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~ell-tg~~p~~~~~~ 805 (948)
.+ .++++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||....+
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred cCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 43 3899999987643322 12357888999998865 56899999999999999995 69999976554
Q ss_pred hhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 806 EESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 806 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
.+.... ... .... .. .....+.+++.+||+.+|++||++.+|++.|
T Consensus 228 ~~~~~~---~~~----~~~~----~~---------~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 228 SEKERF---YEK----KHRL----PE---------PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHH---HHh----ccCC----CC---------CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 332111 110 0000 00 0113588999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=318.14 Aligned_cols=266 Identities=24% Similarity=0.359 Sum_probs=199.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|+..+.||+|+||.||+|..+ +++.||+|.+.... .......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccc-ccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 56889999999999999999865 68899999987542 22234567889999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|++ ++|.+++.. ....+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.++|+|||++.....
T Consensus 85 ~~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 85 YLD-KDLKQYLDD----CGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred ccc-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 997 588887743 23468899999999999999999997 8999999999999999999999999999875433
Q ss_pred CCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
... ......+++.|+|||++.+. .++.++|||||||++|||++|++||......+....+........ ...+.....
T Consensus 157 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 234 (301)
T cd07873 157 PTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPT-EETWPGILS 234 (301)
T ss_pred CCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC-hhhchhhhc
Confidence 221 12234578999999988654 578999999999999999999999987654332211110000000 000000000
Q ss_pred ---------cccCC---ccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 831 ---------PTIDL---NEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 831 ---------~~~~~---~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+.... ..........+.+++.+|++.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 0000112345789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=311.56 Aligned_cols=249 Identities=26% Similarity=0.435 Sum_probs=204.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|+..+.||.|+||.||+|... +++.||+|.+.... .......+.+|+++++.++|||++++++++.++...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 36888899999999999999865 68999999987542 34445778999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.+++.. ..+++..+..++.|++.|++|||+ .+++||||+|+||++++++.++|+|||+++....
T Consensus 80 ~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 80 YCGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred eeCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 9999999998843 278999999999999999999997 8999999999999999999999999999986654
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
.. .......|++.|+|||++.+..++.++||||||+++|||++|+.||....+..... ... .. ..+
T Consensus 151 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~------~~~--~~-----~~~ 216 (274)
T cd06609 151 TM-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF------LIP--KN-----NPP 216 (274)
T ss_pred cc-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH------Hhh--hc-----CCC
Confidence 32 12334568899999999998889999999999999999999999997654322111 000 00 111
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.+... .....+.+++.+|+..+|++||+++++++
T Consensus 217 ~~~~~----~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 217 SLEGN----KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCccc----ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11100 02345889999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=309.55 Aligned_cols=250 Identities=26% Similarity=0.476 Sum_probs=200.4
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCCh-------hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-------KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 665 (948)
+|.+...||+|+||.||+|... +++.||+|.+....... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999864 68999999886543221 123568899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGl 745 (948)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN-----YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred cEEEEEecCCCCHHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCC
Confidence 9999999999999998843 2468889999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCC-----ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc
Q 002238 746 VRLAPEGKG-----SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL 820 (948)
Q Consensus 746 a~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 820 (948)
++....... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......... ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~ 226 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF------KIGE 226 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH------HHhc
Confidence 886542211 11123458899999999998889999999999999999999999998654322111 1000
Q ss_pred CccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 821 SKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
...+.++ ......+.+++.+|++.+|.+||++.++++
T Consensus 227 -------~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 -------NASPEIP-----SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -------cCCCcCC-----cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0111111 122346889999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=309.24 Aligned_cols=257 Identities=23% Similarity=0.405 Sum_probs=203.8
Q ss_pred CCcccceecccCceEEEEEEEcC--CcEEEEEEeecCc--------CChhhHHHHHHHHHHHHh-cCCCceeeEEeEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGELHD--GTKIAVKRMEAGV--------ISGKGLTEFKSEIAVLTK-VRHRHLVALLGHCLD 662 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~~--g~~vavK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~ 662 (948)
.|++.+.||+|+||.||+|..+. ++.+|||.+.... .......++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999998764 6889999885431 123344567788888875 799999999999999
Q ss_pred CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEee
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~D 742 (948)
++..++||||+++++|.+++.... .....+++..+++++.|++.||.|||+ ..+++||||||+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLK-EKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999998875422 223568999999999999999999995 36899999999999999999999999
Q ss_pred cCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc
Q 002238 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK 822 (948)
Q Consensus 743 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 822 (948)
||++....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||........... .. .
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~---~~-----~ 227 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK---IV-----E 227 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHH---Hh-----h
Confidence 99998654432 23445689999999999988899999999999999999999999976543221111 10 0
Q ss_pred cccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 823 DSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
........ ......+.+++.+|++.||++||++.|+..+++
T Consensus 228 ~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 AVYEPLPE---------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccCCcCCc---------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00000000 012245889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=317.24 Aligned_cols=269 Identities=23% Similarity=0.308 Sum_probs=204.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|+..+.||+|+||.||+|..+ +++.||||+++...........+.+|++++++++|+||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999875 68899999987654344455789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|++++.+..+.. ....+++.++..++.|++.|++|||+ .+++||||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 81 YVERTLLELLEA-----SPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred cCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 999876655442 22458999999999999999999997 8999999999999999999999999999886654
Q ss_pred CCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh--------hcCc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI--------HLSK 822 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~~ 822 (948)
..........++..|+|||++.+. .++.++||||||+++|||++|+.||......+........... ....
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 433233445688999999999888 8899999999999999999999999865433221111110000 0000
Q ss_pred cccccccCcccCCc-----cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 823 DSFHKAIDPTIDLN-----EGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 823 ~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..+...-.+..... ........++.+++.+|++.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000000000000 001112467899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=324.83 Aligned_cols=244 Identities=25% Similarity=0.445 Sum_probs=199.2
Q ss_pred eecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCCCh
Q 002238 600 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 678 (948)
Q Consensus 600 ~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 678 (948)
+||+|.||+||-|++. +...+|||.+... .....+-+..|+..-++++|.|||+++|.|.+++..-+.||-++||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 6999999999999865 4567999988754 455567789999999999999999999999999999999999999999
Q ss_pred hHHHHhhhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEc-CCCCeEEeecCCceecCCCCCc
Q 002238 679 SRHIFNWAEEGLKPL--EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLAPEGKGS 755 (948)
Q Consensus 679 ~~~l~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~-~~~~~kl~DfGla~~~~~~~~~ 755 (948)
.++++. ..+++ .+.+.-.+..||++||.|||+ ..|||||||-+|||++ -.|.+||+|||-++.... -+.
T Consensus 660 SsLLrs----kWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP 731 (1226)
T KOG4279|consen 660 SSLLRS----KWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INP 731 (1226)
T ss_pred HHHHHh----ccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhcc-CCc
Confidence 999953 33555 677788899999999999997 8999999999999996 578999999998886543 234
Q ss_pred eeeeecccccccCceecccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCccc
Q 002238 756 IETRIAGTFGYLAPEYAVTG--RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTI 833 (948)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (948)
....+.||..|||||++..+ .|+.++|||||||.+.||.||++||.+....... .......+. .|.+
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-------MFkVGmyKv----HP~i 800 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-------MFKVGMYKV----HPPI 800 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-------hhhhcceec----CCCC
Confidence 56667899999999999876 5899999999999999999999999876543321 111111111 2222
Q ss_pred CCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 834 DLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 834 ~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+ .+...+...+|.+|+.++|.+||++.++++
T Consensus 801 P-----eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 P-----EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred c-----HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 2 233456789999999999999999999876
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=312.13 Aligned_cols=257 Identities=28% Similarity=0.444 Sum_probs=204.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCc----EEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
.+|+..+.||+|+||.||+|.++ +|+ .||+|++.... ......++.+|+.++++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 56788899999999999999864 343 58999876542 23445778999999999999999999999987 7889
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+||||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++
T Consensus 85 ~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 85 LITQLMPLGCLLDYVRN----HKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred EEEecCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 99999999999998843 23458999999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCcee-eeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 748 LAPEGKGSIE-TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 748 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
.......... ....++..|+|||.+....++.++|+||||+++||+++ |+.||......+....+ . . ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~---~-~~~~ 230 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL---E---K-GERL 230 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH---h---C-CCCC
Confidence 6543322111 11223578999999988899999999999999999999 99999876543321111 1 0 0000
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
..+ ......+.+++.+|+..+|.+||++.++++.|.++.+
T Consensus 231 ---~~~--------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 231 ---PQP--------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ---CCC--------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 000 0112357899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=339.25 Aligned_cols=276 Identities=17% Similarity=0.233 Sum_probs=193.6
Q ss_pred HhhcCCcccceecccCceEEEEEEEc--CCcEEEEEEe--------------ecC-cCChhhHHHHHHHHHHHHhcCCCc
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH--DGTKIAVKRM--------------EAG-VISGKGLTEFKSEIAVLTKVRHRH 652 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~g~~vavK~~--------------~~~-~~~~~~~~~~~~E~~~l~~l~H~n 652 (948)
...++|++.+.||+|+||+||++.++ +++.+++|.+ .+. .........+.+|+.++++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34578999999999999999998754 2222332211 110 112233456889999999999999
Q ss_pred eeeEEeEEEeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE
Q 002238 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732 (948)
Q Consensus 653 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill 732 (948)
|+++++++.+.+..|+|+|++. ++|.+++..............++..++.|++.||+|||+ ++||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEE
Confidence 9999999999999999999985 577776643211111233456677899999999999997 899999999999999
Q ss_pred cCCCCeEEeecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCchhhhhH
Q 002238 733 GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRK-ALDESQPEESMHL 811 (948)
Q Consensus 733 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~-p~~~~~~~~~~~~ 811 (948)
+.++.+||+|||+++..............||+.|+|||++.+..++.++|||||||++|||++|.. |+..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999998765544333445679999999999999999999999999999999999875 4443332222222
Q ss_pred HHHHHHhhcCcccccc-------ccCc--------ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 812 VTWFRRIHLSKDSFHK-------AIDP--------TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 812 ~~~~~~~~~~~~~~~~-------~~~~--------~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
...+.........+.. .++. .+...-........+.+++.+|++.||.+||++.|+++
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 2222211111110000 0000 00000000012235678899999999999999999986
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=309.40 Aligned_cols=252 Identities=32% Similarity=0.497 Sum_probs=202.8
Q ss_pred ceecccCceEEEEEEEcC----CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecC
Q 002238 599 NILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 674 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 674 (948)
+.||+|+||.||+|...+ +..||+|.+....... ..+.+.+|+++++.++|+|++++++++.++...++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 469999999999998753 7899999987653222 46789999999999999999999999999999999999999
Q ss_pred CCChhHHHHhhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 675 QGTLSRHIFNWAEE----GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 675 ~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
+++|.+++...... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999998542100 13678999999999999999999997 899999999999999999999999999998665
Q ss_pred CCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 751 EGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 751 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
.... .......+++.|+|||.+....++.++||||+|+++|||++ |..||......+....+ .. ..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~------~~--~~---- 224 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL------RK--GY---- 224 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH------Hc--CC----
Confidence 4321 12233457889999999988899999999999999999999 69999876443321111 10 00
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
... .......++.+++.+|++.+|++||++.++++.|+
T Consensus 225 ---~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 ---RLP---KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCC---CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 000 01112356889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=314.97 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=202.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|++.+.||+|+||.||+|..+ +++.||+|++... .....+.+.+|++++++++||||+++++++.++...++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 356888999999999999999874 6899999998754 4445678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++++|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 82 EFCDGGALDSIMLE----LERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred eccCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 99999999988743 22568999999999999999999997 899999999999999999999999999887543
Q ss_pred CCCCceeeeecccccccCceecc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
.... ......|++.|+|||++. ...++.++||||||+++|||++|+.||......... . ......
T Consensus 155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~--~----~~~~~~--- 224 (280)
T cd06611 155 STLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL--L----KILKSE--- 224 (280)
T ss_pred cccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH--H----HHhcCC---
Confidence 3221 223456899999999875 344678999999999999999999999765433211 1 111100
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.+.+... .....++.+++.+|++.+|.+||++.++++.
T Consensus 225 ----~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 225 ----PPTLDQP---SKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----CCCcCCc---ccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0111101 1123458899999999999999999999774
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=308.34 Aligned_cols=252 Identities=22% Similarity=0.376 Sum_probs=205.1
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
+|+..+.||+|+||.||++... +|+.||+|++...........++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999764 689999999876544455567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++++|.+++.. .....+++.++++++.|++.|++|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 81 CEGGDLYKKINA---QRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 999999988843 222467899999999999999999997 89999999999999999999999999998865443
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (948)
.. ......|++.|+|||++.+..++.++|||||||++|||++|+.||......+.. ....... .. .
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~------~~~~~~~--~~-----~ 220 (256)
T cd08218 155 VE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV------LKIIRGS--YP-----P 220 (256)
T ss_pred hh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHH------HHHhcCC--CC-----C
Confidence 21 122345889999999999889999999999999999999999999765433221 1111100 00 0
Q ss_pred cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 833 IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 833 ~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
. .......+.+++.+|++.+|++||++.+|++.
T Consensus 221 ~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 V-----SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred C-----cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0 11223458899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=317.79 Aligned_cols=268 Identities=24% Similarity=0.363 Sum_probs=202.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|+..+.||+|+||.||+|..+ +++.||+|++..........+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999875 58999999986643333345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.++... ...+++.+++.++.|+++||+|||+ .+++||||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999888776532 2458999999999999999999997 7999999999999999999999999999886544
Q ss_pred CCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc--------
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK-------- 822 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 822 (948)
.. .......++..|+|||++.+ ..++.++||||||+++|||++|++||......+....+..........
T Consensus 153 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 153 PG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred Cc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 32 22233568899999999875 457889999999999999999999997654322211111100000000
Q ss_pred cccccccCcccCC----ccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 823 DSFHKAIDPTIDL----NEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 823 ~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
........+.... ..........+.+++.+|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000000000 0001123456889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.46 Aligned_cols=255 Identities=22% Similarity=0.387 Sum_probs=201.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|++.+.||+|+||.||+|..+ +|+.||+|.+... ........+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 36788899999999999999875 7899999988754 234445789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.+++... .....+++..+..++.|++.||+|||+ +.+|+||||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 80 YMDAGSLDKLYAGG--VATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred ecCCCCHHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 99999998887431 112478999999999999999999996 36899999999999999999999999999875533
Q ss_pred CCCceeeeecccccccCceecccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTG------RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
.. .....|++.|+|||++.+. .++.++|||||||++|||++|+.||............ ..... .
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~--~-- 225 (286)
T cd06622 156 SL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL---SAIVD--G-- 225 (286)
T ss_pred Cc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH---HHHhh--c--
Confidence 22 2234588899999998554 3588999999999999999999999764332221111 11100 0
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
..+.+ ......++.+++.+|++.+|++||++.+++..
T Consensus 226 ---~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 226 ---DPPTL-----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---CCCCC-----CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 00111 11133458899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=309.29 Aligned_cols=254 Identities=26% Similarity=0.375 Sum_probs=189.8
Q ss_pred eecccCceEEEEEEEcCCc---EEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCC
Q 002238 600 ILGRGGFGTVYKGELHDGT---KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676 (948)
Q Consensus 600 ~lg~G~fg~Vy~~~~~~g~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 676 (948)
.||+|+||.||+|+..++. .+++|.+.... .......+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 5999999999999765433 45666655432 2344578999999999999999999999999999999999999999
Q ss_pred ChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCC-Cc
Q 002238 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK-GS 755 (948)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~-~~ 755 (948)
+|.+++.... ......++..+..++.||++||+|||+ .+++||||||+|||++.++.++|+|||++....... ..
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 81 DLKSYLSQEQ-WHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred cHHHHHHhhh-cccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 9999986421 122456777888999999999999997 899999999999999999999999999986432211 11
Q ss_pred eeeeecccccccCceeccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 756 IETRIAGTFGYLAPEYAVT-------GRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
......|+..|+|||++.. ..++.++||||||+++|||++ |..||....+.+....+ . ......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~------~--~~~~~~ 228 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV------I--KDQQVK 228 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------H--hhcccc
Confidence 2234568899999998753 245789999999999999997 56788655433221111 1 111122
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
..++.+... ....+.+++..|+ .+|++||++++|++.|.
T Consensus 229 ~~~~~~~~~-----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLELP-----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCCC-----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 233332211 2235778999999 67999999999998773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=310.88 Aligned_cols=259 Identities=26% Similarity=0.429 Sum_probs=203.6
Q ss_pred cCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCce
Q 002238 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 666 (948)
++|++.+.||+|+||.||+|+.+ +.+.||+|.+.... ......++.+|++++++++||||+++++++.+....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 57888999999999999999864 34679999876431 222457899999999999999999999999998999
Q ss_pred EEEEEecCCCChhHHHHhhhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEee
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEG----LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~D 742 (948)
++||||+++|+|.+++....... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999986422110 1268999999999999999999997 8999999999999999999999999
Q ss_pred cCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcC
Q 002238 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLS 821 (948)
Q Consensus 743 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 821 (948)
||+++..............++..|+|||.+.+..++.++||||||+++||+++ |..||........ .... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~---~~~~---~~- 233 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV---LNRL---QA- 233 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH---HHHH---Hc-
Confidence 99987443322222233456788999999988889999999999999999999 7889865443221 1111 10
Q ss_pred ccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 822 KDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
........ ...+..+.+++.+|++.+|++||++.+++..|.
T Consensus 234 -~~~~~~~~---------~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 -GKLELPVP---------EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -CCcCCCCC---------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 01100000 122346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=308.43 Aligned_cols=251 Identities=28% Similarity=0.438 Sum_probs=193.1
Q ss_pred ceecccCceEEEEEEEc----CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe-CCceEEEEEec
Q 002238 599 NILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-GNEKLLVFEYM 673 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~ 673 (948)
+.||+|+||.||+|.+. ++..||+|++... ......+.+.+|+.+++.++||||+++++++.. ++..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 46899999999999853 2457999987542 234456788999999999999999999998764 55678999999
Q ss_pred CCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCC
Q 002238 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (948)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~ 753 (948)
.+|+|.+++.. .....++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 80 ~~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 80 KHGDLRNFIRS----ETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 99999998843 22456788889999999999999997 899999999999999999999999999987543321
Q ss_pred C---ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 754 G---SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG-RKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 754 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
. .......++..|+|||++.+..++.++||||||+++|||++| .+||......+ ..... .. ...
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~---~~-~~~----- 220 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYL---LQ-GRR----- 220 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH---hc-CCC-----
Confidence 1 111233467789999999888999999999999999999995 55665443222 11111 10 000
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhh
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~ 875 (948)
+.. . ...+..+.+++.+|++.+|++||++.++++.|+++.
T Consensus 221 -~~~--~---~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 221 -LLQ--P---EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -CCC--C---CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 000 0 011245889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=310.12 Aligned_cols=254 Identities=23% Similarity=0.390 Sum_probs=198.6
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEE
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
..++++.....||+|+||.||+|... ++..||+|.+... .....+.+.+|+++++.++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 34566666788999999999999864 6788999988654 33455789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC-CCCeEEeecCC
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPL--EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGL 745 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~-~~~~kl~DfGl 745 (948)
||||+++++|.+++... ...+ ++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.++|+|||+
T Consensus 83 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 83 FMEQVPGGSLSALLRSK----WGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred EEecCCCCCHHHHHHHh----cccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchh
Confidence 99999999999988541 1234 788889999999999999997 89999999999999986 67999999999
Q ss_pred ceecCCCCCceeeeecccccccCceecccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcc
Q 002238 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVTGR--VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD 823 (948)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 823 (948)
+........ ......|++.|+|||++.+.. ++.++||||||+++|||++|+.||......... .+......
T Consensus 156 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~~--- 228 (268)
T cd06624 156 SKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMFK--- 228 (268)
T ss_pred heecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhhhc---
Confidence 875543221 223345899999999986643 789999999999999999999999764322111 11000000
Q ss_pred ccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 824 SFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
. .+.++ .....++.+++.+|++.+|.+||++.++++
T Consensus 229 -~----~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 -I----HPEIP-----ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -c----CCCCC-----cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0 01111 112245889999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=308.39 Aligned_cols=257 Identities=24% Similarity=0.380 Sum_probs=206.5
Q ss_pred CCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCceEEEE
Q 002238 594 NFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNEKLLVF 670 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~ 670 (948)
+|++.+.||.|+||.||+|.. .+++.||+|++..........+.+..|++++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999975 468999999987665556667789999999999999999999998764 34578999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcc--CCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA--HQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||+++++|.+++.... .....+++..++.++.|++.||+|||..+ ..+++||||||+||+++.++.++|+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999999986532 22367899999999999999999999332 38999999999999999999999999999886
Q ss_pred cCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
...... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+.. ...
T Consensus 160 ~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~-----~~~--- 227 (265)
T cd08217 160 LGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASKIKE-----GKF--- 227 (265)
T ss_pred ccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHHHhc-----CCC---
Confidence 654332 1233568999999999998889999999999999999999999998754322 1111111 100
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+.+ .......+.+++.+|++.+|++||++.+|+++
T Consensus 228 --~~~-----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 --RRI-----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --CCC-----ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 011 11223568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=309.07 Aligned_cols=254 Identities=26% Similarity=0.438 Sum_probs=205.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|+..+.||+|+||.||+|... +++.+|+|++... .....+.+.+|++++++++||||+++++++.+++..+++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC--chhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 357889999999999999999864 5789999998764 2335678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++++|.+++.. ....+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++....
T Consensus 80 e~~~~~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 80 EYCGGGSLQDIYQV----TRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred eCCCCCcHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhh
Confidence 99999999988743 22568899999999999999999997 899999999999999999999999999987554
Q ss_pred CCCCceeeeecccccccCceecccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTG---RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||....+........ ...+
T Consensus 153 ~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~--------~~~~-- 221 (262)
T cd06613 153 ATI-AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS--------KSNF-- 221 (262)
T ss_pred hhh-hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hccC--
Confidence 322 122345688999999999776 88999999999999999999999998765433211110 0000
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..+.+ ........++.+++.+|+..+|.+||++.+|+.
T Consensus 222 -~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 222 -PPPKL---KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -CCccc---cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00111 111233456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=315.43 Aligned_cols=253 Identities=23% Similarity=0.359 Sum_probs=204.4
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 671 (948)
..|++.+.||+||.+.||++...+.+.||+|++.....+.+...-|..|+..|.++ .|.+||++++|-..++..|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 45788899999999999999988889999998877666778888999999999999 69999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|= ..+|.++|.. .......| .+..+..|++.|+.++|. +||||.|+||.|+|+- .|.+||+|||+|.....
T Consensus 441 ~G-d~DL~kiL~k---~~~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 441 CG-DIDLNKILKK---KKSIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred cc-cccHHHHHHh---ccCCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 75 5699999854 22233445 677889999999999996 8999999999999986 57999999999997666
Q ss_pred CCCc-eeeeecccccccCceecccC-----------CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh
Q 002238 752 GKGS-IETRIAGTFGYLAPEYAVTG-----------RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH 819 (948)
Q Consensus 752 ~~~~-~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 819 (948)
+... .....+||+.||+||.+... +.++++||||+||+||+|+.|+.||..... .
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~-------- 578 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----Q-------- 578 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----H--------
Confidence 5543 34567899999999998543 256899999999999999999999975321 1
Q ss_pred cCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 820 LSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
...+..+.+|...++........+++++++.|++.||.+||+..++++
T Consensus 579 --~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 579 --IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 112344455533222222233334899999999999999999999987
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=313.96 Aligned_cols=262 Identities=27% Similarity=0.447 Sum_probs=204.2
Q ss_pred cCCcccceecccCceEEEEEEEc-----CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCc
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNE 665 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~ 665 (948)
++|+..+.||+|+||.||+|++. +++.||||++...... .....|.+|+++++.++||||+++++++.. +..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 45777899999999999999864 3689999998765322 356789999999999999999999999877 557
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGl 745 (948)
.++||||+++++|.+++.. ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+
T Consensus 83 ~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQR----HRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred eEEEEecCCCCCHHHHHHh----CccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccc
Confidence 8999999999999999853 22358999999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCce--eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhh---------hHHHH
Q 002238 746 VRLAPEGKGSI--ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESM---------HLVTW 814 (948)
Q Consensus 746 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~---------~~~~~ 814 (948)
+.......... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......... ....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 98665332211 11233566799999998889999999999999999999999998654322100 00000
Q ss_pred HHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 815 FRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
...... .. ... .....+.++.+++.+|++.+|++||++.||+++|+.+
T Consensus 236 ~~~~~~-~~--------~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKE-GE--------RLP---RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHc-CC--------cCC---CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 000000 00 000 0112235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.08 Aligned_cols=252 Identities=31% Similarity=0.515 Sum_probs=198.0
Q ss_pred ceecccCceEEEEEEEcC-------CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 599 NILGRGGFGTVYKGELHD-------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
+.||+|+||.||+|+..+ ++.||||.+.... .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999998642 2579999876532 23446788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC-----CeEEeecC
Q 002238 672 YMPQGTLSRHIFNWAEE--GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-----RAKVADFG 744 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~-----~~kl~DfG 744 (948)
|+++++|.+++...... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++ .++++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999998653221 22457899999999999999999997 7999999999999999877 89999999
Q ss_pred CceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCc
Q 002238 745 LVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSK 822 (948)
Q Consensus 745 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 822 (948)
+++....... .......++..|+|||++.++.++.++|||||||++|||++ |+.||......+.... +.. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~---~~~----~ 229 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH---VTA----G 229 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH---Hhc----C
Confidence 9875433221 11122345788999999999999999999999999999998 9999976543322111 110 0
Q ss_pred cccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 823 DSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
. .+. .....+..+.+++.+|+..+|.+||++.++.+.|.
T Consensus 230 ~--------~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 230 G--------RLQ---KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred C--------ccC---CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 000 01122356889999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=314.57 Aligned_cols=263 Identities=23% Similarity=0.352 Sum_probs=203.9
Q ss_pred eHHHHHHhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEE
Q 002238 584 SIQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCL 661 (948)
Q Consensus 584 ~~~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~ 661 (948)
..+.+..+.++|++.+.||+|+||.||+|..+ +++.+|+|++... ......+.+|+.+++++ +|||++++++++.
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 34455566889999999999999999999874 6889999998643 22245678899999999 8999999999987
Q ss_pred eC-----CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC
Q 002238 662 DG-----NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 736 (948)
Q Consensus 662 ~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~ 736 (948)
.. +..++||||+++++|.++++.... ....+++..++.++.|++.||+|||+ .+++||||||+||++++++
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEG 165 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCC
Confidence 53 357999999999999998854322 23568999999999999999999997 8999999999999999999
Q ss_pred CeEEeecCCceecCCCCCceeeeecccccccCceecccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhH
Q 002238 737 RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG-----RVTTKVDVFSFGVILMELITGRKALDESQPEESMHL 811 (948)
Q Consensus 737 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~ 811 (948)
.++|+|||+++....... ......|+..|+|||++... .++.++|||||||++|||++|+.||....+....
T Consensus 166 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~-- 242 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL-- 242 (291)
T ss_pred CEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH--
Confidence 999999999885543221 12234688999999987543 3688999999999999999999999765432221
Q ss_pred HHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 812 VTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.. .. ........++ ......+.+++.+|++.+|++||++.++++.
T Consensus 243 ~~----~~--~~~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 FK----IP--RNPPPTLLHP--------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HH----Hh--cCCCCCCCcc--------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11 10 0000011111 1122358899999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=315.07 Aligned_cols=259 Identities=27% Similarity=0.438 Sum_probs=202.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCc----EEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCce
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 666 (948)
.++|+..+.||+|+||.||+|.+. +|+ .||+|.+.... ......++.+|+.+++.++||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 356788899999999999999864 454 47888876532 233345789999999999999999999998754 56
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCc
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla 746 (948)
++|+||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 84 ~~v~e~~~~g~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~ 156 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHE----HKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLA 156 (303)
T ss_pred eeeehhcCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEcccccc
Confidence 799999999999988743 23468899999999999999999997 89999999999999999999999999999
Q ss_pred eecCCCCCc-eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 747 RLAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 747 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
+........ ......++..|+|||++.+..++.++||||||+++||+++ |+.||......+.. .+... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~---~~~~~----~~~ 229 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP---DLLEK----GER 229 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHC----CCC
Confidence 865432221 1122345778999999998999999999999999999998 89999765433221 11111 100
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
.. .+ ......+.+++..|+..+|++||+++++++.|+.+...
T Consensus 230 ~~---~~--------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 230 LP---QP--------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CC---CC--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00 00 11223578999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=305.45 Aligned_cols=250 Identities=22% Similarity=0.385 Sum_probs=203.8
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
+|+..+.||+|+||.||+|... +++.+|||++............+.+|+++++.++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5788899999999999999764 689999999987655556678899999999999999999999999989999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC-CeEEeecCCceecCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVRLAPE 751 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~-~~kl~DfGla~~~~~ 751 (948)
+++++|.+++.. .....+++..+.+++.+++.|++|||+ ++++||||||+||+++.++ .++|+|||++.....
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQK---RCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 999999999854 223468999999999999999999997 8999999999999998554 589999999986644
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
.. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||........ ...... ..... +..
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~-----~~~~~-~~~ 223 (256)
T cd08220 155 KS--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLKIMS-----GTFAP-ISD 223 (256)
T ss_pred Cc--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HHHHHh-----cCCCC-CCC
Confidence 32 22335689999999999988899999999999999999999999976543321 111110 00000 000
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.....+.+++.+|++.+|++||++.++++
T Consensus 224 ---------~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 224 ---------RYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ---------CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 12345889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=309.70 Aligned_cols=259 Identities=28% Similarity=0.464 Sum_probs=202.5
Q ss_pred CcccceecccCceEEEEEEEc----CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------
Q 002238 595 FSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN------ 664 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 664 (948)
|.+.+.||+|+||.||+|.+. +++.||||++..........+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999753 3689999999876555566778999999999999999999999886542
Q ss_pred ceEEEEEecCCCChhHHHHhhh-hcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeec
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWA-EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~Df 743 (948)
..++++||+.+|+|.+++.... ......+++..+++++.|++.||+|||+ .+|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 2378999999999988875321 1122357899999999999999999997 89999999999999999999999999
Q ss_pred CCceecCCCCCc-eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcC
Q 002238 744 GLVRLAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLS 821 (948)
Q Consensus 744 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 821 (948)
|+++........ ......+++.|++||.+....++.++||||||+++|||++ |++||......+. ..+...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~---~~~~~~---- 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI---YNYLIK---- 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH---HHHHHc----
Confidence 998865432211 1122345678999999998889999999999999999999 8899876543221 111110
Q ss_pred ccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 822 KDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
..... .. ......+.+++.+|++.+|++||++.++++.|+.+
T Consensus 231 ~~~~~------~~-----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRLK------QP-----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcCC------CC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00000 00 11234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=317.06 Aligned_cols=199 Identities=29% Similarity=0.427 Sum_probs=160.8
Q ss_pred cceecccCceEEEEEEEc---CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCceEEEEEe
Q 002238 598 ENILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNEKLLVFEY 672 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~ 672 (948)
.++||+|+||.||+|+.+ +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999864 46789999986532 12457889999999999999999998864 4567899999
Q ss_pred cCCCChhHHHHhhhh----cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE----cCCCCeEEeecC
Q 002238 673 MPQGTLSRHIFNWAE----EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFG 744 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill----~~~~~~kl~DfG 744 (948)
+. ++|.+++..... .....+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 85 588777643111 112358899999999999999999997 899999999999999 456789999999
Q ss_pred CceecCCCCC--ceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 002238 745 LVRLAPEGKG--SIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQ 804 (948)
Q Consensus 745 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~ 804 (948)
+++....... .......||+.|+|||++.+ ..++.++||||+||++|||++|++||....
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 9986543321 11234578999999999877 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=316.62 Aligned_cols=257 Identities=23% Similarity=0.366 Sum_probs=202.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|+..+.||+|+||.||+|... +++.||+|.+...... ......+.+|+++++.++||||+++++.+..+++.++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999875 5789999998764322 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++++|||+++...
T Consensus 81 e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 81 EYVEGGDCATLLKN-----IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 99999999999843 2468999999999999999999997 899999999999999999999999999986321
Q ss_pred CCC--------------CceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH
Q 002238 751 EGK--------------GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFR 816 (948)
Q Consensus 751 ~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~ 816 (948)
... ........|+..|+|||++.+..++.++|+||||+++||+++|+.||.+....+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~------ 226 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG------ 226 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------
Confidence 100 001122457889999999988899999999999999999999999997654432211
Q ss_pred HhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHh
Q 002238 817 RIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873 (948)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~ 873 (948)
...... ...+. .....+..+.+++.+|++.+|++||+..++.+.|+.
T Consensus 227 ~~~~~~-----~~~~~-----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 227 QVISDD-----IEWPE-----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHhcc-----cCCCC-----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111000 00010 001223458899999999999999998767666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=305.20 Aligned_cols=249 Identities=24% Similarity=0.425 Sum_probs=201.6
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC---ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI---SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
+|+..+.||+|+||.||+|..+ +++.||+|.+..... ..+..+.+.+|+++++.++||||+++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999876 789999999865421 233457899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++++|.+++.. ...+++..+..++.|++.|++|||+ .+++|+||+|+||+++.++.+||+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLKK-----YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 999999999998843 2468899999999999999999997 89999999999999999999999999998865
Q ss_pred CCCCCceeeeecccccccCceecccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGR-VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
.... ......|+..|+|||.+.... ++.++|+||||+++|||++|+.||......... ..+.. .... ..
T Consensus 153 ~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~-----~~~~-~~ 222 (258)
T cd06632 153 VEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV--FKIGR-----SKEL-PP 222 (258)
T ss_pred cccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH--HHHHh-----cccC-CC
Confidence 4332 233456899999999987766 899999999999999999999999765532211 11100 0000 01
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+.+ .....+.+++.+|++.+|++||++.++++
T Consensus 223 ~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 IPD---------HLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cCC---------CcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111 12245789999999999999999999976
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=306.57 Aligned_cols=251 Identities=24% Similarity=0.398 Sum_probs=195.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC---hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--Cce
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEK 666 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 666 (948)
.+|+..+.||+|+||.||+|... ++..||+|++...... ......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999864 6899999988654222 23346788999999999999999999988753 567
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCc
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla 746 (948)
+++|||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++
T Consensus 82 ~l~~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA-----YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 899999999999988843 2458899999999999999999997 89999999999999999999999999998
Q ss_pred eecCCCC--CceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 747 RLAPEGK--GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 747 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
+...... ........++..|+|||++.+..++.++|||||||++|||++|+.||.......... .... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~------~~~~-~-- 224 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF------KIAT-Q-- 224 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH------HHhc-C--
Confidence 7543211 111223458899999999998889999999999999999999999997654322111 1100 0
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
...+.++ ......+.+++ +|+..+|++||+++||++
T Consensus 225 ---~~~~~~~-----~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 225 ---PTNPQLP-----SHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---CCCCCCc-----hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0011111 11223456676 688899999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=305.96 Aligned_cols=247 Identities=34% Similarity=0.544 Sum_probs=198.7
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
++|++.+.||+|+||.||+|.. +++.||+|.++.. .....+.+|+.+++.++|||++++++++... ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4688899999999999999975 4889999988643 2346789999999999999999999998654 47999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++++|.+++.. .....+++.+++.++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 80 MSKGNLVNFLRT---RGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred CCCCCHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 999999999854 223468899999999999999999996 89999999999999999999999999998864332
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
. .....+..|+|||++.+..++.++||||||+++|||++ |+.||......+..... . .. .. .++
T Consensus 154 ~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~-----~~-~~--~~~ 218 (254)
T cd05083 154 V----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV---E-----KG-YR--MEP 218 (254)
T ss_pred C----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH---h-----CC-CC--CCC
Confidence 1 12234678999999988899999999999999999998 99999765543221111 1 10 00 000
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHh
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~ 873 (948)
....+..+.+++.+|++.+|++||+++++++.|++
T Consensus 219 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 -------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 01223468899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=312.51 Aligned_cols=248 Identities=27% Similarity=0.458 Sum_probs=201.4
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
.|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+.+|++++++++||||+++++++..+...++||||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 4566788999999999999864 57899999887542 234457899999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++++|.+++.. ..+++..+..++.|+++|++|||+ .+++|+||+|+||++++++.++++|||++......
T Consensus 84 ~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 84 LGGGSALDLLKP------GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred cCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 999999988732 468899999999999999999997 89999999999999999999999999998765432
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (948)
.. ......|+..|+|||++.+..++.++||||||+++|||++|+.|+....+...... .. .. ..+.
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~------~~--~~-----~~~~ 220 (277)
T cd06642 155 QI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL------IP--KN-----SPPT 220 (277)
T ss_pred ch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh------hh--cC-----CCCC
Confidence 21 22334688999999999998999999999999999999999999976543321110 00 00 0111
Q ss_pred cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 833 IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 833 ~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+. ......+.+++.+|++.+|++||++.+++++
T Consensus 221 ~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 LE-----GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CC-----cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11 1223458899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=320.99 Aligned_cols=253 Identities=28% Similarity=0.414 Sum_probs=207.6
Q ss_pred ccceecccCceEEEEEEE-cCCc----EEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 597 EENILGRGGFGTVYKGEL-HDGT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 597 ~~~~lg~G~fg~Vy~~~~-~~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
..++||+|+||+||+|.| ..|+ +||+|++... ...+...++.+|+-+|.+++|||+++++|+|.... ..||++
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 468899999999999986 3344 6889988654 24555688999999999999999999999998776 789999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
||+.|+|.++++. .+..+.-+..+.|..|||+|+.|||. +.+|||||.++|||+.+...+||.|||+++....
T Consensus 778 ~mP~G~LlDyvr~----hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE----HRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred hcccchHHHHHHH----hhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 9999999999854 34678888899999999999999996 8999999999999999999999999999996654
Q ss_pred CCCce-eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 752 GKGSI-ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 752 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
+.... .....-.+.|||-|.+....|+.++|||||||.+||++| |..|+++...++..++.+-.. + +-
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge-------R---Ls 920 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE-------R---LS 920 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc-------c---CC
Confidence 33222 222233678999999999999999999999999999999 999999887666544433111 1 11
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
.| ..+..++..++.+||..|++.||+++++...+.+..+
T Consensus 921 qP--------piCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 921 QP--------PICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CC--------CCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 11 2234458899999999999999999999999988764
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=321.69 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=205.3
Q ss_pred hcCCcccceecccCceEEEEEEEcC-CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.+.|.+...||.|+||.||+|..++ +-..|-|++... ...+.++|.-|++||..+.||+||++++.|..++..+++.
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 3457778889999999999998763 445677887654 6677889999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
|||.||-+..++.. -...+...++..+++|++.||.|||+ ..|||||+|+.|||++-+|.++|+|||.+....
T Consensus 109 EFC~GGAVDaimlE----L~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~ 181 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLE----LGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK 181 (1187)
T ss_pred eecCCchHhHHHHH----hccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccch
Confidence 99999999888743 23689999999999999999999998 899999999999999999999999999876433
Q ss_pred CCCCceeeeecccccccCceecc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
... .....+.|||.|||||+.+ ...|+.++||||||+.|.||..+.+|-.+..+... ++. +
T Consensus 182 ~t~-qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV--llK----i------- 247 (1187)
T KOG0579|consen 182 STR-QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLK----I------- 247 (1187)
T ss_pred hHH-hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH--HHH----H-------
Confidence 222 2345678999999999874 45799999999999999999999999887765432 111 1
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.+.-.|.+-. +......+.+++.+|+..+|..||+++++++
T Consensus 248 aKSePPTLlq---PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 248 AKSEPPTLLQ---PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hhcCCCcccC---cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1111222221 1233456899999999999999999999986
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=311.01 Aligned_cols=239 Identities=22% Similarity=0.407 Sum_probs=187.4
Q ss_pred ceecccCceEEEEEEEcC--------CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 599 NILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
+.||+|+||.||+|..+. ...||+|.+... .....+.+.+|+.+++.++|||++++++++..++..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 369999999999997642 234888887543 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCC--------eEEee
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR--------AKVAD 742 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~--------~kl~D 742 (948)
||+++|+|.++++. ....+++..++.++.||+.||+|||+ ++|+||||||+||+++.++. ++++|
T Consensus 79 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 79 EYVKFGSLDTYLKK----NKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred ecCCCCcHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecc
Confidence 99999999998843 22468899999999999999999997 89999999999999987765 69999
Q ss_pred cCCceecCCCCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCC-CCCCCCCchhhhhHHHHHHHhhc
Q 002238 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGR-KALDESQPEESMHLVTWFRRIHL 820 (948)
Q Consensus 743 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~ 820 (948)
||++...... ....++..|+|||++.+. .++.++||||||+++|||++|. .|+....+....... .
T Consensus 152 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-------~ 219 (258)
T cd05078 152 PGISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-------E 219 (258)
T ss_pred cccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-------H
Confidence 9988654321 234578899999999764 5799999999999999999985 555544332211110 0
Q ss_pred CccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 821 SKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
... .++ .....++.+++.+|++.+|++||+++++++.|
T Consensus 220 ~~~--------~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 220 DRH--------QLP-----APKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ccc--------cCC-----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000 010 01123588999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.62 Aligned_cols=249 Identities=26% Similarity=0.415 Sum_probs=199.7
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
.|.....||+|+||.||++... ++..||||++... .....+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 3444567999999999999864 6899999998653 334456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++++|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++......
T Consensus 101 ~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 101 LEGGALTDIVTH------TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence 999999887732 358899999999999999999997 79999999999999999999999999998754332
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (948)
.. ......|+..|+|||+..+..++.++||||||+++|||++|+.||....+......+ .. ...+.
T Consensus 172 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~---~~----------~~~~~ 237 (292)
T cd06658 172 VP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI---RD----------NLPPR 237 (292)
T ss_pred cc-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hh----------cCCCc
Confidence 22 223456899999999998888999999999999999999999999865543221111 10 01111
Q ss_pred cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 833 IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 833 ~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+.. .......+.+++.+|+..+|.+||++.++++.
T Consensus 238 ~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 238 VKD---SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccc---ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 110 01122357899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=307.75 Aligned_cols=237 Identities=24% Similarity=0.447 Sum_probs=188.3
Q ss_pred ceecccCceEEEEEEEcCCc-----------EEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 599 NILGRGGFGTVYKGELHDGT-----------KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
+.||+|+||.||+|.+++.. .|++|++.... .....+.+|+.++++++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999876432 57888765432 125788999999999999999999999988 7789
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC-------CeEE
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-------RAKV 740 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~-------~~kl 740 (948)
+||||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++ .++|
T Consensus 77 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 77 MVEEYVKFGPLDVFLHR----EKNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred EEEEcCCCCcHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEe
Confidence 99999999999998854 12368899999999999999999997 8999999999999999887 7999
Q ss_pred eecCCceecCCCCCceeeeecccccccCceecccC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHH
Q 002238 741 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG--RVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRR 817 (948)
Q Consensus 741 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 817 (948)
+|||+++.... .....++..|+|||++.+. .++.++||||||+++|||++ |..||......+..... .
T Consensus 150 ~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~---~- 220 (259)
T cd05037 150 SDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY---Q- 220 (259)
T ss_pred CCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH---h-
Confidence 99999886533 1223467889999998876 78999999999999999999 57777665432211110 0
Q ss_pred hhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 818 IHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
.... .+. . ....+.+++.+|++.+|.+||++.++++.|
T Consensus 221 ---~~~~-----~~~---~-----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 ---DQHR-----LPM---P-----DCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ---cCCC-----CCC---C-----CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0000 000 0 014688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=323.58 Aligned_cols=238 Identities=25% Similarity=0.358 Sum_probs=185.5
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhc---CCCceeeEEeEEEeCCceEEEEEecCC
Q 002238 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV---RHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (948)
Q Consensus 601 lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lv~e~~~~ 675 (948)
||+|+||.||+|+.+ +++.||||++..... .......+..|..++... +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 689999999865322 222334556677777665 699999999999999999999999999
Q ss_pred CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc
Q 002238 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (948)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 755 (948)
|+|.+++.. ...+++..+..++.||++||+|||+ .+|+||||||+|||++.++.++|+|||+++...... .
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~ 151 (330)
T cd05586 81 GELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-K 151 (330)
T ss_pred ChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-C
Confidence 999888743 2568899999999999999999997 899999999999999999999999999987543222 1
Q ss_pred eeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccC
Q 002238 756 IETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTID 834 (948)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (948)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.. ..+......+. ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~------~~i~~~~~~~~---~~--- 219 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY------RNIAFGKVRFP---KN--- 219 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH------HHHHcCCCCCC---Cc---
Confidence 23345799999999998764 4899999999999999999999999765433221 11111111110 00
Q ss_pred CccchHHHHHHHHHHHHHhcccCCCCCCChH
Q 002238 835 LNEGILASISTVAELAGHCCAREPYQRPDMG 865 (948)
Q Consensus 835 ~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ 865 (948)
.....+.+++.+|++.+|.+||++.
T Consensus 220 ------~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 220 ------VLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred ------cCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 1123577999999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=310.36 Aligned_cols=268 Identities=22% Similarity=0.323 Sum_probs=197.6
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
++++|.+.+.||+|+||.||+|... +|+.||+|++.... .......+.+|+++++.++|+||+++.+++.+++..++|
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT-EEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccC-cCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 3578999999999999999999764 68999999987542 223335678899999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+. +++.+.+.. ....+.+..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||+++..
T Consensus 82 ~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 82 FEYMH-TDLAQYMIQ----HPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred Eeccc-CCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEecccccccc
Confidence 99995 677666532 22457788899999999999999997 79999999999999999999999999998754
Q ss_pred CCCCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc------
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK------ 822 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 822 (948)
..... ......+++.|+|||++.+. .++.++|||||||++|||++|+.||....+... .............
T Consensus 154 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 154 SIPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred CCCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHcCCCChhhhhh
Confidence 33221 12234578999999998764 578999999999999999999999976543211 1111000000000
Q ss_pred ----ccccccc-----CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 823 ----DSFHKAI-----DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 823 ----~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
....... ...+............+.+++.+|+..||.+|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000 0000000000112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=310.98 Aligned_cols=258 Identities=25% Similarity=0.436 Sum_probs=201.6
Q ss_pred HHHHHHhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEe
Q 002238 585 IQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD 662 (948)
Q Consensus 585 ~~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 662 (948)
+.++....+.|++.+.||+|+||.||+|... +++.||+|++... .....++..|+.++.++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 3444556678999999999999999999874 6899999988653 33446788999999999 79999999999853
Q ss_pred ------CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC
Q 002238 663 ------GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 736 (948)
Q Consensus 663 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~ 736 (948)
....++||||+++|+|.+++.. .....+++..+..++.|++.|++|||+ .+++||||||+||++++++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKN---TKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENA 158 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHH---ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCC
Confidence 4567999999999999998854 222457888899999999999999997 8999999999999999999
Q ss_pred CeEEeecCCceecCCCCCceeeeecccccccCceecc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhH
Q 002238 737 RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHL 811 (948)
Q Consensus 737 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~ 811 (948)
.++|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|||++|+.||....+......
T Consensus 159 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~ 237 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL 237 (282)
T ss_pred CEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh
Confidence 999999999875432221 223356899999999875 34678899999999999999999999976543322111
Q ss_pred HHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 812 VTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.. ....+.+. ....+..+.+++.+|++.+|.+||++.|+++
T Consensus 238 ~~-------------~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 IP-------------RNPPPKLK----SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred Hh-------------hCCCCCCc----ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 10 00011111 1122346889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=319.43 Aligned_cols=263 Identities=25% Similarity=0.337 Sum_probs=204.5
Q ss_pred CCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-C-----CceeeEEeEEEeCCce
Q 002238 594 NFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-H-----RHLVALLGHCLDGNEK 666 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~~~~~~~~~~ 666 (948)
+|.+.++||+|+||.|-+|.. ++++.||||+++.. ..-..+-..|+.+|..++ | -|+|++++++...++.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 899999999999999999965 57999999999864 333466778999999996 4 4899999999999999
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC--CeEEeecC
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM--RAKVADFG 744 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~--~~kl~DfG 744 (948)
|||+|.+ .-+|.++++. .....++...+..++.||+.||.+||+ .+|||+||||+||||.+.. .+||+|||
T Consensus 264 ciVfELL-~~NLYellK~---n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKN---NKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred eeeehhh-hhhHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecc
Confidence 9999998 5699999964 445679999999999999999999996 8999999999999997543 79999999
Q ss_pred CceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh-----
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH----- 819 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~----- 819 (948)
.|+...... ....-+..|+|||++.+..|+.+.||||||||++||++|.+-|.+..+.+....+-.+-...
T Consensus 337 SSc~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL 412 (586)
T KOG0667|consen 337 SSCFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML 412 (586)
T ss_pred cccccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 998654432 24556889999999999999999999999999999999998888877655443332111100
Q ss_pred ----cCcccccc-------c---------------------cCc-ccC-----CccchH-HHHHHHHHHHHHhcccCCCC
Q 002238 820 ----LSKDSFHK-------A---------------------IDP-TID-----LNEGIL-ASISTVAELAGHCCAREPYQ 860 (948)
Q Consensus 820 ----~~~~~~~~-------~---------------------~~~-~~~-----~~~~~~-~~~~~l~~li~~c~~~~P~~ 860 (948)
.....+.+ . .+. ..+ ...... .....+++++++|+..||.+
T Consensus 413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~ 492 (586)
T KOG0667|consen 413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE 492 (586)
T ss_pred HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence 00000000 0 000 000 000111 33456899999999999999
Q ss_pred CCChHHHHHH
Q 002238 861 RPDMGHAVNV 870 (948)
Q Consensus 861 RPt~~ev~~~ 870 (948)
|+|..+++++
T Consensus 493 R~tp~qal~H 502 (586)
T KOG0667|consen 493 RITPAQALNH 502 (586)
T ss_pred cCCHHHHhcC
Confidence 9999999874
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=311.93 Aligned_cols=265 Identities=26% Similarity=0.349 Sum_probs=200.7
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC---hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
+|+..+.||+|+||.||+|..+ +|+.||||++...... ......+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999865 6899999999765332 22345677899999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+ +|+|.+++.. ....+++..++.++.||++||+|||+ .+++||||||+||+++.++.++|+|||+++..
T Consensus 81 ~e~~-~~~L~~~i~~----~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 81 FEFM-ETDLEKVIKD----KSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred Eccc-CCCHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 9999 8999998843 11368999999999999999999997 89999999999999999999999999999866
Q ss_pred CCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcc-----
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD----- 823 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 823 (948)
..... ......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||....+.+..... .........
T Consensus 153 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 229 (298)
T cd07841 153 GSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKI--FEALGTPTEENWPG 229 (298)
T ss_pred cCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHH--HHHcCCCchhhhhh
Confidence 44322 1223356889999998865 45789999999999999999998888765443221111 111000000
Q ss_pred --cccccc----CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 824 --SFHKAI----DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 824 --~~~~~~----~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
...... .+..............+.+++.+|++.+|++||+++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000 0000001111223456889999999999999999999988
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=306.09 Aligned_cols=253 Identities=26% Similarity=0.444 Sum_probs=203.1
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
+|+..+.||+|+||.||+|... +++.||+|.++.........+.+..|+++++.++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999864 689999999987644445678899999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++++|.+++.. ...+++..+..++.|+++|++|||+ .+++||||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhh-----cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 999999998843 2457889999999999999999997 89999999999999999999999999998865543
Q ss_pred CCceee---eecccccccCceecccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 753 KGSIET---RIAGTFGYLAPEYAVTGR---VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 753 ~~~~~~---~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
...... ...+++.|+|||++.+.. ++.++||||||+++||+++|+.||......... . ..... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~--~---~~~~~--~--- 222 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI--M---FHVGA--G--- 222 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH--H---HHHhc--C---
Confidence 322211 356789999999998766 889999999999999999999999765322111 1 00000 0
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..+.++. .......+.+++.+|++.+|.+||++.+++.
T Consensus 223 --~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 --HKPPIPD---SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred --CCCCCCc---ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0111110 0111345779999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=313.40 Aligned_cols=199 Identities=30% Similarity=0.434 Sum_probs=160.5
Q ss_pred cceecccCceEEEEEEEc---CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCceEEEEEe
Q 002238 598 ENILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNEKLLVFEY 672 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~ 672 (948)
..+||+|+||.||+|+.+ ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 468999999999999865 45789999886532 22467899999999999999999998854 4567899999
Q ss_pred cCCCChhHHHHhhhh----cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE----cCCCCeEEeecC
Q 002238 673 MPQGTLSRHIFNWAE----EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFG 744 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill----~~~~~~kl~DfG 744 (948)
+++ +|.+++..... .....+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 864 77777643111 112358899999999999999999997 899999999999999 466789999999
Q ss_pred CceecCCCCCc--eeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 002238 745 LVRLAPEGKGS--IETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQ 804 (948)
Q Consensus 745 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~ 804 (948)
+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+||++||....
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 99865433221 1234568999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=308.23 Aligned_cols=256 Identities=23% Similarity=0.426 Sum_probs=199.4
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC--------hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS--------GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN 664 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 664 (948)
+|...+.||+|+||.||+|... +|+.||+|.++..... ....+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999754 6899999988642111 112346888999999999999999999999999
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++++|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecc
Confidence 999999999999999988431 468899999999999999999997 799999999999999999999999999
Q ss_pred CceecCCCCCc-eeeeecccccccCceecccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcC
Q 002238 745 LVRLAPEGKGS-IETRIAGTFGYLAPEYAVTGR--VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS 821 (948)
Q Consensus 745 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 821 (948)
+++........ ......|+..|+|||++.... ++.++||||||+++||+++|..||......+.. .. ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~----~~-- 225 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM--FK----LG-- 225 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH--HH----hh--
Confidence 98865432211 123456889999999987654 789999999999999999999999654332111 10 00
Q ss_pred ccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 822 KDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.......++.. ........+.+++.+|++.+|++||++.+|++.
T Consensus 226 ~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 226 NKRSAPPIPPD-----VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccccCCcCCcc-----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00001111111 111223568899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=307.27 Aligned_cols=248 Identities=25% Similarity=0.467 Sum_probs=200.8
Q ss_pred CCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC---CCceeeEEeEEEeCCceEEE
Q 002238 594 NFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR---HRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv 669 (948)
.|+..+.||+|+||.||+|.. .+++.||+|++.... .....+++.+|+.++++++ |||++++++++.++...++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 477788999999999999986 478999999987542 3444577889999999997 99999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++++|.+++.. ..+++..++.++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 81 MEYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 999999999988732 368899999999999999999997 89999999999999999999999999999866
Q ss_pred CCCCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
..... ......|+..|+|||.+.++ .++.++||||||+++|||++|+.||.......... . ....
T Consensus 152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~------~-------~~~~ 217 (277)
T cd06917 152 NQNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM------L-------IPKS 217 (277)
T ss_pred CCCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh------c-------cccC
Confidence 54432 23345689999999988654 46899999999999999999999997654322110 0 0001
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..+.+... ....++.+++.+|++.+|++||++.++++
T Consensus 218 ~~~~~~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 218 KPPRLEDN----GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCCcc----cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11111111 12346889999999999999999999977
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=314.70 Aligned_cols=254 Identities=24% Similarity=0.343 Sum_probs=201.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCCh-hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|+..+.||+|+||.||+|... +++.||+|.+....... ...+.+..|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999875 58999999997653332 35567899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+.+++|.+++.. .....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQR---QPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHh---CCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 99999999998853 223578999999999999999999997 899999999999999999999999999987443
Q ss_pred CCCCc----------------------------eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 002238 751 EGKGS----------------------------IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDE 802 (948)
Q Consensus 751 ~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~ 802 (948)
..... ......||..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 21110 11134689999999999998999999999999999999999999976
Q ss_pred CCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 803 SQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 803 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
......... ....... .. . .......+.+++.+|++.+|++||+.+..++
T Consensus 235 ~~~~~~~~~------~~~~~~~--------~~--~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 235 SNRDETFSN------ILKKEVT--------FP--G-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred CchHHHHHH------HhcCCcc--------CC--C-ccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 554322111 1100000 00 0 0013456899999999999999999444433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=308.62 Aligned_cols=264 Identities=25% Similarity=0.381 Sum_probs=199.9
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
+|+..+.||+|+||.||+|+.+ +|+.||||++............+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999865 689999999876543344456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+. ++|.+++.. .....+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||+++.....
T Consensus 81 ~~-~~l~~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 81 LH-QDLKKFMDA---SPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred cc-cCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 95 688887743 223568999999999999999999997 89999999999999999999999999998754332
Q ss_pred CCceeeeecccccccCceecccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcc--------
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGR-VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD-------- 823 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 823 (948)
.. ......+++.|+|||+..+.. ++.++||||||+++|||+||+.||......+. .............
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 154 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred cc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhhhhH
Confidence 21 122335788999999887644 68899999999999999999999976543322 1111111100000
Q ss_pred ------ccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 824 ------SFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 824 ------~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.+.......+ .........++.+++.+|++.||++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDF--SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCH--HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 0000112245779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=303.81 Aligned_cols=252 Identities=32% Similarity=0.536 Sum_probs=200.8
Q ss_pred CcccceecccCceEEEEEEEcC-----CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 595 FSEENILGRGGFGTVYKGELHD-----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
|++.+.||+|+||.||+|...+ +..||+|++.... .....+.+..|+++++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567889999999999998753 3889999986542 222567899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++++|.+++.... ...+++.++..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++..
T Consensus 80 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 80 MEYMEGGDLLDYLRKNR---PKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EeccCCCCHHHHHHhhh---hccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceec
Confidence 99999999999885421 1228999999999999999999997 89999999999999999999999999999866
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
............+++.|+|||.+.+..++.++||||+|+++|||++ |+.||........... ... ....
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~---~~~-----~~~~-- 223 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY---LKK-----GYRL-- 223 (258)
T ss_pred ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---Hhc-----CCCC--
Confidence 5443222222337889999999988889999999999999999998 7888876443222111 111 0000
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
.. ....+.++.+++.+|+..+|++||++.++++.|
T Consensus 224 ---~~-----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ---PK-----PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CC-----CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00 011334688999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=310.03 Aligned_cols=255 Identities=25% Similarity=0.382 Sum_probs=195.8
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHH-HHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAV-LTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|++.+.||+|+||.||+|..+ +|+.||+|+++..... ....++..|+.. ++..+||||+++++++..++..++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 46888999999999999999875 6999999998765322 233455566665 66679999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||++ |+|.+++...... ...+++..++.++.|++.||+|||+ +.+++||||||+||+++.++.+||+|||+++...
T Consensus 80 e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhc-ccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9996 6888887553322 3578999999999999999999997 2389999999999999999999999999988654
Q ss_pred CCCCceeeeecccccccCceeccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVT----GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
... ..+...|+..|+|||++.+ ..++.++|+||||+++|||++|+.||....... .... ... .
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~---~~~--~---- 222 (283)
T cd06617 156 DSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF--QQLK---QVV--E---- 222 (283)
T ss_pred ccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH--HHHH---HHH--h----
Confidence 322 1233568899999998865 456889999999999999999999996533211 1111 000 0
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
...+.++.. ....++.+++.+|++.+|++||++.++++.
T Consensus 223 -~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 223 -EPSPQLPAE----KFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred -cCCCCCCcc----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111100 123458899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=305.20 Aligned_cols=261 Identities=23% Similarity=0.325 Sum_probs=203.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CceEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKLLV 669 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv 669 (948)
++|+..+.||.|++|.||+|..+ +++.+|+|.+.... ......++.+|++++++++||||+++++++.+. ...++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 36788899999999999999874 68999999987542 234457789999999999999999999998654 367999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++++|.+++..... ....+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++...
T Consensus 80 ~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 999999999988754322 33568899999999999999999997 89999999999999999999999999998754
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hhhhhHHHHHHHhhcCcccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQP--EESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
.... .....++..|+|||.+.+..++.++||||+|+++|||++|+.||..... ........+..... ...
T Consensus 156 ~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~--- 227 (287)
T cd06621 156 VNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP--NPE--- 227 (287)
T ss_pred cccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC--chh---
Confidence 3322 1234578899999999989999999999999999999999999986532 11112222221110 000
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+..... ........+.+++.+|++.+|.+||++.|+++.
T Consensus 228 -~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 228 -LKDEPG---NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred -hccCCC---CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 000000 001124568899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=313.68 Aligned_cols=248 Identities=24% Similarity=0.401 Sum_probs=199.0
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEec
Q 002238 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 673 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 673 (948)
|+....||+|+||.||+|... +++.||+|++... .......+.+|+.+++.++|||++++++++..++..++||||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec--ccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 334557999999999999864 6899999998654 2233567889999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCC
Q 002238 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (948)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~ 753 (948)
++++|.+++.. ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 101 ~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 101 QGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred CCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 99999887632 468899999999999999999997 899999999999999999999999999987544322
Q ss_pred CceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCccc
Q 002238 754 GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTI 833 (948)
Q Consensus 754 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (948)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||....+.+.... .... . .+..
T Consensus 172 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~---~-------~~~~ 237 (297)
T cd06659 172 P-KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR---LRDS---P-------PPKL 237 (297)
T ss_pred c-cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---Hhcc---C-------CCCc
Confidence 1 22345689999999999988999999999999999999999999976543322111 1100 0 0000
Q ss_pred CCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 834 DLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 834 ~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.........+.+++.+|++.+|.+||++.++++.
T Consensus 238 ---~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 ---KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ---cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0011123458899999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=308.06 Aligned_cols=255 Identities=27% Similarity=0.415 Sum_probs=201.2
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCC----
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN---- 664 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~---- 664 (948)
.+++|++.+.||+|+||.||+|..+ +++.|++|++... ....+++.+|+++++++ +|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII---EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC---chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4688999999999999999999875 6789999998754 23446789999999999 7999999999997644
Q ss_pred --ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEee
Q 002238 665 --EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (948)
Q Consensus 665 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~D 742 (948)
..++||||+++++|.+++.... .....+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECC
Confidence 4799999999999998885432 123578999999999999999999997 8999999999999999999999999
Q ss_pred cCCceecCCCCCceeeeecccccccCceeccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH
Q 002238 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT-----GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRR 817 (948)
Q Consensus 743 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 817 (948)
||++........ ......|+..|+|||++.. ..++.++||||||+++|||++|+.||....+..... .
T Consensus 157 ~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~---- 229 (275)
T cd06608 157 FGVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF--K---- 229 (275)
T ss_pred Cccceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH--H----
Confidence 999876543222 2233568999999998753 346789999999999999999999997543322111 1
Q ss_pred hhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 818 IHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.. .. ..+.+. ........+.+++.+|++.||++||++.++++
T Consensus 230 ~~--~~-----~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IP--RN-----PPPTLK---SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hh--cc-----CCCCCC---chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 10 00 011111 11123346889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=309.45 Aligned_cols=250 Identities=24% Similarity=0.417 Sum_probs=202.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|+..+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++|||++++++++..++..++|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 67888999999999999999754 6889999998643 23345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.+++.. ..+++..+..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 97 ~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 97 YLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred cCCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999988843 357899999999999999999997 8999999999999999999999999998875543
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
... ......|++.|+|||++.+..++.++||||||+++||+++|+.||............ .... .+
T Consensus 168 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~~~-------~~ 233 (293)
T cd06647 168 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNG-------TP 233 (293)
T ss_pred ccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hcCC-------CC
Confidence 322 223346889999999998888999999999999999999999999765432211100 0000 00
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
... ........+.+++.+|++.+|++||++.+++.+
T Consensus 234 ~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 234 ELQ---NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 111123458899999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=304.78 Aligned_cols=254 Identities=22% Similarity=0.409 Sum_probs=200.9
Q ss_pred CCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCC----hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEE
Q 002238 594 NFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVIS----GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
+|+..+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999975 57899999998754311 1235678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC-CeEEeecCCce
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVR 747 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~-~~kl~DfGla~ 747 (948)
||||+++++|.+++.. ..++++..+..++.|++.||+|||+ .+++||||||+||+++.++ .++|+|||++.
T Consensus 81 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 81 FVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEeccCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 9999999999998843 2468899999999999999999997 8999999999999998776 59999999987
Q ss_pred ecCCCCC---ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 748 LAPEGKG---SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 748 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
....... .......|+..|+|||++.+..++.++||||+|+++|||++|+.||............. .....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~--- 226 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF---KIASA--- 226 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH---HHhcc---
Confidence 6543211 11233568999999999988889999999999999999999999997543322111111 11000
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
...+. ........+.+++.+|++.+|++||++.++++
T Consensus 227 ---~~~~~-----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 ---TTAPS-----IPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---CCCCC-----CchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00011 11122345889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=302.18 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=196.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC---hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--Cce
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEK 666 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 666 (948)
.+|++.+.||+|+||.||+|..+ +|..||||.+...... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57889999999999999999864 6899999988643211 23456788999999999999999999988764 457
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCc
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla 746 (948)
++||||+++++|.+++.. ...+++..+.+++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS-----YGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccc
Confidence 899999999999988743 2457888899999999999999997 89999999999999999999999999998
Q ss_pred eecCCCCC--ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 747 RLAPEGKG--SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 747 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
+....... .......|+..|+|||++.+..++.++||||||+++|||++|+.||......... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~-- 225 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIATQP-- 225 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH------HHHhcCC--
Confidence 75432111 1122345899999999998888999999999999999999999999765332211 1111100
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..+.. .......+.+++.+|+ .+|.+||+++++++
T Consensus 226 ----~~~~~-----~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~ 260 (265)
T cd06652 226 ----TNPVL-----PPHVSDHCRDFLKRIF-VEAKLRPSADELLR 260 (265)
T ss_pred ----CCCCC-----chhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence 01111 1122345778999998 49999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=308.97 Aligned_cols=246 Identities=27% Similarity=0.382 Sum_probs=200.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|+..+.||+|+||.||+|... +++.||+|++..... .......+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999865 689999999875432 2334567899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||+++...
T Consensus 81 e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 81 EYVPGGELFSHLRK-----SGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred ecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 99999999988843 2568899999999999999999997 899999999999999999999999999988654
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
.. .....|++.|+|||.+.+...+.++||||||+++|||++|+.||........... ....... +.
T Consensus 153 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~~~~~----~~ 218 (290)
T cd05580 153 GR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK------ILEGKVR----FP 218 (290)
T ss_pred CC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HhcCCcc----CC
Confidence 43 2334689999999999888899999999999999999999999976553221111 1100000 11
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRP-----DMGHAVN 869 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RP-----t~~ev~~ 869 (948)
. .....+.+++.+|++.+|.+|| +++|+++
T Consensus 219 ~---------~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 219 S---------FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred c---------cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1 1124588999999999999999 5555544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=302.94 Aligned_cols=248 Identities=25% Similarity=0.443 Sum_probs=201.5
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
-|+..+.||+|+||.||+|... +++.||||.+.... .....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 4677889999999999999864 68899999876532 234457789999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++++|.+++.. ..+++..+..++.|++.|++|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 84 LGGGSALDLLEP------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 999999988732 468899999999999999999997 89999999999999999999999999998755432
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (948)
.. ......|+..|+|||++.+..++.++|||||||++|||++|..||....+...... ... .. ...++
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~------~~~--~~-~~~~~-- 222 (277)
T cd06641 155 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL------IPK--NN-PPTLE-- 222 (277)
T ss_pred hh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH------Hhc--CC-CCCCC--
Confidence 21 22334688999999999888899999999999999999999999976543221111 110 00 00111
Q ss_pred cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 833 IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 833 ~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
...+..+.+++.+|++.+|.+||++.++++.
T Consensus 223 -------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 -------GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -------cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1123458899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=309.02 Aligned_cols=265 Identities=25% Similarity=0.360 Sum_probs=196.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|+..+.||+|+||.||+|..+ +++.||||.+..... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 57889999999999999999875 689999999875422 2223457789999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++ +|.+++.. ....+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.++|+|||+++....
T Consensus 84 ~~~~-~L~~~~~~----~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 84 YLDT-DLKQYMDD----CGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred cCCC-CHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 9974 89887743 22468899999999999999999997 8999999999999999999999999999874432
Q ss_pred CCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-hhhhHHHHHHHhhcCcc-ccccc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPE-ESMHLVTWFRRIHLSKD-SFHKA 828 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~ 828 (948)
... ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||...... +....+. ........ .+...
T Consensus 156 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 232 (291)
T cd07844 156 PSK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIF--RVLGTPTEETWPGV 232 (291)
T ss_pred CCc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHH--HhcCCCChhhhhhh
Confidence 211 1122346889999998875 45889999999999999999999999765421 1111110 00000000 00000
Q ss_pred -------------c-CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 829 -------------I-DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 829 -------------~-~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
. ...+............+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0000000000111245789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.54 Aligned_cols=267 Identities=23% Similarity=0.323 Sum_probs=200.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CceEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKLLV 669 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv 669 (948)
++|+..+.||+|+||.||+|..+ +++.||+|.++...........+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999876 688999999976543333345678899999999999999999998877 889999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||++ ++|.+++.. ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++..
T Consensus 85 ~e~~~-~~L~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 85 MEYVE-HDLKSLMET----MKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred ehhcC-cCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99997 488887743 22368999999999999999999997 79999999999999999999999999999866
Q ss_pred CCCCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHH----------HHHHh
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVT----------WFRRI 818 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~----------~~~~~ 818 (948)
..... ......+++.|+|||++.+. .++.++|+||||+++|||++|+.||......+....+. |....
T Consensus 157 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 157 GSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred cCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 54321 12334578999999988764 46899999999999999999999998655433221110 00000
Q ss_pred hcC--c-cccccccCcccCCccchHH-HHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 819 HLS--K-DSFHKAIDPTIDLNEGILA-SISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 819 ~~~--~-~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
... . ..........+. ...... ....+.+++.+|++.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLR-KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhh-ccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000 0 000000000000 000000 2345789999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=307.16 Aligned_cols=258 Identities=24% Similarity=0.338 Sum_probs=197.2
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCceEEEEE
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e 671 (948)
+|+..+.||+|+||.||++... +++.||+|.+..... ......+.+|+.++.++. ||||+++++++..+...+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD-EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC-hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 4556778999999999999865 689999999875432 244567899999999996 9999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+. +++.++...........+++..+..++.|++.||+|||+ +.+++||||||+||+++.++.++|+|||+++....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 985 466554422112223678999999999999999999996 35899999999999999999999999999875443
Q ss_pred CCCceeeeecccccccCceecccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTG---RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
.. ......|+..|+|||++.+. .++.++|||||||++|||++|+.||..... .......... .
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~--~----- 226 (288)
T cd06616 161 SI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK--G----- 226 (288)
T ss_pred CC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC--C-----
Confidence 22 12334588999999998776 689999999999999999999999975431 1111111110 0
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
..+.+. .........++.+++.+|++.+|++||++.+|++.
T Consensus 227 ~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 227 DPPILS-NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcCC-CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011111 11112234568999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=307.69 Aligned_cols=270 Identities=23% Similarity=0.307 Sum_probs=199.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCc-----
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNE----- 665 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~----- 665 (948)
++|++.+.||+|+||.||+|... +++.||||++............+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999865 6899999988764333333467889999999995 6999999999887665
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC-CCCeEEeecC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFG 744 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~-~~~~kl~DfG 744 (948)
.++||||+++ +|.+++..........+++..++.++.||+.||+|||+ .+|+||||||+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 88888755332223578999999999999999999997 89999999999999998 8899999999
Q ss_pred CceecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcc
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD 823 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 823 (948)
+++........ .....+++.|+|||++.+ ..++.++||||||+++|||++|..||....+.+.. ............
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LHIFKLLGTPTE 233 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHHHhCCCCh
Confidence 98855332211 122357889999998865 45789999999999999999999999865433221 111111100000
Q ss_pred c-cccccC-------ccc---CCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 824 S-FHKAID-------PTI---DLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 824 ~-~~~~~~-------~~~---~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
. +..... +.. ...........++.+++.+|++.+|.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 000000 000 000001123456889999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.83 Aligned_cols=252 Identities=23% Similarity=0.405 Sum_probs=202.9
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
+|+..+.||+|+||.||+|..+ +|..||+|.+..........+.+.+|+++++.++|+||+++++++.++...++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788899999999999999875 688999999876544445567788999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC-CeEEeecCCceecCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVRLAPE 751 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~-~~kl~DfGla~~~~~ 751 (948)
+++++|.+++.. .....+++..+..++.|+++||+|||+ .+++|+||||+||++++++ .++++|||.+.....
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINR---QRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 999999998853 222457999999999999999999997 8999999999999999886 469999999876543
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
... ......|++.|+|||+..+..++.++||||||+++||+++|+.||......+. ...... ..... ..+
T Consensus 155 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~--~~~~~-~~~ 224 (257)
T cd08225 155 SME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL------VLKICQ--GYFAP-ISP 224 (257)
T ss_pred Ccc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHhc--ccCCC-CCC
Confidence 322 22334589999999999888899999999999999999999999976543221 111111 11110 111
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.....+.+++.+|++.+|++||++.++++.
T Consensus 225 ---------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 225 ---------NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---------CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 122458899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=300.86 Aligned_cols=254 Identities=23% Similarity=0.383 Sum_probs=207.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|++.+.||+|++|.||+|+.+ +++.||||++...... .....+.+|+.++.+++|+|++++++++..+...++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 36888899999999999999876 5999999998765322 456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.+++.. ...+++..++.++.|+++|++|||+ ..+++||||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 80 YMDGGSLADLLKK-----VGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred ecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999843 1578999999999999999999995 27999999999999999999999999999886644
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.||.............++... ..+
T Consensus 153 ~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~----------~~~ 221 (264)
T cd06623 153 TLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG----------PPP 221 (264)
T ss_pred CCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC----------CCC
Confidence 3322 23456889999999999999999999999999999999999999776532222222221110 001
Q ss_pred ccCCccchHH-HHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 832 TIDLNEGILA-SISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 832 ~~~~~~~~~~-~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
... .. .+..+.+++.+|++.+|++||++.++++.
T Consensus 222 ~~~-----~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 SLP-----AEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCC-----cccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 11 23468899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=305.58 Aligned_cols=265 Identities=24% Similarity=0.367 Sum_probs=199.6
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEec
Q 002238 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 673 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 673 (948)
|+..+.||+|++|.||+|..+ +|..||+|++............+.+|+++++.++|||++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999864 7999999998765433444467889999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCC
Q 002238 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (948)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~ 753 (948)
+ ++|.+++.. .....+++..++.++.|+++||+|||+ .+++||||+|+||+++.++.++|+|||+++......
T Consensus 81 ~-~~l~~~~~~---~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 81 D-LDLKKYMDS---SPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred C-cCHHHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 5 689888743 112468999999999999999999997 799999999999999999999999999987543322
Q ss_pred CceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcc---------
Q 002238 754 GSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD--------- 823 (948)
Q Consensus 754 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 823 (948)
. ......++..|+|||++.+. .++.++||||||+++|||++|+.||....+.... ....+.......
T Consensus 154 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 154 R-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL--FRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred c-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCChHHhhhhhhc
Confidence 1 12233568899999987664 5789999999999999999999999765543221 111111100000
Q ss_pred -ccccccCc--ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 824 -SFHKAIDP--TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 824 -~~~~~~~~--~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.+...+.. ..............+.+++.+|++.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000 00001111122346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=308.67 Aligned_cols=249 Identities=27% Similarity=0.405 Sum_probs=198.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.+.|+..+.||+|+||.||+|... +++.||+|++..... .....+++.+|+++++.++||||+++.+++.+++..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 456888999999999999999865 689999999865422 233456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||++ |++.+.+.. ....+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++...
T Consensus 94 ~e~~~-g~l~~~~~~----~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 94 MEYCL-GSASDILEV----HKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred HHhhC-CCHHHHHHH----cccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceec
Confidence 99996 577666632 22468999999999999999999997 89999999999999999999999999998755
Q ss_pred CCCCCceeeeecccccccCceecc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAV---TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
... ....|++.|+|||++. ...++.++||||||+++|||++|+.||............ .. .
T Consensus 166 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~------~~--~--- 229 (307)
T cd06607 166 SPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------AQ--N--- 229 (307)
T ss_pred CCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH------hc--C---
Confidence 332 2345788999999874 456889999999999999999999999765433221111 00 0
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
..+.+. .......+.+++.+||+.+|++||++.+++.+
T Consensus 230 --~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 230 --DSPTLS----SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CCCCCC----chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 001111 11123468899999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=305.70 Aligned_cols=248 Identities=25% Similarity=0.432 Sum_probs=199.6
Q ss_pred CCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
.|...+.||+|++|.||+|.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 355567899999999999986 47899999988643 333456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++++|.+++.. ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++......
T Consensus 98 ~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 98 LEGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred cCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 999999988843 468899999999999999999997 89999999999999999999999999988754332
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (948)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....+..... ..... ..+.
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~------~~~~~-------~~~~ 234 (285)
T cd06648 169 VP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK------RIRDN-------LPPK 234 (285)
T ss_pred Cc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH------HHHhc-------CCCC
Confidence 21 2233568999999999988889999999999999999999999997654432211 11100 0011
Q ss_pred cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 833 IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 833 ~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+. ........+.+++.+|++.+|++||++.++++
T Consensus 235 ~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 235 LK---NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred Cc---ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 11 01112346889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.07 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=203.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|+..+.||+|+||.||+|..+ +++.||+|++.... ......++.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI-NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc-ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 35777889999999999999876 68999999987653 23456788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.+++.. ....+++..+.+++.|++.|++|||+ ..+++||||||+||++++++.++|+|||.+.....
T Consensus 80 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 80 YMDGGSLDKILKE----VQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred ecCCCcHHHHHHH----ccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 9999999998843 12578889999999999999999995 37999999999999999999999999999875433
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
... ....++..|+|||++.+..++.++||||||+++|+|++|+.||....... ............. ..+
T Consensus 154 ~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~-------~~~ 222 (265)
T cd06605 154 SLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNE-------PPP 222 (265)
T ss_pred HHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcC-------CCC
Confidence 221 12568899999999999999999999999999999999999997653211 1111111111110 001
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.+... ....++.+++.+|+..+|++||++.+++..
T Consensus 223 ~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 223 RLPSG----KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCChh----hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11100 133458899999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=305.35 Aligned_cols=254 Identities=26% Similarity=0.437 Sum_probs=205.9
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEE
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
..++.|+..+.||+|+||.||+|..+ +++.||+|++..... ....+.+|+++++.++|+|++++++++......++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 34667888899999999999999876 689999999876422 45778999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
|+||+++++|.+++... ...+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++..
T Consensus 93 v~e~~~~~~L~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 165 (286)
T cd06614 93 VMEYMDGGSLTDIITQN----FVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQ 165 (286)
T ss_pred EEeccCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhh
Confidence 99999999999998542 1478999999999999999999997 8999999999999999999999999998775
Q ss_pred cCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
...... ......++..|+|||++.+..++.++||||||+++|||++|+.||....+....... . ......
T Consensus 166 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~---~-----~~~~~~- 235 (286)
T cd06614 166 LTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI---T-----TKGIPP- 235 (286)
T ss_pred hccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H-----hcCCCC-
Confidence 433221 223345789999999998888999999999999999999999999765543221111 0 000000
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.. .....+..+.+++.+|++.+|.+||++.++++.
T Consensus 236 ----~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 236 ----LK---NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ----Cc---chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00 111123468899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=344.43 Aligned_cols=258 Identities=26% Similarity=0.404 Sum_probs=206.9
Q ss_pred HHHhhcCCcccceecccCceEEEEEE-EcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCce
Q 002238 588 LRNVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 588 l~~~~~~~~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 666 (948)
++.++-+|.....||.|.||.||-|. .++|+-.|||-++...........+.+|..++..++|||+|+++|+-.+++..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 45566789999999999999999997 46799999998876555556677899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCc
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla 746 (948)
+|.||||++|+|.+.+.. .+..++.....+..|++.|++|||+ .|||||||||.||+++.+|.+|++|||.|
T Consensus 1310 ~IFMEyC~~GsLa~ll~~-----gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEH-----GRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHhccCcHHHHHHh-----cchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccce
Confidence 999999999999999843 2345555566678899999999997 89999999999999999999999999999
Q ss_pred eecCCCCCce---eeeecccccccCceecccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc
Q 002238 747 RLAPEGKGSI---ETRIAGTFGYLAPEYAVTG---RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL 820 (948)
Q Consensus 747 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 820 (948)
.......... ....+||+.|||||++.+. .-..++||||+|||+.||+||++||...+.+ |.-..+.
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V 1454 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHV 1454 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHH
Confidence 8655443222 2346899999999999764 3567999999999999999999999876532 2222222
Q ss_pred CccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 821 SKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
..+.. |.++ .....+-.+++.+|+..||++|.++.|+++.
T Consensus 1455 ~~gh~-----Pq~P-----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 AAGHK-----PQIP-----ERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hccCC-----CCCc-----hhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 22211 2222 1133456799999999999999888877663
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=314.43 Aligned_cols=266 Identities=23% Similarity=0.375 Sum_probs=197.8
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-----
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----- 664 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 664 (948)
+.++|++.+.||+|+||.||+|... +|+.||||++.... .......+.+|+.++++++||||+++++++....
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 3578999999999999999999864 78999999986421 2334566888999999999999999999876543
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
..++||||+++ +|.+.+.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg 151 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFG 151 (336)
T ss_pred eEEEEehhccc-CHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECccc
Confidence 47999999964 77766632 468999999999999999999997 899999999999999999999999999
Q ss_pred CceecCCCCC--ceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcC
Q 002238 745 LVRLAPEGKG--SIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS 821 (948)
Q Consensus 745 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 821 (948)
+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+........ ........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~---~~~~~~~~ 228 (336)
T cd07849 152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN---LILGVLGT 228 (336)
T ss_pred ceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCC
Confidence 9886543221 11233568999999998755 568999999999999999999999997654322111 11000000
Q ss_pred --cccccccc-------------CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 822 --KDSFHKAI-------------DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 822 --~~~~~~~~-------------~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
...+.... .+.............++.+++.+|++.+|++||++.++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 00000000011123568899999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=304.42 Aligned_cols=266 Identities=25% Similarity=0.344 Sum_probs=200.8
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CceEEEEE
Q 002238 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKLLVFE 671 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 671 (948)
|++.+.||+|+||.||+|+.. +++.||+|++............+.+|+++++.++|||++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999876 589999999987542334456788999999999999999999999887 78999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++ +|.+++.. ....+++..++.++.|+++||+|||+ .+++|+||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~-~l~~~~~~----~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMDH-DLTGLLDS----PEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred cccc-cHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 9974 88877743 22578999999999999999999997 7999999999999999999999999999986655
Q ss_pred CCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc----
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH---- 826 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 826 (948)
..........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+....... ....+.
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 231 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP-TDENWPGVSK 231 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-chhhcccccc
Confidence 43222334457889999998765 457899999999999999999999998765433222111100000 000000
Q ss_pred ----cccCcccCCc----cchHH-HHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 827 ----KAIDPTIDLN----EGILA-SISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 827 ----~~~~~~~~~~----~~~~~-~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
....+..... ..... +...+.+++.+|++.+|.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000 00001 2456889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=309.27 Aligned_cols=268 Identities=26% Similarity=0.352 Sum_probs=199.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CceEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKLL 668 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 668 (948)
.++|++.+.||+|+||.||+|..+ +|+.||+|+++...........+.+|++++++++|+|++++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 457899999999999999999875 689999999875433333334567899999999999999999998765 45799
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||||++ ++|.+++.. ....+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++..
T Consensus 86 v~e~~~-~~l~~~l~~----~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 86 VMEYCE-QDLASLLDN----MPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEecCC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeee
Confidence 999996 488877743 22578999999999999999999997 8999999999999999999999999999986
Q ss_pred cCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc-
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH- 826 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 826 (948)
...... ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||....+.+....+... .........
T Consensus 158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~--~~~~~~~~~~ 234 (309)
T cd07845 158 YGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQL--LGTPNESIWP 234 (309)
T ss_pred cCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh--cCCCChhhch
Confidence 654322 1223346788999999865 45789999999999999999999999876554332222110 000000000
Q ss_pred --------ccc--C-cccC-CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 827 --------KAI--D-PTID-LNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 827 --------~~~--~-~~~~-~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
..+ . .... ...........+.+++.+|++.||++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 0 0000 000001123457799999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=307.61 Aligned_cols=270 Identities=27% Similarity=0.383 Sum_probs=201.6
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC----
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN---- 664 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 664 (948)
...++|++.+.||+|+||.||+|..+ +|+.||||+++...........+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678999999999999999999875 6899999999765433344467789999999999999999999987654
Q ss_pred ------ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCe
Q 002238 665 ------EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 738 (948)
Q Consensus 665 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~ 738 (948)
..++|+||+++ ++.+.+.. ....+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES----GLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcE
Confidence 78999999976 67666632 23468999999999999999999997 899999999999999999999
Q ss_pred EEeecCCceecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH
Q 002238 739 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRR 817 (948)
Q Consensus 739 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 817 (948)
||+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|++||......+....+...
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~-- 233 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL-- 233 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH--
Confidence 999999988654433222233456889999998765 35789999999999999999999999865433222111111
Q ss_pred hhcCcc-ccccc--------cCccc----CCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 818 IHLSKD-SFHKA--------IDPTI----DLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 818 ~~~~~~-~~~~~--------~~~~~----~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
...... .+... .++.. .........+..+.+++.+|++.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000 00000 00000 000011112456889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=313.57 Aligned_cols=268 Identities=24% Similarity=0.325 Sum_probs=201.5
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG----- 663 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 663 (948)
.+.++|+..+.||+|+||.||+|... +|+.||||++............+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35678999999999999999999864 789999999875433444556788999999999999999999988643
Q ss_pred -CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEee
Q 002238 664 -NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (948)
Q Consensus 664 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~D 742 (948)
...++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEcc
Confidence 34699999995 588777632 27888999999999999999997 7999999999999999999999999
Q ss_pred cCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHH-H--------
Q 002238 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLV-T-------- 813 (948)
Q Consensus 743 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~-~-------- 813 (948)
||+++...... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...........+ .
T Consensus 162 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 162 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239 (353)
T ss_pred CccceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 99998654322 223346889999999999999999999999999999999999999765432211100 0
Q ss_pred HHH-------HhhcCc-----cccccccCcccC---CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 814 WFR-------RIHLSK-----DSFHKAIDPTID---LNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 814 ~~~-------~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+.. ...... ..+.+.+..... ...........+.+++.+|++.||++||++.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 000000 000111111000 000011234568899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=299.92 Aligned_cols=251 Identities=27% Similarity=0.401 Sum_probs=206.8
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
+|++.+.||+|+||.||++..+ +++.+|+|++...........++.+|+++++.++||||+++.+++.++...++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999764 788999999987554555567888999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++++|.+++.... .....+++..++.++.|++.||+|||+ .+++||||+|+||+++.++.++++|||++......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999886532 223578999999999999999999997 89999999999999999999999999999866543
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (948)
......|++.|+|||.+.+..++.++|+||||+++|||++|+.||......+....+ . ..... .
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~--~~~~~-----~ 220 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV------Q--RGKYP-----P 220 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------h--cCCCC-----C
Confidence 122345889999999999989999999999999999999999999876543211111 0 11111 0
Q ss_pred cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 833 IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 833 ~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.......++.+++.+|++.+|++||++.++++
T Consensus 221 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 -----IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -----CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11133456899999999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=309.37 Aligned_cols=269 Identities=22% Similarity=0.307 Sum_probs=197.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc-----
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE----- 665 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 665 (948)
.++|+..+.||+|+||.||+|..+ +++.||||++............+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457999999999999999999875 68999999987543333334456789999999999999999999876543
Q ss_pred ---eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEee
Q 002238 666 ---KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (948)
Q Consensus 666 ---~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~D 742 (948)
.++||||+. ++|.+.+.. ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSN----KNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECc
Confidence 499999996 478777632 22468999999999999999999997 7999999999999999999999999
Q ss_pred cCCceecCCCCCc---eeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh
Q 002238 743 FGLVRLAPEGKGS---IETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI 818 (948)
Q Consensus 743 fGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 818 (948)
||++......... ......++..|+|||++.+. .++.++||||||+++|||++|+.||....+......+..+...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999855432211 12234578899999988664 4788999999999999999999999876554333222221110
Q ss_pred hcCccccccc-----cCc-ccCCc--cc------hHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 819 HLSKDSFHKA-----IDP-TIDLN--EG------ILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 819 ~~~~~~~~~~-----~~~-~~~~~--~~------~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
. ....+... .+. ..... .. .......+.+++.+|++.+|++||+++++++
T Consensus 243 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 243 I-TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred C-ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 00000000 000 00000 00 0001235679999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=312.58 Aligned_cols=270 Identities=27% Similarity=0.354 Sum_probs=201.4
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeC--Cce
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG--NEK 666 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~--~~~ 666 (948)
+.++|++.+.||+|+||.||+|... +|+.||||++............+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4678999999999999999999875 688999999865433344456788899999999 999999999988653 357
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCc
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla 746 (948)
++||||++ ++|.+++.. ..++|..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++
T Consensus 85 ~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred EEEecccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccch
Confidence 99999997 588877732 267899999999999999999997 89999999999999999999999999998
Q ss_pred eecCCCCC----ceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh--
Q 002238 747 RLAPEGKG----SIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH-- 819 (948)
Q Consensus 747 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-- 819 (948)
+....... .......||..|+|||++.+ ..++.++||||||+++|||++|+.||......+............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 85543322 12334568999999998765 457899999999999999999999997655433221111110000
Q ss_pred ---------cCccccccccCcc-cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 820 ---------LSKDSFHKAIDPT-IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 820 ---------~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.....+....... ............++.+++.+|++.+|++||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000000 00001111134568899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=309.72 Aligned_cols=272 Identities=24% Similarity=0.332 Sum_probs=198.9
Q ss_pred CCcccceecccCceEEEEEEEc---CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CceE
Q 002238 594 NFSEENILGRGGFGTVYKGELH---DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKL 667 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 667 (948)
+|++.+.||+|+||.||+|..+ +++.||+|.+..... .......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999875 479999999876421 122346678899999999999999999999988 7899
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC----CCCeEEeec
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD----DMRAKVADF 743 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~----~~~~kl~Df 743 (948)
+||||+++ ++.+.+..........+++..++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999965 67776644333333478899999999999999999997 89999999999999999 899999999
Q ss_pred CCceecCCCCC--ceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh-------hhHHH
Q 002238 744 GLVRLAPEGKG--SIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEES-------MHLVT 813 (948)
Q Consensus 744 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~-------~~~~~ 813 (948)
|+++....... .......+|+.|+|||++.+. .++.++||||||+++|||++|++||........ .....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99886543322 112335688999999988764 578999999999999999999999986543320 01111
Q ss_pred HHHHhhcCc----------ccccc---cc-CcccCCcc----ch--HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 814 WFRRIHLSK----------DSFHK---AI-DPTIDLNE----GI--LASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 814 ~~~~~~~~~----------~~~~~---~~-~~~~~~~~----~~--~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.+....... ..+.. .. ........ .. .....++.+++.+|++.+|++||++.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111000000 00000 00 00000000 00 022346889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=302.47 Aligned_cols=266 Identities=25% Similarity=0.372 Sum_probs=200.1
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
+|+..+.||+|++|.||+|+.. +|+.||||+++... .......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA-EEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccc-cccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 5788999999999999999875 68999999987643 223346678899999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++ +|.+++.... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.++++|||+++.....
T Consensus 80 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 80 MDK-DLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred CCc-cHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 975 8888774421 22468999999999999999999997 79999999999999999999999999998754332
Q ss_pred CCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcC----------
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS---------- 821 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 821 (948)
.. ......++..|+|||++.+. .++.++||||||+++|||++|+.||......+....+. ......
T Consensus 154 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 154 VN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIF--RIMGTPTESTWPGISQ 230 (284)
T ss_pred cc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH--HHhCCCChhhHHHHhc
Confidence 21 12234578999999988664 57899999999999999999999998765433221111 000000
Q ss_pred ccccccccCccc--CCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 822 KDSFHKAIDPTI--DLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 822 ~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
...+...+.... ............+.+++.+|++.+|.+||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000000 000001122356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=305.04 Aligned_cols=267 Identities=24% Similarity=0.349 Sum_probs=198.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|+..+.||+|++|.||+|..+ +|+.||+|.+............+.+|++++++++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 47889999999999999999875 68999999986543333445678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC-CCCeEEeecCCceecC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRLAP 750 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~-~~~~kl~DfGla~~~~ 750 (948)
|++ ++|.+++.. .....+++..+..++.||+.||+|||+ ++++||||||+||+++. ++.+||+|||++....
T Consensus 82 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDS---SPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHh---CCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 995 578777633 222346788889999999999999997 79999999999999985 5579999999987543
Q ss_pred CCCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc----
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF---- 825 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 825 (948)
.... ......+++.|+|||++.+. .++.++||||||+++|||+||+.||......+..... ...........
T Consensus 155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 155 IPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI--FRILGTPNEETWPGV 231 (294)
T ss_pred CCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHhCCCChhhcccc
Confidence 3221 12334578999999988664 5789999999999999999999999865543221111 11000000000
Q ss_pred ------ccccC--cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 826 ------HKAID--PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 826 ------~~~~~--~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..... ..............++.+++.+|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 000000011122345789999999999999999999987
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=304.84 Aligned_cols=257 Identities=16% Similarity=0.214 Sum_probs=184.7
Q ss_pred hcCCcccceecccCceEEEEEEEcC----CcEEEEEEeecCcCChh-h--------HHHHHHHHHHHHhcCCCceeeEEe
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGK-G--------LTEFKSEIAVLTKVRHRHLVALLG 658 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~-~--------~~~~~~E~~~l~~l~H~niv~l~~ 658 (948)
.++|++.+.||+|+||.||+|...+ +..+|+|+......... + ......+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999998754 34666765432211100 0 011223344556678999999999
Q ss_pred EEEeCC----ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC
Q 002238 659 HCLDGN----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 734 (948)
Q Consensus 659 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~ 734 (948)
++.... ..++++|++. .++.+.+.. ....++..+..++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR-----IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDG 161 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHh-----hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcC
Confidence 776543 3467888774 366555522 1335678889999999999999997 89999999999999999
Q ss_pred CCCeEEeecCCceecCCCCC------ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 002238 735 DMRAKVADFGLVRLAPEGKG------SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEES 808 (948)
Q Consensus 735 ~~~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~ 808 (948)
++.++|+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 99999999999986533211 111234699999999999999999999999999999999999999987632221
Q ss_pred -hhH--HHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 809 -MHL--VTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 809 -~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
... .++..+... +... ....+..+.+++..|++.+|++||++.++++.+
T Consensus 242 ~~~~~~~~~~~~~~~----------~~~~----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHAAKCDFIKRLHE----------GKIK----IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhHHHHHHHhhh----------hhhc----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111 111222111 1111 111235688999999999999999999999876
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=295.92 Aligned_cols=249 Identities=27% Similarity=0.465 Sum_probs=203.9
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
+|+..+.||+|++|.||+|... +++.+++|++.... ......+.+|++++++++|||++++++++..+...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES--KEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccc--hhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4778899999999999999875 68999999987643 24567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++++|.+++.. ....+++..+..++.|++.|++|||+ .+++||||+|+||++++++.++|+|||.+......
T Consensus 79 ~~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 79 CSGGSLKDLLKS----TNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCCCcHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 999999988843 12578999999999999999999997 89999999999999999999999999998866543
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (948)
.. .....|+..|+|||++.+..++.++||||||+++|||++|+.||............. . ........+
T Consensus 152 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~-----~~~~~~~~~- 220 (253)
T cd05122 152 KA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA---T-----NGPPGLRNP- 220 (253)
T ss_pred cc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---h-----cCCCCcCcc-
Confidence 32 334568999999999988889999999999999999999999997654322211110 0 001111100
Q ss_pred cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 833 IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 833 ~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
......+.+++.+|++.+|++||++.++++
T Consensus 221 -------~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 -------EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -------cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111345889999999999999999999876
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.86 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=202.2
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
+|++.+.||.|+||.||+|..+ +++.||+|++...... ....+.+.+|++++++++||||+++++++.++...++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788999999999999999875 6899999999764332 2456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.+++.. ...+++..+..++.|+++||+|||+ .+++|+||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQ-----KVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 9999999988843 1478899999999999999999997 7999999999999999999999999999886544
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
.. ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||............ ..... ......
T Consensus 153 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~---~~~~~~- 222 (258)
T cd05578 153 DT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----AKQET---ADVLYP- 222 (258)
T ss_pred Cc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----HHhcc---ccccCc-
Confidence 32 223456889999999998888999999999999999999999999876532111111 11110 000111
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCCh--HHHH
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDM--GHAV 868 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~--~ev~ 868 (948)
...+..+.+++.+|++.+|.+||+. +|+.
T Consensus 223 --------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 223 --------ATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --------ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1123568899999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=303.61 Aligned_cols=253 Identities=26% Similarity=0.412 Sum_probs=200.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
+.|+..+.||+|+||.||+|+.. +++.||+|++..... .......+.+|++++++++|||++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34777889999999999999864 689999999875422 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||++ |++.+.+.. ...++++.++..++.|++.|+.|||+ .+|+||||+|+||+++.++.++|+|||++....
T Consensus 105 e~~~-g~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 105 EYCL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred eCCC-CCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 9996 577776632 23568999999999999999999997 899999999999999999999999999987543
Q ss_pred CCCCceeeeecccccccCceecc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAV---TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
.. ....|++.|+|||++. .+.++.++|||||||++|||++|+.||............ .... .
T Consensus 177 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~------~~~~--~-- 241 (317)
T cd06635 177 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------AQNE--S-- 241 (317)
T ss_pred Cc-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH------Hhcc--C--
Confidence 32 2345889999999974 456889999999999999999999998765432221111 0000 0
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhh
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~ 875 (948)
+... .......+.+++.+|++.+|.+||++.++++......
T Consensus 242 ---~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 242 ---PTLQ----SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ---CCCC----CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0000 1112345889999999999999999999998766544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=298.85 Aligned_cols=249 Identities=31% Similarity=0.419 Sum_probs=202.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.+.|+.-++||+||||.||-+..+ +|+.||.|.+.++... .........|-.++.+++.+.||.+--++.+.+..++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356888899999999999999754 7999999988765433 33455677899999999999999999899999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
+..|.||+|.-++.+ .+...+++.+++-+|.+|+.||++||. .+||.||+||+|||+|+.|+++|+|.|+|...
T Consensus 264 LtlMNGGDLkfHiyn---~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYN---HGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEeecCCceeEEeec---cCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEec
Confidence 999999999988854 444679999999999999999999997 89999999999999999999999999999988
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
+++.. ....+||.+|||||++.++.|+...|.||+||++|||+.|+.||...........+ -++......
T Consensus 338 ~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv--drr~~~~~~------ 407 (591)
T KOG0986|consen 338 PEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV--DRRTLEDPE------ 407 (591)
T ss_pred CCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH--HHHHhcchh------
Confidence 87653 34458999999999999999999999999999999999999999765432211111 111111111
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCC
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPD 863 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt 863 (948)
++......+...+.+..++.||.+|..
T Consensus 408 -------ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 408 -------EYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred -------hcccccCHHHHHHHHHHHccCHHHhcc
Confidence 111222345778888899999999973
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=301.32 Aligned_cols=261 Identities=23% Similarity=0.292 Sum_probs=194.4
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeC--CceEEEE
Q 002238 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDG--NEKLLVF 670 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~ 670 (948)
|++.+.||+|+||.||+|... +++.||+|+++...... ......+|+.++.++. |||++++++++.+. +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 567889999999999999864 68999999987643222 2234557899999885 99999999999987 8899999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||++ |++.+.+.. ....++|.+++.++.|++.||+|||+ .+++||||||+||+++. +.++|+|||+++...
T Consensus 80 e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 80 ELMD-MNLYELIKG----RKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred ecCC-ccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 9996 578777643 22578999999999999999999997 89999999999999999 999999999998654
Q ss_pred CCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc-cccc--
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK-DSFH-- 826 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~-- 826 (948)
.... .....++..|+|||++.. ..++.++|||||||++|||++|..||....+.+.. .+........ ..+.
T Consensus 151 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 151 SKPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI---AKIHDVLGTPDAEVLKK 225 (282)
T ss_pred cCCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHH---HHHHHHcCCCCHHHHHh
Confidence 3322 223457899999997644 55789999999999999999999999876543321 1111111000 0000
Q ss_pred ----cccCcccCC------ccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 827 ----KAIDPTIDL------NEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 827 ----~~~~~~~~~------~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
...+...+. ..........+.+++.+|++.+|++||++.++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000 00011234678999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=301.01 Aligned_cols=244 Identities=24% Similarity=0.359 Sum_probs=186.9
Q ss_pred eecccCceEEEEEEEc-CCcEEEEEEeecCcCChh-hHHHHHHHHHHHHh---cCCCceeeEEeEEEeCCceEEEEEecC
Q 002238 600 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGK-GLTEFKSEIAVLTK---VRHRHLVALLGHCLDGNEKLLVFEYMP 674 (948)
Q Consensus 600 ~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~---l~H~niv~l~~~~~~~~~~~lv~e~~~ 674 (948)
+||+|+||.||+|... +++.||+|.+........ ....+.+|..+++. .+|||++.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 689999999876433222 22334455444443 479999999999999999999999999
Q ss_pred CCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCC
Q 002238 675 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 754 (948)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~ 754 (948)
+|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~- 151 (279)
T cd05633 81 GGDLHYHLSQ-----HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (279)
T ss_pred CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence 9999888743 2468999999999999999999997 899999999999999999999999999987553322
Q ss_pred ceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCccc
Q 002238 755 SIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTI 833 (948)
Q Consensus 755 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (948)
.....||..|+|||.+.+ ..++.++|||||||++|||++|..||........... ...... ....+
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~-------~~~~~ 218 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLT-------VNVEL 218 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH----HHHhhc-------CCcCC
Confidence 223468999999998864 5689999999999999999999999976543221111 111100 00111
Q ss_pred CCccchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHHH
Q 002238 834 DLNEGILASISTVAELAGHCCAREPYQRP-----DMGHAVNV 870 (948)
Q Consensus 834 ~~~~~~~~~~~~l~~li~~c~~~~P~~RP-----t~~ev~~~ 870 (948)
+ .....++.+++.+|++.+|++|| ++++++++
T Consensus 219 ~-----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 P-----DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred c-----cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1 11234688999999999999999 58877664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=293.26 Aligned_cols=249 Identities=27% Similarity=0.490 Sum_probs=204.7
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
+|+..+.||+|++|.||+|... +++.||+|.+............+.+|++++++++|||++++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999865 678999999987654445667899999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++++|.+++.. ...+++..+..++.|++.|+.|||+ .+++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKK-----FGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 999999988843 2578999999999999999999997 89999999999999999999999999999866544
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (948)
... .....++..|+|||...+..++.++||||+|+++|+|++|+.||......... .. .. .... ..+.+
T Consensus 153 ~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~--~~----~~--~~~~-~~~~~- 221 (254)
T cd06627 153 SKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL--FR----IV--QDDH-PPLPE- 221 (254)
T ss_pred ccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH--HH----Hh--ccCC-CCCCC-
Confidence 322 23456899999999998888899999999999999999999999765432111 11 00 0000 01111
Q ss_pred cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 833 IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 833 ~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.....+.+++.+|++.+|++||++.+++.
T Consensus 222 --------~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 --------GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --------CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 12345889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.86 Aligned_cols=253 Identities=25% Similarity=0.430 Sum_probs=207.7
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
+|+..+.||+|+||.||++... +++.||+|++............+.+|+++++.++|||++++.+.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999865 689999999987654556677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++++|.+++..... ....+++.+++.++.+++.||+|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999998865321 23678999999999999999999997 79999999999999999999999999999866543
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (948)
. .......|++.|+|||...+..++.++||||+|+++|+|++|+.||......+.. ..... ... +.
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~--~~~-----~~ 222 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA------LKILK--GQY-----PP 222 (258)
T ss_pred c-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH------HHHhc--CCC-----CC
Confidence 3 2233456899999999998888999999999999999999999999765432211 11111 000 01
Q ss_pred cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 833 IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 833 ~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
++ ......+.+++.+|+..+|++||++.++++
T Consensus 223 ~~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 IP-----SQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11 122345889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=286.51 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=205.2
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|...++||+|.||.|-.++- .+|+.||+|+++++.. ...+.+.-..|-++++..+||.+..+--.++..+..++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 46788899999999999999974 4799999999988754 355567788899999999999999998889999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||..||.|.-++.. .+.+++.+..-+...|+.||.|||+ .+||.||+|.+|.|+|++|.+||+|||+++.-
T Consensus 247 MeyanGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhc
Confidence 999999999888833 3578888888899999999999997 89999999999999999999999999999844
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
... +.....++|||.|+|||++....|+++.|.|.+|||+|||++|+.||...+.+....++. ..+-.+..
T Consensus 319 I~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl------~ed~kFPr-- 389 (516)
T KOG0690|consen 319 IKY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL------MEDLKFPR-- 389 (516)
T ss_pred ccc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH------hhhccCCc--
Confidence 332 234567899999999999999999999999999999999999999998765443333321 11111111
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRP-----DMGHAVN 869 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RP-----t~~ev~~ 869 (948)
....+...|+...+..||.+|. ++.||.+
T Consensus 390 -----------~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 390 -----------TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred -----------cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 1123467889999999999996 4555544
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=309.05 Aligned_cols=265 Identities=22% Similarity=0.365 Sum_probs=199.0
Q ss_pred HHhhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC---
Q 002238 589 RNVTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN--- 664 (948)
Q Consensus 589 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--- 664 (948)
..+.++|++.+.||+|+||.||+|.. .+|..||||++............+.+|++++++++||||+++++++..+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34678899999999999999999975 47899999998654333344567889999999999999999999887543
Q ss_pred ---ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEe
Q 002238 665 ---EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 741 (948)
Q Consensus 665 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~ 741 (948)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.++|+
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEe
Confidence 358999999 7788877632 468999999999999999999997 899999999999999999999999
Q ss_pred ecCCceecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc
Q 002238 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL 820 (948)
Q Consensus 742 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 820 (948)
|||++...... .....+++.|+|||++.+ ..++.++|+||||+++|++++|+.||...........+ ......
T Consensus 161 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~--~~~~~~ 234 (343)
T cd07880 161 DFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI--MKVTGT 234 (343)
T ss_pred ecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcCC
Confidence 99998855332 223457899999999876 45889999999999999999999999865432211100 000000
Q ss_pred CccccccccC-----------cccC---CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 821 SKDSFHKAID-----------PTID---LNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 821 ~~~~~~~~~~-----------~~~~---~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
....+.+.+. +... ...........+.+++.+|++.||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000 0000 00001122345889999999999999999999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=295.11 Aligned_cols=251 Identities=25% Similarity=0.383 Sum_probs=197.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCc---CChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--Cce
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV---ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEK 666 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 666 (948)
.+|++.+.||+|+||.||+|... +++.||+|.+.... ........+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57889999999999999999864 68999999875432 1234456889999999999999999999998764 457
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCc
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla 746 (948)
++||||+++++|.+++.. ...+++..+.+++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccc
Confidence 899999999999988843 2457889999999999999999997 89999999999999999999999999998
Q ss_pred eecCCCC--CceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 747 RLAPEGK--GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 747 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
+...... ........|+..|+|||++.+..++.++|||||||++||+++|+.||......... . ......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~----~~~~~~-- 225 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI--F----KIATQP-- 225 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH--H----HHHcCC--
Confidence 8543211 11123356899999999998888999999999999999999999999765432211 1 111000
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..+.+ ......++.+++.+|++ +|.+||+..+++.
T Consensus 226 ----~~~~~-----p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 ----TKPML-----PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ----CCCCC-----CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00111 11223458899999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=293.76 Aligned_cols=252 Identities=26% Similarity=0.398 Sum_probs=205.4
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CceEEEE
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKLLVF 670 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 670 (948)
+|+..+.||+|++|.||+|... +++.|++|++..........+.+.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999876 789999999876544445678899999999999999999999999988 8899999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++++|.+++.. ...+++..++.++.|+++||+|||+ .+++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 81 EYVSGGSLSSLLKK-----FGKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 99999999998843 1378999999999999999999997 899999999999999999999999999988665
Q ss_pred CCCCc-eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 751 EGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 751 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
..... ......++..|+|||...+...+.++||||||+++|+|++|+.||........ . ...... ......
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~---~~~~~~-~~~~~~-- 224 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA--A---LYKIGS-SGEPPE-- 224 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--H---HHhccc-cCCCcC--
Confidence 54321 12335688999999999888899999999999999999999999987651110 0 111100 000000
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+ .......+.+++.+|++.+|++||++.+++.
T Consensus 225 ---~-----~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 ---I-----PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ---C-----CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 0 0111356889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=329.16 Aligned_cols=263 Identities=27% Similarity=0.448 Sum_probs=209.4
Q ss_pred cCCcccceecccCceEEEEEEEc----C----CcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeC
Q 002238 593 NNFSEENILGRGGFGTVYKGELH----D----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG 663 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~----~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 663 (948)
++..+.+.||+|.||.||+|..+ . ...||||.++.... ..+.+.+..|+++|+.+ +|+||+.++|+|..+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~-~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS-SSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC-cHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 34455669999999999999753 1 45799999887543 47788999999999999 699999999999999
Q ss_pred CceEEEEEecCCCChhHHHHhhh---h------cCC--CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE
Q 002238 664 NEKLLVFEYMPQGTLSRHIFNWA---E------EGL--KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732 (948)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~---~------~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill 732 (948)
+..++|+||+..|+|.++++... . ... ..++....+.++.|||.|++||++ .++||||+.++|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEe
Confidence 99999999999999999997643 0 001 238899999999999999999997 789999999999999
Q ss_pred cCCCCeEEeecCCceecCCCCCceeeeecc--cccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhh
Q 002238 733 GDDMRAKVADFGLVRLAPEGKGSIETRIAG--TFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESM 809 (948)
Q Consensus 733 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~ 809 (948)
+++..+||+|||+|+............-.| ...|||||.+....|+.|+|||||||+|||++| |..||.+.......
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l 531 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL 531 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence 999999999999999655444333222222 457999999999999999999999999999999 88999874422221
Q ss_pred hHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 810 HLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
.++.+.-. . + +.+..+..++.++++.||+.+|++||++.++++.++....
T Consensus 532 --~~~l~~G~----r--------~---~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 532 --LEFLKEGN----R--------M---EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred --HHHHhcCC----C--------C---CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 22222110 0 1 1112234568899999999999999999999999999543
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=311.18 Aligned_cols=270 Identities=21% Similarity=0.339 Sum_probs=201.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe----CCce
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD----GNEK 666 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~ 666 (948)
.++|++.+.||+|+||.||+|..+ +|+.||+|++............+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999864 69999999987654333445678889999999999999999988753 3467
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCc
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla 746 (948)
++||||+. ++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEehhh-hhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccc
Confidence 99999995 688887732 2458999999999999999999997 89999999999999999999999999998
Q ss_pred eecCCCCC---ceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh---
Q 002238 747 RLAPEGKG---SIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH--- 819 (948)
Q Consensus 747 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~--- 819 (948)
+....... .......|+..|+|||++.+ ..++.++||||||+++|||++|+.||...........+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 75533221 11234568999999998865 468999999999999999999999997754432211111000000
Q ss_pred ----cCcccccc---ccCcc--cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 820 ----LSKDSFHK---AIDPT--IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 820 ----~~~~~~~~---~~~~~--~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.......+ ..... ............++.+++.+|++.+|++||++++++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000 00000 00001111234568999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=313.05 Aligned_cols=244 Identities=24% Similarity=0.416 Sum_probs=193.5
Q ss_pred ccceecccCceEEEEEEEc-CCcEEEEEEeecCc--CChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc--eEEEEE
Q 002238 597 EENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV--ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE--KLLVFE 671 (948)
Q Consensus 597 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~lv~e 671 (948)
...+||+|+|-+||||.+. +|-+||=-.++... -.+...++|..|+++|+.|+|||||+++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3467999999999999764 56666543222221 134556899999999999999999999999987655 679999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEc-CCCCeEEeecCCceecC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLAP 750 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~-~~~~~kl~DfGla~~~~ 750 (948)
.+..|+|..+++.+ +.++.+....|+.||++||.|||++ .++|||||||-+||+++ ..|.|||+|.|||....
T Consensus 124 L~TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred cccCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999998543 5677888999999999999999986 58999999999999997 56899999999999765
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcC--ccccccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS--KDSFHKA 828 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 828 (948)
... ...+.|||.|||||+.. ..|.+.+||||||++++||+|+..||.+-..... ..+++... ...+.++
T Consensus 198 ~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ-----IYKKV~SGiKP~sl~kV 268 (632)
T KOG0584|consen 198 KSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ-----IYKKVTSGIKPAALSKV 268 (632)
T ss_pred ccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH-----HHHHHHcCCCHHHhhcc
Confidence 432 33478999999999876 8899999999999999999999999987553322 11121111 1122223
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
-| .++.++|.+|+.. ..+||++.|+++
T Consensus 269 ~d-------------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 269 KD-------------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred CC-------------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 23 3588999999999 899999999876
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=311.65 Aligned_cols=274 Identities=25% Similarity=0.362 Sum_probs=206.0
Q ss_pred CcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC------CceE
Q 002238 595 FSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------NEKL 667 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~ 667 (948)
|...+.||+|+||.||+|+. .+|+.||||.++... .....+...+|++++++++|||||++++.-.+. ....
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 45567899999999999995 589999999998753 455678899999999999999999999875543 3568
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEc--CCC--CeEEeec
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDM--RAKVADF 743 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~--~~~--~~kl~Df 743 (948)
+|||||.+|+|...+.. -++...+++.+.+.+..+++.||.|||+ ++||||||||.||++- .+| ..||+||
T Consensus 94 lvmEyC~gGsL~~~L~~--PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNS--PENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred EEEeecCCCcHHHHhcC--cccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 99999999999999965 3445789999999999999999999997 8999999999999984 434 4899999
Q ss_pred CCceecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc
Q 002238 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK 822 (948)
Q Consensus 744 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 822 (948)
|.|+...++. ..+.++||..|++||+... +.|+..+|.|||||++||..||..||...........+.|..-.....
T Consensus 169 G~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 169 GAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred cccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 9999887755 6788999999999999985 889999999999999999999999997654332211122221111111
Q ss_pred cccc---c------ccCcccCC-ccchHHHHHHHHHHHHHhcccCCCCCC--ChHHHHHHHHhhhh
Q 002238 823 DSFH---K------AIDPTIDL-NEGILASISTVAELAGHCCAREPYQRP--DMGHAVNVLSSLVE 876 (948)
Q Consensus 823 ~~~~---~------~~~~~~~~-~~~~~~~~~~l~~li~~c~~~~P~~RP--t~~ev~~~L~~~~~ 876 (948)
+... + .....++. ..........+-..+..++..+|.+|- ...+....+..++.
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 1000 0 00001111 111123334455677778888999998 66666666666554
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=296.37 Aligned_cols=244 Identities=25% Similarity=0.342 Sum_probs=195.1
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCCCh
Q 002238 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 678 (948)
Q Consensus 601 lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 678 (948)
||.|+||.||+|+.. +++.||+|++...... ....+.+.+|+.+++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999875 5899999998764332 23457799999999999999999999999999999999999999999
Q ss_pred hHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCceee
Q 002238 679 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET 758 (948)
Q Consensus 679 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 758 (948)
.+++.. ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||+++...... ...
T Consensus 81 ~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~ 150 (262)
T cd05572 81 WTILRD-----RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTW 150 (262)
T ss_pred HHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccc
Confidence 998843 2458899999999999999999997 899999999999999999999999999988665432 223
Q ss_pred eecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccc
Q 002238 759 RIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEG 838 (948)
Q Consensus 759 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (948)
...|+..|+|||++.+..++.++|+||||+++|||++|..||........ ........... .... .
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~------~~~~--~-- 216 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM----EIYNDILKGNG------KLEF--P-- 216 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH----HHHHHHhccCC------CCCC--C--
Confidence 35689999999999888899999999999999999999999987652111 11111110000 0000 0
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 002238 839 ILASISTVAELAGHCCAREPYQRPD-----MGHAVN 869 (948)
Q Consensus 839 ~~~~~~~l~~li~~c~~~~P~~RPt-----~~ev~~ 869 (948)
......+.+++.+|++.+|++||+ ++|+++
T Consensus 217 -~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 -NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred -cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 111346889999999999999999 555544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=299.52 Aligned_cols=243 Identities=29% Similarity=0.394 Sum_probs=190.6
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCCCh
Q 002238 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 678 (948)
Q Consensus 601 lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 678 (948)
||+|+||+||+|..+ +|+.||+|.+...... ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999754 6899999998754322 22345677899999999999999999999999999999999999999
Q ss_pred hHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCceee
Q 002238 679 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET 758 (948)
Q Consensus 679 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 758 (948)
.+++.. .....+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++....... ...
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 152 (277)
T cd05577 81 KYHIYN---VGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIK 152 (277)
T ss_pred HHHHHH---cCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccc
Confidence 988854 222468999999999999999999997 899999999999999999999999999987654322 223
Q ss_pred eecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccc
Q 002238 759 RIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEG 838 (948)
Q Consensus 759 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (948)
...++..|+|||++.+..++.++||||||+++|+|++|+.||............ ...... .....
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~----~~~~~--------- 217 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL--KRRTLE----MAVEY--------- 217 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH--Hhcccc----ccccC---------
Confidence 345788999999998888999999999999999999999999765432111111 000000 00000
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCChHH
Q 002238 839 ILASISTVAELAGHCCAREPYQRPDMGH 866 (948)
Q Consensus 839 ~~~~~~~l~~li~~c~~~~P~~RPt~~e 866 (948)
.......+.+++.+|++.+|.+||+..+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCc
Confidence 0112345889999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=281.63 Aligned_cols=265 Identities=22% Similarity=0.336 Sum_probs=204.3
Q ss_pred HHHHHHhhcCCcccceecccCceEEEEEE-EcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEe
Q 002238 585 IQVLRNVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD 662 (948)
Q Consensus 585 ~~~l~~~~~~~~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 662 (948)
++++...+ .+.||+|+||.|--++ ..+|.+||||++.+. ....+.++.+|++++.++ .|+||++++++|.+
T Consensus 75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 56666665 4779999999999885 678999999999875 455678899999999999 59999999999999
Q ss_pred CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC---CeE
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAK 739 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~---~~k 739 (948)
++.+|||||.|.||.|..+++. .+.+++.++-++..+|+.||.+||. +||.|||+||+|||-.+.. -+|
T Consensus 148 d~~FYLVfEKm~GGplLshI~~-----~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvK 219 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQK-----RKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVK 219 (463)
T ss_pred cceEEEEEecccCchHHHHHHH-----hhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCcee
Confidence 9999999999999999999854 3678999999999999999999996 8999999999999997554 489
Q ss_pred EeecCCceecCCC------CCceeeeecccccccCceecc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 002238 740 VADFGLVRLAPEG------KGSIETRIAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDESQPEES 808 (948)
Q Consensus 740 l~DfGla~~~~~~------~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~ 808 (948)
||||.+..-.... ........+|+..|||||+.. ...|+.++|.||+||++|-|++|.+||.+....+-
T Consensus 220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC 299 (463)
T KOG0607|consen 220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC 299 (463)
T ss_pred eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence 9999887632211 112233467999999999873 23588999999999999999999999987654321
Q ss_pred ----hhHHHHHHHhhcCccccccccCcccCCcc-chHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 809 ----MHLVTWFRRIHLSKDSFHKAIDPTIDLNE-GILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 809 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.....-..+. -+..+-+....+.+ .+.....+..+++...+-.++.+|-++.+++.
T Consensus 300 GWdrGe~Cr~CQ~~-----LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 300 GWDRGEVCRVCQNK-----LFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccCCCccHHHHHH-----HHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 0111111111 11112222222222 33344456779999999999999999888876
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=301.79 Aligned_cols=244 Identities=23% Similarity=0.424 Sum_probs=196.5
Q ss_pred cceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCC
Q 002238 598 ENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 676 (948)
..+||+|+||.||+|..+ +++.||||++... .......+.+|+.+++.++|+|++++++++..++..++||||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 356999999999999874 7899999987543 3344567899999999999999999999999999999999999999
Q ss_pred ChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCce
Q 002238 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI 756 (948)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 756 (948)
+|.+++.. ..+++..+..++.|++.|++|||+ .+++||||||+||++++++.++|+|||++........ .
T Consensus 103 ~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~ 172 (292)
T cd06657 103 ALTDIVTH------TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 172 (292)
T ss_pred cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc-c
Confidence 99887632 357899999999999999999997 7999999999999999999999999999875543221 2
Q ss_pred eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCc
Q 002238 757 ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLN 836 (948)
Q Consensus 757 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (948)
.....|++.|+|||++.+..++.++||||||+++|||++|..||......+..... .. ...+.+..
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~---~~----------~~~~~~~~- 238 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RD----------NLPPKLKN- 238 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hh----------hCCcccCC-
Confidence 23356899999999998888999999999999999999999999765433221111 11 00111100
Q ss_pred cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 837 EGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 837 ~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.......+.+++.+|++.+|.+||++.++++
T Consensus 239 --~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 239 --LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred --cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 0112335789999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=279.45 Aligned_cols=209 Identities=29% Similarity=0.406 Sum_probs=173.4
Q ss_pred hhcCCcccceecccCceEEEEEEEc---C--CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe-CC
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH---D--GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-GN 664 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~---~--g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~ 664 (948)
....|+....||+|+||.||+|.-+ + ...+|+|+++.+.....-....-+|+.+++.++|||++.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3456888999999999999999543 2 2379999997653222223567899999999999999999999887 77
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC----CCeEE
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD----MRAKV 740 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~----~~~kl 740 (948)
..+|++||.+. +|.+.++.......+.++-..+..|+.||+.|+.|||+ +-|+|||+||.|||+..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEe
Confidence 88999999976 88888876555555788999999999999999999997 779999999999999876 89999
Q ss_pred eecCCceecCCCCCc--eeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 002238 741 ADFGLVRLAPEGKGS--IETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDES 803 (948)
Q Consensus 741 ~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~ 803 (948)
+|||++|.+.+.-.. ....++-|.+|.|||.+.+. .||.+.||||.||++.||+|-++-|.+.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999999977654322 23456789999999999875 6999999999999999999988777653
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=304.38 Aligned_cols=254 Identities=24% Similarity=0.393 Sum_probs=195.4
Q ss_pred hcCCcccceecccCceEEEEEEEcC-CcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|++.+.||+|+||.||+|.+++ ++.||||+++... ......++.+|+.++.+. .||||+++++++.++...++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC-ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 3568889999999999999999864 8999999987643 223345677788777777 499999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||++ +++.+++.. ....+++..+..++.|++.|++|||+ ..+|+||||+|+||++++++.++|+|||++...
T Consensus 93 ~e~~~-~~l~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 93 MELMS-TCLDKLLKR----IQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred eeccC-cCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 99985 477666533 12478999999999999999999996 358999999999999999999999999998765
Q ss_pred CCCCCceeeeecccccccCceecccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGR----VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
..... .....++..|+|||++.+.. ++.++||||||+++|||++|+.||....... .. ........
T Consensus 166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~---~~~~~~~~--- 235 (296)
T cd06618 166 VDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF--EV---LTKILQEE--- 235 (296)
T ss_pred cCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH--HH---HHHHhcCC---
Confidence 43221 22345788999999987554 7899999999999999999999997533211 11 11111100
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.+.+... .....++.+++.+|++.+|.+||++.+++++
T Consensus 236 ----~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 236 ----PPSLPPN---EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ----CCCCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0011100 0123468899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=309.76 Aligned_cols=270 Identities=24% Similarity=0.353 Sum_probs=200.6
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----C
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-----N 664 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~ 664 (948)
+.++|.+.+.||+|+||.||+|... +++.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3567999999999999999999864 689999999876433344456778899999999999999999987644 3
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
..++||||+. ++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg 153 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFG 153 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCc
Confidence 4799999995 688777732 2568999999999999999999997 899999999999999999999999999
Q ss_pred CceecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc---
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL--- 820 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--- 820 (948)
+++...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||....................
T Consensus 154 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 154 LARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232 (337)
T ss_pred cccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 998654332 22234468899999998865 4688999999999999999999999976543221111110000000
Q ss_pred ----Cccccccc---cC--cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 821 ----SKDSFHKA---ID--PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 821 ----~~~~~~~~---~~--~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
......+. +. +.............++.+++.+|++.+|++||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000 00 0000001111234568899999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=298.54 Aligned_cols=264 Identities=27% Similarity=0.370 Sum_probs=198.1
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc---CCCceeeEEeEEEeCCc-----
Q 002238 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV---RHRHLVALLGHCLDGNE----- 665 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~----- 665 (948)
|++.+.||+|+||.||+|+.+ +++.||+|+++...........+.+|+.+++++ +|||++++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999986 589999999975433333345677788877766 59999999999988776
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGl 745 (948)
.+++|||+. ++|.+++... ....+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~---~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKC---PKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhcc-cCHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCc
Confidence 899999996 4888877431 22368999999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc-cc
Q 002238 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK-DS 824 (948)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 824 (948)
+........ .....++..|+|||++.+..++.++||||||+++|||++|++||......+.... ......... ..
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 229 (287)
T cd07838 154 ARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDK--IFDVIGLPSEEE 229 (287)
T ss_pred ceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHH--HHHHcCCCChHh
Confidence 886543321 2234578899999999999999999999999999999999999987554332211 111111000 00
Q ss_pred cc-------cccCcccC--CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 825 FH-------KAIDPTID--LNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 825 ~~-------~~~~~~~~--~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+. ........ ...........+.+++.+|++.||++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 00000000 01111223456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=327.31 Aligned_cols=254 Identities=28% Similarity=0.445 Sum_probs=190.6
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG----- 663 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 663 (948)
....+|++.++||+||||.||+++.+ ||+.||||++.... +......+.+|+..+.+|+|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 34567888999999999999999977 89999999998765 666778899999999999999999987542110
Q ss_pred --------------------------------------------------------------------------------
Q 002238 664 -------------------------------------------------------------------------------- 663 (948)
Q Consensus 664 -------------------------------------------------------------------------------- 663 (948)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CceEEEEEecCCCChhHHHHhhhhcCCCCC-CHHHHHHHHHHHHHH
Q 002238 664 ----------------------------------NEKLLVFEYMPQGTLSRHIFNWAEEGLKPL-EWNRRLTIALDVARG 708 (948)
Q Consensus 664 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l-~~~~~~~i~~~i~~~ 708 (948)
...||=||||+..++.+++.. + ... .....|+++.+|++|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~----N-~~~~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR----N-HFNSQRDEAWRLFREILEG 709 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh----c-ccchhhHHHHHHHHHHHHH
Confidence 012677888887666666632 1 111 356788999999999
Q ss_pred HHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC------C----------C-CCceeeeecccccccCcee
Q 002238 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP------E----------G-KGSIETRIAGTFGYLAPEY 771 (948)
Q Consensus 709 l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~------~----------~-~~~~~~~~~gt~~y~aPE~ 771 (948)
|+|+|+ .|||||||||.||+++++..|||+|||+|+... + + .....+..+||.-|+|||+
T Consensus 710 LaYIH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 999997 789999999999999999999999999998511 0 0 1113466789999999999
Q ss_pred cccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHH
Q 002238 772 AVTG---RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAE 848 (948)
Q Consensus 772 ~~~~---~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 848 (948)
+.+. .|+.|+|+||+|||++||+. ||.... +....+.-.+ .+.+... + ....+....-+.
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~iL~~LR-----~g~iP~~--~-----~f~~~~~~~e~s 849 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASILTNLR-----KGSIPEP--A-----DFFDPEHPEEAS 849 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHhc---cCCchH--HHHHHHHhcc-----cCCCCCC--c-----ccccccchHHHH
Confidence 8764 49999999999999999986 565433 2222222111 2222211 1 111222334568
Q ss_pred HHHHhcccCCCCCCChHHHHH
Q 002238 849 LAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 849 li~~c~~~~P~~RPt~~ev~~ 869 (948)
+|.++++.||.+|||+.|++.
T Consensus 850 lI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 850 LIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHhcCCCccCCCHHHHhh
Confidence 999999999999999999876
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=308.40 Aligned_cols=266 Identities=23% Similarity=0.370 Sum_probs=197.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN------ 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 664 (948)
.++|...+.||+|+||.||+|... +|+.||||++............+.+|+++++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 578999999999999999999864 6899999998764333334467889999999999999999999987543
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
..++|+||+.. +|.++. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||
T Consensus 94 ~~~lv~e~~~~-~l~~~~-------~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-------GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred eEEEEeccccc-CHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCC
Confidence 46899999964 665543 1368899999999999999999997 799999999999999999999999999
Q ss_pred CceecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcc
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD 823 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 823 (948)
+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+..... ....
T Consensus 163 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~ 236 (342)
T cd07879 163 LARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG--VPGP 236 (342)
T ss_pred CCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC--CCCH
Confidence 98754322 223457889999999876 4688999999999999999999999987543322211111000 0000
Q ss_pred ccccccC-----------cccC---CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH--HHhh
Q 002238 824 SFHKAID-----------PTID---LNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV--LSSL 874 (948)
Q Consensus 824 ~~~~~~~-----------~~~~---~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~--L~~~ 874 (948)
.+.+..+ +... ...........+.+++.+|++.||.+||++++++.. ++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0000000 0000 000001123457899999999999999999999865 5554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=299.46 Aligned_cols=264 Identities=24% Similarity=0.346 Sum_probs=202.6
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEec
Q 002238 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 673 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 673 (948)
|+..+.||+|++|.||+|... +++.+|+|++............+.+|++++++++|+||+++++++.++...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566788999999999999864 7899999998765434344578889999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCC
Q 002238 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (948)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~ 753 (948)
++ ++.+++.. ....+++.++..++.|++.||+|||+ .+|+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 DT-DLYKLIKD----RQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred CC-CHHHHHHh----hcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 75 88877743 12578999999999999999999997 899999999999999999999999999988665433
Q ss_pred CceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccc-cccccC-
Q 002238 754 GSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDS-FHKAID- 830 (948)
Q Consensus 754 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~- 830 (948)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+. ......... +....+
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF--RTLGTPDPEVWPKFTSL 229 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HHcCCCchHhcccchhh
Confidence 122334578899999998876 78999999999999999999999997665433221111 000000000 000000
Q ss_pred -----------cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 831 -----------PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 831 -----------~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..............++.+++.+|++.+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000001111233467889999999999999999999976
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=304.42 Aligned_cols=263 Identities=18% Similarity=0.292 Sum_probs=194.6
Q ss_pred ceeccc--CceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCC
Q 002238 599 NILGRG--GFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (948)
Q Consensus 599 ~~lg~G--~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 675 (948)
..||+| +||+||+|... +|+.||||++..........+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 99999999864 799999999876544455567899999999999999999999999999999999999999
Q ss_pred CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc
Q 002238 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (948)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 755 (948)
+++.+++.... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99999885421 2458899999999999999999997 89999999999999999999999999865422211110
Q ss_pred e------eeeecccccccCceecccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc-------
Q 002238 756 I------ETRIAGTFGYLAPEYAVTG--RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL------- 820 (948)
Q Consensus 756 ~------~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------- 820 (948)
. .....++..|+|||++.+. .++.++|||||||++|||++|+.||......... .........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccccc
Confidence 0 1112356779999998763 4789999999999999999999999765432211 110000000
Q ss_pred ----------Cccccc--------------cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 821 ----------SKDSFH--------------KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 821 ----------~~~~~~--------------~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
...... ...+..+. ..........+.+++.+|++.||++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR-TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred cchhhhhhccchhhhhcccccchhcccccccccccccc-chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000000 00000000 11122345678999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=305.05 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=209.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
...|.+.+.||+|.|+.|..|++. ++..||||.+.+........+.+.+|+++|..++|||||+++.+.......|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 467889999999999999999864 7999999999887766666677999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+.+|.+.+++... .......+..++.|+.+|++|||+ +.|||||||++||||+.+.++||+|||++..+.
T Consensus 135 eya~~ge~~~yl~~~-----gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 135 EYASGGELFDYLVKH-----GRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EeccCchhHHHHHhc-----ccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeec
Confidence 999999999999542 334447788899999999999997 899999999999999999999999999999776
Q ss_pred CCCCceeeeecccccccCceecccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
. .......+|++.|.|||++.+.+| ++++|+||+|+++|-|+.|..||++..-.+....+ ...+..+...
T Consensus 207 ~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv------l~gk~rIp~~- 277 (596)
T KOG0586|consen 207 Y--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV------LRGKYRIPFY- 277 (596)
T ss_pred c--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh------eeeeecccce-
Confidence 4 345667889999999999999876 57999999999999999999999975533221111 1111111100
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
...+..+++++++-.+|.+|++++++.+.-+
T Consensus 278 ------------ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 278 ------------MSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred ------------eechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 1124679999999999999999999987543
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=300.28 Aligned_cols=257 Identities=25% Similarity=0.347 Sum_probs=200.2
Q ss_pred CCcccceecccCceEEEEEEE----cCCcEEEEEEeecCcC--ChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCce
Q 002238 594 NFSEENILGRGGFGTVYKGEL----HDGTKIAVKRMEAGVI--SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 666 (948)
+|++.+.||+|+||.||+|+. .+++.||||+++.... .......+..|++++.++ +||||+++++++..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999974 2578899999875321 123346788999999999 599999999999999999
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCc
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla 746 (948)
++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccc
Confidence 999999999999988743 2468899999999999999999997 89999999999999999999999999998
Q ss_pred eecCCCCCceeeeecccccccCceecccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 747 RLAPEGKGSIETRIAGTFGYLAPEYAVTGR--VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
+..............|+..|+|||.+.+.. .+.++||||||+++|||++|..||........ .............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~- 229 (288)
T cd05583 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKSKP- 229 (288)
T ss_pred cccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHccCC-
Confidence 865443322333456899999999987665 78899999999999999999999964322111 1111111111000
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHh
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~ 873 (948)
.. .......+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 230 -------~~-----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 230 -------PF-----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -------CC-----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 00 01122457899999999999999999988877655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=304.54 Aligned_cols=270 Identities=26% Similarity=0.340 Sum_probs=197.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN------ 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 664 (948)
.++|++.+.||+|+||.||+|..+ +++.||||++............+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999865 6899999998765333333456789999999999999999998875433
Q ss_pred --ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEee
Q 002238 665 --EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (948)
Q Consensus 665 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~D 742 (948)
..++||||+.+ ++...+.. ....+++.++..++.|+++||+|||+ .+++||||||+||++++++.++|+|
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~----~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN----PSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECc
Confidence 45999999964 67666532 23578999999999999999999997 7999999999999999999999999
Q ss_pred cCCceecCCCCCc----------eeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhH
Q 002238 743 FGLVRLAPEGKGS----------IETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHL 811 (948)
Q Consensus 743 fGla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~ 811 (948)
||+++........ ..+...|++.|+|||++.+. .++.++||||||+++|||++|++||.+.........
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~ 238 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9998754332211 11234578899999987654 588999999999999999999999987654332222
Q ss_pred HHHHHHhhcCc-----cccccc----cCcccC--CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 812 VTWFRRIHLSK-----DSFHKA----IDPTID--LNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 812 ~~~~~~~~~~~-----~~~~~~----~~~~~~--~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+.......... ...... .....+ ...........+.+++.+|++.+|++||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 11110000000 000000 000000 00000112246889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=295.19 Aligned_cols=245 Identities=24% Similarity=0.353 Sum_probs=189.9
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHH-HhcCCCceeeEEeEEEeCCceEEEEEecCC
Q 002238 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVL-TKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 675 (948)
+.||+|+||.||+|... +|+.||||++...... ......+..|..++ ...+|+|++++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999864 6899999998654221 22233445555544 455899999999999999999999999999
Q ss_pred CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc
Q 002238 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (948)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 755 (948)
++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||+++....
T Consensus 82 ~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 82 GDCASLIKT-----LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 999998843 2468889999999999999999997 7999999999999999999999999999875433
Q ss_pred eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCC
Q 002238 756 IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDL 835 (948)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (948)
.....|++.|+|||.+.+..++.++||||||+++|||++|..||............ ...........
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~------ 216 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI------LSRRINWPEEV------ 216 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HhcccCCCCcc------
Confidence 22345889999999998888999999999999999999999999765543221111 11010010000
Q ss_pred ccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 836 NEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 836 ~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
.......+.+++.+|++.+|++||++.++.+.+
T Consensus 217 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 217 ---KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ---cccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 012234688999999999999999876665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=280.04 Aligned_cols=254 Identities=24% Similarity=0.323 Sum_probs=199.7
Q ss_pred HhhcCCccc-ceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEe----
Q 002238 590 NVTNNFSEE-NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD---- 662 (948)
Q Consensus 590 ~~~~~~~~~-~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~---- 662 (948)
.++++|++. ++||-|-.|.|-.+..+ +|+.+|+|++... ...++|++.--.. .|||||.+++++..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 456777765 57999999999999765 7999999988643 3457888875444 79999999998864
Q ss_pred CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC---CCCeE
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAK 739 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~---~~~~k 739 (948)
..-.++|||.|+||.|...+.+ .+.+.++++++-.|+.||+.|+.|||+ .+|.||||||+|+|... +..+|
T Consensus 131 rkcLLiVmE~meGGeLfsriq~---~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lK 204 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQD---RGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLK 204 (400)
T ss_pred ceeeEeeeecccchHHHHHHHH---cccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceE
Confidence 3345799999999999988854 555789999999999999999999998 89999999999999964 45799
Q ss_pred EeecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh
Q 002238 740 VADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH 819 (948)
Q Consensus 740 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 819 (948)
|+|||+|+...... .....+-||.|.|||++...+|+..+|+||+||++|-|++|.+||........ -....+++.
T Consensus 205 LtDfGFAK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai--spgMk~rI~ 280 (400)
T KOG0604|consen 205 LTDFGFAKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKRRIR 280 (400)
T ss_pred ecccccccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC--ChhHHhHhh
Confidence 99999999765432 23445679999999999999999999999999999999999999987654211 011111122
Q ss_pred cCccccccccCcccCCccchHHHH-HHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 820 LSKDSFHKAIDPTIDLNEGILASI-STVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
... ..+....+.+. .+..++|+.++..+|.+|.|+.+++..
T Consensus 281 ~gq----------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 281 TGQ----------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ccC----------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 212 22233334444 456799999999999999999999874
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=292.31 Aligned_cols=249 Identities=20% Similarity=0.261 Sum_probs=191.6
Q ss_pred HHHHHhhcCCccccee--cccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEE
Q 002238 586 QVLRNVTNNFSEENIL--GRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCL 661 (948)
Q Consensus 586 ~~l~~~~~~~~~~~~l--g~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~ 661 (948)
.+.....++|++.+.+ |+|+||.||++..+ +++.+|+|.+....... .|+.....+ +|||++++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEe
Confidence 3344445677777776 99999999999864 68899999986542211 122222222 7999999999999
Q ss_pred eCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC-CeEE
Q 002238 662 DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKV 740 (948)
Q Consensus 662 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~-~~kl 740 (948)
..+..++||||+++++|.+++.. ...+++.++..++.|+++||+|||+ .+++||||||+||+++.++ .++|
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l 151 (267)
T PHA03390 80 TLKGHVLIMDYIKDGDLFDLLKK-----EGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYL 151 (267)
T ss_pred cCCeeEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEE
Confidence 99999999999999999998843 1378999999999999999999997 7999999999999999988 9999
Q ss_pred eecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc
Q 002238 741 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL 820 (948)
Q Consensus 741 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 820 (948)
+|||+++..... ....|+..|+|||++.+..++.++||||||+++|||++|+.||....... .....+.... .
T Consensus 152 ~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~ 224 (267)
T PHA03390 152 CDYGLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-Q 224 (267)
T ss_pred ecCccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-c
Confidence 999998755332 22358999999999999899999999999999999999999998544322 1112221111 0
Q ss_pred CccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCC-hHHHHH
Q 002238 821 SKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPD-MGHAVN 869 (948)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt-~~ev~~ 869 (948)
.... ........+.+++.+|++.+|.+||+ ++++++
T Consensus 225 ----------~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 ----------KKLP---FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----------ccCC---cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0000 00123345889999999999999995 688875
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=307.04 Aligned_cols=270 Identities=24% Similarity=0.391 Sum_probs=202.2
Q ss_pred HHHHHHhhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC
Q 002238 585 IQVLRNVTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG 663 (948)
Q Consensus 585 ~~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 663 (948)
...+..++++|++.+.||+|+||.||+|.. ++++.||||++..........+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345667789999999999999999999975 4789999999876433333456788999999999999999999988643
Q ss_pred ------CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCC
Q 002238 664 ------NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 737 (948)
Q Consensus 664 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~ 737 (948)
...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCC
Confidence 3467888877 7899877632 358999999999999999999997 89999999999999999999
Q ss_pred eEEeecCCceecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH
Q 002238 738 AKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFR 816 (948)
Q Consensus 738 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~ 816 (948)
++|+|||+++..... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...........+ ..
T Consensus 159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~--~~ 232 (345)
T cd07877 159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI--LR 232 (345)
T ss_pred EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HH
Confidence 999999998854332 233468899999998866 56889999999999999999999999765433221111 11
Q ss_pred HhhcCcccccccc------------C--cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 817 RIHLSKDSFHKAI------------D--PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 817 ~~~~~~~~~~~~~------------~--~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
............+ + +..............+.+++.+|++.+|.+||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000000000 0 0000000011123458899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=297.47 Aligned_cols=247 Identities=26% Similarity=0.423 Sum_probs=197.4
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCCCh
Q 002238 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 678 (948)
Q Consensus 601 lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 678 (948)
||+|+||.||+|+.. +|+.||+|++..... .....+.+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999876 589999999875432 224467789999999999999999999999999999999999999999
Q ss_pred hHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCC----
Q 002238 679 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG---- 754 (948)
Q Consensus 679 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~---- 754 (948)
.+++.. ...+++..++.++.|+++||+|||+ .+++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLEN-----VGSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 998853 1368999999999999999999997 8999999999999999999999999999875433211
Q ss_pred ---ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 755 ---SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 755 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
.......++..|+|||.......+.++||||||+++||+++|+.||......+... ..........
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~------~~~~~~~~~~----- 221 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ------NILNGKIEWP----- 221 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHhcCCcCCC-----
Confidence 12234568889999999988889999999999999999999999997665433211 1111010000
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
.. ......+.+++.+|++.+|++||++.++.+.|+
T Consensus 222 -----~~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 222 -----ED-VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -----cc-ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00 002346889999999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=298.53 Aligned_cols=246 Identities=25% Similarity=0.353 Sum_probs=192.3
Q ss_pred CCcccceecccCceEEEEEEE----cCCcEEEEEEeecCcC--ChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCce
Q 002238 594 NFSEENILGRGGFGTVYKGEL----HDGTKIAVKRMEAGVI--SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 666 (948)
+|++.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999976 3689999999875322 123346788999999999 599999999999988899
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCc
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla 746 (948)
++||||+++++|.+++.. ...+++.++..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-----RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 999999999999998843 2468889999999999999999997 89999999999999999999999999999
Q ss_pred eecCCCCCceeeeecccccccCceecccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 747 RLAPEGKGSIETRIAGTFGYLAPEYAVTG--RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
+..............|+..|+|||.+.+. .++.++||||||+++|+|++|+.||........ .............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~- 229 (290)
T cd05613 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSEP- 229 (290)
T ss_pred eecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhccCC-
Confidence 86544332223345689999999998753 467899999999999999999999975332111 1111111111000
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCC
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRP 862 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RP 862 (948)
.. .......+.+++.+|++.+|++||
T Consensus 230 -------~~-----~~~~~~~~~~ll~~~l~~~p~~R~ 255 (290)
T cd05613 230 -------PY-----PQEMSALAKDIIQRLLMKDPKKRL 255 (290)
T ss_pred -------CC-----CccCCHHHHHHHHHHhcCCHHHhc
Confidence 00 011234578999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=307.24 Aligned_cols=268 Identities=24% Similarity=0.351 Sum_probs=203.9
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-----ceE
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-----EKL 667 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 667 (948)
+|++.+.||+|+||.||+|+.. +++.||||++..........+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999875 5899999998765433455678999999999999999999999988775 789
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+||||++ ++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++.
T Consensus 81 lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELME-TDLHKVIKS-----PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchh-hhHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 9999997 578877732 2378999999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCC--ceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc----
Q 002238 748 LAPEGKG--SIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL---- 820 (948)
Q Consensus 748 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 820 (948)
....... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+....+........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence 6654321 122334678999999999887 789999999999999999999999987664332221110000000
Q ss_pred ---CccccccccC---c--ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 821 ---SKDSFHKAID---P--TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 821 ---~~~~~~~~~~---~--~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
........+. . ..............+.+++.+|++.+|.+||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000000000 0 000000111134568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=283.56 Aligned_cols=256 Identities=23% Similarity=0.315 Sum_probs=198.9
Q ss_pred ccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEEEEEecC
Q 002238 597 EENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMP 674 (948)
Q Consensus 597 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 674 (948)
....||.|+||+|++-.++ .|+..|||+++... ...+.+++..|.+...+- ++||||+++|++..++..|+.||.|
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n-~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM- 145 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN-IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM- 145 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc-chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence 3566999999999999765 79999999998764 355667888888865554 8999999999999999999999999
Q ss_pred CCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCC
Q 002238 675 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 754 (948)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~ 754 (948)
.-+|..+-..........+++.-.-+|+...+.||.||.. ...||||||||+|||++..|.+||||||++-...+..
T Consensus 146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si- 222 (361)
T KOG1006|consen 146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI- 222 (361)
T ss_pred hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHH-
Confidence 4577655433222333578888888899999999999998 5789999999999999999999999999987554322
Q ss_pred ceeeeecccccccCceeccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcc
Q 002238 755 SIETRIAGTFGYLAPEYAVT--GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832 (948)
Q Consensus 755 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (948)
..+.-+|-..|||||.+.. ..|+-++||||+|+.|||+.||+.|+..... ..+.+.++... .. |.
T Consensus 223 -AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~g--dp-----p~ 289 (361)
T KOG1006|consen 223 -AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIG--DP-----PI 289 (361)
T ss_pred -HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcC--CC-----Ce
Confidence 3455578899999999864 3489999999999999999999999987543 22222222211 11 12
Q ss_pred cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 833 IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 833 ~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+.......+....+..++..|+..|-..||.+.++.+.
T Consensus 290 l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 290 LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 22233333445568999999999999999999998764
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=301.97 Aligned_cols=265 Identities=19% Similarity=0.235 Sum_probs=195.5
Q ss_pred ccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCC
Q 002238 597 EENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676 (948)
Q Consensus 597 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 676 (948)
+.+.+|.|+++.||++.. +++.||||++..........+.+.+|+++++.++||||+++++++.+.+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344456666666666654 6999999999875445566788999999999999999999999999999999999999999
Q ss_pred ChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCC--
Q 002238 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG-- 754 (948)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~-- 754 (948)
+|.+++... ....+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.++++|||.+........
T Consensus 85 ~l~~~l~~~---~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 85 SCEDLLKTH---FPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 999988542 22457888999999999999999997 8999999999999999999999999998874432211
Q ss_pred ----ceeeeecccccccCceeccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc---Cccc-
Q 002238 755 ----SIETRIAGTFGYLAPEYAVT--GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL---SKDS- 824 (948)
Q Consensus 755 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~- 824 (948)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||........ .......... ....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCch
Confidence 11223457889999999876 3588999999999999999999999986543221 1111100000 0000
Q ss_pred ------ccc----ccCcccC---CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 825 ------FHK----AIDPTID---LNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 825 ------~~~----~~~~~~~---~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
... ..++... ..........++.+++.+||+.+|++||+++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 0000000 011112233568899999999999999999999884
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=303.22 Aligned_cols=268 Identities=24% Similarity=0.394 Sum_probs=200.3
Q ss_pred HHhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe-CCce
Q 002238 589 RNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-GNEK 666 (948)
Q Consensus 589 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~ 666 (948)
..++++|+..+.||+|+||.||+|... +++.||||++..........+.+.+|+++++.++||||+++.+++.. +...
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346789999999999999999999754 78999999886543334445778899999999999999999998875 5678
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCc
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla 746 (948)
++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.++|+|||++
T Consensus 86 ~lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EEEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccc
Confidence 9999998 5688877632 457888888999999999999997 89999999999999999999999999998
Q ss_pred eecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHH-H--------HH
Q 002238 747 RLAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVT-W--------FR 816 (948)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~-~--------~~ 816 (948)
...... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||............. + ..
T Consensus 156 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 156 RIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred cccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 754322 123457889999998766 568999999999999999999999997655422111110 0 00
Q ss_pred HhhcC-ccccccccC--cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 817 RIHLS-KDSFHKAID--PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 817 ~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
..... ...+..... ...............+.+++.+|++.+|++||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 000000000 0000001111223568899999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-32 Score=297.04 Aligned_cols=246 Identities=26% Similarity=0.401 Sum_probs=194.9
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
|...+.||+|+||.||+|+.. +|+.||+|++..... .......+.+|+++++.++|||++++++++.++...++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999864 689999999875422 233446788999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+. |++.+.+.. ...++++.+++.++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~----~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 103 CL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred CC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 95 577776632 23568999999999999999999997 7999999999999999999999999998864322
Q ss_pred CCceeeeecccccccCceecc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 753 KGSIETRIAGTFGYLAPEYAV---TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
.....|+..|+|||++. ...++.++|||||||++|||++|..||............ .. .......
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~---~~-----~~~~~~~ 241 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQ-----NDSPTLQ 241 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---Hh-----cCCCCCC
Confidence 22356889999999984 456889999999999999999999999775433221111 00 0011111
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.+ .....+.+++.+|++.+|.+||++.+++..
T Consensus 242 ~~---------~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 SN---------EWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred cc---------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 112348899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=294.23 Aligned_cols=243 Identities=23% Similarity=0.343 Sum_probs=186.4
Q ss_pred eecccCceEEEEEEEc-CCcEEEEEEeecCcCCh-hhHHHHHHHHH---HHHhcCCCceeeEEeEEEeCCceEEEEEecC
Q 002238 600 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-KGLTEFKSEIA---VLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 674 (948)
Q Consensus 600 ~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~E~~---~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 674 (948)
+||+|+||.||+|... +++.||+|.+....... .....+..|.. .++...||+|+++.+++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999764 68999999987643322 11222344443 4444589999999999999999999999999
Q ss_pred CCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCC
Q 002238 675 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 754 (948)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~ 754 (948)
+|+|.+++.. ...+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.++|+|||+++......
T Consensus 81 g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~- 151 (278)
T cd05606 81 GGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (278)
T ss_pred CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-
Confidence 9999887732 2568999999999999999999997 899999999999999999999999999987543322
Q ss_pred ceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCccc
Q 002238 755 SIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTI 833 (948)
Q Consensus 755 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (948)
.....|+..|+|||++.++ .++.++||||+||++|||++|+.||............ ..... ....+
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~--------~~~~~ 218 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTLT--------MAVEL 218 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---HHhhc--------cCCCC
Confidence 1234689999999998754 6899999999999999999999999865332211110 00000 01111
Q ss_pred CCccchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 002238 834 DLNEGILASISTVAELAGHCCAREPYQRP-----DMGHAVN 869 (948)
Q Consensus 834 ~~~~~~~~~~~~l~~li~~c~~~~P~~RP-----t~~ev~~ 869 (948)
+ ......+.+++.+|+..+|.+|| ++.++++
T Consensus 219 ~-----~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 P-----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred C-----CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1 01134588999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=301.66 Aligned_cols=276 Identities=24% Similarity=0.354 Sum_probs=198.1
Q ss_pred CCcccceecccCceEEEEEEEc-C--CcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeC----Cc
Q 002238 594 NFSEENILGRGGFGTVYKGELH-D--GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG----NE 665 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~--g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~----~~ 665 (948)
+|++.+.||+|+||.||+|+.. + +..||+|++..........+.+.+|+++++++ .||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999865 4 77999999875433333456788999999999 599999999875432 45
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGl 745 (948)
.++++||+. ++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 688899885 688887732 3568999999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCC---ceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHH-------
Q 002238 746 VRLAPEGKG---SIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTW------- 814 (948)
Q Consensus 746 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~------- 814 (948)
++....... .......||..|+|||++.+ ..++.++|||||||++|++++|++||..............
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence 985543221 11233568999999998765 4689999999999999999999999976543221111000
Q ss_pred --HHHhhcCcc-cccccc--CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCC
Q 002238 815 --FRRIHLSKD-SFHKAI--DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKP 880 (948)
Q Consensus 815 --~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~ 880 (948)
......... ...... .+..............+.+++.+|++.+|.+||++.++++. .....|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~--~~~~~~~~ 300 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH--PYLAIWHD 300 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC--hhhhhhcC
Confidence 000000000 000000 00000011111123468899999999999999999998753 33444443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=298.63 Aligned_cols=249 Identities=26% Similarity=0.402 Sum_probs=196.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCc-CChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
+.|+..+.||+|+||.||+|+.. +++.||+|.+.... .......++.+|+++++.++|+|++++.+++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34677788999999999999865 67899999986432 23334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+. |++.+.+.. ....+++.++..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 95 e~~~-~~l~~~~~~----~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 95 EYCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EccC-CCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 9996 688776632 22468899999999999999999997 899999999999999999999999999987553
Q ss_pred CCCCceeeeecccccccCceecc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAV---TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
.. ....|++.|+|||++. ...++.++|||||||++|||++|+.||......+..... . ....
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~------~~~~-- 231 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--A------QNES-- 231 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH--h------hcCC--
Confidence 32 2346889999999974 356788999999999999999999998765432221111 0 0000
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
+... .......+.+++.+|++.+|++||++.++++.-
T Consensus 232 ---~~~~----~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 232 ---PALQ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred ---CCcC----cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 1000 112234588999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=296.42 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=202.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCceEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv 669 (948)
++|...+.||+|+||.||+|... +|+.||+|++..... .....+.+.+|++++++++ ||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999875 789999999876322 3344577899999999998 99999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++++|||++...
T Consensus 81 ~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 81 LEYAPNGELLQYIRK-----YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 999999999998843 2479999999999999999999997 89999999999999999999999999998854
Q ss_pred CCCCC-------------------ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhh
Q 002238 750 PEGKG-------------------SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMH 810 (948)
Q Consensus 750 ~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~ 810 (948)
..... .......|+..|+|||+.....++.++||||||++++|+++|+.||.........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~- 231 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF- 231 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH-
Confidence 43221 1223356789999999998888999999999999999999999999865432211
Q ss_pred HHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCCh----HHHHH
Q 002238 811 LVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDM----GHAVN 869 (948)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~----~ev~~ 869 (948)
. ........+ .. .....+.+++.+|++.+|.+||++ +++++
T Consensus 232 --~---~~~~~~~~~----~~---------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 --Q---KILKLEYSF----PP---------NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --H---HHHhcCCCC----CC---------ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1 111000000 01 113458899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=295.29 Aligned_cols=264 Identities=27% Similarity=0.392 Sum_probs=197.7
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCceEEEEEe
Q 002238 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
|++.+.||+|+||.||+|... +++.||||++...... .......+|+..+++++ |||++++++++.+++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 567889999999999999875 5789999998764322 23344567999999998 99999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+ +|+|.+++.. .....+++..++.++.|++.+|+|||+ ++++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~-~~~l~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 80 M-EGNLYQLMKD---RKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred C-CCCHHHHHHh---cccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 9 8899888743 112478999999999999999999997 89999999999999999999999999998865432
Q ss_pred CCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHH----------HHHHhhcC
Q 002238 753 KGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVT----------WFRRIHLS 821 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~----------~~~~~~~~ 821 (948)
.. .....++..|+|||++.+ ..++.++|+||||+++|||++|+.||......+...... |.......
T Consensus 153 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 153 PP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred CC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence 21 233458899999998754 457899999999999999999999997665433221110 10000000
Q ss_pred ccccccccCcccC--CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 822 KDSFHKAIDPTID--LNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 822 ~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
......+..... ...........+.+++.+|++.+|++||++.|++.
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 231 -SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred -ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000000 00001112356889999999999999999999876
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=306.19 Aligned_cols=265 Identities=25% Similarity=0.387 Sum_probs=200.1
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc---
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE--- 665 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--- 665 (948)
.+.++|+..+.||+|+||.||+|... +++.||||++............+.+|+.++++++|||++++.+++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999875 68899999987543334445678889999999999999999988766554
Q ss_pred ---eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEee
Q 002238 666 ---KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (948)
Q Consensus 666 ---~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~D 742 (948)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.++|+|
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcc
Confidence 89999998 6699888742 468999999999999999999997 8999999999999999999999999
Q ss_pred cCCceecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcC
Q 002238 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS 821 (948)
Q Consensus 743 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 821 (948)
||++...... .....++..|+|||.+.+ ..++.++||||||+++||+++|+.||......+....+. ......
T Consensus 162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~--~~~~~~ 235 (343)
T cd07851 162 FGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIM--NLVGTP 235 (343)
T ss_pred cccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--HhcCCC
Confidence 9998865432 223457889999998865 367899999999999999999999997655432211110 000000
Q ss_pred cccc---------ccccC-----cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 822 KDSF---------HKAID-----PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 822 ~~~~---------~~~~~-----~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
...+ ...+. ..............++.+++.+|++.+|++|||+.+|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000 00000 0000000011124568899999999999999999998764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=253.12 Aligned_cols=266 Identities=24% Similarity=0.334 Sum_probs=200.5
Q ss_pred CCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
+|...++||+|.||+||+|+. ++++.||+|+++.+..++.......+|+.+++.++|+|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 456678899999999999985 4689999999987755555567789999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
|. .+|..+. ..-.+.++...+..++.|+++||.++|+ +++.|||+||+|.|++.+|+.|++|||+++.+.-.
T Consensus 83 cd-qdlkkyf----dslng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 83 CD-QDLKKYF----DSLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred hh-HHHHHHH----HhcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 94 4776665 3344678899999999999999999998 89999999999999999999999999999966543
Q ss_pred CCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccc---c
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFH---K 827 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 827 (948)
.. .....+-|.+|.+|.++.+. -|++..|+||.||++.|+.. |++-|.+.+..+....+-|.-.... ++.+. +
T Consensus 155 vr-cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~-ed~wps~t~ 232 (292)
T KOG0662|consen 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT-EDQWPSMTK 232 (292)
T ss_pred eE-eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCc-cccCCcccc
Confidence 32 22334579999999999875 48999999999999999987 6666666655554444433322221 11111 1
Q ss_pred ccC----cccCCccchHHHH----HHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 828 AID----PTIDLNEGILASI----STVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 828 ~~~----~~~~~~~~~~~~~----~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..| |..+....+.+.. ..=.+++.+.+.-+|.+|.++++.++
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111 1111111111111 22347777778889999999887765
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=299.00 Aligned_cols=267 Identities=24% Similarity=0.338 Sum_probs=196.6
Q ss_pred hcCCc-ccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChh------------hHHHHHHHHHHHHhcCCCceeeEE
Q 002238 592 TNNFS-EENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGK------------GLTEFKSEIAVLTKVRHRHLVALL 657 (948)
Q Consensus 592 ~~~~~-~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~H~niv~l~ 657 (948)
.++|. +.+.||+|+||.||+|..+ +++.||||++........ ....+.+|+++++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 45565 4577999999999999865 689999999865422210 012577899999999999999999
Q ss_pred eEEEeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCC
Q 002238 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 737 (948)
Q Consensus 658 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~ 737 (948)
+++..++..++||||++ |+|.+++.. ...+++.....++.|++.||+|||+ .+++||||||+||+++.++.
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGI 157 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCC
Confidence 99999999999999996 688888732 2468899999999999999999997 89999999999999999999
Q ss_pred eEEeecCCceecCCCC-------------CceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 002238 738 AKVADFGLVRLAPEGK-------------GSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDES 803 (948)
Q Consensus 738 ~kl~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~ 803 (948)
++|+|||+++...... ........++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999988554110 1111223468899999998764 4689999999999999999999999876
Q ss_pred CchhhhhHHHHHHHhhcC-cccccccc--------CcccC--CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 804 QPEESMHLVTWFRRIHLS-KDSFHKAI--------DPTID--LNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 804 ~~~~~~~~~~~~~~~~~~-~~~~~~~~--------~~~~~--~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.+.+....+. ...... ...+.... ..... ...........+.+++.+|++.+|++||++++++.
T Consensus 238 ~~~~~~~~i~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 238 NEIDQLGRIF--ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CHHHHHHHHH--HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 6433221111 100000 00000000 00000 00001112356889999999999999999999986
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=324.30 Aligned_cols=148 Identities=27% Similarity=0.441 Sum_probs=131.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|.+.+.||+|+||.||+|... +++.||||+++.... .......+..|+.++..++||||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367899999999999999999876 689999999975432 334457789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
|||+.+++|.+++.. ...+++..++.|+.||+.||+|||+ .+||||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~-----~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI-----YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998843 2457888999999999999999997 799999999999999999999999999976
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=302.48 Aligned_cols=265 Identities=21% Similarity=0.352 Sum_probs=194.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-------
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------- 663 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------- 663 (948)
..+|+..+.||+|+||.||+|... +|+.||+|++... .....+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecC--CCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 468999999999999999999864 6899999998664 234457788999999999999999999776543
Q ss_pred -------CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC-C
Q 002238 664 -------NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-D 735 (948)
Q Consensus 664 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~-~ 735 (948)
...++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++. +
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~ 151 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTED 151 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCC
Confidence 34689999996 588777632 368899999999999999999997 89999999999999974 5
Q ss_pred CCeEEeecCCceecCCCCCc--eeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHH
Q 002238 736 MRAKVADFGLVRLAPEGKGS--IETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLV 812 (948)
Q Consensus 736 ~~~kl~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~ 812 (948)
+.++++|||+++........ ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||....+.+.....
T Consensus 152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~ 231 (342)
T cd07854 152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231 (342)
T ss_pred ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 57899999998754322111 1123357889999998654 56889999999999999999999999766543322111
Q ss_pred HHHHHhhcCcc--------cccc-----ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 813 TWFRRIHLSKD--------SFHK-----AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 813 ~~~~~~~~~~~--------~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
. ........ .... ...+.............++.+++.+|++.+|.+||++.++++.
T Consensus 232 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 232 L--ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred H--HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 1 00000000 0000 0000000000011223468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-33 Score=293.08 Aligned_cols=246 Identities=24% Similarity=0.381 Sum_probs=200.7
Q ss_pred cceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCC
Q 002238 598 ENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 676 (948)
.++||+|.||+||-|++ ++|+.||||++.+..+......+++.|+.+++++.||.||.+.-.|...+..+.|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 47899999999999986 4899999999998888888889999999999999999999999999999999999999955
Q ss_pred ChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC---CCeEEeecCCceecCCCC
Q 002238 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAKVADFGLVRLAPEGK 753 (948)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~---~~~kl~DfGla~~~~~~~ 753 (948)
+..+.+.. .....++...-..++.||+.||.|||. ++|||+|+||+|||+... .++||||||.||+..+..
T Consensus 648 DMLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 648 DMLEMILS---SEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hHHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 55555533 334678888888889999999999996 899999999999999744 379999999999886643
Q ss_pred CceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCccc
Q 002238 754 GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTI 833 (948)
Q Consensus 754 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (948)
....++|||.|+|||++..+.|.+.-|+||.||++|--++|..||.+..+-.. .+ ... . .+-|
T Consensus 722 --FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd--QI---QNA---a-----FMyP-- 784 (888)
T KOG4236|consen 722 --FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND--QI---QNA---A-----FMYP-- 784 (888)
T ss_pred --hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH--Hh---hcc---c-----cccC--
Confidence 45668899999999999999999999999999999999999999986543211 11 110 0 0111
Q ss_pred CCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 834 DLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 834 ~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
...+.+...+.+++|...++..-.+|-+....+.
T Consensus 785 --p~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 785 --PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred --CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 1223333456789999999999999998776654
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=292.25 Aligned_cols=264 Identities=27% Similarity=0.372 Sum_probs=200.1
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEec
Q 002238 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 673 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 673 (948)
|+..+.||+|+||.||+|+.. +++.||+|++..........+.+..|++++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999875 5899999998865433344567889999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCC
Q 002238 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (948)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~ 753 (948)
+ ++|.+++.. ....+++..+.+++.|++.||+|||+ .+|+||||+|+||++++++.++|+|||.++......
T Consensus 81 ~-~~l~~~i~~----~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 81 D-MDLKKYLDK----RPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred C-cCHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 7 589988854 11468999999999999999999997 799999999999999999999999999988654432
Q ss_pred CceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccc--------
Q 002238 754 GSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDS-------- 824 (948)
Q Consensus 754 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 824 (948)
. ......++..|+|||++.+. .++.++||||||+++||+++|+.||......+....+ ..........
T Consensus 153 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 153 R-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI--FQILGTPTEESWPGVTKL 229 (282)
T ss_pred c-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH--HHHhCCCcHHHHHhhccc
Confidence 2 12233467889999998776 7899999999999999999999999775533221111 0000000000
Q ss_pred --cccccCcccC--CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 825 --FHKAIDPTID--LNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 825 --~~~~~~~~~~--~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
....+..... ...........+.+++.+|++.+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000 00011112456899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=303.54 Aligned_cols=261 Identities=24% Similarity=0.414 Sum_probs=213.0
Q ss_pred eeHHHHHHhhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEE
Q 002238 583 ISIQVLRNVTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHC 660 (948)
Q Consensus 583 ~~~~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~ 660 (948)
..++.+..-++.|++.+.||.|.+|.||+++. ++|+.+|||++.. .....++++.|.++++.+ .|||++.++|++
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~---~~d~deEiE~eynil~~~~~hpnv~~fyg~~ 85 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP---TEDEEEEIELEYNMLKKYSHHPNVATFYGAF 85 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC---CccccHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 34444555567899999999999999999974 5789999998765 344457889999999998 799999999998
Q ss_pred Ee-----CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC
Q 002238 661 LD-----GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 735 (948)
Q Consensus 661 ~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~ 735 (948)
.. +++.|||||||.+|+..+++++.. ...+.|..+..|++.++.|+.+||. ..++|||||-.|||++.+
T Consensus 86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e 159 (953)
T KOG0587|consen 86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTEN 159 (953)
T ss_pred EEecCCCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEecc
Confidence 74 578899999999999999997744 4678999999999999999999996 889999999999999999
Q ss_pred CCeEEeecCCceecCCCCCceeeeecccccccCceecccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhh
Q 002238 736 MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG-----RVTTKVDVFSFGVILMELITGRKALDESQPEESMH 810 (948)
Q Consensus 736 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~ 810 (948)
+.||++|||++........ ......|||.|||||++... .|+.++|+||+|++..||--|.+|+.+..+.....
T Consensus 160 ~~VKLvDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF 238 (953)
T KOG0587|consen 160 AEVKLVDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF 238 (953)
T ss_pred CcEEEeeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc
Confidence 9999999999987655443 34456799999999998643 47789999999999999999999999887643211
Q ss_pred HHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 811 LVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
. ......|.+.. +.....++.++|..|+..|..+||++.++++
T Consensus 239 ~-------------IpRNPPPkLkr---p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 239 L-------------IPRNPPPKLKR---PKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred c-------------CCCCCCccccc---hhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1 12222333322 2334456999999999999999999988875
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=287.03 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=196.9
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCc---CChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV---ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
+|.+.+.||+|+||.||+|+.. .+..+++|+++... .......++..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5788899999999999999865 34556666654322 2233345677899999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++++|.+++.... .....+++..++.++.|++.|++|||+ .+++|+||||+||+++. +.++|+|||+++..
T Consensus 81 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELK-HTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHh-hcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeec
Confidence 99999999998886532 233578999999999999999999997 89999999999999975 57999999998865
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
..... ......|++.|+|||...+..++.++|+||||+++|+|++|..||........ ...... . .
T Consensus 156 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~------~~~~~~--~-----~ 221 (260)
T cd08222 156 MGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV------VLRIVE--G-----P 221 (260)
T ss_pred CCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHHc--C-----C
Confidence 43322 22345688999999999888889999999999999999999999965432211 111111 0 0
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.+.. ......++.+++.+|++.+|++||++.++++
T Consensus 222 ~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 TPSL-----PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCC-----cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1111 1123346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=281.89 Aligned_cols=238 Identities=29% Similarity=0.408 Sum_probs=193.4
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCCCh
Q 002238 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 678 (948)
Q Consensus 601 lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 678 (948)
||+|+||.||++... +++.||+|++...... ......+..|++++++++|||++++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999875 5899999998765332 23466889999999999999999999999999999999999999999
Q ss_pred hHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCceee
Q 002238 679 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET 758 (948)
Q Consensus 679 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 758 (948)
.+++.. ...+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 151 (250)
T cd05123 81 FSHLSK-----EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTN 151 (250)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC-Cccc
Confidence 998843 2368999999999999999999997 899999999999999999999999999988654432 1233
Q ss_pred eecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccc
Q 002238 759 RIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEG 838 (948)
Q Consensus 759 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (948)
...++..|+|||...+...+.++|+||||+++||+++|+.||........ .. ........+ ..
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~---~~~~~~~~~----~~------- 214 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI---YE---KILKDPLRF----PE------- 214 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HH---HHhcCCCCC----CC-------
Confidence 45688999999999888899999999999999999999999976543211 11 111111101 11
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCChHH
Q 002238 839 ILASISTVAELAGHCCAREPYQRPDMGH 866 (948)
Q Consensus 839 ~~~~~~~l~~li~~c~~~~P~~RPt~~e 866 (948)
.....+.+++.+|+..||++||++++
T Consensus 215 --~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 --FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred --CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11345789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=311.49 Aligned_cols=265 Identities=23% Similarity=0.317 Sum_probs=207.9
Q ss_pred eeeHHHHHHhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeE
Q 002238 582 VISIQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGH 659 (948)
Q Consensus 582 ~~~~~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 659 (948)
+....+++--.++|.+.++||+|+||.|..++++ +++.||+|++.+... ...+.+.|..|-++|..-+.+=|+.+.-+
T Consensus 64 v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA 143 (1317)
T KOG0612|consen 64 VKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA 143 (1317)
T ss_pred HHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH
Confidence 3345666777889999999999999999999875 688999999976322 23445778999999999999999999999
Q ss_pred EEeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeE
Q 002238 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 739 (948)
Q Consensus 660 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~k 739 (948)
|.+..+.|+|||||+||+|-.++-.+ .+++...+..++..|+-||.-+|+ .|+|||||||+|||+|..|++|
T Consensus 144 FQD~~~LYlVMdY~pGGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHik 215 (1317)
T KOG0612|consen 144 FQDERYLYLVMDYMPGGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIK 215 (1317)
T ss_pred hcCccceEEEEecccCchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEe
Confidence 99999999999999999999998442 357777788899999999999997 8999999999999999999999
Q ss_pred EeecCCceecCCCCCceeeeecccccccCceeccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHH
Q 002238 740 VADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT-----GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTW 814 (948)
Q Consensus 740 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~ 814 (948)
|+|||-+..+..+..-.....+|||.|.+||++.. +.|++.+|.||+||++|||+.|.-||....-.+.+
T Consensus 216 LADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY----- 290 (1317)
T KOG0612|consen 216 LADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY----- 290 (1317)
T ss_pred eccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH-----
Confidence 99999887766555445566789999999999852 57999999999999999999999999764433322
Q ss_pred HHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCC---hHHHHHH
Q 002238 815 FRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPD---MGHAVNV 870 (948)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt---~~ev~~~ 870 (948)
.++...+..+. +.+... ...+..+||.+.+. +|+.|.. +.++..+
T Consensus 291 -~KIm~hk~~l~--FP~~~~-------VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 291 -GKIMNHKESLS--FPDETD-------VSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred -HHHhchhhhcC--CCcccc-------cCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 22222222111 111111 22346678877654 5677776 7777653
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=280.25 Aligned_cols=242 Identities=25% Similarity=0.354 Sum_probs=196.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 669 (948)
.+|....+||+|+||.|..|..+ +.+.+|||+++++..- ..+.+--..|-++|... +-|.++++..+++.-+..|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46778899999999999999866 5678999999887543 33444556677777776 678899999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+.||+|--+++.. ..+.+..+.-+|..||-||-+||+ +|||.||+|.+||+++.+|.+||+|||+++..
T Consensus 429 MEyvnGGDLMyhiQQ~-----GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQV-----GKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEecCchhhhHHHHh-----cccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999998877542 456777888999999999999997 89999999999999999999999999999854
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
.-+. .....++|||.|+|||++....|+..+|.|||||+||||+.|++||++.+.++....+.
T Consensus 501 i~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~---------------- 563 (683)
T KOG0696|consen 501 IFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM---------------- 563 (683)
T ss_pred ccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH----------------
Confidence 3332 23456899999999999999999999999999999999999999999877655432221
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCC
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRP 862 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RP 862 (948)
+.... +......+...+.+..+...|.+|.
T Consensus 564 ehnvs---yPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 564 EHNVS---YPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HccCc---CcccccHHHHHHHHHHhhcCCcccc
Confidence 11111 1222334577888889999999996
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-33 Score=269.31 Aligned_cols=271 Identities=21% Similarity=0.320 Sum_probs=199.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe--------C
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--------G 663 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------~ 663 (948)
..|+...+||+|.||+||+|+.+ +|+.||+|++.-+.....-.....+|++++..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34556678999999999999754 67889998764321111112456789999999999999999988764 2
Q ss_pred CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeec
Q 002238 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (948)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~Df 743 (948)
...|+||++|+. +|.-++. .....++..++.+++.++..||.|+|. ..|+|||+||.|+|++.++.+||+||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLs----n~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLS----NRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhc----CccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecc
Confidence 347999999976 7777773 233578899999999999999999997 78999999999999999999999999
Q ss_pred CCceecCCCCCc---eeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh
Q 002238 744 GLVRLAPEGKGS---IETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH 819 (948)
Q Consensus 744 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 819 (948)
|+++.+...+.. ..+..+-|..|.+||.+.+ .+|+++.|||..||++.||+||.+-+++.......+.+...-...
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 999854432221 1234567999999999887 469999999999999999999999998887766666655433322
Q ss_pred cCccc-------cccccCcc-cCCccch--HH------HHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 820 LSKDS-------FHKAIDPT-IDLNEGI--LA------SISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 820 ~~~~~-------~~~~~~~~-~~~~~~~--~~------~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
..+.+ +.+.+..+ +...... .+ ...+..+++..++..||.+|+++.+++..-
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 21110 00111000 1100000 01 123577999999999999999999998753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=292.21 Aligned_cols=241 Identities=28% Similarity=0.374 Sum_probs=193.2
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 668 (948)
.++.|.....+|.|+|+.|-++... +++..+||++.+. ..+-.+|+.++... +||||+++.+.+.++.+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR------ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc------ccccccccchhhhhcCCCcceeecceecCCceeee
Confidence 3567788888999999999999754 7899999998764 13345677776666 79999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE-cCCCCeEEeecCCce
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVR 747 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill-~~~~~~kl~DfGla~ 747 (948)
|||++.++-+.+.+.. .+..-..+..|+.+|+.|+.|||+ +||||||+||+|||+ +..+.++|+|||.++
T Consensus 394 v~e~l~g~ell~ri~~------~~~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRS------KPEFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred eehhccccHHHHHHHh------cchhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhh
Confidence 9999999988877743 222226777899999999999997 899999999999999 689999999999998
Q ss_pred ecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 748 LAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
..... ....+-|..|.|||+.....|++++|+||||++||+|++|+.||...... +....++.. ..+.
T Consensus 465 ~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~ei~~~i~~--~~~s- 532 (612)
T KOG0603|consen 465 ELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IEIHTRIQM--PKFS- 532 (612)
T ss_pred hCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HHHHHhhcC--Cccc-
Confidence 76554 12234578999999999999999999999999999999999999876544 111112211 1111
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
........+|+.+|++.||.+||+|.++...
T Consensus 533 ------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 ------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ------------cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1122357899999999999999999999764
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=285.16 Aligned_cols=242 Identities=24% Similarity=0.369 Sum_probs=202.5
Q ss_pred CCcccceecccCceEEEEEEEcCCc-EEEEEEeecCc-CChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 594 NFSEENILGRGGFGTVYKGELHDGT-KIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~~g~-~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
+++....||-||||.|-.+..+... .+|+|.+++.. ....+.+.+..|-.+|..++.|.||+++..|.+.+..|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4445567999999999999876333 38999887653 345556778999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
-|-||.|...+++ ++.++..+...++..+++|++|||+ ++||.||+||+|.+++.+|-+||.|||+|+....
T Consensus 501 aClGGElWTiLrd-----Rg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 501 ACLGGELWTILRD-----RGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhcCchhhhhhhh-----cCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999954 3578888888899999999999997 8999999999999999999999999999997765
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHH-HHHHhhcCccccccccC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVT-WFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 830 (948)
+. .+.+++|||.|.|||++.++..+.++|.||+|+++|||++|.+||.+.++...+..+- -+..+..+
T Consensus 573 g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--------- 641 (732)
T KOG0614|consen 573 GR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--------- 641 (732)
T ss_pred CC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc---------
Confidence 43 5678999999999999999999999999999999999999999999988766554442 11111111
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCC
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPD 863 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt 863 (948)
........+++++.+..+|.+|..
T Consensus 642 ---------r~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 642 ---------RRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ---------cccchhHHHHHHHHHhcCcHhhhc
Confidence 111234678999999999999975
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=274.60 Aligned_cols=222 Identities=21% Similarity=0.216 Sum_probs=176.1
Q ss_pred cCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCCChhHHH
Q 002238 604 GGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI 682 (948)
Q Consensus 604 G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l 682 (948)
|.||.||++... +++.||+|++... ..+.+|...+....||||+++++++.+.+..++||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~-------~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKS-------SEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecch-------hhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 899999999864 7899999998753 12345555566678999999999999999999999999999999888
Q ss_pred HhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCceeeeecc
Q 002238 683 FNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG 762 (948)
Q Consensus 683 ~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 762 (948)
.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++|||.+...... .....+
T Consensus 77 ~~-----~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~ 144 (237)
T cd05576 77 SK-----FLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAV 144 (237)
T ss_pred HH-----hcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCc
Confidence 43 1358999999999999999999997 89999999999999999999999999987654332 122346
Q ss_pred cccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHH
Q 002238 763 TFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILAS 842 (948)
Q Consensus 763 t~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (948)
+..|+|||++.+..++.++||||+|+++|||++|+.|+........ . . .. ..++ ...
T Consensus 145 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----------~-~--~~----~~~~-----~~~ 201 (237)
T cd05576 145 ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----------T-H--TT----LNIP-----EWV 201 (237)
T ss_pred CccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----------c-c--cc----cCCc-----ccC
Confidence 7789999999888899999999999999999999988754321100 0 0 00 0000 012
Q ss_pred HHHHHHHHHHhcccCCCCCCChHHH
Q 002238 843 ISTVAELAGHCCAREPYQRPDMGHA 867 (948)
Q Consensus 843 ~~~l~~li~~c~~~~P~~RPt~~ev 867 (948)
...+.+++.+|++.||++||++.+.
T Consensus 202 ~~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 202 SEEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred CHHHHHHHHHHccCCHHHhcCCCcc
Confidence 2458899999999999999997433
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=271.78 Aligned_cols=266 Identities=23% Similarity=0.276 Sum_probs=200.9
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCC--Cc----eeeEEeEEEe
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH--RH----LVALLGHCLD 662 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H--~n----iv~l~~~~~~ 662 (948)
..+++|.+...+|+|+||.|-++..+ .+..||||+++.- ..-.+...-|+++++++.+ |+ +|.+.+++.-
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 34789999999999999999999654 5789999998752 2233556789999999943 22 7788889999
Q ss_pred CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC--------
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-------- 734 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~-------- 734 (948)
.++.++|+|.+ |-++.+++.. .+..+++...+..++.|++++++|||+ .+++|-|+||+|||+-+
T Consensus 163 rghiCivfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred cCceEEEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEec
Confidence 99999999988 6699999843 455789999999999999999999997 89999999999999931
Q ss_pred ------------CCCeEEeecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 002238 735 ------------DMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDE 802 (948)
Q Consensus 735 ------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~ 802 (948)
+..++|+|||.|+...... ..++.|..|.|||++.+-.++.++||||+||+|+|+.||..-|+.
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 3358999999998654433 556789999999999999999999999999999999999999987
Q ss_pred CCchhhhhHHHHHHH---------h----hcCccc-----------cccccCcccC---CccchHHHHHHHHHHHHHhcc
Q 002238 803 SQPEESMHLVTWFRR---------I----HLSKDS-----------FHKAIDPTID---LNEGILASISTVAELAGHCCA 855 (948)
Q Consensus 803 ~~~~~~~~~~~~~~~---------~----~~~~~~-----------~~~~~~~~~~---~~~~~~~~~~~l~~li~~c~~ 855 (948)
....+...+.+.+-+ . ....+. .....++..+ .-.....+...+.+|+++|+.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 664442211111100 0 000000 0000010000 001112345579999999999
Q ss_pred cCCCCCCChHHHHH
Q 002238 856 REPYQRPDMGHAVN 869 (948)
Q Consensus 856 ~~P~~RPt~~ev~~ 869 (948)
.||.+|+|+.|++.
T Consensus 392 fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 392 FDPARRITLREALS 405 (415)
T ss_pred cCccccccHHHHhc
Confidence 99999999999876
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=274.87 Aligned_cols=257 Identities=27% Similarity=0.408 Sum_probs=194.0
Q ss_pred hcCCcccceecccCceEEEEEE-EcCCcEEEEEEeecCcCChhh-----HHHHHHHHHHHHhcCCCceeeEEeEEE-eCC
Q 002238 592 TNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKG-----LTEFKSEIAVLTKVRHRHLVALLGHCL-DGN 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~-----~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~ 664 (948)
.++|-..++||+|||+.||+|- +...+.||||+-........+ .+...+|.++-+.+.||.||++++++. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 4578888999999999999995 445788999975433222222 234678999999999999999999986 556
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEc---CCCCeEEe
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKVA 741 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~---~~~~~kl~ 741 (948)
.++-|.|||+|.+|.=+|+. .+-++++++..|+.||+.||.||.+. +.+|||-|+||.|||+- .-|.+||+
T Consensus 542 sFCTVLEYceGNDLDFYLKQ-----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQ-----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cceeeeeecCCCchhHHHHh-----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 67899999999999877743 25688999999999999999999986 58999999999999995 44689999
Q ss_pred ecCCceecCCCCCc------eeeeecccccccCceecccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhH
Q 002238 742 DFGLVRLAPEGKGS------IETRIAGTFGYLAPEYAVTG----RVTTKVDVFSFGVILMELITGRKALDESQPEESMHL 811 (948)
Q Consensus 742 DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~ 811 (948)
|||+++++.++... .....+||.+|++||.+.-+ +.+.|+||||.||++|+.+.|+.||........ .
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--I 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--I 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--H
Confidence 99999987654432 23457899999999987543 578899999999999999999999987553221 1
Q ss_pred HHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHH
Q 002238 812 VTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHA 867 (948)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev 867 (948)
.. ...+.+...-.++.. +....+...+|++|++..-++|.+..++
T Consensus 694 Lq--------eNTIlkAtEVqFP~K---PvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 694 LQ--------ENTILKATEVQFPPK---PVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred Hh--------hhchhcceeccCCCC---CccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 11 000100000011101 1122457789999999999999776555
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=246.89 Aligned_cols=204 Identities=27% Similarity=0.397 Sum_probs=170.1
Q ss_pred CCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEEEEE
Q 002238 594 NFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.......||+|++|.|-+-++ .+|+..|||++.... ..++.++..+|+.+..+. .+|.+|.++|...+....++.||
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 344456799999999988876 479999999998754 566677888899886655 89999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
.|. -+|..+-....+ ....+++...-+||..+++||.|||+ +..+||||+||+|||++.+|++|+||||.+-...+
T Consensus 126 ~M~-tSldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred Hhh-hhHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 994 478766544333 34678888899999999999999999 68899999999999999999999999999876544
Q ss_pred CCCceeeeecccccccCceeccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVT----GRVTTKVDVFSFGVILMELITGRKALDESQ 804 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~ 804 (948)
.- ..+.-.|-..|||||.+.. ..|+.|+||||+|+.++||.+++.||+...
T Consensus 202 Si--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 202 SI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred hh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 32 2233468889999999854 368999999999999999999999998654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=288.96 Aligned_cols=263 Identities=20% Similarity=0.235 Sum_probs=182.0
Q ss_pred hhcCCcccceecccCceEEEEEEE-----------------cCCcEEEEEEeecCcCChhhH--------------HHHH
Q 002238 591 VTNNFSEENILGRGGFGTVYKGEL-----------------HDGTKIAVKRMEAGVISGKGL--------------TEFK 639 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~--------------~~~~ 639 (948)
..++|++.++||+|+||.||+|.+ .+++.||||++.... .... +...
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~--~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDR--QGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccc--hhhHHHHHhhhhhhhcccchhH
Confidence 367899999999999999999964 235689999986431 1111 2234
Q ss_pred HHHHHHHhcCCCce-----eeEEeEEEe--------CCceEEEEEecCCCChhHHHHhhhh-------------------
Q 002238 640 SEIAVLTKVRHRHL-----VALLGHCLD--------GNEKLLVFEYMPQGTLSRHIFNWAE------------------- 687 (948)
Q Consensus 640 ~E~~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~------------------- 687 (948)
.|+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57778888877654 677777653 3567999999999999999864210
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCceeeeeccccccc
Q 002238 688 EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767 (948)
Q Consensus 688 ~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~ 767 (948)
.....++|..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..............+|+.|+
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~ 377 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS 377 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence 011245788899999999999999997 79999999999999999999999999999755433222222233588999
Q ss_pred CceecccCCC----------------------CchhhHHHHHHHHHHHHhCCC-CCCCCCchhh------hhHHHHHHHh
Q 002238 768 APEYAVTGRV----------------------TTKVDVFSFGVILMELITGRK-ALDESQPEES------MHLVTWFRRI 818 (948)
Q Consensus 768 aPE~~~~~~~----------------------~~~~Dv~s~Gv~l~elltg~~-p~~~~~~~~~------~~~~~~~~~~ 818 (948)
|||.+..... ..+.||||+||++|||++|.. |+........ .....|...
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~- 456 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY- 456 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh-
Confidence 9998754321 134799999999999999875 6653221110 011111110
Q ss_pred hcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCC---CCCCChHHHHHH
Q 002238 819 HLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREP---YQRPDMGHAVNV 870 (948)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P---~~RPt~~ev~~~ 870 (948)
...... +. ..........+++.+++..+| .+|++++|++++
T Consensus 457 ~~~~~~--------~~---~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 457 KGQKYD--------FS---LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cccCCC--------cc---cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000000 10 011122457789999999766 689999999873
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=301.21 Aligned_cols=267 Identities=20% Similarity=0.226 Sum_probs=170.6
Q ss_pred hhcCCcccceecccCceEEEEEEEc-C----CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeE------
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-D----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH------ 659 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~------ 659 (948)
..++|+..+.||+|+||.||+|++. + +..||||++.... . .+.+..| .++...+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--A--VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc--h--hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 4578999999999999999999875 4 6899999875421 1 1111111 1111122222222111
Q ss_pred EEeCCceEEEEEecCCCChhHHHHhhhhc---------------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecC
Q 002238 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEE---------------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRD 724 (948)
Q Consensus 660 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrD 724 (948)
+..+.+.++||||+++++|.+++...... .........+..++.|++.||+|||+ .+|+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCc
Confidence 24567789999999999999988541100 00111234456899999999999997 7999999
Q ss_pred CCCccEEEcC-CCCeEEeecCCceecCCCCCceeeeecccccccCceecccC----------------------CCCchh
Q 002238 725 LKPSNILLGD-DMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG----------------------RVTTKV 781 (948)
Q Consensus 725 ik~~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~ 781 (948)
|||+|||++. ++.+||+|||+|+..............||++|+|||.+... .++.++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999985 57999999999986655444445567899999999965322 234567
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCc----c-chHHHHHHHHHHHHHhccc
Q 002238 782 DVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLN----E-GILASISTVAELAGHCCAR 856 (948)
Q Consensus 782 Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~-~~~~~~~~l~~li~~c~~~ 856 (948)
|||||||++|||+++..+++... ......+.........+...+.+..... . ..........+|+.+|++.
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNL----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHH----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 99999999999999776654321 1111111100000000111111110000 0 0000112345899999999
Q ss_pred CCCCCCChHHHHHH
Q 002238 857 EPYQRPDMGHAVNV 870 (948)
Q Consensus 857 ~P~~RPt~~ev~~~ 870 (948)
||.+|||+.+++++
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999884
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=265.85 Aligned_cols=239 Identities=31% Similarity=0.448 Sum_probs=191.7
Q ss_pred CceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCCChhHHHH
Q 002238 605 GFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIF 683 (948)
Q Consensus 605 ~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 683 (948)
+||.||+|+.. +|+.+|+|++........ .+.+.+|++.+++++|+|++++++++..+...+++|||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999986 489999999876432211 6789999999999999999999999999999999999999999999884
Q ss_pred hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCceeeeeccc
Q 002238 684 NWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT 763 (948)
Q Consensus 684 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt 763 (948)
.. ..+++..++.++.+++++++|||+ .+++|+||+|+||+++.++.++++|||.+....... ......++
T Consensus 80 ~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~ 149 (244)
T smart00220 80 KR-----GRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGT 149 (244)
T ss_pred hc-----cCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCC
Confidence 31 238899999999999999999997 799999999999999999999999999988665432 23345688
Q ss_pred ccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHH
Q 002238 764 FGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASI 843 (948)
Q Consensus 764 ~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (948)
..|+|||.+.+..++.++||||||+++|++++|..||....... ........ ..... ........
T Consensus 150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~~~~~---~~~~~----------~~~~~~~~ 214 (244)
T smart00220 150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFKKIGK---PKPPF----------PPPEWKIS 214 (244)
T ss_pred cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHhc---cCCCC----------ccccccCC
Confidence 99999999988889999999999999999999999997632211 11111111 00000 00000033
Q ss_pred HHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 844 STVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 844 ~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.++.+++.+|+..+|++||++.++++
T Consensus 215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 215 PEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHHccCCchhccCHHHHhh
Confidence 46889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=278.66 Aligned_cols=370 Identities=21% Similarity=0.238 Sum_probs=281.6
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCC-CCCCcEEEcccccccCCCCccccCCCCCCEEEc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNG-LASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~-l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (948)
..+..|++++|.|+..-+..|-++++|++++|.+|.++. +|.|++ ..+|+.|+|.+|.|+.+..+.++.++.|+.|||
T Consensus 78 ~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~-IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDL 156 (873)
T KOG4194|consen 78 SQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTR-IPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDL 156 (873)
T ss_pred cceeeeeccccccccCcHHHHhcCCcceeeeeccchhhh-cccccccccceeEEeeeccccccccHHHHHhHhhhhhhhh
Confidence 367889999999998888889999999999999999985 566666 455999999999999999999999999999999
Q ss_pred cCCCCCCCCCCc-cccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCccc-ccccceeccCCC
Q 002238 147 DNNPFSSWEIPQ-SLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQN 224 (948)
Q Consensus 147 s~N~l~~~~~p~-~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~~~~~~ 224 (948)
|.|.|+ ++|. +|..-.++++|+|++|.|+......|. .+.+|..|.|+.|+++...+..|.. .+|+.|++.-
T Consensus 157 SrN~is--~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~--~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnr-- 230 (873)
T KOG4194|consen 157 SRNLIS--EIPKPSFPAKVNIKKLNLASNRITTLETGHFD--SLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNR-- 230 (873)
T ss_pred hhchhh--cccCCCCCCCCCceEEeecccccccccccccc--ccchheeeecccCcccccCHHHhhhcchhhhhhccc--
Confidence 999999 5554 455667899999999999988888887 8899999999999999777777763 5566666543
Q ss_pred CCCccCCCccccccCCCccEEEccCCcccccCC-CCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccC
Q 002238 225 GNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPV 303 (948)
Q Consensus 225 ~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~ 303 (948)
|.+...---.|.++++|+.|.|..|.++..-. .|.++.++++|+|+.|++...--.++.+|+.|+.|+||+|.+...-
T Consensus 231 -N~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih 309 (873)
T KOG4194|consen 231 -NRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIH 309 (873)
T ss_pred -cceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheee
Confidence 33322222346778888888888888876444 4777888888888888888777777888888888888888887654
Q ss_pred CC-CCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcc
Q 002238 304 PE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNL 382 (948)
Q Consensus 304 p~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l 382 (948)
++ +....+|..++++.|.+...+...+.-+..++.+.-....... ..-+.|..+.+|+.|||++|.+
T Consensus 310 ~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~------------l~e~af~~lssL~~LdLr~N~l 377 (873)
T KOG4194|consen 310 IDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDH------------LAEGAFVGLSSLHKLDLRSNEL 377 (873)
T ss_pred cchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHH------------HHhhHHHHhhhhhhhcCcCCeE
Confidence 43 6666778888888877777765555544444333221111111 1124566778999999999999
Q ss_pred cccCCcc---ccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCCC-CC--cccccccCCCCCCCCccC
Q 002238 383 TGTISPE---FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS-FK--SNAIVNTDGNPDIGKEKS 456 (948)
Q Consensus 383 ~g~ip~~---~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~-~~--~~~~~~~~gnp~~~~~~~ 456 (948)
++.|.+. |..|++|+.|+|.+|+|..+--..|.+++.|+.|||.+|.+-..-|. |. ..+.+.+..-..+|++..
T Consensus 378 s~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql 457 (873)
T KOG4194|consen 378 SWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQL 457 (873)
T ss_pred EEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEeccH
Confidence 9877554 77899999999999999955557899999999999999999876553 32 234455555566776655
Q ss_pred C
Q 002238 457 S 457 (948)
Q Consensus 457 ~ 457 (948)
.
T Consensus 458 ~ 458 (873)
T KOG4194|consen 458 K 458 (873)
T ss_pred H
Confidence 3
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=289.49 Aligned_cols=247 Identities=28% Similarity=0.428 Sum_probs=189.4
Q ss_pred CCcccceecccCce-EEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEEEEE
Q 002238 594 NFSEENILGRGGFG-TVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 594 ~~~~~~~lg~G~fg-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 671 (948)
-|...+++|.|+.| .||+|... |+.||||++-.+ ......+|+..++.- +|||||++++.-.++...|++.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 35556779999986 57999987 899999987542 345678999999998 79999999988888888999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC---C--CCeEEeecCCc
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---D--MRAKVADFGLV 746 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~---~--~~~kl~DfGla 746 (948)
.| ..+|.+++.....+ .....-...+.+..|++.||++||+ .+|||||+||+|||++. + .+++|+|||++
T Consensus 584 LC-~~sL~dlie~~~~d-~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 584 LC-ACSLQDLIESSGLD-VEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred Hh-hhhHHHHHhccccc-hhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccc
Confidence 99 45999998542000 0111113356788999999999998 79999999999999975 3 47999999999
Q ss_pred eecCCCCCcee--eeecccccccCceecccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCchhhhhHHHHHHHhhcCcc
Q 002238 747 RLAPEGKGSIE--TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG-RKALDESQPEESMHLVTWFRRIHLSKD 823 (948)
Q Consensus 747 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 823 (948)
+....++.... ....||-+|+|||.+.....+.++||||+|||+|+.++| .+||.+.-..+. .+.....
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~~ 730 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGNY 730 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCcc
Confidence 98776655433 346799999999999999889999999999999999996 899987543322 1111122
Q ss_pred ccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 824 SFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.+..+. + ..++ +..+||.+|++.+|..||++.+|+.
T Consensus 731 ~L~~L~-~-------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 731 TLVHLE-P-------LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ceeeec-c-------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 111111 1 0111 5779999999999999999999975
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=253.06 Aligned_cols=250 Identities=21% Similarity=0.361 Sum_probs=196.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChh-hHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGK-GLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 668 (948)
.++|...++||+|+|++|..++++ +.+.||+|+++++..... +..=.+.|-.+..+. +||.+|.+..++..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 367999999999999999999865 678999999988765543 345567788888777 79999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
|.||++||+|--+++. .+.+++..+..+...|+-||.|||+ .|||.||+|.+|||+|..|.+|++|+|+++.
T Consensus 329 vieyv~ggdlmfhmqr-----qrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEecCcceeeehhh-----hhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhc
Confidence 9999999999665532 2568888888899999999999997 8999999999999999999999999999985
Q ss_pred cCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-hhhhHHHHHHHhhcCcccccc
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPE-ESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 827 (948)
--.. +.....++|||.|.|||++.+.+|+...|.|++||+++||+.|+.||+-.... .....-++.-++...
T Consensus 401 ~l~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile------ 473 (593)
T KOG0695|consen 401 GLGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE------ 473 (593)
T ss_pred CCCC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh------
Confidence 4332 23456789999999999999999999999999999999999999999743211 111122222222211
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCC
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRP 862 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RP 862 (948)
..+... .........+++.-++.||.+|.
T Consensus 474 ---kqirip---rslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 474 ---KQIRIP---RSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ---hccccc---ceeehhhHHHHHHhhcCCcHHhc
Confidence 111111 11122356788889999999985
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=270.89 Aligned_cols=209 Identities=27% Similarity=0.426 Sum_probs=176.6
Q ss_pred cCCcccceecccCceEEEEEE-EcCCcEEEEEEeecCc-CChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.-|..++.||-|+||+|.+++ .++...||+|.+++.. .........+.|-+||.....+=||+++-.|.+++..|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 457778899999999999996 4556789999987653 33555677899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee--
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL-- 748 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~-- 748 (948)
||++||++-.+|.. ...+.+.-+..++..+.+|+++.|. .|+|||||||+|||+|.+|.+||+||||+.-
T Consensus 709 dYIPGGDmMSLLIr-----mgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIR-----MGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred eccCCccHHHHHHH-----hccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccce
Confidence 99999999988854 1457777777888899999999995 8999999999999999999999999999762
Q ss_pred -------cCCCCCce--------------------------------eeeecccccccCceecccCCCCchhhHHHHHHH
Q 002238 749 -------APEGKGSI--------------------------------ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVI 789 (948)
Q Consensus 749 -------~~~~~~~~--------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~ 789 (948)
+..+.... .-..+||+.|+|||++....|+.-+|.||.||+
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 11111000 012479999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCchhhh
Q 002238 790 LMELITGRKALDESQPEESM 809 (948)
Q Consensus 790 l~elltg~~p~~~~~~~~~~ 809 (948)
||||+.|+.||....+.+..
T Consensus 861 l~em~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQ 880 (1034)
T ss_pred HHHHhhCCCCccCCCCCcce
Confidence 99999999999988776543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=254.66 Aligned_cols=268 Identities=23% Similarity=0.329 Sum_probs=198.4
Q ss_pred CcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----CceEE
Q 002238 595 FSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-----NEKLL 668 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~l 668 (948)
.+..+.||-|+||.||.+++ ++|+.||.|++..-.-.-...+.+.+|++++..++|.|++..++...-. .+.|.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34468899999999999976 4899999999876433344567899999999999999999888765533 24578
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
|+|.|. .+|..++ -.-+.++-..+.-+.+||++||+|||+ .+|.||||||.|.|++.+...||||||+|+.
T Consensus 135 ~TELmQ-SDLHKII-----VSPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 135 LTELMQ-SDLHKII-----VSPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHH-hhhhhee-----ccCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccc
Confidence 888884 4777666 233677777888899999999999998 8999999999999999999999999999997
Q ss_pred cCCCCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh-------c
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH-------L 820 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-------~ 820 (948)
...+.....+..+-|..|.|||++++. .|+.+.||||.||++.|++.++.-|+...+-+...++...-.-. .
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 665555556666789999999999885 69999999999999999999998888777655544442111000 0
Q ss_pred Ccc----ccccc-cCcccCCcc---chHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 821 SKD----SFHKA-IDPTIDLNE---GILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 821 ~~~----~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
-++ .+... -.|.+.... .......+...+...++..||++|.+..+.+..+
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 000 00000 011111100 0011223456788889999999999988887755
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=244.83 Aligned_cols=280 Identities=16% Similarity=0.255 Sum_probs=229.6
Q ss_pred cCCcccceecccCceEEEEEE-EcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 670 (948)
-.|+++++||+|+||.++.|+ +-+++.||||.-... .+..++..|.+..+.| ..+.|..++-+..++.+-.||+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 368999999999999999997 447999999975432 2335688899999988 5799999998888899999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC-----CeEEeecCC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-----RAKVADFGL 745 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~-----~~kl~DfGl 745 (948)
|.+ |.+|++++ +-..+.++.++++.||.|++.-++|+|+ +.+|.|||||+|+|+...+ .+.++||||
T Consensus 104 dLL-GPSLEDLF----D~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 104 DLL-GPSLEDLF----DLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhh-CcCHHHHH----HHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 988 88999887 3345789999999999999999999997 8999999999999997543 589999999
Q ss_pred ceecCCCCCc------eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh
Q 002238 746 VRLAPEGKGS------IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH 819 (948)
Q Consensus 746 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 819 (948)
|+.+.+.+.. ......||.+||+...+.+.+.+++.|+-|+|-++++++.|..||++..........+-+...
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~- 254 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET- 254 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc-
Confidence 9988776542 234567999999999999999999999999999999999999999997765433222211110
Q ss_pred cCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCCCCCCCcccccccccc
Q 002238 820 LSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDQNSEDIYGIDLEM 895 (948)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~~~~~~ 895 (948)
....+..+-+...+.+++..+......+..+-|+++-+...+.++.+....+++..+||.+.....
T Consensus 255 ----------Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln~g~ 320 (449)
T KOG1165|consen 255 ----------KRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLNNGK 320 (449)
T ss_pred ----------cccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccCCCC
Confidence 011223444555677899999999999999999999999999999999999999999998766433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=233.05 Aligned_cols=276 Identities=18% Similarity=0.223 Sum_probs=222.8
Q ss_pred hhcCCcccceecccCceEEEEEE-EcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCC-CceeeEEeEEEeCCceEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH-RHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~l 668 (948)
...+|...++||.|+||.+|.|. ..+|++||||+-.... ...++..|..+.+.++| ..|..+..+..++..-.+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC----CCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 35789999999999999999996 5689999999876542 22467889999999975 667777777888888999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC---CCeEEeecCC
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAKVADFGL 745 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~---~~~kl~DfGl 745 (948)
|||.+ |.+|++++.- ..+.++.++++-.|-|++.-++|+|. +++|||||||+|+|+.-+ ..+.++|||+
T Consensus 89 VMdLL-GPsLEdLfnf----C~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNF----CSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred eeecc-CccHHHHHHH----HhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccc
Confidence 99988 8899988743 33578999999999999999999997 899999999999999743 4689999999
Q ss_pred ceecCCCCCc------eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh
Q 002238 746 VRLAPEGKGS------IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH 819 (948)
Q Consensus 746 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 819 (948)
|+.+.+.... ......||.+|.+-..+.+.+.+++.|+-|+|++|.++..|..||++..+.......+-+....
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 9977654432 2345789999999999999999999999999999999999999999988765544443332221
Q ss_pred cCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCCCCCCCcccc
Q 002238 820 LSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDQNSEDIY 889 (948)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~ 889 (948)
. ....+.-+...+.++...+..|-....++-|++..+.+.+.-+........+..+||.
T Consensus 241 ~-----------s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~ 299 (341)
T KOG1163|consen 241 M-----------STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWT 299 (341)
T ss_pred c-----------CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHH
Confidence 1 1222344556677899999999999999999999999999888877666666555553
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=237.75 Aligned_cols=255 Identities=21% Similarity=0.331 Sum_probs=188.0
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeE-EEeCCceE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGH-CLDGNEKL 667 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~-~~~~~~~~ 667 (948)
..+.|.+.+.+|+|.||.+-.++++ +.+.+|+|.+... ....++|.+|..---.+ .|.||+.-+++ +...+.++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 4567889999999999999999986 5788999988764 34468899998876666 68999987764 56677888
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEc--CCCCeEEeecCC
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGL 745 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~--~~~~~kl~DfGl 745 (948)
+++||++.|+|..-+.. ..+.+....+++.|++.|+.|||+ +++||||||.+|||+- +..++|+||||+
T Consensus 99 F~qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred EeeccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeeccc
Confidence 99999999999876622 456677788999999999999998 8999999999999994 445899999999
Q ss_pred ceecCCCCCceeeeecccccccCceecccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc
Q 002238 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVTG-----RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL 820 (948)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 820 (948)
.+..... ....--+..|.|||..... ...+.+|+|.||+++|.++||++||+.... .......|......
T Consensus 170 t~k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~~w~~r 244 (378)
T KOG1345|consen 170 TRKVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWEQWLKR 244 (378)
T ss_pred ccccCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHHHHhcc
Confidence 8754321 1122245679999987542 246789999999999999999999984332 23334444443322
Q ss_pred CccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 821 SKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
....+.+.+.+ ..+.+.++.++-+..+|++|=-..++.++..
T Consensus 245 k~~~~P~~F~~----------fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 245 KNPALPKKFNP----------FSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred cCccCchhhcc----------cCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 12222222222 2235778899999999999955555544443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=233.21 Aligned_cols=259 Identities=19% Similarity=0.339 Sum_probs=193.7
Q ss_pred hcCCcccceecccCceEEEEEE-EcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeC--CceE
Q 002238 592 TNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDG--NEKL 667 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~ 667 (948)
.++|++.+++|+|.|++||.|. ..+.+.++||+++. -..+.+.+|+.+++.++ ||||+++++...+. ....
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 4678889999999999999996 45789999999864 23478999999999996 99999999988765 4567
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC-CCeEEeecCCc
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGLV 746 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~-~~~kl~DfGla 746 (948)
||+||+.+.+...+. ..++...+..++.+++.||.|+|+ .||+|||+||.|+++|.. ...+|+|+|+|
T Consensus 112 LiFE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred hHhhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchH
Confidence 999999998876655 456667788899999999999998 899999999999999955 46999999999
Q ss_pred eecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHH------------
Q 002238 747 RLAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVT------------ 813 (948)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~------------ 813 (948)
.++..+... .-.+.+..|.-||.+.. ..|+..-|+|||||++..|+..+.||....+.. ..+++
T Consensus 181 EFYHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQLVkIakVLGt~el~~ 257 (338)
T KOG0668|consen 181 EFYHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVKIAKVLGTDELYA 257 (338)
T ss_pred hhcCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HHHHHHHHHhChHHHHH
Confidence 988765532 22345677889998865 458889999999999999999999997654321 12222
Q ss_pred HHHHhhcC-ccccccccCcc-------cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 814 WFRRIHLS-KDSFHKAIDPT-------IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 814 ~~~~~~~~-~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
++...... ...+..++... +...+...-...+..+++.+.+..|-.+|||++|...
T Consensus 258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 11111110 00111111110 0001111112257889999999999999999999876
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-29 Score=270.56 Aligned_cols=254 Identities=26% Similarity=0.403 Sum_probs=206.0
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
-.++|+....+|.|+||.||||+.+ +++..|||+++.. .....+-++.|+-+++..+|||||.++|.+...+..+++
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe--p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE--PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeecc--CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 3568899999999999999999864 7999999999876 455667889999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+.+|+|.+.-+ ...++++.++..+++...+|++|||+ .+=+|||||-.||++++.|.+|++|||.+...
T Consensus 91 MEycgggslQdiy~-----~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYH-----VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQI 162 (829)
T ss_pred EEecCCCcccceee-----ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhh
Confidence 99999999987653 34689999999999999999999998 78899999999999999999999999987755
Q ss_pred CCCCCceeeeecccccccCceec---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYA---VTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
...- .....+.||+.|||||+. ..+.|..++|||+.|+...|+---++|..+..+.....+.. .
T Consensus 163 tati-~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT------------k 229 (829)
T KOG0576|consen 163 TATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT------------K 229 (829)
T ss_pred hhhh-hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh------------c
Confidence 4322 234557899999999987 35679999999999999999988888877665543322211 1
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..++|.-. +........+.++++.|+..+|++||++..++.
T Consensus 230 S~~qpp~l--kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 230 SGFQPPTL--KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cCCCCCcc--cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 22222211 111223345889999999999999999887654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-26 Score=237.55 Aligned_cols=211 Identities=38% Similarity=0.586 Sum_probs=181.9
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCCChh
Q 002238 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLS 679 (948)
Q Consensus 601 lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 679 (948)
||+|++|.||++... +++.+++|++....... ..+.+.+|++.++.++|++++++++++......+++|||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999876 48999999987642211 3578999999999999999999999999989999999999999999
Q ss_pred HHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC-CCCeEEeecCCceecCCCCCceee
Q 002238 680 RHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRLAPEGKGSIET 758 (948)
Q Consensus 680 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~ 758 (948)
+++... ...+++..++.++.+++++++|||+ .+++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 80 ~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 151 (215)
T cd00180 80 DLLKEN----EGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLK 151 (215)
T ss_pred HHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhh
Confidence 988431 1468899999999999999999997 79999999999999999 89999999999986654321 123
Q ss_pred eecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCcc
Q 002238 759 RIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNE 837 (948)
Q Consensus 759 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (948)
...+...|++||..... .++.++|+|++|++++++
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence 34578899999999887 888999999999999999
Q ss_pred chHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 838 GILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 838 ~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 137789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=260.01 Aligned_cols=198 Identities=23% Similarity=0.339 Sum_probs=168.8
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC------hhhHHHHHHHHHHHHhcC---CCceeeEEeEEEe
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS------GKGLTEFKSEIAVLTKVR---HRHLVALLGHCLD 662 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~ 662 (948)
.+|+..+.+|+|+||.|+.|.++ +...|+||.+.++..- ....-.+-.|+++|..++ |+||++++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46899999999999999999876 4567899988765321 111223567999999997 9999999999999
Q ss_pred CCceEEEEEecC-CCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEe
Q 002238 663 GNEKLLVFEYMP-QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 741 (948)
Q Consensus 663 ~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~ 741 (948)
++.+||+||-.. +-+|.+++ +-...+++.++..|+.||+.|+++||+ .+|||||||-+||.++.+|-+||+
T Consensus 641 dd~yyl~te~hg~gIDLFd~I-----E~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI-----EFKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh-----hccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEe
Confidence 999999999764 45777777 334678999999999999999999997 899999999999999999999999
Q ss_pred ecCCceecCCCCCceeeeecccccccCceecccCCC-CchhhHHHHHHHHHHHHhCCCCCC
Q 002238 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALD 801 (948)
Q Consensus 742 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~elltg~~p~~ 801 (948)
|||.|.....+ ....++||.+|.|||++.+..| +..-|||++|++||-++....||.
T Consensus 713 dfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99998876554 3456789999999999999887 566899999999999999888874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=239.86 Aligned_cols=265 Identities=25% Similarity=0.323 Sum_probs=198.4
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC------C
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------N 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~ 664 (948)
..+|...+.+|.|.- .|--|-+ -.+++||+|++........+.++..+|..++..+.|+||++++.++.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456777888999988 5555533 2589999999877655566678889999999999999999999988643 3
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
+.|+||||| .++|.+.++ -.++-.+...|..|+++|++|||+ .+|+|||+||+||++..+..+||.|||
T Consensus 95 e~y~v~e~m-~~nl~~vi~-------~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL-------MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH-------HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccch
Confidence 569999999 568988875 246677888999999999999998 899999999999999999999999999
Q ss_pred CceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhh---------------
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESM--------------- 809 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~--------------- 809 (948)
+|+..... ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+...-+..
T Consensus 164 ~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 164 LARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred hhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 99854332 3456677899999999999988999999999999999999999888754322111
Q ss_pred -hHHHHHHHhhcCc-----cccccccCcc-cC-CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 810 -HLVTWFRRIHLSK-----DSFHKAIDPT-ID-LNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 810 -~~~~~~~~~~~~~-----~~~~~~~~~~-~~-~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.+...++...... ..+.+.+... +. ..+...-......+++.+|+-.+|++|-++.+++++
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 1111111111100 1222222211 11 111122233457799999999999999999998874
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-28 Score=260.93 Aligned_cols=348 Identities=19% Similarity=0.204 Sum_probs=257.6
Q ss_pred CCCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEE
Q 002238 67 DKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145 (948)
Q Consensus 67 ~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 145 (948)
-.+++++++..|.|+ .||...+...+|+.|+|.+|.|+.+-. ++..++.|+.|||+.|.|+.++...|..-.++++|+
T Consensus 101 l~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~ 179 (873)
T KOG4194|consen 101 LPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLN 179 (873)
T ss_pred CCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEe
Confidence 357888888888887 777666666678888888888876544 577788888888888888888888888878888888
Q ss_pred ccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCC
Q 002238 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNG 225 (948)
Q Consensus 146 Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~ 225 (948)
|++|+|+.+ --..|.++.+|..|.|++|+|+...+..|. +++.|+.|+|..|+|.-..-..|.+ |.+|.......
T Consensus 180 La~N~It~l-~~~~F~~lnsL~tlkLsrNrittLp~r~Fk--~L~~L~~LdLnrN~irive~ltFqg--L~Sl~nlklqr 254 (873)
T KOG4194|consen 180 LASNRITTL-ETGHFDSLNSLLTLKLSRNRITTLPQRSFK--RLPKLESLDLNRNRIRIVEGLTFQG--LPSLQNLKLQR 254 (873)
T ss_pred ecccccccc-ccccccccchheeeecccCcccccCHHHhh--hcchhhhhhccccceeeehhhhhcC--chhhhhhhhhh
Confidence 888888852 256677788888888888888877777776 7888888888888887443444543 33333333344
Q ss_pred CCccCCCccccccCCCccEEEccCCcccccCC-CCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCC
Q 002238 226 NAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP 304 (948)
Q Consensus 226 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p 304 (948)
|++.......|..+.++++|+|+.|++...-. .+.+++.|+.|+|+.|.|...-++++...++|++|+|++|+++...+
T Consensus 255 N~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~ 334 (873)
T KOG4194|consen 255 NDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDE 334 (873)
T ss_pred cCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCCh
Confidence 44444444567788888999999998887555 36788889999999999888888888888899999999999887666
Q ss_pred C-CCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCccc
Q 002238 305 E-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLT 383 (948)
Q Consensus 305 ~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~ 383 (948)
. |..+..|..+.+.+|.+..+....+..+.++..+.- .+-...|-= ++.-..|..++.|+.|+|.+|++.
T Consensus 335 ~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdL-----r~N~ls~~I----EDaa~~f~gl~~LrkL~l~gNqlk 405 (873)
T KOG4194|consen 335 GSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDL-----RSNELSWCI----EDAAVAFNGLPSLRKLRLTGNQLK 405 (873)
T ss_pred hHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcC-----cCCeEEEEE----ecchhhhccchhhhheeecCceee
Confidence 4 555666777777777665554444433333322211 111122211 123345778999999999999999
Q ss_pred ccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcc
Q 002238 384 GTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430 (948)
Q Consensus 384 g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l 430 (948)
.+--.+|..++.|+.|||.+|-|..+-|..|..+ +|+.|.+..-.|
T Consensus 406 ~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssf 451 (873)
T KOG4194|consen 406 SIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSF 451 (873)
T ss_pred ecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccce
Confidence 8777889999999999999999998889999999 999988876554
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-29 Score=270.97 Aligned_cols=338 Identities=24% Similarity=0.328 Sum_probs=240.0
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEccccccc--CCCCccccCCCCCCEEE
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFT--SVPSDFFTGLSSLQSIE 145 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~ 145 (948)
.+++.|.|...+|. .+|+.++.+.+|++|.+++|++..+.-.+..|+.|+.+++..|++. |+|++ +-.|..|..||
T Consensus 32 t~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~d-iF~l~dLt~lD 109 (1255)
T KOG0444|consen 32 TQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKNSGIPTD-IFRLKDLTILD 109 (1255)
T ss_pred hheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhccccccCCCCch-hcccccceeee
Confidence 57888999998888 8999999999999999999999887778899999999999999886 56666 56899999999
Q ss_pred ccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCccc-ccccceeccCCC
Q 002238 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQN 224 (948)
Q Consensus 146 Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~~~~~~ 224 (948)
||+|++. ++|..+...+++-.|+|++|+|..++...|. +++.|-+||||+|++. .+|..... .+|+.|.++++-
T Consensus 110 LShNqL~--EvP~~LE~AKn~iVLNLS~N~IetIPn~lfi--nLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NP 184 (1255)
T KOG0444|consen 110 LSHNQLR--EVPTNLEYAKNSIVLNLSYNNIETIPNSLFI--NLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNP 184 (1255)
T ss_pred cchhhhh--hcchhhhhhcCcEEEEcccCccccCCchHHH--hhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCCh
Confidence 9999999 8999999999999999999999866666665 8999999999999998 55555433 567777776554
Q ss_pred CCCc-cCCCccccccCCCccEEEccCCccc--ccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccc
Q 002238 225 GNAK-LGGGIDVIQNMTSLKEIWLHSNAFS--GPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG 301 (948)
Q Consensus 225 ~~~~-~~~~~~~l~~l~~L~~L~Ls~N~l~--~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 301 (948)
.+.. +.. +-.+++|..|++++.+-+ ..++.+..+.+|..+||+.|++. .+|+++.++++|+.|+||+|+++.
T Consensus 185 L~hfQLrQ----LPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite 259 (1255)
T KOG0444|consen 185 LNHFQLRQ----LPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE 259 (1255)
T ss_pred hhHHHHhc----CccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceee
Confidence 3322 222 335778888999887654 35557888999999999999999 899999999999999999999885
Q ss_pred cCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCc
Q 002238 302 PVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMN 381 (948)
Q Consensus 302 ~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~ 381 (948)
.--....-.+|..+..+.|.....|.+ +..+..+.++....+. .++.|. .+. +..+.+|+.+..++|.
T Consensus 260 L~~~~~~W~~lEtLNlSrNQLt~LP~a----vcKL~kL~kLy~n~Nk--L~FeGi---PSG---IGKL~~Levf~aanN~ 327 (1255)
T KOG0444|consen 260 LNMTEGEWENLETLNLSRNQLTVLPDA----VCKLTKLTKLYANNNK--LTFEGI---PSG---IGKLIQLEVFHAANNK 327 (1255)
T ss_pred eeccHHHHhhhhhhccccchhccchHH----HhhhHHHHHHHhccCc--ccccCC---ccc---hhhhhhhHHHHhhccc
Confidence 433223333455556666665555432 1111112222111110 011110 011 1233445555566666
Q ss_pred ccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCccc
Q 002238 382 LTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY 431 (948)
Q Consensus 382 l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~ 431 (948)
+. ..|..++.+..|+.|.|++|+|- ++|..|.-|+.|++|||..|+=-
T Consensus 328 LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 328 LE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred cc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 54 56666666666666666666665 66666666666666666666433
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=242.94 Aligned_cols=130 Identities=30% Similarity=0.452 Sum_probs=110.0
Q ss_pred cCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhH-HHHHHHHHHHHhcC-----C---CceeeEEeEEEe
Q 002238 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGL-TEFKSEIAVLTKVR-----H---RHLVALLGHCLD 662 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~-~~~~~E~~~l~~l~-----H---~niv~l~~~~~~ 662 (948)
.+|-+.++||.|.|++||+|.+ .+.+.||+|+.+.. +++ +....||++|++++ | ..||+++++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 6899999999999999999964 56789999998753 332 45678999999993 3 469999999874
Q ss_pred ----CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE
Q 002238 663 ----GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732 (948)
Q Consensus 663 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill 732 (948)
+.+++||+|++ |.+|..++.. ...+.++...+.+|++||+.||.|||. +.+|||-||||+|||+
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~---s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKY---SNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHH---hCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 56889999999 6788888854 334678889999999999999999998 5799999999999998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-26 Score=236.60 Aligned_cols=200 Identities=35% Similarity=0.487 Sum_probs=172.2
Q ss_pred CcccceecccCceEEEEEEEcC-CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEec
Q 002238 595 FSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 673 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 673 (948)
|+..+.||+|++|.||+|...+ ++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 5667889999999999998764 899999998764322 25678999999999999999999999999989999999999
Q ss_pred CCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCC
Q 002238 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (948)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~ 753 (948)
++++|.+++... ...+++..+..++.+++.++.|||+ .+++|+||+|.||+++.++.++|+|||.+.......
T Consensus 80 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 80 EGGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred CCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 999999988531 1127899999999999999999997 799999999999999999999999999998765543
Q ss_pred CceeeeecccccccCceec-ccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 002238 754 GSIETRIAGTFGYLAPEYA-VTGRVTTKVDVFSFGVILMELITGRKALDE 802 (948)
Q Consensus 754 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~ 802 (948)
........++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 1123345678899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-30 Score=261.53 Aligned_cols=369 Identities=22% Similarity=0.284 Sum_probs=247.7
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEcc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 147 (948)
.-++.+++.+|+++ ++|++++.+..++.|+.++|+++..++.+..+.+|+.|+.++|.+...+++ ++.+-.|+.|+..
T Consensus 68 ~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~~~el~~~-i~~~~~l~dl~~~ 145 (565)
T KOG0472|consen 68 ACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNELKELPDS-IGRLLDLEDLDAT 145 (565)
T ss_pred cceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhccccceeecCch-HHHHhhhhhhhcc
Confidence 35788899999988 888889999999999999999988888888888999999999998888766 7788888888888
Q ss_pred CCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCC
Q 002238 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNA 227 (948)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~ 227 (948)
+|+++ .+|.+++++.+|..|++.+|+++...|..+ .++.|++||.-.|-+. .+|..+++ +++|.+.+...|.
T Consensus 146 ~N~i~--slp~~~~~~~~l~~l~~~~n~l~~l~~~~i---~m~~L~~ld~~~N~L~-tlP~~lg~--l~~L~~LyL~~Nk 217 (565)
T KOG0472|consen 146 NNQIS--SLPEDMVNLSKLSKLDLEGNKLKALPENHI---AMKRLKHLDCNSNLLE-TLPPELGG--LESLELLYLRRNK 217 (565)
T ss_pred ccccc--cCchHHHHHHHHHHhhccccchhhCCHHHH---HHHHHHhcccchhhhh-cCChhhcc--hhhhHHHHhhhcc
Confidence 88888 678888888888888888888876666655 4777777777777765 66666643 4444444444444
Q ss_pred ccCCCccccccCCCccEEEccCCcccccCCC-CCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCC
Q 002238 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEF 306 (948)
Q Consensus 228 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 306 (948)
+.... .|.++..|++|+++.|+++-.+.+ ...+..|.+|||++|+++ ..|+.++-+.+|..||+|+|.+++.++.+
T Consensus 218 i~~lP--ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sL 294 (565)
T KOG0472|consen 218 IRFLP--EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSL 294 (565)
T ss_pred cccCC--CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCccc
Confidence 43322 456666666677666666633333 345666777777777776 66776776766777777777777666666
Q ss_pred CCccccccccccCCCCC--------------------------------------CCCCCCchhhhhhHHHHHhh-----
Q 002238 307 DRSVSLDMAKGSNNFCL--------------------------------------PSPGACDPRLNALLSVVKLM----- 343 (948)
Q Consensus 307 ~~~~~l~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~l~~~~~~~----- 343 (948)
+++ .|.++....|-.. ..+...++....+.+...+.
T Consensus 295 gnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~q 373 (565)
T KOG0472|consen 295 GNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQ 373 (565)
T ss_pred ccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccc
Confidence 555 3332222221100 00000011000000000000
Q ss_pred --CCcch----------hccccCCC----------------------CCCCCccc-eeecCCceEEEEccCCcccccCCc
Q 002238 344 --GYPQR----------FAENWKGN----------------------DPCSDWIG-VTCTKGNITVINFQKMNLTGTISP 388 (948)
Q Consensus 344 --~~~~~----------~~~~~~~~----------------------~~~~~~~~-~~~~~~~L~~L~ls~n~l~g~ip~ 388 (948)
..|.. ...++.++ ....+|.+ ..+.+++|+.|+|++|-+. .+|.
T Consensus 374 lt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~ 452 (565)
T KOG0472|consen 374 LTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPE 452 (565)
T ss_pred cccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcch
Confidence 00000 00011111 11223443 4678899999999998886 8999
Q ss_pred cccCccccceEeCcccccc----------------------ccCCcC-CcCCCCCcEEEccCCcccCCCCCC---Ccccc
Q 002238 389 EFASFKSLQRLILADNNLS----------------------GMIPEG-LSVLGALKELDVSNNQLYGKIPSF---KSNAI 442 (948)
Q Consensus 389 ~~~~l~~L~~L~Ls~N~l~----------------------g~ip~~-l~~l~~L~~L~ls~N~l~g~ip~~---~~~~~ 442 (948)
+++.+-.|++||||+|+|. |.+|.+ +.+|.+|..|||.+|.+...+|.+ .....
T Consensus 453 e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~h 532 (565)
T KOG0472|consen 453 EMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRH 532 (565)
T ss_pred hhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeE
Confidence 9999999999999999886 334444 889999999999999998877753 45668
Q ss_pred cccCCCCCC
Q 002238 443 VNTDGNPDI 451 (948)
Q Consensus 443 ~~~~gnp~~ 451 (948)
+.++|||+.
T Consensus 533 LeL~gNpfr 541 (565)
T KOG0472|consen 533 LELDGNPFR 541 (565)
T ss_pred EEecCCccC
Confidence 889999976
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=244.65 Aligned_cols=270 Identities=23% Similarity=0.352 Sum_probs=198.9
Q ss_pred HHHHHhhcCCcccceecccCceEEEEEEEc----CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEE
Q 002238 586 QVLRNVTNNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHC 660 (948)
Q Consensus 586 ~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~ 660 (948)
+....+.+.|...++||+|.|++||+|.+. ..+.||+|.+... .....+..|+++|..+ .+.||+++.+++
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~ 104 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCF 104 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhh
Confidence 445566788999999999999999999753 3678999998653 3346799999999999 699999999999
Q ss_pred EeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEc-CCCCeE
Q 002238 661 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAK 739 (948)
Q Consensus 661 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~-~~~~~k 739 (948)
...+.+.+|+||++.....++. ..++...+..+++.+..||+++|. .|||||||||+|+|.+ ..+.-.
T Consensus 105 rnnd~v~ivlp~~~H~~f~~l~--------~~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~ 173 (418)
T KOG1167|consen 105 RNNDQVAIVLPYFEHDRFRDLY--------RSLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGV 173 (418)
T ss_pred ccCCeeEEEecccCccCHHHHH--------hcCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCce
Confidence 9999999999999998888877 346678888999999999999996 8999999999999998 456789
Q ss_pred EeecCCceecCCC-------------------C--------------C----------ceeeeecccccccCceeccc-C
Q 002238 740 VADFGLVRLAPEG-------------------K--------------G----------SIETRIAGTFGYLAPEYAVT-G 775 (948)
Q Consensus 740 l~DfGla~~~~~~-------------------~--------------~----------~~~~~~~gt~~y~aPE~~~~-~ 775 (948)
|+|||+|...... . + ......+||+||.|||++.. .
T Consensus 174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~ 253 (418)
T KOG1167|consen 174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP 253 (418)
T ss_pred EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence 9999998711000 0 0 00123579999999999876 5
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCchh--hhhHHHH-----HHHhhcCccc--c----------------ccc--
Q 002238 776 RVTTKVDVFSFGVILMELITGRKALDESQPEE--SMHLVTW-----FRRIHLSKDS--F----------------HKA-- 828 (948)
Q Consensus 776 ~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~--~~~~~~~-----~~~~~~~~~~--~----------------~~~-- 828 (948)
..+.+.||||.||+++.+++++.||.....+- ....+.. +++.....+. + ...
T Consensus 254 ~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~ 333 (418)
T KOG1167|consen 254 RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHI 333 (418)
T ss_pred CcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccCh
Confidence 68999999999999999999999997544321 1111110 0111000111 0 000
Q ss_pred --cCc----ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 829 --IDP----TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 829 --~~~----~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+.+ ...........+..+.+++.+|+..||.+|-++++.+++
T Consensus 334 ~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 334 ESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred hhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 000 001111111123367899999999999999999998873
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=249.85 Aligned_cols=278 Identities=21% Similarity=0.290 Sum_probs=211.4
Q ss_pred cceeeHHHHHHhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCC------Cc
Q 002238 580 NMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH------RH 652 (948)
Q Consensus 580 ~~~~~~~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H------~n 652 (948)
.-++.++..+.+-.+|.+....|+|-|++|.+|... -|+.||||++.... .-.+.=.+|+++|++|+. -|
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhH
Confidence 345667777778889999999999999999999754 58899999998642 223445789999999953 47
Q ss_pred eeeEEeEEEeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE
Q 002238 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732 (948)
Q Consensus 653 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill 732 (948)
+++++..|....+.|||+|-+ .-+|.+.|..+... -.+....+..++.|+.-||..|.. ++|+|.||||+|||+
T Consensus 496 clrl~r~F~hknHLClVFE~L-slNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLV 569 (752)
T KOG0670|consen 496 CLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILV 569 (752)
T ss_pred HHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEe
Confidence 899999999999999999988 45999999876543 357778889999999999999995 899999999999999
Q ss_pred cCCC-CeEEeecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhH
Q 002238 733 GDDM-RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHL 811 (948)
Q Consensus 733 ~~~~-~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~ 811 (948)
++.. .+||||||.|....++. .+.+.-+..|.|||++.+..|+...|+||.||+||||.||+.-|.+........+
T Consensus 570 NE~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl 646 (752)
T KOG0670|consen 570 NESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL 646 (752)
T ss_pred ccCcceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence 8654 68999999988665543 2333456689999999999999999999999999999999999988766554433
Q ss_pred HHHHHH---------hhcCcccc----------------------ccccCcccC----------CccchHHHHHHHHHHH
Q 002238 812 VTWFRR---------IHLSKDSF----------------------HKAIDPTID----------LNEGILASISTVAELA 850 (948)
Q Consensus 812 ~~~~~~---------~~~~~~~~----------------------~~~~~~~~~----------~~~~~~~~~~~l~~li 850 (948)
...+.. -.+....| ...+.|.-+ ...........+.+|+
T Consensus 647 ~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLL 726 (752)
T KOG0670|consen 647 FMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLL 726 (752)
T ss_pred HHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHH
Confidence 221111 00000000 001111100 1222334456788999
Q ss_pred HHhcccCCCCCCChHHHHH
Q 002238 851 GHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 851 ~~c~~~~P~~RPt~~ev~~ 869 (948)
..|+..||++|-+..+++.
T Consensus 727 dkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 727 DKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHhccChhhcCCHHHHhc
Confidence 9999999999999988875
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-25 Score=240.35 Aligned_cols=272 Identities=22% Similarity=0.249 Sum_probs=204.7
Q ss_pred CCcccceecccCceEEEEEEEcCC--cEEEEEEeecCcCChhhHHHHHHHHHHHHhcCC----CceeeEEeEE-EeCCce
Q 002238 594 NFSEENILGRGGFGTVYKGELHDG--TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH----RHLVALLGHC-LDGNEK 666 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~-~~~~~~ 666 (948)
+|++.+.||+|+||.||.|...+. ..+|+|........ . ...+..|+.++..+.. +++..+++.. ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~-~-~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGS-K-PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccC-C-CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 899999999999999999986543 47899987653211 1 1268889999999863 6888888888 477788
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC-----CCeEEe
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-----MRAKVA 741 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~-----~~~kl~ 741 (948)
++||+.+ |.+|.++..... .+.++..++++|+.|++.+|++||+ .|++||||||.|+++... ..++|.
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred EEEEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEE
Confidence 9999988 889999774422 4689999999999999999999997 899999999999999855 359999
Q ss_pred ecCCce--ecCCCCCc----e---eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHH
Q 002238 742 DFGLVR--LAPEGKGS----I---ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLV 812 (948)
Q Consensus 742 DfGla~--~~~~~~~~----~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~ 812 (948)
|||+++ .+...... . .....||.+|++++++.+.+.+++.|+||+++++.|++.|..||............
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~ 249 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF 249 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence 999999 33222211 1 22356999999999999999999999999999999999999999765543221111
Q ss_pred HHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCCCCCCCccc
Q 002238 813 TWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDQNSEDI 888 (948)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~ 888 (948)
...... ..... .....+.++.++...+-..+..++|++..+...+.+.............||
T Consensus 250 ~~~~~~--------~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw 311 (322)
T KOG1164|consen 250 EKDPRK--------LLTDR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDW 311 (322)
T ss_pred HHHhhh--------hcccc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcc
Confidence 111110 00000 111123457777777777999999999999999988877654444444444
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-28 Score=262.67 Aligned_cols=311 Identities=21% Similarity=0.296 Sum_probs=178.8
Q ss_pred CEEEEEeCCCCCcC-CCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEcc
Q 002238 69 RITRIQIGHQNLQG-TLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (948)
Q Consensus 69 ~v~~l~l~~~~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 147 (948)
++..+.+..|+|.. -||+.+..|..|+.|||++|++...+..+...+++-+|+|++|+|..+|...|.+|+.|-.||||
T Consensus 79 ~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS 158 (1255)
T KOG0444|consen 79 RLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLS 158 (1255)
T ss_pred hhHHHhhhccccccCCCCchhcccccceeeecchhhhhhcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccc
Confidence 34444455555532 35555555666666666666665554455555556666666666666655555666666666666
Q ss_pred CCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEccccccc-ccCCCCccc-ccccceeccCCCC
Q 002238 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLI-GGLPASFSG-SQIQSLWVNGQNG 225 (948)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~-~~l~~l~~~~~~~ 225 (948)
+|++. .+|.....|..|++|.|++|.+...--..+. .+++|++|++++.+=+ ..+|.++.+ .+|..++++.
T Consensus 159 ~NrLe--~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLP--smtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~--- 231 (1255)
T KOG0444|consen 159 NNRLE--MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLP--SMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSE--- 231 (1255)
T ss_pred cchhh--hcCHHHHHHhhhhhhhcCCChhhHHHHhcCc--cchhhhhhhcccccchhhcCCCchhhhhhhhhccccc---
Confidence 66665 4555566666666666666655432222222 4555555666554322 234554433 3444444442
Q ss_pred CCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCccc--ccC
Q 002238 226 NAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ--GPV 303 (948)
Q Consensus 226 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~--g~~ 303 (948)
+.+...|+.+.++++|+.|+||+|+|+..--......+|+.|+|+.|+++ .+|++++.+++|+.|++.+|+|+ |.+
T Consensus 232 -N~Lp~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiP 309 (1255)
T KOG0444|consen 232 -NNLPIVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIP 309 (1255)
T ss_pred -cCCCcchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCc
Confidence 22344455555666666666666666543323333455666666666666 66666666666666666666653 333
Q ss_pred CCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCccc
Q 002238 304 PEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLT 383 (948)
Q Consensus 304 p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~ 383 (948)
..++.+..|......+|...-+| ...|..+.|+.|.|+.|.+.
T Consensus 310 SGIGKL~~Levf~aanN~LElVP-------------------------------------EglcRC~kL~kL~L~~NrLi 352 (1255)
T KOG0444|consen 310 SGIGKLIQLEVFHAANNKLELVP-------------------------------------EGLCRCVKLQKLKLDHNRLI 352 (1255)
T ss_pred cchhhhhhhHHHHhhccccccCc-------------------------------------hhhhhhHHHHHhccccccee
Confidence 34555555555555555433332 23567789999999999998
Q ss_pred ccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEcc
Q 002238 384 GTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVS 426 (948)
Q Consensus 384 g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls 426 (948)
.+|+.|--++.|+.|||..|.-.-..|.--..-++|+.-++.
T Consensus 353 -TLPeaIHlL~~l~vLDlreNpnLVMPPKP~da~~~lefYNID 394 (1255)
T KOG0444|consen 353 -TLPEAIHLLPDLKVLDLRENPNLVMPPKPNDARKKLEFYNID 394 (1255)
T ss_pred -echhhhhhcCCcceeeccCCcCccCCCCcchhhhcceeeecc
Confidence 799999999999999999996542333322222456554444
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-27 Score=244.93 Aligned_cols=316 Identities=22% Similarity=0.305 Sum_probs=213.0
Q ss_pred CEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccC
Q 002238 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148 (948)
Q Consensus 69 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 148 (948)
++.+||+..|-+. ++|+.++.+.+|..|+|..|+|... |+|.++..|++|++..|+|.-++.+...++++|..|||.+
T Consensus 184 ~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~l-Pef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRd 261 (565)
T KOG0472|consen 184 RLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFL-PEFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRD 261 (565)
T ss_pred HHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccC-CCCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccc
Confidence 4455555554444 7777777777777777777777743 4777777777777777777777777777788888888888
Q ss_pred CCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCccccc---ccceec-----
Q 002238 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQ---IQSLWV----- 220 (948)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~---l~~l~~----- 220 (948)
|+++ ++|..+.-+++|.+||+++|.|++ .|..++ ++ .|+.|-|.+|.+..+--..+..++ ++.|.=
T Consensus 262 Nklk--e~Pde~clLrsL~rLDlSNN~is~-Lp~sLg--nl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~d 335 (565)
T KOG0472|consen 262 NKLK--EVPDEICLLRSLERLDLSNNDISS-LPYSLG--NL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDD 335 (565)
T ss_pred cccc--cCchHHHHhhhhhhhcccCCcccc-CCcccc--cc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccC
Confidence 8887 678888888888888888888874 444555 66 777777888877532111111111 111100
Q ss_pred --cCCCCCCc-cCC----CccccccCCC--------------------------ccEEEccCCcccccCCCCCCCCCCc-
Q 002238 221 --NGQNGNAK-LGG----GIDVIQNMTS--------------------------LKEIWLHSNAFSGPLPDFSGVKQLE- 266 (948)
Q Consensus 221 --~~~~~~~~-~~~----~~~~l~~l~~--------------------------L~~L~Ls~N~l~~~~~~~~~l~~L~- 266 (948)
+.-.+... ... .......+.+ ...++++.|++...+..+..++.+.
T Consensus 336 glS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT 415 (565)
T KOG0472|consen 336 GLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVT 415 (565)
T ss_pred CCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHH
Confidence 00000000 000 0011112223 3455566666654444444444443
Q ss_pred EEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCc
Q 002238 267 SLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYP 346 (948)
Q Consensus 267 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 346 (948)
.+++++|.+. -+|..++.+++|..|+|++|.+...+-+++.+..|+.+++++|.....|.+|..
T Consensus 416 ~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~--------------- 479 (565)
T KOG0472|consen 416 DLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLNDLPEEMGSLVRLQTLNLSFNRFRMLPECLYE--------------- 479 (565)
T ss_pred HHHhhcCccc-cchHHHHhhhcceeeecccchhhhcchhhhhhhhhheecccccccccchHHHhh---------------
Confidence 3444555554 778888999999999999999998777899999999999998876666654432
Q ss_pred chhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEcc
Q 002238 347 QRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVS 426 (948)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls 426 (948)
+..++.+-.++|++...-|..+.+|.+|.+|||.+|.|. .||+.++++++|++|+++
T Consensus 480 ----------------------lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~ 536 (565)
T KOG0472|consen 480 ----------------------LQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELD 536 (565)
T ss_pred ----------------------HHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEec
Confidence 112344455678887666666999999999999999998 999999999999999999
Q ss_pred CCccc
Q 002238 427 NNQLY 431 (948)
Q Consensus 427 ~N~l~ 431 (948)
+|+|.
T Consensus 537 gNpfr 541 (565)
T KOG0472|consen 537 GNPFR 541 (565)
T ss_pred CCccC
Confidence 99998
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-25 Score=214.20 Aligned_cols=247 Identities=22% Similarity=0.424 Sum_probs=194.4
Q ss_pred cceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCCC
Q 002238 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGT 677 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 677 (948)
..+|.+...|+.|+|+|+ |..+++|++....++....++|..|.-.++-+.||||++++|+|....+..++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 456889999999999998 8889999988776666667889999999999999999999999999999999999999999
Q ss_pred hhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCee-ecCCCCccEEEcCCCCeEEe--ecCCceecCCCCC
Q 002238 678 LSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFI-HRDLKPSNILLGDDMRAKVA--DFGLVRLAPEGKG 754 (948)
Q Consensus 678 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv-HrDik~~Nill~~~~~~kl~--DfGla~~~~~~~~ 754 (948)
|...++. ...-..+-.++.++|.++|+|++|||+. .+++ ---+.+..|++|++.+++|. |--++..
T Consensus 274 lynvlhe---~t~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarismad~kfsfq------ 342 (448)
T KOG0195|consen 274 LYNVLHE---QTSVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------ 342 (448)
T ss_pred HHHHHhc---CccEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheecccceeeee------
Confidence 9999975 3334678889999999999999999986 3444 44688999999999887774 3222111
Q ss_pred ceeeeecccccccCceecccCCC---CchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 755 SIETRIAGTFGYLAPEYAVTGRV---TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 755 ~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
.....-.|.||+||.+...+- -+++|+|||++++||+.|+..||.+..+.+..-.+. -+.+..-+.|
T Consensus 343 --e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia--------leglrv~ipp 412 (448)
T KOG0195|consen 343 --EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA--------LEGLRVHIPP 412 (448)
T ss_pred --ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh--------hccccccCCC
Confidence 111223688999999987653 358999999999999999999999887765422221 1112222222
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhh
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~ 875 (948)
.+ ...+.+++.-|+..||.+||.+..|+-.|++.+
T Consensus 413 gi---------s~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 413 GI---------SRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred Cc---------cHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 22 234788999999999999999999999988763
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=267.04 Aligned_cols=196 Identities=20% Similarity=0.254 Sum_probs=138.6
Q ss_pred hcCC-CceeeEEeEE-------EeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCC
Q 002238 647 KVRH-RHLVALLGHC-------LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718 (948)
Q Consensus 647 ~l~H-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 718 (948)
.++| +||+++++++ ...+..+.++||+ +++|.+++.. ....+++.+++.++.||++||+|||+ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~---~ 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN----PDRSVDAFECFHVFRQIVEIVNAAHS---Q 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc----ccccccHHHHHHHHHHHHHHHHHHHh---C
Confidence 3455 5777777776 2334567889987 6699999842 23568999999999999999999997 8
Q ss_pred CeeecCCCCccEEEcC-------------------CCCeEEeecCCceecCCCC---------------Cceeeeecccc
Q 002238 719 SFIHRDLKPSNILLGD-------------------DMRAKVADFGLVRLAPEGK---------------GSIETRIAGTF 764 (948)
Q Consensus 719 ~ivHrDik~~Nill~~-------------------~~~~kl~DfGla~~~~~~~---------------~~~~~~~~gt~ 764 (948)
+|+||||||+|||++. ++.+|++|||+++...... ........||+
T Consensus 100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 9999999999999954 4456666777665321100 00011245899
Q ss_pred cccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHH
Q 002238 765 GYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASIS 844 (948)
Q Consensus 765 ~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (948)
.|||||++.+..++.++|||||||+||||++|.+|+..... ........ ..++.. .....
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~~~---------~~~~~~------~~~~~ 239 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLRHR---------VLPPQI------LLNWP 239 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHHHh---------hcChhh------hhcCH
Confidence 99999999999999999999999999999999887653211 11101000 011110 01122
Q ss_pred HHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 845 TVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 845 ~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
...+++.+|++.+|.+||+|.|++++
T Consensus 240 ~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 240 KEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHHHhCCCChhhCcChHHHhhc
Confidence 35678899999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=207.11 Aligned_cols=169 Identities=22% Similarity=0.260 Sum_probs=126.6
Q ss_pred CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc
Q 002238 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (948)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 755 (948)
|+|.+++.. ....++|.+++.|+.|+++||+|||+ .+ ||+||+++.++.+++ ||+++......
T Consensus 1 GsL~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEV----RGRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc--
Confidence 688888843 23579999999999999999999997 34 999999999999999 99988654422
Q ss_pred eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCC
Q 002238 756 IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDL 835 (948)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (948)
..||+.|||||++.+..++.++|||||||++|||++|+.||........ ....+...... .++..
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~--------~~~~~-- 128 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGMPA--------DDPRD-- 128 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHhcc--------CCccc--
Confidence 2589999999999999999999999999999999999999975432211 11111111100 00000
Q ss_pred ccchHHHH--HHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 836 NEGILASI--STVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 836 ~~~~~~~~--~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
........ .++.+++.+|++.+|.+||++.++++++.....
T Consensus 129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 00011111 258999999999999999999999999877643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-23 Score=224.12 Aligned_cols=170 Identities=25% Similarity=0.232 Sum_probs=131.6
Q ss_pred HHhhcCCcccceecccCceEEEEEEEc--CCcEEEEEEeecCcC---ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC
Q 002238 589 RNVTNNFSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVI---SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG 663 (948)
Q Consensus 589 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~g~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 663 (948)
+.+.++|...+.||+|+||+||+|.++ +++.||||++..... .....+.|.+|++++++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 345678999999999999999999764 577889998753311 22335679999999999999999853322 2
Q ss_pred CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCC-CCccEEEcCCCCeEEee
Q 002238 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDL-KPSNILLGDDMRAKVAD 742 (948)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDi-k~~Nill~~~~~~kl~D 742 (948)
+..++||||++|++|.... .. . ...++.+++++|+|||+ .||+|||| ||+|||++.++.++|+|
T Consensus 91 ~~~~LVmE~~~G~~L~~~~----~~--~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR----PH--G------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred CCcEEEEEccCCCCHHHhC----cc--c------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEE
Confidence 4679999999999996211 00 1 13578899999999997 89999999 99999999999999999
Q ss_pred cCCceecCCCCCce-------eeeecccccccCceecccCC
Q 002238 743 FGLVRLAPEGKGSI-------ETRIAGTFGYLAPEYAVTGR 776 (948)
Q Consensus 743 fGla~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~ 776 (948)
||+|+......... -+...+++.|+|||++...+
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 99999665432111 13567899999999986543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=239.10 Aligned_cols=262 Identities=24% Similarity=0.311 Sum_probs=184.7
Q ss_pred CEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccC
Q 002238 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148 (948)
Q Consensus 69 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 148 (948)
.-..|+|+.++|+ .+|+.+. .+|+.|+|++|+|+.++ .+ +++|++|+|++|+|+.+++ ..++|+.|+|++
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~LP-~l--p~~Lk~LdLs~N~LtsLP~----lp~sL~~L~Ls~ 271 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLP-AL--PPELRTLEVSGNQLTSLPV----LPPGLLELSIFS 271 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCCC-CC--CCCCcEEEecCCccCcccC----cccccceeeccC
Confidence 3457899999999 7888776 48999999999999754 32 5789999999999998864 257899999999
Q ss_pred CCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCc
Q 002238 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAK 228 (948)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~ 228 (948)
|+++ .+|.. ..+|+.|++++|+|+. +|. .+++|+.|+|++|+|++ +|... ..+..|++.++...
T Consensus 272 N~L~--~Lp~l---p~~L~~L~Ls~N~Lt~-LP~-----~p~~L~~LdLS~N~L~~-Lp~lp--~~L~~L~Ls~N~L~-- 335 (788)
T PRK15387 272 NPLT--HLPAL---PSGLCKLWIFGNQLTS-LPV-----LPPGLQELSVSDNQLAS-LPALP--SELCKLWAYNNQLT-- 335 (788)
T ss_pred Cchh--hhhhc---hhhcCEEECcCCcccc-ccc-----cccccceeECCCCcccc-CCCCc--ccccccccccCccc--
Confidence 9998 56653 3678899999999984 444 34789999999999985 45422 23444443332211
Q ss_pred cCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCC
Q 002238 229 LGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDR 308 (948)
Q Consensus 229 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~ 308 (948)
..+. -..+|+.|+|++|+|++.++ + ..+|+.|++++|+|+ .+|.. .++|+.|+|++|+|++ +|.
T Consensus 336 --~LP~---lp~~Lq~LdLS~N~Ls~LP~-l--p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt~-LP~--- 399 (788)
T PRK15387 336 --SLPT---LPSGLQELSVSDNQLASLPT-L--PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LPV--- 399 (788)
T ss_pred --cccc---cccccceEecCCCccCCCCC-C--Ccccceehhhccccc-cCccc---ccccceEEecCCcccC-CCC---
Confidence 1111 01345566666666654222 1 234555566666665 34432 2345566666666553 221
Q ss_pred ccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCc
Q 002238 309 SVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISP 388 (948)
Q Consensus 309 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~ 388 (948)
..++|+.|++++|+|++ +|.
T Consensus 400 -----------------------------------------------------------l~s~L~~LdLS~N~Lss-IP~ 419 (788)
T PRK15387 400 -----------------------------------------------------------LPSELKELMVSGNRLTS-LPM 419 (788)
T ss_pred -----------------------------------------------------------cccCCCEEEccCCcCCC-CCc
Confidence 01268889999999985 675
Q ss_pred cccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCCC
Q 002238 389 EFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 436 (948)
Q Consensus 389 ~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~ 436 (948)
.+ .+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+|.+|+
T Consensus 420 l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 420 LP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred ch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 43 46889999999998 8999999999999999999999998875
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=229.24 Aligned_cols=229 Identities=17% Similarity=0.263 Sum_probs=154.2
Q ss_pred hcCCCChHHHHHHHHHHHhcCCCCCC-----CCCC-CCCCCccc----------------eEEeCCCCEEEEEeCCCCCc
Q 002238 24 VSASGDDGDAAVMLALKKSLNPPESL-----GWSD-TDPCKWNH----------------VVCIEDKRITRIQIGHQNLQ 81 (948)
Q Consensus 24 ~~~~~~~~d~~~l~~~k~~~~~~~~~-----~w~~-~~~C~w~g----------------v~c~~~~~v~~l~l~~~~l~ 81 (948)
..+...+.|.+.++.+.+.+..|... .|.+ ++.|--.. |.|. .+.|+.+.+-+....
T Consensus 56 ~~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~-~~~vt~l~~~g~~~~ 134 (754)
T PRK15370 56 PPETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGG-GKSVTYTRVTESEQA 134 (754)
T ss_pred CCCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecC-CCccccccccccccc
Confidence 35667889999999999999877654 4854 57884332 5663 345555554332111
Q ss_pred C--------------------C-CC-------cc-----ccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEccccccc
Q 002238 82 G--------------------T-LP-------SN-----LQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFT 128 (948)
Q Consensus 82 ~--------------------~-~p-------~~-----l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~ 128 (948)
. . .+ .+ -+-..+.+.|+|++++++..+..+. +.|+.|+|++|.|+
T Consensus 135 ~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~LtsLP~~Ip--~~L~~L~Ls~N~Lt 212 (754)
T PRK15370 135 SSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTTIPACIP--EQITTLILDNNELK 212 (754)
T ss_pred ccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCcCCcccc--cCCcEEEecCCCCC
Confidence 0 0 00 00 1122457889999999887554453 57899999999999
Q ss_pred CCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCC
Q 002238 129 SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPA 208 (948)
Q Consensus 129 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 208 (948)
.++...+ ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|+++ .+|..+. .+|+.|+|++|+|+ .+|.
T Consensus 213 sLP~~l~---~nL~~L~Ls~N~Lt--sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~----s~L~~L~Ls~N~L~-~LP~ 279 (754)
T PRK15370 213 SLPENLQ---GNIKTLYANSNQLT--SIPATLP--DTIQEMELSINRIT-ELPERLP----SALQSLDLFHNKIS-CLPE 279 (754)
T ss_pred cCChhhc---cCCCEEECCCCccc--cCChhhh--ccccEEECcCCccC-cCChhHh----CCCCEEECcCCccC-cccc
Confidence 8876543 58999999999998 5676554 47999999999988 5666553 57999999999988 5676
Q ss_pred CcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCC
Q 002238 209 SFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLES 288 (948)
Q Consensus 209 ~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 288 (948)
.+. ++|+.|+|++|+|+..++.+. .+|+.|+|++|+++ .+|..+. ++
T Consensus 280 ~l~----------------------------~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~s 326 (754)
T PRK15370 280 NLP----------------------------EELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNSLT-ALPETLP--PG 326 (754)
T ss_pred ccC----------------------------CCCcEEECCCCccccCcccch--hhHHHHHhcCCccc-cCCcccc--cc
Confidence 542 367777777777775433332 45677777777777 4554432 56
Q ss_pred CcEEEcccCcccc
Q 002238 289 LKIVNMTNNLLQG 301 (948)
Q Consensus 289 L~~L~Ls~N~l~g 301 (948)
|+.|++++|.+++
T Consensus 327 L~~L~Ls~N~Lt~ 339 (754)
T PRK15370 327 LKTLEAGENALTS 339 (754)
T ss_pred ceeccccCCcccc
Confidence 7777777777764
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-23 Score=233.50 Aligned_cols=373 Identities=20% Similarity=0.259 Sum_probs=228.9
Q ss_pred CEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccC
Q 002238 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148 (948)
Q Consensus 69 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 148 (948)
+++.|+|++|.+. ..|..+..+.+|+.|+++.|.|...+-+..++.+|++|+|.+|++...|.+ +..+++|+.|+++.
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~vp~s~~~~~~l~~lnL~~n~l~~lP~~-~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSVPSSCSNMRNLQYLNLKNNRLQSLPAS-ISELKNLQYLDLSF 123 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhCchhhhhhhcchhheeccchhhcCchh-HHhhhcccccccch
Confidence 4788899888877 888888889999999999999987766788899999999999998877654 88999999999999
Q ss_pred CCCCCCCCCccccCCCCCCEEEcc-------------------CccccccCCCCCCCCCCCCCcEEEcccccccccCCCC
Q 002238 149 NPFSSWEIPQSLRNASGLQNFSAN-------------------SANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS 209 (948)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~-------------------~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 209 (948)
|++. .+|.-+..++.+..+.++ .|.+.+.++.... .+.. .|+|.+|++....-..
T Consensus 124 N~f~--~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~--~l~~--~ldLr~N~~~~~dls~ 197 (1081)
T KOG0618|consen 124 NHFG--PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIY--NLTH--QLDLRYNEMEVLDLSN 197 (1081)
T ss_pred hccC--CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchh--hhhe--eeecccchhhhhhhhh
Confidence 9988 566555554444444444 4444444444332 2222 3667777665221111
Q ss_pred ccc--------ccccceeccCCCCCCccCCCc-----cccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccc
Q 002238 210 FSG--------SQIQSLWVNGQNGNAKLGGGI-----DVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFT 276 (948)
Q Consensus 210 ~~~--------~~l~~l~~~~~~~~~~~~~~~-----~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~ 276 (948)
+.. .++.++.+.+.+.+......- ..-.--.+|+++++++|++++.+.-+..+.+|+.|...+|+|+
T Consensus 198 ~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~~lp~wi~~~~nle~l~~n~N~l~ 277 (1081)
T KOG0618|consen 198 LANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLSNLPEWIGACANLEALNANHNRLV 277 (1081)
T ss_pred ccchhhhhhhhcccceEEecCcchheeeeccCcceeeccccccccceeeecchhhhhcchHHHHhcccceEecccchhHH
Confidence 110 111222221111111100000 0000123466666666666655533445666666666666665
Q ss_pred cccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhh-hHHHHHhhC----Cc---ch
Q 002238 277 GPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNA-LLSVVKLMG----YP---QR 348 (948)
Q Consensus 277 ~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~----~~---~~ 348 (948)
.+|..+...++|+.|.+.+|.+.-.+|.......|..+++..|.+...|...+..... +..+..... ++ +.
T Consensus 278 -~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~ 356 (1081)
T KOG0618|consen 278 -ALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEEN 356 (1081)
T ss_pred -hhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccch
Confidence 5666666666666666666666655555666777777777777776666533222211 111111100 00 00
Q ss_pred h-----ccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCc-----------
Q 002238 349 F-----AENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE----------- 412 (948)
Q Consensus 349 ~-----~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~----------- 412 (948)
. .....+|...+.-+..+....+|+.|+|++|++.......+.+++.|+.|+||+|+|+ .+|.
T Consensus 357 ~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL 435 (1081)
T KOG0618|consen 357 NHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTL 435 (1081)
T ss_pred hhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHH
Confidence 0 0011122222233345667789999999999998555555788999999999999998 4443
Q ss_pred -----------CCcCCCCCcEEEccCCcccC-CCCC---CCcccccccCCCCCC
Q 002238 413 -----------GLSVLGALKELDVSNNQLYG-KIPS---FKSNAIVNTDGNPDI 451 (948)
Q Consensus 413 -----------~l~~l~~L~~L~ls~N~l~g-~ip~---~~~~~~~~~~gnp~~ 451 (948)
++..++.|+.+|||.|+|+. .+|. ++....+++.||++.
T Consensus 436 ~ahsN~l~~fPe~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 436 RAHSNQLLSFPELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred hhcCCceeechhhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 56678889999999999985 3332 356788999999974
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-23 Score=214.35 Aligned_cols=259 Identities=25% Similarity=0.371 Sum_probs=204.9
Q ss_pred CCCCCccc-----eEEeCC----------CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCC
Q 002238 54 TDPCKWNH-----VVCIED----------KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASL 117 (948)
Q Consensus 54 ~~~C~w~g-----v~c~~~----------~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L 117 (948)
+.||+..+ |.|+.. ...++|.|..|+|+...|.+|..+.+|++|||++|+|+.+-| +|.+|.+|
T Consensus 38 P~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l 117 (498)
T KOG4237|consen 38 PAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASL 117 (498)
T ss_pred CCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhh
Confidence 55665544 778643 478999999999997777899999999999999999999888 89999999
Q ss_pred cEEEccc-ccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEE
Q 002238 118 EVVMLSN-NQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILH 196 (948)
Q Consensus 118 ~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~ 196 (948)
..|-|.+ |+|+.++.++|++|..|+.|.+.-|++.. .....|..+++|..|.+.+|.+...-...|. .+..++.++
T Consensus 118 ~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~C-ir~~al~dL~~l~lLslyDn~~q~i~~~tf~--~l~~i~tlh 194 (498)
T KOG4237|consen 118 LSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINC-IRQDALRDLPSLSLLSLYDNKIQSICKGTFQ--GLAAIKTLH 194 (498)
T ss_pred hHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcc-hhHHHHHHhhhcchhcccchhhhhhcccccc--chhccchHh
Confidence 8888777 99999999999999999999999999996 5578899999999999999999866555775 889999999
Q ss_pred ccccccc------------ccCCCCccccc-----------------------ccceeccCCCCC--CccCCCccccccC
Q 002238 197 LAFNQLI------------GGLPASFSGSQ-----------------------IQSLWVNGQNGN--AKLGGGIDVIQNM 239 (948)
Q Consensus 197 Ls~N~l~------------~~~p~~~~~~~-----------------------l~~l~~~~~~~~--~~~~~~~~~l~~l 239 (948)
+..|.+. ...|..+++-+ ++++. ...... .........|..+
T Consensus 195 lA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~-s~~~~~d~~d~~cP~~cf~~L 273 (498)
T KOG4237|consen 195 LAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLP-SRLSSEDFPDSICPAKCFKKL 273 (498)
T ss_pred hhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHH-HhhccccCcCCcChHHHHhhc
Confidence 9999832 22233332200 00110 000111 1122233568999
Q ss_pred CCccEEEccCCcccccCC-CCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCC-CCCcccccccc
Q 002238 240 TSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAK 316 (948)
Q Consensus 240 ~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~l~~~~ 316 (948)
++|+.|+|++|++++.-+ .|.++..++.|.|..|+|...--..|.++..|+.|+|.+|+|+..-|. |..+.+|..+.
T Consensus 274 ~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~ 352 (498)
T KOG4237|consen 274 PNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLN 352 (498)
T ss_pred ccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeee
Confidence 999999999999998766 589999999999999999977788899999999999999999987775 44555555444
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-20 Score=205.04 Aligned_cols=262 Identities=27% Similarity=0.455 Sum_probs=199.0
Q ss_pred CcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChh-hHHHHHHHHHHHHhcCCC-ceeeEEeEEEeCCceEEEEEe
Q 002238 595 FSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK-GLTEFKSEIAVLTKVRHR-HLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lv~e~ 672 (948)
|...+.||.|+||.||++... ..+|+|.+........ ....+.+|+.+++.+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667788999999999999876 8899999987644432 567899999999999988 799999999777778999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC-CeEEeecCCceecCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVRLAPE 751 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~-~~kl~DfGla~~~~~ 751 (948)
+.++++.+++...... ..+.......++.|++.+++|+|+ .+++|||+||+||+++..+ .++++|||.++....
T Consensus 80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999999665321100 268888999999999999999997 7899999999999999988 799999999985544
Q ss_pred CCCc-----eeeeecccccccCceeccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-hhhhHHHHHHHhhcCc
Q 002238 752 GKGS-----IETRIAGTFGYLAPEYAVT---GRVTTKVDVFSFGVILMELITGRKALDESQPE-ESMHLVTWFRRIHLSK 822 (948)
Q Consensus 752 ~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~ 822 (948)
.... ......||..|+|||.+.+ ..++...|+||+|++++++++|..||...... ........+......
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP- 233 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-
Confidence 3321 2356779999999999987 57889999999999999999999997665431 011111111111100
Q ss_pred cccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 823 DSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
........... ......+.+++..|+..+|..|.++.+....
T Consensus 234 -~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNP-----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCcccc-----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000000 1223457799999999999999999887775
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-21 Score=228.62 Aligned_cols=255 Identities=22% Similarity=0.273 Sum_probs=187.8
Q ss_pred cccceecccCceEEEEEEEc-CCcEEEEEEeec---CcCChhh-HHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 596 SEENILGRGGFGTVYKGELH-DGTKIAVKRMEA---GVISGKG-LTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 596 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~---~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
....++|.|++|.|+.+... ..+.++.|.+.. ....... ...+..|+.+-..+.|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34678999999988877533 344455554331 1111211 122677888889999999998887777766666669
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++ +|..++.. ...+.-.++..++.|+..|++|+|+ .||.|||+|++|+++..+|.+||+|||.+..+.
T Consensus 401 E~~~~-Dlf~~~~~-----~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS-----NGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hcccH-HHHHHHhc-----ccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeec
Confidence 99999 99988843 1467777888999999999999997 899999999999999999999999999988554
Q ss_pred CCCC---ceeeeecccccccCceecccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 751 EGKG---SIETRIAGTFGYLAPEYAVTGRVTT-KVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 751 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
.+.. .....++|+..|+|||++.+.+|.+ ..||||.|++++.|.+|+.||......+.... .....
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~----------~~~~~ 541 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK----------TNNYS 541 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh----------hhccc
Confidence 3332 4456688999999999999999975 69999999999999999999986554433210 00000
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..+........-....+.+...++.++++.+|.+|-|+++|++
T Consensus 542 ~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 542 DQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000001111222344566789999999999999999999977
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-19 Score=230.91 Aligned_cols=294 Identities=19% Similarity=0.169 Sum_probs=138.9
Q ss_pred CCCccccCC-CCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCcccc
Q 002238 83 TLPSNLQNL-TKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLR 161 (948)
Q Consensus 83 ~~p~~l~~l-~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~ 161 (948)
.+|..|..+ .+|+.|++.+|.+...+..| ...+|++|+|.+|++..++. .+..+++|+.|+|++|.... .+| .+.
T Consensus 579 ~lp~~~~~lp~~Lr~L~~~~~~l~~lP~~f-~~~~L~~L~L~~s~l~~L~~-~~~~l~~Lk~L~Ls~~~~l~-~ip-~ls 654 (1153)
T PLN03210 579 HLPEGFDYLPPKLRLLRWDKYPLRCMPSNF-RPENLVKLQMQGSKLEKLWD-GVHSLTGLRNIDLRGSKNLK-EIP-DLS 654 (1153)
T ss_pred ecCcchhhcCcccEEEEecCCCCCCCCCcC-CccCCcEEECcCcccccccc-ccccCCCCCEEECCCCCCcC-cCC-ccc
Confidence 344444433 23555555554444333233 33445555555554444322 23444555555554443221 333 244
Q ss_pred CCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCC
Q 002238 162 NASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTS 241 (948)
Q Consensus 162 ~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~ 241 (948)
.+++|+.|+|++|.....+|..++ .+++|+.|+|++|...+.+|..+....|+.|.+.++. .+...+. ..++
T Consensus 655 ~l~~Le~L~L~~c~~L~~lp~si~--~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~---~L~~~p~---~~~n 726 (1153)
T PLN03210 655 MATNLETLKLSDCSSLVELPSSIQ--YLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCS---RLKSFPD---ISTN 726 (1153)
T ss_pred cCCcccEEEecCCCCccccchhhh--ccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCC---Ccccccc---ccCC
Confidence 444555555554444444444443 4445555555544333344443322233333333221 1111111 1234
Q ss_pred ccEEEccCCcccccCCC------------------------------CCCCCCCcEEeccCCccccccchhhhCCCCCcE
Q 002238 242 LKEIWLHSNAFSGPLPD------------------------------FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 291 (948)
Q Consensus 242 L~~L~Ls~N~l~~~~~~------------------------------~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 291 (948)
|++|+|++|.+...+.. +...++|+.|+|++|...+.+|..++++++|+.
T Consensus 727 L~~L~L~~n~i~~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~ 806 (1153)
T PLN03210 727 ISWLDLDETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEH 806 (1153)
T ss_pred cCeeecCCCccccccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCE
Confidence 44444444444322111 112346777777777666667777777777777
Q ss_pred EEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCc
Q 002238 292 VNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGN 371 (948)
Q Consensus 292 L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (948)
|+|++|..-+.+|....+.+|..+++.++..... ......+
T Consensus 807 L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~---------------------------------------~p~~~~n 847 (1153)
T PLN03210 807 LEIENCINLETLPTGINLESLESLDLSGCSRLRT---------------------------------------FPDISTN 847 (1153)
T ss_pred EECCCCCCcCeeCCCCCccccCEEECCCCCcccc---------------------------------------ccccccc
Confidence 7777765444555433334443333332210000 0001135
Q ss_pred eEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCC
Q 002238 372 ITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNN 428 (948)
Q Consensus 372 L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N 428 (948)
|+.|+|++|.++ .+|.++.++++|+.|+|++|+--..+|..+..+++|+.|++++|
T Consensus 848 L~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 848 ISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred cCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCC
Confidence 666666666665 45666666666666666664333346666666666666666665
|
syringae 6; Provisional |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=188.69 Aligned_cols=141 Identities=18% Similarity=0.201 Sum_probs=108.4
Q ss_pred cceecccCceEEEEEEEcCCcEEEEEEeecCcCChhh------------------------HHHHHHHHHHHHhcCCCce
Q 002238 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKG------------------------LTEFKSEIAVLTKVRHRHL 653 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~H~ni 653 (948)
...||+|+||.||+|...+|+.||||+++........ ......|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999999765321111 1122459999999987776
Q ss_pred eeEEeEEEeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhccCCCeeecCCCCccEEE
Q 002238 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL-HGLAHQSFIHRDLKPSNILL 732 (948)
Q Consensus 654 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivHrDik~~Nill 732 (948)
.....+. ....++||||++++++..... . ...+++.++.+++.|++.+|+|+ |+ .+|+||||||+||++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~--~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---K--DAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhh---h--cCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEE
Confidence 4332222 223489999999887754431 1 24688999999999999999999 55 799999999999999
Q ss_pred cCCCCeEEeecCCceec
Q 002238 733 GDDMRAKVADFGLVRLA 749 (948)
Q Consensus 733 ~~~~~~kl~DfGla~~~ 749 (948)
+ ++.++|+|||+|...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-20 Score=221.24 Aligned_cols=247 Identities=24% Similarity=0.306 Sum_probs=191.8
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEcc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 147 (948)
.+++.|++.+|+|+ .+|.. +++|++|+|++|+|+.+++ + .++|+.|+|++|.|+.++. ..++|+.|+|+
T Consensus 222 ~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~LtsLP~-l--p~sL~~L~Ls~N~L~~Lp~----lp~~L~~L~Ls 290 (788)
T PRK15387 222 AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTSLPV-L--PPGLLELSIFSNPLTHLPA----LPSGLCKLWIF 290 (788)
T ss_pred cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCcccC-c--ccccceeeccCCchhhhhh----chhhcCEEECc
Confidence 37899999999999 46642 5789999999999997643 2 4689999999999998764 23678899999
Q ss_pred CCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCC
Q 002238 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNA 227 (948)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~ 227 (948)
+|+++ .+|.. +++|+.|+|++|+|++. |.. ..+|..|++++|+|++ +|... ..|+.|++.++....
T Consensus 291 ~N~Lt--~LP~~---p~~L~~LdLS~N~L~~L-p~l-----p~~L~~L~Ls~N~L~~-LP~lp--~~Lq~LdLS~N~Ls~ 356 (788)
T PRK15387 291 GNQLT--SLPVL---PPGLQELSVSDNQLASL-PAL-----PSELCKLWAYNNQLTS-LPTLP--SGLQELSVSDNQLAS 356 (788)
T ss_pred CCccc--ccccc---ccccceeECCCCccccC-CCC-----cccccccccccCcccc-ccccc--cccceEecCCCccCC
Confidence 99998 56653 47899999999999864 442 2468889999999984 66422 467777776544332
Q ss_pred ccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCC
Q 002238 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFD 307 (948)
Q Consensus 228 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~ 307 (948)
.+.. ..+|+.|++++|+++. +|.+ ..+|+.|+|++|+|+ .+|.. .++|+.|++++|+|++ +|.+
T Consensus 357 ----LP~l---p~~L~~L~Ls~N~L~~-LP~l--~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Lss-IP~l- 420 (788)
T PRK15387 357 ----LPTL---PSELYKLWAYNNRLTS-LPAL--PSGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLTS-LPML- 420 (788)
T ss_pred ----CCCC---Ccccceehhhcccccc-Cccc--ccccceEEecCCccc-CCCCc---ccCCCEEEccCCcCCC-CCcc-
Confidence 2221 3578899999999996 4443 367999999999999 57754 3689999999999985 4431
Q ss_pred CccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCC
Q 002238 308 RSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTIS 387 (948)
Q Consensus 308 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip 387 (948)
..+|+.|+|++|+|+ .+|
T Consensus 421 -------------------------------------------------------------~~~L~~L~Ls~NqLt-~LP 438 (788)
T PRK15387 421 -------------------------------------------------------------PSGLLSLSVYRNQLT-RLP 438 (788)
T ss_pred -------------------------------------------------------------hhhhhhhhhccCccc-ccC
Confidence 014667899999998 789
Q ss_pred ccccCccccceEeCccccccccCCcCCcCC
Q 002238 388 PEFASFKSLQRLILADNNLSGMIPEGLSVL 417 (948)
Q Consensus 388 ~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l 417 (948)
..|+++++|+.|+|++|+|+|.+|..+..+
T Consensus 439 ~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 439 ESLIHLSSETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred hHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence 999999999999999999999988777444
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-20 Score=189.86 Aligned_cols=174 Identities=16% Similarity=0.183 Sum_probs=134.9
Q ss_pred HhhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhh-HHH------HHHHHHHHHhcCCCceeeEEeEEEe
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKG-LTE------FKSEIAVLTKVRHRHLVALLGHCLD 662 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~-~~~------~~~E~~~l~~l~H~niv~l~~~~~~ 662 (948)
.+.++|+..+++|.|+||.||.+.. ++..+|||++......... .+. +.+|+..+.+++||+|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3578999999999999999999766 5778999999765332221 122 6899999999999999999887653
Q ss_pred C--------CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC
Q 002238 663 G--------NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 734 (948)
Q Consensus 663 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~ 734 (948)
. ...++||||++|.+|.++. .++. ....+++.++..+|+ .|++|||+||+||+++.
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~---------~~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP---------EISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSK 170 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh---------hccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeC
Confidence 3 3578999999999997763 1221 245699999999997 89999999999999999
Q ss_pred CCCeEEeecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHH
Q 002238 735 DMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELI 794 (948)
Q Consensus 735 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ell 794 (948)
++ ++++|||..+......... .+.....+..++|+|+|||.+..+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence 88 9999999877553322110 0334455667999999999887664
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.7e-21 Score=220.35 Aligned_cols=248 Identities=22% Similarity=0.242 Sum_probs=178.9
Q ss_pred CCcccceecccCceEEEEEEEcCCcEEEEEEeecCc--CChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 594 NFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGV--ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.|...+.||.+.|=+|.+|+++.|. |+||++-+.. .+-....+..+|++ ...++|||.+++..+-...+..|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5666788999999999999988777 9999986643 12222333344444 556699999999888777777889999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce--ec
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR--LA 749 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~--~~ 749 (948)
|+.+ +|.|.+- .+.-+...+..-|+.|++.||..+|. .||+|||||.+|||++.-.-+.|+||..-+ ..
T Consensus 102 yvkh-nLyDRlS-----TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 102 YVKH-NLYDRLS-----TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHhh-hhhhhhc-----cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccC
Confidence 9855 8888872 23456777788899999999999996 899999999999999999999999998655 33
Q ss_pred CCCCCceeeeeccc----ccccCceecccC-----------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHH
Q 002238 750 PEGKGSIETRIAGT----FGYLAPEYAVTG-----------RVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVT 813 (948)
Q Consensus 750 ~~~~~~~~~~~~gt----~~y~aPE~~~~~-----------~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~ 813 (948)
+++.....+.+..| ..|+|||.+... ..+++.||||+||+++||++ |+++|.... +..
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~a 246 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLA 246 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHh
Confidence 33333322222233 469999987441 16789999999999999999 677775321 221
Q ss_pred HHHHhhcC-ccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 814 WFRRIHLS-KDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 814 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
+.+.-... +.-+.++-|. .+.+++..|++.||++|-++++.++.-
T Consensus 247 Yr~~~~~~~e~~Le~Ied~-------------~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKIEDV-------------SLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred HhccCccCHHHHHHhCcCc-------------cHHHHHHHHHccCchhccCHHHHHHhh
Confidence 11110000 0011111122 377999999999999999999999873
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-19 Score=180.53 Aligned_cols=144 Identities=20% Similarity=0.238 Sum_probs=111.4
Q ss_pred cceecccCceEEEEEEEcCCcEEEEEEeecCcCChhh------------------------HHHHHHHHHHHHhcCCCce
Q 002238 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKG------------------------LTEFKSEIAVLTKVRHRHL 653 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~H~ni 653 (948)
...||+|+||.||+|...+|+.||||+++........ ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999878999999998765211000 1224689999999999987
Q ss_pred eeEEeEEEeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEc
Q 002238 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 733 (948)
Q Consensus 654 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~ 733 (948)
.....+... ..++||||++++++...... . ..++..++.+++.|++.++.++|+ ..||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~--~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---D--VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh---h--ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE
Confidence 544333322 34899999998865433211 1 356778889999999999999996 37999999999999999
Q ss_pred CCCCeEEeecCCceecCC
Q 002238 734 DDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 734 ~~~~~kl~DfGla~~~~~ 751 (948)
++.++|+|||+++....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 88999999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.7e-19 Score=185.57 Aligned_cols=235 Identities=26% Similarity=0.347 Sum_probs=153.6
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCC-----------CceeeEEeEEE
Q 002238 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRH-----------RHLVALLGHCL 661 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H-----------~niv~l~~~~~ 661 (948)
+...+.||.|+++.||.+++. +|+++|||++..... .....+++++|.-....+.+ ..++++ +...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~-d~~~ 92 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL-DLLR 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S-EEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee-EEEE
Confidence 445788999999999999875 689999999865432 34457788888776666533 122221 1111
Q ss_pred ---------eC---C-----ceEEEEEecCCCChhHHHHhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhccCCCeee
Q 002238 662 ---------DG---N-----EKLLVFEYMPQGTLSRHIFNWAEEGL--KPLEWNRRLTIALDVARGVEYLHGLAHQSFIH 722 (948)
Q Consensus 662 ---------~~---~-----~~~lv~e~~~~gsL~~~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 722 (948)
.. . ..+++|+-+ -++|.+++........ ..+....++.+..|+++.+++||+ .|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence 11 1 236788877 5688877643222221 234455667788999999999997 89999
Q ss_pred cCCCCccEEEcCCCCeEEeecCCceecCCCCCceeeeecccccccCceecccC--------CCCchhhHHHHHHHHHHHH
Q 002238 723 RDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG--------RVTTKVDVFSFGVILMELI 794 (948)
Q Consensus 723 rDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~Dv~s~Gv~l~ell 794 (948)
+||||+|++++.+|.++|+||+......... .....+..|.+||..... .++.+.|.|++|+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEE----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCcee----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999999776543321 113356789999977442 4788999999999999999
Q ss_pred hCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCC
Q 002238 795 TGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQR 861 (948)
Q Consensus 795 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~R 861 (948)
+|+.||....+...... +... +.+.++.+..||..+++.+|.+|
T Consensus 245 C~~lPf~~~~~~~~~~~----------------------~f~~-C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW----------------------DFSR-CRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG----------------------GGTT-SS---HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc----------------------cchh-cCCcCHHHHHHHHHHccCCcccC
Confidence 99999987644321100 1111 22556679999999999999988
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.2e-20 Score=217.09 Aligned_cols=256 Identities=23% Similarity=0.360 Sum_probs=198.2
Q ss_pred ccceEEeCCCCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCC
Q 002238 59 WNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGL 138 (948)
Q Consensus 59 w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 138 (948)
+.-..|.. .+.+.|++++++++ .+|..+. ++|+.|+|++|+|+.+++.+. .+|++|+|++|+|+.++.. + .
T Consensus 170 ~r~~~Cl~-~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~LtsLP~~-l--~ 240 (754)
T PRK15370 170 QRMRDCLK-NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELKSLPENLQ--GNIKTLYANSNQLTSIPAT-L--P 240 (754)
T ss_pred HHHHhhcc-cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCcCChhhc--cCCCEEECCCCccccCChh-h--h
Confidence 33345643 46789999999998 5776664 579999999999997655544 5899999999999987654 3 3
Q ss_pred CCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccce
Q 002238 139 SSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSL 218 (948)
Q Consensus 139 ~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l 218 (948)
.+|+.|+|++|++. .+|..+. ++|+.|++++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+
T Consensus 241 ~~L~~L~Ls~N~L~--~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~----~sL~~L~Ls~N~Lt-~LP~~l-------- 302 (754)
T PRK15370 241 DTIQEMELSINRIT--ELPERLP--SALQSLDLFHNKIS-CLPENLP----EELRYLSVYDNSIR-TLPAHL-------- 302 (754)
T ss_pred ccccEEECcCCccC--cCChhHh--CCCCEEECcCCccC-ccccccC----CCCcEEECCCCccc-cCcccc--------
Confidence 47999999999998 6787764 58999999999998 4666553 58999999999998 355443
Q ss_pred eccCCCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCc
Q 002238 219 WVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 298 (948)
Q Consensus 219 ~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 298 (948)
.++|+.|+|++|+++..++.+. ++|+.|++++|.++ .+|..+. ++|+.|+|++|+
T Consensus 303 --------------------p~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~ 357 (754)
T PRK15370 303 --------------------PSGITHLNVQSNSLTALPETLP--PGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQ 357 (754)
T ss_pred --------------------hhhHHHHHhcCCccccCCcccc--ccceeccccCCccc-cCChhhc--CcccEEECCCCC
Confidence 1478899999999996544333 68999999999999 5787664 699999999999
Q ss_pred ccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEcc
Q 002238 299 LQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQ 378 (948)
Q Consensus 299 l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls 378 (948)
|+. +|.. -.++|+.|+|+
T Consensus 358 L~~-LP~~-------------------------------------------------------------lp~~L~~LdLs 375 (754)
T PRK15370 358 ITV-LPET-------------------------------------------------------------LPPTITTLDVS 375 (754)
T ss_pred CCc-CChh-------------------------------------------------------------hcCCcCEEECC
Confidence 873 3420 01268889999
Q ss_pred CCcccccCCccccCccccceEeCccccccccCCcCC----cCCCCCcEEEccCCcccC
Q 002238 379 KMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL----SVLGALKELDVSNNQLYG 432 (948)
Q Consensus 379 ~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l----~~l~~L~~L~ls~N~l~g 432 (948)
+|+++ .+|+.+. ..|+.|++++|+|+ .+|..+ ..++.+..|+|.+|+|+.
T Consensus 376 ~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 376 RNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE 429 (754)
T ss_pred CCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH
Confidence 99998 5676654 36999999999998 666655 345788999999999874
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.6e-19 Score=174.45 Aligned_cols=189 Identities=18% Similarity=0.119 Sum_probs=140.9
Q ss_pred cccceecccCceEEEEEEEcCCcEEEEEEeecCcCChh--hHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCceEEEEEe
Q 002238 596 SEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK--GLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 596 ~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
.+...|++|+||+||.+.. ++.+++.+.+........ ....+.+|+++|+++. |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999998875 588888887765432111 1235889999999995 5889999876 446999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCC-CCccEEEcCCCCeEEeecCCceecCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDL-KPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDi-k~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
+.|.+|.+... . . ...++.|++++|+++|+ .||+|||| ||+|||++.++.++|+|||+|.....
T Consensus 80 I~G~~L~~~~~----~--~------~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 80 LAGAAMYQRPP----R--G------DLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred ecCccHHhhhh----h--h------hHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 99999865431 0 1 13467899999999997 89999999 79999999999999999999985543
Q ss_pred CCCc----e--------eeeecccccccCceecccC-CCC-chhhHHHHHHHHHHHHhCCCCCCCCC
Q 002238 752 GKGS----I--------ETRIAGTFGYLAPEYAVTG-RVT-TKVDVFSFGVILMELITGRKALDESQ 804 (948)
Q Consensus 752 ~~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~s~Gv~l~elltg~~p~~~~~ 804 (948)
.... . ......++.|++|+-..-- ..+ .+.+.++-|+-+|.++||+.+..+..
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 2210 0 1112357788888754332 233 56788999999999999998876544
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-21 Score=202.20 Aligned_cols=315 Identities=22% Similarity=0.252 Sum_probs=217.6
Q ss_pred ceEEeCCCCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCC
Q 002238 61 HVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLS 139 (948)
Q Consensus 61 gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 139 (948)
+.+|.+.. -..++.++-+|+ .+|..+. ..-++|+|..|+|+.++| +|..+++|+.|||++|+|+.+-|++|.++.
T Consensus 40 pC~Cs~~~-g~~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~ 115 (498)
T KOG4237|consen 40 PCTCSDVE-GGIVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLA 115 (498)
T ss_pred CcccCCCC-CceEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhH
Confidence 34554433 355677888888 7776665 467889999999999888 799999999999999999999999999999
Q ss_pred CCCEEEccC-CCCCCCCCCc-cccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccc
Q 002238 140 SLQSIEIDN-NPFSSWEIPQ-SLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQS 217 (948)
Q Consensus 140 ~L~~L~Ls~-N~l~~~~~p~-~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~ 217 (948)
+|..|-+.+ |+|+ .+|. .|.+|..|+-|.+.-|++.-.....|. .+++|..|.|..|.+. .++..-
T Consensus 116 ~l~~Lvlyg~NkI~--~l~k~~F~gL~slqrLllNan~i~Cir~~al~--dL~~l~lLslyDn~~q-~i~~~t------- 183 (498)
T KOG4237|consen 116 SLLSLVLYGNNKIT--DLPKGAFGGLSSLQRLLLNANHINCIRQDALR--DLPSLSLLSLYDNKIQ-SICKGT------- 183 (498)
T ss_pred hhhHHHhhcCCchh--hhhhhHhhhHHHHHHHhcChhhhcchhHHHHH--Hhhhcchhcccchhhh-hhcccc-------
Confidence 988887766 8898 5664 577789999999999998877777776 8888888888888887 444421
Q ss_pred eeccCCCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccC
Q 002238 218 LWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297 (948)
Q Consensus 218 l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 297 (948)
|..+.+++.+++..|.+- ..++++.|... +. ..|-.++...-..-..|.++
T Consensus 184 ------------------f~~l~~i~tlhlA~np~i----cdCnL~wla~~-~a------~~~ietsgarc~~p~rl~~~ 234 (498)
T KOG4237|consen 184 ------------------FQGLAAIKTLHLAQNPFI----CDCNLPWLADD-LA------MNPIETSGARCVSPYRLYYK 234 (498)
T ss_pred ------------------ccchhccchHhhhcCccc----cccccchhhhH-Hh------hchhhcccceecchHHHHHH
Confidence 346778888888888743 12222222111 11 11222333322333333333
Q ss_pred cccccCCC-CCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCC-CCCCc-cceeecCCceEE
Q 002238 298 LLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND-PCSDW-IGVTCTKGNITV 374 (948)
Q Consensus 298 ~l~g~~p~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~L~~ 374 (948)
++...-+. +.-. +++ +.....+.+ +...- ..-|..+++|+.
T Consensus 235 Ri~q~~a~kf~c~--------------------------~es----------l~s~~~~~d~~d~~cP~~cf~~L~~L~~ 278 (498)
T KOG4237|consen 235 RINQEDARKFLCS--------------------------LES----------LPSRLSSEDFPDSICPAKCFKKLPNLRK 278 (498)
T ss_pred Hhcccchhhhhhh--------------------------HHh----------HHHhhccccCcCCcChHHHHhhcccceE
Confidence 33221111 0000 000 000000000 00000 011557889999
Q ss_pred EEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCCC----CCcccccccCCCCC
Q 002238 375 INFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNPD 450 (948)
Q Consensus 375 L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~----~~~~~~~~~~gnp~ 450 (948)
|+|++|+++++-+.+|..+..|++|.|..|+|...--..|.++..|+.|+|.+|+++-.-|. ......+++-+|||
T Consensus 279 lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 279 LNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF 358 (498)
T ss_pred eccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcc
Confidence 99999999999999999999999999999999877677899999999999999999976553 33456788999999
Q ss_pred CCCccC
Q 002238 451 IGKEKS 456 (948)
Q Consensus 451 ~~~~~~ 456 (948)
.|.+-.
T Consensus 359 ~CnC~l 364 (498)
T KOG4237|consen 359 NCNCRL 364 (498)
T ss_pred cCccch
Confidence 998753
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-20 Score=214.66 Aligned_cols=221 Identities=22% Similarity=0.287 Sum_probs=163.0
Q ss_pred CCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEc
Q 002238 92 TKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSA 171 (948)
Q Consensus 92 ~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l 171 (948)
++|+.|+.++|.+....+.+ .-.+|+++++++|++++++ ++++.+.+|+.|+..+|++. .+|..+...++|++|.+
T Consensus 219 ~~l~~L~a~~n~l~~~~~~p-~p~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~--~lp~ri~~~~~L~~l~~ 294 (1081)
T KOG0618|consen 219 PSLTALYADHNPLTTLDVHP-VPLNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLV--ALPLRISRITSLVSLSA 294 (1081)
T ss_pred cchheeeeccCcceeecccc-ccccceeeecchhhhhcch-HHHHhcccceEecccchhHH--hhHHHHhhhhhHHHHHh
Confidence 44555666666555322222 2357999999999999998 99999999999999999997 78999999999999999
Q ss_pred cCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCc
Q 002238 172 NSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA 251 (948)
Q Consensus 172 ~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~ 251 (948)
.+|.+. .+|.... .++.|++|+|..|+|. ..|..+-..-..+|+..+.+.+......-..=..++.|+.|+|.+|.
T Consensus 295 ~~nel~-yip~~le--~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~ 370 (1081)
T KOG0618|consen 295 AYNELE-YIPPFLE--GLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNH 370 (1081)
T ss_pred hhhhhh-hCCCccc--ccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCc
Confidence 999998 4555554 6899999999999998 66665433333334444444443322221111245679999999999
Q ss_pred ccc-cCCCCCCCCCCcEEeccCCccccccc-hhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCC
Q 002238 252 FSG-PLPDFSGVKQLESLSLRDNFFTGPVP-DSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNF 321 (948)
Q Consensus 252 l~~-~~~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~ 321 (948)
++. .+|.+.+.++|++|+|++|+|. .+| ..+.+++.|++|+||+|+|+........+..|..+....|.
T Consensus 371 Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~ 441 (1081)
T KOG0618|consen 371 LTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQ 441 (1081)
T ss_pred ccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCc
Confidence 998 5677899999999999999999 566 45788999999999999998544334444444444444443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.7e-21 Score=174.95 Aligned_cols=168 Identities=30% Similarity=0.536 Sum_probs=143.7
Q ss_pred CCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCC
Q 002238 109 PSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDE 188 (948)
Q Consensus 109 p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~ 188 (948)
|.+..+...+.|.|++|+++.++|. ++.+.+|+.|++++|+|+ ++|.+++.+++|+.|++.-|++. ..|..|+ .
T Consensus 27 ~gLf~~s~ITrLtLSHNKl~~vppn-ia~l~nlevln~~nnqie--~lp~~issl~klr~lnvgmnrl~-~lprgfg--s 100 (264)
T KOG0617|consen 27 PGLFNMSNITRLTLSHNKLTVVPPN-IAELKNLEVLNLSNNQIE--ELPTSISSLPKLRILNVGMNRLN-ILPRGFG--S 100 (264)
T ss_pred ccccchhhhhhhhcccCceeecCCc-HHHhhhhhhhhcccchhh--hcChhhhhchhhhheecchhhhh-cCccccC--C
Confidence 3455566677777777777777776 778888888888888888 78888888889999998888887 7888898 9
Q ss_pred CCCCcEEEcccccccc-cCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcE
Q 002238 189 FPGLTILHLAFNQLIG-GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLES 267 (948)
Q Consensus 189 l~~L~~L~Ls~N~l~~-~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~ 267 (948)
+|.|+.|||++|++.. .+|..| ..++.|+.|+|++|.|.-.+|+..++++|+.
T Consensus 101 ~p~levldltynnl~e~~lpgnf--------------------------f~m~tlralyl~dndfe~lp~dvg~lt~lqi 154 (264)
T KOG0617|consen 101 FPALEVLDLTYNNLNENSLPGNF--------------------------FYMTTLRALYLGDNDFEILPPDVGKLTNLQI 154 (264)
T ss_pred CchhhhhhccccccccccCCcch--------------------------hHHHHHHHHHhcCCCcccCChhhhhhcceeE
Confidence 9999999999999874 455554 3688999999999999988889999999999
Q ss_pred EeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCc
Q 002238 268 LSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRS 309 (948)
Q Consensus 268 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~ 309 (948)
|.+++|.+- .+|..++.++.|++|++.+|+++-.+|++.++
T Consensus 155 l~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlppel~~l 195 (264)
T KOG0617|consen 155 LSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPELANL 195 (264)
T ss_pred EeeccCchh-hCcHHHHHHHHHHHHhcccceeeecChhhhhh
Confidence 999999999 89999999999999999999999888876543
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.4e-18 Score=214.98 Aligned_cols=290 Identities=15% Similarity=0.215 Sum_probs=186.5
Q ss_pred CEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccC
Q 002238 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148 (948)
Q Consensus 69 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 148 (948)
.++.|++.++.+. .+|..| .+.+|++|+|.+|+|...+..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|++
T Consensus 590 ~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~ 666 (1153)
T PLN03210 590 KLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSD 666 (1153)
T ss_pred ccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecC
Confidence 4666677666665 556555 35677777777777766555666677777777776554343443 66677777777776
Q ss_pred CCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCC--------------------
Q 002238 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPA-------------------- 208 (948)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~-------------------- 208 (948)
|.... .+|..+.++++|+.|++++|...+.+|..+ .+++|+.|+|++|...+.+|.
T Consensus 667 c~~L~-~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i---~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~~lP~ 742 (1153)
T PLN03210 667 CSSLV-ELPSSIQYLNKLEDLDMSRCENLEILPTGI---NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIEEFPS 742 (1153)
T ss_pred CCCcc-ccchhhhccCCCCEEeCCCCCCcCccCCcC---CCCCCCEEeCCCCCCccccccccCCcCeeecCCCccccccc
Confidence 65443 567777777777777777765555555544 455666666666554444443
Q ss_pred CcccccccceeccCCCCCCccCC----CccccccCCCccEEEccCCcccccCC-CCCCCCCCcEEeccCCccccccchhh
Q 002238 209 SFSGSQIQSLWVNGQNGNAKLGG----GIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSL 283 (948)
Q Consensus 209 ~~~~~~l~~l~~~~~~~~~~~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l 283 (948)
.+...+|..|.+..+..+..... .+......++|+.|+|++|...+.+| .+.++++|+.|+|++|...+.+|..+
T Consensus 743 ~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~ 822 (1153)
T PLN03210 743 NLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI 822 (1153)
T ss_pred cccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC
Confidence 22222233333322111111000 00111234689999999998777777 58899999999999986555888876
Q ss_pred hCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCcc
Q 002238 284 VKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWI 363 (948)
Q Consensus 284 ~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (948)
++++|+.|+|++|..-..+|... .++..+++.+|.+..+|.
T Consensus 823 -~L~sL~~L~Ls~c~~L~~~p~~~--~nL~~L~Ls~n~i~~iP~------------------------------------ 863 (1153)
T PLN03210 823 -NLESLESLDLSGCSRLRTFPDIS--TNISDLNLSRTGIEEVPW------------------------------------ 863 (1153)
T ss_pred -CccccCEEECCCCCccccccccc--cccCEeECCCCCCccChH------------------------------------
Confidence 79999999999987666666532 345555555554443331
Q ss_pred ceeecCCceEEEEccCCcccccCCccccCccccceEeCcccc
Q 002238 364 GVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNN 405 (948)
Q Consensus 364 ~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~ 405 (948)
.+..+++|+.|+|++|+-...+|..+..+++|+.|++++|.
T Consensus 864 -si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 864 -WIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred -HHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 12345689999999976666789899999999999999985
|
syringae 6; Provisional |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.3e-20 Score=202.79 Aligned_cols=227 Identities=26% Similarity=0.324 Sum_probs=177.7
Q ss_pred eecccCceEEEEEE----EcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCceEEEEEecC
Q 002238 600 ILGRGGFGTVYKGE----LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFEYMP 674 (948)
Q Consensus 600 ~lg~G~fg~Vy~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~ 674 (948)
.+|+|+||.|+.+. .+.|.-+|+|+.++.............|..++..++ ||.+|++.-++..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999774 234778999998765433333335667888899886 9999999999999999999999999
Q ss_pred CCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCC
Q 002238 675 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 754 (948)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~ 754 (948)
+|.|..++.. ...++......+...++-+++++|. .+++|||+|++||+++.+|.+++.|||+++..-+.+.
T Consensus 81 gg~lft~l~~-----~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLSK-----EVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhcccc-----CCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 9999887733 2456666677778889999999996 8999999999999999999999999999986654332
Q ss_pred ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccC
Q 002238 755 SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTID 834 (948)
Q Consensus 755 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (948)
. +||..|||||++. ....++|.||||++++||+||..||.. +.. .++...+.
T Consensus 153 ~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~------~~Il~~~~----------- 204 (612)
T KOG0603|consen 153 A-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTM------KRILKAEL----------- 204 (612)
T ss_pred c-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHH------HHHhhhcc-----------
Confidence 2 7999999999987 567889999999999999999999987 111 11111111
Q ss_pred CccchHHHHHHHHHHHHHhcccCCCCCCCh
Q 002238 835 LNEGILASISTVAELAGHCCAREPYQRPDM 864 (948)
Q Consensus 835 ~~~~~~~~~~~l~~li~~c~~~~P~~RPt~ 864 (948)
...........+++..+...+|..|--.
T Consensus 205 --~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 205 --EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred --CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1112233456688888899999999755
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-18 Score=192.41 Aligned_cols=217 Identities=25% Similarity=0.410 Sum_probs=164.7
Q ss_pred HHhcCCCceeeEEeEEEeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecC
Q 002238 645 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRD 724 (948)
Q Consensus 645 l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrD 724 (948)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....++|.....+.++|+.||+|+|+ ..-..|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeee
Confidence 3578999999999999999999999999999999999954 34678999999999999999999997 23338999
Q ss_pred CCCccEEEcCCCCeEEeecCCceecCCCCC-ceeeeecccccccCceecccC-------CCCchhhHHHHHHHHHHHHhC
Q 002238 725 LKPSNILLGDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTG-------RVTTKVDVFSFGVILMELITG 796 (948)
Q Consensus 725 ik~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~s~Gv~l~elltg 796 (948)
+++.|++++....+|++|||+.....+... .......-..-|.|||.+... ..+.++||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 999999999999999999999876543100 111111234569999998763 146789999999999999999
Q ss_pred CCCCCCCCchhhh-hHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhh
Q 002238 797 RKALDESQPEESM-HLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875 (948)
Q Consensus 797 ~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~ 875 (948)
+.||+........ ..+..+.. .....+.|.+.... +...++..++..||..+|.+||++++|...++.+.
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred cCccccccccCChHHHHHHHHh------cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 9999875433221 22222221 12223334433221 23336889999999999999999999999888875
Q ss_pred h
Q 002238 876 E 876 (948)
Q Consensus 876 ~ 876 (948)
.
T Consensus 226 ~ 226 (484)
T KOG1023|consen 226 K 226 (484)
T ss_pred c
Confidence 4
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.5e-18 Score=177.59 Aligned_cols=197 Identities=24% Similarity=0.317 Sum_probs=137.2
Q ss_pred CCCceeeEEeEEEeC---------------------------CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHH
Q 002238 649 RHRHLVALLGHCLDG---------------------------NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTI 701 (948)
Q Consensus 649 ~H~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 701 (948)
+|||||+++++|.+. ...|+||..++ .+|.+++.. ...+...+.-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~------~~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT------RHRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc------CCCchHHHHHH
Confidence 699999999887641 23589999885 488888843 34555667778
Q ss_pred HHHHHHHHHHHHhccCCCeeecCCCCccEEEc--CCC--CeEEeecCCceecCC-----CCCceeeeecccccccCceec
Q 002238 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDM--RAKVADFGLVRLAPE-----GKGSIETRIAGTFGYLAPEYA 772 (948)
Q Consensus 702 ~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~--~~~--~~kl~DfGla~~~~~-----~~~~~~~~~~gt~~y~aPE~~ 772 (948)
+.|+++|+.|||. +||.|||+|++|||+. +|+ ...|+|||.+--... .........-|.-..||||+.
T Consensus 347 laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 8999999999995 8999999999999994 333 478899997653222 111222334578889999998
Q ss_pred ccCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHH
Q 002238 773 VTGR------VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTV 846 (948)
Q Consensus 773 ~~~~------~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 846 (948)
.... --.|+|.|+.|.+.||+++...||...... ...... ..+..+ |.++ ...+..+
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~------Yqe~qL-----Palp-----~~vpp~~ 486 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT------YQESQL-----PALP-----SRVPPVA 486 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh------hhhhhC-----CCCc-----ccCChHH
Confidence 6532 225899999999999999999999763221 111111 111111 1111 1223457
Q ss_pred HHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 847 AELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 847 ~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
.+++...++.||.+|++..-....|.
T Consensus 487 rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 487 RQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHHhcCCccccCCccHHHhHHH
Confidence 79999999999999998776665553
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.8e-17 Score=167.94 Aligned_cols=135 Identities=19% Similarity=0.257 Sum_probs=103.9
Q ss_pred CcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-----CCCceeeEEeEEEeCC---c-
Q 002238 595 FSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-----RHRHLVALLGHCLDGN---E- 665 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~---~- 665 (948)
+...+.||+|+||.||. .-+++.. +||++... .....+.+.+|+.+++.+ .||||++++|++.++. .
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~--~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHR--GDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEecc--ccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 34567899999999996 3234444 79988654 223457799999999999 5799999999998763 3
Q ss_pred eEEEEEe--cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHH-HHHHhccCCCeeecCCCCccEEEcC----CCCe
Q 002238 666 KLLVFEY--MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV-EYLHGLAHQSFIHRDLKPSNILLGD----DMRA 738 (948)
Q Consensus 666 ~~lv~e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivHrDik~~Nill~~----~~~~ 738 (948)
..+|+|| +.+|+|.+++.. ..+++. ..++.+++.++ +|||+ .+||||||||+|||++. ++.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~ 148 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIP 148 (210)
T ss_pred EEEEecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcE
Confidence 3378999 557999999943 234444 35677888777 99997 89999999999999974 3379
Q ss_pred EEeecC
Q 002238 739 KVADFG 744 (948)
Q Consensus 739 kl~DfG 744 (948)
+|+||+
T Consensus 149 ~LiDg~ 154 (210)
T PRK10345 149 VVCDNI 154 (210)
T ss_pred EEEECC
Confidence 999954
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-18 Score=199.18 Aligned_cols=211 Identities=27% Similarity=0.410 Sum_probs=149.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
..+|..++.|..|+||.||.++++ +.+++|+|.=+.. .+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~--------lilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN--------LILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc--------hhhhc--cccccCCccee----------------
Confidence 467888999999999999999876 5688999532221 11110 22333344443
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
|+-.+.++. .++++. +++.+++|||+ .+|+|||+||+|.+++.-|.+|+.|||+++.-.
T Consensus 136 -----gDc~tllk~-----~g~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 -----GDCATLLKN-----IGPLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred -----chhhhhccc-----CCCCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhh
Confidence 444444422 123332 23789999997 899999999999999999999999999977221
Q ss_pred CCC--------------CceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH
Q 002238 751 EGK--------------GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFR 816 (948)
Q Consensus 751 ~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~ 816 (948)
... ......++||+.|.|||++....|+..+|.|++|+++||++.|+.||.+..+++....+-
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi--- 271 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI--- 271 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh---
Confidence 110 112345689999999999999999999999999999999999999999988876533221
Q ss_pred HhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChH
Q 002238 817 RIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMG 865 (948)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ 865 (948)
...+...+.....+.+.++++.+.++.+|..|--..
T Consensus 272 -------------sd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 272 -------------SDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred -------------hhhccccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 111111222333445788999999999999997433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.6e-17 Score=169.35 Aligned_cols=143 Identities=18% Similarity=0.164 Sum_probs=110.7
Q ss_pred CCcccceecccCceEEEEEE--EcCCcEEEEEEeecCcCChh----------------------hHHHHHHHHHHHHhcC
Q 002238 594 NFSEENILGRGGFGTVYKGE--LHDGTKIAVKRMEAGVISGK----------------------GLTEFKSEIAVLTKVR 649 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~--~~~g~~vavK~~~~~~~~~~----------------------~~~~~~~E~~~l~~l~ 649 (948)
.|++.+.||+|+||.||+|. ..+|+.||||+++....... ....+.+|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48889999999999999998 46899999999875421100 1134678999999997
Q ss_pred CC--ceeeEEeEEEeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCC-eeecCCC
Q 002238 650 HR--HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS-FIHRDLK 726 (948)
Q Consensus 650 H~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivHrDik 726 (948)
+. .+.+++++ ...++||||+++++|...... .......+...++.|++.+++|||+ .+ ++|||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dik 176 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLS 176 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCC
Confidence 53 34444443 235899999999888655411 1345566678899999999999997 78 9999999
Q ss_pred CccEEEcCCCCeEEeecCCceec
Q 002238 727 PSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 727 ~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|+||+++ ++.++|+|||.+...
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999 889999999988754
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.6e-19 Score=197.98 Aligned_cols=280 Identities=21% Similarity=0.259 Sum_probs=170.8
Q ss_pred EEEeCCCCCc-CCCCccccCCCCCcEEEcccCCCCCC----CC-CcCCCCCCcEEEcccccccC------CCCccccCCC
Q 002238 72 RIQIGHQNLQ-GTLPSNLQNLTKLERLELQWNSISGP----LP-SLNGLASLEVVMLSNNQFTS------VPSDFFTGLS 139 (948)
Q Consensus 72 ~l~l~~~~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~----~p-~~~~l~~L~~L~L~~N~l~~------~~~~~~~~l~ 139 (948)
.|+|..++++ ......+..+.+|+.|+++++.++.. ++ .+...+.|++|++++|.+.+ ..+..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 3667777776 34445566677788888888887542 22 35566778888888887763 2234566777
Q ss_pred CCCEEEccCCCCCCCCCCccccCCCC---CCEEEccCcccccc----CCCCCCCCCC-CCCcEEEcccccccccCCCCcc
Q 002238 140 SLQSIEIDNNPFSSWEIPQSLRNASG---LQNFSANSANITGQ----IPSFFGPDEF-PGLTILHLAFNQLIGGLPASFS 211 (948)
Q Consensus 140 ~L~~L~Ls~N~l~~~~~p~~~~~l~~---L~~L~l~~n~l~~~----~p~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~ 211 (948)
+|+.|+|++|.+.. ..+..+..+.+ |++|++++|++++. +...+. .+ ++|+.|+|++|.+++.....+
T Consensus 82 ~L~~L~l~~~~~~~-~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~--~~~~~L~~L~L~~n~l~~~~~~~~- 157 (319)
T cd00116 82 GLQELDLSDNALGP-DGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLK--DLPPALEKLVLGRNRLEGASCEAL- 157 (319)
T ss_pred ceeEEEccCCCCCh-hHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHH--hCCCCceEEEcCCCcCCchHHHHH-
Confidence 88888888888764 44555555444 88888888877632 222232 44 677888888887774322221
Q ss_pred cccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccC-----CCCCCCCCCcEEeccCCccccc----cchh
Q 002238 212 GSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPL-----PDFSGVKQLESLSLRDNFFTGP----VPDS 282 (948)
Q Consensus 212 ~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~-----~~~~~l~~L~~L~L~~N~l~~~----~p~~ 282 (948)
...+..+++|+.|+|++|.+++.. ..+..+++|+.|+|++|.+++. ++..
T Consensus 158 ---------------------~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~ 216 (319)
T cd00116 158 ---------------------AKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAET 216 (319)
T ss_pred ---------------------HHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHH
Confidence 122445667788888888777411 1234456788888888877633 3344
Q ss_pred hhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCc
Q 002238 283 LVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDW 362 (948)
Q Consensus 283 l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (948)
+..+++|++|++++|.+++.... .+...
T Consensus 217 ~~~~~~L~~L~ls~n~l~~~~~~--------------------------------~l~~~-------------------- 244 (319)
T cd00116 217 LASLKSLEVLNLGDNNLTDAGAA--------------------------------ALASA-------------------- 244 (319)
T ss_pred hcccCCCCEEecCCCcCchHHHH--------------------------------HHHHH--------------------
Confidence 55677788888888777631110 00000
Q ss_pred cceeecCCceEEEEccCCccc----ccCCccccCccccceEeCcccccccc----CCcCCcCC-CCCcEEEccCCcc
Q 002238 363 IGVTCTKGNITVINFQKMNLT----GTISPEFASFKSLQRLILADNNLSGM----IPEGLSVL-GALKELDVSNNQL 430 (948)
Q Consensus 363 ~~~~~~~~~L~~L~ls~n~l~----g~ip~~~~~l~~L~~L~Ls~N~l~g~----ip~~l~~l-~~L~~L~ls~N~l 430 (948)
.......|+.|++++|.++ ..+...+..+++|+.|++++|+++.. +...+... +.|++||+.+|++
T Consensus 245 --~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 245 --LLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred --HhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 0001236777777777776 23445556667777777777777733 44444444 6777777777754
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.9e-17 Score=190.71 Aligned_cols=248 Identities=19% Similarity=0.202 Sum_probs=178.9
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC---CCceeeEEeEEEeCCceEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR---HRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~l 668 (948)
.+.|.+.+.||+|+||+||+|...+|+.||+|+-+.... -+|.-=.+++.+|+ -+-|..+..++.-.+..+|
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~-----WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP-----WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc-----eeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 457888899999999999999988899999998765421 12222233444444 2344455555566777899
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC-------CCCeEEe
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-------DMRAKVA 741 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~-------~~~~kl~ 741 (948)
|+||.+.|+|.+++. ..+.++|.-++.++.|+++.+++||. .+|||+||||+|+||.. ..-++|+
T Consensus 772 v~ey~~~Gtlld~~N-----~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN-----TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeccccccHHHhhc-----cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEE
Confidence 999999999999983 45788999999999999999999997 89999999999999952 3358999
Q ss_pred ecCCceecCC-CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc
Q 002238 742 DFGLVRLAPE-GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL 820 (948)
Q Consensus 742 DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 820 (948)
|||-+..+.- ..+......++|-.+--+|...+..++...|-|.++.+++-|+.|+.-- ..
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-~~----------------- 905 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-VK----------------- 905 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-hc-----------------
Confidence 9998873321 1123556678899999999999999999999999999999999986421 00
Q ss_pred CccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 821 SKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
.+ ....++..+ ..++... ..-+++..++..|-..=|...++...+++...
T Consensus 906 -~g-~~~~~~~~~--~Ry~~~~--~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 906 -NG-SSWMVKTNF--PRYWKRD--MWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred -CC-cceeccccc--hhhhhHH--HHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 00 011111111 1111111 13356666777666666777888777777653
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-16 Score=164.23 Aligned_cols=136 Identities=23% Similarity=0.348 Sum_probs=113.3
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEeecCcCChh------hHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK------GLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
+.||+|++|.||+|.. +|..|+||+......... ....+.+|++++..++|+++.....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 588999998664322211 224578899999999999988777777777888999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
++|++|.+.+.. ..+ ++..++.+++.+|+++|+ .+++|||++|.||+++ ++.++++|||.++.
T Consensus 81 ~~G~~L~~~~~~--------~~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINS--------NGM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHh--------ccH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999988732 112 788999999999999997 8999999999999999 78999999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=162.64 Aligned_cols=145 Identities=22% Similarity=0.176 Sum_probs=111.6
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCCh--------------------hhHHHHHHHHHHHHh
Q 002238 588 LRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISG--------------------KGLTEFKSEIAVLTK 647 (948)
Q Consensus 588 l~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~--------------------~~~~~~~~E~~~l~~ 647 (948)
+......|.+.+.||+|+||.||+|..++|+.||||++....... .....+..|+.++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 333333488889999999999999998889999999876532110 011236789999999
Q ss_pred cCCCc--eeeEEeEEEeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCC
Q 002238 648 VRHRH--LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDL 725 (948)
Q Consensus 648 l~H~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDi 725 (948)
+.|++ +.+.++ ....++||||+++++|.+.... .....++.+++.++.++|+ .+++||||
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl 151 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYK---HGIIHGDL 151 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHH---CCCCcCCC
Confidence 98874 444443 2455899999999998765310 2345788999999999997 89999999
Q ss_pred CCccEEEcCCCCeEEeecCCceecC
Q 002238 726 KPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 726 k~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+||++++++.++|+|||++....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.4e-16 Score=161.23 Aligned_cols=133 Identities=23% Similarity=0.352 Sum_probs=107.1
Q ss_pred eecccCceEEEEEEEcCCcEEEEEEeecCcCCh------hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEec
Q 002238 600 ILGRGGFGTVYKGELHDGTKIAVKRMEAGVISG------KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 673 (948)
Q Consensus 600 ~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 673 (948)
.||+|+||.||+|.+. |..|++|+........ ....++.+|+++++.++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 3899999999999864 7899999865432211 12356788999999999887665555566677789999999
Q ss_pred CCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
+|++|.+.+... .. .++.+++++|++||+ .+++|||++|.||+++ ++.++++|||+++..
T Consensus 80 ~g~~l~~~~~~~-----~~-------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEG-----ND-------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhc-----HH-------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999998876321 00 789999999999997 8999999999999999 789999999987753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.4e-19 Score=162.07 Aligned_cols=130 Identities=25% Similarity=0.448 Sum_probs=66.5
Q ss_pred CEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccC
Q 002238 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148 (948)
Q Consensus 69 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 148 (948)
+++.|.|++|+++ .+|+.+.+|.+|+.|++++|+|+..+++++.|++|+.|++.-|++..+|.+ |+.++.|+.|||.+
T Consensus 34 ~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~~lprg-fgs~p~levldlty 111 (264)
T KOG0617|consen 34 NITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLNILPRG-FGSFPALEVLDLTY 111 (264)
T ss_pred hhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhhcCccc-cCCCchhhhhhccc
Confidence 4555555555555 555555555555555555555555555555555555555555555544332 55555555555555
Q ss_pred CCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEccccccc
Q 002238 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLI 203 (948)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~ 203 (948)
|++..-.+|..|+.++.|+.|+|++|.+. .+|...+ .+++|+.|.+..|.+.
T Consensus 112 nnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg--~lt~lqil~lrdndll 163 (264)
T KOG0617|consen 112 NNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVG--KLTNLQILSLRDNDLL 163 (264)
T ss_pred cccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhh--hhcceeEEeeccCchh
Confidence 55554344555555555555555555444 3333333 4444444444444443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.2e-16 Score=183.28 Aligned_cols=141 Identities=23% Similarity=0.316 Sum_probs=113.9
Q ss_pred HhhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCC------hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS------GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG 663 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 663 (948)
.....|...+.||+|+||.||+|.+. +..+++|+....... ....+.+.+|+++++.++|++++....++.+.
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYL-GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeec-CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 33455677899999999999999876 445555543222111 11235688999999999999999888788877
Q ss_pred CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeec
Q 002238 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (948)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~Df 743 (948)
...++||||+++++|.+++. ....++.+++++|+|||+ .+++|||+||+||++ .++.++|+||
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeC
Confidence 78899999999999988773 346789999999999997 899999999999999 5779999999
Q ss_pred CCcee
Q 002238 744 GLVRL 748 (948)
Q Consensus 744 Gla~~ 748 (948)
|+++.
T Consensus 472 Gla~~ 476 (535)
T PRK09605 472 GLGKY 476 (535)
T ss_pred ccccc
Confidence 99875
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.1e-18 Score=190.65 Aligned_cols=276 Identities=20% Similarity=0.209 Sum_probs=196.3
Q ss_pred EEEcccCCCCC-CCC-CcCCCCCCcEEEcccccccCC----CCccccCCCCCCEEEccCCCCCC-----CCCCccccCCC
Q 002238 96 RLELQWNSISG-PLP-SLNGLASLEVVMLSNNQFTSV----PSDFFTGLSSLQSIEIDNNPFSS-----WEIPQSLRNAS 164 (948)
Q Consensus 96 ~L~L~~N~l~~-~~p-~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~-----~~~p~~~~~l~ 164 (948)
.|+|..+.+++ ... -+..+..|++|+|++|.++.. ++..+...++|+.|++++|.+.. ..++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 57888888874 333 466688899999999998642 45557788899999999998862 12345677889
Q ss_pred CCCEEEccCccccccCCCCCCCCCCC---CCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccC-C
Q 002238 165 GLQNFSANSANITGQIPSFFGPDEFP---GLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNM-T 240 (948)
Q Consensus 165 ~L~~L~l~~n~l~~~~p~~~~~~~l~---~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l-~ 240 (948)
+|+.|++++|.+.+..+..+. .+. +|++|++++|++++.....+ ...+..+ +
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~--~l~~~~~L~~L~ls~~~~~~~~~~~l----------------------~~~l~~~~~ 137 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLE--SLLRSSSLQELKLNNNGLGDRGLRLL----------------------AKGLKDLPP 137 (319)
T ss_pred ceeEEEccCCCCChhHHHHHH--HHhccCcccEEEeeCCccchHHHHHH----------------------HHHHHhCCC
Confidence 999999999999876666554 344 49999999999874211111 1123455 8
Q ss_pred CccEEEccCCcccccC----C-CCCCCCCCcEEeccCCcccc----ccchhhhCCCCCcEEEcccCcccccCCCCCCccc
Q 002238 241 SLKEIWLHSNAFSGPL----P-DFSGVKQLESLSLRDNFFTG----PVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVS 311 (948)
Q Consensus 241 ~L~~L~Ls~N~l~~~~----~-~~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~ 311 (948)
+|+.|+|++|.+++.. . .+..+.+|++|+|++|.+++ .++..+..+++|+.|+|++|.+++.-..
T Consensus 138 ~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~------ 211 (319)
T cd00116 138 ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS------ 211 (319)
T ss_pred CceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH------
Confidence 9999999999998522 1 35567889999999999984 3445566778999999999998632110
Q ss_pred cccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCcccc
Q 002238 312 LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFA 391 (948)
Q Consensus 312 l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~ 391 (948)
.+ ...+..+++|+.|++++|.+++.....+.
T Consensus 212 -----------------------~l--------------------------~~~~~~~~~L~~L~ls~n~l~~~~~~~l~ 242 (319)
T cd00116 212 -----------------------AL--------------------------AETLASLKSLEVLNLGDNNLTDAGAAALA 242 (319)
T ss_pred -----------------------HH--------------------------HHHhcccCCCCEEecCCCcCchHHHHHHH
Confidence 00 01123456899999999999874444443
Q ss_pred C-----ccccceEeCcccccc----ccCCcCCcCCCCCcEEEccCCcccCC----CC----CC-CcccccccCCCCC
Q 002238 392 S-----FKSLQRLILADNNLS----GMIPEGLSVLGALKELDVSNNQLYGK----IP----SF-KSNAIVNTDGNPD 450 (948)
Q Consensus 392 ~-----l~~L~~L~Ls~N~l~----g~ip~~l~~l~~L~~L~ls~N~l~g~----ip----~~-~~~~~~~~~gnp~ 450 (948)
. .+.|+.|++++|+++ ..+...+..+++|++||+++|+++.. +. .+ .....++...|||
T Consensus 243 ~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 243 SALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 3 379999999999997 33456677779999999999999854 11 22 2344555666654
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.4e-17 Score=175.86 Aligned_cols=123 Identities=33% Similarity=0.502 Sum_probs=107.1
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
..|+.|+++.-.+|.+++.. .......+|.....++.|++.|++| ++.+|||+||.||++..+..+||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~r--r~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRR--RRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhC--CCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence 46899999999999999954 2333567888899999999999999 589999999999999999999999999
Q ss_pred CceecCCCC-----CceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh
Q 002238 745 LVRLAPEGK-----GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795 (948)
Q Consensus 745 la~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt 795 (948)
+........ ....+...||..||+||.+.+..|+.|+||||+|++|+|+++
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 988665544 233456789999999999999999999999999999999997
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.5e-16 Score=182.33 Aligned_cols=134 Identities=32% Similarity=0.585 Sum_probs=98.9
Q ss_pred cCCCChHHHHHHHHHHHhcCCCCCCCCCCCCCC-----CccceEEeCC-----CCEEEEEeCCCCCcCCCCccccCCCCC
Q 002238 25 SASGDDGDAAVMLALKKSLNPPESLGWSDTDPC-----KWNHVVCIED-----KRITRIQIGHQNLQGTLPSNLQNLTKL 94 (948)
Q Consensus 25 ~~~~~~~d~~~l~~~k~~~~~~~~~~w~~~~~C-----~w~gv~c~~~-----~~v~~l~l~~~~l~~~~p~~l~~l~~L 94 (948)
..++.+.|.+||+++|+++..+...+|.+ +|| .|.||.|... ..|+.|+|++|++.|.+|..++++++|
T Consensus 366 ~~~t~~~~~~aL~~~k~~~~~~~~~~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L 444 (623)
T PLN03150 366 ESKTLLEEVSALQTLKSSLGLPLRFGWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHL 444 (623)
T ss_pred ccccCchHHHHHHHHHHhcCCcccCCCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCC
Confidence 44567889999999999998766568965 565 6999999532 247788888888888888888888888
Q ss_pred cEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccc
Q 002238 95 ERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSL 160 (948)
Q Consensus 95 ~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~ 160 (948)
+.|+|++|.|.|.+| .+..+++|+.|+|++|++++.+|+.++++++|+.|+|++|++++ .+|..+
T Consensus 445 ~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g-~iP~~l 510 (623)
T PLN03150 445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSG-RVPAAL 510 (623)
T ss_pred CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccc-cCChHH
Confidence 888888888877666 56677777777777777777666666666666666666666665 445444
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.4e-15 Score=150.24 Aligned_cols=139 Identities=20% Similarity=0.204 Sum_probs=100.0
Q ss_pred cceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHH----------------------HHHHHHHHHhcCCCc--e
Q 002238 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTE----------------------FKSEIAVLTKVRHRH--L 653 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~----------------------~~~E~~~l~~l~H~n--i 653 (948)
.+.||+|+||.||+|...+|+.||||++............ ...|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998764322111111 135666666664433 4
Q ss_pred eeEEeEEEeCCceEEEEEecCCCChhHH-HHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE
Q 002238 654 VALLGHCLDGNEKLLVFEYMPQGTLSRH-IFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732 (948)
Q Consensus 654 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill 732 (948)
.+.+++ ...++||||++++.+... +.... .. .+...++.+++.++.++|. ..+|+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEE
Confidence 444433 346899999999654321 11100 01 4577899999999999995 3799999999999999
Q ss_pred cCCCCeEEeecCCceecC
Q 002238 733 GDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 733 ~~~~~~kl~DfGla~~~~ 750 (948)
+ ++.++++|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8899999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.9e-14 Score=140.00 Aligned_cols=135 Identities=21% Similarity=0.211 Sum_probs=113.2
Q ss_pred ccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCC--CceeeEEeEEEeCCceEEEEEecC
Q 002238 597 EENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH--RHLVALLGHCLDGNEKLLVFEYMP 674 (948)
Q Consensus 597 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~ 674 (948)
+.+.||+|.++.||++... +..++||....... ...+.+|+..++.++| .++++++++...++..+++|||++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 3577999999999999986 48899998765421 4678999999999976 588999988887788999999999
Q ss_pred CCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 675 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
++.+... +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.++.
T Consensus 77 g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8777432 4456677899999999999974445799999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.7e-14 Score=147.97 Aligned_cols=138 Identities=20% Similarity=0.243 Sum_probs=106.2
Q ss_pred cceec-ccCceEEEEEEEcCCcEEEEEEeecCcC-----------ChhhHHHHHHHHHHHHhcCCCce--eeEEeEEEeC
Q 002238 598 ENILG-RGGFGTVYKGELHDGTKIAVKRMEAGVI-----------SGKGLTEFKSEIAVLTKVRHRHL--VALLGHCLDG 663 (948)
Q Consensus 598 ~~~lg-~G~fg~Vy~~~~~~g~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~ 663 (948)
...|| .||.|+||++... +..+|||++..... .......+.+|++++..++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46688 8999999999876 78999998854211 11234568899999999998775 6777665433
Q ss_pred Cc----eEEEEEecCC-CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCe
Q 002238 664 NE----KLLVFEYMPQ-GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 738 (948)
Q Consensus 664 ~~----~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~ 738 (948)
.. .++||||++| .+|.+++.. ..++.. .+.+++.++.+||+ .||+||||||.|||++.++.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKF 181 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCE
Confidence 22 2599999997 688887732 234432 35789999999997 899999999999999998899
Q ss_pred EEeecCCceec
Q 002238 739 KVADFGLVRLA 749 (948)
Q Consensus 739 kl~DfGla~~~ 749 (948)
+|+|||.++..
T Consensus 182 ~LIDfg~~~~~ 192 (239)
T PRK01723 182 WLIDFDRGELR 192 (239)
T ss_pred EEEECCCcccC
Confidence 99999987653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.5e-15 Score=175.53 Aligned_cols=257 Identities=21% Similarity=0.286 Sum_probs=187.4
Q ss_pred CCcccceecccCceEEEEEEEc--CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCceEEEE
Q 002238 594 NFSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 670 (948)
.|...+.||+|+|+.|-..... ....+|+|.+...............|..+-..+. |+|++.+++...+.+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4556677999999999988653 3455677766544322333455666888888886 999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC-CeEEeecCCceec
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVRLA 749 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~-~~kl~DfGla~~~ 749 (948)
+|..++++.+.+. .......+....-.+..|+..++.|+|. ..++.||||||+|.+++..+ ..+++|||+|..+
T Consensus 101 ~~s~g~~~f~~i~---~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 101 SYSDGGSLFSKIS---HPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred Ccccccccccccc---cCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999987762 1111134444566789999999999993 28999999999999999999 9999999999966
Q ss_pred CC--CCCceeeeecc-cccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 750 PE--GKGSIETRIAG-TFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 750 ~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
.. +.........| ++.|+|||...+. ......|+||.|+++.-+++|..||+....... ....|.... ..+
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~----~~~ 250 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK----GRF 250 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc----ccc
Confidence 55 33344455678 9999999999885 446789999999999999999999987554331 111111110 010
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
...... .......++..+++..+|..|.+.+++..
T Consensus 251 ~~~~~~---------~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 251 TQLPWN---------SISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccCccc---------cCChhhhhcccccccCCchhccccccccc
Confidence 111111 11234667888889899999999877654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=9.2e-13 Score=149.54 Aligned_cols=143 Identities=25% Similarity=0.314 Sum_probs=101.1
Q ss_pred cceecccCceEEEEEEEcCCcEEEEEEeecCcCChh--------------------------------------hHHHHH
Q 002238 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK--------------------------------------GLTEFK 639 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~--------------------------------------~~~~~~ 639 (948)
.+.||.|++|.||+|++++|+.||||+.+......- ..-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 368999999999999999999999999865421100 001255
Q ss_pred HHHHHHHhcC----CCceeeEEeEEE-eCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 002238 640 SEIAVLTKVR----HRHLVALLGHCL-DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR-GVEYLH 713 (948)
Q Consensus 640 ~E~~~l~~l~----H~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH 713 (948)
+|++.+.+++ |.+-+.+-.++. .....+|||||++|++|.+..... . ...+ +.+++..++. .+.++|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~--~--~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD--E--AGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH--h--cCCC---HHHHHHHHHHHHHHHHH
Confidence 6666666662 333333333332 245579999999999998876321 1 1122 3456666666 467888
Q ss_pred hccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 714 ~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
. .|++|+|+||.||+++.+++++++|||++....
T Consensus 275 ~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 R---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred h---CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 6 899999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.42 E-value=4.3e-13 Score=159.42 Aligned_cols=88 Identities=30% Similarity=0.449 Sum_probs=75.6
Q ss_pred cCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCCCCC-----cccc
Q 002238 368 TKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFK-----SNAI 442 (948)
Q Consensus 368 ~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~~~-----~~~~ 442 (948)
.+++|+.|+|++|++.|.+|..++++++|+.|+|++|+|+|.+|..++.|++|++|+|++|+|+|.+|... ....
T Consensus 440 ~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~ 519 (623)
T PLN03150 440 KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRAS 519 (623)
T ss_pred CCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCce
Confidence 34578889999999999999999999999999999999999999999999999999999999999999632 2345
Q ss_pred cccCCCCCCCCcc
Q 002238 443 VNTDGNPDIGKEK 455 (948)
Q Consensus 443 ~~~~gnp~~~~~~ 455 (948)
+.+.+|+.+|..+
T Consensus 520 l~~~~N~~lc~~p 532 (623)
T PLN03150 520 FNFTDNAGLCGIP 532 (623)
T ss_pred EEecCCccccCCC
Confidence 6788999988654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.4e-12 Score=132.67 Aligned_cols=206 Identities=19% Similarity=0.240 Sum_probs=141.8
Q ss_pred HHHHHhcCCCceeeEEeEEEeCC-----ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcc
Q 002238 642 IAVLTKVRHRHLVALLGHCLDGN-----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716 (948)
Q Consensus 642 ~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ 716 (948)
..-+-++.|.|||++..|+.+.. ...+++|||.-|++.++|+...+ ..+.+......+|+.||..||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-~~~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-NQKALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH-hhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 34556668999999998876543 46899999999999999976433 335677777788999999999999984
Q ss_pred CCCeeecCCCCccEEEcCCCCeEEeecCCceecCC---CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHH
Q 002238 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE---GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMEL 793 (948)
Q Consensus 717 ~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el 793 (948)
.++|+|+++.-+-|++..++-+|+.----...... ........-.+-++|.|||+-.....+.++|||+||++..||
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 68999999999999999999888742211111100 011112223467899999998888888999999999999999
Q ss_pred HhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 794 ITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 794 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
..+..--....... ..-.-+... +...+.. .=+.++.+|++..|..||+|.+++.+
T Consensus 276 ailEiq~tnseS~~--~~ee~ia~~--------------i~~len~-----lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 276 AILEIQSTNSESKV--EVEENIANV--------------IIGLENG-----LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHheeccCCCccee--ehhhhhhhh--------------eeeccCc-----cccCcCcccccCCCCCCcchhhhhcC
Confidence 98765322111100 000000000 0000000 01367889999999999999988654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.31 E-value=9e-14 Score=150.72 Aligned_cols=194 Identities=24% Similarity=0.317 Sum_probs=120.7
Q ss_pred CCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccce
Q 002238 139 SSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSL 218 (948)
Q Consensus 139 ~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l 218 (948)
+--...||+.|++. ++|..+..+..|+.|.|+.|.+. .+|..+. .+..|.+|||+.|+++ ..|..++
T Consensus 75 tdt~~aDlsrNR~~--elp~~~~~f~~Le~liLy~n~~r-~ip~~i~--~L~~lt~l~ls~NqlS-~lp~~lC------- 141 (722)
T KOG0532|consen 75 TDTVFADLSRNRFS--ELPEEACAFVSLESLILYHNCIR-TIPEAIC--NLEALTFLDLSSNQLS-HLPDGLC------- 141 (722)
T ss_pred cchhhhhccccccc--cCchHHHHHHHHHHHHHHhccce-ecchhhh--hhhHHHHhhhccchhh-cCChhhh-------
Confidence 33344566666666 56666666666666666666665 4455444 5666666777777666 4444432
Q ss_pred eccCCCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCc
Q 002238 219 WVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 298 (948)
Q Consensus 219 ~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 298 (948)
.--|+.|-+++|+++-.++.+..+..|..||.+.|.+. .+|..++++.+|+.|++..|+
T Consensus 142 --------------------~lpLkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~ 200 (722)
T KOG0532|consen 142 --------------------DLPLKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNH 200 (722)
T ss_pred --------------------cCcceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhh
Confidence 12466677777777655556666777777777777777 777777888888888887777
Q ss_pred ccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEcc
Q 002238 299 LQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQ 378 (948)
Q Consensus 299 l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls 378 (948)
+...++++..+ .|..||+|
T Consensus 201 l~~lp~El~~L-------------------------------------------------------------pLi~lDfS 219 (722)
T KOG0532|consen 201 LEDLPEELCSL-------------------------------------------------------------PLIRLDFS 219 (722)
T ss_pred hhhCCHHHhCC-------------------------------------------------------------ceeeeecc
Confidence 76555442100 35666777
Q ss_pred CCcccccCCccccCccccceEeCccccccccCCcCCcCCCC---CcEEEccCCc
Q 002238 379 KMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGA---LKELDVSNNQ 429 (948)
Q Consensus 379 ~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~---L~~L~ls~N~ 429 (948)
.|+++ .||-.|.+|+.|++|-|.+|-|. .-|.+++.... .++|+..-++
T Consensus 220 cNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 220 CNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred cCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 77766 56666666777777777777666 55555544433 2455555553
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.4e-12 Score=140.34 Aligned_cols=249 Identities=22% Similarity=0.251 Sum_probs=179.0
Q ss_pred CCcccceecc--cCceEEEEEEE---cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceE
Q 002238 594 NFSEENILGR--GGFGTVYKGEL---HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 594 ~~~~~~~lg~--G~fg~Vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 667 (948)
.|...+.+|. |.+|.||.+.. .++..+|+|+-+.....+.....=.+|+.....+ .|+|.++....+.+++..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556778999 99999999976 4788999998544333334444446677777777 5999999888888999999
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHH----HHHHHHhccCCCeeecCCCCccEEEcCC-CCeEEee
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR----GVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVAD 742 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivHrDik~~Nill~~~-~~~kl~D 742 (948)
+-+|++. .+|.++.+.. ...++....+.+..+..+ |+.++|+ .+++|-|+||.||+...+ ...+++|
T Consensus 195 iqtE~~~-~sl~~~~~~~----~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTP----CNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeecccc-chhHHhhhcc----cccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCC
Confidence 9999884 6777766432 233555566677777777 9999997 899999999999999999 8899999
Q ss_pred cCCceecCCCCC----ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh
Q 002238 743 FGLVRLAPEGKG----SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI 818 (948)
Q Consensus 743 fGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 818 (948)
||+.....++.- ....+..|...|++||.. .+.++.++|+|++|.+..|..++........-.. |.+-
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W~~~- 338 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS------WSQL- 338 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC------cccc-
Confidence 999887665441 112233678899999975 5678899999999999999999876654331111 1100
Q ss_pred hcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 819 HLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+.. .++ .+.+.....++...+..+++.+|..|++.+.+..
T Consensus 339 ---r~~-------~ip-~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 ---RQG-------YIP-LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ---ccc-------cCc-hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000 011 2222233344556888999999999998766544
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.4e-12 Score=144.40 Aligned_cols=61 Identities=28% Similarity=0.467 Sum_probs=39.2
Q ss_pred EEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCCC
Q 002238 373 TVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 436 (948)
Q Consensus 373 ~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~ 436 (948)
..+.+.+|++.. ++..+++++.|++|++++|.++ .++. +..+.+|+.|++++|.++..+|.
T Consensus 235 ~~l~l~~n~~~~-~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 235 SGLELSNNKLED-LPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred cccccCCceeee-ccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchh
Confidence 333344444432 2455667777777777777777 4444 77777777888887777766664
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.3e-13 Score=149.54 Aligned_cols=195 Identities=23% Similarity=0.375 Sum_probs=157.8
Q ss_pred EEeCCCCCcCCCCc--cccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCC
Q 002238 73 IQIGHQNLQGTLPS--NLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNP 150 (948)
Q Consensus 73 l~l~~~~l~~~~p~--~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 150 (948)
|.|++..+. ..|- .=-.|+--+..||+.|++..++..+..+..|+.|.|..|.|..+++ .+.++..|+.|||+.|+
T Consensus 55 l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~elp~~~~~f~~Le~liLy~n~~r~ip~-~i~~L~~lt~l~ls~Nq 132 (722)
T KOG0532|consen 55 LLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFSELPEEACAFVSLESLILYHNCIRTIPE-AICNLEALTFLDLSSNQ 132 (722)
T ss_pred cccccchhh-cCCCccccccccchhhhhccccccccCchHHHHHHHHHHHHHHhccceecch-hhhhhhHHHHhhhccch
Confidence 445555555 3331 1144666777899999998766677778888889999999887664 48889999999999999
Q ss_pred CCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccC
Q 002238 151 FSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLG 230 (948)
Q Consensus 151 l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~ 230 (948)
++ .+|..+..|+ |+.|-+++|+++ .+|..++ .++.|..||.+.|.+. .+|..+
T Consensus 133 lS--~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig--~~~tl~~ld~s~nei~-slpsql-------------------- 185 (722)
T KOG0532|consen 133 LS--HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIG--LLPTLAHLDVSKNEIQ-SLPSQL-------------------- 185 (722)
T ss_pred hh--cCChhhhcCc-ceeEEEecCccc-cCCcccc--cchhHHHhhhhhhhhh-hchHHh--------------------
Confidence 98 6788887776 888999999987 6677777 7889999999999987 555553
Q ss_pred CCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCC
Q 002238 231 GGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP 304 (948)
Q Consensus 231 ~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p 304 (948)
+++.+|+.|.+..|++...++.+. --.|..||+++|++. .+|-.|.+|..|++|-|.+|.|+..+-
T Consensus 186 ------~~l~slr~l~vrRn~l~~lp~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPA 251 (722)
T KOG0532|consen 186 ------GYLTSLRDLNVRRNHLEDLPEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPA 251 (722)
T ss_pred ------hhHHHHHHHHHhhhhhhhCCHHHh-CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCChH
Confidence 478999999999999998888877 446899999999999 899999999999999999999985443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.1e-11 Score=138.34 Aligned_cols=150 Identities=20% Similarity=0.265 Sum_probs=97.0
Q ss_pred hhcCCcccceecccCceEEEEEEEcC-CcEEEEEEeecCcCC---------------------------hh----h-H--
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVIS---------------------------GK----G-L-- 635 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~---------------------------~~----~-~-- 635 (948)
....|+. +.||+|++|.||+|++++ |+.||||+.+..... .. + .
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3446776 789999999999999987 999999999754210 00 0 0
Q ss_pred ----HHHHHHHHHHHhcC----CCceeeEEeEEEe-CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHH
Q 002238 636 ----TEFKSEIAVLTKVR----HRHLVALLGHCLD-GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 706 (948)
Q Consensus 636 ----~~~~~E~~~l~~l~----H~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~ 706 (948)
-++.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.+.-.- ... ..+.. .++...+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~~---g~d~~---~la~~~v 269 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RAA---GTDMK---LLAERGV 269 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-Hhc---CCCHH---HHHHHHH
Confidence 12455666665553 4444444344433 4567999999999999774211 111 11111 1222222
Q ss_pred HH-HHHHHhccCCCeeecCCCCccEEEcCCC----CeEEeecCCceecCC
Q 002238 707 RG-VEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVADFGLVRLAPE 751 (948)
Q Consensus 707 ~~-l~~LH~~~~~~ivHrDik~~Nill~~~~----~~kl~DfGla~~~~~ 751 (948)
+. +..++ ..|++|+|+||.||+++.++ +++++|||++.....
T Consensus 270 ~~~~~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 270 EVFFTQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 11 22233 27999999999999999888 999999999886543
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.25 E-value=7.6e-12 Score=142.45 Aligned_cols=198 Identities=26% Similarity=0.421 Sum_probs=145.8
Q ss_pred EEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCC-CCcEEEcccccccCCCCccccCCCCCCEEEccCCC
Q 002238 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLA-SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNP 150 (948)
Q Consensus 72 ~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 150 (948)
.+++..+.+...+ ..+..++.++.|++.+|.++.+.+....+. +|+.|++++|++..++ ..+..+++|+.|++++|+
T Consensus 97 ~l~~~~~~~~~~~-~~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~~l~-~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 97 SLDLNLNRLRSNI-SELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLP-SPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeeccccccccCc-hhhhcccceeEEecCCcccccCccccccchhhcccccccccchhhhh-hhhhccccccccccCCch
Confidence 4666666664232 234455778888888888887766666664 7888888888888765 336778888888888888
Q ss_pred CCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccC
Q 002238 151 FSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLG 230 (948)
Q Consensus 151 l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~ 230 (948)
++ .+|.....+++|+.|++++|+++.. |.... ....|++|.+++|++. .++.
T Consensus 175 l~--~l~~~~~~~~~L~~L~ls~N~i~~l-~~~~~--~~~~L~~l~~~~N~~~-~~~~---------------------- 226 (394)
T COG4886 175 LS--DLPKLLSNLSNLNNLDLSGNKISDL-PPEIE--LLSALEELDLSNNSII-ELLS---------------------- 226 (394)
T ss_pred hh--hhhhhhhhhhhhhheeccCCccccC-chhhh--hhhhhhhhhhcCCcce-ecch----------------------
Confidence 87 5677766788888888888888743 33322 3445888888888533 2222
Q ss_pred CCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCC
Q 002238 231 GGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE 305 (948)
Q Consensus 231 ~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 305 (948)
.+.+++++..|.+.+|++...+..+..+.+|+.|++++|.++ .++. ++.+.+|+.|++++|.+...+|.
T Consensus 227 ----~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 227 ----SLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred ----hhhhcccccccccCCceeeeccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchh
Confidence 245788888889999999876666778888999999999999 5665 89999999999999999987775
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.3e-11 Score=120.79 Aligned_cols=130 Identities=21% Similarity=0.184 Sum_probs=95.9
Q ss_pred cceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCcee-eEEeEEEeCCceEEEEEecCCC
Q 002238 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV-ALLGHCLDGNEKLLVFEYMPQG 676 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lv~e~~~~g 676 (948)
.+.|+.|.++.||+++.. ++.|++|+..... .....+.+|+++++.+.+.+++ +++.+ .....++||||++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGT---ELLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCc---ccccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCC
Confidence 356899999999999876 8899999875431 1234568899999998665554 44443 334468999999998
Q ss_pred ChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcc--CCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA--HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
++.+.. . ....++.+++++++.||+.. ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 77 ~l~~~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccccc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 875320 0 11245678999999999732 12369999999999999 6789999999765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.8e-10 Score=127.66 Aligned_cols=166 Identities=16% Similarity=0.222 Sum_probs=125.4
Q ss_pred EcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCCChhHHHHhhhhcCCCCC
Q 002238 614 LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPL 693 (948)
Q Consensus 614 ~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l 693 (948)
..++.+|.|++.+.. +........+-++.++.+|||||++++.....++..|+|+|-+. .|...+.. +
T Consensus 34 k~~~~~vsVF~~~~~--~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------l 101 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRS--NGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------L 101 (690)
T ss_pred eccCCceEEEEEeCC--CchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------h
Confidence 347889999988764 33334567788899999999999999999999999999999884 46666633 2
Q ss_pred CHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCceeeeecccccccCceecc
Q 002238 694 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV 773 (948)
Q Consensus 694 ~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 773 (948)
....+...+.||+.||.+||+ +.+++|++|..+.|+++..|+.||++|-++........ ......---.|..|+.+.
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEID 178 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcC
Confidence 234556678999999999997 57999999999999999999999999987764332221 111111223466676554
Q ss_pred cCCCCchhhHHHHHHHHHHHHhC
Q 002238 774 TGRVTTKVDVFSFGVILMELITG 796 (948)
Q Consensus 774 ~~~~~~~~Dv~s~Gv~l~elltg 796 (948)
... -..|.|-||++++|++.|
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCc
Confidence 332 356999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.5e-10 Score=113.44 Aligned_cols=138 Identities=14% Similarity=0.139 Sum_probs=98.4
Q ss_pred ceecccCceEEEEEEEcC-------CcEEEEEEeecCcCC--------------------hhhHHHHH----HHHHHHHh
Q 002238 599 NILGRGGFGTVYKGELHD-------GTKIAVKRMEAGVIS--------------------GKGLTEFK----SEIAVLTK 647 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~~-------g~~vavK~~~~~~~~--------------------~~~~~~~~----~E~~~l~~ 647 (948)
..||.|--+.||.|...+ +..+|||+.+..... ....+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 479999987532110 01122333 89999999
Q ss_pred cCC--CceeeEEeEEEeCCceEEEEEecCCCChhH-HHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhccCCCeeec
Q 002238 648 VRH--RHLVALLGHCLDGNEKLLVFEYMPQGTLSR-HIFNWAEEGLKPLEWNRRLTIALDVARGVEYL-HGLAHQSFIHR 723 (948)
Q Consensus 648 l~H--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivHr 723 (948)
+.. -++.+.+++ ...++||||+.++.+.. .+.+ ..++..+...+..+++.+|.+| |. .++|||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 943 455666654 45689999997654422 2211 2344455667889999999999 65 899999
Q ss_pred CCCCccEEEcCCCCeEEeecCCceecC
Q 002238 724 DLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 724 Dik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
|+++.||+++ ++.++++|||.+....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 9999999997 4689999999877543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=5.3e-10 Score=106.52 Aligned_cols=134 Identities=24% Similarity=0.329 Sum_probs=101.0
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEeecCcCChhh------HHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKG------LTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
..+++|+-+.+|.+.+. |.++++|.-..+...... ..+-.+|+.++.+++--.|.-.+-+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35889999999999886 556777765433322221 24467899999998655554444456677888999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
++|..|.+.+.. . ...++..+-+-+.-||. .+|||+|+.++||.+..+. +.++||||+...
T Consensus 81 I~G~~lkd~l~~----~--------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEE----A--------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHh----c--------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999888888732 1 24567778888889996 8999999999999998764 999999998743
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.8e-11 Score=122.79 Aligned_cols=136 Identities=22% Similarity=0.288 Sum_probs=109.7
Q ss_pred ccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCcccccc
Q 002238 235 VIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDM 314 (948)
Q Consensus 235 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~ 314 (948)
.+.-+..|++||||+|.|+..-....-++.++.|++++|.|. .+.. +..+++|++||||+|.|+...-
T Consensus 279 ~~dTWq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls~~~G---------- 346 (490)
T KOG1259|consen 279 SADTWQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLAECVG---------- 346 (490)
T ss_pred ecchHhhhhhccccccchhhhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhHhhhh----------
Confidence 344568899999999999977777777899999999999999 5554 9999999999999999973211
Q ss_pred ccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCcc
Q 002238 315 AKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFK 394 (948)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~ 394 (948)
-...++|++.|+|+.|.+... ..++.+=
T Consensus 347 --------------------------------------------------wh~KLGNIKtL~La~N~iE~L--SGL~KLY 374 (490)
T KOG1259|consen 347 --------------------------------------------------WHLKLGNIKTLKLAQNKIETL--SGLRKLY 374 (490)
T ss_pred --------------------------------------------------hHhhhcCEeeeehhhhhHhhh--hhhHhhh
Confidence 122567999999999998632 2356677
Q ss_pred ccceEeCccccccccC-CcCCcCCCCCcEEEccCCcccCCC
Q 002238 395 SLQRLILADNNLSGMI-PEGLSVLGALKELDVSNNQLYGKI 434 (948)
Q Consensus 395 ~L~~L~Ls~N~l~g~i-p~~l~~l~~L~~L~ls~N~l~g~i 434 (948)
+|..||+++|+|...- -..+++|+.|+.|.|.+|+|.+.+
T Consensus 375 SLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 375 SLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 8999999999997322 367899999999999999998754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=7.3e-10 Score=115.38 Aligned_cols=142 Identities=20% Similarity=0.284 Sum_probs=108.0
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCC--CceeeEEeEEEeC---CceEEEEEec
Q 002238 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH--RHLVALLGHCLDG---NEKLLVFEYM 673 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~---~~~~lv~e~~ 673 (948)
+.|+.|.++.||+++..+|+.+++|....... ......+..|+++++.+++ .++.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~-~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGAL-LPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCccc-CcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 56899999999999887678999998765321 1234678999999999975 3456677766553 2568999999
Q ss_pred CCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcc-------------------------------------
Q 002238 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA------------------------------------- 716 (948)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------- 716 (948)
+|.++.+.+.. ..++..++..++.+++++|.+||+..
T Consensus 83 ~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 83 DGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred CCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99888664410 24566677778888888888888421
Q ss_pred ----------------CCCeeecCCCCccEEEcC--CCCeEEeecCCce
Q 002238 717 ----------------HQSFIHRDLKPSNILLGD--DMRAKVADFGLVR 747 (948)
Q Consensus 717 ----------------~~~ivHrDik~~Nill~~--~~~~kl~DfGla~ 747 (948)
...++|+|+++.||+++. ++.+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 256799999999999998 5668999999765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.2e-09 Score=100.48 Aligned_cols=145 Identities=23% Similarity=0.264 Sum_probs=105.7
Q ss_pred ccceecccCceEEEEEEEcCCcEEEEEEeecCcCC------hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 597 EENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS------GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 597 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
...++-+|+-+.|+++.+. |+.++||.-..+... .-..++...|++.+.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4678899999999999987 899888854333221 223456788999999986545443333555666678999
Q ss_pred EecCC-CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC---CeEEeecCCc
Q 002238 671 EYMPQ-GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKVADFGLV 746 (948)
Q Consensus 671 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~---~~kl~DfGla 746 (948)
||++| .++.+++...... ..........+..|-+.+.-||. .+|||+|+..+||++..++ .+.++|||++
T Consensus 90 E~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EeccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecch
Confidence 99976 4777777543222 22222236788899999999996 8999999999999997555 4589999997
Q ss_pred ee
Q 002238 747 RL 748 (948)
Q Consensus 747 ~~ 748 (948)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 64
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.04 E-value=8.4e-11 Score=114.47 Aligned_cols=106 Identities=26% Similarity=0.392 Sum_probs=29.6
Q ss_pred CEEEEEeCCCCCcCCCCcccc-CCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEcc
Q 002238 69 RITRIQIGHQNLQGTLPSNLQ-NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (948)
Q Consensus 69 ~v~~l~l~~~~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 147 (948)
++++|+|.+|.|+. + +.++ .+.+|+.|+|++|.|+.+ +.+..+++|++|+|++|+|+.+.+.....+++|++|+|+
T Consensus 20 ~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l-~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~ 96 (175)
T PF14580_consen 20 KLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL-EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLS 96 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS---S-CHHHHHH-TT--EEE-T
T ss_pred cccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc-cCccChhhhhhcccCCCCCCccccchHHhCCcCCEEECc
Confidence 34556666666552 2 2343 355666666666666542 345556666666666666665543322345666666666
Q ss_pred CCCCCCCCCCccccCCCCCCEEEccCcccc
Q 002238 148 NNPFSSWEIPQSLRNASGLQNFSANSANIT 177 (948)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~ 177 (948)
+|+|..+.--..+..+++|+.|+|.+|.++
T Consensus 97 ~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 97 NNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp TS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 666654333344555555666666655554
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.9e-11 Score=129.34 Aligned_cols=10 Identities=30% Similarity=0.444 Sum_probs=6.6
Q ss_pred CccceEEeCC
Q 002238 58 KWNHVVCIED 67 (948)
Q Consensus 58 ~w~gv~c~~~ 67 (948)
+|.||..++.
T Consensus 30 ~w~GvEWDd~ 39 (505)
T KOG3207|consen 30 KWYGVEWDDP 39 (505)
T ss_pred cceeeEecCC
Confidence 6777777643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=6.9e-11 Score=137.79 Aligned_cols=252 Identities=22% Similarity=0.285 Sum_probs=172.6
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCc-CChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
...+.+.+.+.+-+|+++.++.++-. .|...+.|+..... ......+....+-.+.-..+||-++...--+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34566777788899999999988643 34344444433221 11122333444444444456677776665555667789
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
||++|+.+++|...++... ..+..........+..+.+|||+ ..++|||++|.|.+...++..+++|||...
T Consensus 881 L~~~~~~~~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG-----CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred hhhHHhccCCchhhhhcCC-----CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccc
Confidence 9999999999998886522 23333334455678889999997 558999999999999999999999998432
Q ss_pred ecC------CC-----------------C-------CceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCC
Q 002238 748 LAP------EG-----------------K-------GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 797 (948)
Q Consensus 748 ~~~------~~-----------------~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~ 797 (948)
... .. . ........||+.|.+||...+......+|.|++|++++|.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 110 00 0 01123356999999999999999999999999999999999999
Q ss_pred CCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChH
Q 002238 798 KALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMG 865 (948)
Q Consensus 798 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ 865 (948)
+||....+.... ..+....+....+......+..+++...+..+|.+|-.+.
T Consensus 1033 pp~na~tpq~~f----------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQIF----------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCcchhhhh----------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999887765432 1111122222233333445677899999999999998775
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=9.5e-12 Score=128.19 Aligned_cols=65 Identities=29% Similarity=0.388 Sum_probs=37.3
Q ss_pred cccCCCccEEEccCCcccccCC-----CCCCCCCCcEEeccCCcccc----ccchhhhCCCCCcEEEcccCccc
Q 002238 236 IQNMTSLKEIWLHSNAFSGPLP-----DFSGVKQLESLSLRDNFFTG----PVPDSLVKLESLKIVNMTNNLLQ 300 (948)
Q Consensus 236 l~~l~~L~~L~Ls~N~l~~~~~-----~~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~ 300 (948)
|...+.|+.+.+++|.+...-- .|..+++|++|||.+|-|+- .+...+..+++|++|++++|.+.
T Consensus 181 ~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~ 254 (382)
T KOG1909|consen 181 FQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLE 254 (382)
T ss_pred HHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccc
Confidence 4455667777777776653111 24556666666666666652 12344555566666666666654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.99 E-value=6.6e-11 Score=118.79 Aligned_cols=187 Identities=20% Similarity=0.252 Sum_probs=130.7
Q ss_pred CCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCC---CC--------------------ccccCCC
Q 002238 83 TLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSV---PS--------------------DFFTGLS 139 (948)
Q Consensus 83 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~---~~--------------------~~~~~l~ 139 (948)
.+|-.+.-+.+|..+.++.+.-..+..-...-+.|++|...+..++.. .| .....-.
T Consensus 205 ~l~f~l~~f~~l~~~~~s~~~~~~i~~~~~~kptl~t~~v~~s~~~~~~~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq 284 (490)
T KOG1259|consen 205 RLSFNLNAFRNLKTLKFSALSTENIVDIELLKPTLQTICVHNTTIQDVPSLLPETILADPSGSEPSTSNGSALVSADTWQ 284 (490)
T ss_pred ccccchHHhhhhheeeeeccchhheeceeecCchhheeeeecccccccccccchhhhcCccCCCCCccCCceEEecchHh
Confidence 344455556677777777664332222112234566666655444321 11 1122235
Q ss_pred CCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCccccccccee
Q 002238 140 SLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLW 219 (948)
Q Consensus 140 ~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~ 219 (948)
.|++||||+|.|+ .+..+..-+++++.|++++|.|+.... +. .+++|+.||||+|.++....-.
T Consensus 285 ~LtelDLS~N~I~--~iDESvKL~Pkir~L~lS~N~i~~v~n--La--~L~~L~~LDLS~N~Ls~~~Gwh---------- 348 (490)
T KOG1259|consen 285 ELTELDLSGNLIT--QIDESVKLAPKLRRLILSQNRIRTVQN--LA--ELPQLQLLDLSGNLLAECVGWH---------- 348 (490)
T ss_pred hhhhccccccchh--hhhhhhhhccceeEEeccccceeeehh--hh--hcccceEeecccchhHhhhhhH----------
Confidence 6899999999998 678888889999999999999985543 43 7899999999999987332211
Q ss_pred ccCCCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccc--hhhhCCCCCcEEEcccC
Q 002238 220 VNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVP--DSLVKLESLKIVNMTNN 297 (948)
Q Consensus 220 ~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p--~~l~~l~~L~~L~Ls~N 297 (948)
.++-+++.|.|++|.+. .+..+..+-+|..||+++|+|. .+. ..++++|-|+++.|.+|
T Consensus 349 -----------------~KLGNIKtL~La~N~iE-~LSGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~LPCLE~l~L~~N 409 (490)
T KOG1259|consen 349 -----------------LKLGNIKTLKLAQNKIE-TLSGLRKLYSLVNLDLSSNQIE-ELDEVNHIGNLPCLETLRLTGN 409 (490)
T ss_pred -----------------hhhcCEeeeehhhhhHh-hhhhhHhhhhheeccccccchh-hHHHhcccccccHHHHHhhcCC
Confidence 15678999999999987 4556777888999999999998 332 45889999999999999
Q ss_pred cccccCC
Q 002238 298 LLQGPVP 304 (948)
Q Consensus 298 ~l~g~~p 304 (948)
.+.+.+.
T Consensus 410 Pl~~~vd 416 (490)
T KOG1259|consen 410 PLAGSVD 416 (490)
T ss_pred Cccccch
Confidence 9986543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.99 E-value=5.3e-11 Score=125.91 Aligned_cols=185 Identities=21% Similarity=0.221 Sum_probs=128.2
Q ss_pred cCCCCCcEEEcccCCCCCCCC--CcCCCCCCcEEEcccccccCCC--CccccCCCCCCEEEccCCCCCCCCCCccccCCC
Q 002238 89 QNLTKLERLELQWNSISGPLP--SLNGLASLEVVMLSNNQFTSVP--SDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNAS 164 (948)
Q Consensus 89 ~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~ 164 (948)
.++.+|++..|.+..+....- -...+++++.|||++|-|.... ......|++|+.|+|+.|++..+.-...-..++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 467788888888887765332 3555888999999998887643 334678899999999999887521112223577
Q ss_pred CCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccE
Q 002238 165 GLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKE 244 (948)
Q Consensus 165 ~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~ 244 (948)
.|+.|.|+.|.|+..-...+. ..+|+|+.|+|..|...+..... ...+..|++
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~-~~fPsl~~L~L~~N~~~~~~~~~--------------------------~~i~~~L~~ 250 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWIL-LTFPSLEVLYLEANEIILIKATS--------------------------TKILQTLQE 250 (505)
T ss_pred hhheEEeccCCCCHHHHHHHH-HhCCcHHHhhhhcccccceecch--------------------------hhhhhHHhh
Confidence 889999999988844332222 36889999999999622222211 224567888
Q ss_pred EEccCCcccccC--CCCCCCCCCcEEeccCCcccccc-chh-----hhCCCCCcEEEcccCccc
Q 002238 245 IWLHSNAFSGPL--PDFSGVKQLESLSLRDNFFTGPV-PDS-----LVKLESLKIVNMTNNLLQ 300 (948)
Q Consensus 245 L~Ls~N~l~~~~--~~~~~l~~L~~L~L~~N~l~~~~-p~~-----l~~l~~L~~L~Ls~N~l~ 300 (948)
|||++|++-... +....++.|+.|+++.+.+...- |+. ...+++|++|+++.|++.
T Consensus 251 LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 251 LDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred ccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 888888887644 45677888888888888887432 333 356788888888888885
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.7e-10 Score=125.90 Aligned_cols=249 Identities=18% Similarity=0.168 Sum_probs=175.2
Q ss_pred HhhcCCcccceecccCceEEEEEEEc--CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCce
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 666 (948)
....+|..+..||.|.|+.|+....+ ++..|++|.+........+...-..|+.+...+ .|.++++.+..+..-++.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34567888999999999999998643 678999998876654443333345677776666 689999888777777788
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC-CCeEEeecCC
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGL 745 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~-~~~kl~DfGl 745 (948)
|+=-||++++++..... ....++...++++..|++.++.++|+ +.++|+|+||+||++..+ +..++.|||.
T Consensus 342 ~ip~e~~~~~s~~l~~~-----~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV-----TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred cCchhhhcCcchhhhhH-----HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccc
Confidence 89999999999876552 12456777788999999999999996 899999999999999886 7889999998
Q ss_pred ceecCCCCCceeeeeccccccc--CceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcc
Q 002238 746 VRLAPEGKGSIETRIAGTFGYL--APEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD 823 (948)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 823 (948)
+....-. ......+-+++ +++......+-.+.|+||||.-+.|.++|..--.....
T Consensus 414 ~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------------------ 471 (524)
T KOG0601|consen 414 WTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------------------ 471 (524)
T ss_pred cccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc------------------
Confidence 7642111 11122333444 55555666788999999999999999997643221110
Q ss_pred ccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 824 SFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
...+.......... ....+..+.+.+..+++..||.+.+...+.+
T Consensus 472 -~~~i~~~~~p~~~~---~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 472 -SLTIRSGDTPNLPG---LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred -ceeeecccccCCCc---hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 00000011111111 1134667888889999999999877765443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.6e-11 Score=135.48 Aligned_cols=174 Identities=24% Similarity=0.319 Sum_probs=97.0
Q ss_pred CCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEE
Q 002238 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNF 169 (948)
Q Consensus 90 ~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 169 (948)
.+..++.+++..|.|......+..+++|+.|+|.+|+|..+... +..+++|++|+|++|+|+. -..+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~~i~~~-l~~~~~L~~L~ls~N~I~~---i~~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIEKIENL-LSSLVNLQVLDLSFNKITK---LEGLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhhhhcccccccceeeeeccccchhhcccc-hhhhhcchheecccccccc---ccchhhccchhhh
Confidence 34555666666666665444466666677777777776665542 4566677777777776664 2345555557777
Q ss_pred EccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccC
Q 002238 170 SANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHS 249 (948)
Q Consensus 170 ~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~ 249 (948)
++++|.|+..- .+. .++.|+.+++++|++...-+.. +..+.+|+.+++..
T Consensus 146 ~l~~N~i~~~~--~~~--~l~~L~~l~l~~n~i~~ie~~~--------------------------~~~~~~l~~l~l~~ 195 (414)
T KOG0531|consen 146 NLSGNLISDIS--GLE--SLKSLKLLDLSYNRIVDIENDE--------------------------LSELISLEELDLGG 195 (414)
T ss_pred eeccCcchhcc--CCc--cchhhhcccCCcchhhhhhhhh--------------------------hhhccchHHHhccC
Confidence 77777766332 222 4667777777777766433310 11455666666666
Q ss_pred CcccccCCCCCCCCCCcEEeccCCccccccchhhhCCC--CCcEEEcccCccc
Q 002238 250 NAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLE--SLKIVNMTNNLLQ 300 (948)
Q Consensus 250 N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~--~L~~L~Ls~N~l~ 300 (948)
|.+. .+..+..+..+..+++.+|.++-.-+ +..+. .|+.+++++|.+.
T Consensus 196 n~i~-~i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~ 245 (414)
T KOG0531|consen 196 NSIR-EIEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS 245 (414)
T ss_pred Cchh-cccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc
Confidence 6665 22333334444444666666652222 11222 2566666666665
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.2e-08 Score=104.77 Aligned_cols=271 Identities=15% Similarity=0.157 Sum_probs=165.8
Q ss_pred ccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeE------EEeCCc-eEE
Q 002238 597 EENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGH------CLDGNE-KLL 668 (948)
Q Consensus 597 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~------~~~~~~-~~l 668 (948)
..+.||+|+.+.+|-.- .-...+-|+.... ..... .+.+++|... .||-+-.-+.+ ..++.. .-+
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~P--ppa~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAP--PPAAQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCC--CchHH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 45779999999999652 1122355666543 11111 1223334443 56654431211 112222 567
Q ss_pred EEEecCCCChhHHHHh--hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCc
Q 002238 669 VFEYMPQGTLSRHIFN--WAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~--~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla 746 (948)
+|..+++..=-..+.. ..........|...++++..+|.+.+-||+ .|.+-+|+.++|+|+++++.|.|+|-..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccce
Confidence 8888876532222211 122334568999999999999999999997 89999999999999999999999986543
Q ss_pred eecCCCCCceeeeecccccccCceecc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCchh---hhhHHHHHHH
Q 002238 747 RLAPEGKGSIETRIAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITG-RKALDESQPEE---SMHLVTWFRR 817 (948)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~elltg-~~p~~~~~~~~---~~~~~~~~~~ 817 (948)
... ..+......+|...|++||.-. +-+-+...|.|.+||++++++.| ++||.+..-.. ......+...
T Consensus 165 qi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 165 QIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred eec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 333 2223444567899999999764 34567789999999999999996 99998643210 0000010100
Q ss_pred hh-cCccccccccCcccCCccchHHHHHHHHHHHHHhcccC--CCCCCChHHHHHHHHhhhhhhCCC
Q 002238 818 IH-LSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCARE--PYQRPDMGHAVNVLSSLVELWKPT 881 (948)
Q Consensus 818 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~--P~~RPt~~ev~~~L~~~~~~~~~~ 881 (948)
.. ...+.-.... ..+........+..+.-+..+|+... +.-||+++..+..|..+.+...+.
T Consensus 243 ~f~ya~~~~~g~~--p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C 307 (637)
T COG4248 243 RFAYASDQRRGLK--PPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKC 307 (637)
T ss_pred eeeechhccCCCC--CCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhh
Confidence 00 0000000000 01112222334456777888888663 568999999999998887765443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.93 E-value=8.2e-10 Score=107.61 Aligned_cols=111 Identities=32% Similarity=0.447 Sum_probs=43.0
Q ss_pred cccCCCCCcEEEcccCCCCCCCCCcC-CCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccc-cCCC
Q 002238 87 NLQNLTKLERLELQWNSISGPLPSLN-GLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSL-RNAS 164 (948)
Q Consensus 87 ~l~~l~~L~~L~L~~N~l~~~~p~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~-~~l~ 164 (948)
.+.+...+++|+|++|.|+.+ ..++ .+.+|+.|+|++|.|+.+.. +..++.|++|+|++|+|+ .+...+ ..++
T Consensus 14 ~~~n~~~~~~L~L~~n~I~~I-e~L~~~l~~L~~L~Ls~N~I~~l~~--l~~L~~L~~L~L~~N~I~--~i~~~l~~~lp 88 (175)
T PF14580_consen 14 QYNNPVKLRELNLRGNQISTI-ENLGATLDKLEVLDLSNNQITKLEG--LPGLPRLKTLDLSNNRIS--SISEGLDKNLP 88 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S--TT------TT--EEE--SS-----S-CHHHHHH-T
T ss_pred ccccccccccccccccccccc-cchhhhhcCCCEEECCCCCCccccC--ccChhhhhhcccCCCCCC--ccccchHHhCC
Confidence 355666799999999999974 4565 58999999999999998763 889999999999999999 466555 4699
Q ss_pred CCCEEEccCccccccCC-CCCCCCCCCCCcEEEcccccccc
Q 002238 165 GLQNFSANSANITGQIP-SFFGPDEFPGLTILHLAFNQLIG 204 (948)
Q Consensus 165 ~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~Ls~N~l~~ 204 (948)
+|+.|+|++|+|...-- ..+ ..+++|++|+|.+|.++.
T Consensus 89 ~L~~L~L~~N~I~~l~~l~~L--~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 89 NLQELYLSNNKISDLNELEPL--SSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp T--EEE-TTS---SCCCCGGG--GG-TT--EEE-TT-GGGG
T ss_pred cCCEEECcCCcCCChHHhHHH--HcCCCcceeeccCCcccc
Confidence 99999999999975422 233 379999999999999873
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.1e-10 Score=130.83 Aligned_cols=61 Identities=28% Similarity=0.390 Sum_probs=39.0
Q ss_pred cCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchh-hhCCCCCcEEEcccCccc
Q 002238 238 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDS-LVKLESLKIVNMTNNLLQ 300 (948)
Q Consensus 238 ~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~ 300 (948)
.++.|+.|++++|.++ .+..+..++.|+.+++++|++. .+... ...+.+|+.+++.+|.+.
T Consensus 138 ~l~~L~~L~l~~N~i~-~~~~~~~l~~L~~l~l~~n~i~-~ie~~~~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 138 TLTLLKELNLSGNLIS-DISGLESLKSLKLLDLSYNRIV-DIENDELSELISLEELDLGGNSIR 199 (414)
T ss_pred hccchhhheeccCcch-hccCCccchhhhcccCCcchhh-hhhhhhhhhccchHHHhccCCchh
Confidence 4555677777777776 3444555677777777777777 33332 466677777777777665
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=5.8e-08 Score=102.43 Aligned_cols=143 Identities=15% Similarity=0.151 Sum_probs=100.8
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEeecCcCCh---------hhHHHHHHHHHHHHhcCCCc--eeeEEeEEEe-----
Q 002238 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISG---------KGLTEFKSEIAVLTKVRHRH--LVALLGHCLD----- 662 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~---------~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~----- 662 (948)
+.+-+.....|+++.+. |+.|.||+........ .....+.+|...+.++..-+ .++.+++...
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 44544445567787775 8899999774332110 11124789999998884322 3344444432
Q ss_pred CCceEEEEEecCCC-ChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC-------
Q 002238 663 GNEKLLVFEYMPQG-TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD------- 734 (948)
Q Consensus 663 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~------- 734 (948)
....++|||++++. +|.+++..+.. .+.+...+..++.+++..+.-||. .||+|+|+++.|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCC
Confidence 23468999999886 79888754322 344556677899999999999997 89999999999999985
Q ss_pred CCCeEEeecCCcee
Q 002238 735 DMRAKVADFGLVRL 748 (948)
Q Consensus 735 ~~~~kl~DfGla~~ 748 (948)
+..+.++||+.++.
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46799999997753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=4.3e-08 Score=97.27 Aligned_cols=128 Identities=23% Similarity=0.254 Sum_probs=82.2
Q ss_pred EEEEEEEcCCcEEEEEEeecCcCC------------------------hhhHHHHHHHHHHHHhcCCC--ceeeEEeEEE
Q 002238 608 TVYKGELHDGTKIAVKRMEAGVIS------------------------GKGLTEFKSEIAVLTKVRHR--HLVALLGHCL 661 (948)
Q Consensus 608 ~Vy~~~~~~g~~vavK~~~~~~~~------------------------~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~ 661 (948)
.||.|...+|+.+|||..+..... ........+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999888999999987432110 01123467899999999765 456665442
Q ss_pred eCCceEEEEEecC--CCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhccCCCeeecCCCCccEEEcCCCCe
Q 002238 662 DGNEKLLVFEYMP--QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL-HGLAHQSFIHRDLKPSNILLGDDMRA 738 (948)
Q Consensus 662 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivHrDik~~Nill~~~~~~ 738 (948)
..++||||++ |..+.++. .. .++......++.+++..+..+ |. .|++|+|+.+.||+++++ .+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~-~~------~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK-DV------DLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH-HC------GGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CE
T ss_pred ---CCEEEEEecCCCccchhhHH-hc------cccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eE
Confidence 4479999998 55554433 21 111223455777888866664 54 899999999999999987 99
Q ss_pred EEeecCCceecC
Q 002238 739 KVADFGLVRLAP 750 (948)
Q Consensus 739 kl~DfGla~~~~ 750 (948)
.++|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999887554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.3e-07 Score=102.94 Aligned_cols=171 Identities=20% Similarity=0.280 Sum_probs=126.2
Q ss_pred ceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe----CCceEEEEEecCC-CChh
Q 002238 606 FGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD----GNEKLLVFEYMPQ-GTLS 679 (948)
Q Consensus 606 fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~ 679 (948)
-.+.|++... ||..|+.|+++... .........-+++++++.|+|+|++.+++.. +...++||+|.++ ++|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r--~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDR--DQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeecccc--ccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3678999654 89999999995431 1122233456789999999999999988763 4457899999986 4666
Q ss_pred HHHHhhh----------hcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 680 RHIFNWA----------EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 680 ~~l~~~~----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
+.-..-. -......++...|.++.|+..||.++|+ .|+..+-+.+.+|+++.+.+++|+..|.....
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeee
Confidence 5543211 1112346788999999999999999997 79999999999999999999999988876544
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCC
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKA 799 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p 799 (948)
..+.. |-+ +.-.+-|.=.||.+++-|.||..-
T Consensus 444 ~~d~~---------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDPT---------------EPL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCCC---------------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 33320 001 112467888999999999999653
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.75 E-value=8.3e-09 Score=82.57 Aligned_cols=61 Identities=33% Similarity=0.517 Sum_probs=57.4
Q ss_pred CceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcc
Q 002238 370 GNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430 (948)
Q Consensus 370 ~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l 430 (948)
++|+.|++++|++....+..|.++++|++|+|++|+++...|..|..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4789999999999988888999999999999999999988889999999999999999986
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.74 E-value=4.6e-09 Score=84.08 Aligned_cols=58 Identities=40% Similarity=0.637 Sum_probs=34.6
Q ss_pred CCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCC
Q 002238 93 KLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNP 150 (948)
Q Consensus 93 ~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 150 (948)
+|++|+|++|+|+.+++ .|.++++|++|+|++|.++.+++++|.++++|++|+|++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 45566666666665544 45556666666666666666666666666666666666654
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=8.4e-09 Score=125.35 Aligned_cols=275 Identities=24% Similarity=0.262 Sum_probs=134.4
Q ss_pred CCcEEEcccCC--CCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEE
Q 002238 93 KLERLELQWNS--ISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNF 169 (948)
Q Consensus 93 ~L~~L~L~~N~--l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 169 (948)
.|++|-+..|. +..... .|..++.|++|||++|.=-+..|..++.|-+|++|+|++..+. .+|.++.+|++|.+|
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~--~LP~~l~~Lk~L~~L 623 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS--HLPSGLGNLKKLIYL 623 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc--ccchHHHHHHhhhee
Confidence 45555555553 222211 2444555555555555444444555555555555555555555 455555555555555
Q ss_pred EccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccC
Q 002238 170 SANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHS 249 (948)
Q Consensus 170 ~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~ 249 (948)
++..+.-...+|.... .+++|++|.|..-.. .........+.++.+|+.+....
T Consensus 624 nl~~~~~l~~~~~i~~--~L~~Lr~L~l~~s~~------------------------~~~~~~l~el~~Le~L~~ls~~~ 677 (889)
T KOG4658|consen 624 NLEVTGRLESIPGILL--ELQSLRVLRLPRSAL------------------------SNDKLLLKELENLEHLENLSITI 677 (889)
T ss_pred ccccccccccccchhh--hcccccEEEeecccc------------------------ccchhhHHhhhcccchhhheeec
Confidence 5555544444443332 355555555443331 11111122344566666666654
Q ss_pred CcccccCCCCCCCCCCc----EEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCC
Q 002238 250 NAFSGPLPDFSGVKQLE----SLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPS 325 (948)
Q Consensus 250 N~l~~~~~~~~~l~~L~----~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~ 325 (948)
... ..+..+..+..|. .+.+..+... ..+..+..+.+|+.|.+.++......-.... ......
T Consensus 678 ~s~-~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~--~~~~~~--------- 744 (889)
T KOG4658|consen 678 SSV-LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEE--SLIVLL--------- 744 (889)
T ss_pred chh-HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhccccc--ccchhh---------
Confidence 444 2223344444433 4444444544 5677788899999999988887643221110 000000
Q ss_pred CCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCcccc
Q 002238 326 PGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNN 405 (948)
Q Consensus 326 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~ 405 (948)
+++.+..+ .....+ +. ....|. -..++|+.|.+..+.....+.+....+..+..+-+..+.
T Consensus 745 ---~f~~l~~~---~~~~~~---------~~-r~l~~~---~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~ 805 (889)
T KOG4658|consen 745 ---CFPNLSKV---SILNCH---------ML-RDLTWL---LFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNK 805 (889)
T ss_pred ---hHHHHHHH---Hhhccc---------cc-cccchh---hccCcccEEEEecccccccCCCHHHHhhhcccEEecccc
Confidence 01111110 000000 00 001111 123578888888887777777677777777776677777
Q ss_pred cccc-CCcCCcCCCCCcEEEccC
Q 002238 406 LSGM-IPEGLSVLGALKELDVSN 427 (948)
Q Consensus 406 l~g~-ip~~l~~l~~L~~L~ls~ 427 (948)
+.+. .-.+...++++..+.+++
T Consensus 806 ~~~l~~~~~l~~l~~i~~~~l~~ 828 (889)
T KOG4658|consen 806 LEGLRMLCSLGGLPQLYWLPLSF 828 (889)
T ss_pred cccceeeecCCCCceeEecccCc
Confidence 7655 233444444444444443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.3e-09 Score=110.82 Aligned_cols=187 Identities=17% Similarity=0.208 Sum_probs=91.3
Q ss_pred cCCCCCcEEEcccCCCCCC-CC----CcCCCCCCcEEEcccccccCCCCc-------------cccCCCCCCEEEccCCC
Q 002238 89 QNLTKLERLELQWNSISGP-LP----SLNGLASLEVVMLSNNQFTSVPSD-------------FFTGLSSLQSIEIDNNP 150 (948)
Q Consensus 89 ~~l~~L~~L~L~~N~l~~~-~p----~~~~l~~L~~L~L~~N~l~~~~~~-------------~~~~l~~L~~L~Ls~N~ 150 (948)
...++|+.||||+|.|... ++ -+.+.+.|++|+|.+|.+...-.. -...-++|+++..++|+
T Consensus 89 ~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNr 168 (382)
T KOG1909|consen 89 LGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNR 168 (382)
T ss_pred hcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccc
Confidence 3344555556655555431 11 133455555555555555422111 12233455555556555
Q ss_pred CCCCC---CCccccCCCCCCEEEccCccccccCC----CCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCC
Q 002238 151 FSSWE---IPQSLRNASGLQNFSANSANITGQIP----SFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQ 223 (948)
Q Consensus 151 l~~~~---~p~~~~~l~~L~~L~l~~n~l~~~~p----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~ 223 (948)
+.... +-..|...+.|+.+.+..|.|..... ..| ..++.|++|||..|-++..-...+
T Consensus 169 len~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal--~~~~~LevLdl~DNtft~egs~~L------------- 233 (382)
T KOG1909|consen 169 LENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEAL--EHCPHLEVLDLRDNTFTLEGSVAL------------- 233 (382)
T ss_pred cccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHH--HhCCcceeeecccchhhhHHHHHH-------------
Confidence 55311 11234445555556665555532111 122 245556666666665542211111
Q ss_pred CCCCccCCCccccccCCCccEEEccCCcccccCC-----CC-CCCCCCcEEeccCCcccc----ccchhhhCCCCCcEEE
Q 002238 224 NGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-----DF-SGVKQLESLSLRDNFFTG----PVPDSLVKLESLKIVN 293 (948)
Q Consensus 224 ~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-----~~-~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~ 293 (948)
.+.+..++.|++|+++++.++.... .+ .+.+.|+.|.|.+|.|+. .+-.++...+.|..|+
T Consensus 234 ---------akaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLn 304 (382)
T KOG1909|consen 234 ---------AKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLN 304 (382)
T ss_pred ---------HHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhc
Confidence 1234455666777777776654221 12 225667777777776662 2233445566677777
Q ss_pred cccCcc
Q 002238 294 MTNNLL 299 (948)
Q Consensus 294 Ls~N~l 299 (948)
|++|.+
T Consensus 305 LngN~l 310 (382)
T KOG1909|consen 305 LNGNRL 310 (382)
T ss_pred CCcccc
Confidence 777766
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.9e-07 Score=93.43 Aligned_cols=136 Identities=22% Similarity=0.189 Sum_probs=94.3
Q ss_pred CcccceecccCceEEEEEEEcCCcEEEEEEeecCcC--------------------ChhhHHHHHHHHHHHHhcCCC--c
Q 002238 595 FSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVI--------------------SGKGLTEFKSEIAVLTKVRHR--H 652 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~--------------------~~~~~~~~~~E~~~l~~l~H~--n 652 (948)
..++..||.|--+.||.|....|.++|||.=+.... -.-.....++|.++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456789999999999999998999999994321110 011223467899999999644 5
Q ss_pred eeeEEeEEEeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE
Q 002238 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732 (948)
Q Consensus 653 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill 732 (948)
+.+.++ -+...+||||++|-.|...- ++....-.|+..|++-+.-+-. .||||+|+.+-||++
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV 235 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILV 235 (304)
T ss_pred CCCccc----cccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEE
Confidence 666553 34558999999987665332 1111222344444444443333 799999999999999
Q ss_pred cCCCCeEEeecCCce
Q 002238 733 GDDMRAKVADFGLVR 747 (948)
Q Consensus 733 ~~~~~~kl~DfGla~ 747 (948)
+++|.+.++||--+.
T Consensus 236 ~~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 TEDGDIVVIDWPQAV 250 (304)
T ss_pred ecCCCEEEEeCcccc
Confidence 999999999996543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=4.5e-07 Score=103.59 Aligned_cols=141 Identities=21% Similarity=0.317 Sum_probs=93.4
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEeecCcCCh----------------------------hhHH----------HHHH
Q 002238 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISG----------------------------KGLT----------EFKS 640 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~----------------------------~~~~----------~~~~ 640 (948)
+.|+.++-|.||+|++++|+.||||+.+...... ...+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6899999999999999999999999875421100 0001 2445
Q ss_pred HHHHHHhcC-----CCceeeEEeEEE-eCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHH-HHHH
Q 002238 641 EIAVLTKVR-----HRHLVALLGHCL-DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV-EYLH 713 (948)
Q Consensus 641 E~~~l~~l~-----H~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH 713 (948)
|+..+.+++ .+++ ++=.++. -.....|+|||++|-.+.+...- +. ...+ +..++..++++. ..+-
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l--~~--~g~d---~k~ia~~~~~~f~~q~~ 282 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAAL--KS--AGID---RKELAELLVRAFLRQLL 282 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHH--Hh--cCCC---HHHHHHHHHHHHHHHHH
Confidence 666666652 2333 2223333 35677999999999988877422 11 2333 223444444432 2222
Q ss_pred hccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 714 ~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
..|+.|.|..|.||+++.++++.+.|||+.....
T Consensus 283 ---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 283 ---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ---hcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 2689999999999999999999999999977554
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=9.3e-08 Score=116.42 Aligned_cols=156 Identities=22% Similarity=0.387 Sum_probs=121.3
Q ss_pred cCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEccccc--ccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCC
Q 002238 89 QNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQ--FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGL 166 (948)
Q Consensus 89 ~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~--l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L 166 (948)
.+....++..+.+|.+........ .++|++|-+.+|. +..++.++|..++.|+.|||++|.=.+ ++|..++.|-+|
T Consensus 520 ~~~~~~rr~s~~~~~~~~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~-~LP~~I~~Li~L 597 (889)
T KOG4658|consen 520 KSWNSVRRMSLMNNKIEHIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLS-KLPSSIGELVHL 597 (889)
T ss_pred cchhheeEEEEeccchhhccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccC-cCChHHhhhhhh
Confidence 344778999999998875443333 3479999999997 888888899999999999999986544 899999999999
Q ss_pred CEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEE
Q 002238 167 QNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIW 246 (948)
Q Consensus 167 ~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~ 246 (948)
++|+|++..++ .+|..++ .|..|.+|++..+.-...+|... ..+++|++|.
T Consensus 598 ryL~L~~t~I~-~LP~~l~--~Lk~L~~Lnl~~~~~l~~~~~i~--------------------------~~L~~Lr~L~ 648 (889)
T KOG4658|consen 598 RYLDLSDTGIS-HLPSGLG--NLKKLIYLNLEVTGRLESIPGIL--------------------------LELQSLRVLR 648 (889)
T ss_pred hcccccCCCcc-ccchHHH--HHHhhheeccccccccccccchh--------------------------hhcccccEEE
Confidence 99999999998 7888887 89999999999987655554432 3588999999
Q ss_pred ccCCccccc---CCCCCCCCCCcEEeccCCcc
Q 002238 247 LHSNAFSGP---LPDFSGVKQLESLSLRDNFF 275 (948)
Q Consensus 247 Ls~N~l~~~---~~~~~~l~~L~~L~L~~N~l 275 (948)
|..-..... ...+.++.+|+.+.......
T Consensus 649 l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~ 680 (889)
T KOG4658|consen 649 LPRSALSNDKLLLKELENLEHLENLSITISSV 680 (889)
T ss_pred eeccccccchhhHHhhhcccchhhheeecchh
Confidence 988764332 22355566666666644443
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.4e-09 Score=119.65 Aligned_cols=130 Identities=29% Similarity=0.296 Sum_probs=94.1
Q ss_pred CCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCcccccccccc
Q 002238 239 MTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGS 318 (948)
Q Consensus 239 l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~ 318 (948)
+..|...+.++|.+.-.-..+.-++.|+.|+|++|+++ .+. .+..+++|++|||++|.|+ .+|.+...
T Consensus 163 Wn~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~-~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~--------- 230 (1096)
T KOG1859|consen 163 WNKLATASFSYNRLVLMDESLQLLPALESLNLSHNKFT-KVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMV--------- 230 (1096)
T ss_pred hhhHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhh-hhH-HHHhcccccccccccchhc-cccccchh---------
Confidence 45688899999999876667778899999999999998 344 7899999999999999997 34432100
Q ss_pred CCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccce
Q 002238 319 NNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQR 398 (948)
Q Consensus 319 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~ 398 (948)
-| +|..|+|+||.++... .+.+|.+|+.
T Consensus 231 -----------------------------------------------gc---~L~~L~lrnN~l~tL~--gie~LksL~~ 258 (1096)
T KOG1859|consen 231 -----------------------------------------------GC---KLQLLNLRNNALTTLR--GIENLKSLYG 258 (1096)
T ss_pred -----------------------------------------------hh---hheeeeecccHHHhhh--hHHhhhhhhc
Confidence 00 4777888888876432 3667788888
Q ss_pred EeCccccccccC-CcCCcCCCCCcEEEccCCcccC
Q 002238 399 LILADNNLSGMI-PEGLSVLGALKELDVSNNQLYG 432 (948)
Q Consensus 399 L~Ls~N~l~g~i-p~~l~~l~~L~~L~ls~N~l~g 432 (948)
|||++|-|++-- -.-+..|..|+.|+|.+|+|.-
T Consensus 259 LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 259 LDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred cchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 888888776432 1224556677778888887753
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.3e-06 Score=89.23 Aligned_cols=125 Identities=24% Similarity=0.294 Sum_probs=89.6
Q ss_pred CcEEEEEEeecCcCC-----hhhHHHHHHHHHHHHhcCCC--ceeeEEeEEEeC----CceEEEEEecCCC-ChhHHHHh
Q 002238 617 GTKIAVKRMEAGVIS-----GKGLTEFKSEIAVLTKVRHR--HLVALLGHCLDG----NEKLLVFEYMPQG-TLSRHIFN 684 (948)
Q Consensus 617 g~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~ 684 (948)
++.+-+|........ ........+|...+..+... ...+.+++.... ...++|+|++++. +|.+++..
T Consensus 32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~ 111 (206)
T PF06293_consen 32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ 111 (206)
T ss_pred ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence 556666654322111 13345688899988888433 344555555542 2348999999884 78888854
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC---CeEEeecCCceec
Q 002238 685 WAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKVADFGLVRLA 749 (948)
Q Consensus 685 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~---~~kl~DfGla~~~ 749 (948)
.. ..+......++.+++..++-||+ .||+|+|+++.|||++.++ .+.++||+-++..
T Consensus 112 ~~-----~~~~~~~~~ll~~l~~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 112 WE-----QLDPSQRRELLRALARLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hc-----ccchhhHHHHHHHHHHHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 21 14555677899999999999997 8999999999999999887 8999999976643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.47 E-value=3.6e-06 Score=83.91 Aligned_cols=140 Identities=21% Similarity=0.175 Sum_probs=102.6
Q ss_pred ecccCceEEEEEEEcCCcEEEEEEeecCcC---C-hhhHHHHHHHHHHHHhcCC--CceeeEEeEEEe--C--CceEEEE
Q 002238 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVI---S-GKGLTEFKSEIAVLTKVRH--RHLVALLGHCLD--G--NEKLLVF 670 (948)
Q Consensus 601 lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~---~-~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~--~--~~~~lv~ 670 (948)
-|+||-+.|++..+. |+.+-+|+-..... . +.....|.+|+..++++.. -.+.+.+.+... + ..-+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467999999998876 66799997642111 1 4466889999999999953 234455422222 1 2358999
Q ss_pred EecCC-CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCC--eEEeecCCce
Q 002238 671 EYMPQ-GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR--AKVADFGLVR 747 (948)
Q Consensus 671 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~--~kl~DfGla~ 747 (948)
|-++| -+|.+++.. ....+.+...+..+..++++.++-||+ .|+.|+|+.+.||+++.++. ++++||--++
T Consensus 105 e~L~g~~~L~~~l~~---~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQ---HAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhc---CCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 98754 478887743 222456677788999999999999997 89999999999999986666 9999997554
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.7e-08 Score=100.38 Aligned_cols=187 Identities=18% Similarity=0.189 Sum_probs=103.4
Q ss_pred CCCCcEEEcccCCCCCCCC---CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCC
Q 002238 91 LTKLERLELQWNSISGPLP---SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ 167 (948)
Q Consensus 91 l~~L~~L~L~~N~l~~~~p---~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 167 (948)
.+.+++|||.+|.|+..-. -+.+|+.|++|+|+.|++...+...-..+.+|++|-|.+..+..-.....+..++.++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 4677888888888876322 2556888888888888887766443246678888888887776534556677777888
Q ss_pred EEEccCccccccCCC--CCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEE
Q 002238 168 NFSANSANITGQIPS--FFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEI 245 (948)
Q Consensus 168 ~L~l~~n~l~~~~p~--~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L 245 (948)
.|+++.|++....-+ ... ..-+.+..|++-.|... +|.+-+. .-.-++++..+
T Consensus 150 elHmS~N~~rq~n~Dd~c~e-~~s~~v~tlh~~~c~~~--------------~w~~~~~----------l~r~Fpnv~sv 204 (418)
T KOG2982|consen 150 ELHMSDNSLRQLNLDDNCIE-DWSTEVLTLHQLPCLEQ--------------LWLNKNK----------LSRIFPNVNSV 204 (418)
T ss_pred hhhhccchhhhhcccccccc-ccchhhhhhhcCCcHHH--------------HHHHHHh----------HHhhcccchhe
Confidence 888877754322111 110 01123333433333211 0000000 00123555666
Q ss_pred EccCCcccccCC--CCCCCCCCcEEeccCCccccc-cchhhhCCCCCcEEEcccCccccc
Q 002238 246 WLHSNAFSGPLP--DFSGVKQLESLSLRDNFFTGP-VPDSLVKLESLKIVNMTNNLLQGP 302 (948)
Q Consensus 246 ~Ls~N~l~~~~~--~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~g~ 302 (948)
.+..|.+...-. .+..++.+.-|.|+.|+|..- --+.+..+++|..|-+++|.|...
T Consensus 205 ~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~ 264 (418)
T KOG2982|consen 205 FVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDP 264 (418)
T ss_pred eeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccccc
Confidence 666665554221 233445555666666666521 124456666666677777666543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=7.2e-08 Score=109.13 Aligned_cols=150 Identities=21% Similarity=0.264 Sum_probs=102.5
Q ss_pred HHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCce--------eeeecccccccCceeccc
Q 002238 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI--------ETRIAGTFGYLAPEYAVT 774 (948)
Q Consensus 703 ~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~ 774 (948)
.+++.|+.|+|. ..++||+.|.|++|.++..+..||+.|+.+.....+.... ..-..-...|.|||++..
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 455589999998 5889999999999999999999999999876433322111 111223457999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCC-CCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHh
Q 002238 775 GRVTTKVDVFSFGVILMELITGRKA-LDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHC 853 (948)
Q Consensus 775 ~~~~~~~Dv~s~Gv~l~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 853 (948)
...+.++|+||+|+++|.+..|..+ +............ +. ... ........+.+.++.+-+.++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~----~~---~~~--------~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS----RN---LLN--------AGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh----hc---ccc--------cccccccccCcHHHHHHHHHH
Confidence 8889999999999999999954444 4332211111000 00 000 000111234556788999999
Q ss_pred cccCCCCCCChHHHHH
Q 002238 854 CAREPYQRPDMGHAVN 869 (948)
Q Consensus 854 ~~~~P~~RPt~~ev~~ 869 (948)
+..++..||++.++..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 9999999998766654
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.35 E-value=6e-08 Score=97.96 Aligned_cols=85 Identities=18% Similarity=0.220 Sum_probs=44.9
Q ss_pred CCCcEEEcccCCCCCCCC--CcCC-CCCCcEEEcccccccC--CCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCC
Q 002238 92 TKLERLELQWNSISGPLP--SLNG-LASLEVVMLSNNQFTS--VPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGL 166 (948)
Q Consensus 92 ~~L~~L~L~~N~l~~~~p--~~~~-l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L 166 (948)
..++-|.+.++.|...-. .|+. .+.+++|||.+|.|+. .+...+.+|+.|++|+|+.|++.. .|-.--..+.+|
T Consensus 45 ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s-~I~~lp~p~~nl 123 (418)
T KOG2982|consen 45 RALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSS-DIKSLPLPLKNL 123 (418)
T ss_pred cchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCC-ccccCcccccce
Confidence 344455555555543222 2333 5567777777777774 233345667777777777776663 221111234455
Q ss_pred CEEEccCcccc
Q 002238 167 QNFSANSANIT 177 (948)
Q Consensus 167 ~~L~l~~n~l~ 177 (948)
+.|-|.+..+.
T Consensus 124 ~~lVLNgT~L~ 134 (418)
T KOG2982|consen 124 RVLVLNGTGLS 134 (418)
T ss_pred EEEEEcCCCCC
Confidence 55555554443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.31 E-value=7.3e-06 Score=84.85 Aligned_cols=141 Identities=18% Similarity=0.205 Sum_probs=84.9
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCc--eeeEEeEEEeCCceEEEEEecCCC
Q 002238 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH--LVALLGHCLDGNEKLLVFEYMPQG 676 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~g 676 (948)
..||+|..+.||+. .|..+++|..... .......+|.++++.+..-. +.+.+++....+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~----~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG----FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC----CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 56899999999984 2567888987542 13355789999999985433 467777777777788999999986
Q ss_pred C-hhHHH------------------HhhhhcCCCCCCHHHHHH-HHH----------HHHH-HHHHHHhc-cCCCeeecC
Q 002238 677 T-LSRHI------------------FNWAEEGLKPLEWNRRLT-IAL----------DVAR-GVEYLHGL-AHQSFIHRD 724 (948)
Q Consensus 677 s-L~~~l------------------~~~~~~~~~~l~~~~~~~-i~~----------~i~~-~l~~LH~~-~~~~ivHrD 724 (948)
+ +...+ .....-............ +-. .+.+ ..++|... ....++|+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 3 21111 000000000111111000 000 0011 12222211 134678999
Q ss_pred CCCccEEEcCCCCeEEeecCCce
Q 002238 725 LKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 725 ik~~Nill~~~~~~kl~DfGla~ 747 (948)
+.|.||++++++ +.++||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999888 9999998654
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 948 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-51 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-49 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-46 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-45 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-43 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-43 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-43 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-40 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-27 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-25 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-24 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-24 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-24 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-24 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-24 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-24 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-24 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-24 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-24 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-24 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-24 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-24 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-24 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-24 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-24 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-23 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-23 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-23 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-23 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-23 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-23 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-23 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-23 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-23 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-22 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-22 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-21 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-21 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-21 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-21 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-21 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-21 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-21 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-21 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-21 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-21 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-21 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-21 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-21 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-21 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-20 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-20 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-20 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-20 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-20 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-20 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-20 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-20 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-20 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-20 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-20 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-20 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-19 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-19 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-19 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-19 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-19 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-19 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-19 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-19 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-19 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-19 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-19 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-19 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-19 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-19 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-18 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-18 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-18 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-18 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-18 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-18 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-17 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-17 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 9e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-16 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-16 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-15 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-14 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-14 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-14 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-14 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-14 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-11 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-10 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-06 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 3e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 398 bits (1024), Expect = e-132
Identities = 109/316 (34%), Positives = 169/316 (53%), Gaps = 20/316 (6%)
Query: 569 EPGDIQMLEAGNMVISIQVLRNVTNNFSEE------NILGRGGFGTVYKGELHDGTKIAV 622
E +++ + S L+NVTNNF E N +G GGFG VYKG + + T +AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 623 KRMEAGVI--SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSR 680
K++ A V + + +F EI V+ K +H +LV LLG DG++ LV+ YMP G+L
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 681 HIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 740
+ +G PL W+ R IA A G+ +LH IHRD+K +NILL + AK+
Sbjct: 120 RLSCL--DGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKI 174
Query: 741 ADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKA 799
+DFGL R + + + + +RI GT Y+APE + G +T K D++SFGV+L+E+ITG A
Sbjct: 175 SDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPA 233
Query: 800 LDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPY 859
+DE + + L+ I + + ID +N+ S+ + +A C +
Sbjct: 234 VDEHREPQ--LLLDIKEEIEDEEKTIEDYIDK--KMNDADSTSVEAMYSVASQCLHEKKN 289
Query: 860 QRPDMGHAVNVLSSLV 875
+RPD+ +L +
Sbjct: 290 KRPDIKKVQQLLQEMT 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 379 bits (976), Expect = e-124
Identities = 108/319 (33%), Positives = 172/319 (53%), Gaps = 9/319 (2%)
Query: 560 SETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTK 619
S+ + ++ + + + L TNNF + ++G G FG VYKG L DG K
Sbjct: 6 SKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK 65
Query: 620 IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLS 679
+A+KR S +G+ EF++EI L+ RH HLV+L+G C + NE +L+++YM G L
Sbjct: 66 VALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 680 RHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 739
RH++ ++ + W +RL I + ARG+ YLH ++ IHRD+K NILL ++ K
Sbjct: 124 RHLYG-SDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPK 179
Query: 740 VADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRK 798
+ DFG+ + E + + T + GT GY+ PEY + GR+T K DV+SFGV+L E++ R
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 799 ALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREP 858
A+ +S P E ++L W + + +DP + ++ S+ + A C A
Sbjct: 240 AIVQSLPREMVNLAEWAVE-SHNNGQLEQIVDPNLA-DKIRPESLRKFGDTAVKCLALSS 297
Query: 859 YQRPDMGHAVNVLSSLVEL 877
RP MG + L + L
Sbjct: 298 EDRPSMGDVLWKLEYALRL 316
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 362 bits (932), Expect = e-118
Identities = 111/296 (37%), Positives = 170/296 (57%), Gaps = 8/296 (2%)
Query: 588 LRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
L+ ++NFS +NILGRGGFG VYKG L DGT +AVKR++ G G +F++E+ +++
Sbjct: 25 LQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISM 83
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
HR+L+ L G C+ E+LLV+ YM G+++ + E PL+W +R IAL AR
Sbjct: 84 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPESQPPLDWPKRQRIALGSAR 142
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
G+ YLH IHRD+K +NILL ++ A V DFGL +L + T + GT G++
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 202
Query: 768 APEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQP--EESMHLVTWFRRIHLSKDSF 825
APEY TG+ + K DVF +GV+L+ELITG++A D ++ ++ + L+ W + + K
Sbjct: 203 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK-L 261
Query: 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS--LVELWK 879
+D + + + ++A C P +RP M V +L L E W+
Sbjct: 262 EALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWE 316
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 1e-73
Identities = 68/317 (21%), Positives = 124/317 (39%), Gaps = 33/317 (10%)
Query: 583 ISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEI 642
+ + L + + RG FG V+K + +AVK + + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSW---QNEYEV 69
Query: 643 AVLTKVRHRHLVALLGHCLDGN----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRR 698
L ++H +++ +G G + L+ + +G+LS + + WN
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA------NVVSWNEL 123
Query: 699 LTIALDVARGVEYLH-------GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751
IA +ARG+ YLH + HRD+K N+LL +++ A +ADFGL
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183
Query: 752 GKGSIET-RIAGTFGYLAPEYA-----VTGRVTTKVDVFSFGVILMELITGRKALDESQP 805
GK + +T GT Y+APE ++D+++ G++L EL + A D
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
Query: 806 EESMHLVTWFRRIHLSKDSFHKAI-----DPTIDLNEGILASISTVAELAGHCCAREPYQ 860
E + + H S + + + P + A ++ + E C +
Sbjct: 244 EYMLPFEEEIGQ-HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 861 RPDMGHAVNVLSSLVEL 877
R G ++ + L
Sbjct: 303 RLSAGCVGERITQMQRL 319
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 4e-69
Identities = 87/297 (29%), Positives = 139/297 (46%), Gaps = 29/297 (9%)
Query: 594 NFSE---ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 650
+ + + +G G FGTV++ E H G+ +AVK + + + EF E+A++ ++RH
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
++V +G +V EY+ +G+L R + + L+ RRL++A DVA+G+
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK--SGAREQLDERRRLSMAYDVAKGMN 151
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
YLH + +HR+LK N+L+ KV DFGL RL S AGT ++APE
Sbjct: 152 YLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS-KSAAGTPEWMAPE 209
Query: 771 YAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830
K DV+SFGVIL EL T ++ P + + V K
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG------------FKCKR 257
Query: 831 PTI--DLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDQNS 885
I +LN + A + C EP++RP +++L L++ P S
Sbjct: 258 LEIPRNLNPQV-------AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRS 307
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 9e-65
Identities = 87/323 (26%), Positives = 136/323 (42%), Gaps = 42/323 (13%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
E ++GRG FG V K + +A+K++E S F E+ L++V H +
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIE----SESERKAFIVELRQLSRVNHPN 62
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+V L G CL N LV EY G+L + E L ++ L ++GV YL
Sbjct: 63 IVKLYGACL--NPVCLVMEYAEGGSLYNVLHG--AEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMR-AKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
H + ++ IHRDLKP N+LL K+ DFG + T G+ ++APE
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPEV 174
Query: 772 AVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID- 830
+ K DVFS+G+IL E+IT RK P F I A+
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRK------P---------FDEIGGPAFRIMWAVHN 219
Query: 831 ---PTI--DLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDQNS 885
P + +L + I L C +++P QRP M V +++ L+ + D+
Sbjct: 220 GTRPPLIKNLPKPI-------ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272
Query: 886 EDIYGIDLEMSLPQALKKWQAYE 908
+ L ++ + +
Sbjct: 273 QYPCQHSLPPGEDGRVEPYVDFA 295
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 1e-63
Identities = 78/296 (26%), Positives = 126/296 (42%), Gaps = 44/296 (14%)
Query: 594 NFSE---ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS--GKGLTEFKSEIAVLTKV 648
+F+E E I+G GGFG VY+ G ++AVK + + + E + +
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
+H +++AL G CL LV E+ G L+R + K + + + A+ +ARG
Sbjct: 64 KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG------KRIPPDILVNWAVQIARG 117
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMR--------AKVADFGLVRLAPEGKGSIETRI 760
+ YLH A IHRDLK SNIL+ + K+ DFGL R + +
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSA 174
Query: 761 AGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL 820
AG + ++APE + DV+S+GV+L EL+TG + V
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA------- 227
Query: 821 SKDSFHKAIDPTI--DLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874
+ I E A+L C +P+ RP + ++ L+++
Sbjct: 228 -----MNKLALPIPSTCPEPF-------AKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 4e-62
Identities = 71/278 (25%), Positives = 123/278 (44%), Gaps = 27/278 (9%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
+G G FGTVYKG+ H +AVK + + + L FK+E+ VL K RH +++ +G+
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 661 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 720
+V ++ +L H+ E + + IA ARG++YLH +S
Sbjct: 90 TAPQ-LAIVTQWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHA---KSI 141
Query: 721 IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE-TRIAGTFGYLAPE---YAVTGR 776
IHRDLK +NI L +D K+ DFGL GS + +++G+ ++APE +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 777 VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLN 836
+ + DV++FG++L EL+TG+ + + + + +
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM--- 258
Query: 837 EGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874
L C ++ +RP + + L
Sbjct: 259 ----------KRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 4e-62
Identities = 63/297 (21%), Positives = 115/297 (38%), Gaps = 43/297 (14%)
Query: 594 NFSE---ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 650
F + ++G+G FG VY G H ++A++ ++ + L FK E+ + RH
Sbjct: 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
++V +G C+ ++ TL + + L+ N+ IA ++ +G+
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMG 144
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE----TRIAGTFGY 766
YLH + +H+DLK N+ D+ + + DFGL ++ + G +
Sbjct: 145 YLHA---KGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 767 LAPE---------YAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRR 817
LAPE + DVF+ G I EL E + + +
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK 260
Query: 818 IHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874
+LS+ K I +++ C A E +RP +++L L
Sbjct: 261 PNLSQIGMGKEI-----------------SDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 6e-62
Identities = 81/297 (27%), Positives = 137/297 (46%), Gaps = 43/297 (14%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKG-----LTEFKSEIAVLT 646
N E +G+GGFG V+KG + D + +A+K + G G+ EF+ E+ +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 647 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 706
+ H ++V L G + +V E++P G L + + A P++W+ +L + LD+A
Sbjct: 79 NLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIA 132
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILL-----GDDMRAKVADFGLVRLAPEGKGSIETRIA 761
G+EY+ + +HRDL+ NI L + AKVADFGL + + + +
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV----SGLL 187
Query: 762 GTFGYLAPE--YAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH 819
G F ++APE A T K D +SF +IL ++TG P + + +I
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE------GPFDEYS----YGKIK 237
Query: 820 LSKDSFHKAIDPTI--DLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874
+ + PTI D + + C + +P +RP + V LS L
Sbjct: 238 FINMIREEGLRPTIPEDCPPRL-------RNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 2e-60
Identities = 87/432 (20%), Positives = 160/432 (37%), Gaps = 78/432 (18%)
Query: 20 SILFVSASGDDGDAAVMLALKKSLNPPESL-GWS-DTDPCKWNHVVCIEDKRITRIQIGH 77
S + + +++ K L L WS + +PC ++ V C D ++T I +
Sbjct: 1 SFQASPSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPCTFDGVTC-RDDKVTSIDLSS 59
Query: 78 QNLQ---GTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFT-SVPSD 133
+ L + S+L +LT LE L L + I+G + ASL + LS N + V +
Sbjct: 60 KPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTL 119
Query: 134 F-FTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIP-SFFGPDEFPG 191
S L+ + + +N + L+ ++ +I+G + D
Sbjct: 120 TSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGE 179
Query: 192 LTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA 251
L L ++ N++ G + + +L+ + + SN
Sbjct: 180 LKHLAISGNKISGDVD----------------------------VSRCVNLEFLDVSSNN 211
Query: 252 FSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRS-- 309
FS +P L+ L + N +G ++ LK++N+++N GP+P
Sbjct: 212 FSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSL 271
Query: 310 VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTK 369
L + N F D++ C
Sbjct: 272 QYLSL--AENKF----------------------------------TGEIPDFLSGACD- 294
Query: 370 GNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP-EGLSVLGALKELDVSNN 428
+T ++ + G + P F S L+ L L+ NN SG +P + L + LK LD+S N
Sbjct: 295 -TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFN 353
Query: 429 QLYGKIPSFKSN 440
+ G++P +N
Sbjct: 354 EFSGELPESLTN 365
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 8e-59
Identities = 102/399 (25%), Positives = 166/399 (41%), Gaps = 40/399 (10%)
Query: 68 KRITRIQIGHQNLQGTLP-SNLQNLTKLERLELQWNSISGPLPS--LNGLASLEVVMLSN 124
+ + + N G LP L + L+ L+L +N SG LP N ASL + LS+
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377
Query: 125 NQFT-SVPSDFF-TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQI 180
N F+ + + ++LQ + + NN F+ +IP +L N S L + S N ++G I
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNGFT-GKIPPTLSNCSELVSLHLSFN--YLSGTI 434
Query: 181 PSFFGPDEFPGLTILHLAFNQLIGGLPASFS-GSQIQSLWVNGQNGNAKLGGGI-DVIQN 238
PS G L L L N L G +P +++L ++ N L G I + N
Sbjct: 435 PSSLG--SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF---N-DLTGEIPSGLSN 488
Query: 239 MTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
T+L I L +N +G +P ++ L L L +N F+G +P L SL +++ N
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 548
Query: 298 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL---LSVVKLMG-YPQRFAE-- 351
L G +P S +A D ++++ G ++
Sbjct: 549 LFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS 608
Query: 352 ----------NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLIL 401
+ G+ ++ ++ L+G I E S L L L
Sbjct: 609 TRNPCNITSRVYGGHTS--PTFD-NNG--SMMFLDMSYNMLSGYIPKEIGSMPYLFILNL 663
Query: 402 ADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN 440
N++SG IP+ + L L LD+S+N+L G+IP S
Sbjct: 664 GHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSA 702
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 4e-53
Identities = 88/384 (22%), Positives = 148/384 (38%), Gaps = 57/384 (14%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQ---NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSN 124
+ + + ++ G +L+ L + N ISG + +LE + +S+
Sbjct: 151 NSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSR-CVNLEFLDVSS 209
Query: 125 NQFT-SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSF 183
N F+ +P S+LQ ++I N S + +++ + L+ + +S G IP
Sbjct: 210 NNFSTGIPF--LGDCSALQHLDISGNKLSG-DFSRAISTCTELKLLNISSNQFVGPIPPL 266
Query: 184 FGPDEFPGLTILHLAFNQLIGGLPASFSG--SQIQSLWVNGQNGNAKLGGGI-DVIQNMT 240
L L LA N+ G +P SG + L + G + + +
Sbjct: 267 ----PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDL----SGNHFYGAVPPFFGSCS 318
Query: 241 SLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKL-ESLKIVNMTNN 297
L+ + L SN FSG LP ++ L+ L L N F+G +P+SL L SL +++++N
Sbjct: 319 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSN 378
Query: 298 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRFAENWKGN 356
GP+ + L L L G
Sbjct: 379 NFSGPIL-----------PNLCQNPKNT-------LQELYLQNNGFTG------------ 408
Query: 357 DPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSV 416
+ C+ + ++ L+GTI S L+ L L N L G IP+ L
Sbjct: 409 -KIPPTLS-NCS--ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY 464
Query: 417 LGALKELDVSNNQLYGKIPSFKSN 440
+ L+ L + N L G+IPS SN
Sbjct: 465 VKTLETLILDFNDLTGEIPSGLSN 488
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-52
Identities = 87/383 (22%), Positives = 150/383 (39%), Gaps = 79/383 (20%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQF 127
+ + I L G + T+L+ L + N GP+P L L SL+ + L+ N+F
Sbjct: 223 SALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP-LKSLQYLSLAENKF 281
Query: 128 T-SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIP-SFFG 185
T +P +L +++ N F +P + S L++ + +S N +G++P
Sbjct: 282 TGEIPDFLSGACDTLTGLDLSGNHFYG-AVPPFFGSCSLLESLALSSNNFSGELPMDTLL 340
Query: 186 PDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMT-SLKE 244
+ GL +L L+FN+ G LP S + N++ SL
Sbjct: 341 --KMRGLKVLDLSFNEFSGELPESLT--------------------------NLSASLLT 372
Query: 245 IWLHSNAFSGPLPDFSGV---KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG 301
+ L SN FSGP+ L+ L L++N FTG +P +L L ++++ N L G
Sbjct: 373 LDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSG 432
Query: 302 PVP----EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 357
+P + L + N +G
Sbjct: 433 TIPSSLGSLSKLRDLKL--WLNML--------------------------------EGEI 458
Query: 358 PCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVL 417
P + + + +LTG I ++ +L + L++N L+G IP+ + L
Sbjct: 459 P--QELMYVK---TLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRL 513
Query: 418 GALKELDVSNNQLYGKIPSFKSN 440
L L +SNN G IP+ +
Sbjct: 514 ENLAILKLSNNSFSGNIPAELGD 536
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 1e-50
Identities = 79/382 (20%), Positives = 133/382 (34%), Gaps = 79/382 (20%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQ-NLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNN 125
K + + + G +P L L L+L N G +P + LE + LS+N
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328
Query: 126 QFT-SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASG-LQNFSANSANITGQIPSF 183
F+ +P D + L+ +++ N FS E+P+SL N S L +S N +G I
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSG-ELPESLTNLSASLLTLDLSSNNFSGPILPN 387
Query: 184 FGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLK 243
+ L L+L N G +P + S N + L
Sbjct: 388 LCQNPKNTLQELYLQNNGFTGKIPPTLS--------------------------NCSELV 421
Query: 244 EIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302
+ L N SG +P + +L L L N G +P L+ +++L+ + + N L G
Sbjct: 422 SLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGE 481
Query: 303 VPEFDRS----VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDP 358
+P + + + +N
Sbjct: 482 IPSGLSNCTNLNWISL--SNNRL----------------------------------TGE 505
Query: 359 CSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLG 418
WIG N+ ++ + +G I E +SL L L N +G IP +
Sbjct: 506 IPKWIG---RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ- 561
Query: 419 ALKELDVSNNQLYGKIPSFKSN 440
++ N + GK + N
Sbjct: 562 ---SGKIAANFIAGKRYVYIKN 580
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 3e-48
Identities = 92/382 (24%), Positives = 145/382 (37%), Gaps = 84/382 (21%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQ 126
+ + + N +P L + + L+ L++ N +SG +++ L+++ +S+NQ
Sbjct: 200 VNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQ 258
Query: 127 FT-SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLR-NASGLQNFSANSANITGQIPSFF 184
F +P L SLQ + + N F+ EIP L L + + G +P FF
Sbjct: 259 FVGPIPP---LPLKSLQYLSLAENKFTG-EIPDFLSGACDTLTGLDLSGNHFYGAVPPFF 314
Query: 185 GPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKE 244
G L L L+ N G LP + M LK
Sbjct: 315 G--SCSLLESLALSSNNFSGELPMDT-------------------------LLKMRGLKV 347
Query: 245 IWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVK--LESLKIVNMTNNLLQ 300
+ L N FSG LP+ + L +L L N F+GP+ +L + +L+ + + NN
Sbjct: 348 LDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFT 407
Query: 301 GPVPEFDRSVS----LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGY-PQRFAENWKG 355
G +P + S L + S N L G P
Sbjct: 408 GKIPPTLSNCSELVSLHL---SFN--------------------YLSGTIPSSLGSL--- 441
Query: 356 NDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLS 415
+ + L G I E K+L+ LIL N+L+G IP GLS
Sbjct: 442 --------------SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS 487
Query: 416 VLGALKELDVSNNQLYGKIPSF 437
L + +SNN+L G+IP +
Sbjct: 488 NCTNLNWISLSNNRLTGEIPKW 509
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-46
Identities = 89/379 (23%), Positives = 148/379 (39%), Gaps = 64/379 (16%)
Query: 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFT 128
+ + + + G +P L N ++L L L +N +SG +P SL L+ L + L N
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455
Query: 129 -SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187
+P + + +L+++ +D N + EIP L N + L S ++ +TG+IP + G
Sbjct: 456 GEIPQELMY-VKTLETLILDFNDLT-GEIPSGLSNCTNLNWISLSNNRLTGEIPKWIG-- 511
Query: 188 EFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEI 245
L IL L+ N G +PA + L +N N G I + +
Sbjct: 512 RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT---N-LFNGTIPAAMFKQSGK--- 564
Query: 246 WLHSNAFSGPLP-DFSGVKQLESLSLRDNF--FTGPVPDSLVKLESLKIVNMTNNLLQGP 302
+ +N +G + N F G + L +L + N+T+ + G
Sbjct: 565 -IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGH 623
Query: 303 VPEFDRS----VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGY-PQRFAENWKGND 357
+ + LDM S N L GY P+
Sbjct: 624 TSPTFDNNGSMMFLDM---SYN--------------------MLSGYIPKEIGS------ 654
Query: 358 PCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVL 417
+ ++N +++G+I E + L L L+ N L G IP+ +S L
Sbjct: 655 -MP----------YLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSAL 703
Query: 418 GALKELDVSNNQLYGKIPS 436
L E+D+SNN L G IP
Sbjct: 704 TMLTEIDLSNNNLSGPIPE 722
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-23
Identities = 41/209 (19%), Positives = 74/209 (35%), Gaps = 15/209 (7%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGL 138
+ G +P+ L + L L+L N +G +P+ + ++ N +
Sbjct: 525 SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA--AMFKQSG-KIAANFIAGKRYVYIKND 581
Query: 139 SSLQSIEIDNNPFS-SWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHL 197
+ N + L S + S G F + L +
Sbjct: 582 GMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFD--NNGSMMFLDM 639
Query: 198 AFNQLIGGLPASFSG-SQIQSLWVN-GQNGNAKLGGGI-DVIQNMTSLKEIWLHSNAFSG 254
++N L G +P + L N G N + G I D + ++ L + L SN G
Sbjct: 640 SYNMLSGYIPKEIGSMPYLFIL--NLGHN---DISGSIPDEVGDLRGLNILDLSSNKLDG 694
Query: 255 PLPD-FSGVKQLESLSLRDNFFTGPVPDS 282
+P S + L + L +N +GP+P+
Sbjct: 695 RIPQAMSALTMLTEIDLSNNNLSGPIPEM 723
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 2e-60
Identities = 58/290 (20%), Positives = 106/290 (36%), Gaps = 38/290 (13%)
Query: 594 NFSE---ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 650
+F + L G ++KG G I VK ++ S + +F E L H
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 651 RHLVALLGHCLDGNEKLL--VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
+++ +LG C + +MP G+L + E ++ ++ + ALD+ARG
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL---HEGTNFVVDQSQAVKFALDMARG 123
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 768
+ +LH L L ++++ +DM A+++ + ++A
Sbjct: 124 MAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVA 176
Query: 769 PE---YAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWF-RRIHLSKDS 824
PE D++SF V+L EL+T + E V R +
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG- 235
Query: 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874
I P + ++L C +P +RP V +L +
Sbjct: 236 ----ISPHV-------------SKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 5e-59
Identities = 65/322 (20%), Positives = 115/322 (35%), Gaps = 46/322 (14%)
Query: 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAV--LTKVR 649
+N ++GRG +G VYKG L +AVK S F +E + + +
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVF-----SFANRQNFINEKNIYRVPLME 65
Query: 650 HRHLVALLGHCLDGN-----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALD 704
H ++ + E LLV EY P G+L +++ +W +A
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHS 119
Query: 705 VARGVEYLH------GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE- 757
V RG+ YLH + HRDL N+L+ +D ++DFGL +
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 758 ------TRIAGTFGYLAPEYA-------VTGRVTTKVDVFSFGVILMELITGRKALDESQ 804
GT Y+APE +VD+++ G+I E+ L +
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239
Query: 805 PEESMHLV-TWFRRIHLSKDSFHKAID-----PTIDLN-EGILASISTVAELAGHCCARE 857
+ H + + + P + ++ ++ E C ++
Sbjct: 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299
Query: 858 PYQRPDMGHAVNVLSSLVELWK 879
R A ++ L+ +W+
Sbjct: 300 AEARLTAQXAEERMAELMMIWE 321
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 1e-58
Identities = 72/293 (24%), Positives = 116/293 (39%), Gaps = 43/293 (14%)
Query: 598 ENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
+LG+G FG K + G + +K + + F E+ V+ + H +++
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKF 72
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
+G + EY+ GTL I + W++R++ A D+A G+ YLH
Sbjct: 73 IGVLYKDKRLNFITEYIKGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLH--- 125
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR-------------IAGT 763
+ IHRDL N L+ ++ VADFGL RL + K E + G
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 764 FGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQP--EESMHLVTWFRRIHLS 821
++APE KVDVFSFG++L E+I A + P + V F +
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245
Query: 822 KDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874
+ P+ + CC +P +RP + L +L
Sbjct: 246 PN-----CPPSF-------------FPITVRCCDLDPEKRPSFVKLEHWLETL 280
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 1e-54
Identities = 62/317 (19%), Positives = 119/317 (37%), Gaps = 47/317 (14%)
Query: 587 VLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSE--IAV 644
+ R V + + +G+G +G V++G G +AVK + S + + E +
Sbjct: 2 MQRTVARDITLLECVGKGRYGEVWRGSWQ-GENVAVK-----IFSSRDEKSWFRETELYN 55
Query: 645 LTKVRHRHLVALLGHCLDGNEK----LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT 700
+RH +++ + + L+ Y G+L ++ L+ L
Sbjct: 56 TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL------TTLDTVSCLR 109
Query: 701 IALDVARGVEYLHGLAHQSF-----IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755
I L +A G+ +LH + HRDLK NIL+ + + +AD GL + +
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 756 IE---TRIAGTFGYLAPE------YAVTGRVTTKVDVFSFGVILMELITGRKALDES--- 803
++ GT Y+APE +VD+++FG++L E+ +
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229
Query: 804 -QPEESMHLVTWFRRIHLSKDSFHKAID-----PTIDLNEGILASISTVAELAGHCCARE 857
P + S + K + P I +++++A+L C +
Sbjct: 230 KPPFYDVV------PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQN 283
Query: 858 PYQRPDMGHAVNVLSSL 874
P R L+ +
Sbjct: 284 PSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 5e-54
Identities = 62/307 (20%), Positives = 108/307 (35%), Gaps = 45/307 (14%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSE--IAVLTKVRHRHLVA 655
+G+G +G V+ G+ G K+AVK V + E I +RH +++
Sbjct: 42 VKQIGKGRYGEVWMGKWR-GEKVAVK-----VFFTTEEASWFRETEIYQTVLMRHENILG 95
Query: 656 LLGHCLDGNEK----LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
+ + G L+ +Y G+L ++ + L+ L +A G+ +
Sbjct: 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCH 149
Query: 712 LHGLAHQSF-----IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE---TRIAGT 763
LH + HRDLK NIL+ + +AD GL ++ GT
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
Query: 764 FGYLAPE------YAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRR 817
Y+ PE + D++SFG+IL E+ R E + +
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLP----YHD 264
Query: 818 IHLSKDSFHKAID--------PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869
+ S S+ + P+ + + +L C A P R
Sbjct: 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
Query: 870 VLSSLVE 876
L+ + E
Sbjct: 325 TLAKMSE 331
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 8e-51
Identities = 79/306 (25%), Positives = 144/306 (47%), Gaps = 22/306 (7%)
Query: 32 DAAVMLALKKSLNPPESL-GWSDTDPC---KWNHVVCIED---KRITRIQIGHQNLQGT- 83
D +L +KK L P +L W T C W V+C D R+ + + NL
Sbjct: 7 DKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPY 66
Query: 84 -LPSNLQNLTKLERLELQ-WNSISGPLP-SLNGLASLEVVMLSNNQFT-SVPSDFFTGLS 139
+PS+L NL L L + N++ GP+P ++ L L + +++ + ++P F + +
Sbjct: 67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD-FLSQIK 125
Query: 140 SLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGL-TILHLA 198
+L +++ N S +P S+ + L + + I+G IP +G F L T + ++
Sbjct: 126 TLVTLDFSYNALSG-TLPPSISSLPNLVGITFDGNRISGAIPDSYG--SFSKLFTSMTIS 182
Query: 199 FNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSNAFSGPLP 257
N+L G +P +F+ + + + +N L G + + + ++I L N+ + L
Sbjct: 183 RNRLTGKIPPTFANLNLAFVDL-SRN---MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
Query: 258 DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKG 317
K L L LR+N G +P L +L+ L +N++ N L G +P+ D++
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298
Query: 318 SNNFCL 323
+NN CL
Sbjct: 299 ANNKCL 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-38
Identities = 68/319 (21%), Positives = 108/319 (33%), Gaps = 69/319 (21%)
Query: 122 LSNNQFTSVPSDFFTGLSSLQSIEIDNNPFS-SWEIPQSLRNASGLQNFS-ANSANITGQ 179
N + V D T + ++++ + IP SL N L N+ G
Sbjct: 33 CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP 92
Query: 180 IPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNM 239
IP + L L++ + G +P S +
Sbjct: 93 IPPAIA--KLTQLHYLYITHTNVSGAIPDFLS--------------------------QI 124
Query: 240 TSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV-NMTNN 297
+L + NA SG LP S + L ++ N +G +PDS L ++ N
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 298 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 357
L G +P +++L S N L G
Sbjct: 185 RLTGKIPPTFANLNLAFVDLSRN--------------------MLEG------------- 211
Query: 358 PCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVL 417
S G + N I+ K +L + + K+L L L +N + G +P+GL+ L
Sbjct: 212 DASVLFG-SDK--NTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQL 267
Query: 418 GALKELDVSNNQLYGKIPS 436
L L+VS N L G+IP
Sbjct: 268 KFLHSLNVSFNNLCGEIPQ 286
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 63/297 (21%), Positives = 115/297 (38%), Gaps = 60/297 (20%)
Query: 155 EIPQSLRNASGLQNFSANS----ANITGQIPSFFGPDEFPGLTILHLAFNQLIG--GLPA 208
+I + L N + L ++ + G + + + L L+ L +P+
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDT--QTYRVNNLDLSGLNLPKPYPIPS 70
Query: 209 SFSG-SQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSNAFSGPLPDF-SGVKQL 265
S + + L++ G N L G I I +T L +++ SG +PDF S +K L
Sbjct: 71 SLANLPYLNFLYIGGIN---NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 266 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-----FDRSVSLDMAKGSNN 320
+L N +G +P S+ L +L + N + G +P+ S+ + S N
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI---SRN 184
Query: 321 FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKM 380
L+ G P + N+ ++ +
Sbjct: 185 R---------------LT----------------GKIPPT--FA----NLNLAFVDLSRN 207
Query: 381 NLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSF 437
L G S F S K+ Q++ LA N+L+ + + + + L LD+ NN++YG +P
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQG 263
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 34/122 (27%), Positives = 54/122 (44%), Gaps = 11/122 (9%)
Query: 329 CDPR-LNALLSVVKLMGYPQRFAENWKGNDPCSD--WIGVTCTK----GNITVINFQKMN 381
C+P+ ALL + K +G P + +W C + W+GV C + ++ +N
Sbjct: 3 CNPQDKQALLQIKKDLGNPTTLS-SWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 382 LTGT--ISPEFASFKSLQRLILAD-NNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFK 438
L I A+ L L + NNL G IP ++ L L L +++ + G IP F
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121
Query: 439 SN 440
S
Sbjct: 122 SQ 123
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-50
Identities = 59/307 (19%), Positives = 109/307 (35%), Gaps = 45/307 (14%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSE--IAVLTKVRHRHLVA 655
+ +G+G FG V++G+ G ++AVK + S + + E I +RH +++
Sbjct: 47 QESIGKGRFGEVWRGKWR-GEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILG 100
Query: 656 LLGHCLDGNEK----LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
+ N LV +Y G+L ++ + + +AL A G+ +
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAH 154
Query: 712 LHGLAHQS-----FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE---TRIAGT 763
LH + HRDLK NIL+ + +AD GL +I+ GT
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
Query: 764 FGYLAPE------YAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRR 817
Y+APE + D+++ G++ E+ + + +
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-----YYD 269
Query: 818 IHLSKDSFHKAID--------PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869
+ S S + P I ++ +A++ C R
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
Query: 870 VLSSLVE 876
LS L +
Sbjct: 330 TLSQLSQ 336
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-42
Identities = 60/203 (29%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 598 ENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
+GRG FG V+ G L D T +AVK + +F E +L + H ++V L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
+G C +V E + G + EG L L + D A G+EYL
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFL---RTEG-ARLRVKTLLQMVGDAAAGMEYLES-- 231
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY----LAPEYA 772
+ IHRDL N L+ + K++DFG+ R +G + G APE
Sbjct: 232 -KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGLRQVPVKWTAPEAL 287
Query: 773 VTGRVTTKVDVFSFGVILMELIT 795
GR +++ DV+SFG++L E +
Sbjct: 288 NYGRYSSESDVWSFGILLWETFS 310
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 18/207 (8%)
Query: 598 ENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
LG+G FG+V G +AVK+++ + + L +F+ EI +L ++H +
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDN 72
Query: 653 LVALLGHCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
+V G C + L+ EY+P G+L ++ ++ + ++ + L + +G+E
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQICKGME 128
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF--GYLA 768
YL + +IHRDL NIL+ ++ R K+ DFGL ++ P+ K + + G + A
Sbjct: 129 YLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 769 PEYAVTGRVTTKVDVFSFGVILMELIT 795
PE + + DV+SFGV+L EL T
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-42
Identities = 61/207 (29%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 598 ENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
LG+G FG+V G +AVK+++ + + L +F+ EI +L ++H +
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDN 103
Query: 653 LVALLGHCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
+V G C + L+ EY+P G+L ++ E ++ + L + +G+E
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGME 159
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF--GYLA 768
YL + +IHRDL NIL+ ++ R K+ DFGL ++ P+ K + + G + A
Sbjct: 160 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 216
Query: 769 PEYAVTGRVTTKVDVFSFGVILMELIT 795
PE + + DV+SFGV+L EL T
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFT 243
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-42
Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 18/222 (8%)
Query: 598 ENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
LG G FG V G ++AVK ++ G + + K EI +L + H +
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHEN 84
Query: 653 LVALLGHCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
+V G C + L+ E++P G+L ++ + + ++L A+ + +G++
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKNKINLKQQLKYAVQICKGMD 140
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF--GYLA 768
YL + ++HRDL N+L+ + + K+ DFGL + K + + A
Sbjct: 141 YL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA 197
Query: 769 PEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESM 809
PE + + DV+SFGV L EL+T M
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM 239
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 8e-42
Identities = 71/404 (17%), Positives = 131/404 (32%), Gaps = 66/404 (16%)
Query: 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQF 127
++T + +G + P Q L L+ L LQ N +S + +L + L +N
Sbjct: 50 QLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSI 109
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFFG 185
+ ++ F +L ++++ +N SS + LQ S N I
Sbjct: 110 QKIKNNPFVKQKNLITLDLSHNGLSS-TKLGTQVQLENLQELLLSNN--KIQALKSEELD 166
Query: 186 PDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKE 244
L L L+ NQ+ P F ++ L++N L + + TS++
Sbjct: 167 IFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRN 226
Query: 245 IWLHSNAFSGPLPD-FSGVK--QLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG 301
+ L ++ S F G+K L L L N DS L L+ + N +Q
Sbjct: 227 LSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH 286
Query: 302 PVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCS 360
++ +F +S+ L + K
Sbjct: 287 LFSHSLHGLFNVRYLNLKRSF-----------TKQSISLASLPKIDDFSFQWLK------ 329
Query: 361 DWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQ----------------------- 397
+ +N + ++ G S F +L+
Sbjct: 330 ----------CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLA 379
Query: 398 -----RLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 436
L L N +S + + S LG L+ LD+ N++ ++
Sbjct: 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-40
Identities = 67/408 (16%), Positives = 139/408 (34%), Gaps = 63/408 (15%)
Query: 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNN-- 125
+T + + + NL + L +LE L++N+I SL+GL ++ + L +
Sbjct: 249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFT 308
Query: 126 -------QFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANI 176
+ F L L+ + +++N L+ + S + ++
Sbjct: 309 KQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG-IKSNMFTGLINLKYLSLSNSFTSL 367
Query: 177 TGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGI-- 233
F L IL+L N++ +FS ++ L + N ++G +
Sbjct: 368 RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGL---N-EIGQELTG 423
Query: 234 DVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTG--PVPDSLVKLESLK 290
+ + ++ EI+L N + + F+ V L+ L LR P L +L
Sbjct: 424 QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483
Query: 291 IVNMTNNLLQGPVPEFDRSVS----LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYP 346
I++++NN + + + LD+ +N L L G
Sbjct: 484 ILDLSNNNIANINDDMLEGLEKLEILDL---QHN-----------NLARLWKHANPGGPI 529
Query: 347 QRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNL 406
++ ++N + F L+ + L NNL
Sbjct: 530 YFLKGL-----------------SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNL 572
Query: 407 SGMIPEGLSVLGALKELDVSNNQLYGKIPS-----FKSNAIVNTDGNP 449
+ + + +LK L++ N + F++ ++ NP
Sbjct: 573 NTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNP 620
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-39
Identities = 60/390 (15%), Positives = 125/390 (32%), Gaps = 59/390 (15%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQ 126
+T + + ++Q + L L+L N +S L + L +L+ ++LSNN+
Sbjct: 97 TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK 156
Query: 127 FTSVPSDFFT--GLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIP-SF 183
++ S+ SSL+ +E+ +N P L N+ + +
Sbjct: 157 IQALKSEELDIFANSSLKKLELSSNQIKE-FSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 215
Query: 184 FGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLK 243
+ L L+ +QL +F G T+L
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGL------------------------KWTNLT 251
Query: 244 EIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302
+ L N + D F+ + QLE L N SL L +++ +N+ + +
Sbjct: 252 MLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQS 311
Query: 303 VPEFDRSVSLDMAKGSNNFCLPSPGACD--PRLNAL-LSVVKLMGYPQRF---------- 349
+ + + L L + + G
Sbjct: 312 IS-------------LASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYL 358
Query: 350 --AENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLS 407
+ ++ ++ V+ + ++N K ++ S F+ L+ L L N +
Sbjct: 359 SLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIG 418
Query: 408 GMIPEG-LSVLGALKELDVSNNQLYGKIPS 436
+ L + E+ +S N+ +
Sbjct: 419 QELTGQEWRGLENIFEIYLSYNKYLQLTRN 448
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-38
Identities = 58/376 (15%), Positives = 128/376 (34%), Gaps = 52/376 (13%)
Query: 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFT 128
IT + + H L+ +N ++L L++ +N+IS P L L+V+ L +N+ +
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 129 SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDE 188
+ F ++L + + +N L + ++
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQK-IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ-- 143
Query: 189 FPGLTILHLAFNQLIGGLPASFSG---SQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKE 244
L L L+ N++ S ++ L ++ N ++ + L
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS-N---QIKEFSPGCFHAIGRLFG 199
Query: 245 IWLHSNAFSGPLPD----FSGVKQLESLSLRDNFFTGPVPDSLVKLE--SLKIVNMTNNL 298
++L++ L + + +LSL ++ + + + L+ +L +++++ N
Sbjct: 200 LFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNN 259
Query: 299 LQGPVPE----FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 354
L + + + NN + L+ L +V L
Sbjct: 260 LNVVGNDSFAWLPQLEYFFL--EYNNIQHLFSHS----LHGLFNVRYLNLK--------- 304
Query: 355 GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL 414
+ T + +L F K L+ L + DN++ G+
Sbjct: 305 ---------------RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMF 349
Query: 415 SVLGALKELDVSNNQL 430
+ L LK L +SN+
Sbjct: 350 TGLINLKYLSLSNSFT 365
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-36
Identities = 56/364 (15%), Positives = 106/364 (29%), Gaps = 68/364 (18%)
Query: 77 HQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFF 135
H L +P +L T + L L N + + + L + + N + + +
Sbjct: 13 HLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELC 69
Query: 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTIL 195
L L+ + + +N S ++ + L S +I + F L L
Sbjct: 70 QKLPMLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK--QKNLITL 126
Query: 196 HLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG- 254
L+ N L + + +L+E+ L +N
Sbjct: 127 DLSHNGLSSTKLGTQV--------------------------QLENLQELLLSNNKIQAL 160
Query: 255 PLPDFSGVK--QLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSL 312
+ L+ L L N P + L + + N L + E
Sbjct: 161 KSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTE------- 213
Query: 313 DMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGN 371
CL + L LS +L + + N
Sbjct: 214 -------KLCLELAN---TSIRNLSLSNSQL----STTSNTTFLGLKWT----------N 249
Query: 372 ITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY 431
+T+++ NL + FA L+ L NN+ + L L ++ L++ +
Sbjct: 250 LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK 309
Query: 432 GKIP 435
I
Sbjct: 310 QSIS 313
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-26
Identities = 62/334 (18%), Positives = 109/334 (32%), Gaps = 83/334 (24%)
Query: 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175
S EV S+ + T VP D T ++ + + +N + S L +
Sbjct: 5 SHEVADCSHLKLTQVPDDLPT---NITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNT 60
Query: 176 ITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDV 235
I+ P P L +L+L N+L +F+
Sbjct: 61 ISKLEPELCQK--LPMLKVLNLQHNELSQLSDKTFA------------------------ 94
Query: 236 IQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 294
T+L E+ L SN+ + F K L +L L N + + V+LE+L+ + +
Sbjct: 95 --FCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLL 152
Query: 295 TNNLLQGPVPEFDRS------VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQR 348
+NN +Q E L+++ SN SPG +A+
Sbjct: 153 SNNKIQALKSEELDIFANSSLKKLELS--SNQIKEFSPGC----FHAI------------ 194
Query: 349 FAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASF---KSLQRLILADNN 405
G + + + L +++ + S++ L L+++
Sbjct: 195 ---------------------GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQ 233
Query: 406 LSGMIPEGLSVLG--ALKELDVSNNQLYGKIPSF 437
LS L L LD+S N L
Sbjct: 234 LSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDS 267
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-22
Identities = 42/239 (17%), Positives = 78/239 (32%), Gaps = 50/239 (20%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG---PLPSLNGLASLEVVMLSN 124
+ I I + + ++ + L+RL L+ ++ L +L ++ LSN
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 125 NQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFF 184
N ++ D GL L+ +++ +N L ++ G F
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNN---------------LARLWKHA--NPGGPIYFL 532
Query: 185 GPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKE 244
L IL+L N +P +V +++ LK
Sbjct: 533 K--GLSHLHILNLESNG-FDEIPV-------------------------EVFKDLFELKI 564
Query: 245 IWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSL-VKLESLKIVNMTNNLLQG 301
I L N + F+ L+SL+L+ N T +L ++M N
Sbjct: 565 IDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-21
Identities = 60/377 (15%), Positives = 98/377 (25%), Gaps = 111/377 (29%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLP--SLNGLASLEVVMLSNNQFTSVPSDFFT 136
+ L LE L+L N I L GL ++ + LS N++ + + F
Sbjct: 392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFA 451
Query: 137 GLSSLQSIEIDNNPFSS-WEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTIL 195
+ SLQ + + + P + L ++ NI L IL
Sbjct: 452 LVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEG--LEKLEIL 509
Query: 196 HLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGP 255
L N L LW + G GP
Sbjct: 510 DLQHNNL-------------ARLWKHANPG----------------------------GP 528
Query: 256 LPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMA 315
+ G+ L L+L N F + L LK +D+
Sbjct: 529 IYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK--------------------IIDL- 567
Query: 316 KGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVI 375
N LN L F + ++ +
Sbjct: 568 --GLN-----------NLNTLP--------ASVFN-----------------NQVSLKSL 589
Query: 376 NFQKMNLTGTISPEFA-SFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKI 434
N QK +T F +F++L L + N + + E + +L
Sbjct: 590 NLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHY 649
Query: 435 -----PSFKSNAIVNTD 446
P + + D
Sbjct: 650 LCNTPPHYHGFPVRLFD 666
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 30/195 (15%), Positives = 57/195 (29%), Gaps = 45/195 (23%)
Query: 240 TSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 299
S + + +PD + L+L N + + L +++ N +
Sbjct: 4 VSHEVADCSHLKLTQ-VPDDLP-TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 300 QGPVPEFDRSVS----LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 355
PE + + L++ N S ++ +L N
Sbjct: 62 SKLEPELCQKLPMLKVLNLQ--HNELSQLSDKT----FAFCTNLTEL-----HLMSN--- 107
Query: 356 NDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLS 415
++ + F K+L L L+ N LS
Sbjct: 108 -------------------------SIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQV 142
Query: 416 VLGALKELDVSNNQL 430
L L+EL +SNN++
Sbjct: 143 QLENLQELLLSNNKI 157
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 598 ENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
+LG+G FG+V + +L K+AVK ++A +I+ + EF E A + + H H+
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 654 VALLGHCLDGNEK------LLVFEYMPQGTLSRHI-FNWAEEGLKPLEWNRRLTIALDVA 706
L+G L K +++ +M G L + + E L + +D+A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR---IAGT 763
G+EYL + ++FIHRDL N +L +DM VADFGL R I + G
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK-------IYSGDYYRQGC 197
Query: 764 FGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 795
L A E T DV++FGV + E++T
Sbjct: 198 ASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-41
Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 22/213 (10%)
Query: 598 ENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
ILG G FG+V +G L K+AVK M+ S + + EF SE A + H ++
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 654 VALLGHCLDGN-----EKLLVFEYMPQGTLSRHI-FNWAEEGLKPLEWNRRLTIALDVAR 707
+ LLG C++ + + +++ +M G L ++ ++ E G K + L +D+A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
G+EYL ++++F+HRDL N +L DDM VADFGL + G + G +
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG----DYYRQGRIAKM 211
Query: 768 -----APEYAVTGRVTTKVDVFSFGVILMELIT 795
A E T+K DV++FGV + E+ T
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-41
Identities = 67/223 (30%), Positives = 103/223 (46%), Gaps = 33/223 (14%)
Query: 598 ENILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV- 648
LG G FG V E TK+AVK +++ + K L++ SE+ ++ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIG 132
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----------SRHIFNWAEEGLKPLEWNR 697
+H++++ LLG C ++ EY +G L + +N + + L
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE 757
++ A VARG+EYL A + IHRDL N+L+ +D K+ADFGL R +
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI----D 245
Query: 758 TRIAGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 795
T G L APE T + DV+SFGV+L E+ T
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+G G FG V+ G + K+A+K + G +S + +F E V+ K+ H LV L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLY 69
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
G CL+ LV E+M G L ++ L + LDV G+ YL
Sbjct: 70 GVCLEQAPICLVTEFMEHGCL----SDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EE 122
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT---FGYLAPEYAVT 774
IHRDL N L+G++ KV+DFG+ R + T GT + +PE
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFPVKWASPEVFSF 179
Query: 775 GRVTTKVDVFSFGVILMELIT-GRK 798
R ++K DV+SFGV++ E+ + G+
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-41
Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 33/223 (14%)
Query: 598 ENILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV- 648
LG G FG V E +AVK ++ + K L++ SE+ ++ +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIG 98
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----------SRHIFNWAEEGLKPLEWNR 697
+H++++ LLG C ++ EY +G L + ++ + + +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE 757
++ +ARG+EY LA Q IHRDL N+L+ ++ K+ADFGL R +
Sbjct: 159 LVSCTYQLARGMEY---LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI----D 211
Query: 758 TRIAGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 795
T G L APE T + DV+SFGV++ E+ T
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-41
Identities = 72/218 (33%), Positives = 102/218 (46%), Gaps = 31/218 (14%)
Query: 598 ENILGRGGFGTVYKGELHDG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHL 653
++++G G FG V K + A+KRM+ S +F E+ VL K+ H ++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNI 88
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTL-----------SRHIFNWAEEGLKPLEWNRRLTIA 702
+ LLG C L EY P G L + F A L + L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG 762
DVARG++YL + + FIHRDL NIL+G++ AK+ADFGL R E +
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKK 198
Query: 763 TFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 795
T G L A E TT DV+S+GV+L E+++
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 5e-41
Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 33/223 (14%)
Query: 598 ENILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV- 648
LG G FG V E +AVK ++ + K L++ SE+ ++ +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIG 144
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----------SRHIFNWAEEGLKPLEWNR 697
+H++++ LLG C ++ EY +G L + ++ + + +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE 757
++ +ARG+EY LA Q IHRDL N+L+ ++ K+ADFGL R +
Sbjct: 205 LVSCTYQLARGMEY---LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI----D 257
Query: 758 TRIAGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 795
T G L APE T + DV+SFGV++ E+ T
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-41
Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
LG G FG V G+ +AVK ++ G +S EF E + K+ H LV
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFY 69
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
G C +V EY+ G L N+ K LE ++ L + DV G+ +L
Sbjct: 70 GVCSKEYPIYIVTEYISNGCLL----NYLRSHGKGLEPSQLLEMCYDVCEGMAFL---ES 122
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT---FGYLAPEYAVT 774
FIHRDL N L+ D+ KV+DFG+ R + GT + APE
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD---DQYVSSVGTKFPVKWSAPEVFHY 179
Query: 775 GRVTTKVDVFSFGVILMELIT-GRK 798
+ ++K DV++FG+++ E+ + G+
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKM 204
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-41
Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 599 NILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
LG+G FG VY+G T++A+K + S + EF +E +V+ + H
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHH 89
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+V LLG G L++ E M +G L S L P ++ + +A ++A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL-------APEGKGSIETRI 760
G+ YL F+HRDL N ++ +D K+ DFG+ R GKG + R
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 205
Query: 761 AGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
+++PE G TT DV+SFGV+L E+ T
Sbjct: 206 -----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 8e-41
Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 38/228 (16%)
Query: 598 ENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
LG G FG V K T +AVK ++ S L + SE VL +V H
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHP 86
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTL-------------------SRHIFNWAEEGLKP 692
H++ L G C LL+ EY G+L SR+ + +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 693 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752
L ++ A +++G++Y LA +HRDL NIL+ + + K++DFGL R E
Sbjct: 147 LTMGDLISFAWQISQGMQY---LAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 753 KGSIETRIAGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 795
++ + + G + A E TT+ DV+SFGV+L E++T
Sbjct: 204 ----DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 8e-41
Identities = 63/228 (27%), Positives = 92/228 (40%), Gaps = 33/228 (14%)
Query: 593 NNFSEENILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLT 646
N S LG G FG V + + +AVK ++ SE+ VL+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLS 81
Query: 647 KV-RHRHLVALLGHCLDGNEKLLVFEYMPQGTL-------------SRHIFNWAEEGLKP 692
+ H ++V LLG C G L++ EY G L S+ E+
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 693 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752
L+ L+ + VA+G+ +L A ++ IHRDL NILL K+ DFGL R
Sbjct: 142 LDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 753 KGSIETRIAGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 795
+ L APE T + DV+S+G+ L EL +
Sbjct: 199 ----SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 9e-41
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 597 EENILGRGGFGTVYKGELHDG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
E+ LG G FGTV KG +AVK ++ E +E V+ ++ + ++
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVAR 707
V ++G C +LV E G L K L+ NR + + V+
Sbjct: 81 VRMIGICE-AESWMLVMEMAELGPL-----------NKYLQQNRHVKDKNIIELVHQVSM 128
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF--G 765
G++YL +F+HRDL N+LL AK++DFGL + + + + G +
Sbjct: 129 GMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 766 YLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRK 798
+ APE + ++K DV+SFGV++ E + G+K
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 60/207 (28%), Positives = 92/207 (44%), Gaps = 21/207 (10%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
LG G FG V G+ +A+K ++ G +S EF E V+ + H LV L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLY 85
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
G C ++ EYM G L N+ E + + L + DV +EYL
Sbjct: 86 GVCTKQRPIFIITEYMANGCL----LNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ES 138
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL-----APEYA 772
+ F+HRDL N L+ D KV+DFGL R + T G PE
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSVG--SKFPVRWSPPEVL 193
Query: 773 VTGRVTTKVDVFSFGVILMELIT-GRK 798
+ + ++K D+++FGV++ E+ + G+
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKM 220
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 68/226 (30%), Positives = 95/226 (42%), Gaps = 28/226 (12%)
Query: 598 ENILGRGGFGTVYKGELHD-----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
LG G FG V G +AVK ++A + + +K EI +L + H H
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEH 94
Query: 653 LVALLGHCLDGNEK--LLVFEYMPQGTL----SRHIFNWAEEGLKPLEWNRRLTIALDVA 706
++ G C D LV EY+P G+L RH + + L A +
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----------SIGLAQLLLFAQQIC 144
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF-- 764
G+ YLH Q +IHRDL N+LL +D K+ DFGL + PEG R G
Sbjct: 145 EGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 201
Query: 765 GYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESM 809
+ APE + DV+SFGV L EL+T + +
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL 247
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-40
Identities = 61/221 (27%), Positives = 92/221 (41%), Gaps = 32/221 (14%)
Query: 599 NILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHR 651
LGRG FG V + + +AVK ++ G + SE+ +L + H
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHL 91
Query: 652 HLVALLGHCLDGNEKL-LVFEYMPQGTL------SRHIFNWAEEGL-----KPLEWNRRL 699
++V LLG C L ++ E+ G L R+ F + L +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 700 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR 759
+ VA+G+E+L A + IHRDL NILL + K+ DFGL R +
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK----DPDY 204
Query: 760 IAGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 795
+ L APE T + DV+SFGV+L E+ +
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 67/222 (30%), Positives = 104/222 (46%), Gaps = 35/222 (15%)
Query: 598 ENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
+ LG G FG V+ E ++ +AVK ++ + +F+ E +LT ++H
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHE 77
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTL-----------SRHIFNWAEEGLKPLEWNRRLT 700
H+V G C DG+ ++VFEYM G L + + L ++ L
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL-------APEGK 753
IA +A G+ YL A Q F+HRDL N L+G ++ K+ DFG+ R G
Sbjct: 138 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 754 GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
+ R ++ PE + + TT+ DV+SFGVIL E+ T
Sbjct: 195 TMLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-40
Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 28/223 (12%)
Query: 594 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
++ LG GGF V E LHDG A+KR+ + E + E + H +
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLFNHPN 87
Query: 653 LVALLGHCLD----GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
++ L+ +CL +E L+ + +GTL I ++ L ++ L + L + RG
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQILWLLLGICRG 146
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA------- 761
+E +H + + HRDLKP+NILLGD+ + + D G + A +
Sbjct: 147 LEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 762 -GTFGYLAPE------YAVTGRVTTKVDVFSFGVILMELITGR 797
T Y APE + V + + DV+S G +L ++ G
Sbjct: 204 RCTISYRAPELFSVQSHCV---IDERTDVWSLGCVLYAMMFGE 243
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-40
Identities = 56/219 (25%), Positives = 88/219 (40%), Gaps = 29/219 (13%)
Query: 598 ENILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RH 650
LG G FG V + K+AVK +++ SE+ +++ + +H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQH 109
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTL---------SRHIFNWAEEGLKPLEWNRRLTI 701
++V LLG C G L++ EY G L L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA 761
+ VA+G+ +L A ++ IHRD+ N+LL + AK+ DFGL R I
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND----SNYIV 222
Query: 762 GTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 795
L APE T + DV+S+G++L E+ +
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-40
Identities = 66/209 (31%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 597 EENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+ ++G+G FG VY GE D + A+K + + + F E ++ + H +
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPN 83
Query: 653 LVALLGHCLDGNE-KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
++AL+G L ++ YM G L + I + ++ L VARG+EY
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFI----RSPQRNPTVKDLISFGLQVARGMEY 139
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL---- 767
L A Q F+HRDL N +L + KVADFGL R + + L
Sbjct: 140 L---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD--REYYSVQQHRHARLPVKW 194
Query: 768 -APEYAVTGRVTTKVDVFSFGVILMELIT 795
A E T R TTK DV+SFGV+L EL+T
Sbjct: 195 TALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-40
Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 16/209 (7%)
Query: 598 ENILGRGGFGTVYKGELHDGT-----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+ ++G G FG VYKG L + +A+K ++AG + K +F E ++ + H +
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHN 107
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
++ L G +++ EYM G L + E + + + +A G++YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGAL----DKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY--LAPE 770
A+ +++HRDL NIL+ ++ KV+DFGL R+ + + T G APE
Sbjct: 164 ---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 771 YAVTGRVTTKVDVFSFGVILMELIT-GRK 798
+ T+ DV+SFG+++ E++T G +
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 5e-40
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 16/209 (7%)
Query: 598 ENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRH 652
LG G FG V +GE +AVK ++ V+S + + +F E+ + + HR+
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
L+ L G L +V E P G+L + + A+ VA G+ YL
Sbjct: 83 LIRLYGVVL-TPPMKMVTELAPLGSLLDRL----RKHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY--LAPE 770
+ FIHRDL N+LL K+ DFGL+R P+ + + APE
Sbjct: 138 ---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 771 YAVTGRVTTKVDVFSFGVILMELIT-GRK 798
T + D + FGV L E+ T G++
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-40
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 598 ENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+ LG+G FG+V G +AVK+++ +F+ EI +L +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDF 85
Query: 653 LVALLGHCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
+V G + LV EY+P G L + + L+ +R L + + +G+E
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGME 141
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF--GYLA 768
YL + +HRDL NIL+ + K+ADFGL +L P K R G + A
Sbjct: 142 YLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198
Query: 769 PEYAVTGRVTTKVDVFSFGVILMELIT 795
PE + + DV+SFGV+L EL T
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-40
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 598 ENILGRGGFGTVYKGELHDG-TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
++ LG G +G VY+G +AVK ++ + + EF E AV+ +++H +LV L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQL 74
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
LG C ++ E+M G L ++ E + + L +A ++ +EYL
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYL---E 128
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL-----APEY 771
++FIHRDL N L+G++ KVADFGL RL +T A APE
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-----DTYTAHAGAKFPIKWTAPES 183
Query: 772 AVTGRVTTKVDVFSFGVILMELIT-GRK 798
+ + K DV++FGV+L E+ T G
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMS 211
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-40
Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 598 ENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
E I+G G G V G L +A+K ++AG + +F SE +++ + H ++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE-RQRRDFLSEASIMGQFDHPNI 112
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
+ L G G ++V EYM G+L + + + + V G+ YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSL----DTFLRTHDGQFTIMQLVGMLRGVGAGMRYL- 167
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL--APEY 771
+ ++HRDL N+L+ ++ KV+DFGL R+ + + T G APE
Sbjct: 168 --SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 772 AVTGRVTTKVDVFSFGVILMELIT-GRK 798
++ DV+SFGV++ E++ G +
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-40
Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 34/221 (15%)
Query: 598 ENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
+ LG G FG V+ E H+ +AVK ++ S +F+ E +LT ++H+
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQ 103
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTL----------SRHIFNWAEEGLKPLEWNRRLTI 701
H+V G C +G L+VFEYM G L ++ + + PL + L +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE-------GKG 754
A VA G+ YL A F+HRDL N L+G + K+ DFG+ R G+
Sbjct: 164 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 755 SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
+ R ++ PE + + TT+ DV+SFGV+L E+ T
Sbjct: 221 MLPIR------WMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-39
Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 598 ENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
++ LG G +G VY+G +AVK ++ + + EF E AV+ +++H +LV L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQL 281
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
LG C ++ E+M G L ++ E + + L +A ++ +EYL
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYL---E 335
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR 776
++FIHR+L N L+G++ KVADFGL RL + + APE +
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 777 VTTKVDVFSFGVILMELIT 795
+ K DV++FGV+L E+ T
Sbjct: 396 FSIKSDVWAFGVLLWEIAT 414
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 34/222 (15%)
Query: 598 ENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
LG FG VYKG L +A+K ++ G EF+ E + +++H
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHP 72
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTL-----------SRHIFNWAEEGLKPLEWNRRLT 700
++V LLG ++F Y G L + LE +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL-------APEGK 753
+ +A G+EYL + +H+DL N+L+ D + K++D GL R G
Sbjct: 133 LVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 754 GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
+ R ++APE + G+ + D++S+GV+L E+ +
Sbjct: 190 SLLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 1e-39
Identities = 70/205 (34%), Positives = 108/205 (52%), Gaps = 21/205 (10%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+G+G FG V G+ G K+AVK ++ + F +E +V+T++RH +LV LL
Sbjct: 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA----QAFLAEASVMTQLRHSNLVQLL 80
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
G ++ L +V EYM +G+L ++ G L + L +LDV +EYL
Sbjct: 81 GVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYL---E 134
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY--LAPEYAVT 774
+F+HRDL N+L+ +D AKV+DFGL + A T+ G APE
Sbjct: 135 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA------SSTQDTGKLPVKWTAPEALRE 188
Query: 775 GRVTTKVDVFSFGVILMELIT-GRK 798
+ +TK DV+SFG++L E+ + GR
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRV 213
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 26/215 (12%)
Query: 598 ENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
LG G FG VY+G++ ++AVK + S + +F E +++K H+
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQ 93
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLS---RHIFNWAEEGLKPLEWNRRLTIALDVARG 708
++V +G L + ++ E M G L R + L L +A D+A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQP-SSLAMLDLLHVARDIACG 152
Query: 709 VEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFG 765
+Y L FIHRD+ N LL G AK+ DFG+ R G
Sbjct: 153 CQY---LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----SYYRKGGCA 205
Query: 766 YL-----APEYAVTGRVTTKVDVFSFGVILMELIT 795
L PE + G T+K D +SFGV+L E+ +
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-39
Identities = 63/228 (27%), Positives = 94/228 (41%), Gaps = 38/228 (16%)
Query: 598 ENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RH 650
+LG G FG V + ++AVK ++ SE+ ++T++ H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSH 108
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTL------SRHIFNWA------------EEGLKP 692
++V LLG C L+FEY G L R F+ EE L
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 693 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752
L + L A VA+G+E+L +S +HRDL N+L+ K+ DFGL R
Sbjct: 169 LTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 753 KGSIETRIAGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 795
+ L APE G T K DV+S+G++L E+ +
Sbjct: 226 ----SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-39
Identities = 65/199 (32%), Positives = 105/199 (52%), Gaps = 16/199 (8%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+G+G FG V G+ G K+AVK ++ + F +E +V+T++RH +LV LL
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA----QAFLAEASVMTQLRHSNLVQLL 252
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
G ++ L +V EYM +G+L ++ G L + L +LDV +EYL
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYL---E 306
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR 776
+F+HRDL N+L+ +D AKV+DFGL + ++ + APE +
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKK 362
Query: 777 VTTKVDVFSFGVILMELIT 795
+TK DV+SFG++L E+ +
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-39
Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 597 EENILGRGGFGTVYKGELHDG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
+ LG G FG+V +G +A+K ++ G E E ++ ++ + ++
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYI 72
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
V L+G C +LV E G L + + EE + + + V+ G++YL
Sbjct: 73 VRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYL- 126
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF--GYLAPEY 771
++F+HRDL N+LL + AK++DFGL + R AG + + APE
Sbjct: 127 --EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 184
Query: 772 AVTGRVTTKVDVFSFGVILMELIT-GRK 798
+ +++ DV+S+GV + E ++ G+K
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-39
Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 16/201 (7%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
LG G FG V+ G + TK+AVK ++ G +S F +E ++ +++H+ LV L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLY 74
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
++ EYM G+L F G L N+ L +A +A G+ ++
Sbjct: 75 AVVT-QEPIYIITEYMENGSLVD--FLKTPSG-IKLTINKLLDMAAQIAEGMAFI---EE 127
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT---FGYLAPEYAVT 774
+++IHRDL+ +NIL+ D + K+ADFGL RL + + T G + APE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAINY 184
Query: 775 GRVTTKVDVFSFGVILMELIT 795
G T K DV+SFG++L E++T
Sbjct: 185 GTFTIKSDVWSFGILLTEIVT 205
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 9e-39
Identities = 60/242 (24%), Positives = 101/242 (41%), Gaps = 32/242 (13%)
Query: 566 PSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRM 625
PS E D + +V I F +++LG G GT+ + D +AVKR
Sbjct: 5 PSLEQDDGDEETSVVIVGKIS--------FCPKDVLGHGAEGTIVYRGMFDNRDVAVKR- 55
Query: 626 EAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFN 684
I + + E+ +L + H +++ D + + E TL ++
Sbjct: 56 ----ILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV-- 108
Query: 685 WAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-----DMRAK 739
E+ +T+ G+ +LH + +HRDLKP NIL+ ++A
Sbjct: 109 --EQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAM 163
Query: 740 VADFGLVRLAPEGKGSIETR--IAGTFGYLAPEY---AVTGRVTTKVDVFSFGVILMELI 794
++DFGL + G+ S R + GT G++APE T VD+FS G + +I
Sbjct: 164 ISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVI 223
Query: 795 TG 796
+
Sbjct: 224 SE 225
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 68/208 (32%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 598 ENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
++GRG FG VY G L D AVK + +++F +E ++ H ++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNV 88
Query: 654 VALLGHCLDGNEKLL-VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
++LLG CL L V YM G L I + L VA+G++YL
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL----- 767
A + F+HRDL N +L + KVADFGL R + + T L
Sbjct: 145 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD--KEYYSVHNKTGAKLPVKWM 199
Query: 768 APEYAVTGRVTTKVDVFSFGVILMELIT 795
A E T + TTK DV+SFGV+L EL+T
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-38
Identities = 65/228 (28%), Positives = 99/228 (43%), Gaps = 38/228 (16%)
Query: 598 ENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
+G G FG V++ T +AVK ++ S +F+ E A++ + +
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNP 110
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTL-------------------SRHIFNWAEEGLKP 692
++V LLG C G L+FEYM G L + G P
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 693 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752
L +L IA VA G+ Y L+ + F+HRDL N L+G++M K+ADFGL R
Sbjct: 171 LSCAEQLCIARQVAAGMAY---LSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 753 KGSIETRIAGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 795
+ A + PE R TT+ DV+++GV+L E+ +
Sbjct: 228 ----DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-38
Identities = 67/296 (22%), Positives = 110/296 (37%), Gaps = 38/296 (12%)
Query: 517 KQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQML 576
+ + + S K++ ++ + + + +
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLK 66
Query: 577 EAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVI 630
E V R N + LG G FG VY+G++ ++AVK +
Sbjct: 67 E---------VPRK---NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC- 113
Query: 631 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLS---RHIFNWAE 687
S + +F E +++K H+++V +G L + ++ E M G L R
Sbjct: 114 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPS 173
Query: 688 EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFG 744
+ L L +A D+A G +Y L FIHRD+ N LL G AK+ DFG
Sbjct: 174 QP-SSLAMLDLLHVARDIACGCQY---LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229
Query: 745 LVRLAPEGKGSIETRIAGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 795
+ R G L PE + G T+K D +SFGV+L E+ +
Sbjct: 230 MARDIYRA----GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 598 ENILGRGGFGTVYKGELHDG-----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+LG G FGTVYKG +A+K + S K E E V+ V + H
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPH 78
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE-GLKPLEWNRRLTIALDVARGVEY 711
+ LLG CL + L+ + MP G L ++ + G + L L + +A+G+ Y
Sbjct: 79 VCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNY 132
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT---FGYLA 768
L + +HRDL N+L+ K+ DFGL +L E G ++A
Sbjct: 133 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMA 187
Query: 769 PEYAVTGRVTTKVDVFSFGVILMELIT-GRK 798
E + T + DV+S+GV + EL+T G K
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-38
Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 14/200 (7%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
E LG G FG V+ + TK+AVK M+ G +S + F +E V+ ++H LV L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLH 249
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
++ E+M +G+L + + +EG + + + +A G+ ++
Sbjct: 250 AVVT-KEPIYIITEFMAKGSLLDFLKS--DEG-SKQPLPKLIDFSAQIAEGMAFI---EQ 302
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY--LAPEYAVTG 775
+++IHRDL+ +NIL+ + K+ADFGL R+ + + R F APE G
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFG 360
Query: 776 RVTTKVDVFSFGVILMELIT 795
T K DV+SFG++LME++T
Sbjct: 361 SFTIKSDVWSFGILLMEIVT 380
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-38
Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 598 ENILGRGGFGTVYKGELHDGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
+ ++G G FG V G L +K +A+K ++ G K +F E +++ + H ++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE-KQRRDFLGEASIMGQFDHPNI 108
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
+ L G ++V EYM G+L ++ + + + + +A G++YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLD----SFLRKHDAQFTVIQLVGMLRGIASGMKYL- 163
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL--APEY 771
+ ++HRDL NIL+ ++ KV+DFGL R+ + + T G +PE
Sbjct: 164 --SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 772 AVTGRVTTKVDVFSFGVILMELIT-GRK 798
+ T+ DV+S+G++L E+++ G +
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-38
Identities = 66/299 (22%), Positives = 109/299 (36%), Gaps = 55/299 (18%)
Query: 592 TNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 650
++F E +LG+G FG V K D A+K++ + + L+ SE+ +L + H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNH 61
Query: 651 RHLVALLGHCLDGNEKL-------------LVFEYMPQGTLSRHIFNWAEEGLKPLEWNR 697
+++V L+ + + EY GTL ++ + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDE 117
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--------- 748
+ + + Y+H Q IHRDLKP NI + + K+ DFGL +
Sbjct: 118 YWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 749 ----APEGKGSIETRIAGTFGYLAPE-YAVTGRVTTKVDVFSFGVILMELITGRKALDES 803
G T GT Y+A E TG K+D++S G+I E+I
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP------- 227
Query: 804 QPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRP 862
M V +++ F D E + I +P +RP
Sbjct: 228 -FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKI--IR-------LLIDHDPNKRP 276
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-38
Identities = 78/293 (26%), Positives = 119/293 (40%), Gaps = 27/293 (9%)
Query: 518 QKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLE 577
R ++ A I I +++ A SE + I +
Sbjct: 11 HHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSA 70
Query: 578 AGNMVISIQVLRNVTNNFSEENI-----LGRGGFGTVYKGELHDG----TKIAVKRMEAG 628
++ Q +++V S + +GRG FG VY G L D AVK +
Sbjct: 71 LNPELV--QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI 128
Query: 629 VISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL-VFEYMPQGTLSRHIFNWAE 687
+++F +E ++ H ++++LLG CL L V YM G L I
Sbjct: 129 T-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----R 183
Query: 688 EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+ L VA+G+++L A + F+HRDL N +L + KVADFGL R
Sbjct: 184 NETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240
Query: 748 LAPEGKGSIETRIAGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 795
+ ++ T L A E T + TTK DV+SFGV+L EL+T
Sbjct: 241 DMYD--KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-38
Identities = 59/370 (15%), Positives = 119/370 (32%), Gaps = 30/370 (8%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTG 137
+ L N LE L L N IS LP L+V+ NN + + +
Sbjct: 116 GISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSS 175
Query: 138 LSSLQSIEID--NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTIL 195
L ++ ++ N + I +++ Q+ + I L +
Sbjct: 176 LQQATNLSLNLNGNDIAG--IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLG 233
Query: 196 HLAFNQLIGGLPASFSG---SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAF 252
PA F G ++S+ + + + + L+E+ L +
Sbjct: 234 TFEDMDDEDISPAVFEGLCEMSVESINL---QKHYFFNISSNTFHCFSGLQELDLTATHL 290
Query: 253 SGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE--FDRSV 310
S G+ L+ L L N F S SL +++ N + + +
Sbjct: 291 SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE 350
Query: 311 SL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTC 367
+L D+ S++ + + C+ +L L + L + N + +
Sbjct: 351 NLRELDL---SHD-DIETSDCCNLQLRNLSHLQSL-----NLSYNEPLSLKTEAFKECP- 400
Query: 368 TKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVS 426
+ +++ L + F + L+ L L+ + L + L AL+ L++
Sbjct: 401 ---QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQ 457
Query: 427 NNQLYGKIPS 436
N
Sbjct: 458 GNHFPKGNIQ 467
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-32
Identities = 71/388 (18%), Positives = 129/388 (33%), Gaps = 54/388 (13%)
Query: 74 QIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSD 133
Q +G S +Q+L ++ IS + S+E + L + F ++ S+
Sbjct: 213 QNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272
Query: 134 FFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLT 193
F S LQ +++ S +P L S L+ ++ FP LT
Sbjct: 273 TFHCFSGLQELDLTATHLSE--LPSGLVGLSTLKKLVLSANKFENLCQISAS--NFPSLT 328
Query: 194 ILHLAFNQLIGGL-PASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA 251
L + N L ++ L ++ + ++N++ L+ + L N
Sbjct: 329 HLSIKGNTKRLELGTGCLENLENLRELDLSH-DDIETSDCCNLQLRNLSHLQSLNLSYNE 387
Query: 252 FSG-PLPDFSGVKQLESLSLRDNFFTGPVPDS-LVKLESLKIVNMTNNLLQGPVPE-FDR 308
F QLE L L S L LK++N++++LL + FD
Sbjct: 388 PLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDG 447
Query: 309 SVS---LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGV 365
+ L++ N L L
Sbjct: 448 LPALQHLNL---QGNHFPKGNIQKTNSLQTL----------------------------- 475
Query: 366 TCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDV 425
G + ++ +L+ F S K + + L+ N L+ E LS L + L++
Sbjct: 476 ----GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNL 530
Query: 426 SNNQLYGKIPS----FKSNAIVNTDGNP 449
++N + +PS +N NP
Sbjct: 531 ASNHISIILPSLLPILSQQRTINLRQNP 558
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-32
Identities = 63/381 (16%), Positives = 125/381 (32%), Gaps = 37/381 (9%)
Query: 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFT 128
+T + + + Q+ +L+ L L N + +L+G +L+ + +
Sbjct: 59 LTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118
Query: 129 SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFFGP 186
S+ +L+S+ + +N SS L+ +F N I
Sbjct: 119 SIDFIPLHNQKTLESLYLGSNHISS-IKLPKGFPTEKLKVLDFQNN--AIHYLSKEDMSS 175
Query: 187 DEFPGLTI--LHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKE 244
T L+L N + G P +F + QSL G N + + SL
Sbjct: 176 --LQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGG-TQNLLVIFKGLKNSTIQSLWL 232
Query: 245 IWLHSNAFSGPLPD-FSGVK--QLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG 301
P F G+ +ES++L+ ++F ++ L+ +++T L
Sbjct: 233 GTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE 292
Query: 302 PVPEFDRSVS---LDMAKGSNNFCLPSPGACD--PRLNALLSVVKLMGYPQRFAENWKGN 356
+ L + +N F + P L L N K
Sbjct: 293 LPSGLVGLSTLKKLVL--SANKFENLCQISASNFPSLTHL-----------SIKGNTKRL 339
Query: 357 DPCSDWIGVTCTKGNITVINFQKMNLT--GTISPEFASFKSLQRLILADNNLSGMIPEGL 414
+ + + N+ ++ ++ + + + LQ L L+ N + E
Sbjct: 340 ELGTGCLENL---ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAF 396
Query: 415 SVLGALKELDVSNNQLYGKIP 435
L+ LD++ +L K
Sbjct: 397 KECPQLELLDLAFTRLKVKDA 417
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-30
Identities = 68/413 (16%), Positives = 115/413 (27%), Gaps = 81/413 (19%)
Query: 64 CIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVML 122
CIE + + L +P L E LE +N + + + L +L + L
Sbjct: 8 CIEKEVNKTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDL 64
Query: 123 SNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPS 182
+ Q + D F L ++ + NP +L L++ I+
Sbjct: 65 TRCQIYWIHEDTFQSQHRLDTLVLTANPLIF-MAETALSGPKALKHLFFIQTGISSIDFI 123
Query: 183 FFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSL 242
L L+L N + L
Sbjct: 124 PLHN--QKTLESLYLGSNHISSIKLPKG--------------------------FPTEKL 155
Query: 243 KEIWLHSNAFSG-PLPDFSGVKQLE--SLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 299
K + +NA D S ++Q SL+L N G + + +N
Sbjct: 156 KVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQN 214
Query: 300 QGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPC 359
+ + G N + S +
Sbjct: 215 LLVIFK-----------GLKNSTIQSLWLGTFEDMDDEDI-------------------- 243
Query: 360 SDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGA 419
S + + ++ IN QK S F F LQ L L +LS +P GL L
Sbjct: 244 SPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLST 302
Query: 420 LKELDVSNNQLYGKIPSFKSNAIVNT--------DGNPDIGKEKSSSFQGSPS 464
LK+L +S N+ + + N GN + + + +
Sbjct: 303 LKKLVLSANK----FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-29
Identities = 60/367 (16%), Positives = 114/367 (31%), Gaps = 67/367 (18%)
Query: 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFT 128
+ I + + + L+ L+L +S L GL++L+ ++LS N+F
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFE 314
Query: 129 SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFFGP 186
++ + SL + I N L N L+ + S + +I
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD--DIETSDCCNLQL 372
Query: 187 DEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIW 246
L L+L++N+ +++ + + L+ +
Sbjct: 373 RNLSHLQSLNLSYNEP----------LSLKT----------------EAFKECPQLELLD 406
Query: 247 LHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP 304
L F + L+ L+L + L +L+ +N+ N
Sbjct: 407 LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHF----- 461
Query: 305 EFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWI 363
N S RL L LS L Q +
Sbjct: 462 -----------PKGNIQKTNSLQTL-GRLEILVLSFCDLSSIDQHAFTS----------- 498
Query: 364 GVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKEL 423
+ ++ LT + S E S L LA N++S ++P L +L + +
Sbjct: 499 -----LKMMNHVDLSHNRLT-SSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTI 552
Query: 424 DVSNNQL 430
++ N L
Sbjct: 553 NLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-28
Identities = 71/374 (18%), Positives = 111/374 (29%), Gaps = 58/374 (15%)
Query: 78 QNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFT--SVPSDFF 135
L S+LQ T L L L N I+G P A + + Q
Sbjct: 166 HYLSKEDMSSLQQATNLS-LNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKN 224
Query: 136 TGLSSLQSIEIDNNPFS--SWEIPQSLRNASGLQ-NFSANSANITGQIPSFFGPDEFPGL 192
+ + SL ++ S + + L S N + + F F GL
Sbjct: 225 STIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKH--YFFNISSNTFHC--FSGL 280
Query: 193 TILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA 251
L L + LP+ G S ++ L ++ N L N SL + + N
Sbjct: 281 QELDLTATH-LSELPSGLVGLSTLKKLVLSA-NKFENLCQI--SASNFPSLTHLSIKGNT 336
Query: 252 FSGPLPD--FSGVKQLESLSLRDNFFT--GPVPDSLVKLESLKIVNMTNNLLQGPVPE-F 306
L ++ L L L + L L L+ +N++ N E F
Sbjct: 337 KRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAF 396
Query: 307 DRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVT 366
L+ L+ L+ +L K D S + +
Sbjct: 397 KECPQLE------------------LLD--LAFTRL-----------KVKDAQSPFQNLH 425
Query: 367 CTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMI---PEGLSVLGALKEL 423
+ V+N L + F +LQ L L N+ L LG L+ L
Sbjct: 426 ----LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL 481
Query: 424 DVSNNQLYGKIPSF 437
+S L
Sbjct: 482 VLSFCDLSSIDQHA 495
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-26
Identities = 42/234 (17%), Positives = 83/234 (35%), Gaps = 19/234 (8%)
Query: 79 NLQGTLPSN-LQNLTKLERLELQWNSISG---PLPSLNGLASLEVVMLSNNQFTSVPSDF 134
+ L + L+NL L L+L + I L L+ L+ + LS N+ S+ ++
Sbjct: 336 TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395
Query: 135 FTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFFGPDEFPGL 192
F L+ +++ + +N L+ N S + + F P L
Sbjct: 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS--LLDISSEQLFD--GLPAL 451
Query: 193 TILHLAFNQL---IGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLH 248
L+L N S +++ L ++ ++ + + L
Sbjct: 452 QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF---CDLSSIDQHAFTSLKMMNHVDLS 508
Query: 249 SNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG 301
N + + S +K + L+L N + +P L L + +N+ N L
Sbjct: 509 HNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-17
Identities = 31/140 (22%), Positives = 58/140 (41%), Gaps = 10/140 (7%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG----PLPSLNGLASLEVVMLS 123
+ + + H L + L L+ L LQ N SL L LE+++LS
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484
Query: 124 NNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ-NFSANSANITGQIPS 182
+S+ FT L + +++ +N +S ++L + G+ N ++N +I+ +PS
Sbjct: 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTS-SSIEALSHLKGIYLNLASN--HISIILPS 541
Query: 183 FFGPDEFPGLTILHLAFNQL 202
++L N L
Sbjct: 542 LLPI--LSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 16/72 (22%), Positives = 25/72 (34%), Gaps = 4/72 (5%)
Query: 359 CSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLG 418
S + N T N + + L I S + L + N L + S L
Sbjct: 2 TSSDQKCIEKEVNKTY-NCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLI 57
Query: 419 ALKELDVSNNQL 430
L LD++ Q+
Sbjct: 58 NLTFLDLTRCQI 69
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 6e-38
Identities = 69/198 (34%), Positives = 108/198 (54%), Gaps = 10/198 (5%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
E LG+G FG V+ G + T++A+K ++ G +S F E V+ K+RH LV L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLY 245
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
+ +V EYM +G+L + E K L + + +A +A G+ Y+
Sbjct: 246 AVVSE-EPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYV---ER 298
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV 777
+++HRDL+ +NIL+G+++ KVADFGL RL + + + + APE A+ GR
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 778 TTKVDVFSFGVILMELIT 795
T K DV+SFG++L EL T
Sbjct: 359 TIKSDVWSFGILLTELTT 376
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 598 ENILGRGGFGTVYKGELHDG-----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+LG G FGTV+KG + +K +E + + + + H H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAH 76
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE-GLKPLEWNRRLTIALDVARGVEY 711
+V LLG C G+ LV +Y+P G+L H+ G + L L + +A+G+ Y
Sbjct: 77 IVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLL-----LNWGVQIAKGMYY 130
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT---FGYLA 768
L +HR+L N+LL + +VADFG+ L P + + ++A
Sbjct: 131 L---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP--DDKQLLYSEAKTPIKWMA 185
Query: 769 PEYAVTGRVTTKVDVFSFGVILMELIT-GRK 798
E G+ T + DV+S+GV + EL+T G +
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 598 ENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
ILG G FG VY+G + +AVK + + +F SE ++ + H H+
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHI 75
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
V L+G ++ E P G L ++ E L+ + +L + + + YL
Sbjct: 76 VKLIGIIE-EEPTWIIMELYPYGELGHYL----ERNKNSLKVLTLVLYSLQICKAMAYL- 129
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT---FGYLAPE 770
+ +HRD+ NIL+ K+ DFGL R + + + T +++PE
Sbjct: 130 --ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED---EDYYKASVTRLPIKWMSPE 184
Query: 771 YAVTGRVTTKVDVFSFGVILMELIT-GRK 798
R TT DV+ F V + E+++ G++
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 65/227 (28%), Positives = 94/227 (41%), Gaps = 30/227 (13%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
+F LGRGGFG V++ + D A+KR+ + E+ L K+ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHP 63
Query: 652 HLVALLGHCLDGNEKL------------LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL 699
+V L+ N + + + L + ++ E + L
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG--RCTIEERERSVCL 121
Query: 700 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-----------L 748
I L +A VE+LH + +HRDLKPSNI D KV DFGLV L
Sbjct: 122 HIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT 795
P + T GT Y++PE + KVD+FS G+IL EL+
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 147 bits (371), Expect = 6e-37
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 15/207 (7%)
Query: 598 ENILGRGGFGTVYKGELHDG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
+ LG G FG+V +G +A+K ++ G E E ++ ++ + ++V
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIV 399
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
L+G C +LV E G L + + EE + + + V+ G++YL
Sbjct: 400 RLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYL-- 452
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY--LAPEYA 772
++F+HR+L N+LL + AK++DFGL + R AG + APE
Sbjct: 453 -EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511
Query: 773 VTGRVTTKVDVFSFGVILMELIT-GRK 798
+ +++ DV+S+GV + E ++ G+K
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 45/219 (20%), Positives = 86/219 (39%), Gaps = 24/219 (10%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH-- 650
+S +G GG V++ A+K + + L +++EIA L K++
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
++ L + + +V E L+ + ++ + ++ V
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKS--YWKNMLEAVH 141
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYLAP 769
+H +H DLKP+N L+ D K+ DFG+ + P+ ++ GT Y+ P
Sbjct: 142 TIH---QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 770 E-----------YAVTGRVTTKVDVFSFGVILMELITGR 797
E +++ K DV+S G IL + G+
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-37
Identities = 69/198 (34%), Positives = 108/198 (54%), Gaps = 10/198 (5%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
E LG+G FG V+ G + T++A+K ++ G +S F E V+ K+RH LV L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLY 328
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
+ +V EYM +G+L + E K L + + +A +A G+ Y+
Sbjct: 329 AVVSE-EPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYV---ER 381
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV 777
+++HRDL+ +NIL+G+++ KVADFGL RL + + + + APE A+ GR
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 441
Query: 778 TTKVDVFSFGVILMELIT 795
T K DV+SFG++L EL T
Sbjct: 442 TIKSDVWSFGILLTELTT 459
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-37
Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 19/218 (8%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
++ +G G +G K DG + K ++ G ++ SE+ +L +++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 652 HLVALLGHCLDGNEKLL--VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
++V +D L V EY G L+ I +E + L+ L + + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLAL 124
Query: 710 EYLH--GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
+ H + +HRDLKP+N+ L K+ DFGL R+ +T + GT Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYM 183
Query: 768 APE------YAVTGRVTTKVDVFSFGVILMELITGRKA 799
+PE Y K D++S G +L EL
Sbjct: 184 SPEQMNRMSY------NEKSDIWSLGCLLYELCALMPP 215
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 9e-37
Identities = 56/388 (14%), Positives = 116/388 (29%), Gaps = 59/388 (15%)
Query: 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFT 128
+ + I Q ++ + + K ++ N+I+ ++ L L + N+ F
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFV 219
Query: 129 SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDE 188
+ + + + N L + + ++P+F
Sbjct: 220 AENICEAWENENSEYAQQYKT------EDLKWDNLKDLTDVEVYNCPNLTKLPTFLK--A 271
Query: 189 FPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQ------NGNAKLGGGI-DVIQNMTS 241
P + ++++A N+ I G + V + N + +Q M
Sbjct: 272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKK 331
Query: 242 LKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG 301
L + N G LP F +L SL+L N T + E ++ ++ +N L+
Sbjct: 332 LGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY 391
Query: 302 PVPEFDRS-----VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGN 356
FD ++D S N ++
Sbjct: 392 IPNIFDAKSVSVMSAIDF---SYN--------------------EIGSVD----GKNFDP 424
Query: 357 DPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGM------- 409
+ N++ IN ++ F++ L + L N L+ +
Sbjct: 425 LDPT-----PFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479
Query: 410 IPEGLSVLGALKELDVSNNQLYGKIPSF 437
E L +D+ N+L F
Sbjct: 480 ENENFKNTYLLTSIDLRFNKLTKLSDDF 507
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-34
Identities = 60/440 (13%), Positives = 118/440 (26%), Gaps = 87/440 (19%)
Query: 20 SILFVSASGDDGDAAVMLALKKSLNPPE--SLGWSDTDPCKWNH------------VVCI 65
I + D + + +LN G+ WN V
Sbjct: 19 PIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLN 78
Query: 66 EDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGP-----LPSLNGLASLEVV 120
+ R+T + + G +P + LT+LE L L + ++ S E
Sbjct: 79 SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQK 138
Query: 121 MLSNNQFT--SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITG 178
+ V D S L I+++P I +S R S NIT
Sbjct: 139 QKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQK-SIKKSSRITLKDTQIGQLSNNITF 197
Query: 179 QIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQN 238
+ L ++ + + + ++ Q N
Sbjct: 198 -VSKAVM--RLTKLRQFYMGNSPFVAENICEAW--ENENSEYAQQYKT-----EDLKWDN 247
Query: 239 MTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
+ L ++ +++ LP + +++ +++ N
Sbjct: 248 LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK- 306
Query: 298 LLQGPVPEFDRSVSLDMAKGSNNFC-LPSPGACDPRLNALLSVVKLMGYPQRFAENWKGN 356
+Q + + G NN P
Sbjct: 307 -IQ----------IIYI--GYNNLKTFPVE------------------------------ 323
Query: 357 DPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSV 416
+ + ++ L G + P F S L L LA N ++ +
Sbjct: 324 ----TSLQ-KMK--KLGMLECLYNQLEGKL-PAFGSEIKLASLNLAYNQITEIPANFCGF 375
Query: 417 LGALKELDVSNNQLYGKIPS 436
++ L ++N+L IP+
Sbjct: 376 TEQVENLSFAHNKLKY-IPN 394
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-33
Identities = 54/258 (20%), Positives = 100/258 (38%), Gaps = 22/258 (8%)
Query: 68 KRITRIQIGHQNLQ-GTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQ 126
++I I IG+ NL+ + ++LQ + KL LE +N + G LP+ L + L+ NQ
Sbjct: 305 EKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQ 364
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGP 186
T +P++F ++++ +N ++ S + + I F P
Sbjct: 365 ITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
Query: 187 -----DEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNG----QNGNAKLGGGIDVI 236
+ ++ ++L+ NQ+ FS S + S+ + G + L +
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484
Query: 237 QNMTSLKEIWLHSNAFSGPLPD---FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 293
+N L I L N + L D + + L + L N F+ P + +LK
Sbjct: 485 KNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFG 542
Query: 294 MTNNL------LQGPVPE 305
+ N PE
Sbjct: 543 IRNQRDAQGNRTLREWPE 560
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-28
Identities = 50/363 (13%), Positives = 108/363 (29%), Gaps = 91/363 (25%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNG-LASLEVVMLSNNQFTSVPSDFFTG 137
L+G LP+ + KL L L +N I+ + G +E + ++N+ +P+ F
Sbjct: 341 QLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAK 399
Query: 138 -LSSLQSIEIDNNPFSS------WEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFP 190
+S + +I+ N S + + + + + ++ I+ F
Sbjct: 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS--TGS 457
Query: 191 GLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250
L+ ++L N L +P + + ++ +N L I L N
Sbjct: 458 PLSSINLMGNML-TEIPKNSLKDENEN------------------FKNTYLLTSIDLRFN 498
Query: 251 AFSGPLPD---FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFD 307
+ L D + + L + L N F+ P + +LK F
Sbjct: 499 KLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLK--------------GFG 542
Query: 308 RSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTC 367
D N P + I C
Sbjct: 543 IRNQRDAQ--GNRTL--------------------------------REWP--EGIT-LC 565
Query: 368 TKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSN 427
++T + ++ ++ + ++ L + DN + + +
Sbjct: 566 P--SLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFY 620
Query: 428 NQL 430
++
Sbjct: 621 DKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 6e-20
Identities = 32/242 (13%), Positives = 64/242 (26%), Gaps = 59/242 (24%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG--------PLPSLNGLASLEV 119
++ I + + + + L + L N ++ + L
Sbjct: 433 INVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTS 492
Query: 120 VMLSNNQFTSVPSDF-FTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITG 178
+ L N+ T + DF T L L I++ N FS P N+S L+ F +
Sbjct: 493 IDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK--FPTQPLNSSTLKGFGIRN----- 545
Query: 179 QIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQN 238
N+ + P +
Sbjct: 546 ---------------QRDAQGNRTLREWPEGIT--------------------------L 564
Query: 239 MTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 298
SL ++ + SN + + L ++DN + + + +
Sbjct: 565 CPSLTQLQIGSNDIRKVNEKIT--PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622
Query: 299 LQ 300
Q
Sbjct: 623 TQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-06
Identities = 11/89 (12%), Positives = 26/89 (29%), Gaps = 8/89 (8%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGL 138
P + L +L++ N I + ++ V+ + +N S+ +
Sbjct: 553 RTLREWPEGITLCPSLTQLQIGSNDIRKVNEKI--TPNISVLDIKDNPNISIDLSYVCPY 610
Query: 139 SSLQSIEIDNNPFSSWEIPQSLRNASGLQ 167
+ + Q +R L
Sbjct: 611 IEAGMYMLFYDK------TQDIRGCDALD 633
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 6e-05
Identities = 16/96 (16%), Positives = 26/96 (27%), Gaps = 26/96 (27%)
Query: 352 NWKGNDPCSDW---IGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSG 408
NW N W GV+ + + L L SG
Sbjct: 59 NWNFNKELDMWGAQPGVSL--NSNG---------------------RVTGLSLEGFGASG 95
Query: 409 MIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVN 444
+P+ + L L+ L + ++ F I
Sbjct: 96 RVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISA 131
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 9e-37
Identities = 53/279 (18%), Positives = 103/279 (36%), Gaps = 29/279 (10%)
Query: 533 HPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVT 592
H H S + + + + D + + N IS++
Sbjct: 1 HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG----- 55
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH-- 650
+S +G GG V++ A+K + + L +++EIA L K++
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
++ L + + +V E L+ + + K ++ R + ++ V
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVH 169
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYLAP 769
+H +H DLKP+N L+ D K+ DFG+ + P+ ++ G Y+ P
Sbjct: 170 TIH---QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 770 E-----------YAVTGRVTTKVDVFSFGVILMELITGR 797
E +++ K DV+S G IL + G+
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-36
Identities = 64/390 (16%), Positives = 136/390 (34%), Gaps = 48/390 (12%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQ 126
+ + + +Q Q+L+ L L L N I L + +GL+SL+ ++
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFF 184
S+ + L +L+ + + +N S+++P+ N + L+ + S+N I +
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN--KIQSIYCTDL 169
Query: 185 GPDEFPGLTI----LHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGI--DVIQN 238
+ + L L+ N + P +F ++ L + N + IQ
Sbjct: 170 RV--LHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR----NNFDSLNVMKTCIQG 223
Query: 239 MTSLKEIWLHSNAFSG----PLPDFSGVKQLESLSLRDN------FFTGPVPDSLVKLES 288
+ L+ L F D S ++ L +L++ + ++ + D L +
Sbjct: 224 LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283
Query: 289 LKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQR 348
+ ++ + ++ V +F + + N P L L
Sbjct: 284 VSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRL-----------T 331
Query: 349 FAENWKGNDPCSDWIGVTCTKGNITVINFQ--KMNLTGTISPEFASFKSLQRLILADNNL 406
F N GN + ++ ++ ++ G S SL+ L L+ N +
Sbjct: 332 FTSNKGGNAFSEVDL------PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385
Query: 407 SGMIPEGLSVLGALKELDVSNNQLYGKIPS 436
+ L L+ LD ++ L
Sbjct: 386 IT-MSSNFLGLEQLEHLDFQHSNLKQMSEF 414
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-35
Identities = 73/374 (19%), Positives = 128/374 (34%), Gaps = 37/374 (9%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSI-SGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFT 136
NL + +L L+ L + N I S LP + L +LE + LS+N+ S+
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170
Query: 137 GLSSLQ----SIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGL 192
L + S+++ NP + P + + L + + + + GL
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIR-LHKLTLRNNFDSLNVMKTCI-QGLAGL 227
Query: 193 TILHLAFNQLIG-GLPASFSGSQIQSLWV------NGQNGNAKLGGGIDVIQNMTSLKEI 245
+ L + G F S ++ L + L ID+ +T++
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 246 WLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE 305
L S + DFS + L L + F L L+ L T+N E
Sbjct: 288 SLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRL---TFTSNKGGNAFSE 343
Query: 306 FDRS--VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWI 363
D LD+ S N L G C S+ L + N S+++
Sbjct: 344 VDLPSLEFLDL---SRNG-LSFKGCCSQSDFGTTSLKYL-----DLSFNGVITMS-SNFL 393
Query: 364 GVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKE 422
G+ + ++FQ NL F S ++L L ++ + + L +L+
Sbjct: 394 GLE----QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV 449
Query: 423 LDVSNNQLYGKIPS 436
L ++ N
Sbjct: 450 LKMAGNSFQENFLP 463
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-34
Identities = 64/410 (15%), Positives = 118/410 (28%), Gaps = 73/410 (17%)
Query: 64 CIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVML 122
C+E Q N +P NL + L+L +N + S L+V+ L
Sbjct: 3 CVEVVPNITYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 123 SNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPS 182
S + ++ + LS L ++ + NP S + S LQ A N+
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENF 118
Query: 183 FFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSL 242
G L L++A N + + N+T+L
Sbjct: 119 PIGH--LKTLKELNVAHNLIQSFKLPEY-------------------------FSNLTNL 151
Query: 243 KEIWLHSNAFSGPLP-DFSGVKQLE----SLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
+ + L SN D + Q+ SL L N P + ++ L + + NN
Sbjct: 152 EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNN 210
Query: 298 LLQGPVPE--FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 355
V + L++ + +AL + L
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL------------- 257
Query: 356 NDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGL 414
I ++ + F ++ L + +
Sbjct: 258 ---------------TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--F 300
Query: 415 SVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGNPDIGKEKSSSFQGSPS 464
S + L++ N + G+ P+ K ++ + S PS
Sbjct: 301 SYNFGWQHLELVNCKF-GQFPTLKLKSLKRLTFT-SNKGGNAFSEVDLPS 348
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-32
Identities = 67/395 (16%), Positives = 116/395 (29%), Gaps = 85/395 (21%)
Query: 82 GTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVM----LSNNQFTSVPSDFFT 136
LP NLT LE L+L N I L L + ++ LS N + F
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 137 GLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFFGPDEFPGLTI 194
+ L + + NN S + ++ +GL+ G + F GL
Sbjct: 199 EIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD-KSALEGLCN 256
Query: 195 LHLAFNQL------IGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWL 247
L + +L + + F+ + + S + + + + L
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-----RVKDFSYNFGWQHLEL 311
Query: 248 HSNAFSG--------------------PLPDFSGVKQLESLSLRDNF--FTGPVPDSLVK 285
+ F + LE L L N F G S
Sbjct: 312 VNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 286 LESLKIVNMTNNLLQGPVPEFDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKL 342
SLK ++++ N + F L D ++
Sbjct: 372 TTSLKYLDLSFNGVITMSSNFLGLEQLEHLDF---QHS---------------------- 406
Query: 343 MGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILA 402
N K S ++ + N+ ++ + + F SL+ L +A
Sbjct: 407 ---------NLKQMSEFSVFLSLR----NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 453
Query: 403 DNNLSGMI-PEGLSVLGALKELDVSNNQLYGKIPS 436
N+ P+ + L L LD+S QL P+
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-30
Identities = 76/388 (19%), Positives = 122/388 (31%), Gaps = 86/388 (22%)
Query: 76 GHQNLQGTLPSNLQNLTKLERLELQWNSISG----PLPSLNGLASLEVVMLSNNQFTSVP 131
NL+ S L+ L L E + + + N L ++ L + V
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK 298
Query: 132 SDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPG 191
F+ Q +E+ N F L++ L F++N S P
Sbjct: 299 D--FSYNFGWQHLELVNCKFGQ-FPTLKLKSLKRL-TFTSNKGGN---AFSEVD---LPS 348
Query: 192 LTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA 251
L L L+ N L SF G QS + TSLK + L N
Sbjct: 349 LEFLDLSRNGL------SFKGCCSQSDF------------------GTTSLKYLDLSFNG 384
Query: 252 FSGPLPDFSGVKQLESLSLRDNFFTGPVPDS-LVKLESLKIVNMTNNLLQGPVPE-FDRS 309
+F G++QLE L + + S + L +L +++++ + F+
Sbjct: 385 VITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 444
Query: 310 VSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVT 366
SL M + N F EN+ +
Sbjct: 445 SSLEVLKM---AGN---------------------------SFQENFLPDIFTE------ 468
Query: 367 CTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVS 426
N+T ++ + L F S SLQ L ++ NN + L +L+ LD S
Sbjct: 469 LR--NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYS 526
Query: 427 NNQLYGKIPS-----FKSNAIVNTDGNP 449
N + S A +N N
Sbjct: 527 LNHIMTSKKQELQHFPSSLAFLNLTQND 554
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-29
Identities = 43/233 (18%), Positives = 79/233 (33%), Gaps = 19/233 (8%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSIS--GPLP-SLNGLASLEVVMLSNNQFTSVPSDFF 135
+ +G + +L LE L+L N +S G S G SL+ + LS N ++ S+F
Sbjct: 334 SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFL 393
Query: 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFFGPDEFPGLT 193
GL L+ ++ ++ + L + S + F L
Sbjct: 394 -GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT--HTRVAFNGIFN--GLSSLE 448
Query: 194 ILHLAFNQLIGGLPASFSG--SQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSN 250
+L +A N + L ++ +L +++SL+ + + N
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQ---C-QLEQLSPTAFNSLSSLQVLNMSHN 504
Query: 251 AFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLE-SLKIVNMTNNLLQG 301
F + + L+ L N L SL +N+T N
Sbjct: 505 NFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-28
Identities = 63/381 (16%), Positives = 118/381 (30%), Gaps = 71/381 (18%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLP--SLNGLASLEVVMLSNNQFTS------V 130
+ P + + +L +L L+ N S + + GLA LEV L +F +
Sbjct: 188 PMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 131 PSDFFTGLSSLQSIEIDNN--PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDE 188
GL +L E + +I + + +FS S I +
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY---- 302
Query: 189 FPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLH 248
G L L + G P S ++ L G ++ SL+ + L
Sbjct: 303 NFGWQHLELVNCKF-GQFPTLKLKS-LKRLTFTSNKGG-----NAFSEVDLPSLEFLDLS 355
Query: 249 SNA--FSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE 305
N F G G L+ L L N + + + LE L+ ++ ++ L+
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEF 414
Query: 306 --FDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCS 360
F +L D++ + + G
Sbjct: 415 SVFLSLRNLIYLDIS--HTHTRVAFNGIF-------------------------NGLS-- 445
Query: 361 DWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGA 419
++ V+ + P+ F ++L L L+ L + P + L +
Sbjct: 446 ----------SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495
Query: 420 LKELDVSNNQLYGKIPSFKSN 440
L+ L++S+N +
Sbjct: 496 LQVLNMSHNNFFSLDTFPYKC 516
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 16/80 (20%), Positives = 26/80 (32%), Gaps = 10/80 (12%)
Query: 357 DPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSV 416
+PC NIT ++N I S + L L+ N L +
Sbjct: 1 EPC------VEVVPNITY-QCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFS 50
Query: 417 LGALKELDVSNNQLYGKIPS 436
L+ LD+S ++
Sbjct: 51 FPELQVLDLSRCEIQTIEDG 70
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 61/208 (29%), Positives = 89/208 (42%), Gaps = 15/208 (7%)
Query: 594 NFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHR 651
+F + LG G +G V+K DG AVKR + K +E+ KV +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
V L +G L E +L +H E L + D + +
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHC----EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYLAPE 770
LH Q +H D+KP+NI LG R K+ DFGL+ L G G ++ G Y+APE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPE 226
Query: 771 YAVTGRVTTKVDVFSFGVILMELITGRK 798
+ G T DVFS G+ ++E+ +
Sbjct: 227 -LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 16/202 (7%)
Query: 601 LGRGGFGTVYKGELHD---GTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVAL 656
LG GG TVY D K+A+K + + + F+ E+ +++ H+++V++
Sbjct: 19 LGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
+ + + LV EY+ TLS +I G PL + + + G+++ A
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI---ESHG--PLSVDTAINFTNQILDGIKH----A 127
Query: 717 HQS-FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG 775
H +HRD+KP NIL+ + K+ DFG+ + E + + GT Y +PE A
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 776 RVTTKVDVFSFGVILMELITGR 797
D++S G++L E++ G
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGE 209
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 598 ENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
+G G FG V++G +A+K + S +F E + + H H+
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHI 78
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
V L+G N ++ E G L ++ + L+ + A ++ + YL
Sbjct: 79 VKLIGVIT-ENPVWIIMELCTLGEL----RSFLQVRKYSLDLASLILYAYQLSTALAYL- 132
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT---FGYLAPE 770
+ F+HRD+ N+L+ + K+ DFGL R + S + + ++APE
Sbjct: 133 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKGKLPIKWMAPE 187
Query: 771 YAVTGRVTTKVDVFSFGVILMELIT-GRK 798
R T+ DV+ FGV + E++ G K
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 598 ENILGRGGFGTVYKGELHDG-----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+LG G FGTVYKG +A+K + S K E E V+ V + H
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPH 78
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE-GLKPLEWNRRLTIALDVARGVEY 711
+ LLG CL + L+ + MP G L ++ + G + L L + +A+G+ Y
Sbjct: 79 VCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNY 132
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT---FGYLA 768
L + +HRDL N+L+ K+ DFGL +L E G ++A
Sbjct: 133 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMA 187
Query: 769 PEYAVTGRVTTKVDVFSFGVILMELIT-GRK 798
E + T + DV+S+GV + EL+T G K
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 5e-36
Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 35/234 (14%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
+++ N E ILG G GTV G +AVKRM EI +LT+
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD-----IALMEIKLLTES 65
Query: 649 -RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI--FNWAEEGLKPLEWNRRLTIALDV 705
H +++ + E L + N ++E LK + +++ +
Sbjct: 66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILL-------------GDDMRAKVADFGLVRLAPEG 752
A GV +LH IHRDLKP NIL+ +++R ++DFGL + G
Sbjct: 125 ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 753 KGSIETR---IAGTFGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITG 796
+ S T +GT G+ APE R+T +D+FS G + +++
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-36
Identities = 47/218 (21%), Positives = 90/218 (41%), Gaps = 28/218 (12%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVK---------------RMEAGVISGKGLTEFKSEIAVL 645
L +G F + E D A+K + +FK+E+ ++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 646 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI---FNWAEEGLKPLEWNRRLTIA 702
T +++ + + G + +E +++EYM ++ + F + + I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG 762
V Y+H ++ HRD+KPSNIL+ + R K++DFG + K I+ G
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK--IKG-SRG 212
Query: 763 TFGYLAPEYAVTGRVTT---KVDVFSFGVILMELITGR 797
T+ ++ PE + + KVD++S G+ L +
Sbjct: 213 TYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-36
Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 20/214 (9%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
+ +G G FG + DG + +K + +S K E + E+AVL ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
++V + +V +Y G L + I + + ++ L + + +++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI---NAQKGVLFQEDQILDWFVQICLALKH 140
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE- 770
+H + +HRD+K NI L D ++ DFG+ R+ I GT YL+PE
Sbjct: 141 VH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEI 196
Query: 771 -----YAVTGRVTTKVDVFSFGVILMELITGRKA 799
Y K D+++ G +L EL T + A
Sbjct: 197 CENKPY------NNKSDIWALGCVLYELCTLKHA 224
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 61/269 (22%), Positives = 108/269 (40%), Gaps = 32/269 (11%)
Query: 600 ILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
+GRG F TVYKG + ++A ++ ++ FK E +L ++H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 659 HCLDG--NEKLLVF--EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
+K +V E M GTL ++ + K ++ + + +G+++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL-----KRFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 715 LAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV 773
IHRDLK NI + G K+ D G LA + S + GT ++APE
Sbjct: 148 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLG---LATLKRASFAKAVIGTPEFMAPEM-Y 202
Query: 774 TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTI 833
+ VDV++FG+ ++E+ T E Q + + +
Sbjct: 203 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------YRRVTSGVK 247
Query: 834 DLNEGILASISTVAELAGHCCAREPYQRP 862
+ +A V E+ C + +R
Sbjct: 248 PASFDKVAI-PEVKEIIEGCIRQNKDERY 275
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 50/219 (22%), Positives = 95/219 (43%), Gaps = 32/219 (14%)
Query: 598 ENILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 649
LG+G F ++KG + T++ +K ++ + F ++++K+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS--ESFFEAASMMSKLS 70
Query: 650 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
H+HLV G C+ G+E +LV E++ G+L ++ ++ + +L +A +A +
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL----KKNKNCINILWKLEVAKQLAAAM 126
Query: 710 EYLHGLAHQSFIHRDLKPSNILL--------GDDMRAKVADFGLVRLAPEGKGSIETRIA 761
+ L + IH ++ NILL G+ K++D G+ K ++ RI
Sbjct: 127 HF---LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQERIP 182
Query: 762 GTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELIT-GRK 798
PE + D +SFG L E+ + G K
Sbjct: 183 WV----PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-35
Identities = 46/213 (21%), Positives = 87/213 (40%), Gaps = 24/213 (11%)
Query: 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH--RHLVAL 656
+G GG V++ A+K + + L +++EIA L K++ ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
+ + +V E L+ + + K ++ R + ++ V +H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIH--- 125
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYLAPE----- 770
+H DLKP+N L+ D K+ DFG+ + P+ ++ GT Y+ PE
Sbjct: 126 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 771 ------YAVTGRVTTKVDVFSFGVILMELITGR 797
+++ K DV+S G IL + G+
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 33/224 (14%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
+F E ++G GGFG V+K + DG +KR++ + + E+ L K+ H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDHV 64
Query: 652 HLVALLGHCLDGNEKL----------------LVFEYMPQGTLSRHIFNWAEEGLKPLEW 695
++V G + + E+ +GTL + I + + L+
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI---EKRRGEKLDK 121
Query: 696 NRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKG 754
L + + +GV+Y+H + I+RDLKPSNI L D + K+ DFGLV L +GK
Sbjct: 122 VLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 755 SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRK 798
TR GT Y++PE + +VD+++ G+IL EL+
Sbjct: 179 ---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 68/228 (29%), Positives = 111/228 (48%), Gaps = 21/228 (9%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 658
LG+G FG VY E +A+K + + G+ + E+ + + +RH +++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
+ D L+ EY P GT+ R + L + R T ++A + Y H +
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCH---SK 128
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV- 777
IHRD+KP N+LLG K+ADFG AP + T + GT YL PE + GR+
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPPE-MIEGRMH 184
Query: 778 TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825
KVD++S GV+ E + G+ + + +E+ ++RI + +F
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTF 226
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 52/209 (24%), Positives = 99/209 (47%), Gaps = 7/209 (3%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKVRH 650
NF E +GRG F VY+ L DG +A+K+++ ++ K + EI +L ++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
+++ ++ NE +V E G LSR I ++ ++ + + + + +E
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK-RLIPERTVWKYFVQLCSALE 150
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
++H + +HRD+KP+N+ + K+ D GL R + + + GT Y++PE
Sbjct: 151 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 206
Query: 771 YAVTGRVTTKVDVFSFGVILMELITGRKA 799
K D++S G +L E+ +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-35
Identities = 70/276 (25%), Positives = 111/276 (40%), Gaps = 43/276 (15%)
Query: 601 LGRGGFGTVYKGELHD---GTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVAL 656
LG GG V+ D +AVK + A + F+ E + H +VA+
Sbjct: 20 LGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 657 L--GHCLDGNEKL--LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
G L +V EY+ TL + EG P+ R + + D + + +
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEG--PMTPKRAIEVIADACQALNF- 131
Query: 713 HGLAHQS-FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR---IAGTFGYLA 768
+HQ+ IHRD+KP+NI++ KV DFG+ R + S+ T+ + GT YL+
Sbjct: 132 ---SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-TQTAAVIGTAQYLS 187
Query: 769 PEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEE--SMHLVTWFRRIHLSKDSFH 826
PE A V + DV+S G +L E++TG P H+
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV--------------R 233
Query: 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRP 862
+ P +EG+ A + + A+ P R
Sbjct: 234 EDPIPPSARHEGLSAD---LDAVVLKALAKNPENRY 266
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 5e-34
Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 16/202 (7%)
Query: 601 LGRGGFGTVYKGELHD---GTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVAL 656
+GRGG G VY+ D +A+K M + S + E +++ H+V +
Sbjct: 42 VGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
+ + + L+ + +G PL R + I + ++ A
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML---RRQG--PLAPPRAVAIVRQIGSALDA----A 150
Query: 717 HQS-FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG 775
H + HRD+KP NIL+ D A + DFG+ + K + GT Y+APE
Sbjct: 151 HAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSES 210
Query: 776 RVTTKVDVFSFGVILMELITGR 797
T + D+++ +L E +TG
Sbjct: 211 HATYRADIYALTCVLYECLTGS 232
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-34
Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 26/212 (12%)
Query: 598 ENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
+G G FG V++G +A+K + S +F E + + H H+
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHI 453
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
V L+G + N ++ E G L + + L+ + A ++ + YL
Sbjct: 454 VKLIGVITE-NPVWIIMELCTLGELRSFL----QVRKFSLDLASLILYAYQLSTALAYL- 507
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE------GKGSIETRIAGTFGYL 767
+ F+HRD+ N+L+ + K+ DFGL R + KG + + ++
Sbjct: 508 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK------WM 559
Query: 768 APEYAVTGRVTTKVDVFSFGVILMELIT-GRK 798
APE R T+ DV+ FGV + E++ G K
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEILMHGVK 591
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 35/229 (15%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 658
LG+GGF ++ + A K + ++ E EI++ + H+H+V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVE 710
D + +V E + +L + LT AR G +
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKR-----------RKALT--EPEARYYLRQIVLGCQ 129
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
YLH IHRDLK N+ L +D+ K+ DFGL E G + + GT Y+APE
Sbjct: 130 YLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERKKVLCGTPNYIAPE 185
Query: 771 YAVTGRV-TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI 818
++ + + +VDV+S G I+ L+ G+ P E+ L + RI
Sbjct: 186 -VLSKKGHSFEVDVWSIGCIMYTLLVGKP------PFETSCLKETYLRI 227
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 7e-34
Identities = 26/230 (11%), Positives = 52/230 (22%), Gaps = 40/230 (17%)
Query: 600 ILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALL 657
L G V+ ++ A+K G S L ++
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 658 GHC--------------------------LDGNEKLLVFEYMPQGTLSRHI--FNWAEEG 689
LL+ L ++
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVF 187
Query: 690 LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749
+ + R L + +H P N+ + D R + D +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 750 PEGKGSIETRIAGTFGYLAPEY--AVTGRVTTKVDVFSFGVILMELITGR 797
G+ + Y E+ A T T ++ + G+ + +
Sbjct: 245 ----GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 658
LG+G F VY+ +H G ++A+K ++ + G+ + ++E+ + +++H ++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
+ D N LV E G ++R++ + +KP N + G+ YLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYL----KNRVKPFSENEARHFMHQIITGMLYLH---SH 131
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV- 777
+HRDL SN+LL +M K+ADFGL T + GT Y++PE T
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPE-IATRSAH 189
Query: 778 TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI 818
+ DV+S G + L+ GR P ++ + ++
Sbjct: 190 GLESDVWSLGCMFYTLLIGRP------PFDTDTVKNTLNKV 224
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 21/222 (9%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 658
LG+G FG VY E + +A+K + + +G+ + EI + + +RH +++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
+ D L+ E+ P+G L + + + G E + ++A + Y H +
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKEL---QKHGRFD-EQRSATFME-ELADALHYCHE---R 133
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV- 777
IHRD+KP N+L+G K+ADFG AP + T + GT YL PE + G+
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--RRT-MCGTLDYLPPE-MIEGKTH 189
Query: 778 TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH 819
KVD++ GV+ E + G P +S RRI
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMP------PFDSPSHTETHRRIV 225
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 64/270 (23%), Positives = 105/270 (38%), Gaps = 35/270 (12%)
Query: 560 SETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGT 618
+ + PG + + V + LG+GGF ++ +
Sbjct: 8 GKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKE 67
Query: 619 KIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGT 677
A K + ++ E EI++ + H+H+V G D + +V E + +
Sbjct: 68 VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 127
Query: 678 LSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVEYLHGLAHQSFIHRDLKPSN 729
L + LT AR G +YLH IHRDLK N
Sbjct: 128 LLELHKR-----------RKALT--EPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGN 171
Query: 730 ILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV-TTKVDVFSFGV 788
+ L +D+ K+ DFGL E G + + GT Y+APE ++ + + +VDV+S G
Sbjct: 172 LFLNEDLEVKIGDFGLATK-VEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGC 229
Query: 789 ILMELITGRKALDESQPEESMHLVTWFRRI 818
I+ L+ G+ P E+ L + RI
Sbjct: 230 IMYTLLVGKP------PFETSCLKETYLRI 253
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-33
Identities = 51/229 (22%), Positives = 87/229 (37%), Gaps = 28/229 (12%)
Query: 598 ENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVA 655
+L GGF VY+ + + G + A+KR+ + E+ + K+ H ++V
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLL--SNEEEKNRAIIQEVCFMKKLSGHPNIVQ 90
Query: 656 LLGHCL-------DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
G + L+ + +G L + G PL + L I R
Sbjct: 91 FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG--PLSCDTVLKIFYQTCRA 148
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA---------PEGKGSIETR 759
V+++H IHRDLK N+LL + K+ DFG + + +E
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 760 IA--GTFGYLAPE-YAVTGR--VTTKVDVFSFGVILMELITGRKALDES 803
I T Y PE + + K D+++ G IL L + ++
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-33
Identities = 48/254 (18%), Positives = 84/254 (33%), Gaps = 31/254 (12%)
Query: 566 PSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGE------LHDGTK 619
SS P + + + + ++LG G F VY+ + K
Sbjct: 38 VSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQK 97
Query: 620 IAVKRMEAGVISGKGLTEF---KSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676
+K V EF + L + L N +LV E G
Sbjct: 98 FVLK-----VQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYG 152
Query: 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 736
TL I + K + ++ A+ + +E +H IH D+KP N +LG+
Sbjct: 153 TLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGF 209
Query: 737 RA-----------KVADFGL-VRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV-TTKVDV 783
+ D G + + KG+I T T G+ E ++ + ++D
Sbjct: 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE-MLSNKPWNYQIDY 268
Query: 784 FSFGVILMELITGR 797
F + ++ G
Sbjct: 269 FGVAATVYCMLFGT 282
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 51/223 (22%), Positives = 84/223 (37%), Gaps = 23/223 (10%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
+ + +ILG+G V++G G A+K + E VL K+
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-VDVQMREFEVLKKL 64
Query: 649 RHRHLVALLG--HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 706
H+++V L K+L+ E+ P G+L + L + L + DV
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE--EPSNAYGLPESEFLIVLRDVV 122
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLG----DDMRAKVADFGLVRLAPEGKGSIETRIAG 762
G+ +L +HR++KP NI+ K+ DFG R + + + G
Sbjct: 123 GGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLY-G 177
Query: 763 TFGYLAPE--------YAVTGRVTTKVDVFSFGVILMELITGR 797
T YL P+ + VD++S GV TG
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-32
Identities = 68/266 (25%), Positives = 108/266 (40%), Gaps = 21/266 (7%)
Query: 591 VTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 649
+ + LG GGFG V + G ++A+K+ + K + EI ++ K+
Sbjct: 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP-KNRERWCLEIQIMKKLN 70
Query: 650 HRHLVALL------GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 703
H ++V+ + LL EY G L +++ E L+ T+
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN--QFENCCGLKEGPIRTLLS 128
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRI 760
D++ + YLH IHRDLKP NI+L + K+ D G + +G+ +
Sbjct: 129 DISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFV 184
Query: 761 AGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRK-ALDESQPEESMHLVT--WFRR 817
GT YLAPE + T VD +SFG + E ITG + L QP + V
Sbjct: 185 -GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243
Query: 818 IHLSKDSFHKAIDPTIDLNEGILASI 843
I + D ++ L+ I
Sbjct: 244 IVVYDDLTGAVKFSSVLPTPNHLSGI 269
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 6e-32
Identities = 57/406 (14%), Positives = 122/406 (30%), Gaps = 88/406 (21%)
Query: 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG--PLPSLNGLASLEVVMLSNNQ 126
R + L + K++ + +N++ SL + L ++ +N+
Sbjct: 526 RGISAAQLKADW-TRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNK 584
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSL-RNASGLQNFSANSANITGQIPSFFG 185
+ + F L +++D N EIP+ ++ + + IP+ F
Sbjct: 585 VRHLEA--FGTNVKLTDLKLDYNQIE--EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFN 639
Query: 186 PDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEI 245
+ + ++N+ IG + S S + +
Sbjct: 640 AKSVYVMGSVDFSYNK-IGSEGRNISCSM--------------------DDYKGINASTV 678
Query: 246 WLHSNAFSGPLPD-FSGVKQLESLSLRDNFFT-------GPVPDSLVKLESLKIVNMTNN 297
L N + F+ + ++ L +N T P + L +++ N
Sbjct: 679 TLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFN 738
Query: 298 LLQGPVPEFDRS-----VSLDMAKGSNNF-CLPSPGACDPRLNALLSVVKLMGYPQRFAE 351
L +F + ++D++ N F P+ L+ +L + R
Sbjct: 739 KLTSLSDDFRATTLPYLSNMDVS--YNCFSSFPT---------QPLNSSQLKAFGIRHQR 787
Query: 352 NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 411
+ +GN + + SL +L + N++ +
Sbjct: 788 DAEGN------------------------RILRQWPTGITTCPSLIQLQIGSNDIRK-VD 822
Query: 412 EGLSVLGALKELDVSNNQL-YGKIPSFKSNAIVNT-----DGNPDI 451
E L L LD+++N + S D DI
Sbjct: 823 EKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDI 866
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-31
Identities = 61/465 (13%), Positives = 127/465 (27%), Gaps = 73/465 (15%)
Query: 21 ILFVSASGDDGDAAVMLALKKSLN-------------PPESLGWS-DTDPCKWNH---VV 63
I + D + A+ ++L+ SL W+ + + W V
Sbjct: 259 IQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVD 318
Query: 64 CIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG--PLPSLNGLASLEVVM 121
+ R+T + + +G +P + LT+L+ L +S + L L
Sbjct: 319 LDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEE 378
Query: 122 LSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGL---QNFSANSANITG 178
+ F L ++ + + + ++ S + N N
Sbjct: 379 RKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT 438
Query: 179 QIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQN 238
I L I++ A + + S + + N
Sbjct: 439 FISKAIQ--RLTKLQIIYFANSPF-TYDNIAVDWEDANS------DYAKQYENEELSWSN 489
Query: 239 MTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGP---------VPDSLVKLES 288
+ L ++ L++ LPD + +L+SL++ N + D
Sbjct: 490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK 549
Query: 289 LKIVNMTNNLLQGPVPEFDRS-----VSLDMAKGSNNF-CLPSPGACDPRLNAL-LSVVK 341
++I M N L+ LD N L + G +L L L +
Sbjct: 550 IQIFYMGYNNLEEFPASASLQKMVKLGLLDC--VHNKVRHLEAFGTN-VKLTDLKLDYNQ 606
Query: 342 LMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTG-TISPEFASFKSLQRLI 400
+ P+ F + + F L S + +
Sbjct: 607 IEEIPEDFCAFTD----------------QVEGLGFSHNKLKYIPNIFNAKSVYVMGSVD 650
Query: 401 LADNNLSGMIPEGLSVLGA-----LKELDVSNNQLYGKIPSFKSN 440
+ N + + + +S N++ +
Sbjct: 651 FSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFAT 695
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-30
Identities = 59/387 (15%), Positives = 117/387 (30%), Gaps = 74/387 (19%)
Query: 76 GHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFF 135
N + +Q LTKL+ + + + +++ + + +
Sbjct: 432 NLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDAN----SDYAKQYENEELSW 487
Query: 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFFG----PDEF 189
+ L L +E+ N P + ++P L + LQ N + N D+
Sbjct: 488 SNLKDLTDVELYNCPNMT-QLPDFLYDLPELQSLNIACN--RGISAAQLKADWTRLADDE 544
Query: 190 ---PGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIW 246
P + I ++ +N L PAS S ++ L + N K+ ++ L ++
Sbjct: 545 DTGPKIQIFYMGYNNL-EEFPASASLQKMVKLGLLDCVHN-KVRH-LEAFGTNVKLTDLK 601
Query: 247 LHSNAFSGPLPD--FSGVKQLESLSLRDNFFTG-PVPDSLVKLESLKIVNMTNNLLQGPV 303
L N +P+ + Q+E L N P + + + V+ + N +
Sbjct: 602 LDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEG 660
Query: 304 PEFDRS---------VSLDMAKGSNNFCLPSPGACD--PRLNAL-LSVVKLMGYPQRFAE 351
S ++ + N ++ + LS
Sbjct: 661 RNISCSMDDYKGINASTVTL--SYNEIQKFPTELFATGSPISTIILS------------- 705
Query: 352 NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 411
N +T I N + + L + L N L+ +
Sbjct: 706 ---NN--------------LMTSIPE---NSLKPKDGNYKNTYLLTTIDLRFNKLTS-LS 744
Query: 412 EGLSV--LGALKELDVSNNQLYGKIPS 436
+ L L +DVS N P+
Sbjct: 745 DDFRATTLPYLSNMDVSYNCF-SSFPT 770
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-30
Identities = 50/388 (12%), Positives = 118/388 (30%), Gaps = 48/388 (12%)
Query: 67 DKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLA-SLEVVMLSNN 125
++R RI++ ++ + L L+ + + P+ + ++ + N
Sbjct: 377 EERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEM-KPIKKDSRISLKDTQIGNLTN 435
Query: 126 QFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFG 185
+ T + L+ LQ I N+PF+ I +A+ +
Sbjct: 436 RITFISKAIQ-RLTKLQIIYFANSPFTYDNIAVDWEDANSDYA------KQYENEELSWS 488
Query: 186 PDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNG------QNGNAKLGGGIDVIQN 238
LT + L + LP ++QSL + A D
Sbjct: 489 --NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDT 546
Query: 239 MTSLKEIWLHSNAFSG--PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTN 296
++ ++ N + +L L N ++ L + +
Sbjct: 547 GPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDY 604
Query: 297 NLLQGPVPE--FDRSVSLDMAKGSNNF--CLPSPGACD--PRLNAL-LSVVKLMGYPQRF 349
N ++ +PE + ++ S+N +P+ + ++ S K+ +
Sbjct: 605 NQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNI 663
Query: 350 AENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLS-- 407
+ + N + + + + FA+ + +IL++N ++
Sbjct: 664 SCSMD-----------DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSI 712
Query: 408 -----GMIPEGLSVLGALKELDVSNNQL 430
L +D+ N+L
Sbjct: 713 PENSLKPKDGNYKNTYLLTTIDLRFNKL 740
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-29
Identities = 49/395 (12%), Positives = 113/395 (28%), Gaps = 88/395 (22%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPL----------PSLNGLASL 117
K +T +++ + LP L +L +L+ L + N + +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550
Query: 118 EVVMLSNNQFTSVP-SDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANI 176
++ + N P S + L ++ +N + + L + + I
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH--LE-AFGTNVKLTDLKLDYNQI 607
Query: 177 TGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVI 236
+IP F + L + N+L +P F+
Sbjct: 608 E-EIPEDFCAF-TDQVEGLGFSHNKL-KYIPNIFN------------------------A 640
Query: 237 QNMTSLKEIWLHSNAFSGPLPDFSG------VKQLESLSLRDNFFTGPVPDSLVKLESLK 290
+++ + + N + S +++L N + +
Sbjct: 641 KSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPIS 700
Query: 291 IVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACD--PRLNAL-LSVVKLMGYPQ 347
+ ++NNL+ +PE N P G L + L KL
Sbjct: 701 TIILSNNLMTS-IPE--------------NSLKPKDGNYKNTYLLTTIDLRFNKLTSLSD 745
Query: 348 RFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADN--- 404
F T ++ ++ + + + + L+ +
Sbjct: 746 DFRA---------------TTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDA 789
Query: 405 ---NLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 436
+ P G++ +L +L + +N + K+
Sbjct: 790 EGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDE 823
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 2e-18
Identities = 35/199 (17%), Positives = 63/199 (31%), Gaps = 36/199 (18%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSIS--------GPLPSLNGLASLEV 119
+ + + + +Q + + + L N ++ + L
Sbjct: 673 INASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTT 732
Query: 120 VMLSNNQFTSVPSDF-FTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ------NFSAN 172
+ L N+ TS+ DF T L L ++++ N FSS P N+S L+ A
Sbjct: 733 IDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS--FPTQPLNSSQLKAFGIRHQRDAE 790
Query: 173 SANITGQIPSFFG------------------PDE-FPGLTILHLAFNQLIGGLPASFSGS 213
I Q P+ ++ P L IL +A N I S
Sbjct: 791 GNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQLYILDIADNPNISIDVTSVCPY 850
Query: 214 QIQSLWVNGQNGNAKLGGG 232
++V + + G
Sbjct: 851 IEAGMYVLLYDKTQDIRGC 869
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-32
Identities = 36/249 (14%), Positives = 68/249 (27%), Gaps = 40/249 (16%)
Query: 600 ILGRGGFGTVYKGE-LHDGTKIAVKRMEAG-VISGKGLTEFKSEIAVLTKVR-------- 649
+LG+ + G V + + K E+ L +R
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 650 --HRHLVALLGHCLDGNEKLLV--------------FEYMPQ-----GTLSRHIFNWAEE 688
H + D +K ++ F P+ T + + +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 689 GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748
K L + RL + L V R + LH H +H L+P +I+L + F +
Sbjct: 205 H-KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 749 APEGKGSIETRIAGTFGYLAPE-----YAVTGRVTTKVDVFSFGVILMELITGRKALDES 803
S R A +T D ++ G+ + + +
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320
Query: 804 QPEESMHLV 812
+
Sbjct: 321 AALGGSEWI 329
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 8e-32
Identities = 46/319 (14%), Positives = 94/319 (29%), Gaps = 65/319 (20%)
Query: 533 HPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLR--- 589
H H S E++ G V + + + M A + ++S +
Sbjct: 3 HHHHH-SSGRENLYFQGPGDVV-IEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQ 60
Query: 590 --NVTNNFSEE-------NILGRGGFGTVYKG-ELHDGTKIAVK--------------RM 625
V + E +LG+ + + G V +M
Sbjct: 61 PFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQM 120
Query: 626 EAGVISGKGLTEFKSEIAVLTKVR------------HRHLVALLGHCLDGNEKLLVFEYM 673
+ V+ + L K++ +R + ++ + D F Y
Sbjct: 121 KEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP 180
Query: 674 ----PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSN 729
T + + + K L + RL + L V R + LH H +H L+P +
Sbjct: 181 RMQSNLQTFGEVLLSHSSTH-KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVD 236
Query: 730 ILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT-----------GRVT 778
I+L + F + + + + G+ PE +T
Sbjct: 237 IVLDQRGGVFLTGFEHLV-----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMT 291
Query: 779 TKVDVFSFGVILMELITGR 797
D ++ G+++ +
Sbjct: 292 FSFDAWALGLVIYWIWCAD 310
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-32
Identities = 74/255 (29%), Positives = 118/255 (46%), Gaps = 18/255 (7%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 650
+ F + +LGRGGFG V+ ++ K+ A K++ + KG E +L KV
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 651 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
R +V+L + + L LV M G + HI+N E+ E A + G+
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA-QIVSGL 302
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
E+LH ++ I+RDLKP N+LL DD +++D GL G+ + AGT G++AP
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-AGTPGFMAP 358
Query: 770 EYAVTGRVTTKVDVFSFGVILMELITGR---KALDESQPEESMHLVTWFRRIHLSKDSFH 826
E + VD F+ GV L E+I R +A E + + +R+ ++
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL-----KQRVLEQAVTYP 413
Query: 827 KAIDP-TIDLNEGIL 840
P + D E +L
Sbjct: 414 DKFSPASKDFCEALL 428
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 61/373 (16%), Positives = 123/373 (32%), Gaps = 64/373 (17%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQF 127
R + ++ T + L + +L + ++ + + L +LE + L+ NQ
Sbjct: 22 AEGIRAVLQKASV--TDVVTQEELESITKLVVAGEKVAS-IQGIEYLTNLEYLNLNGNQI 78
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187
T + + L L ++ I N + +L+N + L+ N NI+ I
Sbjct: 79 TDISP--LSNLVKLTNLYIGTNKITD---ISALQNLTNLRELYLNEDNISD-ISPL---A 129
Query: 188 EFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIW 246
+ L+L N + + S + + L V +K+ + I N+T L +
Sbjct: 130 NLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVT----ESKV-KDVTPIANLTDLYSLS 183
Query: 247 LHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEF 306
L+ N + + + L + N T + + L + + NN + +
Sbjct: 184 LNYNQIED-ISPLASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITD-LSPL 239
Query: 307 DRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVT 366
L + N +++ + +V L
Sbjct: 240 ANLSQLTWLEIGTN-----------QISDINAVKDL------------------------ 264
Query: 367 CTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVS 426
+ ++N ++ IS + L L L +N L E + L L L +S
Sbjct: 265 ---TKLKMLNVGSNQISD-ISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLS 319
Query: 427 NNQLYGKIPSFKS 439
N + I S
Sbjct: 320 QNHITD-IRPLAS 331
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 58/368 (15%), Positives = 129/368 (35%), Gaps = 71/368 (19%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQF 127
+ IT++ + + + ++ LT LE L L N I+ + L+ L L + + N+
Sbjct: 44 ESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNKI 100
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187
T + + L++L+ + ++ + S I L N + + + + + + +
Sbjct: 101 TDISA--LQNLTNLRELYLNEDNISD--IS-PLANLTKMYSLNLGANHNLSDLSPLSN-- 153
Query: 188 EFPGLTILHLAFNQL-----IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSL 242
GL L + +++ I L + SL +N N ++ I + ++TSL
Sbjct: 154 -MTGLNYLTVTESKVKDVTPIANLT------DLYSLSLNY---N-QIED-ISPLASLTSL 201
Query: 243 KEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302
+ N + + + + +L SL + +N T L L L + + N +
Sbjct: 202 HYFTAYVNQITD-ITPVANMTRLNSLKIGNNKITDL--SPLANLSQLTWLEIGTNQISD- 257
Query: 303 VPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDW 362
+ L M +N +++ + + L
Sbjct: 258 INAVKDLTKLKMLNVGSN-----------QISDISVLNNL-------------------- 286
Query: 363 IGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKE 422
+ + L +L L L+ N+++ + P L+ L +
Sbjct: 287 -------SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDS 337
Query: 423 LDVSNNQL 430
D +N +
Sbjct: 338 ADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-25
Identities = 52/354 (14%), Positives = 109/354 (30%), Gaps = 84/354 (23%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
+L + R LQ S++ + + L S+ ++++ + S+ L++L+ +
Sbjct: 16 FPDADLAEGIRAVLQKASVTD-VVTQEELESITKLVVAGEKVASIQG--IEYLTNLEYLN 72
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGG 205
++ N + L N L N + IT I + L L+L + +
Sbjct: 73 LNGNQITD---ISPLSNLVKLTNLYIGTNKIT-DISAL---QNLTNLRELYLNEDNI--- 122
Query: 206 LPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL 265
I + N+T + + L +N L S + L
Sbjct: 123 -------------------------SDISPLANLTKMYSLNLGANHNLSDLSPLSNMTGL 157
Query: 266 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPS 325
L++ ++ P + L L +++ N ++ + SL N
Sbjct: 158 NYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVN----- 209
Query: 326 PGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT 385
++ + V + + + +T
Sbjct: 210 ------QITDITPVANM---------------------------TRLNSLKIGNNKITD- 235
Query: 386 ISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS 439
A+ L L + N +S + L LK L+V +NQ+ I +
Sbjct: 236 -LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI-SDISVLNN 285
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 2e-12
Identities = 39/303 (12%), Positives = 86/303 (28%), Gaps = 84/303 (27%)
Query: 137 GLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILH 196
G ++L ++ P + L A++T + +E +T L
Sbjct: 1 GAATLATL---PAPINQIFPDADLAE---GIRAVLQKASVTDVVT----QEELESITKLV 50
Query: 197 LAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPL 256
+A ++ I I+ +T+L+ + L+ N + +
Sbjct: 51 VAGEKV----------------------------ASIQGIEYLTNLEYLNLNGNQITD-I 81
Query: 257 PDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAK 316
S + +L +L + N T +L L +L+ + + + + + +
Sbjct: 82 SPLSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISD-ISPLANLTKMY--- 135
Query: 317 GSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVIN 376
LN L + + + +
Sbjct: 136 ---------------SLN--LGANHNLSDLSPLSNM-----------------TGLNYLT 161
Query: 377 FQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 436
+ + A+ L L L N + + P L+ L +L NQ+ I
Sbjct: 162 VTESKVKD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD-ITP 216
Query: 437 FKS 439
+
Sbjct: 217 VAN 219
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 2e-11
Identities = 26/110 (23%), Positives = 53/110 (48%), Gaps = 6/110 (5%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQF 127
++T ++IG + + +++LTKL+ L + N IS + LN L+ L + L+NNQ
Sbjct: 243 SQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQL 299
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANIT 177
+ + GL++L ++ + N + L + S + + + I
Sbjct: 300 GNEDMEVIGGLTNLTTLFLSQNHITDIR---PLASLSKMDSADFANQVIK 346
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-31
Identities = 47/206 (22%), Positives = 79/206 (38%), Gaps = 29/206 (14%)
Query: 601 LGRGGFGTVYKGELH--DGTKIAVKRMEAGVISG--KGLTEFKSEIAVLTKVRHRHLVAL 656
+ GG G +Y +G + +K + SG + +E L +V H +V +
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVH---SGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 657 L--GHCLDGNEKL---LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
D + +V EY+ +L R + L + L++ + Y
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSY 197
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
LH ++ DLKP NI+L ++ + K+ D G V G + GT G+ APE
Sbjct: 198 LH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGY----LYGTPGFQAPEI 248
Query: 772 AVTGRVTTKVDVFSFGVILMELITGR 797
T D+++ G L L
Sbjct: 249 V-RTGPTVATDIYTVGRTLAALTLDL 273
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-31
Identities = 51/223 (22%), Positives = 84/223 (37%), Gaps = 23/223 (10%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
+ + +ILG+G V++G G A+K + E VL K+
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-VDVQMREFEVLKKL 64
Query: 649 RHRHLVALLG--HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 706
H+++V L K+L+ E+ P G+L + L + L + DV
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE--EPSNAYGLPESEFLIVLRDVV 122
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLG----DDMRAKVADFGLVRLAPEGKGSIETRIAG 762
G+ +L +HR++KP NI+ K+ DFG R + + + G
Sbjct: 123 GGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLY-G 177
Query: 763 TFGYLAPE--------YAVTGRVTTKVDVFSFGVILMELITGR 797
T YL P+ + VD++S GV TG
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 75/367 (20%), Positives = 131/367 (35%), Gaps = 47/367 (12%)
Query: 537 SGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFS 596
SGS +S + + ++ + + +L + R + +
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61
Query: 597 EENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-EIAVLTKVRHRHLV 654
+ +GRG FG V++ + G + AVK++ L F+ E+ + +V
Sbjct: 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACAGLSSPRIV 113
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
L G +G + E + G+L + I L +R L G+EYLH
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLHT 168
Query: 715 LAHQSFIHRDLKPSNILLGDD-MRAKVADFGL-VRLAPEGKGSIETR---IAGTFGYLAP 769
+ +H D+K N+LL D RA + DFG + L P+G G I GT ++AP
Sbjct: 169 ---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 770 EYAVTGR-VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828
E V G+ KVD++S +++ ++ G + A
Sbjct: 226 E-VVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---------------LKIA 269
Query: 829 IDPTIDLNEGILASISTVA-ELAGHCCAREPYQRPD----MGHAVNVLSSLVELWKPTDQ 883
+P I S + + + +EP R L + L P
Sbjct: 270 SEPPPIRE--IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKG 327
Query: 884 NSEDIYG 890
++ G
Sbjct: 328 EYKEPRG 334
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-30
Identities = 66/249 (26%), Positives = 98/249 (39%), Gaps = 30/249 (12%)
Query: 563 HTVPSSEPGDIQMLEAGNMVISIQVL-----RNVTNNFSEENILGRGGFGTVYKG-ELHD 616
H G + G++ + + +++ + LG G +G V +
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 617 GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676
+ A+K + +S ++ E+AVL + H +++ L D LV E G
Sbjct: 62 HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121
Query: 677 TL-----SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731
L R FN E I V GV YLH + +HRDLKP N+L
Sbjct: 122 ELFDEIIHRMKFN--EVDAA--------VIIKQVLSGVTYLH---KHNIVHRDLKPENLL 168
Query: 732 L---GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGV 788
L D K+ DFGL + K GT Y+APE + + K DV+S GV
Sbjct: 169 LESKEKDALIKIVDFGLSAVFENQK--KMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGV 225
Query: 789 ILMELITGR 797
IL L+ G
Sbjct: 226 ILFILLAGY 234
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-30
Identities = 60/397 (15%), Positives = 130/397 (32%), Gaps = 35/397 (8%)
Query: 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQF 127
R ++ +L+ L S Q+ ++ L+L N +S L LE++ LS+N
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187
LS+L++++++NN + S+ L + + N NI+ ++
Sbjct: 71 YETLD--LESLSTLRTLDLNNNYVQELLVGPSIET---L-HAANN--NIS-RVS----CS 117
Query: 188 EFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIW 246
G ++LA N++ S++Q L + N + ++ + +L+ +
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL-NEIDTVNFA-ELAASSDTLEHLN 175
Query: 247 LHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEF 306
L N + +L++L L N + + +++ NN L
Sbjct: 176 LQYNFIYD-VKGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKAL 233
Query: 307 DRSVSLDMAKGSNN----FCLPSPGACDPRL-----NALLSVVKLMGYPQRFAENWKGND 357
S +L+ N L + + R+ + +
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA 293
Query: 358 PCSDWI------GVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 411
C + + + K + + + T + E + + + +I
Sbjct: 294 YCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVID 353
Query: 412 EGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGN 448
+ A L+ L + S A DG
Sbjct: 354 QVTLRKQAKITLEQKKKALD-EQVSNGRRAHAELDGT 389
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 18/127 (14%), Positives = 32/127 (25%), Gaps = 6/127 (4%)
Query: 78 QNLQGTLPSNLQNLT--KLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFF 135
++L L L + L Q + A + Q+ +V
Sbjct: 297 EDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVT 356
Query: 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTIL 195
+ ++E E + R A GQI +E L +L
Sbjct: 357 LRKQAKITLEQKKKALD--EQVSNGRRA--HAELDGTLQQAVGQIELQHATEEQSPLQLL 412
Query: 196 HLAFNQL 202
+
Sbjct: 413 RAIVKRY 419
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-30
Identities = 62/218 (28%), Positives = 90/218 (41%), Gaps = 25/218 (11%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
++ +LG+G FG V K + + AVK + K + E+ +L K
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTIA 702
+ H +++ L D + +V E G L R F+ E I
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS--EHDAA--------RII 127
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETR 759
V G+ Y+H + +HRDLKP NILL D K+ DFGL +
Sbjct: 128 KQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKD 182
Query: 760 IAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 797
GT Y+APE + G K DV+S GVIL L++G
Sbjct: 183 RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 5e-30
Identities = 55/264 (20%), Positives = 88/264 (33%), Gaps = 49/264 (18%)
Query: 580 NMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK---RMEAGVISGKGL 635
N+ L + + + +G+G +G V E A+K + + I+ K +
Sbjct: 13 NLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDV 72
Query: 636 TEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI------------- 682
K+E+ ++ K+ H ++ L D LV E G L +
Sbjct: 73 ERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 683 ----------------FNWAEEGLKPLEWNRRLT------IALDVARGVEYLHGLAHQSF 720
+ I + + YLH +Q
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGI 189
Query: 721 IHRDLKPSNILLGDDMRA--KVADFGL---VRLAPEGKGSIETRIAGTFGYLAPE--YAV 773
HRD+KP N L + K+ DFGL G+ T AGT ++APE
Sbjct: 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249
Query: 774 TGRVTTKVDVFSFGVILMELITGR 797
K D +S GV+L L+ G
Sbjct: 250 NESYGPKCDAWSAGVLLHLLLMGA 273
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 50/236 (21%), Positives = 83/236 (35%), Gaps = 43/236 (18%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
T F E +G G FG+V+K + DG A+KR + + E+ +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 649 -RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+H H+V + + L+ EY G+L+ I + + L V R
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIM-SYFKEAELKDLLLQVGR 126
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDD-------------------MRAKVADFGLVRL 748
G+ Y+H S +H D+KPSNI + + K+ D G V
Sbjct: 127 GLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 749 APEGKGSIETRIAGTFGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 797
S + G +LA E + K D+F+ + ++
Sbjct: 184 I----SSPQVEE-GDSRFLANEVLQENYTH------LPKADIFALALTVVCAAGAE 228
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-30
Identities = 75/255 (29%), Positives = 120/255 (47%), Gaps = 21/255 (8%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 650
N F + +LG+GGFG V ++ K+ A K++E + KG +E +L KV
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 651 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
R +V+L + + + L LV M G L HI++ + G E A ++ G+
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP--EARAVFYAA-EICCGL 299
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
E LH + ++RDLKP NILL D +++D GL PEG+ +I+ R GT GY+AP
Sbjct: 300 EDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGR-VGTVGYMAP 354
Query: 770 EYAVTGRVTTKVDVFSFGVILMELITGR---KALDESQPEESMHLVTWFRRIHLSKDSFH 826
E R T D ++ G +L E+I G+ + + E + R + + +
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV-----ERLVKEVPEEYS 409
Query: 827 KAIDP-TIDLNEGIL 840
+ P L +L
Sbjct: 410 ERFSPQARSLCSQLL 424
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 600 ILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
+LG+G +G VY G +L + +IA+K + + EIA+ ++H+++V LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 659 HCLDGNEKLLVF-EYMPQGTLSRHIFNWAEEGLKPLEWNRRLT--IALDVARGVEYLHGL 715
+ + +F E +P G+LS + PL+ N + + G++YLH
Sbjct: 87 SFSENG-FIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIGFYTKQILEGLKYLHD- 140
Query: 716 AHQSFIHRDLKPSNILLGDDM-RAKVADFGL-VRLAPEGKGSIETRIAGTFGYLAPE--- 770
+HRD+K N+L+ K++DFG RLA G GT Y+APE
Sbjct: 141 --NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA--GINPCTETFTGTLQYMAPEIID 196
Query: 771 YAVTGRVTTKVDVFSFGVILMELITGR 797
G D++S G ++E+ TG+
Sbjct: 197 KGPRGY-GKAADIWSLGCTIIEMATGK 222
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-29
Identities = 63/392 (16%), Positives = 131/392 (33%), Gaps = 39/392 (9%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQ 126
+ + + +Q Q+L+ L L L N I L + +GL+SL+ ++
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFF 184
S+ + L +L+ + + +N S+++P+ N + L+ + S+N I +
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN--KIQSIYCTDL 169
Query: 185 GPDEFPGLTI----LHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMT 240
+ + L L+ N + P +F ++ L + + + IQ +
Sbjct: 170 RV--LHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKT--CIQGLA 225
Query: 241 SLKEIWLHSNAFSG-------PLPDFSGVKQLESLSLR---DNFFTGPVPDSLVKLESLK 290
L+ L F G+ L R +++ + D L ++
Sbjct: 226 GLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVS 285
Query: 291 IVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRF 349
++ + ++ V +F + + N P L L + K
Sbjct: 286 SFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV 344
Query: 350 ----------AENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRL 399
+ N C T ++ ++ + T+S F + L+ L
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTT--SLKYLDLSFNGVI-TMSSNFLGLEQLEHL 401
Query: 400 ILADNNLSGMIPEG-LSVLGALKELDVSNNQL 430
+NL M L L LD+S+
Sbjct: 402 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-26
Identities = 71/382 (18%), Positives = 121/382 (31%), Gaps = 49/382 (12%)
Query: 64 CIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVML 122
C+E Q N +P NL + L+L +N + S L+V+ L
Sbjct: 3 CVEVVPNITYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 123 SNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPS 182
S + ++ + LS L ++ + NP S + S LQ A N+
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENF 118
Query: 183 FFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSL 242
G L L++A N IQS + + N+T+L
Sbjct: 119 PIGH--LKTLKELNVAHN-------------LIQSFKLP------------EYFSNLTNL 151
Query: 243 KEIWLHSNAFSG-PLPDFSGVKQLE----SLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
+ + L SN D + Q+ SL L N + K L + + NN
Sbjct: 152 EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNN 210
Query: 298 LLQGPVPE--FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 355
V + L++ + +AL + L R A
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL--- 267
Query: 356 NDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLS 415
+ D I + N++ + + + +F+ Q L L + L
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLKLK 325
Query: 416 VLGALKELDVSNNQLYGKIPSF 437
+LK L ++N+ G S
Sbjct: 326 ---SLKRLTFTSNKG-GNAFSE 343
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-24
Identities = 71/376 (18%), Positives = 125/376 (33%), Gaps = 41/376 (10%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSI-SGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFT 136
NL + +L L+ L + N I S LP + L +LE + LS+N+ S+
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170
Query: 137 GLSSLQ----SIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGL 192
L + S+++ NP + I L + + + + GL
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNF--IQPGAFKEIRLHKLTLRNNFDSLNVMKTC-IQGLAGL 227
Query: 193 TILHLA------FNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEI 245
+ L L ++ G + + L ID+ +T++
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 246 WLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE 305
L S + DFS + L L + F L L+ L T+N
Sbjct: 288 SLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRL---TFTSNKGGN-AFS 342
Query: 306 FDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDW 362
SL D+ S N L G C S+ L + N S++
Sbjct: 343 EVDLPSLEFLDL---SRN-GLSFKGCCSQSDFGTTSLKYL-----DLSFN-GVITMSSNF 392
Query: 363 IGVTCTKGNITVINFQKMNLTGTISPE--FASFKSLQRLILADNNLSGMIPEGLSVLGAL 420
+G+ + ++FQ NL +S F S ++L L ++ + + L +L
Sbjct: 393 LGLE----QLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
Query: 421 KELDVSNNQLYGKIPS 436
+ L ++ N
Sbjct: 448 EVLKMAGNSFQENFLP 463
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 8e-22
Identities = 50/242 (20%), Positives = 91/242 (37%), Gaps = 18/242 (7%)
Query: 78 QNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTG 137
++ + + LEL P+L L SL+ + ++N+ + S
Sbjct: 290 VSVTIERVKDFSYNFGWQHLELVNCKFGQ-FPTLK-LKSLKRLTFTSNKGGNAFS--EVD 345
Query: 138 LSSLQSIEIDNNPFSSWEI-PQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILH 196
L SL+ +++ N S QS + L+ + + + S F L L
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNF--LGLEQLEHLD 402
Query: 197 LAFNQLIGGLPAS-FSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG 254
+ L S F + L ++ G + ++SL+ + + N+F
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISH-THTRVAFNG--IFNGLSSLEVLKMAGNSFQE 459
Query: 255 PLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE--FDRSV 310
F+ ++ L L L P + L SL+++NM +N L+ VP+ FDR
Sbjct: 460 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS-VPDGIFDRLT 518
Query: 311 SL 312
SL
Sbjct: 519 SL 520
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-21
Identities = 45/248 (18%), Positives = 82/248 (33%), Gaps = 40/248 (16%)
Query: 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG---PLPSLNG 113
CK+ ++ K + R+ N G S +L LE L+L N +S S G
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTS-NKGGNAFS-EVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 114 LASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSA 171
SL+ + LS N ++ S+F GL L+ ++ ++ + L + S
Sbjct: 372 TTSLKYLDLSFNGVITMSSNFL-GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 172 NSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGG 231
+ F + L +L +A N
Sbjct: 431 T--HTRVAFNGIF--NGLSSLEVLKMAGNSFQENFLP----------------------- 463
Query: 232 GIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESL 289
D+ + +L + L L F+ + L+ L++ N +L SL
Sbjct: 464 --DIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSL 520
Query: 290 KIVNMTNN 297
+ + + N
Sbjct: 521 QKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-21
Identities = 68/390 (17%), Positives = 126/390 (32%), Gaps = 74/390 (18%)
Query: 83 TLPSNLQNLTKLERLELQWNSISGPLPS--LNGLASLEVVML------SNNQFTSVPSDF 134
+ +L +L L+ N S + + GLA LEV L +
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 135 FTGLSSLQSIEIDNN--PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGL 192
GL +L E + +I + + +FS S I ++ F + L
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHL 309
Query: 193 TILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAF 252
+++ F Q +++SL N GG ++ SL+ + L N
Sbjct: 310 ELVNCKFGQF--------PTLKLKSLKRLTFTSN--KGGNAFSEVDLPSLEFLDLSRNGL 359
Query: 253 SG---PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG--PVPEFD 307
S G L+ L L N + + + LE L+ ++ ++ L+ F
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 308 RSVS---LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIG 364
+ LD+ + + G + L++L
Sbjct: 419 SLRNLIYLDI--SHTHTRVAFNGIFN-GLSSL---------------------------- 447
Query: 365 VTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKEL 423
V+ + P+ F ++L L L+ L + P + L +L+ L
Sbjct: 448 --------EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499
Query: 424 DVSNNQLY----GKIPSFKSNAIVNTDGNP 449
++++NQL G S + NP
Sbjct: 500 NMASNQLKSVPDGIFDRLTSLQKIWLHTNP 529
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 6e-16
Identities = 39/179 (21%), Positives = 69/179 (38%), Gaps = 34/179 (18%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISG--PLPSLNGLASLEVVMLSNNQFTSVPSDFFT 136
N T+ SN L +LE L+ Q +++ L +L + +S+ + F
Sbjct: 383 NGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442
Query: 137 GLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFFGPDEFPGLTI 194
GLSSL+ +++ N F +P L + S + P+ F + L +
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC--QLEQLSPTAF--NSLSSLQV 498
Query: 195 LHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS 253
L++A NQL + + +TSL++IWLH+N +
Sbjct: 499 LNMASNQL----------KSVPD----------------GIFDRLTSLQKIWLHTNPWD 531
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 60/222 (27%), Positives = 89/222 (40%), Gaps = 38/222 (17%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE------FKSE 641
+ + + + LG G G V E K+A+K + + E ++E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 642 IAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRLT 700
I +L K+ H ++ + D + +V E M G L F+ RL
Sbjct: 66 IEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNK--------RLK 112
Query: 701 ------IALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPE 751
+ V+YLH IHRDLKP N+LL +D K+ DFG ++
Sbjct: 113 EATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--L 167
Query: 752 GKGSIETRIAGTFGYLAPE---YAVTGRVTTKVDVFSFGVIL 790
G+ S+ + GT YLAPE T VD +S GVIL
Sbjct: 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 62/219 (28%), Positives = 90/219 (41%), Gaps = 26/219 (11%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLT 646
++ + + +LG+G FG V + G + AVK + V E+ +L
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 647 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTI 701
++ H +++ L D LV E G L SR F+ E I
Sbjct: 82 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS--EVDAA--------RI 131
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIET 758
V G+ Y+H +HRDLKP N+LL D ++ DFGL K
Sbjct: 132 IRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMK 186
Query: 759 RIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 797
GT Y+APE + G K DV+S GVIL L++G
Sbjct: 187 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 59/210 (28%), Positives = 86/210 (40%), Gaps = 25/210 (11%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
++ +LG+G FG V K + + AVK + K + E+ +L K+
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTIAL 703
H +++ L D + +V E G L R F+ + I
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIK 128
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRI 760
V G+ Y+H + +HRDLKP NILL D K+ DFGL +
Sbjct: 129 QVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDR 183
Query: 761 AGTFGYLAPEYAVTGRVTTKVDVFSFGVIL 790
GT Y+APE + G K DV+S GVIL
Sbjct: 184 IGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-29
Identities = 61/215 (28%), Positives = 90/215 (41%), Gaps = 36/215 (16%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE------FKSEIAVLTKVRHRHL 653
LG G G V E K+A++ + + E ++EI +L K+ H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVAR 707
+ + D + +V E M G L F+ N+RL +
Sbjct: 203 IKIKNFF-DAEDYYIVLELMEGGEL----FDKVVG-------NKRLKEATCKLYFYQMLL 250
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIAGTF 764
V+YLH IHRDLKP N+LL +D K+ DFG ++ G+ S+ + GT
Sbjct: 251 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTP 305
Query: 765 GYLAPE---YAVTGRVTTKVDVFSFGVILMELITG 796
YLAPE T VD +S GVIL ++G
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 40/218 (18%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
++N+ + LG+G F V + G + A K + +S + + + E + K+
Sbjct: 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRLT------I 701
+H ++V L + + LVF+ + G L F +
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVARE--------FYSEADASHC 110
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIET 758
+ + Y H +HR+LKP N+LL K+ADFGL + +
Sbjct: 111 IQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWH 165
Query: 759 RIAGTFGYLAPE------YAVTGRVTTKVDVFSFGVIL 790
AGT GYL+PE Y + VD+++ GVIL
Sbjct: 166 GFAGTPGYLSPEVLKKDPY------SKPVDIWACGVIL 197
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 48/222 (21%), Positives = 86/222 (38%), Gaps = 37/222 (16%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE--FKSEIAVL 645
+ + + LGRG FG V++ E K + KG + K EI++L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK-----FVKVKGTDQVLVKKEISIL 55
Query: 646 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 705
RHR+++ L E +++FE++ + I + E ++
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERI---NTSAFELNE--------REI 104
Query: 706 AR-------GVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLAPEGKGSI 756
+++LH + H D++P NI+ K+ +FG R G
Sbjct: 105 VSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--N 159
Query: 757 ETRIAGTFGYLAPEYAVTGR--VTTKVDVFSFGVILMELITG 796
+ Y APE V V+T D++S G ++ L++G
Sbjct: 160 FRLLFTAPEYYAPE--VHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-29
Identities = 55/385 (14%), Positives = 121/385 (31%), Gaps = 41/385 (10%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQ 126
+ + + ++ L L L L N I S +GL SLE ++ +
Sbjct: 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFF 184
S+ S L +L+ + + +N S ++P N + L + S N I +
Sbjct: 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN--YIQTITVNDL 173
Query: 185 GP--DEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSL 242
+ L ++ N + +F G ++ L + G ++ + +QN+ L
Sbjct: 174 QFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTC--LQNLAGL 231
Query: 243 KEIWLHSNAFSG-------PLPDFSGVKQL--ESLSLRDNFFTGPVPDSLVKLESLKIVN 293
L F G+ + + L L ++ ++
Sbjct: 232 HVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMS 291
Query: 294 MTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRFAEN 352
+ ++ + + + P P L +L L++ K +
Sbjct: 292 LAGVSIKY-LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGS-ISFKKVAL 349
Query: 353 WKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFK--SLQRLILADNNLSGMI 410
+++ ++ + L+ + ++ SL+ L L+ N +
Sbjct: 350 -----------------PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-M 391
Query: 411 PEGLSVLGALKELDVSNNQLYGKIP 435
L L+ LD ++ L
Sbjct: 392 SANFMGLEELQHLDFQHSTLKRVTE 416
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-28
Identities = 58/376 (15%), Positives = 119/376 (31%), Gaps = 51/376 (13%)
Query: 64 CIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVML 122
CIE Q Q L +P ++ + + ++L +N + S + + L+ + L
Sbjct: 7 CIEVVPNITYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDL 63
Query: 123 SNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPS 182
S + ++ + GL L ++ + NP S P S + L+N A +
Sbjct: 64 SRCEIETIEDKAWHGLHHLSNLILTGNPIQS-FSPGSFSGLTSLENLVAVETKLASLESF 122
Query: 183 FFGPDEFPGLTILHLAFNQLIG-GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTS 241
G L L++A N + LPA FS N+T+
Sbjct: 123 PIGQ--LITLKKLNVAHNFIHSCKLPAYFS--------------------------NLTN 154
Query: 242 LKEIWLHSNAFSG-PLPDFSGVKQL----ESLSLRDNFFTGPVPDSLVKLESLKIVNMTN 296
L + L N + D +++ SL + N + D + L + +
Sbjct: 155 LVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRG 213
Query: 297 NLLQGPVPE--FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 354
N + + L + + + + + + R
Sbjct: 214 NFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTND 273
Query: 355 GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL 414
+D + + N++ ++ +++ + Q L + L L
Sbjct: 274 FSDDIVKFHCLA----NVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQLKQFPTLDL 327
Query: 415 SVLGALKELDVSNNQL 430
LK L ++ N+
Sbjct: 328 P---FLKSLTLTMNKG 340
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-28
Identities = 63/392 (16%), Positives = 120/392 (30%), Gaps = 66/392 (16%)
Query: 76 GHQNLQGTLPSNLQNLTKLERLELQWNSISG-------PLPSLNGLASLEVVML--SNNQ 126
G+ N + + LQNL L L + GL + + +
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGP 186
S F L+++ ++ + + + Q+ S + Q P+
Sbjct: 273 DFSDDIVKFHCLANVSAMSLAGVSIKY---LEDVPKHFKWQSLSIIRCQLK-QFPTLD-- 326
Query: 187 DEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIW 246
P L L L N+ + + L ++ N + G SL+ +
Sbjct: 327 --LPFLKSLTLTMNK-GSISFKKVALPSLSYLDLSR-NALSFSGCCSYSDLGTNSLRHLD 382
Query: 247 LHSNAFSGPLPDFSGVKQLESLSLRDNFFTG-PVPDSLVKLESLKIVNMTNNLLQGPVPE 305
L N +F G+++L+ L + + + + LE L ++++ +
Sbjct: 383 LSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDG 442
Query: 306 -FDRSVS---LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSD 361
F S L M + N ++K N +
Sbjct: 443 IFLGLTSLNTLKM---AGN-------------------------------SFKDNTLSNV 468
Query: 362 WIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALK 421
+ T N+T ++ K L F + LQ L ++ NNL + + L +L
Sbjct: 469 FANTT----NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLS 524
Query: 422 ELDVSNNQLYGKIPSFKSNA----IVNTDGNP 449
LD S N++ + N N
Sbjct: 525 TLDCSFNRIETSKGILQHFPKSLAFFNLTNNS 556
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-27
Identities = 53/357 (14%), Positives = 93/357 (26%), Gaps = 76/357 (21%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGL 138
N L + + L SI L + + + + Q P L
Sbjct: 272 NDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRCQLKQFP---TLDL 327
Query: 139 SSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFFGPDEFPGLTILH 196
L+S+ + N S I L + S N ++ + L L
Sbjct: 328 PFLKSLTLTMNKGS---ISFKKVALPSLSYLDLSRN--ALSFSGCCSYSDLGTNSLRHLD 382
Query: 197 LAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG-- 254
L+FN I + A+F + L+ + +
Sbjct: 383 LSFNGAII-MSANFM--------------------------GLEELQHLDFQHSTLKRVT 415
Query: 255 PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDM 314
F +++L L + + L SL + M N +
Sbjct: 416 EFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL---------- 465
Query: 315 AKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNIT 373
SN F L L LS +L + +
Sbjct: 466 ---SNVFANT------TNLTFLDLSKCQLEQISWGVFDTLH----------------RLQ 500
Query: 374 VINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
++N NL S + SL L + N + +L +++NN +
Sbjct: 501 LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-25
Identities = 43/267 (16%), Positives = 79/267 (29%), Gaps = 48/267 (17%)
Query: 81 QGTLPSNLQNLTKLERLELQWNSISGPLP---SLNGLASLEVVMLSNNQFTSVPSDFFTG 137
+G++ L L L+L N++S S G SL + LS N + + F G
Sbjct: 339 KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSA-NFMG 397
Query: 138 LSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFFGPDEFPGLTIL 195
L LQ ++ ++ + + L + S N F L L
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT--NTKIDFDGIFLG--LTSLNTL 453
Query: 196 HLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGP 255
+A N ++ N T+L + L
Sbjct: 454 KMAGNSFKDNTLSNV-------------------------FANTTNLTFLDLSKCQLEQI 488
Query: 256 LPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVS--- 311
F + +L+ L++ N +L SL ++ + N ++
Sbjct: 489 SWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLA 548
Query: 312 -LDMAKGSNNFCLPSPGACDPRLNALL 337
++ +N+ AC L
Sbjct: 549 FFNL--TNNSV------ACICEHQKFL 567
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-23
Identities = 63/337 (18%), Positives = 109/337 (32%), Gaps = 31/337 (9%)
Query: 106 GPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASG 165
G L + + + + VP D SS ++I++ NP S N S
Sbjct: 2 GSLNPCIEVVPNITYQCMDQKLSKVPDDIP---SSTKNIDLSFNPLKI-LKSYSFSNFSE 57
Query: 166 LQ--NFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNG 222
LQ + S I + L+ L L N + P SFSG + +++L
Sbjct: 58 LQWLDLSRC--EIETIEDKAWHG--LHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVE 113
Query: 223 QNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG-PLPD-FSGVKQLESLSLRDNFFTGPVP 280
A L I + +LK++ + N LP FS + L + L N+
Sbjct: 114 -TKLASLESF--PIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV 170
Query: 281 DSLVKLESLKIVNMTNNLLQGPVPEFDRSV-------SLDMAKGSNNFCLPSPGACDPRL 333
+ L L VN++ ++ P+ L + NF + +
Sbjct: 171 NDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTL---RGNFNSSNIMKTCLQN 227
Query: 334 NALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASF 393
A L V +L F + + C I N +F
Sbjct: 228 LAGLHVHRL--ILGEFKDERNLEIFEPSIMEGLC-DVTIDEFRLTYTNDFSDDIVKFHCL 284
Query: 394 KSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
++ + LA ++ + E + + L + QL
Sbjct: 285 ANVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQL 319
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-12
Identities = 15/76 (19%), Positives = 26/76 (34%), Gaps = 1/76 (1%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTG 137
L+ L +L+ L + N++ N L SL + S N+ +
Sbjct: 484 QLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHF 543
Query: 138 LSSLQSIEIDNNPFSS 153
SL + NN +
Sbjct: 544 PKSLAFFNLTNNSVAC 559
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 14/66 (21%), Positives = 25/66 (37%)
Query: 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
+ I+ L S F++F LQ L L+ + + + L L L ++ N +
Sbjct: 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 431 YGKIPS 436
P
Sbjct: 93 QSFSPG 98
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 15/71 (21%), Positives = 36/71 (50%), Gaps = 1/71 (1%)
Query: 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
+++ + + F+ SL+ L+ + L+ + + L LK+L+V++N +
Sbjct: 81 HLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI 140
Query: 431 YG-KIPSFKSN 440
+ K+P++ SN
Sbjct: 141 HSCKLPAYFSN 151
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 4e-06
Identities = 11/66 (16%), Positives = 21/66 (31%)
Query: 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
+ ++ + + + L LIL N + P S L +L+ L +L
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
Query: 431 YGKIPS 436
Sbjct: 117 ASLESF 122
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 6e-29
Identities = 59/223 (26%), Positives = 86/223 (38%), Gaps = 39/223 (17%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK-------RMEAGVISGKGLTEFKSE 641
N+ + ILGRG V + + AVK + + E
Sbjct: 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 642 IAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRL 699
+ +L KV H +++ L LVF+ M +G L F++ E+ L
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKV--------TL 121
Query: 700 T------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753
+ I + + LH + +HRDLKP NILL DDM K+ DFG
Sbjct: 122 SEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-- 176
Query: 754 GSIETRIAGTFGYLAPE------YAVTGRVTTKVDVFSFGVIL 790
G + GT YLAPE +VD++S GVI+
Sbjct: 177 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-29
Identities = 61/248 (24%), Positives = 107/248 (43%), Gaps = 20/248 (8%)
Query: 552 SNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYK 611
+ V +E S Q A MV+ + +G G G V
Sbjct: 7 HSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQG---DPRLLLDSYVKIGEGSTGIVCL 63
Query: 612 G-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670
E H G ++AVK M+ + + +E+ ++ +H ++V + L G E ++
Sbjct: 64 AREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM 121
Query: 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNI 730
E++ G L+ + L + T+ V + + YLH Q IHRD+K +I
Sbjct: 122 EFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSI 172
Query: 731 LLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFGYLAPEYAVTGRVTTKVDVFSFGV 788
LL D R K++DFG + + R + GT ++APE T+VD++S G+
Sbjct: 173 LLTLDGRVKLSDFG---FCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGI 229
Query: 789 ILMELITG 796
+++E++ G
Sbjct: 230 MVIEMVDG 237
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 67/238 (28%), Positives = 99/238 (41%), Gaps = 62/238 (26%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVK-----------------------RMEAGVISGKGLT 636
+G+G +G V +D T A+K G I +G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 637 EF-KSEIAVLTKVRHRHLVALLGHCLDGNEKLL--VFEYMPQGTLSRHIFNWAEEGLKPL 693
E EIA+L K+ H ++V L+ D NE L VFE + QG +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLK---- 132
Query: 694 EWNRRLTIALDVAR--------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745
L+ D AR G+EYLH +Q IHRD+KPSN+L+G+D K+ADFG+
Sbjct: 133 ----PLSE--DQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 746 VRLAPEGKGSIETRIAGTFGYLAPE------YAVTGRVTTKVDVFSFGVILMELITGR 797
+ GT ++APE +G+ +DV++ GV L + G+
Sbjct: 184 SNEFKGSDALLSNT-VGTPAFMAPESLSETRKIFSGK---ALDVWAMGVTLYCFVFGQ 237
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 71/366 (19%), Positives = 132/366 (36%), Gaps = 64/366 (17%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
+ L NLT L L L N I+ + L L +L + LS+N + + + +GL+SLQ +
Sbjct: 106 TPLANLTNLTGLTLFNNQITD-IDPLKNLTNLNRLELSSNTISDISA--LSGLTSLQQLS 162
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGG 205
N + L N + L+ +S ++ I + L L NQ I
Sbjct: 163 FGNQVTD----LKPLANLTTLERLDISSNKVSD-ISVL---AKLTNLESLIATNNQ-ISD 213
Query: 206 LPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL 265
+ + + L +NG I + ++T+L ++ L +N S L SG+ +L
Sbjct: 214 ITPLGILTNLDELSLNGNQLK-----DIGTLASLTNLTDLDLANNQISN-LAPLSGLTKL 267
Query: 266 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPS 325
L L N + L L +L + + N L+ + +L N
Sbjct: 268 TELKLGANQISNI--SPLAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFN----- 319
Query: 326 PGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT 385
++ + V L + + F ++
Sbjct: 320 ------NISDISPVSSL---------------------------TKLQRLFFYNNKVSD- 345
Query: 386 ISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN-AIVN 444
A+ ++ L N +S + P L+ L + +L +++ ++K+N +I N
Sbjct: 346 -VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPN 402
Query: 445 TDGNPD 450
T N
Sbjct: 403 TVKNVT 408
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 78/388 (20%), Positives = 135/388 (34%), Gaps = 61/388 (15%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQF 127
+ +G N+ T+ +L ++ L+ I + + L +L + SNNQ
Sbjct: 24 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQL 80
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187
T + L+ L I ++NN + L N + L + + IT I
Sbjct: 81 TDITP--LKNLTKLVDILMNNNQIAD---ITPLANLTNLTGLTLFNNQITD-IDPL---K 131
Query: 188 EFPGLTILHLAFNQLIGGLPASFSGSQIQSLWV-NGQNGNAKLGG--------------- 231
L L L+ N I + A + +Q L N L
Sbjct: 132 NLTNLNRLELSSNT-ISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS 190
Query: 232 GIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 291
I V+ +T+L+ + +N S + + L+ LSL N +L L +L
Sbjct: 191 DISVLAKLTNLESLIATNNQISD-ITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTD 247
Query: 292 VNMTNNLLQGPVPEFDRSVSL---DMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQ 347
+++ NN + + L + G+N SP A L L L+ +L
Sbjct: 248 LDLANNQISN-LAPLSGLTKLTELKL--GANQISNISPLAGLTALTNLELNENQL----- 299
Query: 348 RFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLS 407
D ++ K N+T + N++ +S LQRL +N +S
Sbjct: 300 ------------EDISPISNLK-NLTYLTLYFNNISD--ISPVSSLTKLQRLFFYNNKVS 344
Query: 408 GMIPEGLSVLGALKELDVSNNQLYGKIP 435
L+ L + L +NQ+ P
Sbjct: 345 D--VSSLANLTNINWLSAGHNQISDLTP 370
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-25
Identities = 47/222 (21%), Positives = 85/222 (38%), Gaps = 27/222 (12%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
+ L LT L+ L L N + + +L L +L + L+NNQ +++ +GL+ L ++
Sbjct: 215 TPLGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELK 271
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL--- 202
+ N S+ L + L N N + I LT L L FN +
Sbjct: 272 LGANQISNIS---PLAGLTALTNLELNENQLED-ISPI---SNLKNLTYLTLYFNNISDI 324
Query: 203 --IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFS 260
+ L ++Q L+ N K+ + + N+T++ + N S L +
Sbjct: 325 SPVSSLT------KLQRLFFYN---N-KVSD-VSSLANLTNINWLSAGHNQISD-LTPLA 372
Query: 261 GVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302
+ ++ L L D +T + + V L P
Sbjct: 373 NLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAP 414
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-23
Identities = 64/350 (18%), Positives = 119/350 (34%), Gaps = 63/350 (18%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
L + + L +++ S L + + S+ L++L I
Sbjct: 18 FTDTALAEKMKTVLGKTNVTD-TVSQTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQIN 74
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGG 205
NN + I L+N + L + N+ I I LT L L NQ I
Sbjct: 75 FSNNQLTD--IT-PLKNLTKLVDILMNNNQIAD-ITPL---ANLTNLTGLTLFNNQ-ITD 126
Query: 206 LPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL 265
+ + + + L ++ + I + +TSL+++ N + P + + L
Sbjct: 127 IDPLKNLTNLNRLELSSNTIS-----DISALSGLTSLQQLSF-GNQVTDLKP-LANLTTL 179
Query: 266 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPS 325
E L + N + L KL +L+ + TNN + + +LD + N
Sbjct: 180 ERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD-ITPLGILTNLDELSLNGN----- 231
Query: 326 PGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT 385
+L + ++ L N+T ++ ++
Sbjct: 232 ------QLKDIGTLASLT---------------------------NLTDLDLANNQISN- 257
Query: 386 ISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP 435
+ L L L N +S + P L+ L AL L+++ NQL P
Sbjct: 258 -LAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-23
Identities = 78/395 (19%), Positives = 141/395 (35%), Gaps = 71/395 (17%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
L+NLT L RLEL N+IS + +L+GL SL+ + N P L++L+ ++
Sbjct: 128 DPLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLSFGNQVTDLKP---LANLTTLERLD 183
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGG 205
I +N S + L N L++ A + I+ I L L L NQL
Sbjct: 184 ISSNKVSDISVLAKLTN---LESLIATNNQISD-ITPL---GILTNLDELSLNGNQLKD- 235
Query: 206 LPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQ 264
+ + + + L + N ++ + + +T L E+ L +N S + +G+
Sbjct: 236 -IGTLASLTNLTDLDLA----NNQISN-LAPLSGLTKLTELKLGANQISN-ISPLAGLTA 288
Query: 265 LESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLP 324
L +L L +N P + L++L + + N + + L NN
Sbjct: 289 LTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD-ISPVSSLTKLQRLFFYNN---- 341
Query: 325 SPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTG 384
+++ + S+ L NI ++ ++
Sbjct: 342 -------KVSDVSSLANL---------------------------TNINWLSAGHNQISD 367
Query: 385 TISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVN 444
A+ + +L L D + + + + L P+ S+
Sbjct: 368 --LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSY 423
Query: 445 TDGN-----PDIGKEKSSSF-QGSPSGSPTGTGSG 473
T+ + P E S +F Q G T T SG
Sbjct: 424 TEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSG 458
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-14
Identities = 56/338 (16%), Positives = 108/338 (31%), Gaps = 108/338 (31%)
Query: 102 NSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLR 161
I+ + + LA +L T S T L + +++ D ++
Sbjct: 12 TPINQ-IFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL---------GIK 59
Query: 162 NASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVN 221
+ G++ + LT ++ + NQL
Sbjct: 60 SIDGVEYLNN--------------------LTQINFSNNQL------------------- 80
Query: 222 GQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPD 281
I ++N+T L +I +++N + + + + L L+L +N T D
Sbjct: 81 ---------TDITPLKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITDI--D 128
Query: 282 SLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVK 341
L L +L + +++N + + SL N P L L ++ +
Sbjct: 129 PLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLSFGNQVTDLKP------LANLTTLER 181
Query: 342 LMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLIL 401
L + ++ I A +L+ LI
Sbjct: 182 L-----------------------DISSNKVSDI------------SVLAKLTNLESLIA 206
Query: 402 ADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS 439
+N +S + P L +L L EL ++ NQL I + S
Sbjct: 207 TNNQISDITP--LGILTNLDELSLNGNQL-KDIGTLAS 241
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 8e-13
Identities = 41/261 (15%), Positives = 88/261 (33%), Gaps = 55/261 (21%)
Query: 172 NSANITG--QIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKL 229
SA IT I F L + + Q+ +L +
Sbjct: 4 GSATITQDTPINQIFTDTALAEKMKTVLGKTN-VTDTVSQTDLDQVTTLQADRLGIK--- 59
Query: 230 GGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESL 289
ID ++ + +L +I +N + + + +L + + +N P L L +L
Sbjct: 60 --SIDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQIADITP--LANLTNL 114
Query: 290 KIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRF 349
+ + NN + + +L+ + S+N ++ + ++ L
Sbjct: 115 TGLTLFNNQITD-IDPLKNLTNLNRLELSSN-----------TISDISALSGL------- 155
Query: 350 AENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGM 409
++ ++F +T A+ +L+RL ++ N +S
Sbjct: 156 --------------------TSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD- 191
Query: 410 IPEGLSVLGALKELDVSNNQL 430
L+ L L+ L +NNQ+
Sbjct: 192 -ISVLAKLTNLESLIATNNQI 211
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 30/138 (21%), Positives = 56/138 (40%), Gaps = 19/138 (13%)
Query: 83 TLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQ 142
+ S+L NLT + L N IS L L L + + L++ +T+ P ++ +S
Sbjct: 344 SDVSSLANLTNINWLSAGHNQISD-LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPN 402
Query: 143 SIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL 202
+++ + P ++ + +IT +PS+ + F+Q
Sbjct: 403 TVKNVTGALIA---PATISDGGSYTEP-----DITWNLPSY--------TNEVSYTFSQP 446
Query: 203 --IGGLPASFSGSQIQSL 218
IG +FSG+ Q L
Sbjct: 447 VTIGKGTTTFSGTVTQPL 464
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 33/223 (14%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK----RMEAGVISGKGLTEFKSEIAV 644
V +++ LG G F V K + G + A K R + G E + E+ +
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 645 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRLT--- 700
L ++RH +++ L + + +L+ E + G L F++ AE+ LT
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKE--------SLTEDE 109
Query: 701 ---IALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRLAPEGK 753
+ GV YLH + H DLKP NI+L + R K+ DFG+ G
Sbjct: 110 ATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166
Query: 754 GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG 796
I GT ++APE + + D++S GVI L++G
Sbjct: 167 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 62/301 (20%), Positives = 114/301 (37%), Gaps = 39/301 (12%)
Query: 511 FCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEP 570
K++++ ++ + R + + A +++ +
Sbjct: 13 NKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENL 72
Query: 571 GDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK-----R 624
M + + + ++++GRG V + G + AVK
Sbjct: 73 YFQSMGPEDELPDWAAA-KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTA 131
Query: 625 MEAGVISGKGLTE-FKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI 682
+ + E + E +L +V H H++ L+ + LVF+ M +G L
Sbjct: 132 ERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL---- 187
Query: 683 FNW-AEEGLKPLEWNRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 735
F++ E+ L+ I + V +LH + +HRDLKP NILL D+
Sbjct: 188 FDYLTEKV--------ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDN 236
Query: 736 MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE------YAVTGRVTTKVDVFSFGVI 789
M+ +++DFG G+ + GT GYLAPE +VD+++ GVI
Sbjct: 237 MQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294
Query: 790 L 790
L
Sbjct: 295 L 295
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 59/215 (27%), Positives = 87/215 (40%), Gaps = 37/215 (17%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE---FKSEIAVL 645
N+ F +LG G F V+ + G A+K I ++EIAVL
Sbjct: 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALK-----CIKKSPAFRDSSLENEIAVL 60
Query: 646 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRLT---- 700
K++H ++V L LV + + G L F+ E G T
Sbjct: 61 KKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL----FDRILERG--------VYTEKDA 108
Query: 701 --IALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGS 755
+ V V+YLH +HRDLKP N+L ++ + + DFGL ++ G
Sbjct: 109 SLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-- 163
Query: 756 IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVIL 790
+ GT GY+APE + VD +S GVI
Sbjct: 164 -MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 58/244 (23%), Positives = 100/244 (40%), Gaps = 46/244 (18%)
Query: 566 PSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKR 624
+S G QM +++ ++N+ + LG+G F V + G + A K
Sbjct: 4 MASMTGGQQMGRGSEFMMNAS--TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 625 MEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----S 679
+ +S + + + E + K++H ++V L + + LVF+ + G L +
Sbjct: 62 INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA 121
Query: 680 RHIFNWAEEGLKPLEWNRRLTIALDVAR----GVEYLHGLAHQSFIHRDLKPSNILL--- 732
R ++ A+ A + + Y H +HR+LKP N+LL
Sbjct: 122 REFYSEAD--------------ASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASK 164
Query: 733 GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE------YAVTGRVTTKVDVFSF 786
K+ADFGL + + AGT GYL+PE Y + VD+++
Sbjct: 165 AKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPY------SKPVDIWAC 216
Query: 787 GVIL 790
GVIL
Sbjct: 217 GVIL 220
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-28
Identities = 57/256 (22%), Positives = 109/256 (42%), Gaps = 41/256 (16%)
Query: 560 SETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTK 619
+ P D + + ++ ++G G FG V++ +L + +
Sbjct: 7 NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE 66
Query: 620 IAVKRMEAGVISGKGLTEFKS-EIAVLTKVRHRHLVALL------GHCLDGNEKLLVFEY 672
+A+K++ FK+ E+ ++ V+H ++V L G D LV EY
Sbjct: 67 VAIKKVLQD-------KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119
Query: 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL------DVARGVEYLHGLAHQSFIHRDLK 726
+P+ T+ R ++A+ + + + L + R + Y+H + HRD+K
Sbjct: 120 VPE-TVYRASRHYAKL-------KQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIK 168
Query: 727 PSNILL-GDDMRAKVADFGLVRLAPEGKGSIE---TRIAGTFGYLAPEYAVTGRV-TTKV 781
P N+LL K+ DFG ++ G+ ++ +R Y APE TT +
Sbjct: 169 PQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPELIFGATNYTTNI 223
Query: 782 DVFSFGVILMELITGR 797
D++S G ++ EL+ G+
Sbjct: 224 DIWSTGCVMAELMQGQ 239
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 54/213 (25%), Positives = 86/213 (40%), Gaps = 33/213 (15%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE---FKSEIAVL 645
++ ++ EN +GRG +G V + + A K I + + FK EI ++
Sbjct: 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAK-----KIPKYFVEDVDRFKQEIEIM 60
Query: 646 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLT 700
+ H +++ L D + LV E G L + +F ++
Sbjct: 61 KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA----------R 110
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIE 757
I DV V Y H + HRDLKP N L D K+ DFGL GK +
Sbjct: 111 IMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MM 165
Query: 758 TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVIL 790
GT Y++P+ + G + D +S GV++
Sbjct: 166 RTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMM 197
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-28
Identities = 63/365 (17%), Positives = 144/365 (39%), Gaps = 43/365 (11%)
Query: 77 HQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFF 135
++ ++PS L ++ L+L +N I+ L A+L+V++L +++ ++ D F
Sbjct: 14 SRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAF 70
Query: 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTIL 195
L SL+ +++ +N SS + S+FGP L L
Sbjct: 71 YSLGSLEHLDLSDNHLSS--LS-----------------------SSWFGP--LSSLKYL 103
Query: 196 HLAFNQLIG-GLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS 253
+L N G+ + F + +Q+L + +++ +TSL E+ + + +
Sbjct: 104 NLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI--DFAGLTSLNELEIKALSLR 161
Query: 254 G-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG--PVPEFDRSV 310
++ + L+L + + L S++ + + + L P V
Sbjct: 162 NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEV 221
Query: 311 SLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYP-QRFAENWKGNDPCSDWIGVTCTK 369
S M K + + + + + L L +++L N G+ S+ V+
Sbjct: 222 SSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELG 281
Query: 370 G----NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDV 425
I ++ + L +S ++ + ++R+ + ++ + + L +L+ LD+
Sbjct: 282 KVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDL 341
Query: 426 SNNQL 430
S N +
Sbjct: 342 SENLM 346
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-24
Identities = 66/380 (17%), Positives = 117/380 (30%), Gaps = 53/380 (13%)
Query: 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFT 128
+ + + + +L+ L+ L L+ + I+ + L SLE + LS+N +
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87
Query: 129 SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIP-SFFGPD 187
S+ S +F LSSL+ + + NP+ + + N + LQ + +I F
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG- 146
Query: 188 EFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWL 247
L L + L QS ++++ + + L
Sbjct: 147 -LTSLNELEIKALSL----------RNYQS----------------QSLKSIRDIHHLTL 179
Query: 248 HSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE- 305
H + + L + + L LRD L E + E
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239
Query: 306 FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK----------- 354
F+ + L L D LN L +E K
Sbjct: 240 FNELLKLL----RYILELSEVEFDDCTLNGLGDFNPS--ESDVVSELGKVETVTIRRLHI 293
Query: 355 -GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEG 413
D V + I + + KSL+ L L++N + +
Sbjct: 294 PQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKN 353
Query: 414 LSVLGA---LKELDVSNNQL 430
+ GA L+ L +S N L
Sbjct: 354 SACKGAWPSLQTLVLSQNHL 373
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 51/372 (13%), Positives = 118/372 (31%), Gaps = 66/372 (17%)
Query: 85 PSNLQNLTKLERLELQWNSIS--GPLPSLNGLASLEVVMLS-NNQFTSVPSDFFTGLSSL 141
S L+ L+ L L N G L +L+ + + F+ + F GL+SL
Sbjct: 91 SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSL 150
Query: 142 QSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQ 201
+EI +++ QSL++ + + + + + + F D + L L
Sbjct: 151 NELEIKALSLRNYQ-SQSLKSIRDIHHLTLHLSESAFLLEIFA--DILSSVRYLELRDTN 207
Query: 202 LIGGLPASFSGSQIQSLWVNGQNGNAKLGGG-----IDVIQNMTSLKEIWLHSNAFSG-- 254
L + ++ S + L + +++ + L E+ +G
Sbjct: 208 LARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLG 267
Query: 255 -----PLPDFSGVKQLESLSLR-----DNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PV 303
S + ++E++++R + + LE +K + + N+ + P
Sbjct: 268 DFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPC 327
Query: 304 PEFDRSVS---LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCS 360
S LD+ S N + +
Sbjct: 328 SFSQHLKSLEFLDL---SEN-LMVEEYLKNSACKGAWP---------------------- 361
Query: 361 DWIGVTCTKGNITVINFQKMNLT--GTISPEFASFKSLQRLILADNNLSGMIPEGLSVLG 418
++ + + +L + K+L L ++ N +P+
Sbjct: 362 ----------SLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPE 410
Query: 419 ALKELDVSNNQL 430
++ L++S+ +
Sbjct: 411 KMRFLNLSSTGI 422
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-23
Identities = 49/258 (18%), Positives = 90/258 (34%), Gaps = 24/258 (9%)
Query: 51 WSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLP 109
++ ++ + + +E I R+ I L L + L K++R+ ++ + + P
Sbjct: 269 FNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCS 328
Query: 110 SLNGLASLEVVMLSNNQFTSVP---SDFFTGLSSLQSIEIDNNPFSS-WEIPQSLRNASG 165
L SLE + LS N S SLQ++ + N S + + L
Sbjct: 329 FSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKN 388
Query: 166 LQ--NFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQ 223
L + S N S P + L+L+ + Q+L V
Sbjct: 389 LTSLDISRN--TFHPMPDSCQWP---EKMRFLNLSSTGI-----RVVKTCIPQTLEVLDV 438
Query: 224 NGNAKLGGGIDVI-QNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDS 282
+ N +D + L+E+++ N LPD S L + + N
Sbjct: 439 SNN-----NLDSFSLFLPRLQELYISRNKLKT-LPDASLFPVLLVMKISRNQLKSVPDGI 492
Query: 283 LVKLESLKIVNMTNNLLQ 300
+L SL+ + + N
Sbjct: 493 FDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-22
Identities = 50/379 (13%), Positives = 126/379 (33%), Gaps = 61/379 (16%)
Query: 71 TRIQIGHQNLQGTLPSN-LQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFT 128
++IG+ + LT L LE++ S+ SL + + + L ++
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185
Query: 129 SVPSDFFTGLSSLQSIEIDNNPFSS--WEIPQSLRNASGLQNFSANSANITGQIPSFFGP 186
+ F LSS++ +E+ + + + +S ++ + + +T
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT--------D 237
Query: 187 DEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIW 246
+ F L L +L + + + + + ++LG +++ +
Sbjct: 238 ESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGK-----VETVTIRRLH 292
Query: 247 LHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE 305
+ L +S +++++ +++ ++ L+SL+ ++++ NL+
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV----- 347
Query: 306 FDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-LS---VVKLMGYPQRFAENWKGNDPCSD 361
+ P L L LS + + +
Sbjct: 348 ------------EEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL--------- 386
Query: 362 WIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALK 421
N+T ++ + N + + ++ L L+ + ++ + L+
Sbjct: 387 --------KNLTSLDISR-NTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLE 434
Query: 422 ELDVSNNQLYGKIPSFKSN 440
LDVSNN L F
Sbjct: 435 VLDVSNNNL-DSFSLFLPR 452
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-19
Identities = 52/392 (13%), Positives = 120/392 (30%), Gaps = 57/392 (14%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQ 126
+ ++I +L+ +L+++ + L L + + L + L+S+ + L +
Sbjct: 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTN 207
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSW------EIPQSLRNASGLQNFSANSANITGQI 180
++ S E+ + LR L + + G
Sbjct: 208 LARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLG 267
Query: 181 PSFFGPDEFPG---------LTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLG 230
+ + LH+ L L +S +++ + V + +
Sbjct: 268 DFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVEN-SKVFLVP 326
Query: 231 GGIDVIQNMTSLKEIWLHSNAFS----GPLPDFSGVKQLESLSLRDNFFT--GPVPDSLV 284
Q++ SL+ + L N L++L L N + L+
Sbjct: 327 CS--FSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILL 384
Query: 285 KLESLKIVNMTNNLLQGPVPEFDRSVS---LDMAKGSNNFCLPSPGACDP-RLNAL-LSV 339
L++L ++++ N L++ S+ + C P L L +S
Sbjct: 385 TLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNL---SSTG-IRVVKTCIPQTLEVLDVSN 440
Query: 340 VKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRL 399
L + + + + L T+ P+ + F L +
Sbjct: 441 NNLDSFSLFL--------------------PRLQELYISRNKLK-TL-PDASLFPVLLVM 478
Query: 400 ILADNNLSGMIPEGLSVLGALKELDVSNNQLY 431
++ N L + L +L+++ + N
Sbjct: 479 KISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 19/217 (8%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK----RMEAGVISGKGLTEFKSEIA 643
+ V + + LG G F V K E G + A K R G E + E++
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 644 VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 703
+L +V H +++ L + + +L+ E + G L F++ + E I
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFI-K 122
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRLAPEGKGSIETR 759
+ GV YLH + H DLKP NI+L K+ DFGL +G
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKN 177
Query: 760 IAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG 796
I GT ++APE + + D++S GVI L++G
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 58/223 (26%), Positives = 91/223 (40%), Gaps = 33/223 (14%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK----RMEAGVISGKGLTEFKSEIAV 644
V + + LG G F V K E G + A K R G E + E+++
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 645 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRLT--- 700
L +V H +++ L + + +L+ E + G L F++ A++ L+
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKE--------SLSEEE 116
Query: 701 ---IALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRLAPEGK 753
+ GV YLH + H DLKP NI+L K+ DFGL
Sbjct: 117 ATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IED 171
Query: 754 GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG 796
G I GT ++APE + + D++S GVI L++G
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-28
Identities = 67/211 (31%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 594 NFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLT---EFKSEIAVLTKVR 649
S+ ILG G FG V+K E G K+A K +I +G+ E K+EI+V+ ++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAK-----IIKTRGMKDKEEVKNEISVMNQLD 144
Query: 650 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
H +L+ L N+ +LV EY+ G L I +E E + L + + G+
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRI---IDESYNLTELDTILFM-KQICEGI 200
Query: 710 EYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
++H +H DLKP NIL D + K+ DFGL R GT +L
Sbjct: 201 RHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARR--YKPREKLKVNFGTPEFL 255
Query: 768 APEYAVTGR--VTTKVDVFSFGVILMELITG 796
APE V V+ D++S GVI L++G
Sbjct: 256 APE--VVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 59/215 (27%), Positives = 89/215 (41%), Gaps = 20/215 (9%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE----FKSEIAV 644
+ + F + LG G FG V+ E G + +K I+ ++EI V
Sbjct: 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIK-----TINKDRSQVPMEQIEAEIEV 73
Query: 645 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALD 704
L + H +++ + D + +V E G L I + G E +
Sbjct: 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA-ELMKQ 132
Query: 705 VARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIA 761
+ + Y H Q +H+DLKP NIL K+ DFGL L + T A
Sbjct: 133 MMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAA 187
Query: 762 GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG 796
GT Y+APE VT K D++S GV++ L+TG
Sbjct: 188 GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-28
Identities = 62/257 (24%), Positives = 99/257 (38%), Gaps = 36/257 (14%)
Query: 561 ETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTK 619
H E Q + + + + ++ + LG G +G V E + ++
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63
Query: 620 IAVK-----------RMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668
A+K + K E +EI++L + H +++ L D L
Sbjct: 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL 123
Query: 669 VFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHR 723
V E+ G L +RH F+ E I + G+ YLH + +HR
Sbjct: 124 VTEFYEGGELFEQIINRHKFD--ECDAA--------NIMKQILSGICYLH---KHNIVHR 170
Query: 724 DLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTK 780
D+KP NILL + K+ DFGL + GT Y+APE + + K
Sbjct: 171 DIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPE-VLKKKYNEK 227
Query: 781 VDVFSFGVILMELITGR 797
DV+S GVI+ L+ G
Sbjct: 228 CDVWSCGVIMYILLCGY 244
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 59/218 (27%), Positives = 91/218 (41%), Gaps = 31/218 (14%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 650
+F ILG G F TV ++ A+K +E +I + E V++++ H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 651 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR-- 707
V L D +EKL Y G L ++I + + R
Sbjct: 90 PFFVKLYFTFQD-DEKLYFGLSYAKNGELLKYI-------------RKIGSFDETCTRFY 135
Query: 708 ------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR-I 760
+EYLHG IHRDLKP NILL +DM ++ DFG ++
Sbjct: 136 TAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
Query: 761 AGTFGYLAPEYAVTGRVTTK-VDVFSFGVILMELITGR 797
GT Y++PE +T + K D+++ G I+ +L+ G
Sbjct: 193 VGTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-28
Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 28/217 (12%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE---FKSEIAVL 645
+V + + LG G FG V++ E G K I+ + K+EI+++
Sbjct: 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK-----FINTPYPLDKYTVKNEISIM 102
Query: 646 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 705
++ H L+ L D E +L+ E++ G L I A E K E ++
Sbjct: 103 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSE-----AEVINY 154
Query: 706 AR----GVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLAPEGKGSIETR 759
R G++++H S +H D+KP NI+ K+ DFGL + I
Sbjct: 155 MRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKV 209
Query: 760 IAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG 796
T + APE V D+++ GV+ L++G
Sbjct: 210 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 20/228 (8%)
Query: 572 DIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI 630
D ++LE ++S+ + ++ +G+G GTVY ++ G ++A+++M +
Sbjct: 2 DEEILEKLRSIVSV---GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQ 56
Query: 631 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL 690
+EI V+ + ++ ++V L L G+E +V EY+ G+L+ +
Sbjct: 57 QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------ 110
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750
++ + + + + +E+LH IHRD+K NILLG D K+ DFG
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFG---FCA 164
Query: 751 EGKGSIETR--IAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG 796
+ R + GT ++APE KVD++S G++ +E+I G
Sbjct: 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 61/247 (24%), Positives = 105/247 (42%), Gaps = 47/247 (19%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
+G+G F V + G ++A+K ++ ++ L + E+ ++ + H ++V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF-E 81
Query: 660 CLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVE 710
++ + L L+ EY G + ++ + R+ AR V+
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVA-----------HGRMKE--KEARSKFRQIVSAVQ 128
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
Y H + +HRDLK N+LL DM K+ADFG G G ++ G Y APE
Sbjct: 129 YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAF-CGAPPYAAPE 183
Query: 771 YAVTGRVTT--KVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI---------H 819
G+ +VDV+S GVIL L++G P + +L R+ +
Sbjct: 184 -LFQGKKYDGPEVDVWSLGVILYTLVSGS------LPFDGQNLKELRERVLRGKYRIPFY 236
Query: 820 LSKDSFH 826
+S D +
Sbjct: 237 MSTDCEN 243
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-27
Identities = 66/275 (24%), Positives = 115/275 (41%), Gaps = 54/275 (19%)
Query: 548 TVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFG 607
+ A S V S ++ S D + R ++++ ++G G FG
Sbjct: 9 SFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFG 68
Query: 608 TVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKS-EIAVLTKVRHRHLVALLGHCLDGNE 665
VY+ +L D G +A+K++ FK+ E+ ++ K+ H ++V L E
Sbjct: 69 VVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 121
Query: 666 KL------LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL------DVARGVEYLH 713
K LV +Y+P+ T+ R +++ + L + + R + Y+H
Sbjct: 122 KKDEVYLNLVLDYVPE-TVYRVARHYSRA-------KQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRA-KVADFGLVRLAPEGKGSIE---TRIAGTFGYLAP 769
HRD+KP N+LL D K+ DFG + G+ ++ +R Y AP
Sbjct: 174 SF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 225
Query: 770 E-------YAVTGRVTTKVDVFSFGVILMELITGR 797
E Y T+ +DV+S G +L EL+ G+
Sbjct: 226 ELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 60/222 (27%), Positives = 92/222 (41%), Gaps = 31/222 (13%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK----RMEAGVISGKGLTEFKSEIAV 644
NV + + LG G F V K E G + A K R G + + E+++
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 645 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT---- 700
L +++H +++ L + + +L+ E + G L + AE+ LT
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKE--------SLTEEEA 116
Query: 701 --IALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRLAPEGKG 754
+ GV YLH L H DLKP NI+L R K+ DFGL G
Sbjct: 117 TEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN- 172
Query: 755 SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG 796
I GT ++APE + + D++S GVI L++G
Sbjct: 173 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 35/216 (16%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
T + LG+G F V + ++ G + A + +S + + + E + +
Sbjct: 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTIAL 703
+H ++V L + L+F+ + G L +R ++ A+ A
Sbjct: 68 KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD--------------AS 113
Query: 704 DVAR----GVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSI 756
+ V + H +HR+LKP N+LL K+ADFGL + +
Sbjct: 114 HCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170
Query: 757 ETRIAGTFGYLAPEYAVTGRV--TTKVDVFSFGVIL 790
AGT GYL+PE V + VD+++ GVIL
Sbjct: 171 FG-FAGTPGYLSPE--VLRKDPYGKPVDLWACGVIL 203
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 54/206 (26%), Positives = 77/206 (37%), Gaps = 35/206 (16%)
Query: 598 ENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVA 655
+ LG G F K AVK +IS + + EI L H ++V
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVK-----IISKRMEANTQKEITALKLCEGHPNIVK 70
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVARGV 709
L D LV E + G L I + + I + V
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKK-----------KKHFSETEASYIMRKLVSAV 119
Query: 710 EYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY 766
++H +HRDLKP N+L D++ K+ DFG RL P ++T T Y
Sbjct: 120 SHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHY 175
Query: 767 LAPEYAVTGRVT--TKVDVFSFGVIL 790
APE + + D++S GVIL
Sbjct: 176 AAPE--LLNQNGYDESCDLWSLGVIL 199
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 17/219 (7%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
+++ + ++G G V K+A+KR+ + E EI +++
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMSQC 70
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLS---RHIFNWAEEGLKPLEWNRRLTIALDV 705
H ++V+ + +E LV + + G++ +HI E L+ + TI +V
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPEGKGSIETRIA 761
G+EYLH IHRD+K NILLG+D ++ADFG L + +
Sbjct: 131 LEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 762 GTFGYLAPEYAVTGRVT---TKVDVFSFGVILMELITGR 797
GT ++APE V +V K D++SFG+ +EL TG
Sbjct: 188 GTPCWMAPE--VMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 72/301 (23%), Positives = 114/301 (37%), Gaps = 63/301 (20%)
Query: 585 IQVLRNVTNNFSEE----NILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFK 639
+Q L + F++ +G G + + + AVK +I K +
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK-----IID-KSKRDPT 63
Query: 640 SEIAVLTK-VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRR 698
EI +L + +H +++ L DG +V E M G L I +
Sbjct: 64 EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR-----------QKF 112
Query: 699 LT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRL 748
+ + + + VEYLH Q +HRDLKPSNIL G+ ++ DFG +
Sbjct: 113 FSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169
Query: 749 APEGKGSIETRIAGTFGYLAPEYAVTGRV--TTKVDVFSFGVILMELITG----RKALDE 802
G + T T ++APE V R D++S GV+L ++TG D+
Sbjct: 170 LRAENGLLMT-PCYTANFVAPE--VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD 226
Query: 803 SQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVA-ELAGHCCAREPYQR 861
+ E RI K L+ G S+S A +L +P+QR
Sbjct: 227 TPEEI-------LARIGSGK----------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQR 269
Query: 862 P 862
Sbjct: 270 L 270
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 20/220 (9%)
Query: 585 IQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIA 643
++ + + LG G FG VYK G A K +E S + L ++ EI
Sbjct: 11 VRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIE 68
Query: 644 VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 703
+L H ++V LLG + ++ E+ P G + E + L + +
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVD----AIMLELDRGLTEPQIQVVCR 124
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IA 761
+ + +LH + IHRDLK N+L+ + ++ADFG ++ + +++ R
Sbjct: 125 QMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFG---VSAKNLKTLQKRDSFI 178
Query: 762 GTFGYLAPEYAVTGRVT-----TKVDVFSFGVILMELITG 796
GT ++APE + + K D++S G+ L+E+
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 66/270 (24%), Positives = 100/270 (37%), Gaps = 44/270 (16%)
Query: 533 HPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVT 592
H H S + S SV A + T I ++
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDA----------LS 52
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRH 650
+ F E+ LGRG VY+ + A+K V+ + ++EI VL ++ H
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALK-----VLKKTVDKKIVRTEIGVLLRLSH 107
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRLT------IAL 703
+++ L E LV E + G L F+ E+G +
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKG--------YYSERDAADAVK 155
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRI 760
+ V YLH +HRDLKP N+L D K+ADFGL ++ + +
Sbjct: 156 QILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTV 210
Query: 761 AGTFGYLAPEYAVTGRVTTKVDVFSFGVIL 790
GT GY APE +VD++S G+I
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-27
Identities = 60/374 (16%), Positives = 117/374 (31%), Gaps = 86/374 (22%)
Query: 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQF 127
+ +G ++ + LE LEL N +S + N L +L + L +N+
Sbjct: 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPS--FFG 185
+P FTGLS+L ++I N ++ L++ ++ I F G
Sbjct: 93 KLIPLGVFTGLSNLTKLDISENKIVILL-DYMFQDLYNLKSLEVGDNDLV-YISHRAFSG 150
Query: 186 PDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEI 245
L L L L + I + + + ++ L +
Sbjct: 151 ---LNSLEQLTLEKCNL----------TSIPT----------------EALSHLHGLIVL 181
Query: 246 WLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPV 303
L + + D F + +L+ L + + + + + +L +++T+ L V
Sbjct: 182 RLRHLNINA-IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-V 239
Query: 304 PE--FDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDP 358
P V L ++ N E
Sbjct: 240 PYLAVRHLVYLRFLNL--SYNPISTIEGSM--------------------LHEL------ 271
Query: 359 CSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGL-SV 416
+ I L + P F L+ L ++ N L+ + E +
Sbjct: 272 -----------LRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHS 318
Query: 417 LGALKELDVSNNQL 430
+G L+ L + +N L
Sbjct: 319 VGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 41/223 (18%), Positives = 87/223 (39%), Gaps = 17/223 (7%)
Query: 85 PSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQS 143
Q+L L+ LE+ N + + +GL SLE + L TS+P++ + L L
Sbjct: 121 DYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIV 180
Query: 144 IEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPG--LTILHLAFNQ 201
+ + + ++ S + L+ + + P+ G LT L +
Sbjct: 181 LRLRHLNINAIR-DYSFKRLYRLKVLEISHWPYLDTMT----PNCLYGLNLTSLSITHCN 235
Query: 202 LIGGLPA-SFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD- 258
+ +P + ++ L ++ N + + G + + + L+EI L + +
Sbjct: 236 -LTAVPYLAVRHLVYLRFLNLSY-NPISTIEGSM--LHELLRLQEIQLVGGQLAV-VEPY 290
Query: 259 -FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ 300
F G+ L L++ N T + +L+ + + +N L
Sbjct: 291 AFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-19
Identities = 63/373 (16%), Positives = 117/373 (31%), Gaps = 101/373 (27%)
Query: 64 CIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVML 122
C + + + +P + T+ L+L N I LE + L
Sbjct: 7 CECSAQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELEL 63
Query: 123 SNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPS 182
+ N ++V F L +L+++ + +N IP + +GL N
Sbjct: 64 NENIVSAVEPGAFNNLFNLRTLGLRSNRLKL--IPLGVF--TGLSN-------------- 105
Query: 183 FFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSL 242
LT L ++ N++ + + Q++ +L
Sbjct: 106 ---------LTKLDISENKI----------VILLD----------------YMFQDLYNL 130
Query: 243 KEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ 300
K + + N + FSG+ LE L+L T ++L L L ++ + + +
Sbjct: 131 KSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN 189
Query: 301 G-PVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPC 359
F R L + + S+ L + P L++ L
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTM---TPNCLYGLNLTSL----------------- 229
Query: 360 SDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEG-LSVL 417
+ NLT + L+ L L+ N +S I L L
Sbjct: 230 ----------------SITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHEL 271
Query: 418 GALKELDVSNNQL 430
L+E+ + QL
Sbjct: 272 LRLQEIQLVGGQL 284
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-15
Identities = 66/343 (19%), Positives = 106/343 (30%), Gaps = 80/343 (23%)
Query: 119 VVMLSNNQFTSVPSDF---------------------FTGLSSLQSIEIDNNPFSSWEIP 157
V+ +F +VP F L+ +E++ N S+ E P
Sbjct: 15 AVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVE-P 73
Query: 158 QSLRNASGLQNFSANSANITGQIPSFFGPDEFPG---LTILHLAFNQLIGGLPASFSG-S 213
+ N L+ S + IP F G LT L ++ N+++ L F
Sbjct: 74 GAFNNLFNLRTLGLRSNRLK-LIP----LGVFTGLSNLTKLDISENKIVILLDYMFQDLY 128
Query: 214 QIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRD 272
++SL V N + + SL+++ L + P S + L L LR
Sbjct: 129 NLKSLEVGD-NDLVYISHR--AFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRH 185
Query: 273 NFFTGPVPDSLVKLESLKIVNMT-NNLLQGPVPEFDRSVSL-DMAKGSNNFCLPSPGACD 330
S +L LK++ ++ L P ++L ++ N A
Sbjct: 186 LNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVR 245
Query: 331 --PRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTIS 387
L L LS N I+ I
Sbjct: 246 HLVYLRFLNLS----------------YN--------------PISTIE------GSM-- 267
Query: 388 PEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
LQ + L L+ + P L L+ L+VS NQL
Sbjct: 268 --LHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQL 308
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-13
Identities = 31/181 (17%), Positives = 63/181 (34%), Gaps = 35/181 (19%)
Query: 77 HQNLQGTLPSN-LQNLTKLERLELQ-WNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDF 134
+ + L +L+ LE+ W + P+ +L + +++ T+VP
Sbjct: 184 RHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLA 243
Query: 135 FTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPS--FFGPDEFPGL 192
L L+ + + NP S+ E L LQ + + F G L
Sbjct: 244 VRHLVYLRFLNLSYNPISTIE-GSMLHELLRLQEIQLVGGQLA-VVEPYAFRG---LNYL 298
Query: 193 TILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAF 252
+L+++ NQL + ++ V ++ +L+ + L SN
Sbjct: 299 RVLNVSGNQL----------TTLEE----------------SVFHSVGNLETLILDSNPL 332
Query: 253 S 253
+
Sbjct: 333 A 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 18/86 (20%), Positives = 42/86 (48%), Gaps = 1/86 (1%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQ 126
+ + + + + S L L +L+ ++L ++ + GL L V+ +S NQ
Sbjct: 248 VYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQ 307
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFS 152
T++ F + +L+++ +D+NP +
Sbjct: 308 LTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 8e-07
Identities = 38/203 (18%), Positives = 74/203 (36%), Gaps = 22/203 (10%)
Query: 240 TSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 298
T + + L N +F+ LE L L +N + P + L +L+ + + +N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 299 LQG-PVPEFDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 354
L+ P+ F +L D++ N + L ++ L +N
Sbjct: 92 LKLIPLGVFTGLSNLTKLDIS--ENKIVILLDYM----FQDLYNLKSL-----EVGDNDL 140
Query: 355 GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEG 413
+ G+ ++ + +K NLT +I E + L L L N++ +
Sbjct: 141 VYISHRAFSGLN----SLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYS 195
Query: 414 LSVLGALKELDVSNNQLYGKIPS 436
L LK L++S+ +
Sbjct: 196 FKRLYRLKVLEISHWPYLDTMTP 218
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 40/267 (14%), Positives = 80/267 (29%), Gaps = 58/267 (21%)
Query: 601 LGRGGFGTVYKGELHD---GTKIAVKRMEA-GVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
G ++ D ++A+ ++ GV+ L E S L+++ + +
Sbjct: 39 HGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
L L+V E++ G+L + P+ + +A + A
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPV---GAIRAMQSLAAAADA----A 145
Query: 717 HQS-FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG 775
H++ PS + + D +A +
Sbjct: 146 HRAGVALSIDHPSRVRVSIDGDVVLAY---------------------PATMPD------ 178
Query: 776 RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDL 835
+ D+ G L L+ R L E+ + +D+ + I+P D+
Sbjct: 179 -ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--------RDTAGQPIEPA-DI 228
Query: 836 NEGILASISTVAELAGHCCAREPYQRP 862
+ I IS VA + R
Sbjct: 229 DRDIPFQISAVAA---RSVQGDGGIRS 252
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 50/202 (24%), Positives = 81/202 (40%), Gaps = 20/202 (9%)
Query: 600 ILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE---FKSEIAVLTKVRHRHLVA 655
++G+G F V + G + AVK ++ + K E ++ ++H H+V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL--DVARGVEYLH 713
LL +VFE+M L I + ++ + + + Y H
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEI---VKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 714 GLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+ IHRD+KP +LL + K+ FG+ E G + GT ++APE
Sbjct: 148 ---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES-GLVAGGRVGTPHFMAPE 203
Query: 771 YAVTGRVT--TKVDVFSFGVIL 790
V R VDV+ GVIL
Sbjct: 204 --VVKREPYGKPVDVWGCGVIL 223
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-26
Identities = 59/280 (21%), Positives = 103/280 (36%), Gaps = 19/280 (6%)
Query: 522 SRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNM 581
QS P + + + + T + +
Sbjct: 87 KHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQ 146
Query: 582 VISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS 640
+ I+ +V +++ LG G FG V++ E G A K + +
Sbjct: 147 PVEIKH-DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM--TPHESDKETVRK 203
Query: 641 EIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT 700
EI ++ +RH LV L D NE ++++E+M G L + E + +
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHN----KMSEDEA 257
Query: 701 IAL--DVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLAPEGKGSI 756
+ V +G+ ++H +++H DLKP NI+ K+ DFGL +
Sbjct: 258 VEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--S 312
Query: 757 ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG 796
GT + APE A V D++S GV+ L++G
Sbjct: 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 61/239 (25%), Positives = 92/239 (38%), Gaps = 58/239 (24%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFK----SEIA 643
R + F E + G+G FGTV G E G +A+K+ VI F+ +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK----VIQDP---RFRNRELQIMQ 71
Query: 644 VLTKVRHRHLVALLGHCL------DGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEW 695
L + H ++V L D + +V EY+P TL R N+
Sbjct: 72 DLAVLHHPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR------- 122
Query: 696 NRRLTIAL------DVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRL 748
L + R + LH + HRD+KP N+L+ D K+ DFG +
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181
Query: 749 APEGKGSIE---TRIAGTFGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 797
+ ++ +R Y APE Y TT VD++S G I E++ G
Sbjct: 182 LSPSEPNVAYICSRY-----YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 61/215 (28%), Positives = 88/215 (40%), Gaps = 18/215 (8%)
Query: 590 NVTNNFS-EENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
N N + LGRG F V + G + A K ++ E EIAVL
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84
Query: 648 VRHR-HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL--D 704
+ ++ L + +E +L+ EY G + E + + + I L
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC---LPELAEMV--SENDVIRLIKQ 139
Query: 705 VARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIA 761
+ GV YLH + +H DLKP NILL K+ DFG+ R G I
Sbjct: 140 ILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACELREIM 194
Query: 762 GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG 796
GT YLAPE +TT D+++ G+I L+T
Sbjct: 195 GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 43/234 (18%), Positives = 92/234 (39%), Gaps = 19/234 (8%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQ 126
R ++ +L+ L S Q+ ++ L+L N +S L LE++ LS+N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGP 186
LS+L++++++NN + S+ L + + N NI+ ++
Sbjct: 70 LYETLD--LESLSTLRTLDLNNNYVQELLVGPSIET---L-HAANN--NIS-RVS----C 116
Query: 187 DEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEI 245
G ++LA N++ S++Q L + N + ++ + +L+ +
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL-NEIDTVNFA-ELAASSDTLEHL 174
Query: 246 WLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 299
L N + +L++L L N + + +++ NN L
Sbjct: 175 NLQYNFIYD-VKGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL 226
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 46/255 (18%), Positives = 79/255 (30%), Gaps = 41/255 (16%)
Query: 86 SNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSI 144
L +E L N+IS G ++ L+NN+ T + S +Q +
Sbjct: 93 QELLVGPSIETLHAANNNISRVSCSRGQGKKNIY---LANNKITMLRDLDEGCRSRVQYL 149
Query: 145 EIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIG 204
++ N + + ++ L++ + I + F L L L+ N+L
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV---FAKLKTLDLSSNKLA- 204
Query: 205 GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVK 263
+ F + + I L +N + +
Sbjct: 205 FMGPEFQ--------------------------SAAGVTWISLRNNKLVL-IEKALRFSQ 237
Query: 264 QLESLSLRDN-FFTGPVPDSLVKLESLK-IVNMTNNLLQGPVPEFDRSVSLDMAKGSNNF 321
LE LR N F G + D K + ++ + T L G E +L
Sbjct: 238 NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLG--HYGAYC 295
Query: 322 CLPSPGACDPRLNAL 336
C P RL AL
Sbjct: 296 CEDLPAPFADRLIAL 310
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 37/245 (15%), Positives = 83/245 (33%), Gaps = 36/245 (14%)
Query: 192 LTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250
I + + L L + ++ L ++G N +++ + T L+ + L SN
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSG-NPLSQISAA--DLAPFTKLELLNLSSN 68
Query: 251 AFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRS 309
D + L +L L +N+ L+ S++ ++ NN +
Sbjct: 69 VLYE-TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQGK 122
Query: 310 VSLDMAKGSNNFCLPSPGACD--PRLNAL-LSVVKLMGYPQR-FAENWKGNDPCSDWIGV 365
++ +A +N + R+ L L + ++ A +
Sbjct: 123 KNIYLA--NNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD----------- 169
Query: 366 TCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDV 425
+ +N Q + + + F L+ L L+ N L+ + + + +
Sbjct: 170 -----TLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221
Query: 426 SNNQL 430
NN+L
Sbjct: 222 RNNKL 226
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 25/198 (12%), Positives = 63/198 (31%), Gaps = 46/198 (23%)
Query: 234 DVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 292
++ QN K + ++ L ++ L L N + L L+++
Sbjct: 4 EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63
Query: 293 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 352
N+++N+L + + +L +NN + LL +
Sbjct: 64 NLSSNVLYE-TLDLESLSTLRTLDLNNN-----------YVQELLVGPSI---------- 101
Query: 353 WKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE 412
++ N++ +S + + + LA+N ++ +
Sbjct: 102 --------------------ETLHAANNNIS-RVSCS--RGQGKKNIYLANNKITMLRDL 138
Query: 413 GLSVLGALKELDVSNNQL 430
++ LD+ N++
Sbjct: 139 DEGCRSRVQYLDLKLNEI 156
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 14/67 (20%), Positives = 29/67 (43%), Gaps = 1/67 (1%)
Query: 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
+ +L ++ S +++ L L+ N LS + L+ L+ L++S+N L
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 431 YGKIPSF 437
Y +
Sbjct: 71 Y-ETLDL 76
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 13/80 (16%), Positives = 28/80 (35%), Gaps = 1/80 (1%)
Query: 83 TLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVP-SDFFTGLSSL 141
+ Q+ + + L+ N + +L +LE L N F DFF+ +
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264
Query: 142 QSIEIDNNPFSSWEIPQSLR 161
Q++ + + +
Sbjct: 265 QTVAKQTVKKLTGQNEEECT 284
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 57/238 (23%), Positives = 92/238 (38%), Gaps = 43/238 (18%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFK--SEIAVLTKVRHRHLVALL 657
LG G +G V + + AVK ++ + E EI +L ++RH++++ L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 658 GHCLDGNEKL---LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR------- 707
L EK +V EY G + + E R + A
Sbjct: 73 -DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK--------RFPV--CQAHGYFCQLI 119
Query: 708 -GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK--GSIETRIAGTF 764
G+EYLH Q +H+D+KP N+LL K++ G+ + T G+
Sbjct: 120 DGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSP 175
Query: 765 GYLAPEYAVTGRVT---TKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH 819
+ PE G T KVD++S GV L + TG + ++ F I
Sbjct: 176 AFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD------NIYKLFENIG 226
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 28/214 (13%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 650
++F + + LG G G V+K H + +A K + + + E+ VL +
Sbjct: 33 DDFEKISELGAGNGGVVFKV-SHKPSGLVMARKLIHLEIKPAI-RNQIIRELQVLHECNS 90
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLS---RHIFNWAEEGLKPLEWNRRLTIALDVAR 707
++V G E + E+M G+L + E+ L +++ V +
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG--------KVSIAVIK 142
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPEGKGSIETRIAGT 763
G+ YL +HRD+KPSNIL+ K+ DFG L+ S+ GT
Sbjct: 143 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-------SMANSFVGT 193
Query: 764 FGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 797
Y++PE + + D++S G+ L+E+ GR
Sbjct: 194 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 53/209 (25%), Positives = 102/209 (48%), Gaps = 12/209 (5%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
+ F++ +G+G FG V+KG + +A+K ++ + + + + EI VL++
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQ 76
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
++ G L + ++ EY+ G+ + PL+ + TI ++ +
Sbjct: 77 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP------GPLDETQIATILREILK 130
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
G++YLH + IHRD+K +N+LL + K+ADFG+ + + T + GT ++
Sbjct: 131 GLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWM 186
Query: 768 APEYAVTGRVTTKVDVFSFGVILMELITG 796
APE +K D++S G+ +EL G
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARG 215
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 13/214 (6%)
Query: 584 SIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEI 642
+ + F LG G +G+VYK G +A+K++ L E EI
Sbjct: 20 EDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEI 75
Query: 643 AVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIA 702
+++ + H+V G + +V EY G++S I K L + TI
Sbjct: 76 SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII----RLRNKTLTEDEIATIL 131
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG 762
+G+EYLH IHRD+K NILL + AK+ADFG+ + T I G
Sbjct: 132 QSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-G 187
Query: 763 TFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG 796
T ++APE D++S G+ +E+ G
Sbjct: 188 TPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-26
Identities = 79/398 (19%), Positives = 135/398 (33%), Gaps = 42/398 (10%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS---LNGLASLEVVMLSN 124
+ + +G + P Q L L L L + +S + L +L + LS
Sbjct: 73 PNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSK 132
Query: 125 NQFTSVP-SDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASG--LQNFSANSANITGQIP 181
NQ S+ F L+SL+SI+ +N L G L FS + ++ ++
Sbjct: 133 NQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVC-EHELEPLQGKTLSFFSLAANSLYSRVS 191
Query: 182 SFF----GPDEFPGLTILHLAFNQLIGGLPASF----SGSQIQSLWVNGQNGNAKLGG-G 232
+ P L IL ++ N + +F S SQ SL + A G
Sbjct: 192 VDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251
Query: 233 IDVIQNMT-------SLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLV 284
I T S++ + L F +K L+ L+L N ++
Sbjct: 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFY 311
Query: 285 KLESLKIVNMTNNLLQGPVPEFDRSVS----LDMAKGSNNFCLPSPGACD--PRLNAL-L 337
L++L+++N++ NLL + +D+ N+ + +L L L
Sbjct: 312 GLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQ--KNHIAIIQDQTFKFLEKLQTLDL 369
Query: 338 SV---VKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTG-TISPEFASF 393
+ P GN + +I+ + L I
Sbjct: 370 RDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTA----NLIHLSENRLENLDILYFLLRV 425
Query: 394 KSLQRLILADNNLSGMIPEGL-SVLGALKELDVSNNQL 430
LQ LIL N S + S +L++L + N L
Sbjct: 426 PHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENML 463
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 5e-25
Identities = 59/369 (15%), Positives = 115/369 (31%), Gaps = 76/369 (20%)
Query: 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP--SLNGLASLEVVMLSNNQF 127
R+ + ++ S+ L +L+ LEL + + L +L ++ L +++
Sbjct: 26 TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI 85
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187
+ D F GL L + + S + +F
Sbjct: 86 YFLHPDAFQGLFHLFELRLYFCGLSDAVLK-----------------------DGYFRN- 121
Query: 188 EFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWL 247
LT L L+ N QI+SL+++ + SLK I
Sbjct: 122 -LKALTRLDLSKN-------------QIRSLYLHP------------SFGKLNSLKSIDF 155
Query: 248 HSNAFSG-PLPDFSGVKQ--LESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP 304
SN + ++ L SL N SL S+ N
Sbjct: 156 SSNQIFLVCEHELEPLQGKTLSFFSLAAN--------SLYSRVSVDWGKCMNPF------ 201
Query: 305 EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND--PCSDW 362
R++ L++ S N + L+ + ++
Sbjct: 202 ---RNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQN 258
Query: 363 IGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALK 421
+ ++ ++ + +++ F + K L+ L LA N ++ + E L L+
Sbjct: 259 TFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQ 317
Query: 422 ELDVSNNQL 430
L++S N L
Sbjct: 318 VLNLSYNLL 326
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-24
Identities = 63/395 (15%), Positives = 130/395 (32%), Gaps = 57/395 (14%)
Query: 68 KRITRIQIGHQNLQG-TLPSNLQNLTKLERLELQWNSISG-PLPSLNGLA--SLEVVMLS 123
K +TR+ + ++ L + L L+ ++ N I L L +L L+
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182
Query: 124 NNQFTSVPSDFFTGLS------SLQSIEIDNNPFS-----------SWEIPQSLRNASGL 166
N S S + L+ +++ N ++ S SL A +
Sbjct: 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI 242
Query: 167 QNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNG 225
NI + F + L L+ + F ++ L + N
Sbjct: 243 MGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAY-NK 301
Query: 226 NAKLGGGIDVIQNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLV 284
K+ + +L+ + L N +F G+ ++ + L+ N +
Sbjct: 302 INKIADEA--FYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFK 359
Query: 285 KLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNF-CLPSPGACDPRLNALLSVVKLM 343
LE L+ +++ +N L + + + N LP + N +
Sbjct: 360 FLEKLQTLDLRDNALTT-IHFIPSIPDIFL--SGNKLVTLPK---INLTANLI------- 406
Query: 344 GYPQRFAENW-KGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE--FASFKSLQRLI 400
+EN + D + V ++ ++ + + + S + + SL++L
Sbjct: 407 ----HLSENRLENLDILYFLLRVP----HLQILILNQNRFS-SCSGDQTPSENPSLEQLF 457
Query: 401 LADNNLSGMIPEGLSV-----LGALKELDVSNNQL 430
L +N L L L L+ L +++N L
Sbjct: 458 LGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL 492
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 1e-21
Identities = 54/293 (18%), Positives = 113/293 (38%), Gaps = 28/293 (9%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQ 126
K + + + + + L L+ L L +N + + GL + + L N
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQN---------FSANSANIT 177
+ F L LQ++++ +N ++ S+ + N +AN +++
Sbjct: 350 IAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLS 409
Query: 178 G----QIPSFFGPDEFPGLTILHLAFNQLIGGLP-ASFSG-SQIQSLWVNGQNGNAKLGG 231
+ + P L IL L N+ + S ++ L++
Sbjct: 410 ENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWET 469
Query: 232 GI--DVIQNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLES 288
+ DV + ++ L+ ++L+ N + P FS + L LSL N T + L +
Sbjct: 470 ELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PAN 527
Query: 289 LKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVK 341
L+I++++ N L P P+ VSL + ++N C+ L+ ++ +
Sbjct: 528 LEILDISRNQLLAPNPDV--FVSLSVLDITHN-----KFICECELSTFINWLN 573
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 7e-19
Identities = 66/394 (16%), Positives = 119/394 (30%), Gaps = 87/394 (22%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTK--LERLELQWNSISGPLPS-LNGLASLEVVMLSN 124
I G N++ + L + + L+L + L L+V+ L+
Sbjct: 240 HHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAY 299
Query: 125 NQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQ-SLRNASGLQNFSANSANITGQIPSF 183
N+ + + F GL +LQ + + N E+ + + +I
Sbjct: 300 NKINKIADEAFYGLDNLQVLNLSYNLLG--ELYSSNFYGLPKVAYIDLQKNHIAIIQDQT 357
Query: 184 FGPDEFPGLTILHLAFNQL--IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMT- 240
F L L L N L I +P I ++++G + + +
Sbjct: 358 FKF--LEKLQTLDLRDNALTTIHFIP------SIPDIFLSGNK--------LVTLPKINL 401
Query: 241 SLKEIWLHSNAFSG--PLPDFSGVKQLESLSLRDNFFTG-PVPDSLVKLESLKIVNMTNN 297
+ I L N L V L+ L L N F+ + + SL+ + +
Sbjct: 402 TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGE- 460
Query: 298 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 357
N L + LS
Sbjct: 461 ---------------------NMLQLAWETELCWDVFEGLS------------------- 480
Query: 358 PCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSV 416
++ V+ L ++ P F+ +L+ L L N L+ + L
Sbjct: 481 -------------HLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLTVLSHNDL-- 524
Query: 417 LGALKELDVSNNQLYGKIPS-FKSNAIVNTDGNP 449
L+ LD+S NQL P F S ++++ N
Sbjct: 525 PANLEILDISRNQLLAPNPDVFVSLSVLDITHNK 558
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 6e-13
Identities = 46/264 (17%), Positives = 89/264 (33%), Gaps = 24/264 (9%)
Query: 186 PDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKE 244
P L L+FN + +SF Q+Q L + Q + + +N+ +L+
Sbjct: 20 PQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK--EAFRNLPNLRI 77
Query: 245 IWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPV--PDSLVKLESLKIVNMTNNLLQ- 300
+ L S+ PD F G+ L L L + V L++L ++++ N ++
Sbjct: 78 LDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRS 137
Query: 301 -GPVPEFDRSVSL---DMAKGSNNFCLPSPGACD----PRLNAL-LSVVKLMGYPQRFAE 351
P F + SL D SN L + L+ L+ L
Sbjct: 138 LYLHPSFGKLNSLKSIDF--SSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWG 195
Query: 352 NWKGNDPCSDWIGVTCTKGNITVI---NFQKMNLTGTISPEFASFKSLQRLILADNNLSG 408
+ + TV NF ++ + + + +N+
Sbjct: 196 KCMNPFRNMVLEILDVSGNGWTVDITGNFSN-AISKSQAFSLILAHHIMGAGFGFHNIKD 254
Query: 409 MIPEGLSVLG--ALKELDVSNNQL 430
+ L +++ LD+S+ +
Sbjct: 255 PDQNTFAGLARSSVRHLDLSHGFV 278
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-26
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKV-- 648
N+FS I+GRGGFG VY D K+ A+K ++ + +G T +E +L+ V
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 649 -RHRHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 706
+V + + +KL + + M G L H+ G+ E + R A ++
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQ---HGVFS-EADMRFYAA-EII 302
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY 766
G+E++H ++RDLKP+NILL + +++D GL + K GT GY
Sbjct: 303 LGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--AS-VGTHGY 356
Query: 767 LAPEYAVTGRVTTK-VDVFSFGVILMELITGR 797
+APE G D FS G +L +L+ G
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-26
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 34/218 (15%)
Query: 601 LGRGGFGTVYKG---ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+GRG +G VYK + D A+K++E IS EIA+L +++H ++++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----REIALLRELKHPNVISLQ 84
Query: 658 GHCLDGNEKL--LVFEYMPQ---GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
L ++ L+F+Y + H + A + L ++ + G+ YL
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRA----KVADFGLVRL--APEGKGSIETRIAGTFGY 766
H +HRDLKP+NIL+ + K+AD G RL +P + + TF Y
Sbjct: 145 H---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201
Query: 767 LAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 797
APE Y T +D+++ G I EL+T
Sbjct: 202 RAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 75/246 (30%), Positives = 107/246 (43%), Gaps = 48/246 (19%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 658
LG G FG V GE G K+AVK + I + K EI L RH H++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY- 77
Query: 659 HCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GV 709
+ +V EY+ G L +I + R+ AR V
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICK-----------HGRVEE--MEARRLFQQILSAV 124
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
+Y H +HRDLKP N+LL M AK+ADFGL + +G + T G+ Y AP
Sbjct: 125 DYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS-CGSPNYAAP 179
Query: 770 EYAVTGR--VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI--------- 818
E ++GR +VD++S GVIL L+ G D+ H+ T F++I
Sbjct: 180 E-VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE------HVPTLFKKIRGGVFYIPE 232
Query: 819 HLSKDS 824
+L++
Sbjct: 233 YLNRSV 238
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 41/225 (18%)
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVK--RMEA---GVISGKGLTEFKSEIAVLT 646
+ + +G G +GTV+K +A+K R++ GV S + + EI +L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS----SALR-EICLLK 56
Query: 647 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 706
+++H+++V L + LVFE+ Q L ++ + L+ + +
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF----DSCNGDLDPEIVKSFLFQLL 111
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRI----AG 762
+G+ + H ++ +HRDLKP N+L+ + K+A+FGL R I R
Sbjct: 112 KGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAF-----GIPVRCYSAEVV 163
Query: 763 TFGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGRKAL 800
T Y P+ Y +T +D++S G I EL + L
Sbjct: 164 TLWYRPPDVLFGAKLY------STSIDMWSAGCIFAELANAGRPL 202
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-26
Identities = 52/385 (13%), Positives = 119/385 (30%), Gaps = 68/385 (17%)
Query: 73 IQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVP 131
+ I Q L + + + +++ P L+ +E++ L++ Q +
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 85
Query: 132 SDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPG 191
+ F ++Q + + N P +N L +++ +P F
Sbjct: 86 TYAFAYAHTIQKLYMGFNAIRYLP-PHVFQNVPLLTVLVLERNDLS-SLP----RGIFHN 139
Query: 192 LT---ILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLH 248
L ++ N L +I+ D Q TSL+ + L
Sbjct: 140 TPKLTTLSMSNNNL----------ERIED----------------DTFQATTSLQNLQLS 173
Query: 249 SNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFD 307
SN + + S + L ++ N + +L +++ ++ ++N + P
Sbjct: 174 SNRLTH-VD-LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNV 226
Query: 308 RSVSLDMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGVT 366
L + NN + P L + LS +L +
Sbjct: 227 ELTILKLQ--HNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ------------ 272
Query: 367 CTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVS 426
+ + L ++ +L+ L L+ N+L + L+ L +
Sbjct: 273 ----RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLD 326
Query: 427 NNQLYGKIP--SFKSNAIVNTDGNP 449
+N + + + + + N
Sbjct: 327 HNSI-VTLKLSTHHTLKNLTLSHND 350
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-24
Identities = 46/280 (16%), Positives = 97/280 (34%), Gaps = 40/280 (14%)
Query: 83 TLPSN-LQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSS 140
LP + QN+ L L L+ N +S P + L + +SNN + D F +S
Sbjct: 107 YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS 166
Query: 141 LQSIEIDNNPFSSWEIP-----------------QSLRNASGLQNFSANSANITGQIPSF 183
LQ++++ +N + + +L ++ A+ +I +
Sbjct: 167 LQNLQLSSNRLTH--VDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVR-- 221
Query: 184 FGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLK 243
LTIL L N L + + + + N K+ M L+
Sbjct: 222 --GPVNVELTILKLQHNNLT-DTAWLLNYPGLVEVDL-SYNELEKIMYHP--FVKMQRLE 275
Query: 244 EIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-P 302
+++ +N + L+ L L N V + + + L+ + + +N +
Sbjct: 276 RLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLK 334
Query: 303 VPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKL 342
+ +L ++ N++ C+ +V +
Sbjct: 335 LSTHHTLKNLTLS--HNDW------DCNSLRALFRNVARP 366
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-21
Identities = 57/358 (15%), Positives = 112/358 (31%), Gaps = 87/358 (24%)
Query: 77 HQNLQGTLPSN-LQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDF 134
+ + + +++L + +N+I P + L V++L N +S+P
Sbjct: 77 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGI 136
Query: 135 FTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTI 194
F L ++ + NN E + + + LQN +S +T + P L
Sbjct: 137 FHNTPKLTTLSMSNNNLERIE-DDTFQATTSLQNLQLSSNRLT-HVD----LSLIPSLFH 190
Query: 195 LHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG 254
++++N + + +++E+ N+ +
Sbjct: 191 ANVSYNL-------------------------------LSTLAIPIAVEELDASHNSINV 219
Query: 255 -PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSL 312
P +L L L+ N T L+ L V+++ N L+ F + L
Sbjct: 220 VRGPVNV---ELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL 274
Query: 313 DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNI 372
+ SNN RL AL +
Sbjct: 275 ERLYISNN-----------RLVAL---------NLYGQPI-----------------PTL 297
Query: 373 TVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
V++ +L + F L+ L L N++ + LK L +S+N
Sbjct: 298 KVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 61/355 (17%), Positives = 107/355 (30%), Gaps = 89/355 (25%)
Query: 83 TLPSNLQNLTKLERLEL--QWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSS 140
+ SNLQ + + Q + + L + ++V N+ +P+
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDIT-LNNQKIVTFKNSTMRKLPAALLDSFRQ 70
Query: 141 LQSIEIDNNPFSSWEIPQ-SLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAF 199
++ + +++ EI + A +Q I P F P LT+L L
Sbjct: 71 VELLNLNDLQIE--EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF--QNVPLLTVLVLER 126
Query: 200 NQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD- 258
N L S + + N L + + +N + D
Sbjct: 127 NDL----------SSLPR----------------GIFHNTPKLTTLSMSNNNLER-IEDD 159
Query: 259 -FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSLDMAK 316
F L++L L N T V SL + SL N++ NLL +P +
Sbjct: 160 TFQATTSLQNLQLSSNRLTH-VDLSL--IPSLFHANVSYNLLSTLAIPIAVEELDAS--- 213
Query: 317 GSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVI 375
N+ + L L L N N+T
Sbjct: 214 -HNSINVVRGPVN-VELTILKLQ----------------HN--------------NLTDT 241
Query: 376 NFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
++ L + L+ N L ++ + L+ L +SNN+L
Sbjct: 242 ------------AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL 284
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-15
Identities = 63/349 (18%), Positives = 116/349 (33%), Gaps = 64/349 (18%)
Query: 98 ELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIP 157
+ ++ I L + + M + + + L++ + + N+ +P
Sbjct: 7 QPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFE---DITLNNQKIVTFKNSTMRK--LP 61
Query: 158 QS-LRNASGLQNFSANSANITGQIPSFFGPDEFPG---LTILHLAFNQLIGGLPASFSG- 212
+ L + ++ + N I +I F + L++ FN + P F
Sbjct: 62 AALLDSFRQVELLNLNDLQIE-EID----TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV 116
Query: 213 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSL 270
+ L + N + L GI N L + + +N + D F L++L L
Sbjct: 117 PLLTVLVLER-NDLSSLPRGI--FHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQL 172
Query: 271 RDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSLDMAKGSNNFCLPSPGAC 329
N T V SL + SL N++ NLL +P + N+ +
Sbjct: 173 SSNRLTH-VDLSL--IPSLFHANVSYNLLSTLAIPIAVEELDAS----HNSINVVRGPVN 225
Query: 330 DPRL-------NALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNL 382
L N L L+ YP + ++ L
Sbjct: 226 -VELTILKLQHNNLTDTAWLLNYP------------------------GLVEVDLSYNEL 260
Query: 383 TGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
I F + L+RL +++N L + + LK LD+S+N L
Sbjct: 261 E-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 307
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 8e-05
Identities = 32/296 (10%), Positives = 85/296 (28%), Gaps = 74/296 (25%)
Query: 156 IPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQI 215
I +L+ + + T + F I+ + + ++
Sbjct: 13 IDSNLQYDCVFYDVHID--MQTQDVYFGFEDITLNNQKIVTFKNSTM----------RKL 60
Query: 216 QSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDN 273
+ ++ + ++ + L+ + F+ ++ L + N
Sbjct: 61 PA----------------ALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFN 103
Query: 274 FFTGPVPDSLVKLESLKIVNMT-NNLLQGPVPEFDRSVSL---DMAKGSNNFCLPSPGAC 329
P + L ++ + N+L P F + L M+ +NN
Sbjct: 104 AIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMS--NNNLERIEDDT- 160
Query: 330 DPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINF------QKMNLT 383
A S+ L + + N +T ++ N++
Sbjct: 161 ---FQATTSLQNL-----QLSSN------------------RLTHVDLSLIPSLFHANVS 194
Query: 384 GTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS 439
+ A +++ L + N+++ ++ + L L + +N L +
Sbjct: 195 YNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL-TDTAWLLN 246
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 24/217 (11%)
Query: 593 NNFSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK-VR 649
+ + +GRG +G+V K +H G +AVKR+ + V + + ++ V+ +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKM-VHKPSGQIMAVKRIRSTVDEKE-QKQLLMDLDVVMRSSD 79
Query: 650 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
++V G + + E M + + + I L + +
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPEGKGSI-ETRIAGTF 764
+L + IHRD+KPSNILL K+ DFG LV SI +TR AG
Sbjct: 139 NHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD-------SIAKTRDAGCR 189
Query: 765 GYLAPE----YAVTGRVTTKVDVFSFGVILMELITGR 797
Y+APE A + DV+S G+ L EL TGR
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-25
Identities = 50/191 (26%), Positives = 75/191 (39%), Gaps = 16/191 (8%)
Query: 623 KRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI 682
+ + + S + +I + ++ V L + + + L +
Sbjct: 93 ESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM 152
Query: 683 FNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742
L+ E L I + +A VE+LH + +HRDLKPSNI D KV D
Sbjct: 153 NR--RCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD 207
Query: 743 FGLVR-----------LAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILM 791
FGLV L P + T GT Y++PE + KVD+FS G+IL
Sbjct: 208 FGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILF 267
Query: 792 ELITGRKALDE 802
EL+ E
Sbjct: 268 ELLYSFSTQME 278
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 593 NNFSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK-VR 649
++ LGRG +G V K H G +AVKR+ A ++ + ++ + + V
Sbjct: 7 DDLEPIMELGRGAYGVVEKM-RHVPSGQIMAVKRIRA-TVNSQEQKRLLMDLDISMRTVD 64
Query: 650 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
V G + + E M +L + + + + + + IA+ + + +
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMD-TSLDK-FYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPEGKGSI-ETRIAGTF 764
E+LH IHRD+KPSN+L+ + K+ DFG LV + + AG
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVD-------DVAKDIDAGCK 173
Query: 765 GYLAPE----YAVTGRVTTKVDVFSFGVILMELITGR 797
Y+APE + K D++S G+ ++EL R
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 40/221 (18%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVK--RMEA---GVISGKGLTEFKSEIAVLTK 647
+ + +G G +G VYK + G +A+K R++A G+ S T + EI++L +
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPS----TAIR-EISLLKE 75
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+ H ++V+L+ LVFE+M + L + + +E L+ ++ + R
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL----DENKTGLQDSQIKIYLYQLLR 130
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRI----AGT 763
GV + H +HRDLKP N+L+ D K+ADFGL R I R T
Sbjct: 131 GVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAF-----GIPVRSYTHEVVT 182
Query: 764 FGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 797
Y AP+ Y +T VD++S G I E+ITG+
Sbjct: 183 LWYRAPDVLMGSKKY------STSVDIWSIGCIFAEMITGK 217
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLT 646
+ FS+ +G G FG VY ++ + +A+K+M +G S + + E+ L
Sbjct: 50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 647 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 706
K+RH + + G L + LV EY G+ S + E KPL+ +
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLL----EVHKKPLQEVEIAAVTHGAL 164
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTF 764
+G+ YLH + IHRD+K NILL + K+ DFG + GT
Sbjct: 165 QGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANSFVGTP 214
Query: 765 GYLAPEYAVTGRVTT---KVDVFSFGVILMELITG 796
++APE + KVDV+S G+ +EL
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 53/215 (24%), Positives = 86/215 (40%), Gaps = 27/215 (12%)
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS--------EIA 643
+ + +G G +G V+K G +A+K+ +E EI
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL--------ESEDDPVIKKIALREIR 54
Query: 644 VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 703
+L +++H +LV LL LVFEY T+ + + + + + +I
Sbjct: 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL----DRYQRGVPEHLVKSITW 109
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT 763
+ V + H + IHRD+KP NIL+ K+ DFG R G T
Sbjct: 110 QTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFAR-LLTGPSDYYDDEVAT 165
Query: 764 FGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGR 797
Y +PE V VDV++ G + EL++G
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 59/239 (24%), Positives = 89/239 (37%), Gaps = 45/239 (18%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
LG G +G V +AVK ++ K EI + + H ++V GH
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGH 73
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVEY 711
+GN + L EY G L I + + A+ GV Y
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPE--PDAQRFFHQLMAGVVY 120
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK--GSIETRIAGTFGYLAP 769
LH HRD+KP N+LL + K++DFGL + + GT Y+AP
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAP 176
Query: 770 E------YAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK 822
E + VDV+S G++L ++ G D+ P +S + K
Sbjct: 177 ELLKRREFH--AE---PVDVWSCGIVLTAMLAGELPWDQ--PSDSCQE---YSDWKEKK 225
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 63/233 (27%), Positives = 104/233 (44%), Gaps = 35/233 (15%)
Query: 583 ISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSE 641
I + LR+ F ++G G +G VYKG + G A+K M+ ++G E K E
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQE 70
Query: 642 IAVLTKV-RHRHLVALLG-----HCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLE 694
I +L K HR++ G + +++L LV E+ G+++ + +K +
Sbjct: 71 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT--------DLIKNTK 122
Query: 695 WNRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748
L I ++ RG+ +LH IHRD+K N+LL ++ K+ DFG+
Sbjct: 123 -GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178
Query: 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVT-----TKVDVFSFGVILMELITG 796
G T I GT ++APE K D++S G+ +E+ G
Sbjct: 179 LDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 41/224 (18%)
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVK--RMEA--GVISGKGLTEFKSEIAVLTK 647
+ F + LG G + TVYKG G +A+K ++++ G S T + EI+++ +
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPS----TAIR-EISLMKE 59
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQ---GTLSRHIFNWAEEGLKPLEWNRRLTIALD 704
++H ++V L N+ LVFE+M + GL+
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNL---VKYFQWQ 116
Query: 705 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRI---- 760
+ +G+ + H +HRDLKP N+L+ + K+ DFGL R I
Sbjct: 117 LLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF-----GIPVNTFSSE 168
Query: 761 AGTFGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 797
T Y AP+ Y +T +D++S G IL E+ITG+
Sbjct: 169 VVTLWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 56/257 (21%), Positives = 96/257 (37%), Gaps = 39/257 (15%)
Query: 560 SETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGE-LHDGT 618
+ VP + + + + + +LG GGFG+VY G + D
Sbjct: 10 HSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 69
Query: 619 KIAVKRMEAGVISGKGLTEF----KSEIAVLTKVRHR--HLVALLGHCLDGNEKLLVFEY 672
+A+K +E IS G E+ +L KV ++ LL + +L+ E
Sbjct: 70 PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 129
Query: 673 -MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVEYLHGLAHQSFIHR 723
P L F++ + L ++AR V + H + +HR
Sbjct: 130 PEPVQDL----FDF-------ITERGALQ--EELARSFFWQVLEAVRHCH---NCGVLHR 173
Query: 724 DLKPSNILL-GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR--VTTK 780
D+K NIL+ + K+ DFG L + GT Y PE+ +
Sbjct: 174 DIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDF-DGTRVYSPPEW-IRYHRYHGRS 229
Query: 781 VDVFSFGVILMELITGR 797
V+S G++L +++ G
Sbjct: 230 AAVWSLGILLYDMVCGD 246
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 61/233 (26%), Positives = 92/233 (39%), Gaps = 53/233 (22%)
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVK--RMEAGVISGKGLTEFKS----EIAVL 645
+ + +G G +GTVYK + H G +A+K R+ G G E+A+L
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN---GGGGGGGLPISTVREVALL 65
Query: 646 ---TKVRHRHLVALL----GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNR 697
H ++V L+ D K+ LVFE++ Q L ++ GL
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA---ET 121
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE 757
+ RG+++LH +HRDLKP NIL+ K+ADFGL R
Sbjct: 122 IKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR---------- 168
Query: 758 TRIAGTFG-------------YLAPEYAVTGRVTTKVDVFSFGVILMELITGR 797
+ Y APE + T VD++S G I E+ +
Sbjct: 169 -----IYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-25
Identities = 41/217 (18%), Positives = 81/217 (37%), Gaps = 17/217 (7%)
Query: 592 TNNFSEENILGRG--GFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
+ ++G+G TV G + V+R+ S + +T + E+ V
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
H ++V + NE +V +M G+ + + + I V +
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTHFMD--GMNELAIAYILQGVLKA 140
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG-LVRLAPEGK-----GSIETRIAG 762
++Y+H H ++HR +K S+IL+ D + ++ + + G+
Sbjct: 141 LDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 763 TFGYLAPEYAVTGRV--TTKVDVFSFGVILMELITGR 797
+L+PE K D++S G+ EL G
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-25
Identities = 60/244 (24%), Positives = 99/244 (40%), Gaps = 63/244 (25%)
Query: 583 ISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK--RMEAGVISGKGLTEFK 639
+++ V + + + LG G F TVYK + + +A+K ++ + G
Sbjct: 1 MALDVKSRA-KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDG---IN 56
Query: 640 S----EIAVLTKVRHRHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLE 694
EI +L ++ H +++ LL + LVF++M L I ++ L
Sbjct: 57 RTALREIKLLQELSHPNIIGLLD-AFGHKSNISLVFDFMETD-LEVII----KDNSLVLT 110
Query: 695 WNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 754
+ L +G+EYLH +HRDLKP+N+LL ++ K+ADFGL +
Sbjct: 111 PSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK------- 160
Query: 755 SIETRIAGTFG--------------YLAPE-------YAVTGRVTTKVDVFSFGVILMEL 793
+FG Y APE Y VD+++ G IL EL
Sbjct: 161 --------SFGSPNRAYTHQVVTRWYRAPELLFGARMY------GVGVDMWAVGCILAEL 206
Query: 794 ITGR 797
+
Sbjct: 207 LLRV 210
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 20/222 (9%)
Query: 88 LQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147
L KLERL L N + LP +L+ + + N+ T V F GL+ + +E+
Sbjct: 96 FAPLVKLERLYLSKNQLKE-LPE-KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELG 153
Query: 148 NNPFSSWEIP-QSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGL 206
NP S I + + L NIT IP P LT LHL N+ I +
Sbjct: 154 TNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIP----QGLPPSLTELHLDGNK-ITKV 207
Query: 207 PA-SFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQ 264
A S G + + L ++ N + + G + N L+E+ L++N + K
Sbjct: 208 DAASLKGLNNLAKLGLSF-NSISAVDNG--SLANTPHLRELHLNNNKLVKVPGGLADHKY 264
Query: 265 LESLSLRDNFFTG------PVPDSLVKLESLKIVNMTNNLLQ 300
++ + L +N + P K S V++ +N +Q
Sbjct: 265 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 54/254 (21%), Positives = 92/254 (36%), Gaps = 41/254 (16%)
Query: 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLA 115
C V C D + ++ P +L T L+LQ N I+ L
Sbjct: 31 CHLRVVQC-SDLGLEKV-----------PKDLPPDTA--LLDLQNNKITEIKDGDFKNLK 76
Query: 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175
+L ++L NN+ + + F L L+ + + N E+P+ + LQ +
Sbjct: 77 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK--ELPEKM--PKTLQELRVHENE 132
Query: 176 ITGQIPSFFGPDEFPG---LTILHLAFNQL-IGGLPA-SFSG-SQIQSLWVNGQNGNAKL 229
IT ++ F G + ++ L N L G+ +F G ++ + + N
Sbjct: 133 IT-KVR----KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN----- 182
Query: 230 GGGIDVIQN--MTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKL 286
I I SL E+ L N + G+ L L L N + SL
Sbjct: 183 ---ITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT 239
Query: 287 ESLKIVNMTNNLLQ 300
L+ +++ NN L
Sbjct: 240 PHLRELHLNNNKLV 253
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 37/232 (15%), Positives = 72/232 (31%), Gaps = 61/232 (26%)
Query: 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSIS---------GPLPSLNGL----- 114
IT+++ S L ++ +EL N + + L+ +
Sbjct: 132 EITKVR----------KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181
Query: 115 ----------ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNAS 164
SL + L N+ T V + GL++L + + N S+ + SL N
Sbjct: 182 NITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD-NGSLANTP 240
Query: 165 GLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQN 224
L+ N+ + ++P + + +++L N + S I S
Sbjct: 241 HLRELHLNNNKLV-KVPGGL--ADHKYIQVVYLHNNNI----------SAIGSNDFCPPG 287
Query: 225 GNAKLGGGIDVIQNMTSLKEIWLHSNAFS-GPLPD--FSGVKQLESLSLRDN 273
S + L SN + F V ++ L +
Sbjct: 288 ----------YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 17/106 (16%), Positives = 40/106 (37%), Gaps = 16/106 (15%)
Query: 59 WNHVVCIED------KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSIS------- 105
+N + +++ + + + + L +P L + ++ + L N+IS
Sbjct: 225 FNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF 283
Query: 106 GPLPSLNGLASLEVVMLSNN--QFTSVPSDFFTGLSSLQSIEIDNN 149
P AS V L +N Q+ + F + ++++ N
Sbjct: 284 CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 52/329 (15%), Positives = 90/329 (27%), Gaps = 111/329 (33%)
Query: 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175
L VV S+ VP D + L ++ NN + I
Sbjct: 32 HLRVVQCSDLGLEKVPKDLPPDTALL---DLQNNKITE--IKDG---------------- 70
Query: 176 ITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDV 235
F L L L N++ S+I
Sbjct: 71 ------DFKN---LKNLHTLILINNKI----------SKISP----------------GA 95
Query: 236 IQNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 294
+ L+ ++L N P L+ L + +N T L + +V +
Sbjct: 96 FAPLVKLERLYLSKNQLKELPEKMPKT---LQELRVHENEITKVRKSVFNGLNQMIVVEL 152
Query: 295 -TNNLLQGPVPE--FDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQR 348
TN L + F L +A N G
Sbjct: 153 GTNPLKSSGIENGAFQGMKKLSYIRIA--DTNITTIPQGL-------------------- 190
Query: 349 FAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLS 407
++T ++ +T + +L +L L+ N++S
Sbjct: 191 PP--------------------SLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS 229
Query: 408 GMIPEGLSVLGALKELDVSNNQLYGKIPS 436
+ L+ L+EL ++NN+L K+P
Sbjct: 230 AVDNGSLANTPHLRELHLNNNKLV-KVPG 257
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 56/217 (25%), Positives = 85/217 (39%), Gaps = 42/217 (19%)
Query: 598 ENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVR-HRH 652
E++LG G V L + AVK +I G + E+ +L + + HR+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVK-----IIEKQPGHIRSRVFREVEMLYQCQGHRN 72
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHI-----FNWAEEGLKPLEWNRRLTIALDVAR 707
++ L+ + + LVFE M G++ HI FN E + DVA
Sbjct: 73 VLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS----------VVVQDVAS 122
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETR----- 759
+++LH ++ HRDLKP NIL K+ DF L
Sbjct: 123 ALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 760 -IAGTFGYLAPE-----YAVTGRVTTKVDVFSFGVIL 790
G+ Y+APE + D++S GVIL
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 54/387 (13%), Positives = 121/387 (31%), Gaps = 72/387 (18%)
Query: 73 IQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVP 131
+ I Q L + + + +++ P L+ +E++ L++ Q +
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 91
Query: 132 SDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPG 191
+ F ++Q + + N P +N L +++ +P F
Sbjct: 92 TYAFAYAHTIQKLYMGFNAIRYLP-PHVFQNVPLLTVLVLERNDLS-SLP----RGIFHN 145
Query: 192 ---LTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLH 248
LT L ++ N L +I+ D Q TSL+ + L
Sbjct: 146 TPKLTTLSMSNNNL----------ERIED----------------DTFQATTSLQNLQLS 179
Query: 249 SNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFD 307
SN + + S + L ++ N + +L +++ ++ ++N + P
Sbjct: 180 SNRLTH-VD-LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNV 232
Query: 308 RSVSLDMAKGSNNFCLPSPGACD--PRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIG 364
L + +N L P L + LS +L +
Sbjct: 233 ELTILKL---QHNN-LTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ---------- 278
Query: 365 VTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELD 424
+ + L ++ +L+ L L+ N+L + L+ L
Sbjct: 279 ------RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 330
Query: 425 VSNNQLYGKIP--SFKSNAIVNTDGNP 449
+ +N + + + + + N
Sbjct: 331 LDHNSI-VTLKLSTHHTLKNLTLSHND 356
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 1e-20
Identities = 61/357 (17%), Positives = 111/357 (31%), Gaps = 85/357 (23%)
Query: 77 HQNLQGTLPSN-LQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDF 134
+ + + +++L + +N+I P + L V++L N +S+P
Sbjct: 83 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGI 142
Query: 135 FTGLSSLQSIEIDNNPFSSWEIP-QSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLT 193
F L ++ + NN I + + + LQN +S +T + P L
Sbjct: 143 FHNTPKLTTLSMSNNNLER--IEDDTFQATTSLQNLQLSSNRLT-HVD----LSLIPSLF 195
Query: 194 ILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS 253
++++N L L + ++ L + N + G + L + L N +
Sbjct: 196 HANVSYNLL-STLAIPIA---VEELDASH-NSINVVRGPV-----NVELTILKLQHNNLT 245
Query: 254 GPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLD 313
L + L N L K+ V M L+ L
Sbjct: 246 -DTAWLLNYPGLVEVDLSYN--------ELEKIMYHPFVKMQR--LE----------RLY 284
Query: 314 MAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNIT 373
+ SNN RL AL +
Sbjct: 285 I---SNN-----------RLVAL---------NLYGQPI-----------------PTLK 304
Query: 374 VINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
V++ +L + F L+ L L N++ + LS LK L +S+N
Sbjct: 305 VLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 3e-20
Identities = 61/357 (17%), Positives = 108/357 (30%), Gaps = 93/357 (26%)
Query: 83 TLPSNLQNLTKLERLELQWNS--ISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSS 140
+ SNLQ + + + + + L + ++V N+ +P+
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDIT-LNNQKIVTFKNSTMRKLPAALLDSFRQ 76
Query: 141 LQSIEIDNNPFSSWEIPQ-SLRNASGLQ--NFSANSANITGQIPSFFGPDEFPGLTILHL 197
++ + +++ EI + A +Q N I P F P LT+L L
Sbjct: 77 VELLNLNDLQIE--EIDTYAFAYAHTIQKLYMGFN--AIRYLPPHVF--QNVPLLTVLVL 130
Query: 198 AFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP 257
N L S + + N L + + +N +
Sbjct: 131 ERNDL----------SSLPR----------------GIFHNTPKLTTLSMSNNNLER-IE 163
Query: 258 D--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSLDM 314
D F L++L L N T V SL + SL N++ NLL +P +
Sbjct: 164 DDTFQATTSLQNLQLSSNRLTH-VDLSL--IPSLFHANVSYNLLSTLAIPIAVEELDAS- 219
Query: 315 AKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNIT 373
N+ + L L L N N+T
Sbjct: 220 ---HNSINVVRGPVN-VELTILKLQ----------------HN--------------NLT 245
Query: 374 VINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
++ L + L+ N L ++ + L+ L +SNN+L
Sbjct: 246 DT------------AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL 290
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 4e-20
Identities = 40/256 (15%), Positives = 87/256 (33%), Gaps = 38/256 (14%)
Query: 68 KRITRIQIGHQNLQGTLPSN-LQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNN 125
+ + ++ LP+ L + ++E L L I + +++ + + N
Sbjct: 51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 109
Query: 126 QFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSL-RNASGLQNFSANSANITGQIP--- 181
+P F + L + ++ N SS +P+ + N L S ++ N+ +I
Sbjct: 110 AIRYLPPHVFQNVPLLTVLVLERNDLSS--LPRGIFHNTPKLTTLSMSNNNLE-RIEDDT 166
Query: 182 -----------------SFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQN 224
+ P L ++++N L L + ++ L + N
Sbjct: 167 FQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLL-STLAIPIA---VEELDASH-N 221
Query: 225 GNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLV 284
+ G + L + L N + L + L N + V
Sbjct: 222 SINVVRGPV-----NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELEKIMYHPFV 275
Query: 285 KLESLKIVNMTNNLLQ 300
K++ L+ + ++NN L
Sbjct: 276 KMQRLERLYISNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 1e-17
Identities = 56/362 (15%), Positives = 123/362 (33%), Gaps = 51/362 (14%)
Query: 83 TLPSN-LQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSL 141
+ + Q T L+ L+L N ++ + L+ + SL +S N +++ ++
Sbjct: 161 RIEDDTFQATTSLQNLQLSSNRLTH-VD-LSLIPSLFHANVSYNLLSTLA-----IPIAV 213
Query: 142 QSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQ 201
+ ++ +N + + + L N+T +PGL + L++N+
Sbjct: 214 EELDASHNSINV--VRGPV--NVELTILKLQHNNLT-DTAWLLN---YPGLVEVDLSYNE 265
Query: 202 LIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFS 260
L + F +++ L+++ N +L Q + +LK + L N +
Sbjct: 266 LEKIMYHPFVKMQRLERLYISN---N-RLVALNLYGQPIPTLKVLDLSHNHLLHVERNQP 321
Query: 261 GVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN----------MTNNLLQGPVPEFDRSV 310
+LE+L L N + L++L + + + N+ + V + D+
Sbjct: 322 QFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHC 381
Query: 311 SLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKG 370
+D C S RL +++ ++ QR CS
Sbjct: 382 KIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQR------AQGRCSA--------- 426
Query: 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADN----NLSGMIPEGLSVLGALKELDVS 426
IN + + ++L N + + E + L+ L
Sbjct: 427 -TDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAE 485
Query: 427 NN 428
+
Sbjct: 486 ID 487
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 6e-16
Identities = 65/361 (18%), Positives = 118/361 (32%), Gaps = 65/361 (18%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
Q R + ++ I L + + M + + + L++ + +
Sbjct: 2 GGQQRYNVKPR-QPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFE---DITLNNQKIVT 57
Query: 146 IDNNPFSSWEIPQS-LRNASGLQNFSANSANITGQIPSFFGPDEFPG---LTILHLAFNQ 201
N+ +P + L + ++ + N I +I F + L++ FN
Sbjct: 58 FKNSTMRK--LPAALLDSFRQVELLNLNDLQIE-EID----TYAFAYAHTIQKLYMGFNA 110
Query: 202 LIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-- 258
+ P F + L + N + L GI N L + + +N + D
Sbjct: 111 IRYLPPHVFQNVPLLTVLVLER-NDLSSLPRGI--FHNTPKLTTLSMSNNNLER-IEDDT 166
Query: 259 FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSLDMAKG 317
F L++L L N T V SL + SL N++ NLL +P +
Sbjct: 167 FQATTSLQNLQLSSNRLTH-VDLSL--IPSLFHANVSYNLLSTLAIPIAVEELDAS---- 219
Query: 318 SNNFCLPSPGACDPRL-------NALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKG 370
N+ + L N L L+ YP
Sbjct: 220 HNSINVVRGPVN-VELTILKLQHNNLTDTAWLLNYP------------------------ 254
Query: 371 NITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQ 429
+ ++ L I F + L+RL +++N L + + LK LD+S+N
Sbjct: 255 GLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 312
Query: 430 L 430
L
Sbjct: 313 L 313
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 57/234 (24%), Positives = 90/234 (38%), Gaps = 29/234 (12%)
Query: 577 EAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKG 634
+ G + I Q + N+ +G G G V+K T IAVK+M +
Sbjct: 9 QTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKM-RFRKTGHVIAVKQMRRSGNKEE- 66
Query: 635 LTEFKSEIAVLTK-VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPL 693
++ V+ K ++V G + + + E M P+
Sbjct: 67 NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKK-----RMQGPI 121
Query: 694 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLA 749
+ + + + + YL IHRD+KPSNILL + + K+ DFG LV
Sbjct: 122 PERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-- 177
Query: 750 PEGKGSI-ETRIAGTFGYLAPE-----YAVTGRVTTKVDVFSFGVILMELITGR 797
+ R AG Y+APE + DV+S G+ L+EL TG+
Sbjct: 178 -----DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-24
Identities = 59/259 (22%), Positives = 105/259 (40%), Gaps = 30/259 (11%)
Query: 60 NHVVCIEDKRITRIQIG----------HQNLQGTLPSN-LQNLTKLERLELQWNSISGPL 108
+ V+C K + + G H+N + N ++L LE L+L N I
Sbjct: 46 SKVIC-VRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIE 104
Query: 109 P-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIP-QSLRNASGL 166
+ NGLA+L + L +N+ T++P+ F LS L+ + + NNP S IP + L
Sbjct: 105 IGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES--IPSYAFNRIPSL 162
Query: 167 QNFSANSANITGQIPSFFGPDEFPG---LTILHLAFNQLIGGLPASFSG-SQIQSLWVNG 222
+ I F G L L+LA L +P + ++ L ++G
Sbjct: 163 RRLDLGELKRLSYIS----EGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSG 216
Query: 223 QNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPD 281
N + + G Q + L+++W+ + F ++ L ++L N T D
Sbjct: 217 -NHLSAIRPG--SFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHD 273
Query: 282 SLVKLESLKIVNMTNNLLQ 300
L L+ +++ +N
Sbjct: 274 LFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 54/325 (16%), Positives = 104/325 (32%), Gaps = 87/325 (26%)
Query: 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175
V+ VP T + + + + N + S ++ L+ + +
Sbjct: 44 QFSKVICVRKNLREVPDGIST---NTRLLNLHENQIQIIK-VNSFKHLRHLEILQLSRNH 99
Query: 176 ITGQIP--SFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGI 233
I I +F G L L L N+L + I +
Sbjct: 100 IR-TIEIGAFNG---LANLNTLELFDNRL----------TTIPN---------------- 129
Query: 234 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRD-NFFTGPVPDSLVKLESLK 290
++ LKE+WL +N +P F+ + L L L + + + L +L+
Sbjct: 130 GAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLR 188
Query: 291 IVNMTNNLLQGPVPEFDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQ 347
+N+ L+ +P + L D+ N+ PG+ L+ + KL
Sbjct: 189 YLNLAMCNLRE-IPNLTPLIKLDELDL--SGNHLSAIRPGS----FQGLMHLQKL----- 236
Query: 348 RFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNL 406
+ + I F + +SL + LA NNL
Sbjct: 237 ----------------------------WMIQSQIQ-VIERNAFDNLQSLVEINLAHNNL 267
Query: 407 SGMIPEG-LSVLGALKELDVSNNQL 430
+ ++P + L L+ + + +N
Sbjct: 268 T-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 28/126 (22%), Positives = 50/126 (39%), Gaps = 23/126 (18%)
Query: 323 LPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPC-------SDWIGVTCTKGNITVI 375
LPSPG L +LLSV+ + + C + + V C + N+ +
Sbjct: 4 LPSPGMPALLLVSLLSVLLMGCVAE-----TGSAQTCPSVCSCSNQFSKVICVRKNLREV 58
Query: 376 ------NFQKMNLTG----TISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELD 424
N + +NL I F + L+ L L+ N++ + + L L L+
Sbjct: 59 PDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLE 118
Query: 425 VSNNQL 430
+ +N+L
Sbjct: 119 LFDNRL 124
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 13/70 (18%), Positives = 27/70 (38%), Gaps = 5/70 (7%)
Query: 385 TISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL----YGKIPSFKS 439
I P F LQ+L + + + + L +L E+++++N L +
Sbjct: 221 AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHH 280
Query: 440 NAIVNTDGNP 449
++ NP
Sbjct: 281 LERIHLHHNP 290
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 55/214 (25%), Positives = 82/214 (38%), Gaps = 40/214 (18%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
LG G +G V +AVK ++ K EI + + H ++V GH
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGH 73
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVEY 711
+GN + L EY G L I + + A+ GV Y
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPE--PDAQRFFHQLMAGVVY 120
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK--GSIETRIAGTFGYLAP 769
LH HRD+KP N+LL + K++DFGL + + GT Y+AP
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAP 176
Query: 770 E------YAVTGRVTTKVDVFSFGVILMELITGR 797
E + VDV+S G++L ++ G
Sbjct: 177 ELLKRREFH--AE---PVDVWSCGIVLTAMLAGE 205
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 4e-24
Identities = 76/250 (30%), Positives = 107/250 (42%), Gaps = 56/250 (22%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 658
LG G FG V G+ G K+AVK + I + + EI L RH H++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY- 82
Query: 659 HCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GV 709
+ + +V EY+ G L +I N RL +R GV
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICK-----------NGRLDE--KESRRLFQQILSGV 129
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
+Y H +HRDLKP N+LL M AK+ADFGL + +G + T G+ Y AP
Sbjct: 130 DYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS-CGSPNYAAP 184
Query: 770 E------YAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI----- 818
E YA G +VD++S GVIL L+ G D+ H+ T F++I
Sbjct: 185 EVISGRLYA--GP---EVDIWSSGVILYALLCGTLPFDDD------HVPTLFKKICDGIF 233
Query: 819 ----HLSKDS 824
+L+
Sbjct: 234 YTPQYLNPSV 243
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 40/221 (18%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVK--RMEA---GVISGKGLTEFKSEIAVLTK 647
+ +G G +G VYK + + G A+K R+E G+ S T + EI++L +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS----TTIR-EISILKE 56
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
++H ++V L +LVFE++ Q L + + + LE + L +
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLL----DVCEGGLESVTAKSFLLQLLN 111
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRI----AGT 763
G+ Y H + +HRDLKP N+L+ + K+ADFGL R I R T
Sbjct: 112 GIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAF-----GIPVRKYTHEIVT 163
Query: 764 FGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 797
Y AP+ Y +T +D++S G I E++ G
Sbjct: 164 LWYRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-24
Identities = 75/349 (21%), Positives = 127/349 (36%), Gaps = 85/349 (24%)
Query: 83 TLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQ 142
LP Q+L L ++S LP LE + +SNNQ +P S L+
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSD-LPP-----LLEYLGVSNNQLEKLPE--LQNSSFLK 156
Query: 143 SIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL 202
I++DNN +P + L+ +A + + ++P P LT ++ N L
Sbjct: 157 IIDVDNNSLKK--LPDLPPS---LEFIAAGNNQLE-ELPELQ---NLPFLTAIYADNNSL 207
Query: 203 IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGV 262
LP ++S+ N L + +QN+ L I+ +N LPD
Sbjct: 208 K-KLPDLP--LSLESIVAGN-N---IL-EELPELQNLPFLTTIYADNNLLKT-LPDLPP- 257
Query: 263 KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSV-SLDMAKGSNNF 321
LE+L++RDN+ T +P+ L L + + L E ++ L+ S+N
Sbjct: 258 -SLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGL----SELPPNLYYLNA---SSN- 307
Query: 322 CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMN 381
+ +L + ++ +N
Sbjct: 308 ----------EIRSLCDLPP-----------------------------SLEELNVSNNK 328
Query: 382 LTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
L + L+RLI + N+L+ +PE LK+L V N L
Sbjct: 329 LI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPL 369
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-21
Identities = 72/369 (19%), Positives = 127/369 (34%), Gaps = 78/369 (21%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNG--------------LASLEVVMLSN 124
NL +P +N+ W+ P NG + L+N
Sbjct: 22 NLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNN 80
Query: 125 NQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFF 184
+S+P L+S+ N + +P+ ++ L + N ++ P
Sbjct: 81 LGLSSLPEL----PPHLESLVASCNSLTE--LPELPQSLKSLLVDNNNLKALSDLPPL-- 132
Query: 185 GPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKE 244
L L ++ NQL LP + S ++ + V+ N L + SL+
Sbjct: 133 -------LEYLGVSNNQLE-KLPELQNSSFLKIIDVDN-N---SL---KKLPDLPPSLEF 177
Query: 245 IWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP 304
I +N LP+ + L ++ +N +PD + LES+ NN+L+ P
Sbjct: 178 IAAGNNQLEE-LPELQNLPFLTAIYADNNSLKK-LPDLPLSLESI---VAGNNILEEL-P 231
Query: 305 EFDRSVSLDMAKGSNNF--CLPSPGACDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCSD 361
E L NN LP P L AL + L P+
Sbjct: 232 ELQNLPFLTTIYADNNLLKTLPDLP---PSLEALNVRDNYLTDLPELP------------ 276
Query: 362 WIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALK 421
++T ++ + + +S +L L + N + + +L+
Sbjct: 277 --------QSLTFLDVSENIFS-GLS---ELPPNLYYLNASSNEIRSLCDL----PPSLE 320
Query: 422 ELDVSNNQL 430
EL+VSNN+L
Sbjct: 321 ELNVSNNKL 329
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-18
Identities = 61/348 (17%), Positives = 108/348 (31%), Gaps = 82/348 (23%)
Query: 83 TLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQ 142
LP LQNL L + NS+ LP L SLE ++ NN +P L L
Sbjct: 187 ELP-ELQNLPFLTAIYADNNSLKK-LPDL--PLSLESIVAGNNILEELPE--LQNLPFLT 240
Query: 143 SIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL 202
+I DNN + +P + L+ + +T P+ LT L ++ N
Sbjct: 241 TIYADNNLLKT--LPDLPPS---LEALNVRDNYLTD------LPELPQSLTFLDVSENIF 289
Query: 203 IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGV 262
G L + L + + ++ + SL+E+ + +N LP
Sbjct: 290 SG-LSELPP--NLYYLNAS----SNEIR---SLCDLPPSLEELNVSNNKLIE-LPALPP- 337
Query: 263 KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFC 322
+LE L N VP+ L+ L ++ N L+ + L M
Sbjct: 338 -RLERLIASFNHLAE-VPELPQNLKQL---HVEYNPLREFPDIPESVEDLRM-------- 384
Query: 323 LPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNL 382
+ L V +L N+ ++ + L
Sbjct: 385 ----------NSHLAEVPELPQ--------------------------NLKQLHVETNPL 408
Query: 383 TGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
+S++ L + + L++ ++
Sbjct: 409 R-EFPDIP---ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-17
Identities = 41/221 (18%), Positives = 79/221 (35%), Gaps = 35/221 (15%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGL 138
N LP Q+LT L+ E ++ +S P+L L S+N+ S+
Sbjct: 267 NYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYL------NASSNEIRSLCDL----P 316
Query: 139 SSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLA 198
SL+ + + NN +P L+ A+ ++ ++P L LH+
Sbjct: 317 PSLEELNVSNNKLIE--LPALPPR---LERLIASFNHLA-EVPE-----LPQNLKQLHVE 365
Query: 199 FNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD 258
+N L P ++ L +N +V + +LK++ + +N PD
Sbjct: 366 YNPLR-EFPDIP--ESVEDLRMNSH--------LAEVPELPQNLKQLHVETNPLRE-FPD 413
Query: 259 FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 299
+E L + P + + L+ ++
Sbjct: 414 IPE--SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-14
Identities = 62/349 (17%), Positives = 107/349 (30%), Gaps = 71/349 (20%)
Query: 109 PSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQN 168
P L+ + ++ T +P + + S + + P +
Sbjct: 5 PRNVSNTFLQEPLRHSSNLTEMPVEAEN-VKSKTEYYNAWSEWER-NAPPGNGEQREMAV 62
Query: 169 FSANSANITG---------QIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLW 219
+ S P+ P L L + N L LP ++SL
Sbjct: 63 SRLRDCLDRQAHELELNNLGLSSL--PELPPHLESLVASCNSLT-ELPELP--QSLKSLL 117
Query: 220 VNGQNGNAKLGG----------------GIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVK 263
V+ N L + +QN + LK I + +N+ LPD
Sbjct: 118 VDNNNLK-ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKK-LPDL--PP 173
Query: 264 QLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNF-C 322
LE ++ +N L L L + NN L+ S+ G+N
Sbjct: 174 SLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVA--GNNILEE 229
Query: 323 LPSPGACDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMN 381
LP P L + L P D ++ +N +
Sbjct: 230 LPELQNL-PFLTTIYADNNLLKTLP--------------DLP------PSLEALNVRDNY 268
Query: 382 LTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
LT + +SL L +++N SG + E + L L+ S+N++
Sbjct: 269 LT-DLPEL---PQSLTFLDVSENIFSG-LSE---LPPNLYYLNASSNEI 309
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 33/216 (15%), Positives = 65/216 (30%), Gaps = 68/216 (31%)
Query: 236 IQNMTSLKEIWLHSNAFSGPLPDFSG--------------VKQLESLSLRDNFFTGPVPD 281
+N+ S E + + + P +G +Q L L + + +P+
Sbjct: 30 AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPE 88
Query: 282 SLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVK 341
LESL N+L + P SL + + L+ L
Sbjct: 89 LPPHLESLVASC--NSLTELP-ELPQSLKSLLVDNNNLK-----------ALSDLPP--- 131
Query: 342 LMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLIL 401
+ + L + PE + L+ + +
Sbjct: 132 -----------------------------LLEYLGVSNNQLE-KL-PELQNSSFLKIIDV 160
Query: 402 ADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSF 437
+N+L +P+ +L+ + NNQL ++P
Sbjct: 161 DNNSLK-KLPDL---PPSLEFIAAGNNQL-EELPEL 191
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 10/74 (13%), Positives = 27/74 (36%), Gaps = 6/74 (8%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGL 138
+ +P QNL +L ++ N + P + S+E + +++ +
Sbjct: 386 SHLAEVPELPQNLKQLH---VETNPLRE-FPDI--PESVEDLRMNSERVVDPYEFAHETT 439
Query: 139 SSLQSIEIDNNPFS 152
L+ +++
Sbjct: 440 DKLEDDVFEHHHHH 453
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 54/215 (25%), Positives = 87/215 (40%), Gaps = 27/215 (12%)
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS--------EIA 643
+ ++G G +G V K G +A+K+ ++ EI
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL--------ESDDDKMVKKIAMREIK 76
Query: 644 VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 703
+L ++RH +LV LL C LVFE++ T+ + E L++
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL----ELFPNGLDYQVVQKYLF 131
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT 763
+ G+ + H + IHRD+KP NIL+ K+ DFG R + +A T
Sbjct: 132 QIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-T 187
Query: 764 FGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGR 797
Y APE V VDV++ G ++ E+ G
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 50/231 (21%), Positives = 88/231 (38%), Gaps = 42/231 (18%)
Query: 580 NMVISIQVLRNVTNNFSE-----ENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGK 633
+ + Q ++ + +LG G G V + G K A+K ++
Sbjct: 11 GLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK-----LLYDS 65
Query: 634 GLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEK----LLVFEYMPQGTLSRHIFNWAEE 688
+ E+ + H+V +L + + L++ E M G L I E
Sbjct: 66 PK--ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI---QER 120
Query: 689 GLKPLEWNRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAK 739
G ++ T I D+ +++LH + HRD+KP N+L D K
Sbjct: 121 G------DQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLK 171
Query: 740 VADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVIL 790
+ DFG + + ++T T Y+APE + D++S GVI+
Sbjct: 172 LTDFGFAKETTQNA--LQT-PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-24
Identities = 61/264 (23%), Positives = 108/264 (40%), Gaps = 32/264 (12%)
Query: 57 CKWN--HVVCIEDKRITRIQIG----------HQNLQGTLPSN-LQNLTKLERLELQWNS 103
C VVC + ++ + G +N + ++ ++L LE L+L NS
Sbjct: 52 CSNQFSKVVC-TRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 104 ISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIP-QSLR 161
I + + NGLASL + L +N T +PS F LS L+ + + NNP S IP +
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIES--IPSYAFN 168
Query: 162 NASGLQNFSANSANITGQIPSFFGPDEFPGLT---ILHLAFNQLIGGLPASFSG-SQIQS 217
L ++ + F GL L+L + +P + ++
Sbjct: 169 RVPSLMRLDLGELK---KL-EYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEE 222
Query: 218 LWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFT 276
L ++G N ++ G ++SLK++W+ ++ S F G+ L L+L N +
Sbjct: 223 LEMSG-NHFPEIRPG--SFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279
Query: 277 GPVPDSLVKLESLKIVNMTNNLLQ 300
D L L +++ +N
Sbjct: 280 SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 9e-15
Identities = 61/324 (18%), Positives = 101/324 (31%), Gaps = 104/324 (32%)
Query: 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA 174
++ + L N + +D F L L+ +++ N E + +GL +
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIE-VGAF---NGLAS------ 124
Query: 175 NITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGID 234
L L L N L + I S
Sbjct: 125 -----------------LNTLELFDNWL----------TVIPS----------------G 141
Query: 235 VIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRD-NFFTGPVPDSLVKLESLKI 291
+ ++ L+E+WL +N +P F+ V L L L + + L +LK
Sbjct: 142 AFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKY 200
Query: 292 VNMTNNLLQGPVPEFDRSVS---LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQR 348
+N+ ++ +P V L+M N+F PG+ + L S+ KL
Sbjct: 201 LNLGMCNIKD-MPNLTPLVGLEELEM--SGNHFPEIRPGS----FHGLSSLKKL------ 247
Query: 349 FAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLS 407
++ I F SL L LA NNLS
Sbjct: 248 ---------------------------WVMNSQVS-LIERNAFDGLASLVELNLAHNNLS 279
Query: 408 GMIPEG-LSVLGALKELDVSNNQL 430
+P + L L EL + +N
Sbjct: 280 -SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 48/283 (16%), Positives = 88/283 (31%), Gaps = 77/283 (27%)
Query: 189 FPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLH 248
L+L N + +F ++ L+ + L
Sbjct: 74 PSNTRYLNLMENNIQMIQADTFR--------------------------HLHHLEVLQLG 107
Query: 249 SNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM-TNNLLQGPVPE 305
N+ + F+G+ L +L L DN+ T + L L+ + + N + P
Sbjct: 108 RNSIRQ-IEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYA 166
Query: 306 FDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDW 362
F+R SL D+ S GA L ++ L
Sbjct: 167 FNRVPSLMRLDLG-ELKKLEYISEGA----FEGLFNLKYL-----NLGMC---------- 206
Query: 363 IGVTCTKGNITVI-NFQKM-NLT---------GTISPE-FASFKSLQRLILADNNLSGMI 410
NI + N + L I P F SL++L + ++ +S +
Sbjct: 207 --------NIKDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIE 258
Query: 411 PEGLSVLGALKELDVSNNQL----YGKIPSFKSNAIVNTDGNP 449
L +L EL++++N L + + ++ NP
Sbjct: 259 RNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNP 301
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 19/78 (24%), Positives = 34/78 (43%), Gaps = 13/78 (16%)
Query: 365 VTCTKGNITVI------NFQKMNLTG----TISPE-FASFKSLQRLILADNNLSGMIPEG 413
V CT+ ++ + N + +NL I + F L+ L L N++ I G
Sbjct: 59 VVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVG 117
Query: 414 -LSVLGALKELDVSNNQL 430
+ L +L L++ +N L
Sbjct: 118 AFNGLASLNTLELFDNWL 135
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-24
Identities = 67/250 (26%), Positives = 107/250 (42%), Gaps = 57/250 (22%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 658
LG G FG V K+A+K + ++ + + EI+ L +RH H++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY- 75
Query: 659 HCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GV 709
+ + +V EY G L +I +R+T D R +
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVE-----------KKRMTE--DEGRRFFQQIICAI 121
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
EY H +HRDLKP N+LL D++ K+ADFGL + +G ++T G+ Y AP
Sbjct: 122 EYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTS-CGSPNYAAP 176
Query: 770 E------YAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI----- 818
E YA G +VDV+S G++L ++ GR D+ + F+++
Sbjct: 177 EVINGKLYA--GP---EVDVWSCGIVLYVMLVGRLPFDDE------FIPNLFKKVNSCVY 225
Query: 819 ----HLSKDS 824
LS +
Sbjct: 226 VMPDFLSPGA 235
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 39/217 (17%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRME----AGVISGKGLTEFKSEIAVLTKVR----HR 651
LG+GGFGTV+ G L D ++A+K + G E+A+L KV H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR---- 707
++ LL +LV E + +F++ + L +R
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPA---QDLFDY-------ITEKGPLG--EGPSRCFFG 146
Query: 708 ----GVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPEGKGSIETRIAG 762
+++ H + +HRD+K NIL+ AK+ DFG L + G
Sbjct: 147 QVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--YTD-FDG 200
Query: 763 TFGYLAPEYAVTGR--VTTKVDVFSFGVILMELITGR 797
T Y PE+ ++ V+S G++L +++ G
Sbjct: 201 TRVYSPPEW-ISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 50/226 (22%), Positives = 86/226 (38%), Gaps = 31/226 (13%)
Query: 590 NVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKS--------- 640
+ + ++ + + G +G V G +G +A+KR+ V G+ +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 641 EIAVLTKVRHRHLVALL-----GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEW 695
EI +L H +++ L ++ LV E M + L++ I + +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVI----HDQRIVISP 133
Query: 696 NRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755
+ G+ LH A +HRDL P NILL D+ + DF L R
Sbjct: 134 QHIQYFMYHILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
Query: 756 IE---TRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGR 797
R Y APE + T VD++S G ++ E+ +
Sbjct: 191 THYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 58/219 (26%), Positives = 92/219 (42%), Gaps = 33/219 (15%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 650
++F +G+G FG V + +D K+ A+K M + + E+ ++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 651 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR-- 707
LV L D E + +V + + G L H L+ N + +
Sbjct: 75 PFLVNLWYSFQD-EEDMFMVVDLLLGGDLRYH-----------LQQNVHFKE--ETVKLF 120
Query: 708 ------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA 761
++YL Q IHRD+KP NILL + + DF + + P T +A
Sbjct: 121 ICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--TTMA 175
Query: 762 GTFGYLAPE--YAVTGRVTTK-VDVFSFGVILMELITGR 797
GT Y+APE + G + VD +S GV EL+ GR
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 59/233 (25%), Positives = 95/233 (40%), Gaps = 55/233 (23%)
Query: 593 NNFSEENILGRGGFGTVYKG--ELHDGTKIAVK--RMEA---GVISGKGLTEFKSEIAVL 645
+ +G G +G V+K + G +A+K R++ G+ + + E+AVL
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL----STIR-EVAVL 65
Query: 646 ---TKVRHRHLVALL----GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNR 697
H ++V L D KL LVFE++ Q L+ ++ E G+
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT---ET 121
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE 757
+ + RG+++LH +HRDLKP NIL+ + K+ADFGL R
Sbjct: 122 IKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR---------- 168
Query: 758 TRIAGTFG-------------YLAPEYAVTGRVTTKVDVFSFGVILMELITGR 797
+ Y APE + T VD++S G I E+ +
Sbjct: 169 -----IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 40/221 (18%)
Query: 593 NNFSEENILGRGGFGTVYKGELHD-GTKIAVK--RMEA--GVISGKGLTEFKSEIAVLTK 647
+ + + LG G + TVYKG+ +A+K R+E G T + E+++L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPC----TAIR-EVSLLKD 56
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
++H ++V L LVFEY+ + L +++ ++ + + + R
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL----DDCGNIINMHNVKLFLFQLLR 111
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRI----AGT 763
G+ Y H Q +HRDLKP N+L+ + K+ADFGL R SI T+ T
Sbjct: 112 GLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAK-----SIPTKTYDNEVVT 163
Query: 764 FGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 797
Y P+ Y +T++D++ G I E+ TGR
Sbjct: 164 LWYRPPDILLGSTDY------STQIDMWGVGCIFYEMATGR 198
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 60/258 (23%), Positives = 100/258 (38%), Gaps = 47/258 (18%)
Query: 562 THTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKI 620
H + Q G+M +S + + LG G +G VYK + +
Sbjct: 3 HHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETV 62
Query: 621 AVK--RMEA---GVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675
A+K R+E GV T + E+++L +++HR+++ L + L+FEY
Sbjct: 63 AIKRIRLEHEEEGVPG----TAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN 117
Query: 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL--- 732
L +++ + + + + GV + H + +HRDLKP N+LL
Sbjct: 118 -DLKKYM-----DKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVS 168
Query: 733 --GDDMRAKVADFGLVRLAPEGKGSIETRI----AGTFGYLAPE-------YAVTGRVTT 779
+ K+ DFGL R I R T Y PE Y +T
Sbjct: 169 DASETPVLKIGDFGLARAF-----GIPIRQFTHEIITLWYRPPEILLGSRHY------ST 217
Query: 780 KVDVFSFGVILMELITGR 797
VD++S I E++
Sbjct: 218 SVDIWSIACIWAEMLMKT 235
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 55/226 (24%), Positives = 83/226 (36%), Gaps = 59/226 (26%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRM------EAGVISGKGLTEFKSEIAVLTKVRHRHL 653
LG G FG V+ ++ VK + E I L + EIA+L++V H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 654 VALLGHCLDGNEKL-LVFEYMPQG---------------TLSRHIFNWAEEGLKPLEWNR 697
+ +L + LV E G L+ +IF
Sbjct: 92 IKVL-DIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR------------- 137
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE 757
+ V YL + IHRD+K NI++ +D K+ DFG G
Sbjct: 138 ------QLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFY 187
Query: 758 TRIAGTFGYLAPE------YAVTGRVTTKVDVFSFGVILMELITGR 797
T GT Y APE Y G +++++S GV L L+
Sbjct: 188 T-FCGTIEYCAPEVLMGNPYR--GP---ELEMWSLGVTLYTLVFEE 227
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 51/268 (19%), Positives = 97/268 (36%), Gaps = 92/268 (34%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS----EIAV 644
+ +S LG G FG V + ++ G + A+K+ + + E+ +
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK----------VLQDPRYKNRELDI 53
Query: 645 LTKVRHRHLVALLGHCLDGNEKL------------------------------------- 667
+ + H +++ L+ + ++
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 668 -LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL------DVARGVEYLHGLAHQSF 720
++ EY+P TL + + ++ R + + L + R V ++H L
Sbjct: 114 NVIMEYVPD-TLHKVLKSFIRS-------GRSIPMNLISIYIYQLFRAVGFIHSL---GI 162
Query: 721 IHRDLKPSNILL-GDDMRAKVADFGLVRLAPEGKGSIE---TRIAGTFGYLAPE------ 770
HRD+KP N+L+ D K+ DFG + + S+ +R Y APE
Sbjct: 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGAT 217
Query: 771 -YAVTGRVTTKVDVFSFGVILMELITGR 797
Y T +D++S G + ELI G+
Sbjct: 218 EY------TPSIDLWSIGCVFGELILGK 239
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 60/288 (20%), Positives = 103/288 (35%), Gaps = 36/288 (12%)
Query: 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFT 128
+ + + + + S+LQ L+ L L N I+ S + L SLE + LS N +
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS 113
Query: 129 SVPSDFFTGLSSLQSIEIDNNPFSS---WEIPQSLRNASGLQNFSANSANITGQIPSFFG 185
++ S +F LSSL + + NP+ + + L L+ N T +I
Sbjct: 114 NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRV--GNMDTFT-KIQ---- 166
Query: 186 PDEFPGLT---ILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTS 241
+F GLT L + + L P S + L ++ + L + +S
Sbjct: 167 RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHM-KQHILLLEI--FVDVTSS 223
Query: 242 LKEIWLHSNAF---------SGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 292
++ + L +G ++ + D V L ++ L +
Sbjct: 224 VECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLEL 282
Query: 293 NMTNNLLQGPVPE--FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLS 338
+ N L+ VP+ FDR SL N P C LS
Sbjct: 283 EFSRNQLKS-VPDGIFDRLTSLQKIWLHTN-----PWDCSCPRIDYLS 324
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 51/352 (14%), Positives = 114/352 (32%), Gaps = 111/352 (31%)
Query: 83 TLPSNLQNLTKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQFTSVPSDFFTGLSS 140
++PS L ++ L+L N I+ + + L +L+ ++L++N ++ D F+ L S
Sbjct: 45 SIPSGL--TEAVKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGS 101
Query: 141 LQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFN 200
L+ +++ N S+ + S+F LT L+L N
Sbjct: 102 LEHLDLSYNYLSN--LS-----------------------SSWF--KPLSSLTFLNLLGN 134
Query: 201 QLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-- 258
++L G + ++T L+ + + + +
Sbjct: 135 P-------------YKTL------------GETSLFSHLTKLQILRVGNMDTFTKIQRKD 169
Query: 259 FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGS 318
F+G+ LE L + + P SL ++++ + +
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHM---------------------- 207
Query: 319 NNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQ 378
L D +++ + + + F
Sbjct: 208 KQHILLLEIFVD-VTSSVECL--------ELRDTD--------------------LDTFH 238
Query: 379 KMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
L+ + + + + + D +L + + L+ + L EL+ S NQL
Sbjct: 239 FSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 20/83 (24%), Positives = 34/83 (40%), Gaps = 2/83 (2%)
Query: 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFT 128
+ L ++L +++ S+ + LN ++ L + S NQ
Sbjct: 233 DLDTFHF--SELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK 290
Query: 129 SVPSDFFTGLSSLQSIEIDNNPF 151
SVP F L+SLQ I + NP+
Sbjct: 291 SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 28/220 (12%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKVRH 650
++F ++GRG F V ++ ++ A+K M + +G F+ E VL
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 651 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNR----RLTIALDV 705
R + L L LV EY G L + P E R + +A+
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMAI-- 175
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETRIAGTF 764
+ +H L ++HRD+KP NILL ++ADFG ++L +G GT
Sbjct: 176 ----DSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTP 227
Query: 765 GYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 797
YL+PE TG + D ++ GV E+ G+
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 56/236 (23%), Positives = 91/236 (38%), Gaps = 57/236 (24%)
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVK--RMEAGVISGKGLTE---FKS----EI 642
+ + + +G+G FG V+K G K+A+K ME E F EI
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME---------NEKEGFPITALREI 67
Query: 643 AVLTKVRHRHLVALLGHCLDGNEKL--------LVFEYMPQ---GTLSRHIFNWAEEGLK 691
+L ++H ++V L+ C LVF++ G LS + + +K
Sbjct: 68 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 127
Query: 692 PLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--A 749
+ + G+ Y+H +HRD+K +N+L+ D K+ADFGL R
Sbjct: 128 --------RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 176
Query: 750 PEGKGSIE-TRIAGTFGYLAPE-------YAVTGRVTTKVDVFSFGVILMELITGR 797
+ T T Y PE Y +D++ G I+ E+ T
Sbjct: 177 AKNSQPNRYTNRVVTLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 54/375 (14%), Positives = 112/375 (29%), Gaps = 85/375 (22%)
Query: 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQF 127
+ + + ++ ++ L L+ L+++ + + + GL+SL ++ L NQF
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187
+ + F GL++L+ + + + +FF
Sbjct: 92 LQLETGAFNGLANLEVLTLTQCNLDGAVLS-----------------------GNFF--K 126
Query: 188 EFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWL 247
L +L L N I+ + NM + L
Sbjct: 127 PLTSLEMLVLRDNN-------------IKKIQPAS------------FFLNMRRFHVLDL 161
Query: 248 HSNAFSG-PLPDFSG--VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP 304
N D K L L L+ + L
Sbjct: 162 TFNKVKSICEEDLLNFQGKHFTLLRLSSI-----------TLQDMN----EYWLGWEKCG 206
Query: 305 EFDRSVSLDMAKGSNNF--CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDW 362
++ S+ S N + D ++ K+ + N + +++
Sbjct: 207 NPFKNTSITTLDLSGNGFKESMAKRFFD-----AIAGTKIQSLILSNSYNMGSSFGHTNF 261
Query: 363 IGVT-CTKGNITVINFQKMNLTG----TISPE-FASFKSLQRLILADNNLSGMIPEG-LS 415
T + + +L+ + F+ F L++L LA N ++ I +
Sbjct: 262 KDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFW 320
Query: 416 VLGALKELDVSNNQL 430
L L +L++S N L
Sbjct: 321 GLTHLLKLNLSQNFL 335
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-16
Identities = 54/372 (14%), Positives = 113/372 (30%), Gaps = 81/372 (21%)
Query: 83 TLPSN-LQNLTKLERLELQWNSI-SGPLP--SLNGLASLEVVMLSNNQFTSV-PSDFFTG 137
L + L LE L L ++ L L SLE+++L +N + P+ FF
Sbjct: 93 QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLN 152
Query: 138 LSSLQSIEIDNNPFSSWEIP---------QSLRNASGLQNFSANSANITGQIPSFFGPDE 188
+ +++ N S I + + P +
Sbjct: 153 MRRFHVLDLTFNKVKS--ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210
Query: 189 FPGLTILHLAFNQLIGGLPASF----SGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKE 244
+T L L+ N + F +G++IQSL ++ + N G ++ +
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS-NSYNMGSSFGHTNFKDPDNFTF 269
Query: 245 IWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP 304
L ++ +++ L + + L+ + + N + +
Sbjct: 270 KGLEAS-------------GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KID 315
Query: 305 E--FDRSVSLDMAKGSNNF--CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCS 360
+ F L S NF + + L
Sbjct: 316 DNAFWGLTHLLKLNLSQNFLGSID-SRMFE----------NL------------------ 346
Query: 361 DWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEG-LSVLG 418
+ V++ ++ + + F +L+ L L N L +P+G L
Sbjct: 347 ---------DKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLT 395
Query: 419 ALKELDVSNNQL 430
+L+++ + N
Sbjct: 396 SLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 6e-16
Identities = 78/444 (17%), Positives = 149/444 (33%), Gaps = 105/444 (23%)
Query: 71 TRIQIGHQNLQGTLPSNL-QNLTKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQF 127
+++ Q + +N + L+ L L+L +N L + NGLA+LEV+ L+
Sbjct: 57 QFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ-LETGAFNGLANLEVLTLTQCNL 115
Query: 128 TS--VPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSF 183
+ +FF L+SL+ + + +N + N + + N + I
Sbjct: 116 DGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN--KVK-SIC-- 170
Query: 184 FGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLK 243
++ H +L S +Q + N TS+
Sbjct: 171 --EEDLLNFQGKHFTLLRL--------SSITLQDM-----NEYWLGWEKCGNPFKNTSIT 215
Query: 244 EIWLHSNAF----SGPLPDFSGVKQLESLSLRDNF----------FTGPVPDSLVKLE-- 287
+ L N F + D +++SL L +++ F P + LE
Sbjct: 216 TLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEAS 275
Query: 288 SLKIVNMTNNLLQGPVPE--FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGY 345
+K +++ + + + + F L+ + N +N +
Sbjct: 276 GVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQN-----------EINKI--------- 314
Query: 346 PQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADN 404
+ + G+T ++ +N + N G+I F + L+ L L+ N
Sbjct: 315 ------------DDNAFWGLT----HLLKLNLSQ-NFLGSIDSRMFENLDKLEVLDLSYN 357
Query: 405 NLSGMIPEGL-SVLGALKELDVSNNQLYGKIP-----SFKSNAIVNTDGNP------DIG 452
++ + + L LKEL + NQL +P S + NP I
Sbjct: 358 HIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 415
Query: 453 ------KEKSSSFQGSPSGSPTGT 470
+ S QGS S +G
Sbjct: 416 YLSRWLNKNSQKEQGSAKCSGSGK 439
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 36/248 (14%), Positives = 75/248 (30%), Gaps = 72/248 (29%)
Query: 68 KRITRIQIGHQNLQGTLPS---NLQNLTKLERLELQWNSISGPLPSLNGL---------- 114
IT + + + ++ + TK++ L L + G
Sbjct: 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271
Query: 115 ---ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSA 171
+ ++ LS ++ ++ F+ + L+ + + N + I
Sbjct: 272 LEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINK--ID-------------- 315
Query: 172 NSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGG 231
+ F L L+L+ N L G + +
Sbjct: 316 ---------DNAF--WGLTHLLKLNLSQNFL-GSIDS----------------------- 340
Query: 232 GIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESL 289
+ +N+ L+ + L N L D F G+ L+ L+L N +L SL
Sbjct: 341 --RMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSL 397
Query: 290 KIVNMTNN 297
+ + + N
Sbjct: 398 QKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 6e-11
Identities = 45/219 (20%), Positives = 74/219 (33%), Gaps = 58/219 (26%)
Query: 37 LALKKSLNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNL-QNLTKLE 95
L L S N S G ++ +E + + + L ++ + T LE
Sbjct: 244 LILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLE 302
Query: 96 RLELQWNSISGPLPS--LNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSS 153
+L L N I+ + GL L + LS N S+ S F L L+ +++ N +
Sbjct: 303 QLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA 361
Query: 154 WEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGS 213
+ F P L L L NQL
Sbjct: 362 --LG-----------------------DQSF--LGLPNLKELALDTNQL----------- 383
Query: 214 QIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAF 252
+S+ +G + +TSL++IWLH+N +
Sbjct: 384 --KSV----PDG---------IFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 47/282 (16%), Positives = 89/282 (31%), Gaps = 41/282 (14%)
Query: 186 PDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKE 244
P+ + + L+ N + SFS +Q L V Q + + ++SL
Sbjct: 26 PELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNN--TFRGLSSLII 83
Query: 245 IWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPV--PDSLVKLESLKIVNMTNNLLQ 300
+ L N F L F+G+ LE L+L G V + L SL+++ + +N ++
Sbjct: 84 LKLDYNQFLQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK 142
Query: 301 --GPVPEFDRSVSLDMAKGSNN--FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGN 356
P F + + N + ++++L
Sbjct: 143 KIQPASFFLNMRRFHVLDLTFNKVKSIC-EEDLLNFQGKHFTLLRL-------------- 187
Query: 357 DPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSV 416
+IT+ + + L S+ L L+ N + +
Sbjct: 188 -------------SSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFD 234
Query: 417 LGALKEL-DVSNNQLYGKIPSFKSNAIVNTDGNPDIGKEKSS 457
A ++ + + Y SF + D G E S
Sbjct: 235 AIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASG 276
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 41/228 (17%), Positives = 80/228 (35%), Gaps = 20/228 (8%)
Query: 83 TLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSL 141
P L+ L+ + + + LP ++ A LE + L+ N ++P+ L+ L
Sbjct: 95 QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLRALPASI-ASLNRL 152
Query: 142 QSIEIDNNP--------FSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLT 193
+ + I P +S + + LQ+ I +P+ L
Sbjct: 153 RELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIA--NLQNLK 209
Query: 194 ILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAF 252
L + + L L + +++ L + G + LK + L +
Sbjct: 210 SLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNY---PPIFGGRAPLKRLILKDCSN 265
Query: 253 SGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 299
LP + QLE L LR +P + +L + I+ + +L
Sbjct: 266 LLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 6e-20
Identities = 37/233 (15%), Positives = 85/233 (36%), Gaps = 22/233 (9%)
Query: 83 TLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTG-LSSL 141
L + + + + N + ++ + +
Sbjct: 27 PYHDVLSQWQRHYNADRNRWHSAWRQANSN---NPQIETRTGRALKATADLLEDATQPGR 83
Query: 142 QSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQ 201
++E+ + P P S LQ+ + ++A + ++P +F GL L LA N
Sbjct: 84 VALELRSVPLPQ--FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQ--QFAGLETLTLARNP 138
Query: 202 LIGGLPASFSG-SQIQSLWVNGQNGNAKL------GGGIDVIQNMTSLKEIWLHSNAFSG 254
L LPAS + ++++ L + +L Q + +L+ + L
Sbjct: 139 LR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS 197
Query: 255 PLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT-NNLLQGPVPE 305
LP + ++ L+SL +R++ + + ++ L L+ +++ L+ P
Sbjct: 198 -LPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRN-YPP 247
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 38/225 (16%), Positives = 76/225 (33%), Gaps = 41/225 (18%)
Query: 83 TLPSNLQNLT--KLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLS 139
L++ T LEL+ + P L+ L+ + + +P +
Sbjct: 70 ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLMELPDTM-QQFA 127
Query: 140 SLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPG-------L 192
L+++ + NP + +P S+ + + L+ S + ++P + G L
Sbjct: 128 GLETLTLARNPLRA--LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185
Query: 193 TILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAF 252
L L + + LPAS + N+ +LK + + ++
Sbjct: 186 QSLRLEWTGIRS-LPASIA--------------------------NLQNLKSLKIRNSPL 218
Query: 253 SGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
S P + +LE L LR P LK + + +
Sbjct: 219 SALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC 263
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 43/324 (13%), Positives = 78/324 (24%), Gaps = 75/324 (23%)
Query: 114 LASLEVVMLSN-NQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSAN 172
+ E + LS Q + + W N++ Q +
Sbjct: 11 SSGRENLYFQGSTALRPYHD----VLSQWQRHYNADR--NRWHSAWRQANSNNPQIETRT 64
Query: 173 SANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGG 232
+ PG L L +
Sbjct: 65 GRALK-ATADLLEDATQPGRVALEL-------------RSVPLPQFP------------- 97
Query: 233 IDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 291
D ++ L+ + + + LPD LE+L+L N +P S+ L L+
Sbjct: 98 -DQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRE 154
Query: 292 VNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL----LSVVKLMGYPQ 347
+++ +PE L L L + P
Sbjct: 155 LSIRACPELTELPE--------------PLASTDASGEHQGLVNLQSLRLEWTGIRSLPA 200
Query: 348 RFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLS 407
N + N+ + + L+ + P L+ L L
Sbjct: 201 SI-ANLQ----------------NLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTAL 242
Query: 408 GMIPEGLSVLGALKELDVSN-NQL 430
P LK L + + + L
Sbjct: 243 RNYPPIFGGRAPLKRLILKDCSNL 266
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 6e-10
Identities = 22/139 (15%), Positives = 47/139 (33%), Gaps = 8/139 (5%)
Query: 81 QGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSS 140
Q L L+ L L+W I S+ L +L+ + + N+ +++ L
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSALGPA-IHHLPK 230
Query: 141 LQSIEI-DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAF 199
L+ +++ + P + L+ + +P L L L
Sbjct: 231 LEELDLRGCTALRN--YPPIFGGRAPLKRLILKDCSNLLTLPLDIH--RLTQLEKLDLRG 286
Query: 200 NQLIGGLPASFSGSQIQSL 218
+ LP+ +Q+ +
Sbjct: 287 CVNLSRLPSLI--AQLPAN 303
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 16/77 (20%), Positives = 27/77 (35%), Gaps = 3/77 (3%)
Query: 75 IGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNN-QFTSVPS 132
+ P L+RL L+ S LP ++ L LE + L + +PS
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
Query: 133 DFFTGLSSLQSIEIDNN 149
L + I + +
Sbjct: 296 L-IAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 27/217 (12%), Positives = 59/217 (27%), Gaps = 58/217 (26%)
Query: 229 LGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLES 288
+G + + + ++ + P D + Q + D +
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHD--VLSQWQRHYNADRNRWHS-AWRQANSNN 57
Query: 289 LKIVNMTNNLLQGPVPEFDRS-----VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLM 343
+I T L+ + + V+L++ + L
Sbjct: 58 PQIETRTGRALKATADLLEDATQPGRVALEL---RSV-----------PLPQF------- 96
Query: 344 GYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTG----TISPEFASFKSLQRL 399
P + ++ + Q M + + F L+ L
Sbjct: 97 --PDQA--------------------FRLS--HLQHMTIDAAGLMELPDTMQQFAGLETL 132
Query: 400 ILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 436
LA N L +P ++ L L+EL + ++P
Sbjct: 133 TLARNPLRA-LPASIASLNRLRELSIRACPELTELPE 168
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 56/227 (24%), Positives = 90/227 (39%), Gaps = 44/227 (19%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-------- 640
V + +G G G V + +A+K++ F++
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR---------PFQNQTHAKRAY 72
Query: 641 -EIAVLTKVRHRHLVALL------GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPL 693
E+ ++ V H++++ LL + + +V E M L + I L
Sbjct: 73 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-------QMEL 124
Query: 694 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753
+ R + + G+++LH A IHRDLKPSNI++ D K+ DFGL R A
Sbjct: 125 DHERMSYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
Query: 754 GSIE---TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 797
TR Y APE + VD++S G I+ E+I G
Sbjct: 182 MMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 69/264 (26%), Positives = 112/264 (42%), Gaps = 12/264 (4%)
Query: 537 SGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFS 596
+ E E ++ + S P D E + ++ R N F
Sbjct: 92 TPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFE 151
Query: 597 EENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEF-KSEIAVLTKVRHRHLV 654
+LG+G FG V + + A+K ++ VI K +E VL RH L
Sbjct: 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 655 ALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
AL + +++L V EY G L H+ + E + E R A ++ ++YLH
Sbjct: 212 ALK-YSFQTHDRLCFVMEYANGGELFFHL---SRERVFS-EDRARFYGA-EIVSALDYLH 265
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV 773
++ ++RDLK N++L D K+ DFGL + + +++T GT YLAPE
Sbjct: 266 S--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLE 322
Query: 774 TGRVTTKVDVFSFGVILMELITGR 797
VD + GV++ E++ GR
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-22
Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 26/218 (11%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKVRH 650
+F ++GRG FG V +L + K+ A+K + + + T F+ E VL
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 651 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNR----RLTIALDV 705
+ + L D + L LV +Y G L + + E P E R + IA+
Sbjct: 134 KWITTLHYAFQD-DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAI-- 188
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA-GTF 764
+ +H L ++HRD+KP NIL+ + ++ADFG E G++++ +A GT
Sbjct: 189 ----DSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTP 240
Query: 765 GYLAPE-----YAVTGRVTTKVDVFSFGVILMELITGR 797
Y++PE GR + D +S GV + E++ G
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 4e-22
Identities = 71/293 (24%), Positives = 115/293 (39%), Gaps = 58/293 (19%)
Query: 530 MVIHPRHSGSENSESVKITVA---GSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQ 586
M +H + SE + VKI V V I++ H S D Q S++
Sbjct: 1 MSLHFLYYCSEPTLDVKIAFCQGFDKQVDVSYIAK-HYNMSKSKVDNQF-------YSVE 52
Query: 587 VLRN---VTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-- 640
V + V + +G G G V + +A+K++ F++
Sbjct: 53 VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR---------PFQNQT 103
Query: 641 -------EIAVLTKVRHRHLVALL------GHCLDGNEKLLVFEYMPQGTLSRHIFNWAE 687
E+ ++ V H+++++LL + + LV E M L + I
Sbjct: 104 HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI----- 157
Query: 688 EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
L+ R + + G+++LH A IHRDLKPSNI++ D K+ DFGL R
Sbjct: 158 --QMELDHERMSYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 212
Query: 748 LAPEGKGSIE---TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 797
A TR Y APE + VD++S G I+ E++ +
Sbjct: 213 TAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 5e-22
Identities = 57/214 (26%), Positives = 80/214 (37%), Gaps = 43/214 (20%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
+G G FG +AVK +E G + + + EI +RH ++V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV---QREIINHRSLRHPNIVRFKEV 84
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVEY 711
L ++ EY G L I N R + D AR GV Y
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICN-----------AGRFSE--DEARFFFQQLLSGVSY 131
Query: 712 LHGLAHQSFIHRDLKPSNILL--GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
H HRDLK N LL R K+ DFG + + ++ + GT Y+AP
Sbjct: 132 CH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAP 186
Query: 770 E------YAVTGRVTTKVDVFSFGVILMELITGR 797
E Y G+ DV+S GV L ++ G
Sbjct: 187 EVLLRQEYD--GK---IADVWSCGVTLYVMLVGA 215
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-21
Identities = 56/221 (25%), Positives = 89/221 (40%), Gaps = 35/221 (15%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 650
++ ++GRG FG V K+ A+K + +I F E ++
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 651 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR-- 707
+V L + + L +V EYMP G L + + AR
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM--------------SNYDVPEKWARFY 173
Query: 708 ------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETRI 760
++ +H + FIHRD+KP N+LL K+ADFG +++ EG +T
Sbjct: 174 TAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-A 229
Query: 761 AGTFGYLAPE----YAVTGRVTTKVDVFSFGVILMELITGR 797
GT Y++PE G + D +S GV L E++ G
Sbjct: 230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 2e-21
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 27/208 (12%)
Query: 601 LGRGGFGTVY---KGELHDGTKI-AVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
LG+G FG V+ K D ++ A+K ++ + + K E +L +V H +V L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 657 LGH-CLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNR----RLTIALDVARGVE 710
H KL L+ +++ G L + ++E + E + L +AL +
Sbjct: 92 --HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALAL------D 140
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+LH L I+RDLKP NILL ++ K+ DFGL + + + + + GT Y+APE
Sbjct: 141 HLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPE 196
Query: 771 YAVTGRVTTK-VDVFSFGVILMELITGR 797
V R T+ D +SFGV++ E++TG
Sbjct: 197 -VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-21
Identities = 61/216 (28%), Positives = 87/216 (40%), Gaps = 32/216 (14%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 650
+ F LG G FG V + + A+K ++ V+ K + +E +L V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 651 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR-- 707
LV L D N L +V EY+ G + H L R + AR
Sbjct: 101 PFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSH-----------LRRIGRFSE--PHARFY 146
Query: 708 ------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA 761
EYLH I+RDLKP N+L+ +V DFG A KG T +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFG---FAKRVKGRTWT-LC 199
Query: 762 GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 797
GT LAPE ++ VD ++ GV++ E+ G
Sbjct: 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 50/222 (22%), Positives = 88/222 (39%), Gaps = 21/222 (9%)
Query: 88 LQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147
L KL++L + N + +P N +SL + + +N+ VP F+GL ++ IE+
Sbjct: 98 FSPLRKLQKLYISKNHLVE-IPP-NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMG 155
Query: 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLP 207
NP + + L + A +T IP D L LHL N+ I +
Sbjct: 156 GNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIP----KDLPETLNELHLDHNK-IQAIE 209
Query: 208 A-SFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL 265
S++ L + N + G + + +L+E+ L +N S +K L
Sbjct: 210 LEDLLRYSKLYRLGLGH-NQIRMIENG--SLSFLPTLRELHLDNNKLSRVPAGLPDLKLL 266
Query: 266 ESLSLRDNFFTGPVPDS-------LVKLESLKIVNMTNNLLQ 300
+ + L N T V + VK +++ NN +
Sbjct: 267 QVVYLHTNNITK-VGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 55/253 (21%), Positives = 88/253 (34%), Gaps = 40/253 (15%)
Query: 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLA 115
C V C D + + + + L+LQ N IS GL
Sbjct: 33 CHLRVVQC-SDLGLKAVPKE-------ISPDTT------LLDLQNNDISELRKDDFKGLQ 78
Query: 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175
L ++L NN+ + + F+ L LQ + I N IP +L S L +
Sbjct: 79 HLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVE--IPPNL--PSSLVELRIHDNR 134
Query: 176 ITGQIPSFFGPDEFPG---LTILHLAFNQLIGGL--PASFSGSQIQSLWVNGQNGNAKLG 230
I ++P F G + + + N L P +F G ++ L ++
Sbjct: 135 IR-KVP----KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK------ 183
Query: 231 GGIDVIQNM--TSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLE 287
+ I +L E+ L N L D +L L L N SL L
Sbjct: 184 --LTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLP 241
Query: 288 SLKIVNMTNNLLQ 300
+L+ +++ NN L
Sbjct: 242 TLRELHLDNNKLS 254
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 30/195 (15%), Positives = 53/195 (27%), Gaps = 54/195 (27%)
Query: 83 TLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSL 141
+P +L L L L N I L L + L + L +NQ + + + L +L
Sbjct: 186 GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTL 243
Query: 142 QSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQ 201
+ + +DNN S +P L + L +++L N
Sbjct: 244 RELHLDNNKLSR--VPAGLPD--------------------------LKLLQVVYLHTNN 275
Query: 202 LIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS-GPLPD-- 258
+ F I L +N +
Sbjct: 276 ITKVGVNDFCPVGFGV--------------------KRAYYNGISLFNNPVPYWEVQPAT 315
Query: 259 FSGVKQLESLSLRDN 273
F V ++ +
Sbjct: 316 FRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 61/334 (18%), Positives = 98/334 (29%), Gaps = 122/334 (36%)
Query: 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175
L VV S+ +VP + + L ++ NN S + +
Sbjct: 34 HLRVVQCSDLGLKAVPKEISPDTTLL---DLQNNDISE--LRKD---------------- 72
Query: 176 ITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDV 235
F G L L L N++ S+I
Sbjct: 73 ------DFKG---LQHLYALVLVNNKI----------SKIHE----------------KA 97
Query: 236 IQNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 294
+ L+++++ N P S L L + DN L ++ + M
Sbjct: 98 FSPLRKLQKLYISKNHLVEIPPNLPSS---LVELRIHDNRIRKVPKGVFSGLRNMNCIEM 154
Query: 295 TNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 354
N L+ + PGA D L + L R +E
Sbjct: 155 GGNPLE--------NSGF------------EPGAFDG-----LKLNYL-----RISEA-- 182
Query: 355 GNDPCSDWIGVTCTKGNITVI------NFQKMNLTG----TISPE-FASFKSLQRLILAD 403
+T I +++L I E + L RL L
Sbjct: 183 ----------------KLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGH 226
Query: 404 NNLSGMIPEG-LSVLGALKELDVSNNQLYGKIPS 436
N + MI G LS L L+EL + NN+L ++P+
Sbjct: 227 NQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPA 258
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 3e-21
Identities = 68/285 (23%), Positives = 97/285 (34%), Gaps = 44/285 (15%)
Query: 83 TLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQ 142
+LP L +L + LPS GL L + NQ TS+P LQ
Sbjct: 95 SLPVLPPGLLELSIFSNPLTHLP-ALPS--GLCKLW---IFGNQLTSLPVL----PPGLQ 144
Query: 143 SIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL 202
+ + +N +S +P L A + +T + P GL L ++ NQL
Sbjct: 145 ELSVSDNQLAS--LPALPSE---LCKLWAYNNQLT-SL-----PMLPSGLQELSVSDNQL 193
Query: 203 IGGLPASFSGSQIQSLWVNGQNGNAKLGGGI------DVIQN--------MTSLKEIWLH 248
LP S++ LW N L V N + LKE+ +
Sbjct: 194 A-SLPTLP--SELYKLWAY-NNRLTSLPALPSGLKELIVSGNRLTSLPVLPSELKELMVS 249
Query: 249 SNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDR 308
N + LP L SLS+ N T +P+SL+ L S VN+ N L + R
Sbjct: 250 GNRLTS-LPMLPS--GLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALR 305
Query: 309 S-VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 352
S G + + AL P R E
Sbjct: 306 EITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEP 350
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 3e-19
Identities = 67/360 (18%), Positives = 119/360 (33%), Gaps = 86/360 (23%)
Query: 74 QIGHQNLQGTLPSNLQN--LTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVP 131
+ + ++ L + + ++ LP A + +++ +N TS+P
Sbjct: 20 PAEESRGRAAVVQKMRACLNNGNAVLNVGESGLTT-LPD-CLPAHITTLVIPDNNLTSLP 77
Query: 132 SDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPG 191
+ L+++E+ N +S +P L FS ++ P G
Sbjct: 78 A----LPPELRTLEVSGNQLTS--LPVLPPGLLELSIFSNPLTHL---------PALPSG 122
Query: 192 LTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA 251
L L + NQL LP +Q L V+ N A L + L ++W ++N
Sbjct: 123 LCKLWIFGNQLTS-LPVLPP--GLQELSVSD-NQLASLPALP------SELCKLWAYNNQ 172
Query: 252 FSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSV- 310
+ LP L+ LS+ DN +P +L L N N L +P +
Sbjct: 173 LTS-LPM--LPSGLQELSVSDNQLAS-LPTLPSELYKLWAYN--NRLTS--LPALPSGLK 224
Query: 311 SLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKG 370
L + S N RL +L P
Sbjct: 225 ELIV---SGN-----------RLTSL---------------------PVL--------PS 241
Query: 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
+ + LT ++ + L L + N L+ +PE L L + +++ N L
Sbjct: 242 ELKELMVSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 296
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 2e-14
Identities = 55/343 (16%), Positives = 96/343 (27%), Gaps = 94/343 (27%)
Query: 116 SLEVVMLSNNQFTSVPSDFFTGL-----------------SSLQSIEIDNNPFSSWEIPQ 158
V+ + + T++P + L+++E+ N +S +P
Sbjct: 41 GNAVLNVGESGLTTLPDCLPAHITTLVIPDNNLTSLPALPPELRTLEVSGNQLTS--LPV 98
Query: 159 SLRNASGLQNFSANSANITGQIPSFFG-----------PDEFPGLTILHLAFNQLIGGLP 207
L FS ++ P PGL L ++ NQL LP
Sbjct: 99 LPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQL-ASLP 157
Query: 208 ASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLES 267
A S++ LW N L + L+E+ + N + LP +L
Sbjct: 158 ALP--SELCKLWAYN-NQLTSLPMLP------SGLQELSVSDNQLAS-LPT--LPSELYK 205
Query: 268 LSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPG 327
L +N T +P L+ L ++ N L L + S N
Sbjct: 206 LWAYNNRLT-SLPALPSGLKEL---IVSGNRLTSLPVLPSELKELMV---SGN------- 251
Query: 328 ACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTIS 387
RL +L + ++ + LT +
Sbjct: 252 ----RLTSL-----------------------PMLP------SGLLSLSVYRNQLT-RLP 277
Query: 388 PEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
S + L N LS + L + + +
Sbjct: 278 ESLIHLSSETTVNLEGNPLSERTLQ---ALREITSAPGYSGPI 317
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-21
Identities = 48/271 (17%), Positives = 93/271 (34%), Gaps = 40/271 (14%)
Query: 539 SENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSE- 597
+ +S + + P ++P + + + +
Sbjct: 4 NSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDY 63
Query: 598 ---ENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRH 652
+LG G G V + K A+K ++ + + E+ + + + H
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALK-----MLQDC--PKARREVELHWRASQCPH 116
Query: 653 LVALLGHCLDGNEK----LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IA 702
+V ++ + L+V E + G L I + G ++ T I
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ---DRG------DQAFTEREASEIM 167
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETR 759
+ ++YLH + HRD+KP N+L + K+ DFG + + T
Sbjct: 168 KSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTT- 222
Query: 760 IAGTFGYLAPEYAVTGRVTTKVDVFSFGVIL 790
T Y+APE + D++S GVI+
Sbjct: 223 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 46/250 (18%), Positives = 95/250 (38%), Gaps = 34/250 (13%)
Query: 60 NHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLE 118
C + + + P + +R+ L N IS P S +L
Sbjct: 14 VTTSC-PQQGLQAV-----------PVGI--PAASQRIFLHGNRISHVPAASFRACRNLT 59
Query: 119 VVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQS-LRNASGLQNFSANSANIT 177
++ L +N + + FTGL+ L+ +++ +N + + L + +
Sbjct: 60 ILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR-SVDPATFHGLGRLHTLHLDRCGLQ 118
Query: 178 GQIPSFFGPDEFPGLT---ILHLAFNQLIGGLPA-SFSG-SQIQSLWVNGQNGNAKLGGG 232
++ P F GL L+L N + LP +F + L+++G N + +
Sbjct: 119 -ELG----PGLFRGLAALQYLYLQDNA-LQALPDDTFRDLGNLTHLFLHG-NRISSVPER 171
Query: 233 IDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLK 290
+ + SL + LH N + + F + +L +L L N + ++L L +L+
Sbjct: 172 --AFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228
Query: 291 IVNMTNNLLQ 300
+ + +N
Sbjct: 229 YLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 31/139 (22%), Positives = 54/139 (38%), Gaps = 27/139 (19%)
Query: 77 HQNLQGTLPSN-LQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDF 134
H N ++P + L L+RL L N ++ + L L + L N +++P++
Sbjct: 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEA 220
Query: 135 FTGLSSLQSIEIDNNP---------FSSWEIPQSLRNASGLQNFSANSANITGQIPSFFG 185
L +LQ + +++NP +W LQ F +S+ +
Sbjct: 221 LAPLRALQYLRLNDNPWVCDCRARPLWAW-----------LQKFRGSSSEVPCS-----L 264
Query: 186 PDEFPGLTILHLAFNQLIG 204
P G + LA N L G
Sbjct: 265 PQRLAGRDLKRLAANDLQG 283
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 53/319 (16%), Positives = 87/319 (27%), Gaps = 105/319 (32%)
Query: 120 VMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQ 179
+VP + Q I + N S +P +
Sbjct: 16 TSCPQQGLQAVPVGIPA---ASQRIFLHGNRISH--VPAA-------------------- 50
Query: 180 IPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNM 239
SF LTIL L N L ++I + +
Sbjct: 51 --SFRA---CRNLTILWLHSNVL----------ARIDA----------------AAFTGL 79
Query: 240 TSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT-N 296
L+++ L NA + F G+ +L +L L P L +L+ + + N
Sbjct: 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDN 139
Query: 297 NLLQGPVPEFDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENW 353
L P F +L + N A L
Sbjct: 140 ALQALPDDTFRDLGNLTHLFL--HGNRISSVPERA----FRGL----------------- 176
Query: 354 KGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPE 412
++ + + + + P F L L L NNLS +P
Sbjct: 177 ----------------HSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPT 218
Query: 413 G-LSVLGALKELDVSNNQL 430
L+ L AL+ L +++N
Sbjct: 219 EALAPLRALQYLRLNDNPW 237
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 4e-21
Identities = 63/237 (26%), Positives = 101/237 (42%), Gaps = 45/237 (18%)
Query: 586 QVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS---- 640
+++ N++++F +++LG G +G V G +A+K++E F
Sbjct: 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP----------FDKPLFA 53
Query: 641 -----EIAVLTKVRHRHLVALL-----GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL 690
EI +L +H +++ + + NE ++ E M Q L R I
Sbjct: 54 LRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIST------ 106
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750
+ L + R V+ LHG ++ IHRDLKPSN+L+ + KV DFGL R+
Sbjct: 107 QMLSDDHIQYFIYQTLRAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163
Query: 751 EGKGSIETRIAGTFG---------YLAPEYAVT-GRVTTKVDVFSFGVILMELITGR 797
E G Y APE +T + + +DV+S G IL EL R
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 48/261 (18%), Positives = 89/261 (34%), Gaps = 48/261 (18%)
Query: 57 CKWNHVVCIEDKRITRIQIG----------HQNLQGTLPSN-LQNLTKLERLELQWNSIS 105
C + C K +T + G N +LP LT+L +L L N +S
Sbjct: 7 CSGTEIRC-NSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 106 G---PLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRN 162
S G SL+ + LS N ++ S+F GL L+ ++ ++ + +
Sbjct: 66 FKGCCSQSDFGTTSLKYLDLSFNGVITMSSNF-LGLEQLEHLDFQHSNLKQ--MSE---- 118
Query: 163 ASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVN 221
S F L L ++ F+G S ++ L +
Sbjct: 119 ------------------FSVF--LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 158
Query: 222 GQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPV 279
G + + + +L + L L F+ + L+ L++ N F
Sbjct: 159 GNSFQENFLPD--IFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNFFSLD 215
Query: 280 PDSLVKLESLKIVNMTNNLLQ 300
L SL++++ + N +
Sbjct: 216 TFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 45/249 (18%), Positives = 78/249 (31%), Gaps = 73/249 (29%)
Query: 69 RITRIQIGHQNLQG---------------TLPSNLQNLTKLERLELQWNSIS--GPLPSL 111
++ Q+ G T+ SN L +LE L+ Q +++
Sbjct: 63 GLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 122
Query: 112 NGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSA 171
L +L + +S+ + F GLSSL+ +++ N F +P L+N
Sbjct: 123 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT---ELRN--- 176
Query: 172 NSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGG 231
LT L L+ QL Q+
Sbjct: 177 --------------------LTFLDLSQCQL----------EQLSP-------------- 192
Query: 232 GIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKL-ES 288
+++SL+ + + N F L + + L+ L N L S
Sbjct: 193 --TAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 249
Query: 289 LKIVNMTNN 297
L +N+T N
Sbjct: 250 LAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 30/182 (16%), Positives = 59/182 (32%), Gaps = 34/182 (18%)
Query: 77 HQNLQGTLPSN--LQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQF-TSVPS 132
+ + +L L L++ NGL+SLEV+ ++ N F +
Sbjct: 109 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 168
Query: 133 DFFTGLSSLQSIEIDNNPFSSWEIPQ-SLRNASGLQNFSANSANITGQIPSFFGPDEFPG 191
D FT L +L +++ + + + S LQ + + N +
Sbjct: 169 DIFTELRNLTFLDLSQCQLEQ--LSPTAFNSLSSLQVLNMSHNNFFSLDTFPY--KCLNS 224
Query: 192 LTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA 251
L +L + N + + ++Q +SL + L N
Sbjct: 225 LQVLDYSLNHI-----MTSKKQELQHFP--------------------SSLAFLNLTQND 259
Query: 252 FS 253
F+
Sbjct: 260 FA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 51/250 (20%), Positives = 88/250 (35%), Gaps = 42/250 (16%)
Query: 186 PDEFP-GLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLK 243
P P T L L N+L F +Q+ L ++ NG + G TSLK
Sbjct: 23 PTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLS-SNGLSFKGCCSQSDFGTTSLK 81
Query: 244 EIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTG-PVPDSLVKLESLKIVNMTNNLLQG- 301
+ L N +F G++QLE L + + + L +L +++++ +
Sbjct: 82 YLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 141
Query: 302 PVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSD 361
F+ SL++ K + N + + + L
Sbjct: 142 FNGIFNGLSSLEVLKMAGNSFQENFLP-----DIFTELRNL------------------- 177
Query: 362 WIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGAL 420
T ++ + L +SP F S SLQ L ++ NN + L +L
Sbjct: 178 -----------TFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 225
Query: 421 KELDVSNNQL 430
+ LD S N +
Sbjct: 226 QVLDYSLNHI 235
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 3e-20
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 32/216 (14%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 650
+F LG G FG V+ + A+K ++ V+ K + E +L+ V H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 651 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR-- 707
++ + G D +++ ++ +Y+ G L L ++R VA+
Sbjct: 66 PFIIRMWGTFQD-AQQIFMIMDYIEGGELFSL-----------LRKSQRFPN--PVAKFY 111
Query: 708 ------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA 761
+EYLH + I+RDLKP NILL + K+ DFG A T +
Sbjct: 112 AAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFG---FAKYVPDVTYT-LC 164
Query: 762 GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 797
GT Y+APE T +D +SFG+++ E++ G
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-20
Identities = 52/226 (23%), Positives = 96/226 (42%), Gaps = 38/226 (16%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-------- 640
+V ++ + +G G +G V + + ++A+K++ F+
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP----------FEHQTYCQRTL 73
Query: 641 -EIAVLTKVRHRHLVALL-----GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLE 694
EI +L + RH +++ + + +V + M + L + + + L
Sbjct: 74 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT------QHLS 126
Query: 695 WNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 754
+ + RG++Y+H + +HRDLKPSN+LL K+ DFGL R+A
Sbjct: 127 NDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 755 SIE--TRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGR 797
T T Y APE + T +D++S G IL E+++ R
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 5e-20
Identities = 59/207 (28%), Positives = 88/207 (42%), Gaps = 27/207 (13%)
Query: 601 LGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEF-KSEIAVLTKVRHRHLVALLG 658
LG+G FG V + A+K + VI K +E VL RH L AL
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 659 HCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTI------ALDVARGVEY 711
+ +++L V EY G L H L R T ++ +EY
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFH-----------LSRERVFTEERARFYGAEIVSALEY 120
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
LH ++RD+K N++L D K+ DFGL + +++T GT YLAPE
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPE- 175
Query: 772 AVTGRVTTK-VDVFSFGVILMELITGR 797
+ + VD + GV++ E++ GR
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 43/226 (19%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-------- 640
+ + +G G +G+V + G K+A+K++ F+S
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR---------PFQSEIFAKRAY 71
Query: 641 -EIAVLTKVRHRHLVALL-----GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPL 693
E+ +L ++H +++ LL L LV +M Q L + +
Sbjct: 72 RELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM-------GLKF 123
Query: 694 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEG 752
+ + + +G++Y+H +HRDLKP N+ + +D K+ DFGL R A E
Sbjct: 124 SEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180
Query: 753 KGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGR 797
G + TR Y APE ++ VD++S G I+ E++TG+
Sbjct: 181 TGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-19
Identities = 62/361 (17%), Positives = 122/361 (33%), Gaps = 47/361 (13%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGL 138
+Q T + + L L L+ +SI+ + + L L ++ ++N T++ +
Sbjct: 29 EMQATDTISEEQLATLTSLDCHNSSITD-MTGIEKLTGLTKLICTSNNITTLD---LSQN 84
Query: 139 SSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLA 198
++L + D+N ++ + + + L + ++ +T + P LT L+ A
Sbjct: 85 TNLTYLACDSNKLTN--LD--VTPLTKLTYLNCDTNKLTK-----LDVSQNPLLTYLNCA 135
Query: 199 FNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD 258
N L S L + N K+ + T L + N + D
Sbjct: 136 RNTL-----TEIDVSHNTQLTELDCHLNKKI--TKLDVTPQTQLTTLDCSFNKITE--LD 186
Query: 259 FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGS 318
S K L L+ N T + ++L L + N L + V + D S
Sbjct: 187 VSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSS--NKLTEIDVTPLTQLTYFDC---S 241
Query: 319 NNFCLPSPGACDPRLNAL---------LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTK 369
N + +L L + + AE + + VT
Sbjct: 242 VNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKE----LDVTHNT 297
Query: 370 GNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQ 429
+ +++ Q +T + + L L L + L+ + +S LK L N
Sbjct: 298 -QLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAH 350
Query: 430 L 430
+
Sbjct: 351 I 351
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 39/233 (16%), Positives = 74/233 (31%), Gaps = 42/233 (18%)
Query: 87 NLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146
++ + T+L L+ N L + L + S N+ T + + L +
Sbjct: 143 DVSHNTQLTELDCHLNKKITKLD-VTPQTQLTTLDCSFNKITELD---VSQNKLLNRLNC 198
Query: 147 DNNPFSSWEIPQ-----------------SLRNASGLQNFSANSANITGQIPSFFGPDEF 189
D N + ++ Q + + L F + +T S
Sbjct: 199 DTNNITKLDLNQNIQLTFLDCSSNKLTEIDVTPLTQLTYFDCSVNPLTELDVS-----TL 253
Query: 190 PGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHS 249
LT LH L+ + + + +Q+ G +L + + T L + +
Sbjct: 254 SKLTTLHCIQTDLL-EIDLTHN-TQLIYFQAEGCRKIKELD-----VTHNTQLYLLDCQA 306
Query: 250 NAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSL--VKLESLKIVNMTNNLLQ 300
+ L D S +L L L + T L LK ++ N +Q
Sbjct: 307 AGIT-EL-DLSQNPKLVYLYLNNTELT-----ELDVSHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 6e-13
Identities = 28/226 (12%), Positives = 62/226 (27%), Gaps = 49/226 (21%)
Query: 87 NLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146
+L +L L+ N ++ + + L L S N T + + LS L ++
Sbjct: 207 DLNQNIQLTFLDCSSNKLTE-ID-VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHC 261
Query: 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL---- 202
++ + + L F A + L +L +
Sbjct: 262 IQTDLLEIDLTHNTQ----LIYFQAEGCRKI-KELDVTH---NTQLYLLDCQAAGITELD 313
Query: 203 IGGLPA----SFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD 258
+ P + +++ L + + T LK + +
Sbjct: 314 LSQNPKLVYLYLNNTELTEL----------------DVSHNTKLKSLSCVNAHIQD-FSS 356
Query: 259 FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP 304
+ L + + + ++ +TNN L V
Sbjct: 357 VGKIPALNNNFEAEG-----------QTITMPKETLTNNSLTIAVS 391
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 34/219 (15%), Positives = 69/219 (31%), Gaps = 41/219 (18%)
Query: 89 QNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148
N + + S LA+L + N+ T + L+ L + +
Sbjct: 18 DNFASEVAAAFEMQATD--TISEEQLATLTSLDCHNSSITDMTG--IEKLTGLTKLICTS 73
Query: 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL----IG 204
N ++ + L + L + +S +T + LT L+ N+L +
Sbjct: 74 NNITT--LD--LSQNTNLTYLACDSNKLT-NLD----VTPLTKLTYLNCDTNKLTKLDVS 124
Query: 205 GLPA----SFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFS 260
P + + + + + + + T L E+ H N D +
Sbjct: 125 QNPLLTYLNCARNTLTEI----------------DVSHNTQLTELDCHLNKKI-TKLDVT 167
Query: 261 GVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 299
QL +L N T + + + L +N N +
Sbjct: 168 PQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNI 203
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 47/262 (17%), Positives = 81/262 (30%), Gaps = 39/262 (14%)
Query: 170 SANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAK 228
+ A T +F D F S + + SL + +
Sbjct: 1 NTLKAGQTQSFNDWFPDDNFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITD- 56
Query: 229 LGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLES 288
+ I+ +T L ++ SN + D S L L+ N T L KL
Sbjct: 57 ----MTGIEKLTGLTKLICTSNNITTL--DLSQNTNLTYLACDSNKLTNLDVTPLTKLTY 110
Query: 289 LKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQR 348
L N L + V + L+ + N L+ + + Q
Sbjct: 111 LNCDT--NKLTKLDVSQNPLLTYLNC---ARN---------------TLTEIDVSHNTQL 150
Query: 349 FAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSG 408
+ N + T +T ++ +T + + K L RL NN++
Sbjct: 151 TELDCHLNKKITKLDVTPQT--QLTTLDCSFNKIT---ELDVSQNKLLNRLNCDTNNIT- 204
Query: 409 MIPEGLSVLGALKELDVSNNQL 430
+ L+ L LD S+N+L
Sbjct: 205 KLD--LNQNIQLTFLDCSSNKL 224
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 7e-07
Identities = 17/99 (17%), Positives = 34/99 (34%), Gaps = 8/99 (8%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGL 138
+ ++ + T+L L+ Q I+ L L+ L + L+N + T + +
Sbjct: 284 GCRKIKELDVTHNTQLYLLDCQAAGIT-ELD-LSQNPKLVYLYLNNTELTELD---VSHN 338
Query: 139 SSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANIT 177
+ L+S+ N S+ L N
Sbjct: 339 TKLKSLSCVNAHIQD--FS-SVGKIPALNNNFEAEGQTI 374
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-19
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 29/210 (13%)
Query: 601 LGRGGFGTVY---KGELHDGTKI-AVKRMEAGVISGKG--LTEFKSEIAVLTKVRHRHLV 654
LG+GG+G V+ K + KI A+K ++ +I K+E +L +V+H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 655 ALLGH-CLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNR----RLTIALDVARG 708
L KL L+ EY+ G L + EG+ + +++AL
Sbjct: 85 DL--IYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMAL----- 134
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 768
+LH I+RDLKP NI+L K+ DFGL + + T GT Y+A
Sbjct: 135 -GHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYMA 189
Query: 769 PEYAVTGRVTTK-VDVFSFGVILMELITGR 797
PE + + VD +S G ++ +++TG
Sbjct: 190 PE-ILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 2e-19
Identities = 47/264 (17%), Positives = 91/264 (34%), Gaps = 39/264 (14%)
Query: 57 CKWNHVVCIEDKRITRIQIG----------HQNLQGTLPSN-LQNLTKLERLELQWNSIS 105
C +C ++ ++T I + LE++E+ N +
Sbjct: 9 CSNRVFLC-QESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 67
Query: 106 GPLPS--LNGLASLEVVMLSN-NQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRN 162
+ + + L L + + N + + F L +LQ + I N +P +
Sbjct: 68 EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH--LP-DVHK 124
Query: 163 ASGLQNFS---ANSANITGQIPSFFGPDEFPGLT----ILHLAFNQLIGGLPASFSGSQI 215
LQ ++ NI I + F GL+ IL L N + ++F+G+Q+
Sbjct: 125 IHSLQKVLLDIQDNINIH-TIE----RNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQL 179
Query: 216 QSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDN 273
L ++ N +L + + + + LP +K+L + S N
Sbjct: 180 DELNLSDNNNLEELPNDV--FHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTY-N 235
Query: 274 FFTGPVPDSLVKLESLKIVNMTNN 297
P + LV L ++T
Sbjct: 236 LKKLPTLEKLVALMEA---SLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 28/193 (14%), Positives = 56/193 (29%), Gaps = 14/193 (7%)
Query: 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA 174
+ + + + F+G L+ IEI N N L A
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89
Query: 175 NITGQIPSFFGPDEF---PGLTILHLAFNQLIGGLPASFSGS-QIQSLWVNGQNGNAKLG 230
N + + P+ F P L L ++ + S Q L + +
Sbjct: 90 N---NL-LYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 145
Query: 231 GGIDVIQNMTS-LKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLE 287
++ +WL+ N + + F+G + E +N D
Sbjct: 146 RN--SFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGAS 202
Query: 288 SLKIVNMTNNLLQ 300
I++++ +
Sbjct: 203 GPVILDISRTRIH 215
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 2e-19
Identities = 67/286 (23%), Positives = 108/286 (37%), Gaps = 21/286 (7%)
Query: 522 SRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNM 581
S +Q S E + + + G E
Sbjct: 265 SELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTAN 324
Query: 582 VISIQVLRNVTNNFSEEN-----ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGL 635
IS + + +LG+G FG V E ++ AVK ++ V+
Sbjct: 325 TISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD 384
Query: 636 TEF-KSEIAVLTKV-RHRHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKP 692
E E VL + L L C ++L V EY+ G L HI + G
Sbjct: 385 VECTMVEKRVLALPGKPPFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFK 440
Query: 693 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752
A ++A G+ +L + I+RDLK N++L + K+ADFG+ +
Sbjct: 441 EPHAV--FYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495
Query: 753 KGSIETRIAGTFGYLAPEYAVTGRVTTK-VDVFSFGVILMELITGR 797
+ +T GT Y+APE + + K VD ++FGV+L E++ G+
Sbjct: 496 GVTTKT-FCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 42/226 (18%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-------- 640
V + + +G G +G V + G K+A+K++ F+S
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR---------PFQSELFAKRAY 72
Query: 641 -EIAVLTKVRHRHLVALL------GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPL 693
E+ +L +RH +++ LL D + LV +M L + + + + L
Sbjct: 73 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH------EKL 125
Query: 694 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEG 752
+R + + +G+ Y+H IHRDLKP N+ + +D K+ DFGL R A E
Sbjct: 126 GEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 182
Query: 753 KGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGR 797
G + TR Y APE + R T VD++S G I+ E+ITG+
Sbjct: 183 TGYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 45/224 (20%), Positives = 93/224 (41%), Gaps = 38/224 (16%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
+++ LGRG + V++ + + K+ VK ++ + K EI +L +
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVK-----ILKPVKKKKIKREIKILENL 87
Query: 649 R-HRHLVALLGHCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 705
R +++ L D + LVFE++ + + LT D+
Sbjct: 88 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--------------QTLTDY-DI 132
Query: 706 A-------RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA-KVADFGLVRLAPEGKGSIE 757
+ ++Y H +HRD+KP N+++ + R ++ D+GL G+
Sbjct: 133 RFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 189
Query: 758 TRIAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKAL 800
R+A + + PE V ++ +D++S G +L +I ++
Sbjct: 190 -RVA-SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 91.3 bits (226), Expect = 4e-19
Identities = 40/223 (17%), Positives = 85/223 (38%), Gaps = 23/223 (10%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
+ + L+ S++ + N L S++ ++ +N+ SV L ++ +
Sbjct: 15 FPDDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLF 71
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL--I 203
++ N + + +L+N L N +I + L L L N + I
Sbjct: 72 LNGNKLTDIKPLTNLKNLGWL-FLDEN------KIKDLSSLKDLKKLKSLSLEHNGISDI 124
Query: 204 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVK 263
GL Q++SL++ I V+ +T L + L N S + +G+
Sbjct: 125 NGLVHL---PQLESLYLGNNKIT-----DITVLSRLTKLDTLSLEDNQISD-IVPLAGLT 175
Query: 264 QLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEF 306
+L++L L N + +L L++L ++ + +
Sbjct: 176 KLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINH 216
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 78.6 bits (193), Expect = 4e-15
Identities = 42/226 (18%), Positives = 76/226 (33%), Gaps = 57/226 (25%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
+Q L + +L L N ++ + L L +L + L N+ + L L+S+
Sbjct: 59 QGIQYLPNVTKLFLNGNKLTD-IKPLTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSLS 115
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL--- 202
+++N + + +GL + P L L+L N++
Sbjct: 116 LEHNG---------ISDINGLVH--------------------LPQLESLYLGNNKITDI 146
Query: 203 --IGGLPA----SFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPL 256
+ L S +QI I + +T L+ ++L N S L
Sbjct: 147 TVLSRLTKLDTLSLEDNQISD---------------IVPLAGLTKLQNLYLSKNHIS-DL 190
Query: 257 PDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302
+G+K L+ L L + L V T+ L P
Sbjct: 191 RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 236
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 62.8 bits (152), Expect = 4e-10
Identities = 41/243 (16%), Positives = 78/243 (32%), Gaps = 62/243 (25%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
S+L++L KL+ L L+ N IS + L L LE + L NN+ T + + L+ L ++
Sbjct: 103 SSLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLS 159
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGG 205
+++N + + L L L+L+ N +
Sbjct: 160 LEDNQ---------ISDIVPLAG--------------------LTKLQNLYLSKNHI--- 187
Query: 206 LPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQ 264
S +++L + +L + L S + S +
Sbjct: 188 -------SDLRAL------------------AGLKNLDVLELFSQECLNKPINHQSNLVV 222
Query: 265 LESLSLRDNFFTGPVPDS-LVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCL 323
++ D P S E + F + V++ AK + +
Sbjct: 223 PNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRV 282
Query: 324 PSP 326
P
Sbjct: 283 TQP 285
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 50/287 (17%), Positives = 103/287 (35%), Gaps = 65/287 (22%)
Query: 179 QIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQN 238
I F D F +L + + I + N + + G IQ
Sbjct: 10 PIKQIFPDDAFAETIKDNLKKKS-VTDAVTQNELNSIDQIIANN-SDIKSVQG----IQY 63
Query: 239 MTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPD--SLVKLESLKIVNMTN 296
+ ++ +++L+ N + + + +K L L L +N + D SL L+ LK +++ +
Sbjct: 64 LPNVTKLFLNGNKLTD-IKPLTNLKNLGWLFLDEN----KIKDLSSLKDLKKLKSLSLEH 118
Query: 297 NLLQ--GPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 354
N + + + SL + NN ++ + + +L
Sbjct: 119 NGISDINGLVHLPQLESLYL---GNN-----------KITDITVLSRLT----------- 153
Query: 355 GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL 414
+ ++ + ++ I P A LQ L L+ N++S + L
Sbjct: 154 ----------------KLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISDL--RAL 193
Query: 415 SVLGALKELDVSNNQLYGKIPSFKS-----NAIVNTDGNPDIGKEKS 456
+ L L L++ + + K + +S N + NTDG+ + S
Sbjct: 194 AGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 4e-04
Identities = 29/193 (15%), Positives = 57/193 (29%), Gaps = 54/193 (27%)
Query: 242 LKEIWLHSNAFS--GPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 299
+ E S P F + +L+ T V +L S+ + N+ +
Sbjct: 1 MGETITVSTPIKQIFPDDAF---AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI 55
Query: 300 Q--GPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 357
+ + L + + N +L + + L
Sbjct: 56 KSVQGIQYLPNVTKLFL---NGN-----------KLTDIKPLTNL--------------- 86
Query: 358 PCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVL 417
N+ + + + +S K L+ L L N +S + GL L
Sbjct: 87 ------------KNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISDI--NGLVHL 130
Query: 418 GALKELDVSNNQL 430
L+ L + NN++
Sbjct: 131 PQLESLYLGNNKI 143
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 52/231 (22%), Positives = 98/231 (42%), Gaps = 39/231 (16%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS---EIAVL 645
++ + + + LG GG G V+ + ++A+K+ I K EI ++
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK-----IVLTDPQSVKHALREIKII 62
Query: 646 TKVRHRHLVALL--------------GHCLDGNEKLLVFEYMPQGT-LSRHIFNWAEEGL 690
++ H ++V + G + N +V EYM T L+ +
Sbjct: 63 RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQ------ 114
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLA 749
PL + RG++Y+H + +HRDLKP+N+ + +D+ K+ DFGL R+
Sbjct: 115 GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 750 --PEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGR 797
+ T Y +P ++ T +D+++ G I E++TG+
Sbjct: 172 DPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-19
Identities = 70/294 (23%), Positives = 116/294 (39%), Gaps = 46/294 (15%)
Query: 560 SETHTVPSSEPGDIQMLEAGNMVISIQVLRNVT----NNFSEENILGRGGFGTVY---KG 612
T G Q+L + + + + + NF +LG G +G V+ K
Sbjct: 17 GAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKI 76
Query: 613 ELHDGTKI-AVKRME-AGVISGKGLTEF-KSEIAVLTKVRHRHLVALLGHCLDGNEKL-L 668
HD K+ A+K ++ A ++ TE ++E VL +R + L + KL L
Sbjct: 77 SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL 136
Query: 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNR----RLTIALDVARGVEYLHGLAHQSFIHRD 724
+ +Y+ G L H+ ++ + + +AL E+LH L I+RD
Sbjct: 137 ILDYINGGELFTHL---SQRERFTEHEVQIYVGEIVLAL------EHLHKL---GIIYRD 184
Query: 725 LKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV--TTKVD 782
+K NILL + + DFGL + + GT Y+AP+ G VD
Sbjct: 185 IKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVD 244
Query: 783 VFSFGVILMELITGR---KALDESQPEESMHLVTWFRRI---------HLSKDS 824
+S GV++ EL+TG E + + RRI +S +
Sbjct: 245 WWSLGVLMYELLTGASPFTVDGEKNSQAEI-----SRRILKSEPPYPQEMSALA 293
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-19
Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 42/226 (18%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-------- 640
V + + +G G +G+V + G ++AVK K F+S
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---------KLSRPFQSIIHAKRTY 76
Query: 641 -EIAVLTKVRHRHLVALL------GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPL 693
E+ +L ++H +++ LL + N+ LV M L+ + + L
Sbjct: 77 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC------QKL 129
Query: 694 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEG 752
+ + + RG++Y+H IHRDLKPSN+ + +D K+ DFGL R A E
Sbjct: 130 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
Query: 753 KGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGR 797
G + TR Y APE + VD++S G I+ EL+TGR
Sbjct: 187 TGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 38/217 (17%), Positives = 86/217 (39%), Gaps = 29/217 (13%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
+ + + L+ S++ + N L S++ ++ +N+ SV L ++ +
Sbjct: 18 FSDDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLF 74
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL--- 202
++ N + + +L+N L N ++ + L L L N +
Sbjct: 75 LNGNKLTDIKPLANLKNLGWL-FLDEN------KVKDLSSLKDLKKLKSLSLEHNGISDI 127
Query: 203 --IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFS 260
+ LP Q++SL++ I V+ +T L + L N S + +
Sbjct: 128 NGLVHLP------QLESLYLGNNKIT-----DITVLSRLTKLDTLSLEDNQISD-IVPLA 175
Query: 261 GVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
G+ +L++L L N + +L L++L ++ + +
Sbjct: 176 GLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQ 210
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 31/118 (26%), Positives = 56/118 (47%), Gaps = 10/118 (8%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
S+L++L KL+ L L+ N IS + L L LE + L NN+ T + + L+ L ++
Sbjct: 106 SSLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLS 162
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLI 203
+++N S I L + LQN + +I+ + + L +L L + +
Sbjct: 163 LEDNQISD--IV-PLAGLTKLQNLYLSKNHIS-DLRAL---AGLKNLDVLELFSQECL 213
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 31/135 (22%), Positives = 54/135 (40%), Gaps = 19/135 (14%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
L LTKL+ L L N IS L +L GL +L+V+ L + + + P + + L +++
Sbjct: 172 VPLAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVK 230
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLI-- 203
+ + P+ + + + N+ +P F + F Q +
Sbjct: 231 NTDGSLVT---PEIISDDGDYEK-----PNVKWHLPEFTN--------EVSFIFYQPVTI 274
Query: 204 GGLPASFSGSQIQSL 218
G A F G Q L
Sbjct: 275 GKAKARFHGRVTQPL 289
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 21/200 (10%), Positives = 56/200 (28%), Gaps = 50/200 (25%)
Query: 233 IDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 292
I + L + + + + ++ + ++ + L ++ +
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIK--SVQGIQYLPNVTKL 73
Query: 293 NMTNNLLQ--GPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFA 350
+ N L P+ L + + N + + L
Sbjct: 74 FLNGNKLTDIKPLANLKNLGWLFLDE-----------------NKVKDLSSLKDLK---- 112
Query: 351 ENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMI 410
+ ++ + ++ I+ L+ L L +N ++ +
Sbjct: 113 --------------------KLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDI- 149
Query: 411 PEGLSVLGALKELDVSNNQL 430
LS L L L + +NQ+
Sbjct: 150 -TVLSRLTKLDTLSLEDNQI 168
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 42/250 (16%), Positives = 91/250 (36%), Gaps = 31/250 (12%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQF 127
+I G N+ T +L + L ++ + + L +L + L +NQ
Sbjct: 19 ANAIKIAAGKSNV--TDTVTQADLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQI 75
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187
T + L+ + +E+ NP + L++ ++ S IT +
Sbjct: 76 TDLAP--LKNLTKITELELSGNPLKNVSAIAGLQS---IKTLDLTSTQIT-DVTPL---A 126
Query: 188 EFPGLTILHLAFNQL-----IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSL 242
L +L+L NQ+ + GL +Q L + + + + N++ L
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLT------NLQYLSIGN-AQVSD----LTPLANLSKL 175
Query: 243 KEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302
+ N S + + + L + L++N + L +L IV +TN +
Sbjct: 176 TTLKADDNKISD-ISPLASLPNLIEVHLKNNQIS--DVSPLANTSNLFIVTLTNQTITNQ 232
Query: 303 VPEFDRSVSL 312
++ ++ +
Sbjct: 233 PVFYNNNLVV 242
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 43/224 (19%), Positives = 83/224 (37%), Gaps = 30/224 (13%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
+Q L L LEL+ N I+ L L L + + LS N +V + GL S+++++
Sbjct: 57 EGVQYLNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLD 113
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL--- 202
+ + + L S LQ + IT I L L + Q+
Sbjct: 114 LTSTQITDVT---PLAGLSNLQVLYLDLNQIT-NISPL---AGLTNLQYLSIGNAQVSDL 166
Query: 203 --IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFS 260
+ L ++ +L + N + I + ++ +L E+ L +N S + +
Sbjct: 167 TPLANLS------KLTTLKADD-NKISD----ISPLASLPNLIEVHLKNNQISD-VSPLA 214
Query: 261 GVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP 304
L ++L + T + +L + N+ P+
Sbjct: 215 NTSNLFIVTLTNQTITNQ---PVFYNNNLVVPNVVKGPSGAPIA 255
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 9e-18
Identities = 33/212 (15%), Positives = 77/212 (36%), Gaps = 19/212 (8%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
L ++ ++++ + L + + T++ L++L +E
Sbjct: 13 FPDPALANAIKIAAGKSNVTD-TVTQADLDGITTLSAFGTGVTTIE--GVQYLNNLIGLE 69
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGG 205
+ +N + L+N + + + + + + L L Q I
Sbjct: 70 LKDNQITD---LAPLKNLTKITELELSGNPLK----NVSAIAGLQSIKTLDLTSTQ-ITD 121
Query: 206 LPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL 265
+ S +Q L+++ N I + +T+L+ + + + S L + + +L
Sbjct: 122 VTPLAGLSNLQVLYLDL-NQITN----ISPLAGLTNLQYLSIGNAQVSD-LTPLANLSKL 175
Query: 266 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
+L DN + P L L +L V++ NN
Sbjct: 176 TTLKADDNKISDISP--LASLPNLIEVHLKNN 205
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 47/236 (19%), Positives = 83/236 (35%), Gaps = 42/236 (17%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
S + L ++ L+L I+ + L GL++L+V+ L NQ T++ GL++LQ +
Sbjct: 101 SAIAGLQSIKTLDLTSTQITD-VTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLS 157
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGG 205
I N S L N S L A+ I+ I P L +HL NQ+
Sbjct: 158 IGNAQVSDLT---PLANLSKLTTLKADDNKIS-DISPL---ASLPNLIEVHLKNNQIS-- 208
Query: 206 LPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL 265
+ + N ++L + L + + P F +
Sbjct: 209 --------------------------DVSPLANTSNLFIVTLTNQTITN-QPVFYNNNLV 241
Query: 266 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP---VPEFDRSVSLDMAKGS 318
++ P ++ + N+T NL F++SV+
Sbjct: 242 VPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFKNTTVP 297
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 34/209 (16%), Positives = 63/209 (30%), Gaps = 47/209 (22%)
Query: 232 GIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 291
++ + + + + + L L L+DN T P L L +
Sbjct: 33 DTVTQADLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQITDLAP--LKNLTKITE 89
Query: 292 VNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAE 351
+ ++ N L+ V S+ ++ + V L G
Sbjct: 90 LELSGNPLKN-VSAIAGLQSIKTLDLTST--------------QITDVTPLAGLS----- 129
Query: 352 NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 411
N+ V+ +T ISP A +LQ L + + +S +
Sbjct: 130 -------------------NLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDL-- 166
Query: 412 EGLSVLGALKELDVSNNQLYGKIPSFKSN 440
L+ L L L +N++ I S
Sbjct: 167 TPLANLSKLTTLKADDNKI-SDISPLASL 194
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 26/193 (13%), Positives = 63/193 (32%), Gaps = 46/193 (23%)
Query: 238 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
+ + +I + + + + + + +LS T + + L +L + + +N
Sbjct: 17 ALANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 298 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 357
+ + + + S N L + ++ L
Sbjct: 74 QITD-LAPLKNLTKITELELSGN-----------PLKNVSAIAGL--------------- 106
Query: 358 PCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVL 417
+I ++ +T ++P A +LQ L L N ++ + L+ L
Sbjct: 107 ------------QSIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQITNI--SPLAGL 150
Query: 418 GALKELDVSNNQL 430
L+ L + N Q+
Sbjct: 151 TNLQYLSIGNAQV 163
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 3e-18
Identities = 41/268 (15%), Positives = 84/268 (31%), Gaps = 43/268 (16%)
Query: 84 LPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQS 143
S K N L + + L+ +S+P + +
Sbjct: 29 YFSAWDKWEKQALPGENRNEAVSLLKECL-INQFSELQLNRLNLSSLPDNLP---PQITV 84
Query: 144 IEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFG---------------PDE 188
+EI N S +P+ + L+ A ++ +P P+
Sbjct: 85 LEITQNALIS--LPELPAS---LEYLDACDNRLS-TLPELPASLKHLDVDNNQLTMLPEL 138
Query: 189 FPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLH 248
L ++ NQL LP + ++ L V N +L + + SL+ + +
Sbjct: 139 PALLEYINADNNQL-TMLPELPT--SLEVLSVR----NNQLT---FLPELPESLEALDVS 188
Query: 249 SNAFSGPLPDFSG-----VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN-LLQGP 302
+N LP + R+N T +P++++ L+ + + +N L
Sbjct: 189 TNLLES-LPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRI 246
Query: 303 VPEFDRSVSLDMAKGSNNFCLPSPGACD 330
+ + G + S G +
Sbjct: 247 RESLSQQTAQPDYHGPRIYFSMSDGQQN 274
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 4e-16
Identities = 49/271 (18%), Positives = 103/271 (38%), Gaps = 28/271 (10%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQF 127
+ + +Q+ NL +LP NL ++ LE+ N++ LP L ASLE + +N+
Sbjct: 59 NQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPEL--PASLEYLDACDNRL 112
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187
+++P +SL+ +++DNN + +P+ L+ +A++ +T +P +
Sbjct: 113 STLPEL----PASLKHLDVDNNQLTM--LPELPAL---LEYINADNNQLT-MLP-----E 157
Query: 188 EFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSL-KEIW 246
L +L + NQL LP +++L V+ N L +
Sbjct: 158 LPTSLEVLSVRNNQL-TFLPELPE--SLEALDVST-NLLESLPAVPVRNHHSEETEIFFR 213
Query: 247 LHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE 305
N + +P+ + ++ L DN + + +SL + + + +
Sbjct: 214 CRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272
Query: 306 FDRSVSLDMAKGSNNFCLPSPGACDPRLNAL 336
+ + F +A
Sbjct: 273 QNTLHRPLADAVTAWFPENKQSDVSQIWHAF 303
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 49/241 (20%), Positives = 80/241 (33%), Gaps = 61/241 (25%)
Query: 192 LTILHLAFNQLIGGLPASFSG--SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHS 249
++ +F I G A + + + + G+N N + + + + E+ L+
Sbjct: 11 FSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNR 68
Query: 250 NAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRS 309
S LPD Q+ L + N +P+ LE L + N L P
Sbjct: 69 LNLSS-LPDNLP-PQITVLEITQNALI-SLPELPASLEYLDACD--NRLSTLP-ELPASL 122
Query: 310 VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTK 369
LD+ NN +L L +
Sbjct: 123 KHLDV---DNN-----------QLTMLPELP----------------------------- 139
Query: 370 GNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQ 429
+ IN LT PE SL+ L + +N L+ +PE + +L+ LDVS N
Sbjct: 140 ALLEYINADNNQLTML--PE--LPTSLEVLSVRNNQLTF-LPE---LPESLEALDVSTNL 191
Query: 430 L 430
L
Sbjct: 192 L 192
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 4e-18
Identities = 55/256 (21%), Positives = 96/256 (37%), Gaps = 61/256 (23%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-------- 640
+V +N+ ++++GRG +G VY + + +A+K++ F+
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR---------MFEDLIDCKRIL 73
Query: 641 -EIAVLTKVRHRHLVALL-----GHCLDGNEKLLVFEYMPQGT-LSRHIFNWAEEGLKPL 693
EI +L +++ +++ L L +E +V E + L + + L
Sbjct: 74 REITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLF-----KTPIFL 126
Query: 694 EWNRRLTIALDVARGVEYLH--GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751
TI ++ G ++H G+ IHRDLKP+N LL D KV DFGL R
Sbjct: 127 TEEHIKTILYNLLLGENFIHESGI-----IHRDLKPANCLLNQDCSVKVCDFGLARTINS 181
Query: 752 GKGSIETRIAGTFGYLAP----------EYAVT------------GRVTTKVDVFSFGVI 789
K + P + VT T +D++S G I
Sbjct: 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCI 241
Query: 790 LMELITGRKALDESQP 805
EL+ ++
Sbjct: 242 FAELLNMLQSHINDPT 257
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 6e-18
Identities = 51/259 (19%), Positives = 88/259 (33%), Gaps = 60/259 (23%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-------- 640
+ + + +++G G +G V + + + +A+K++ F+
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL---------RVFEDLIDCKRIL 100
Query: 641 -EIAVLTKVRHRHLVALL-----GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLE 694
EIA+L ++ H H+V +L +E +V E + L
Sbjct: 101 REIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLF-----RTPVYLT 154
Query: 695 WNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 754
T+ ++ GV+Y+H +HRDLKP+N L+ D KV DFGL R +
Sbjct: 155 ELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 755 SIETRIAGTFGYLAP---------------EYAVT------------GRVTTKVDVFSFG 787
+ VT T +DV+S G
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271
Query: 788 VILMELITGRKALDESQPE 806
I EL+ K +
Sbjct: 272 CIFAELLNMIKENVAYHAD 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 6e-18
Identities = 35/110 (31%), Positives = 50/110 (45%), Gaps = 12/110 (10%)
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750
L + + VA+G+E+L A + IHRDL NILL + K+ DFGL R
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 244
Query: 751 EGKGSIETRIAGTFGYL-----APEYAVTGRVTTKVDVFSFGVILMELIT 795
+ + L APE T + DV+SFGV+L E+ +
Sbjct: 245 KD----PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 34/151 (22%), Positives = 57/151 (37%), Gaps = 26/151 (17%)
Query: 595 FSEENI-----LGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIA 643
F + + LGRG FG V + + +AVK ++ G + SE+
Sbjct: 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELK 77
Query: 644 VLTKV-RHRHLVALLGHCLDGNEKLLV-FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTI 701
+L + H ++V LLG C L+V E+ G LS ++ ++R
Sbjct: 78 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL------------RSKRNEF 125
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732
+G + G + I DLK +
Sbjct: 126 VPYKTKGARFRQGKDYVGAIPVDLKRRLDSI 156
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-18
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 601 LGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEF-KSEIAVLTKV-RHRHLVALL 657
LG+G FG V E ++ AVK ++ V+ E E VL + L L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
C ++L V EY+ G L HI + G A ++A G+ +L
Sbjct: 88 -SCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHAV--FYAAEIAIGLFFLQS-- 139
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR 776
+ I+RDLK N++L + K+ADFG+ + + +T GT Y+APE + +
Sbjct: 140 -KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPE-IIAYQ 196
Query: 777 VTTK-VDVFSFGVILMELITGR 797
K VD ++FGV+L E++ G+
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 8e-18
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 16/203 (7%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEF-KSEIAVLTKV-RHRHLVAL 656
++GRG + V L +I A+K ++ +++ ++ ++E V + H LV L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 657 LGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
C +L V EY+ G L H+ + P E R A +++ + YLH
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHAR-FYSA-EISLALNYLHE- 128
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG 775
+ I+RDLK N+LL + K+ D+G+ + + T GT Y+APE + G
Sbjct: 129 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPE-ILRG 184
Query: 776 RVTTK-VDVFSFGVILMELITGR 797
VD ++ GV++ E++ GR
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGR 207
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 9e-18
Identities = 54/375 (14%), Positives = 103/375 (27%), Gaps = 51/375 (13%)
Query: 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFT 128
T + I + S++ +L+KL L + N I + LE + LS+N+
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 129 SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDE 188
+ +L+ +++ N F + +P I F
Sbjct: 83 KISCH---PTVNLKHLDLSFNAFDA--LP----------------------ICKEF--GN 113
Query: 189 FPGLTILHLAFNQLIGGLPASFSGSQIQSLWVN-GQNGNAKLGGGIDVIQNMTSLKEIWL 247
L L L+ L + I + + G+ K N SL ++
Sbjct: 114 MSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173
Query: 248 HSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLE-----------SLKIVNMT 295
+ F L V LE +++ L L +L + T
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETT 233
Query: 296 NNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 355
N + + + + L + +
Sbjct: 234 WNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSI--------HQVVS 285
Query: 356 NDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLS 415
+ + N+ + NF + L ++N L+ + E
Sbjct: 286 DVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCG 345
Query: 416 VLGALKELDVSNNQL 430
L L+ L + NQL
Sbjct: 346 HLTELETLILQMNQL 360
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 2e-17
Identities = 48/371 (12%), Positives = 110/371 (29%), Gaps = 43/371 (11%)
Query: 83 TLPSNLQNLTKLERLELQWNSIS--GPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSS 140
+ L+ L+L +N+ ++ L+ + LS L+
Sbjct: 83 KISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNI 140
Query: 141 LQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFN 200
+ + + + E P+ L++ + N L + ++
Sbjct: 141 SKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV 200
Query: 201 QLIGGLPASFS-------GSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS 253
S ++ +L +N I + T++ + +
Sbjct: 201 LEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQ 260
Query: 254 GPLP------DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEF 306
G L + +K L + + F P ++ I N T + + +
Sbjct: 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP 320
Query: 307 DRSVS---LDMAKGSNNFCLPSPGACD--PRLNAL-LSVVKLMGYPQRFAENWKGNDPCS 360
+ LD +N C L L L + +L +
Sbjct: 321 SKISPFLHLDF--SNNLLTDTVFENCGHLTELETLILQMNQLKELSKIA----------- 367
Query: 361 DWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGA 419
+T ++ ++ + +++ + KSL L ++ N L+ I L
Sbjct: 368 ---EMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR-- 422
Query: 420 LKELDVSNNQL 430
+K LD+ +N++
Sbjct: 423 IKVLDLHSNKI 433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 2e-16
Identities = 32/214 (14%), Positives = 75/214 (35%), Gaps = 15/214 (7%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSI-SGPLPSLNGLASLEVVMLSNNQ 126
K ++ Q+ + + + + + + ++ + SNN
Sbjct: 276 KALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNL 335
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSS-WEIPQSLRNASGLQ--NFSANSANITGQIPSF 183
T + L+ L+++ + N +I + LQ + S NS + +
Sbjct: 336 LTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDC 395
Query: 184 FGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLK 243
L L+++ N L + +I+ L ++ N + + + +L+
Sbjct: 396 SWT---KSLLSLNMSSNILTDTIFRCLP-PRIKVLDLH-SNKIKSIPKQVV---KLEALQ 447
Query: 244 EIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFF 275
E+ + SN +PD F + L+ + L N +
Sbjct: 448 ELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 8e-13
Identities = 44/321 (13%), Positives = 85/321 (26%), Gaps = 43/321 (13%)
Query: 119 VVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITG 178
+V S N VP D + I N S + + S L+ + I
Sbjct: 4 LVDRSKNGLIHVPKDLSQ---KTTILNISQNYISELW-TSDILSLSKLRILIISHNRIQY 59
Query: 179 QIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQN 238
S F L L L+ N+L +
Sbjct: 60 LDISVF--KFNQELEYLDLSHNKL-VKIS----------------------------CHP 88
Query: 239 MTSLKEIWLHSNAFS--GPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV-NMT 295
+LK + L NAF +F + QL+ L L + L K++ +
Sbjct: 89 TVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLG 148
Query: 296 NNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 355
+ PE + + + D + + ++
Sbjct: 149 ETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSY 208
Query: 356 NDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL- 414
+ N+T+ N + + + ++ +++ L G +
Sbjct: 209 FLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDF 268
Query: 415 ----SVLGALKELDVSNNQLY 431
+ L AL V ++
Sbjct: 269 DYSGTSLKALSIHQVVSDVFG 289
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 1e-12
Identities = 58/386 (15%), Positives = 125/386 (32%), Gaps = 43/386 (11%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERL--ELQWNSISGPLPSLNGLA--SLEVVMLS 123
++ + + +L+ + + +L + L + L SL +V +
Sbjct: 115 SQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT 174
Query: 124 NNQFTSVPSDFFTGLSSLQSIEIDNNPF-----SSWEIPQSLRNASGLQNFSANSANITG 178
N +F + +++L+ I I L+ L N + N+ T
Sbjct: 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTW 234
Query: 179 ----QIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGID 234
+I +I ++ + +SG+ +++L ++ +
Sbjct: 235 NSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSY 294
Query: 235 VIQNMTSLKEIWLH-SNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 293
+ + +++ S + S + L +N T V ++ L L+ +
Sbjct: 295 IYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLI 354
Query: 294 MTNNLLQ---GPVPEFDRSVSLDMAKGSNNF--CLPSPGACD--PRLNAL-LSVVKLMGY 345
+ N L+ + SL S N G C L +L +S L
Sbjct: 355 LQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDT 414
Query: 346 PQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNN 405
R C I V++ + +I + ++LQ L +A N
Sbjct: 415 IFR------------------CLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQ 455
Query: 406 LSGMIPEG-LSVLGALKELDVSNNQL 430
L +P+G L +L+++ + N
Sbjct: 456 LK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-17
Identities = 68/242 (28%), Positives = 97/242 (40%), Gaps = 33/242 (13%)
Query: 566 PSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKI-AVKR 624
P + I + + N +F ++G+G FG V AVK
Sbjct: 18 PPAPSQQINLGPSSNPHAKPS-------DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKV 70
Query: 625 MEAGVISGKGLTEF-KSEIAVLTK-VRHRHLVALLGH-CLDGNEKL-LVFEYMPQGTLSR 680
++ I K + SE VL K V+H LV L H +KL V +Y+ G L
Sbjct: 71 LQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL--HFSFQTADKLYFVLDYINGGELFY 128
Query: 681 HIFNWAEEGLKPLEWNR----RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 736
H+ E R + AL YLH L + ++RDLKP NILL
Sbjct: 129 HL---QRERCFLEPRARFYAAEIASAL------GYLHSL---NIVYRDLKPENILLDSQG 176
Query: 737 RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTK-VDVFSFGVILMELIT 795
+ DFGL + E + T GT YLAPE + + + VD + G +L E++
Sbjct: 177 HIVLTDFGLCKENIEHNSTTST-FCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLY 234
Query: 796 GR 797
G
Sbjct: 235 GL 236
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 16/203 (7%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEF-KSEIAVLTKV-RHRHLVAL 656
++GRG + V L +I A++ ++ +++ ++ ++E V + H LV L
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 657 LGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
C +L V EY+ G L H+ + P E R A +++ + YLH
Sbjct: 119 HS-CFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHAR-FYSA-EISLALNYLHE- 171
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG 775
+ I+RDLK N+LL + K+ D+G+ + + T GT Y+APE + G
Sbjct: 172 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPE-ILRG 227
Query: 776 RVTTK-VDVFSFGVILMELITGR 797
VD ++ GV++ E++ GR
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGR 250
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 16/202 (7%)
Query: 601 LGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEF-KSEIAVLTKV-RHRHLVALL 657
LG+G FG V + + + AVK ++ VI E +E +L+ H L L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
C ++L V E++ G L HI + R A ++ + +LH
Sbjct: 91 -CCFQTPDRLFFVMEFVNGGDLMFHI---QKSRRFDEARAR--FYAAEIISALMFLHD-- 142
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR 776
+ I+RDLK N+LL + K+ADFG+ + + T GT Y+APE +
Sbjct: 143 -KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAPE-ILQEM 199
Query: 777 VTTK-VDVFSFGVILMELITGR 797
+ VD ++ GV+L E++ G
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGH 221
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 62/201 (30%), Positives = 90/201 (44%), Gaps = 14/201 (6%)
Query: 601 LGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKV-RHRHLVALL 657
LG+G FG V+ E + A+K ++ V+ E E VL+ H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
E L V EY+ G L HI L R A ++ G+++LH
Sbjct: 85 C-TFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLS--RATFYAAEIILGLQFLHSK- 137
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR 776
++RDLK NILL D K+ADFG+ + G T GT Y+APE + +
Sbjct: 138 --GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLGQK 194
Query: 777 VTTKVDVFSFGVILMELITGR 797
VD +SFGV+L E++ G+
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQ 215
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-17
Identities = 63/247 (25%), Positives = 103/247 (41%), Gaps = 55/247 (22%)
Query: 586 QVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS---- 640
+V R+V + LG+G +G V+K + G +AVK++ F++
Sbjct: 2 RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA---------FQNSTDA 52
Query: 641 -----EIAVLTKVR-HRHLVALLGHCL---DGNEKLLVFEYMPQGTLSRHIFNWAEEGLK 691
EI +LT++ H ++V LL + L + + LVF+YM + L I
Sbjct: 53 QRTFREIMILTELSGHENIVNLL-NVLRADNDRDVYLVFDYM-ETDLHAVIRA------N 104
Query: 692 PLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751
LE + + + + ++YLH +HRD+KPSNILL + KVADFGL R
Sbjct: 105 ILEPVHKQYVVYQLIKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161
Query: 752 GKGSIETRIAGTFGYLAP---------EYAVT------------GRVTTKVDVFSFGVIL 790
+ +Y T + T +D++S G IL
Sbjct: 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL 221
Query: 791 MELITGR 797
E++ G+
Sbjct: 222 GEILCGK 228
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 42/201 (20%), Positives = 72/201 (35%), Gaps = 47/201 (23%)
Query: 600 ILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALL 657
+LG G G V + K A+K ++ + + E+ + + + H+V ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALK-----MLQDC--PKARREVELHWRASQCPHIVRIV 77
Query: 658 GHCLDGNEK----LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
+ L+V E + G L I + G + I + ++YLH
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 714 GLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+ HRD+KP N+L + K+ DFG A E
Sbjct: 135 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFG---FAKE------------------- 169
Query: 771 YAVTGRV-TTKVDVFSFGVIL 790
TG D++S GVI+
Sbjct: 170 --TTGEKYDKSCDMWSLGVIM 188
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 52/273 (19%), Positives = 90/273 (32%), Gaps = 69/273 (25%)
Query: 55 DPCK----WNHVVCIEDKRITRIQIG----------HQNLQGTLPSN-LQNLTKLERLEL 99
+PC C + +I N L S + +L+ L+L
Sbjct: 1 EPCVEVVPNITYQC-MELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 100 QWNSISGPLPS--LNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIP 157
I + L+ L ++L+ N S+ F+GLSSLQ + +S +
Sbjct: 60 SRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS--LE 116
Query: 158 ----QSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLT---ILHLAFNQLIGGLPASF 210
L+ L N + N I SF P+ F LT L L+ N
Sbjct: 117 NFPIGHLKTLKEL-NVAHN------LIQSFKLPEYFSNLTNLEHLDLSSN---------- 159
Query: 211 SGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLK----EIWLHSNAFSGPLPD--FSGVKQ 264
+IQS+ ++ + + + L N + + F + +
Sbjct: 160 ---KIQSI----YCT---------DLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEI-R 201
Query: 265 LESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
L+ L+L N +L SL+ + + N
Sbjct: 202 LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 22/76 (28%), Positives = 35/76 (46%), Gaps = 3/76 (3%)
Query: 78 QNLQGTLPSNLQNLTKLE-RLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFF 135
Q++ T L + L L+L N ++ + + L+ + L NQ SVP F
Sbjct: 162 QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLKSVPDGIF 220
Query: 136 TGLSSLQSIEIDNNPF 151
L+SLQ I + NP+
Sbjct: 221 DRLTSLQKIWLHTNPW 236
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 47/292 (16%), Positives = 76/292 (26%), Gaps = 74/292 (25%)
Query: 205 GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGV 262
LP S ++L ++ N LG + L+ + L + D + +
Sbjct: 25 NLPFS-----TKNLDLSF-NPLRHLGSY--SFFSFPELQVLDLSRCEIQT-IEDGAYQSL 75
Query: 263 KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSLDMAKGSNNF 321
L +L L N + L SL+ + L +L ++N
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 322 --CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQK 379
P L L ++
Sbjct: 136 IQSFKLPEYFS-NLTNL------------------------------------EHLDLSS 158
Query: 380 MNLTGTISPE-FASFKSLQ----RLILADNNLSGMIPEGLSVLGALKELDVSNNQL---- 430
+ +I + L L+ N ++ I G LKEL + NQL
Sbjct: 159 NKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVP 216
Query: 431 YGKIPSFKSNAIVNTDGNP------DIG------KEKSSSFQGSPSGSPTGT 470
G S + NP I + S QGS S +G
Sbjct: 217 DGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSAKCSGSGK 268
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 47/260 (18%), Positives = 79/260 (30%), Gaps = 57/260 (21%)
Query: 57 CKWNHVVCIEDKRITRIQIGHQNLQG---------TLPSN-LQNLTKLERLELQWNSISG 106
C + K I RI + Q T+PS+ NL + R+ + +
Sbjct: 10 CHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ 69
Query: 107 PLPS--LNGLASLEVVMLSNNQF-TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNA 163
L S L+ + + + N + T + D L L+ + I N
Sbjct: 70 QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM---------- 119
Query: 164 SGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPA-SFSG--SQIQSLWV 220
P IL + N + +P +F G ++ +L +
Sbjct: 120 ----------------FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKL 163
Query: 221 NGQNGNAKLGGGIDVIQ----NMTSLKEIWLHSNAFSGPLPD--FSGVKQ-LESLSLRDN 273
N G +Q N T L ++L+ N + + F GV L +
Sbjct: 164 YN-N-------GFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQT 215
Query: 274 FFTGPVPDSLVKLESLKIVN 293
T L L+ L N
Sbjct: 216 SVTALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 40/205 (19%), Positives = 78/205 (38%), Gaps = 24/205 (11%)
Query: 108 LPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID-NNPFSSWEIPQSLRNASGL 166
+PSL S + + L ++PS F+ L ++ I + + E S N S +
Sbjct: 26 IPSL--PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLE-SHSFYNLSKV 82
Query: 167 QNFS-ANSANITGQIPSFFGPDEF---PGLTILHLAFNQL--IGGLPASFSGSQIQSLWV 220
+ N+ N+T I PD P L L + L L +S L +
Sbjct: 83 THIEIRNTRNLT-YID----PDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEI 137
Query: 221 NGQNGNAKLGGGIDVIQNMTS-LKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDN-FFT 276
+ Q + + + L++N F+ + F+G K L+++ L N + T
Sbjct: 138 TDNPYMTSIPVN--AFQGLCNETLTLKLYNNGFTS-VQGYAFNGTK-LDAVYLNKNKYLT 193
Query: 277 GPVPDSLVKLES-LKIVNMTNNLLQ 300
D+ + S +++++ +
Sbjct: 194 VIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 48/278 (17%), Positives = 79/278 (28%), Gaps = 82/278 (29%)
Query: 164 SGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQ 223
++F +I +IPS P P L L L I S
Sbjct: 11 HQEEDFRVTCKDIQ-RIPSL--P---PSTQTLKLIETHL----------RTIPS------ 48
Query: 224 NGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDN-FFTGPVP 280
N+ ++ I++ + L F + ++ + +R+ T P
Sbjct: 49 ----------HAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDP 98
Query: 281 DSLVKLESLKIVNMTNNLLQGPVPEF------DRSVSLDMAKGSNNFCLPSPGACDPRLN 334
D+L +L LK + + N L+ P+ D L++ +P A L
Sbjct: 99 DALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIP-VNAFQ-GLC 155
Query: 335 ALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFK 394
+KL N T + Q GT
Sbjct: 156 NETLTLKLYN-----------N--------------GFTSV--QGYAFNGT--------- 179
Query: 395 SLQRLILADNNLSGMIPEGL--SVLGALKELDVSNNQL 430
L + L N +I + V LDVS +
Sbjct: 180 KLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV 217
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 13/89 (14%), Positives = 30/89 (33%), Gaps = 11/89 (12%)
Query: 359 CSDWIGVTCTKGNITVI-----NFQKMNLTG----TISPE-FASFKSLQRLILADNNLSG 408
C T +I I + Q + L TI F++ ++ R+ ++ +
Sbjct: 10 CHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ 69
Query: 409 MIPEGL-SVLGALKELDVSNNQLYGKIPS 436
+ L + +++ N + I
Sbjct: 70 QLESHSFYNLSKVTHIEIRNTRNLTYIDP 98
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 63/255 (24%), Positives = 95/255 (37%), Gaps = 69/255 (27%)
Query: 57 CKWNHVVCIEDKRITRIQIG----------HQNLQGTLPSN-LQNLTKLERLELQWNSIS 105
N V C K++T I N +LPS LTKL L L N +
Sbjct: 16 NNKNSVDC-SSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ 74
Query: 106 GPLPS--LNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNA 163
LP+ L +LE + +++N+ ++P F L +L + +D N S +P
Sbjct: 75 T-LPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKS--LP------ 125
Query: 164 SGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQ 223
P F D LT L L +N+L QSL
Sbjct: 126 -----------------PRVF--DSLTKLTYLSLGYNEL-------------QSL----P 149
Query: 224 NGNAKLGGGIDVIQNMTSLKEIWLHSNAF-SGPLPDFSGVKQLESLSLRDNFFTGPVPDS 282
G V +TSLKE+ L++N P F + +L++L L +N +
Sbjct: 150 KG---------VFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGA 200
Query: 283 LVKLESLKIVNMTNN 297
LE LK++ + N
Sbjct: 201 FDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 25/78 (32%), Positives = 38/78 (48%), Gaps = 4/78 (5%)
Query: 77 HQN-LQGTLPSNL-QNLTKLERLELQWNSI-SGPLPSLNGLASLEVVMLSNNQFTSVPSD 133
N LQ +LP + LT L+ L L N + P + + L L+ + L NNQ VP
Sbjct: 141 GYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEG 199
Query: 134 FFTGLSSLQSIEIDNNPF 151
F L L+ +++ NP+
Sbjct: 200 AFDSLEKLKMLQLQENPW 217
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 4e-16
Identities = 46/356 (12%), Positives = 104/356 (29%), Gaps = 45/356 (12%)
Query: 85 PSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQS 143
++ L++L L L N I LE + +S+N+ ++ ++SL+
Sbjct: 69 MPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC---PMASLRH 125
Query: 144 IEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLI 203
+++ N F +P + F LT L L+ +
Sbjct: 126 LDLSFNDFDV--LP----------------------VCKEF--GNLTKLTFLGLSAAKFR 159
Query: 204 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA-FSGPLPD-FSG 261
+ + + ++ + + K G + T++ + H N+ FS + +
Sbjct: 160 QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNA 219
Query: 262 VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGS--- 318
+ L+ +++ N + + + + L
Sbjct: 220 LGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVE 279
Query: 319 ----NNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITV 374
N + + + ++ LM E+ K + + +
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLM------IEHVKNQVFLFSKEALYSVFAEMNI 333
Query: 375 INFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
+ S S L N + + +G S L L+ L + N L
Sbjct: 334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL 389
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 2e-14
Identities = 66/378 (17%), Positives = 107/378 (28%), Gaps = 45/378 (11%)
Query: 77 HQNLQGTLPSN--LQNLTKLERLELQWNSI-SGPLPSLNGLASLEVVMLSNNQFTSVPSD 133
N LP NLTKL L L L + L +L + +
Sbjct: 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHL--HLSCILLDLVSYHIKGG 186
Query: 134 FFTGLSSLQ----SIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEF 189
L + N S ++ S+ LQ + + Q F +
Sbjct: 187 ETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELT 246
Query: 190 PGLTILHLAFNQLIGGLPASFSGSQIQSLWV--------NGQNGNAKLGGGIDVIQNMTS 241
G T+L++ + S Q + S
Sbjct: 247 RGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKS 306
Query: 242 LKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDN---FFTGPVPDSLVKLESLKIVNMTNN 297
L + + F +S ++ L + F P S L N T N
Sbjct: 307 LMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFL---NFTQN 363
Query: 298 LLQG-PVPEFDRSVSLDMAKGSNNFC--LPSPGACDPRLNAL-LSVVKLMGYPQRFAENW 353
+ L N +++L V L
Sbjct: 364 VFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLN------S 417
Query: 354 KGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASF-KSLQRLILADNNLSGMIPE 412
D W +I V+N LTG++ F ++ L L +N + IP+
Sbjct: 418 HAYDRTCAW------AESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNNRIMS-IPK 467
Query: 413 GLSVLGALKELDVSNNQL 430
++ L AL+EL+V++NQL
Sbjct: 468 DVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 6e-13
Identities = 52/288 (18%), Positives = 103/288 (35%), Gaps = 22/288 (7%)
Query: 48 SLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPS-----NLQNLTKLERLELQWN 102
++ +D + + + + T + + Q+++ T +E L +
Sbjct: 227 NIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNL 286
Query: 103 SISGPLP------SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN--PFSSW 154
+I+ + S L SL + + N F ++ + + + + PF
Sbjct: 287 TITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHM 346
Query: 155 EIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQ 214
P S + + L NF+ N T + L L L N L +
Sbjct: 347 VCPPSPSSFTFL-NFTQNV--FTDSVFQGC--STLKRLQTLILQRNGLKNFFKVALMTKN 401
Query: 215 IQSLWVNGQNGNAKLGGGIDVI-QNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDN 273
+ SL + N+ D S+ + L SN +G + +++ L L +N
Sbjct: 402 MSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR-CLPPKVKVLDLHNN 460
Query: 274 FFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSLDMAKGSNN 320
+P + L++L+ +N+ +N L+ P FDR SL +N
Sbjct: 461 RIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 6e-13
Identities = 33/205 (16%), Positives = 75/205 (36%), Gaps = 9/205 (4%)
Query: 74 QIGHQNLQGTLPSNLQNLTKLERLELQWNSI-SGPLPSLNGLASLEVVMLSNNQFTSVPS 132
+ +Q + + ++ L + + +S + + N FT
Sbjct: 311 HVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVF 370
Query: 133 DFFTGLSSLQSIEIDNNPFSSWE-IPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPG 191
+ L LQ++ + N ++ + +N S L+ S N
Sbjct: 371 QGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLD-VSLNSLNSHAYDRTCAWAES 429
Query: 192 LTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA 251
+ +L+L+ N L G + +++ L ++ N + + ++ +L+E+ + SN
Sbjct: 430 ILVLNLSSNMLTGSVFRCLP-PKVKVLDLH-NNRIMSIPKDVT---HLQALQELNVASNQ 484
Query: 252 F-SGPLPDFSGVKQLESLSLRDNFF 275
S P F + L+ + L DN +
Sbjct: 485 LKSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 49/323 (15%), Positives = 96/323 (29%), Gaps = 21/323 (6%)
Query: 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175
+V SN T VP D +++ + N S + S L+ +
Sbjct: 32 LESMVDYSNRNLTHVPKDL---PPRTKALSLSQNSISELR-MPDISFLSELRVLRLSHNR 87
Query: 176 ITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGID 234
I F L L ++ N+L + + ++ L ++ N L
Sbjct: 88 IRSLDFHVF--LFNQDLEYLDVSHNRL-QNIS--CCPMASLRHLDLSF-NDFDVLPVC-K 140
Query: 235 VIQNMTSLKEIWLHSNAF-SGPLPDFSGVK-QLESLSLRDNFFTGPVPDSLVKLESLKIV 292
N+T L + L + F L + + L L G +SL + +
Sbjct: 141 EFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLH 200
Query: 293 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 352
+ + V +L + SN C + L + + ++
Sbjct: 201 LVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDEN--CQRLMTFLSELTRGPTLLNVTLQH 258
Query: 353 WKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSG---- 408
+ CS + + +N + +T I E ++ L ++
Sbjct: 259 IETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL 318
Query: 409 MIPEGL-SVLGALKELDVSNNQL 430
E L SV + +S +
Sbjct: 319 FSKEALYSVFAEMNIKMLSISDT 341
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 22/101 (21%), Positives = 41/101 (40%), Gaps = 16/101 (15%)
Query: 67 DKRITRIQIGHQNLQGTLPSNLQNL----------------TKLERLELQWNSISGPLPS 110
D + + + ++ L K++ L+L N I
Sbjct: 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPKD 468
Query: 111 LNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPF 151
+ L +L+ + +++NQ SVP F L+SLQ I + +NP+
Sbjct: 469 VTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 49/216 (22%), Positives = 82/216 (37%), Gaps = 20/216 (9%)
Query: 110 SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNF 169
++ +AS V T++P D + + N ++ +L + L
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLPK---DTTILHLSENLLYTFS-LATLMPYTRLTQL 60
Query: 170 SANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAK 228
+ + A +T ++ P L L L+ NQL LP + L V+ N
Sbjct: 61 NLDRAELT-KLQVD---GTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVS-FNRLTS 114
Query: 229 LGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKL 286
L G ++ + L+E++L N LP + +LE LSL +N T L L
Sbjct: 115 LPLG--ALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL 171
Query: 287 ESLKIVNMTNNLLQGPVPE--FDRSVSLDMAKGSNN 320
E+L + + N L +P+ F L A N
Sbjct: 172 ENLDTLLLQENSLYT-IPKGFFGSH-LLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 45/254 (17%), Positives = 81/254 (31%), Gaps = 71/254 (27%)
Query: 57 CKWNHVVCIEDKRITRIQIG----------HQNLQGTLPSN-LQNLTKLERLELQWNSIS 105
V C + + +T + +NL T L T+L +L L ++
Sbjct: 10 ASHLEVNC-DKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 106 GPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASG 165
L L L + LS+NQ S+P L +L +++ N +S +P
Sbjct: 69 K-LQVDGTLPVLGTLDLSHNQLQSLPL-LGQTLPALTVLDVSFNRLTS--LP-------- 116
Query: 166 LQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNG 225
L L+L N+L LP
Sbjct: 117 ---------------LGAL--RGLGELQELYLKGNEL-KTLPP----------------- 141
Query: 226 NAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSL 283
++ L+++ L +N + LP +G++ L++L L++N +P
Sbjct: 142 --------GLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLYT-IPKGF 191
Query: 284 VKLESLKIVNMTNN 297
L + N
Sbjct: 192 FGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 26/77 (33%), Positives = 38/77 (49%), Gaps = 3/77 (3%)
Query: 77 HQNLQGTLPSNL-QNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDF 134
N TLP L KLE+L L N+++ P LNGL +L+ ++L N ++P F
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGF 191
Query: 135 FTGLSSLQSIEIDNNPF 151
F G L + NP+
Sbjct: 192 F-GSHLLPFAFLHGNPW 207
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 38/228 (16%), Positives = 64/228 (28%), Gaps = 54/228 (23%)
Query: 205 GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQ 264
LP L ++ N + T L ++ L + L +
Sbjct: 28 DLPKD-----TTILHLSE-NLLYTFSLA--TLMPYTRLTQLNLDRAELTK-LQVDGTLPV 78
Query: 265 LESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSLDMAKGSNN--F 321
L +L L N +P L +L +++++ N L P+ L N
Sbjct: 79 LGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK 137
Query: 322 CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMN 381
LP PG L ++ N
Sbjct: 138 TLP-PGLLT-PTPKL------------------------------------EKLSLANNN 159
Query: 382 LTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNN 428
LT + ++L L+L +N+L IP+G L + N
Sbjct: 160 LT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 36/197 (18%), Positives = 61/197 (30%), Gaps = 46/197 (23%)
Query: 237 QNMTSLKEIWLHSNAFSGPLPDFSGV-KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 295
+ S E+ + LP + K L L +N +L+ L +N+
Sbjct: 7 SKVASHLEVNCDKRNLTA-LP--PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 296 NNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 355
L + L S+N +L +L P
Sbjct: 64 RAELTK-LQVDGTLPVLGTLDLSHN-----------QLQSL---------PLLGQ----- 97
Query: 356 NDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGL 414
+ +TV++ LT ++ LQ L L N L +P GL
Sbjct: 98 --------TLP----ALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGL 143
Query: 415 -SVLGALKELDVSNNQL 430
+ L++L ++NN L
Sbjct: 144 LTPTPKLEKLSLANNNL 160
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 6e-15
Identities = 57/230 (24%), Positives = 95/230 (41%), Gaps = 55/230 (23%)
Query: 600 ILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVI-SGKGLTE-FKSEIAVLTKVR------- 649
LG G F TV+ + + + T +A+K ++ K TE + EI +L +V
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMK-----IVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 650 ----HRHLVALLGH-----------CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLE 694
H++ LL H + VFE + + L I + G+ PL
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVM-------VFEVLGE-NLLALIKKYEHRGI-PLI 131
Query: 695 WNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA------KVADFGLVRL 748
+ ++ I+ + G++Y+H IH D+KP N+L+ K+AD G
Sbjct: 132 YVKQ--ISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 749 APEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 797
E + I+TR Y +PE + D++S ++ ELITG
Sbjct: 188 YDEHYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-15
Identities = 22/185 (11%), Positives = 60/185 (32%), Gaps = 15/185 (8%)
Query: 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149
L +S + + + SL + L+N T + +++ + I+N
Sbjct: 21 TFKAYLNGLLGQSSTANITEA--QMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNI 76
Query: 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS 209
+++ + S L+ ++T LT+L ++ + +
Sbjct: 77 HATNYN---PISGLSNLERLRIMGKDVTSDKIPNLS--GLTSLTLLDISHSAHDDSILTK 131
Query: 210 FSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESL 268
+ ++ S+ + + N + I ++ + LK + + + +L L
Sbjct: 132 INTLPKVNSIDL---SYNGAI-TDIMPLKTLPELKSLNIQFDGVHD-YRGIEDFPKLNQL 186
Query: 269 SLRDN 273
Sbjct: 187 YAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 27/165 (16%), Positives = 68/165 (41%), Gaps = 11/165 (6%)
Query: 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149
+ L + L +++ L + +++ + ++N T+ + +GLS+L+ + I
Sbjct: 42 QMNSLTYITLANINVTD-LTGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGK 98
Query: 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS 209
+S +IP +L + L + + I + P + + L++N I +
Sbjct: 99 DVTSDKIP-NLSGLTSLTLLDISHSAHDDSILTKIN--TLPKVNSIDLSYNGAITDIMPL 155
Query: 210 FSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG 254
+ +++SL + +G I++ L +++ S G
Sbjct: 156 KTLPELKSLNIQF-DGVHD----YRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 5e-10
Identities = 11/88 (12%), Positives = 29/88 (32%), Gaps = 2/88 (2%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQF 127
+T + I H ++ + + L K+ ++L +N + L L L+ + + +
Sbjct: 112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGV 171
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWE 155
L + + +
Sbjct: 172 HDY--RGIEDFPKLNQLYAFSQTIGGKK 197
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 15/163 (9%), Positives = 50/163 (30%), Gaps = 37/163 (22%)
Query: 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTIL 195
+ + + + + + I ++ + L + + N+T G + + L
Sbjct: 20 STFKAYLNGLLGQSSTA--NITEA--QMNSLTYITLANINVT----DLTGIEYAHNIKDL 71
Query: 196 HLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG- 254
+ + I +++L+ + + +
Sbjct: 72 TINNIHA----------------------------TNYNPISGLSNLERLRIMGKDVTSD 103
Query: 255 PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
+P+ SG+ L L + + + + L + ++++ N
Sbjct: 104 KIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN 146
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 12/73 (16%), Positives = 33/73 (45%), Gaps = 1/73 (1%)
Query: 233 IDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 292
+ I+ ++K++ +++ + SG+ LE L + T +L L SL ++
Sbjct: 59 LTGIEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117
Query: 293 NMTNNLLQGPVPE 305
+++++ +
Sbjct: 118 DISHSAHDDSILT 130
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 15/70 (21%), Positives = 32/70 (45%), Gaps = 2/70 (2%)
Query: 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
NI + ++ T +P + +L+RL + +++ LS L +L LD+S++
Sbjct: 67 NIKDLTINNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH 124
Query: 431 YGKIPSFKSN 440
I + +
Sbjct: 125 DDSILTKINT 134
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 13/70 (18%), Positives = 27/70 (38%)
Query: 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
N+ + ++T P + SL L ++ + I ++ L + +D+S N
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
Query: 431 YGKIPSFKSN 440
I K+
Sbjct: 149 ITDIMPLKTL 158
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 29/194 (14%), Positives = 58/194 (29%), Gaps = 43/194 (22%)
Query: 238 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVP-DSLVKLESLKIVNMTN 296
M SL I L + + L ++ L++ + T P L LE L+I+
Sbjct: 42 QMNSLTYITLANINVTD-LTGIEYAHNIKDLTINNIHATNYNPISGLSNLERLRIMG--K 98
Query: 297 NLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGN 356
++ +P SL + S++ D L + ++ K+
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHS------AHDDSILTKINTLPKV-------------- 138
Query: 357 DPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSV 416
I+ I P + L+ L + + + G+
Sbjct: 139 ----------------NSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDY--RGIED 179
Query: 417 LGALKELDVSNNQL 430
L +L + +
Sbjct: 180 FPKLNQLYAFSQTI 193
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 9e-15
Identities = 29/152 (19%), Positives = 59/152 (38%), Gaps = 10/152 (6%)
Query: 67 DKRITRIQIGHQNLQGTLPSN--LQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLS 123
+ + H NL L + LT L L L N ++ + + +L + LS
Sbjct: 38 PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96
Query: 124 NNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQ-SLRNASGLQNFSANSANITGQIPS 182
+N ++ F+ L +L+ + + NN + + + + + LQ + I+ + P
Sbjct: 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVV--VDRNAFEDMAQLQKLYLSQNQIS-RFPV 153
Query: 183 --FFGPDEFPGLTILHLAFNQLIGGLPASFSG 212
++ P L +L L+ N+L
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQK 185
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 46/293 (15%), Positives = 91/293 (31%), Gaps = 109/293 (37%)
Query: 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSIS--GPLPSLNGL 114
C N + C +++ + P +L + T L+L N++S + L
Sbjct: 18 CASNILSCS-KQQLPNV-----------PQSLPSYT--ALLDLSHNNLSRLRAEWTPTRL 63
Query: 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA 174
+L ++LS+N + S+ F + +
Sbjct: 64 TNLHSLLLSHNHLNFISSEAFVPVPN---------------------------------- 89
Query: 175 NITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGID 234
L L L+ N L +
Sbjct: 90 -----------------LRYLDLSSNHL----------HTLDE----------------F 106
Query: 235 VIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVP----DSLVKLES 288
+ ++ +L+ + L++N + F + QL+ L L N + P KL
Sbjct: 107 LFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPK 164
Query: 289 LKIVNMTNNLLQG-PVPEFDRSVSLDMAKGS--NNFCLPSPGACDPRLNALLS 338
L ++++++N L+ P+ + + + NN P CD +L L S
Sbjct: 165 LMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN-----PLECDCKLYQLFS 212
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 15/63 (23%), Positives = 29/63 (46%), Gaps = 5/63 (7%)
Query: 371 NITVINFQKMNLTGTISPE--FASFKSLQRLILADNNLSGMIPEG-LSVLGALKELDVSN 427
+++ NL+ + E +L L+L+ N+L+ I + L+ LD+S+
Sbjct: 40 YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97
Query: 428 NQL 430
N L
Sbjct: 98 NHL 100
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 32/212 (15%), Positives = 69/212 (32%), Gaps = 42/212 (19%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
L + L S++ L S L+ ++ N+ S+ ++L+ +
Sbjct: 13 FPDPGLANAVKQNLGKQSVTD-LVSQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELH 69
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGG 205
+ +N S + L L+ S N + + L+ L L N+L
Sbjct: 70 LSHNQISDLSPLKDLTK---LEELSVNRNRLK-NLN----GIPSACLSRLFLDNNELR-- 119
Query: 206 LPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL 265
D + ++ +L+ + + +N + + +L
Sbjct: 120 --------------------------DTDSLIHLKNLEILSIRNNKLKS-IVMLGFLSKL 152
Query: 266 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
E L L N T L +L+ + +++T
Sbjct: 153 EVLDLHGNEIT--NTGGLTRLKKVNWIDLTGQ 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 28/118 (23%), Positives = 45/118 (38%), Gaps = 11/118 (9%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
S L++LTKLE L + N + L + L + L NN+ S L +L+ +
Sbjct: 79 SPLKDLTKLEELSVNRNRLKN-LNGIPSA-CLSRLFLDNNELRDTDS--LIHLKNLEILS 134
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLI 203
I NN S L S L+ + IT + G + + L + +
Sbjct: 135 IRNNKLKSIV---MLGFLSKLEVLDLHGNEIT----NTGGLTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 27/151 (17%), Positives = 55/151 (36%), Gaps = 29/151 (19%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
+L +L LE L ++ N + + L L+ LEV+ L N+ T+ T L + I+
Sbjct: 122 DSLIHLKNLEILSIRNNKLKS-IVMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWID 178
Query: 146 IDNNPFSSWE--------IPQSLRNASGLQ--------NFSANSANITGQIPSFFGPDEF 189
+ + I ++++ G S + ++P +
Sbjct: 179 LTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVY------ 232
Query: 190 PGLTILHLAFNQL--IGGLPASFSGSQIQSL 218
+ F++ +G A F G+ Q +
Sbjct: 233 --TDEVSYKFSEYINVGETEAIFDGTVTQPI 261
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 36/217 (16%), Positives = 68/217 (31%), Gaps = 62/217 (28%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
+ +Q T L+ L L N IS L L L LE + ++ N+ ++ + L +
Sbjct: 57 AGMQFFTNLKELHLSHNQISD-LSPLKDLTKLEELSVNRNRLKNLN---GIPSACLSRLF 112
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGG 205
+DNN LR+ L + L IL + N
Sbjct: 113 LDNN---------ELRDTDSLIH--------------------LKNLEILSIRNN----- 138
Query: 206 LPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL 265
+++S I ++ ++ L+ + LH N + + +K++
Sbjct: 139 --------KLKS---------------IVMLGFLSKLEVLDLHGNEITN-TGGLTRLKKV 174
Query: 266 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302
+ L +L V + P
Sbjct: 175 NWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISP 211
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 34/248 (13%), Positives = 64/248 (25%), Gaps = 46/248 (18%)
Query: 69 RITRIQIGHQNLQGTLPSNLQNLT--KLERLELQWNSISGPLPSLNGL-----ASLEVVM 121
+ + + + + GT P L T L L L+ S + L L L+V+
Sbjct: 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155
Query: 122 LSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWE------IPQSLRNASGLQNFSANS-A 174
++ + + +L ++++ +NP P L
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVL-ALRNAGME 214
Query: 175 NITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGID 234
+G + L L L+ N L A
Sbjct: 215 TPSGVCSALAA--ARVQLQGLDLSHNSLRDAAGAPSC----------------------- 249
Query: 235 VIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 294
+ L + L +L L L N P +L + +++
Sbjct: 250 --DWPSQLNSLNLSFTGLKQVPKGLP--AKLSVLDLSYNRLDR-NPSPD-ELPQVGNLSL 303
Query: 295 TNNLLQGP 302
N
Sbjct: 304 KGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 41/258 (15%), Positives = 79/258 (30%), Gaps = 42/258 (16%)
Query: 69 RITRIQIGHQNLQGTLPSN---LQNLTKLERLELQWNSISGPLPS---LNGLASLEVVML 122
+ R+ + + + + ++ L+ L L+ ++G P L ++ L
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 123 SNNQFTSVPSD----FFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANI 176
N + + + L+ + I ++ Q +R L + S N
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ-VRVFPALSTLDLSDNPELG 187
Query: 177 TGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVI 236
+ S P +FP L +L L + + SG
Sbjct: 188 ERGLISALCPLKFPTLQVLALRNAGM-----ETPSGVCSALA------------------ 224
Query: 237 QNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 294
L+ + L N+ QL SL+L VP L L ++++
Sbjct: 225 AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL--PAKLSVLDL 281
Query: 295 TNNLLQGPVPEFDRSVSL 312
+ N L P D +
Sbjct: 282 SYNRLDR-NPSPDELPQV 298
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 9e-10
Identities = 47/324 (14%), Positives = 89/324 (27%), Gaps = 68/324 (20%)
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQ-IPSFFGP 186
+ + + G SL+ + + + + + L+ + +A I + +
Sbjct: 32 GAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRV 91
Query: 187 DEFPGLTILHLAFNQLIGGLP---ASFSGSQIQSLWVNGQNGNAKLGGGIDVIQN--MTS 241
GL L L ++ G P +G + L + A + +Q
Sbjct: 92 LGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR-NVSWATRDAWLAELQQWLKPG 150
Query: 242 LKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVP----DSLVKLESLKIVNMTN 296
LK + + L +L L DN G +K +L+++ + N
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRN 210
Query: 297 NLLQGPVPEFDRSV-------SLDMAKGSNNF-CLPSPGACD--PRLNALLSVVKLMGYP 346
++ P LD++ N+ +CD +LN+L
Sbjct: 211 AGMETPSGVCSALAAARVQLQGLDLS--HNSLRDAAGAPSCDWPSQLNSL---------- 258
Query: 347 QRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNL 406
N L + L L L+ N L
Sbjct: 259 -----NLSFT------------------------GLK-QVPKG--LPAKLSVLDLSYNRL 286
Query: 407 SGMIPEGLSVLGALKELDVSNNQL 430
P L + L + N
Sbjct: 287 DR-NPSPDE-LPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 33/213 (15%), Positives = 62/213 (29%), Gaps = 46/213 (21%)
Query: 238 NMTSLKEIWLHSNAFSGPLPD----FSGVKQLESLSLRDNFFTGPVPDSLVKL--ESLKI 291
SLK + + + + G+ L+ L+L + TG P L++ L I
Sbjct: 66 KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125
Query: 292 VNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRFA 350
+N+ N P L L ++ + +
Sbjct: 126 LNLRNVSWATRDAWLAELQQW----------------LKPGLKVLSIAQAHSLNFSCEQV 169
Query: 351 ENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFA----SFKSLQRLILADNN- 405
+ ++ ++ G A F +LQ L L +
Sbjct: 170 RVFP----------------ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213
Query: 406 --LSGMIPEGLSVLGALKELDVSNNQLYGKIPS 436
SG+ + L+ LD+S+N L +
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 49/220 (22%)
Query: 600 ILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEF----KSEIAVLTKVRHR--- 651
++G+G FG V K +A+K ++ + F EI +L +R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALK-----MV--RNEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 652 ---HLVALL------GH-CLDGNEKLLVFEYMPQGTLSRHIFNWAEEG-LKPLEWNRRLT 700
+++ +L H C+ FE LS +++ ++ +
Sbjct: 157 NTMNVIHMLENFTFRNHICM-------TFEL-----LSMNLYELIKKNKFQGFSLPLVRK 204
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA--KVADFGLVRLAPEGKGS-IE 757
A + + ++ LH IH DLKP NILL R+ KV DFG + + I+
Sbjct: 205 FAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ 261
Query: 758 TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 797
+R F Y APE + R +D++S G IL EL+TG
Sbjct: 262 SR----F-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 45/220 (20%)
Query: 599 NILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEF----KSEIAVLTKVRHR-- 651
+++G+G FG V K + +A+K +I K F + E+ +L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIK-----II--KNKKAFLNQAQIEVRLLELMNKHDT 112
Query: 652 ----HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLK-------PLEWNRRLT 700
++V L H + N LVFE LS +++ + L+ L R+
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEM-----LSYNLY----DLLRNTNFRGVSLNLTRK-- 161
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA--KVADFGLVRLAPEGKGS-IE 757
A + + +L S IH DLKP NILL + R+ K+ DFG + I+
Sbjct: 162 FAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ 220
Query: 758 TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR 797
+R F Y +PE + +D++S G IL+E+ TG
Sbjct: 221 SR----F-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 32/210 (15%), Positives = 68/210 (32%), Gaps = 69/210 (32%)
Query: 57 CKWNHVVCIEDKRITRIQIG----------HQNLQGTLPSN--LQNLTKLERLELQWNSI 104
C+ V C ++++ +I + N L + + L +L ++ N I
Sbjct: 11 CEGTTVDC-SNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI 69
Query: 105 SGPLPS--LNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRN 162
+ + G + + ++L++N+ +V F GL SL+++ + +N + +
Sbjct: 70 TD-IEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITC--VG----- 121
Query: 163 ASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNG 222
F + +L L NQ+ P +F
Sbjct: 122 ------------------NDSF--IGLSSVRLLSLYDNQITTVAPGAFD----------- 150
Query: 223 QNGNAKLGGGIDVIQNMTSLKEIWLHSNAF 252
+ SL + L +N F
Sbjct: 151 ---------------TLHSLSTLNLLANPF 165
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 37/161 (22%), Positives = 62/161 (38%), Gaps = 14/161 (8%)
Query: 95 ERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSS 153
E+L+LQ ++ + GL L + L NQ ++ + F L+ L ++ + NN +S
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 154 WE--IPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS-F 210
+ L L + F D L L L NQL +PA F
Sbjct: 98 LPLGVFDHLTQ---LDKLYLGGNQLKSLPSGVF--DRLTKLKELRLNTNQL-QSIPAGAF 151
Query: 211 SG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250
+ +Q+L ++ + G D + L+ I L N
Sbjct: 152 DKLTNLQTLSLSTNQLQSVPHGAFD---RLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 24/63 (38%), Positives = 34/63 (53%), Gaps = 3/63 (4%)
Query: 91 LTKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148
LTKL+ L L N + +P+ + L +L+ + LS NQ SVP F L LQ+I +
Sbjct: 130 LTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFG 188
Query: 149 NPF 151
N F
Sbjct: 189 NQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 39/187 (20%), Positives = 66/187 (35%), Gaps = 36/187 (19%)
Query: 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWE--IPQSLRNASGLQNFSAN 172
A E + L + ++ F GL+ L + +D N + + L L
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTE---LGTLGLA 91
Query: 173 SANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGG 232
+ + F D L L+L NQL +SL +G
Sbjct: 92 NNQLASLPLGVF--DHLTQLDKLYLGGNQL-------------KSL----PSG------- 125
Query: 233 IDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLK 290
V +T LKE+ L++N +P F + L++LSL N + +L L+
Sbjct: 126 --VFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQ 182
Query: 291 IVNMTNN 297
+ + N
Sbjct: 183 TITLFGN 189
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.1 bits (160), Expect = 1e-11
Identities = 31/214 (14%), Positives = 55/214 (25%), Gaps = 54/214 (25%)
Query: 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRM------EAGVISGKGLTEFKSEIAVL 645
T +G G FG V++ D T +A+K + K E EI +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 646 TKV---------RHRHLVALLGHCL------------------------------DGNEK 666
++ R + L ++
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLK 726
+V E+ G + K +I + + F HRDL
Sbjct: 138 FIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189
Query: 727 PSNILLGDDMRAKVADFGLVRLAPEGKGSIETRI 760
N+LL K+ + + ++ I
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 2e-11
Identities = 81/484 (16%), Positives = 152/484 (31%), Gaps = 121/484 (25%)
Query: 503 ISLTGVLVFCLCKKKQ---KRF-SRVQSPN----AMVIHPRHSGSENSESVKITVAGSNV 554
+S T L + L K++ ++F V N I + I
Sbjct: 61 VSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY 120
Query: 555 SVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFG-TVYKGE 613
+ + + V +P L+ ++ ++ +NV I G G G T +
Sbjct: 121 NDNQVFAKYNVSRLQP----YLKLRQALLELRPAKNVL-------IDGVLGSGKTWVALD 169
Query: 614 LHDGTKIAVKRMEAGV--ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671
+ K+ +M+ + ++ L S VL L LL + +D N +
Sbjct: 170 VCLSYKV-QCKMDFKIFWLN---LKNCNSPETVL-----EMLQKLL-YQIDPN-----WT 214
Query: 672 YMPQGTLS-RHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNI 730
+ + + + + L+ L ++ L V V+ +F +L I
Sbjct: 215 SRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW--NAF---NLS-CKI 268
Query: 731 LL--GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGV 788
LL +V DF + A S++ L P+ +
Sbjct: 269 LLTTRF---KQVTDF--LSAATTTHISLDHHSMT----LTPDEVKS-------------- 305
Query: 789 ILMELITGRKALDESQPEE---------SM-------HLVTWFRRIHLSKDSFHKAIDPT 832
L+ + D P E S+ L TW H++ D I+ +
Sbjct: 306 -LLLKYLDCRPQDL--PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESS 362
Query: 833 ID-LNEGILASISTVAELAGHCCAREPYQR----PDMGHAVNVLSSLVE-LW-KPTDQNS 885
++ L AE R+ + R P + ++ + L+ +W +
Sbjct: 363 LNVLEP---------AEY------RKMFDRLSVFPP---SAHIPTILLSLIWFDVIKSDV 404
Query: 886 EDIYGIDLEMSLPQALKKWQAYEGRSYMESSSSSLLPSLDNTQT---SIPTRPYGFAESF 942
+ + SL ++K E + S L L+N SI Y ++F
Sbjct: 405 MVVVNKLHKYSL---VEKQP-KESTISIPSIYLELKVKLENEYALHRSIVDH-YNIPKTF 459
Query: 943 KSAD 946
S D
Sbjct: 460 DSDD 463
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 6e-05
Identities = 68/429 (15%), Positives = 131/429 (30%), Gaps = 96/429 (22%)
Query: 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLAS 116
C V C D +I + + + N T+ LQ L L +++ W S S ++
Sbjct: 171 CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL--LYQIDPNWTSRSDHSSNI----- 223
Query: 117 LEVVMLSNNQFTSVPSDFFTGLSSLQSIEI-DNNPFSSWEIPQSL----------RNASG 165
L + + + + N + + + R
Sbjct: 224 ----KLRIHSIQAELRRLLKSKPYENCLLVLLN--VQNAKAWNAFNLSCKILLTTRFKQ- 276
Query: 166 LQNFSANSANITGQIPSF-----FGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWV 220
SA T I PDE ++L + LP ++ +
Sbjct: 277 --VTDFLSAATTTHISLDHHSMTLTPDE--VKSLLLKYLDCRPQDLP-----REVLT--- 324
Query: 221 NGQNGNAKLGGGI-DVIQNMTSLKEIWLHSN--AFSGPLPDFSGVKQLESLSLRDNF--- 274
N + I + I++ + + W H N + + + LE R F
Sbjct: 325 ----TNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESS--LNVLEPAEYRKMFDRL 378
Query: 275 --FTGPVPDSLVKLESLKIV--NMTNNLLQGPVPEFDRSVSLDMAKGSNNFC--LPS--- 325
F P P + + L ++ ++ + + V + + SL + K +PS
Sbjct: 379 SVF--P-PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKY-SL-VEKQPKESTISIPSIYL 433
Query: 326 ----PGACDPRLNALLSVVKLMGY-PQRFAENWKGNDPCSD--W---IGVTCTKGNITVI 375
+ L+ + + Y + ++ P D + IG
Sbjct: 434 ELKVKLENEYALHRSI----VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIE---- 485
Query: 376 NFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALK-------ELDVSNN 428
+ ++M L + F F+ L++ I D+ L+ L LK + D
Sbjct: 486 HPERMTLFRMV---FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYE 542
Query: 429 QLYGKIPSF 437
+L I F
Sbjct: 543 RLVNAILDF 551
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 42/200 (21%), Positives = 69/200 (34%), Gaps = 50/200 (25%)
Query: 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS--LNGL 114
C N V C K +T I LP + + L+ N+I +P +
Sbjct: 11 CSNNIVDC-RGKGLTEIPTN-------LPETIT------EIRLEQNTIKV-IPPGAFSPY 55
Query: 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA 174
L + LSNNQ + + D F GL SL S+ + N + +P
Sbjct: 56 KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE--LP----------------- 96
Query: 175 NITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPA-SFSG-SQIQSLWVNGQNGNAKLGGG 232
S F + L +L L N++ L +F + L + N + G
Sbjct: 97 ------KSLF--EGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLY-DNKLQTIAKG 146
Query: 233 IDVIQNMTSLKEIWLHSNAF 252
+ +++ + L N F
Sbjct: 147 T--FSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 8e-09
Identities = 31/185 (16%), Positives = 58/185 (31%), Gaps = 56/185 (30%)
Query: 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA 174
++ + L N +P F+ L+ I++ NN S +
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE--LA----------------- 72
Query: 175 NITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGID 234
P F L L L N++ LP
Sbjct: 73 ------PDAF--QGLRSLNSLVLYGNKI-TELPK-------------------------S 98
Query: 235 VIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 292
+ + + SL+ + L++N + L F + L LSL DN + L +++ +
Sbjct: 99 LFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTM 157
Query: 293 NMTNN 297
++ N
Sbjct: 158 HLAQN 162
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 28/171 (16%)
Query: 91 LTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNP 150
L + L L N + + +L L +L ++L+ NQ S+P+ F L++L+ + + N
Sbjct: 62 LPNVRYLALGGNKLH-DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQ 120
Query: 151 FSSWE--IPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPA 208
S + L N L + + F D+ LT L L++NQL LP
Sbjct: 121 LQSLPDGVFDKLTN---LTYLNLAHNQLQSLPKGVF--DKLTNLTELDLSYNQL-QSLPE 174
Query: 209 SFSG-----SQIQSLWVNGQNGNAKL----GGGIDVIQNMTSLKEIWLHSN 250
G +Q++ L + +L G D +TSL+ IWLH N
Sbjct: 175 ---GVFDKLTQLKDLRLY----QNQLKSVPDGVFD---RLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 54/238 (22%), Positives = 86/238 (36%), Gaps = 50/238 (21%)
Query: 92 TKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPF 151
+ + L+ S++ + N L S++ ++ +N+ SV L +++ + + N
Sbjct: 19 AETIKANLKKKSVTD-AVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKL 75
Query: 152 SSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS-F 210
I + E LT L L NQL LP F
Sbjct: 76 HD--------------------------ISAL---KELTNLTYLILTGNQL-QSLPNGVF 105
Query: 211 SG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLES 267
+ ++ L + N L G V +T+L + L N LP F + L
Sbjct: 106 DKLTNLKELVLVE-NQLQSLPDG--VFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTE 161
Query: 268 LSLRDNFFTG-P--VPDSLVKLESLKIVNMTNNLLQGPVPE--FDRSVSLDMAKGSNN 320
L L N P V D L +L+ L + N L+ VP+ FDR SL +N
Sbjct: 162 LDLSYNQLQSLPEGVFDKLTQLKDL---RLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 26/65 (40%), Positives = 33/65 (50%), Gaps = 9/65 (13%)
Query: 91 LTKLERLELQWNSISGPLPSL-NG----LASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
LT L L+L +N L SL G L L+ + L NQ SVP F L+SLQ I
Sbjct: 156 LTNLTELDLSYNQ----LQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW 211
Query: 146 IDNNP 150
+ +NP
Sbjct: 212 LHDNP 216
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 51/242 (21%), Positives = 81/242 (33%), Gaps = 73/242 (30%)
Query: 600 ILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEF----KSEIAVLTKVRHR--- 651
+G G FG V + + + AVK V+ + + ++ K E +L K+++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVK-----VV--RNIKKYTRSAKIEADILKKIQNDDIN 94
Query: 652 --HLVALL------GH-CLDGNEKLLVFEYMPQGTLSRHIFNWAEE-GLKPLEWNRRLTI 701
++V H CL +FE L ++
Sbjct: 95 NNNIVKYHGKFMYYDHMCL-------IFE-----PLGPSLYEIITRNNYNGFHIEDIKLY 142
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA 761
+++ + + YL + S H DLKP NILL D K + T+
Sbjct: 143 CIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 762 GT----FG-----------------YLAPE------YAVTGRVTTKVDVFSFGVILMELI 794
G FG Y APE + D++SFG +L EL
Sbjct: 200 GIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAELY 253
Query: 795 TG 796
TG
Sbjct: 254 TG 255
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 52/225 (23%), Positives = 91/225 (40%), Gaps = 37/225 (16%)
Query: 591 VTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 649
V N + +G G FG +Y G + G ++A+K +E L E + ++
Sbjct: 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQL---HIESKIYKMMQ 62
Query: 650 H-RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IA 702
+ + +G+ ++V E + G +FN+ +R+ + +A
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFC---------SRKFSLKTVLLLA 111
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK---VADFGLVR--LAPEGKGSIE 757
+ +EY+H ++FIHRD+KP N L+G + + DFGL + I
Sbjct: 112 DQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 168
Query: 758 TR----IAGTFGYLAPEYAVTGRVTT-KVDVFSFGVILMELITGR 797
R + GT Y A G + + D+ S G +LM G
Sbjct: 169 YRENKNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 61/263 (23%), Positives = 88/263 (33%), Gaps = 83/263 (31%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEF-KSEIAVLTKVR--------H 650
LG G F TV+ + +A+K V S + TE EI +L VR
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKV----VKSAEHYTETALDEIRLLKSVRNSDPNDPNR 100
Query: 651 RHLVALLGH-----------CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL 699
+V LL C+ VFE + L + I +GL PL ++
Sbjct: 101 EMVVQLLDDFKISGVNGTHICM-------VFEVL-GHHLLKWIIKSNYQGL-PLPCVKK- 150
Query: 700 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD------------------------ 735
I V +G++YLH IH D+KP NILL +
Sbjct: 151 -IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 736 -----------------MRAKVADFGLVRLAPEGKGSIE----TRIAGTFGYLAPEYAVT 774
+ K A+ V++A G T T Y + E +
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIG 267
Query: 775 GRVTTKVDVFSFGVILMELITGR 797
T D++S + EL TG
Sbjct: 268 SGYNTPADIWSTACMAFELATGD 290
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 53/243 (21%), Positives = 82/243 (33%), Gaps = 79/243 (32%)
Query: 600 ILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTEF----KSEIAVLTKVRHR-- 651
LG G FG V + H K +A+K +I + + ++ + EI VL K++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALK-----II--RNVGKYREAARLEINVLKKIKEKDK 78
Query: 652 ----HLVALL------GH-CLDGNEKLLVFEYMPQGTLSRHIFNWAEE-GLKPLEWNRRL 699
V + GH C+ FE L ++ F + +E +P
Sbjct: 79 ENKFLCVLMSDWFNFHGHMCI-------AFE-----LLGKNTFEFLKENNFQPYPLPHVR 126
Query: 700 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK------ 753
+A + + +LH H DLKP NIL + + + K
Sbjct: 127 HMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 754 ---GS-----------IETRIAGTFGYLAPE------YAVTGRVTTKVDVFSFGVILMEL 793
GS + TR Y PE + DV+S G IL E
Sbjct: 184 ADFGSATFDHEHHTTIVATR----H-YRPPEVILELGW------AQPCDVWSIGCILFEY 232
Query: 794 ITG 796
G
Sbjct: 233 YRG 235
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 26/174 (14%), Positives = 58/174 (33%), Gaps = 41/174 (23%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL--- 657
+G+GGFG +Y +++ + + +E+ + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 658 --------------GHCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT- 700
G + ++ + G+ + I+ +R +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEAN---------AKRFSR 151
Query: 701 -----IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV--ADFGLVR 747
++L + +EY+H ++H D+K SN+LL +V D+GL
Sbjct: 152 KTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.1 bits (150), Expect = 6e-10
Identities = 25/97 (25%), Positives = 39/97 (40%), Gaps = 4/97 (4%)
Query: 78 QNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTG 137
+ T+ +L+ L + L+L N + P+L L LEV+ S+N +V
Sbjct: 449 AHKDLTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG--VAN 506
Query: 138 LSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSAN 172
L LQ + + NN Q L + L N N
Sbjct: 507 LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 3e-09
Identities = 18/99 (18%), Positives = 36/99 (36%), Gaps = 7/99 (7%)
Query: 60 NHVVCIED----KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLA 115
+ + +T + + H L+ LP L L LE L+ N++ + + L
Sbjct: 451 KDLTVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLP 508
Query: 116 SLEVVMLSNNQFTSVPS-DFFTGLSSLQSIEIDNNPFSS 153
L+ ++L NN+ + L + + N
Sbjct: 509 RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 547
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 6e-08
Identities = 33/258 (12%), Positives = 79/258 (30%), Gaps = 23/258 (8%)
Query: 49 LGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPL 108
+ + V + + ++ + +L R EL +
Sbjct: 306 AASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQ 365
Query: 109 PSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQN 168
L L+ + N T + +++++ + + +L+ ++
Sbjct: 366 SELESCKELQELEPENKWCL------LTIILLMRALDPLLYEKETLQYFSTLKAVDPMRA 419
Query: 169 FSANSANITGQIPSFFGPDEFPGLTILHLAFNQL-----IGGLPASFSGSQIQSLWVNGQ 223
+ + + E+ + +LHLA L + L + L ++
Sbjct: 420 AYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQLL------LVTHLDLSH- 472
Query: 224 NGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTG-PVPDS 282
N L + + L+ + NA + + + +L+ L L +N
Sbjct: 473 NRLRALPPALA---ALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSAAIQP 528
Query: 283 LVKLESLKIVNMTNNLLQ 300
LV L ++N+ N L
Sbjct: 529 LVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 52.1 bits (124), Expect = 7e-07
Identities = 35/269 (13%), Positives = 76/269 (28%), Gaps = 26/269 (9%)
Query: 37 LALKKSLNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLER 96
L L P + + +HV + + Q+ + + + +
Sbjct: 274 LLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVL 333
Query: 97 LELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPF--SSW 154
L+ + + L E LS + T + S LQ +E +N +
Sbjct: 334 LKDRPECWCRDSATDEQLFRCE---LSVEKSTVLQS-ELESCKELQELEPENKWCLLTII 389
Query: 155 EIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPA---SFS 211
+ ++L + + + P + L + +
Sbjct: 390 LLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLA 449
Query: 212 GSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLR 271
+ + ++ + + + L N P + ++ LE L
Sbjct: 450 HKDLTV---------------LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQAS 494
Query: 272 DNFFTGPVPDSLVKLESLKIVNMTNNLLQ 300
DN D + L L+ + + NN LQ
Sbjct: 495 DNALE--NVDGVANLPRLQELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 47.1 bits (111), Expect = 2e-05
Identities = 25/160 (15%), Positives = 51/160 (31%), Gaps = 12/160 (7%)
Query: 280 PDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPS---------PGACD 330
E L ++ E + L + N +CL + P +
Sbjct: 342 CRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYE 401
Query: 331 PRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEF 390
S +K + + + + + + ++ V++ +LT +
Sbjct: 402 KETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VL-CHL 459
Query: 391 ASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
+ L L+ N L +P L+ L L+ L S+N L
Sbjct: 460 EQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNAL 498
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 9e-05
Identities = 21/84 (25%), Positives = 39/84 (46%), Gaps = 8/84 (9%)
Query: 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
+T ++ L + P A+ + L+ L +DN L + +G++ L L+EL + NN+L
Sbjct: 464 LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRL 520
Query: 431 -----YGKIPSFKSNAIVNTDGNP 449
+ S ++N GN
Sbjct: 521 QQSAAIQPLVSCPRLVLLNLQGNS 544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 33/170 (19%), Positives = 66/170 (38%), Gaps = 31/170 (18%)
Query: 591 VTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 649
V ++ +G G FG +++G L + ++A+K E L + E +
Sbjct: 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-FEPRRSDAPQL---RDEYRTYKLLA 63
Query: 650 H-RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IA 702
+ + +G +LV + + +L + + R+ + A
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLC---------GRKFSVKTVAMAA 112
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK-----VADFGLVR 747
+ V+ +H +S ++RD+KP N L+G V DFG+V+
Sbjct: 113 KQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 31/202 (15%), Positives = 67/202 (33%), Gaps = 66/202 (32%)
Query: 586 QVLRNVT-NNFSEENILGRGGFGTVYKGE---------LHDGTKIAVKRMEAGVISGKGL 635
VL + + + ++ R G +Y+ K ++K ++A G+
Sbjct: 34 TVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDA--KDGRLF 90
Query: 636 TEFKS--------EIAVLTKV-------------------RHRHLV-ALLGHCLDGNEKL 667
E ++ K+ ++R LV LG L +
Sbjct: 91 NEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSL---QSA 147
Query: 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKP 727
+ P+ LS + + L +A + +E+LH ++H ++
Sbjct: 148 --LDVSPKHVLS----------ERSV-----LQVACRLLDALEFLH---ENEYVHGNVTA 187
Query: 728 SNILLGDDMRAKV--ADFGLVR 747
NI + + +++V A +G
Sbjct: 188 ENIFVDPEDQSQVTLAGYGFAF 209
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 52/234 (22%), Positives = 90/234 (38%), Gaps = 40/234 (17%)
Query: 584 SIQVLRNVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEI 642
S+ VL V NF +G G FG + G+ L+ +A+K +E L E
Sbjct: 1 SMGVLM-VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQL---HLEY 55
Query: 643 AVLTKVRH-RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT- 700
++ + + G +V E + G +F+ +R +
Sbjct: 56 RFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLC---------DRTFSL 104
Query: 701 -----IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK-----VADFGLVR--L 748
IA+ + +EY+H ++ I+RD+KP N L+G + DF L + +
Sbjct: 105 KTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161
Query: 749 APEGKGSIETR----IAGTFGYLAPEYAVTGRVTT-KVDVFSFGVILMELITGR 797
PE K I R + GT Y G+ + + D+ + G + M + G
Sbjct: 162 DPETKKHIPYREHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-09
Identities = 15/95 (15%), Positives = 35/95 (36%), Gaps = 1/95 (1%)
Query: 76 GHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFF 135
++ +G L +LE L ++ + +L L L+ + LS+N+ +
Sbjct: 26 NSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSDNRVSGGLEVLA 84
Query: 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFS 170
+L + + N + L+ L++
Sbjct: 85 EKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 15/88 (17%), Positives = 37/88 (42%), Gaps = 3/88 (3%)
Query: 213 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRD 272
S ++ L ++ N G + L+ + + + + + + +L+ L L D
Sbjct: 17 SDVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSD 73
Query: 273 NFFTGPVPDSLVKLESLKIVNMTNNLLQ 300
N +G + K +L +N++ N ++
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 35/172 (20%), Positives = 62/172 (36%), Gaps = 40/172 (23%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGL-TEFK-----SEIAVLTKVRHRHL 653
+G GGFG +Y + K A ++ L +E K ++ + K R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 654 VALLG----------HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT--- 700
+ LG + + +V E + G + I N
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQ----------NGTFKKST 152
Query: 701 ---IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV--ADFGLVR 747
+ + + +EY+H ++H D+K +N+LLG +V AD+GL
Sbjct: 153 VLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 4e-09
Identities = 58/249 (23%), Positives = 85/249 (34%), Gaps = 91/249 (36%)
Query: 600 ILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEF----KSEIAVLTKVRHR-- 651
LG G FG V + H G +AVK ++ K + + +SEI VL +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVK-----IV--KNVDRYCEAARSEIQVLEHLNTTDP 73
Query: 652 ----HLVALL------GH-CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLK-------PL 693
V +L GH C+ VFE L + + +K L
Sbjct: 74 NSTFRCVQMLEWFEHHGHICI-------VFE-----LLGLSTY----DFIKENGFLPFRL 117
Query: 694 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753
+ R+ +A + + V +LH H DLKP NIL + + + R
Sbjct: 118 DHIRK--MAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172
Query: 754 ---------GS-----------IETRIAGTFGYLAPE------YAVTGRVTTKVDVFSFG 787
GS + TR Y APE + + DV+S G
Sbjct: 173 NPDIKVVDFGSATYDDEHHSTLVSTR----H-YRAPEVILALGW------SQPCDVWSIG 221
Query: 788 VILMELITG 796
IL+E G
Sbjct: 222 CILIEYYLG 230
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.1 bits (137), Expect = 1e-08
Identities = 16/115 (13%), Positives = 27/115 (23%), Gaps = 15/115 (13%)
Query: 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP--SLNGL 114
+ + +L L L ++ L L GL
Sbjct: 7 PHGSSGLRCTRDGALDS-----------LHHLPGAENLTELYIENQQHLQHLELRDLRGL 55
Query: 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNF 169
L + + + V D F L + + N S + LQ
Sbjct: 56 GELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES--LSWKTVQGLSLQEL 108
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 3e-05
Identities = 19/116 (16%), Positives = 37/116 (31%), Gaps = 30/116 (25%)
Query: 186 PDEFPG---LTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSL 242
PG LT L++ Q + L ++ + L
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLEL-------------------------RDLRGLGEL 58
Query: 243 KEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
+ + + + PD F +L L+L N + V+ SL+ + ++ N
Sbjct: 59 RNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 4e-05
Identities = 20/104 (19%), Positives = 40/104 (38%), Gaps = 9/104 (8%)
Query: 123 SNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIP-QSLRNASGLQNFSANSANITGQIP 181
+ + G +L + I+N + + LR L+N + + + +
Sbjct: 16 TRDGALDSLHHL-PGAENLTELYIENQQ-HLQHLELRDLRGLGELRNLTIVKSGLR-FVA 72
Query: 182 --SFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQ 223
+F P L+ L+L+FN L + G +Q L ++G
Sbjct: 73 PDAFHF---TPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 5e-05
Identities = 21/129 (16%), Positives = 44/129 (34%), Gaps = 12/129 (9%)
Query: 236 IQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 293
+ +L E+++ + L G+ +L +L++ + PD+ L +N
Sbjct: 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86
Query: 294 MTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENW 353
++ N L+ + + +SL S N P C L L + +
Sbjct: 87 LSFNALESLSWKTVQGLSLQELVLSGN-----PLHCSCALRWLQRWEE-----EGLGGVP 136
Query: 354 KGNDPCSDW 362
+ C
Sbjct: 137 EQKLQCHGQ 145
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 8e-04
Identities = 14/86 (16%), Positives = 27/86 (31%), Gaps = 14/86 (16%)
Query: 359 CSDWIGVTCTK-------------GNITVINFQKMNLTGTISPE-FASFKSLQRLILADN 404
G+ CT+ N+T + + + L+ L + +
Sbjct: 7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 405 NLSGMIPEGLSVLGALKELDVSNNQL 430
L + P+ L L++S N L
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNAL 92
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 27/87 (31%), Positives = 43/87 (49%), Gaps = 5/87 (5%)
Query: 68 KRITRIQIGHQNLQGTLPSNL-QNLTKLERLELQWNSISGPLPS--LNGLASLEVVMLSN 124
K +T I + + + TL + N+T+L L L +N + +P +GL SL ++ L
Sbjct: 54 KHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRC-IPPRTFDGLKSLRLLSLHG 111
Query: 125 NQFTSVPSDFFTGLSSLQSIEIDNNPF 151
N + VP F LS+L + I NP
Sbjct: 112 NDISVVPEGAFNDLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 9e-07
Identities = 23/84 (27%), Positives = 38/84 (45%), Gaps = 5/84 (5%)
Query: 77 HQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQFTSVPSDF 134
N +P L N L ++L N IS L + + + L ++LS N+ +P
Sbjct: 39 DGNQFTLVPKELSNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILSYNRLRCIPPRT 97
Query: 135 FTGLSSLQSIEIDNNPFSSWEIPQ 158
F GL SL+ + + N S +P+
Sbjct: 98 FDGLKSLRLLSLHGNDISV--VPE 119
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 24/156 (15%), Positives = 49/156 (31%), Gaps = 53/156 (33%)
Query: 95 ERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSW 154
L L N + L+ L ++ LSNN+ +++ + F+ ++ L ++ + N
Sbjct: 34 TELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC- 92
Query: 155 EIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQ 214
IP P F D L +L L N +
Sbjct: 93 -IP-----------------------PRTF--DGLKSLRLLSLHGNDI------------ 114
Query: 215 IQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250
+ G ++++L + + +N
Sbjct: 115 -SVV-PEG------------AFNDLSALSHLAIGAN 136
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 37/225 (16%)
Query: 591 VTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 649
V N F +G G FG +Y G + ++A+K +E L E + ++
Sbjct: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQL---LYESKIYRILQ 60
Query: 650 -HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IA 702
+ + ++G+ +LV + + +L +FN+ +R+L+ +A
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFC---------SRKLSLKTVLMLA 109
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK---VADFGLVRL--APEGKGSIE 757
+ VE++H +SF+HRD+KP N L+G RA + DFGL + I
Sbjct: 110 DQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166
Query: 758 TR----IAGTFGYLAPEYAVTGRVTT-KVDVFSFGVILMELITGR 797
R + GT Y A G + + D+ S G +LM + G
Sbjct: 167 YRENKNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 7e-08
Identities = 16/93 (17%), Positives = 32/93 (34%), Gaps = 1/93 (1%)
Query: 76 GHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFF 135
++ G + LE L L + + +L L L+ + LS N+
Sbjct: 33 NCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKKLELSENRIFGGLDMLA 91
Query: 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQN 168
L +L + + N + L+ L++
Sbjct: 92 EKLPNLTHLNLSGNKLKDISTLEPLKKLECLKS 124
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 24/101 (23%), Positives = 45/101 (44%), Gaps = 5/101 (4%)
Query: 60 NHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTK---LERLELQWNSISGPLPSL-NGLA 115
++ IE + + +L ++ NL K L++LEL N I G L L L
Sbjct: 36 SNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLP 95
Query: 116 SLEVVMLSNNQFTSVPS-DFFTGLSSLQSIEIDNNPFSSWE 155
+L + LS N+ + + + L L+S+++ N ++
Sbjct: 96 NLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 20/72 (27%), Positives = 36/72 (50%), Gaps = 4/72 (5%)
Query: 83 TLPSNL-QNLTKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQFTSVPSDFFTGLS 139
+ N + + ++ L+L N I + + GL L+ + L +NQ + V F L+
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLN 126
Query: 140 SLQSIEIDNNPF 151
SL S+ + +NPF
Sbjct: 127 SLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 36/200 (18%), Positives = 56/200 (28%), Gaps = 73/200 (36%)
Query: 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG--PLPSLNGL 114
C+ V C + + I P ++ T L L N + L
Sbjct: 8 CEGTTVDC-TGRGLKEI-----------PRDIPLHT--TELLLNDNELGRISSDGLFGRL 53
Query: 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA 174
L + L NQ T + + F G S +Q +++ N
Sbjct: 54 PHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE--------------------- 92
Query: 175 NITGQIPS--FFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGG 232
I + F L L+L NQ+ +P SF
Sbjct: 93 -----ISNKMF---LGLHQLKTLNLYDNQISCVMPGSFE--------------------- 123
Query: 233 IDVIQNMTSLKEIWLHSNAF 252
++ SL + L SN F
Sbjct: 124 -----HLNSLTSLNLASNPF 138
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 17/94 (18%), Positives = 35/94 (37%), Gaps = 5/94 (5%)
Query: 79 NLQGTLPSNLQNL----TKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDF 134
+L+G ++NL + + ++ N I L L L+ ++++NN+ +
Sbjct: 25 DLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGL 83
Query: 135 FTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQN 168
L L + + NN L + L
Sbjct: 84 DQALPDLTELILTNNSLVELGDLDPLASLKSLTY 117
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 25/129 (19%), Positives = 44/129 (34%), Gaps = 14/129 (10%)
Query: 173 SANITGQIPSFFGPDEFPGLTILHLAFNQL--IGGLPASFSGSQIQSLWVNGQNGNAKLG 230
+A + Q + L L ++ I L A+ Q ++ + N KL
Sbjct: 5 TAELIEQAAQY---TNAVRDRELDLRGYKIPVIENLGATLD--QFDAIDFSD-NEIRKLD 58
Query: 231 GGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVP-DSLVKLES 288
G + LK + +++N + L L L +N D L L+S
Sbjct: 59 G----FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKS 114
Query: 289 LKIVNMTNN 297
L + + N
Sbjct: 115 LTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 23/101 (22%), Positives = 36/101 (35%), Gaps = 5/101 (4%)
Query: 60 NHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLE---LQWNSISGPLPSL-NGLA 115
+ IE+ T Q + L L RL+ + N I L L
Sbjct: 29 YKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88
Query: 116 SLEVVMLSNNQFTSVPS-DFFTGLSSLQSIEIDNNPFSSWE 155
L ++L+NN + D L SL + I NP ++ +
Sbjct: 89 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 129
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 31/161 (19%), Positives = 57/161 (35%), Gaps = 33/161 (20%)
Query: 92 TKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNP 150
T + L L N I+ + L +L+ + L +NQ ++P F L+ L +++ N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99
Query: 151 FSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASF 210
+ +P + F D L L + N+L LP
Sbjct: 100 LTV--LP-----------------------SAVF--DRLVHLKELFMCCNKL-TELPRGI 131
Query: 211 -SGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250
+ + L ++ + G D ++SL +L N
Sbjct: 132 ERLTHLTHLALDQNQLKSIPHGAFD---RLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 20/64 (31%), Positives = 25/64 (39%), Gaps = 8/64 (12%)
Query: 91 LTKLERLELQWNSISGPLPSL----NGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146
L L+ L + N L L L L + L NQ S+P F LSSL +
Sbjct: 111 LVHLKELFMCCNK----LTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYL 166
Query: 147 DNNP 150
NP
Sbjct: 167 FGNP 170
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 31/168 (18%), Positives = 63/168 (37%), Gaps = 39/168 (23%)
Query: 87 NLQNLTKLERLEL--QWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSI 144
T+ E++EL I +L+ L + + + LS N + +G+ +L+ +
Sbjct: 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRIL 75
Query: 145 EIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL 202
+ N E ++ + L+ S N QI S G ++ L +L+++ N
Sbjct: 76 SLGRNLIKKIENLDAVADT--LEELWISYN------QIASLSGIEKLVNLRVLYMSNN-- 125
Query: 203 IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250
+I + G ID + + L+++ L N
Sbjct: 126 -----------KITNW------------GEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 22/84 (26%), Positives = 40/84 (47%), Gaps = 4/84 (4%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLA-SLEVVMLSNNQFTSVPSDFFTGLSSLQSI 144
S+L + L L L N I + +L+ +A +LE + +S NQ S+ L +L+ +
Sbjct: 64 SSLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASLSG--IEKLVNLRVL 120
Query: 145 EIDNNPFSSWEIPQSLRNASGLQN 168
+ NN ++W L L++
Sbjct: 121 YMSNNKITNWGEIDKLAALDKLED 144
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 28/65 (43%), Positives = 32/65 (49%), Gaps = 9/65 (13%)
Query: 91 LTKLERLELQWNSISGPLPSL-NG----LASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
LTKL L L N L SL NG L L+ + L NQ SVP F L+SLQ I
Sbjct: 75 LTKLTILYLHENK----LQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIW 130
Query: 146 IDNNP 150
+ NP
Sbjct: 131 LHTNP 135
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 40/161 (24%), Positives = 58/161 (36%), Gaps = 56/161 (34%)
Query: 92 TKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149
+ RLEL+ N + LP + L L + LS NQ S+P F L+ L + + N
Sbjct: 28 SSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86
Query: 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS 209
S +P + F D+ L L L NQL
Sbjct: 87 KLQS--LPNGV--------F-----------------DKLTQLKELALDTNQL------- 112
Query: 210 FSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250
+S+ G D +TSL++IWLH+N
Sbjct: 113 ------KSV----------PDGIFD---RLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 24/80 (30%), Positives = 38/80 (47%), Gaps = 4/80 (5%)
Query: 77 HQNLQGTLPSNL-QNLTKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQFTSVPSD 133
N +LP + LT+L +L L N I LP + L L ++ L N+ S+P+
Sbjct: 36 ESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHENKLQSLPNG 94
Query: 134 FFTGLSSLQSIEIDNNPFSS 153
F L+ L+ + +D N S
Sbjct: 95 VFDKLTQLKELALDTNQLKS 114
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 26/66 (39%), Positives = 35/66 (53%), Gaps = 9/66 (13%)
Query: 91 LTKLERLELQWNSISGPLPSL-NG----LASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
LT+L+ L L N L SL +G L L+ + L NQ SVP F L+SLQ I
Sbjct: 99 LTQLKELALNTNQ----LQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW 154
Query: 146 IDNNPF 151
+ +NP+
Sbjct: 155 LHDNPW 160
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 44/172 (25%), Positives = 66/172 (38%), Gaps = 42/172 (24%)
Query: 85 PSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQS 143
P+ + T L+L+ NS+ P + L SL + L N+ S+P+ F L+SL
Sbjct: 23 PTGIPAQT--TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTY 80
Query: 144 IEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLI 203
+ + N S +P F D+ L L L NQL
Sbjct: 81 LNLSTNQLQS--LP-----------------------NGVF--DKLTQLKELALNTNQL- 112
Query: 204 GGLPASFSG-----SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250
LP G +Q++ L + + G D +TSL+ IWLH N
Sbjct: 113 QSLPD---GVFDKLTQLKDLRLYQNQLKSVPDGVFD---RLTSLQYIWLHDN 158
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 5e-06
Identities = 26/77 (33%), Positives = 39/77 (50%), Gaps = 4/77 (5%)
Query: 77 HQNLQGTLPSNL-QNLTKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQFTSVPSD 133
+ N L + LT+L RL+L N ++ LP+ + L L + L++NQ S+P
Sbjct: 38 YDNQITKLEPGVFDRLTQLTRLDLDNNQLTV-LPAGVFDKLTQLTQLSLNDNQLKSIPRG 96
Query: 134 FFTGLSSLQSIEIDNNP 150
F L SL I + NNP
Sbjct: 97 AFDNLKSLTHIWLLNNP 113
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 19/62 (30%), Positives = 31/62 (50%), Gaps = 3/62 (4%)
Query: 91 LTKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148
L L++L N ++ +P+ + L L + L++N S+P F L SL I + N
Sbjct: 56 LVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYN 114
Query: 149 NP 150
NP
Sbjct: 115 NP 116
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Length = 130 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-05
Identities = 8/37 (21%), Positives = 18/37 (48%)
Query: 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPF 151
++L+ N T++P L +L++ + NP+
Sbjct: 31 VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 42/260 (16%), Positives = 83/260 (31%), Gaps = 53/260 (20%)
Query: 84 LPSNLQNLTKLERLELQWNSISGP--------LPSLNGLASLEVVMLSNNQFTSVP---- 131
+ S L+ L L L+ N + L + + ++ + L N T
Sbjct: 48 ISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPS--CKIQKLSLQNCCLTGAGCGVL 105
Query: 132 SDFFTGLSSLQSIEIDNNPFSSWEIPQ----SLRNASGLQNFSANSANITGQIPSFFGP- 186
S L +LQ + + +N + L L+ +++
Sbjct: 106 SSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165
Query: 187 -DEFPGLTILHLAFNQLIG-GLPA-----SFSGSQIQSLWVN----GQNGNAKLGGGIDV 235
P L ++ N + G+ S Q+++L + + L +
Sbjct: 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLC---GI 222
Query: 236 IQNMTSLKEIWLHSNAFSGPLPDFSGVK-----------QLESLSLRDNFFTGP----VP 280
+ + SL+E+ L SN G+ +L +L + + T +
Sbjct: 223 VASKASLRELALGSNKLGD-----VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLC 277
Query: 281 DSLVKLESLKIVNMTNNLLQ 300
L ESLK +++ N L
Sbjct: 278 RVLRAKESLKELSLAGNELG 297
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 948 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.98 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.97 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.97 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.97 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.97 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.97 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.97 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.97 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.97 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.96 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.96 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.96 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.94 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.94 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.94 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.94 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.93 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.89 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.87 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.86 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.84 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.82 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.76 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.75 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.75 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.75 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.74 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.74 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.74 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.72 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.72 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.72 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.71 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.7 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.7 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.7 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.69 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.67 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.65 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.65 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.64 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.61 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.59 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.55 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.54 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.54 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.53 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.49 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.47 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.47 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.45 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.41 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.4 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.39 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.37 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.37 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.36 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.32 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.23 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.17 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.17 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.09 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.97 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.91 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.85 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.83 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.78 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.73 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.72 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.61 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.54 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.51 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.41 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.37 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.32 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.29 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.15 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.14 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.09 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.0 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.98 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.84 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.81 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.75 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.73 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.7 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.4 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.4 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.25 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.25 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.19 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.16 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.03 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.93 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.9 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.8 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.73 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.59 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.49 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.45 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.22 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.87 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.85 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.38 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 89.63 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 89.31 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.81 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.12 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 81.3 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=454.91 Aligned_cols=261 Identities=31% Similarity=0.516 Sum_probs=209.1
Q ss_pred cCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCce
Q 002238 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 666 (948)
++|.+.++||+|+||+||+|+++ +++.||||+++.. .....++|.+|++++++++|||||+++|+|.+++..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46777889999999999999864 4788999999754 556678899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHhhhh----------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC
Q 002238 667 LLVFEYMPQGTLSRHIFNWAE----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 736 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~ 736 (948)
+|||||+++|+|.++++.... ....+++|.++++|+.|||+||+|||+ ++||||||||+|||+++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCC
Confidence 999999999999999965321 123579999999999999999999997 8999999999999999999
Q ss_pred CeEEeecCCceecCCCC-CceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHH
Q 002238 737 RAKVADFGLVRLAPEGK-GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTW 814 (948)
Q Consensus 737 ~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~ 814 (948)
.+||+|||+|+...... ....+...||+.|||||++.+..++.++|||||||++|||+| |+.||.+....+....+
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i-- 273 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI-- 273 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH--
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH--
Confidence 99999999998654332 223345679999999999999999999999999999999999 89999876654432222
Q ss_pred HHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 815 FRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
..- . .+.. . ...+.++.+++.+||+.||++||||+||++.|+.+.+
T Consensus 274 -~~g---~-------~~~~--p---~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 274 -TQG---R-------ELER--P---RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp -HHT---C-------CCCC--C---TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -HcC---C-------CCCC--c---ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 110 0 0011 1 1223468899999999999999999999999999865
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=452.11 Aligned_cols=262 Identities=29% Similarity=0.488 Sum_probs=214.7
Q ss_pred hcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 665 (948)
.++|.+.+.||+|+||+||+|++. ++..||||+++.. .....++|.+|++++++++|||||+++|+|.+++.
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 356888899999999999999864 4788999999754 55567889999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHhhh--------hcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWA--------EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 737 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~ 737 (948)
.+|||||+++|+|.++++... ......++|.++++|+.|||+||+|||+ ++||||||||+|||+++++.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCc
Confidence 999999999999999996532 1223579999999999999999999997 89999999999999999999
Q ss_pred eEEeecCCceecCCCCCc-eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHH
Q 002238 738 AKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWF 815 (948)
Q Consensus 738 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 815 (948)
+||+|||+|+........ ......||++|||||++.+..|+.++|||||||++|||+| |+.||.+....+....+
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i--- 243 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI--- 243 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---
Confidence 999999999865433222 2233569999999999999999999999999999999999 89999887654432222
Q ss_pred HHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 816 RRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
.. +... .. ....+.++.+++.+||+.||++|||+++|.+.|+++.+
T Consensus 244 ~~-----~~~~-----~~-----p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 244 TQ-----GRVL-----QR-----PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HH-----TCCC-----CC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Hc-----CCCC-----CC-----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11 1000 00 11233468899999999999999999999999998764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-52 Score=446.58 Aligned_cols=263 Identities=25% Similarity=0.447 Sum_probs=208.7
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.++|++.+.||+|+||+||+|+++ ..||||+++.........++|.+|++++++++|||||+++|+|.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 356788899999999999999875 369999998665566677899999999999999999999998864 56899999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++|+|.++++. ....++|.++++|+.|||+||+|||+ ++||||||||+|||+++++.+||+|||+|+....
T Consensus 112 y~~gGsL~~~l~~----~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 112 WCEGSSLYKHLHV----QETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp CCSSCBHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred cCCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999853 23579999999999999999999997 8999999999999999999999999999986543
Q ss_pred CC-CceeeeecccccccCceeccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 752 GK-GSIETRIAGTFGYLAPEYAVT---GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 752 ~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
.. .......+||+.|||||++.+ +.|+.++|||||||++|||+||+.||.+......... .+.. +
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~--~~~~-----~---- 253 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF--MVGR-----G---- 253 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH--HHHT-----T----
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHH--HHhc-----C----
Confidence 32 223445689999999999864 4589999999999999999999999987654332111 1110 0
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
...|.+. ......+.++.+++.+||+.||++||||+||++.|+.+...
T Consensus 254 ~~~p~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 254 YASPDLS--KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp CCCCCST--TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred CCCCCcc--cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 1111111 11122345688999999999999999999999999887643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-52 Score=447.86 Aligned_cols=260 Identities=23% Similarity=0.390 Sum_probs=211.5
Q ss_pred cCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCce
Q 002238 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 666 (948)
..++..+.||+|+||+||+|++. +++.||||+++... .....++|.+|+.++++++|||||+++|+|.+++..
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 34566788999999999999863 46889999997542 344567899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHhhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 735 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~ 735 (948)
+|||||+++|+|.++++..... ....++|.++++|+.|||+||+|||+ ++||||||||+|||++++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCC
Confidence 9999999999999999653211 12469999999999999999999997 899999999999999999
Q ss_pred CCeEEeecCCceecCCCC-CceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHH
Q 002238 736 MRAKVADFGLVRLAPEGK-GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVT 813 (948)
Q Consensus 736 ~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~ 813 (948)
+.+||+|||+|+...... ....+...||++|||||++.++.|+.++|||||||++|||+| |+.||.+....+....+
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i- 260 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI- 260 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH-
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-
Confidence 999999999998553322 223345679999999999999999999999999999999999 89999887654432221
Q ss_pred HHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 814 WFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
.. +... +. ....+.++.+++.+||+.||++||+|+||++.|+..
T Consensus 261 --~~-----~~~~-------~~---p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 261 --RN-----RQVL-------PC---PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp --HT-----TCCC-------CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --Hc-----CCCC-------CC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11 1100 00 112345688999999999999999999999999764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-51 Score=444.58 Aligned_cols=253 Identities=23% Similarity=0.387 Sum_probs=207.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|++.+.||+|+||+||+|+.+ +|+.||||++..........+.+.+|++++++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999875 79999999998776666677889999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|++||+|.+++.. .....+++.+++.|+.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+....
T Consensus 104 y~~gg~L~~~i~~---~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 104 YCEGGDLFKRINA---QKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp CCTTCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred CCCCCcHHHHHHH---cCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 9999999999854 333567899999999999999999997 8999999999999999999999999999986543
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
.. ...+..+||+.|||||++.+..|+.++|||||||++|||+||+.||.+....+....+ .. ..+. +
T Consensus 178 ~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i------~~--~~~~----~ 244 (350)
T 4b9d_A 178 TV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI------IS--GSFP----P 244 (350)
T ss_dssp HH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HH--TCCC----C
T ss_pred Cc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH------Hc--CCCC----C
Confidence 21 1234567999999999999999999999999999999999999999876544332211 11 1110 0
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+ ......++.+++.+||+.||++|||++|+++.
T Consensus 245 -~-----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 245 -V-----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -C-----CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 01123458899999999999999999999874
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=440.37 Aligned_cols=250 Identities=23% Similarity=0.421 Sum_probs=209.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.+.|+..+.||+|+||.||+|+.+ +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 357999999999999999999875 79999999997642 333466899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||++||+|.+++.. ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 151 Ey~~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 221 (346)
T 4fih_A 151 EFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 221 (346)
T ss_dssp CCCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecC
Confidence 99999999998843 468999999999999999999997 899999999999999999999999999999765
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
... ...+..+||+.|||||++.+..|+.++||||+||++|||++|++||.+....+....+ .. ...
T Consensus 222 ~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~~----------~~~ 287 (346)
T 4fih_A 222 KEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RD----------NLP 287 (346)
T ss_dssp SSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HH----------SSC
T ss_pred CCC-CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---Hc----------CCC
Confidence 433 2345678999999999999999999999999999999999999999876554432221 11 011
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+.+. .......++.+++.+|++.||++|||++|+++
T Consensus 288 ~~~~---~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 288 PRLK---NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CCCS---CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCC---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 11122346889999999999999999999876
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=439.14 Aligned_cols=255 Identities=22% Similarity=0.291 Sum_probs=208.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
+.|+..++||+|+||.||+|+++ +|+.||||+++.... ..+|+.++++++|||||++++++.+++..|||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46788899999999999999875 799999999986422 2479999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC-CeEEeecCCceecC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVRLAP 750 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~-~~kl~DfGla~~~~ 750 (948)
|++||+|.+++.. ...+++.++..++.||+.||+|||+ ++||||||||+|||++.++ .+||+|||+|+...
T Consensus 131 y~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 131 LLEGGSLGQLIKQ-----MGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp CCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred ccCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 9999999999954 1479999999999999999999997 8999999999999999987 69999999999765
Q ss_pred CCCCc----eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 751 EGKGS----IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 751 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
..... .....+||+.|||||++.+..|+.++|||||||++|||+||++||.+....+....+. .....+.
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------~~~~~~~ 276 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA------SEPPPIR 276 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH------HSCCGGG
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH------cCCCCch
Confidence 43211 1233579999999999999999999999999999999999999998766544322211 1111111
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhh
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELW 878 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 878 (948)
.+. ......+.+++.+|++.||++|||+.|+++.|....+..
T Consensus 277 -~~~---------~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 277 -EIP---------PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp -GSC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -hcC---------ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 111 122346889999999999999999999999998877643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=435.08 Aligned_cols=269 Identities=21% Similarity=0.303 Sum_probs=205.2
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC----ceEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----EKLL 668 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~l 668 (948)
++|.+.+.||+|+||+||+|+++ |+.||||++... ......++.|+..+.+++|||||+++++|.+++ +.+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 46788899999999999999985 899999998653 222233445666677889999999999998754 5799
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcc-----CCCeeecCCCCccEEEcCCCCeEEeec
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA-----HQSFIHRDLKPSNILLGDDMRAKVADF 743 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivHrDik~~Nill~~~~~~kl~Df 743 (948)
||||+++|+|.++++. ..++|..+++++.|+++||+|||+.+ +++||||||||+|||++.++.+||+||
T Consensus 79 V~Ey~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EecCCCCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 9999999999999954 46899999999999999999999731 349999999999999999999999999
Q ss_pred CCceecCCCCCc---eeeeecccccccCceecccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhh-----
Q 002238 744 GLVRLAPEGKGS---IETRIAGTFGYLAPEYAVTG------RVTTKVDVFSFGVILMELITGRKALDESQPEESM----- 809 (948)
Q Consensus 744 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~----- 809 (948)
|+|+........ .....+||++|||||++.+. .++.++|||||||++|||+||++|+......+..
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 999866544322 22346799999999998764 4678999999999999999998877543221100
Q ss_pred ---hHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 810 ---HLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 810 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
.......... ..+..+|.++......+.+..+.+++.+||+.||++||||.||++.|+++.+
T Consensus 233 ~~~~~~~~~~~~~-----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 233 PSDPSVEEMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CSSCCHHHHHHHH-----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHH-----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 0011111111 1122334444333334556678999999999999999999999999999865
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=426.84 Aligned_cols=246 Identities=26% Similarity=0.407 Sum_probs=200.0
Q ss_pred cccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe----CCceEEEE
Q 002238 596 SEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD----GNEKLLVF 670 (948)
Q Consensus 596 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~ 670 (948)
+..+.||+|+||.||+|.+. +++.||||++..........+.|.+|++++++++|||||++++++.+ +...||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999875 68999999998766666677889999999999999999999999865 34579999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCC--eeecCCCCccEEEc-CCCCeEEeecCCce
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLG-DDMRAKVADFGLVR 747 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrDik~~Nill~-~~~~~kl~DfGla~ 747 (948)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++ ||||||||+|||++ .++.+||+|||+|+
T Consensus 109 Ey~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp ECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 99999999999954 2578999999999999999999997 55 99999999999998 47899999999998
Q ss_pred ecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 748 LAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
..... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+...... +. ..+.. +....
T Consensus 181 ~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~---~~i~~--~~~~~ 249 (290)
T 3fpq_A 181 LKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IY---RRVTS--GVKPA 249 (290)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HH---HHHTT--TCCCG
T ss_pred eCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HH---HHHHc--CCCCC
Confidence 64332 3455789999999998864 699999999999999999999999976543221 11 11111 10000
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.++ .....++.+++.+||+.||++|||++|+++
T Consensus 250 ~~~---------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 SFD---------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGG---------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCC---------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 112235889999999999999999999876
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=429.66 Aligned_cols=251 Identities=23% Similarity=0.365 Sum_probs=210.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|++.+.||+|+||+||+|+.+ +|+.||||++.+... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999875 799999999976432 2344678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||++||+|.+++.. .+.+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 112 Ey~~gG~L~~~i~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 112 SYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp CCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 99999999999854 2578999999999999999999997 899999999999999999999999999999765
Q ss_pred CC-CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 751 EG-KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 751 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
.. ........+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+.... +...+..+.
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~------i~~~~~~~p--- 254 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAK------IIKLEYDFP--- 254 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHTCCCCC---
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHcCCCCCC---
Confidence 43 23334567899999999999999999999999999999999999999987654433221 111111111
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.. ...++.+++.+|++.||++||+++|+...
T Consensus 255 -~~---------~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 255 -EK---------FFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp -TT---------CCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred -cc---------cCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 11 12357899999999999999999987543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=435.14 Aligned_cols=268 Identities=26% Similarity=0.401 Sum_probs=216.9
Q ss_pred HhhcCCcccceecccCceEEEEEEEcC------CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCC-CceeeEEeEEEe
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH-RHLVALLGHCLD 662 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~ 662 (948)
...++|++.+.||+|+||+||+|++.. ++.||||++.... .....++|.+|++++.+++| ||||+++|+|.+
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 345789999999999999999998652 3689999997642 44556789999999999965 899999999976
Q ss_pred C-CceEEEEEecCCCChhHHHHhhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccE
Q 002238 663 G-NEKLLVFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNI 730 (948)
Q Consensus 663 ~-~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Ni 730 (948)
. +..++|||||++|+|.++++..... ....++|.+++.++.|||+||+|||+ ++||||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccce
Confidence 4 5689999999999999999763321 13468999999999999999999998 8999999999999
Q ss_pred EEcCCCCeEEeecCCceecCCCCCc-eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhh
Q 002238 731 LLGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEES 808 (948)
Q Consensus 731 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~ 808 (948)
|+++++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+.
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~ 296 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999999966544332 3345679999999999999999999999999999999998 9999987654332
Q ss_pred hhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhh
Q 002238 809 MHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELW 878 (948)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 878 (948)
. ...+.. + ..+.. .. ..+.++.+++.+||+.||++|||++||+++|+.+++..
T Consensus 297 ~--~~~i~~-----g-----~~~~~--p~---~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 297 F--CRRLKE-----G-----TRMRA--PD---YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp H--HHHHHH-----T-----CCCCC--CT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred H--HHHHHc-----C-----CCCCC--Cc---cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 1 111111 0 00111 11 12346889999999999999999999999999987643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=441.65 Aligned_cols=250 Identities=23% Similarity=0.420 Sum_probs=210.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|+..+.||+|+||.||+|+.+ +|+.||||++... .....+.+.+|+.+|+.++|||||++++++.+++..||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEST--TCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 467999999999999999999875 7999999999765 3334567899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
|||+||+|.+++.. ..+++.++..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 228 Ey~~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 228 EFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp ECCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred eCCCCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECC
Confidence 99999999998843 468999999999999999999997 899999999999999999999999999999765
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+....+ ... ..
T Consensus 299 ~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~~~----------~~ 364 (423)
T 4fie_A 299 KEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDN----------LP 364 (423)
T ss_dssp SSC-CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHS----------CC
T ss_pred CCC-ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---HcC----------CC
Confidence 433 2345678999999999999999999999999999999999999999876654432222 110 11
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+.+. .......++.+|+.+||+.||++|||++|+++
T Consensus 365 ~~~~---~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 365 PRLK---NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CCCS---CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCc---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 01112345889999999999999999999876
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=415.59 Aligned_cols=247 Identities=26% Similarity=0.393 Sum_probs=192.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|++.+.||+|+||+||+|+.+ +|+.||||++.+.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999864 7999999999765433 334567999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+ +|+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+...
T Consensus 93 Ey~-~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ-----RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp ECC-CEEHHHHHHH-----SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred eCC-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 999 6899988843 2579999999999999999999997 899999999999999999999999999998654
Q ss_pred CCCCceeeeecccccccCceecccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
+.. .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||.+....+... .+......+.
T Consensus 164 ~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~------~i~~~~~~~p--- 232 (275)
T 3hyh_A 164 DGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFK------NISNGVYTLP--- 232 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHTCCCCC---
T ss_pred CCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHHcCCCCCC---
Confidence 432 3345689999999999998876 589999999999999999999998755433211 1111111111
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
. ....++.+++.+|++.||++|||++|+++
T Consensus 233 -~---------~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 233 -K---------FLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -T---------TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -C---------CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 11245789999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=424.25 Aligned_cols=245 Identities=24% Similarity=0.356 Sum_probs=197.5
Q ss_pred cCCcccceecccCceEEEEEEEc----CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
++|++.+.||+|+||+||+|+.. +++.||||++++..........+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999762 47899999997654444445678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||||++||+|.+++.. ...+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.
T Consensus 104 vmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EECCCTTCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEcCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 9999999999999854 2578999999999999999999997 8999999999999999999999999999986
Q ss_pred cCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
...... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+....+ ......+.
T Consensus 176 ~~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i------~~~~~~~p-- 246 (304)
T 3ubd_A 176 SIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI------LKAKLGMP-- 246 (304)
T ss_dssp -----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCCCCC--
T ss_pred ccCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH------HcCCCCCC--
Confidence 544322 334568999999999999999999999999999999999999999876654432221 11111111
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMG 865 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ 865 (948)
. ....++.+++.+|++.||++||++.
T Consensus 247 --~---------~~s~~~~~li~~~L~~dP~~R~ta~ 272 (304)
T 3ubd_A 247 --Q---------FLSPEAQSLLRMLFKRNPANRLGAG 272 (304)
T ss_dssp --T---------TSCHHHHHHHHHHTCSSGGGSTTCS
T ss_pred --C---------cCCHHHHHHHHHHcccCHHHCCCCC
Confidence 1 1224588999999999999999863
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=409.02 Aligned_cols=251 Identities=28% Similarity=0.414 Sum_probs=189.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-------
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN------- 664 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------- 664 (948)
++|++.+.||+|+||+||+|+.+ +|+.||||+++... .....+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 45899999999999999999875 79999999997642 3445678999999999999999999999987644
Q ss_pred -----ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeE
Q 002238 665 -----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 739 (948)
Q Consensus 665 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~k 739 (948)
..|+||||+++|+|.+++... ......++..++.|+.||+.||+|||+ ++||||||||+|||++.++.+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGR--CTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTC--CSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhc--CCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEE
Confidence 368999999999999998542 112345677889999999999999998 8999999999999999999999
Q ss_pred EeecCCceecCCCCCc-----------eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 002238 740 VADFGLVRLAPEGKGS-----------IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEES 808 (948)
Q Consensus 740 l~DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~ 808 (948)
|+|||+|+........ ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||.... +.
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~ 233 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ER 233 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HH
Confidence 9999999865443211 1234679999999999999999999999999999999996 775321 11
Q ss_pred hhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 809 MHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
......+.. ..+ ............+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~-----~~~----------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRTLTDVRN-----LKF----------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHHT-----TCC----------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhc-----CCC----------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111111 000 1111222345678999999999999999999876
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=411.33 Aligned_cols=268 Identities=21% Similarity=0.336 Sum_probs=207.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe------CC
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD------GN 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~ 664 (948)
.++|++.+.||+|+||.||+|+.+ +|+.||||+++.........+.+.+|+++|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 468999999999999999999875 79999999998765555666788999999999999999999998764 35
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
..||||||++ |+|.+++.. .+.+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~-----~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS-----SQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS-----SSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEEeCCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecc
Confidence 6899999995 689888832 3679999999999999999999997 899999999999999999999999999
Q ss_pred CceecCCCC---CceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc
Q 002238 745 LVRLAPEGK---GSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL 820 (948)
Q Consensus 745 la~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 820 (948)
+|+...... .......+||+.|||||++.+. .++.++||||+||++|||++|++||.+....+....+..... .
T Consensus 204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g--~ 281 (398)
T 4b99_A 204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG--T 281 (398)
T ss_dssp TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC--C
T ss_pred eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC--C
Confidence 998654321 2234457899999999998875 569999999999999999999999988765544333321111 0
Q ss_pred Ccccccc------------ccCccc--CCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 821 SKDSFHK------------AIDPTI--DLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 821 ~~~~~~~------------~~~~~~--~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
....... .+.+.. ...........++.+|+.+|+..||++|||+.|++++
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 000000 0000011123468899999999999999999998763
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=405.74 Aligned_cols=202 Identities=24% Similarity=0.404 Sum_probs=173.3
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEc----CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEe
Q 002238 588 LRNVTNNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD 662 (948)
Q Consensus 588 l~~~~~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 662 (948)
+..+.++|++.+.||+|+||+||+|+.+ +++.||||++... ....++.+|+++++.+ +|||||++++++.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 3356789999999999999999999753 4688999998653 2346788999999998 69999999999999
Q ss_pred CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC-CCeEEe
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVA 741 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~-~~~kl~ 741 (948)
.++.|+||||+++|+|.+++ +.+++.++..++.|++.||+|||+ ++||||||||+|||++.+ +.+||+
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~--------~~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~ 160 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDIL--------NSLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALV 160 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHH--------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEEC
T ss_pred CCEEEEEEeCCCcccHHHHH--------cCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEEC
Confidence 99999999999999999887 358899999999999999999997 899999999999999876 799999
Q ss_pred ecCCceecCCCCC---------------------------ceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHH
Q 002238 742 DFGLVRLAPEGKG---------------------------SIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMEL 793 (948)
Q Consensus 742 DfGla~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el 793 (948)
|||+|+...+... ...+..+||+.|||||++.+. .|+.++||||+||++|||
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~el 240 (361)
T 4f9c_A 161 DFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSL 240 (361)
T ss_dssp CCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHH
T ss_pred cCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHH
Confidence 9999986543221 112345799999999999875 589999999999999999
Q ss_pred HhCCCCCCCCC
Q 002238 794 ITGRKALDESQ 804 (948)
Q Consensus 794 ltg~~p~~~~~ 804 (948)
++|+.||....
T Consensus 241 l~G~~Pf~~~~ 251 (361)
T 4f9c_A 241 LSGRYPFYKAS 251 (361)
T ss_dssp HHTCSSSSCCS
T ss_pred HHCCCCCCCCC
Confidence 99999996554
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=414.19 Aligned_cols=252 Identities=22% Similarity=0.350 Sum_probs=210.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|++.+.||+|+||.||+|+.+ +|+.||||++... .....+.+.+|+++|+.++|||||++++++.+++..||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 468999999999999999999875 7999999999764 3445678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC--CCeEEeecCCcee
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD--MRAKVADFGLVRL 748 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~--~~~kl~DfGla~~ 748 (948)
||++||+|.+++.. ....+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 234 E~~~gg~L~~~i~~----~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 234 EFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp ECCCCCBHHHHHTC----TTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred eecCCCcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 99999999988832 23579999999999999999999997 899999999999999854 7999999999997
Q ss_pred cCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
..... .....+||+.|||||++.+..|+.++||||+||++|||++|++||.+....+....+ ......+...
T Consensus 307 ~~~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i------~~~~~~~~~~ 378 (573)
T 3uto_A 307 LDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV------KSCDWNMDDS 378 (573)
T ss_dssp CCTTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HTTCCCCCSG
T ss_pred ccCCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH------HhCCCCCCcc
Confidence 75433 345568999999999999999999999999999999999999999876654432221 1111111111
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.......++.+|+.+||+.||.+||++.|+++
T Consensus 379 ---------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 379 ---------AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp ---------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---------cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122345889999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=390.25 Aligned_cols=284 Identities=38% Similarity=0.702 Sum_probs=236.1
Q ss_pred HHHHHhhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc
Q 002238 586 QVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (948)
Q Consensus 586 ~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 665 (948)
.++..++++|+..+.||+|+||.||+|++++|+.||||++... .....+.+.+|+++++.++||||+++++++.+++.
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 3445578899999999999999999999888999999998754 34456789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGl 745 (948)
.++||||+++|+|.+++.... .....++|.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred EEEEEEcCCCCcHHHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 999999999999999885421 122468999999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCC-CceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 746 VRLAPEGK-GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 746 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
++...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||....+.+......|...... ...
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 264 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NGQ 264 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-TTC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-ccc
Confidence 98654322 2223445689999999999999999999999999999999999999988776665555555544332 333
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
+...+++.+. ..........+.+++.+|++.||++||++.++++.|+.+.+.
T Consensus 265 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 265 LEQIVDPNLA-DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CCSSSSSSCT-TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHhcChhhc-cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 4455555443 233456677899999999999999999999999999998753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=411.82 Aligned_cols=250 Identities=23% Similarity=0.336 Sum_probs=200.1
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHH---HHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEF---KSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~---~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
++|++.++||+|+||.||+|+.+ +|+.||||++.+.... ......+ ..++.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67999999999999999999875 7999999999764322 1122233 34466777789999999999999999999
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
|||||++||+|.+++.. ...+++..+..++.||+.||+|||+ ++||||||||+|||++.+|.+||+|||+|+
T Consensus 269 lVmEy~~GGdL~~~l~~-----~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEECCCCSCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999954 2568999999999999999999997 899999999999999999999999999999
Q ss_pred ecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 748 LAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
...... ....+||+.|||||++.+ ..|+.++|+||+||++|||++|++||.+....+...... ........+.
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~---~i~~~~~~~p 414 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTLTMAVELP 414 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH---HHHHCCCCCC
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hhcCCCCCCC
Confidence 765433 345689999999999975 579999999999999999999999997644332222111 1111111111
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPD-----MGHAVN 869 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt-----~~ev~~ 869 (948)
. ....++.+|+.+|++.||.+|++ ++||.+
T Consensus 415 ----~---------~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 415 ----D---------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ----T---------TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ----c---------cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1 12245889999999999999998 577765
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=427.33 Aligned_cols=400 Identities=20% Similarity=0.228 Sum_probs=266.6
Q ss_pred CChHHHHHHHHHHHhcCCCCC----------CCCC-CCCCCCc---cceEEeCCCCEEEEEeCCCCCcCCCCccccCCCC
Q 002238 28 GDDGDAAVMLALKKSLNPPES----------LGWS-DTDPCKW---NHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTK 93 (948)
Q Consensus 28 ~~~~d~~~l~~~k~~~~~~~~----------~~w~-~~~~C~w---~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~ 93 (948)
....|++||.+|+++++.+.. .+|. +++||.| .||+|+..+||+.|+|++++++|.+|++|++|++
T Consensus 27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~ 106 (636)
T 4eco_A 27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTE 106 (636)
T ss_dssp HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTT
T ss_pred hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCcc
Confidence 345799999999999876532 1685 5689999 9999988899999999999999999999999999
Q ss_pred CcEEEcccCCC---------------------------------------------------------------------
Q 002238 94 LERLELQWNSI--------------------------------------------------------------------- 104 (948)
Q Consensus 94 L~~L~L~~N~l--------------------------------------------------------------------- 104 (948)
|++|+|++|.+
T Consensus 107 L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l 186 (636)
T 4eco_A 107 LEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186 (636)
T ss_dssp CCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTT
T ss_pred ceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhh
Confidence 99999998843
Q ss_pred ---------CCCCCCcCCCCCCcEEEcccccccCC-----------------CCcccc--CCCCCCEEEccCCCCCCCCC
Q 002238 105 ---------SGPLPSLNGLASLEVVMLSNNQFTSV-----------------PSDFFT--GLSSLQSIEIDNNPFSSWEI 156 (948)
Q Consensus 105 ---------~~~~p~~~~l~~L~~L~L~~N~l~~~-----------------~~~~~~--~l~~L~~L~Ls~N~l~~~~~ 156 (948)
+++++.++++++|++|+|++|.+++. +|..++ ++++|++|+|++|++.+ .+
T Consensus 187 ~l~~~~n~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~-~~ 265 (636)
T 4eco_A 187 QIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT-KL 265 (636)
T ss_dssp TTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCS-SC
T ss_pred hhccccCCCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCc-cC
Confidence 34333688899999999999999984 667788 99999999999999887 88
Q ss_pred CccccCCCCCCEEEccCcc-ccc-cCCCCCCCCCC------CCCcEEEcccccccccCCC--Cccc-ccccceeccCCCC
Q 002238 157 PQSLRNASGLQNFSANSAN-ITG-QIPSFFGPDEF------PGLTILHLAFNQLIGGLPA--SFSG-SQIQSLWVNGQNG 225 (948)
Q Consensus 157 p~~~~~l~~L~~L~l~~n~-l~~-~~p~~~~~~~l------~~L~~L~Ls~N~l~~~~p~--~~~~-~~l~~l~~~~~~~ 225 (948)
|..+.++++|++|++++|+ ++| .+|..++ .+ ++|++|+|++|+++ .+|. .+.. .+|+.|++.+
T Consensus 266 p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~--~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~--- 339 (636)
T 4eco_A 266 PTFLKALPEMQLINVACNRGISGEQLKDDWQ--ALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLY--- 339 (636)
T ss_dssp CTTTTTCSSCCEEECTTCTTSCHHHHHHHHH--HHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCS---
T ss_pred hHHHhcCCCCCEEECcCCCCCccccchHHHH--hhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcC---
Confidence 9999999999999999998 888 7777665 44 77888888888887 6776 5543 3455555543
Q ss_pred CCccCCCccccccCCCccEEEccCCcccccCCCCCCCCC-CcEEeccCCccccccchhhhCCC--CCcEEEcccCccccc
Q 002238 226 NAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQ-LESLSLRDNFFTGPVPDSLVKLE--SLKIVNMTNNLLQGP 302 (948)
Q Consensus 226 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~-L~~L~L~~N~l~~~~p~~l~~l~--~L~~L~Ls~N~l~g~ 302 (948)
|...+..+ .|.++++|++|+|++|+++..+..+..+++ |+.|+|++|.++ .+|..+..++ +|+.|+|++|++++.
T Consensus 340 N~l~g~ip-~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~ 417 (636)
T 4eco_A 340 NQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSV 417 (636)
T ss_dssp CCCEEECC-CCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTT
T ss_pred CcCccchh-hhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCc
Confidence 33333333 566777777777777777744445666776 777777777777 6676666544 677777777777776
Q ss_pred CCC-CC-------CccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceee-------
Q 002238 303 VPE-FD-------RSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTC------- 367 (948)
Q Consensus 303 ~p~-~~-------~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 367 (948)
+|. +. .+.+|..++..+|....+|......+..+.. .+..++.........+.
T Consensus 418 ~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~------------L~Ls~N~l~~i~~~~~~~~~~~~~ 485 (636)
T 4eco_A 418 DGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSS------------INLMGNMLTEIPKNSLKDENENFK 485 (636)
T ss_dssp TTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSE------------EECCSSCCSBCCSSSSEETTEECT
T ss_pred chhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCE------------EECCCCCCCCcCHHHhcccccccc
Confidence 654 33 4445666666666555444322111111110 01111100000000111
Q ss_pred cCCceEEEEccCCcccccCCcccc--CccccceEeCccccccccCCcCCcCCCCCcEEEc------cCCcccCCCCC---
Q 002238 368 TKGNITVINFQKMNLTGTISPEFA--SFKSLQRLILADNNLSGMIPEGLSVLGALKELDV------SNNQLYGKIPS--- 436 (948)
Q Consensus 368 ~~~~L~~L~ls~n~l~g~ip~~~~--~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~l------s~N~l~g~ip~--- 436 (948)
.+++|+.|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|++|+| ++|++.+.+|.
T Consensus 486 ~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~ 563 (636)
T 4eco_A 486 NTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGIT 563 (636)
T ss_dssp TGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGG
T ss_pred ccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHh
Confidence 1125566666666665 4555554 56666666666666654 5555666666666665 34555555553
Q ss_pred -CCcccccccCCCCC
Q 002238 437 -FKSNAIVNTDGNPD 450 (948)
Q Consensus 437 -~~~~~~~~~~gnp~ 450 (948)
+.....+.+++|..
T Consensus 564 ~l~~L~~L~Ls~N~l 578 (636)
T 4eco_A 564 LCPSLTQLQIGSNDI 578 (636)
T ss_dssp GCSSCCEEECCSSCC
T ss_pred cCCCCCEEECCCCcC
Confidence 23344555555554
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=433.99 Aligned_cols=409 Identities=26% Similarity=0.380 Sum_probs=243.1
Q ss_pred hhcCCCChHHHHHHHHHHHhcCCCCCC-CCC-CCCCCCccceEEeCCCCEEEEEeCCCCCcCC---CC------------
Q 002238 23 FVSASGDDGDAAVMLALKKSLNPPESL-GWS-DTDPCKWNHVVCIEDKRITRIQIGHQNLQGT---LP------------ 85 (948)
Q Consensus 23 ~~~~~~~~~d~~~l~~~k~~~~~~~~~-~w~-~~~~C~w~gv~c~~~~~v~~l~l~~~~l~~~---~p------------ 85 (948)
++++++.+.|++||++||+++.+|..+ +|. ++|||.|.||+|+ .++|+.|+|+++++.|. +|
T Consensus 4 ~~~~~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 4 ASPSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp ----CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred CccccCCHHHHHHHHHHHhhCCCcccccCCCCCCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 344556788999999999999877633 895 6799999999998 78999999999999887 54
Q ss_pred -----------ccccCCCCCcEEEcccCCCCCCCC---CcCCCCCCcEEEcccccccCCCCccc-cCCCCCCEEEccCCC
Q 002238 86 -----------SNLQNLTKLERLELQWNSISGPLP---SLNGLASLEVVMLSNNQFTSVPSDFF-TGLSSLQSIEIDNNP 150 (948)
Q Consensus 86 -----------~~l~~l~~L~~L~L~~N~l~~~~p---~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~ 150 (948)
..|+++++|++|+|++|.++|.+| .+.++++|++|+|++|.+++..|..+ .++++|++|+|++|+
T Consensus 83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 162 (768)
T 3rgz_A 83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162 (768)
T ss_dssp ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence 456666777777777777776444 46667777777777777776655544 667777777777777
Q ss_pred CCCCCCCcc---ccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCccc-ccccceeccCCCCC
Q 002238 151 FSSWEIPQS---LRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGN 226 (948)
Q Consensus 151 l~~~~~p~~---~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~~~~~~~~ 226 (948)
+++ ..|.. +.++++|++|++++|.+++.++. . .+++|++|+|++|++++.+|. +.. .+|+.|++. .|
T Consensus 163 l~~-~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~--~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls---~n 233 (768)
T 3rgz_A 163 ISG-ANVVGWVLSDGCGELKHLAISGNKISGDVDV--S--RCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDIS---GN 233 (768)
T ss_dssp CEE-ETHHHHHHTTCCTTCCEEECCSSEEESCCBC--T--TCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECC---SS
T ss_pred cCC-cCChhhhhhccCCCCCEEECCCCcccccCCc--c--cCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECc---CC
Confidence 665 33444 55566666666666666655443 2 566777777777777666665 432 334444443 33
Q ss_pred CccCCCccccccCCCccEEEccCCcccccCCCC-----------------------CC-CCCCcEEeccCCccccccchh
Q 002238 227 AKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDF-----------------------SG-VKQLESLSLRDNFFTGPVPDS 282 (948)
Q Consensus 227 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~-----------------------~~-l~~L~~L~L~~N~l~~~~p~~ 282 (948)
...+..+..+.++++|++|+|++|++++.+|.. .. +++|++|+|++|.+++.+|..
T Consensus 234 ~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~ 313 (768)
T 3rgz_A 234 KLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPF 313 (768)
T ss_dssp CCCSCHHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGG
T ss_pred cCCCcccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchH
Confidence 344444555566666666666666655544433 22 245555555555555555555
Q ss_pred hhCCCCCcEEEcccCcccccCCC--CCCccccccccccCCCCC-CCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCC
Q 002238 283 LVKLESLKIVNMTNNLLQGPVPE--FDRSVSLDMAKGSNNFCL-PSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPC 359 (948)
Q Consensus 283 l~~l~~L~~L~Ls~N~l~g~~p~--~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 359 (948)
++++++|++|+|++|+++|.+|. +..+.+|+.++..+|... .+|.. +..+. ..... .+..++...
T Consensus 314 ~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~----l~~l~------~~L~~--L~Ls~N~l~ 381 (768)
T 3rgz_A 314 FGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES----LTNLS------ASLLT--LDLSSNNFS 381 (768)
T ss_dssp GGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTT----HHHHT------TTCSE--EECCSSEEE
T ss_pred HhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHH----HHhhh------cCCcE--EEccCCCcC
Confidence 55555555555555555554442 444445555554444332 12211 00000 00000 001111000
Q ss_pred CCccceeec--CCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCCC-
Q 002238 360 SDWIGVTCT--KGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS- 436 (948)
Q Consensus 360 ~~~~~~~~~--~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~- 436 (948)
......++. +++|+.|++++|++++.+|..|+++++|++|+|++|+++|.+|..+..+++|++|++++|+++|.+|.
T Consensus 382 ~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~ 461 (768)
T 3rgz_A 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQE 461 (768)
T ss_dssp EECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGG
T ss_pred CCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHH
Confidence 000001111 45677777777777777777777777777777777777777777777777777777777777776664
Q ss_pred ---CCcccccccCCCCCCCC
Q 002238 437 ---FKSNAIVNTDGNPDIGK 453 (948)
Q Consensus 437 ---~~~~~~~~~~gnp~~~~ 453 (948)
+.....+.+++|...+.
T Consensus 462 ~~~l~~L~~L~L~~N~l~~~ 481 (768)
T 3rgz_A 462 LMYVKTLETLILDFNDLTGE 481 (768)
T ss_dssp GGGCTTCCEEECCSSCCCSC
T ss_pred HcCCCCceEEEecCCcccCc
Confidence 33455666666655433
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=430.17 Aligned_cols=404 Identities=18% Similarity=0.237 Sum_probs=304.5
Q ss_pred CCCChHHHHHHHHHHHhcCCCCCCCCC--C----CCC--CCc------------cceEEeCCCCEEEEEeCCCCCcCCCC
Q 002238 26 ASGDDGDAAVMLALKKSLNPPESLGWS--D----TDP--CKW------------NHVVCIEDKRITRIQIGHQNLQGTLP 85 (948)
Q Consensus 26 ~~~~~~d~~~l~~~k~~~~~~~~~~w~--~----~~~--C~w------------~gv~c~~~~~v~~l~l~~~~l~~~~p 85 (948)
+++...|++||++||+++.+| +|+ + .+| |.| .||.|+..+||+.|+|++++++|.+|
T Consensus 264 ~~~~~~d~~ALl~~k~~l~~~---~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip 340 (876)
T 4ecn_A 264 TAEYIKDYKALKAIWEALDGK---NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVP 340 (876)
T ss_dssp CCHHHHHHHHHHHHHHHTTGG---GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEEC
T ss_pred cccchHHHHHHHHHHHHcCCC---CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCc
Confidence 344568999999999999876 553 2 356 999 99999888999999999999999999
Q ss_pred ccccCCCCCcEEEc-ccCCCCCC---------------------------------------------------------
Q 002238 86 SNLQNLTKLERLEL-QWNSISGP--------------------------------------------------------- 107 (948)
Q Consensus 86 ~~l~~l~~L~~L~L-~~N~l~~~--------------------------------------------------------- 107 (948)
+.|++|++|+.|+| ++|.++|.
T Consensus 341 ~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~ 420 (876)
T 4ecn_A 341 DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD 420 (876)
T ss_dssp GGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCC
T ss_pred hHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccc
Confidence 99999999999999 77754332
Q ss_pred -------------------CC-CcCCCCCCcEEEcccccccC-----------------CCCcccc--CCCCCCEEEccC
Q 002238 108 -------------------LP-SLNGLASLEVVMLSNNQFTS-----------------VPSDFFT--GLSSLQSIEIDN 148 (948)
Q Consensus 108 -------------------~p-~~~~l~~L~~L~L~~N~l~~-----------------~~~~~~~--~l~~L~~L~Ls~ 148 (948)
+| .|.++++|++|+|++|+|++ .+|..++ ++++|+.|+|++
T Consensus 421 ~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~ 500 (876)
T 4ecn_A 421 SRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYN 500 (876)
T ss_dssp CCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEES
T ss_pred cccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcC
Confidence 45 68889999999999999999 2566666 999999999999
Q ss_pred CCCCCCCCCccccCCCCCCEEEccCcc-ccc-cCCCCCC-----CCCCCCCcEEEcccccccccCCC--Cccc-ccccce
Q 002238 149 NPFSSWEIPQSLRNASGLQNFSANSAN-ITG-QIPSFFG-----PDEFPGLTILHLAFNQLIGGLPA--SFSG-SQIQSL 218 (948)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n~-l~~-~~p~~~~-----~~~l~~L~~L~Ls~N~l~~~~p~--~~~~-~~l~~l 218 (948)
|++.+ .+|..+.++++|+.|+|++|+ +++ .+|..++ ...+++|++|+|++|+++ .+|. .+.. .+|+.|
T Consensus 501 N~l~~-~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L 578 (876)
T 4ecn_A 501 CPNMT-QLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLL 578 (876)
T ss_dssp CTTCC-SCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEE
T ss_pred CCCCc-cChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEE
Confidence 99988 899999999999999999998 888 7776543 114569999999999999 8887 6654 456666
Q ss_pred eccCCCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCCCC-CcEEeccCCccccccchhhhCCCC--CcEEEcc
Q 002238 219 WVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQ-LESLSLRDNFFTGPVPDSLVKLES--LKIVNMT 295 (948)
Q Consensus 219 ~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~-L~~L~L~~N~l~~~~p~~l~~l~~--L~~L~Ls 295 (948)
++.++... ..+ .|.++++|+.|+|++|+++..+..+..+++ |+.|+|++|+|+ .+|..+..++. |+.|+|+
T Consensus 579 ~Ls~N~l~----~lp-~~~~L~~L~~L~Ls~N~l~~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls 652 (876)
T 4ecn_A 579 DCVHNKVR----HLE-AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFS 652 (876)
T ss_dssp ECTTSCCC----BCC-CCCTTSEESEEECCSSCCSCCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECC
T ss_pred ECCCCCcc----cch-hhcCCCcceEEECcCCccccchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECc
Confidence 66654433 334 788999999999999999944446888888 999999999999 88988887754 9999999
Q ss_pred cCcccccCCCCC------CccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCC----CCCCCccce
Q 002238 296 NNLLQGPVPEFD------RSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGN----DPCSDWIGV 365 (948)
Q Consensus 296 ~N~l~g~~p~~~------~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 365 (948)
+|+++|.+|.+. ...+|..+++.+|....+|......+..+. . .+..++ .|.....+.
T Consensus 653 ~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~----------~--L~Ls~N~L~~ip~~~~~~~ 720 (876)
T 4ecn_A 653 YNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPIS----------T--IILSNNLMTSIPENSLKPK 720 (876)
T ss_dssp SSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCS----------E--EECCSCCCSCCCTTSSSCT
T ss_pred CCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCC----------E--EECCCCcCCccChHHhccc
Confidence 999999887654 334677778787776655432211111111 0 111111 111000000
Q ss_pred ---eecCCceEEEEccCCcccccCCcccc--CccccceEeCccccccccCCcCCcCCCCCcEEEccC------CcccCCC
Q 002238 366 ---TCTKGNITVINFQKMNLTGTISPEFA--SFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSN------NQLYGKI 434 (948)
Q Consensus 366 ---~~~~~~L~~L~ls~n~l~g~ip~~~~--~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~------N~l~g~i 434 (948)
..++++|+.|+|++|+++ .+|..+. ++++|+.|+|++|+|++ +|..+..+++|+.|+|++ |++.+.+
T Consensus 721 ~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~i 798 (876)
T 4ecn_A 721 DGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQW 798 (876)
T ss_dssp TSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCC
T ss_pred cccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccC
Confidence 112337888888888887 6777776 78888888888888876 777788888888888865 6777777
Q ss_pred CC----CCcccccccCCCCCCCCcc
Q 002238 435 PS----FKSNAIVNTDGNPDIGKEK 455 (948)
Q Consensus 435 p~----~~~~~~~~~~gnp~~~~~~ 455 (948)
|. +.....+.+++|.. ...|
T Consensus 799 p~~l~~L~~L~~L~Ls~N~L-~~Ip 822 (876)
T 4ecn_A 799 PTGITTCPSLIQLQIGSNDI-RKVD 822 (876)
T ss_dssp CTTGGGCSSCCEEECCSSCC-CBCC
T ss_pred hHHHhcCCCCCEEECCCCCC-CccC
Confidence 74 34556677777776 4444
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=386.42 Aligned_cols=290 Identities=37% Similarity=0.689 Sum_probs=236.4
Q ss_pred ceeeHHHHHHhhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEE
Q 002238 581 MVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660 (948)
Q Consensus 581 ~~~~~~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 660 (948)
..+++.++....++|+..+.||+|+||.||+|+.++|+.||||++.... .......+.+|+++++.++||||+++++++
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEecccc-CchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 4577889999999999999999999999999998889999999987643 222234689999999999999999999999
Q ss_pred EeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEE
Q 002238 661 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 740 (948)
Q Consensus 661 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl 740 (948)
.+.+..++||||+++|+|.+++.... .....++|..++.++.|++.||+|||+.+..+|+||||||+|||++.++.+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 99999999999999999999986532 22356999999999999999999999833339999999999999999999999
Q ss_pred eecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chhhhhHHHHHHHh
Q 002238 741 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQ--PEESMHLVTWFRRI 818 (948)
Q Consensus 741 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~--~~~~~~~~~~~~~~ 818 (948)
+|||+++..............||+.|+|||++.+..++.++||||||+++|||++|+.||.... .........|....
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999999776555555566679999999999999999999999999999999999999996321 11222334444333
Q ss_pred hcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 819 HLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
.. ........+..+. ..........+.+++.+|++.||.+||++.+|+++|+..
T Consensus 256 ~~-~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 256 LK-EKKLEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TS-SCCSTTSSCTTCT-TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hh-chhhhhhcChhhc-cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 22 2334444444443 334456677899999999999999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=375.77 Aligned_cols=267 Identities=31% Similarity=0.509 Sum_probs=208.4
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
..++|++.+.||+|+||.||+|+.. |+.||||++..........+++.+|++++++++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 3568999999999999999999875 899999999876556666788999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCC--eeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||+++|+|.+++..... ...+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++.+||+|||+++.
T Consensus 114 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp ECCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred ecCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 99999999999854211 1248999999999999999999997 67 99999999999999999999999999985
Q ss_pred cCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+. . .....
T Consensus 189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~---~-~~~~~----- 258 (309)
T 3p86_A 189 KASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG---F-KCKRL----- 258 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH---H-SCCCC-----
T ss_pred ccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---h-cCCCC-----
Confidence 44332 12334579999999999999999999999999999999999999998766543221111 0 00000
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCCC
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPT 881 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~~ 881 (948)
.+ ......++.+++.+|++.+|.+||+++++++.|+.+.+...+.
T Consensus 259 ---~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 259 ---EI-----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp ---CC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred ---CC-----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 00 0112345889999999999999999999999999998765543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=372.10 Aligned_cols=260 Identities=27% Similarity=0.439 Sum_probs=213.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|+..+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 467889999999999999999875 6899999988643 5566788999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 87 e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 87 EYIKGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159 (310)
T ss_dssp ECCTTCBHHHHHHH----CCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence 99999999999853 23579999999999999999999997 899999999999999999999999999998654
Q ss_pred CCCCce-------------eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhh---hHHHH
Q 002238 751 EGKGSI-------------ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESM---HLVTW 814 (948)
Q Consensus 751 ~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~---~~~~~ 814 (948)
...... .....||+.|+|||++.+..++.++||||||+++|||++|..|+....+.... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~ 239 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF 239 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc
Confidence 433211 11457999999999999999999999999999999999999998765432211 01110
Q ss_pred HHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhC
Q 002238 815 FRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWK 879 (948)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~ 879 (948)
.. ....+. .+..+.+++.+|++.||++||++.++++.|+.+.....
T Consensus 240 ~~----------~~~~~~---------~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 240 LD----------RYCPPN---------CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp HH----------HTCCTT---------CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cc----------ccCCCC---------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00 001111 12348899999999999999999999999999976543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=364.80 Aligned_cols=285 Identities=37% Similarity=0.634 Sum_probs=231.0
Q ss_pred cceeeHHHHHHhhcCCccc------ceecccCceEEEEEEEcCCcEEEEEEeecCc--CChhhHHHHHHHHHHHHhcCCC
Q 002238 580 NMVISIQVLRNVTNNFSEE------NILGRGGFGTVYKGELHDGTKIAVKRMEAGV--ISGKGLTEFKSEIAVLTKVRHR 651 (948)
Q Consensus 580 ~~~~~~~~l~~~~~~~~~~------~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~H~ 651 (948)
...+++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ......+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4567899999999999887 8999999999999987 48999999987542 1234467899999999999999
Q ss_pred ceeeEEeEEEeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEE
Q 002238 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (948)
Q Consensus 652 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nil 731 (948)
||+++++++.+.+..++||||+++|+|.+++... .....+++..++.++.|++.||+|||+ .+|+||||||+||+
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil 165 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL--DGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANIL 165 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG--GGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEE
Confidence 9999999999999999999999999999998642 223579999999999999999999997 89999999999999
Q ss_pred EcCCCCeEEeecCCceecCCCCCc-eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhh
Q 002238 732 LGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMH 810 (948)
Q Consensus 732 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~ 810 (948)
++.++.+||+|||+++........ ......||+.|+|||++.+ .++.++||||||+++|||++|+.||..........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence 999999999999999866543322 2334579999999998764 58999999999999999999999998755433221
Q ss_pred HHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhh
Q 002238 811 LVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875 (948)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~ 875 (948)
.+..........+...+++.+. .........+.+++.+|++.+|.+||++.++++.|+++.
T Consensus 245 --~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 245 --DIKEEIEDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp --HHHHHHHTTSCCHHHHSCSSCS--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred --HHHHHhhhhhhhhhhhcccccc--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1222222222333344444332 233455677999999999999999999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=373.91 Aligned_cols=275 Identities=16% Similarity=0.199 Sum_probs=222.4
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|++.+.||+|+||.||+|+. .+|+.||||++.... ..+.+.+|+++++++ +||||+++++++.+++..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 46899999999999999999986 478999999987542 224688999999999 999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCC-----eEEeecC
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR-----AKVADFG 744 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~-----~kl~DfG 744 (948)
|||+ +++|.+++... ...+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||
T Consensus 84 ~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 84 LELL-GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp EECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred EEeC-CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 9999 99999998542 3579999999999999999999997 79999999999999998887 9999999
Q ss_pred CceecCCCCCc------eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh
Q 002238 745 LVRLAPEGKGS------IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI 818 (948)
Q Consensus 745 la~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 818 (948)
+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.......+...
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~ 235 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT 235 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence 99966543321 124567999999999999999999999999999999999999999886544433322222111
Q ss_pred hcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCCCCCCCccccc
Q 002238 819 HLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDQNSEDIYG 890 (948)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~ 890 (948)
.... .........+ ++.+++.+|++.+|.+||++.+|.+.|+++.+..........+|..
T Consensus 236 ~~~~-----------~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 295 (330)
T 2izr_A 236 KRAT-----------PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIG 295 (330)
T ss_dssp HHHS-----------CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTT
T ss_pred hccC-----------CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCC
Confidence 1000 0000011122 6899999999999999999999999999998877766666666654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=367.06 Aligned_cols=250 Identities=23% Similarity=0.412 Sum_probs=208.5
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|+..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 46899999999999999999986 478999999987642 334567899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 97 e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp ECCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred ECCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999998853 358999999999999999999997 899999999999999999999999999998665
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....+......+. ... .
T Consensus 168 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---~~~----------~ 233 (297)
T 3fxz_A 168 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---TNG----------T 233 (297)
T ss_dssp STTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HHC----------S
T ss_pred Cccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hCC----------C
Confidence 4332 2345679999999999999999999999999999999999999998765443222111 000 0
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+.+. ........+.+++.+|++.||++||+++|+++
T Consensus 234 ~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 234 PELQ---NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CCCS---CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCC---CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0111 01122345889999999999999999999976
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=376.47 Aligned_cols=267 Identities=25% Similarity=0.392 Sum_probs=210.9
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc----eE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE----KL 667 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----~~ 667 (948)
.++|++.+.||+|+||.||+|++. ++.||||++... ......+.+|+.++++++||||+++++++.+... .+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 467999999999999999999876 899999998653 3344566779999999999999999999987543 69
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCC----------CeeecCCCCccEEEcCCCC
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ----------SFIHRDLKPSNILLGDDMR 737 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~----------~ivHrDik~~Nill~~~~~ 737 (948)
+||||+++|+|.+++.. ..+++..++.++.|++.||+|||+ . +|+||||||+|||++.++.
T Consensus 99 lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp EEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred EEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCe
Confidence 99999999999999854 458999999999999999999997 5 9999999999999999999
Q ss_pred eEEeecCCceecCCCCCc-eeeeecccccccCceecccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhH
Q 002238 738 AKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVTG-----RVTTKVDVFSFGVILMELITGRKALDESQPEESMHL 811 (948)
Q Consensus 738 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~ 811 (948)
+||+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 999999999865543322 23335799999999999863 566789999999999999999999976543221111
Q ss_pred ----------HHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 812 ----------VTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 812 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
..+.... ......+.+...........++.+++.+||+.||++|||+.+|++.|+++.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVV------VHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHCSSCCHHHHHHHH------TTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhccCCchhhhhhhh------hcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111111 01111222221222234556799999999999999999999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=377.85 Aligned_cols=265 Identities=26% Similarity=0.419 Sum_probs=215.7
Q ss_pred hcCCcccceecccCceEEEEEEEc--------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEe
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH--------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD 662 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 662 (948)
.++|++.+.||+|+||.||+|++. ++..||||+++.. ......+.+.+|+++++++ +||||+++++++.+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 467899999999999999999862 3567999999764 2445567899999999999 89999999999999
Q ss_pred CCceEEEEEecCCCChhHHHHhhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEE
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nil 731 (948)
.+..++||||+++|+|.+++..... .....+++.+++.++.||++||+|||+ .+|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEE
Confidence 9999999999999999999965321 112458999999999999999999997 89999999999999
Q ss_pred EcCCCCeEEeecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhh
Q 002238 732 LGDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESM 809 (948)
Q Consensus 732 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~ 809 (948)
++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+..
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999986544322 12233457889999999999999999999999999999999 99999876544332
Q ss_pred hHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhh
Q 002238 810 HLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELW 878 (948)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 878 (948)
..+ .. .. .+.. ......++.+++.+||+.+|++||++.|+++.|+.+....
T Consensus 316 ~~~---~~-----~~-----~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 316 KLL---KE-----GH-----RMDK-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHH---HT-----TC-----CCCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHH---hc-----CC-----CCCC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 211 11 00 0001 1122346889999999999999999999999999987644
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=373.95 Aligned_cols=251 Identities=23% Similarity=0.352 Sum_probs=211.0
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
..++|++.+.||+|+||.||+|.+ .+|+.||||++..........+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 356899999999999999999987 5799999999987665666678899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp ECCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 9999999999988541 468999999999999999999997 89999999999999999999999999999865
Q ss_pred CCCCCceeeeecccccccCceecccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVT-TKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
.... ......||+.|+|||++.+..+. .++||||+||++|||++|+.||.+....+....+ ........
T Consensus 165 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i------~~~~~~~p-- 234 (328)
T 3fe3_A 165 TVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV------LRGKYRIP-- 234 (328)
T ss_dssp SSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCCCCC--
T ss_pred CCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCCCCC--
Confidence 4432 23456799999999999888775 8999999999999999999999876544322211 11111110
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
......+.+++.+|++.||.+|||++|+++.
T Consensus 235 -----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 235 -----------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -----------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -----------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0122458899999999999999999999873
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=362.17 Aligned_cols=257 Identities=29% Similarity=0.490 Sum_probs=213.5
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.++|+..+.||+|+||.||+|.+.+++.||||++.... ...+++.+|++++++++||||+++++++.+++..++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc---cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 35788999999999999999999889999999997643 234679999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 86 FMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp CCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred eCCCCcHHHHHHh----cCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 9999999999843 33568999999999999999999997 8999999999999999999999999999986544
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
..........||+.|+|||++.+..++.++||||+|+++|||++ |+.||......+....+ ... . ....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~------~~~---~-~~~~ 228 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI------STG---F-RLYK 228 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH------HTT---C-CCCC
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH------hcC---c-cCCC
Confidence 33222334457889999999999999999999999999999999 99999876544322111 110 0 0011
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
+ ......+.+++.+|++.+|++||++.++++.|+++.+
T Consensus 229 ~--------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 229 P--------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp C--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C--------CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 1 1112458899999999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=361.05 Aligned_cols=258 Identities=27% Similarity=0.414 Sum_probs=214.7
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.++|++.+.||+|+||.||+|+++++..||||++.... ...+++.+|++++++++||||+++++++.++...++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT---BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC---CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 46789999999999999999999888899999997642 234678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.+++... ...+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||+++....
T Consensus 84 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 84 YISNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp CCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred ccCCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 99999999998542 2468999999999999999999997 8999999999999999999999999999987665
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
..........+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+ .... ....
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~------~~~~----~~~~ 226 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV------SQGH----RLYR 226 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH------HTTC----CCCC
T ss_pred hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH------HcCC----CCCC
Confidence 54333344557788999999999899999999999999999999 99999876544322111 1100 0011
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
+. .....+.+++.+|++.+|++||++.++++.|+.+.++
T Consensus 227 ~~--------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 227 PH--------LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CT--------TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CC--------cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 11 1123588999999999999999999999999988643
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=369.72 Aligned_cols=292 Identities=26% Similarity=0.484 Sum_probs=220.7
Q ss_pred CCChHHHHHHHHHHHhcCCCCCC-CCC-CCCCCC--ccceEEeCC---CCEEEEEeCCCCCcC--CCCccccCCCCCcEE
Q 002238 27 SGDDGDAAVMLALKKSLNPPESL-GWS-DTDPCK--WNHVVCIED---KRITRIQIGHQNLQG--TLPSNLQNLTKLERL 97 (948)
Q Consensus 27 ~~~~~d~~~l~~~k~~~~~~~~~-~w~-~~~~C~--w~gv~c~~~---~~v~~l~l~~~~l~~--~~p~~l~~l~~L~~L 97 (948)
.|.+.|++||++||+++.++..+ +|. +++||. |.||.|+.. ++|+.|+|++|+++| .+|+.|.++++|++|
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L 81 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCee
Confidence 58999999999999999876543 785 468998 999999764 799999999999999 899999999999999
Q ss_pred Eccc-CCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCcc
Q 002238 98 ELQW-NSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175 (948)
Q Consensus 98 ~L~~-N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~ 175 (948)
+|++ |.+.+.+| .|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++ .+|..+..+++|++|++++|+
T Consensus 82 ~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~ 160 (313)
T 1ogq_A 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG-TLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEES-CCCGGGGGCTTCCEEECCSSC
T ss_pred eCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCC-cCChHHhcCCCCCeEECcCCc
Confidence 9994 88888777 68888888888888888888888888888888888888888876 567777777777777777777
Q ss_pred ccccCCCCCCCCCCC-CCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccc
Q 002238 176 ITGQIPSFFGPDEFP-GLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG 254 (948)
Q Consensus 176 l~~~~p~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~ 254 (948)
+++.+|..++ .++ +|++|+|++|++++.+|..+
T Consensus 161 l~~~~p~~l~--~l~~~L~~L~L~~N~l~~~~~~~~-------------------------------------------- 194 (313)
T 1ogq_A 161 ISGAIPDSYG--SFSKLFTSMTISRNRLTGKIPPTF-------------------------------------------- 194 (313)
T ss_dssp CEEECCGGGG--CCCTTCCEEECCSSEEEEECCGGG--------------------------------------------
T ss_pred ccCcCCHHHh--hhhhcCcEEECcCCeeeccCChHH--------------------------------------------
Confidence 7766666665 555 66666666666665555443
Q ss_pred cCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhh
Q 002238 255 PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLN 334 (948)
Q Consensus 255 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 334 (948)
..+. |+.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|.+.
T Consensus 195 -----~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~--------------------------- 241 (313)
T 1ogq_A 195 -----ANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVG--------------------------- 241 (313)
T ss_dssp -----GGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCC---------------------------
T ss_pred -----hCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCccc---------------------------
Confidence 2233 6777777777777777777777778888887777765544311
Q ss_pred hhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCC
Q 002238 335 ALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL 414 (948)
Q Consensus 335 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l 414 (948)
.+++|+.|+|++|++++.+|..|.++++|+.|+|++|+|+|.+|..
T Consensus 242 ---------------------------------~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~- 287 (313)
T 1ogq_A 242 ---------------------------------LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG- 287 (313)
T ss_dssp ---------------------------------CCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-
T ss_pred ---------------------------------ccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-
Confidence 1235666666666666677777777777777777777777777765
Q ss_pred cCCCCCcEEEccCCc-ccC
Q 002238 415 SVLGALKELDVSNNQ-LYG 432 (948)
Q Consensus 415 ~~l~~L~~L~ls~N~-l~g 432 (948)
..+++|+.|++++|+ +.|
T Consensus 288 ~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 288 GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp TTGGGSCGGGTCSSSEEES
T ss_pred ccccccChHHhcCCCCccC
Confidence 667777777777666 444
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=368.03 Aligned_cols=260 Identities=25% Similarity=0.421 Sum_probs=211.7
Q ss_pred hcCCcccceecccCceEEEEEEEc----CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
.++|++.+.||+|+||.||+|.+. .+..||||+++... .....+.+.+|++++++++||||+++++++.+++..+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 467899999999999999999874 34569999997642 4555678999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 127 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EEEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEeeCCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 99999999999999843 23579999999999999999999997 899999999999999999999999999999
Q ss_pred ecCCCCCc--eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 748 LAPEGKGS--IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 748 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+. . ...
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~------~-~~~ 272 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE------E-GYR 272 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH------T-TCC
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH------c-CCC
Confidence 76543322 2223446789999999999999999999999999999999 999998765543221111 0 000
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
.. .....+..+.+++.+|++.||.+||++.+|++.|+.+.+.
T Consensus 273 ------~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 273 ------LP-----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp ------CC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ------CC-----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 00 0112234688999999999999999999999999998754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=362.74 Aligned_cols=276 Identities=16% Similarity=0.220 Sum_probs=222.5
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 668 (948)
..++|++.+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+++++.+ +|+|++++++++.++...++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 356899999999999999999986 478999999986532 234688999999999 89999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCC-----eEEeec
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR-----AKVADF 743 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~-----~kl~Df 743 (948)
||||+ +++|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++. +||+||
T Consensus 84 v~e~~-~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df 155 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 155 (298)
T ss_dssp EEECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred EEEec-CCCHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence 99999 9999999853 23469999999999999999999997 89999999999999987776 999999
Q ss_pred CCceecCCCCCc------eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH
Q 002238 744 GLVRLAPEGKGS------IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRR 817 (948)
Q Consensus 744 Gla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 817 (948)
|+++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||..............+..
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (298)
T 1csn_A 156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235 (298)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence 999866544321 23456799999999999999999999999999999999999999987654332222222111
Q ss_pred hhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCCCCCCCcccc
Q 002238 818 IHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDQNSEDIY 889 (948)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~ 889 (948)
..... .. .......+.++.+++.+|++.+|++||++++|++.|+++.+..........||.
T Consensus 236 ~~~~~-~~----------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 296 (298)
T 1csn_A 236 KKQST-PL----------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN 296 (298)
T ss_dssp HHHHS-CH----------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred hccCc-cH----------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccC
Confidence 11000 00 000112235688999999999999999999999999999988777666666664
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=361.90 Aligned_cols=265 Identities=22% Similarity=0.373 Sum_probs=210.0
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
+.++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 3568999999999999999999865 689999999865432 33446789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||||+++++|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 89 v~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp EEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred EEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 99999999999998541 468999999999999999999997 8999999999999999999999999999986
Q ss_pred cCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
.............||+.|+|||++.+..++.++||||||+++|||++|+.||......... . .............
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~---~~~~~~~~~~~~~ 235 (294)
T 4eqm_A 161 LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA--I---KHIQDSVPNVTTD 235 (294)
T ss_dssp C-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH--H---HHHSSCCCCHHHH
T ss_pred cccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--H---HHhhccCCCcchh
Confidence 6544333344567999999999999999999999999999999999999999876543221 1 1111100001011
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCC-ChHHHHHHHHhhhhh
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRP-DMGHAVNVLSSLVEL 877 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RP-t~~ev~~~L~~~~~~ 877 (948)
.. ...+..+.+++.+|++.||.+|| +++++.+.|+.+...
T Consensus 236 ~~---------~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 236 VR---------KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp SC---------TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred cc---------cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 11 12235688999999999999999 899999998887643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=366.02 Aligned_cols=261 Identities=23% Similarity=0.382 Sum_probs=213.8
Q ss_pred eeeHHHHHHhhcC----------CcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCC
Q 002238 582 VISIQVLRNVTNN----------FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 650 (948)
Q Consensus 582 ~~~~~~l~~~~~~----------~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H 650 (948)
.++.++++.+++. |+..+.||+|+||.||+|+.+ +|+.||||++... .....+.+.+|+.++++++|
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT--TCCSHHHHHHHHHHHTTCCC
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEecc--chhHHHHHHHHHHHHHhCCC
Confidence 3566777766653 677789999999999999876 7999999999764 33445778999999999999
Q ss_pred CceeeEEeEEEeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccE
Q 002238 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNI 730 (948)
Q Consensus 651 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Ni 730 (948)
|||+++++++..++..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NI 172 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSI 172 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHE
Confidence 9999999999999999999999999999998732 468999999999999999999997 8999999999999
Q ss_pred EEcCCCCeEEeecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhh
Q 002238 731 LLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMH 810 (948)
Q Consensus 731 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~ 810 (948)
+++.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+..
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~- 250 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM- 250 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-
T ss_pred EECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-
Confidence 999999999999999986654322 234567999999999999999999999999999999999999999876543321
Q ss_pred HHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 811 LVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
..+... ..+.+. ........+.+++.+|++.||++||++.++++.
T Consensus 251 --~~~~~~----------~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 251 --KRLRDS----------PPPKLK---NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp --HHHHHS----------SCCCCT---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HHHhcC----------CCCCcC---ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111110 111111 111223458899999999999999999999773
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=368.57 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=209.6
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCCh----hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG----KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 665 (948)
+.++|++.+.||+|+||.||+|+.+ +|+.||||++....... ...+.+.+|+.++++++||||+++++++.++..
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4678999999999999999999875 68999999998654322 235789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC----CeEEe
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVA 741 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~----~~kl~ 741 (948)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT-----CSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEE
Confidence 9999999999999998832 3579999999999999999999997 8999999999999998777 79999
Q ss_pred ecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcC
Q 002238 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS 821 (948)
Q Consensus 742 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 821 (948)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+....+... .+...
T Consensus 162 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~------~i~~~ 233 (361)
T 2yab_A 162 DFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------NITAV 233 (361)
T ss_dssp CCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH------HHHTT
T ss_pred ecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhc
Confidence 999998765532 2344679999999999999999999999999999999999999998765433221 11111
Q ss_pred ccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 822 KDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
...+.. .........+.+++.+|+..||.+||++.|+++
T Consensus 234 ~~~~~~---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 SYDFDE---------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCCCCH---------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCc---------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111110 111122346889999999999999999999876
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=379.18 Aligned_cols=260 Identities=27% Similarity=0.415 Sum_probs=212.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|++.+.||+|+||.||+|+++ +++.||||+++.. ......++|.+|++++++++||||+++++++.+++..++||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 457888999999999999999986 7899999998754 23444567899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++... ...+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 192 e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp ECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 999999999998542 2458999999999999999999997 899999999999999999999999999998654
Q ss_pred CCCCce-eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 751 EGKGSI-ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 751 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
...... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+ .. ...
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~---~~----~~~---- 333 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV---EK----GGR---- 333 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH---HT----TCC----
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc----CCC----
Confidence 322111 112235788999999999999999999999999999998 99999876544322111 11 000
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
+... ...+.++.+++.+||+.||++||+++++++.|+++.+.
T Consensus 334 ----~~~~---~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 334 ----LPCP---ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ----CCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCC---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 0001 11234688999999999999999999999999998754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=366.87 Aligned_cols=253 Identities=20% Similarity=0.302 Sum_probs=209.7
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
+.++|++.+.||+|+||.||+|... +++.||+|++... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 4578999999999999999999875 6889999998753 34456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC--CCCeEEeecCCce
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD--DMRAKVADFGLVR 747 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~--~~~~kl~DfGla~ 747 (948)
|||+++|+|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 80 ~e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 80 FEFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp ECCCCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEeCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence 999999999998832 33578999999999999999999997 89999999999999987 7899999999998
Q ss_pred ecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 748 LAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ......+.
T Consensus 153 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i------~~~~~~~~- 223 (321)
T 1tki_A 153 QLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI------MNAEYTFD- 223 (321)
T ss_dssp ECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHTCCCCC-
T ss_pred ECCCCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH------HcCCCCCC-
Confidence 765433 344567999999999999988999999999999999999999999876543322111 11111110
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.........++.+++.+|++.||.+|||+.|+++.
T Consensus 224 --------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 224 --------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01111223568899999999999999999999884
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=360.81 Aligned_cols=265 Identities=22% Similarity=0.383 Sum_probs=205.7
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHh--cCCCceeeEEeEEEeC----C
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK--VRHRHLVALLGHCLDG----N 664 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~----~ 664 (948)
..++|++.+.||+|+||.||+|++ +|+.||||++... ....+.+|.+++.. ++||||+++++++.+. .
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 467899999999999999999988 4899999998642 34556677777776 7999999999987653 4
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcc-----CCCeeecCCCCccEEEcCCCCeE
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA-----HQSFIHRDLKPSNILLGDDMRAK 739 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivHrDik~~Nill~~~~~~k 739 (948)
..++||||+++|+|.+++.. ..+++..+++++.|++.||+|||+.. +++|+||||||+|||++.++.+|
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred eeEEehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence 57899999999999999832 47999999999999999999999211 28999999999999999999999
Q ss_pred EeecCCceecCCCCCce---eeeecccccccCceecccC------CCCchhhHHHHHHHHHHHHhC----------CCCC
Q 002238 740 VADFGLVRLAPEGKGSI---ETRIAGTFGYLAPEYAVTG------RVTTKVDVFSFGVILMELITG----------RKAL 800 (948)
Q Consensus 740 l~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~Gv~l~elltg----------~~p~ 800 (948)
|+|||+++......... .....||+.|+|||++.+. .++.++||||||+++|||++| +.||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999998655443322 2234799999999999876 456799999999999999999 8888
Q ss_pred CCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 801 DESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
....+...... . ...... .....+.++...........+.+++.+||+.||++|||+.+|++.|+++
T Consensus 234 ~~~~~~~~~~~-~-~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPSFE-D-MRKVVC-----VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCCHH-H-HHHHHT-----TSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcchh-h-hhHHHh-----ccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 66543221111 1 111111 0111222222223334567799999999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=359.98 Aligned_cols=257 Identities=24% Similarity=0.414 Sum_probs=210.3
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.++|++.+.||+|+||.||+|+++++..||||++.... ...+++.+|++++++++||||+++++++.+++..++|||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC---CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 46789999999999999999999888899999997642 234678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.+++... ...+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 100 YMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCTTCBHHHHHHCG----GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred ccCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999998542 2468999999999999999999997 8999999999999999999999999999986544
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
..........+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+ .... ....
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~------~~~~----~~~~ 242 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI------AQGL----RLYR 242 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH------HTTC----CCCC
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH------hccc----CCCC
Confidence 32222233457889999999999999999999999999999998 99999876644322211 1100 0000
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
+ ......+.+++.+|++.+|++||++.++++.|+++.+
T Consensus 243 ~--------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 243 P--------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp C--------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C--------CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 1 1112458899999999999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=372.74 Aligned_cols=260 Identities=24% Similarity=0.447 Sum_probs=202.3
Q ss_pred hcCCcccceecccCceEEEEEEEc----CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
.++|++.+.||+|+||.||+|+++ ++..||||+++... .....++|.+|+.++++++||||+++++++.+++..+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 457999999999999999999864 57789999987642 4455678999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+||||+++|+|.+++.. ....+++.+++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 123 lv~e~~~~~sL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp EEEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 99999999999999853 23578999999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCce--eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 748 LAPEGKGSI--ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 748 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
......... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+ . . ...
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i---~---~-~~~ 268 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV---D---E-GYR 268 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH---H---T-TEE
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H---c-CCC
Confidence 665432211 122345788999999999999999999999999999998 99999876543322111 1 0 000
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
. .. ....+..+.+++.+|++.+|.+||++.+|++.|+.+.+.
T Consensus 269 ~----~~-------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 269 L----PP-------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp C----CC-------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred C----CC-------CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 0 00 112234688999999999999999999999999998763
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=361.63 Aligned_cols=269 Identities=24% Similarity=0.332 Sum_probs=205.4
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
..++|++.+.||+|+||.||+|+.++|+.||||++............+.+|++++++++||||+++++++.+++..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 45789999999999999999999988999999999765444444678899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||++ |+|.+.+.. ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 99 e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 99 EFME-KDLKKVLDE----NKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp ECCS-EEHHHHHHT----CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred cCCC-CCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 9997 488777743 33568999999999999999999997 899999999999999999999999999998764
Q ss_pred CCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+........ ...+....
T Consensus 171 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~ 248 (311)
T 3niz_A 171 IPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN-PREWPQVQ 248 (311)
T ss_dssp SCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCC-TTTSGGGT
T ss_pred CCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCC-hHHhhhhh
Confidence 4322 2344568999999999876 5689999999999999999999999987665443222211110000 00000000
Q ss_pred ------C---cccC---CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 830 ------D---PTID---LNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 830 ------~---~~~~---~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+ .... ..........++.+++.+|++.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 0000 00001112346889999999999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=370.84 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=211.3
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEE
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
...++|++.+.||+|+||.||+|..+ +|+.||||++..........+.+.+|++++++++||||+++++++.+++..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34578999999999999999999875 68999999998765566667889999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC---CeEEeecCC
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKVADFGL 745 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~---~~kl~DfGl 745 (948)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 106 v~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EECCCCSCBHHHHHTT-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 9999999999988842 3568999999999999999999997 8999999999999998654 599999999
Q ss_pred ceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +......+
T Consensus 178 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~------i~~~~~~~ 249 (362)
T 2bdw_A 178 AIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ------IKAGAYDY 249 (362)
T ss_dssp CBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHTCCCC
T ss_pred ceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH------HHhCCCCC
Confidence 98665432 23346799999999999999999999999999999999999999987654322111 11111111
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
. .........++.+++.+|++.||++||++.+++++
T Consensus 250 ~---------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 P---------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp C---------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred C---------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 01111223568899999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=373.89 Aligned_cols=284 Identities=15% Similarity=0.196 Sum_probs=214.2
Q ss_pred hhcCCcccceecccCceEEEEEEEcC------CcEEEEEEeecCcCChh---------hHHHHHHHHHHHHhcCCCceee
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGK---------GLTEFKSEIAVLTKVRHRHLVA 655 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~ 655 (948)
..++|++.+.||+|+||.||+|.+++ ++.||||++........ ....+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999998764 47899999876421100 0112345566677788999999
Q ss_pred EEeEEEeC----CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEE
Q 002238 656 LLGHCLDG----NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (948)
Q Consensus 656 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nil 731 (948)
+++++... ...++||||+ +++|.+++.. ....+++.+++.++.||+.||+|||+ .+|+||||||+|||
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nil 184 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA----NAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLL 184 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEE
Confidence 99998765 4479999999 9999999853 33579999999999999999999998 79999999999999
Q ss_pred Ec--CCCCeEEeecCCceecCCCCCc------eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 002238 732 LG--DDMRAKVADFGLVRLAPEGKGS------IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDES 803 (948)
Q Consensus 732 l~--~~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~ 803 (948)
++ .++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99 8899999999999865432211 123455999999999999999999999999999999999999999864
Q ss_pred CchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCCCCC
Q 002238 804 QPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDQ 883 (948)
Q Consensus 804 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~~~~ 883 (948)
...... ........ .......+++.+.. ...+.++.+++..|++.+|.+||++.++++.|+++.+.......
T Consensus 265 ~~~~~~--~~~~~~~~--~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 336 (364)
T 3op5_A 265 LKDPKY--VRDSKIRY--RENIASLMDKCFPA----ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDD 336 (364)
T ss_dssp TTCHHH--HHHHHHHH--HHCHHHHHHHHSCT----TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCC
T ss_pred ccCHHH--HHHHHHHh--hhhHHHHHHHhccc----ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcC
Confidence 332211 11111000 01111222211110 11234688999999999999999999999999999998887777
Q ss_pred CCccccc
Q 002238 884 NSEDIYG 890 (948)
Q Consensus 884 ~~~~~~~ 890 (948)
...||.-
T Consensus 337 ~~~dw~~ 343 (364)
T 3op5_A 337 GKLDLSV 343 (364)
T ss_dssp CCCCC--
T ss_pred CccceEe
Confidence 7666653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=370.24 Aligned_cols=269 Identities=29% Similarity=0.446 Sum_probs=215.2
Q ss_pred HHhhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe
Q 002238 589 RNVTNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD 662 (948)
Q Consensus 589 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 662 (948)
....++|++.+.||+|+||.||+|+.. +++.||||+++... .....+.+.+|++++++++||||+++++++.+
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 345688999999999999999999875 34889999997642 44456789999999999999999999999999
Q ss_pred CCceEEEEEecCCCChhHHHHhhhhc-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeec
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAEE-------------------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHR 723 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHr 723 (948)
++..++||||+++|+|.+++...... ....+++.+++.++.||++||+|||+ .+|+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 99999999999999999998653211 12578999999999999999999997 899999
Q ss_pred CCCCccEEEcCCCCeEEeecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 002238 724 DLKPSNILLGDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALD 801 (948)
Q Consensus 724 Dik~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~ 801 (948)
||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999985432211 22334568999999999999999999999999999999999 999998
Q ss_pred CCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhC
Q 002238 802 ESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWK 879 (948)
Q Consensus 802 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~ 879 (948)
.....+....+ .. ..... .. ...+..+.+++.+|++.||++||++.++++.|+++.+.+.
T Consensus 279 ~~~~~~~~~~~------~~--~~~~~-~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 279 GMAHEEVIYYV------RD--GNILA-CP---------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TSCHHHHHHHH------HT--TCCCC-CC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCChHHHHHHH------hC--CCcCC-CC---------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 76543322111 11 11000 00 1223468899999999999999999999999999876553
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=362.79 Aligned_cols=254 Identities=23% Similarity=0.362 Sum_probs=208.4
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCCh----hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG----KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 665 (948)
+.++|++.+.||+|+||.||+|..+ +|+.||||++....... ...+.+.+|+.++++++||||+++++++.++..
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3467999999999999999999875 68999999997653221 235789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC----CeEEe
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVA 741 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~----~~kl~ 741 (948)
.++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++ .+||+
T Consensus 89 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 9999999999999998832 3578999999999999999999997 8999999999999999887 79999
Q ss_pred ecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcC
Q 002238 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS 821 (948)
Q Consensus 742 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 821 (948)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ...
T Consensus 161 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~---~~~--- 232 (326)
T 2y0a_A 161 DFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV---SAV--- 232 (326)
T ss_dssp CCTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH---HHT---
T ss_pred ECCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH---Hhc---
Confidence 999998765432 233457999999999999999999999999999999999999999876543322111 110
Q ss_pred ccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 822 KDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
...+. ..........+.+++.+|++.||++||++.++++
T Consensus 233 ~~~~~---------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 233 NYEFE---------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCCCC---------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCcC---------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11010 0111122345889999999999999999999987
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=374.97 Aligned_cols=257 Identities=22% Similarity=0.307 Sum_probs=210.3
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEE
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
...++|++.+.||+|+||.||+|... +|+.||+|++..........+.+.+|+++++.++||||+++++++.+++..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34678999999999999999999864 78999999998765555667789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEc---CCCCeEEeecCC
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKVADFGL 745 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~---~~~~~kl~DfGl 745 (948)
||||+++|+|.+.+.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+
T Consensus 88 v~E~~~gg~L~~~i~~-----~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EECCCBCCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 9999999999988853 2568999999999999999999997 8999999999999998 467899999999
Q ss_pred ceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
++....... ......||+.|+|||++.+..++.++||||+||++|||++|++||......+....+ ......+
T Consensus 160 a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~~~~~~ 232 (444)
T 3soa_A 160 AIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI------KAGAYDF 232 (444)
T ss_dssp CBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HHTCCCC
T ss_pred eEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHH------HhCCCCC
Confidence 986654332 234567999999999999999999999999999999999999999876543322111 1111111
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
. .+ .......++.+++.+|++.||.+||++.|+++.
T Consensus 233 ~---~~------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 P---SP------EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp C---TT------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred C---cc------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1 01 111223468899999999999999999999873
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=380.15 Aligned_cols=261 Identities=30% Similarity=0.486 Sum_probs=208.1
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.++|++.+.||+|+||.||+|.++++..||||+++... ...++|.+|++++++++||||+++++++.+ +..++|||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 46788899999999999999999878889999997642 235689999999999999999999999876 67899999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++|+|.+++... ....+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 259 ~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 259 YMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CCTTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hhcCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 99999999999542 12468999999999999999999997 8999999999999999999999999999986654
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
..........+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+....+....+ .. . .....
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i------~~-~--~~~~~- 402 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV------ER-G--YRMPC- 402 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH------HT-T--CCCCC-
T ss_pred CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH------Hc-C--CCCCC-
Confidence 33333334557889999999999999999999999999999999 99999876544322111 11 0 00000
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCC
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKP 880 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~ 880 (948)
....+..+.+++.+||+.+|++||+++++++.|+.+.....+
T Consensus 403 --------~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 403 --------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred --------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 012234688999999999999999999999999998754443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=359.97 Aligned_cols=266 Identities=24% Similarity=0.432 Sum_probs=206.4
Q ss_pred hcCCcccceecccCceEEEEEEE-----cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--C
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--N 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~ 664 (948)
.++|++.+.||+|+||.||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++... .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 46799999999999999999984 26899999998754 455567899999999999999999999998653 5
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
..++||||+++|+|.+++... ...+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHC----GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred ceEEEEEeCCCCCHHHHHHhc----ccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCc
Confidence 689999999999999998542 2358999999999999999999997 899999999999999999999999999
Q ss_pred CceecCCCCC--ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh---------hhHHH
Q 002238 745 LVRLAPEGKG--SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEES---------MHLVT 813 (948)
Q Consensus 745 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~---------~~~~~ 813 (948)
+++....... .......||..|+|||++.+..++.++||||||+++|||++|..|+........ .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 9986644322 122334577889999999999999999999999999999999999865321100 00000
Q ss_pred HHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 814 WFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
.......... ... .....+.++.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 240 ~~~~~~~~~~--------~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 240 HLIELLKNNG--------RLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHTTC--------CCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHhccC--------cCC---CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 0000000000 000 0112335688999999999999999999999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=362.73 Aligned_cols=251 Identities=26% Similarity=0.375 Sum_probs=207.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|+..+.||+|+||.||+|+.+ +|+.||||++++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367999999999999999999875 689999999976422 233457789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++|+|.+++.. ...+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 84 MEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 999999999988853 1468999999999999999999997 89999999999999999999999999999854
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ......+.
T Consensus 156 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~~~~~~~p--- 225 (337)
T 1o6l_A 156 ISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------LMEEIRFP--- 225 (337)
T ss_dssp CCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCCCCC---
T ss_pred ccCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH------HcCCCCCC---
Confidence 3322 2334567999999999999999999999999999999999999999876543322111 11111111
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRP-----DMGHAVNV 870 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RP-----t~~ev~~~ 870 (948)
. ....++.+++.+|++.||++|| +++|++++
T Consensus 226 -~---------~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 226 -R---------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -T---------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -C---------CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1 1224588999999999999999 88888764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=382.54 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=211.7
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.++|++.+.||+|+||.||+|.++++..||||+++.. ....+.|.+|++++++++||||+++++++. .+..++|||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT---SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC---CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 5678899999999999999999988899999999764 234678999999999999999999999986 667899999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++|+|.+++.... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 263 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CCTTCBHHHHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred ecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 999999999996422 1357889999999999999999997 7999999999999999999999999999986543
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
..........+|+.|+|||++....++.++|||||||++|||+| |+.||.+....+....+ ... ..
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---~~~----~~------ 403 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---ERG----YR------ 403 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH---HHT----CC------
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HcC----CC------
Confidence 22112233446789999999999999999999999999999999 99999876544332211 110 00
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
+.. ....+.++.+++.+||+.||++||++.+|++.|+.+..
T Consensus 404 --~~~---~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 404 --MPR---PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp --CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred --CCC---CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 000 11223468899999999999999999999999998864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=368.30 Aligned_cols=267 Identities=28% Similarity=0.419 Sum_probs=217.0
Q ss_pred hcCCcccceecccCceEEEEEEEc--------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEe
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH--------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD 662 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 662 (948)
.++|.+.+.||+|+||.||+|+.. ++..||||++... ......+++.+|+++++++ +||||+++++++.+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 468899999999999999999863 2367999999764 3455568899999999999 99999999999999
Q ss_pred CCceEEEEEecCCCChhHHHHhhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEE
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nil 731 (948)
++..++||||+++|+|.+++...... ....+++.+++.++.|++.||+|||+ .+|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEE
Confidence 99999999999999999999653211 12468999999999999999999997 79999999999999
Q ss_pred EcCCCCeEEeecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhh
Q 002238 732 LGDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESM 809 (948)
Q Consensus 732 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~ 809 (948)
++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+..
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999986544322 22334567899999999999999999999999999999999 99999876544322
Q ss_pred hHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCC
Q 002238 810 HLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKP 880 (948)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~ 880 (948)
..+ .. .. ..... .....++.+++.+|++.+|++||++.++++.|+++......
T Consensus 304 ~~~---~~----~~------~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 304 KLL---KE----GH------RMDKP-----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp HHH---HT----TC------CCCCC-----SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred HHH---Hc----CC------CCCCC-----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 111 11 00 00000 11234688999999999999999999999999999865443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=356.67 Aligned_cols=277 Identities=19% Similarity=0.259 Sum_probs=214.9
Q ss_pred HhhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEE-EeCCceE
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC-LDGNEKL 667 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~ 667 (948)
.+.++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+|+++++.++|++++..++++ .+++..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 3567899999999999999999986 578999999876532 224588999999999988877766655 5677789
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE---cCCCCeEEeecC
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFG 744 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill---~~~~~~kl~DfG 744 (948)
+||||+ +++|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||
T Consensus 82 lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EEEECC-CCBHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred EEEEcc-CCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 999999 9999998843 23569999999999999999999997 899999999999999 788999999999
Q ss_pred CceecCCCCCc------eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh
Q 002238 745 LVRLAPEGKGS------IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI 818 (948)
Q Consensus 745 la~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 818 (948)
+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..................
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc
Confidence 99866544321 223467999999999999999999999999999999999999999875543332222211111
Q ss_pred hcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCCCCCCCcccc
Q 002238 819 HLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDQNSEDIY 889 (948)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~ 889 (948)
..... . .......+..+.+++.+|++.+|++||+++++++.|+++............||.
T Consensus 234 ~~~~~--~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 4hgt_A 234 KMSTP--I---------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp HHHSC--H---------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGG
T ss_pred cccch--h---------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchh
Confidence 10000 0 000011234688999999999999999999999999999988877666666664
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=354.28 Aligned_cols=260 Identities=23% Similarity=0.363 Sum_probs=200.8
Q ss_pred hcCCcccceecccCceEEEEEEEcC----CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
.++|++.+.||+|+||.||+|.... +..||||++... ......+.+.+|+.++++++||||+++++++ .++..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~ 91 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW 91 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence 5689999999999999999998742 457999998653 2445567899999999999999999999997 456789
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+||||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccc
Confidence 99999999999999853 23468999999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 748 LAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
..............+|+.|+|||++.+..++.++||||||+++|||++ |..||......+....+ .. .. .
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i---~~---~~--~- 235 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---EN---GE--R- 235 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---HT---TC--C-
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH---Hc---CC--C-
Confidence 665443333344557889999999999999999999999999999997 99999876654332111 11 00 0
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhh
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELW 878 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 878 (948)
.... ...+..+.+++.+|++.||++||++.++++.|+.+.+..
T Consensus 236 ~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 236 LPMP---------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp CCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCC---------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 0011 122346889999999999999999999999999987643
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=411.69 Aligned_cols=381 Identities=28% Similarity=0.396 Sum_probs=213.1
Q ss_pred CEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-C-cCCCCCCcEEEcccccccCCCCccccCCC-CCCEEE
Q 002238 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-S-LNGLASLEVVMLSNNQFTSVPSDFFTGLS-SLQSIE 145 (948)
Q Consensus 69 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~ 145 (948)
+++.|+|++|++++.+|..|+++++|++|+|++|.+.+.+| . +.++++|++|+|++|.+++..|..+.+++ +|+.|+
T Consensus 295 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~ 374 (768)
T 3rgz_A 295 TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLD 374 (768)
T ss_dssp TCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEE
T ss_pred cCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEE
Confidence 34444444444444444444444444444444444444333 1 44444444444444444444444444433 444444
Q ss_pred ccCCCCCCCCCCccccC--CCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCccc-ccccceeccC
Q 002238 146 IDNNPFSSWEIPQSLRN--ASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNG 222 (948)
Q Consensus 146 Ls~N~l~~~~~p~~~~~--l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~~~~ 222 (948)
|++|++++ .+|..+.. +++|++|++++|++++.+|..+. .+++|++|+|++|++++.+|..+.. .+|+.|++
T Consensus 375 Ls~N~l~~-~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~--~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L-- 449 (768)
T 3rgz_A 375 LSSNNFSG-PILPNLCQNPKNTLQELYLQNNGFTGKIPPTLS--NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL-- 449 (768)
T ss_dssp CCSSEEEE-ECCTTTTCSTTCCCCEEECCSSEEEEECCGGGG--GCTTCCEEECCSSEEESCCCGGGGGCTTCCEEEC--
T ss_pred ccCCCcCC-CcChhhhhcccCCccEEECCCCccccccCHHHh--cCCCCCEEECcCCcccCcccHHHhcCCCCCEEEC--
Confidence 44444433 23333333 44555555555555555555554 5566666666666666666655543 22333333
Q ss_pred CCCCCccCCCccccccCCCccEEEccCCcccccCC-CCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccc
Q 002238 223 QNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG 301 (948)
Q Consensus 223 ~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 301 (948)
..|...+..+..+..+++|++|+|++|++++.+| .+.++++|+.|+|++|++++.+|..++.+++|++|+|++|+++|
T Consensus 450 -~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 528 (768)
T 3rgz_A 450 -WLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSG 528 (768)
T ss_dssp -CSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEE
T ss_pred -CCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccC
Confidence 3344444555666667777777777777776655 36667777777777777777777777777777777777777776
Q ss_pred cCCC-CCCccccccccccCCCCC-CCCCCCchh------------------------------------------hhhhH
Q 002238 302 PVPE-FDRSVSLDMAKGSNNFCL-PSPGACDPR------------------------------------------LNALL 337 (948)
Q Consensus 302 ~~p~-~~~~~~l~~~~~~~~~~~-~~~~~~~~~------------------------------------------~~~l~ 337 (948)
.+|. +..+.+|..++..+|... .+|...... +..+.
T Consensus 529 ~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (768)
T 3rgz_A 529 NIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS 608 (768)
T ss_dssp ECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGG
T ss_pred cCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccc
Confidence 6664 555666666666555432 222111100 00000
Q ss_pred HHHH--------------hhCC-cchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCc
Q 002238 338 SVVK--------------LMGY-PQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILA 402 (948)
Q Consensus 338 ~~~~--------------~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls 402 (948)
.... .+.. ..-...+..++.-.......+..++.|+.|+|++|+++|.+|..|+++++|+.|||+
T Consensus 609 ~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs 688 (768)
T 3rgz_A 609 TRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLS 688 (768)
T ss_dssp GTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECC
T ss_pred cccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECC
Confidence 0000 0000 000001112221111111234566778888888888888888888888888888888
Q ss_pred cccccccCCcCCcCCCCCcEEEccCCcccCCCCC---CCcccccccCCCCCCCCcc
Q 002238 403 DNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS---FKSNAIVNTDGNPDIGKEK 455 (948)
Q Consensus 403 ~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~---~~~~~~~~~~gnp~~~~~~ 455 (948)
+|+++|.+|..+..+++|++|||++|+|+|.||. +.......+.|||.+|+.|
T Consensus 689 ~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~ 744 (768)
T 3rgz_A 689 SNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP 744 (768)
T ss_dssp SSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT
T ss_pred CCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCC
Confidence 8888888888888888888888888888888885 3445566778888888765
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=370.41 Aligned_cols=273 Identities=25% Similarity=0.377 Sum_probs=216.4
Q ss_pred HHHHHHhhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEE
Q 002238 585 IQVLRNVTNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALL 657 (948)
Q Consensus 585 ~~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~ 657 (948)
....+...++|++.+.||+|+||.||+|++. +++.||||+++.. ......+.+.+|++++.++ +||||++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3444456789999999999999999999742 4689999999764 2444567899999999999 899999999
Q ss_pred eEEEeCCc-eEEEEEecCCCChhHHHHhhhhcC-----------------------------------------------
Q 002238 658 GHCLDGNE-KLLVFEYMPQGTLSRHIFNWAEEG----------------------------------------------- 689 (948)
Q Consensus 658 ~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~----------------------------------------------- 689 (948)
+++.+.+. .++||||+++|+|.+++.......
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99987654 899999999999999996532110
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCC-
Q 002238 690 --------------LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG- 754 (948)
Q Consensus 690 --------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~- 754 (948)
...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 1228999999999999999999998 7999999999999999999999999999986544332
Q ss_pred ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCccc
Q 002238 755 SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTI 833 (948)
Q Consensus 755 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (948)
.......||+.|+|||++.+..++.++||||||+++|||++ |+.||......+... ...... . ....
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~--~~~~~~---~-------~~~~ 317 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC--RRLKEG---T-------RMRA 317 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH--HHHHHT---C-------CCCC
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH--HHHHcC---C-------CCCC
Confidence 23344678999999999999999999999999999999998 999998765433211 111110 0 0000
Q ss_pred CCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhh
Q 002238 834 DLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELW 878 (948)
Q Consensus 834 ~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 878 (948)
. .....++.+++.+|++.||++||++.|++++|+.+.+..
T Consensus 318 ~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 318 P-----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp C-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred C-----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 0 112245889999999999999999999999999987643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=356.31 Aligned_cols=266 Identities=24% Similarity=0.360 Sum_probs=203.9
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
++|++.+.||+|+||.||+|+.++|+.||||++..........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57899999999999999999988899999999976543344457889999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++ +|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 82 LDQ-DLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CSE-EHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred cCC-CHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 975 88888743 23568999999999999999999997 89999999999999999999999999999865432
Q ss_pred CCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc-cccc----
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK-DSFH---- 826 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~---- 826 (948)
.. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+ ........ ..+.
T Consensus 154 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI--FRILGTPNSKNWPNVTE 230 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCCCCTTTSTTGGG
T ss_pred cc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHHCCCChhhchhhhc
Confidence 21 23345689999999998764 5899999999999999999999999876543322211 11111000 0000
Q ss_pred -cccCcccC------CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 827 -KAIDPTID------LNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 827 -~~~~~~~~------~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
...++... ..........++.+++.+|++.||++||+++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00111110 01111123456889999999999999999999876
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=356.32 Aligned_cols=275 Identities=20% Similarity=0.250 Sum_probs=212.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC--ceEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN--EKLL 668 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~l 668 (948)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... .....+.+.+|++++++++||||+++++++.... ..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 467999999999999999999876 58999999987542 2334577889999999999999999999998765 6799
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE----cCCCCeEEeecC
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFG 744 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill----~~~~~~kl~DfG 744 (948)
||||+++|+|.+++.... ....+++.+++.++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||
T Consensus 87 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp EEECCTTCBHHHHHHSGG--GTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred EEeCCCCCCHHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 999999999999986522 22348999999999999999999997 899999999999999 777889999999
Q ss_pred CceecCCCCCceeeeecccccccCceecc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh-hhHHHHH
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAV--------TGRVTTKVDVFSFGVILMELITGRKALDESQPEES-MHLVTWF 815 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~-~~~~~~~ 815 (948)
+++...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||........ ......+
T Consensus 162 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 162 AARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred CceecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 998765543 233456999999999986 57889999999999999999999999975443221 1111111
Q ss_pred HHhhcCccccc---cccC------cccC-CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhh
Q 002238 816 RRIHLSKDSFH---KAID------PTID-LNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875 (948)
Q Consensus 816 ~~~~~~~~~~~---~~~~------~~~~-~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~ 875 (948)
... ....... .... +.+. ...........+.+++.+|++.||++||+++|+++...+..
T Consensus 240 ~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 240 ITG-KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHH-CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred hcC-CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 111 1000000 0000 0111 01223455667889999999999999999999999887653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=355.49 Aligned_cols=276 Identities=19% Similarity=0.259 Sum_probs=217.9
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEE-EeCCceEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC-LDGNEKLL 668 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~l 668 (948)
..++|++.+.||+|+||.||+|+. .+|+.||||++.... ...++.+|+.+++.++|++++..+.++ .+++..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc----chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 457899999999999999999986 579999999987542 224689999999999998877666655 56677899
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE---cCCCCeEEeecCC
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGL 745 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill---~~~~~~kl~DfGl 745 (948)
||||+ +++|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||+
T Consensus 83 v~e~~-~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 99999 9999999853 23579999999999999999999997 899999999999999 4888999999999
Q ss_pred ceecCCCCCc------eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh
Q 002238 746 VRLAPEGKGS------IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH 819 (948)
Q Consensus 746 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 819 (948)
++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||..............+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc
Confidence 9866554321 1244679999999999999999999999999999999999999998754332222222111111
Q ss_pred cCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCCCCCCCcccc
Q 002238 820 LSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDQNSEDIY 889 (948)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~ 889 (948)
.... . .......+..+.+++.+|++.||++||++.++++.|+++............||.
T Consensus 235 ~~~~--~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 3uzp_A 235 MSTP--I---------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp HHSC--H---------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGG
T ss_pred cCCc--h---------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence 0000 0 000111234688999999999999999999999999999988877666666664
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=376.68 Aligned_cols=262 Identities=22% Similarity=0.274 Sum_probs=211.1
Q ss_pred HHHHHHhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe
Q 002238 585 IQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD 662 (948)
Q Consensus 585 ~~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 662 (948)
++.++...++|++.+.||+|+||.||+|+.+ +++.||||++.+... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4455556789999999999999999999876 689999999875321 12223458899999999999999999999999
Q ss_pred CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEee
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~D 742 (948)
++..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEec
Confidence 9999999999999999998843 358899999999999999999997 8999999999999999999999999
Q ss_pred cCCceecCCCCCceeeeecccccccCceecccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh
Q 002238 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR----VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI 818 (948)
Q Consensus 743 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 818 (948)
||+++.............+||+.|+|||++.+.. ++.++|||||||++|||++|+.||......+....+...
T Consensus 212 FG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--- 288 (410)
T 3v8s_A 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH--- 288 (410)
T ss_dssp CTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH---
T ss_pred cceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhc---
Confidence 9999876554433344578999999999998765 889999999999999999999999876544332222100
Q ss_pred hcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCC--CCChHHHHHH
Q 002238 819 HLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQ--RPDMGHAVNV 870 (948)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~--RPt~~ev~~~ 870 (948)
...+. + +. ......++.+++.+|++.+|.+ ||+++||+++
T Consensus 289 ---~~~~~--~-p~------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 289 ---KNSLT--F-PD------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ---HHHCC--C-CT------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ---ccccc--C-CC------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00000 0 00 0011245889999999999998 9999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=371.36 Aligned_cols=264 Identities=25% Similarity=0.375 Sum_probs=212.6
Q ss_pred hcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 665 (948)
.++|++.+.||+|+||.||+|++. +++.||||+++.. .......++.+|+.++++++||||+++++++.++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 467899999999999999999853 4678999998653 345556789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC---CeEE
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAE--EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKV 740 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~---~~kl 740 (948)
.++||||+++|+|.+++..... .....+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEE
Confidence 9999999999999999965322 122468999999999999999999997 8999999999999999555 5999
Q ss_pred eecCCceecCCC-CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHh
Q 002238 741 ADFGLVRLAPEG-KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRI 818 (948)
Q Consensus 741 ~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 818 (948)
+|||+++..... .........||+.|+|||++.+..++.++|||||||++|||++ |..||......+....+ .
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i---~-- 300 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV---T-- 300 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH---H--
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H--
Confidence 999999743221 1122334568999999999999999999999999999999998 99999876544322111 1
Q ss_pred hcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 819 HLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
. ... ... ....+..+.+++.+||+.+|++||++.+|++.|+.+.+.
T Consensus 301 -~-~~~------~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 301 -S-GGR------MDP-----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp -T-TCC------CCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -c-CCC------CCC-----CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 1 000 000 111234588999999999999999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=383.90 Aligned_cols=257 Identities=27% Similarity=0.449 Sum_probs=213.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|++.+.||+|+||.||+|.++ ++..||||+++.. ....++|.+|++++++++||||++++++|.+.+..++||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc---ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 456888999999999999999986 4889999998754 234678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. .....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 296 E~~~~g~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 296 EFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp ECCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EccCCCCHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 99999999999854 233568999999999999999999997 899999999999999999999999999999765
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
...........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+ .. . ..
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~---~~----~--~~--- 437 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---EK----D--YR--- 437 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH---HT----T--CC---
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc----C--CC---
Confidence 433222333456789999999999999999999999999999999 99999876644322211 11 0 00
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhh
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~ 875 (948)
+. .....+..+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 438 ---~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 438 ---ME---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ---CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ---CC---CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 00 01122346889999999999999999999999998875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=352.06 Aligned_cols=257 Identities=29% Similarity=0.475 Sum_probs=212.4
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.++|+..+.||+|+||.||+|...+++.||||++.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 35788999999999999999999888999999997643 234679999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.+++.. ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 84 FMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp CCTTCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCCCCcHHHHHhh----CcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccc
Confidence 9999999999853 23568999999999999999999997 8999999999999999999999999999986543
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
..........||+.|+|||++.+..++.++||||||+++|||++ |+.||......+.... +... ... ..
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~------i~~~---~~~-~~ 226 (267)
T 3t9t_A 157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED------ISTG---FRL-YK 226 (267)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH------HHTT---CCC-CC
T ss_pred ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH------HhcC---CcC-CC
Confidence 22222233457889999999999999999999999999999999 8999987654332111 1110 000 00
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
+ ......+.+++.+|++.+|++||++.++++.|+++.+
T Consensus 227 ~--------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 227 P--------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp C--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C--------ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1 1123458899999999999999999999999999865
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=358.64 Aligned_cols=264 Identities=28% Similarity=0.411 Sum_probs=215.5
Q ss_pred hcCCcccceecccCceEEEEEEE------cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 665 (948)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|++++++++||||+++++++.+++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 56799999999999999999986 245889999987542 45556789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHhhhhc-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEE-------------------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLK 726 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik 726 (948)
.++||||+++|+|.+++...... ....+++.+++.++.|+++||+|||+ .+|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccc
Confidence 99999999999999999653221 12358999999999999999999997 899999999
Q ss_pred CccEEEcCCCCeEEeecCCceecCCCCCc-eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 002238 727 PSNILLGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQ 804 (948)
Q Consensus 727 ~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~ 804 (948)
|+||+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999866543322 1233457889999999999999999999999999999999 999998766
Q ss_pred chhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 805 PEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 805 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
.......+. .. . . ... .......+.+++.+|++.||++||++.++++.|+++...
T Consensus 258 ~~~~~~~~~---~~---~---~----~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 PERLFNLLK---TG---H---R----MER-----PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGGHHHHHH---TT---C---C----CCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHhh---cC---C---c----CCC-----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 544322111 10 0 0 000 012234688999999999999999999999999998764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=364.21 Aligned_cols=258 Identities=23% Similarity=0.323 Sum_probs=207.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC---ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI---SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
.++|++.+.||+|+||.||+|..+ +|+.||||++..... .....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999875 789999999864321 1224578999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCC---eEEeecC
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AKVADFG 744 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~---~kl~DfG 744 (948)
+||||+++|+|.+.+..... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||
T Consensus 103 lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEeCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 99999999999888765332 23568999999999999999999997 89999999999999986654 9999999
Q ss_pred CceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... .+......
T Consensus 179 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~---~i~~~~~~ 250 (351)
T 3c0i_A 179 VAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----LFE---GIIKGKYK 250 (351)
T ss_dssp TCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----HHH---HHHHTCCC
T ss_pred ceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----HHH---HHHcCCCC
Confidence 998765432 2234457999999999999999999999999999999999999999864211 111 11111100
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.. ..........+.+++.+|++.||++||++.+++++
T Consensus 251 ~~---------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 251 MN---------PRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CC---------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CC---------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 00111223468899999999999999999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=361.62 Aligned_cols=265 Identities=28% Similarity=0.448 Sum_probs=198.9
Q ss_pred hhcCCcccceecccCceEEEEEEEcC-Cc---EEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCce
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELHD-GT---KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 666 (948)
..++|++.+.||+|+||.||+|.+.. ++ .||||+++.........+.+.+|++++++++||||+++++++.+....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 35689999999999999999998653 32 799999987655566678899999999999999999999999877655
Q ss_pred ------EEEEEecCCCChhHHHHhhhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeE
Q 002238 667 ------LLVFEYMPQGTLSRHIFNWAE-EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 739 (948)
Q Consensus 667 ------~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~k 739 (948)
++||||+++|+|.+++..... .....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEE
Confidence 999999999999999865322 222368999999999999999999997 8999999999999999999999
Q ss_pred EeecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHH
Q 002238 740 VADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRR 817 (948)
Q Consensus 740 l~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 817 (948)
|+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+.
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~---- 253 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI---- 253 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH----
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh----
Confidence 999999986544322 12233457889999999999999999999999999999999 999998766543321111
Q ss_pred hhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 818 IHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
. .... .. .......+.+++.+|++.||++||++.++++.|+++..
T Consensus 254 --~-~~~~--~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 254 --G-GNRL--KQ---------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp --T-TCCC--CC---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --c-CCCC--CC---------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0 0000 00 11223468899999999999999999999999999976
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=376.82 Aligned_cols=265 Identities=21% Similarity=0.286 Sum_probs=213.6
Q ss_pred eHHHHHHhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEE
Q 002238 584 SIQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCL 661 (948)
Q Consensus 584 ~~~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 661 (948)
.+.+++...++|++.++||+|+||+||+|+.+ +++.||||++.+... .......+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34556666789999999999999999999976 578999999975321 1222344889999999999999999999999
Q ss_pred eCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEe
Q 002238 662 DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 741 (948)
Q Consensus 662 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~ 741 (948)
+++..++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+ .+||||||||+|||++.++.+||+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~----~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSK----FEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEecCCCCcHHHHHHH----ccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEc
Confidence 99999999999999999999853 23578999999999999999999997 899999999999999999999999
Q ss_pred ecCCceecCCCCCceeeeecccccccCceecc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHH-H
Q 002238 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTW-F 815 (948)
Q Consensus 742 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~-~ 815 (948)
|||+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+.. .
T Consensus 218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 297 (437)
T 4aw2_A 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 297 (437)
T ss_dssp CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc
Confidence 99999876555444445568999999999987 56789999999999999999999999987665443222210 0
Q ss_pred HHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCC--CCChHHHHHH
Q 002238 816 RRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQ--RPDMGHAVNV 870 (948)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~--RPt~~ev~~~ 870 (948)
.... +. .. ......++.+++.+|+..+|++ ||+++|++++
T Consensus 298 ~~~~-----~p----~~------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 298 ERFQ-----FP----TQ------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHCC-----CC----SS------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccc-----CC----cc------cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0000 00 00 0112245889999999888888 9999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=350.50 Aligned_cols=255 Identities=23% Similarity=0.356 Sum_probs=209.2
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv 669 (948)
.++|++.+.||+|+||.||+|+++ ++.||||++..........+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 457899999999999999999986 89999999987655666678899999999999999999999999877 778999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCC--eeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
|||+++|+|.+++.. .....+++.+++.++.|++.||+|||+ .+ |+||||||+||+++.++.++|+|||++.
T Consensus 88 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 88 THWMPYGSLYNVLHE---GTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EECCTTCBHHHHHHS---CSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred ecccCCCcHHHHHhh---cccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEecccee
Confidence 999999999999953 222468999999999999999999997 67 9999999999999999999999998866
Q ss_pred ecCCCCCceeeeecccccccCceecccCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 748 LAPEGKGSIETRIAGTFGYLAPEYAVTGRVTT---KVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
.... ....||+.|+|||++.+..++. ++||||||+++|||++|+.||......+..... ....
T Consensus 162 ~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~------~~~~-- 227 (271)
T 3kmu_A 162 SFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV------ALEG-- 227 (271)
T ss_dssp TTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH------HHSC--
T ss_pred eecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH------HhcC--
Confidence 4322 2246899999999998765544 899999999999999999999876543321111 1000
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
..+.+. ......+.+++.+|++.||++||+++++++.|+++.+
T Consensus 228 ----~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 228 ----LRPTIP-----PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ----CCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ----CCCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 011111 1123458899999999999999999999999998753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=362.88 Aligned_cols=253 Identities=25% Similarity=0.375 Sum_probs=203.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|++.+.||+|+||.||+|... +++.||||++.... .....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccc-ccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 468999999999999999999876 78999999987542 2223467899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++. ....+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 85 e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 85 EYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp ECCTTEEGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EcCCCCcHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 9999999998883 23568999999999999999999997 899999999999999999999999999998654
Q ss_pred CCC-CceeeeecccccccCceecccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 751 EGK-GSIETRIAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 751 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
... ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ....+... ...
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~----~~~---- 227 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEK----KTY---- 227 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHTT----CTT----
T ss_pred cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhcc----ccc----
Confidence 322 122345679999999999988775 7899999999999999999999986554321 11111110 000
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
. .........+.+++.+|++.||++||++.|+++
T Consensus 228 ~-------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 228 L-------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp S-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 001122345789999999999999999999876
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.29 Aligned_cols=256 Identities=29% Similarity=0.477 Sum_probs=196.0
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCC--hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS--GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|+..+.||+|+||.||+|.+. |+.||||+++..... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 467899999999999999999976 899999998754322 23357899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC--------CCCeEEe
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD--------DMRAKVA 741 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~--------~~~~kl~ 741 (948)
|||+++++|.+++. ...+++..++.++.|++.||+|||+....+|+||||||+||+++. ++.+||+
T Consensus 85 ~e~~~~~~L~~~~~------~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 85 MEFARGGPLNRVLS------GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EECCTTEEHHHHHT------SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEcCCCCCHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 99999999998873 257899999999999999999999822122999999999999986 6789999
Q ss_pred ecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcC
Q 002238 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS 821 (948)
Q Consensus 742 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 821 (948)
|||+++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||............ ..
T Consensus 159 Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------~~- 228 (271)
T 3dtc_A 159 DFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV------AM- 228 (271)
T ss_dssp CCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH------HT-
T ss_pred cCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh------hc-
Confidence 999998654332 22456999999999999999999999999999999999999999876543321111 11
Q ss_pred ccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 822 KDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
........ ...+..+.+++.+|++.+|.+||++.|+++.|+++
T Consensus 229 -~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 229 -NKLALPIP---------STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -SCCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -CCCCCCCC---------cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 00000011 12234688999999999999999999999999764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=352.56 Aligned_cols=267 Identities=23% Similarity=0.326 Sum_probs=204.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|++.+.||+|+||+||+|..+ +|+.||||++............+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999875 68999999998765555556789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++ ++.+.+.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~-~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9975 66555532 23579999999999999999999997 7999999999999999999999999999987643
Q ss_pred CCCceeeeecccccccCceecccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcc-ccc---
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGR-VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD-SFH--- 826 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~--- 826 (948)
... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||........ .............. .+.
T Consensus 154 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 154 PVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTGG
T ss_pred ccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhhhhhc
Confidence 322 234457899999999998766 79999999999999999998888654432221 11111111111000 000
Q ss_pred cccC--------cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 827 KAID--------PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 827 ~~~~--------~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+..+ ...............+.+++.+|++.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 000001111123456889999999999999999999976
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=362.24 Aligned_cols=258 Identities=27% Similarity=0.426 Sum_probs=202.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcE----EEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCce
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 666 (948)
.++|+..+.||+|+||.||+|++. +++. ||+|.+.... .....+++.+|+.++++++||||++++++|.++. .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 357899999999999999999864 4544 5788775432 3445678999999999999999999999998754 7
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCc
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla 746 (948)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 92 ~~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEEEECCTTCBHHHHHHH----STTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred EEEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcce
Confidence 899999999999998854 23579999999999999999999997 79999999999999999999999999999
Q ss_pred eecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 747 RLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 747 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
+....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+. . ...
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~---~----~~~ 237 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---K----GER 237 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---T----TCC
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH---c----CCC
Confidence 86544332 22233457889999999999999999999999999999999 999998766544322211 1 000
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
. . ........+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 238 ~--~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 238 L--P---------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp C--C---------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred C--C---------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 0 011123458899999999999999999999999998864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=355.04 Aligned_cols=262 Identities=27% Similarity=0.498 Sum_probs=200.6
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.++|++.+.||+|+||.||+|++. ..||||+++.........+.+.+|++++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467999999999999999999864 4699999987655666678899999999999999999999965 5567899999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 100 WCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp CCCEEEHHHHHTT----C---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ecCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccccc
Confidence 9999999988843 33578999999999999999999997 8999999999999999999999999999985543
Q ss_pred CC-CceeeeecccccccCceecc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 752 GK-GSIETRIAGTFGYLAPEYAV---TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 752 ~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
.. ........||+.|+|||++. +..++.++||||||+++|||++|+.||......+. ..........
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~~------- 243 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGRGSL------- 243 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHHHTSC-------
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhccccc-------
Confidence 22 22234457999999999986 56789999999999999999999999987654332 1111111110
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
.+.+ .......+..+.+++.+|++.+|.+||++.++++.|+++.+
T Consensus 244 --~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 244 --SPDL--SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp --CCCT--TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --Ccch--hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0100 01111233568999999999999999999999999998753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=363.31 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=208.2
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
..++|++.+.||+|+||.||+|..+ +|+.||+|++... .......+.+|+++++.++||||+++++++.++...++|
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 3568999999999999999999875 6899999998764 344456899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC--CCCeEEeecCCce
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD--DMRAKVADFGLVR 747 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~--~~~~kl~DfGla~ 747 (948)
|||+++|+|.+++.. ....+++.+++.++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 127 ~E~~~gg~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~ 199 (387)
T 1kob_A 127 LEFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLAT 199 (387)
T ss_dssp EECCCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEcCCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccce
Confidence 999999999988842 23478999999999999999999997 89999999999999974 4679999999999
Q ss_pred ecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 748 LAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ .. ....+
T Consensus 200 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i---~~---~~~~~-- 269 (387)
T 1kob_A 200 KLNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV---KR---CDWEF-- 269 (387)
T ss_dssp ECCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH---HH---CCCCC--
T ss_pred ecCCCc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHH---Hh---CCCCC--
Confidence 765432 234457999999999999999999999999999999999999999876543322111 11 11001
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
++. .......++.+++.+|++.||.+||++.++++.
T Consensus 270 --~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 --DED-----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp --CSS-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --Ccc-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 110 011223468899999999999999999999863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.17 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=217.7
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
..++|++.+.||+|+||.||+|.++ +++.||||++... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 3567899999999999999999876 5889999998753 34567899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++++|.+++.. .....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||+++..
T Consensus 88 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EECCTTEEHHHHHHH---CCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEcCCCCcHHHHHHh---cccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 999999999999854 233568999999999999999999997 79999999999999999999999999999876
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
............+|+.|+|||++.+..++.++||||||+++|||++ |..||...........+. .. .
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~---~~------~--- 229 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---KD------Y--- 229 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---TT------C---
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---cc------C---
Confidence 6554444455668899999999999999999999999999999999 999998766543322111 10 0
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
.... ....+..+.+++.+|++.||.+||++.++++.|+.+...
T Consensus 230 -~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 230 -RMER-----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp -CCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCC-----CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 0000 011234688999999999999999999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=372.77 Aligned_cols=252 Identities=29% Similarity=0.467 Sum_probs=208.3
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-ceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-EKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lv~ 670 (948)
.++|++.+.||+|+||.||+|.++ |+.||||+++... ..+.|.+|++++++++||||+++++++.+.+ ..++||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 467888999999999999999986 8899999997542 4578999999999999999999999987765 789999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. .+...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 267 e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 267 EYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp ECCTTCBHHHHHHH---HCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 99999999999964 233457999999999999999999997 899999999999999999999999999998543
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
... ....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+. . + ..
T Consensus 341 ~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~------~--~-~~--- 404 (450)
T 1k9a_A 341 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE------K--G-YK--- 404 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH------T--T-CC---
T ss_pred ccc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH------c--C-CC---
Confidence 321 22357899999999999999999999999999999998 999998765443322111 0 0 00
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
... ....+..+.+++.+||+.||++||++.++++.|+.+..
T Consensus 405 -~~~-----p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 405 -MDA-----PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp -CCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCC-----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 000 11233568899999999999999999999999999865
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=366.25 Aligned_cols=250 Identities=23% Similarity=0.352 Sum_probs=201.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 668 (948)
.++|++.+.||+|+||.||+|+.+ +|+.||||++++... .......+.+|.++++.+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999875 689999999976422 233456788999999998 79999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||||+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 102 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999988541 468999999999999999999997 8999999999999999999999999999985
Q ss_pred cCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ......+.
T Consensus 174 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i------~~~~~~~p-- 244 (353)
T 3txo_A 174 GICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI------LNDEVVYP-- 244 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCCCCC--
T ss_pred cccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH------HcCCCCCC--
Confidence 43322 2344567999999999999999999999999999999999999999876654332211 11111111
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCCh------HHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDM------GHAVN 869 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~------~ev~~ 869 (948)
. .....+.+++.+|++.||.+||++ .++++
T Consensus 245 --~---------~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 245 --T---------WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --T---------TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --C---------CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1 122358899999999999999998 56654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=357.44 Aligned_cols=259 Identities=32% Similarity=0.549 Sum_probs=202.2
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
++|++.+.||+|+||.||+|++. ++.||||++.. ....+.+.+|++++++++||||+++++++. +..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEc
Confidence 57888999999999999999986 88999999864 234578999999999999999999999876 457999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCC-eEEeecCCceecCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR-AKVADFGLVRLAPE 751 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~-~kl~DfGla~~~~~ 751 (948)
+++|+|.+++... .....+++..++.++.|+++||+|||+...++|+||||||+||+++.++. +||+|||+++....
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 81 AEGGSLYNVLHGA--EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp CTTCBHHHHHHCS--SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCCHHHHHhcc--CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 9999999998541 11235789999999999999999999744368999999999999998886 79999999875433
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..+. ... .. .+
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~--~~~--~~-----~~ 223 (307)
T 2eva_A 159 H----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWA--VHN--GT-----RP 223 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHHH--HHT--TC-----CC
T ss_pred c----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHHH--Hhc--CC-----CC
Confidence 2 22346999999999999999999999999999999999999999865432211 1111 111 00 00
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCC
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKP 880 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~ 880 (948)
.. ....+..+.+++.+|++.||++||+++++++.|+.+.+.+..
T Consensus 224 ~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 224 PL-----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp CC-----BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred Cc-----ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 00 011234588999999999999999999999999998765543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=374.68 Aligned_cols=277 Identities=18% Similarity=0.233 Sum_probs=220.1
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCC-CceeeEEeEEEeCCceEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH-RHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~l 668 (948)
+.++|++.++||+|+||.||+|+. .+++.||||++..... ..++.+|+++++.++| +++..+..++.+.+..++
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 357899999999999999999986 4789999998875422 2357899999999977 556666667778888899
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE---cCCCCeEEeecCC
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGL 745 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill---~~~~~~kl~DfGl 745 (948)
||||+ +++|.+++.. ....+++.+++.|+.||+.||+|||+ .+||||||||+|||+ +.++.+||+|||+
T Consensus 81 vme~~-g~sL~~ll~~----~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp EEECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEECC-CCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 99999 9999999853 23579999999999999999999997 899999999999999 5888999999999
Q ss_pred ceecCCCCCc------eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh
Q 002238 746 VRLAPEGKGS------IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH 819 (948)
Q Consensus 746 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 819 (948)
++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+....
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH
T ss_pred ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc
Confidence 9976554321 1235679999999999999999999999999999999999999998866543333332222211
Q ss_pred cCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCCCCCCCccccc
Q 002238 820 LSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDQNSEDIYG 890 (948)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~ 890 (948)
... .. .......+.++.+++.+|++.+|++||++.+|++.|+++............||..
T Consensus 233 ~~~-~~----------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~ 292 (483)
T 3sv0_A 233 VAT-SI----------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTI 292 (483)
T ss_dssp HHS-CH----------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHH
T ss_pred ccc-cH----------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchh
Confidence 100 00 0011122356899999999999999999999999999998877666666666653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=351.55 Aligned_cols=255 Identities=32% Similarity=0.577 Sum_probs=203.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhh-----HHHHHHHHHHHHhcCCCceeeEEeEEEeCCc
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKG-----LTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~-----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 665 (948)
.++|++.+.||+|+||.||+|++. +++.||||++......... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467999999999999999999874 7899999998754322221 267899999999999999999999986554
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCC--eeecCCCCccEEEcCCCC-----e
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLGDDMR-----A 738 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrDik~~Nill~~~~~-----~ 738 (948)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++. +
T Consensus 97 -~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred -eEEEEecCCCCHHHHHhc----ccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeE
Confidence 799999999999888743 33579999999999999999999997 67 999999999999988776 9
Q ss_pred EEeecCCceecCCCCCceeeeecccccccCceec--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH
Q 002238 739 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA--VTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFR 816 (948)
Q Consensus 739 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~ 816 (948)
||+|||+++.... ......||+.|+|||++ ....++.++||||||+++|||++|+.||.......... .....
T Consensus 169 kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~ 243 (287)
T 4f0f_A 169 KVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-INMIR 243 (287)
T ss_dssp EECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH-HHHHH
T ss_pred EeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH-HHHHh
Confidence 9999999985433 23446799999999998 44567899999999999999999999998765433211 11111
Q ss_pred HhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 817 RIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
.. ... +.+. ...+..+.+++.+|++.||.+||++.++++.|+++
T Consensus 244 ~~-----~~~----~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EE-----GLR----PTIP-----EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HS-----CCC----CCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred cc-----CCC----CCCC-----cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 10 011 1111 12234688999999999999999999999999764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=365.26 Aligned_cols=252 Identities=24% Similarity=0.361 Sum_probs=205.3
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|++.+.||+|+||.||+|..+ +++.||||++..... .......+.+|+++++.++|||||++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367999999999999999999875 688999999875421 233457889999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+.+|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp ECCCTTEEHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 999999999998843 3568999999999999999999997 89999999999999999999999999999876
Q ss_pred CCCCCceeeeecccccccCceeccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVT---GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..............+... ...+
T Consensus 166 ~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~---~~~~- 239 (384)
T 4fr4_A 166 PRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT---VVTY- 239 (384)
T ss_dssp CTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC---CCCC-
T ss_pred cCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc---ccCC-
Confidence 5432 3445679999999999864 45899999999999999999999999865443332222221111 1000
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCC-hHHHHH
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPD-MGHAVN 869 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt-~~ev~~ 869 (948)
. ......+.+++.+|++.||.+||+ ++++.+
T Consensus 240 ---p---------~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 240 ---P---------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---C---------TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---C---------CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0 112245889999999999999998 565544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=349.55 Aligned_cols=259 Identities=27% Similarity=0.442 Sum_probs=212.3
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.++|++.+.||+|+||.||+|..++++.||||++.... ...+.+.+|++++++++||||+++++++. .+..++|||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 46789999999999999999998888899999987542 33578999999999999999999999886 456899999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++++|.+++.... ...+++.+++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 88 ~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 88 YMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 999999999985421 1368999999999999999999997 8999999999999999999999999999987655
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
..........+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.... .... ......
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~------~~~~---~~~~~~ 232 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN------LERG---YRMVRP 232 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH------HHTT---CCCCCC
T ss_pred cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH------Hhcc---cCCCCc
Confidence 43323334457889999999998999999999999999999999 9999987654332111 1110 000000
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELW 878 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 878 (948)
...+..+.+++.+|++.+|++||++.++++.|+++....
T Consensus 233 ---------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 233 ---------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp ---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---------ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 112346889999999999999999999999999987644
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=356.80 Aligned_cols=275 Identities=23% Similarity=0.363 Sum_probs=208.8
Q ss_pred HHHHHHhhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc--CCCceeeEEeEEEe
Q 002238 585 IQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV--RHRHLVALLGHCLD 662 (948)
Q Consensus 585 ~~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~ 662 (948)
......+.++|++.+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++... +||||+++++++.+
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 3444556789999999999999999999986 899999998643 234455666666655 99999999999988
Q ss_pred C----CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcc-----CCCeeecCCCCccEEEc
Q 002238 663 G----NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA-----HQSFIHRDLKPSNILLG 733 (948)
Q Consensus 663 ~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivHrDik~~Nill~ 733 (948)
. ...++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ +.+|+||||||+|||++
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence 7 678999999999999999853 46899999999999999999999721 12999999999999999
Q ss_pred CCCCeEEeecCCceecCCCCCce---eeeecccccccCceecccCCCCch------hhHHHHHHHHHHHHhC--------
Q 002238 734 DDMRAKVADFGLVRLAPEGKGSI---ETRIAGTFGYLAPEYAVTGRVTTK------VDVFSFGVILMELITG-------- 796 (948)
Q Consensus 734 ~~~~~kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~s~Gv~l~elltg-------- 796 (948)
.++.+||+|||+++......... .....||+.|+|||++.+...+.+ +|||||||++|||++|
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 99999999999998654433221 124579999999999987766654 9999999999999999
Q ss_pred --CCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 797 --RKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 797 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
+.||....+..... .. ...... .....+.++..........++.+++.+||+.||++||++.++++.|+.+
T Consensus 257 ~~~~p~~~~~~~~~~~-~~-~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPSY-ED-MREIVC-----IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CCCCTTTTTSCSSCCH-HH-HHHHHT-----TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccHhhhcCCCCch-hh-hHHHHh-----hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 66665543322111 00 111110 1111222222222335667799999999999999999999999999998
Q ss_pred hhhh
Q 002238 875 VELW 878 (948)
Q Consensus 875 ~~~~ 878 (948)
.+..
T Consensus 330 ~~~~ 333 (337)
T 3mdy_A 330 SESQ 333 (337)
T ss_dssp HHTT
T ss_pred Hhhc
Confidence 7643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=352.77 Aligned_cols=251 Identities=27% Similarity=0.396 Sum_probs=197.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCCh------------------------hhHHHHHHHHHHHH
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG------------------------KGLTEFKSEIAVLT 646 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~------------------------~~~~~~~~E~~~l~ 646 (948)
.++|++.+.||+|+||.||+|... +++.||||++....... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999864 68999999997643211 12356899999999
Q ss_pred hcCCCceeeEEeEEEe--CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecC
Q 002238 647 KVRHRHLVALLGHCLD--GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRD 724 (948)
Q Consensus 647 ~l~H~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrD 724 (948)
+++||||+++++++.+ .+..++||||+++++|.+++. ...+++.+++.++.|++.||+|||+ .+|+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~D 162 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRD 162 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccC
Confidence 9999999999999986 567899999999999987542 2579999999999999999999997 7999999
Q ss_pred CCCccEEEcCCCCeEEeecCCceecCCCCCceeeeecccccccCceecccCC---CCchhhHHHHHHHHHHHHhCCCCCC
Q 002238 725 LKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR---VTTKVDVFSFGVILMELITGRKALD 801 (948)
Q Consensus 725 ik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gv~l~elltg~~p~~ 801 (948)
|||+||+++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999999987654332 334567999999999997765 4789999999999999999999998
Q ss_pred CCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 802 ESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 802 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
........ . .+......+ +. .......+.+++.+|++.||++||++.|+++
T Consensus 242 ~~~~~~~~---~---~~~~~~~~~-----~~------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 242 DERIMCLH---S---KIKSQALEF-----PD------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CSSHHHHH---H---HHHHCCCCC-----CS------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccHHHHH---H---HHhcccCCC-----CC------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 75432211 1 111101000 00 0112245889999999999999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=356.56 Aligned_cols=247 Identities=25% Similarity=0.296 Sum_probs=197.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|++.++||+|+||+||+|+.. +|+.||||++............+..|+..+.++ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999886 799999999876544555556666777666666 999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+ +++|.+++... ...++|..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 136 ~e~~-~~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EECC-CCBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred Eecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 9999 67998887542 3569999999999999999999997 79999999999999999999999999999866
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
.... ......||++|+|||++.+ .++.++|||||||++|||++|..|+....... ... .....
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---------~~~--~~~~~--- 270 (311)
T 3p1a_A 208 GTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---------QLR--QGYLP--- 270 (311)
T ss_dssp C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---------HHT--TTCCC---
T ss_pred ccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---------HHh--ccCCC---
Confidence 4432 2344569999999998875 79999999999999999999977665421110 000 11010
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.........++.+++.+|++.||++||+++|+++
T Consensus 271 ------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 271 ------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0111122356889999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=355.40 Aligned_cols=265 Identities=25% Similarity=0.407 Sum_probs=214.8
Q ss_pred hcCCcccceecccCceEEEEEEE------cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCC
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 664 (948)
.++|+..+.||+|+||.||+|++ .+++.||||++.... .....+.+.+|+++++++ +||||+++++++.+++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 46789999999999999999985 246899999997642 344567899999999999 9999999999999999
Q ss_pred ceEEEEEecCCCChhHHHHhhhh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEE
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAE-------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nil 731 (948)
..++||||+++|+|.+++..... .....+++.+++.++.|++.||+|||+ .+|+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEE
Confidence 99999999999999999865321 112358999999999999999999997 89999999999999
Q ss_pred EcCCCCeEEeecCCceecCCCCCc-eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhh
Q 002238 732 LGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESM 809 (948)
Q Consensus 732 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~ 809 (948)
++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++ |+.||.........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 999999999999999866544332 2234557889999999999999999999999999999999 99999876543221
Q ss_pred hHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 810 HLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
....... ...... ...+..+.+++.+|++.||.+||++.++++.|+++...
T Consensus 258 --~~~~~~~------~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 258 --YKMIKEG------FRMLSP---------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp --HHHHHHT------CCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHhccC------CCCCCc---------ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1111110 000001 11234688999999999999999999999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=364.51 Aligned_cols=251 Identities=21% Similarity=0.338 Sum_probs=199.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 668 (948)
.++|++.++||+|+||.||+|+.+ +++.||||++++.... ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999876 6789999999875433 33345688999999887 89999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 131 V~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEcCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 9999999999988854 1468999999999999999999997 8999999999999999999999999999985
Q ss_pred cCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhh---hHHHHHHHhhcCcccc
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESM---HLVTWFRRIHLSKDSF 825 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~ 825 (948)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ........+......+
T Consensus 203 ~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 281 (396)
T 4dc2_A 203 GLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 281 (396)
T ss_dssp CCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCC
T ss_pred cccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCC
Confidence 33222 2345568999999999999999999999999999999999999999754321110 0000111111111111
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCCh
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDM 864 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~ 864 (948)
. . ....++.+++.+|++.||.+||++
T Consensus 282 p----~---------~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 282 P----R---------SLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp C----T---------TSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred C----C---------cCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1 1 122458899999999999999996
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=355.49 Aligned_cols=247 Identities=26% Similarity=0.416 Sum_probs=205.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|++.+.||+|+||.||+|+.+ +|+.||||++++... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367899999999999999999875 789999999976422 123456788999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 85 MDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp ECCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceec
Confidence 999999999999853 2468999999999999999999997 89999999999999999999999999999875
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+......+.
T Consensus 157 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------~i~~~~~~~p--- 223 (318)
T 1fot_A 157 PDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE------KILNAELRFP--- 223 (318)
T ss_dssp SSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHCCCCCC---
T ss_pred CCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH------HHHhCCCCCC---
Confidence 432 234679999999999999999999999999999999999999998765433211 1111111111
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRP-----DMGHAVN 869 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RP-----t~~ev~~ 869 (948)
+ ....++.+++.+|++.||++|| +++++++
T Consensus 224 -~---------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 224 -P---------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -T---------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -C---------CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1 1124588999999999999999 7877765
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=372.04 Aligned_cols=265 Identities=22% Similarity=0.315 Sum_probs=211.1
Q ss_pred eeHHHHHHhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEE
Q 002238 583 ISIQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660 (948)
Q Consensus 583 ~~~~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 660 (948)
+.+++.+...++|++.+.||+|+||.||+|+.+ +|+.||||++.+... .....+.+.+|..++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345555666789999999999999999999875 799999999975321 222345688999999999999999999999
Q ss_pred EeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEE
Q 002238 661 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 740 (948)
Q Consensus 661 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl 740 (948)
.+.+..|+||||+++|+|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL 203 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRL 203 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEE
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEE
Confidence 9999999999999999999998542 2468999999999999999999997 89999999999999999999999
Q ss_pred eecCCceecCCCCCceeeeecccccccCceecc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHH
Q 002238 741 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV-------TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVT 813 (948)
Q Consensus 741 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~ 813 (948)
+|||+++.............+||+.|+|||++. +..++.++|||||||++|||++|+.||......+....+.
T Consensus 204 ~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 283 (412)
T 2vd5_A 204 ADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283 (412)
T ss_dssp CCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred eechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999876554433334568999999999987 3578999999999999999999999998766544322221
Q ss_pred HHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCC---CChHHHHH
Q 002238 814 WFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQR---PDMGHAVN 869 (948)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~R---Pt~~ev~~ 869 (948)
..... . .+ +.. ......++.+++.+|+. +|.+| |+++|+++
T Consensus 284 ~~~~~-~---~~-----p~~-----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 284 HYKEH-L---SL-----PLV-----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp THHHH-C---CC-----C---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred hcccC-c---CC-----Ccc-----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 10000 0 00 000 01123458899999999 99998 58888765
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=346.97 Aligned_cols=255 Identities=23% Similarity=0.382 Sum_probs=210.6
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
..++|++.+.||+|+||.||+|..+ +|+.||+|++..........+.+.+|++++++++||||+++++++.+++..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999875 689999999987665666678899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCC---eEEeecCCc
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AKVADFGLV 746 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~---~kl~DfGla 746 (948)
|||+++++|.+.+... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||++
T Consensus 84 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 9999999998887531 468999999999999999999997 89999999999999986655 999999999
Q ss_pred eecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 747 RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+ .. ......
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~---~~---~~~~~~ 227 (284)
T 3kk8_A 156 IEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI---KA---GAYDYP 227 (284)
T ss_dssp EECCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH---TCCCCC
T ss_pred EEcccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH---Hh---ccccCC
Confidence 8665433 233457999999999999999999999999999999999999999876543322111 11 111000
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.+. ......++.+++.+|++.||++||++.|+++.
T Consensus 228 ---~~~------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 228 ---SPE------WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ---TTT------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---chh------hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000 11223458899999999999999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=356.92 Aligned_cols=252 Identities=27% Similarity=0.411 Sum_probs=199.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc-----
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE----- 665 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 665 (948)
.++|++.+.||+|+||.||+|+.+ +|+.||||++.... .....+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 467999999999999999999986 79999999997643 34456789999999999999999999999866442
Q ss_pred ----------------------------------------------------eEEEEEecCCCChhHHHHhhhhcCCCCC
Q 002238 666 ----------------------------------------------------KLLVFEYMPQGTLSRHIFNWAEEGLKPL 693 (948)
Q Consensus 666 ----------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~~~l 693 (948)
.++||||+++|+|.+++... ......
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~ 161 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR--CSLEDR 161 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC--CSGGGS
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc--cCccch
Confidence 79999999999999998642 222456
Q ss_pred CHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCC-----------ceeeeecc
Q 002238 694 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG-----------SIETRIAG 762 (948)
Q Consensus 694 ~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~g 762 (948)
++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... .......|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 777899999999999999997 8999999999999999999999999999987655421 12234569
Q ss_pred cccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHH
Q 002238 763 TFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILAS 842 (948)
Q Consensus 763 t~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (948)
|+.|+|||++.+..++.++||||||+++|||++|..|+.. ........... .........
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~---------------~~~~~~~~~ 298 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNL---------------KFPLLFTQK 298 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTT---------------CCCHHHHHH
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhcc---------------CCCcccccC
Confidence 9999999999999999999999999999999998765421 11111111100 001112233
Q ss_pred HHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 843 ISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 843 ~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
...+.+++.+|++.||++||++.|+++
T Consensus 299 ~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 299 YPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp CHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 456789999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=352.72 Aligned_cols=270 Identities=23% Similarity=0.289 Sum_probs=204.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|++.+.||+|+||.||+|... +|+.||||++..........+.+.+|++++++++||||+++++++.+++..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 468999999999999999999875 5899999998766545555678899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 82 e~~~~~~l~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 82 EYCDHTVLHELDRY-----QRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp ECCSEEHHHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeCCCchHHHHHhh-----hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 99999999887632 2568999999999999999999997 899999999999999999999999999998765
Q ss_pred CCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh--------hcC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI--------HLS 821 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~ 821 (948)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+...... ...
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 154 GPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred Cccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 4322 2334578999999999876 56899999999999999999999999887654433222211000 000
Q ss_pred cccccc--ccCccc--CCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 822 KDSFHK--AIDPTI--DLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 822 ~~~~~~--~~~~~~--~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
...+.. ..++.- ............+.+++.+|++.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000 000000 0000111234568899999999999999999999873
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=353.41 Aligned_cols=270 Identities=24% Similarity=0.365 Sum_probs=194.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|++.+.||+|+||.||+|..+ +|+.||||+++... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 467899999999999999999865 68999999997643 3334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 671 EYMPQGTLSRHIFNWAEE-GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
||++ |+|.+++...... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9997 5999888653221 22468999999999999999999997 89999999999999999999999999999876
Q ss_pred CCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc-cc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF-HK 827 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 827 (948)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+. .......... ..
T Consensus 159 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 159 GIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF--DIMGTPNESLWPS 235 (317)
T ss_dssp TSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HHHCSCCTTTCGG
T ss_pred CCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--HHhCCCChhHhhh
Confidence 43322 2234568999999999876 468999999999999999999999998766544322221 1111000000 00
Q ss_pred ---c--cCcccCC-----------ccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 828 ---A--IDPTIDL-----------NEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 828 ---~--~~~~~~~-----------~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
. ..+.+.. .........++.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 0000000 0000112346889999999999999999999876
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=365.14 Aligned_cols=273 Identities=17% Similarity=0.249 Sum_probs=208.2
Q ss_pred hcCCcccceeccc--CceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEE
Q 002238 592 TNNFSEENILGRG--GFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 592 ~~~~~~~~~lg~G--~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
.++|++.+.||+| +||.||+|+.+ +|+.||||++..........+.+.+|+.+++.++|||||++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 99999999976 79999999998765556667889999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||||+++|+|.+++.. .....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||.+..
T Consensus 104 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 104 VTSFMAYGSAKDLICT---HFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEECCTTCBHHHHHHH---TCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEccCCCCHHHHHhh---hcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999854 223568999999999999999999997 8999999999999999999999999998874
Q ss_pred cCCCCC------ceeeeecccccccCceeccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHH--HHHh
Q 002238 749 APEGKG------SIETRIAGTFGYLAPEYAVT--GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTW--FRRI 818 (948)
Q Consensus 749 ~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~--~~~~ 818 (948)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....... ....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 322111 11223468999999999987 5799999999999999999999999987554332111000 0000
Q ss_pred ----hcCccc-------------cccccC--------cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 819 ----HLSKDS-------------FHKAID--------PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 819 ----~~~~~~-------------~~~~~~--------~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
...... ....+. ...............+.+++.+|++.||++|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000000 000000 0000001112233568899999999999999999999863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=352.32 Aligned_cols=272 Identities=22% Similarity=0.359 Sum_probs=205.7
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCc-CChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ........+.+|+.++++++||||+++++++.+++..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 45799999999999999999986 478999999997532 2345567899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++++|.+++..... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 111 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EECCCSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EecCCCCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999865332 34678999999999999999999997 89999999999999999999999999998865
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..... .... .......
T Consensus 187 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~---~~~~--~~~~~~~ 259 (310)
T 2wqm_A 187 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCK---KIEQ--CDYPPLP 259 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHH---HHHT--TCSCCCC
T ss_pred cCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHH---Hhhc--ccCCCCc
Confidence 44322 2234568999999999999999999999999999999999999997643221 11111 1111 1111100
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCCCCC
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDQ 883 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~~~~ 883 (948)
. .....++.+++.+|++.||++||++.++++.|+++...+.++..
T Consensus 260 ~---------~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 260 S---------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp T---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred c---------cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 0 11234588999999999999999999999999999887776543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=361.48 Aligned_cols=250 Identities=26% Similarity=0.435 Sum_probs=205.3
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 667 (948)
..++|++.+.||+|+||.||+|+.+ +|+.||||+++.... .......+..|..++..+ +||||+++++++.+.+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4578999999999999999999875 689999999976421 123456788999999887 9999999999999999999
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+||||+++|+|.+++.. ...+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 95 lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 99999999999999854 1468999999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 748 LAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ......+.
T Consensus 167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~~~~~~~p- 238 (345)
T 1xjd_A 167 ENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI------RMDNPFYP- 238 (345)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCCCCC-
T ss_pred hcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH------HhCCCCCC-
Confidence 543322 2244567999999999999999999999999999999999999999876543322211 11111111
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChH-HHH
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMG-HAV 868 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~-ev~ 868 (948)
. ....++.+++.+|++.||++||++. ++.
T Consensus 239 ---~---------~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 239 ---R---------WLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ---T---------TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ---c---------ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1 1224588999999999999999997 554
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=359.40 Aligned_cols=265 Identities=25% Similarity=0.412 Sum_probs=209.7
Q ss_pred hcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCC
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 664 (948)
.++|++.+.||+|+||.||+|... ++..||||++.... .....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 578999999999999999999862 45689999997542 334457899999999999 9999999999999999
Q ss_pred ceEEEEEecCCCChhHHHHhhhhc------------------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEE------------------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLK 726 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik 726 (948)
..++||||+++|+|.+++...... ....+++..++.++.|++.||+|||+ .+|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCC
Confidence 999999999999999998652210 11348999999999999999999997 899999999
Q ss_pred CccEEEcCCCCeEEeecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 002238 727 PSNILLGDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQ 804 (948)
Q Consensus 727 ~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~ 804 (948)
|+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||+| |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999986544332 22334568899999999999999999999999999999998 999998765
Q ss_pred chhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 805 PEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 805 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
..... ...... . . ....+ ......+.+++.+|++.||.+||++.++++.|+.+...
T Consensus 280 ~~~~~--~~~~~~----~--~----~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 280 VDANF--YKLIQN----G--F----KMDQP-----FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CSHHH--HHHHHT----T--C----CCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cHHHH--HHHHhc----C--C----CCCCC-----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 43221 111111 0 0 00000 11234688999999999999999999999999998653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=355.35 Aligned_cols=264 Identities=28% Similarity=0.425 Sum_probs=210.3
Q ss_pred CcccceecccCceEEEEEEEc-----CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CceE
Q 002238 595 FSEENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKL 667 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 667 (948)
|++.+.||+|+||.||+|.++ +++.||||++... ......+.+.+|++++++++||||+++++++.+. ...+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 488999999999999998653 6889999999764 2445567899999999999999999999999874 5679
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+||||+++|+|.+++.. ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 112 lv~e~~~~~~L~~~l~~------~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEECCCTTCBHHHHGGG------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEecccCCcHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccc
Confidence 99999999999998843 358999999999999999999997 899999999999999999999999999999
Q ss_pred ecCCCCCc--eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh---------hhhHHHHHH
Q 002238 748 LAPEGKGS--IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEE---------SMHLVTWFR 816 (948)
Q Consensus 748 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~---------~~~~~~~~~ 816 (948)
........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .........
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 76554322 2234568889999999999999999999999999999999999987532210 000111111
Q ss_pred HhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCC
Q 002238 817 RIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKP 880 (948)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~ 880 (948)
.... . ... ......+.++.+++.+|++.||.+||++.++++.|+.+.+.+..
T Consensus 263 ~~~~-~------~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 263 LLER-G------ERL-----PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHT-T------CCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred HHhc-c------cCC-----CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 1000 0 000 01112335689999999999999999999999999999876643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=356.75 Aligned_cols=266 Identities=26% Similarity=0.421 Sum_probs=214.6
Q ss_pred hcCCcccceecccCceEEEEEEEc--------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEe
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH--------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD 662 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 662 (948)
.++|++.+.||+|+||.||+|++. ++..||||++.... .....+.+.+|+++++++ +||||+++++++.+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 468999999999999999999863 46789999987642 445567899999999999 99999999999999
Q ss_pred CCceEEEEEecCCCChhHHHHhhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEE
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nil 731 (948)
.+..++||||+++|+|.+++...... ....+++..++.++.|++.||+|||+ .+|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEE
Confidence 99999999999999999998653211 12358999999999999999999997 89999999999999
Q ss_pred EcCCCCeEEeecCCceecCCCCCc-eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhh
Q 002238 732 LGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESM 809 (948)
Q Consensus 732 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~ 809 (948)
++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+..
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 999999999999999866543321 1233457889999999999999999999999999999999 99999876543322
Q ss_pred hHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhC
Q 002238 810 HLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWK 879 (948)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~ 879 (948)
..+ ..... ... .......+.+++.+|++.+|.+||++.++++.|+.+.....
T Consensus 270 ~~~---~~~~~----------~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 270 KLL---KEGHR----------MDK-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHH---HHTCC----------CCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHH---hcCCC----------CCC-----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 111 11100 000 01123458899999999999999999999999999987544
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=360.21 Aligned_cols=249 Identities=25% Similarity=0.377 Sum_probs=203.8
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|++.+.||+|+||.||+|.. .+++.||||++...... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999987 47899999998754222 22246789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+ +|+|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~E~~-~g~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE-----KKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp ECCC-CEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred EECC-CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 9999 7899888753 1468999999999999999999997 79999999999999999999999999999866
Q ss_pred CCCCCceeeeecccccccCceecccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
.... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+....... ...
T Consensus 159 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i 220 (336)
T 3h4j_B 159 TDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKV 220 (336)
T ss_dssp TTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCC
T ss_pred cCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHH
Confidence 5432 2344579999999999988776 78999999999999999999999765432210 011
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
........ ......+.+++.+|++.||.+|||++|+++.
T Consensus 221 ~~~~~~~p---~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 221 NSCVYVMP---DFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CSSCCCCC---TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred HcCCCCCc---ccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 01111101 1123458899999999999999999999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=357.95 Aligned_cols=252 Identities=26% Similarity=0.371 Sum_probs=190.9
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEE
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
.+.++|++.+.||+|+||.||+|+.+ +++.||||++.... ..+.+.+|++++++++||||+++++++.+++..++
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 35678999999999999999999876 57899999987542 34678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC---CCCeEEeecCC
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVADFGL 745 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~---~~~~kl~DfGl 745 (948)
||||+++|+|.+++.. ...+++.+++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+
T Consensus 126 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 126 VLELVTGGELFDRIVE-----KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGL 197 (349)
T ss_dssp EECCCCSCBHHHHHTT-----CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred EEEeCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCcc
Confidence 9999999999998842 3568999999999999999999997 79999999999999975 88999999999
Q ss_pred ceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. ..+.......
T Consensus 198 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~---~~i~~~~~~~ 270 (349)
T 2w4o_A 198 SKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MF---RRILNCEYYF 270 (349)
T ss_dssp -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HH---HHHHTTCCCC
T ss_pred ccccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HH---HHHHhCCCcc
Confidence 98654322 23446799999999999999999999999999999999999999976554321 11 1111111110
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
. .+ .......++.+++.+|++.||++||++.++++
T Consensus 271 ~---~~------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 271 I---SP------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp C---TT------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C---Cc------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00 11122346889999999999999999999977
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=358.75 Aligned_cols=247 Identities=25% Similarity=0.333 Sum_probs=205.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|++.+.||+|+||.||+|+.+ +|+.||||++..... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367999999999999999999875 689999999975422 223457789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 120 ~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceec
Confidence 9999999999998541 468999999999999999999997 89999999999999999999999999999876
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+......+
T Consensus 192 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~------~i~~~~~~~---- 257 (350)
T 1rdq_E 192 KGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE------KIVSGKVRF---- 257 (350)
T ss_dssp SSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCCCCC----
T ss_pred cCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHH------HHHcCCCCC----
Confidence 442 234579999999999999999999999999999999999999998765433221 111111111
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPD-----MGHAVN 869 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt-----~~ev~~ 869 (948)
.. .....+.+++.+|++.||.+||+ ++++++
T Consensus 258 p~---------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 258 PS---------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CT---------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CC---------CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11 12245889999999999999998 777765
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=353.52 Aligned_cols=264 Identities=23% Similarity=0.427 Sum_probs=206.8
Q ss_pred hcCCcccceecccCceEEEEEEE-----cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--C
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--N 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~ 664 (948)
.++|++.+.||+|+||.||+|++ .+++.||||++.... .....+.+.+|++++++++||||+++++++.+. .
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 35688899999999999999984 368999999987543 344567899999999999999999999999876 6
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
..++||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPK----NKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHH----HTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred eEEEEEEeCCCCcHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccc
Confidence 68999999999999999844 22568999999999999999999997 899999999999999999999999999
Q ss_pred CceecCCCCCc--eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---------hhhhHHH
Q 002238 745 LVRLAPEGKGS--IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPE---------ESMHLVT 813 (948)
Q Consensus 745 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~---------~~~~~~~ 813 (948)
+++........ ......||..|+|||++.+..++.++||||||+++|||++|+.|+...... .......
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 99876554321 223456888999999999999999999999999999999999986432110 0001111
Q ss_pred HHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhh
Q 002238 814 WFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875 (948)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~ 875 (948)
....... .. ... ........+.+++.+|++.||.+||++.++++.|+.++
T Consensus 252 ~~~~~~~-~~------~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 252 LVNTLKE-GK------RLP-----CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHT-TC------CCC-----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhc-cC------CCC-----CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111100 00 000 01122346889999999999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=365.15 Aligned_cols=270 Identities=27% Similarity=0.387 Sum_probs=198.6
Q ss_pred HHhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCC--
Q 002238 589 RNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGN-- 664 (948)
Q Consensus 589 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~-- 664 (948)
+.+.++|++.+.||+|+||.||+|... +|+.||||++............+.+|+.+++.+. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 356789999999999999999999864 7899999999765555666778899999999997 999999999997544
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
..++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG 154 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFG 154 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCc
Confidence 6899999997 689888843 468999999999999999999997 899999999999999999999999999
Q ss_pred CceecCCCC--------------------CceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 002238 745 LVRLAPEGK--------------------GSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDES 803 (948)
Q Consensus 745 la~~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~ 803 (948)
+++...... ....+..+||+.|+|||++.+ ..++.++||||+||++|||++|++||.+.
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 998653311 112344679999999999987 67899999999999999999999999876
Q ss_pred CchhhhhHHHHHHHhhcCccccccccCc-----------------ccCCccc-------------hHHHHHHHHHHHHHh
Q 002238 804 QPEESMHLVTWFRRIHLSKDSFHKAIDP-----------------TIDLNEG-------------ILASISTVAELAGHC 853 (948)
Q Consensus 804 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~-------------~~~~~~~l~~li~~c 853 (948)
...+....+. .............+.. ....... ......++.+++.+|
T Consensus 235 ~~~~~~~~i~--~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~ 312 (388)
T 3oz6_A 235 STMNQLERII--GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKL 312 (388)
T ss_dssp SHHHHHHHHH--HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHH
T ss_pred CHHHHHHHHH--HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHh
Confidence 6544322221 1111110000000000 0000000 001234688999999
Q ss_pred cccCCCCCCChHHHHHH
Q 002238 854 CAREPYQRPDMGHAVNV 870 (948)
Q Consensus 854 ~~~~P~~RPt~~ev~~~ 870 (948)
++.||++|||++|++++
T Consensus 313 L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 313 LQFNPNKRISANDALKH 329 (388)
T ss_dssp CCSSGGGSCCHHHHTTS
T ss_pred hccCcccCCCHHHHhCC
Confidence 99999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=346.77 Aligned_cols=261 Identities=23% Similarity=0.379 Sum_probs=211.7
Q ss_pred cCCcccc-eecccCceEEEEEEEc---CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEE
Q 002238 593 NNFSEEN-ILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 593 ~~~~~~~-~lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
++|.+.. .||+|+||.||+|.+. ++..||||+++.. ......+.+.+|++++++++||||+++++++ ..+..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 4566665 8999999999999753 5788999999764 2445567899999999999999999999999 5667899
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||||+++++|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||+++.
T Consensus 87 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHHh----CCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceee
Confidence 9999999999998842 33568999999999999999999997 8999999999999999999999999999987
Q ss_pred cCCCCCce--eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 749 APEGKGSI--ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 749 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
........ .....||+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+ .. ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i---~~---~~--- 230 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI---EQ---GK--- 230 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH---HT---TC---
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH---hc---CC---
Confidence 65433221 223456899999999998999999999999999999999 99999876544322111 11 00
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCC
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKP 880 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~ 880 (948)
.+.. ....+..+.+++.+|++.+|++||++.++++.|+.+......
T Consensus 231 ----~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 231 ----RMEC-----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp ----CCCC-----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred ----cCCC-----CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 0001 112234688999999999999999999999999999765543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=361.73 Aligned_cols=255 Identities=21% Similarity=0.311 Sum_probs=200.6
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCC--CceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH--RHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv 669 (948)
.++|++.+.||+|+||.||+|..++++.||||++..........+.+.+|++++++++| |||+++++++.++...++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45799999999999999999998889999999998765566667889999999999986 9999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|| +.+|+|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+|||++ ++.+||+|||+++..
T Consensus 88 ~e-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EC-CCSEEHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred Ee-CCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 99 568899999853 2578999999999999999999997 8999999999999997 578999999999866
Q ss_pred CCCCCc-eeeeecccccccCceeccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH
Q 002238 750 PEGKGS-IETRIAGTFGYLAPEYAVT-----------GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRR 817 (948)
Q Consensus 750 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 817 (948)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ....
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~ 232 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----KLHA 232 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----HHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-----HHHH
Confidence 443322 2345679999999999865 6789999999999999999999999976433211 1111
Q ss_pred hhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 818 IHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
...... ...+.. .....+.+++.+|++.||.+||++.|+++.-.
T Consensus 233 ~~~~~~--~~~~~~---------~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 233 IIDPNH--EIEFPD---------IPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp HHCTTS--CCCCCC---------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HhcCCc--ccCCcc---------cCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 111000 000000 11235889999999999999999999988643
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=382.80 Aligned_cols=260 Identities=30% Similarity=0.483 Sum_probs=211.9
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.++|++.+.||+|+||.||+|.++++..||||+++... ...++|.+|++++++++||||+++++++.+ +..++|||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 46788899999999999999999878899999997643 234689999999999999999999999876 67899999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++|+|.+++.... ...+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 342 ~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 342 YMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CCTTEEHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred hhcCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 999999999995421 2468999999999999999999997 8999999999999999999999999999986543
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
..........+|..|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+ .. . ......
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i------~~-~--~~~~~~ 486 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV------ER-G--YRMPCP 486 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH------HT-T--CCCCCC
T ss_pred CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------Hc-C--CCCCCC
Confidence 22111223456789999999999999999999999999999999 99999876544322111 11 0 000001
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhC
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWK 879 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~ 879 (948)
......+.+++.+||+.||++||++.+|++.|+.+.....
T Consensus 487 ---------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 487 ---------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp ---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred ---------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 1223468899999999999999999999999998865433
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=365.56 Aligned_cols=275 Identities=13% Similarity=0.184 Sum_probs=214.3
Q ss_pred hcCCcccceecccCceEEEEEEEcC---------CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceee-------
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHD---------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA------- 655 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~------- 655 (948)
.++|++.+.||+|+||.||+|+... ++.||||++... ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 3689999999999999999998763 789999998753 36889999999999999987
Q ss_pred --------EEeEEEe-CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCC
Q 002238 656 --------LLGHCLD-GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLK 726 (948)
Q Consensus 656 --------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik 726 (948)
+++++.. +...++||||+ +++|.+++... ....+++.+++.++.||+.||+|||+ .+|+|||||
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dik 186 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS---PKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVT 186 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCC
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC---CcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCC
Confidence 6777776 67789999999 99999999642 12579999999999999999999997 799999999
Q ss_pred CccEEEcCCC--CeEEeecCCceecCCCCC------ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCC
Q 002238 727 PSNILLGDDM--RAKVADFGLVRLAPEGKG------SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRK 798 (948)
Q Consensus 727 ~~Nill~~~~--~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~ 798 (948)
|+||+++.++ .+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.
T Consensus 187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 266 (352)
T 2jii_A 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL 266 (352)
T ss_dssp GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999998 899999999986543221 11233579999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhh
Q 002238 799 ALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELW 878 (948)
Q Consensus 799 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 878 (948)
||....+... .............. ...+... .......++.+++.+|++.||++||+++++++.|+++.+..
T Consensus 267 pf~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 267 PWTNCLPNTE-DIMKQKQKFVDKPG---PFVGPCG----HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp TTGGGTTCHH-HHHHHHHHHHHSCC---CEECTTS----CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CcccCCcCHH-HHHHHHHhccCChh---hhhhhcc----ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 9987542221 11111111111111 1111100 01112346889999999999999999999999999999887
Q ss_pred CCCCCCCccc
Q 002238 879 KPTDQNSEDI 888 (948)
Q Consensus 879 ~~~~~~~~~~ 888 (948)
........+|
T Consensus 339 ~~~~~~~~dw 348 (352)
T 2jii_A 339 RVSPYDPIGL 348 (352)
T ss_dssp TCCTTSCCCC
T ss_pred CCCcCccccC
Confidence 7665555555
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=348.12 Aligned_cols=258 Identities=23% Similarity=0.387 Sum_probs=206.7
Q ss_pred hcCCcccceecccCceEEEEEEEcC----CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
.++|++.+.||+|+||.||+|.+.+ +..||||++.... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 4679999999999999999998642 3469999987642 34556789999999999999999999999764 4578
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 89 ~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER----NKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EEEECCTTCBHHHHHHH----HTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EEEecCCCCCHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCc
Confidence 99999999999999854 22568999999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 748 LAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
..............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+ ..... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~---~~~~~----~- 233 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL---EKGDR----L- 233 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH---HHTCC----C-
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH---hcCCC----C-
Confidence 665443333344567889999999999999999999999999999998 99999876544332211 11000 0
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
..+ ......+.+++.+|++.||++||++.++++.|+.+.+
T Consensus 234 --~~~--------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 234 --PKP--------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp --CCC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCC--------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 000 1122458899999999999999999999999999865
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=357.03 Aligned_cols=258 Identities=26% Similarity=0.446 Sum_probs=204.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcE----EEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCce
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 666 (948)
.++|++.+.||+|+||.||+|.+. +++. ||+|++.... .......+.+|+.++++++||||+++++++. ++..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 89 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL 89 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence 357899999999999999999864 4554 7788775432 2333456789999999999999999999886 5678
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCc
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla 746 (948)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 90 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQ----HRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp EEEEECCTTCBSHHHHHS----SGGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred EEEEEeCCCCCHHHHHHH----ccccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcc
Confidence 999999999999998853 22468889999999999999999997 79999999999999999999999999999
Q ss_pred eecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 747 RLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 747 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
+....... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+. . ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~----~~~ 235 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE---K----GER 235 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH---T----TCB
T ss_pred cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH---c----CCC
Confidence 87654432 22344568889999999999999999999999999999999 999998765443322221 1 000
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
...+. .....+.+++.+|++.||.+||++.++++.|+.+..
T Consensus 236 ---~~~~~--------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 236 ---LAQPQ--------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ---CCCCT--------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ---CCCCC--------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00000 011237789999999999999999999999998864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=354.41 Aligned_cols=276 Identities=21% Similarity=0.335 Sum_probs=215.7
Q ss_pred eHHHHHHhhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHh--cCCCceeeEEeEEE
Q 002238 584 SIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK--VRHRHLVALLGHCL 661 (948)
Q Consensus 584 ~~~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~ 661 (948)
+....+.+.++|++.+.||+|+||.||+|+.. |+.||||++... ....+.+|++++.. ++||||+++++++.
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 34445667789999999999999999999985 899999998642 34678889999888 79999999999998
Q ss_pred eCC----ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcc-----CCCeeecCCCCccEEE
Q 002238 662 DGN----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA-----HQSFIHRDLKPSNILL 732 (948)
Q Consensus 662 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivHrDik~~Nill 732 (948)
... ..++||||+++|+|.+++.. ..+++.+++.++.|++.||+|||+.. +.+|+||||||+||++
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll 180 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 180 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE
Confidence 776 78999999999999999853 46899999999999999999999210 2799999999999999
Q ss_pred cCCCCeEEeecCCceecCCCCCc---eeeeecccccccCceecccC------CCCchhhHHHHHHHHHHHHhC-------
Q 002238 733 GDDMRAKVADFGLVRLAPEGKGS---IETRIAGTFGYLAPEYAVTG------RVTTKVDVFSFGVILMELITG------- 796 (948)
Q Consensus 733 ~~~~~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~Gv~l~elltg------- 796 (948)
+.++.+||+|||+++........ ......||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 99999999999999866544322 12345799999999998775 334789999999999999999
Q ss_pred ---CCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHh
Q 002238 797 ---RKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873 (948)
Q Consensus 797 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~ 873 (948)
+.||........ ....+..... .....+.+............+.+++.+||+.||++||++.+|++.|+.
T Consensus 261 ~~~~~p~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 261 EDYQLPYYDLVPSDP-SVEEMRKVVC------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp CCCCCTTTTTSCSSC-CHHHHHHHHT------TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccccCccccCcCcc-cHHHHHHHHH------HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 778866543211 1111111111 111222222122233556679999999999999999999999999999
Q ss_pred hhhhh
Q 002238 874 LVELW 878 (948)
Q Consensus 874 ~~~~~ 878 (948)
+.+..
T Consensus 334 i~~~~ 338 (342)
T 1b6c_B 334 LSQQE 338 (342)
T ss_dssp HHHTT
T ss_pred HHHHh
Confidence 97654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=360.23 Aligned_cols=247 Identities=28% Similarity=0.361 Sum_probs=197.7
Q ss_pred cceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCCC
Q 002238 598 ENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 676 (948)
.+.||+|+||.||+|... +|+.||||+++.. .....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 578999999999999874 6899999999864 3355678999999999999999999999999999999999999999
Q ss_pred ChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE--cCCCCeEEeecCCceecCCCCC
Q 002238 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL--GDDMRAKVADFGLVRLAPEGKG 754 (948)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill--~~~~~~kl~DfGla~~~~~~~~ 754 (948)
+|.+++.. ....+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++......
T Consensus 172 ~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~- 243 (373)
T 2x4f_A 172 ELFDRIID----ESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE- 243 (373)
T ss_dssp EEHHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred cHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence 99988853 22468999999999999999999997 899999999999999 567789999999999765433
Q ss_pred ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccC
Q 002238 755 SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTID 834 (948)
Q Consensus 755 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (948)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ......+.
T Consensus 244 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i------~~~~~~~~-------- 308 (373)
T 2x4f_A 244 -KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI------LACRWDLE-------- 308 (373)
T ss_dssp -BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHTCCCSC--------
T ss_pred -ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhccCCCC--------
Confidence 223456999999999999999999999999999999999999999876543321111 11010000
Q ss_pred CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 835 LNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 835 ~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.........++.+++.+|++.||.+||++.|+++.
T Consensus 309 -~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 309 -DEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp -SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 01111223568899999999999999999999873
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=349.01 Aligned_cols=255 Identities=26% Similarity=0.378 Sum_probs=202.2
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
+.++|.+.+.||+|+||.||+|..+ +++.||+|++.... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 3467999999999999999999875 68999999987653 334467899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE---cCCCCeEEeecCCc
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLV 746 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill---~~~~~~kl~DfGla 746 (948)
|||+++|+|.+++...... ...+++..++.++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||++
T Consensus 99 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 99 METCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 9999999999988654332 3679999999999999999999997 899999999999999 45678999999999
Q ss_pred eecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 747 RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
+...... ......||+.|+|||++. ..++.++||||||+++|||++|+.||......+...... .......
T Consensus 175 ~~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~------~~~~~~~ 245 (285)
T 3is5_A 175 ELFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT------YKEPNYA 245 (285)
T ss_dssp CC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCCCCCC
T ss_pred eecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc------cCCcccc
Confidence 8654432 234457999999999875 578999999999999999999999998765433221111 1011000
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
. ........+.+++.+|++.||++||++.|+++
T Consensus 246 ~----------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 246 V----------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp C------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred c----------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00112245889999999999999999999976
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=351.39 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=208.6
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCCh----hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG----KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 665 (948)
+.++|++.+.||+|+||.||+|..+ +|+.||||++....... ...+.+.+|+.++++++||||+++++++.+++.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3567999999999999999999875 68999999997653322 236789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC----CeEEe
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVA 741 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~----~~kl~ 741 (948)
.++||||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++ .+||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT-----CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEc
Confidence 9999999999999998843 3568999999999999999999997 8999999999999999887 79999
Q ss_pred ecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcC
Q 002238 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS 821 (948)
Q Consensus 742 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 821 (948)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.... +...
T Consensus 162 Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~------i~~~ 233 (321)
T 2a2a_A 162 DFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN------ITSV 233 (321)
T ss_dssp CCTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH------HHTT
T ss_pred cCccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHH------HHhc
Confidence 999998765433 23345699999999999999999999999999999999999999987654332111 1111
Q ss_pred ccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 822 KDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
...+.. .........+.+++.+|++.||++||++.|+++
T Consensus 234 ~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 234 SYDFDE---------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCCCCH---------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ccccCh---------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111100 001122345889999999999999999999987
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=354.91 Aligned_cols=251 Identities=22% Similarity=0.340 Sum_probs=201.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 668 (948)
.++|++.+.||+|+||.||+|+.+ +++.||||++.+... .....+.+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357899999999999999999875 689999999986543 334466788999999988 89999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 88 v~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp EECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred EEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEecccccc
Confidence 99999999999988531 468999999999999999999997 8999999999999999999999999999985
Q ss_pred cCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhh---hHHHHHHHhhcCcccc
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESM---HLVTWFRRIHLSKDSF 825 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~ 825 (948)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ........+......
T Consensus 160 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~- 237 (345)
T 3a8x_A 160 GLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR- 237 (345)
T ss_dssp SCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC-
T ss_pred ccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC-
Confidence 43322 2344567999999999999999999999999999999999999999753221100 000011111111111
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCCh
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDM 864 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~ 864 (948)
++ .....++.+++.+|++.||.+||++
T Consensus 238 -------~p-----~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 238 -------IP-----RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -------CC-----TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -------CC-----CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11 1122458899999999999999996
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=354.03 Aligned_cols=257 Identities=23% Similarity=0.354 Sum_probs=198.2
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCce--
Q 002238 591 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK-- 666 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-- 666 (948)
+.++|++.+.||+|+||.||+|+. .+++.||||++...... ......+.+|++++++++||||+++++++......
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 357899999999999999999986 47899999999765332 34456789999999999999999999998765543
Q ss_pred --EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 667 --LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 667 --~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
++||||+++|+|.+++.. ...+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg 161 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFG 161 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred ccEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeecc
Confidence 999999999999999854 1468999999999999999999997 899999999999999999999999999
Q ss_pred CceecCCCCC--ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc
Q 002238 745 LVRLAPEGKG--SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK 822 (948)
Q Consensus 745 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 822 (948)
+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.... .....
T Consensus 162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~------~~~~~ 235 (311)
T 3ork_A 162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ------HVRED 235 (311)
T ss_dssp CC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH------HHHCC
T ss_pred CcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH------HhcCC
Confidence 9986544322 122345699999999999999999999999999999999999999987654332111 11000
Q ss_pred cccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 823 DSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.... .........++.+++.+|++.||++||+..+++..
T Consensus 236 ~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 236 PIPP---------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp CCCH---------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCCc---------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 0000 00111123468899999999999999977766543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=352.31 Aligned_cols=260 Identities=25% Similarity=0.454 Sum_probs=205.3
Q ss_pred hcCCcccceecccCceEEEEEEEcC-----CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCce
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHD-----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 666 (948)
.++|+..+.||+|+||.||+|..+. +..||||+++... .......+.+|++++++++||||+++++++.+.+..
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 3578888999999999999998652 2359999987542 445567899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCc
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla 746 (948)
++||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 122 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 122 MIITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp EEEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcc
Confidence 999999999999999853 23578999999999999999999997 79999999999999999999999999999
Q ss_pred eecCCCCCc--eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCcc
Q 002238 747 RLAPEGKGS--IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKD 823 (948)
Q Consensus 747 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 823 (948)
+........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+ .. ..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~------~~-~~ 267 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI------ND-GF 267 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH------HT-TC
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH------HC-CC
Confidence 865443211 1223346889999999999999999999999999999999 99999876543321111 11 00
Q ss_pred ccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 824 SFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
.. .. ....+..+.+++.+||+.+|++||++.++++.|+++...
T Consensus 268 ~~------~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 268 RL------PT-----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp CC------CC-----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cC------CC-----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00 00 012234688999999999999999999999999998753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=347.80 Aligned_cols=259 Identities=24% Similarity=0.356 Sum_probs=208.1
Q ss_pred hcCCcccc-eecccCceEEEEEEEc---CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 592 TNNFSEEN-ILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 592 ~~~~~~~~-~lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
.++|++.+ .||+|+||.||+|.+. +++.||||++..........+++.+|+++++.++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45788877 9999999999999642 468899999976544445567899999999999999999999999 667789
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+||||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 94 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEeCCCCCHHHHHHh-----CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 99999999999999853 2468999999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCcee--eeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 748 LAPEGKGSIE--TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 748 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
.......... ....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+ .. ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~~-----~~ 237 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---EK-----GE 237 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---HT-----TC
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---Hc-----CC
Confidence 7655433222 22346789999999999899999999999999999999 99999876654322111 11 00
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
.+.. ....+..+.+++.+|++.||.+||++.++++.|+.+...
T Consensus 238 -----~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 238 -----RMGC-----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp -----CCCC-----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -----CCCC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0001 112234688999999999999999999999999998653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=364.93 Aligned_cols=253 Identities=21% Similarity=0.311 Sum_probs=200.4
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC--CCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR--HRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|++.+.||+|+||.||+|...+++.||||++..........+.+.+|++++++++ ||||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 469999999999999999999888999999999876555666788999999999996 599999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
| +.+++|.+++.. ...+++.++..++.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+++...
T Consensus 136 E-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp E-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred e-cCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 9 568899998853 2478899999999999999999997 8999999999999996 5899999999998664
Q ss_pred CCCCc-eeeeecccccccCceeccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh
Q 002238 751 EGKGS-IETRIAGTFGYLAPEYAVT-----------GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI 818 (948)
Q Consensus 751 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 818 (948)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .....
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-----~~~~~ 280 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----KLHAI 280 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-----HHHHH
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-----HHHHH
Confidence 43322 2345679999999999865 4689999999999999999999999976543211 11111
Q ss_pred hcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 819 HLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
...... ... ... ....+.+++.+|++.||.+||++.|+++.-
T Consensus 281 ~~~~~~------~~~--~~~---~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 281 IDPNHE------IEF--PDI---PEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp HCTTSC------CCC--CCC---SCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred hCcccc------CCC--Ccc---chHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 111100 000 000 123588999999999999999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=351.88 Aligned_cols=266 Identities=29% Similarity=0.438 Sum_probs=204.5
Q ss_pred hhcCCcccceecccCceEEEEEEEc----CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc-
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE- 665 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~- 665 (948)
..++|.+.+.||+|+||.||+|... +++.||||++..........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 4578999999999999999999764 34589999998765556667889999999999999999999999987553
Q ss_pred ----eEEEEEecCCCChhHHHHhhh-hcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEE
Q 002238 666 ----KLLVFEYMPQGTLSRHIFNWA-EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 740 (948)
Q Consensus 666 ----~~lv~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl 740 (948)
.++||||+++|+|.+++.... ......+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEE
Confidence 499999999999999985422 2334679999999999999999999997 89999999999999999999999
Q ss_pred eecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHh
Q 002238 741 ADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRI 818 (948)
Q Consensus 741 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 818 (948)
+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |..||......+..... .
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~---~-- 263 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL---L-- 263 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH---H--
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH---H--
Confidence 99999986543321 12233457889999999999999999999999999999999 89999876554322111 1
Q ss_pred hcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 819 HLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
... .+.. .......+.+++.+|++.+|.+||++.++++.|+++.+.
T Consensus 264 -~~~-------~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 264 -HGH-------RLKQ-----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp -TTC-------CCCC-----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -cCC-------CCCC-----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 000 0000 112234688999999999999999999999999998764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=360.62 Aligned_cols=265 Identities=24% Similarity=0.276 Sum_probs=204.8
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCc---CChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC
Q 002238 588 LRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV---ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG 663 (948)
Q Consensus 588 l~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 663 (948)
+..+.++|++.+.||+|+||.||+|... +++.||||++.... ......+.+.+|++++++++||||+++++++.++
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3456788999999999999999999874 68899999987542 1344567899999999999999999999999999
Q ss_pred CceEEEEEecCCCChhHHHHhhhhc-----------------------------------CCCCCCHHHHHHHHHHHHHH
Q 002238 664 NEKLLVFEYMPQGTLSRHIFNWAEE-----------------------------------GLKPLEWNRRLTIALDVARG 708 (948)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~i~~~ 708 (948)
+..++||||+++|+|.+++...... ....+++..++.++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999988421111 01234677888999999999
Q ss_pred HHHHHhccCCCeeecCCCCccEEEcCCC--CeEEeecCCceecCCCC---CceeeeecccccccCceeccc--CCCCchh
Q 002238 709 VEYLHGLAHQSFIHRDLKPSNILLGDDM--RAKVADFGLVRLAPEGK---GSIETRIAGTFGYLAPEYAVT--GRVTTKV 781 (948)
Q Consensus 709 l~~LH~~~~~~ivHrDik~~Nill~~~~--~~kl~DfGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 781 (948)
|+|||+ .+|+||||||+||+++.++ .+||+|||+++...... ........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 999997 7999999999999998776 89999999998653322 112345679999999999875 6789999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCC
Q 002238 782 DVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQR 861 (948)
Q Consensus 782 Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~R 861 (948)
||||||+++|||++|+.||......+....+ ......+. ..........+.+++.+|++.+|.+|
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~------~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQV------LNKKLCFE---------NPNYNVLSPLARDLLSNLLNRNVDER 322 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCCCTT---------SGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHH------HhcccccC---------CcccccCCHHHHHHHHHHcCCChhHC
Confidence 9999999999999999999876644322111 11010000 01111223468899999999999999
Q ss_pred CChHHHHHH
Q 002238 862 PDMGHAVNV 870 (948)
Q Consensus 862 Pt~~ev~~~ 870 (948)
|++.++++.
T Consensus 323 ps~~~~l~h 331 (345)
T 3hko_A 323 FDAMRALQH 331 (345)
T ss_dssp CCHHHHHHS
T ss_pred CCHHHHhcC
Confidence 999999873
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=369.37 Aligned_cols=265 Identities=23% Similarity=0.313 Sum_probs=201.4
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC------
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------ 663 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 663 (948)
..++|++.+.||+|+||.||+|... +|+.||||++..........+.+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999865 689999999987654556678899999999999999999999999754
Q ss_pred CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeec
Q 002238 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (948)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~Df 743 (948)
.+.++||||+++ +|.+.+. ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DF 208 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 208 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred CeEEEEEeCCCC-CHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEE
Confidence 356999999976 4655552 348899999999999999999997 79999999999999999999999999
Q ss_pred CCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcc
Q 002238 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD 823 (948)
Q Consensus 744 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 823 (948)
|+++...... ..+...||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+....+ +........
T Consensus 209 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i--~~~lg~p~~ 284 (464)
T 3ttj_A 209 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV--IEQLGTPCP 284 (464)
T ss_dssp CCC-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHHHCSCCH
T ss_pred EeeeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcCCCCH
Confidence 9998654422 344567999999999999999999999999999999999999999876643322211 111100000
Q ss_pred -----------------------ccccccCccc-C-CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 824 -----------------------SFHKAIDPTI-D-LNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 824 -----------------------~~~~~~~~~~-~-~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.+...+...+ . ..........++.+++.+|++.||++|||++|++++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0001111100 0 001111224578999999999999999999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=358.74 Aligned_cols=253 Identities=23% Similarity=0.301 Sum_probs=194.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|++.+.||+|+||.||+|+.+ +++.||||++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA---AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST---TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc---cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 468999999999999999999876 78999999997642 22367889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCC--eEEeecCCcee
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR--AKVADFGLVRL 748 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~--~kl~DfGla~~ 748 (948)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||+++.
T Consensus 96 e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 96 EYASGGELYERICN-----AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp ECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EeCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 99999999998853 1468999999999999999999997 89999999999999987765 99999999874
Q ss_pred cCCCCCceeeeecccccccCceecccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTK-VDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
..... ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||......... .............+.
T Consensus 168 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~- 242 (361)
T 3uc3_A 168 SVLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRILSVKYSIP- 242 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHHTTCCCCC-
T ss_pred ccccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhcCCCCCC-
Confidence 33222 2334579999999999988887665 89999999999999999999875432221 111222211111110
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.. ......+.+++.+|++.||.+|||+.|++++
T Consensus 243 ---~~-------~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 243 ---DD-------IRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ---TT-------SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ---Cc-------CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00 0112458899999999999999999999886
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=351.33 Aligned_cols=268 Identities=25% Similarity=0.358 Sum_probs=202.3
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCC---hhhHHHHHHHHHHHHhcC---CCceeeEEeEEEeC
Q 002238 591 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVR---HRHLVALLGHCLDG 663 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~ 663 (948)
+.++|++.+.||+|+||.||+|+. .+|+.||||++...... ......+.+|+++++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467999999999999999999986 47899999998753211 122356778888877774 99999999999876
Q ss_pred C-----ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCe
Q 002238 664 N-----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 738 (948)
Q Consensus 664 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~ 738 (948)
. ..++||||++ |+|.+++.. .....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDK---APPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHT---CCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhh---ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCE
Confidence 5 4799999996 599998853 222458999999999999999999997 899999999999999999999
Q ss_pred EEeecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh
Q 002238 739 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI 818 (948)
Q Consensus 739 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 818 (948)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. ...
T Consensus 160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~--~~~ 235 (308)
T 3g33_A 160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF--DLI 235 (308)
T ss_dssp EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHH--HHH
T ss_pred EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HHh
Confidence 999999998654332 2345679999999999999999999999999999999999999998766544322221 111
Q ss_pred hcC-cccccccc-------Cccc--CCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 819 HLS-KDSFHKAI-------DPTI--DLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 819 ~~~-~~~~~~~~-------~~~~--~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
... ...+.... .+.. ............+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 110 00010000 0000 000011123356889999999999999999999876
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=360.33 Aligned_cols=260 Identities=29% Similarity=0.453 Sum_probs=199.3
Q ss_pred CCcccceecccCceEEEEEEEc--CC--cEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe-CCceEE
Q 002238 594 NFSEENILGRGGFGTVYKGELH--DG--TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-GNEKLL 668 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~--~g--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~l 668 (948)
.|+..+.||+|+||.||+|.+. ++ ..||||.++.. ......+++.+|+.++++++||||+++++++.+ ++..++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 4677889999999999999864 22 36899988653 244557889999999999999999999998765 457899
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||||+++|+|.+++.. ....+++.+++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 169 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp EEECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEECCCCCCHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccc
Confidence 9999999999999843 33568999999999999999999997 8999999999999999999999999999985
Q ss_pred cCCCCC---ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 749 APEGKG---SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 749 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
...... .......+|+.|+|||++.+..++.++||||||+++|||++ |.+||......+....+ . ...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~---~---~~~-- 313 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---L---QGR-- 313 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH---H---TTC--
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH---H---cCC--
Confidence 543221 11234567889999999999999999999999999999999 77788765543322111 1 100
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhC
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWK 879 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~ 879 (948)
....+ ...+..+.+++.+||+.+|++||++.++++.|+.+...+.
T Consensus 314 --~~~~p--------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 314 --RLLQP--------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp --CCCCC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred --CCCCC--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00011 1123458899999999999999999999999999987654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=354.23 Aligned_cols=250 Identities=24% Similarity=0.410 Sum_probs=194.3
Q ss_pred hcCCcccceecccCceEEEEEEE----cCCcEEEEEEeecCcC--ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL----HDGTKIAVKRMEAGVI--SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 665 (948)
.++|++.+.||+|+||.||+|+. .+|+.||||+++.... .......+.+|+++++.++||||+++++++.+++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999987 4789999999976532 22345668899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGl 745 (948)
.++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEeCCCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 9999999999999998853 1468899999999999999999997 7999999999999999999999999999
Q ss_pred ceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.... +......+
T Consensus 168 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~------i~~~~~~~ 240 (327)
T 3a62_A 168 CKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK------ILKCKLNL 240 (327)
T ss_dssp C-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH------HHHTCCCC
T ss_pred ccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHH------HHhCCCCC
Confidence 88543322 123345799999999999999999999999999999999999999987654332111 11111111
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRP-----DMGHAVN 869 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RP-----t~~ev~~ 869 (948)
.+ .....+.+++.+|++.||.+|| ++.++++
T Consensus 241 ----p~---------~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 241 ----PP---------YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ----CT---------TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ----CC---------CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11 1224588999999999999999 5666655
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=354.69 Aligned_cols=265 Identities=26% Similarity=0.426 Sum_probs=213.7
Q ss_pred HhhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG 663 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 663 (948)
...++|++.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.++++++||||+++++++.++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 34678999999999999999999764 36889999987542 344566799999999999999999999999999
Q ss_pred CceEEEEEecCCCChhHHHHhhhh-----cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCe
Q 002238 664 NEKLLVFEYMPQGTLSRHIFNWAE-----EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 738 (948)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~ 738 (948)
+..++||||+++|+|.+++..... .....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeE
Confidence 999999999999999999865321 112467899999999999999999997 799999999999999999999
Q ss_pred EEeecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHH
Q 002238 739 KVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFR 816 (948)
Q Consensus 739 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 816 (948)
||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~---- 253 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV---- 253 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH----
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH----
Confidence 9999999985433221 11223457899999999999999999999999999999999 89999876543321111
Q ss_pred HhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 817 RIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
.. ..... .....+..+.+++.+|++.+|.+||++.++++.|++...
T Consensus 254 --~~--~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 --ME--GGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp --HT--TCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --Hc--CCcCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11 00000 011223458899999999999999999999999988754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=351.83 Aligned_cols=273 Identities=25% Similarity=0.384 Sum_probs=216.6
Q ss_pred HHHHHhhcCCcccceecccCceEEEEEEE------cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEe
Q 002238 586 QVLRNVTNNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLG 658 (948)
Q Consensus 586 ~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~ 658 (948)
.......++|++.+.||+|+||.||+|++ .+++.||||++.... .....+.+.+|++++.++ +||||+++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 34444568899999999999999999974 246899999997642 444567899999999999 7999999999
Q ss_pred EEEeCC-ceEEEEEecCCCChhHHHHhhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCC
Q 002238 659 HCLDGN-EKLLVFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLK 726 (948)
Q Consensus 659 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik 726 (948)
++...+ ..++||||+++|+|.+++...... ....+++..++.++.|++.||+|||+ .+|+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCc
Confidence 988755 489999999999999998642211 01238999999999999999999997 899999999
Q ss_pred CccEEEcCCCCeEEeecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 002238 727 PSNILLGDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQ 804 (948)
Q Consensus 727 ~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~ 804 (948)
|+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999986544332 22334568999999999999999999999999999999998 999998765
Q ss_pred chhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhC
Q 002238 805 PEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWK 879 (948)
Q Consensus 805 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~ 879 (948)
..+.. ........ . .... ......+.+++.+|++.||.+||++.++++.|+.+.+...
T Consensus 256 ~~~~~--~~~~~~~~--~--------~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 256 IDEEF--CRRLKEGT--R--------MRAP-----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CSHHH--HHHHHHTC--C--------CCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hhHHH--HHHhccCc--c--------CCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 33221 11111100 0 0000 1122458899999999999999999999999999987654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=357.10 Aligned_cols=250 Identities=23% Similarity=0.331 Sum_probs=204.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 668 (948)
.++|++.+.||+|+||.||+|+.+ +|+.||||++++... .....+.+..|..++..+ +||||+++++++.+.+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 578999999999999999999876 578999999976422 223456788999999988 89999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 99 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999998541 468999999999999999999997 8999999999999999999999999999985
Q ss_pred cCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +......+.
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~------i~~~~~~~p-- 241 (353)
T 2i0e_A 171 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS------IMEHNVAYP-- 241 (353)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHCCCCCC--
T ss_pred cccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHH------HHhCCCCCC--
Confidence 43322 234456799999999999999999999999999999999999999987654332211 111111111
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCCh-----HHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDM-----GHAVN 869 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~-----~ev~~ 869 (948)
. ....++.+++.+|++.||.+||++ .++++
T Consensus 242 --~---------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 242 --K---------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp --T---------TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred --C---------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1 122458899999999999999964 55554
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=360.27 Aligned_cols=275 Identities=23% Similarity=0.388 Sum_probs=200.5
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHH--HHhcCCCceeeEEeEEEe-----CC
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAV--LTKVRHRHLVALLGHCLD-----GN 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~-----~~ 664 (948)
.++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.++ +..++||||+++++++.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 46899999999999999999987 4899999998643 22344445444 455899999999986543 22
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcc------CCCeeecCCCCccEEEcCCCCe
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA------HQSFIHRDLKPSNILLGDDMRA 738 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~ivHrDik~~Nill~~~~~~ 738 (948)
..++||||+++|+|.+++.. ...++..+++++.|++.||+|||+.. +.+|+||||||+|||++.++.+
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred eEEEEEecCCCCcHHHHHhh------cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 56899999999999999843 34589999999999999999999721 1199999999999999999999
Q ss_pred EEeecCCceecCCCCC-------ceeeeecccccccCceeccc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 002238 739 KVADFGLVRLAPEGKG-------SIETRIAGTFGYLAPEYAVT-------GRVTTKVDVFSFGVILMELITGRKALDESQ 804 (948)
Q Consensus 739 kl~DfGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~ 804 (948)
||+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 9999999986643221 12234569999999999976 456789999999999999999977765432
Q ss_pred chhhhh-H----------HHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHh
Q 002238 805 PEESMH-L----------VTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873 (948)
Q Consensus 805 ~~~~~~-~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~ 873 (948)
...... . ......... .......+.... .........+.+++.+||+.||++|||++|+++.|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVS-REKQRPKFPEAW---KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHT-TSCCCCCCCTTC---CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhc-ccccCCCCCccc---ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 211100 0 000000000 000011111111 1122345579999999999999999999999999999
Q ss_pred hhhhhCCCC
Q 002238 874 LVELWKPTD 882 (948)
Q Consensus 874 ~~~~~~~~~ 882 (948)
+...|....
T Consensus 316 ll~~~~~~~ 324 (336)
T 3g2f_A 316 LMMIWERNK 324 (336)
T ss_dssp HHHCCCC--
T ss_pred HHHHHHhcc
Confidence 998876543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=345.47 Aligned_cols=252 Identities=25% Similarity=0.355 Sum_probs=205.9
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
+.++|++.+.||+|+||.||+|..+ ++..||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF--VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 4578999999999999999999875 57899999987642 33467899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE---cCCCCeEEeecCCc
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLV 746 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill---~~~~~~kl~DfGla 746 (948)
|||+++++|.+++.. ...+++.+++.++.|++.||+|||+ .+|+||||||+||++ +.++.++|+|||++
T Consensus 85 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 85 MELCTGGELFERVVH-----KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156 (277)
T ss_dssp EECCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EeccCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence 999999999988854 1468999999999999999999997 899999999999999 78889999999999
Q ss_pred eecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 747 RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
....... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||......+....+ ........
T Consensus 157 ~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------~~~~~~~~ 227 (277)
T 3f3z_A 157 ARFKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI------REGTFTFP 227 (277)
T ss_dssp EECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCCCCC
T ss_pred eeccCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH------HhCCCCCC
Confidence 8765433 2344569999999998865 4899999999999999999999999876543321111 11010000
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
..........+.+++.+|++.||++||++.++++.
T Consensus 228 ---------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 228 ---------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp ---------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111223568899999999999999999999763
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=350.50 Aligned_cols=262 Identities=21% Similarity=0.285 Sum_probs=201.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|++.+.||+|+||.||+|... +++.||||++...... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 578999999999999999999875 6899999998764322 33357899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++++|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 113 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 9999999999998541 468999999999999999999997 89999999999999999999999999999866
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
............||+.|+|||++.+..++.++||||||+++|||++|+.||....... ...... . ........
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~---~-~~~~~~~~ 257 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---MGAHIN---Q-AIPRPSTV 257 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH---HHHHHH---S-CCCCGGGT
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH---HHHHhc---c-CCCCcccc
Confidence 5543333445679999999999999999999999999999999999999998654321 111111 0 10001111
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCC-ChHHHHHHHHhhhhh
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRP-DMGHAVNVLSSLVEL 877 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RP-t~~ev~~~L~~~~~~ 877 (948)
.+ ..+.++.+++.+|++.||++|| +++++++.|+.....
T Consensus 258 ~~---------~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 258 RP---------GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp ST---------TCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred CC---------CCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 11 1223588999999999999999 999999999987643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=358.90 Aligned_cols=256 Identities=18% Similarity=0.222 Sum_probs=209.4
Q ss_pred hcCCcccceecccCceEEEEEE------EcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC---CCceeeEEeEEEe
Q 002238 592 TNNFSEENILGRGGFGTVYKGE------LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR---HRHLVALLGHCLD 662 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~ 662 (948)
.++|.+.+.||+|+||.||+|. ..+++.||||++... ...++.+|+++++.++ |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 4679999999999999999994 446899999998653 2457888888888886 9999999999999
Q ss_pred CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC--------
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-------- 734 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~-------- 734 (948)
++..++||||+++|+|.+++..........+++..++.|+.||+.||+|||+ .+||||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999976544445789999999999999999999997 89999999999999998
Q ss_pred ---CCCeEEeecCCceecCC-CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhh
Q 002238 735 ---DMRAKVADFGLVRLAPE-GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMH 810 (948)
Q Consensus 735 ---~~~~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~ 810 (948)
++.+||+|||+|+.... ..........||++|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 89999999999985432 22334455679999999999999999999999999999999999999986432211
Q ss_pred HHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCC-CChHHHHHHHHhhhhhh
Q 002238 811 LVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQR-PDMGHAVNVLSSLVELW 878 (948)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~R-Pt~~ev~~~L~~~~~~~ 878 (948)
......+... .....+.+++..|++.+|.+| |+++++.+.|++.....
T Consensus 293 ------------~~~~~~~~~~--------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 ------------CKPEGLFRRL--------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ------------EEECSCCTTC--------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ------------eeechhcccc--------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 0011111110 113357789999999999998 68888999998887653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=359.89 Aligned_cols=271 Identities=23% Similarity=0.290 Sum_probs=209.3
Q ss_pred eHHHHHHhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-----CCceeeEE
Q 002238 584 SIQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-----HRHLVALL 657 (948)
Q Consensus 584 ~~~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~ 657 (948)
++++...+.++|++.+.||+|+||.||+|+.. +++.||||++.. .......+..|+++++.++ ||||++++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 33444456789999999999999999999874 789999999864 3444567888999999996 99999999
Q ss_pred eEEEeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC---
Q 002238 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD--- 734 (948)
Q Consensus 658 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~--- 734 (948)
+++...+..++||||+ +++|.+++.. .....+++..+..++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITR---NNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTC
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccc
Confidence 9999999999999999 9999999854 223468999999999999999999997 89999999999999975
Q ss_pred ----------------------CCCeEEeecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHH
Q 002238 735 ----------------------DMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILME 792 (948)
Q Consensus 735 ----------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~e 792 (948)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 789999999999865442 234578999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc--------ccccC-----cccCCcc---------------chHHHHH
Q 002238 793 LITGRKALDESQPEESMHLVTWFRRIHLSKDSF--------HKAID-----PTIDLNE---------------GILASIS 844 (948)
Q Consensus 793 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~-----~~~~~~~---------------~~~~~~~ 844 (948)
|++|+.||......+....+...... ...... ...++ ...+... .......
T Consensus 252 ll~g~~pf~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (360)
T 3llt_A 252 LYTGSLLFRTHEHMEHLAMMESIIQP-IPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE 330 (360)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHTCC-CCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred HHHCCCCCCCCcHHHHHHHHHHhcCC-CCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence 99999999876654332222111000 000000 00000 0000000 0000114
Q ss_pred HHHHHHHHhcccCCCCCCChHHHHH
Q 002238 845 TVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 845 ~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.+.+++.+|++.||++|||++|+++
T Consensus 331 ~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 331 LFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhc
Confidence 5789999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=380.72 Aligned_cols=261 Identities=22% Similarity=0.370 Sum_probs=206.6
Q ss_pred CCcccc-eecccCceEEEEEEEc---CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 594 NFSEEN-ILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 594 ~~~~~~-~lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
++.+.+ .||+|+||.||+|.++ ++..||||+++... .....++|.+|++++++++|||||++++++.+ +..++|
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 344444 7999999999999864 46679999997642 34456889999999999999999999999976 568999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++|+|.+++.. ....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 414 ~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp EECCTTCBHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred EEeCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 999999999998843 23579999999999999999999997 89999999999999999999999999999865
Q ss_pred CCCCCce--eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 750 PEGKGSI--ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 750 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
....... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+. . +. .
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~------~--~~-~ 557 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE------Q--GK-R 557 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH------T--TC-C
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH------c--CC-C
Confidence 4332211 122346789999999999999999999999999999998 999998866544322111 1 00 0
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCCC
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPT 881 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~~ 881 (948)
+. .....+.++.+++.+||+.+|++||++.+|++.|+.+.......
T Consensus 558 ------~~---~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~ 603 (613)
T 2ozo_A 558 ------ME---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603 (613)
T ss_dssp ------CC---CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred ------CC---CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence 00 01123356889999999999999999999999999987665543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=354.83 Aligned_cols=251 Identities=26% Similarity=0.402 Sum_probs=203.5
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.+.|+..+.||+|+||.||+|+. .+|+.||||++...... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35688999999999999999986 47899999999764322 33456799999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+. |+|.+.+.. ....+++.++..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 133 ~e~~~-g~l~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp EECCS-EEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EecCC-CCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 99997 688877743 23578999999999999999999997 79999999999999999999999999999865
Q ss_pred CCCCCceeeeecccccccCceecc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAV---TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
... ....||+.|+|||++. ...++.++|||||||++|||++|+.||.......... ......
T Consensus 205 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~------~~~~~~---- 269 (348)
T 1u5q_A 205 APA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQNE---- 269 (348)
T ss_dssp SSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHSC----
T ss_pred CCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHHhcC----
Confidence 432 2356999999999984 5678999999999999999999999998765433211 111100
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
.+... .......+.+++.+|++.||++||++.++++.-.
T Consensus 270 ---~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 270 ---SPALQ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp ---CCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred ---CCCCC----CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 01111 0112245889999999999999999999987543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=348.29 Aligned_cols=251 Identities=23% Similarity=0.417 Sum_probs=202.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CC-------cEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DG-------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG 663 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 663 (948)
.++|++.+.||+|+||.||+|... ++ ..||+|++... .....+.+.+|++++++++||||+++++++.++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 467899999999999999999865 33 47999998654 345567899999999999999999999999999
Q ss_pred CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCC------
Q 002238 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR------ 737 (948)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~------ 737 (948)
+..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKK----NKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred CCCEEEEECCCCCCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccc
Confidence 999999999999999999854 22348999999999999999999997 89999999999999998887
Q ss_pred --eEEeecCCceecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCC-CCCCCCchhhhhHHH
Q 002238 738 --AKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRK-ALDESQPEESMHLVT 813 (948)
Q Consensus 738 --~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~-p~~~~~~~~~~~~~~ 813 (948)
+||+|||+++.... .....||+.|+|||++.+ ..++.++||||||+++|||++|.. |+......... .
T Consensus 158 ~~~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~---~ 229 (289)
T 4fvq_A 158 PFIKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL---Q 229 (289)
T ss_dssp CEEEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH---H
T ss_pred ceeeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH---H
Confidence 99999999865432 233568999999999987 679999999999999999999655 44443322211 1
Q ss_pred HHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 814 WFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
... ......... ..++.+++.+|++.||++||++.++++.|+++..
T Consensus 230 ~~~----~~~~~~~~~-------------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 230 FYE----DRHQLPAPK-------------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHH----TTCCCCCCS-------------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred Hhh----ccCCCCCCC-------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111 011111111 1237799999999999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=373.95 Aligned_cols=256 Identities=29% Similarity=0.438 Sum_probs=208.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|+..+.||+|+||.||+|+.+ +|+.||||++..... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999875 799999999976422 223456788999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||++||+|.+++.. .+...+++..++.++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+++..
T Consensus 263 mEy~~gg~L~~~l~~---~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 263 LTLMNGGDLKFHIYH---MGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp ECCCCSCBHHHHHHS---SSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999998854 223458999999999999999999997 89999999999999999999999999999876
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ...+......+
T Consensus 337 ~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i--~~~i~~~~~~~---- 408 (576)
T 2acx_A 337 PEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV--ERLVKEVPEEY---- 408 (576)
T ss_dssp CTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH--HHHHHHCCCCC----
T ss_pred ccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH--HHHhhcccccC----
Confidence 5433 234457999999999999999999999999999999999999999875432211111 11111111111
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRP-----DMGHAVNV 870 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RP-----t~~ev~~~ 870 (948)
.. ....++.+++.+|++.||.+|| +++||+++
T Consensus 409 p~---------~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 409 SE---------RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CT---------TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred Cc---------cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 11 1224588999999999999999 67887753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=353.77 Aligned_cols=265 Identities=25% Similarity=0.411 Sum_probs=213.2
Q ss_pred hcCCcccceecccCceEEEEEEEcC-C-----cEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCC
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHD-G-----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~-g-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 664 (948)
.++|+..+.||+|+||.||+|.... + ..||||++.... .....+.+.+|+++++++ +||||+++++++.+++
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 5789999999999999999998642 2 479999987642 344567899999999999 8999999999999999
Q ss_pred ceEEEEEecCCCChhHHHHhhhhc---------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEE---------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 735 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~ 735 (948)
..++||||+++|+|.+++...... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCC
Confidence 999999999999999998653211 12468999999999999999999997 799999999999999999
Q ss_pred CCeEEeecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHH
Q 002238 736 MRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVT 813 (948)
Q Consensus 736 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~ 813 (948)
+.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |..||.......... .
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~--~ 278 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY--K 278 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH--H
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH--H
Confidence 9999999999985543322 22334567889999999999999999999999999999999 999998755432211 1
Q ss_pred HHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 814 WFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
..... .... .+ ...+..+.+++.+|++.||.+||++.++++.|+++...
T Consensus 279 ~~~~~------~~~~-~~--------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 279 LVKDG------YQMA-QP--------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHT------CCCC-CC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhcC------CCCC-CC--------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 11110 0000 00 11134588999999999999999999999999988654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=362.67 Aligned_cols=277 Identities=19% Similarity=0.247 Sum_probs=212.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC--ceEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN--EKLL 668 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~l 668 (948)
.++|++.+.||+|+||.||+|... +|+.||||++.... .....+.+.+|++++++++||||+++++++.+.. ..++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 467999999999999999999876 58999999997542 2334577889999999999999999999998765 6799
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE----cCCCCeEEeecC
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFG 744 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill----~~~~~~kl~DfG 744 (948)
||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||
T Consensus 87 v~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp EECCCTTEEHHHHTTSGG--GTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred EEecCCCCCHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 999999999999985422 22348999999999999999999997 899999999999999 777789999999
Q ss_pred CceecCCCCCceeeeecccccccCceeccc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh-hhHHHHH
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVT--------GRVTTKVDVFSFGVILMELITGRKALDESQPEES-MHLVTWF 815 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~-~~~~~~~ 815 (948)
+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ......+
T Consensus 162 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 162 AARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp GCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred CceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 998765432 2334569999999999865 5678899999999999999999999975432211 1111111
Q ss_pred HHhhcCcccc---ccccC------cccC-CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 816 RRIHLSKDSF---HKAID------PTID-LNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 816 ~~~~~~~~~~---~~~~~------~~~~-~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
... ...... ..... ..++ ...........+.+++.+|++.||++||++.++++.++++...
T Consensus 240 ~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 240 ITG-KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHS-CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred hcC-CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 110 000000 00000 0011 0112245566788999999999999999999999999998753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=353.97 Aligned_cols=258 Identities=27% Similarity=0.427 Sum_probs=202.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcE----EEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCce
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 666 (948)
.++|++.+.||+|+||.||+|.+. +++. ||+|.+... ......+.+.+|+.++++++||||+++++++.++. .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 467999999999999999999864 4554 577766543 23445688999999999999999999999998754 7
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCc
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla 746 (948)
++||||+.+|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 92 ~~v~~~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEEECCCSSCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred eEEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 899999999999998854 23568999999999999999999997 89999999999999999999999999999
Q ss_pred eecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 747 RLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 747 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
+....... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+. . ...
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~---~----~~~ 237 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---K----GER 237 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---T----TCC
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH---c----CCC
Confidence 86543322 22233457889999999999999999999999999999999 999998766544322111 1 000
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
. .. .......+.+++.+|++.||.+||++.|+++.|+.+..
T Consensus 238 ~--~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 238 L--PQ---------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp C--CC---------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred C--CC---------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 0 00 11123458899999999999999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=367.31 Aligned_cols=250 Identities=28% Similarity=0.418 Sum_probs=206.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|.+.+.||+|+||.||+|+.. +|+.||||++...... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367999999999999999999875 7999999999754221 23356789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 95 ~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 95 MEYVSGGELFDYICK-----NGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EECCSSEEHHHHTTS-----SSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 999999999998832 3578999999999999999999997 89999999999999999999999999999976
Q ss_pred CCCCCceeeeecccccccCceecccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
.... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+........ .+.......
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~------~i~~~~~~~--- 235 (476)
T 2y94_A 167 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK------KICDGIFYT--- 235 (476)
T ss_dssp CTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH------HHHTTCCCC---
T ss_pred cccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH------HHhcCCcCC---
Confidence 5432 2344579999999999988765 789999999999999999999998765433211 111111000
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+ ......+.+++.+|++.||.+|||+.+++++
T Consensus 236 --p--------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 236 --P--------QYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp --C--------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred --C--------ccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 0 0112358899999999999999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=354.52 Aligned_cols=246 Identities=25% Similarity=0.344 Sum_probs=203.9
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCCh------hhHHHHHHHHHHHHhcCCCceeeEEeEEEe
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG------KGLTEFKSEIAVLTKVRHRHLVALLGHCLD 662 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 662 (948)
...++|++.+.||+|+||.||+|... +++.||||++....... .....+.+|++++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 34678999999999999999999864 78999999998653221 134467889999999999999999999999
Q ss_pred CCceEEEEEecCCC-ChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEe
Q 002238 663 GNEKLLVFEYMPQG-TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 741 (948)
Q Consensus 663 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~ 741 (948)
.+..++||||+.+| +|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR-----HPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT-----CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEe
Confidence 99999999999777 99888843 3569999999999999999999997 899999999999999999999999
Q ss_pred ecCCceecCCCCCceeeeecccccccCceecccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc
Q 002238 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL 820 (948)
Q Consensus 742 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 820 (948)
|||+++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......
T Consensus 173 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------- 237 (335)
T 3dls_A 173 DFGSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------------- 237 (335)
T ss_dssp CCTTCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-------------
T ss_pred ecccceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-------------
Confidence 999998765543 2344679999999999988876 889999999999999999999997532110
Q ss_pred CccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 821 SKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.....+.. ....++.+++.+|++.||++||++.++++.
T Consensus 238 -----~~~~~~~~-------~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 -----EAAIHPPY-------LVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----TTCCCCSS-------CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----hhccCCCc-------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011000 122458899999999999999999999873
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=355.55 Aligned_cols=262 Identities=25% Similarity=0.339 Sum_probs=209.1
Q ss_pred HHHHHHhhcCCccc-ceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEE
Q 002238 585 IQVLRNVTNNFSEE-NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCL 661 (948)
Q Consensus 585 ~~~l~~~~~~~~~~-~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~ 661 (948)
++..+...++|.+. +.||+|+||.||+|... +|+.||||++............+.+|+.+++.+ .||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33445667788887 89999999999999875 689999999987654555578899999999999 5699999999999
Q ss_pred eCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC---CCCe
Q 002238 662 DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRA 738 (948)
Q Consensus 662 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~---~~~~ 738 (948)
+.+..++||||+++|+|.+++.. .....+++.+++.++.|++.||+|||+ .+|+||||||+||+++. ++.+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSS---CC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCE
T ss_pred eCCeEEEEEEecCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcE
Confidence 99999999999999999988743 233678999999999999999999997 89999999999999997 7899
Q ss_pred EEeecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh
Q 002238 739 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI 818 (948)
Q Consensus 739 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 818 (948)
||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+ ...
T Consensus 174 kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~~ 248 (327)
T 3lm5_A 174 KIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI---SQV 248 (327)
T ss_dssp EECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHT
T ss_pred EEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH---Hhc
Confidence 999999998764432 233457999999999999999999999999999999999999999876543322111 111
Q ss_pred hcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 819 HLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
...... .........+.+++.+|++.||++||+++++++
T Consensus 249 ---~~~~~~---------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 249 ---NVDYSE---------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp ---CCCCCT---------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---ccccCc---------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 111100 011122345889999999999999999999876
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=352.88 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=180.4
Q ss_pred cceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCceEEEEEecCC
Q 002238 598 ENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFEYMPQ 675 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~ 675 (948)
.+.||+|+||.||+|..+ +++.||||++... ....+.+|+.+++.+. ||||+++++++.++...++||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 478999999999999875 6899999998643 3467889999999997 99999999999999999999999999
Q ss_pred CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC---CeEEeecCCceecCCC
Q 002238 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKVADFGLVRLAPEG 752 (948)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~---~~kl~DfGla~~~~~~ 752 (948)
|+|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+++.....
T Consensus 91 ~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 91 GELFERIKK-----KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp CBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 999999853 2578999999999999999999997 8999999999999998765 7999999999866543
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh-hhHHHHHHHhhcCccccccccCc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEES-MHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .........+......
T Consensus 163 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------- 234 (325)
T 3kn6_A 163 NQ-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------- 234 (325)
T ss_dssp ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC-------
T ss_pred CC-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC-------
Confidence 32 23445689999999999999999999999999999999999999986543211 1111112222111110
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.. .........++.+++.+|++.||.+||+++++++
T Consensus 235 -~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 235 -FE-GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp -CC-SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred -CC-cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 00 1111223456889999999999999999999865
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=346.63 Aligned_cols=261 Identities=29% Similarity=0.443 Sum_probs=205.9
Q ss_pred cCCcccceecccCceEEEEEEEcC----CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe-CCceE
Q 002238 593 NNFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-GNEKL 667 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~ 667 (948)
.+|+..+.||+|+||.||+|.+.+ ...||||.+... ......+.+.+|+.++++++||||+++++++.+ ++..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 468889999999999999998642 235899988753 244556789999999999999999999998754 55789
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp EEEECCTTCBHHHHHHC----TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred EEEeCCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccc
Confidence 99999999999999843 33568999999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCC---ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCcc
Q 002238 748 LAPEGKG---SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKD 823 (948)
Q Consensus 748 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 823 (948)
....... .......||+.|+|||.+.+..++.++||||||+++|||++ |.+||......+..... ....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~------~~~~- 249 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL------LQGR- 249 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH------HTTC-
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH------hcCC-
Confidence 6543321 12334567889999999999999999999999999999999 56666654433321111 1000
Q ss_pred ccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhC
Q 002238 824 SFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWK 879 (948)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~ 879 (948)
....+ ...+..+.+++.+|++.+|++||++.++++.|+++...+.
T Consensus 250 ---~~~~~--------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 250 ---RLLQP--------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp ---CCCCC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred ---CCCCC--------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 00001 1122458899999999999999999999999999987543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=356.53 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=202.1
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 668 (948)
..++|++.+.||+|+||.||+|..+ +|+.||||++..... ...+|++++.++ +||||+++++++.+++..++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 4678999999999999999999875 689999999976421 245788888888 79999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC----CCeEEeecC
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD----MRAKVADFG 744 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~----~~~kl~DfG 744 (948)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||+.++ +.+||+|||
T Consensus 94 v~E~~~gg~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 94 VTELMKGGELLDKILR-----QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EECCCCSCBHHHHHHT-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 9999999999998843 2568999999999999999999997 899999999999998543 359999999
Q ss_pred CceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+. .....
T Consensus 166 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~---~~~~~ 241 (342)
T 2qr7_A 166 FAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG---SGKFS 241 (342)
T ss_dssp TCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH---HCCCC
T ss_pred CcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc---cCCcc
Confidence 9987654332 2344578999999999988889999999999999999999999998643322222222111 11111
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+.. ..+.....++.+++.+|++.||++||++.+++++
T Consensus 242 ~~~---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 LSG---------GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp CCS---------TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cCc---------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 110 0111223468899999999999999999998875
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=353.64 Aligned_cols=270 Identities=23% Similarity=0.354 Sum_probs=205.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|++.+.||+|+||.||+|+.. +|+.||||++..........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 467999999999999999999875 5899999999776545555677889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 104 e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 104 EFVDHTILDDLELF-----PNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp ECCSEEHHHHHHHS-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecCCcchHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 99999988877532 2568999999999999999999997 899999999999999999999999999998654
Q ss_pred CCCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH--------hhcC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRR--------IHLS 821 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~ 821 (948)
.... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+....+..... ....
T Consensus 176 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 176 APGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred CCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 3322 23345689999999999875 789999999999999999999999987665433222111000 0000
Q ss_pred ccccccccCcccCC----ccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 822 KDSFHKAIDPTIDL----NEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 822 ~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
...+.....+.+.. ..........+.+++.+|++.||++||+++|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00011111111110 11111234568999999999999999999998873
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=356.95 Aligned_cols=267 Identities=16% Similarity=0.167 Sum_probs=199.7
Q ss_pred hcCCcccceecccCceEEEEEEEc----CCcEEEEEEeecCcCCh---------hhHHHHHHHHHHHHhcCCCceeeEEe
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISG---------KGLTEFKSEIAVLTKVRHRHLVALLG 658 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~---------~~~~~~~~E~~~l~~l~H~niv~l~~ 658 (948)
.++|++.+.||+|+||.||+|... ++..||||++....... .....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999875 57899999987642111 01234678889999999999999999
Q ss_pred EEEe----CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC
Q 002238 659 HCLD----GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 734 (948)
Q Consensus 659 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~ 734 (948)
++.+ ....++||||+ +++|.+++.. ...+++.+++.++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ-----NGTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG-----GGBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEES
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEcc
Confidence 9987 67789999999 9999998843 1378999999999999999999997 79999999999999998
Q ss_pred CC--CeEEeecCCceecCCCCC------ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Q 002238 735 DM--RAKVADFGLVRLAPEGKG------SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPE 806 (948)
Q Consensus 735 ~~--~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~ 806 (948)
++ .+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 87 999999999986543211 1123457999999999999999999999999999999999999999653222
Q ss_pred hhhhHHHHHHHhhc-CccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 807 ESMHLVTWFRRIHL-SKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 807 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
.... ......... .......... ....+.++.+++.+|++.||++||++.+|++.|+.+..
T Consensus 267 ~~~~-~~~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 267 PVAV-QTAKTNLLDELPQSVLKWAP--------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHH-HHHHHHHHHTTTHHHHHHSC--------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cHHH-HHHHHhhcccccHHHHhhcc--------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1111 111111100 0000000000 00223468999999999999999999999999988643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=354.97 Aligned_cols=266 Identities=27% Similarity=0.377 Sum_probs=209.3
Q ss_pred hcCCcccceecccCceEEEEEEE-----cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEE--eCC
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCL--DGN 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~ 664 (948)
.++|++.+.||+|+||.||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++. +..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 36789999999999999999984 36889999998764 4555678999999999999999999999987 445
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
..++||||+++++|.+++... ...+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGG
T ss_pred eEEEEEeecCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccc
Confidence 688999999999999998542 1358999999999999999999997 899999999999999999999999999
Q ss_pred CceecCCCCCc--eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhh---------hHHH
Q 002238 745 LVRLAPEGKGS--IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESM---------HLVT 813 (948)
Q Consensus 745 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~---------~~~~ 813 (948)
+++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred cceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence 99976544322 123345888999999999999999999999999999999999998653321100 0000
Q ss_pred HHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhh
Q 002238 814 WFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELW 878 (948)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 878 (948)
....... . .. ..........+.+++.+|++.||.+||++.++++.|+.+....
T Consensus 253 ~~~~~~~-~------~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 253 LLELLEE-G------QR-----LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHHT-T------CC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHHhhc-c------cC-----CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 0000000 0 00 0011223356889999999999999999999999999986544
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=346.09 Aligned_cols=257 Identities=23% Similarity=0.366 Sum_probs=207.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCceEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNEKLL 668 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~l 668 (948)
.++|++.+.||+|+||.||+|... +|+.||+|++..........+.+.+|++++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467999999999999999999875 78999999998765566667889999999999999999999998854 567899
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCC-----eeecCCCCccEEEcCCCCeEEeec
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS-----FIHRDLKPSNILLGDDMRAKVADF 743 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivHrDik~~Nill~~~~~~kl~Df 743 (948)
||||+++++|.+++..... ....+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++.+||+||
T Consensus 85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 9999999999999865332 33568999999999999999999997 56 999999999999999999999999
Q ss_pred CCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcc
Q 002238 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD 823 (948)
Q Consensus 744 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 823 (948)
|+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.... +.. .
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---i~~-----~ 231 (279)
T 2w5a_A 161 GLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK---IRE-----G 231 (279)
T ss_dssp CHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHH-----T
T ss_pred chheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHH---Hhh-----c
Confidence 99986543321 22345689999999999999999999999999999999999999987654322111 111 1
Q ss_pred ccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHH
Q 002238 824 SFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871 (948)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L 871 (948)
... .+. .....++.+++.+|++.||.+||++.|+++.+
T Consensus 232 ~~~-----~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 232 KFR-----RIP-----YRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp CCC-----CCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred ccc-----cCC-----cccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 110 011 11234688999999999999999999998854
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=359.31 Aligned_cols=254 Identities=22% Similarity=0.302 Sum_probs=193.1
Q ss_pred hcCCccc-ceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHh-cCCCceeeEEeEEEe----CC
Q 002238 592 TNNFSEE-NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK-VRHRHLVALLGHCLD----GN 664 (948)
Q Consensus 592 ~~~~~~~-~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~----~~ 664 (948)
.++|.+. ++||+|+||.||+|..+ +|+.||||++... ..+.+|++++.+ .+||||+++++++.. ..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 3566665 78999999999999875 6899999998642 457788888754 589999999998875 55
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC---CCCeEEe
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVA 741 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~---~~~~kl~ 741 (948)
..++||||+++|+|.+++.. .....+++.++..|+.||+.||+|||+ .+|+||||||+|||++. ++.+||+
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHC---C---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEEEEEeCCCCcHHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEE
Confidence 68999999999999999854 223469999999999999999999997 89999999999999997 7889999
Q ss_pred ecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhh-hHHHHHHHhhc
Q 002238 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESM-HLVTWFRRIHL 820 (948)
Q Consensus 742 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~ 820 (948)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+. .
T Consensus 207 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---~ 281 (400)
T 1nxk_A 207 DFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---M 281 (400)
T ss_dssp CCTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---H
T ss_pred ecccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---c
Confidence 999998654332 234567899999999999999999999999999999999999999875432211 0111111 1
Q ss_pred CccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 821 SKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
....+. .+ .......++.+++.+|++.||++||++.++++.-.
T Consensus 282 ~~~~~~---~~------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 282 GQYEFP---NP------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp TCCCCC---TT------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred CcccCC---Cc------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 111110 00 01122346889999999999999999999998643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=344.02 Aligned_cols=249 Identities=25% Similarity=0.391 Sum_probs=201.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe----CCceE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD----GNEKL 667 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~ 667 (948)
+.|++.+.||+|+||.||+|... ++..||+|++..........+.+.+|+.++++++||||+++++++.. +...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34778889999999999999874 68899999998766666777889999999999999999999999875 34579
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCC--eeecCCCCccEEEc-CCCCeEEeecC
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLG-DDMRAKVADFG 744 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrDik~~Nill~-~~~~~kl~DfG 744 (948)
+||||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+ |+||||||+||+++ .++.+||+|||
T Consensus 106 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EEEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 999999999999998542 468999999999999999999997 66 99999999999997 78899999999
Q ss_pred CceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
++...... ......||+.|+|||++. +.++.++||||||+++|||++|+.||......... . ..... ..
T Consensus 178 ~~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~---~~~~~--~~ 246 (290)
T 1t4h_A 178 LATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--Y---RRVTS--GV 246 (290)
T ss_dssp GGGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--H---HHHTT--TC
T ss_pred Cccccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--H---HHHhc--cC
Confidence 99754432 234457999999999876 46999999999999999999999999875433221 1 11111 00
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
....+ ......++.+++.+|++.||.+||++.++++
T Consensus 247 ~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 247 KPASF---------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCGGG---------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Ccccc---------CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 00001 1112245889999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=345.37 Aligned_cols=249 Identities=27% Similarity=0.478 Sum_probs=202.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|++.+.||+|+||.||+|... +++.||||++...... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 568999999999999999999875 5789999998654222 22356789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++...
T Consensus 88 ~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999988542 468999999999999999999997 89999999999999999999999999998654
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+. .. ...+
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~---~~~~---- 226 (279)
T 3fdn_A 160 PSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS---RV---EFTF---- 226 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---HT---CCCC----
T ss_pred Ccc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH---hC---CCCC----
Confidence 332 2334578999999999999999999999999999999999999998765433222111 10 1001
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.. .....+.+++.+|++.||.+||++.|+++.
T Consensus 227 ~~---------~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 227 PD---------FVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CT---------TSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CC---------cCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01 122358899999999999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=344.41 Aligned_cols=261 Identities=27% Similarity=0.387 Sum_probs=206.5
Q ss_pred CCcccceecccCceEEEEEEEc-CC---cEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCce-EE
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK-LL 668 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-~l 668 (948)
.|...++||+|+||.||+|.+. ++ ..||+|++... ......+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 4566789999999999999863 23 37999998753 2445567899999999999999999999999876665 99
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||||+.+|+|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 101 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp EECCCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred EEecccCCCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 9999999999998843 34678999999999999999999997 7999999999999999999999999999985
Q ss_pred cCCCC---CceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCchhhhhHHHHHHHhhcCccc
Q 002238 749 APEGK---GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKA-LDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 749 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
..... ........+|+.|+|||.+.+..++.++||||||+++|||++|..| |......+.. ....... .
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~---~~~~~~~----~ 246 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT---HFLAQGR----R 246 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHH---HHHHTTC----C
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHH---HHhhcCC----C
Confidence 43321 1122345688999999999999999999999999999999995555 4444333221 1111100 0
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCC
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKP 880 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~ 880 (948)
... .......+.+++.+|++.+|.+||++.++++.|+++......
T Consensus 247 ------~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 247 ------LPQ-----PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp ------CCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred ------CCC-----CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 000 011224588999999999999999999999999999876543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=341.11 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=205.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCCh----hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCce
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG----KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 666 (948)
.++|++.+.||+|+||.||+|... +|+.||||+++...... ...+.+.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 457999999999999999999876 68999999997653322 2367899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC----CeEEee
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVAD 742 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~----~~kl~D 742 (948)
++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++ .+||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE-----KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEeecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEe
Confidence 999999999999999853 2468999999999999999999997 8999999999999998877 899999
Q ss_pred cCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc
Q 002238 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK 822 (948)
Q Consensus 743 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 822 (948)
||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.... .....
T Consensus 156 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~~~ 227 (283)
T 3bhy_A 156 FGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTN------ISAVN 227 (283)
T ss_dssp CTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHTTC
T ss_pred cccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHH------hHhcc
Confidence 99998664432 23345699999999999999999999999999999999999999987654332111 11111
Q ss_pred cccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 823 DSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.... ..........+.+++.+|++.||++||++.++++.
T Consensus 228 ~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 228 YDFD---------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp CCCC---------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred cCCc---------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 1000 01111223468899999999999999999999983
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=358.74 Aligned_cols=250 Identities=26% Similarity=0.343 Sum_probs=195.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHH-HHhcCCCceeeEEeEEEeCCceEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAV-LTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
.++|++.+.||+|+||.||+|+.+ +++.||||++.+.... ......+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467999999999999999999876 6889999999875432 3334567777776 577899999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 117 v~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 9999999999998854 1468899999999999999999997 8999999999999999999999999999985
Q ss_pred cCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +......
T Consensus 189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~------i~~~~~~---- 257 (373)
T 2r5t_A 189 NIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN------ILNKPLQ---- 257 (373)
T ss_dssp GBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHH------HHHSCCC----
T ss_pred cccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH------HHhcccC----
Confidence 43322 234456799999999999999999999999999999999999999987654332211 1111111
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+.+. ....+.+++.+|++.||.+||++.+.++
T Consensus 258 ~~~~---------~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 258 LKPN---------ITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp CCSS---------SCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred CCCC---------CCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 1111 1235889999999999999999864433
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=380.45 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=203.3
Q ss_pred ceecccCceEEEEEEEc---CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCC
Q 002238 599 NILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 675 (948)
+.||+|+||.||+|.+. +++.||||+++.........+++.+|++++++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 57999999999999653 4678999999876545556788999999999999999999999986 4568999999999
Q ss_pred CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCC-
Q 002238 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG- 754 (948)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~- 754 (948)
|+|.+++.. ...+++.+++.++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+++.......
T Consensus 454 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 454 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 999999843 2568999999999999999999997 8999999999999999999999999999986654332
Q ss_pred -ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcc
Q 002238 755 -SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832 (948)
Q Consensus 755 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (948)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+. . .. ...
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~---~-----~~-----~~~ 592 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---K-----GE-----RMG 592 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---T-----TC-----CCC
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---c-----CC-----CCC
Confidence 12233457889999999999999999999999999999998 999998876544322211 1 00 000
Q ss_pred cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 833 IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 833 ~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
. ....+.++.+++.+||+.||++||++++|++.|+++...
T Consensus 593 ~-----p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 593 C-----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp C-----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred C-----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0 112235688999999999999999999999999988653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=353.22 Aligned_cols=264 Identities=25% Similarity=0.377 Sum_probs=200.8
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-----
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----- 664 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 664 (948)
+.++|+..+.||+|+||.||+|... +|+.||||++..........+.+.+|+++++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3578999999999999999999874 7999999999765445555678999999999999999999999997653
Q ss_pred -ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeec
Q 002238 665 -EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (948)
Q Consensus 665 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~Df 743 (948)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Df 172 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDF 172 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEee
Confidence 459999999 8899988843 468999999999999999999997 89999999999999999999999999
Q ss_pred CCceecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc
Q 002238 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK 822 (948)
Q Consensus 744 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 822 (948)
|+++..... .+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+....+. .......
T Consensus 173 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~--~~~g~~~ 246 (367)
T 1cm8_A 173 GLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM--KVTGTPP 246 (367)
T ss_dssp TTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HHHCCCC
T ss_pred ecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HhcCCCC
Confidence 999875432 334578999999999887 679999999999999999999999998766443322211 1000000
Q ss_pred ccccc------------ccC--cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 823 DSFHK------------AID--PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 823 ~~~~~------------~~~--~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
..+.. .+. +..............+.+++.+|++.||++|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00000 000 0000011111234568899999999999999999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=342.51 Aligned_cols=251 Identities=25% Similarity=0.458 Sum_probs=184.3
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|++.+.||+|+||.||+|+. .+|+.||||++...... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999987 47899999998754221 22347789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++++|.+++.. ....+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN----RVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EECCTTEEHHHHHHT----CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 999999999998843 33578999999999999999999997 89999999999999999999999999999866
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ... .
T Consensus 163 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~----------~ 225 (278)
T 3cok_A 163 KMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------NKV----------V 225 (278)
T ss_dssp C-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------C----------C
T ss_pred cCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH------HHH----------h
Confidence 43322 223456899999999999989999999999999999999999999865432211 000 0
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
....... .....++.+++.+|++.||++||+++++++
T Consensus 226 ~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 226 LADYEMP---SFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SSCCCCC---TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccCCc---cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0001101 112345889999999999999999999876
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=354.54 Aligned_cols=260 Identities=26% Similarity=0.393 Sum_probs=209.3
Q ss_pred HHHHHHhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC--h----hhHHHHHHHHHHHHhc-CCCceeeE
Q 002238 585 IQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS--G----KGLTEFKSEIAVLTKV-RHRHLVAL 656 (948)
Q Consensus 585 ~~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~----~~~~~~~~E~~~l~~l-~H~niv~l 656 (948)
........++|++.+.||+|+||.||+|.++ +|+.||||++...... . ...+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 4455666788999999999999999999985 7999999998764321 1 1245688999999999 89999999
Q ss_pred EeEEEeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC
Q 002238 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 736 (948)
Q Consensus 657 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~ 736 (948)
++++......++||||+++++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~ 237 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTE-----KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNM 237 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCC
Confidence 9999999999999999999999998853 1468999999999999999999997 7999999999999999999
Q ss_pred CeEEeecCCceecCCCCCceeeeecccccccCceeccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhh
Q 002238 737 RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT------GRVTTKVDVFSFGVILMELITGRKALDESQPEESMH 810 (948)
Q Consensus 737 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~ 810 (948)
.++|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 238 ~ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 315 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR 315 (365)
T ss_dssp CEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CEEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 99999999998765432 2344679999999999863 358899999999999999999999998755432211
Q ss_pred HHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 811 LVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.+ .. ...... ..........+.+++.+|++.||++||++.++++
T Consensus 316 ~i---~~---~~~~~~---------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 316 MI---ME---GQYQFS---------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HH---HH---TCCCCC---------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HH---Hh---CCCCCC---------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 11 010000 0001122345889999999999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=349.37 Aligned_cols=263 Identities=31% Similarity=0.482 Sum_probs=207.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEE--EEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKI--AVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~v--avK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 667 (948)
.++|++.+.||+|+||.||+|+.. ++..+ |||++... ......+.+.+|+++++++ +||||+++++++.+.+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 367899999999999999999865 56644 99988753 2344556799999999999 9999999999999999999
Q ss_pred EEEEecCCCChhHHHHhhh-----------hcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC
Q 002238 668 LVFEYMPQGTLSRHIFNWA-----------EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 736 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~ 736 (948)
+||||+++|+|.+++.... ......+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCC
Confidence 9999999999999986421 0123578999999999999999999997 8999999999999999999
Q ss_pred CeEEeecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHH
Q 002238 737 RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWF 815 (948)
Q Consensus 737 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 815 (948)
.+||+|||+++...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+...
T Consensus 180 ~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~----- 252 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----- 252 (327)
T ss_dssp CEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-----
T ss_pred eEEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH-----
Confidence 99999999987432211 1233457889999999999899999999999999999998 999998765433211
Q ss_pred HHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhh
Q 002238 816 RRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELW 878 (948)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 878 (948)
.... . ..... .......+.+++.+|++.+|.+||++.++++.|+.+....
T Consensus 253 -~~~~--~-----~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 253 -KLPQ--G-----YRLEK-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp -HGGG--T-----CCCCC-----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred -Hhhc--C-----CCCCC-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111 0 00000 1122346889999999999999999999999999987654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=353.84 Aligned_cols=268 Identities=21% Similarity=0.293 Sum_probs=196.0
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEE
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
...++|++.+.||+|+||.||+|... +++.||||++............+.+|++++++++||||+++++++.+++..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34578999999999999999999864 78999999997654444445678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEc-----CCCCeEEeec
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-----DDMRAKVADF 743 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~-----~~~~~kl~Df 743 (948)
||||++ |+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+||
T Consensus 111 v~e~~~-~~L~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDK-----NPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEECCS-EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEecCC-CCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 999997 599888843 2468999999999999999999997 8999999999999994 4455999999
Q ss_pred CCceecCCCCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc
Q 002238 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK 822 (948)
Q Consensus 744 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 822 (948)
|+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+ ........
T Consensus 182 g~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~~~~ 258 (329)
T 3gbz_A 182 GLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI--FEVLGLPD 258 (329)
T ss_dssp THHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHHHCCCC
T ss_pred CCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHH--HHHhCCCc
Confidence 99986543322 23445689999999999875 4899999999999999999999999876554332221 11111111
Q ss_pred cc-ccc------ccC--cccCCc----cchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 823 DS-FHK------AID--PTIDLN----EGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 823 ~~-~~~------~~~--~~~~~~----~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.. +.. ... +..... ........++.+++.+|++.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 000 000 000000 000112356889999999999999999999976
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=341.41 Aligned_cols=253 Identities=29% Similarity=0.459 Sum_probs=201.0
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-CceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-NEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lv~ 670 (948)
.++|++.+.||+|+||.||+|+.+ |+.||||+++.. ...+.+.+|++++++++||||+++++++.+. +..++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 467899999999999999999876 899999998753 2457799999999999999999999997654 4789999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||+++...
T Consensus 95 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCCTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ecCCCCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 9999999999986422 1347899999999999999999997 899999999999999999999999999988544
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
.. .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+.... .. .. .
T Consensus 169 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~------~~--~~-~---- 231 (278)
T 1byg_A 169 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR------VE--KG-Y---- 231 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH------HT--TT-C----
T ss_pred cc----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------Hh--cC-C----
Confidence 32 123357899999999999999999999999999999998 9999987654332111 11 00 0
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
.... ....+..+.+++.+|++.||++||++.++++.|+.+...
T Consensus 232 ~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 232 KMDA-----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCC-----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 0011 112234688999999999999999999999999998654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=370.24 Aligned_cols=251 Identities=26% Similarity=0.376 Sum_probs=196.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|++.+.||+|+||.||+|... +|+.||||++..... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999865 789999999976422 334456788999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999988843 1468999999999999999999995 278999999999999999999999999999854
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ......+.
T Consensus 300 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~~~~~~~p--- 369 (446)
T 4ejn_A 300 IKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LMEEIRFP--- 369 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCCCCC---
T ss_pred cCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH------HhCCCCCC---
Confidence 3322 2234567999999999999999999999999999999999999999876543322211 11111111
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRP-----DMGHAVN 869 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RP-----t~~ev~~ 869 (948)
. ....++.+++.+|++.||.+|| +++|+++
T Consensus 370 -~---------~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 370 -R---------TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -T---------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -c---------cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1 1224588999999999999999 9988876
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=365.54 Aligned_cols=270 Identities=23% Similarity=0.315 Sum_probs=189.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----Cc
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-----NE 665 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 665 (948)
.++|++.+.||+|+||.||+|..+ +|+.||||++..........+.+.+|+++++.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999865 789999999976554556678899999999999999999999998543 56
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGl 745 (948)
.|+||||+ +|+|.+++.. ...+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT-----PVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecc-ccchhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeeccccc
Confidence 89999998 5789888732 3579999999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCC--------------------------ceeeeecccccccCceec-ccCCCCchhhHHHHHHHHHHHHh---
Q 002238 746 VRLAPEGKG--------------------------SIETRIAGTFGYLAPEYA-VTGRVTTKVDVFSFGVILMELIT--- 795 (948)
Q Consensus 746 a~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~Gv~l~ellt--- 795 (948)
++....... ...+..+||+.|+|||++ ....++.++|||||||++|||++
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 986542211 123446789999999986 45679999999999999999999
Q ss_pred --------CCCCCCCCCchh-----------------hhhHHHHHHHhhc-Cccc------------cccccC--cccCC
Q 002238 796 --------GRKALDESQPEE-----------------SMHLVTWFRRIHL-SKDS------------FHKAID--PTIDL 835 (948)
Q Consensus 796 --------g~~p~~~~~~~~-----------------~~~~~~~~~~~~~-~~~~------------~~~~~~--~~~~~ 835 (948)
|+++|.+..... .......+..... .... +...+. .....
T Consensus 283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (458)
T 3rp9_A 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL 362 (458)
T ss_dssp TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence 666665432100 0000010100000 0000 000000 00011
Q ss_pred ccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 836 NEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 836 ~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.........++.+|+.+|++.||++|||++|++++
T Consensus 363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11112224568899999999999999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=346.30 Aligned_cols=259 Identities=24% Similarity=0.331 Sum_probs=197.7
Q ss_pred hcCCccc-ceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEE
Q 002238 592 TNNFSEE-NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 592 ~~~~~~~-~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 668 (948)
.++|++. +.||+|+||.||+|... +++.||||++... .....+.+.+|++++.++ +||||+++++++.+++..++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC--SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 4578774 78999999999999864 7899999999764 334467899999999985 79999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCC---eEEeecCC
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AKVADFGL 745 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~---~kl~DfGl 745 (948)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||+
T Consensus 89 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred EEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 99999999999998541 468999999999999999999997 79999999999999998776 99999999
Q ss_pred ceecCCCCC------ceeeeecccccccCceeccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhh----
Q 002238 746 VRLAPEGKG------SIETRIAGTFGYLAPEYAVT-----GRVTTKVDVFSFGVILMELITGRKALDESQPEESMH---- 810 (948)
Q Consensus 746 a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~---- 810 (948)
++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 240 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence 875432211 11223569999999999875 568899999999999999999999998754322000
Q ss_pred -----HHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 811 -----LVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 811 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.......+......+ + .........++.+++.+|++.||++||++.|+++
T Consensus 241 ~~~~~~~~~~~~i~~~~~~~--------~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 241 ACPACQNMLFESIQEGKYEF--------P-DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CCHHHHHHHHHHHHHCCCCC--------C-HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cchhHHHHHHHHHhccCccc--------C-chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000111111101000 0 0001122346889999999999999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=370.74 Aligned_cols=254 Identities=26% Similarity=0.350 Sum_probs=206.6
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
..++|++.+.||+|+||.||+|..+ +++.||||++............+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4568999999999999999999875 789999999976543444567899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEc---CCCCeEEeecCCc
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKVADFGLV 746 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~---~~~~~kl~DfGla 746 (948)
|||+++|+|.+.+... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++ .++.+||+|||++
T Consensus 100 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999888541 468999999999999999999997 8999999999999995 4567999999999
Q ss_pred eecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 747 RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
+...... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||.+....+....+ ......+.
T Consensus 172 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i------~~~~~~~~ 242 (486)
T 3mwu_A 172 TCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV------ETGKYAFD 242 (486)
T ss_dssp TTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHTCCCSC
T ss_pred eECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCCCCC
Confidence 8654432 2344579999999999875 5999999999999999999999999876544322211 11111000
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
...+......+.+++.+|++.||.+|||+.++++.
T Consensus 243 ---------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 ---------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ---------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ---------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01112233568899999999999999999999885
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=348.94 Aligned_cols=267 Identities=24% Similarity=0.423 Sum_probs=209.8
Q ss_pred hcCCcccceecccCceEEEEEEE-----cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC--
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-- 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-- 664 (948)
.++|++.+.||+|+||.||+|++ .+|+.||||++... .....+.+.+|++++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 45788999999999999999984 36899999998764 4455678999999999999999999999987654
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
..++||||+++++|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHH----STTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred ceEEEEECCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCc
Confidence 67999999999999999854 23568999999999999999999997 899999999999999999999999999
Q ss_pred CceecCCCCCce--eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh---------hhHHH
Q 002238 745 LVRLAPEGKGSI--ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEES---------MHLVT 813 (948)
Q Consensus 745 la~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~---------~~~~~ 813 (948)
+++......... .....+|..|+|||++.+..++.++||||||+++|||++|..|+......-. .....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 998765543321 2234577889999999999999999999999999999999998864211000 00000
Q ss_pred HHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhh
Q 002238 814 WFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELW 878 (948)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 878 (948)
.......... ... .....+.++.+++.+|++.||++||++.++++.|+.+.+..
T Consensus 271 ~~~~~~~~~~--------~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 271 HLIELLKNNG--------RLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHHHTTC--------CCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhhcCC--------CCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 0001000000 000 01123356889999999999999999999999999987653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=370.58 Aligned_cols=254 Identities=26% Similarity=0.356 Sum_probs=202.6
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
+.++|++.+.||+|+||.||+|+.+ +++.||||++............+.+|+.+++.++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3567999999999999999999875 789999999987654455567899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC---CCeEEeecCCc
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAKVADFGLV 746 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~---~~~kl~DfGla 746 (948)
|||+++|+|.+.+... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.. +.+||+|||++
T Consensus 115 ~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999888541 468999999999999999999997 899999999999999764 45999999999
Q ss_pred eecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 747 RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
+...... ......||+.|+|||++. +.++.++||||+||++|||++|+.||......+....+ ......+.
T Consensus 187 ~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i------~~~~~~~~ 257 (494)
T 3lij_A 187 AVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV------EKGKYTFD 257 (494)
T ss_dssp EECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHTCCCCC
T ss_pred eECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCCCCC
Confidence 8765432 234467999999999876 56999999999999999999999999876654332211 11111110
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
...+......+.+++.+|++.+|.+|||+.+++++
T Consensus 258 ---------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 258 ---------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp ---------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 01111223468899999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=351.83 Aligned_cols=269 Identities=22% Similarity=0.330 Sum_probs=204.8
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe--------
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-------- 662 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-------- 662 (948)
.++|++.+.||+|+||.||+|+. .+|+.||||++............+.+|+++++.++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36799999999999999999987 478999999987664444455778899999999999999999999987
Q ss_pred CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEee
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~D 742 (948)
.+..++||||+++ +|.+.+.. ....+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~D 167 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLAD 167 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred CceEEEEEeccCC-CHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEcc
Confidence 3467999999975 77776633 23568999999999999999999997 8999999999999999999999999
Q ss_pred cCCceecCCCCC---ceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh
Q 002238 743 FGLVRLAPEGKG---SIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI 818 (948)
Q Consensus 743 fGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 818 (948)
||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+......
T Consensus 168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 247 (351)
T ss_dssp CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 999986543221 22344578999999999876 45899999999999999999999999887654433332211111
Q ss_pred hcCccccccc--------cCcccCCccchHH------HHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 819 HLSKDSFHKA--------IDPTIDLNEGILA------SISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 819 ~~~~~~~~~~--------~~~~~~~~~~~~~------~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.. ...+... +............ ....+.+++.+|++.||++||+++|+++
T Consensus 248 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 248 IT-PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CC-TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC-hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 00 0000000 0000000000000 1245889999999999999999999987
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=367.02 Aligned_cols=253 Identities=27% Similarity=0.410 Sum_probs=204.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|+..+.||+|+||.||+|+.+ +|+.||||++.+.... ......+.+|++++++++||||+++++++.+.+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999875 6999999999764322 23456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||++||+|.+++.... .....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 264 mE~~~gg~L~~~l~~~~-~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVD-EDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp ECCCTTCBHHHHHHTSS-TTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeccCCCHHHHHHHhh-cccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999999885422 123569999999999999999999997 89999999999999999999999999999876
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......+......+
T Consensus 340 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~~~~~i~~~~~~~---- 412 (543)
T 3c4z_A 340 KAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRVLEQAVTY---- 412 (543)
T ss_dssp CTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HHHHHHHHHCCCCC----
T ss_pred cCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HHHHHHHhhcccCC----
Confidence 54432 233457999999999999999999999999999999999999999875432111 11111111111111
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCCh
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDM 864 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~ 864 (948)
. ......+.+++.+|++.||.+||++
T Consensus 413 p---------~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 413 P---------DKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp C---------TTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred C---------cccCHHHHHHHHHhccCCHhHCCCC
Confidence 1 1123458899999999999999976
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=357.87 Aligned_cols=257 Identities=24% Similarity=0.335 Sum_probs=203.5
Q ss_pred hcCCcccceecccCceEEEEEEE----cCCcEEEEEEeecCcC--ChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCC
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL----HDGTKIAVKRMEAGVI--SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 664 (948)
.++|++.+.||+|+||.||+|+. .+|+.||||+++.... .......+.+|+++++.+ +||||+++++++.+++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999987 3689999999865321 122345678899999999 6999999999999999
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
..++||||+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred eEEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCC
Confidence 999999999999999998541 468999999999999999999997 799999999999999999999999999
Q ss_pred CceecCCCCCceeeeecccccccCceeccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVT--GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK 822 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 822 (948)
+++..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ..........
T Consensus 205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~~~ 282 (355)
T 1vzo_A 205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRILKSE 282 (355)
T ss_dssp EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHHHCC
T ss_pred CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH--HHHHHHhccC
Confidence 998665443333445679999999999986 347899999999999999999999997644322211 1111111111
Q ss_pred cccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHHHH
Q 002238 823 DSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRP-----DMGHAVNVL 871 (948)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RP-----t~~ev~~~L 871 (948)
.. .. ......+.+++.+|++.||.+|| ++.++++..
T Consensus 283 ~~----~~---------~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 PP----YP---------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CC----CC---------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CC----CC---------cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 10 01 11224578999999999999999 888887743
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=339.00 Aligned_cols=249 Identities=23% Similarity=0.333 Sum_probs=202.8
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 668 (948)
..++|++.+.||+|+||.||+|... +++.||||++...........++.+|+..+..+ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4578999999999999999999876 799999999987655556678899999999999 99999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC-------------
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD------------- 735 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~------------- 735 (948)
||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEECCTTCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC---------------
T ss_pred EEEecCCCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 9999999999999865332 22568999999999999999999997 899999999999999844
Q ss_pred ------CCeEEeecCCceecCCCCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 002238 736 ------MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEES 808 (948)
Q Consensus 736 ------~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~ 808 (948)
..+||+|||++....... ...||+.|+|||++.+. .++.++||||||+++|||++|.+++......
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-- 237 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW-- 237 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH--
T ss_pred cccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH--
Confidence 479999999998765432 23589999999999776 5678999999999999999998876543211
Q ss_pred hhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 809 MHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
. ... .... +.++ ......+.+++.+|++.||++||++.++++
T Consensus 238 ----~---~~~--~~~~-----~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 238 ----H---EIR--QGRL-----PRIP-----QVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ----H---HHH--TTCC-----CCCS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----H---HHH--cCCC-----CCCC-----cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 0 010 1111 1111 112245889999999999999999999976
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.67 Aligned_cols=263 Identities=26% Similarity=0.351 Sum_probs=205.2
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe----CCce
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD----GNEK 666 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~ 666 (948)
.++|++.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++++.++||||+++++++.. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 46799999999999999999987 57899999998754 45566789999999999999999999999873 3467
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCc
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla 746 (948)
++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEEEeCCCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 999999999999999865332 34679999999999999999999997 79999999999999999999999999998
Q ss_pred eecCCCCCc--------eeeeecccccccCceecccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHH
Q 002238 747 RLAPEGKGS--------IETRIAGTFGYLAPEYAVTGR---VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWF 815 (948)
Q Consensus 747 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~ 815 (948)
+........ ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||........ ......
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~ 260 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALAV 260 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHHh
Confidence 754321110 012245799999999987654 68999999999999999999999954211110 000000
Q ss_pred HHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 816 RRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
.. .... + ........+.+++.+|++.||.+||++.++++.|+.+..
T Consensus 261 ~~----~~~~--------~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 261 QN----QLSI--------P---QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HC----C--C--------C---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hc----cCCC--------C---ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 00 0000 0 001123468899999999999999999999999998753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=353.43 Aligned_cols=266 Identities=24% Similarity=0.344 Sum_probs=197.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|++.+.||+|+||.||+|+.. +++.||||++.... .......+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc-ccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 57899999999999999999876 78999999986542 11222345679999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|++ |+|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 81 YLD-KDLKQYLDD----CGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp CCS-EEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred ccc-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 997 588888743 23568999999999999999999997 8999999999999999999999999999986543
Q ss_pred CCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+........ ...+.....
T Consensus 153 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~ 230 (324)
T 3mtl_A 153 PTK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT-EETWPGILS 230 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-TTTSTTGGG
T ss_pred Ccc-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC-hHhchhhhc
Confidence 322 2334568999999999876 5689999999999999999999999988765443322211110000 000000000
Q ss_pred ---------cccCC---ccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 831 ---------PTIDL---NEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 831 ---------~~~~~---~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+.... .........++.+++.+|++.||.+|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000 0001122356889999999999999999999987
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=339.48 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=205.7
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
..++|++.+.||+|+||.||+|... +++.||||++.... .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 3467999999999999999999875 78999999987543 234457899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++++|.+++. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++...
T Consensus 84 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 84 LEYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp EECCTTEEGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCcHHHHHh-----hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 99999999998873 23568999999999999999999997 89999999999999999999999999999865
Q ss_pred CCCC-CceeeeecccccccCceecccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 750 PEGK-GSIETRIAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 750 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
.... ........||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ ....+.. ....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~----~~~~--- 227 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE----KKTY--- 227 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHT----TCTT---
T ss_pred CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhh----cccc---
Confidence 4322 122334578999999999987765 7899999999999999999999987553221 1111111 0000
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.. ........+.+++.+|++.||++||++.++++
T Consensus 228 -~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 -LN-------PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -ST-------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -cC-------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00 01122345889999999999999999999876
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.77 Aligned_cols=252 Identities=25% Similarity=0.449 Sum_probs=209.3
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.+.|+..+.||+|+||.||+|... +++.||||++.... .....+.+.+|+.+++.++||||+++++++.++...++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT-CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 467899999999999999999864 68999999997653 2345688999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++++|.+++.. ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++....
T Consensus 100 e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 100 EYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp ECCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred EeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecC
Confidence 99999999998832 468999999999999999999997 899999999999999999999999999998665
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+ .. .. .
T Consensus 171 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~-----~~-----~ 236 (303)
T 3a7i_A 171 DTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI---PK-----NN-----P 236 (303)
T ss_dssp TTBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HH-----SC-----C
T ss_pred cccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh---hc-----CC-----C
Confidence 4322 233457999999999999999999999999999999999999999876543322111 11 00 0
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHH
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~ 872 (948)
+.+. ......+.+++.+|++.+|.+||++.++++...
T Consensus 237 ~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 237 PTLE-----GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp CCCC-----SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred CCCc-----cccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 1111 112245889999999999999999999988644
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=349.01 Aligned_cols=264 Identities=25% Similarity=0.378 Sum_probs=207.7
Q ss_pred hcCCcccceecccCceEEEEEEE------cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 665 (948)
.++|++.+.||+|+||.||+|++ .+++.||||++... .......++.+|+.++++++||||+++++++.+...
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 46899999999999999999984 25778999998643 244556789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC---CCCeEE
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEE--GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKV 740 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~---~~~~kl 740 (948)
.++||||+++|+|.+++...... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999653211 12458999999999999999999997 89999999999999984 446999
Q ss_pred eecCCceecCCCC-CceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHh
Q 002238 741 ADFGLVRLAPEGK-GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRI 818 (948)
Q Consensus 741 ~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 818 (948)
+|||+++...... ........||+.|+|||++.+..++.++||||||+++|||++ |+.||......+.... +..
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~---~~~- 260 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF---VTS- 260 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH---HHT-
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH---Hhc-
Confidence 9999987443222 122234568999999999999999999999999999999998 9999987654332111 111
Q ss_pred hcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 819 HLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
... ... .......+.+++.+|++.||.+||++.++++.|+.+...
T Consensus 261 ---~~~------~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 261 ---GGR------MDP-----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp ---TCC------CCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---CCC------CCC-----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 000 000 011234588999999999999999999999999988653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=340.62 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=208.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467899999999999999999876 588999999876533 344567889999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++++|.+++.. ...+++.+++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 94 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 94 LELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EECCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 999999999988743 1468999999999999999999997 89999999999999999999999999999866
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+... ..........
T Consensus 166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~~~~~~~--- 235 (294)
T 2rku_A 166 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------RIKKNEYSIP--- 235 (294)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHTTCCCCC---
T ss_pred ccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHhhccCCCc---
Confidence 43322 2344579999999999999899999999999999999999999998765433211 1111111110
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
. .....+.+++.+|++.||++||++.++++.
T Consensus 236 -~---------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 236 -K---------HINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -T---------TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -c---------ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1 122358899999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=360.45 Aligned_cols=255 Identities=26% Similarity=0.371 Sum_probs=193.5
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC------hhhHHHHHHHHHHHHhcCCCceeeEEeEEEe
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS------GKGLTEFKSEIAVLTKVRHRHLVALLGHCLD 662 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 662 (948)
...++|.+.+.||+|+||.||+|..+ +++.||||++...... ......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45789999999999999999999875 6899999999764321 112235889999999999999999999975
Q ss_pred CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC---CeE
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAK 739 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~---~~k 739 (948)
.+..++||||+++|+|.+++. ....+++.++..++.|++.||+|||+ .+|+||||||+|||++.++ .+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS-----SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred cCceEEEEEcCCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEE
Confidence 456899999999999988873 23578999999999999999999997 7999999999999997544 599
Q ss_pred EeecCCceecCCCCCceeeeecccccccCceeccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH
Q 002238 740 VADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT---GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFR 816 (948)
Q Consensus 740 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~ 816 (948)
|+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ....+.
T Consensus 283 l~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i~ 358 (419)
T 3i6u_A 283 ITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT 358 (419)
T ss_dssp ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHHH
T ss_pred EeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHHh
Confidence 9999999865432 23345679999999999863 6788999999999999999999999976543221 111111
Q ss_pred HhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 817 RIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
. ....+. ..........+.+++.+|++.||++||+++|+++
T Consensus 359 ~---~~~~~~---------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 359 S---GKYNFI---------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp T---TCCCCC---------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred c---CCCCCC---------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1 000000 0111122356889999999999999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=358.62 Aligned_cols=201 Identities=27% Similarity=0.397 Sum_probs=169.6
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----C
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-----N 664 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~ 664 (948)
+.++|++.+.||+|+||.||+|... +++.||||++..........+.+.+|+++++.++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4578999999999999999999875 688999999986554556678899999999999999999999999766 5
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
..|+||||++ |+|.+++.. ...+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT-----PIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecCC-cCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCC
Confidence 6899999986 699988842 3569999999999999999999998 899999999999999999999999999
Q ss_pred CceecCCCCC---------------------ceeeeecccccccCceec-ccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 002238 745 LVRLAPEGKG---------------------SIETRIAGTFGYLAPEYA-VTGRVTTKVDVFSFGVILMELITGRKAL 800 (948)
Q Consensus 745 la~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~Gv~l~elltg~~p~ 800 (948)
+++....... ...+..+||+.|+|||++ ....++.++||||+||++|||++|..||
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 9996544321 123556799999999986 5567999999999999999999855444
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=364.78 Aligned_cols=246 Identities=15% Similarity=0.158 Sum_probs=192.5
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcC-ChhhHHHHHHHHH---HHHhcCCCceeeEE-------eE
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVI-SGKGLTEFKSEIA---VLTKVRHRHLVALL-------GH 659 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~---~l~~l~H~niv~l~-------~~ 659 (948)
.++|++.+.||+|+||.||+|+. .+|+.||||++..... .....+.+.+|++ ++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788999999999999999986 4799999999975422 3445678999994 55555899999998 66
Q ss_pred EEeCC-----------------ceEEEEEecCCCChhHHHHhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCe
Q 002238 660 CLDGN-----------------EKLLVFEYMPQGTLSRHIFNWAEE--GLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 720 (948)
Q Consensus 660 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 720 (948)
+.+.+ ..++||||+ +|+|.+++...... ....+++..++.|+.||+.||+|||+ .+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 55543 278999999 68999999653221 11345678899999999999999998 799
Q ss_pred eecCCCCccEEEcCCCCeEEeecCCceecCCCCCceeeeecccccccCceecccC-----------CCCchhhHHHHHHH
Q 002238 721 IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG-----------RVTTKVDVFSFGVI 789 (948)
Q Consensus 721 vHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~Gv~ 789 (948)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 3445667 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 790 LMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 790 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+|||++|+.||......... ...... ....+.++.+++.+|++.||++||++.++++
T Consensus 303 l~elltg~~Pf~~~~~~~~~----------------~~~~~~-------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGS----------------EWIFRS-------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CCS----------------GGGGSS-------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccch----------------hhhhhh-------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999765432211 011110 0112245889999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=341.18 Aligned_cols=255 Identities=23% Similarity=0.315 Sum_probs=190.3
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|++.+.||+|+||.||+|.. .+|+.||||++..........+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46899999999999999999987 47899999999765433334445555666688889999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCC-CeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
||++ |+|.+++..... ....+++..++.++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp ECCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred ehhc-cchHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9997 588888765333 34679999999999999999999997 5 9999999999999999999999999999865
Q ss_pred CCCCCceeeeecccccccCceec----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYA----VTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
.... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||........ ...... ....
T Consensus 161 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~---~~~~--- 231 (290)
T 3fme_A 161 VDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLKQVV---EEPS--- 231 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHHHHH---HSCC---
T ss_pred cccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHHHHh---ccCC---
Confidence 4432 22334699999999996 566789999999999999999999999986433211 111111 1000
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+... ......++.+++.+|++.||++||++.|+++
T Consensus 232 -----~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 -----PQLP----ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -----CCCC----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCcc----cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0010 0112345889999999999999999999987
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=342.84 Aligned_cols=250 Identities=27% Similarity=0.444 Sum_probs=205.1
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe-------
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD------- 662 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------- 662 (948)
..++|++.+.||+|+||.||+|... +|+.||||++.... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 4567999999999999999999886 79999999987542 356789999999999999999998864
Q ss_pred ---------CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEc
Q 002238 663 ---------GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 733 (948)
Q Consensus 663 ---------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~ 733 (948)
....++||||+++|+|.+++... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR---RGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLV 156 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHG---GGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEc
Confidence 34579999999999999998642 22578999999999999999999997 7999999999999999
Q ss_pred CCCCeEEeecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHH
Q 002238 734 DDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVT 813 (948)
Q Consensus 734 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~ 813 (948)
.++.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|..|+... ....
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~- 228 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKFF- 228 (284)
T ss_dssp ETTEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHH-
T ss_pred CCCCEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHH-
Confidence 99999999999998765433 233456999999999999999999999999999999999999887421 1111
Q ss_pred HHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 814 WFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
.... .. .+... ....+.+++.+|++.||.+||++.|+++.|+.+.+.
T Consensus 229 --~~~~--~~----~~~~~---------~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 229 --TDLR--DG----IISDI---------FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp --HHHH--TT----CCCTT---------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred --HHhh--cc----ccccc---------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 1111 01 11111 123578999999999999999999999999988653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=342.22 Aligned_cols=252 Identities=25% Similarity=0.392 Sum_probs=204.0
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
+.++|++.+.||+|+||.||+|+.. +|+.||||++... .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS--PAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecc--cccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 4578999999999999999999875 7899999999764 223346789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE---cCCCCeEEeecCCc
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLV 746 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill---~~~~~~kl~DfGla 746 (948)
|||+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||++ +.++.++|+|||++
T Consensus 85 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 85 MQLVSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156 (304)
T ss_dssp ECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred EEcCCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence 9999999999988531 468999999999999999999997 899999999999999 78889999999998
Q ss_pred eecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 747 RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
+..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.... +......+.
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~------i~~~~~~~~ 227 (304)
T 2jam_A 157 KMEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEK------IKEGYYEFE 227 (304)
T ss_dssp CCCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HHHCCCCCC
T ss_pred eecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH------HHcCCCCCC
Confidence 754332 22345699999999999999999999999999999999999999987654332111 111111111
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.. ........+.+++.+|++.||++||++.++++.
T Consensus 228 ~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 228 SP---------FWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TT---------TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cc---------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 011223468899999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=367.98 Aligned_cols=254 Identities=25% Similarity=0.345 Sum_probs=204.2
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCCh-----------hhHHHHHHHHHHHHhcCCCceeeEEe
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-----------KGLTEFKSEIAVLTKVRHRHLVALLG 658 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~H~niv~l~~ 658 (948)
+.++|++.+.||+|+||.||+|+.+ +++.||||++....... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4678999999999999999999875 68899999997643221 33577899999999999999999999
Q ss_pred EEEeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC--
Q 002238 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-- 736 (948)
Q Consensus 659 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~-- 736 (948)
++.++...++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN-----RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCC
Confidence 99999999999999999999988854 1468999999999999999999997 8999999999999998776
Q ss_pred -CeEEeecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHH
Q 002238 737 -RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWF 815 (948)
Q Consensus 737 -~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~ 815 (948)
.+||+|||+++...... ......||+.|+|||++. +.++.++||||+||++|||++|+.||......+....+.
T Consensus 186 ~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-- 260 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE-- 260 (504)
T ss_dssp SSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--
T ss_pred ccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--
Confidence 69999999998765432 234457999999999986 569999999999999999999999998766543322211
Q ss_pred HHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 816 RRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.....+. ...+.....++.+++.+|++.||.+|||+.|+++.
T Consensus 261 ----~~~~~~~---------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 261 ----KGKYYFD---------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp ----HCCCCCC---------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----cCCCCCC---------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1111000 01111223568899999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=347.08 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=208.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999875 578999999876532 344567899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++++|.+++.. ...+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 120 ~e~~~~~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 120 LELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp ECCCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 999999999988743 1468999999999999999999997 89999999999999999999999999999866
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+ ......+.
T Consensus 192 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------~~~~~~~~--- 261 (335)
T 2owb_A 192 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI------KKNEYSIP--- 261 (335)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHTCCCCC---
T ss_pred ccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------hcCCCCCC---
Confidence 43322 234457999999999999999999999999999999999999999876543321111 11111110
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
. .....+.+++.+|++.||++||++.++++.
T Consensus 262 -~---------~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 262 -K---------HINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -T---------TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -c---------cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 112357899999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=350.24 Aligned_cols=270 Identities=26% Similarity=0.344 Sum_probs=199.7
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCCh---hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG---KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 665 (948)
...++|++.+.||+|+||.||+|... +|+.||||++....... ...+.+.+|+++++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999875 68999999987542221 113468899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGl 745 (948)
.++||||+++ +|.+++.. ....+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred eEEEEEcCCC-CHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEeccc
Confidence 9999999975 88877732 33568889999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc-c
Q 002238 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK-D 823 (948)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~ 823 (948)
++...... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||......+....+ ........ .
T Consensus 159 a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i--~~~~~~~~~~ 235 (346)
T 1ua2_A 159 AKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI--FETLGTPTEE 235 (346)
T ss_dssp GSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHHHCCCCTT
T ss_pred ceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH--HHHcCCCChh
Confidence 98654332 223445789999999998764 5899999999999999999999999876544332211 11111100 0
Q ss_pred cccccc---C-------cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 824 SFHKAI---D-------PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 824 ~~~~~~---~-------~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.+.... + +..............+.+++.+|++.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000 0 0000000112233568999999999999999999999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=345.85 Aligned_cols=259 Identities=22% Similarity=0.302 Sum_probs=190.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEe-------
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLD------- 662 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~------- 662 (948)
..+|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++++. ||||+++++++..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 357899999999999999999874 7899999998654 4455678999999999996 9999999999953
Q ss_pred -CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCC--eeecCCCCccEEEcCCCCeE
Q 002238 663 -GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLGDDMRAK 739 (948)
Q Consensus 663 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrDik~~Nill~~~~~~k 739 (948)
....++||||+. |+|.+++.... ....+++.+++.++.||+.||+|||+ .+ |+||||||+|||++.++.+|
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKME--SRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHH--TTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEE
T ss_pred CCceEEEEEEecC-CCHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEE
Confidence 334789999995 79998886532 23579999999999999999999997 67 99999999999999999999
Q ss_pred EeecCCceecCCCCCc-----------eeeeecccccccCceec---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 002238 740 VADFGLVRLAPEGKGS-----------IETRIAGTFGYLAPEYA---VTGRVTTKVDVFSFGVILMELITGRKALDESQP 805 (948)
Q Consensus 740 l~DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~ 805 (948)
|+|||+++........ ......||+.|+|||++ .+..++.++||||||+++|||++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 9999999865443221 11234689999999998 566789999999999999999999999975432
Q ss_pred hhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhC
Q 002238 806 EESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWK 879 (948)
Q Consensus 806 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~ 879 (948)
... . .......... .....+.+++.+|++.||.+||++.|+++.|+.+.....
T Consensus 259 ~~~------~------~~~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 259 LRI------V------NGKYSIPPHD---------TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp -------------------CCCCTTC---------CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HHh------h------cCcccCCccc---------ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 211 0 0000000000 011237789999999999999999999999999876543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=368.86 Aligned_cols=254 Identities=26% Similarity=0.356 Sum_probs=208.7
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
..++|++.+.||+|+||.||+|+.+ +|+.||||++...... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3567999999999999999999875 7899999999765432 3456789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE---cCCCCeEEeecCC
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGL 745 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill---~~~~~~kl~DfGl 745 (948)
||||+.+|+|.+++.. ...+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+
T Consensus 104 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EECCCCSCBHHHHHHT-----CSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 9999999999988843 3578999999999999999999997 899999999999999 5678999999999
Q ss_pred ceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
++...... ......||+.|+|||++.+ .++.++||||+||++|||++|++||......+....+ . .....+
T Consensus 176 a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~---~~~~~~ 246 (484)
T 3nyv_A 176 STHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV---E---KGKYTF 246 (484)
T ss_dssp HHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H---HCCCCC
T ss_pred eEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---H---cCCCCC
Confidence 98665433 2334579999999999865 6999999999999999999999999876654332211 1 111100
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
. ...+......+.+++.+|++.+|.+|||+.|++++
T Consensus 247 ------~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 247 ------E---LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp ------C---SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------C---CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0 01112233568899999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=350.08 Aligned_cols=264 Identities=22% Similarity=0.359 Sum_probs=203.4
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
..++|++.+.||+|+||.||+|+.++ .||||++..........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 35789999999999999999998753 5999998765444445567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++++|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++ ++.+||+|||+++...
T Consensus 109 e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 109 SLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp BCCCSEEHHHHTTS----SCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred ecccCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 99999999998843 33578999999999999999999997 8999999999999998 6799999999987543
Q ss_pred CCC----CceeeeecccccccCceeccc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH
Q 002238 751 EGK----GSIETRIAGTFGYLAPEYAVT---------GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRR 817 (948)
Q Consensus 751 ~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 817 (948)
... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~------ 254 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ------ 254 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH------
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------
Confidence 211 112233568999999999864 4578999999999999999999999987654332111
Q ss_pred hhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCCC
Q 002238 818 IHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPT 881 (948)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~~ 881 (948)
... ......... ....++.+++.+|++.+|++||++.++++.|+.+.+.....
T Consensus 255 ~~~--~~~~~~~~~---------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~ 307 (319)
T 2y4i_B 255 MGT--GMKPNLSQI---------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307 (319)
T ss_dssp HHT--TCCCCCCCS---------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred hcc--CCCCCCCcC---------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 111 000011010 11234889999999999999999999999999987655443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=353.30 Aligned_cols=264 Identities=24% Similarity=0.395 Sum_probs=190.0
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC------
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------ 663 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 663 (948)
+.++|++.+.||+|+||.||+|... +|+.||||++..........+.+.+|+++++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3578999999999999999999864 789999999976544555667899999999999999999999998754
Q ss_pred CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeec
Q 002238 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (948)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~Df 743 (948)
...++||||+ +++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp CCCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-
T ss_pred CeEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeec
Confidence 5679999999 7899888732 468999999999999999999997 89999999999999999999999999
Q ss_pred CCceecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc
Q 002238 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK 822 (948)
Q Consensus 744 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 822 (948)
|+++..... .+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+. .......
T Consensus 177 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~--~~~g~p~ 250 (367)
T 2fst_X 177 GLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL--RLVGTPG 250 (367)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HHHCSCC
T ss_pred ccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HHhCCCC
Confidence 999865432 344679999999999887 678999999999999999999999998766543322221 1100000
Q ss_pred ccccc------------ccC--cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 823 DSFHK------------AID--PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 823 ~~~~~------------~~~--~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
..... .+. +..............+.+++.+|++.||++|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000 000 0000011111223568899999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=350.04 Aligned_cols=266 Identities=24% Similarity=0.303 Sum_probs=197.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN------ 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 664 (948)
.++|++.+.||+|+||.||+|... +++.||||++..........+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999865 6899999999875545566678999999999999999999999997654
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
..++||||++ |+|.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ceEEEEEcCC-CCHHHHHh-------hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEee
Confidence 6799999996 47877763 358899999999999999999997 899999999999999999999999999
Q ss_pred CceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHH----------
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTW---------- 814 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~---------- 814 (948)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+..
T Consensus 173 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 173 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp C------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred ccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 998654322 23446799999999999999999999999999999999999999987654332111100
Q ss_pred ------HHHhhcCc-----cccccccCccc-C-CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 815 ------FRRIHLSK-----DSFHKAIDPTI-D-LNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 815 ------~~~~~~~~-----~~~~~~~~~~~-~-~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
........ ..+.+.+.... + ...........+.+++.+|++.||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000 00000000000 0 001112235678999999999999999999999884
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=353.29 Aligned_cols=264 Identities=21% Similarity=0.326 Sum_probs=205.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 467999999999999999999876 78999999997642 4455678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++++|.+++... ..+++..+..++.|++.||+|||+ +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 111 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred ECCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999998541 468899999999999999999997 2489999999999999999999999999987442
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc----------
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL---------- 820 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------- 820 (948)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.............
T Consensus 184 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 184 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp HH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred cc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 21 22345799999999999999999999999999999999999999987654332111100000000
Q ss_pred ------------Cccc-------cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 821 ------------SKDS-------FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 821 ------------~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.... ......+... ......++.+++.+|++.||++|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP----SGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCC----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCC----cccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000 0000000000 01123468899999999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=340.48 Aligned_cols=260 Identities=27% Similarity=0.435 Sum_probs=199.3
Q ss_pred hcCCcccceecccCceEEEEEEEc--CCc--EEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCce
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH--DGT--KIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~--~g~--~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 666 (948)
.++|++.+.||+|+||.||+|++. +++ .||||+++.... .....+.+.+|++++++++||||+++++++.++. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 457999999999999999999864 333 689999876432 2345678999999999999999999999998754 8
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCc
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla 746 (948)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 96 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eeeEecccCCCHHHHHHhc----cCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccc
Confidence 8999999999999998542 2468899999999999999999997 89999999999999999999999999999
Q ss_pred eecCCCCCc--eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCcc
Q 002238 747 RLAPEGKGS--IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKD 823 (948)
Q Consensus 747 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 823 (948)
+........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+... .......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~~~~~~~ 242 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH------KIDKEGE 242 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------HHHTSCC
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH------HHHccCC
Confidence 876544322 1233457889999999999899999999999999999999 999998765433211 1111110
Q ss_pred ccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 824 SFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
.. . .....+..+.+++.+|++.+|++||++.++++.|+++..
T Consensus 243 ~~--------~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 243 RL--------P---RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CC--------C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CC--------C---CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 00 0 011223468899999999999999999999999988753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=337.92 Aligned_cols=249 Identities=25% Similarity=0.411 Sum_probs=205.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ......+.+|++++++++||||+++++++.+++..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367999999999999999999875 6789999998654221 22346789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++...
T Consensus 93 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 9999999999988541 468999999999999999999997 89999999999999999999999999998765
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
.... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+... .+...... +
T Consensus 165 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~~~~----~ 231 (284)
T 2vgo_A 165 PSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR------RIVNVDLK----F 231 (284)
T ss_dssp SSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHTTCCC----C
T ss_pred cccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH------HHhccccC----C
Confidence 4422 234569999999999999999999999999999999999999998755433211 11111100 1
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.+ .....+.+++.+|++.||.+||++.++++.
T Consensus 232 ~~---------~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 232 PP---------FLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CT---------TSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred CC---------cCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 11 122458899999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=351.63 Aligned_cols=276 Identities=21% Similarity=0.278 Sum_probs=202.9
Q ss_pred eHHHHHHhhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCC---------hhhHHHHHHHHHHHHhcCCCcee
Q 002238 584 SIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS---------GKGLTEFKSEIAVLTKVRHRHLV 654 (948)
Q Consensus 584 ~~~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---------~~~~~~~~~E~~~l~~l~H~niv 654 (948)
...++..+.++|++.+.||+|+||.||+|...+|+.||||++...... ....+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 467788899999999999999999999999888999999998654222 12237899999999999999999
Q ss_pred eEEeEEEeC-----CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCcc
Q 002238 655 ALLGHCLDG-----NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSN 729 (948)
Q Consensus 655 ~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~N 729 (948)
++++++... ...++||||++ |+|.+.+.. ....+++..+..++.|++.||+|||+ .+|+||||||+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~N 164 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD----QRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGN 164 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGG
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHH
Confidence 999998543 35799999997 688887742 33578999999999999999999997 799999999999
Q ss_pred EEEcCCCCeEEeecCCceecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 002238 730 ILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEES 808 (948)
Q Consensus 730 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~ 808 (948)
|+++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999998543322 2344578999999999877 6789999999999999999999999987664433
Q ss_pred hhHHHHHHHh-------hcCccccccccCcc---c---CCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 809 MHLVTWFRRI-------HLSKDSFHKAIDPT---I---DLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 809 ~~~~~~~~~~-------~~~~~~~~~~~~~~---~---~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
...+...... ..........+... . ............+.+++.+|++.||.+|||+.|+++
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 2211100000 00000000000000 0 000111122356889999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=354.56 Aligned_cols=203 Identities=26% Similarity=0.355 Sum_probs=175.9
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc------CCCceeeEEeEEEeC
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV------RHRHLVALLGHCLDG 663 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~~~~~~~ 663 (948)
+..+|++.+.||+|+||.||+|... +++.||||++.. .......+.+|+++++.+ +|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC---ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 3568999999999999999999865 689999999875 334456788899988887 577999999999999
Q ss_pred CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCC--eEEe
Q 002238 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR--AKVA 741 (948)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~--~kl~ 741 (948)
...++||||+. ++|.+++.. .....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~ 244 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKK---NKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVI 244 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEEC
T ss_pred CeEEEEEeccC-CCHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEe
Confidence 99999999995 689888854 233468999999999999999999997 79999999999999999887 9999
Q ss_pred ecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q 002238 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEE 807 (948)
Q Consensus 742 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~ 807 (948)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|++||......+
T Consensus 245 DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 306 (429)
T 3kvw_A 245 DFGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306 (429)
T ss_dssp CCTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ecccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999865432 234578999999999999999999999999999999999999998776543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=340.00 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=202.1
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEE
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
...++|++.+.||+|+||.||+|... +|+.||||++... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 34678999999999999999999875 5899999998753 234678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||||+++++|.+++.. ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus 102 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 102 VMEYCGAGSVSDIIRL----RNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp EEECCTTEEHHHHHHH----HTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EeecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 9999999999998843 23578999999999999999999997 8999999999999999999999999999986
Q ss_pred cCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||............ ...
T Consensus 175 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~---------- 240 (314)
T 3com_A 175 LTDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI---PTN---------- 240 (314)
T ss_dssp CBTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHS----------
T ss_pred hhhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---hcC----------
Confidence 654322 233456999999999999999999999999999999999999999876543221111 000
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
..+.... .......+.+++.+|++.||.+||++.++++.
T Consensus 241 ~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 241 PPPTFRK---PELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp CCCCCSS---GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCcccCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0111110 11123468899999999999999999999773
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=336.79 Aligned_cols=252 Identities=22% Similarity=0.377 Sum_probs=198.1
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
.|....+||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 4555668999999999999864 6889999998764 334457899999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC-CCCeEEeecCCceecCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRLAPE 751 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~-~~~~kl~DfGla~~~~~ 751 (948)
+++++|.+++... .....+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++....
T Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 101 VPGGSLSALLRSK--WGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp CSEEEHHHHHHHT--TCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCCCHHHHHHhh--ccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999998542 223456789999999999999999997 89999999999999987 89999999999986644
Q ss_pred CCCceeeeecccccccCceecccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGR--VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||......... ... ..... .
T Consensus 176 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~--~~~~~--------~ 243 (295)
T 2clq_A 176 INP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MFK--VGMFK--------V 243 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HHH--HHHHC--------C
T ss_pred CCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HHh--hcccc--------c
Confidence 321 233456999999999987653 889999999999999999999999754332211 100 00000 0
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.+.+. .....++.+++.+|++.||++||++.++++
T Consensus 244 ~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 HPEIP-----ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCC-----TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccc-----ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111 112345889999999999999999999976
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=349.61 Aligned_cols=265 Identities=20% Similarity=0.311 Sum_probs=199.8
Q ss_pred HhhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG----- 663 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 663 (948)
...++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+|+++++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 4567899999999999999999986 479999999987542 1234799999999999999999998543
Q ss_pred ---------------------------------CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 002238 664 ---------------------------------NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710 (948)
Q Consensus 664 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~ 710 (948)
...++||||++ |+|.+.+..+... ...+++..+..++.|+++||+
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHH
Confidence 23789999997 5888888664433 367999999999999999999
Q ss_pred HHHhccCCCeeecCCCCccEEEc-CCCCeEEeecCCceecCCCCCceeeeecccccccCceecccC-CCCchhhHHHHHH
Q 002238 711 YLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGV 788 (948)
Q Consensus 711 ~LH~~~~~~ivHrDik~~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv 788 (948)
|||+ .+|+||||||+||+++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++||||+||
T Consensus 156 ~LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 156 FIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 9997 8999999999999998 68899999999998664433 23345689999999998775 4899999999999
Q ss_pred HHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc--------cccccccCcccCCcc----chHHHHHHHHHHHHHhccc
Q 002238 789 ILMELITGRKALDESQPEESMHLVTWFRRIHLSK--------DSFHKAIDPTIDLNE----GILASISTVAELAGHCCAR 856 (948)
Q Consensus 789 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~c~~~ 856 (948)
++|||++|+.||.+....+....+ +....... ..+.+..-+.+.... ........+.+++.+|++.
T Consensus 231 il~ell~g~~pf~~~~~~~~~~~i--~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQLVRI--IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHH--HHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHHhCCCCCCCCChHHHHHHH--HHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 999999999999876654332211 11110000 000000001100000 0111234688999999999
Q ss_pred CCCCCCChHHHHH
Q 002238 857 EPYQRPDMGHAVN 869 (948)
Q Consensus 857 ~P~~RPt~~ev~~ 869 (948)
||.+|||+.|+++
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=345.92 Aligned_cols=266 Identities=24% Similarity=0.404 Sum_probs=189.0
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
..++|++.+.||+|+||.||+|... +++.||||++.... .....+++.+|+.++++++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 3578999999999999999999854 68999999886542 233456788999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCc
Q 002238 670 FEYMPQGTLSRHIFNWAEE---GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla 746 (948)
|||+++++|.+++...... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999998653222 23568999999999999999999997 89999999999999999999999999998
Q ss_pred eecCCCCC----ceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcC
Q 002238 747 RLAPEGKG----SIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS 821 (948)
Q Consensus 747 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 821 (948)
+....... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||............ ....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-----~~~~ 243 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT-----LQND 243 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH-----HTSS
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH-----hccC
Confidence 75543211 12234579999999999876 56899999999999999999999999876544321111 1100
Q ss_pred ccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 822 KDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
........ ............+.+++.+|++.||.+||++.++++
T Consensus 244 ~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLETGV----QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTTC---------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCcccccc----ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00010000 000011122346889999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=335.38 Aligned_cols=250 Identities=30% Similarity=0.417 Sum_probs=197.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999876 799999999875421 123356789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999998541 468999999999999999999997 79999999999999999999999999999865
Q ss_pred CCCCCceeeeecccccccCceecccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
.... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........... +.. ....
T Consensus 162 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~---~~~~---- 229 (276)
T 2h6d_A 162 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK---IRG---GVFY---- 229 (276)
T ss_dssp CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHH---CCCC----
T ss_pred CCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH---hhc---Cccc----
Confidence 4432 2234568999999999987765 6899999999999999999999987543322111 111 0000
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+.. .....+.+++.+|++.||.+||++.++++.
T Consensus 230 ~~~---------~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 IPE---------YLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Cch---------hcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 001 112458899999999999999999999884
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=354.30 Aligned_cols=255 Identities=12% Similarity=0.076 Sum_probs=184.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhc--CCCceeeEE-------eEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV--RHRHLVALL-------GHCL 661 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l--~H~niv~l~-------~~~~ 661 (948)
.+|+..+.||+|+||.||+|++. +|+.||||++..... .....+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45888999999999999999875 789999999987643 234456788886555555 699988755 4444
Q ss_pred eC-----------------CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHH------HHHHHHHHHHHHHHHhccCC
Q 002238 662 DG-----------------NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRR------LTIALDVARGVEYLHGLAHQ 718 (948)
Q Consensus 662 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~ 718 (948)
.. ...++||||++ |+|.+++.... ..+++..+ +.++.||+.||+|||+ .
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~ 213 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQS---K 213 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHHH---C
Confidence 33 23799999998 89999996532 23345555 7888999999999997 8
Q ss_pred CeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCceeeeecccccccCceeccc--CCCCchhhHHHHHHHHHHHHhC
Q 002238 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT--GRVTTKVDVFSFGVILMELITG 796 (948)
Q Consensus 719 ~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~elltg 796 (948)
+|+||||||+|||++.++.+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999986643 2224567899999999987 6799999999999999999999
Q ss_pred CCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 797 RKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 797 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+.||....+..... ................. ........+.+++.+|++.||++||++.++++
T Consensus 290 ~~Pf~~~~~~~~~~---------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGS---------WKRPSLRVPGTDSLAFG-SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTC---------CCBCCTTSCCCCSCCCT-TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccc---------hhhhhhhhccccccchh-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99998764432100 00000000001111100 01123456889999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=346.45 Aligned_cols=272 Identities=23% Similarity=0.315 Sum_probs=194.2
Q ss_pred HHHHhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc
Q 002238 587 VLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (948)
Q Consensus 587 ~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 665 (948)
......++|++.+.||+|+||.||+|+.. +|+.||||++... ......+.+|++.+..++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD---PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC---TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC---ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 44566789999999999999999999875 6899999998653 2223456788888999999999999999976443
Q ss_pred -------eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hccCCCeeecCCCCccEEEcC-C
Q 002238 666 -------KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH--GLAHQSFIHRDLKPSNILLGD-D 735 (948)
Q Consensus 666 -------~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~ivHrDik~~Nill~~-~ 735 (948)
.++||||+++ +|.+.+.... .....+++..+..++.|++.||+||| + .+|+||||||+|||++. +
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~ 168 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEAD 168 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCC
Confidence 7899999976 5655554322 23467899999999999999999999 6 89999999999999996 8
Q ss_pred CCeEEeecCCceecCCCCCceeeeecccccccCceecccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHH
Q 002238 736 MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR-VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTW 814 (948)
Q Consensus 736 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~ 814 (948)
+.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+
T Consensus 169 ~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~-- 244 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI-- 244 (360)
T ss_dssp TEEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--
T ss_pred CcEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH--
Confidence 999999999998665433 233456899999999987654 899999999999999999999999886654332222
Q ss_pred HHHhhcCccccccccCc-----------ccC----CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 815 FRRIHLSKDSFHKAIDP-----------TID----LNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 815 ~~~~~~~~~~~~~~~~~-----------~~~----~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.+............+++ ... ..........++.+++.+|++.||.+||++.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111110000000000 000 000111134578999999999999999999999873
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=342.43 Aligned_cols=268 Identities=24% Similarity=0.354 Sum_probs=204.2
Q ss_pred hhcCCcccceecccCceEEEEEEE--cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc---CCCceeeEEeEEE----
Q 002238 591 VTNNFSEENILGRGGFGTVYKGEL--HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV---RHRHLVALLGHCL---- 661 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~---- 661 (948)
+.++|++.+.||+|+||.||+|.. .+|+.||||++............+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999987 3688999999876533333334567788877776 8999999999987
Q ss_pred -eCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEE
Q 002238 662 -DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 740 (948)
Q Consensus 662 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl 740 (948)
.....++||||++ |+|.+++.. .....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred CCCceEEEEEecCC-CCHHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEE
Confidence 4567899999997 699998854 223458999999999999999999997 89999999999999999999999
Q ss_pred eecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc
Q 002238 741 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL 820 (948)
Q Consensus 741 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 820 (948)
+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+ ......
T Consensus 162 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i--~~~~~~ 237 (326)
T 1blx_A 162 ADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI--LDVIGL 237 (326)
T ss_dssp CSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCC
T ss_pred ecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--HHHcCC
Confidence 9999998654321 233457899999999999999999999999999999999999999876644322211 111110
Q ss_pred C-cccccccc-------C--cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 821 S-KDSFHKAI-------D--PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 821 ~-~~~~~~~~-------~--~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
. ...+.... . ...............+.+++.+|++.||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 00010000 0 000001111223456889999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=371.68 Aligned_cols=260 Identities=23% Similarity=0.363 Sum_probs=207.8
Q ss_pred hhcCCcccceecccCceEEEEEEEc----CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCce
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 666 (948)
..++|++.+.||+|+||.||+|.+. .+..||||++... ......+.+.+|+.++++++||||+++++++. ++..
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 3567999999999999999999874 2467999988653 23445678999999999999999999999985 5678
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCc
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla 746 (948)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 466 ~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp EEEEECCTTCBHHHHHHH----TTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred EEEEEcCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCC
Confidence 999999999999999853 23468999999999999999999997 89999999999999999999999999999
Q ss_pred eecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 747 RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
+..............+|+.|+|||++.+..++.++||||||+++|||++ |..||.+....+....+ .... .
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i---~~~~--~--- 610 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---ENGE--R--- 610 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---HHTC--C---
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---HcCC--C---
Confidence 8765544333344567889999999999999999999999999999997 99999876544322111 1100 0
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
.... ...+..+.+++.+|++.||++||++.++++.|+.+.+.
T Consensus 611 -~~~~---------~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 611 -LPMP---------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp -CCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCC---------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 0001 12234688999999999999999999999999998653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=343.57 Aligned_cols=253 Identities=24% Similarity=0.362 Sum_probs=199.3
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
..++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 3578999999999999999999876 6899999998754 344567899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++++|.+++.. ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 95 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLE----LDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp EECCTTEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred EEeCCCCcHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 999999999988753 12568999999999999999999997 89999999999999999999999999987632
Q ss_pred CCCCCceeeeecccccccCceec-----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYA-----VTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
.... .......||+.|+|||++ .+..++.++||||||+++|||++|+.||.......... ......
T Consensus 168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~-- 238 (302)
T 2j7t_A 168 LKTL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL------KIAKSD-- 238 (302)
T ss_dssp HHHH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHSC--
T ss_pred cccc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH------HHhccC--
Confidence 1110 112235689999999998 36678999999999999999999999998765432211 111000
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
. +... ........+.+++.+|++.||++||++.++++
T Consensus 239 ~-----~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 239 P-----PTLL---TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp C-----CCCS---SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred C-----cccC---CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 0000 01122345889999999999999999999876
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=340.89 Aligned_cols=254 Identities=26% Similarity=0.424 Sum_probs=198.1
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEe-----
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD----- 662 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----- 662 (948)
...++|++.+.||+|+||.||+|+.. +|+.||||++... ......+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC---cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 45678999999999999999999874 7899999998753 23457889999999999 89999999999987
Q ss_pred -CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEe
Q 002238 663 -GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 741 (948)
Q Consensus 663 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~ 741 (948)
.+..++||||+++|+|.+++... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEEC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEe
Confidence 46789999999999999998642 22468899999999999999999997 899999999999999999999999
Q ss_pred ecCCceecCCCCCceeeeecccccccCceecc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH
Q 002238 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFR 816 (948)
Q Consensus 742 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~ 816 (948)
|||++........ ......||+.|+|||++. +..++.++||||||+++|||++|+.||...........+ .
T Consensus 172 Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~ 247 (326)
T 2x7f_A 172 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---P 247 (326)
T ss_dssp CCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---H
T ss_pred eCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh---h
Confidence 9999886543221 233456999999999987 567899999999999999999999999876543321111 1
Q ss_pred HhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 817 RIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
. ......... .....+.+++.+|++.||.+||++.++++.
T Consensus 248 ~-----~~~~~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 248 R-----NPAPRLKSK---------KWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp H-----SCCCCCSCS---------CSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred c-----CccccCCcc---------ccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 000011111 112458899999999999999999999873
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=374.67 Aligned_cols=245 Identities=24% Similarity=0.342 Sum_probs=203.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 668 (948)
.++|++.+.||+|+||.||+|+.+ +++.||||++++... .....+.+..|..++..+ +||+|+++++++.+.+..|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 468999999999999999999875 688999999976422 233456788999999988 79999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||||+++|+|.+++... ..+++.+++.++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+++.
T Consensus 420 V~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999998542 468999999999999999999997 8999999999999999999999999999986
Q ss_pred cCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+... .+......+.
T Consensus 492 ~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~------~i~~~~~~~p-- 562 (674)
T 3pfq_A 492 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ------SIMEHNVAYP-- 562 (674)
T ss_dssp CCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHSSCCCCC--
T ss_pred cccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH------HHHhCCCCCC--
Confidence 43332 23445789999999999999999999999999999999999999998765443221 1221111111
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCCh
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDM 864 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~ 864 (948)
.....++.+++.+|++.||++||++
T Consensus 563 -----------~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 563 -----------KSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp -----------TTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred -----------ccCCHHHHHHHHHHccCCHHHCCCC
Confidence 1123458899999999999999998
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=353.59 Aligned_cols=263 Identities=22% Similarity=0.342 Sum_probs=197.1
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------c
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN------E 665 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~ 665 (948)
.+|+..+.||+|+||.||+|++. +|+.||||++.... ..+.+|+++++.++|||||++++++.... .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 46888999999999999999985 68999999987532 22357999999999999999999886421 2
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC-CCeEEeecC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFG 744 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~-~~~kl~DfG 744 (948)
.++||||+++ ++.+.+..+. .....+++..+..++.||++||+|||+ .+|+||||||+|||++.+ +.+||+|||
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEeehhcccc-cHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccch
Confidence 5799999975 6766665432 234679999999999999999999997 899999999999999965 568999999
Q ss_pred CceecCCCCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcC--
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS-- 821 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 821 (948)
+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+.. ...+......
T Consensus 203 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l--~~i~~~lg~p~~ 278 (420)
T 1j1b_A 203 SAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL--VEIIKVLGTPTR 278 (420)
T ss_dssp TCEECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCSCCH
T ss_pred hhhhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCH
Confidence 999764433 23345789999999998765 7999999999999999999999999876543322 2222111000
Q ss_pred ------ccccccccCcccCCcc----chHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 822 ------KDSFHKAIDPTIDLNE----GILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 822 ------~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
...+.+...+.+.... .......++.+|+.+|++.||.+||++.|++++
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0001111111111000 001123568899999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=347.38 Aligned_cols=266 Identities=21% Similarity=0.338 Sum_probs=204.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----Cc
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-----NE 665 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 665 (948)
.++|++.+.||+|+||.||+|... +++.||||++.... .....+.+.+|++++++++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 468999999999999999999865 68899999987532 344457899999999999999999999999765 36
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGl 745 (948)
.++||||++ |+|.+++.. ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 105 ~~iv~e~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEcccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcc
Confidence 799999996 599888843 468999999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCc--eeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc
Q 002238 746 VRLAPEGKGS--IETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK 822 (948)
Q Consensus 746 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 822 (948)
++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+... .....
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~ 252 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI--LGSPS 252 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHH--HCSCC
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHH--hCCCC
Confidence 9865433221 1244579999999998754 45899999999999999999999999877654433222110 00000
Q ss_pred c-ccc------------cccC-cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 823 D-SFH------------KAID-PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 823 ~-~~~------------~~~~-~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
. .+. .... ..............++.+++.+|++.||.+|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000 0000 0000011111223568899999999999999999999873
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=342.84 Aligned_cols=255 Identities=26% Similarity=0.354 Sum_probs=197.9
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC------hhhHHHHHHHHHHHHhcCCCceeeEEeEEEe
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS------GKGLTEFKSEIAVLTKVRHRHLVALLGHCLD 662 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 662 (948)
.+.++|++.+.||+|+||.||+|... +++.||||++...... ......+.+|++++++++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 34578999999999999999999875 6899999998654221 1223458899999999999999999999876
Q ss_pred CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCC---eE
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AK 739 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~---~k 739 (948)
+. .++||||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++. +|
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHST-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEE
T ss_pred Cc-eEEEEecCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEE
Confidence 54 8999999999999988732 3578999999999999999999997 89999999999999987654 99
Q ss_pred EeecCCceecCCCCCceeeeecccccccCceecc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH
Q 002238 740 VADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV---TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFR 816 (948)
Q Consensus 740 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~ 816 (948)
|+|||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||........ ....+.
T Consensus 158 l~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~ 233 (322)
T 2ycf_A 158 ITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT 233 (322)
T ss_dssp ECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHH
T ss_pred EccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHH
Confidence 99999998764421 223456999999999974 46789999999999999999999999976543221 111111
Q ss_pred HhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 817 RIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.. .... . ..........+.+++.+|++.||++||++.++++
T Consensus 234 ~~---~~~~----~-----~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 SG---KYNF----I-----PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HT---CCCC----C-----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hC---cccc----C-----chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 10 0000 0 0111122356889999999999999999999876
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=346.23 Aligned_cols=263 Identities=21% Similarity=0.355 Sum_probs=201.8
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCce---
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK--- 666 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~--- 666 (948)
+.++|...+.||+|+||.||+|... +|+.||||++..........+.+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4578999999999999999999865 689999999987654555568899999999999999999999999877654
Q ss_pred ---EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeec
Q 002238 667 ---LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (948)
Q Consensus 667 ---~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~Df 743 (948)
++||||+. ++|.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECST
T ss_pred eeEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEec
Confidence 99999997 68877662 358999999999999999999997 79999999999999999999999999
Q ss_pred CCceecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc
Q 002238 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK 822 (948)
Q Consensus 744 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 822 (948)
|+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+ ........
T Consensus 189 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--~~~~~~~~ 262 (371)
T 4exu_A 189 GLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI--LKVTGVPG 262 (371)
T ss_dssp TCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCCCC
T ss_pred CcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--HHHhCCCc
Confidence 999855332 334578999999999987 67899999999999999999999999876543322211 11110000
Q ss_pred ccccccc------------Cc--ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 823 DSFHKAI------------DP--TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 823 ~~~~~~~------------~~--~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
..+...+ .. ..............+.+++.+|++.||++||+++|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000 00 000000111224568899999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=341.15 Aligned_cols=260 Identities=17% Similarity=0.295 Sum_probs=199.9
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEe--CCceE
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLD--GNEKL 667 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~ 667 (948)
.++|++.+.||+|+||.||+|.. .+++.||||++... ..+.+.+|++++++++ ||||+++++++.+ ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 36799999999999999999986 47899999998642 2467899999999997 9999999999987 66789
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC-CeEEeecCCc
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLV 746 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~-~~kl~DfGla 746 (948)
+||||+++++|.+++ ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||++
T Consensus 110 lv~e~~~~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178 (330)
T ss_dssp EEEECCCCCCHHHHG--------GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeccCchhHHHHH--------HhCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence 999999999998887 247889999999999999999997 8999999999999999777 8999999999
Q ss_pred eecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhh-hH----------HHH
Q 002238 747 RLAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESM-HL----------VTW 814 (948)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~-~~----------~~~ 814 (948)
+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .. ..+
T Consensus 179 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 256 (330)
T 3nsz_A 179 EFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256 (330)
T ss_dssp EECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred eEcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhH
Confidence 87654332 334568999999999877 67899999999999999999999999654432111 00 011
Q ss_pred HHHhhcCc-cccccccC-------cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 815 FRRIHLSK-DSFHKAID-------PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 815 ~~~~~~~~-~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
........ ..+..... ..............++.+++.+|++.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11000000 00000000 000001111123456899999999999999999999987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=344.86 Aligned_cols=268 Identities=25% Similarity=0.352 Sum_probs=202.3
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----C
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-----N 664 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~ 664 (948)
+.++|++.+.||+|+||.||+|... +|+.||||++... ........+.+|++++++++||||+++++++..+ .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 4578999999999999999999875 6899999998643 2344567788999999999999999999988764 6
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
..++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecc
Confidence 7899999996 689888743 468999999999999999999997 899999999999999999999999999
Q ss_pred CceecCCCCCc---------eeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHH
Q 002238 745 LVRLAPEGKGS---------IETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTW 814 (948)
Q Consensus 745 la~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~ 814 (948)
+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 237 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 99865432211 1223568999999998765 6789999999999999999999999987654332221111
Q ss_pred HHHhhcCcccccc--------c---c--CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 815 FRRIHLSKDSFHK--------A---I--DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 815 ~~~~~~~~~~~~~--------~---~--~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
............. . + .+.............++.+++.+|++.||++||+++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000000 0 0 0000000111123456889999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=341.35 Aligned_cols=265 Identities=23% Similarity=0.347 Sum_probs=205.8
Q ss_pred hhcCCcccceecccCceEEEEEEE-c-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCc------eeeEEeEEEe
Q 002238 591 VTNNFSEENILGRGGFGTVYKGEL-H-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH------LVALLGHCLD 662 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~-~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~ 662 (948)
..++|++.+.||+|+||.||+|.. + +++.||||+++. .....+.+.+|+++++.++|++ ++++++++.+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec---CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 356899999999999999999986 3 688999999864 3344577899999999997664 9999999999
Q ss_pred CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC--------
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-------- 734 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~-------- 734 (948)
.+..++||||+ +++|.+++.. .....+++.++..++.|++.||+|||+ .+|+||||||+||+++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKE---NGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC
T ss_pred CCcEEEEEcCC-CCCHHHHHHh---cCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccC
Confidence 99999999999 8899998854 233578999999999999999999997 89999999999999987
Q ss_pred -----------CCCeEEeecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 002238 735 -----------DMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDES 803 (948)
Q Consensus 735 -----------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~ 803 (948)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 668999999999865432 23457899999999999999999999999999999999999999876
Q ss_pred CchhhhhHHHHHHHhh--------cCcccc-----------------ccccCcccCCccchHHHHHHHHHHHHHhcccCC
Q 002238 804 QPEESMHLVTWFRRIH--------LSKDSF-----------------HKAIDPTIDLNEGILASISTVAELAGHCCAREP 858 (948)
Q Consensus 804 ~~~~~~~~~~~~~~~~--------~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P 858 (948)
...+....+....... .....+ .....+.............++.+++.+|++.||
T Consensus 238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 6544322221111000 000000 000000000011112345678999999999999
Q ss_pred CCCCChHHHHH
Q 002238 859 YQRPDMGHAVN 869 (948)
Q Consensus 859 ~~RPt~~ev~~ 869 (948)
.+||++.|+++
T Consensus 318 ~~Rpt~~ell~ 328 (339)
T 1z57_A 318 AKRITLREALK 328 (339)
T ss_dssp TTSCCHHHHTT
T ss_pred ccccCHHHHhc
Confidence 99999999976
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=379.86 Aligned_cols=393 Identities=19% Similarity=0.216 Sum_probs=261.4
Q ss_pred CCccceEEeCCCCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCC-C-CcCCCCCCcEEEcccccccCCCCcc
Q 002238 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPL-P-SLNGLASLEVVMLSNNQFTSVPSDF 134 (948)
Q Consensus 57 C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p-~~~~l~~L~~L~L~~N~l~~~~~~~ 134 (948)
|.|+.|-+ -..+++.|+|++|.+++..|..|.++++|++|+|++|.+.+.+ | .|.++++|++|+|++|.++++.|..
T Consensus 14 ~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~ 92 (844)
T 3j0a_A 14 CNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA 92 (844)
T ss_dssp CCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred CCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence 45666655 4578999999999999888889999999999999999666544 4 6888999999999999999998888
Q ss_pred ccCCCCCCEEEccCCCCCCCCCCcc--ccCCCCCCEEEccCccccccCC-CCCCCCCCCCCcEEEcccccccccCCCCcc
Q 002238 135 FTGLSSLQSIEIDNNPFSSWEIPQS--LRNASGLQNFSANSANITGQIP-SFFGPDEFPGLTILHLAFNQLIGGLPASFS 211 (948)
Q Consensus 135 ~~~l~~L~~L~Ls~N~l~~~~~p~~--~~~l~~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 211 (948)
|+++++|++|+|++|++++ .+|.. +.++++|++|+|++|.+++..+ ..|+ .+++|++|+|++|++++..+..+.
T Consensus 93 ~~~l~~L~~L~Ls~n~l~~-~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~--~L~~L~~L~Ls~N~i~~~~~~~l~ 169 (844)
T 3j0a_A 93 FQGLFHLFELRLYFCGLSD-AVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFG--KLNSLKSIDFSSNQIFLVCEHELE 169 (844)
T ss_dssp SCSCSSCCCEECTTCCCSS-CCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGG--TCSSCCEEEEESSCCCCCCSGGGH
T ss_pred ccCCcccCEeeCcCCCCCc-ccccCccccccCCCCEEECCCCcccccccchhHh--hCCCCCEEECCCCcCCeeCHHHcc
Confidence 9999999999999999886 45554 8889999999999999987765 4566 788888888888888776665443
Q ss_pred c---cc------------------------------ccceeccCCC----------------------------------
Q 002238 212 G---SQ------------------------------IQSLWVNGQN---------------------------------- 224 (948)
Q Consensus 212 ~---~~------------------------------l~~l~~~~~~---------------------------------- 224 (948)
. .+ ++.|++.++.
T Consensus 170 ~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~ 249 (844)
T 3j0a_A 170 PLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGF 249 (844)
T ss_dssp HHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSC
T ss_pred cccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccc
Confidence 2 11 3334333321
Q ss_pred -------------------------CCCccCCCccccccCCCccEEEccCCcccccCC-CCCCCCCCcEEeccCCccccc
Q 002238 225 -------------------------GNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGP 278 (948)
Q Consensus 225 -------------------------~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~ 278 (948)
.+......+..|.++++|+.|+|++|++++..+ .|.++++|+.|+|++|.+++.
T Consensus 250 ~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 329 (844)
T 3j0a_A 250 HNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGEL 329 (844)
T ss_dssp SSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCC
T ss_pred cccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCcc
Confidence 111111122345566667777777777766555 466677777777777777766
Q ss_pred cchhhhCCCCCcEEEcccCcccccCCC-CCCccccccccccCCCCCCCCCCCchhhhhh---------------------
Q 002238 279 VPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNAL--------------------- 336 (948)
Q Consensus 279 ~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l--------------------- 336 (948)
.|..+..+++|+.|+|++|++++..+. +..+.+|..++..+|....++.. +.+..+
T Consensus 330 ~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~--~~L~~L~l~~N~l~~l~~~~~~l~~L~ 407 (844)
T 3j0a_A 330 YSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFI--PSIPDIFLSGNKLVTLPKINLTANLIH 407 (844)
T ss_dssp CSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSC--CSCSEEEEESCCCCCCCCCCTTCCEEE
T ss_pred CHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCC--CCcchhccCCCCcccccccccccceee
Confidence 666777777777777777777665553 45555666666555544332210 000000
Q ss_pred ---------HHHHHhhCCcchhccccCC-------------------------CCCCCCc-----cceeecCCceEEEEc
Q 002238 337 ---------LSVVKLMGYPQRFAENWKG-------------------------NDPCSDW-----IGVTCTKGNITVINF 377 (948)
Q Consensus 337 ---------~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~-----~~~~~~~~~L~~L~l 377 (948)
.........+.-...+..+ +.....| ...+..+++|+.|+|
T Consensus 408 ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~L 487 (844)
T 3j0a_A 408 LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYL 487 (844)
T ss_dssp CCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCC
T ss_pred cccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEEC
Confidence 0000000000000000000 0000000 022445677888888
Q ss_pred cCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCCC-CCcccccccCCCCCCCCccC
Q 002238 378 QKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS-FKSNAIVNTDGNPDIGKEKS 456 (948)
Q Consensus 378 s~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~-~~~~~~~~~~gnp~~~~~~~ 456 (948)
++|++++..|..|.++++|+.|+|++|+|++..|..+. ++|++|||++|+|+|.+|. +.....+.+.|||+.|.++.
T Consensus 488 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 488 NHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp CHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSC
T ss_pred CCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccccc
Confidence 88888888888888888888888888888866666555 7888888888888888775 45567889999999997764
Q ss_pred C
Q 002238 457 S 457 (948)
Q Consensus 457 ~ 457 (948)
.
T Consensus 566 ~ 566 (844)
T 3j0a_A 566 S 566 (844)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=336.07 Aligned_cols=256 Identities=25% Similarity=0.348 Sum_probs=207.6
Q ss_pred HHhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 589 RNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 589 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
....++|++.+.||+|+||.||+|+.. +++.||||++..........+.+.+|++++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345678999999999999999999875 7899999999776545556788999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC---CCeEEeecC
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAKVADFG 744 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~---~~~kl~DfG 744 (948)
+||||+++++|.+.+... ..+++.+++.++.|++.||+|||+ .+++||||||+||+++.+ +.+||+|||
T Consensus 98 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred EEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccC
Confidence 999999999999887531 468999999999999999999997 899999999999999754 469999999
Q ss_pred CceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
+++...... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||......+.... +......
T Consensus 170 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~------~~~~~~~ 240 (287)
T 2wei_A 170 LSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR------VETGKYA 240 (287)
T ss_dssp GGGTBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHCCCC
T ss_pred cceeecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH------HHcCCCC
Confidence 988654432 2233468999999998865 589999999999999999999999987654332111 1111100
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
. .. ........++.+++.+|++.||++||++.++++.
T Consensus 241 ~------~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 241 F------DL---PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp C------CS---GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred C------Cc---hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0 00 0011223468899999999999999999999873
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=353.34 Aligned_cols=264 Identities=22% Similarity=0.265 Sum_probs=201.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC--------CCceeeEEeEEE-
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR--------HRHLVALLGHCL- 661 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~~~~~- 661 (948)
.++|++.+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|+++++.++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 478999999999999999999864 688999999874 3445677899999999995 788999999987
Q ss_pred ---eCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCC-CeeecCCCCccEEEcCCC-
Q 002238 662 ---DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLGDDM- 736 (948)
Q Consensus 662 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivHrDik~~Nill~~~~- 736 (948)
++...++||||+ +++|.+.+.. .....+++..++.++.||+.||+|||+ + +|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIK---SNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccch
Confidence 456789999999 5666666643 233568999999999999999999997 6 999999999999999775
Q ss_pred ------------------------------------------------CeEEeecCCceecCCCCCceeeeecccccccC
Q 002238 737 ------------------------------------------------RAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 768 (948)
Q Consensus 737 ------------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~a 768 (948)
.+||+|||+++..... .....||+.|+|
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~a 261 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCC
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccC
Confidence 7999999999866432 234568999999
Q ss_pred ceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhH---HHHHHHhhcCc-------ccc-ccccCcc-----
Q 002238 769 PEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHL---VTWFRRIHLSK-------DSF-HKAIDPT----- 832 (948)
Q Consensus 769 PE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~-------~~~-~~~~~~~----- 832 (948)
||++.+..++.++|||||||++|||++|+.||......+.... ...+....... ... ...+...
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 9999999999999999999999999999999986553321111 11111110000 000 0000000
Q ss_pred cC-------------CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 833 ID-------------LNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 833 ~~-------------~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+. ...........+.+++.+|++.||++|||++|+++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 00112345567899999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=334.05 Aligned_cols=254 Identities=22% Similarity=0.296 Sum_probs=199.9
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC--ChhhHHHHHHHHHHHHhcCCCceeeEEeEEE--eCCc
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI--SGKGLTEFKSEIAVLTKVRHRHLVALLGHCL--DGNE 665 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~ 665 (948)
..++|++.+.||+|+||.||+|... +++.||||++..... .....+.+.+|++++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4578999999999999999999874 689999999875421 1234578999999999999999999999984 4557
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGl 745 (948)
.++||||++++ |.+++.. .....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~lv~e~~~~~-l~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDS---VPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp EEEEEECCSEE-HHHHHHH---STTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEehhccCC-HHHHHHh---CcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccc
Confidence 89999999876 7666643 233578999999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCC-CceeeeecccccccCceecccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc
Q 002238 746 VRLAPEGK-GSIETRIAGTFGYLAPEYAVTGR--VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK 822 (948)
Q Consensus 746 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 822 (948)
+....... ........||+.|+|||++.+.. ++.++||||||+++|||++|+.||......+.... +....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------i~~~~ 229 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN------IGKGS 229 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH------HHHCC
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH------HhcCC
Confidence 98654322 22334456999999999987654 47899999999999999999999987553322111 11111
Q ss_pred cccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 823 DSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.. +.. .....+.+++.+|++.||.+||++.++++.
T Consensus 230 ~~----~~~---------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 YA----IPG---------DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CC----CCS---------SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CC----CCC---------ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 011 122458899999999999999999999875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=349.03 Aligned_cols=264 Identities=20% Similarity=0.324 Sum_probs=197.3
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc------
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE------ 665 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------ 665 (948)
..+|+..+.||+|+||.||+|+..++..||+|++.... ....+|+++++.++||||+++++++.....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK------RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc------chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 45799999999999999999998777779999886532 122479999999999999999999965443
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEc-CCCCeEEeecC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFG 744 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~-~~~~~kl~DfG 744 (948)
.++||||++++ +.+.+..+. .....+++..+..++.|+++||+|||+ .+|+||||||+|||++ .++.+||+|||
T Consensus 113 ~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 113 LNLVLEYVPET-VYRASRHYA-KLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEECCSEE-HHHHHHHHH-HTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEeeccCcc-HHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 78999999764 444443322 223678999999999999999999997 8999999999999999 78999999999
Q ss_pred CceecCCCCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc-
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK- 822 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 822 (948)
+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....+ ........
T Consensus 188 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i--~~~~g~p~~ 263 (394)
T 4e7w_A 188 SAKILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEI--IKVLGTPSR 263 (394)
T ss_dssp TCEECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHHHCCCCH
T ss_pred CcccccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHhCCCCH
Confidence 998764433 23345789999999998765 5899999999999999999999999886644332211 11110000
Q ss_pred -------cccccccCcccCCc----cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 823 -------DSFHKAIDPTIDLN----EGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 823 -------~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
..+....-+..... ........++.+++.+|++.||.+||++.|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000000000000 0001133568999999999999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=335.88 Aligned_cols=255 Identities=26% Similarity=0.323 Sum_probs=205.5
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-------hhhHHHHHHHHHHHHhcC-CCceeeEEeEE
Q 002238 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-------GKGLTEFKSEIAVLTKVR-HRHLVALLGHC 660 (948)
Q Consensus 590 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~-H~niv~l~~~~ 660 (948)
...++|++.+.||+|+||.||+|..+ +|+.||||++...... ....+.+.+|++++++++ ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34678999999999999999999875 6899999999764311 122456889999999995 99999999999
Q ss_pred EeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEE
Q 002238 661 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 740 (948)
Q Consensus 661 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl 740 (948)
.+++..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEE
Confidence 999999999999999999999854 1468999999999999999999997 89999999999999999999999
Q ss_pred eecCCceecCCCCCceeeeecccccccCceecc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHH
Q 002238 741 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV------TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTW 814 (948)
Q Consensus 741 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~ 814 (948)
+|||++....... ......||+.|+|||++. ...++.++||||||+++|||++|+.||...........
T Consensus 166 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--- 240 (298)
T 1phk_A 166 TDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM--- 240 (298)
T ss_dssp CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---
T ss_pred ecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH---
Confidence 9999998765432 233456899999999985 45688999999999999999999999987554322111
Q ss_pred HHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 815 FRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
......... . .........+.+++.+|++.||.+||++.++++
T Consensus 241 ---~~~~~~~~~---~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 ---IMSGNYQFG---S------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp ---HHHTCCCCC---T------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---HhcCCcccC---c------ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111010000 0 011123456889999999999999999999876
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=351.66 Aligned_cols=271 Identities=25% Similarity=0.352 Sum_probs=184.9
Q ss_pred hcCCcc-cceecccCceEEEEEEEc---CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCc
Q 002238 592 TNNFSE-ENILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNE 665 (948)
Q Consensus 592 ~~~~~~-~~~lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~ 665 (948)
.+.|++ +++||+|+||.||+|+++ +++.||||++..... ...+.+|++++++++||||+++++++.. +..
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 445665 568999999999999875 578999999875422 2568899999999999999999999964 667
Q ss_pred eEEEEEecCCCChhHHHHhhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE----cCCCC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEE----GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMR 737 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill----~~~~~ 737 (948)
.++||||++ |+|.+++...... ....+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCc
Confidence 899999996 5888777542211 12358999999999999999999997 899999999999999 67789
Q ss_pred eEEeecCCceecCCCCC--ceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchh-------
Q 002238 738 AKVADFGLVRLAPEGKG--SIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEE------- 807 (948)
Q Consensus 738 ~kl~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~------- 807 (948)
+||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 99999999986543221 223446799999999999874 58999999999999999999999997654321
Q ss_pred hhhHHHHHHHhhcCccc-cccc------------cC-cccCCcc-------chHHHHHHHHHHHHHhcccCCCCCCChHH
Q 002238 808 SMHLVTWFRRIHLSKDS-FHKA------------ID-PTIDLNE-------GILASISTVAELAGHCCAREPYQRPDMGH 866 (948)
Q Consensus 808 ~~~~~~~~~~~~~~~~~-~~~~------------~~-~~~~~~~-------~~~~~~~~l~~li~~c~~~~P~~RPt~~e 866 (948)
...+...+......... +... +. ....... ........+.+|+.+|++.||.+|||++|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 11111111111111000 0000 00 0000000 00001245789999999999999999999
Q ss_pred HHHH
Q 002238 867 AVNV 870 (948)
Q Consensus 867 v~~~ 870 (948)
++++
T Consensus 331 ~L~h 334 (405)
T 3rgf_A 331 AMQD 334 (405)
T ss_dssp HHTS
T ss_pred HhcC
Confidence 9874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=340.68 Aligned_cols=259 Identities=23% Similarity=0.329 Sum_probs=182.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHH-HHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIA-VLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|+..+.||+|+||.||+|..+ +|+.||||++.... ......++..|+. +++.++||||+++++++.+++..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 367889999999999999999875 78999999997653 3334455666666 77778999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCC-CeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
|||+++ +|.+++..........+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999975 88887754333334678999999999999999999997 5 999999999999999999999999999986
Q ss_pred cCCCCCceeeeecccccccCceec----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYA----VTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
..... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||........ ....
T Consensus 176 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~------- 241 (327)
T 3aln_A 176 LVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQ------- 241 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC-------
T ss_pred ccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHH-------
Confidence 54432 22334699999999998 456789999999999999999999999976432110 0000
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
......+.+. ..........+.+++.+|++.||++||++.++++.
T Consensus 242 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 242 VVKGDPPQLS-NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCSCCCCCC-CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HhcCCCCCCC-CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0000001111 00111233468899999999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=339.27 Aligned_cols=254 Identities=21% Similarity=0.320 Sum_probs=199.3
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC--CCceeeEEeEEEeCCceEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR--HRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~l 668 (948)
..++|++.+.||+|+||.||+|..++++.||||++..........+.+.+|++++++++ ||||+++++++.+++..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 45679999999999999999999888999999999876556666788999999999997 5999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||| +.+++|.+++.. ...+++..++.++.|+++||+|||+ .+|+||||||+||++++ +.+||+|||+++.
T Consensus 106 v~e-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 106 VME-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EEC-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred EEe-cCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeecccccc
Confidence 999 568899999853 2478999999999999999999997 79999999999999974 8999999999986
Q ss_pred cCCCCCc-eeeeecccccccCceeccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH
Q 002238 749 APEGKGS-IETRIAGTFGYLAPEYAVT-----------GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFR 816 (948)
Q Consensus 749 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~ 816 (948)
....... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ...
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-----~~~ 250 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----KLH 250 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----HHH
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH-----HHH
Confidence 5443221 2234569999999999875 4688999999999999999999999976543211 111
Q ss_pred HhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 817 RIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
....... ..... . .....+.+++.+|++.||.+||++.++++.
T Consensus 251 ~~~~~~~------~~~~~--~---~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 251 AIIDPNH------EIEFP--D---IPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHCTTS------CCCCC--C---CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhccc------ccCCc--c---cchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1111000 00000 0 112458899999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.07 Aligned_cols=252 Identities=25% Similarity=0.424 Sum_probs=192.9
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe-------
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD------- 662 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------- 662 (948)
..++|++.+.||+|+||.||+|+.. +|+.||||++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 3567999999999999999999874 789999999865 34456789999999999999999999998865
Q ss_pred ------CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC
Q 002238 663 ------GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 736 (948)
Q Consensus 663 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~ 736 (948)
....++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~ 153 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHS----ENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESR 153 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHH----SCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTS
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhc----cccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCC
Confidence 3467999999999999999853 23467889999999999999999997 7999999999999999999
Q ss_pred CeEEeecCCceecCCCC-------------CceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 002238 737 RAKVADFGLVRLAPEGK-------------GSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDE 802 (948)
Q Consensus 737 ~~kl~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~ 802 (948)
.+||+|||+++...... ........||+.|+|||++.+. .++.++||||||+++|||++ ||..
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 99999999998654321 1122345689999999999764 68999999999999999998 5442
Q ss_pred CCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 803 SQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 803 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.. +.... ..........+. +.+ ....+..+.+++.+|++.||.+||++.++++
T Consensus 231 ~~--~~~~~---~~~~~~~~~~~~----~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 231 GM--ERVNI---LKKLRSVSIEFP----PDF-----DDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HH--HHHHH---HHHHHSTTCCCC----TTC-----CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ch--hHHHH---HHhccccccccC----ccc-----cccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 21 11111 111111111111 111 1122345889999999999999999999987
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=347.47 Aligned_cols=267 Identities=20% Similarity=0.297 Sum_probs=206.3
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhh---------------HHHHHHHHHHHHhcCCCceeeE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKG---------------LTEFKSEIAVLTKVRHRHLVAL 656 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~---------------~~~~~~E~~~l~~l~H~niv~l 656 (948)
.++|++.+.||+|+||.||+|.. +|+.||||++......... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999998 7999999998754322111 1789999999999999999999
Q ss_pred EeEEEeCCceEEEEEecCCCChhHHHHhh---hhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEc
Q 002238 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNW---AEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 733 (948)
Q Consensus 657 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~ 733 (948)
++++.+.+..++||||+++|+|.+++... .......+++..++.++.|++.||+|||+ ..+|+||||||+||+++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence 99999999999999999999999883210 11224679999999999999999999996 37999999999999999
Q ss_pred CCCCeEEeecCCceecCCCCCceeeeecccccccCceecccC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCchhhhhH
Q 002238 734 DDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG-RVTT-KVDVFSFGVILMELITGRKALDESQPEESMHL 811 (948)
Q Consensus 734 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~ 811 (948)
.++.++|+|||+++..... ......||+.|+|||++.+. .++. ++||||||+++|||++|+.||........ .
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~ 261 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE--L 261 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH--H
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--H
Confidence 9999999999999876443 33456799999999999887 6666 99999999999999999999987654211 1
Q ss_pred HHHHHHhhcCcccccccc----CcccC--CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 812 VTWFRRIHLSKDSFHKAI----DPTID--LNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~----~~~~~--~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.. .+......+.... .+... ...........+.+++.+|++.||.+||++.|+++
T Consensus 262 ~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 FN---NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HH---HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HH---HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 1111111111000 00000 00000223456889999999999999999999987
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=353.26 Aligned_cols=363 Identities=17% Similarity=0.212 Sum_probs=254.2
Q ss_pred CCCCCccc--eEEeCC---------CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC--CcCCCCCCcEE
Q 002238 54 TDPCKWNH--VVCIED---------KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP--SLNGLASLEVV 120 (948)
Q Consensus 54 ~~~C~w~g--v~c~~~---------~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L 120 (948)
...|.|.+ |.|... .+++.|+|++|++++..|..|.++++|++|+|++|.+.+.++ .|.++++|++|
T Consensus 5 ~~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L 84 (455)
T 3v47_A 5 TSECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIIL 84 (455)
T ss_dssp --CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEE
T ss_pred cceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEE
Confidence 34566666 778543 579999999999999889999999999999999999986543 69999999999
Q ss_pred EcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCcc--ccCCCCCCEEEccCccccccCCCC-CCCCCCCCCcEEEc
Q 002238 121 MLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQS--LRNASGLQNFSANSANITGQIPSF-FGPDEFPGLTILHL 197 (948)
Q Consensus 121 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~--~~~l~~L~~L~l~~n~l~~~~p~~-~~~~~l~~L~~L~L 197 (948)
+|++|.+++++|..|+++++|++|+|++|++++ .+|.. +.++++|++|+|++|++++..|.. +. .+++|++|+|
T Consensus 85 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~--~l~~L~~L~L 161 (455)
T 3v47_A 85 KLDYNQFLQLETGAFNGLANLEVLTLTQCNLDG-AVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL--NMRRFHVLDL 161 (455)
T ss_dssp ECTTCTTCEECTTTTTTCTTCCEEECTTSCCBT-HHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGG--GCTTCCEEEC
T ss_pred eCCCCccCccChhhccCcccCCEEeCCCCCCCc-cccCcccccCcccCCEEECCCCccCccCcccccC--CCCcccEEeC
Confidence 999999999999999999999999999999986 44544 899999999999999999998876 65 8999999999
Q ss_pred ccccccccCCCCccc---ccccceeccCCCCCCccCCCc-----cccccCCCccEEEccCCcccccCCC-CC---CCCCC
Q 002238 198 AFNQLIGGLPASFSG---SQIQSLWVNGQNGNAKLGGGI-----DVIQNMTSLKEIWLHSNAFSGPLPD-FS---GVKQL 265 (948)
Q Consensus 198 s~N~l~~~~p~~~~~---~~l~~l~~~~~~~~~~~~~~~-----~~l~~l~~L~~L~Ls~N~l~~~~~~-~~---~l~~L 265 (948)
++|++++..|..+.. .+++.|++.++.......... ..+..+++|++|+|++|++++.++. +. ...+|
T Consensus 162 ~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L 241 (455)
T 3v47_A 162 TFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKI 241 (455)
T ss_dssp TTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCE
T ss_pred CCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccce
Confidence 999999998888765 345555554443332221111 1233567888899998888764432 11 12444
Q ss_pred cEEeccCCccccc----------cchhhhC--CCCCcEEEcccCcccccCCC-CCCccccccccccCCCCCCCCCCCchh
Q 002238 266 ESLSLRDNFFTGP----------VPDSLVK--LESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPR 332 (948)
Q Consensus 266 ~~L~L~~N~l~~~----------~p~~l~~--l~~L~~L~Ls~N~l~g~~p~-~~~~~~l~~~~~~~~~~~~~~~~~~~~ 332 (948)
+.|++++|.+.+. .+..+.. .++|+.|+|++|++++.+|. +..+.+|..++..+|.+...+.
T Consensus 242 ~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~----- 316 (455)
T 3v47_A 242 QSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDD----- 316 (455)
T ss_dssp EEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECT-----
T ss_pred eeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccCh-----
Confidence 4444444432211 1111111 13445555555555444443 3334444444444433222110
Q ss_pred hhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCc
Q 002238 333 LNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE 412 (948)
Q Consensus 333 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~ 412 (948)
..+..+++|+.|+|++|.+.+..|..|+++++|++|+|++|++++..|.
T Consensus 317 -------------------------------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 365 (455)
T 3v47_A 317 -------------------------------NAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQ 365 (455)
T ss_dssp -------------------------------TTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTT
T ss_pred -------------------------------hHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChh
Confidence 0122345778888888888877788888888888888888888877788
Q ss_pred CCcCCCCCcEEEccCCcccCCCCC----CCcccccccCCCCCCCCcc
Q 002238 413 GLSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNPDIGKEK 455 (948)
Q Consensus 413 ~l~~l~~L~~L~ls~N~l~g~ip~----~~~~~~~~~~gnp~~~~~~ 455 (948)
.|..+++|++|+|++|+|++.++. +.....+.+++||+.|.++
T Consensus 366 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 366 SFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred hccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 888888888888888888775553 3456677788888877665
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=336.70 Aligned_cols=266 Identities=21% Similarity=0.372 Sum_probs=196.3
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEE--------
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCL-------- 661 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-------- 661 (948)
..++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 3578999999999999999999876 5899999998754 4556678999999999999999999999874
Q ss_pred ------eCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEc-C
Q 002238 662 ------DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-D 734 (948)
Q Consensus 662 ------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~-~ 734 (948)
+....++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+ .+|+||||||+||+++ +
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~ 156 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTE 156 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETT
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCC
Confidence 3467799999997 699888732 568999999999999999999997 8999999999999997 5
Q ss_pred CCCeEEeecCCceecCCCCC--ceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhH
Q 002238 735 DMRAKVADFGLVRLAPEGKG--SIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHL 811 (948)
Q Consensus 735 ~~~~kl~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~ 811 (948)
++.+||+|||+++....... .......||..|+|||++.+ ..++.++||||||+++|||++|+.||......+....
T Consensus 157 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 236 (320)
T 2i6l_A 157 DLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL 236 (320)
T ss_dssp TTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 67999999999986543211 12233467999999998865 6789999999999999999999999987664332221
Q ss_pred HHHHHHhhcCcc-c-----------ccc-ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 812 VTWFRRIHLSKD-S-----------FHK-AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 812 ~~~~~~~~~~~~-~-----------~~~-~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+. ........ . ... ...+.............++.+++.+|++.||++||+++++++.
T Consensus 237 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 237 IL--ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HH--HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HH--HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 11 10000000 0 000 0000000011111234568999999999999999999999873
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=338.73 Aligned_cols=262 Identities=22% Similarity=0.359 Sum_probs=200.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc-----
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE----- 665 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 665 (948)
.++|...+.||+|+||.||+|..+ +|+.||||++..........+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999875 68999999997654455556789999999999999999999999987654
Q ss_pred -eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 666 -KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 666 -~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
.++||||++ ++|.+++. ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred eEEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecc
Confidence 499999997 68877662 358999999999999999999997 899999999999999999999999999
Q ss_pred CceecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcc
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD 823 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 823 (948)
+++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+. ........
T Consensus 172 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~ 245 (353)
T 3coi_A 172 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL--KVTGVPGT 245 (353)
T ss_dssp CTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHH--HHHCBCCH
T ss_pred cccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HHhCCCCH
Confidence 98754332 234578999999999877 678999999999999999999999998765433222111 10000000
Q ss_pred cccc------------ccC--cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 824 SFHK------------AID--PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 824 ~~~~------------~~~--~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.+.. .+. +.............++.+++.+|++.||++||+++++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 000 0000011112234568999999999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=339.76 Aligned_cols=205 Identities=25% Similarity=0.342 Sum_probs=175.3
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CC-----ceeeEEeEEEeC
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HR-----HLVALLGHCLDG 663 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~~ 663 (948)
+.++|++.+.||+|+||.||+|... +++.||||+++. ......++..|+.+++.++ |+ +|+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 4678999999999999999999875 688999999874 3344567888999999885 55 499999999999
Q ss_pred CceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEc--CCCCeEEe
Q 002238 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVA 741 (948)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~--~~~~~kl~ 741 (948)
+..++||||++ |+|.+++.. .....+++..+..++.|++.||+|||+. +.+|+||||||+|||++ .++.+||+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRN---TNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred CceEEEEecCC-CCHHHHHhh---cCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 99999999996 599998854 2235689999999999999999999952 36899999999999995 47789999
Q ss_pred ecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q 002238 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEE 807 (948)
Q Consensus 742 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~ 807 (948)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 204 DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 265 (382)
T 2vx3_A 204 DFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD 265 (382)
T ss_dssp CCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred eccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999876432 234578999999999999999999999999999999999999998766544
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=338.24 Aligned_cols=264 Identities=23% Similarity=0.316 Sum_probs=202.8
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CC-cEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCc------eeeEEeEEEe
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DG-TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH------LVALLGHCLD 662 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~ 662 (948)
..++|++.+.||+|+||.||+|... ++ +.||||+++. .....+.+.+|++++++++|++ ++.+++++..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 3578999999999999999999874 34 6899999864 3345577889999999997766 8999999999
Q ss_pred CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE----------
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---------- 732 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill---------- 732 (948)
.+..++||||+ ++++.+.+.. .....+++.+++.++.||+.||+|||+ .+|+||||||+|||+
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKE---NNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEEC
T ss_pred CCeEEEEEecc-CCChHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccc
Confidence 99999999999 6677776643 233578999999999999999999997 899999999999999
Q ss_pred ---------cCCCCeEEeecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 002238 733 ---------GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDES 803 (948)
Q Consensus 733 ---------~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~ 803 (948)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 56789999999999865432 23457999999999999999999999999999999999999999876
Q ss_pred CchhhhhHHHHHHHhhcCccccc--------------------------cccCcccCCccchHHHHHHHHHHHHHhcccC
Q 002238 804 QPEESMHLVTWFRRIHLSKDSFH--------------------------KAIDPTIDLNEGILASISTVAELAGHCCARE 857 (948)
Q Consensus 804 ~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~ 857 (948)
...+....+...... ....... +...+..............+.+++.+|++.|
T Consensus 243 ~~~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 243 ENREHLVMMEKILGP-IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp SHHHHHHHHHHHHCC-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CHHHHHHHHHHHcCC-CcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 654332222111100 0000000 0000000000111223457889999999999
Q ss_pred CCCCCChHHHHH
Q 002238 858 PYQRPDMGHAVN 869 (948)
Q Consensus 858 P~~RPt~~ev~~ 869 (948)
|++|||+.|+++
T Consensus 322 P~~Rpt~~e~l~ 333 (355)
T 2eu9_A 322 PAQRITLAEALL 333 (355)
T ss_dssp TTTSCCHHHHTT
T ss_pred hhhCcCHHHHhc
Confidence 999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=336.10 Aligned_cols=254 Identities=23% Similarity=0.306 Sum_probs=173.4
Q ss_pred hhcCCccc-ceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe----CC
Q 002238 591 VTNNFSEE-NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD----GN 664 (948)
Q Consensus 591 ~~~~~~~~-~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~ 664 (948)
+.++|.+. ++||+|+||.||+|..+ +|+.||||++... . ....+....++.++||||+++++++.. +.
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 46788885 46999999999999876 7899999998653 1 122223334667799999999999876 44
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC---CCCeEEe
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVA 741 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~---~~~~kl~ 741 (948)
..++||||+++|+|.+++.. .....+++.+++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||+
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~---~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQE---RGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHT---C-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred eEEEEEeccCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEe
Confidence 57999999999999999854 223579999999999999999999997 79999999999999986 4559999
Q ss_pred ecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcC
Q 002238 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS 821 (948)
Q Consensus 742 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 821 (948)
|||+++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||............ .......
T Consensus 174 Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~ 248 (336)
T 3fhr_A 174 DFGFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM--KRRIRLG 248 (336)
T ss_dssp CCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred ccccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH--HHhhhcc
Confidence 999998654322 23456899999999998889999999999999999999999999765433211000 0000000
Q ss_pred ccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 822 KDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
...+ . ..........+.+++.+|++.||.+||++.|+++.
T Consensus 249 ~~~~--------~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 249 QYGF--------P-NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp --CC--------C-TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cccc--------C-chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 0 00111233468899999999999999999999984
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=344.09 Aligned_cols=264 Identities=22% Similarity=0.317 Sum_probs=197.7
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-----------CCceeeEEeE
Q 002238 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-----------HRHLVALLGH 659 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~ 659 (948)
.++|++.+.||+|+||.||+|+. .+++.||||++.. .......+.+|++++++++ ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 36799999999999999999986 4789999999874 3344577889999999886 8999999999
Q ss_pred EEeCC----ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCC-CeeecCCCCccEEEc-
Q 002238 660 CLDGN----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLG- 733 (948)
Q Consensus 660 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivHrDik~~Nill~- 733 (948)
+...+ ..++||||+ +++|.+++... ....+++..++.++.||+.||+|||+ . +|+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~ 167 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEI 167 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEE
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHh---hccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEec
Confidence 88654 679999999 89999988542 23468999999999999999999997 6 999999999999995
Q ss_pred -----CCCCeEEeecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 002238 734 -----DDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEES 808 (948)
Q Consensus 734 -----~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~ 808 (948)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 168 ~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 243 (373)
T 1q8y_A 168 VDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243 (373)
T ss_dssp EETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred cCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 3447999999999866432 2335689999999999999999999999999999999999999986542211
Q ss_pred h----hHHHHHHHhhcC----------------ccccccccCc-cc--------CCccchHHHHHHHHHHHHHhcccCCC
Q 002238 809 M----HLVTWFRRIHLS----------------KDSFHKAIDP-TI--------DLNEGILASISTVAELAGHCCAREPY 859 (948)
Q Consensus 809 ~----~~~~~~~~~~~~----------------~~~~~~~~~~-~~--------~~~~~~~~~~~~l~~li~~c~~~~P~ 859 (948)
. ............ .......+.. .. ...........++.+++.+|++.||+
T Consensus 244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (373)
T 1q8y_A 244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 323 (373)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence 1 111111100000 0000000000 00 00011234566789999999999999
Q ss_pred CCCChHHHHH
Q 002238 860 QRPDMGHAVN 869 (948)
Q Consensus 860 ~RPt~~ev~~ 869 (948)
+||+++|+++
T Consensus 324 ~Rpt~~ell~ 333 (373)
T 1q8y_A 324 KRADAGGLVN 333 (373)
T ss_dssp TCBCHHHHHT
T ss_pred ccCCHHHHhh
Confidence 9999999977
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=335.98 Aligned_cols=255 Identities=23% Similarity=0.353 Sum_probs=182.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|+..+.||+|+||.||+|..+ +|+.||||++..........+.+.++..+++.++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467889999999999999999875 7899999999865433333444555666788889999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+ ++.+..+... ....+++..++.++.|++.||+|||+ +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 104 e~~-~~~~~~l~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR----MQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHH--HHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHh--hCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 5555544422 13578999999999999999999997 1389999999999999999999999999997654
Q ss_pred CCCCceeeeecccccccCceecc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
... ......||+.|+|||++. ...++.++||||||+++|||++|+.||........ ... ......
T Consensus 177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~---~~~~~~--- 246 (318)
T 2dyl_A 177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--VLT---KVLQEE--- 246 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHH---HHHHSC---
T ss_pred CCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--HHH---HHhccC---
Confidence 432 233456999999999984 55788999999999999999999999986443211 111 111100
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.+.+.. .......+.+++.+|++.||.+||++.++++.
T Consensus 247 ----~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 247 ----PPLLPG---HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp ----CCCCCS---SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ----CCCCCc---cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 001110 01123458899999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=348.04 Aligned_cols=255 Identities=26% Similarity=0.352 Sum_probs=188.5
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+++..++||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 3456667899999999998776677999999998653 235678999999987 8999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC-------------
Q 002238 671 EYMPQGTLSRHIFNWAEEGL--KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD------------- 735 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~------------- 735 (948)
||++ |+|.+++........ ...++..++.++.||+.||+|||+ .+|+||||||+|||++.+
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCc
Confidence 9995 699999854221110 112334567899999999999997 899999999999999754
Q ss_pred CCeEEeecCCceecCCCCCc---eeeeecccccccCceeccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 002238 736 MRAKVADFGLVRLAPEGKGS---IETRIAGTFGYLAPEYAVT-------GRVTTKVDVFSFGVILMELIT-GRKALDESQ 804 (948)
Q Consensus 736 ~~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~ 804 (948)
+.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||....
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 47999999999976554322 1234579999999999975 678999999999999999999 999997654
Q ss_pred chhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 805 PEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 805 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..+. ..... ...... .. .........++.+++.+|++.||.+||++.++++
T Consensus 245 ~~~~----~i~~~----~~~~~~-----~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 245 SRES----NIIRG----IFSLDE-----MK-CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp THHH----HHHHT----CCCCCC-----CT-TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhHH----HHhcC----CCCccc-----cc-ccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 3221 11111 101100 00 1112344567899999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=337.08 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=200.4
Q ss_pred HHHHHhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCCh----hhHHHHHHHHHHHHhcC--CCceeeEEe
Q 002238 586 QVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG----KGLTEFKSEIAVLTKVR--HRHLVALLG 658 (948)
Q Consensus 586 ~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--H~niv~l~~ 658 (948)
.+.....++|++.+.||+|+||.||+|... +++.||||++....... .....+.+|+.++++++ ||||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 344556788999999999999999999864 78999999997653322 12345778999999996 599999999
Q ss_pred EEEeCCceEEEEEecCC-CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEc-CCC
Q 002238 659 HCLDGNEKLLVFEYMPQ-GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDM 736 (948)
Q Consensus 659 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~-~~~ 736 (948)
++.+++..++||||+.+ ++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++ +++
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRG 187 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTT
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCC
Confidence 99999999999999976 899998854 2468999999999999999999997 8999999999999999 788
Q ss_pred CeEEeecCCceecCCCCCceeeeecccccccCceecccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHH
Q 002238 737 RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWF 815 (948)
Q Consensus 737 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~ 815 (948)
.+||+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ..
T Consensus 188 ~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~~ 256 (320)
T 3a99_A 188 ELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------II 256 (320)
T ss_dssp EEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------HH
T ss_pred CEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--------hh
Confidence 99999999998765432 334569999999999987766 6889999999999999999999965211 00
Q ss_pred HHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 816 RRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
. ... ..... ...++.+++.+|++.||++||+++++++
T Consensus 257 ~----~~~----~~~~~---------~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 257 R----GQV----FFRQR---------VSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp H----CCC----CCSSC---------CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c----ccc----ccccc---------CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000 01111 1245889999999999999999999976
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=357.59 Aligned_cols=373 Identities=20% Similarity=0.182 Sum_probs=278.6
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (948)
.+++.|+|++|++++..+..|.++++|++|+|++|.|++..| .|.++++|++|+|++|.+++++|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 578899999999988888889999999999999999988777 6888999999999999999988888999999999999
Q ss_pred cCCCCCCCCCCccccCCCCCCEEEccCccccc-cCCCCCCCCCCCCCcEEEcccccccccCCCCccc-------------
Q 002238 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITG-QIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG------------- 212 (948)
Q Consensus 147 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~-~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------------- 212 (948)
++|+++. ..+..+.++++|++|++++|.+++ .+|..|+ .+++|++|+|++|++++..|..+..
T Consensus 112 ~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~--~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l 188 (606)
T 3vq2_A 112 VETKLAS-LESFPIGQLITLKKLNVAHNFIHSCKLPAYFS--NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188 (606)
T ss_dssp TTSCCCC-SSSSCCTTCTTCCEEECCSSCCCCCCCCGGGG--TCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEEC
T ss_pred cCCcccc-ccccccCCCCCCCEEeCCCCcccceechHhHh--hcCCCCEEEccCCcceecChhhhhhhhccccccceeec
Confidence 9998885 334678888888888888888876 5688777 7888888888888888766654432
Q ss_pred ---------------ccccceeccCCCCC---------------------------------------------------
Q 002238 213 ---------------SQIQSLWVNGQNGN--------------------------------------------------- 226 (948)
Q Consensus 213 ---------------~~l~~l~~~~~~~~--------------------------------------------------- 226 (948)
.+++.|++.++...
T Consensus 189 ~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l 268 (606)
T 3vq2_A 189 SLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL 268 (606)
T ss_dssp TTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEE
T ss_pred cCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheec
Confidence 12333333222110
Q ss_pred -------------------------------------------------Cc--c-----------------CCCcccccc
Q 002238 227 -------------------------------------------------AK--L-----------------GGGIDVIQN 238 (948)
Q Consensus 227 -------------------------------------------------~~--~-----------------~~~~~~l~~ 238 (948)
.. . ......+..
T Consensus 269 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~ 348 (606)
T 3vq2_A 269 TYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVA 348 (606)
T ss_dssp CCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCC
T ss_pred cccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhcc
Confidence 00 0 000112345
Q ss_pred CCCccEEEccCCcccccC--C-CCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCC--CCCCccccc
Q 002238 239 MTSLKEIWLHSNAFSGPL--P-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP--EFDRSVSLD 313 (948)
Q Consensus 239 l~~L~~L~Ls~N~l~~~~--~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p--~~~~~~~l~ 313 (948)
+++|++|+|++|++++.. + .+..+++|+.|+|++|.++ .+|..+..+++|+.|++++|++.+.+| .+..+.+|.
T Consensus 349 l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 427 (606)
T 3vq2_A 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLL 427 (606)
T ss_dssp CTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCC
T ss_pred CCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccccCC
Confidence 678888888888888752 3 5778899999999999988 477888999999999999999988776 477788888
Q ss_pred cccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCC-CccceeecCCceEEEEccCCcccccCCccccC
Q 002238 314 MAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCS-DWIGVTCTKGNITVINFQKMNLTGTISPEFAS 392 (948)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~ 392 (948)
.++..+|............+..+..+ +..++.... .....+..+++|+.|+|++|++++.+|..|++
T Consensus 428 ~L~l~~n~l~~~~~~~~~~l~~L~~L------------~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 495 (606)
T 3vq2_A 428 YLDISYTNTKIDFDGIFLGLTSLNTL------------KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDT 495 (606)
T ss_dssp EEECTTSCCEECCTTTTTTCTTCCEE------------ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred EEECcCCCCCccchhhhcCCCCCCEE------------ECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcc
Confidence 88888776554433322222221111 111111000 01123456789999999999999999999999
Q ss_pred ccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCCC---CC-cccccccCCCCCCCCccC
Q 002238 393 FKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS---FK-SNAIVNTDGNPDIGKEKS 456 (948)
Q Consensus 393 l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~---~~-~~~~~~~~gnp~~~~~~~ 456 (948)
+++|++|+|++|++++.+|..+..+++|++|||++|+|+..++. +. ....+.+++||+.|.++.
T Consensus 496 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 496 LHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp CTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred cccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 99999999999999999999999999999999999999854333 22 366788999999987764
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=351.31 Aligned_cols=375 Identities=20% Similarity=0.211 Sum_probs=260.7
Q ss_pred CCCccceEEeCC------------CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEc
Q 002238 56 PCKWNHVVCIED------------KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVML 122 (948)
Q Consensus 56 ~C~w~gv~c~~~------------~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L 122 (948)
.|.|.|+ |+.. .+++.|+|++|++++..|..|.++++|++|+|++|+|++.+| .|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 4899998 8532 479999999999998889999999999999999999999887 7999999999999
Q ss_pred ccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCC-CCCCCCCCCCCcEEEccccc
Q 002238 123 SNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIP-SFFGPDEFPGLTILHLAFNQ 201 (948)
Q Consensus 123 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~Ls~N~ 201 (948)
++|+++++++..|+++++|++|+|++|+++...+|..+.++++|++|++++|++.+.+| ..|. .+++|++|+|++|+
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~--~l~~L~~L~L~~n~ 159 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFA--GLTSLNELEIKALS 159 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTT--TCCEEEEEEEEETT
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhh--cccccCeeeccCCc
Confidence 99999999999999999999999999999975678899999999999999999555555 5676 89999999999999
Q ss_pred ccccCCCCccc-c------------------------cccceeccCCCCCCccCCCc-----------------------
Q 002238 202 LIGGLPASFSG-S------------------------QIQSLWVNGQNGNAKLGGGI----------------------- 233 (948)
Q Consensus 202 l~~~~p~~~~~-~------------------------~l~~l~~~~~~~~~~~~~~~----------------------- 233 (948)
+++.+|..+.. . +++.|++.++..........
T Consensus 160 l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 239 (549)
T 2z81_A 160 LRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239 (549)
T ss_dssp CCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHH
T ss_pred ccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhH
Confidence 99888877653 2 23333333222111000000
Q ss_pred -----cc-----------------------------------------------------------cccCCCccEEEccC
Q 002238 234 -----DV-----------------------------------------------------------IQNMTSLKEIWLHS 249 (948)
Q Consensus 234 -----~~-----------------------------------------------------------l~~l~~L~~L~Ls~ 249 (948)
.. +..+++|+.|++++
T Consensus 240 ~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~ 319 (549)
T 2z81_A 240 FNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVEN 319 (549)
T ss_dssp HHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEES
T ss_pred HHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEecc
Confidence 00 00012233333333
Q ss_pred CcccccCCCC-CCCCCCcEEeccCCccccccch---hhhCCCCCcEEEcccCcccccCC---CCCCccccccccccCCCC
Q 002238 250 NAFSGPLPDF-SGVKQLESLSLRDNFFTGPVPD---SLVKLESLKIVNMTNNLLQGPVP---EFDRSVSLDMAKGSNNFC 322 (948)
Q Consensus 250 N~l~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~---~l~~l~~L~~L~Ls~N~l~g~~p---~~~~~~~l~~~~~~~~~~ 322 (948)
|+++..+..+ ..+++|+.|+|++|++++.+|. .++.+++|+.|+|++|++++..+ .+..+.+|..++..+|..
T Consensus 320 n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l 399 (549)
T 2z81_A 320 SKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF 399 (549)
T ss_dssp SCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCC
T ss_pred CccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCC
Confidence 3333211122 2466677777777777665543 25666677777777777665432 144555666666666655
Q ss_pred CCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCc
Q 002238 323 LPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILA 402 (948)
Q Consensus 323 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls 402 (948)
..+|.... ....+. ..+..++.-. ...+ +..++|+.|+|++|++++.+ +++++|++|+|+
T Consensus 400 ~~lp~~~~-~~~~L~------------~L~Ls~N~l~-~l~~--~~~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls 459 (549)
T 2z81_A 400 HPMPDSCQ-WPEKMR------------FLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLDSFS----LFLPRLQELYIS 459 (549)
T ss_dssp CCCCSCCC-CCTTCC------------EEECTTSCCS-CCCT--TSCTTCSEEECCSSCCSCCC----CCCTTCCEEECC
T ss_pred ccCChhhc-cccccc------------EEECCCCCcc-cccc--hhcCCceEEECCCCChhhhc----ccCChhcEEECC
Confidence 54443211 000000 0011111100 0000 01247999999999998753 578999999999
Q ss_pred cccccccCCcCCcCCCCCcEEEccCCcccCCCCC----CCcccccccCCCCCCCCcc
Q 002238 403 DNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNPDIGKEK 455 (948)
Q Consensus 403 ~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~----~~~~~~~~~~gnp~~~~~~ 455 (948)
+|+|+ .+|. ...+++|++|||++|+|++.+|. +.....+.+++||+.|.++
T Consensus 460 ~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 460 RNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp SSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred CCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 99998 7886 57899999999999999998885 3456788999999998775
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=331.73 Aligned_cols=246 Identities=25% Similarity=0.383 Sum_probs=190.9
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCCh----hhHHHHHHHHHHHHhc----CCCceeeEEe
Q 002238 588 LRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG----KGLTEFKSEIAVLTKV----RHRHLVALLG 658 (948)
Q Consensus 588 l~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l----~H~niv~l~~ 658 (948)
.....++|++.+.||+|+||.||+|+.. +++.||||++....... .....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3456788999999999999999999864 78999999997643221 1233466899999999 8999999999
Q ss_pred EEEeCCceEEEEEe-cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEc-CCC
Q 002238 659 HCLDGNEKLLVFEY-MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDM 736 (948)
Q Consensus 659 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~-~~~ 736 (948)
++.+.+..++|||| +.+++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++ .++
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE-----KGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTT
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCC
Confidence 99999999999999 789999999854 1468999999999999999999997 7999999999999999 889
Q ss_pred CeEEeecCCceecCCCCCceeeeecccccccCceecccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHH
Q 002238 737 RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVT-TKVDVFSFGVILMELITGRKALDESQPEESMHLVTWF 815 (948)
Q Consensus 737 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~ 815 (948)
.+||+|||+++...... .....||+.|+|||++.+..+. .++||||||+++|||++|+.||..... . .
T Consensus 178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~---~ 246 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----I---L 246 (312)
T ss_dssp EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H---H
T ss_pred eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----H---h
Confidence 99999999998765432 3345699999999999877664 599999999999999999999965211 0 0
Q ss_pred HHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 816 RRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..... +.. .....+.+++.+|++.+|++||++.|+++
T Consensus 247 ----~~~~~----~~~---------~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 247 ----EAELH----FPA---------HVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ----HTCCC----CCT---------TSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----hhccC----Ccc---------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 011 12245889999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=343.26 Aligned_cols=249 Identities=25% Similarity=0.367 Sum_probs=186.4
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 670 (948)
..+|+..++||+|+||+||.....+|+.||||++..... ..+.+|+++++.+ +|||||++++++.+....++||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 346888999999999997655556799999999865321 2357899999999 8999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC-----CCCeEEeecCC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-----DMRAKVADFGL 745 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~-----~~~~kl~DfGl 745 (948)
||++ |+|.+++.. ......+.+++.++.||+.||+|||+ .+|+||||||+|||++. ...+||+|||+
T Consensus 98 E~~~-g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 98 ELCA-ATLQEYVEQ----KDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp ECCS-EEHHHHHHS----SSCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred ECCC-CCHHHHHHh----cCCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 9996 699988853 22334445567899999999999997 89999999999999953 23588999999
Q ss_pred ceecCCCCC--ceeeeecccccccCceecc---cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhh
Q 002238 746 VRLAPEGKG--SIETRIAGTFGYLAPEYAV---TGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIH 819 (948)
Q Consensus 746 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 819 (948)
++....... .......||+.|+|||++. ...++.++|||||||++|||++ |..||.......... .
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~--------~ 241 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--------L 241 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH--------H
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH--------H
Confidence 986654322 2234467999999999997 4567889999999999999999 999996543322110 0
Q ss_pred cCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 820 LSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
...... .. ..........+.+++.+|++.||.+||++.++++
T Consensus 242 ~~~~~~-~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 242 LGACSL-DC-------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTCCCC-TT-------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccCCc-cc-------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 101000 00 1111223445789999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=349.64 Aligned_cols=272 Identities=25% Similarity=0.376 Sum_probs=204.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe------CC
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD------GN 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~ 664 (948)
.++|++.+.||+|+||.||+|... +|+.||||++... ......+.+.+|++++++++||||+++++++.. ++
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 368999999999999999999864 6899999998764 345556789999999999999999999998765 66
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCC---eEEe
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AKVA 741 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~---~kl~ 741 (948)
..++||||+++|+|.+++... .....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++. +||+
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~--~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQF--ENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSS--SCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred eEEEEEEeCCCCCHHHHHHhc--ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEc
Confidence 779999999999999998542 222468889999999999999999997 89999999999999997765 9999
Q ss_pred ecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh--
Q 002238 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH-- 819 (948)
Q Consensus 742 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-- 819 (948)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ |.....
T Consensus 167 DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~-----~~~~i~~~ 239 (676)
T 3qa8_A 167 DLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ-----WHGKVREK 239 (676)
T ss_dssp SCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH-----SSTTCC--
T ss_pred cccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh-----hhhhhhcc
Confidence 999998765433 23446799999999999999999999999999999999999999976432110 000000
Q ss_pred -----cCcccccc--ccCcccC-CccchHHHHHHHHHHHHHhcccCCCCCCChHH-----HHHHHHhhhh
Q 002238 820 -----LSKDSFHK--AIDPTID-LNEGILASISTVAELAGHCCAREPYQRPDMGH-----AVNVLSSLVE 876 (948)
Q Consensus 820 -----~~~~~~~~--~~~~~~~-~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~e-----v~~~L~~~~~ 876 (948)
........ .+...++ ...........+.+++.+|++.||++||++++ ..+.+..+..
T Consensus 240 ~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp ----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred cchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 00000000 0001111 01122335667999999999999999999988 5566666654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=315.32 Aligned_cols=233 Identities=12% Similarity=0.056 Sum_probs=186.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
.++|++.+.||+|+||.||+|... +|+.||||++...... ....+.+.+|+.++.+++||||+++++++.+++..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999875 5899999999865433 34457899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++++|.+++.. . ....++.+|+.|++.||+|||+ .+|+||||||+|||++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~------~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT------S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EECCCEEEHHHHHTT------C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEecCCCCHHHHHhc------C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 999999999998832 2 3455788999999999999997 899999999999999999999997443
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
|++| ++.++|||||||++|||++|+.||.+....+... .....+
T Consensus 175 ----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-------------~~~~~~ 218 (286)
T 3uqc_A 175 ----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-------------PAERDT 218 (286)
T ss_dssp ----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-------------ECCBCT
T ss_pred ----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-------------HHHHHh
Confidence 4433 6889999999999999999999998765432100 000000
Q ss_pred CcccC-CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 830 DPTID-LNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 830 ~~~~~-~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
..... ........+.++.+++.+|++.||.+| |+.|+++.|+++..
T Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 219 AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 00000 001112233568999999999999999 99999999999864
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=353.99 Aligned_cols=241 Identities=21% Similarity=0.336 Sum_probs=195.6
Q ss_pred hcCCcccceecccCceEEEEEEEc--CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc----
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE---- 665 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---- 665 (948)
.++|++.+.||+|+||.||+|.+. +|+.||||++... ........+.+|++++++++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 478999999999999999999875 5899999998653 234456788999999999999999999999987665
Q ss_pred -eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 666 -KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 666 -~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
.|+||||+++++|.+++. ..+++.+++.++.||+.||+|||+ .+||||||||+|||++.+ .+||+|||
T Consensus 158 ~~~lv~E~~~g~~L~~~~~-------~~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp EEEEEEECCCCEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCT
T ss_pred eeEEEEEeCCCCcHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecc
Confidence 699999999999987662 268999999999999999999997 899999999999999975 99999999
Q ss_pred CceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
+++..... ....||++|+|||++.+.. +.++|||||||++|||++|.+||........
T Consensus 227 ~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------------- 284 (681)
T 2pzi_A 227 AVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------------- 284 (681)
T ss_dssp TCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------------
T ss_pred cchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------------
Confidence 99876443 3456999999999987654 8999999999999999999988764221100
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCC-hHHHHHHHHhhh
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPD-MGHAVNVLSSLV 875 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt-~~ev~~~L~~~~ 875 (948)
............+.+++.+|++.||.+||+ ++++.+.|..+.
T Consensus 285 ---------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 285 ---------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ---------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 001111122346889999999999999995 666666666554
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=341.58 Aligned_cols=368 Identities=18% Similarity=0.131 Sum_probs=240.1
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (948)
..++.|+|++|++++..|..|.++++|++|+|++|.+.+..| .|.++++|++|+|++|++++++|..|+++++|++|+|
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 579999999999998889999999999999999999999877 6999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCccc-cccc--ceeccCC
Q 002238 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQ--SLWVNGQ 223 (948)
Q Consensus 147 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~--~l~~~~~ 223 (948)
++|+++. ..|..+.++++|++|++++|++++.....+. .+++|++|+|++|++++..|..|.. .+++ .|++.++
T Consensus 113 ~~n~i~~-l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n 189 (606)
T 3t6q_A 113 IQTGISS-IDFIPLHNQKTLESLYLGSNHISSIKLPKGF--PTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN 189 (606)
T ss_dssp TTSCCSC-GGGSCCTTCTTCCEEECCSSCCCCCCCCTTC--CCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTC
T ss_pred cccCccc-CCcchhccCCcccEEECCCCcccccCccccc--CCcccCEEEcccCcccccChhhhhhhcccceeEEecCCC
Confidence 9999985 3367788999999999999999885444443 5888888888888888766655543 2344 3444333
Q ss_pred CCCCccCCC----------------------------------------------ccccccCC--CccEEEccCCccccc
Q 002238 224 NGNAKLGGG----------------------------------------------IDVIQNMT--SLKEIWLHSNAFSGP 255 (948)
Q Consensus 224 ~~~~~~~~~----------------------------------------------~~~l~~l~--~L~~L~Ls~N~l~~~ 255 (948)
......... ...+..+. +|+.|++++|.+++.
T Consensus 190 ~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~ 269 (606)
T 3t6q_A 190 DIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNI 269 (606)
T ss_dssp CCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSC
T ss_pred ccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCcc
Confidence 222111100 01111111 566666666666665
Q ss_pred CCC-CCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCC-CCCCccccccccccCCCCC-CCCCCCchh
Q 002238 256 LPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP-EFDRSVSLDMAKGSNNFCL-PSPGACDPR 332 (948)
Q Consensus 256 ~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~~~l~~~~~~~~~~~-~~~~~~~~~ 332 (948)
.+. |..+++|+.|+|++|+++ .+|..+.++++|++|++++|++++..| .+..+.+|..++..+|... .++......
T Consensus 270 ~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~ 348 (606)
T 3t6q_A 270 SSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLEN 348 (606)
T ss_dssp CTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTT
T ss_pred CHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhc
Confidence 553 666667777777777766 566666666777777777777666555 3555556666665555432 222211111
Q ss_pred hhhhHHHHHhhCCcchhccccCCCCCCCCc--cceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccC
Q 002238 333 LNALLSVVKLMGYPQRFAENWKGNDPCSDW--IGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMI 410 (948)
Q Consensus 333 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~i 410 (948)
+..+.. .+..++...... ...+..+++|+.|++++|.+.+..|..|.++++|+.|+|++|++++..
T Consensus 349 l~~L~~------------L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 416 (606)
T 3t6q_A 349 LENLRE------------LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKD 416 (606)
T ss_dssp CTTCCE------------EECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCT
T ss_pred cCcCCE------------EECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcc
Confidence 111100 001111000000 012334556677777777776666666777777777777777776655
Q ss_pred CcC-CcCCCCCcEEEccCCcccCCCCC----CCcccccccCCCCCC
Q 002238 411 PEG-LSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNPDI 451 (948)
Q Consensus 411 p~~-l~~l~~L~~L~ls~N~l~g~ip~----~~~~~~~~~~gnp~~ 451 (948)
|.. +..+++|++|++++|.+++.+|. +.....+.+++|+..
T Consensus 417 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 462 (606)
T 3t6q_A 417 AQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFP 462 (606)
T ss_dssp TCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCG
T ss_pred cchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCC
Confidence 543 66667777777777777665553 234455666666543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=334.70 Aligned_cols=300 Identities=18% Similarity=0.208 Sum_probs=173.8
Q ss_pred CEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEcc
Q 002238 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (948)
Q Consensus 69 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 147 (948)
+++.|+|++|++++..+..|.++++|++|+|++|.|++..| .|.++++|++|+|++|+++++++..|.++++|++|+|+
T Consensus 33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 112 (477)
T 2id5_A 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDIS 112 (477)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECT
T ss_pred CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECC
Confidence 44555555555555445555555555555555555555444 45555555555555555555555555555555555555
Q ss_pred CCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCC
Q 002238 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNA 227 (948)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~ 227 (948)
+|+++. ..|..+.++++|+.|++++|.+++..+..|. .+++|+.|+|++|++++..+.
T Consensus 113 ~n~i~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~------------------- 170 (477)
T 2id5_A 113 ENKIVI-LLDYMFQDLYNLKSLEVGDNDLVYISHRAFS--GLNSLEQLTLEKCNLTSIPTE------------------- 170 (477)
T ss_dssp TSCCCE-ECTTTTTTCTTCCEEEECCTTCCEECTTSST--TCTTCCEEEEESCCCSSCCHH-------------------
T ss_pred CCcccc-CChhHccccccCCEEECCCCccceeChhhcc--CCCCCCEEECCCCcCcccChh-------------------
Confidence 555553 3344455555555555555555555555554 455555555555555432222
Q ss_pred ccCCCccccccCCCccEEEccCCcccccCC-CCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCC
Q 002238 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEF 306 (948)
Q Consensus 228 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 306 (948)
.|.++++|+.|+|++|.+.+..+ .+..+++|+.|+|++|.+.+.+|..+....+|+.|+|++|++++..+.
T Consensus 171 -------~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~- 242 (477)
T 2id5_A 171 -------ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYL- 242 (477)
T ss_dssp -------HHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHH-
T ss_pred -------HhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHH-
Confidence 23355566666666666655444 355556666666666555555555555555566666666655532111
Q ss_pred CCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccC
Q 002238 307 DRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTI 386 (948)
Q Consensus 307 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~i 386 (948)
.+..+++|+.|+|++|.+++..
T Consensus 243 ----------------------------------------------------------~~~~l~~L~~L~Ls~n~l~~~~ 264 (477)
T 2id5_A 243 ----------------------------------------------------------AVRHLVYLRFLNLSYNPISTIE 264 (477)
T ss_dssp ----------------------------------------------------------HHTTCTTCCEEECCSSCCCEEC
T ss_pred ----------------------------------------------------------HhcCccccCeeECCCCcCCccC
Confidence 1223456777777777777777
Q ss_pred CccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCCC----CCcccccccCCCCCCCCccC
Q 002238 387 SPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNPDIGKEKS 456 (948)
Q Consensus 387 p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~----~~~~~~~~~~gnp~~~~~~~ 456 (948)
+..|.++++|+.|+|++|++++..|..|..+++|++|+|++|+|++..+. +.....+.+++||+.|.+..
T Consensus 265 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~ 338 (477)
T 2id5_A 265 GSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRL 338 (477)
T ss_dssp TTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGG
T ss_pred hhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccch
Confidence 77777777777777777777777777777777777777777777765543 23455677777777776543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=343.98 Aligned_cols=373 Identities=17% Similarity=0.175 Sum_probs=239.5
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (948)
.+++.|+|++|++++..+..|.++++|++|+|++|++++..+ .|.++++|++|+|++|+++++++..|+++++|++|+|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 356777777777776666667777777777777777776655 4666777777777777777777666777777777777
Q ss_pred cCCCCCCCCCC-ccccCCCCCCEEEccCccccc-cCCCCCCCCCCCCCcEEEcccccccccCCCCc--------------
Q 002238 147 DNNPFSSWEIP-QSLRNASGLQNFSANSANITG-QIPSFFGPDEFPGLTILHLAFNQLIGGLPASF-------------- 210 (948)
Q Consensus 147 s~N~l~~~~~p-~~~~~l~~L~~L~l~~n~l~~-~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-------------- 210 (948)
++|+++. ++ ..+.++++|++|++++|.+++ .+|..|+ .+++|++|++++|++++..|..+
T Consensus 108 ~~n~l~~--l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~--~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~ 183 (570)
T 2z63_A 108 VETNLAS--LENFPIGHLKTLKELNVAHNLIQSFKLPEYFS--NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183 (570)
T ss_dssp TTSCCCC--STTCSCTTCTTCCEEECCSSCCCCCCCCGGGG--GCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEE
T ss_pred ccccccc--CCCccccccccccEEecCCCccceecChhhhc--ccCCCCEEeCcCCccceecHHHccchhccchhhhhcc
Confidence 7776663 33 246666677777777776665 3466665 56666666666666655444333
Q ss_pred --------------ccccccceeccCCCCC--------------------------------------------------
Q 002238 211 --------------SGSQIQSLWVNGQNGN-------------------------------------------------- 226 (948)
Q Consensus 211 --------------~~~~l~~l~~~~~~~~-------------------------------------------------- 226 (948)
....++.|++.++...
T Consensus 184 l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~ 263 (570)
T 2z63_A 184 LSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263 (570)
T ss_dssp CTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEE
T ss_pred cCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhh
Confidence 2222333333221000
Q ss_pred -----CccCCCccccccCCCccEEEccCCcccccCCCC------------------------------------------
Q 002238 227 -----AKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDF------------------------------------------ 259 (948)
Q Consensus 227 -----~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~------------------------------------------ 259 (948)
...+..+..+..+++|+.|++++|.+++.++.+
T Consensus 264 l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~ 343 (570)
T 2z63_A 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSE 343 (570)
T ss_dssp EEETTEEESCSTTTTGGGTTCSEEEEESCEECSCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCC
T ss_pred hhcchhhhhhchhhhcCcCcccEEEecCccchhhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCcccccccc
Confidence 111222234455566666666666555322222
Q ss_pred CCCCCCcEEeccCCcccccc--chhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCC-CCchhhhhh
Q 002238 260 SGVKQLESLSLRDNFFTGPV--PDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPG-ACDPRLNAL 336 (948)
Q Consensus 260 ~~l~~L~~L~L~~N~l~~~~--p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~l 336 (948)
..+++|+.|++++|++++.. |..+..+++|+.|++++|.+++..+.+..+.+|..++..+|.....+. .....+..+
T Consensus 344 ~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L 423 (570)
T 2z63_A 344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423 (570)
T ss_dssp CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTC
T ss_pred ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCC
Confidence 34567777777777777543 677778888888888888887766666667777777776665443321 111111111
Q ss_pred HHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCccc-ccCCccccCccccceEeCccccccccCCcCCc
Q 002238 337 LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLT-GTISPEFASFKSLQRLILADNNLSGMIPEGLS 415 (948)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~-g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~ 415 (948)
.. .+..++.........+..+++|+.|+|++|.+. +.+|..|..+++|++|+|++|++++..|..+.
T Consensus 424 ~~------------L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 491 (570)
T 2z63_A 424 IY------------LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491 (570)
T ss_dssp CE------------EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred CE------------EeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhh
Confidence 11 111111111111123456778999999999998 68899999999999999999999988899999
Q ss_pred CCCCCcEEEccCCcccCCCCC----CCcccccccCCCCCCCCccC
Q 002238 416 VLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNPDIGKEKS 456 (948)
Q Consensus 416 ~l~~L~~L~ls~N~l~g~ip~----~~~~~~~~~~gnp~~~~~~~ 456 (948)
.+++|++|++++|++++.+|. +.....+.+++||+.|.++.
T Consensus 492 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 492 SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred cccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 999999999999999987764 34566788999999887653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=309.72 Aligned_cols=231 Identities=20% Similarity=0.287 Sum_probs=179.6
Q ss_pred hcCCccc-ceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHH-HhcCCCceeeEEeEEEe----CC
Q 002238 592 TNNFSEE-NILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVL-TKVRHRHLVALLGHCLD----GN 664 (948)
Q Consensus 592 ~~~~~~~-~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~----~~ 664 (948)
.++|.+. +.||+|+||.||+|.. .+++.||||++... ..+.+|++++ +..+||||+++++++.. +.
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 4567776 7899999999999987 47899999998642 4677899888 55699999999999876 66
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC---CCCeEEe
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVA 741 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~---~~~~kl~ 741 (948)
..++||||+++|+|.+++.. .....+++..++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred eEEEEEeecCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 78999999999999999854 233579999999999999999999997 89999999999999998 7889999
Q ss_pred ecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcC
Q 002238 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS 821 (948)
Q Consensus 742 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 821 (948)
|||++.... +..++.++|||||||++|||++|+.||.........
T Consensus 163 Dfg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------------ 207 (299)
T 3m2w_A 163 DFGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------ 207 (299)
T ss_dssp CCTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------
T ss_pred ccccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------------
Confidence 999986432 234678999999999999999999999765432210
Q ss_pred ccccccccCcccCCc-cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 822 KDSFHKAIDPTIDLN-EGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 822 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
............... ........++.+++.+|++.||.+||++.|+++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 208 PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000111111101 0111234568999999999999999999999874
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=331.86 Aligned_cols=246 Identities=16% Similarity=0.160 Sum_probs=183.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCc-CChhhHHHHHHHHHHHHhcCC-Cce---------------
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRH-RHL--------------- 653 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H-~ni--------------- 653 (948)
...|...++||+|+||.||+|++. +|+.||||++.... ......+.+.+|+.+++.++| +|.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345778899999999999999864 79999999987432 223346789999999999987 221
Q ss_pred ee------EEeEEEe-----CCceEEEEEecCCCChhHHHHhhh--hcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCe
Q 002238 654 VA------LLGHCLD-----GNEKLLVFEYMPQGTLSRHIFNWA--EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 720 (948)
Q Consensus 654 v~------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 720 (948)
+. ++.++.. ....+++|+++ +++|.+++.... ......+++..++.++.|+++||+|||+ .+|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Confidence 11 1111111 22457777765 689998885321 1223468889999999999999999997 899
Q ss_pred eecCCCCccEEEcCCCCeEEeecCCceecCCCCCceeeeecccccccCceec----------ccCCCCchhhHHHHHHHH
Q 002238 721 IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA----------VTGRVTTKVDVFSFGVIL 790 (948)
Q Consensus 721 vHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~s~Gv~l 790 (948)
|||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999998865432 344567 999999999 555688999999999999
Q ss_pred HHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 791 MELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 791 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
|||++|+.||......+.. ...+.... ..+..+.+++.+|++.||++||++.++++
T Consensus 308 ~elltg~~Pf~~~~~~~~~----------------~~~~~~~~-------~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGS----------------EWIFRSCK-------NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCS----------------GGGGSSCC-------CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhhhH----------------HHHHhhcc-------cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999765432211 11111000 11246889999999999999999888765
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=340.32 Aligned_cols=368 Identities=20% Similarity=0.226 Sum_probs=243.1
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCc--EEEcccccccCCCCccccCC------
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLE--VVMLSNNQFTSVPSDFFTGL------ 138 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~--~L~L~~N~l~~~~~~~~~~l------ 138 (948)
.+++.|++++|.+++...+.+..+++|++|+|++|.+++..+ .|..+++|+ .|+|++|.++++++..|...
T Consensus 129 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~ 208 (606)
T 3t6q_A 129 KTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLN 208 (606)
T ss_dssp TTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEE
T ss_pred CcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccc
Confidence 467888888888886444455558888888888888877655 466777777 77777777777666554321
Q ss_pred ---------------------------------------------CCCCEEEccCCCCCCCCCCccccCCCCCCEEEccC
Q 002238 139 ---------------------------------------------SSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANS 173 (948)
Q Consensus 139 ---------------------------------------------~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~ 173 (948)
.+|+.|+|++|+++. ..+..+..+++|++|++++
T Consensus 209 l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~ 287 (606)
T 3t6q_A 209 FGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFN-ISSNTFHCFSGLQELDLTA 287 (606)
T ss_dssp CTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSS-CCTTTTTTCTTCSEEECTT
T ss_pred cCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCc-cCHHHhccccCCCEEeccC
Confidence 045666666666664 2344466667777777777
Q ss_pred ccccccCCCCCCCCCCCCCcEEEcccccccccCCCCccc-ccccceeccCCCCCCccCC-CccccccCCCccEEEccCCc
Q 002238 174 ANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGG-GIDVIQNMTSLKEIWLHSNA 251 (948)
Q Consensus 174 n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~~~~~~~~~~~~~-~~~~l~~l~~L~~L~Ls~N~ 251 (948)
|+++ .+|..+. .+++|++|+|++|++.+..|..+.. .+++.|++.++ ..... ....+.++++|++|+|++|.
T Consensus 288 n~l~-~lp~~l~--~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n---~~~~~~~~~~~~~l~~L~~L~l~~n~ 361 (606)
T 3t6q_A 288 THLS-ELPSGLV--GLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGN---TKRLELGTGCLENLENLRELDLSHDD 361 (606)
T ss_dssp SCCS-CCCSSCC--SCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSC---SSCCBCCSSTTTTCTTCCEEECCSSC
T ss_pred CccC-CCChhhc--ccccCCEEECccCCcCcCchhhhhccCcCCEEECCCC---CcccccchhhhhccCcCCEEECCCCc
Confidence 7666 4555554 6666777777777666655555543 34444444432 22211 22335666777777777777
Q ss_pred ccccC--C-CCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCC--CCCccccccccccCCCCCCCC
Q 002238 252 FSGPL--P-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE--FDRSVSLDMAKGSNNFCLPSP 326 (948)
Q Consensus 252 l~~~~--~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~--~~~~~~l~~~~~~~~~~~~~~ 326 (948)
+++.. + .+..+++|+.|+|++|++.+..|..+..+++|+.|+|++|++++..|. +..+.+|..++..+|.....+
T Consensus 362 l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 441 (606)
T 3t6q_A 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISS 441 (606)
T ss_dssp CCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTC
T ss_pred cccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcC
Confidence 76643 2 466667777777777777666666677777777777777777665443 555666666666665544333
Q ss_pred CCCchhhhhhHHHHHhhCCcchhccccCCCCCCC---CccceeecCCceEEEEccCCcccccCCccccCccccceEeCcc
Q 002238 327 GACDPRLNALLSVVKLMGYPQRFAENWKGNDPCS---DWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILAD 403 (948)
Q Consensus 327 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~ 403 (948)
......+..+.. .+..++.-.. .....+..+++|+.|+|++|++++.+|..|+++++|+.|+|++
T Consensus 442 ~~~~~~l~~L~~------------L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 509 (606)
T 3t6q_A 442 EQLFDGLPALQH------------LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSH 509 (606)
T ss_dssp TTTTTTCTTCCE------------EECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred HHHHhCCCCCCE------------EECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCC
Confidence 222211111110 1111111000 0012345678999999999999999999999999999999999
Q ss_pred ccccccCCcCCcCCCCCcEEEccCCcccCCCCC----CCcccccccCCCCCCCCcc
Q 002238 404 NNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNPDIGKEK 455 (948)
Q Consensus 404 N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~----~~~~~~~~~~gnp~~~~~~ 455 (948)
|++++.+|..+..++.| +|+|++|++++.+|. +.....+.++|||+.|.++
T Consensus 510 N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 510 NRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp SCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred CccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 99999999999999999 999999999998875 3456789999999998775
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-33 Score=337.83 Aligned_cols=364 Identities=16% Similarity=0.148 Sum_probs=240.5
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (948)
.+++.|+|++|++++..+..|.++++|++|+|++|.+++..| .|.++++|++|+|++|.++++++..|+++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 579999999999998777789999999999999999999877 5888999999999999999999888999999999999
Q ss_pred cCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCccc---ccccceeccCC
Q 002238 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG---SQIQSLWVNGQ 223 (948)
Q Consensus 147 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~---~~l~~l~~~~~ 223 (948)
++|++++ ..|..+.++++|++|++++|++++..|..++ .+++|++|+|++|++++..+..+.. ..++.|++.++
T Consensus 105 ~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n 181 (680)
T 1ziw_A 105 MSNSIQK-IKNNPFVKQKNLITLDLSHNGLSSTKLGTQV--QLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181 (680)
T ss_dssp CSSCCCC-CCSCTTTTCTTCCEEECCSSCCSCCCCCSSS--CCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTC
T ss_pred CCCccCc-cChhHccccCCCCEEECCCCcccccCchhhc--ccccCCEEEccCCcccccCHHHhhccccccccEEECCCC
Confidence 9999985 3457899999999999999999998888887 8999999999999998777665532 35666666544
Q ss_pred CCCCccCCCccccccC---------------------------CCccEEEccCCcccccCC-CCCCCCC--CcEEeccCC
Q 002238 224 NGNAKLGGGIDVIQNM---------------------------TSLKEIWLHSNAFSGPLP-DFSGVKQ--LESLSLRDN 273 (948)
Q Consensus 224 ~~~~~~~~~~~~l~~l---------------------------~~L~~L~Ls~N~l~~~~~-~~~~l~~--L~~L~L~~N 273 (948)
... +..+..+..+ ++|+.|+|++|.+++..+ .+.+++. |+.|+|++|
T Consensus 182 ~l~---~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n 258 (680)
T 1ziw_A 182 QIK---EFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYN 258 (680)
T ss_dssp CCC---CBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTS
T ss_pred ccc---ccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCC
Confidence 332 2222222222 455666666666666555 3444433 777777777
Q ss_pred ccccccchhhhCCCCCcEEEcccCcccccCCC-CCCccccccccccC---------------------------------
Q 002238 274 FFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSN--------------------------------- 319 (948)
Q Consensus 274 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~l~~~~~~~--------------------------------- 319 (948)
++++..|..+..+++|+.|+|++|++++.+|. +..+.+|+.++..+
T Consensus 259 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~ 338 (680)
T 1ziw_A 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMED 338 (680)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCS
T ss_pred CcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCC
Confidence 77766666667777777777777777665553 44444444444433
Q ss_pred CCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCcc--ceee--cCCceEEEEccCCcccccCCccccCccc
Q 002238 320 NFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWI--GVTC--TKGNITVINFQKMNLTGTISPEFASFKS 395 (948)
Q Consensus 320 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~--~~~~L~~L~ls~n~l~g~ip~~~~~l~~ 395 (948)
|....++...+..+..+..+ +..++......+ ..+. ...+|+.|++++|++++..|..|..+++
T Consensus 339 n~l~~~~~~~~~~l~~L~~L------------~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~ 406 (680)
T 1ziw_A 339 NDIPGIKSNMFTGLINLKYL------------SLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGH 406 (680)
T ss_dssp CCBCCCCTTTTTTCTTCCEE------------ECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTT
T ss_pred CccCCCChhHhccccCCcEE------------ECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCC
Confidence 32222221111111111000 000000000000 0001 1235677777777777777777777777
Q ss_pred cceEeCccccccccCC-cCCcCCCCCcEEEccCCcccCCCCC----CCcccccccCCCC
Q 002238 396 LQRLILADNNLSGMIP-EGLSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNP 449 (948)
Q Consensus 396 L~~L~Ls~N~l~g~ip-~~l~~l~~L~~L~ls~N~l~g~ip~----~~~~~~~~~~gnp 449 (948)
|+.|+|++|++++.+| ..+..+++|++|++++|++++..|. +.....+.+.+|.
T Consensus 407 L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~ 465 (680)
T 1ziw_A 407 LEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVA 465 (680)
T ss_dssp CCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSC
T ss_pred CCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccc
Confidence 7777777777776665 5667777777777777776654332 2334455555554
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-33 Score=329.84 Aligned_cols=341 Identities=18% Similarity=0.167 Sum_probs=260.9
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (948)
.+++.|+|++|++++..|..|.++++|++|+|++|+|++..| .|.++++|++|+|++|+|+.++.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~---~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC---PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC---CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc---ccccCCEEEC
Confidence 589999999999998888899999999999999999999877 689999999999999999987765 8999999999
Q ss_pred cCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCC--cEEEcccccc--cccCCCCccccc--------
Q 002238 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGL--TILHLAFNQL--IGGLPASFSGSQ-------- 214 (948)
Q Consensus 147 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L--~~L~Ls~N~l--~~~~p~~~~~~~-------- 214 (948)
++|+++.+.+|..+.++++|++|++++|++++.. +. .+++| ++|+|++|++ ++..|..+....
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~---~~--~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l 203 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLD---LL--PVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVF 203 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTT---TG--GGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEE
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccccCc---hh--hhhhceeeEEEeecccccccccCcccccccCcceEEEEe
Confidence 9999997666789999999999999999998642 32 45555 9999999998 777777665422
Q ss_pred ----------------ccceeccCCCCCCc----cCCCcccc---------------------------ccCCCccEEEc
Q 002238 215 ----------------IQSLWVNGQNGNAK----LGGGIDVI---------------------------QNMTSLKEIWL 247 (948)
Q Consensus 215 ----------------l~~l~~~~~~~~~~----~~~~~~~l---------------------------~~l~~L~~L~L 247 (948)
+..|...+...|.. ..+.+..+ ...++|++|++
T Consensus 204 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l 283 (562)
T 3a79_B 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNI 283 (562)
T ss_dssp CSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEE
T ss_pred cCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEE
Confidence 11111111111100 00000000 01125555666
Q ss_pred cCCcccccCCC-C-----------------------------------------------------CCCCCCcEEeccCC
Q 002238 248 HSNAFSGPLPD-F-----------------------------------------------------SGVKQLESLSLRDN 273 (948)
Q Consensus 248 s~N~l~~~~~~-~-----------------------------------------------------~~l~~L~~L~L~~N 273 (948)
++|+++|.+|. + ..+++|++|+|++|
T Consensus 284 ~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n 363 (562)
T 3a79_B 284 YNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQN 363 (562)
T ss_dssp EEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSS
T ss_pred eccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCC
Confidence 66665544432 2 56789999999999
Q ss_pred ccccccchhhhCCCCCcEEEcccCcccccC--C-CCCCccccccccccCCCCCC-CCCCCchhhhhhHHHHHhhCCcchh
Q 002238 274 FFTGPVPDSLVKLESLKIVNMTNNLLQGPV--P-EFDRSVSLDMAKGSNNFCLP-SPGACDPRLNALLSVVKLMGYPQRF 349 (948)
Q Consensus 274 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~--p-~~~~~~~l~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~~~ 349 (948)
++++.+|..+.++++|+.|+|++|++++.. | .+..+.+|..++..+|.... ++..
T Consensus 364 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~--------------------- 422 (562)
T 3a79_B 364 VFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDR--------------------- 422 (562)
T ss_dssp CCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSC---------------------
T ss_pred ccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChh---------------------
Confidence 999989999999999999999999999743 3 36778888888888776543 3211
Q ss_pred ccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCc
Q 002238 350 AENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQ 429 (948)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~ 429 (948)
.+..+++|+.|+|++|++++.+|..+. ++|++|+|++|+|+ .+|..+..+++|++|+|++|+
T Consensus 423 ---------------~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~ 484 (562)
T 3a79_B 423 ---------------TCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQ 484 (562)
T ss_dssp ---------------CCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSC
T ss_pred ---------------hhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCC
Confidence 233457899999999999998887765 79999999999999 899888899999999999999
Q ss_pred ccCCCCC----CCcccccccCCCCCCCCcc
Q 002238 430 LYGKIPS----FKSNAIVNTDGNPDIGKEK 455 (948)
Q Consensus 430 l~g~ip~----~~~~~~~~~~gnp~~~~~~ 455 (948)
|++.++. +.....+.+++||+.|.++
T Consensus 485 l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 485 LKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp CCCCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred CCCCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 9964443 3456678999999998875
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=327.70 Aligned_cols=337 Identities=19% Similarity=0.169 Sum_probs=248.5
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (948)
.+++.|+|++|++++..|..|.++++|++|+|++|+|++..| .|.++++|++|+|++|+|+.+++. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~---~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH---PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC---CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc---ccCCccEEec
Confidence 578889999999987777888899999999999999988766 788899999999999999876654 7889999999
Q ss_pred cCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCC--cEEEcccccc--cccCCCCcccc---------
Q 002238 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGL--TILHLAFNQL--IGGLPASFSGS--------- 213 (948)
Q Consensus 147 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L--~~L~Ls~N~l--~~~~p~~~~~~--------- 213 (948)
++|+++++.+|..++++++|++|++++|++++. .+. .+++| ++|+|++|++ .+..|..+...
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~---~~~--~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l 172 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS---SVL--PIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVF 172 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG---GGG--GGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEEC
T ss_pred cCCccccccchhhhccCCcceEEEecCcccchh---hcc--ccccceeeEEEeecccccccccccccccccccceEEEEe
Confidence 999988766788889999999999998888752 232 45555 7777777766 55555444321
Q ss_pred ---------------------------------------------------------------------------cccce
Q 002238 214 ---------------------------------------------------------------------------QIQSL 218 (948)
Q Consensus 214 ---------------------------------------------------------------------------~l~~l 218 (948)
.++.|
T Consensus 173 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L 252 (520)
T 2z7x_B 173 PTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYF 252 (520)
T ss_dssp CSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEE
T ss_pred ccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEE
Confidence 11112
Q ss_pred eccCCCCCCccCCCcccc-----ccCCCc--------------------------cEEEccCCcccccCCCCCCCCCCcE
Q 002238 219 WVNGQNGNAKLGGGIDVI-----QNMTSL--------------------------KEIWLHSNAFSGPLPDFSGVKQLES 267 (948)
Q Consensus 219 ~~~~~~~~~~~~~~~~~l-----~~l~~L--------------------------~~L~Ls~N~l~~~~~~~~~l~~L~~ 267 (948)
++.+ +...+..+..+ .++++| +.|++++|.+.... .+..+++|++
T Consensus 253 ~l~~---n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~-~~~~l~~L~~ 328 (520)
T 2z7x_B 253 SISN---VKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML-CPSKISPFLH 328 (520)
T ss_dssp EEEE---EEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCC-CCSSCCCCCE
T ss_pred Eeec---ccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCcccccc-chhhCCcccE
Confidence 2111 11222333333 444444 44444444443211 1257888999
Q ss_pred EeccCCccccccchhhhCCCCCcEEEcccCcccc--cCCC-CCCccccccccccCCCCCC-CCCCCchhhhhhHHHHHhh
Q 002238 268 LSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG--PVPE-FDRSVSLDMAKGSNNFCLP-SPGACDPRLNALLSVVKLM 343 (948)
Q Consensus 268 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g--~~p~-~~~~~~l~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~ 343 (948)
|+|++|++++.+|..+.++++|+.|+|++|++++ .+|. +..+.+|..++..+|.... ++.
T Consensus 329 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~---------------- 392 (520)
T 2z7x_B 329 LDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKK---------------- 392 (520)
T ss_dssp EECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGG----------------
T ss_pred EEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCccccc----------------
Confidence 9999999998889999999999999999999986 3343 5667777777777765433 221
Q ss_pred CCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEE
Q 002238 344 GYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKEL 423 (948)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L 423 (948)
+.+..+++|+.|++++|.+++.+|..+. ++|+.|+|++|+|+ .+|..+..+++|++|
T Consensus 393 --------------------~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L 449 (520)
T 2z7x_B 393 --------------------GDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQEL 449 (520)
T ss_dssp --------------------CSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEE
T ss_pred --------------------chhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEE
Confidence 1233456899999999999998888775 79999999999999 899989999999999
Q ss_pred EccCCcccCCCCC----CCcccccccCCCCCCCCcc
Q 002238 424 DVSNNQLYGKIPS----FKSNAIVNTDGNPDIGKEK 455 (948)
Q Consensus 424 ~ls~N~l~g~ip~----~~~~~~~~~~gnp~~~~~~ 455 (948)
+|++|+|++.++. +.....+.+++||+.|.++
T Consensus 450 ~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 450 NVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence 9999999964333 3456788999999998775
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=317.74 Aligned_cols=244 Identities=15% Similarity=0.143 Sum_probs=185.0
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcC------ChhhHHHHHHHHHHHHhcC---------CCceeeE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVI------SGKGLTEFKSEIAVLTKVR---------HRHLVAL 656 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------H~niv~l 656 (948)
.++|++.+.||+|+||.||+|+. +|+.||||++..... .....+.+.+|+++++.++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45788899999999999999988 589999999986532 2233478899999999986 7888777
Q ss_pred EeEEE------------------------------eCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHH
Q 002238 657 LGHCL------------------------------DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 706 (948)
Q Consensus 657 ~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~ 706 (948)
.+++. +.+..++||||+++|++.+.+.. ..+++..+..++.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHH
Confidence 77643 26788999999999977666522 4689999999999999
Q ss_pred HHHHHHH-hccCCCeeecCCCCccEEEcCCC--------------------CeEEeecCCceecCCCCCceeeeeccccc
Q 002238 707 RGVEYLH-GLAHQSFIHRDLKPSNILLGDDM--------------------RAKVADFGLVRLAPEGKGSIETRIAGTFG 765 (948)
Q Consensus 707 ~~l~~LH-~~~~~~ivHrDik~~Nill~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~ 765 (948)
.||+||| + .+|+||||||+|||++.++ .+||+|||+|+..... ...||+.
T Consensus 172 ~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 7 7999999999999999887 8999999999866432 3479999
Q ss_pred ccCceecccCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHH
Q 002238 766 YLAPEYAVTGRVTTKVDVFSFGVI-LMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASIS 844 (948)
Q Consensus 766 y~aPE~~~~~~~~~~~Dv~s~Gv~-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (948)
|+|||++.+.. +.++||||+|++ .+++++|..||..... ...... .... ..................
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~~---~~~~------~~~~~~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLTD---KMLK------QMTFKTKCNTPAMKQIKR 310 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHHH---HHHH------TCCCSSCCCSHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHHH---hhhh------hhccCcccchhhhhhcCH
Confidence 99999998766 899999998776 7788889888742100 000111 1000 000001111222344567
Q ss_pred HHHHHHHHhcccCCCCCCChHHHH
Q 002238 845 TVAELAGHCCAREPYQRPDMGHAV 868 (948)
Q Consensus 845 ~l~~li~~c~~~~P~~RPt~~ev~ 868 (948)
++.+++.+|++.| |++|++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHhccC-----CHHHHH
Confidence 7999999999966 888887
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=334.38 Aligned_cols=380 Identities=18% Similarity=0.188 Sum_probs=281.3
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCC--CcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEE
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTK--LERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSI 144 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~--L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 144 (948)
..++.|++++|++++..|..|.+++. |++|+|++|.+++.+| .|..+++|++|+|++|.++++++..|.++++|+.|
T Consensus 222 ~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 301 (680)
T 1ziw_A 222 TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301 (680)
T ss_dssp SCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEE
T ss_pred ccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEE
Confidence 46888999999999888888888865 9999999999998776 68889999999999999999999999999999999
Q ss_pred EccCCCCCC----CCCCc----cccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEccccccccc--CCCCccc--
Q 002238 145 EIDNNPFSS----WEIPQ----SLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGG--LPASFSG-- 212 (948)
Q Consensus 145 ~Ls~N~l~~----~~~p~----~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~-- 212 (948)
+|++|...+ ..+|. .+..+++|++|++++|++++..+..|. .+++|++|+|++|.+... .+..|..
T Consensus 302 ~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~ 379 (680)
T 1ziw_A 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFT--GLINLKYLSLSNSFTSLRTLTNETFVSLA 379 (680)
T ss_dssp ECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTT--TCTTCCEEECTTCBSCCCEECTTTTGGGT
T ss_pred eccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhc--cccCCcEEECCCCchhhhhcchhhhcccc
Confidence 999876542 02333 678899999999999999998888887 889999999998875432 2222322
Q ss_pred -ccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCC--CCCCCCCCcEEeccCCccccccchhhhCCCCC
Q 002238 213 -SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP--DFSGVKQLESLSLRDNFFTGPVPDSLVKLESL 289 (948)
Q Consensus 213 -~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 289 (948)
..++.|++. .|......+..|.++++|+.|+|++|++++.++ .+.++++|+.|+|++|++.+..+..+..+++|
T Consensus 380 ~~~L~~L~L~---~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L 456 (680)
T 1ziw_A 380 HSPLHILNLT---KNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSL 456 (680)
T ss_dssp TSCCCEEECT---TSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTC
T ss_pred cCcCceEECC---CCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCccc
Confidence 234445444 344444555677788888888888888887555 47778888888888888887777778888888
Q ss_pred cEEEcccCccc--ccCCC-CCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCcccee
Q 002238 290 KIVNMTNNLLQ--GPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVT 366 (948)
Q Consensus 290 ~~L~Ls~N~l~--g~~p~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (948)
+.|++++|.++ +.+|. +..+.+|..++..+|....++...+..+..+..+.-. ...+..-+.+..|. .....+
T Consensus 457 ~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls---~N~l~~~~~~~~~~-~~~~~~ 532 (680)
T 1ziw_A 457 QRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQ---HNNLARLWKHANPG-GPIYFL 532 (680)
T ss_dssp CEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC---SSCCGGGGSTTSTT-SCCCTT
T ss_pred ccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCC---CCCccccchhhccC-Ccchhh
Confidence 88888888776 34443 6667777777777776666654443333222111100 00011001111000 001124
Q ss_pred ecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCCC-----CCccc
Q 002238 367 CTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS-----FKSNA 441 (948)
Q Consensus 367 ~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~-----~~~~~ 441 (948)
..+++|+.|+|++|+++...+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++.+|. +....
T Consensus 533 ~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~ 612 (680)
T 1ziw_A 533 KGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLT 612 (680)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCS
T ss_pred cCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccC
Confidence 5678999999999999955555799999999999999999977777789999999999999999998773 45677
Q ss_pred ccccCCCCCCCCccC
Q 002238 442 IVNTDGNPDIGKEKS 456 (948)
Q Consensus 442 ~~~~~gnp~~~~~~~ 456 (948)
.+.++||||.|.+..
T Consensus 613 ~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 613 ELDMRFNPFDCTCES 627 (680)
T ss_dssp EEECTTCCCCBCCCC
T ss_pred EEEccCCCcccCCcc
Confidence 899999999998864
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=333.20 Aligned_cols=373 Identities=19% Similarity=0.163 Sum_probs=275.3
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (948)
..++.|+|++|+|++..+.+|.++++|++|+|++|+|++++| +|.+|++|++|+|++|+|+++++++|.++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 479999999999998878899999999999999999999887 6999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCccccCCCCCCEEEccCcccccc-CCCCCCCCCCCCCcEEEcccccccccCCCCcccc-c----------
Q 002238 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQ-IPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGS-Q---------- 214 (948)
Q Consensus 147 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~-~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~---------- 214 (948)
++|+++. ..+..|+++++|++|+|++|.+++. +|..++ .+++|++|+|++|++++..+..|... +
T Consensus 132 s~N~l~~-l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~l 208 (635)
T 4g8a_A 132 VETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFS--NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 208 (635)
T ss_dssp TTSCCCC-STTCCCTTCTTCCEEECCSSCCCCCCCCGGGG--GCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEEC
T ss_pred CCCcCCC-CChhhhhcCcccCeeccccCccccCCCchhhc--cchhhhhhcccCccccccccccccchhhhhhhhhhhhc
Confidence 9999995 3345799999999999999999864 577776 89999999999999987766544210 0
Q ss_pred -----------------ccceeccCC------------------------------------------------------
Q 002238 215 -----------------IQSLWVNGQ------------------------------------------------------ 223 (948)
Q Consensus 215 -----------------l~~l~~~~~------------------------------------------------------ 223 (948)
+..+.+.+.
T Consensus 209 s~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~ 288 (635)
T 4g8a_A 209 SLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 288 (635)
T ss_dssp TTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEE
T ss_pred ccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhh
Confidence 000000000
Q ss_pred --------------------------------------------------CCCCccC----------------CCccccc
Q 002238 224 --------------------------------------------------NGNAKLG----------------GGIDVIQ 237 (948)
Q Consensus 224 --------------------------------------------------~~~~~~~----------------~~~~~l~ 237 (948)
....... ..+....
T Consensus 289 ~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~ 368 (635)
T 4g8a_A 289 AYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV 368 (635)
T ss_dssp ECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCC
T ss_pred hhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccc
Confidence 0000000 0000112
Q ss_pred cCCCccEEEccCCccccc--CC-CCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCC--CCCcccc
Q 002238 238 NMTSLKEIWLHSNAFSGP--LP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE--FDRSVSL 312 (948)
Q Consensus 238 ~l~~L~~L~Ls~N~l~~~--~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~--~~~~~~l 312 (948)
++++|+.|++++|.+... .+ .+..+.+|+.|++..|.+. .++..+..+++|+.+++++|++....+. +..+..+
T Consensus 369 ~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l 447 (635)
T 4g8a_A 369 DLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 447 (635)
T ss_dssp BCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTC
T ss_pred cccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhcccccccccccccccccc
Confidence 467788899999988652 22 2455677888888888777 4556677778888888887777665442 4556666
Q ss_pred ccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCC-ccceeecCCceEEEEccCCcccccCCcccc
Q 002238 313 DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSD-WIGVTCTKGNITVINFQKMNLTGTISPEFA 391 (948)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~ 391 (948)
..++...|.....+.........+. .....++..... ....+..+++|+.|+|++|++++.+|..|.
T Consensus 448 ~~l~ls~n~l~~~~~~~~~~~~~L~------------~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~ 515 (635)
T 4g8a_A 448 IYLDISHTHTRVAFNGIFNGLSSLE------------VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 515 (635)
T ss_dssp CEEECTTSCCEECCTTTTTTCTTCC------------EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred ccccccccccccccccccccchhhh------------hhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHc
Confidence 6666665554433322221111110 011111110000 012455678999999999999999999999
Q ss_pred CccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCCCC-----CcccccccCCCCCCCCccC
Q 002238 392 SFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSF-----KSNAIVNTDGNPDIGKEKS 456 (948)
Q Consensus 392 ~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~~-----~~~~~~~~~gnp~~~~~~~ 456 (948)
++++|++|+|++|+|++..|..|..+++|++|||++|+|++.+|.. .....+.+++|||.|.+..
T Consensus 516 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 516 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp TCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred CCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 9999999999999999998999999999999999999999998853 3466789999999998763
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=329.37 Aligned_cols=308 Identities=15% Similarity=0.141 Sum_probs=235.7
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (948)
.+++.+++++|.+....+..|.++++|++|+|++|.|++.+| .|..+++|++|+|++|.|++++|..|+++++|++|+|
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 467889999999986666668899999999999999999887 8999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCcc-ccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCC
Q 002238 147 DNNPFSSWEIPQS-LRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNG 225 (948)
Q Consensus 147 s~N~l~~~~~p~~-~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~ 225 (948)
++|.++ .+|.. |.++++|++|+|++|.+++..|..|+ .+++|++|+|++|++++..+..+ ..+..|++.++..
T Consensus 131 ~~n~l~--~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~l--~~L~~L~l~~n~l 204 (597)
T 3oja_B 131 ERNDLS--SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ--ATTSLQNLQLSSNRLTHVDLSLI--PSLFHANVSYNLL 204 (597)
T ss_dssp CSSCCC--CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTT--TCTTCCEEECTTSCCSBCCGGGC--TTCSEEECCSSCC
T ss_pred eCCCCC--CCCHHHhccCCCCCEEEeeCCcCCCCChhhhh--cCCcCcEEECcCCCCCCcChhhh--hhhhhhhcccCcc
Confidence 999999 45554 68999999999999999999998887 89999999999999997643333 3456665554322
Q ss_pred CCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCC
Q 002238 226 NAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE 305 (948)
Q Consensus 226 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 305 (948)
..+...++|+.|++++|.++...+.+. ++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++.+|.
T Consensus 205 --------~~l~~~~~L~~L~ls~n~l~~~~~~~~--~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~ 272 (597)
T 3oja_B 205 --------STLAIPIAVEELDASHNSINVVRGPVN--VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYH 272 (597)
T ss_dssp --------SEEECCTTCSEEECCSSCCCEEECSCC--SCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESG
T ss_pred --------ccccCCchhheeeccCCcccccccccC--CCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHH
Confidence 123456788999999999887555432 689999999999985 46788899999999999999887664
Q ss_pred -CCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccc
Q 002238 306 -FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTG 384 (948)
Q Consensus 306 -~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g 384 (948)
+.. +++|+.|+|++|.+++
T Consensus 273 ~~~~------------------------------------------------------------l~~L~~L~Ls~N~l~~ 292 (597)
T 3oja_B 273 PFVK------------------------------------------------------------MQRLERLYISNNRLVA 292 (597)
T ss_dssp GGTT------------------------------------------------------------CSSCCEEECTTSCCCE
T ss_pred HhcC------------------------------------------------------------ccCCCEEECCCCCCCC
Confidence 223 3456666666666665
Q ss_pred cCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCC-CCCcccccccCCCCCCCCcc
Q 002238 385 TISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP-SFKSNAIVNTDGNPDIGKEK 455 (948)
Q Consensus 385 ~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip-~~~~~~~~~~~gnp~~~~~~ 455 (948)
+|..+..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+ .+.....+.+++||+.|.+.
T Consensus 293 -l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~~~~~~~ 362 (597)
T 3oja_B 293 -LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSL 362 (597)
T ss_dssp -EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCSSCEEHHHH
T ss_pred -CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcChhhcCCCCEEEeeCCCCCChhH
Confidence 3555556666666666666666 556666666666666666666665432 24445556666666665543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-33 Score=332.93 Aligned_cols=338 Identities=19% Similarity=0.270 Sum_probs=284.6
Q ss_pred CCEEEEEeCCCCCcCC-----------------CCcccc--CCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEccccc-
Q 002238 68 KRITRIQIGHQNLQGT-----------------LPSNLQ--NLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQ- 126 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~-----------------~p~~l~--~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~- 126 (948)
.+++.|+|++|.++|. +|+.++ ++++|++|+|++|.+.+.+| .|.++++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~ 285 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCC
Confidence 6899999999999996 999999 99999999999999999888 79999999999999998
Q ss_pred ccC-CCCccccCC------CCCCEEEccCCCCCCCCCCc--cccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEc
Q 002238 127 FTS-VPSDFFTGL------SSLQSIEIDNNPFSSWEIPQ--SLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHL 197 (948)
Q Consensus 127 l~~-~~~~~~~~l------~~L~~L~Ls~N~l~~~~~p~--~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L 197 (948)
+++ ..|..++.+ ++|++|+|++|+++ .+|. .+.++++|++|++++|+++|.+| .|+ .+++|++|+|
T Consensus 286 l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~--~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~--~l~~L~~L~L 360 (636)
T 4eco_A 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK--TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFG--SEIKLASLNL 360 (636)
T ss_dssp SCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS--SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCE--EEEEESEEEC
T ss_pred CccccchHHHHhhhccccCCCCCEEECCCCcCC--ccCchhhhccCCCCCEEeCcCCcCccchh-hhC--CCCCCCEEEC
Confidence 998 777778776 99999999999999 7898 99999999999999999999999 776 8999999999
Q ss_pred ccccccccCCCCccc-cc-ccceeccCCCCCCccCCCccccccCC--CccEEEccCCcccccCCC-CC-------CCCCC
Q 002238 198 AFNQLIGGLPASFSG-SQ-IQSLWVNGQNGNAKLGGGIDVIQNMT--SLKEIWLHSNAFSGPLPD-FS-------GVKQL 265 (948)
Q Consensus 198 s~N~l~~~~p~~~~~-~~-l~~l~~~~~~~~~~~~~~~~~l~~l~--~L~~L~Ls~N~l~~~~~~-~~-------~l~~L 265 (948)
++|+++ .+|..+.. .+ |+.|++.++... ..+..+..++ +|+.|+|++|++++.+|. +. .+.+|
T Consensus 361 ~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~----~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L 435 (636)
T 4eco_A 361 AYNQIT-EIPANFCGFTEQVENLSFAHNKLK----YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435 (636)
T ss_dssp CSSEEE-ECCTTSEEECTTCCEEECCSSCCS----SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCE
T ss_pred CCCccc-cccHhhhhhcccCcEEEccCCcCc----ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCC
Confidence 999999 88888765 34 777777655433 4555666554 899999999999997763 66 67899
Q ss_pred cEEeccCCccccccchh-hhCCCCCcEEEcccCcccccCCCCCCcc--------ccccccccCCCCCCCCCCCchhhhhh
Q 002238 266 ESLSLRDNFFTGPVPDS-LVKLESLKIVNMTNNLLQGPVPEFDRSV--------SLDMAKGSNNFCLPSPGACDPRLNAL 336 (948)
Q Consensus 266 ~~L~L~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~g~~p~~~~~~--------~l~~~~~~~~~~~~~~~~~~~~~~~l 336 (948)
+.|+|++|+++ .+|.. +..+++|+.|+|++|+++...+...... +|..++..+|.+..+|..
T Consensus 436 ~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~-------- 506 (636)
T 4eco_A 436 SSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDD-------- 506 (636)
T ss_dssp EEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCCBCCGG--------
T ss_pred CEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCCccChh--------
Confidence 99999999999 55554 5569999999999999994444333322 777777777765544311
Q ss_pred HHHHHhhCCcchhccccCCCCCCCCcccee-ecCCceEEEEccCCcccccCCccccCccccceEeC------cccccccc
Q 002238 337 LSVVKLMGYPQRFAENWKGNDPCSDWIGVT-CTKGNITVINFQKMNLTGTISPEFASFKSLQRLIL------ADNNLSGM 409 (948)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~L------s~N~l~g~ 409 (948)
.+ ..+++|+.|+|++|++++ +|..++++++|+.|+| ++|++.+.
T Consensus 507 ----------------------------~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~ 557 (636)
T 4eco_A 507 ----------------------------FRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLRE 557 (636)
T ss_dssp ----------------------------GSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCC
T ss_pred ----------------------------hhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCccccc
Confidence 01 256789999999999998 9999999999999999 56889999
Q ss_pred CCcCCcCCCCCcEEEccCCcccCCCCC--CCcccccccCCCCCCCCc
Q 002238 410 IPEGLSVLGALKELDVSNNQLYGKIPS--FKSNAIVNTDGNPDIGKE 454 (948)
Q Consensus 410 ip~~l~~l~~L~~L~ls~N~l~g~ip~--~~~~~~~~~~gnp~~~~~ 454 (948)
+|..+..+++|++|+|++|+| +.+|. +.....+.+++||+.|-.
T Consensus 558 ~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 558 WPEGITLCPSLTQLQIGSNDI-RKVNEKITPNISVLDIKDNPNISID 603 (636)
T ss_dssp CCTTGGGCSSCCEEECCSSCC-CBCCSCCCTTCCEEECCSCTTCEEE
T ss_pred ChHHHhcCCCCCEEECCCCcC-CccCHhHhCcCCEEECcCCCCcccc
Confidence 999999999999999999999 77775 345778899999998643
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=317.22 Aligned_cols=330 Identities=17% Similarity=0.179 Sum_probs=257.2
Q ss_pred CCEEEEEeCCCCCcCCC-CccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCc--cccCCCCCCE
Q 002238 68 KRITRIQIGHQNLQGTL-PSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSD--FFTGLSSLQS 143 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~ 143 (948)
.+++.|+|++|.+.+.+ +..|.++++|++|+|++|.+++..| .|.++++|++|+|++|.+++..+. .|..+++|++
T Consensus 54 ~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~ 133 (455)
T 3v47_A 54 QDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEM 133 (455)
T ss_dssp TTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCE
T ss_pred ccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCE
Confidence 58999999999998776 4679999999999999999999876 799999999999999999985444 4999999999
Q ss_pred EEccCCCCCCCCCCcc-ccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcc---------cc
Q 002238 144 IEIDNNPFSSWEIPQS-LRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFS---------GS 213 (948)
Q Consensus 144 L~Ls~N~l~~~~~p~~-~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---------~~ 213 (948)
|+|++|++++ ..|.. +.++++|++|++++|++++..+..+.....++|+.|++++|.+.+..+..+. ..
T Consensus 134 L~L~~n~l~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~ 212 (455)
T 3v47_A 134 LVLRDNNIKK-IQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT 212 (455)
T ss_dssp EECCSSBCCS-CCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTC
T ss_pred EECCCCccCc-cCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccc
Confidence 9999999996 44665 8899999999999999999999887622236888888888888865554432 12
Q ss_pred cccceeccCCCCCCccCCCccccccC---CCccEEEccCCcccccCCC-----------CCC--CCCCcEEeccCCcccc
Q 002238 214 QIQSLWVNGQNGNAKLGGGIDVIQNM---TSLKEIWLHSNAFSGPLPD-----------FSG--VKQLESLSLRDNFFTG 277 (948)
Q Consensus 214 ~l~~l~~~~~~~~~~~~~~~~~l~~l---~~L~~L~Ls~N~l~~~~~~-----------~~~--l~~L~~L~L~~N~l~~ 277 (948)
.++.|++. .|...+..+..+..+ ++|+.|++++|.+.+.... +.+ .++|+.|+|++|.+++
T Consensus 213 ~L~~L~Ls---~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~ 289 (455)
T 3v47_A 213 SITTLDLS---GNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFA 289 (455)
T ss_dssp EEEEEECT---TSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCE
T ss_pred eeeeEecC---CCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccc
Confidence 34455444 344444344433333 7788888887765542111 111 2578888888888887
Q ss_pred ccchhhhCCCCCcEEEcccCcccccCC-CCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCC
Q 002238 278 PVPDSLVKLESLKIVNMTNNLLQGPVP-EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGN 356 (948)
Q Consensus 278 ~~p~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 356 (948)
.+|..+..+++|++|+|++|++++..| .+..+.+|..++..+|....++.
T Consensus 290 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~----------------------------- 340 (455)
T 3v47_A 290 LLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDS----------------------------- 340 (455)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECG-----------------------------
T ss_pred cchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcCh-----------------------------
Confidence 778888888888888888888887766 36667777777776665432211
Q ss_pred CCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCCC
Q 002238 357 DPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 436 (948)
Q Consensus 357 ~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~ 436 (948)
..+..+++|+.|+|++|++++..|..|.++++|++|+|++|+|++..+..+..+++|++|+|++|++++.+|.
T Consensus 341 -------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 341 -------RMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp -------GGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred -------hHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 1233567899999999999999999999999999999999999977777789999999999999999999986
Q ss_pred C
Q 002238 437 F 437 (948)
Q Consensus 437 ~ 437 (948)
.
T Consensus 414 ~ 414 (455)
T 3v47_A 414 I 414 (455)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=307.21 Aligned_cols=282 Identities=12% Similarity=0.150 Sum_probs=168.2
Q ss_pred CCChHHHHHHHHHHHhc-CCCCCC--CCC-----CCCCCCccceEEeCCCCEEEEEeCCCCCcCCCCccc--cCCCCCcE
Q 002238 27 SGDDGDAAVMLALKKSL-NPPESL--GWS-----DTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNL--QNLTKLER 96 (948)
Q Consensus 27 ~~~~~d~~~l~~~k~~~-~~~~~~--~w~-----~~~~C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l--~~l~~L~~ 96 (948)
++-.+|++||++||+++ .++..| +|. ..++|.|.|+.|... +..+ ....+++.
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~-----------------~~~l~~~~~~~l~~ 85 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKAT-----------------ADLLEDATQPGRVA 85 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHH-----------------HHHHHHHTSTTCCE
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhh-----------------HHHHhcccccceeE
Confidence 34567999999999998 455455 672 467899999999421 0000 11234444
Q ss_pred EEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccc
Q 002238 97 LELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANI 176 (948)
Q Consensus 97 L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l 176 (948)
|+|++|.|+.+++.+.++++|++|+|++|.++ .+|..|+++++|++|+|++|+++ .+|..+.++++|++|++++|++
T Consensus 86 L~L~~n~l~~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~--~lp~~l~~l~~L~~L~L~~n~~ 162 (328)
T 4fcg_A 86 LELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR--ALPASIASLNRLRELSIRACPE 162 (328)
T ss_dssp EEEESSCCSSCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC--CCCGGGGGCTTCCEEEEEEETT
T ss_pred EEccCCCchhcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc--cCcHHHhcCcCCCEEECCCCCC
Confidence 44444444433334444444555555555544 23344555555555555555555 4455555555555555555555
Q ss_pred cccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccC
Q 002238 177 TGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPL 256 (948)
Q Consensus 177 ~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 256 (948)
.+.+|..+. . + .++. .|.++++|++|+|++|+++..+
T Consensus 163 ~~~~p~~~~--~-----------~----~~~~--------------------------~~~~l~~L~~L~L~~n~l~~lp 199 (328)
T 4fcg_A 163 LTELPEPLA--S-----------T----DASG--------------------------EHQGLVNLQSLRLEWTGIRSLP 199 (328)
T ss_dssp CCCCCSCSE--E-----------E----C-CC--------------------------CEEESTTCCEEEEEEECCCCCC
T ss_pred ccccChhHh--h-----------c----cchh--------------------------hhccCCCCCEEECcCCCcCcch
Confidence 555555442 1 0 0000 1234555555555555555322
Q ss_pred CCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhh
Q 002238 257 PDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL 336 (948)
Q Consensus 257 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l 336 (948)
..+..+++|+.|+|++|+++ .+|..+..+++|++|+|++|++.+.+|..
T Consensus 200 ~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~------------------------------ 248 (328)
T 4fcg_A 200 ASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPI------------------------------ 248 (328)
T ss_dssp GGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCC------------------------------
T ss_pred HhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHH------------------------------
Confidence 24555566666666666666 34555666666666666666666555531
Q ss_pred HHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcC
Q 002238 337 LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSV 416 (948)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~ 416 (948)
+..+++|+.|+|++|++.+.+|..|+++++|+.|+|++|++.+.+|..+..
T Consensus 249 -----------------------------~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~ 299 (328)
T 4fcg_A 249 -----------------------------FGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299 (328)
T ss_dssp -----------------------------TTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGG
T ss_pred -----------------------------hcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhh
Confidence 112335666677777777777777888888888888888888888888888
Q ss_pred CCCCcEEEccCCccc
Q 002238 417 LGALKELDVSNNQLY 431 (948)
Q Consensus 417 l~~L~~L~ls~N~l~ 431 (948)
+++|+.+++..|.+.
T Consensus 300 L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 300 LPANCIILVPPHLQA 314 (328)
T ss_dssp SCTTCEEECCGGGSC
T ss_pred ccCceEEeCCHHHHH
Confidence 888888888877664
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-32 Score=307.11 Aligned_cols=307 Identities=15% Similarity=0.140 Sum_probs=228.2
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (948)
.+++.|+++++.++...+..|.++++|++|+|++|.+++..+ .|.++++|++|+|++|.++++++..|+++++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 578889999999885544557889999999999999999877 7999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCcc-ccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCC
Q 002238 147 DNNPFSSWEIPQS-LRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNG 225 (948)
Q Consensus 147 s~N~l~~~~~p~~-~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~ 225 (948)
++|+++ .+|.. +.++++|++|++++|++++..+..|. .+++|++|+|++|++++.....+ ..++.|++.++..
T Consensus 125 ~~n~l~--~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~l--~~L~~L~l~~n~l 198 (390)
T 3o6n_A 125 ERNDLS--SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ--ATTSLQNLQLSSNRLTHVDLSLI--PSLFHANVSYNLL 198 (390)
T ss_dssp CSSCCC--CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTS--SCTTCCEEECCSSCCSBCCGGGC--TTCSEEECCSSCC
T ss_pred CCCccC--cCCHHHhcCCCCCcEEECCCCccCccChhhcc--CCCCCCEEECCCCcCCccccccc--cccceeecccccc
Confidence 999999 56665 68899999999999999998888887 89999999999999986533322 3455555554322
Q ss_pred CCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCC
Q 002238 226 NAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE 305 (948)
Q Consensus 226 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 305 (948)
..+...++|++|++++|.++...... .++|+.|+|++|.+++. ..+..+++|++|+|++|.+++.+|.
T Consensus 199 --------~~~~~~~~L~~L~l~~n~l~~~~~~~--~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~ 266 (390)
T 3o6n_A 199 --------STLAIPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYH 266 (390)
T ss_dssp --------SEEECCSSCSEEECCSSCCCEEECCC--CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESG
T ss_pred --------cccCCCCcceEEECCCCeeeeccccc--cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChh
Confidence 12334567888888888888654432 47888888888888853 4688888888888888888876553
Q ss_pred -CCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccc
Q 002238 306 -FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTG 384 (948)
Q Consensus 306 -~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g 384 (948)
+.. +++|+.|+|++|++++
T Consensus 267 ~~~~------------------------------------------------------------l~~L~~L~L~~n~l~~ 286 (390)
T 3o6n_A 267 PFVK------------------------------------------------------------MQRLERLYISNNRLVA 286 (390)
T ss_dssp GGTT------------------------------------------------------------CSSCCEEECCSSCCCE
T ss_pred Hccc------------------------------------------------------------cccCCEEECCCCcCcc
Confidence 223 3456666666666654
Q ss_pred cCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCC-CCCcccccccCCCCCCCCc
Q 002238 385 TISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP-SFKSNAIVNTDGNPDIGKE 454 (948)
Q Consensus 385 ~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip-~~~~~~~~~~~gnp~~~~~ 454 (948)
+|..+..+++|++|+|++|+++ .+|..+..+++|++|+|++|+++.... .+.....+.+++||+.|..
T Consensus 287 -~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~L~~L~l~~N~~~~~~ 355 (390)
T 3o6n_A 287 -LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNS 355 (390)
T ss_dssp -EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCSSCEEHHH
T ss_pred -cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeCchhhccCCEEEcCCCCccchh
Confidence 3444555666666666666665 455556666666666666666654322 2344555666666666543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-32 Score=331.69 Aligned_cols=336 Identities=17% Similarity=0.203 Sum_probs=281.0
Q ss_pred CCEEEEEeCCCCCcC-----------------CCCcccc--CCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEccccc-
Q 002238 68 KRITRIQIGHQNLQG-----------------TLPSNLQ--NLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQ- 126 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~-----------------~~p~~l~--~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~- 126 (948)
.+++.|+|++|+++| .+|+.++ ++++|++|+|++|++.+.+| .|.++++|++|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~ 527 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCC
Confidence 689999999999998 4999988 99999999999999999888 79999999999999998
Q ss_pred ccC-CCCccccCC-------CCCCEEEccCCCCCCCCCCc--cccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEE
Q 002238 127 FTS-VPSDFFTGL-------SSLQSIEIDNNPFSSWEIPQ--SLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILH 196 (948)
Q Consensus 127 l~~-~~~~~~~~l-------~~L~~L~Ls~N~l~~~~~p~--~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~ 196 (948)
+++ .+|..++++ ++|+.|+|++|+++ .+|. .+.++++|+.|+|++|+++ .+| .|+ .+++|+.|+
T Consensus 528 lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~--~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~--~L~~L~~L~ 601 (876)
T 4ecn_A 528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE--EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFG--TNVKLTDLK 601 (876)
T ss_dssp SCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC--BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCC--TTSEESEEE
T ss_pred cccccchHHHHhhhhcccccCCccEEEeeCCcCC--ccCChhhhhcCCCCCEEECCCCCcc-cch-hhc--CCCcceEEE
Confidence 998 667656555 49999999999999 7898 9999999999999999999 778 676 899999999
Q ss_pred cccccccccCCCCccc-cc-ccceeccCCCCCCccCCCccccccCCC--ccEEEccCCcccccCCCCC------CCCCCc
Q 002238 197 LAFNQLIGGLPASFSG-SQ-IQSLWVNGQNGNAKLGGGIDVIQNMTS--LKEIWLHSNAFSGPLPDFS------GVKQLE 266 (948)
Q Consensus 197 Ls~N~l~~~~p~~~~~-~~-l~~l~~~~~~~~~~~~~~~~~l~~l~~--L~~L~Ls~N~l~~~~~~~~------~l~~L~ 266 (948)
|++|+++ .+|..+.. .+ |+.|++.++... ..+..+..++. |+.|+|++|++.+.+|.+. .+.+|+
T Consensus 602 Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~----~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~ 676 (876)
T 4ecn_A 602 LDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK----YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAS 676 (876)
T ss_dssp CCSSCCS-CCCTTSCEECTTCCEEECCSSCCC----SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEE
T ss_pred CcCCccc-cchHHHhhccccCCEEECcCCCCC----cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcC
Confidence 9999999 88887765 44 777777765433 45566666654 9999999999999877544 456899
Q ss_pred EEeccCCccccccchhh-hCCCCCcEEEcccCcccccCCCCCCc--------cccccccccCCCCCCCCCCCchhhhhhH
Q 002238 267 SLSLRDNFFTGPVPDSL-VKLESLKIVNMTNNLLQGPVPEFDRS--------VSLDMAKGSNNFCLPSPGACDPRLNALL 337 (948)
Q Consensus 267 ~L~L~~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~g~~p~~~~~--------~~l~~~~~~~~~~~~~~~~~~~~~~~l~ 337 (948)
.|+|++|+++ .+|..+ ..+++|+.|+|++|+++..++.+... .+|..+++.+|.+..+|....
T Consensus 677 ~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~~lp~~l~------- 748 (876)
T 4ecn_A 677 TVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFR------- 748 (876)
T ss_dssp EEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCCCCCGGGS-------
T ss_pred EEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCccchHHhh-------
Confidence 9999999999 667665 48999999999999999444444332 278888888776654431100
Q ss_pred HHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCcc------ccccccCC
Q 002238 338 SVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILAD------NNLSGMIP 411 (948)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~------N~l~g~ip 411 (948)
...+++|+.|+|++|++++ +|..++++++|+.|+|++ |++.+.+|
T Consensus 749 ----------------------------~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip 799 (876)
T 4ecn_A 749 ----------------------------ATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWP 799 (876)
T ss_dssp ----------------------------TTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCC
T ss_pred ----------------------------hccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccCh
Confidence 0146789999999999998 899999999999999976 88999999
Q ss_pred cCCcCCCCCcEEEccCCcccCCCCC--CCcccccccCCCCCCC
Q 002238 412 EGLSVLGALKELDVSNNQLYGKIPS--FKSNAIVNTDGNPDIG 452 (948)
Q Consensus 412 ~~l~~l~~L~~L~ls~N~l~g~ip~--~~~~~~~~~~gnp~~~ 452 (948)
..|..+++|+.|+|++|+| +.||. ......+.+++||+..
T Consensus 800 ~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~~~L~~LdLs~N~l~~ 841 (876)
T 4ecn_A 800 TGITTCPSLIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNIS 841 (876)
T ss_dssp TTGGGCSSCCEEECCSSCC-CBCCSCCCSSSCEEECCSCTTCE
T ss_pred HHHhcCCCCCEEECCCCCC-CccCHhhcCCCCEEECCCCCCCc
Confidence 9999999999999999999 78885 3456788999999764
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-33 Score=302.77 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=186.3
Q ss_pred CCcEEEcccccccC--CCCccccCCCCCCEEEccC-CCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCC
Q 002238 116 SLEVVMLSNNQFTS--VPSDFFTGLSSLQSIEIDN-NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGL 192 (948)
Q Consensus 116 ~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~-N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L 192 (948)
++++|+|++|.+++ ..|..|.++++|++|+|++ |.+.+ .+|..+.++++|++|+|++|++++.+|..|. .+++|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~-~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~--~l~~L 127 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG-PIPPAIAKLTQLHYLYITHTNVSGAIPDFLS--QIKTL 127 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEES-CCCGGGGGCTTCSEEEEEEECCEEECCGGGG--GCTTC
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccc-cCChhHhcCCCCCEEECcCCeeCCcCCHHHh--CCCCC
Confidence 34444444444444 4444455555555555552 55544 4555555555555555555566556666555 56666
Q ss_pred cEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCC-CCCCCC-CCcEEec
Q 002238 193 TILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVK-QLESLSL 270 (948)
Q Consensus 193 ~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~-~L~~L~L 270 (948)
++|+|++|++++.+|..+ .++++|++|+|++|++++.+| .+..++ +|+.|+|
T Consensus 128 ~~L~Ls~N~l~~~~p~~~--------------------------~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L 181 (313)
T 1ogq_A 128 VTLDFSYNALSGTLPPSI--------------------------SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181 (313)
T ss_dssp CEEECCSSEEESCCCGGG--------------------------GGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEEC
T ss_pred CEEeCCCCccCCcCChHH--------------------------hcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEEC
Confidence 666666666666666543 256677777777777766555 466666 8999999
Q ss_pred cCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhc
Q 002238 271 RDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFA 350 (948)
Q Consensus 271 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 350 (948)
++|++++.+|..+..++ |+.|+|++|++++.+|.
T Consensus 182 ~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~--------------------------------------------- 215 (313)
T 1ogq_A 182 SRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASV--------------------------------------------- 215 (313)
T ss_dssp CSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGG---------------------------------------------
T ss_pred cCCeeeccCChHHhCCc-ccEEECcCCcccCcCCH---------------------------------------------
Confidence 99999999999999997 99999999999987664
Q ss_pred cccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcc
Q 002238 351 ENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430 (948)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l 430 (948)
.+..+++|+.|+|++|.+++.+|. +..+++|++|+|++|+|+|.+|..+..+++|++|+|++|+|
T Consensus 216 --------------~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 280 (313)
T 1ogq_A 216 --------------LFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280 (313)
T ss_dssp --------------GCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEE
T ss_pred --------------HHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcc
Confidence 122445899999999999988777 88999999999999999999999999999999999999999
Q ss_pred cCCCCCC---CcccccccCCCCCCCCccC
Q 002238 431 YGKIPSF---KSNAIVNTDGNPDIGKEKS 456 (948)
Q Consensus 431 ~g~ip~~---~~~~~~~~~gnp~~~~~~~ 456 (948)
+|.+|.. .....+.+.+||+.|..|.
T Consensus 281 ~~~ip~~~~l~~L~~l~l~~N~~lc~~p~ 309 (313)
T 1ogq_A 281 CGEIPQGGNLQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp EEECCCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred cccCCCCccccccChHHhcCCCCccCCCC
Confidence 9999974 4466788999999987654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.9e-32 Score=323.16 Aligned_cols=362 Identities=18% Similarity=0.166 Sum_probs=251.6
Q ss_pred EEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCC
Q 002238 71 TRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149 (948)
Q Consensus 71 ~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 149 (948)
..++.++++++ .+|..+. ++|++|+|++|.+++.++ .|.++++|++|+|++|.+++++|..|.++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n 90 (606)
T 3vq2_A 14 ITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90 (606)
T ss_dssp TEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred CceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCC
Confidence 35788888998 7777665 799999999999999887 7999999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccc-cCCCCccc-ccccceeccCCCCCC
Q 002238 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIG-GLPASFSG-SQIQSLWVNGQNGNA 227 (948)
Q Consensus 150 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~-~~l~~l~~~~~~~~~ 227 (948)
+++. ..|..+.++++|++|++++|++++..+..++ .+++|++|+|++|++++ .+|..|.. .+|+.|++.++....
T Consensus 91 ~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~ 167 (606)
T 3vq2_A 91 PIQS-FSPGSFSGLTSLENLVAVETKLASLESFPIG--QLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167 (606)
T ss_dssp CCCC-CCTTSSTTCTTCCEEECTTSCCCCSSSSCCT--TCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCE
T ss_pred cccc-cChhhcCCcccCCEEEccCCccccccccccC--CCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCccee
Confidence 9996 5589999999999999999999988888887 99999999999999986 56888865 567777776654332
Q ss_pred ccCCCcc-------------------------------------------------------------------------
Q 002238 228 KLGGGID------------------------------------------------------------------------- 234 (948)
Q Consensus 228 ~~~~~~~------------------------------------------------------------------------- 234 (948)
.......
T Consensus 168 ~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l 247 (606)
T 3vq2_A 168 ITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNL 247 (606)
T ss_dssp ECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCC
T ss_pred cChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcc
Confidence 2111000
Q ss_pred ------------------------------------------------------ccccCCCccEEEccCCcccccCCC--
Q 002238 235 ------------------------------------------------------VIQNMTSLKEIWLHSNAFSGPLPD-- 258 (948)
Q Consensus 235 ------------------------------------------------------~l~~l~~L~~L~Ls~N~l~~~~~~-- 258 (948)
.+..+++|+.|++++|.+ +.+|.
T Consensus 248 ~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l-~~lp~~~ 326 (606)
T 3vq2_A 248 EIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQL-KQFPTLD 326 (606)
T ss_dssp SCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCC-SSCCCCC
T ss_pred cccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccC-cccccCC
Confidence 012223444444444444 22222
Q ss_pred -------------------CCCCCCCcEEeccCCccccc--cchhhhCCCCCcEEEcccCcccccCCCCCCccccccccc
Q 002238 259 -------------------FSGVKQLESLSLRDNFFTGP--VPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKG 317 (948)
Q Consensus 259 -------------------~~~l~~L~~L~L~~N~l~~~--~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~ 317 (948)
+..+++|+.|+|++|++++. +|..+..+++|+.|+|++|.+++..+.+..+.+|..++.
T Consensus 327 l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l 406 (606)
T 3vq2_A 327 LPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDF 406 (606)
T ss_dssp CSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEECCCCTTCTTCCEEEC
T ss_pred CCccceeeccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccchhhccCCCCCCeeEC
Confidence 23455666667777777654 367777777777777777777766656667777777777
Q ss_pred cCCCCCCCCC-CCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccc-cCCccccCccc
Q 002238 318 SNNFCLPSPG-ACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTG-TISPEFASFKS 395 (948)
Q Consensus 318 ~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g-~ip~~~~~l~~ 395 (948)
.+|.....+. .....+..+. ..+..++.........+..+++|+.|++++|.+.+ .+|..|+++++
T Consensus 407 ~~n~l~~~~~~~~~~~l~~L~------------~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~ 474 (606)
T 3vq2_A 407 QHSTLKRVTEFSAFLSLEKLL------------YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTN 474 (606)
T ss_dssp TTSEEESTTTTTTTTTCTTCC------------EEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTT
T ss_pred CCCccCCccChhhhhccccCC------------EEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCC
Confidence 6665444322 1111111111 01111111111111224455677777777777776 46777777777
Q ss_pred cceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCCC----CCcccccccCCCCCC
Q 002238 396 LQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNPDI 451 (948)
Q Consensus 396 L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~----~~~~~~~~~~gnp~~ 451 (948)
|+.|+|++|++++..|..+..+++|++|+|++|++++.+|. +.....+.+++|...
T Consensus 475 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 534 (606)
T 3vq2_A 475 LTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE 534 (606)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC
T ss_pred CCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc
Confidence 77777777777777777777777777777777777766553 344556677777644
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=311.39 Aligned_cols=300 Identities=17% Similarity=0.198 Sum_probs=259.6
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (948)
.+++.|+|++|.+++..|..|.++++|++|+|++|.|++.++ .|.++++|++|+|++|.++++++..|..+++|+.|+|
T Consensus 56 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 135 (477)
T 2id5_A 56 PHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEV 135 (477)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEE
T ss_pred CCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEEC
Confidence 589999999999999889999999999999999999998877 5889999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCC
Q 002238 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGN 226 (948)
Q Consensus 147 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~ 226 (948)
++|+++. ..|..|.++++|+.|+|++|++++..+..|. .+++|+.|+|++|++.+..+..|
T Consensus 136 ~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~l~~L~~L~l~~n~i~~~~~~~~---------------- 196 (477)
T 2id5_A 136 GDNDLVY-ISHRAFSGLNSLEQLTLEKCNLTSIPTEALS--HLHGLIVLRLRHLNINAIRDYSF---------------- 196 (477)
T ss_dssp CCTTCCE-ECTTSSTTCTTCCEEEEESCCCSSCCHHHHT--TCTTCCEEEEESCCCCEECTTCS----------------
T ss_pred CCCccce-eChhhccCCCCCCEEECCCCcCcccChhHhc--ccCCCcEEeCCCCcCcEeChhhc----------------
Confidence 9999996 4577899999999999999999988777787 89999999999999997766554
Q ss_pred CccCCCccccccCCCccEEEccCCcccccCC-CCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCC
Q 002238 227 AKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE 305 (948)
Q Consensus 227 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 305 (948)
.++++|+.|+|++|.+.+.++ ......+|+.|+|++|++++..+..+.++++|+.|+|++|++++..+.
T Consensus 197 ----------~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 266 (477)
T 2id5_A 197 ----------KRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGS 266 (477)
T ss_dssp ----------CSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTT
T ss_pred ----------ccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChh
Confidence 478999999999998887665 455567999999999999965557899999999999999999876553
Q ss_pred CCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCccccc
Q 002238 306 FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT 385 (948)
Q Consensus 306 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ 385 (948)
.+..+++|+.|+|++|++++.
T Consensus 267 -----------------------------------------------------------~~~~l~~L~~L~L~~n~l~~~ 287 (477)
T 2id5_A 267 -----------------------------------------------------------MLHELLRLQEIQLVGGQLAVV 287 (477)
T ss_dssp -----------------------------------------------------------SCTTCTTCCEEECCSSCCSEE
T ss_pred -----------------------------------------------------------hccccccCCEEECCCCccceE
Confidence 122345899999999999999
Q ss_pred CCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCCC---CCcccccccCCCCCCCCcc
Q 002238 386 ISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS---FKSNAIVNTDGNPDIGKEK 455 (948)
Q Consensus 386 ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~---~~~~~~~~~~gnp~~~~~~ 455 (948)
.|..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|++.+..+- +.......+.++...|..|
T Consensus 288 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p 360 (477)
T 2id5_A 288 EPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP 360 (477)
T ss_dssp CTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred CHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence 999999999999999999999987778899999999999999999875431 0112224456666666544
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=316.43 Aligned_cols=145 Identities=17% Similarity=0.234 Sum_probs=124.6
Q ss_pred EEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCC
Q 002238 71 TRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149 (948)
Q Consensus 71 ~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 149 (948)
+.|++++|+++ .+|..+. ++|++|+|++|.|++.+| .|.++++|++|+|++|++++++|..|+++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 46899999999 6888777 899999999999999887 7999999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccCCCCCCEEEccCccccc-cCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCC
Q 002238 150 PFSSWEIPQSLRNASGLQNFSANSANITG-QIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQN 224 (948)
Q Consensus 150 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~-~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~ 224 (948)
+++ .+|.. .+++|++|+|++|++++ .+|..|+ .+++|++|+|++|++++.....+...+++.|++.++.
T Consensus 80 ~l~--~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~--~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~l~~n~ 149 (520)
T 2z7x_B 80 KLV--KISCH--PTVNLKHLDLSFNAFDALPICKEFG--NMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGE 149 (520)
T ss_dssp CCC--EEECC--CCCCCSEEECCSSCCSSCCCCGGGG--GCTTCCEEEEEESSCCGGGGGGGTTSCEEEEEEEECT
T ss_pred cee--ecCcc--ccCCccEEeccCCccccccchhhhc--cCCcceEEEecCcccchhhccccccceeeEEEeeccc
Confidence 999 67777 89999999999999998 5788887 8999999999999998743222221222677666544
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=318.21 Aligned_cols=367 Identities=20% Similarity=0.220 Sum_probs=241.5
Q ss_pred EEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCC
Q 002238 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNP 150 (948)
Q Consensus 72 ~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 150 (948)
.++.++.+++ .+|..+. ++|++|+|++|.|++..+ .|.++++|++|+|++|+++++++..|+++++|++|+|++|+
T Consensus 11 ~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 87 (570)
T 2z63_A 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (570)
T ss_dssp EEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred EEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCc
Confidence 4666777777 6777654 579999999999999777 79999999999999999999999999999999999999999
Q ss_pred CCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccc-cCCCCccc-ccccceeccCCCCCCc
Q 002238 151 FSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIG-GLPASFSG-SQIQSLWVNGQNGNAK 228 (948)
Q Consensus 151 l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~-~~l~~l~~~~~~~~~~ 228 (948)
++. ..|..|.++++|++|++++|++++..+..++ .+++|++|+|++|++++ .+|..|.. .+|+.|++.++ ..
T Consensus 88 l~~-~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~--~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n---~l 161 (570)
T 2z63_A 88 IQS-LALGAFSGLSSLQKLVAVETNLASLENFPIG--HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN---KI 161 (570)
T ss_dssp CCE-ECTTTTTTCTTCCEEECTTSCCCCSTTCSCT--TCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTS---CC
T ss_pred CCc-cCHhhhcCccccccccccccccccCCCcccc--ccccccEEecCCCccceecChhhhcccCCCCEEeCcCC---cc
Confidence 995 4468899999999999999999987776776 89999999999999987 46888864 45666666544 44
Q ss_pred cCCCccccccCCCc----cEEEccCCcccccCCC----------------------------------------------
Q 002238 229 LGGGIDVIQNMTSL----KEIWLHSNAFSGPLPD---------------------------------------------- 258 (948)
Q Consensus 229 ~~~~~~~l~~l~~L----~~L~Ls~N~l~~~~~~---------------------------------------------- 258 (948)
....+..+..+++| ..|++++|.+++..+.
T Consensus 162 ~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~ 241 (570)
T 2z63_A 162 QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG 241 (570)
T ss_dssp CEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCS
T ss_pred ceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCch
Confidence 44444556666666 6777777776654432
Q ss_pred ------------------------------------CCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCccccc
Q 002238 259 ------------------------------------FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302 (948)
Q Consensus 259 ------------------------------------~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ 302 (948)
+..+++|+.|++++|.++ .+|..+..+ +|+.|++++|.+. .
T Consensus 242 ~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~ 318 (570)
T 2z63_A 242 NLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-Q 318 (570)
T ss_dssp SCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-S
T ss_pred hhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-c
Confidence 333466666777776666 466555555 5555555555554 2
Q ss_pred CCC--C-------------------CCccccccccccCCCCCCCCCCCchhhhhhHHHHHh--------------hCCcc
Q 002238 303 VPE--F-------------------DRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKL--------------MGYPQ 347 (948)
Q Consensus 303 ~p~--~-------------------~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~--------------~~~~~ 347 (948)
+|. + ..+.+|..++..+|...... ........+..+..+ .....
T Consensus 319 l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~-~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~ 397 (570)
T 2z63_A 319 FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKG-CCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQ 397 (570)
T ss_dssp CCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEE-EEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTT
T ss_pred cCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCccc-cccccccccCccCEEECCCCccccccccccccCC
Confidence 221 1 22333444444444322110 000000000000000 00000
Q ss_pred hhccccCCCCCCCC-ccceeecCCceEEEEccCCcccccCCccccCccccceEeCcccccc-ccCCcCCcCCCCCcEEEc
Q 002238 348 RFAENWKGNDPCSD-WIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLS-GMIPEGLSVLGALKELDV 425 (948)
Q Consensus 348 ~~~~~~~~~~~~~~-~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~-g~ip~~l~~l~~L~~L~l 425 (948)
-...+..++..... ....+..+++|+.|++++|.+.+.+|..|..+++|++|+|++|+++ +.+|..+..+++|++|+|
T Consensus 398 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l 477 (570)
T 2z63_A 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477 (570)
T ss_dssp CCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEEC
T ss_pred CCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEEC
Confidence 00001111100000 0012345667778888888887777777788888888888888876 567777888888888888
Q ss_pred cCCcccCCCCC----CCcccccccCCCCCC
Q 002238 426 SNNQLYGKIPS----FKSNAIVNTDGNPDI 451 (948)
Q Consensus 426 s~N~l~g~ip~----~~~~~~~~~~gnp~~ 451 (948)
++|++++.+|. +.....+.+++|...
T Consensus 478 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 507 (570)
T 2z63_A 478 SQCQLEQLSPTAFNSLSSLQVLNMASNQLK 507 (570)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCccccCChhhhhcccCCCEEeCCCCcCC
Confidence 88888776553 344566777777544
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-30 Score=307.61 Aligned_cols=338 Identities=19% Similarity=0.187 Sum_probs=262.6
Q ss_pred EEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCC
Q 002238 71 TRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149 (948)
Q Consensus 71 ~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 149 (948)
+.++++++++++ +|..+. ++|++|+|++|.|++.++ .|.++++|++|+|++|+|++++|+.|.++++|++|+|++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 789999999994 887665 899999999999999887 7999999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccCCCCCCEEEccCcccccc-CCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCc
Q 002238 150 PFSSWEIPQSLRNASGLQNFSANSANITGQ-IPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAK 228 (948)
Q Consensus 150 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~-~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~ 228 (948)
+++ .+|.. .+++|++|++++|++++. +|..|+ .+++|++|+|++|++++.....+...+++.|++.++....
T Consensus 111 ~l~--~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~--~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l~~- 183 (562)
T 3a79_B 111 RLQ--NISCC--PMASLRHLDLSFNDFDVLPVCKEFG--NLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHI- 183 (562)
T ss_dssp CCC--EECSC--CCTTCSEEECCSSCCSBCCCCGGGG--GCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSCCC-
T ss_pred cCC--ccCcc--ccccCCEEECCCCCccccCchHhhc--ccCcccEEecCCCccccCchhhhhhceeeEEEeecccccc-
Confidence 999 67877 899999999999999974 567887 8999999999999998643333322233667666544300
Q ss_pred cCCCcc--------------------------ccccCCCccEEEccCCcc-----cccCC--------------------
Q 002238 229 LGGGID--------------------------VIQNMTSLKEIWLHSNAF-----SGPLP-------------------- 257 (948)
Q Consensus 229 ~~~~~~--------------------------~l~~l~~L~~L~Ls~N~l-----~~~~~-------------------- 257 (948)
.+..+. .+.++++|+.|++++|+. .+.++
T Consensus 184 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~ 263 (562)
T 3a79_B 184 KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263 (562)
T ss_dssp CSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECH
T ss_pred cccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcH
Confidence 111222 233566777787777741 11000
Q ss_pred -------CCCCCCCCcEEeccCCccccccchhh-----------------------------------------------
Q 002238 258 -------DFSGVKQLESLSLRDNFFTGPVPDSL----------------------------------------------- 283 (948)
Q Consensus 258 -------~~~~l~~L~~L~L~~N~l~~~~p~~l----------------------------------------------- 283 (948)
......+|++|++++|.++|.+|..+
T Consensus 264 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~ 343 (562)
T 3a79_B 264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPF 343 (562)
T ss_dssp HHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCC
T ss_pred HHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCc
Confidence 01112388999999999998888765
Q ss_pred ------hCCCCCcEEEcccCcccccCCC-CCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCC
Q 002238 284 ------VKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGN 356 (948)
Q Consensus 284 ------~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 356 (948)
..+++|++|+|++|++++.+|. +..+.+|+.++..+|....++. +
T Consensus 344 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-----------~----------------- 395 (562)
T 3a79_B 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFK-----------V----------------- 395 (562)
T ss_dssp CCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTH-----------H-----------------
T ss_pred ccccCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCccc-----------c-----------------
Confidence 6789999999999999997664 7788888888888876543320 0
Q ss_pred CCCCCccceeecCCceEEEEccCCcccccCCcc-ccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCC
Q 002238 357 DPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP 435 (948)
Q Consensus 357 ~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~-~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip 435 (948)
...+..+++|+.|+|++|.+++.+|.. +..+++|++|+|++|++++.+|..+. ++|++|+|++|+|+. +|
T Consensus 396 ------~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~-ip 466 (562)
T 3a79_B 396 ------ALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMS-IP 466 (562)
T ss_dssp ------HHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCC-CC
T ss_pred ------hhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcc-cC
Confidence 012345679999999999999966664 88899999999999999998888765 799999999999984 54
Q ss_pred C----CCcccccccCCCCCCCCccC
Q 002238 436 S----FKSNAIVNTDGNPDIGKEKS 456 (948)
Q Consensus 436 ~----~~~~~~~~~~gnp~~~~~~~ 456 (948)
. +.....+.+++|... ..+.
T Consensus 467 ~~~~~l~~L~~L~L~~N~l~-~l~~ 490 (562)
T 3a79_B 467 KDVTHLQALQELNVASNQLK-SVPD 490 (562)
T ss_dssp TTTTSSCCCSEEECCSSCCC-CCCT
T ss_pred hhhcCCCCCCEEECCCCCCC-CCCH
Confidence 3 345677889999766 3443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-31 Score=313.29 Aligned_cols=342 Identities=17% Similarity=0.173 Sum_probs=268.8
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCC-cCCCCCCcEEEcccccccCC-CCccccCCCCCCEEE
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS-LNGLASLEVVMLSNNQFTSV-PSDFFTGLSSLQSIE 145 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~ 145 (948)
.+++.|+|++|++++..|..|.++++|++|+|++|.+++.+|. |.++++|++|+|++|.++++ .|..|+++++|++|+
T Consensus 50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 129 (549)
T 2z81_A 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129 (549)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEE
Confidence 5899999999999988889999999999999999999998884 99999999999999999975 456799999999999
Q ss_pred ccCCCCCCCCCC-ccccCCCCCCEEEccCccccccCCCCCCC----------------------CCCCCCcEEEcccccc
Q 002238 146 IDNNPFSSWEIP-QSLRNASGLQNFSANSANITGQIPSFFGP----------------------DEFPGLTILHLAFNQL 202 (948)
Q Consensus 146 Ls~N~l~~~~~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~----------------------~~l~~L~~L~Ls~N~l 202 (948)
|++|++.+ .+| ..+.++++|++|++++|++++.+|..++. ..+++|++|+|++|++
T Consensus 130 L~~n~~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l 208 (549)
T 2z81_A 130 IGNVETFS-EIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208 (549)
T ss_dssp EEESSSCC-EECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBC
T ss_pred CCCCcccc-ccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCcc
Confidence 99998544 565 68999999999999999999988887751 1367888888888888
Q ss_pred cccC--CCCcc--ccc----------------------------------------------------------------
Q 002238 203 IGGL--PASFS--GSQ---------------------------------------------------------------- 214 (948)
Q Consensus 203 ~~~~--p~~~~--~~~---------------------------------------------------------------- 214 (948)
++.. |..+. ...
T Consensus 209 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l 288 (549)
T 2z81_A 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTI 288 (549)
T ss_dssp TTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEE
T ss_pred ccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccc
Confidence 8642 11100 011
Q ss_pred -----------------------ccceeccCCCCCCccCCCcccc-ccCCCccEEEccCCcccccCC----CCCCCCCCc
Q 002238 215 -----------------------IQSLWVNGQNGNAKLGGGIDVI-QNMTSLKEIWLHSNAFSGPLP----DFSGVKQLE 266 (948)
Q Consensus 215 -----------------------l~~l~~~~~~~~~~~~~~~~~l-~~l~~L~~L~Ls~N~l~~~~~----~~~~l~~L~ 266 (948)
++.|++.+ +. ....+..+ .++++|++|+|++|++++.++ .+..+++|+
T Consensus 289 ~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~---n~-l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~ 364 (549)
T 2z81_A 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVEN---SK-VFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQ 364 (549)
T ss_dssp ESCBCSCGGGSCCCCHHHHHSTTCCEEEEES---SC-CCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCC
T ss_pred cccccchhhhcccchhhhhhcccceEEEecc---Cc-cccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCc
Confidence 11111111 11 12234333 579999999999999998643 367899999
Q ss_pred EEeccCCccccccc--hhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhC
Q 002238 267 SLSLRDNFFTGPVP--DSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMG 344 (948)
Q Consensus 267 ~L~L~~N~l~~~~p--~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 344 (948)
.|+|++|++++..+ ..+..+++|++|+|++|++++.++.+..+.+|+.++..+|....++...+..+..+
T Consensus 365 ~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~~~L~~L-------- 436 (549)
T 2z81_A 365 TLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVL-------- 436 (549)
T ss_dssp EEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCCCCSCCCCCTTCCEEECTTSCCSCCCTTSCTTCSEE--------
T ss_pred EEEccCCcccccccchhhhhcCCCCCEEECCCCCCccCChhhcccccccEEECCCCCcccccchhcCCceEE--------
Confidence 99999999995433 56899999999999999999665567788889999999888776665443322211
Q ss_pred CcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEE
Q 002238 345 YPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELD 424 (948)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ 424 (948)
+..++.- .+....+++|+.|+|++|+++ .+|. .+.+++|++|+|++|+|++.+|..+..+++|++|+
T Consensus 437 -------~Ls~N~l----~~~~~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 503 (549)
T 2z81_A 437 -------DVSNNNL----DSFSLFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIW 503 (549)
T ss_dssp -------ECCSSCC----SCCCCCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEE
T ss_pred -------ECCCCCh----hhhcccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEE
Confidence 1122211 112346789999999999998 6776 57899999999999999999899999999999999
Q ss_pred ccCCcccCCCC
Q 002238 425 VSNNQLYGKIP 435 (948)
Q Consensus 425 ls~N~l~g~ip 435 (948)
+++|++++..|
T Consensus 504 l~~N~~~~~~~ 514 (549)
T 2z81_A 504 LHTNPWDCSCP 514 (549)
T ss_dssp CCSSCBCCCHH
T ss_pred ecCCCccCCCc
Confidence 99999999877
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=309.83 Aligned_cols=306 Identities=18% Similarity=0.221 Sum_probs=257.3
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (948)
.+++.|+|++|.+++..|..|+++++|++|+|++|.|++.+| .|.++++|++|+|++|.|+++++..|+++++|++|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 579999999999998888899999999999999999999888 5799999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCC
Q 002238 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGN 226 (948)
Q Consensus 147 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~ 226 (948)
++|.+++ ..|..+.++++|++|+|++|.+++... + .+++|+.|++++|.+++.... ..++.|++.++...
T Consensus 155 s~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~---~--~l~~L~~L~l~~n~l~~l~~~----~~L~~L~ls~n~l~ 224 (597)
T 3oja_B 155 SNNNLER-IEDDTFQATTSLQNLQLSSNRLTHVDL---S--LIPSLFHANVSYNLLSTLAIP----IAVEELDASHNSIN 224 (597)
T ss_dssp CSSCCCB-CCTTTTTTCTTCCEEECTTSCCSBCCG---G--GCTTCSEEECCSSCCSEEECC----TTCSEEECCSSCCC
T ss_pred eCCcCCC-CChhhhhcCCcCcEEECcCCCCCCcCh---h--hhhhhhhhhcccCccccccCC----chhheeeccCCccc
Confidence 9999996 567789999999999999999997642 2 678999999999999864221 35777877766544
Q ss_pred CccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCC
Q 002238 227 AKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEF 306 (948)
Q Consensus 227 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 306 (948)
..... ..++|+.|+|++|.+++. +.+..+++|+.|+|++|.+++.+|..|..+++|+.|+|++|.+++..+.+
T Consensus 225 ~~~~~------~~~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~ 297 (597)
T 3oja_B 225 VVRGP------VNVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYG 297 (597)
T ss_dssp EEECS------CCSCCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSS
T ss_pred ccccc------cCCCCCEEECCCCCCCCC-hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCccc
Confidence 43322 236899999999999974 66888999999999999999999999999999999999999998743321
Q ss_pred CCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccC
Q 002238 307 DRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTI 386 (948)
Q Consensus 307 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~i 386 (948)
..+++|+.|+|++|.+. .+
T Consensus 298 ------------------------------------------------------------~~l~~L~~L~Ls~N~l~-~i 316 (597)
T 3oja_B 298 ------------------------------------------------------------QPIPTLKVLDLSHNHLL-HV 316 (597)
T ss_dssp ------------------------------------------------------------SCCTTCCEEECCSSCCC-CC
T ss_pred ------------------------------------------------------------ccCCCCcEEECCCCCCC-cc
Confidence 12458999999999999 68
Q ss_pred CccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCCC--CCcccccccCCCCCCCCc
Q 002238 387 SPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS--FKSNAIVNTDGNPDIGKE 454 (948)
Q Consensus 387 p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~--~~~~~~~~~~gnp~~~~~ 454 (948)
|..++.+++|+.|+|++|+|++. | +..+++|+.|+|++|++++..+. +.......+.+++..|..
T Consensus 317 ~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~C~~ 383 (597)
T 3oja_B 317 ERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 383 (597)
T ss_dssp GGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCCCCCT
T ss_pred CcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHHHHHHHHhhhccccccccCCc
Confidence 88899999999999999999854 3 77889999999999999874221 223334445677766654
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-30 Score=296.81 Aligned_cols=321 Identities=19% Similarity=0.281 Sum_probs=175.3
Q ss_pred CEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccC
Q 002238 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148 (948)
Q Consensus 69 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 148 (948)
+++.|++.++++.. +| .+..+++|++|+|++|.+++.++ +.++++|++|+|++|.++++++ ++++++|++|+|++
T Consensus 47 ~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~ 121 (466)
T 1o6v_A 47 QVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFN 121 (466)
T ss_dssp TCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred cccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh-hhccccCCEEECCCCccccChh--hcCCCCCCEEECCC
Confidence 45555555555542 33 24445555555555555555444 5555555555555555555444 55555555555555
Q ss_pred CCCCCCCCCccccCCCCCCEEEccCccccccCCCCCC-------------------CCCCCCCcEEEcccccccccCCCC
Q 002238 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFG-------------------PDEFPGLTILHLAFNQLIGGLPAS 209 (948)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~-------------------~~~l~~L~~L~Ls~N~l~~~~p~~ 209 (948)
|+++. ++. +.++++|++|++++|.+++. + .+. ...+++|++|++++|++++. +.
T Consensus 122 n~l~~--~~~-~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~- 194 (466)
T 1o6v_A 122 NQITD--IDP-LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI-SV- 194 (466)
T ss_dssp SCCCC--CGG-GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC-GG-
T ss_pred CCCCC--ChH-HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC-hh-
Confidence 55553 222 45555555555555555432 1 122 01455555555555555432 11
Q ss_pred ccc-ccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCC
Q 002238 210 FSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLES 288 (948)
Q Consensus 210 ~~~-~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 288 (948)
+.. .+|+.|++.++.. .+..+ ++.+++|++|+|++|++++. +.+..+++|+.|++++|.+++..| +..+++
T Consensus 195 l~~l~~L~~L~l~~n~l---~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~ 266 (466)
T 1o6v_A 195 LAKLTNLESLIATNNQI---SDITP--LGILTNLDELSLNGNQLKDI-GTLASLTNLTDLDLANNQISNLAP--LSGLTK 266 (466)
T ss_dssp GGGCTTCSEEECCSSCC---CCCGG--GGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTT
T ss_pred hccCCCCCEEEecCCcc---ccccc--ccccCCCCEEECCCCCcccc-hhhhcCCCCCEEECCCCccccchh--hhcCCC
Confidence 211 2333333332221 11111 34455555555555555432 334445555555555555553333 455555
Q ss_pred CcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeec
Q 002238 289 LKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCT 368 (948)
Q Consensus 289 L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (948)
|+.|++++|++++..+ +..+..|..++..+|..... ..+..
T Consensus 267 L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~--------------------------------------~~~~~ 307 (466)
T 1o6v_A 267 LTELKLGANQISNISP-LAGLTALTNLELNENQLEDI--------------------------------------SPISN 307 (466)
T ss_dssp CSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCC--------------------------------------GGGGG
T ss_pred CCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCc--------------------------------------hhhcC
Confidence 5555555555554333 44444444444444432221 11345
Q ss_pred CCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCC--CCCcccccccC
Q 002238 369 KGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP--SFKSNAIVNTD 446 (948)
Q Consensus 369 ~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip--~~~~~~~~~~~ 446 (948)
+++|+.|+|++|++++..| +..+++|+.|+|++|++++. ..+..+++|+.|++++|++++.+| .+.....+.++
T Consensus 308 l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~ 383 (466)
T 1o6v_A 308 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLN 383 (466)
T ss_dssp CTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGGGTTCTTCCEEECC
T ss_pred CCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccchhhcCCCCCEEecc
Confidence 6788999999999888766 78889999999999998865 478888999999999999988776 24455677788
Q ss_pred CCCCCC
Q 002238 447 GNPDIG 452 (948)
Q Consensus 447 gnp~~~ 452 (948)
+|++.+
T Consensus 384 ~n~~~~ 389 (466)
T 1o6v_A 384 DQAWTN 389 (466)
T ss_dssp CEEEEC
T ss_pred CCcccC
Confidence 887764
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-30 Score=289.97 Aligned_cols=306 Identities=18% Similarity=0.227 Sum_probs=254.0
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (948)
.+++.|+|++|++++..+..|.++++|++|+|++|.+++.+| .|.++++|++|+|++|.++.+++..|.++++|++|+|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence 589999999999998888899999999999999999999887 5899999999999999999999998999999999999
Q ss_pred cCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCC
Q 002238 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGN 226 (948)
Q Consensus 147 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~ 226 (948)
++|+++. ..|..+..+++|++|++++|++++.. +. .+++|+.|++++|.+++.... ..++.|++.++...
T Consensus 149 ~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~---~~--~l~~L~~L~l~~n~l~~~~~~----~~L~~L~l~~n~l~ 218 (390)
T 3o6n_A 149 SNNNLER-IEDDTFQATTSLQNLQLSSNRLTHVD---LS--LIPSLFHANVSYNLLSTLAIP----IAVEELDASHNSIN 218 (390)
T ss_dssp CSSCCCB-CCTTTTSSCTTCCEEECCSSCCSBCC---GG--GCTTCSEEECCSSCCSEEECC----SSCSEEECCSSCCC
T ss_pred CCCccCc-cChhhccCCCCCCEEECCCCcCCccc---cc--cccccceeecccccccccCCC----CcceEEECCCCeee
Confidence 9999996 45677999999999999999999763 22 678999999999999853211 35777777765544
Q ss_pred CccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCC
Q 002238 227 AKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEF 306 (948)
Q Consensus 227 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 306 (948)
.... ...++|+.|+|++|++++. +.+..+++|+.|+|++|.+++..|..+..+++|+.|+|++|++++..+.+
T Consensus 219 ~~~~------~~~~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 291 (390)
T 3o6n_A 219 VVRG------PVNVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYG 291 (390)
T ss_dssp EEEC------CCCSSCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSS
T ss_pred eccc------cccccccEEECCCCCCccc-HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCccc
Confidence 4322 2357999999999999974 56888999999999999999988999999999999999999998643321
Q ss_pred CCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccC
Q 002238 307 DRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTI 386 (948)
Q Consensus 307 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~i 386 (948)
..+++|+.|+|++|++. .+
T Consensus 292 ------------------------------------------------------------~~l~~L~~L~L~~n~l~-~~ 310 (390)
T 3o6n_A 292 ------------------------------------------------------------QPIPTLKVLDLSHNHLL-HV 310 (390)
T ss_dssp ------------------------------------------------------------SCCTTCCEEECCSSCCC-CC
T ss_pred ------------------------------------------------------------CCCCCCCEEECCCCcce-ec
Confidence 13458999999999998 57
Q ss_pred CccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCCC--CCcccccccCCCCCCCCc
Q 002238 387 SPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS--FKSNAIVNTDGNPDIGKE 454 (948)
Q Consensus 387 p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~--~~~~~~~~~~gnp~~~~~ 454 (948)
|..+..+++|+.|+|++|+|+. +| +..+++|+.|++++|++++.-.. +.......+.+++..|..
T Consensus 311 ~~~~~~l~~L~~L~L~~N~i~~-~~--~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~c~~ 377 (390)
T 3o6n_A 311 ERNQPQFDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 377 (390)
T ss_dssp GGGHHHHTTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCSCCCT
T ss_pred CccccccCcCCEEECCCCccce-eC--chhhccCCEEEcCCCCccchhHHHHHHHHHhhcccccCceecc
Confidence 8889999999999999999984 44 78899999999999999863211 222233345566666653
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=290.25 Aligned_cols=282 Identities=19% Similarity=0.270 Sum_probs=234.9
Q ss_pred CCCCCccceEEeCCCCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCC
Q 002238 54 TDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPS 132 (948)
Q Consensus 54 ~~~C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~ 132 (948)
..+|.|.|+ |+ +++++++ .+|..+. ++|++|+|++|+|++.++ .|.++++|++|+|++|+++++++
T Consensus 27 ~~~C~~~~~-c~---------~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 93 (353)
T 2z80_A 27 SLSCDRNGI-CK---------GSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE 93 (353)
T ss_dssp CCEECTTSE-EE---------CCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECT
T ss_pred CCCCCCCeE-ee---------CCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCH
Confidence 456999887 63 4677777 6777665 589999999999999777 79999999999999999999999
Q ss_pred ccccCCCCCCEEEccCCCCCCCCCCcc-ccCCCCCCEEEccCccccccCC-CCCCCCCCCCCcEEEccccc-ccccCCCC
Q 002238 133 DFFTGLSSLQSIEIDNNPFSSWEIPQS-LRNASGLQNFSANSANITGQIP-SFFGPDEFPGLTILHLAFNQ-LIGGLPAS 209 (948)
Q Consensus 133 ~~~~~l~~L~~L~Ls~N~l~~~~~p~~-~~~l~~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~ 209 (948)
..|+++++|++|+|++|+++ .+|.. +.++++|++|++++|++++..+ ..|. .+++|++|+|++|+ +.+..+..
T Consensus 94 ~~~~~l~~L~~L~Ls~n~l~--~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~--~l~~L~~L~l~~n~~~~~~~~~~ 169 (353)
T 2z80_A 94 DSFSSLGSLEHLDLSYNYLS--NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFS--HLTKLQILRVGNMDTFTKIQRKD 169 (353)
T ss_dssp TTTTTCTTCCEEECCSSCCS--SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCT--TCTTCCEEEEEESSSCCEECTTT
T ss_pred hhcCCCCCCCEEECCCCcCC--cCCHhHhCCCccCCEEECCCCCCcccCchhhhc--cCCCCcEEECCCCccccccCHHH
Confidence 99999999999999999999 46655 8899999999999999996555 4676 89999999999995 66555555
Q ss_pred cccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCC-CCCCCCCCcEEeccCCccccccch-hhhCCC
Q 002238 210 FSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPD-SLVKLE 287 (948)
Q Consensus 210 ~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~-~l~~l~ 287 (948)
| .++++|++|++++|++++..+ .+..+++|++|+|++|.++ .+|. .+..++
T Consensus 170 ~--------------------------~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~ 222 (353)
T 2z80_A 170 F--------------------------AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTS 222 (353)
T ss_dssp T--------------------------TTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTT
T ss_pred c--------------------------cCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcc
Confidence 4 478999999999999999766 5888999999999999998 4554 455699
Q ss_pred CCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceee
Q 002238 288 SLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTC 367 (948)
Q Consensus 288 ~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (948)
+|+.|+|++|++++..+.-.. ...
T Consensus 223 ~L~~L~L~~n~l~~~~~~~l~--------------------------------------------------------~~~ 246 (353)
T 2z80_A 223 SVECLELRDTDLDTFHFSELS--------------------------------------------------------TGE 246 (353)
T ss_dssp TEEEEEEESCBCTTCCCC--------------------------------------------------------------
T ss_pred cccEEECCCCccccccccccc--------------------------------------------------------ccc
Confidence 999999999999875443000 001
Q ss_pred cCCceEEEEccCCcccc----cCCccccCccccceEeCccccccccCCcC-CcCCCCCcEEEccCCcccCCCCC
Q 002238 368 TKGNITVINFQKMNLTG----TISPEFASFKSLQRLILADNNLSGMIPEG-LSVLGALKELDVSNNQLYGKIPS 436 (948)
Q Consensus 368 ~~~~L~~L~ls~n~l~g----~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~-l~~l~~L~~L~ls~N~l~g~ip~ 436 (948)
....++.++|++|.+.+ .+|..+.++++|+.|+|++|+|+ .+|.. |..+++|++|+|++|++++..|.
T Consensus 247 ~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 247 TNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred ccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence 12356778888888877 58889999999999999999999 67766 58999999999999999998773
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-29 Score=283.14 Aligned_cols=298 Identities=19% Similarity=0.287 Sum_probs=190.3
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEcc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 147 (948)
.+++.|+++++++.. ++ .+..+++|++|+|++|.+++..+ +.++++|++|+|++|.++.++ .|..+++|++|+|+
T Consensus 44 ~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~-~~~l~~L~~L~L~~n~i~~~~--~~~~l~~L~~L~l~ 118 (347)
T 4fmz_A 44 ESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP-LSNLVKLTNLYIGTNKITDIS--ALQNLTNLRELYLN 118 (347)
T ss_dssp TTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEECT
T ss_pred ccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh-hhcCCcCCEEEccCCcccCch--HHcCCCcCCEEECc
Confidence 578999999999884 44 48889999999999999998766 889999999999999999863 58999999999999
Q ss_pred CCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCccc-ccccceeccCCCCC
Q 002238 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGN 226 (948)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~~~~~~~~ 226 (948)
+|+++. ++. +..+++|+.|++++|.....++. +. .+++|++|++++|++.+..+ +.. .+++.|++.++...
T Consensus 119 ~n~i~~--~~~-~~~l~~L~~L~l~~n~~~~~~~~-~~--~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~ 190 (347)
T 4fmz_A 119 EDNISD--ISP-LANLTKMYSLNLGANHNLSDLSP-LS--NMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIE 190 (347)
T ss_dssp TSCCCC--CGG-GTTCTTCCEEECTTCTTCCCCGG-GT--TCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCC
T ss_pred CCcccC--chh-hccCCceeEEECCCCCCcccccc-hh--hCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccc
Confidence 999984 454 88999999999999977666555 54 79999999999999875443 321 23444444332211
Q ss_pred CccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCC
Q 002238 227 AKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEF 306 (948)
Q Consensus 227 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 306 (948)
. . ..+..+++|+.|++++|.+.+..+ +..+++|+.|+|++|.+++. +. +..+++|+.|++++|.+++. +.+
T Consensus 191 ~---~--~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~-~~~ 261 (347)
T 4fmz_A 191 D---I--SPLASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDL-SP-LANLSQLTWLEIGTNQISDI-NAV 261 (347)
T ss_dssp C---C--GGGGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC-GGG
T ss_pred c---c--ccccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCccCCC-cc-hhcCCCCCEEECCCCccCCC-hhH
Confidence 1 1 114455555556665555554333 44555555666666555532 22 55555566666655555532 333
Q ss_pred CCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccC
Q 002238 307 DRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTI 386 (948)
Q Consensus 307 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~i 386 (948)
..+ ++|+.|++++|.+++.
T Consensus 262 ~~l------------------------------------------------------------~~L~~L~l~~n~l~~~- 280 (347)
T 4fmz_A 262 KDL------------------------------------------------------------TKLKMLNVGSNQISDI- 280 (347)
T ss_dssp TTC------------------------------------------------------------TTCCEEECCSSCCCCC-
T ss_pred hcC------------------------------------------------------------CCcCEEEccCCccCCC-
Confidence 333 3455555555555543
Q ss_pred CccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCC--CCCcccccccCCCC
Q 002238 387 SPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP--SFKSNAIVNTDGNP 449 (948)
Q Consensus 387 p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip--~~~~~~~~~~~gnp 449 (948)
+.+..+++|+.|+|++|++++..|..+..+++|++|++++|++++.+| .+.....+.+++|+
T Consensus 281 -~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 281 -SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQV 344 (347)
T ss_dssp -GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGGGGGCTTCSEESSSCC-
T ss_pred -hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccChhhhhccceeehhhhc
Confidence 234555555555555555555555555555555555555555554433 22334444455554
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-29 Score=278.88 Aligned_cols=265 Identities=20% Similarity=0.279 Sum_probs=221.1
Q ss_pred EEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccC
Q 002238 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148 (948)
Q Consensus 70 v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 148 (948)
++.+++++++++ .+|..+. +.|+.|+|++|+|++..+ .|.++++|++|+|++|.++++.|..|+++++|++|+|++
T Consensus 33 l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 456677777777 6676654 689999999999999877 799999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccc--cCCCCcccccccceeccCCCCC
Q 002238 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIG--GLPASFSGSQIQSLWVNGQNGN 226 (948)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~~~l~~l~~~~~~~~ 226 (948)
|+++ .+|..+. ++|++|++++|++++..+..|. .+++|++|+|++|++.. ..+..
T Consensus 110 n~l~--~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~----------------- 166 (330)
T 1xku_A 110 NQLK--ELPEKMP--KTLQELRVHENEITKVRKSVFN--GLNQMIVVELGTNPLKSSGIENGA----------------- 166 (330)
T ss_dssp SCCS--BCCSSCC--TTCCEEECCSSCCCBBCHHHHT--TCTTCCEEECCSSCCCGGGBCTTG-----------------
T ss_pred CcCC--ccChhhc--ccccEEECCCCcccccCHhHhc--CCccccEEECCCCcCCccCcChhh-----------------
Confidence 9998 6777665 7999999999999988887787 89999999999999863 44433
Q ss_pred CccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCC
Q 002238 227 AKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEF 306 (948)
Q Consensus 227 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 306 (948)
+.++++|++|++++|.++..+..+. ++|+.|+|++|++++..|..+..+++|+.|+|++|++++..+.
T Consensus 167 ---------~~~l~~L~~L~l~~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~- 234 (330)
T 1xku_A 167 ---------FQGMKKLSYIRIADTNITTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNG- 234 (330)
T ss_dssp ---------GGGCTTCCEEECCSSCCCSCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTT-
T ss_pred ---------ccCCCCcCEEECCCCccccCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChh-
Confidence 4578999999999999987554443 8899999999999988889999999999999999999876553
Q ss_pred CCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccC
Q 002238 307 DRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTI 386 (948)
Q Consensus 307 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~i 386 (948)
.+..+++|+.|+|++|.++ .+
T Consensus 235 ----------------------------------------------------------~~~~l~~L~~L~L~~N~l~-~l 255 (330)
T 1xku_A 235 ----------------------------------------------------------SLANTPHLRELHLNNNKLV-KV 255 (330)
T ss_dssp ----------------------------------------------------------TGGGSTTCCEEECCSSCCS-SC
T ss_pred ----------------------------------------------------------hccCCCCCCEEECCCCcCc-cC
Confidence 1123457888888888888 77
Q ss_pred CccccCccccceEeCccccccccCCcCCcC------CCCCcEEEccCCccc
Q 002238 387 SPEFASFKSLQRLILADNNLSGMIPEGLSV------LGALKELDVSNNQLY 431 (948)
Q Consensus 387 p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~------l~~L~~L~ls~N~l~ 431 (948)
|..+..+++|++|+|++|+|++..+..|.. ...|+.|++++|++.
T Consensus 256 p~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~ 306 (330)
T 1xku_A 256 PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306 (330)
T ss_dssp CTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred ChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCccc
Confidence 888888888999999999888766666654 367888888888886
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-29 Score=316.21 Aligned_cols=334 Identities=18% Similarity=0.205 Sum_probs=256.8
Q ss_pred EEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEccccccc-CCCCccccCCCCCCEEEccC
Q 002238 71 TRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFT-SVPSDFFTGLSSLQSIEIDN 148 (948)
Q Consensus 71 ~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~ 148 (948)
..++.++++++ .+|. ..++|++|||++|.|++..| .|.++++|++|+|++|.+. .+.|..|+++++|++|+|++
T Consensus 7 ~~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~ 82 (844)
T 3j0a_A 7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82 (844)
T ss_dssp EEEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTT
T ss_pred eEEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCC
Confidence 34667788898 6666 45899999999999999776 7999999999999999554 56688999999999999999
Q ss_pred CCCCCCCCCccccCCCCCCEEEccCccccccCCCC--CCCCCCCCCcEEEcccccccccCCC-Cccc-ccccceeccCCC
Q 002238 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSF--FGPDEFPGLTILHLAFNQLIGGLPA-SFSG-SQIQSLWVNGQN 224 (948)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~--~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~-~~l~~l~~~~~~ 224 (948)
|+++. ..|..|.++++|++|+|++|.+++.+|.. |. .+++|++|+|++|.+++..+. .|.. .+|+.|++.+
T Consensus 83 N~l~~-~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~--~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~-- 157 (844)
T 3j0a_A 83 SKIYF-LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR--NLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSS-- 157 (844)
T ss_dssp CCCCE-ECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCS--SCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEES--
T ss_pred CcCcc-cCHhHccCCcccCEeeCcCCCCCcccccCcccc--ccCCCCEEECCCCcccccccchhHhhCCCCCEEECCC--
Confidence 99996 56999999999999999999999877765 65 899999999999999987653 4543 4566666554
Q ss_pred CCCccCCCccccccC--CCccEEEccCCcccccCC-CCCCCCC------CcEEeccCCccccccchhhhCC---------
Q 002238 225 GNAKLGGGIDVIQNM--TSLKEIWLHSNAFSGPLP-DFSGVKQ------LESLSLRDNFFTGPVPDSLVKL--------- 286 (948)
Q Consensus 225 ~~~~~~~~~~~l~~l--~~L~~L~Ls~N~l~~~~~-~~~~l~~------L~~L~L~~N~l~~~~p~~l~~l--------- 286 (948)
|......+..+..+ ++|+.|+|+.|.+.+..+ .+..+.+ |+.|+|++|.+++.+|..+...
T Consensus 158 -N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L 236 (844)
T 3j0a_A 158 -NQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSL 236 (844)
T ss_dssp -SCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEE
T ss_pred -CcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccce
Confidence 44445555666666 789999999999888665 3444443 8999999998877666555432
Q ss_pred -----------------------------CCCcEEEcccCcccccCCC-CCCccccccccccCCCCCCCCCCCchhhhhh
Q 002238 287 -----------------------------ESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNAL 336 (948)
Q Consensus 287 -----------------------------~~L~~L~Ls~N~l~g~~p~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l 336 (948)
++|+.|+|++|.+.+..|. +..+.+|..+++.+|.+...+.
T Consensus 237 ~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~--------- 307 (844)
T 3j0a_A 237 ILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIAD--------- 307 (844)
T ss_dssp ECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECT---------
T ss_pred ecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCCh---------
Confidence 5678888888888776664 5566667666666665433221
Q ss_pred HHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcC
Q 002238 337 LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSV 416 (948)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~ 416 (948)
..+..+++|+.|+|++|.+.+..|..|.++++|+.|+|++|++.+..+..|..
T Consensus 308 ---------------------------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~ 360 (844)
T 3j0a_A 308 ---------------------------EAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF 360 (844)
T ss_dssp ---------------------------TTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCS
T ss_pred ---------------------------HHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcC
Confidence 12334568888888888888888888888888888888888888777778888
Q ss_pred CCCCcEEEccCCcccCCCCCCCcccccccCCCCCC
Q 002238 417 LGALKELDVSNNQLYGKIPSFKSNAIVNTDGNPDI 451 (948)
Q Consensus 417 l~~L~~L~ls~N~l~g~ip~~~~~~~~~~~gnp~~ 451 (948)
+++|++|+|++|.+++ ++.+.....+.+.+|...
T Consensus 361 l~~L~~L~Ls~N~l~~-i~~~~~L~~L~l~~N~l~ 394 (844)
T 3j0a_A 361 LEKLQTLDLRDNALTT-IHFIPSIPDIFLSGNKLV 394 (844)
T ss_dssp CCCCCEEEEETCCSCC-CSSCCSCSEEEEESCCCC
T ss_pred CCCCCEEECCCCCCCc-ccCCCCcchhccCCCCcc
Confidence 8888888888888875 344555666777777654
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-29 Score=278.59 Aligned_cols=197 Identities=22% Similarity=0.326 Sum_probs=149.6
Q ss_pred EEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccC
Q 002238 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148 (948)
Q Consensus 70 v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 148 (948)
++.+++++++++ .+|..+. ++|+.|+|++|.|++..+ .|.++++|++|+|++|++++++|..|+++++|++|+|++
T Consensus 35 l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred CCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 456777777877 6777664 689999999999998777 789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccc--cCCCCcccccccceeccCCCCC
Q 002238 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIG--GLPASFSGSQIQSLWVNGQNGN 226 (948)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~~~l~~l~~~~~~~~ 226 (948)
|+++ .+|..+. ++|++|++++|++++..+..|. .+++|++|+|++|+++. ..|..+.
T Consensus 112 n~l~--~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~~~--------------- 170 (332)
T 2ft3_A 112 NHLV--EIPPNLP--SSLVELRIHDNRIRKVPKGVFS--GLRNMNCIEMGGNPLENSGFEPGAFD--------------- 170 (332)
T ss_dssp SCCC--SCCSSCC--TTCCEEECCSSCCCCCCSGGGS--SCSSCCEEECCSCCCBGGGSCTTSSC---------------
T ss_pred CcCC--ccCcccc--ccCCEEECCCCccCccCHhHhC--CCccCCEEECCCCccccCCCCccccc---------------
Confidence 9998 6777665 8999999999999987777776 89999999999999863 5565554
Q ss_pred CccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCC
Q 002238 227 AKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP 304 (948)
Q Consensus 227 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p 304 (948)
.+ +|++|++++|++++.+..+. ++|+.|+|++|.+++..|..+..+++|+.|+|++|++++..|
T Consensus 171 -----------~l-~L~~L~l~~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 234 (332)
T 2ft3_A 171 -----------GL-KLNYLRISEAKLTGIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIEN 234 (332)
T ss_dssp -----------SC-CCSCCBCCSSBCSSCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCT
T ss_pred -----------CC-ccCEEECcCCCCCccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCCh
Confidence 33 56666666666665333332 566666666666665555666666666666666666655443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-29 Score=287.13 Aligned_cols=303 Identities=17% Similarity=0.146 Sum_probs=229.5
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEcc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 147 (948)
.+++.|++++|++++. | .+..+++|++|+|++|+|++. | +..+++|++|+|++|.+++++ |+++++|++|+|+
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~-~~~l~~L~~L~Ls~N~l~~~~---~~~l~~L~~L~L~ 114 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D-LSQNTNLTYLACDSNKLTNLD---VTPLTKLTYLNCD 114 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C-CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECC
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c-cccCCCCCEEECcCCCCceee---cCCCCcCCEEECC
Confidence 5899999999999974 5 799999999999999999986 3 889999999999999999974 8899999999999
Q ss_pred CCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCccc-ccccceeccCCCCC
Q 002238 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGN 226 (948)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~~~~~~~~ 226 (948)
+|++++ +| +..+++|++|++++|++++. + ++ .+++|++|++++|+..+.++ +.. .+++.|++.++...
T Consensus 115 ~N~l~~--l~--~~~l~~L~~L~l~~N~l~~l-~--l~--~l~~L~~L~l~~n~~~~~~~--~~~l~~L~~L~ls~n~l~ 183 (457)
T 3bz5_A 115 TNKLTK--LD--VSQNPLLTYLNCARNTLTEI-D--VS--HNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183 (457)
T ss_dssp SSCCSC--CC--CTTCTTCCEEECTTSCCSCC-C--CT--TCTTCCEEECTTCSCCCCCC--CTTCTTCCEEECCSSCCC
T ss_pred CCcCCe--ec--CCCCCcCCEEECCCCcccee-c--cc--cCCcCCEEECCCCCcccccc--cccCCcCCEEECCCCccc
Confidence 999995 44 88999999999999999985 3 54 89999999999997666663 222 45666666544332
Q ss_pred CccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCC
Q 002238 227 AKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEF 306 (948)
Q Consensus 227 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~ 306 (948)
. .+ +..+++|+.|++++|++++. .+..+++|+.|+|++|++++ +| +..+++|+.|++++|++++..+
T Consensus 184 ~----l~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~-- 250 (457)
T 3bz5_A 184 E----LD--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDV-- 250 (457)
T ss_dssp C----CC--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCC--
T ss_pred e----ec--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCH--
Confidence 2 22 67888888999998888875 47778888899999998886 66 7888888999999998887543
Q ss_pred CCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccC
Q 002238 307 DRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTI 386 (948)
Q Consensus 307 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~i 386 (948)
..+.+|..+....+....+. ..++.....+ ....+++|+.|++++|.+.|.+
T Consensus 251 ~~l~~L~~L~l~~n~L~~L~--------------------------l~~n~~~~~~--~~~~l~~L~~L~Ls~n~~l~~l 302 (457)
T 3bz5_A 251 STLSKLTTLHCIQTDLLEID--------------------------LTHNTQLIYF--QAEGCRKIKELDVTHNTQLYLL 302 (457)
T ss_dssp TTCTTCCEEECTTCCCSCCC--------------------------CTTCTTCCEE--ECTTCTTCCCCCCTTCTTCCEE
T ss_pred HHCCCCCEEeccCCCCCEEE--------------------------CCCCccCCcc--cccccccCCEEECCCCccccee
Confidence 23334443333333211110 0000000000 1224568888999999888877
Q ss_pred Ccc--------ccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccC
Q 002238 387 SPE--------FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYG 432 (948)
Q Consensus 387 p~~--------~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g 432 (948)
|.. ++++++|+.|+|++|+|++ ++ +..+++|+.||+++|+|+|
T Consensus 303 ~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~ 353 (457)
T 3bz5_A 303 DCQAAGITELDLSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD 353 (457)
T ss_dssp ECTTCCCSCCCCTTCTTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB
T ss_pred ccCCCcceEechhhcccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC
Confidence 753 5566788899999999987 33 8888999999999999987
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-29 Score=291.35 Aligned_cols=306 Identities=23% Similarity=0.334 Sum_probs=252.2
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEcc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 147 (948)
.+++.|+|++|.+++..+ +.++++|++|+|++|.+.+..+ +.++++|++|+|++|.++++++ +.++++|++|+|+
T Consensus 68 ~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~ 142 (466)
T 1o6v_A 68 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELS 142 (466)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEE
T ss_pred cCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh-hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECC
Confidence 589999999999986543 8899999999999999988776 8889999999999999988865 8889999999999
Q ss_pred CCCCCCCCCC--------------------ccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCC
Q 002238 148 NNPFSSWEIP--------------------QSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLP 207 (948)
Q Consensus 148 ~N~l~~~~~p--------------------~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p 207 (948)
+|++.. ++ ..+.++++|+.|++++|.+++.. .+. .+++|++|++++|++.+..|
T Consensus 143 ~n~l~~--~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~l~--~l~~L~~L~l~~n~l~~~~~ 216 (466)
T 1o6v_A 143 SNTISD--ISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS--VLA--KLTNLESLIATNNQISDITP 216 (466)
T ss_dssp EEEECC--CGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCG--GGG--GCTTCSEEECCSSCCCCCGG
T ss_pred CCccCC--ChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCCh--hhc--cCCCCCEEEecCCccccccc
Confidence 988874 22 13667888999999999998653 354 79999999999999997766
Q ss_pred CCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCC
Q 002238 208 ASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLE 287 (948)
Q Consensus 208 ~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 287 (948)
.. ...+++.|++.++.... ...+..+++|+.|++++|.+++..+ +..+++|+.|+|++|.+++..+ +..++
T Consensus 217 ~~-~l~~L~~L~l~~n~l~~-----~~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~ 287 (466)
T 1o6v_A 217 LG-ILTNLDELSLNGNQLKD-----IGTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP--LAGLT 287 (466)
T ss_dssp GG-GCTTCCEEECCSSCCCC-----CGGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG--GTTCT
T ss_pred cc-ccCCCCEEECCCCCccc-----chhhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCcccc--ccCCC
Confidence 22 12567777776554332 2468899999999999999998766 8889999999999999996544 89999
Q ss_pred CCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceee
Q 002238 288 SLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTC 367 (948)
Q Consensus 288 ~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (948)
+|+.|+|++|++++..| +..+.+|..++..+|.....+ .+.
T Consensus 288 ~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~--------------------------------------~~~ 328 (466)
T 1o6v_A 288 ALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNISDIS--------------------------------------PVS 328 (466)
T ss_dssp TCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSCCSCCG--------------------------------------GGG
T ss_pred ccCeEEcCCCcccCchh-hcCCCCCCEEECcCCcCCCch--------------------------------------hhc
Confidence 99999999999998655 777788888888777543332 123
Q ss_pred cCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCCC
Q 002238 368 TKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 436 (948)
Q Consensus 368 ~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~ 436 (948)
.+++|+.|++++|.+++. +.+.++++|+.|+|++|++++..| +..+++|+.|++++|++++.+..
T Consensus 329 ~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~p~~ 393 (466)
T 1o6v_A 329 SLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVN 393 (466)
T ss_dssp GCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECCCBC
T ss_pred cCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCCchh
Confidence 567999999999999986 579999999999999999998887 89999999999999999985433
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-29 Score=274.55 Aligned_cols=278 Identities=20% Similarity=0.276 Sum_probs=228.7
Q ss_pred CCccceEEeCC----------CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccc
Q 002238 57 CKWNHVVCIED----------KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNN 125 (948)
Q Consensus 57 C~w~gv~c~~~----------~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N 125 (948)
|.|..+.|... ..++.|+|++|++++..+..|.++++|++|+|++|.+++..| .|.++++|++|+|++|
T Consensus 31 c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 110 (330)
T 1xku_A 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110 (330)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCC
Confidence 68999998532 478999999999998878899999999999999999999866 7999999999999999
Q ss_pred cccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccc--cCCCCCCCCCCCCCcEEEccccccc
Q 002238 126 QFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITG--QIPSFFGPDEFPGLTILHLAFNQLI 203 (948)
Q Consensus 126 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~--~~p~~~~~~~l~~L~~L~Ls~N~l~ 203 (948)
+++.++...+ ++|++|+|++|+++. ..+..+.++++|+.|++++|.++. ..+..+. .+++|++|++++|+++
T Consensus 111 ~l~~l~~~~~---~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~--~l~~L~~L~l~~n~l~ 184 (330)
T 1xku_A 111 QLKELPEKMP---KTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ--GMKKLSYIRIADTNIT 184 (330)
T ss_dssp CCSBCCSSCC---TTCCEEECCSSCCCB-BCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGG--GCTTCCEEECCSSCCC
T ss_pred cCCccChhhc---ccccEEECCCCcccc-cCHhHhcCCccccEEECCCCcCCccCcChhhcc--CCCCcCEEECCCCccc
Confidence 9998876644 799999999999995 445678999999999999999964 6777776 8999999999999998
Q ss_pred ccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCC-CCCCCCCCcEEeccCCccccccchh
Q 002238 204 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDS 282 (948)
Q Consensus 204 ~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~ 282 (948)
.+|..+ .++|++|+|++|++++..+ .+.++++|+.|+|++|.+++..+..
T Consensus 185 -~l~~~~----------------------------~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 235 (330)
T 1xku_A 185 -TIPQGL----------------------------PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGS 235 (330)
T ss_dssp -SCCSSC----------------------------CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTT
T ss_pred -cCCccc----------------------------cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhh
Confidence 455543 2688999999999988765 5788899999999999999777778
Q ss_pred hhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCc
Q 002238 283 LVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDW 362 (948)
Q Consensus 283 l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (948)
+..+++|+.|+|++|+++ .+|..
T Consensus 236 ~~~l~~L~~L~L~~N~l~-~lp~~-------------------------------------------------------- 258 (330)
T 1xku_A 236 LANTPHLRELHLNNNKLV-KVPGG-------------------------------------------------------- 258 (330)
T ss_dssp GGGSTTCCEEECCSSCCS-SCCTT--------------------------------------------------------
T ss_pred ccCCCCCCEEECCCCcCc-cCChh--------------------------------------------------------
Confidence 889999999999999887 33320
Q ss_pred cceeecCCceEEEEccCCcccccCCccccCc------cccceEeCccccccc--cCCcCCcCCCCCcEEEccCCc
Q 002238 363 IGVTCTKGNITVINFQKMNLTGTISPEFASF------KSLQRLILADNNLSG--MIPEGLSVLGALKELDVSNNQ 429 (948)
Q Consensus 363 ~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l------~~L~~L~Ls~N~l~g--~ip~~l~~l~~L~~L~ls~N~ 429 (948)
+..+++|+.|+|++|++++..+..|+.. +.|+.|+|++|.+.. ..|..|..+.+|+.++|++|+
T Consensus 259 ---l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 259 ---LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp ---TTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred ---hccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 1123478888888888888777777543 678899999998863 557788889999999999885
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-29 Score=277.46 Aligned_cols=285 Identities=21% Similarity=0.267 Sum_probs=208.2
Q ss_pred ccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCC
Q 002238 88 LQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ 167 (948)
Q Consensus 88 l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 167 (948)
+..+++|++|++++|.+... +.+..+++|++|+|++|.++++++ |..+++|++|+|++|+++. +| .+.++++|+
T Consensus 40 ~~~l~~L~~L~l~~~~i~~~-~~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~--~~-~~~~l~~L~ 113 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVASI-QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--IS-ALQNLTNLR 113 (347)
T ss_dssp HHHHTTCSEEECCSSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC--CG-GGTTCTTCS
T ss_pred chhcccccEEEEeCCccccc-hhhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC--ch-HHcCCCcCC
Confidence 45688999999999999865 568999999999999999999876 9999999999999999985 44 699999999
Q ss_pred EEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEc
Q 002238 168 NFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWL 247 (948)
Q Consensus 168 ~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~L 247 (948)
+|++++|.+++..+ +. .+++|++|++++|.....++. + ..+++|++|++
T Consensus 114 ~L~l~~n~i~~~~~--~~--~l~~L~~L~l~~n~~~~~~~~-~--------------------------~~l~~L~~L~l 162 (347)
T 4fmz_A 114 ELYLNEDNISDISP--LA--NLTKMYSLNLGANHNLSDLSP-L--------------------------SNMTGLNYLTV 162 (347)
T ss_dssp EEECTTSCCCCCGG--GT--TCTTCCEEECTTCTTCCCCGG-G--------------------------TTCTTCCEEEC
T ss_pred EEECcCCcccCchh--hc--cCCceeEEECCCCCCcccccc-h--------------------------hhCCCCcEEEe
Confidence 99999999997654 54 899999999999976654443 2 24455555555
Q ss_pred cCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCC
Q 002238 248 HSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPG 327 (948)
Q Consensus 248 s~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~ 327 (948)
++|.+.+..+ +..+++|+.|++++|.+.+ ++. +..+++|+.|++++|.+++..+ +..+.+|..++..+|.....+
T Consensus 163 ~~~~~~~~~~-~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~~~- 237 (347)
T 4fmz_A 163 TESKVKDVTP-IANLTDLYSLSLNYNQIED-ISP-LASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDLS- 237 (347)
T ss_dssp CSSCCCCCGG-GGGCTTCSEEECTTSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCG-
T ss_pred cCCCcCCchh-hccCCCCCEEEccCCcccc-ccc-ccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCccCCCc-
Confidence 5555543332 4445555555555555552 222 4455555555555555544333 334444444444443322211
Q ss_pred CCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCcccccc
Q 002238 328 ACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLS 407 (948)
Q Consensus 328 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~ 407 (948)
.+..+++|+.|++++|.+++. +.+..+++|+.|+|++|+++
T Consensus 238 -------------------------------------~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~ 278 (347)
T 4fmz_A 238 -------------------------------------PLANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQIS 278 (347)
T ss_dssp -------------------------------------GGTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCC
T ss_pred -------------------------------------chhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccC
Confidence 022456899999999999874 57999999999999999999
Q ss_pred ccCCcCCcCCCCCcEEEccCCcccCCCC----CCCcccccccCCCCCCCCcc
Q 002238 408 GMIPEGLSVLGALKELDVSNNQLYGKIP----SFKSNAIVNTDGNPDIGKEK 455 (948)
Q Consensus 408 g~ip~~l~~l~~L~~L~ls~N~l~g~ip----~~~~~~~~~~~gnp~~~~~~ 455 (948)
+. +.+..+++|++|++++|++++..| .+.....+.+++|+..+..+
T Consensus 279 ~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 279 DI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp CC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred CC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC
Confidence 64 468999999999999999998765 35677889999999775544
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=287.05 Aligned_cols=282 Identities=15% Similarity=0.144 Sum_probs=221.1
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEcc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 147 (948)
.+++.|+|++|++++. | ++++++|++|+|++|.|++. + +.++++|++|+|++|++++++ ++.+++|++|+|+
T Consensus 64 ~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~-~~~l~~L~~L~L~~N~l~~l~---~~~l~~L~~L~l~ 135 (457)
T 3bz5_A 64 TGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D-VTPLTKLTYLNCDTNKLTKLD---VSQNPLLTYLNCA 135 (457)
T ss_dssp TTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C-CTTCTTCCEEECCSSCCSCCC---CTTCTTCCEEECT
T ss_pred CCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e-cCCCCcCCEEECCCCcCCeec---CCCCCcCCEEECC
Confidence 6899999999999974 4 89999999999999999986 3 899999999999999999974 8999999999999
Q ss_pred CCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCccc-ccccceeccCCCCC
Q 002238 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGN 226 (948)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~~~~~~~~ 226 (948)
+|++++ ++ +.++++|++|++++|+..+.+ .++ .+++|++|+|++|++++ +| +.. ..++.|++.++...
T Consensus 136 ~N~l~~--l~--l~~l~~L~~L~l~~n~~~~~~--~~~--~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~ 204 (457)
T 3bz5_A 136 RNTLTE--ID--VSHNTQLTELDCHLNKKITKL--DVT--PQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNIT 204 (457)
T ss_dssp TSCCSC--CC--CTTCTTCCEEECTTCSCCCCC--CCT--TCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCS
T ss_pred CCccce--ec--cccCCcCCEEECCCCCccccc--ccc--cCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCC
Confidence 999996 43 889999999999999776666 344 79999999999999997 44 332 45777776655433
Q ss_pred CccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCC-------CCcEEEcccCcc
Q 002238 227 AKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLE-------SLKIVNMTNNLL 299 (948)
Q Consensus 227 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-------~L~~L~Ls~N~l 299 (948)
.. .+.++++|+.|+|++|++++ +| +..+++|+.|+|++|++++..+..+.++. +|+.|++++|.+
T Consensus 205 ~~------~l~~l~~L~~L~Ls~N~l~~-ip-~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~ 276 (457)
T 3bz5_A 205 KL------DLNQNIQLTFLDCSSNKLTE-ID-VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQ 276 (457)
T ss_dssp CC------CCTTCTTCSEEECCSSCCSC-CC-CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTT
T ss_pred ee------ccccCCCCCEEECcCCcccc-cC-ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCcc
Confidence 32 37889999999999999998 45 88899999999999999986655555544 556667777776
Q ss_pred cccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccC
Q 002238 300 QGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQK 379 (948)
Q Consensus 300 ~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~ 379 (948)
.|.+| +..+.+|..++..+|............+.. + .+...++|+.|++++
T Consensus 277 ~~~~~-~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~---------------------------L-~l~~~~~L~~L~L~~ 327 (457)
T 3bz5_A 277 LIYFQ-AEGCRKIKELDVTHNTQLYLLDCQAAGITE---------------------------L-DLSQNPKLVYLYLNN 327 (457)
T ss_dssp CCEEE-CTTCTTCCCCCCTTCTTCCEEECTTCCCSC---------------------------C-CCTTCTTCCEEECTT
T ss_pred CCccc-ccccccCCEEECCCCcccceeccCCCcceE---------------------------e-chhhcccCCEEECCC
Confidence 66666 455667777776666432221110000000 0 123446899999999
Q ss_pred CcccccCCccccCccccceEeCccccccc
Q 002238 380 MNLTGTISPEFASFKSLQRLILADNNLSG 408 (948)
Q Consensus 380 n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g 408 (948)
|++++. + ++++++|+.|+|++|+|++
T Consensus 328 N~l~~l-~--l~~l~~L~~L~l~~N~l~~ 353 (457)
T 3bz5_A 328 TELTEL-D--VSHNTKLKSLSCVNAHIQD 353 (457)
T ss_dssp CCCSCC-C--CTTCTTCSEEECCSSCCCB
T ss_pred Cccccc-c--cccCCcCcEEECCCCCCCC
Confidence 999994 3 9999999999999999996
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=297.88 Aligned_cols=329 Identities=16% Similarity=0.161 Sum_probs=240.4
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (948)
.+++.|+|++|+|++..+.+|.++++|++|+|++|+|++.++ .|.++++|++|+|++|+|+++++..|+++++|++|+|
T Consensus 76 ~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~L 155 (635)
T 4g8a_A 76 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 155 (635)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeecc
Confidence 589999999999998888899999999999999999999877 6899999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCC----------------------------------------
Q 002238 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGP---------------------------------------- 186 (948)
Q Consensus 147 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~---------------------------------------- 186 (948)
++|+++.+.+|..+..+++|++|++++|+|++..+..|..
T Consensus 156 s~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~ 235 (635)
T 4g8a_A 156 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNF 235 (635)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCC
T ss_pred ccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhccc
Confidence 9999998778999999999999999999998765543310
Q ss_pred --------------------------------------------------------------------------------
Q 002238 187 -------------------------------------------------------------------------------- 186 (948)
Q Consensus 187 -------------------------------------------------------------------------------- 186 (948)
T Consensus 236 ~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~ 315 (635)
T 4g8a_A 236 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVS 315 (635)
T ss_dssp SSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEES
T ss_pred ccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccc
Confidence
Q ss_pred ---------CCCCCCcEEEcccccccccCCCCccc-----------------ccccceeccCCCCCCccC--C-------
Q 002238 187 ---------DEFPGLTILHLAFNQLIGGLPASFSG-----------------SQIQSLWVNGQNGNAKLG--G------- 231 (948)
Q Consensus 187 ---------~~l~~L~~L~Ls~N~l~~~~p~~~~~-----------------~~l~~l~~~~~~~~~~~~--~------- 231 (948)
.....|+.|++.+|++.+..+..+.. ..+..|...+...|.... .
T Consensus 316 ~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~ 395 (635)
T 4g8a_A 316 VTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 395 (635)
T ss_dssp CEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHS
T ss_pred cccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccchhh
Confidence 00112333444444333222111100 011122222222222211 1
Q ss_pred ----------------CccccccCCCccEEEccCCcccccCC--CCCCCCCCcEEeccCCccccccchhhhCCCCCcEEE
Q 002238 232 ----------------GIDVIQNMTSLKEIWLHSNAFSGPLP--DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 293 (948)
Q Consensus 232 ----------------~~~~l~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 293 (948)
....+..+++|+.++++.|++....+ .+..+.+++.++++.|.+.+..|..+..+++|+.|+
T Consensus 396 ~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~ 475 (635)
T 4g8a_A 396 TISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 475 (635)
T ss_dssp CSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEE
T ss_pred hhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhh
Confidence 11233455566666666666555433 356677777777777777777777777777777777
Q ss_pred cccCccc-ccCCC-CCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCc
Q 002238 294 MTNNLLQ-GPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGN 371 (948)
Q Consensus 294 Ls~N~l~-g~~p~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (948)
|++|++. +.+|. +..+.+|..+++.+|....++. ..+..+++
T Consensus 476 Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~------------------------------------~~f~~l~~ 519 (635)
T 4g8a_A 476 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP------------------------------------TAFNSLSS 519 (635)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECT------------------------------------TTTTTCTT
T ss_pred hhhcccccccCchhhhhccccCEEECCCCccCCcCh------------------------------------HHHcCCCC
Confidence 7777643 34443 5566667777666665433321 12446679
Q ss_pred eEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCC-CCCcEEEccCCcccC
Q 002238 372 ITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVL-GALKELDVSNNQLYG 432 (948)
Q Consensus 372 L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~~L~~L~ls~N~l~g 432 (948)
|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..+..+ ++|++|+|++|+++.
T Consensus 520 L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C 581 (635)
T 4g8a_A 520 LQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 581 (635)
T ss_dssp CCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred CCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence 9999999999999999999999999999999999999999999998 689999999999986
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-28 Score=279.67 Aligned_cols=246 Identities=24% Similarity=0.275 Sum_probs=192.0
Q ss_pred EEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCC
Q 002238 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNP 150 (948)
Q Consensus 72 ~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 150 (948)
.++.++++++ .+|..+. ++|++|+|++|+|++..+ .|.++++|++|+|++|.|+++++..|.++++|++|+|++|+
T Consensus 58 ~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 58 KVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 4555666776 6776665 689999999999999776 79999999999999999999999999999999999999999
Q ss_pred CCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccC
Q 002238 151 FSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLG 230 (948)
Q Consensus 151 l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~ 230 (948)
++. ..+..+..+++|++|+|++|+|+...+..|. .+++|++|+|++|+..+.++...
T Consensus 135 l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~l~~~~~l~~i~~~~-------------------- 191 (452)
T 3zyi_A 135 LTV-IPSGAFEYLSKLRELWLRNNPIESIPSYAFN--RVPSLMRLDLGELKKLEYISEGA-------------------- 191 (452)
T ss_dssp CSB-CCTTTSSSCTTCCEEECCSCCCCEECTTTTT--TCTTCCEEECCCCTTCCEECTTT--------------------
T ss_pred CCc-cChhhhcccCCCCEEECCCCCcceeCHhHHh--cCCcccEEeCCCCCCccccChhh--------------------
Confidence 984 3345588899999999999999877777776 88899999998855444444321
Q ss_pred CCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCcc
Q 002238 231 GGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSV 310 (948)
Q Consensus 231 ~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~ 310 (948)
|.++++|++|+|++|++++. |.+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..
T Consensus 192 -----~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~------- 258 (452)
T 3zyi_A 192 -----FEGLFNLKYLNLGMCNIKDM-PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIE------- 258 (452)
T ss_dssp -----TTTCTTCCEEECTTSCCSSC-CCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEEC-------
T ss_pred -----ccCCCCCCEEECCCCccccc-ccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceEC-------
Confidence 34678888888888888754 56777778888888888888777777777777777777777766433
Q ss_pred ccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccc
Q 002238 311 SLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEF 390 (948)
Q Consensus 311 ~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~ 390 (948)
|..|
T Consensus 259 ----------------------------------------------------------------------------~~~~ 262 (452)
T 3zyi_A 259 ----------------------------------------------------------------------------RNAF 262 (452)
T ss_dssp ----------------------------------------------------------------------------TTTT
T ss_pred ----------------------------------------------------------------------------HHHh
Confidence 3456
Q ss_pred cCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccC
Q 002238 391 ASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYG 432 (948)
Q Consensus 391 ~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g 432 (948)
.++++|+.|+|++|+|++..+..+..+++|+.|+|++|++..
T Consensus 263 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 263 DGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp TTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred cCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence 667778888888888876666677778888888888777654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-28 Score=278.49 Aligned_cols=247 Identities=21% Similarity=0.295 Sum_probs=189.0
Q ss_pred EEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCC
Q 002238 71 TRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149 (948)
Q Consensus 71 ~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 149 (948)
..++..+++++ .+|..+. ++|+.|+|++|+|++..+ .|.++++|++|+|++|.|+++++..|.++++|++|+|++|
T Consensus 46 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 46 SKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp CEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 35666677777 7777665 689999999999998776 7999999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCcc
Q 002238 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKL 229 (948)
Q Consensus 150 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~ 229 (948)
+++. ..+..+..+++|++|+|++|+|+...+..|. .+++|++|+|++|+..+.++...
T Consensus 123 ~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~--~l~~L~~L~l~~~~~l~~i~~~~------------------- 180 (440)
T 3zyj_A 123 RLTT-IPNGAFVYLSKLKELWLRNNPIESIPSYAFN--RIPSLRRLDLGELKRLSYISEGA------------------- 180 (440)
T ss_dssp CCSS-CCTTTSCSCSSCCEEECCSCCCCEECTTTTT--TCTTCCEEECCCCTTCCEECTTT-------------------
T ss_pred cCCe-eCHhHhhccccCceeeCCCCcccccCHHHhh--hCcccCEeCCCCCCCcceeCcch-------------------
Confidence 9984 2344688888999999999988877777776 78888888888855444444321
Q ss_pred CCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCc
Q 002238 230 GGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRS 309 (948)
Q Consensus 230 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~ 309 (948)
|.++++|++|+|++|+++. +|.+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++
T Consensus 181 ------~~~l~~L~~L~L~~n~l~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-------- 245 (440)
T 3zyj_A 181 ------FEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV-------- 245 (440)
T ss_dssp ------TTTCSSCCEEECTTSCCSS-CCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE--------
T ss_pred ------hhcccccCeecCCCCcCcc-ccccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeE--------
Confidence 3467778888888887773 4556666777777777777776666666666666666666666654
Q ss_pred cccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCcc
Q 002238 310 VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE 389 (948)
Q Consensus 310 ~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~ 389 (948)
..+..
T Consensus 246 ---------------------------------------------------------------------------~~~~~ 250 (440)
T 3zyj_A 246 ---------------------------------------------------------------------------IERNA 250 (440)
T ss_dssp ---------------------------------------------------------------------------ECTTS
T ss_pred ---------------------------------------------------------------------------EChhh
Confidence 34445
Q ss_pred ccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccC
Q 002238 390 FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYG 432 (948)
Q Consensus 390 ~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g 432 (948)
|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++..
T Consensus 251 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 251 FDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp STTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred hcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence 6777788888888888886666777888888888888887753
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-28 Score=279.91 Aligned_cols=326 Identities=21% Similarity=0.224 Sum_probs=176.9
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCC--------------------------------
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGL-------------------------------- 114 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l-------------------------------- 114 (948)
.++++|++++|++ |.+|++++++++|++|++++|.+.|.+| +++.+
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~~ 89 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPEL 89 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCSC
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCCC
Confidence 3555566666666 4566666666666655555555555444 34443
Q ss_pred -CCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCc
Q 002238 115 -ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLT 193 (948)
Q Consensus 115 -~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~ 193 (948)
++|++|+|++|.+++++. .+++|+.|+|++|++++ +|.. .++|++|++++|++++ +| .|+ .+++|+
T Consensus 90 ~~~L~~L~l~~n~l~~lp~----~~~~L~~L~l~~n~l~~--l~~~---~~~L~~L~L~~n~l~~-lp-~~~--~l~~L~ 156 (454)
T 1jl5_A 90 PPHLESLVASCNSLTELPE----LPQSLKSLLVDNNNLKA--LSDL---PPLLEYLGVSNNQLEK-LP-ELQ--NSSFLK 156 (454)
T ss_dssp CTTCSEEECCSSCCSSCCC----CCTTCCEEECCSSCCSC--CCSC---CTTCCEEECCSSCCSS-CC-CCT--TCTTCC
T ss_pred cCCCCEEEccCCcCCcccc----ccCCCcEEECCCCccCc--ccCC---CCCCCEEECcCCCCCC-Cc-ccC--CCCCCC
Confidence 345555555555555332 13566666666666653 3321 1578888888888876 55 355 788888
Q ss_pred EEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCC
Q 002238 194 ILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDN 273 (948)
Q Consensus 194 ~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N 273 (948)
+|++++|++++ +|..+ .+++.|++.++.... .+ .+.++++|++|++++|++++. |.+ ..+|+.|++++|
T Consensus 157 ~L~l~~N~l~~-lp~~~--~~L~~L~L~~n~l~~----l~-~~~~l~~L~~L~l~~N~l~~l-~~~--~~~L~~L~l~~n 225 (454)
T 1jl5_A 157 IIDVDNNSLKK-LPDLP--PSLEFIAAGNNQLEE----LP-ELQNLPFLTAIYADNNSLKKL-PDL--PLSLESIVAGNN 225 (454)
T ss_dssp EEECCSSCCSC-CCCCC--TTCCEEECCSSCCSS----CC-CCTTCTTCCEEECCSSCCSSC-CCC--CTTCCEEECCSS
T ss_pred EEECCCCcCcc-cCCCc--ccccEEECcCCcCCc----Cc-cccCCCCCCEEECCCCcCCcC-CCC--cCcccEEECcCC
Confidence 88888888875 55544 356666666543332 22 477888888888888888763 322 257888888888
Q ss_pred ccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhcccc
Q 002238 274 FFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENW 353 (948)
Q Consensus 274 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 353 (948)
.++ .+|. ++.+++|+.|++++|++++..+.+ .+|..++..+|....++... ..+.. .+.
T Consensus 226 ~l~-~lp~-~~~l~~L~~L~l~~N~l~~l~~~~---~~L~~L~l~~N~l~~l~~~~-~~L~~---------------L~l 284 (454)
T 1jl5_A 226 ILE-ELPE-LQNLPFLTTIYADNNLLKTLPDLP---PSLEALNVRDNYLTDLPELP-QSLTF---------------LDV 284 (454)
T ss_dssp CCS-SCCC-CTTCTTCCEEECCSSCCSSCCSCC---TTCCEEECCSSCCSCCCCCC-TTCCE---------------EEC
T ss_pred cCC-cccc-cCCCCCCCEEECCCCcCCcccccc---cccCEEECCCCcccccCccc-CcCCE---------------EEC
Confidence 887 6774 778888888888888887633322 44555555555554443221 11110 011
Q ss_pred CCCCCCCCccceeecCCceEEEEccCCcccccCCccccCc-cccceEeCccccccccCCcCCcCCCCCcEEEccCCcccC
Q 002238 354 KGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASF-KSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYG 432 (948)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l-~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g 432 (948)
.++... +.....++|+.|++++|.+++ +..+ ++|+.|+|++|++++ +|.. +++|++|++++|++++
T Consensus 285 s~N~l~----~l~~~~~~L~~L~l~~N~l~~-----i~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~ 351 (454)
T 1jl5_A 285 SENIFS----GLSELPPNLYYLNASSNEIRS-----LCDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE 351 (454)
T ss_dssp CSSCCS----EESCCCTTCCEEECCSSCCSE-----ECCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC
T ss_pred cCCccC----cccCcCCcCCEEECcCCcCCc-----ccCCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc
Confidence 111000 000011356666666666664 1223 467777777777774 5544 4677777777777775
Q ss_pred CCCCCCcccccccCCCCCCC
Q 002238 433 KIPSFKSNAIVNTDGNPDIG 452 (948)
Q Consensus 433 ~ip~~~~~~~~~~~gnp~~~ 452 (948)
..+.......+.+++|+..+
T Consensus 352 lp~~l~~L~~L~L~~N~l~~ 371 (454)
T 1jl5_A 352 VPELPQNLKQLHVEYNPLRE 371 (454)
T ss_dssp CCCCCTTCCEEECCSSCCSS
T ss_pred ccchhhhccEEECCCCCCCc
Confidence 32223345566677776554
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-28 Score=266.36 Aligned_cols=250 Identities=21% Similarity=0.296 Sum_probs=169.3
Q ss_pred CCccceEEeCCCCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCC--Cc
Q 002238 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVP--SD 133 (948)
Q Consensus 57 C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~--~~ 133 (948)
|.|.+|.|. +++++ .+|..+. ++|++|+|++|+|+..++ .|.++++|++|+|++|.++... +.
T Consensus 7 C~~~~l~c~-----------~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 72 (306)
T 2z66_A 7 CSGTEIRCN-----------SKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQ 72 (306)
T ss_dssp EETTEEECC-----------SSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEH
T ss_pred eCCCEEEcC-----------CCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCccc
Confidence 667777664 34455 5665444 688899999998887666 3778888888888888887542 45
Q ss_pred cccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCC-CCCCCCCCCCCcEEEcccccccccCCCCccc
Q 002238 134 FFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIP-SFFGPDEFPGLTILHLAFNQLIGGLPASFSG 212 (948)
Q Consensus 134 ~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 212 (948)
.+..+++|++|+|++|.++ .+|..+..+++|++|++++|++++..+ ..+. .+++|++|+|++|++.+..+..+
T Consensus 73 ~~~~~~~L~~L~Ls~n~i~--~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~-- 146 (306)
T 2z66_A 73 SDFGTTSLKYLDLSFNGVI--TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL--SLRNLIYLDISHTHTRVAFNGIF-- 146 (306)
T ss_dssp HHHSCSCCCEEECCSCSEE--EEEEEEETCTTCCEEECTTSEEESSTTTTTTT--TCTTCCEEECTTSCCEECSTTTT--
T ss_pred ccccccccCEEECCCCccc--cChhhcCCCCCCCEEECCCCcccccccchhhh--hccCCCEEECCCCcCCccchhhc--
Confidence 5667888888888888887 567777777777777777777776554 4454 66777777777777665555443
Q ss_pred ccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccc-cCC-CCCCCCCCcEEeccCCccccccchhhhCCCCCc
Q 002238 213 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG-PLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLK 290 (948)
Q Consensus 213 ~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~-~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 290 (948)
.++++|++|+|++|.+++ .+| .+..+++|+.|+|++|++++..|..+..+++|+
T Consensus 147 ------------------------~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 202 (306)
T 2z66_A 147 ------------------------NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 202 (306)
T ss_dssp ------------------------TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred ------------------------ccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCC
Confidence 245666666666666654 222 355555566666666665555555555555555
Q ss_pred EEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCC
Q 002238 291 IVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKG 370 (948)
Q Consensus 291 ~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (948)
.|+|++|+++
T Consensus 203 ~L~L~~N~l~---------------------------------------------------------------------- 212 (306)
T 2z66_A 203 VLNMSHNNFF---------------------------------------------------------------------- 212 (306)
T ss_dssp EEECTTSCCS----------------------------------------------------------------------
T ss_pred EEECCCCccC----------------------------------------------------------------------
Confidence 5555555554
Q ss_pred ceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCC-CCcEEEccCCcccCC
Q 002238 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLG-ALKELDVSNNQLYGK 433 (948)
Q Consensus 371 ~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~-~L~~L~ls~N~l~g~ 433 (948)
+..+..|..+++|+.|+|++|++++..|..+..++ +|++|+|++|++++.
T Consensus 213 -------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 213 -------------SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp -------------BCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred -------------ccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence 44444566677788888888888877777777774 788888888887764
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-28 Score=266.66 Aligned_cols=277 Identities=20% Similarity=0.272 Sum_probs=231.0
Q ss_pred CCccceEEeCC----------CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccc
Q 002238 57 CKWNHVVCIED----------KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNN 125 (948)
Q Consensus 57 C~w~gv~c~~~----------~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N 125 (948)
|.|..+.|... .+++.|+|++|++++..|..|.++++|++|+|++|.|++..| .|.++++|++|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 68999999642 479999999999998888899999999999999999999877 7999999999999999
Q ss_pred cccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCcccc--ccCCCCCCCCCCCCCcEEEccccccc
Q 002238 126 QFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANIT--GQIPSFFGPDEFPGLTILHLAFNQLI 203 (948)
Q Consensus 126 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~--~~~p~~~~~~~l~~L~~L~Ls~N~l~ 203 (948)
+++.+++..+ ++|++|+|++|+++. ..+..+.++++|+.|++++|.++ +..+..+. .+ +|++|++++|+++
T Consensus 113 ~l~~l~~~~~---~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~--~l-~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 113 HLVEIPPNLP---SSLVELRIHDNRIRK-VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD--GL-KLNYLRISEAKLT 185 (332)
T ss_dssp CCCSCCSSCC---TTCCEEECCSSCCCC-CCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSC--SC-CCSCCBCCSSBCS
T ss_pred cCCccCcccc---ccCCEEECCCCccCc-cCHhHhCCCccCCEEECCCCccccCCCCccccc--CC-ccCEEECcCCCCC
Confidence 9998877654 899999999999995 33456899999999999999996 47777776 56 9999999999998
Q ss_pred ccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCC-CCCCCCCCcEEeccCCccccccchh
Q 002238 204 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDS 282 (948)
Q Consensus 204 ~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~ 282 (948)
+ +|..+ .++|++|+|++|++++..+ .+..+++|+.|+|++|++++..|..
T Consensus 186 ~-l~~~~----------------------------~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 236 (332)
T 2ft3_A 186 G-IPKDL----------------------------PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGS 236 (332)
T ss_dssp S-CCSSS----------------------------CSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTG
T ss_pred c-cCccc----------------------------cCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhH
Confidence 5 66543 2688899999999998775 5888899999999999999877788
Q ss_pred hhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCc
Q 002238 283 LVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDW 362 (948)
Q Consensus 283 l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (948)
+..+++|+.|+|++|+++ .+|.
T Consensus 237 ~~~l~~L~~L~L~~N~l~-~lp~--------------------------------------------------------- 258 (332)
T 2ft3_A 237 LSFLPTLRELHLDNNKLS-RVPA--------------------------------------------------------- 258 (332)
T ss_dssp GGGCTTCCEEECCSSCCC-BCCT---------------------------------------------------------
T ss_pred hhCCCCCCEEECCCCcCe-ecCh---------------------------------------------------------
Confidence 999999999999999987 3442
Q ss_pred cceeecCCceEEEEccCCcccccCCccccCc------cccceEeCcccccc--ccCCcCCcCCCCCcEEEccCCc
Q 002238 363 IGVTCTKGNITVINFQKMNLTGTISPEFASF------KSLQRLILADNNLS--GMIPEGLSVLGALKELDVSNNQ 429 (948)
Q Consensus 363 ~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l------~~L~~L~Ls~N~l~--g~ip~~l~~l~~L~~L~ls~N~ 429 (948)
.+..+++|+.|++++|.+++..+..|..+ +.|+.|+|++|.+. +..|..|..+++|+.|++++|+
T Consensus 259 --~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 259 --GLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp --TGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred --hhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 01234578889999999988777777653 67899999999887 6778889999999999999885
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-27 Score=269.98 Aligned_cols=308 Identities=24% Similarity=0.292 Sum_probs=184.0
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEcc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 147 (948)
.+++.|++++|.+++ +|.. +++|++|++++|++++... + .++|++|+|++|++++++ .|+++++|++|+++
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~-~--~~~L~~L~L~~n~l~~lp--~~~~l~~L~~L~l~ 161 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSD-L--PPLLEYLGVSNNQLEKLP--ELQNSSFLKIIDVD 161 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCS-C--CTTCCEEECCSSCCSSCC--CCTTCTTCCEEECC
T ss_pred CCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccC-C--CCCCCEEECcCCCCCCCc--ccCCCCCCCEEECC
Confidence 467888888888886 6643 3678888888888876432 2 168888888888888854 48888888888888
Q ss_pred CCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCC
Q 002238 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNA 227 (948)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~ 227 (948)
+|++++ +|..+ .+|++|++++|++++ +| .++ .+++|++|++++|++++ +|... ..++.|++.++...
T Consensus 162 ~N~l~~--lp~~~---~~L~~L~L~~n~l~~-l~-~~~--~l~~L~~L~l~~N~l~~-l~~~~--~~L~~L~l~~n~l~- 228 (454)
T 1jl5_A 162 NNSLKK--LPDLP---PSLEFIAAGNNQLEE-LP-ELQ--NLPFLTAIYADNNSLKK-LPDLP--LSLESIVAGNNILE- 228 (454)
T ss_dssp SSCCSC--CCCCC---TTCCEEECCSSCCSS-CC-CCT--TCTTCCEEECCSSCCSS-CCCCC--TTCCEEECCSSCCS-
T ss_pred CCcCcc--cCCCc---ccccEEECcCCcCCc-Cc-ccc--CCCCCCEEECCCCcCCc-CCCCc--CcccEEECcCCcCC-
Confidence 888884 56543 488888888888887 45 455 78888888888888885 45433 35677776654333
Q ss_pred ccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCC
Q 002238 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFD 307 (948)
Q Consensus 228 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~ 307 (948)
..+ .+.++++|++|++++|++++.+. .+++|+.|++++|++++ +|.. +++|+.|++++|++++.. .+.
T Consensus 229 ---~lp-~~~~l~~L~~L~l~~N~l~~l~~---~~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~-~~~ 296 (454)
T 1jl5_A 229 ---ELP-ELQNLPFLTTIYADNNLLKTLPD---LPPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLS-ELP 296 (454)
T ss_dssp ---SCC-CCTTCTTCCEEECCSSCCSSCCS---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEES-CCC
T ss_pred ---ccc-ccCCCCCCCEEECCCCcCCcccc---cccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCccc-CcC
Confidence 223 37788888888888888886432 23788888888888885 5653 367888888888888732 111
Q ss_pred CccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCC
Q 002238 308 RSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTIS 387 (948)
Q Consensus 308 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip 387 (948)
.+|..++..+|....++.. ...+.. .+..++... +....+++|+.|++++|+++ .+|
T Consensus 297 --~~L~~L~l~~N~l~~i~~~-~~~L~~---------------L~Ls~N~l~----~lp~~~~~L~~L~L~~N~l~-~lp 353 (454)
T 1jl5_A 297 --PNLYYLNASSNEIRSLCDL-PPSLEE---------------LNVSNNKLI----ELPALPPRLERLIASFNHLA-EVP 353 (454)
T ss_dssp --TTCCEEECCSSCCSEECCC-CTTCCE---------------EECCSSCCS----CCCCCCTTCCEEECCSSCCS-CCC
T ss_pred --CcCCEEECcCCcCCcccCC-cCcCCE---------------EECCCCccc----cccccCCcCCEEECCCCccc-ccc
Confidence 2344444455543322210 000000 001111000 01111345666666666666 344
Q ss_pred ccccCccccceEeCccccccc--cCCcCCcCC-------------CCCcEEEccCCcccC--CCC
Q 002238 388 PEFASFKSLQRLILADNNLSG--MIPEGLSVL-------------GALKELDVSNNQLYG--KIP 435 (948)
Q Consensus 388 ~~~~~l~~L~~L~Ls~N~l~g--~ip~~l~~l-------------~~L~~L~ls~N~l~g--~ip 435 (948)
. .+++|++|+|++|++++ .+|.++..+ ++|++||+++|+++| .+|
T Consensus 354 ~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP 415 (454)
T 1jl5_A 354 E---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIP 415 (454)
T ss_dssp C---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC-----------------------------
T ss_pred c---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccch
Confidence 4 35566666666666666 566666555 556666666666665 444
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-29 Score=274.05 Aligned_cols=249 Identities=16% Similarity=0.199 Sum_probs=178.1
Q ss_pred ccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEccccccc-CCCCcccc-------CCCCCCEEEccCCCCCCCCCCc
Q 002238 88 LQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFT-SVPSDFFT-------GLSSLQSIEIDNNPFSSWEIPQ 158 (948)
Q Consensus 88 l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~-~~~~~~~~-------~l~~L~~L~Ls~N~l~~~~~p~ 158 (948)
++..++|++|++++|.+ .+| .+... |++|+|++|.++ ...+..+. ++++|++|+|++|++++ .+|.
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~ 113 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTG-TAPP 113 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBS-CCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccc-hhHH
Confidence 34556677777777777 333 34433 777777777774 33444443 67777777777777776 5666
Q ss_pred cc--cCCCCCCEEEccCccccccCCCCCCCCCC-----CCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCC
Q 002238 159 SL--RNASGLQNFSANSANITGQIPSFFGPDEF-----PGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGG 231 (948)
Q Consensus 159 ~~--~~l~~L~~L~l~~n~l~~~~p~~~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~ 231 (948)
.+ ..+++|++|+|++|++++. |..++ .+ ++|++|+|++|++++..|..|
T Consensus 114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~--~l~~~~~~~L~~L~L~~N~l~~~~~~~~--------------------- 169 (312)
T 1wwl_A 114 PLLEATGPDLNILNLRNVSWATR-DAWLA--ELQQWLKPGLKVLSIAQAHSLNFSCEQV--------------------- 169 (312)
T ss_dssp CSSSCCSCCCSEEEEESCBCSSS-SSHHH--HHHTTCCTTCCEEEEESCSCCCCCTTTC---------------------
T ss_pred HHHHhcCCCccEEEccCCCCcch-hHHHH--HHHHhhcCCCcEEEeeCCCCccchHHHh---------------------
Confidence 65 6777777777777777766 55554 44 778888888888876666554
Q ss_pred CccccccCCCccEEEccCCccccc---CCCC--CCCCCCcEEeccCCcccc--ccc-hhhhCCCCCcEEEcccCcccccC
Q 002238 232 GIDVIQNMTSLKEIWLHSNAFSGP---LPDF--SGVKQLESLSLRDNFFTG--PVP-DSLVKLESLKIVNMTNNLLQGPV 303 (948)
Q Consensus 232 ~~~~l~~l~~L~~L~Ls~N~l~~~---~~~~--~~l~~L~~L~L~~N~l~~--~~p-~~l~~l~~L~~L~Ls~N~l~g~~ 303 (948)
.++++|++|+|++|++.+. ++.+ ..+++|+.|+|++|+|++ .++ ..+.++++|+.|+|++|++++.+
T Consensus 170 -----~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 244 (312)
T 1wwl_A 170 -----RVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244 (312)
T ss_dssp -----CCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSC
T ss_pred -----ccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCccc
Confidence 3677888888888887664 2233 678888888888888883 222 34467889999999999988765
Q ss_pred CCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCccc
Q 002238 304 PEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLT 383 (948)
Q Consensus 304 p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~ 383 (948)
|.- .+..+++|+.|+|++|+++
T Consensus 245 ~~~----------------------------------------------------------~~~~l~~L~~L~Ls~N~l~ 266 (312)
T 1wwl_A 245 GAP----------------------------------------------------------SCDWPSQLNSLNLSFTGLK 266 (312)
T ss_dssp CCS----------------------------------------------------------CCCCCTTCCEEECTTSCCS
T ss_pred chh----------------------------------------------------------hhhhcCCCCEEECCCCccC
Confidence 420 0112347888999999988
Q ss_pred ccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCC
Q 002238 384 GTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGK 433 (948)
Q Consensus 384 g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ 433 (948)
.+|..+. ++|++|+|++|+|++. |. +..+++|++|+|++|++++.
T Consensus 267 -~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 267 -QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp -SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred -hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 7787776 8899999999999866 66 88999999999999998863
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=281.31 Aligned_cols=281 Identities=23% Similarity=0.288 Sum_probs=203.2
Q ss_pred CCC-CCCCCCccceEEe-------CCCCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEE
Q 002238 50 GWS-DTDPCKWNHVVCI-------EDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVM 121 (948)
Q Consensus 50 ~w~-~~~~C~w~gv~c~-------~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ 121 (948)
.|. ..+||.|.|..|. ...+++.|++++|+++ .+|..+. ++|++|+|++|+|+.+++ .+++|++|+
T Consensus 14 ~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~lp~---~l~~L~~L~ 87 (622)
T 3g06_A 14 AWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA---LPPELRTLE 87 (622)
T ss_dssp HHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSCCCC---CCTTCCEEE
T ss_pred HHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCCCCC---cCCCCCEEE
Confidence 564 4678999775331 1246899999999999 8888776 899999999999997554 678999999
Q ss_pred cccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEccccc
Q 002238 122 LSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQ 201 (948)
Q Consensus 122 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~ 201 (948)
|++|+|++++. .+++|++|+|++|+++ .+|. .+++|+.|++++|+|++ +|. .+++|++|+|++|+
T Consensus 88 Ls~N~l~~lp~----~l~~L~~L~Ls~N~l~--~l~~---~l~~L~~L~L~~N~l~~-lp~-----~l~~L~~L~Ls~N~ 152 (622)
T 3g06_A 88 VSGNQLTSLPV----LPPGLLELSIFSNPLT--HLPA---LPSGLCKLWIFGNQLTS-LPV-----LPPGLQELSVSDNQ 152 (622)
T ss_dssp ECSCCCSCCCC----CCTTCCEEEECSCCCC--CCCC---CCTTCCEEECCSSCCSC-CCC-----CCTTCCEEECCSSC
T ss_pred cCCCcCCcCCC----CCCCCCEEECcCCcCC--CCCC---CCCCcCEEECCCCCCCc-CCC-----CCCCCCEEECcCCc
Confidence 99999998776 7899999999999999 4666 67899999999999986 444 35899999999999
Q ss_pred ccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccch
Q 002238 202 LIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPD 281 (948)
Q Consensus 202 l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 281 (948)
+++ +|..+ .+++.|++.++..... + ..+++|+.|+|++|++++.++. +++|+.|++++|.++ .+|.
T Consensus 153 l~~-l~~~~--~~L~~L~L~~N~l~~l----~---~~~~~L~~L~Ls~N~l~~l~~~---~~~L~~L~L~~N~l~-~l~~ 218 (622)
T 3g06_A 153 LAS-LPALP--SELCKLWAYNNQLTSL----P---MLPSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLT-SLPA 218 (622)
T ss_dssp CSC-CCCCC--TTCCEEECCSSCCSCC----C---CCCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred CCC-cCCcc--CCCCEEECCCCCCCCC----c---ccCCCCcEEECCCCCCCCCCCc---cchhhEEECcCCccc-ccCC
Confidence 985 45432 2344444433222211 1 2334555555555555542221 245555555555555 3332
Q ss_pred hhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCC
Q 002238 282 SLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSD 361 (948)
Q Consensus 282 ~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (948)
. +++|+.|+|++|+|++ +|.
T Consensus 219 ~---~~~L~~L~Ls~N~L~~-lp~-------------------------------------------------------- 238 (622)
T 3g06_A 219 L---PSGLKELIVSGNRLTS-LPV-------------------------------------------------------- 238 (622)
T ss_dssp C---CTTCCEEECCSSCCSC-CCC--------------------------------------------------------
T ss_pred C---CCCCCEEEccCCccCc-CCC--------------------------------------------------------
Confidence 1 2445555555555543 111
Q ss_pred ccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCCC
Q 002238 362 WIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 436 (948)
Q Consensus 362 ~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~ 436 (948)
.+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+|.+|.
T Consensus 239 ------~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 239 ------LPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp ------CCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred ------CCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence 1247899999999998 4665 6789999999999999 8899999999999999999999988774
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=256.01 Aligned_cols=209 Identities=23% Similarity=0.351 Sum_probs=170.2
Q ss_pred eEEeCCCCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCC
Q 002238 62 VVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSS 140 (948)
Q Consensus 62 v~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 140 (948)
..|.... .+.+++++++++ .+|..+ .++|++|+|++|.|++.++ .|..+++|++|+|++|.++++.+..|.++++
T Consensus 6 C~C~~~~-~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 81 (285)
T 1ozn_A 6 CVCYNEP-KVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81 (285)
T ss_dssp CEEECSS-SCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred ceECCCC-CeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccC
Confidence 3454332 367788888888 566554 4689999999999998776 6888999999999999999998899999999
Q ss_pred CCEEEccCCC-CCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCccccccccee
Q 002238 141 LQSIEIDNNP-FSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLW 219 (948)
Q Consensus 141 L~~L~Ls~N~-l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~ 219 (948)
|++|+|++|+ +.. ..|..+..+++|++|++++|.+++..|..|. .+++|++|+|++|++++..+..|
T Consensus 82 L~~L~l~~n~~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~--------- 149 (285)
T 1ozn_A 82 LEQLDLSDNAQLRS-VDPATFHGLGRLHTLHLDRCGLQELGPGLFR--GLAALQYLYLQDNALQALPDDTF--------- 149 (285)
T ss_dssp CCEEECCSCTTCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTT--TCTTCCEEECCSSCCCCCCTTTT---------
T ss_pred CCEEeCCCCCCccc-cCHHHhcCCcCCCEEECCCCcCCEECHhHhh--CCcCCCEEECCCCcccccCHhHh---------
Confidence 9999999997 764 3477888899999999999999988888886 78899999999998885555443
Q ss_pred ccCCCCCCccCCCccccccCCCccEEEccCCcccccCCC-CCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCc
Q 002238 220 VNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 298 (948)
Q Consensus 220 ~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 298 (948)
.++++|++|+|++|++++.++. +.++++|+.|+|++|.+++..|..+.++++|+.|+|++|+
T Consensus 150 -----------------~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 212 (285)
T 1ozn_A 150 -----------------RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212 (285)
T ss_dssp -----------------TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred -----------------ccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCc
Confidence 3678888888888888876664 7778888888888888887778888888888888888888
Q ss_pred ccccC
Q 002238 299 LQGPV 303 (948)
Q Consensus 299 l~g~~ 303 (948)
+++.+
T Consensus 213 l~~~~ 217 (285)
T 1ozn_A 213 LSALP 217 (285)
T ss_dssp CSCCC
T ss_pred CCcCC
Confidence 87543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-28 Score=288.65 Aligned_cols=187 Identities=20% Similarity=0.173 Sum_probs=131.5
Q ss_pred eecccCceEEEEEE-EcCCcEEEEEEeecCcCC--------hhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEEE
Q 002238 600 ILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVIS--------GKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 600 ~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~--------~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 669 (948)
..+.|++|.++.++ .-.|+.||||++.+.... ....++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35677777777664 336899999999765321 23346799999999999 799999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||++|++|.+++.. ..+++.. +|+.||+.||+|+|+ +|||||||||+|||+++++.+||+|||+|+..
T Consensus 321 MEyv~G~~L~d~i~~-----~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA-----GEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EECCCSEEHHHHHHT-----TCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EecCCCCcHHHHHHh-----CCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 999999999999943 2456654 588999999999997 89999999999999999999999999999966
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCC
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKA 799 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p 799 (948)
..... .....+||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 390 ~~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 390 PQDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 54332 3445679999999999865 567789999999998887665433
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-26 Score=243.85 Aligned_cols=217 Identities=23% Similarity=0.385 Sum_probs=193.8
Q ss_pred CCCCCccceEEeCCCCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCC
Q 002238 54 TDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPS 132 (948)
Q Consensus 54 ~~~C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~ 132 (948)
.+.|.|.|+.|....+++.+++++++++ .+|..+. ++|++|+|++|+|++..+ .|.++++|++|+|++|.++.+++
T Consensus 2 ~~~C~~~~~~C~c~~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~ 78 (270)
T 2o6q_A 2 EALCKKDGGVCSCNNNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPA 78 (270)
T ss_dssp CCCBGGGTCSBEEETTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCT
T ss_pred CccCCCCCCCCEeCCCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeCh
Confidence 5789999999977677889999999999 5777665 689999999999999877 79999999999999999999999
Q ss_pred ccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCccc
Q 002238 133 DFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG 212 (948)
Q Consensus 133 ~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 212 (948)
..|.++++|++|+|++|+++. ..+..+..+++|++|++++|++++..+..|. .+++|++|+|++|++++..+..|
T Consensus 79 ~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~Ls~n~l~~~~~~~~-- 153 (270)
T 2o6q_A 79 GIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFD--SLTKLTYLSLGYNELQSLPKGVF-- 153 (270)
T ss_dssp TTTSSCTTCCEEECCSSCCCC-CCTTTTTTCSSCCEEECCSSCCCCCCTTTTT--TCTTCCEEECCSSCCCCCCTTTT--
T ss_pred hhhcCCCCCCEEECCCCcCCc-CCHhHcccccCCCEEECCCCccCeeCHHHhC--cCcCCCEEECCCCcCCccCHhHc--
Confidence 999999999999999999995 3345678999999999999999999888887 89999999999999986555443
Q ss_pred ccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCCC-CCCCCCCcEEeccCCccccccchhhhCCCCCcE
Q 002238 213 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 291 (948)
Q Consensus 213 ~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 291 (948)
.++++|++|+|++|++++.++. |.++++|+.|+|++|++++..+..+..+++|+.
T Consensus 154 ------------------------~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 209 (270)
T 2o6q_A 154 ------------------------DKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKM 209 (270)
T ss_dssp ------------------------TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred ------------------------cCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCE
Confidence 4789999999999999987774 888999999999999999776777999999999
Q ss_pred EEcccCccccc
Q 002238 292 VNMTNNLLQGP 302 (948)
Q Consensus 292 L~Ls~N~l~g~ 302 (948)
|+|++|++...
T Consensus 210 L~l~~N~~~c~ 220 (270)
T 2o6q_A 210 LQLQENPWDCT 220 (270)
T ss_dssp EECCSSCBCCS
T ss_pred EEecCCCeeCC
Confidence 99999998753
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.7e-26 Score=261.25 Aligned_cols=249 Identities=14% Similarity=0.163 Sum_probs=181.4
Q ss_pred CcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccC
Q 002238 94 LERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANS 173 (948)
Q Consensus 94 L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~ 173 (948)
...++.+++.++.++..+. ++++.|+|++|+|+++++..|.++++|++|+|++|+++. ..+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~-i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT-IEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCSSCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCE-ECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcCcCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCc-cChhhccCCccCCEEECCC
Confidence 4578889999987766555 689999999999999999999999999999999999885 3346677777777777777
Q ss_pred ccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCccc
Q 002238 174 ANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS 253 (948)
Q Consensus 174 n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 253 (948)
|+|+...+..|. .+++|++|+|++|+++...+..| .++++|++|+|++|+.
T Consensus 122 n~l~~~~~~~~~--~l~~L~~L~L~~N~i~~~~~~~~--------------------------~~l~~L~~L~l~~~~~- 172 (440)
T 3zyj_A 122 NRLTTIPNGAFV--YLSKLKELWLRNNPIESIPSYAF--------------------------NRIPSLRRLDLGELKR- 172 (440)
T ss_dssp SCCSSCCTTTSC--SCSSCCEEECCSCCCCEECTTTT--------------------------TTCTTCCEEECCCCTT-
T ss_pred CcCCeeCHhHhh--ccccCceeeCCCCcccccCHHHh--------------------------hhCcccCEeCCCCCCC-
Confidence 777766665665 66677777777776664333332 2455555555555322
Q ss_pred ccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhh
Q 002238 254 GPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRL 333 (948)
Q Consensus 254 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 333 (948)
+....+..|.++++|++|+|++|+++. +|.+
T Consensus 173 ---------------------l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~~~--------------------------- 203 (440)
T 3zyj_A 173 ---------------------LSYISEGAFEGLSNLRYLNLAMCNLRE-IPNL--------------------------- 203 (440)
T ss_dssp ---------------------CCEECTTTTTTCSSCCEEECTTSCCSS-CCCC---------------------------
T ss_pred ---------------------cceeCcchhhcccccCeecCCCCcCcc-cccc---------------------------
Confidence 222222345555555555555555542 2211
Q ss_pred hhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcC
Q 002238 334 NALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEG 413 (948)
Q Consensus 334 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~ 413 (948)
..+++|+.|+|++|.+++..|..|.++++|+.|+|++|+|++..|..
T Consensus 204 ---------------------------------~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 250 (440)
T 3zyj_A 204 ---------------------------------TPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNA 250 (440)
T ss_dssp ---------------------------------TTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTS
T ss_pred ---------------------------------CCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhh
Confidence 11235667777777777777888999999999999999999999999
Q ss_pred CcCCCCCcEEEccCCcccCCCCC----CCcccccccCCCCCCCCccC
Q 002238 414 LSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNPDIGKEKS 456 (948)
Q Consensus 414 l~~l~~L~~L~ls~N~l~g~ip~----~~~~~~~~~~gnp~~~~~~~ 456 (948)
|..+++|++|||++|+|++.++. +.....+.+++|||.|.+..
T Consensus 251 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 251 FDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDI 297 (440)
T ss_dssp STTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTT
T ss_pred hcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCc
Confidence 99999999999999999987664 35567889999999998754
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-27 Score=262.49 Aligned_cols=272 Identities=17% Similarity=0.189 Sum_probs=224.6
Q ss_pred CcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccC
Q 002238 94 LERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANS 173 (948)
Q Consensus 94 L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~ 173 (948)
....++++|.++.++..+. ++|++|+|++|.++++++..|.++++|++|+|++|++++ ..|..+.++++|++|++++
T Consensus 33 ~~~c~~~~~~l~~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~ 109 (353)
T 2z80_A 33 NGICKGSSGSLNSIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSY 109 (353)
T ss_dssp TSEEECCSTTCSSCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECCS
T ss_pred CeEeeCCCCCccccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCc-cCHhhcCCCCCCCEEECCC
Confidence 3457889999998766555 589999999999999999899999999999999999996 4467899999999999999
Q ss_pred ccccccCCCCCCCCCCCCCcEEEcccccccccCCC-CcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCc-
Q 002238 174 ANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPA-SFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA- 251 (948)
Q Consensus 174 n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~- 251 (948)
|++++..+..|. .+++|++|+|++|++++ +|. .. +.++++|++|++++|+
T Consensus 110 n~l~~~~~~~~~--~l~~L~~L~L~~n~l~~-l~~~~~-------------------------~~~l~~L~~L~l~~n~~ 161 (353)
T 2z80_A 110 NYLSNLSSSWFK--PLSSLTFLNLLGNPYKT-LGETSL-------------------------FSHLTKLQILRVGNMDT 161 (353)
T ss_dssp SCCSSCCHHHHT--TCTTCSEEECTTCCCSS-SCSSCS-------------------------CTTCTTCCEEEEEESSS
T ss_pred CcCCcCCHhHhC--CCccCCEEECCCCCCcc-cCchhh-------------------------hccCCCCcEEECCCCcc
Confidence 999977766676 89999999999999984 443 21 4578999999999994
Q ss_pred ccccCC-CCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCc
Q 002238 252 FSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACD 330 (948)
Q Consensus 252 l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~ 330 (948)
+....+ .+.++++|+.|++++|.+++..|..+.++++|++|++++|+++...+.
T Consensus 162 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~------------------------- 216 (353)
T 2z80_A 162 FTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEI------------------------- 216 (353)
T ss_dssp CCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHH-------------------------
T ss_pred ccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhh-------------------------
Confidence 666655 588899999999999999998899999999999999999998532211
Q ss_pred hhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCcccc---CccccceEeCcccccc
Q 002238 331 PRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFA---SFKSLQRLILADNNLS 407 (948)
Q Consensus 331 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~---~l~~L~~L~Ls~N~l~ 407 (948)
.+..+++|+.|++++|.+++..+..+. ....++.++|++|+++
T Consensus 217 ----------------------------------~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~ 262 (353)
T 2z80_A 217 ----------------------------------FVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKIT 262 (353)
T ss_dssp ----------------------------------HHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCC
T ss_pred ----------------------------------hhhhcccccEEECCCCccccccccccccccccchhhcccccccccc
Confidence 111245899999999999987766554 3567888999999887
Q ss_pred c----cCCcCCcCCCCCcEEEccCCcccCCCCC----CCcccccccCCCCCCCCcc
Q 002238 408 G----MIPEGLSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNPDIGKEK 455 (948)
Q Consensus 408 g----~ip~~l~~l~~L~~L~ls~N~l~g~ip~----~~~~~~~~~~gnp~~~~~~ 455 (948)
+ .+|..+..+++|++|||++|+++..++. +.....+.+++||+.|.++
T Consensus 263 ~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 263 DESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp HHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 6 4788899999999999999999954332 3456788999999998765
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=253.37 Aligned_cols=253 Identities=15% Similarity=0.181 Sum_probs=193.9
Q ss_pred CCCCCCCCCCcc-ceEEeCCCCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccc
Q 002238 49 LGWSDTDPCKWN-HVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQF 127 (948)
Q Consensus 49 ~~w~~~~~C~w~-gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l 127 (948)
..|.+..|-.+. .+......+|+.|+|++|+++ .+|+.++++++|++|+|++|.|+.++..+.++++|++|+|++|.+
T Consensus 61 ~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l 139 (328)
T 4fcg_A 61 ETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPL 139 (328)
T ss_dssp CCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCC
T ss_pred cccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCccchhHHHhccCCCCEEECCCCcc
Confidence 378654432222 122234578999999999999 889999999999999999999995555799999999999999999
Q ss_pred cCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCC
Q 002238 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLP 207 (948)
Q Consensus 128 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p 207 (948)
+.+ |..|+++++|++|+|++|++.+ .+|..+... ..+..|. .+++|++|+|++|+++ .+|
T Consensus 140 ~~l-p~~l~~l~~L~~L~L~~n~~~~-~~p~~~~~~---------------~~~~~~~--~l~~L~~L~L~~n~l~-~lp 199 (328)
T 4fcg_A 140 RAL-PASIASLNRLRELSIRACPELT-ELPEPLAST---------------DASGEHQ--GLVNLQSLRLEWTGIR-SLP 199 (328)
T ss_dssp CCC-CGGGGGCTTCCEEEEEEETTCC-CCCSCSEEE---------------C-CCCEE--ESTTCCEEEEEEECCC-CCC
T ss_pred ccC-cHHHhcCcCCCEEECCCCCCcc-ccChhHhhc---------------cchhhhc--cCCCCCEEECcCCCcC-cch
Confidence 954 6679999999999999988877 788766541 1112233 5677777777777776 555
Q ss_pred CCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCC
Q 002238 208 ASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLE 287 (948)
Q Consensus 208 ~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 287 (948)
..+ .++++|++|+|++|++++.++.+..+++|+.|+|++|++.+.+|..+..++
T Consensus 200 ~~l--------------------------~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~ 253 (328)
T 4fcg_A 200 ASI--------------------------ANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA 253 (328)
T ss_dssp GGG--------------------------GGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCC
T ss_pred Hhh--------------------------cCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCC
Confidence 443 367777777777777776666677777888888888888878888888888
Q ss_pred CCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceee
Q 002238 288 SLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTC 367 (948)
Q Consensus 288 ~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (948)
+|+.|+|++|++.+.+|.. +.
T Consensus 254 ~L~~L~L~~n~~~~~~p~~-----------------------------------------------------------~~ 274 (328)
T 4fcg_A 254 PLKRLILKDCSNLLTLPLD-----------------------------------------------------------IH 274 (328)
T ss_dssp CCCEEECTTCTTCCBCCTT-----------------------------------------------------------GG
T ss_pred CCCEEECCCCCchhhcchh-----------------------------------------------------------hh
Confidence 8888888888877776641 12
Q ss_pred cCCceEEEEccCCcccccCCccccCccccceEeCcccccc
Q 002238 368 TKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLS 407 (948)
Q Consensus 368 ~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~ 407 (948)
.+++|+.|+|++|++.+.+|..|+++++|+.+++..|.+.
T Consensus 275 ~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 275 RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp GCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred cCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 3457788888888888888999999999999999888765
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-26 Score=248.50 Aligned_cols=247 Identities=20% Similarity=0.231 Sum_probs=171.2
Q ss_pred cEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCC-CCCccccCCCCCCEEEccC
Q 002238 95 ERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSW-EIPQSLRNASGLQNFSANS 173 (948)
Q Consensus 95 ~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~p~~~~~l~~L~~L~l~~ 173 (948)
+.++++++.++..+..+. ++|++|+|++|+++.+++..|.++++|++|+|++|+++.. .+|..+..+++|++|++++
T Consensus 10 ~~l~c~~~~l~~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~ 87 (306)
T 2z66_A 10 TEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87 (306)
T ss_dssp TEEECCSSCCSSCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCS
T ss_pred CEEEcCCCCcccCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCC
Confidence 467888888877655443 5788888888888888877788888888888888887631 1144555555566666655
Q ss_pred ccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCccc
Q 002238 174 ANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS 253 (948)
Q Consensus 174 n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 253 (948)
|.++. +|..+. .+++|++|+|++| +++
T Consensus 88 n~i~~-l~~~~~--~l~~L~~L~l~~n--------------------------------------------------~l~ 114 (306)
T 2z66_A 88 NGVIT-MSSNFL--GLEQLEHLDFQHS--------------------------------------------------NLK 114 (306)
T ss_dssp CSEEE-EEEEEE--TCTTCCEEECTTS--------------------------------------------------EEE
T ss_pred Ccccc-ChhhcC--CCCCCCEEECCCC--------------------------------------------------ccc
Confidence 55553 233233 4444555555554 444
Q ss_pred ccCC--CCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccc-cCCCCCCccccccccccCCCCCCCCCCCc
Q 002238 254 GPLP--DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSLDMAKGSNNFCLPSPGACD 330 (948)
Q Consensus 254 ~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g-~~p~~~~~~~l~~~~~~~~~~~~~~~~~~ 330 (948)
+..+ .+..+++|++|+|++|.+++..|..+..+++|++|+|++|.+++ .+|.
T Consensus 115 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~------------------------- 169 (306)
T 2z66_A 115 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD------------------------- 169 (306)
T ss_dssp SSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECS-------------------------
T ss_pred ccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchh-------------------------
Confidence 4332 34555666666666666666666666666677777777776664 2332
Q ss_pred hhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccC
Q 002238 331 PRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMI 410 (948)
Q Consensus 331 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~i 410 (948)
.+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..
T Consensus 170 ----------------------------------~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 215 (306)
T 2z66_A 170 ----------------------------------IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 215 (306)
T ss_dssp ----------------------------------CCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCC
T ss_pred ----------------------------------HHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccC
Confidence 1112346677777777777777788999999999999999999887
Q ss_pred CcCCcCCCCCcEEEccCCcccCCCCC----C-CcccccccCCCCCCCCcc
Q 002238 411 PEGLSVLGALKELDVSNNQLYGKIPS----F-KSNAIVNTDGNPDIGKEK 455 (948)
Q Consensus 411 p~~l~~l~~L~~L~ls~N~l~g~ip~----~-~~~~~~~~~gnp~~~~~~ 455 (948)
+..+..+++|++|||++|++++.+|. + .....+.+++||+.|.+.
T Consensus 216 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 216 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp SGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred hhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccC
Confidence 87899999999999999999998774 2 256688999999988764
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-25 Score=260.01 Aligned_cols=248 Identities=15% Similarity=0.154 Sum_probs=178.8
Q ss_pred CcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccC
Q 002238 94 LERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANS 173 (948)
Q Consensus 94 L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~ 173 (948)
...++.+++.++.++..+. ++|++|+|++|.|+++++..|.++++|+.|+|++|+|+. ..|..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ-IEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcCccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCC-cChhhccCcccCCEEECCC
Confidence 4578888888887665554 688999999999999888888888888888888888875 3346666677777777777
Q ss_pred ccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCccc
Q 002238 174 ANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS 253 (948)
Q Consensus 174 n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 253 (948)
|+|++..+..|. .+++|++|+|++|+++...+..
T Consensus 133 n~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~-------------------------------------------- 166 (452)
T 3zyi_A 133 NWLTVIPSGAFE--YLSKLRELWLRNNPIESIPSYA-------------------------------------------- 166 (452)
T ss_dssp SCCSBCCTTTSS--SCTTCCEEECCSCCCCEECTTT--------------------------------------------
T ss_pred CcCCccChhhhc--ccCCCCEEECCCCCcceeCHhH--------------------------------------------
Confidence 766665555554 5666666666666665333322
Q ss_pred ccCCCCCCCCCCcEEeccCC-ccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchh
Q 002238 254 GPLPDFSGVKQLESLSLRDN-FFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPR 332 (948)
Q Consensus 254 ~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 332 (948)
|.++++|+.|+|++| .+....+..|.++++|+.|+|++|++++. |.+
T Consensus 167 -----~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~-------------------------- 214 (452)
T 3zyi_A 167 -----FNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-PNL-------------------------- 214 (452)
T ss_dssp -----TTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-CCC--------------------------
T ss_pred -----HhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-ccc--------------------------
Confidence 334444444455442 23222223456666666666666666532 221
Q ss_pred hhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCc
Q 002238 333 LNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE 412 (948)
Q Consensus 333 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~ 412 (948)
..+++|+.|+|++|.+++..|..|.++++|+.|+|++|++++..|.
T Consensus 215 ----------------------------------~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 260 (452)
T 3zyi_A 215 ----------------------------------TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERN 260 (452)
T ss_dssp ----------------------------------TTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTT
T ss_pred ----------------------------------cccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHH
Confidence 1223677788888888888888999999999999999999999999
Q ss_pred CCcCCCCCcEEEccCCcccCCCCC----CCcccccccCCCCCCCCccC
Q 002238 413 GLSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNPDIGKEKS 456 (948)
Q Consensus 413 ~l~~l~~L~~L~ls~N~l~g~ip~----~~~~~~~~~~gnp~~~~~~~ 456 (948)
.|..+++|+.|+|++|+|++.++. +.....+.+++|||.|.+..
T Consensus 261 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 261 AFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTT
T ss_pred HhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCc
Confidence 999999999999999999987664 45567889999999998764
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-28 Score=266.35 Aligned_cols=265 Identities=21% Similarity=0.228 Sum_probs=152.7
Q ss_pred CEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEcc
Q 002238 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (948)
Q Consensus 69 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 147 (948)
++...+++.+++...+...+..+++|++|+|++|+|++.+| .|.++++|++|+|++|.+++.++ |..+++|++|+|+
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 45555566666654444444556677777777777776655 56667777777777777766554 6677777777777
Q ss_pred CCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCC
Q 002238 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNA 227 (948)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~ 227 (948)
+|++++ ++ ..++|++|++++|++++..+. .+++|++|+|++|++++..+..+
T Consensus 89 ~n~l~~--l~----~~~~L~~L~l~~n~l~~~~~~-----~~~~L~~L~l~~N~l~~~~~~~~----------------- 140 (317)
T 3o53_A 89 NNYVQE--LL----VGPSIETLHAANNNISRVSCS-----RGQGKKNIYLANNKITMLRDLDE----------------- 140 (317)
T ss_dssp SSEEEE--EE----ECTTCCEEECCSSCCSEEEEC-----CCSSCEEEECCSSCCCSGGGBCT-----------------
T ss_pred CCcccc--cc----CCCCcCEEECCCCccCCcCcc-----ccCCCCEEECCCCCCCCccchhh-----------------
Confidence 776663 22 236666666666666655443 23556666666666665444333
Q ss_pred ccCCCccccccCCCccEEEccCCcccccCC-CC-CCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCC
Q 002238 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DF-SGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE 305 (948)
Q Consensus 228 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~-~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 305 (948)
..+++|++|+|++|.+++..+ .+ ..+++|++|+|++|.|++. |. ...+++|++|+|++|++++.++.
T Consensus 141 ---------~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~ 209 (317)
T 3o53_A 141 ---------GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPE 209 (317)
T ss_dssp ---------GGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGG
T ss_pred ---------hccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcchhh
Confidence 245666666666666665443 23 2456666666666666533 32 22356666666666666543332
Q ss_pred CCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCccccc
Q 002238 306 FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT 385 (948)
Q Consensus 306 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ 385 (948)
+ ..+++|+.|+|++|+++ .
T Consensus 210 ~------------------------------------------------------------~~l~~L~~L~L~~N~l~-~ 228 (317)
T 3o53_A 210 F------------------------------------------------------------QSAAGVTWISLRNNKLV-L 228 (317)
T ss_dssp G------------------------------------------------------------GGGTTCSEEECTTSCCC-E
T ss_pred h------------------------------------------------------------cccCcccEEECcCCccc-c
Confidence 1 11235555666666665 3
Q ss_pred CCccccCccccceEeCcccccc-ccCCcCCcCCCCCcEEEcc-CCcccCCCC
Q 002238 386 ISPEFASFKSLQRLILADNNLS-GMIPEGLSVLGALKELDVS-NNQLYGKIP 435 (948)
Q Consensus 386 ip~~~~~l~~L~~L~Ls~N~l~-g~ip~~l~~l~~L~~L~ls-~N~l~g~ip 435 (948)
+|..+..+++|+.|+|++|.+. +.+|..+..+++|+.|+++ .+.++|..|
T Consensus 229 l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~ 280 (317)
T 3o53_A 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280 (317)
T ss_dssp ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence 4555556666666666666665 5555555566666666665 334444443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=246.01 Aligned_cols=205 Identities=23% Similarity=0.294 Sum_probs=187.7
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEccccc-ccCCCCccccCCCCCCEEE
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQ-FTSVPSDFFTGLSSLQSIE 145 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~ 145 (948)
.+++.|+|++|++++..+..|.++++|++|+|++|.|++..| .|.++++|++|+|++|. ++.+++..|..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 579999999999998888889999999999999999999866 79999999999999997 9999899999999999999
Q ss_pred ccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCC
Q 002238 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNG 225 (948)
Q Consensus 146 Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~ 225 (948)
|++|+++. ..|..+.++++|++|++++|++++..+..|. .+++|++|+|++|++++..+..|
T Consensus 112 l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~--------------- 173 (285)
T 1ozn_A 112 LDRCGLQE-LGPGLFRGLAALQYLYLQDNALQALPDDTFR--DLGNLTHLFLHGNRISSVPERAF--------------- 173 (285)
T ss_dssp CTTSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTT--TCTTCCEEECCSSCCCEECTTTT---------------
T ss_pred CCCCcCCE-ECHhHhhCCcCCCEEECCCCcccccCHhHhc--cCCCccEEECCCCcccccCHHHh---------------
Confidence 99999996 5578899999999999999999988888887 89999999999999996655544
Q ss_pred CCccCCCccccccCCCccEEEccCCcccccCC-CCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccc
Q 002238 226 NAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG 301 (948)
Q Consensus 226 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 301 (948)
.++++|++|+|++|++++..+ .+..+++|+.|+|++|++++..+..+..+++|+.|+|++|++..
T Consensus 174 -----------~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 239 (285)
T 1ozn_A 174 -----------RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (285)
T ss_dssp -----------TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred -----------cCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccC
Confidence 478999999999999999866 58889999999999999998777889999999999999999974
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.1e-28 Score=264.19 Aligned_cols=264 Identities=17% Similarity=0.203 Sum_probs=213.4
Q ss_pred CCCC-CCCCCccceEEe-CCCCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCC-CCCC-CcC-------CCCCCc
Q 002238 50 GWSD-TDPCKWNHVVCI-EDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSIS-GPLP-SLN-------GLASLE 118 (948)
Q Consensus 50 ~w~~-~~~C~w~gv~c~-~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p-~~~-------~l~~L~ 118 (948)
+|.. ..|+.+..+... ...+++.+++++|++ .+|..+... |+.|+|++|.++ +.+| .+. ++++|+
T Consensus 23 ~~~~~~~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~ 98 (312)
T 1wwl_A 23 DWSSAFNCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98 (312)
T ss_dssp CGGGGGGSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCC
T ss_pred chHHHhhhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCcc
Confidence 5643 345555554432 234678888999999 788877654 999999999994 4455 333 699999
Q ss_pred EEEcccccccCCCCccc--cCCCCCCEEEccCCCCCCCCCCccccCC-----CCCCEEEccCccccccCCCCCCCCCCCC
Q 002238 119 VVMLSNNQFTSVPSDFF--TGLSSLQSIEIDNNPFSSWEIPQSLRNA-----SGLQNFSANSANITGQIPSFFGPDEFPG 191 (948)
Q Consensus 119 ~L~L~~N~l~~~~~~~~--~~l~~L~~L~Ls~N~l~~~~~p~~~~~l-----~~L~~L~l~~n~l~~~~p~~~~~~~l~~ 191 (948)
+|+|++|.+++..|..+ ..+++|++|+|++|++++ +|..+..+ ++|++|+|++|++++..|..|+ .+++
T Consensus 99 ~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~--~l~~ 174 (312)
T 1wwl_A 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT--RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVR--VFPA 174 (312)
T ss_dssp EEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSS--SSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCC--CCSS
T ss_pred EEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcc--hhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhc--cCCC
Confidence 99999999998777765 999999999999999996 48888877 9999999999999999989997 8999
Q ss_pred CcEEEcccccccccC--CCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccC--C-C-CCCCCCC
Q 002238 192 LTILHLAFNQLIGGL--PASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPL--P-D-FSGVKQL 265 (948)
Q Consensus 192 L~~L~Ls~N~l~~~~--p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~--~-~-~~~l~~L 265 (948)
|++|+|++|++.+.+ |..+. +.++++|++|+|++|++++.. + . +.++++|
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L 230 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALC------------------------PLKFPTLQVLALRNAGMETPSGVCSALAAARVQL 230 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSC------------------------TTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCC
T ss_pred CCEEECCCCCcCcchHHHHHHH------------------------hccCCCCCEEECCCCcCcchHHHHHHHHhcCCCC
Confidence 999999999987653 22221 257899999999999998522 2 2 4578999
Q ss_pred cEEeccCCccccccc-hhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhC
Q 002238 266 ESLSLRDNFFTGPVP-DSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMG 344 (948)
Q Consensus 266 ~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 344 (948)
+.|+|++|++++.+| ..+..+++|+.|+|++|+++ .+|..
T Consensus 231 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~-------------------------------------- 271 (312)
T 1wwl_A 231 QGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG-------------------------------------- 271 (312)
T ss_dssp SEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSS--------------------------------------
T ss_pred CEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhh--------------------------------------
Confidence 999999999998775 55667899999999999998 44530
Q ss_pred CcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCcccccccc
Q 002238 345 YPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGM 409 (948)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ 409 (948)
.+ ++|+.|+|++|++++. |. +..+++|++|+|++|+|++.
T Consensus 272 --------------------~~---~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 272 --------------------LP---AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp --------------------CC---SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred --------------------cc---CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 00 3799999999999987 65 99999999999999999853
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=254.56 Aligned_cols=248 Identities=19% Similarity=0.188 Sum_probs=212.8
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEcc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 147 (948)
.+++.|+|++|++++..|..|.++++|++|+|++|.+++.++ +..+++|++|+|++|+++++++ .++|++|+|+
T Consensus 34 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~Ls~n~l~~l~~-----~~~L~~L~l~ 107 (317)
T 3o53_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA 107 (317)
T ss_dssp GGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE-ETTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred CCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh-hhhcCCCCEEECcCCccccccC-----CCCcCEEECC
Confidence 379999999999998888899999999999999999998766 9999999999999999998663 4899999999
Q ss_pred CCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCC
Q 002238 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNA 227 (948)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~ 227 (948)
+|+++. ++. ..+++|+.|++++|++++..+..+. .+++|++|+|++|++++..+..+
T Consensus 108 ~n~l~~--~~~--~~~~~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~----------------- 164 (317)
T 3o53_A 108 NNNISR--VSC--SRGQGKKNIYLANNKITMLRDLDEG--CRSRVQYLDLKLNEIDTVNFAEL----------------- 164 (317)
T ss_dssp SSCCSE--EEE--CCCSSCEEEECCSSCCCSGGGBCTG--GGSSEEEEECTTSCCCEEEGGGG-----------------
T ss_pred CCccCC--cCc--cccCCCCEEECCCCCCCCccchhhh--ccCCCCEEECCCCCCCcccHHHH-----------------
Confidence 999985 332 3478899999999999998888887 89999999999999997766654
Q ss_pred ccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCC
Q 002238 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFD 307 (948)
Q Consensus 228 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~ 307 (948)
+..+++|++|+|++|++++. +....+++|+.|+|++|++++ +|..+..+++|+.|+|++|++++.++.+
T Consensus 165 --------~~~l~~L~~L~L~~N~l~~~-~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~~l~~~~- 233 (317)
T 3o53_A 165 --------AASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKAL- 233 (317)
T ss_dssp --------GGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCEECTTC-
T ss_pred --------hhccCcCCEEECCCCcCccc-ccccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCcccchhhHh-
Confidence 23689999999999999976 444568999999999999994 5666999999999999999998643321
Q ss_pred CccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCccc-ccC
Q 002238 308 RSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLT-GTI 386 (948)
Q Consensus 308 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~-g~i 386 (948)
..+++|+.|+|++|.+. +.+
T Consensus 234 -----------------------------------------------------------~~l~~L~~L~l~~N~~~~~~~ 254 (317)
T 3o53_A 234 -----------------------------------------------------------RFSQNLEHFDLRGNGFHCGTL 254 (317)
T ss_dssp -----------------------------------------------------------CCCTTCCEEECTTCCCBHHHH
T ss_pred -----------------------------------------------------------hcCCCCCEEEccCCCccCcCH
Confidence 12357899999999999 889
Q ss_pred CccccCccccceEeCcc-ccccccCCcCC
Q 002238 387 SPEFASFKSLQRLILAD-NNLSGMIPEGL 414 (948)
Q Consensus 387 p~~~~~l~~L~~L~Ls~-N~l~g~ip~~l 414 (948)
|..+..++.|+.|++++ +.++|..|...
T Consensus 255 ~~~~~~~~~L~~l~l~~~~~l~~~~~~~~ 283 (317)
T 3o53_A 255 RDFFSKNQRVQTVAKQTVKKLTGQNEEEC 283 (317)
T ss_dssp HHHHHTCHHHHHHHHHHHHHHHSSSSCCC
T ss_pred HHHHhccccceEEECCCchhccCCchhcc
Confidence 99999999999999995 56787766543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-26 Score=265.18 Aligned_cols=219 Identities=18% Similarity=0.214 Sum_probs=153.0
Q ss_pred CCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcE
Q 002238 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTI 194 (948)
Q Consensus 115 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~ 194 (948)
++|++|+|++|.+++++|..|+.+++|++|+|++|.+++ ..| +..+++|++|+|++|.|++..+ .++|++
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~--l~~l~~L~~L~Ls~N~l~~l~~-------~~~L~~ 103 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLD--LESLSTLRTLDLNNNYVQELLV-------GPSIET 103 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEE-EEE--CTTCTTCCEEECCSSEEEEEEE-------CTTCCE
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCC-Ccc--cccCCCCCEEEecCCcCCCCCC-------CCCcCE
Confidence 356666666666666666666666666666666666653 222 5666666666666666664332 256777
Q ss_pred EEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCC-CCCCCCCCcEEeccCC
Q 002238 195 LHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDN 273 (948)
Q Consensus 195 L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N 273 (948)
|+|++|++++..+. .+++|+.|+|++|.+++.+| .+.++++|+.|+|++|
T Consensus 104 L~L~~N~l~~~~~~-----------------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 154 (487)
T 3oja_A 104 LHAANNNISRVSCS-----------------------------RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN 154 (487)
T ss_dssp EECCSSCCCCEEEC-----------------------------CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTS
T ss_pred EECcCCcCCCCCcc-----------------------------ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCC
Confidence 77777777654432 24567777777777777655 4667788888888888
Q ss_pred ccccccchhhh-CCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccc
Q 002238 274 FFTGPVPDSLV-KLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 352 (948)
Q Consensus 274 ~l~~~~p~~l~-~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 352 (948)
.|++.+|..+. .+++|+.|+|++|.+++..+.
T Consensus 155 ~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~----------------------------------------------- 187 (487)
T 3oja_A 155 EIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQ----------------------------------------------- 187 (487)
T ss_dssp CCCEEEGGGGGGGTTTCCEEECTTSCCCEEECC-----------------------------------------------
T ss_pred CCCCcChHHHhhhCCcccEEecCCCcccccccc-----------------------------------------------
Confidence 88877777776 688888888888888765331
Q ss_pred cCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCccc-
Q 002238 353 WKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY- 431 (948)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~- 431 (948)
..+++|+.|+|++|.+++..| .|+.+++|+.|+|++|+|++ +|..+..+++|+.|++++|++.
T Consensus 188 --------------~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c 251 (487)
T 3oja_A 188 --------------VVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC 251 (487)
T ss_dssp --------------CCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCH
T ss_pred --------------ccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcC
Confidence 013478888888888887544 48888899999999999984 7888888899999999999887
Q ss_pred CCCC
Q 002238 432 GKIP 435 (948)
Q Consensus 432 g~ip 435 (948)
+.+|
T Consensus 252 ~~~~ 255 (487)
T 3oja_A 252 GTLR 255 (487)
T ss_dssp HHHH
T ss_pred cchH
Confidence 4444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-26 Score=265.96 Aligned_cols=235 Identities=20% Similarity=0.228 Sum_probs=185.9
Q ss_pred CCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCE
Q 002238 90 NLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQN 168 (948)
Q Consensus 90 ~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~ 168 (948)
.+++|++|+|++|.|++.+| .|..+++|++|+|++|.+++.++ |+.+++|++|+|++|.|++ +| ..++|+.
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~--l~----~~~~L~~ 103 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE--LL----VGPSIET 103 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEE--EE----ECTTCCE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCC--CC----CCCCcCE
Confidence 33478888888888888776 68888888888888888888776 8888888888888888873 33 2378888
Q ss_pred EEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEcc
Q 002238 169 FSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLH 248 (948)
Q Consensus 169 L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls 248 (948)
|++++|.|++..+. .+++|+.|+|++|++++..|..+ .++++|+.|+|+
T Consensus 104 L~L~~N~l~~~~~~-----~l~~L~~L~L~~N~l~~~~~~~~--------------------------~~l~~L~~L~Ls 152 (487)
T 3oja_A 104 LHAANNNISRVSCS-----RGQGKKNIYLANNKITMLRDLDE--------------------------GCRSRVQYLDLK 152 (487)
T ss_dssp EECCSSCCCCEEEC-----CCSSCEEEECCSSCCCSGGGBCG--------------------------GGGSSEEEEECT
T ss_pred EECcCCcCCCCCcc-----ccCCCCEEECCCCCCCCCCchhh--------------------------cCCCCCCEEECC
Confidence 88888888877664 35788899999998887766654 367888899999
Q ss_pred CCcccccCC-CCC-CCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCC
Q 002238 249 SNAFSGPLP-DFS-GVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSP 326 (948)
Q Consensus 249 ~N~l~~~~~-~~~-~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~ 326 (948)
+|.+++.+| .+. .+++|+.|+|++|.|++. |. +..+++|+.|+|++|++++.+|.+.
T Consensus 153 ~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~~~------------------- 211 (487)
T 3oja_A 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQ------------------- 211 (487)
T ss_dssp TSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGG-------------------
T ss_pred CCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCCCCHhHc-------------------
Confidence 998888665 454 688899999999998855 33 3468889999999998887655321
Q ss_pred CCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccc
Q 002238 327 GACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNL 406 (948)
Q Consensus 327 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l 406 (948)
.+++|+.|+|++|.+++ +|..++.+++|+.|+|++|.+
T Consensus 212 -----------------------------------------~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l 249 (487)
T 3oja_A 212 -----------------------------------------SAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGF 249 (487)
T ss_dssp -----------------------------------------GGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCB
T ss_pred -----------------------------------------CCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCC
Confidence 23478888999998885 677888899999999999999
Q ss_pred c-ccCCcCCcCCCCCcEEEcc
Q 002238 407 S-GMIPEGLSVLGALKELDVS 426 (948)
Q Consensus 407 ~-g~ip~~l~~l~~L~~L~ls 426 (948)
. +.+|..+..++.|+.|+++
T Consensus 250 ~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 250 HCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CHHHHHHHHTTCHHHHHHHHH
T ss_pred cCcchHHHHHhCCCCcEEecc
Confidence 8 7778888888888887776
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-26 Score=267.34 Aligned_cols=187 Identities=18% Similarity=0.196 Sum_probs=147.5
Q ss_pred cccceecccCceEEEEEEEcCCcEEEEEEeecCcCChh------hHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 596 SEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK------GLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 596 ~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
...++||+|+||.||+|... ++.+|+|+......... ..+.+.+|++++++++||||+++..++...++.++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 44678999999999999654 88999998755432211 235589999999999999999766667788888999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++++|.+++.. +..++.|+++||+|||+ ++|+||||||+|||++. .+||+|||+++..
T Consensus 418 mE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 418 MSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 999999999998832 45799999999999997 89999999999999998 9999999999977
Q ss_pred CCCCCce------eeeecccccccCceeccc--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 002238 750 PEGKGSI------ETRIAGTFGYLAPEYAVT--GRVTTKVDVFSFGVILMELITGRKALD 801 (948)
Q Consensus 750 ~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~elltg~~p~~ 801 (948)
....... .....||+.|||||++.. ..|+.++|+|+..+-.++-+.++.+|.
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 5432211 235679999999999987 568888999999998888888777664
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-23 Score=247.10 Aligned_cols=257 Identities=23% Similarity=0.277 Sum_probs=197.9
Q ss_pred CCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEc
Q 002238 92 TKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSA 171 (948)
Q Consensus 92 ~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l 171 (948)
.+++.|++++|.|+.+++.+. ++|++|+|++|.|+.+++ .+++|++|+|++|+|+ .+|. .+++|++|+|
T Consensus 40 ~~l~~L~ls~n~L~~lp~~l~--~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~--~lp~---~l~~L~~L~L 108 (622)
T 3g06_A 40 NGNAVLNVGESGLTTLPDCLP--AHITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLT--SLPV---LPPGLLELSI 108 (622)
T ss_dssp HCCCEEECCSSCCSCCCSCCC--TTCSEEEECSCCCSCCCC----CCTTCCEEEECSCCCS--CCCC---CCTTCCEEEE
T ss_pred CCCcEEEecCCCcCccChhhC--CCCcEEEecCCCCCCCCC----cCCCCCEEEcCCCcCC--cCCC---CCCCCCEEEC
Confidence 468999999999996655565 899999999999998776 5899999999999999 5676 7899999999
Q ss_pred cCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCc
Q 002238 172 NSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA 251 (948)
Q Consensus 172 ~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~ 251 (948)
++|+|++.. . .+++|+.|+|++|++++ +|.. +++|++|+|++|+
T Consensus 109 s~N~l~~l~-~-----~l~~L~~L~L~~N~l~~-lp~~-----------------------------l~~L~~L~Ls~N~ 152 (622)
T 3g06_A 109 FSNPLTHLP-A-----LPSGLCKLWIFGNQLTS-LPVL-----------------------------PPGLQELSVSDNQ 152 (622)
T ss_dssp CSCCCCCCC-C-----CCTTCCEEECCSSCCSC-CCCC-----------------------------CTTCCEEECCSSC
T ss_pred cCCcCCCCC-C-----CCCCcCEEECCCCCCCc-CCCC-----------------------------CCCCCEEECcCCc
Confidence 999999643 3 36789999999999984 5543 3678888888888
Q ss_pred ccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCch
Q 002238 252 FSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDP 331 (948)
Q Consensus 252 l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~ 331 (948)
+++.+. .+.+|+.|+|++|.|+ .+| ..+++|+.|+|++|++++..+.+ .+|..+...+|.+..++.
T Consensus 153 l~~l~~---~~~~L~~L~L~~N~l~-~l~---~~~~~L~~L~Ls~N~l~~l~~~~---~~L~~L~L~~N~l~~l~~---- 218 (622)
T 3g06_A 153 LASLPA---LPSELCKLWAYNNQLT-SLP---MLPSGLQELSVSDNQLASLPTLP---SELYKLWAYNNRLTSLPA---- 218 (622)
T ss_dssp CSCCCC---CCTTCCEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSCCCCCC---TTCCEEECCSSCCSSCCC----
T ss_pred CCCcCC---ccCCCCEEECCCCCCC-CCc---ccCCCCcEEECCCCCCCCCCCcc---chhhEEECcCCcccccCC----
Confidence 876433 2467888888888887 466 45677888888888887644333 334444444444333221
Q ss_pred hhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCC
Q 002238 332 RLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 411 (948)
Q Consensus 332 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip 411 (948)
..++|+.|+|++|++++ +| ..+++|+.|+|++|+|+ .+|
T Consensus 219 ------------------------------------~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp 257 (622)
T 3g06_A 219 ------------------------------------LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLP 257 (622)
T ss_dssp ------------------------------------CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCC
T ss_pred ------------------------------------CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCC
Confidence 12479999999999997 66 55689999999999999 677
Q ss_pred cCCcCCCCCcEEEccCCcccCCCCC----CCcccccccCCCCCCCCc
Q 002238 412 EGLSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNPDIGKE 454 (948)
Q Consensus 412 ~~l~~l~~L~~L~ls~N~l~g~ip~----~~~~~~~~~~gnp~~~~~ 454 (948)
. .+++|+.|+|++|+|+ .+|. +.....+.+++|++.+..
T Consensus 258 ~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~ 300 (622)
T 3g06_A 258 M---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERT 300 (622)
T ss_dssp C---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHH
T ss_pred c---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcC
Confidence 6 6789999999999999 5553 445667899999987543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.6e-24 Score=229.12 Aligned_cols=212 Identities=19% Similarity=0.243 Sum_probs=173.3
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (948)
..++.|++++|++++..+..|.++++|++|+|++|.+++..+ .|.++++|++|+|++|.++++++..|.++++|++|+|
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 358889999999887777788888999999999998888766 6888889999999999998888888888999999999
Q ss_pred cCCCCCCCCCCccccCCCCCCEEEccCcccccc-CCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCC
Q 002238 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQ-IPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNG 225 (948)
Q Consensus 147 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~-~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~ 225 (948)
++|+++. ..+..+.++++|++|++++|++++. +|..+. .+++|++|+|++|++++..+..+.
T Consensus 108 ~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~-------------- 170 (276)
T 2z62_A 108 VETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFS--NLTNLEHLDLSSNKIQSIYCTDLR-------------- 170 (276)
T ss_dssp TTSCCCC-STTCCCTTCTTCCEEECCSSCCCCCCCCGGGG--GCTTCCEEECCSSCCCEECGGGGH--------------
T ss_pred CCCCccc-cCchhcccCCCCCEEECcCCccceecCchhhc--cCCCCCEEECCCCCCCcCCHHHhh--------------
Confidence 9998885 3344688888999999999988874 577776 788999999999988866555543
Q ss_pred CCccCCCccccccCCCcc-EEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCC
Q 002238 226 NAKLGGGIDVIQNMTSLK-EIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP 304 (948)
Q Consensus 226 ~~~~~~~~~~l~~l~~L~-~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p 304 (948)
.+.+++.|. .|++++|++++..+......+|+.|+|++|++++..+..+..+++|+.|+|++|++++..|
T Consensus 171 ---------~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 171 ---------VLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp ---------HHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred ---------hhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 122333343 8999999999887776666689999999999997666778999999999999999987665
Q ss_pred C
Q 002238 305 E 305 (948)
Q Consensus 305 ~ 305 (948)
.
T Consensus 242 ~ 242 (276)
T 2z62_A 242 R 242 (276)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-23 Score=225.70 Aligned_cols=62 Identities=16% Similarity=0.164 Sum_probs=41.5
Q ss_pred EEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCCC
Q 002238 374 VINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 436 (948)
Q Consensus 374 ~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~ 436 (948)
.|++++|.+++..+..+.. .+|+.|+|++|+|++..+..+..+++|+.|+|++|++++..|.
T Consensus 181 ~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 181 SLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp EEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTT
T ss_pred eeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCc
Confidence 4555555555444433333 3678888888888766556677888888888888888877664
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=225.17 Aligned_cols=227 Identities=19% Similarity=0.208 Sum_probs=130.1
Q ss_pred CCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEcc
Q 002238 93 KLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSAN 172 (948)
Q Consensus 93 ~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~ 172 (948)
++..+++..+.+.... .+..+++|+.|++++|.++.+. .+..+++|++|+|++|++++ + ..+..+++|++|+++
T Consensus 20 ~l~~l~l~~~~~~~~~-~~~~l~~L~~L~l~~~~i~~~~--~l~~l~~L~~L~l~~n~l~~--~-~~l~~l~~L~~L~L~ 93 (272)
T 3rfs_A 20 ETIKANLKKKSVTDAV-TQNELNSIDQIIANNSDIKSVQ--GIQYLPNVRYLALGGNKLHD--I-SALKELTNLTYLILT 93 (272)
T ss_dssp HHHHHHHTCSCTTSEE-CHHHHTTCCEEECTTSCCCCCT--TGGGCTTCCEEECTTSCCCC--C-GGGTTCTTCCEEECT
T ss_pred HHHHHHhcCccccccc-ccccccceeeeeeCCCCccccc--ccccCCCCcEEECCCCCCCC--c-hhhcCCCCCCEEECC
Confidence 3444444454444322 2344555555566555555433 25555666666666665553 2 255556666666666
Q ss_pred CccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcc
Q 002238 173 SANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAF 252 (948)
Q Consensus 173 ~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l 252 (948)
+|.+++..+..|. .+++|++|+|++|++++..+..| .++++|++|+|++|++
T Consensus 94 ~n~l~~~~~~~~~--~l~~L~~L~L~~n~l~~~~~~~~--------------------------~~l~~L~~L~L~~n~l 145 (272)
T 3rfs_A 94 GNQLQSLPNGVFD--KLTNLKELVLVENQLQSLPDGVF--------------------------DKLTNLTYLNLAHNQL 145 (272)
T ss_dssp TSCCCCCCTTTTT--TCTTCCEEECTTSCCCCCCTTTT--------------------------TTCTTCCEEECCSSCC
T ss_pred CCccCccChhHhc--CCcCCCEEECCCCcCCccCHHHh--------------------------ccCCCCCEEECCCCcc
Confidence 6666655555554 56666666666666654444332 2456666666666666
Q ss_pred cccCCC-CCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCch
Q 002238 253 SGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDP 331 (948)
Q Consensus 253 ~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~ 331 (948)
++.++. +..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++.+|..
T Consensus 146 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~------------------------- 200 (272)
T 3rfs_A 146 QSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGV------------------------- 200 (272)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT-------------------------
T ss_pred CccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHH-------------------------
Confidence 655443 455666666666666666555555566666666666666666544421
Q ss_pred hhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCC
Q 002238 332 RLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 411 (948)
Q Consensus 332 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip 411 (948)
+..+++|+.|+|++|.+.+. ++.|+.|+++.|+++|.+|
T Consensus 201 ----------------------------------~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip 239 (272)
T 3rfs_A 201 ----------------------------------FDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVR 239 (272)
T ss_dssp ----------------------------------TTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBB
T ss_pred ----------------------------------HhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCccc
Confidence 11223566666666665533 4467778888888888888
Q ss_pred cCCcCCCC
Q 002238 412 EGLSVLGA 419 (948)
Q Consensus 412 ~~l~~l~~ 419 (948)
..++.+..
T Consensus 240 ~~~~~~~~ 247 (272)
T 3rfs_A 240 NSAGSVAP 247 (272)
T ss_dssp CTTSCBCG
T ss_pred CcccccCC
Confidence 87776654
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-26 Score=269.58 Aligned_cols=326 Identities=19% Similarity=0.187 Sum_probs=180.6
Q ss_pred CEEEEEeCCCCCcC----CCCccccCCCCCcEEEcccCCCCCCCC-Cc-CCCC----CCcEEEcccccccC----CCCcc
Q 002238 69 RITRIQIGHQNLQG----TLPSNLQNLTKLERLELQWNSISGPLP-SL-NGLA----SLEVVMLSNNQFTS----VPSDF 134 (948)
Q Consensus 69 ~v~~l~l~~~~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~-~~l~----~L~~L~L~~N~l~~----~~~~~ 134 (948)
+++.|+|++|+++. .++..+..+++|++|+|++|.++...+ .+ ..++ +|++|+|++|.++. .++..
T Consensus 29 ~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~ 108 (461)
T 1z7x_W 29 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 108 (461)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHH
Confidence 56666777766653 344556666777777777776654222 11 2233 57777777777663 34556
Q ss_pred ccCCCCCCEEEccCCCCCCCCCCcccc-----CCCCCCEEEccCccccccC----CCCCCCCCCCCCcEEEccccccccc
Q 002238 135 FTGLSSLQSIEIDNNPFSSWEIPQSLR-----NASGLQNFSANSANITGQI----PSFFGPDEFPGLTILHLAFNQLIGG 205 (948)
Q Consensus 135 ~~~l~~L~~L~Ls~N~l~~~~~p~~~~-----~l~~L~~L~l~~n~l~~~~----p~~~~~~~l~~L~~L~Ls~N~l~~~ 205 (948)
|..+++|++|+|++|+++. ..+..+. ..++|++|++++|++++.. +..+. .+++|++|+|++|++...
T Consensus 109 l~~~~~L~~L~Ls~n~i~~-~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~--~~~~L~~L~L~~n~i~~~ 185 (461)
T 1z7x_W 109 LRTLPTLQELHLSDNLLGD-AGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLR--AKPDFKELTVSNNDINEA 185 (461)
T ss_dssp TTSCTTCCEEECCSSBCHH-HHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHH--HCTTCCEEECCSSBCHHH
T ss_pred HccCCceeEEECCCCcCch-HHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHh--hCCCCCEEECcCCCcchH
Confidence 6677777777777776653 2122221 2446777777777766533 33333 456777777777776644
Q ss_pred CCCCccc------ccccceeccCCCCCCccCC----CccccccCCCccEEEccCCcccccC-----CC-CCCCCCCcEEe
Q 002238 206 LPASFSG------SQIQSLWVNGQNGNAKLGG----GIDVIQNMTSLKEIWLHSNAFSGPL-----PD-FSGVKQLESLS 269 (948)
Q Consensus 206 ~p~~~~~------~~l~~l~~~~~~~~~~~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~-----~~-~~~l~~L~~L~ 269 (948)
.+..+.. .+++.|++.++. .... .+..+..+++|++|+|++|.+++.. +. +..+++|+.|+
T Consensus 186 ~~~~l~~~l~~~~~~L~~L~L~~n~---l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~ 262 (461)
T 1z7x_W 186 GVRVLCQGLKDSPCQLEALKLESCG---VTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLW 262 (461)
T ss_dssp HHHHHHHHHHHSCCCCCEEECTTSC---CBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEE
T ss_pred HHHHHHHHHhcCCCCceEEEccCCC---CcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEE
Confidence 3333321 245555554432 2221 2345556677777777777766521 22 22466777777
Q ss_pred ccCCccccc----cchhhhCCCCCcEEEcccCcccccCCC-CC-----CccccccccccCCCCCCCCCCCchhhhhhHHH
Q 002238 270 LRDNFFTGP----VPDSLVKLESLKIVNMTNNLLQGPVPE-FD-----RSVSLDMAKGSNNFCLPSPGACDPRLNALLSV 339 (948)
Q Consensus 270 L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~-----~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~ 339 (948)
|++|.++.. ++..+.++++|++|+|++|.+++..+. +. ...+|..++..+|...... . ..
T Consensus 263 L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~------~---~~- 332 (461)
T 1z7x_W 263 IWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAAC------C---SH- 332 (461)
T ss_dssp CTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG------H---HH-
T ss_pred CcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHH------H---HH-
Confidence 777777743 566666677777777777776542211 00 0123333333333211100 0 00
Q ss_pred HHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccC-----ccccceEeCccccccc----cC
Q 002238 340 VKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFAS-----FKSLQRLILADNNLSG----MI 410 (948)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~-----l~~L~~L~Ls~N~l~g----~i 410 (948)
+...+..+++|+.|+|++|.+.+..+..+.. .++|++|+|++|++++ .+
T Consensus 333 ----------------------l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l 390 (461)
T 1z7x_W 333 ----------------------FSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSL 390 (461)
T ss_dssp ----------------------HHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHH
T ss_pred ----------------------HHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHH
Confidence 0011223456677777777766655554443 4567777777777765 56
Q ss_pred CcCCcCCCCCcEEEccCCcccC
Q 002238 411 PEGLSVLGALKELDVSNNQLYG 432 (948)
Q Consensus 411 p~~l~~l~~L~~L~ls~N~l~g 432 (948)
|..+..+++|++|||++|++++
T Consensus 391 ~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 391 AATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp HHHHHHCCCCCEEECCSSSCCH
T ss_pred HHHHHhCCCccEEECCCCCCCH
Confidence 6666667777777777777654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=9e-24 Score=226.13 Aligned_cols=221 Identities=21% Similarity=0.223 Sum_probs=161.3
Q ss_pred CCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEE
Q 002238 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTIL 195 (948)
Q Consensus 116 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L 195 (948)
++..+++.++.+..... +..+++|+.|++++|.++. + ..+..+++|++|++++|++++. ..+. .+++|++|
T Consensus 20 ~l~~l~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~--~-~~l~~l~~L~~L~l~~n~l~~~--~~l~--~l~~L~~L 90 (272)
T 3rfs_A 20 ETIKANLKKKSVTDAVT--QNELNSIDQIIANNSDIKS--V-QGIQYLPNVRYLALGGNKLHDI--SALK--ELTNLTYL 90 (272)
T ss_dssp HHHHHHHTCSCTTSEEC--HHHHTTCCEEECTTSCCCC--C-TTGGGCTTCCEEECTTSCCCCC--GGGT--TCTTCCEE
T ss_pred HHHHHHhcCcccccccc--cccccceeeeeeCCCCccc--c-cccccCCCCcEEECCCCCCCCc--hhhc--CCCCCCEE
Confidence 44455666666665532 5677888888888888773 2 3577788888888888888763 2454 77888888
Q ss_pred EcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCCC-CCCCCCCcEEeccCCc
Q 002238 196 HLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNF 274 (948)
Q Consensus 196 ~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~L~~N~ 274 (948)
+|++|++++..+..| .++++|++|+|++|++++.++. +.++++|++|+|++|+
T Consensus 91 ~L~~n~l~~~~~~~~--------------------------~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 144 (272)
T 3rfs_A 91 ILTGNQLQSLPNGVF--------------------------DKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQ 144 (272)
T ss_dssp ECTTSCCCCCCTTTT--------------------------TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ECCCCccCccChhHh--------------------------cCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCc
Confidence 888888876555443 3678888888888888876664 6778888888888888
Q ss_pred cccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccC
Q 002238 275 FTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 354 (948)
Q Consensus 275 l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 354 (948)
+++..+..+..+++|+.|+|++|++++.++..
T Consensus 145 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~------------------------------------------------ 176 (272)
T 3rfs_A 145 LQSLPKGVFDKLTNLTELDLSYNQLQSLPEGV------------------------------------------------ 176 (272)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT------------------------------------------------
T ss_pred cCccCHHHhccCccCCEEECCCCCcCccCHHH------------------------------------------------
Confidence 88666666778888888888888887655431
Q ss_pred CCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCC
Q 002238 355 GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKI 434 (948)
Q Consensus 355 ~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~i 434 (948)
+..+++|+.|+|++|++++..|..|+++++|+.|+|++|.+.+..| +|+.|+++.|.++|.+
T Consensus 177 -----------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~-------~l~~l~~~~n~~~g~i 238 (272)
T 3rfs_A 177 -----------FDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP-------GIRYLSEWINKHSGVV 238 (272)
T ss_dssp -----------TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT-------TTHHHHHHHHHTGGGB
T ss_pred -----------hcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc-------HHHHHHHHHHhCCCcc
Confidence 1123467888888888888777778888888888888888775543 6788888888888888
Q ss_pred CCC
Q 002238 435 PSF 437 (948)
Q Consensus 435 p~~ 437 (948)
|..
T Consensus 239 p~~ 241 (272)
T 3rfs_A 239 RNS 241 (272)
T ss_dssp BCT
T ss_pred cCc
Confidence 764
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.89 E-value=5e-27 Score=272.26 Aligned_cols=350 Identities=15% Similarity=0.126 Sum_probs=228.0
Q ss_pred CCEEEEEeCCCCCcCCCCcc-ccCCCCCcEEEcccCCCCCC----CC-CcCCCCCCcEEEcccccccCCCCcc-ccCCC-
Q 002238 68 KRITRIQIGHQNLQGTLPSN-LQNLTKLERLELQWNSISGP----LP-SLNGLASLEVVMLSNNQFTSVPSDF-FTGLS- 139 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~----~p-~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~- 139 (948)
.+++.|+|++++++...... +..+++|++|+|++|.++.. ++ .+..+++|++|+|++|.++...+.. +..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 36899999999988544333 77889999999999999853 23 5778899999999999998754433 34455
Q ss_pred ---CCCEEEccCCCCCCC---CCCccccCCCCCCEEEccCccccccCCCCCC---CCCCCCCcEEEcccccccccCCCCc
Q 002238 140 ---SLQSIEIDNNPFSSW---EIPQSLRNASGLQNFSANSANITGQIPSFFG---PDEFPGLTILHLAFNQLIGGLPASF 210 (948)
Q Consensus 140 ---~L~~L~Ls~N~l~~~---~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~---~~~l~~L~~L~Ls~N~l~~~~p~~~ 210 (948)
+|++|+|++|+++.. .++..+..+++|++|++++|.+++..+..+. ....++|++|+|++|++++.....+
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 799999999999841 3578899999999999999999865444332 0135689999999999986543222
Q ss_pred ----cc-ccccceeccCCCCCCccCCCccccc-----cCCCccEEEccCCccccc----CC-CCCCCCCCcEEeccCCcc
Q 002238 211 ----SG-SQIQSLWVNGQNGNAKLGGGIDVIQ-----NMTSLKEIWLHSNAFSGP----LP-DFSGVKQLESLSLRDNFF 275 (948)
Q Consensus 211 ----~~-~~l~~l~~~~~~~~~~~~~~~~~l~-----~l~~L~~L~Ls~N~l~~~----~~-~~~~l~~L~~L~L~~N~l 275 (948)
.. .+++.|++.++ ......+..+. ..++|++|+|++|.+++. ++ .+..+++|+.|+|++|.+
T Consensus 163 ~~~l~~~~~L~~L~L~~n---~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l 239 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNN---DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239 (461)
T ss_dssp HHHHHHCTTCCEEECCSS---BCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBC
T ss_pred HHHHhhCCCCCEEECcCC---CcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcC
Confidence 21 34555555433 22222222222 245677777777776652 12 344566777777777776
Q ss_pred cccc-----chhhhCCCCCcEEEcccCccccc----CCC-CCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCC
Q 002238 276 TGPV-----PDSLVKLESLKIVNMTNNLLQGP----VPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGY 345 (948)
Q Consensus 276 ~~~~-----p~~l~~l~~L~~L~Ls~N~l~g~----~p~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 345 (948)
++.. +..+..+++|+.|+|++|.+++. ++. +..+.+|..++..+|..... ....+...
T Consensus 240 ~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~---------~~~~l~~~--- 307 (461)
T 1z7x_W 240 GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE---------GARLLCET--- 307 (461)
T ss_dssp HHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHH---------HHHHHHHH---
T ss_pred ChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchH---------HHHHHHHH---
Confidence 6432 22222466777777777776652 222 33344444444444421100 00000000
Q ss_pred cchhccccCCCCCCCCccceeecCCceEEEEccCCccccc----CCccccCccccceEeCccccccccCCcCCcC-----
Q 002238 346 PQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT----ISPEFASFKSLQRLILADNNLSGMIPEGLSV----- 416 (948)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~----- 416 (948)
.....++|+.|+|++|.+++. ++..+..+++|++|+|++|++++..+..+..
T Consensus 308 -------------------l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~ 368 (461)
T 1z7x_W 308 -------------------LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQP 368 (461)
T ss_dssp -------------------HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTST
T ss_pred -------------------hccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCC
Confidence 001124788999999998875 5677777889999999999888665555543
Q ss_pred CCCCcEEEccCCcccC----CCCC----CCcccccccCCCCCC
Q 002238 417 LGALKELDVSNNQLYG----KIPS----FKSNAIVNTDGNPDI 451 (948)
Q Consensus 417 l~~L~~L~ls~N~l~g----~ip~----~~~~~~~~~~gnp~~ 451 (948)
.++|++|+|++|++++ .+|. ......+.+++|+..
T Consensus 369 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 369 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp TCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred CCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 6789999999998885 4442 455667788888643
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-22 Score=218.44 Aligned_cols=201 Identities=18% Similarity=0.215 Sum_probs=174.8
Q ss_pred EeCCCCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCC
Q 002238 64 CIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQ 142 (948)
Q Consensus 64 c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 142 (948)
|..-.+++++++++++++ .+|..+. ++|+.|+|++|.|++..+ .|.++++|++|+|++|.|+++++. +.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 445567899999999998 6776665 689999999999998776 689999999999999999987764 7899999
Q ss_pred EEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccC
Q 002238 143 SIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNG 222 (948)
Q Consensus 143 ~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~ 222 (948)
+|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|. .+++|++|+|++|++++..+..|
T Consensus 81 ~L~Ls~N~l~--~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~------------ 144 (290)
T 1p9a_G 81 TLDLSHNQLQ--SLPLLGQTLPALTVLDVSFNRLTSLPLGALR--GLGELQELYLKGNELKTLPPGLL------------ 144 (290)
T ss_dssp EEECCSSCCS--SCCCCTTTCTTCCEEECCSSCCCCCCSSTTT--TCTTCCEEECTTSCCCCCCTTTT------------
T ss_pred EEECCCCcCC--cCchhhccCCCCCEEECCCCcCcccCHHHHc--CCCCCCEEECCCCCCCccChhhc------------
Confidence 9999999998 6888899999999999999999988888887 89999999999999986555443
Q ss_pred CCCCCccCCCccccccCCCccEEEccCCcccccCCC-CCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCccc
Q 002238 223 QNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ 300 (948)
Q Consensus 223 ~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 300 (948)
..+++|+.|+|++|+++..++. |.++++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus 145 --------------~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 145 --------------TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp --------------TTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred --------------ccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 4789999999999999977664 677999999999999999 78888889999999999999885
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-22 Score=218.84 Aligned_cols=203 Identities=17% Similarity=0.146 Sum_probs=109.2
Q ss_pred ccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCccccc
Q 002238 135 FTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQ 214 (948)
Q Consensus 135 ~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 214 (948)
++++++|+++++++|+++ .+|..+. ++|+.|+|++|++++..+..|. .+++|++|+|++|++++..+.
T Consensus 6 ~~~l~~l~~l~~~~~~l~--~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~n~l~~~~~~------ 73 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT--ALPPDLP--KDTTILHLSENLLYTFSLATLM--PYTRLTQLNLDRAELTKLQVD------ 73 (290)
T ss_dssp EECSTTCCEEECTTSCCS--SCCSCCC--TTCCEEECTTSCCSEEEGGGGT--TCTTCCEEECTTSCCCEEECC------
T ss_pred ccccCCccEEECCCCCCC--cCCCCCC--CCCCEEEcCCCcCCccCHHHhh--cCCCCCEEECCCCccCcccCC------
Confidence 334444444444444444 2333332 3444444444444444444444 455555555555555432221
Q ss_pred ccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEc
Q 002238 215 IQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 294 (948)
Q Consensus 215 l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 294 (948)
..+++|++|+|++|+++..+..+.++++|+.|+|++|+|++..|..|.++++|++|+|
T Consensus 74 ----------------------~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L 131 (290)
T 1p9a_G 74 ----------------------GTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131 (290)
T ss_dssp ----------------------SCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEEC
T ss_pred ----------------------CCCCcCCEEECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEEC
Confidence 1345555555555555543334555566666666666666544555666666666666
Q ss_pred ccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEE
Q 002238 295 TNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITV 374 (948)
Q Consensus 295 s~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ 374 (948)
++|++++.++. .+..+++|+.
T Consensus 132 ~~N~l~~~~~~-----------------------------------------------------------~~~~l~~L~~ 152 (290)
T 1p9a_G 132 KGNELKTLPPG-----------------------------------------------------------LLTPTPKLEK 152 (290)
T ss_dssp TTSCCCCCCTT-----------------------------------------------------------TTTTCTTCCE
T ss_pred CCCCCCccChh-----------------------------------------------------------hcccccCCCE
Confidence 66666543332 0112234555
Q ss_pred EEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCccc
Q 002238 375 INFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY 431 (948)
Q Consensus 375 L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~ 431 (948)
|+|++|++++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|++.
T Consensus 153 L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 153 LSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp EECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred EECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 555555555444445667777888888888777 67777777777777777666553
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-23 Score=230.21 Aligned_cols=201 Identities=15% Similarity=0.168 Sum_probs=120.3
Q ss_pred CCCEEEccCCCCCCCCCCccc--cCCCCCCEEEccCccccccCC----CCCCCCCCCCCcEEEcccccccccCCCCcccc
Q 002238 140 SLQSIEIDNNPFSSWEIPQSL--RNASGLQNFSANSANITGQIP----SFFGPDEFPGLTILHLAFNQLIGGLPASFSGS 213 (948)
Q Consensus 140 ~L~~L~Ls~N~l~~~~~p~~~--~~l~~L~~L~l~~n~l~~~~p----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 213 (948)
+|++|+|++|++++ .+|..+ ..+++|++|+|++|.+++..+ ..+. .+++|++|+|++|++.+..|..|
T Consensus 92 ~L~~L~l~~n~l~~-~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~--~~~~L~~L~Ls~n~l~~~~~~~~--- 165 (310)
T 4glp_A 92 RLKELTLEDLKITG-TMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQW--LKPGLKVLSIAQAHSPAFSCEQV--- 165 (310)
T ss_dssp CCCEEEEESCCCBS-CCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTT--BCSCCCEEEEECCSSCCCCTTSC---
T ss_pred ceeEEEeeCCEecc-chhhhhhhccCCCCCEEEeecccccchhhhhHHHHhh--hccCCCEEEeeCCCcchhhHHHh---
Confidence 34444444444443 333333 444444444444444444332 1111 35556666666666554444443
Q ss_pred cccceeccCCCCCCccCCCccccccCCCccEEEccCCcccc---cCCC--CCCCCCCcEEeccCCccccccch----hhh
Q 002238 214 QIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG---PLPD--FSGVKQLESLSLRDNFFTGPVPD----SLV 284 (948)
Q Consensus 214 ~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~---~~~~--~~~l~~L~~L~L~~N~l~~~~p~----~l~ 284 (948)
.++++|++|+|++|++.+ ..+. +..+++|++|+|++|+++ .+|. .+.
T Consensus 166 -----------------------~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~ 221 (310)
T 4glp_A 166 -----------------------RAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAA 221 (310)
T ss_dssp -----------------------CCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHH
T ss_pred -----------------------ccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHh
Confidence 245666666666666544 1111 245677777777777776 3333 246
Q ss_pred CCCCCcEEEcccCcccccCCC-CCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCcc
Q 002238 285 KLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWI 363 (948)
Q Consensus 285 ~l~~L~~L~Ls~N~l~g~~p~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (948)
.+++|++|+|++|++++..|. +..+
T Consensus 222 ~l~~L~~L~Ls~N~l~~~~p~~~~~~------------------------------------------------------ 247 (310)
T 4glp_A 222 AGVQPHSLDLSHNSLRATVNPSAPRC------------------------------------------------------ 247 (310)
T ss_dssp HTCCCSSEECTTSCCCCCCCSCCSSC------------------------------------------------------
T ss_pred cCCCCCEEECCCCCCCccchhhHHhc------------------------------------------------------
Confidence 778888888888888776553 1111
Q ss_pred ceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccC
Q 002238 364 GVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYG 432 (948)
Q Consensus 364 ~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g 432 (948)
..+++|+.|+|++|+++ .+|..+. ++|+.|+|++|+|++. |. +..+++|+.|+|++|+|+.
T Consensus 248 ---~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 248 ---MWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp ---CCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred ---cCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 01246778888888888 6677664 7899999999999853 43 6788899999999998864
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-22 Score=212.21 Aligned_cols=190 Identities=20% Similarity=0.301 Sum_probs=124.7
Q ss_pred CCCCccceEEeCCCCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCc
Q 002238 55 DPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSD 133 (948)
Q Consensus 55 ~~C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~ 133 (948)
+||.|.|+.|.. ..+.+++++++++ .+|..+. ++|+.|+|++|+|++..+ .|.++++|++|+|++|.|+++++.
T Consensus 3 ~Cp~~~gC~C~~--~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 77 (251)
T 3m19_A 3 TCETVTGCTCNE--GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAG 77 (251)
T ss_dssp -CHHHHSSEEEG--GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTT
T ss_pred cCCCCCceEcCC--CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHh
Confidence 578999999964 3446888888888 6776665 578888888888888776 577888888888888888888887
Q ss_pred cccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccc
Q 002238 134 FFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGS 213 (948)
Q Consensus 134 ~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 213 (948)
.|..+++|++|+|++|+++. ..+..+..+++|++|+|++|+|++..+..|. .+++|++|+|++|++
T Consensus 78 ~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l----------- 143 (251)
T 3m19_A 78 VFDDLTELGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFD--RLTKLKELRLNTNQL----------- 143 (251)
T ss_dssp TTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTT--TCTTCCEEECCSSCC-----------
T ss_pred HhccCCcCCEEECCCCcccc-cChhHhcccCCCCEEEcCCCcCCCcChhHhc--cCCcccEEECcCCcC-----------
Confidence 78888888888888887774 2234455555555555555555544444443 445555555555554
Q ss_pred cccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCC-CCCCCCCCcEEeccCCccccccchhhhCCCCCcEE
Q 002238 214 QIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 292 (948)
Q Consensus 214 ~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 292 (948)
++.++ .+..+++|+.|+|++|+|++..+..+..+++|+.|
T Consensus 144 ---------------------------------------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 184 (251)
T 3m19_A 144 ---------------------------------------QSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTI 184 (251)
T ss_dssp ---------------------------------------CCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred ---------------------------------------CccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEE
Confidence 44433 24445555555555555554445555556666666
Q ss_pred EcccCccccc
Q 002238 293 NMTNNLLQGP 302 (948)
Q Consensus 293 ~Ls~N~l~g~ 302 (948)
+|++|++++.
T Consensus 185 ~l~~N~~~c~ 194 (251)
T 3m19_A 185 TLFGNQFDCS 194 (251)
T ss_dssp ECCSCCBCTT
T ss_pred EeeCCceeCC
Confidence 6666666544
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.6e-22 Score=212.61 Aligned_cols=137 Identities=20% Similarity=0.261 Sum_probs=87.3
Q ss_pred cCCCccEEEccCCcccccCCC-CCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCcccccccc
Q 002238 238 NMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAK 316 (948)
Q Consensus 238 ~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~ 316 (948)
++++|++|+|++|++++.++. +.++++|+.|+|++|++++..|..|..+++|++|+|++|++++..+.
T Consensus 83 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~----------- 151 (270)
T 2o6q_A 83 ELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKG----------- 151 (270)
T ss_dssp SCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT-----------
T ss_pred CCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHh-----------
Confidence 455555555555555554442 45556666666666666655555566666666666666666543332
Q ss_pred ccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCcccc
Q 002238 317 GSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSL 396 (948)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L 396 (948)
.+..+++|+.|+|++|.+++..+..|.++++|
T Consensus 152 ------------------------------------------------~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 183 (270)
T 2o6q_A 152 ------------------------------------------------VFDKLTSLKELRLYNNQLKRVPEGAFDKLTEL 183 (270)
T ss_dssp ------------------------------------------------TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTC
T ss_pred ------------------------------------------------HccCCcccceeEecCCcCcEeChhHhccCCCc
Confidence 01122356666666666666555667788888
Q ss_pred ceEeCccccccccCCcCCcCCCCCcEEEccCCcccCC
Q 002238 397 QRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGK 433 (948)
Q Consensus 397 ~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ 433 (948)
++|+|++|+|++..+..+..+++|+.|+|++|++...
T Consensus 184 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 184 KTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp CEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred CEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 8888888888866666788888888888888877543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.9e-24 Score=240.15 Aligned_cols=63 Identities=16% Similarity=0.170 Sum_probs=37.5
Q ss_pred ceEEEEccCCcccccCC----ccccCccccceEeCcccccccc-------CCcCCcCCCCCcEEEccCCcccCC
Q 002238 371 NITVINFQKMNLTGTIS----PEFASFKSLQRLILADNNLSGM-------IPEGLSVLGALKELDVSNNQLYGK 433 (948)
Q Consensus 371 ~L~~L~ls~n~l~g~ip----~~~~~l~~L~~L~Ls~N~l~g~-------ip~~l~~l~~L~~L~ls~N~l~g~ 433 (948)
+|+.|+|++|.+.+..+ ..+..++.|+.|+|++|++.+. ++..+..+++|++||+++|++...
T Consensus 226 ~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 226 HVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp TCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred CceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 56666666666655433 2344556677777777764322 334566666777777777776654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.7e-22 Score=208.50 Aligned_cols=189 Identities=17% Similarity=0.207 Sum_probs=134.2
Q ss_pred CCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEccccc-ccCCCCccccCCCCCCEEEccC-CCCCCCCCCcc
Q 002238 83 TLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQ-FTSVPSDFFTGLSSLQSIEIDN-NPFSSWEIPQS 159 (948)
Q Consensus 83 ~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~p~~ 159 (948)
.+|. +. .+|++|+|++|+|+++++ .|.++++|++|+|++|. ++.+++..|.++++|++|+|++ |+++. ..+..
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~-i~~~~ 100 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTY-IDPDA 100 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCE-ECTTS
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeE-cCHHH
Confidence 4555 33 377888888888887666 67778888888888886 7777777788888888888887 77774 22356
Q ss_pred ccCCCCCCEEEccCccccccCCCCCCCCCCCCCc---EEEcccc-cccccCCCCcccccccceeccCCCCCCccCCCccc
Q 002238 160 LRNASGLQNFSANSANITGQIPSFFGPDEFPGLT---ILHLAFN-QLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDV 235 (948)
Q Consensus 160 ~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~ 235 (948)
|.++++|++|++++|++++ +|. |. .+++|+ +|+|++| ++++..+..|
T Consensus 101 f~~l~~L~~L~l~~n~l~~-lp~-~~--~l~~L~~L~~L~l~~N~~l~~i~~~~~------------------------- 151 (239)
T 2xwt_C 101 LKELPLLKFLGIFNTGLKM-FPD-LT--KVYSTDIFFILEITDNPYMTSIPVNAF------------------------- 151 (239)
T ss_dssp EECCTTCCEEEEEEECCCS-CCC-CT--TCCBCCSEEEEEEESCTTCCEECTTTT-------------------------
T ss_pred hCCCCCCCEEeCCCCCCcc-ccc-cc--cccccccccEEECCCCcchhhcCcccc-------------------------
Confidence 7778888888888888876 454 44 666776 8888888 7775544443
Q ss_pred cccCCCcc-EEEccCCcccccCCCCCCCCCCcEEeccCCc-cccccchhhhCC-CCCcEEEcccCcccccCCC
Q 002238 236 IQNMTSLK-EIWLHSNAFSGPLPDFSGVKQLESLSLRDNF-FTGPVPDSLVKL-ESLKIVNMTNNLLQGPVPE 305 (948)
Q Consensus 236 l~~l~~L~-~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l-~~L~~L~Ls~N~l~g~~p~ 305 (948)
.++++|+ +|+|++|+++..++.....++|+.|+|++|+ +++..+..|..+ ++|+.|+|++|++++.++.
T Consensus 152 -~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~ 223 (239)
T 2xwt_C 152 -QGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK 223 (239)
T ss_dssp -TTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT
T ss_pred -cchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh
Confidence 3677788 8888888877544433333678888888884 775556667777 7888888888888755443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=6.3e-22 Score=215.68 Aligned_cols=189 Identities=24% Similarity=0.364 Sum_probs=94.7
Q ss_pred CEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccC
Q 002238 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148 (948)
Q Consensus 69 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 148 (948)
+++.|++++|+++. ++ .+..+++|++|+|++|.+++..+ +.++++|++|+|++|.+++++ .+..+++|+.|+|++
T Consensus 42 ~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~l~~ 116 (308)
T 1h6u_A 42 GITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNVS--AIAGLQSIKTLDLTS 116 (308)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCCG--GGTTCTTCCEEECTT
T ss_pred CcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCCch--hhcCCCCCCEEECCC
Confidence 45555555555542 33 35555555555555555555444 555555555555555555542 355555555555555
Q ss_pred CCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCc
Q 002238 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAK 228 (948)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~ 228 (948)
|+++. ++. +..+++|++|++++|++++..+ +. .+++|++|+|++|++++..+
T Consensus 117 n~l~~--~~~-l~~l~~L~~L~l~~n~l~~~~~--l~--~l~~L~~L~l~~n~l~~~~~--------------------- 168 (308)
T 1h6u_A 117 TQITD--VTP-LAGLSNLQVLYLDLNQITNISP--LA--GLTNLQYLSIGNAQVSDLTP--------------------- 168 (308)
T ss_dssp SCCCC--CGG-GTTCTTCCEEECCSSCCCCCGG--GG--GCTTCCEEECCSSCCCCCGG---------------------
T ss_pred CCCCC--chh-hcCCCCCCEEECCCCccCcCcc--cc--CCCCccEEEccCCcCCCChh---------------------
Confidence 55553 222 4555555555555555554333 32 45555555555555542211
Q ss_pred cCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCccc
Q 002238 229 LGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ 300 (948)
Q Consensus 229 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 300 (948)
+.++++|+.|+|++|++++..+ +..+++|+.|+|++|++++..| +..+++|+.|+|++|+++
T Consensus 169 -------l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 169 -------LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp -------GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEE
T ss_pred -------hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeee
Confidence 1244555555555555554332 4445555555555555553322 455555555555555554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.6e-22 Score=216.77 Aligned_cols=155 Identities=15% Similarity=0.091 Sum_probs=122.0
Q ss_pred HHHHHHhhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCCh----------------hhHHHHHHHHHHHHhc
Q 002238 585 IQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISG----------------KGLTEFKSEIAVLTKV 648 (948)
Q Consensus 585 ~~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~----------------~~~~~~~~E~~~l~~l 648 (948)
+..+......|++.+.||+|+||.||+|...+|+.||||+++...... .....+.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 334444556788889999999999999998779999999986432111 1356789999999999
Q ss_pred CCCceeeEEeEEEeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCc
Q 002238 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 728 (948)
Q Consensus 649 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~ 728 (948)
+| +++.+++. .+..++||||+++|+|.+ +.. .....++.|++.||+|||+ .+|+||||||+
T Consensus 162 ~~---~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~ 222 (282)
T 1zar_A 162 QG---LAVPKVYA-WEGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQY 222 (282)
T ss_dssp TT---SSSCCEEE-EETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTT
T ss_pred cC---CCcCeEEe-ccceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHH
Confidence 94 55555443 356699999999999987 411 1244699999999999997 89999999999
Q ss_pred cEEEcCCCCeEEeecCCceecCCCCCceeeeecccccccCceecc
Q 002238 729 NILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV 773 (948)
Q Consensus 729 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 773 (948)
|||++ ++.+||+|||+|+. +..|+|||++.
T Consensus 223 NILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 223 NVLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp SEEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred HEEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 99999 99999999999863 34578899874
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=3.3e-24 Score=237.45 Aligned_cols=142 Identities=15% Similarity=0.219 Sum_probs=100.5
Q ss_pred CCCCccceEEeCCCCEEEEEeCCCCCcCCCCccccCC--CCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCC-C
Q 002238 55 DPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNL--TKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSV-P 131 (948)
Q Consensus 55 ~~C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l--~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~-~ 131 (948)
-|..|.++.|+ ...++.++++++++. +..+..+ ++++.|++++|.+.+.++.+.++++|++|+|++|.+++. .
T Consensus 35 vc~~W~~~~~~-~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~ 110 (336)
T 2ast_B 35 VCKRWYRLASD-ESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 110 (336)
T ss_dssp SCHHHHHHHTC-STTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHH
T ss_pred HHHHHHHHhcC-chhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHH
Confidence 34469888875 446778888888776 4456666 788888888888888777777788888888888887764 6
Q ss_pred CccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCc-ccccc-CCCCCCCCCCCCCcEEEcccc-ccc
Q 002238 132 SDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA-NITGQ-IPSFFGPDEFPGLTILHLAFN-QLI 203 (948)
Q Consensus 132 ~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n-~l~~~-~p~~~~~~~l~~L~~L~Ls~N-~l~ 203 (948)
+..+..+++|++|+|++|++++ ..+..+..+++|++|++++| .+++. ++..+. .+++|++|+|++| .++
T Consensus 111 ~~~~~~~~~L~~L~L~~~~l~~-~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~--~~~~L~~L~l~~~~~l~ 182 (336)
T 2ast_B 111 HGILSQCSKLQNLSLEGLRLSD-PIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS--SCSRLDELNLSWCFDFT 182 (336)
T ss_dssp HHHHTTBCCCSEEECTTCBCCH-HHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHH--HCTTCCEEECCCCTTCC
T ss_pred HHHHhhCCCCCEEeCcCcccCH-HHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHh--cCCCCCEEcCCCCCCcC
Confidence 6667778888888888887765 45666666777777777776 45542 344343 5566666666666 554
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=9.7e-22 Score=206.08 Aligned_cols=196 Identities=18% Similarity=0.229 Sum_probs=172.1
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCC-CCCCCC-CcCCCCCCcEEEccc-ccccCCCCccccCCCCCCEE
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNS-ISGPLP-SLNGLASLEVVMLSN-NQFTSVPSDFFTGLSSLQSI 144 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p-~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L 144 (948)
..++.|++++|++++..+..|.++++|++|+|++|. ++.+.+ .|.++++|++|+|++ |+++++++..|.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 479999999999998777799999999999999997 888777 799999999999999 99999999999999999999
Q ss_pred EccCCCCCCCCCCccccCCCCCC---EEEccCc-cccccCCCCCCCCCCCCCc-EEEcccccccccCCCCccccccccee
Q 002238 145 EIDNNPFSSWEIPQSLRNASGLQ---NFSANSA-NITGQIPSFFGPDEFPGLT-ILHLAFNQLIGGLPASFSGSQIQSLW 219 (948)
Q Consensus 145 ~Ls~N~l~~~~~p~~~~~l~~L~---~L~l~~n-~l~~~~p~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~~~l~~l~ 219 (948)
+|++|+++ .+|. +..+++|+ +|++++| ++++..+..|. .+++|+ +|+|++|+++ .+|...
T Consensus 111 ~l~~n~l~--~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~--~l~~L~~~L~l~~n~l~-~i~~~~--------- 175 (239)
T 2xwt_C 111 GIFNTGLK--MFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQ--GLCNETLTLKLYNNGFT-SVQGYA--------- 175 (239)
T ss_dssp EEEEECCC--SCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTT--TTBSSEEEEECCSCCCC-EECTTT---------
T ss_pred eCCCCCCc--cccc-cccccccccccEEECCCCcchhhcCccccc--chhcceeEEEcCCCCCc-ccCHhh---------
Confidence 99999999 4676 88888888 9999999 99988888887 899999 9999999998 555432
Q ss_pred ccCCCCCCccCCCccccccCCCccEEEccCCc-ccccCC-CCCCC-CCCcEEeccCCccccccchhhhCCCCCcEEEccc
Q 002238 220 VNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA-FSGPLP-DFSGV-KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTN 296 (948)
Q Consensus 220 ~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~-l~~~~~-~~~~l-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 296 (948)
+.. ++|+.|+|++|+ +++..+ .|.++ ++|+.|+|++|+++ .+|.. .+++|+.|++++
T Consensus 176 ----------------~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~--~~~~L~~L~l~~ 235 (239)
T 2xwt_C 176 ----------------FNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHLKELIARN 235 (239)
T ss_dssp ----------------TTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT--TCTTCSEEECTT
T ss_pred ----------------cCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh--HhccCceeeccC
Confidence 223 799999999995 997766 47888 99999999999999 56654 688999999987
Q ss_pred Cc
Q 002238 297 NL 298 (948)
Q Consensus 297 N~ 298 (948)
+.
T Consensus 236 ~~ 237 (239)
T 2xwt_C 236 TW 237 (239)
T ss_dssp C-
T ss_pred cc
Confidence 63
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.2e-22 Score=219.90 Aligned_cols=202 Identities=14% Similarity=0.151 Sum_probs=95.3
Q ss_pred EEEEEeCCCCCcCCCCccc--cCCCCCcEEEcccCCCCCCCC-----CcCCCCCCcEEEcccccccCCCCccccCCCCCC
Q 002238 70 ITRIQIGHQNLQGTLPSNL--QNLTKLERLELQWNSISGPLP-----SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQ 142 (948)
Q Consensus 70 v~~l~l~~~~l~~~~p~~l--~~l~~L~~L~L~~N~l~~~~p-----~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 142 (948)
+++|++++|++++.+|..+ .++++|++|+|++|.+++..+ .+..+++|++|+|++|+++++++..|+.+++|+
T Consensus 93 L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 172 (310)
T 4glp_A 93 LKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALT 172 (310)
T ss_dssp CCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCC
T ss_pred eeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCC
Confidence 5555555555555555544 455555555555555554332 123355555555555555555555555555555
Q ss_pred EEEccCCCCCC---CCCCccccCCCCCCEEEccCccccccCCC---CCCCCCCCCCcEEEcccccccccCCCCccccccc
Q 002238 143 SIEIDNNPFSS---WEIPQSLRNASGLQNFSANSANITGQIPS---FFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQ 216 (948)
Q Consensus 143 ~L~Ls~N~l~~---~~~p~~~~~l~~L~~L~l~~n~l~~~~p~---~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~ 216 (948)
+|+|++|++.+ ...+..+..+++|++|+|++|+++...+. .+. .+++|++|+|++|++++.+|..+..
T Consensus 173 ~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~--~l~~L~~L~Ls~N~l~~~~p~~~~~---- 246 (310)
T 4glp_A 173 SLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAA--AGVQPHSLDLSHNSLRATVNPSAPR---- 246 (310)
T ss_dssp EEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHH--HTCCCSSEECTTSCCCCCCCSCCSS----
T ss_pred EEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHh--cCCCCCEEECCCCCCCccchhhHHh----
Confidence 55555555432 00112223455555555555555421110 112 3455555555555555444443320
Q ss_pred ceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEccc
Q 002238 217 SLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTN 296 (948)
Q Consensus 217 ~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 296 (948)
+..+++|++|+|++|+++..+..+. ++|+.|+|++|+|++. |. +..+++|+.|+|++
T Consensus 247 -------------------~~~~~~L~~L~Ls~N~l~~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~ 303 (310)
T 4glp_A 247 -------------------CMWSSALNSLNLSFAGLEQVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDG 303 (310)
T ss_dssp -------------------CCCCTTCCCEECCSSCCCSCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSS
T ss_pred -------------------ccCcCcCCEEECCCCCCCchhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcC
Confidence 1112455555555555553322232 4555555555555532 32 34555555555555
Q ss_pred Cccc
Q 002238 297 NLLQ 300 (948)
Q Consensus 297 N~l~ 300 (948)
|+++
T Consensus 304 N~l~ 307 (310)
T 4glp_A 304 NPFL 307 (310)
T ss_dssp TTTS
T ss_pred CCCC
Confidence 5554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=2e-24 Score=243.92 Aligned_cols=66 Identities=17% Similarity=0.182 Sum_probs=46.9
Q ss_pred CceEEEEccCCccccc----CCccc--cCccccceEeCccccccc----cCCcCC-cCCCCCcEEEccCCcccCCCC
Q 002238 370 GNITVINFQKMNLTGT----ISPEF--ASFKSLQRLILADNNLSG----MIPEGL-SVLGALKELDVSNNQLYGKIP 435 (948)
Q Consensus 370 ~~L~~L~ls~n~l~g~----ip~~~--~~l~~L~~L~Ls~N~l~g----~ip~~l-~~l~~L~~L~ls~N~l~g~ip 435 (948)
++|+.|+|++|.+++. +|..+ +.+++|+.|+|++|++++ .+|..+ .++++|++|+|++|++++..|
T Consensus 244 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred CCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 3555555665555544 45555 347888888888888887 477777 667888888888888887653
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-23 Score=235.04 Aligned_cols=265 Identities=12% Similarity=0.133 Sum_probs=200.0
Q ss_pred EEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-----CcCCCC-CCcEEEcccccccCCCCccccCC-----CC
Q 002238 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-----SLNGLA-SLEVVMLSNNQFTSVPSDFFTGL-----SS 140 (948)
Q Consensus 72 ~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-----~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l-----~~ 140 (948)
..++++|+++|.+|..+...++|++|+|++|.|++..+ .|.+++ +|++|+|++|.+++..+..|..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 36789999999998888888889999999999988664 477788 89999999999999888877775 99
Q ss_pred CCEEEccCCCCCCCCCCcc----ccCC-CCCCEEEccCccccccCCCCCC--CCC-CCCCcEEEcccccccccCCCCccc
Q 002238 141 LQSIEIDNNPFSSWEIPQS----LRNA-SGLQNFSANSANITGQIPSFFG--PDE-FPGLTILHLAFNQLIGGLPASFSG 212 (948)
Q Consensus 141 L~~L~Ls~N~l~~~~~p~~----~~~l-~~L~~L~l~~n~l~~~~p~~~~--~~~-l~~L~~L~Ls~N~l~~~~p~~~~~ 212 (948)
|++|+|++|+++. ..+.. +..+ ++|++|+|++|++++..+..+. ... .++|++|+|++|+++...+..+.
T Consensus 82 L~~L~Ls~n~l~~-~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~- 159 (362)
T 3goz_A 82 VTSLNLSGNFLSY-KSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELI- 159 (362)
T ss_dssp CCEEECCSSCGGG-SCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHH-
T ss_pred ccEEECcCCcCCh-HHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHH-
Confidence 9999999999985 44443 4444 8999999999999877665442 013 35899999999999864443332
Q ss_pred ccccceeccCCCCCCccCCCccccccCC-CccEEEccCCcccccCC-----CCCCC-CCCcEEeccCCccccc----cch
Q 002238 213 SQIQSLWVNGQNGNAKLGGGIDVIQNMT-SLKEIWLHSNAFSGPLP-----DFSGV-KQLESLSLRDNFFTGP----VPD 281 (948)
Q Consensus 213 ~~l~~l~~~~~~~~~~~~~~~~~l~~l~-~L~~L~Ls~N~l~~~~~-----~~~~l-~~L~~L~L~~N~l~~~----~p~ 281 (948)
..+..++ +|++|+|++|++++..+ .+... ++|+.|+|++|.|++. ++.
T Consensus 160 ---------------------~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~ 218 (362)
T 3goz_A 160 ---------------------QILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAY 218 (362)
T ss_dssp ---------------------HHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred ---------------------HHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHH
Confidence 2234455 89999999999987654 23444 5999999999999853 566
Q ss_pred hhhCC-CCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCC
Q 002238 282 SLVKL-ESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCS 360 (948)
Q Consensus 282 ~l~~l-~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 360 (948)
.+..+ ++|++|+|++|++++..+. .+.
T Consensus 219 ~l~~~~~~L~~L~Ls~N~l~~~~~~--------------------------------~l~-------------------- 246 (362)
T 3goz_A 219 IFSSIPNHVVSLNLCLNCLHGPSLE--------------------------------NLK-------------------- 246 (362)
T ss_dssp HHHHSCTTCCEEECCSSCCCCCCHH--------------------------------HHH--------------------
T ss_pred HHhcCCCCceEEECcCCCCCcHHHH--------------------------------HHH--------------------
Confidence 67664 5999999999998753321 000
Q ss_pred CccceeecCCceEEEEccCCcccc-------cCCccccCccccceEeCccccccccCCcCC
Q 002238 361 DWIGVTCTKGNITVINFQKMNLTG-------TISPEFASFKSLQRLILADNNLSGMIPEGL 414 (948)
Q Consensus 361 ~~~~~~~~~~~L~~L~ls~n~l~g-------~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l 414 (948)
..+..+++|+.|+|++|.+.+ .++..+.++++|+.|||++|++.+..|..+
T Consensus 247 ---~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~~ 304 (362)
T 3goz_A 247 ---LLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPI 304 (362)
T ss_dssp ---HTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCHHH
T ss_pred ---HHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchHHH
Confidence 011234578999999998543 344567788999999999999987755444
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.86 E-value=7.6e-21 Score=200.78 Aligned_cols=176 Identities=23% Similarity=0.289 Sum_probs=123.1
Q ss_pred CCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEcc
Q 002238 93 KLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSAN 172 (948)
Q Consensus 93 ~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~ 172 (948)
..++++++++.++.+++.+. ++|+.|+|++|.++++++..|.++++|++|+|++|+++
T Consensus 15 ~~~~l~~~~~~l~~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-------------------- 72 (251)
T 3m19_A 15 GKKEVDCQGKSLDSVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-------------------- 72 (251)
T ss_dssp GGTEEECTTCCCSSCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC--------------------
T ss_pred CCeEEecCCCCccccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCC--------------------
Confidence 34566666666665444433 45666666666666665555555555555555555555
Q ss_pred CccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcc
Q 002238 173 SANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAF 252 (948)
Q Consensus 173 ~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l 252 (948)
+..+..|. .+++|++|+|++|++++..+..| .++++|++|+|++|++
T Consensus 73 -----~~~~~~~~--~l~~L~~L~L~~n~l~~~~~~~~--------------------------~~l~~L~~L~L~~N~l 119 (251)
T 3m19_A 73 -----TLSAGVFD--DLTELGTLGLANNQLASLPLGVF--------------------------DHLTQLDKLYLGGNQL 119 (251)
T ss_dssp -----CCCTTTTT--TCTTCCEEECTTSCCCCCCTTTT--------------------------TTCTTCCEEECCSSCC
T ss_pred -----ccCHhHhc--cCCcCCEEECCCCcccccChhHh--------------------------cccCCCCEEEcCCCcC
Confidence 44444454 56666666666666664444333 3567777777777777
Q ss_pred cccCCC-CCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCC-CCCccccccccccCCCCC
Q 002238 253 SGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCL 323 (948)
Q Consensus 253 ~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~l~~~~~~~~~~~ 323 (948)
++.++. |.++++|+.|+|++|+|++..+..|..+++|++|+|++|++++.++. +..+.+|..+++.+|...
T Consensus 120 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 192 (251)
T 3m19_A 120 KSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFD 192 (251)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred CCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCcee
Confidence 766664 67789999999999999977777899999999999999999988774 677888888888888643
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=3.3e-21 Score=209.94 Aligned_cols=197 Identities=21% Similarity=0.344 Sum_probs=170.3
Q ss_pred ccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCC
Q 002238 88 LQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ 167 (948)
Q Consensus 88 l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 167 (948)
+.++++|++|++++|.++.. +.+..+++|++|+|++|.++++++ +..+++|++|+|++|+++. ++ .+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~l-~~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~--~~-~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTTI-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN--VS-AIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC--CG-GGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCccCc-hhhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC--ch-hhcCCCCCC
Confidence 45688999999999999874 578999999999999999999887 9999999999999999985 44 799999999
Q ss_pred EEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEc
Q 002238 168 NFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWL 247 (948)
Q Consensus 168 ~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~L 247 (948)
+|++++|++++..+ +. .+++|++|+|++|++++..+ +.++++|+.|+|
T Consensus 111 ~L~l~~n~l~~~~~--l~--~l~~L~~L~l~~n~l~~~~~----------------------------l~~l~~L~~L~l 158 (308)
T 1h6u_A 111 TLDLTSTQITDVTP--LA--GLSNLQVLYLDLNQITNISP----------------------------LAGLTNLQYLSI 158 (308)
T ss_dssp EEECTTSCCCCCGG--GT--TCTTCCEEECCSSCCCCCGG----------------------------GGGCTTCCEEEC
T ss_pred EEECCCCCCCCchh--hc--CCCCCCEEECCCCccCcCcc----------------------------ccCCCCccEEEc
Confidence 99999999997543 55 89999999999999985433 347899999999
Q ss_pred cCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCC
Q 002238 248 HSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSP 326 (948)
Q Consensus 248 s~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~ 326 (948)
++|++++..+ +..+++|+.|+|++|++++..+ +..+++|++|+|++|++++..| +..+.+|..++..+|.+...+
T Consensus 159 ~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 159 GNAQVSDLTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTNQTITNQP 233 (308)
T ss_dssp CSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEEEEEECCC
T ss_pred cCCcCCCChh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc-ccCCCCCCEEEccCCeeecCC
Confidence 9999997655 8889999999999999995444 8999999999999999998765 778888888888888765544
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=7.3e-21 Score=211.42 Aligned_cols=196 Identities=17% Similarity=0.209 Sum_probs=142.3
Q ss_pred EeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccC-CCCccccCCCCCCE-EEccCCC
Q 002238 74 QIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTS-VPSDFFTGLSSLQS-IEIDNNP 150 (948)
Q Consensus 74 ~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~-L~Ls~N~ 150 (948)
+.++++|+ .+|..+. ++|++|+|++|+|+.+++ +|.++++|++|+|++|++.+ +++++|.++++|+. +.++.|+
T Consensus 15 ~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~ 91 (350)
T 4ay9_X 15 LCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91 (350)
T ss_dssp EEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETT
T ss_pred EecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCc
Confidence 33456677 6776663 678999999999998776 68899999999999999865 56678888888775 5667788
Q ss_pred CCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEccc-ccccccCCCCcccccccceeccCCCCCCcc
Q 002238 151 FSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAF-NQLIGGLPASFSGSQIQSLWVNGQNGNAKL 229 (948)
Q Consensus 151 l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~ 229 (948)
++. ..|..|..+++|++|++++|+|+...+..+. ...++..|++.+ |++....+..|.
T Consensus 92 l~~-l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~--~~~~l~~l~l~~~~~i~~l~~~~f~------------------ 150 (350)
T 4ay9_X 92 LLY-INPEAFQNLPNLQYLLISNTGIKHLPDVHKI--HSLQKVLLDIQDNINIHTIERNSFV------------------ 150 (350)
T ss_dssp CCE-ECTTSBCCCTTCCEEEEEEECCSSCCCCTTC--CBSSCEEEEEESCTTCCEECTTSST------------------
T ss_pred ccc-cCchhhhhccccccccccccccccCCchhhc--ccchhhhhhhccccccccccccchh------------------
Confidence 884 3366788888888888888888877666654 566777888765 455544333332
Q ss_pred CCCccccccC-CCccEEEccCCcccccCCCCCCCCCCcEEeccC-Cccccccc-hhhhCCCCCcEEEcccCccccc
Q 002238 230 GGGIDVIQNM-TSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRD-NFFTGPVP-DSLVKLESLKIVNMTNNLLQGP 302 (948)
Q Consensus 230 ~~~~~~l~~l-~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~-N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~g~ 302 (948)
.+ ..++.|+|++|+|+...+......+|+.|++.+ |.++ .+| ..|..+++|++|+|++|+|+..
T Consensus 151 --------~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~~l 217 (350)
T 4ay9_X 151 --------GLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSL 217 (350)
T ss_dssp --------TSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCCCC
T ss_pred --------hcchhhhhhccccccccCCChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCcCcc
Confidence 33 357788888888887666655566788888875 5555 454 4567788888888888887743
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.2e-21 Score=226.74 Aligned_cols=197 Identities=24% Similarity=0.398 Sum_probs=167.3
Q ss_pred CCCCC-----Cccce-EEeCCCCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEccccc
Q 002238 53 DTDPC-----KWNHV-VCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQ 126 (948)
Q Consensus 53 ~~~~C-----~w~gv-~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~ 126 (948)
+.+|| .|.|+ .|. .++++.|+|++|+|++ +|..+. ++|++|+|++|+|+. +| ..+++|++|+|++|+
T Consensus 39 ~~~~~~~~~~~~~~l~~C~-~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~-ip--~~l~~L~~L~Ls~N~ 111 (571)
T 3cvr_A 39 QALPGENRNEAVSLLKECL-INQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALIS-LP--ELPASLEYLDACDNR 111 (571)
T ss_dssp TCCTTCCHHHHHHHHHHHH-HTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSC-CC--CCCTTCCEEECCSSC
T ss_pred cCCccccccchhhhccccc-cCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcc-cc--cccCCCCEEEccCCC
Confidence 45778 69999 785 3589999999999997 887664 889999999999995 44 558999999999999
Q ss_pred ccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccC
Q 002238 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGL 206 (948)
Q Consensus 127 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~ 206 (948)
|++++. |.. +|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|++|+|++|+|++ +
T Consensus 112 l~~ip~--l~~--~L~~L~Ls~N~l~~--lp~---~l~~L~~L~Ls~N~l~~-lp~-----~l~~L~~L~Ls~N~L~~-l 175 (571)
T 3cvr_A 112 LSTLPE--LPA--SLKHLDVDNNQLTM--LPE---LPALLEYINADNNQLTM-LPE-----LPTSLEVLSVRNNQLTF-L 175 (571)
T ss_dssp CSCCCC--CCT--TCCEEECCSSCCSC--CCC---CCTTCCEEECCSSCCSC-CCC-----CCTTCCEEECCSSCCSC-C
T ss_pred CCCcch--hhc--CCCEEECCCCcCCC--CCC---cCccccEEeCCCCccCc-CCC-----cCCCcCEEECCCCCCCC-c
Confidence 999665 655 99999999999995 677 68999999999999997 554 36899999999999986 6
Q ss_pred CCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCC-------cEEeccCCcccccc
Q 002238 207 PASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL-------ESLSLRDNFFTGPV 279 (948)
Q Consensus 207 p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L-------~~L~L~~N~l~~~~ 279 (948)
|. | . ++|+.|+|++|+|+..++ +.. +| +.|+|++|+|+ .+
T Consensus 176 p~-l---------------------------~-~~L~~L~Ls~N~L~~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~l 222 (571)
T 3cvr_A 176 PE-L---------------------------P-ESLEALDVSTNLLESLPA-VPV--RNHHSEETEIFFRCRENRIT-HI 222 (571)
T ss_dssp CC-C---------------------------C-TTCCEEECCSSCCSSCCC-CC----------CCEEEECCSSCCC-CC
T ss_pred ch-h---------------------------h-CCCCEEECcCCCCCchhh-HHH--hhhcccccceEEecCCCcce-ec
Confidence 65 4 1 799999999999995444 554 77 99999999999 78
Q ss_pred chhhhCCCCCcEEEcccCcccccCCC
Q 002238 280 PDSLVKLESLKIVNMTNNLLQGPVPE 305 (948)
Q Consensus 280 p~~l~~l~~L~~L~Ls~N~l~g~~p~ 305 (948)
|..+..+++|+.|+|++|+|++.+|.
T Consensus 223 p~~l~~l~~L~~L~L~~N~l~~~~p~ 248 (571)
T 3cvr_A 223 PENILSLDPTCTIILEDNPLSSRIRE 248 (571)
T ss_dssp CGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred CHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence 99999999999999999999987774
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=5.8e-21 Score=195.51 Aligned_cols=183 Identities=25% Similarity=0.366 Sum_probs=148.9
Q ss_pred CCccceEEeCCCCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccc
Q 002238 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFF 135 (948)
Q Consensus 57 C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~ 135 (948)
|.|.+|.|.. ++++ .+|..+ .++|++|+|++|+|++.++ .|.++++|++|+|++|+++++++..|
T Consensus 7 C~~~~v~c~~-----------~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 72 (208)
T 2o6s_A 7 CSGTTVECYS-----------QGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVF 72 (208)
T ss_dssp EETTEEECCS-----------SCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTT
T ss_pred ECCCEEEecC-----------CCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhc
Confidence 6899888853 3344 455444 3689999999999998777 47889999999999999999999889
Q ss_pred cCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccc
Q 002238 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQI 215 (948)
Q Consensus 136 ~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l 215 (948)
..+++|++|+|++|+++. ..+..+..+++|++|++++|++++..+..|. .+++|++|+|++|++++..+..|
T Consensus 73 ~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~l~~N~l~~~~~~~~----- 144 (208)
T 2o6s_A 73 NKLTSLTYLNLSTNQLQS-LPNGVFDKLTQLKELALNTNQLQSLPDGVFD--KLTQLKDLRLYQNQLKSVPDGVF----- 144 (208)
T ss_dssp TTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTT--TCTTCCEEECCSSCCSCCCTTTT-----
T ss_pred CCCCCcCEEECCCCcCCc-cCHhHhcCccCCCEEEcCCCcCcccCHhHhc--cCCcCCEEECCCCccceeCHHHh-----
Confidence 999999999999999985 3345578899999999999999988777776 78999999999999886555443
Q ss_pred cceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCC
Q 002238 216 QSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLES 288 (948)
Q Consensus 216 ~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 288 (948)
.++++|+.|+|++|.+.+. ++.|+.|++..|+++|.+|..++.++.
T Consensus 145 ---------------------~~l~~L~~L~l~~N~~~~~------~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 145 ---------------------DRLTSLQYIWLHDNPWDCT------CPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ---------------------TTCTTCCEEECCSCCBCCC------TTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ---------------------ccCCCccEEEecCCCeecC------CCCHHHHHHHHHhCCceeeccCccccC
Confidence 3678899999999977754 347888888888888888888877664
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.85 E-value=4.5e-23 Score=232.87 Aligned_cols=253 Identities=17% Similarity=0.220 Sum_probs=196.3
Q ss_pred CCCccccCCCCCcEEEcccCCCCCCCC-----CcCCCCCCcEEEccccc---ccCCCCccc-------cCCCCCCEEEcc
Q 002238 83 TLPSNLQNLTKLERLELQWNSISGPLP-----SLNGLASLEVVMLSNNQ---FTSVPSDFF-------TGLSSLQSIEID 147 (948)
Q Consensus 83 ~~p~~l~~l~~L~~L~L~~N~l~~~~p-----~~~~l~~L~~L~L~~N~---l~~~~~~~~-------~~l~~L~~L~Ls 147 (948)
.++..+..+++|++|+|++|.|+...+ .+..+++|++|+|++|. +++..|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 566778888999999999999987432 47789999999999964 444555444 789999999999
Q ss_pred CCCCCCC---CCCccccCCCCCCEEEccCccccccCCCCCCC--CCC---------CCCcEEEccccccc-ccCCCCccc
Q 002238 148 NNPFSSW---EIPQSLRNASGLQNFSANSANITGQIPSFFGP--DEF---------PGLTILHLAFNQLI-GGLPASFSG 212 (948)
Q Consensus 148 ~N~l~~~---~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~--~~l---------~~L~~L~Ls~N~l~-~~~p~~~~~ 212 (948)
+|+++.. .+|..+.++++|++|+|++|.++...+..+.. ..+ ++|++|+|++|+++ +.++. +
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~-l-- 179 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE-W-- 179 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHH-H--
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHH-H--
Confidence 9999852 16778899999999999999997655444430 022 89999999999987 33331 1
Q ss_pred ccccceeccCCCCCCccCCCccccccCCCccEEEccCCccc--c---cCC-CCCCCCCCcEEeccCCccc----cccchh
Q 002238 213 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS--G---PLP-DFSGVKQLESLSLRDNFFT----GPVPDS 282 (948)
Q Consensus 213 ~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~--~---~~~-~~~~l~~L~~L~L~~N~l~----~~~p~~ 282 (948)
...+..+++|++|+|++|+++ + ..+ .+..+++|+.|+|++|.|+ +.+|..
T Consensus 180 --------------------~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~ 239 (386)
T 2ca6_A 180 --------------------AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239 (386)
T ss_dssp --------------------HHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred --------------------HHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHH
Confidence 123557899999999999998 3 345 6888999999999999996 688999
Q ss_pred hhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCc
Q 002238 283 LVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDW 362 (948)
Q Consensus 283 l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (948)
+..+++|+.|+|++|.+++.-.. .+...+
T Consensus 240 l~~~~~L~~L~L~~n~i~~~~~~--------------------------------~l~~~l------------------- 268 (386)
T 2ca6_A 240 LKSWPNLRELGLNDCLLSARGAA--------------------------------AVVDAF------------------- 268 (386)
T ss_dssp GGGCTTCCEEECTTCCCCHHHHH--------------------------------HHHHHH-------------------
T ss_pred HccCCCcCEEECCCCCCchhhHH--------------------------------HHHHHH-------------------
Confidence 99999999999999998753110 000000
Q ss_pred cceeecCCceEEEEccCCcccc----cCCccc-cCccccceEeCccccccccCC
Q 002238 363 IGVTCTKGNITVINFQKMNLTG----TISPEF-ASFKSLQRLILADNNLSGMIP 411 (948)
Q Consensus 363 ~~~~~~~~~L~~L~ls~n~l~g----~ip~~~-~~l~~L~~L~Ls~N~l~g~ip 411 (948)
....+++|+.|+|++|.+++ .+|..+ .++++|++|+|++|++++..|
T Consensus 269 --~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 269 --SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp --HTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred --hhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 00124689999999999998 588888 779999999999999997764
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.1e-20 Score=210.09 Aligned_cols=242 Identities=16% Similarity=0.138 Sum_probs=174.0
Q ss_pred cEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCC-ccccCCCCCCE-EEcc
Q 002238 95 ERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIP-QSLRNASGLQN-FSAN 172 (948)
Q Consensus 95 ~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p-~~~~~l~~L~~-L~l~ 172 (948)
++++.++++|+.++..+. ++|++|+|++|+|+.+++++|+++++|++|+|++|++.+ .+| ..|.++++|+. +.++
T Consensus 12 ~~v~C~~~~Lt~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~-~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE-VIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCCSCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCC-EECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCCccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCC-ccChhHhhcchhhhhhhccc
Confidence 568899999997665553 689999999999999999999999999999999999875 455 46788888765 6677
Q ss_pred CccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccC-Cc
Q 002238 173 SANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHS-NA 251 (948)
Q Consensus 173 ~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~-N~ 251 (948)
.|+|+...|..|. .+++|++|++++|++.+..+..+. ...++..|++.+ |+
T Consensus 89 ~N~l~~l~~~~f~--~l~~L~~L~l~~n~l~~~~~~~~~--------------------------~~~~l~~l~l~~~~~ 140 (350)
T 4ay9_X 89 ANNLLYINPEAFQ--NLPNLQYLLISNTGIKHLPDVHKI--------------------------HSLQKVLLDIQDNIN 140 (350)
T ss_dssp ETTCCEECTTSBC--CCTTCCEEEEEEECCSSCCCCTTC--------------------------CBSSCEEEEEESCTT
T ss_pred CCcccccCchhhh--hccccccccccccccccCCchhhc--------------------------ccchhhhhhhccccc
Confidence 7999988888887 899999999999999865554432 455677888865 45
Q ss_pred ccccCC-CCCCC-CCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCC
Q 002238 252 FSGPLP-DFSGV-KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGAC 329 (948)
Q Consensus 252 l~~~~~-~~~~l-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~ 329 (948)
+....+ .|.++ ..++.|+|++|+|+ .+|......++|+.|++++|+.-+.+|.
T Consensus 141 i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~------------------------ 195 (350)
T 4ay9_X 141 IHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPN------------------------ 195 (350)
T ss_dssp CCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCT------------------------
T ss_pred cccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCH------------------------
Confidence 665444 35554 46888889999888 5666666667888888875433334442
Q ss_pred chhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCcccccccc
Q 002238 330 DPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGM 409 (948)
Q Consensus 330 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ 409 (948)
+.|..+++|+.|+|++|+|+...+..|.+++.|+ +.++.--..
T Consensus 196 ----------------------------------~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~---~l~~~~l~~ 238 (350)
T 4ay9_X 196 ----------------------------------DVFHGASGPVILDISRTRIHSLPSYGLENLKKLR---ARSTYNLKK 238 (350)
T ss_dssp ----------------------------------TTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEE---CTTCTTCCC
T ss_pred ----------------------------------HHhccCcccchhhcCCCCcCccChhhhccchHhh---hccCCCcCc
Confidence 0122334778888888888755444454444444 333333336
Q ss_pred CCcCCcCCCCCcEEEccCCcc
Q 002238 410 IPEGLSVLGALKELDVSNNQL 430 (948)
Q Consensus 410 ip~~l~~l~~L~~L~ls~N~l 430 (948)
+| .+..+++|+.++++++.-
T Consensus 239 lP-~l~~l~~L~~l~l~~~~~ 258 (350)
T 4ay9_X 239 LP-TLEKLVALMEASLTYPSH 258 (350)
T ss_dssp CC-CTTTCCSCCEEECSCHHH
T ss_pred CC-CchhCcChhhCcCCCCcc
Confidence 66 477888888888876543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.84 E-value=2e-22 Score=223.14 Aligned_cols=252 Identities=13% Similarity=0.149 Sum_probs=196.0
Q ss_pred CCcEEEcccCCCCCCCCCcCCC--CCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEE
Q 002238 93 KLERLELQWNSISGPLPSLNGL--ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFS 170 (948)
Q Consensus 93 ~L~~L~L~~N~l~~~~p~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ 170 (948)
.++.|++++|.+.. ..+..+ ++++.|++++|.+++.++. +..+++|++|+|++|.++...+|..+..+++|++|+
T Consensus 48 ~~~~l~l~~~~~~~--~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 48 LWQTLDLTGKNLHP--DVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp TSSEEECTTCBCCH--HHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred hheeeccccccCCH--HHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 47899999998872 245566 8899999999999998877 557999999999999987523788899999999999
Q ss_pred ccCccccccCCCCCCCCCCCCCcEEEcccc-ccccc-CCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEcc
Q 002238 171 ANSANITGQIPSFFGPDEFPGLTILHLAFN-QLIGG-LPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLH 248 (948)
Q Consensus 171 l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls 248 (948)
|++|.+++..+..++ .+++|++|+|++| .+++. ++. .+.++++|++|+|+
T Consensus 125 L~~~~l~~~~~~~l~--~~~~L~~L~L~~~~~l~~~~l~~--------------------------~~~~~~~L~~L~l~ 176 (336)
T 2ast_B 125 LEGLRLSDPIVNTLA--KNSNLVRLNLSGCSGFSEFALQT--------------------------LLSSCSRLDELNLS 176 (336)
T ss_dssp CTTCBCCHHHHHHHT--TCTTCSEEECTTCBSCCHHHHHH--------------------------HHHHCTTCCEEECC
T ss_pred CcCcccCHHHHHHHh--cCCCCCEEECCCCCCCCHHHHHH--------------------------HHhcCCCCCEEcCC
Confidence 999999988888887 7999999999999 56642 332 24578999999999
Q ss_pred CC-ccccc-CC-CCCCCC-CCcEEeccCC--ccc-cccchhhhCCCCCcEEEcccCc-ccccCCCCCCccccccccccCC
Q 002238 249 SN-AFSGP-LP-DFSGVK-QLESLSLRDN--FFT-GPVPDSLVKLESLKIVNMTNNL-LQGPVPEFDRSVSLDMAKGSNN 320 (948)
Q Consensus 249 ~N-~l~~~-~~-~~~~l~-~L~~L~L~~N--~l~-~~~p~~l~~l~~L~~L~Ls~N~-l~g~~p~~~~~~~l~~~~~~~~ 320 (948)
+| .+++. ++ .+..++ +|++|+|++| .++ +.+|..+.++++|+.|+|++|. +++..+.
T Consensus 177 ~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~--------------- 241 (336)
T 2ast_B 177 WCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQ--------------- 241 (336)
T ss_dssp CCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGG---------------
T ss_pred CCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHH---------------
Confidence 99 88863 33 366788 9999999999 455 5678888899999999999998 5543321
Q ss_pred CCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCc-ccccCCccccCccccceE
Q 002238 321 FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMN-LTGTISPEFASFKSLQRL 399 (948)
Q Consensus 321 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~-l~g~ip~~~~~l~~L~~L 399 (948)
.+..+++|+.|+|++|. +.......++++++|+.|
T Consensus 242 --------------------------------------------~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L 277 (336)
T 2ast_B 242 --------------------------------------------EFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTL 277 (336)
T ss_dssp --------------------------------------------GGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred --------------------------------------------HHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEE
Confidence 11234588999999995 333333368889999999
Q ss_pred eCccccccccCCcCCcCCC-CCcEEEccCCcccCCCCCCC
Q 002238 400 ILADNNLSGMIPEGLSVLG-ALKELDVSNNQLYGKIPSFK 438 (948)
Q Consensus 400 ~Ls~N~l~g~ip~~l~~l~-~L~~L~ls~N~l~g~ip~~~ 438 (948)
+|++| +. ...+..+. .|..|++++|++++..|...
T Consensus 278 ~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~ 313 (336)
T 2ast_B 278 QVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTI 313 (336)
T ss_dssp ECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSC
T ss_pred eccCc-cC---HHHHHHHHhhCcceEEecccCccccCCcc
Confidence 99999 33 22344443 47777899999999888643
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.7e-20 Score=219.28 Aligned_cols=196 Identities=26% Similarity=0.363 Sum_probs=134.0
Q ss_pred CCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEE
Q 002238 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTIL 195 (948)
Q Consensus 116 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L 195 (948)
+|+.|+|++|.|+++++.. +++|+.|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +. . +|++|
T Consensus 60 ~L~~L~Ls~n~L~~lp~~l---~~~L~~L~Ls~N~l~--~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~--~--~L~~L 125 (571)
T 3cvr_A 60 QFSELQLNRLNLSSLPDNL---PPQITVLEITQNALI--SLP---ELPASLEYLDACDNRLST-LPE-LP--A--SLKHL 125 (571)
T ss_dssp TCSEEECCSSCCSCCCSCC---CTTCSEEECCSSCCS--CCC---CCCTTCCEEECCSSCCSC-CCC-CC--T--TCCEE
T ss_pred CccEEEeCCCCCCccCHhH---cCCCCEEECcCCCCc--ccc---cccCCCCEEEccCCCCCC-cch-hh--c--CCCEE
Confidence 6666777777666654433 256777777777776 455 346677777777777776 555 54 2 77888
Q ss_pred EcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCcc
Q 002238 196 HLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFF 275 (948)
Q Consensus 196 ~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l 275 (948)
+|++|+|++ +|. .+++|+.|+|++|++++. |. .+++|+.|+|++|+|
T Consensus 126 ~Ls~N~l~~-lp~-----------------------------~l~~L~~L~Ls~N~l~~l-p~--~l~~L~~L~Ls~N~L 172 (571)
T 3cvr_A 126 DVDNNQLTM-LPE-----------------------------LPALLEYINADNNQLTML-PE--LPTSLEVLSVRNNQL 172 (571)
T ss_dssp ECCSSCCSC-CCC-----------------------------CCTTCCEEECCSSCCSCC-CC--CCTTCCEEECCSSCC
T ss_pred ECCCCcCCC-CCC-----------------------------cCccccEEeCCCCccCcC-CC--cCCCcCEEECCCCCC
Confidence 888887775 443 146788888888888763 33 567888888888888
Q ss_pred ccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCC
Q 002238 276 TGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 355 (948)
Q Consensus 276 ~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 355 (948)
++ +|. +. ++|+.|+|++|+|+ .+|.+.. +|
T Consensus 173 ~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~~~~--~L------------------------------------------- 202 (571)
T 3cvr_A 173 TF-LPE-LP--ESLEALDVSTNLLE-SLPAVPV--RN------------------------------------------- 202 (571)
T ss_dssp SC-CCC-CC--TTCCEEECCSSCCS-SCCCCC------------------------------------------------
T ss_pred CC-cch-hh--CCCCEEECcCCCCC-chhhHHH--hh-------------------------------------------
Confidence 85 666 55 78888888888887 3443211 00
Q ss_pred CCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCC
Q 002238 356 NDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGA 419 (948)
Q Consensus 356 ~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~ 419 (948)
......|+.|+|++|.|+ .+|..+.++++|+.|+|++|+|++.+|..+..+..
T Consensus 203 ----------~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 203 ----------HHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp ---------------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred ----------hcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 001124688888888888 57888888888888888888888888887776543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=9e-20 Score=186.63 Aligned_cols=104 Identities=19% Similarity=0.235 Sum_probs=57.2
Q ss_pred cEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCc
Q 002238 95 ERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA 174 (948)
Q Consensus 95 ~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n 174 (948)
+.++++++.++..+..+ .++|++|+|++|+++++++..|+.+++|++|+|++|+++. ..+..+..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRTSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-CCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCccCCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCc-cChhhcCCCCCcCEEECCCC
Confidence 45666666666554333 2466777777777776666666666666666666666663 11223444555555555555
Q ss_pred cccccCCCCCCCCCCCCCcEEEccccccc
Q 002238 175 NITGQIPSFFGPDEFPGLTILHLAFNQLI 203 (948)
Q Consensus 175 ~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~ 203 (948)
++++..+..|. .+++|++|+|++|+++
T Consensus 87 ~l~~~~~~~~~--~l~~L~~L~L~~N~l~ 113 (208)
T 2o6s_A 87 QLQSLPNGVFD--KLTQLKELALNTNQLQ 113 (208)
T ss_dssp CCCCCCTTTTT--TCTTCCEEECCSSCCC
T ss_pred cCCccCHhHhc--CccCCCEEEcCCCcCc
Confidence 55544443333 4444444444444444
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.81 E-value=3.2e-21 Score=233.98 Aligned_cols=225 Identities=16% Similarity=0.178 Sum_probs=112.1
Q ss_pred CChHHHHHHHHHHHhcCCCC---CCCCCC--CCCCCccceEEeCCCCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccC
Q 002238 28 GDDGDAAVMLALKKSLNPPE---SLGWSD--TDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWN 102 (948)
Q Consensus 28 ~~~~d~~~l~~~k~~~~~~~---~~~w~~--~~~C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N 102 (948)
....++++|.++..++.... ...|.. +.++.|.++.+.. .+++.|+|.++++.. ++. ..|+.++|+.|
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~~~~~l~L~~n~~~~-~~~-----~~l~~l~Ls~~ 201 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST-PLTPKIELFANGKDE-ANQ-----ALLQHKKLSQY 201 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC-CccceEEeeCCCCCc-chh-----hHhhcCccCcc
Confidence 44568889999987763322 225643 3457899888854 689999999998885 232 34566777777
Q ss_pred CCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCC
Q 002238 103 SISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPS 182 (948)
Q Consensus 103 ~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~ 182 (948)
.|.+ +++..|++. ++++.|..+++|+.|+|++|++. .+|..+.++++|++|+|++|.|+ .+|.
T Consensus 202 ~i~~-------------~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~--~l~~~~~~l~~L~~L~Ls~N~l~-~lp~ 264 (727)
T 4b8c_D 202 SIDE-------------DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF--NISANIFKYDFLTRLYLNGNSLT-ELPA 264 (727)
T ss_dssp ----------------------------------CCCCCCEEECTTSCCS--CCCGGGGGCCSCSCCBCTTSCCS-CCCG
T ss_pred cccC-------------cccccccee-cChhhhccCCCCcEEECCCCCCC--CCChhhcCCCCCCEEEeeCCcCc-ccCh
Confidence 6654 344556665 56677888888888888888887 67777778888888888888887 6677
Q ss_pred CCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCC
Q 002238 183 FFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGV 262 (948)
Q Consensus 183 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l 262 (948)
.|+ .+++|++|+|++|+|+ .+|..| .++++|++|+|++|.|+..+..|..+
T Consensus 265 ~~~--~l~~L~~L~Ls~N~l~-~lp~~~--------------------------~~l~~L~~L~L~~N~l~~lp~~~~~l 315 (727)
T 4b8c_D 265 EIK--NLSNLRVLDLSHNRLT-SLPAEL--------------------------GSCFQLKYFYFFDNMVTTLPWEFGNL 315 (727)
T ss_dssp GGG--GGTTCCEEECTTSCCS-SCCSSG--------------------------GGGTTCSEEECCSSCCCCCCSSTTSC
T ss_pred hhh--CCCCCCEEeCcCCcCC-ccChhh--------------------------cCCCCCCEEECCCCCCCccChhhhcC
Confidence 676 7788888888888877 566654 36777777777777777544457777
Q ss_pred CCCcEEeccCCccccccchhhhCCCC-CcEEEcccCcccccCCC
Q 002238 263 KQLESLSLRDNFFTGPVPDSLVKLES-LKIVNMTNNLLQGPVPE 305 (948)
Q Consensus 263 ~~L~~L~L~~N~l~~~~p~~l~~l~~-L~~L~Ls~N~l~g~~p~ 305 (948)
++|+.|+|++|.|++.+|..+..+.. +..|+|++|.++|.+|.
T Consensus 316 ~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 316 CNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp TTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred CCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 77777777777777777777655421 22356667777666554
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.5e-19 Score=184.96 Aligned_cols=154 Identities=19% Similarity=0.262 Sum_probs=139.0
Q ss_pred CCCCCCCCCccceEEeCC----------CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCc
Q 002238 50 GWSDTDPCKWNHVVCIED----------KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLE 118 (948)
Q Consensus 50 ~w~~~~~C~w~gv~c~~~----------~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~ 118 (948)
.|.+...|+|++|.|... .+++.|+|++|++++..|..|.++++|++|+|++|+|+..++ .|.++++|+
T Consensus 12 ~~~~~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~ 91 (229)
T 3e6j_A 12 ACPSQCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT 91 (229)
T ss_dssp CCCTTCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred cCCCCCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcC
Confidence 345677899999999642 478999999999999889999999999999999999988776 578999999
Q ss_pred EEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcc
Q 002238 119 VVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLA 198 (948)
Q Consensus 119 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls 198 (948)
+|+|++|+|+++++..|..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|. .+++|+.|+|+
T Consensus 92 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~--~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~l~ 167 (229)
T 3e6j_A 92 VLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT--ELPRGIERLTHLTHLALDQNQLKSIPHGAFD--RLSSLTHAYLF 167 (229)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC--SCCTTGGGCTTCSEEECCSSCCCCCCTTTTT--TCTTCCEEECT
T ss_pred EEECCCCcCCccChhHhCcchhhCeEeccCCccc--ccCcccccCCCCCEEECCCCcCCccCHHHHh--CCCCCCEEEee
Confidence 9999999999999999999999999999999999 7899999999999999999999988877786 89999999999
Q ss_pred cccccccCC
Q 002238 199 FNQLIGGLP 207 (948)
Q Consensus 199 ~N~l~~~~p 207 (948)
+|.+.+..+
T Consensus 168 ~N~~~c~c~ 176 (229)
T 3e6j_A 168 GNPWDCECR 176 (229)
T ss_dssp TSCBCTTBG
T ss_pred CCCccCCcc
Confidence 999986544
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.9e-19 Score=191.00 Aligned_cols=173 Identities=20% Similarity=0.339 Sum_probs=140.0
Q ss_pred ccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCC
Q 002238 88 LQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ 167 (948)
Q Consensus 88 l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 167 (948)
+..+++|++|++++|.+... +.+..+++|++|+|++|+++++++ +..+++|+.|+|++|+++. +| .+..+++|+
T Consensus 42 ~~~l~~L~~L~l~~~~i~~~-~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~--~~-~l~~l~~L~ 115 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD--LS-SLKDLKKLK 115 (291)
T ss_dssp HHHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC--GG-GGTTCTTCC
T ss_pred hhhcCcccEEEccCCCcccC-hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC--Ch-hhccCCCCC
Confidence 35677888888888888765 567788888888888888888776 8888888888888888874 33 488888888
Q ss_pred EEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEc
Q 002238 168 NFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWL 247 (948)
Q Consensus 168 ~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~L 247 (948)
+|++++|++++. ..+. .+++|++|+|++|++++. .. +.++++|+.|+|
T Consensus 116 ~L~L~~n~i~~~--~~l~--~l~~L~~L~l~~n~l~~~--~~--------------------------l~~l~~L~~L~L 163 (291)
T 1h6t_A 116 SLSLEHNGISDI--NGLV--HLPQLESLYLGNNKITDI--TV--------------------------LSRLTKLDTLSL 163 (291)
T ss_dssp EEECTTSCCCCC--GGGG--GCTTCCEEECCSSCCCCC--GG--------------------------GGGCTTCSEEEC
T ss_pred EEECCCCcCCCC--hhhc--CCCCCCEEEccCCcCCcc--hh--------------------------hccCCCCCEEEc
Confidence 888888888864 3454 788899999999988753 22 457889999999
Q ss_pred cCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccc
Q 002238 248 HSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG 301 (948)
Q Consensus 248 s~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 301 (948)
++|++++..+ +..+++|+.|+|++|.|++ +|. +..+++|+.|+|++|+++.
T Consensus 164 ~~N~l~~~~~-l~~l~~L~~L~L~~N~i~~-l~~-l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 164 EDNQISDIVP-LAGLTKLQNLYLSKNHISD-LRA-LAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CSSCCCCCGG-GTTCTTCCEEECCSSCCCB-CGG-GTTCTTCSEEEEEEEEEEC
T ss_pred cCCccccchh-hcCCCccCEEECCCCcCCC-Chh-hccCCCCCEEECcCCcccC
Confidence 9999988666 8888999999999999984 554 8899999999999999875
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=8e-19 Score=207.47 Aligned_cols=188 Identities=19% Similarity=0.323 Sum_probs=153.7
Q ss_pred EEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCC
Q 002238 73 IQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFS 152 (948)
Q Consensus 73 l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 152 (948)
+.+..+.+...++ +..|.+|+.|+|++|.|..+ +.+..+++|+.|+|++|+|+++++ |..+++|+.|+|++|+|+
T Consensus 26 l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~ 100 (605)
T 1m9s_A 26 DNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK 100 (605)
T ss_dssp HHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-TTGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCC
T ss_pred HhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-hHHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCC
Confidence 3444455554332 56678899999999998865 578889999999999999998877 889999999999999998
Q ss_pred CCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCC
Q 002238 153 SWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGG 232 (948)
Q Consensus 153 ~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~ 232 (948)
. +| .+..+++|+.|+|++|+|++. + .+. .+++|+.|+|++|++++. ..
T Consensus 101 ~--l~-~l~~l~~L~~L~Ls~N~l~~l-~-~l~--~l~~L~~L~Ls~N~l~~l--~~----------------------- 148 (605)
T 1m9s_A 101 D--LS-SLKDLKKLKSLSLEHNGISDI-N-GLV--HLPQLESLYLGNNKITDI--TV----------------------- 148 (605)
T ss_dssp C--CT-TSTTCTTCCEEECTTSCCCCC-G-GGG--GCTTCSEEECCSSCCCCC--GG-----------------------
T ss_pred C--Ch-hhccCCCCCEEEecCCCCCCC-c-ccc--CCCccCEEECCCCccCCc--hh-----------------------
Confidence 4 34 788899999999999999864 3 354 789999999999998854 22
Q ss_pred ccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccC
Q 002238 233 IDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPV 303 (948)
Q Consensus 233 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~ 303 (948)
|..+++|+.|+|++|++++.++ +..+++|+.|+|++|+|++ +| .+..+++|+.|+|++|++++.+
T Consensus 149 ---l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~L~~N~l~~~p 213 (605)
T 1m9s_A 149 ---LSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNKP 213 (605)
T ss_dssp ---GGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEECCSEEEECCC
T ss_pred ---hcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEccCCcCcCCc
Confidence 4578999999999999998777 8889999999999999995 44 5899999999999999998643
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=4.5e-18 Score=175.32 Aligned_cols=152 Identities=22% Similarity=0.299 Sum_probs=134.1
Q ss_pred EEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC--CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCC
Q 002238 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP--SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149 (948)
Q Consensus 72 ~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 149 (948)
.+++++++++ .+|..+. ..+++|+|++|+|++.++ .|.++++|++|+|++|+|+++++..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 6788888888 5777665 457899999999999865 4889999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCcc
Q 002238 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKL 229 (948)
Q Consensus 150 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~ 229 (948)
++++ ..+..|..+++|++|+|++|+|++..|..|. .+++|++|+|++|++++..|..|.
T Consensus 92 ~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~------------------ 150 (220)
T 2v70_A 92 RLEN-VQHKMFKGLESLKTLMLRSNRITCVGNDSFI--GLSSVRLLSLYDNQITTVAPGAFD------------------ 150 (220)
T ss_dssp CCCC-CCGGGGTTCSSCCEEECTTSCCCCBCTTSST--TCTTCSEEECTTSCCCCBCTTTTT------------------
T ss_pred ccCc-cCHhHhcCCcCCCEEECCCCcCCeECHhHcC--CCccCCEEECCCCcCCEECHHHhc------------------
Confidence 9996 4466799999999999999999999999997 899999999999999988787753
Q ss_pred CCCccccccCCCccEEEccCCccccc
Q 002238 230 GGGIDVIQNMTSLKEIWLHSNAFSGP 255 (948)
Q Consensus 230 ~~~~~~l~~l~~L~~L~Ls~N~l~~~ 255 (948)
.+++|+.|+|++|.+...
T Consensus 151 --------~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 151 --------TLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp --------TCTTCCEEECCSCCEECS
T ss_pred --------CCCCCCEEEecCcCCcCC
Confidence 678888888888888753
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.76 E-value=1e-20 Score=226.52 Aligned_cols=325 Identities=15% Similarity=0.070 Sum_probs=226.6
Q ss_pred CCEEEEEeCCCCCcCC----CCccccCCCCCcEEEcccCCCCCCC----C-CcCCCCCCcEEEcccccccCCCCccccCC
Q 002238 68 KRITRIQIGHQNLQGT----LPSNLQNLTKLERLELQWNSISGPL----P-SLNGLASLEVVMLSNNQFTSVPSDFFTGL 138 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~----p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 138 (948)
.++++|+|++|.+++. ++..+.++++|++|+|++|.+++.. + .+.++++|++|+|++|.+.+++ ..+.++
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~-~~~~~~ 242 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELV-GFFKAA 242 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGH-HHHHHC
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHH-HHHhhh
Confidence 5899999999998766 4445667899999999999998432 2 3567899999999999999855 778999
Q ss_pred CCCCEEEccCCCCC--CCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCC-ccc-cc
Q 002238 139 SSLQSIEIDNNPFS--SWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS-FSG-SQ 214 (948)
Q Consensus 139 ~~L~~L~Ls~N~l~--~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~-~~ 214 (948)
++|+.|+++.+... ....+..+..+++|+.|+++++. .+.+|..+. .+++|++|+|++|.+++..... +.. .+
T Consensus 243 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~--~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~ 319 (592)
T 3ogk_B 243 ANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFP--FAAQIRKLDLLYALLETEDHCTLIQKCPN 319 (592)
T ss_dssp TTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGG--GGGGCCEEEETTCCCCHHHHHHHHTTCTT
T ss_pred hHHHhhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHHh--hcCCCcEEecCCCcCCHHHHHHHHHhCcC
Confidence 99999999864332 11445677888899999998853 345666665 7889999999999876543322 111 46
Q ss_pred ccceeccCCCCCCcc-CCCccccccCCCccEEEcc-----------CCccccc-CCC-CCCCCCCcEEeccCCccccccc
Q 002238 215 IQSLWVNGQNGNAKL-GGGIDVIQNMTSLKEIWLH-----------SNAFSGP-LPD-FSGVKQLESLSLRDNFFTGPVP 280 (948)
Q Consensus 215 l~~l~~~~~~~~~~~-~~~~~~l~~l~~L~~L~Ls-----------~N~l~~~-~~~-~~~l~~L~~L~L~~N~l~~~~p 280 (948)
|+.|++.+ ... .+....+..+++|++|+|+ .|.+++. +.. ..++++|+.|+++.|++++..+
T Consensus 320 L~~L~L~~----~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~ 395 (592)
T 3ogk_B 320 LEVLETRN----VIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESL 395 (592)
T ss_dssp CCEEEEEG----GGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHH
T ss_pred CCEEeccC----ccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHH
Confidence 77777652 222 2223344678999999999 3666642 222 3457899999999999998888
Q ss_pred hhhhC-CCCCcEEEcc----cCcccccCCC------CCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchh
Q 002238 281 DSLVK-LESLKIVNMT----NNLLQGPVPE------FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRF 349 (948)
Q Consensus 281 ~~l~~-l~~L~~L~Ls----~N~l~g~~p~------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 349 (948)
..+.. +++|+.|+|+ .|.+++.+.+ +.++.+|+.++...+.- .+. . ..+.
T Consensus 396 ~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~-~l~---~---~~~~------------ 456 (592)
T 3ogk_B 396 ESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQG-GLT---D---LGLS------------ 456 (592)
T ss_dssp HHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGG-GCC---H---HHHH------------
T ss_pred HHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCC-Ccc---H---HHHH------------
Confidence 88876 9999999996 6777753211 22233333333221000 000 0 0000
Q ss_pred ccccCCCCCCCCccceeecCCceEEEEccCCcccc-cCCccccCccccceEeCcccccccc-CCcCCcCCCCCcEEEccC
Q 002238 350 AENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTG-TISPEFASFKSLQRLILADNNLSGM-IPEGLSVLGALKELDVSN 427 (948)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g-~ip~~~~~l~~L~~L~Ls~N~l~g~-ip~~l~~l~~L~~L~ls~ 427 (948)
.....+++|+.|+|++|++++ .++..+..+++|+.|+|++|.+++. ++..+..+++|++|+|++
T Consensus 457 --------------~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~ 522 (592)
T 3ogk_B 457 --------------YIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQG 522 (592)
T ss_dssp --------------HHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEES
T ss_pred --------------HHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcC
Confidence 011125689999999999987 4555668899999999999998755 444456789999999999
Q ss_pred CcccCC
Q 002238 428 NQLYGK 433 (948)
Q Consensus 428 N~l~g~ 433 (948)
|++++.
T Consensus 523 n~it~~ 528 (592)
T 3ogk_B 523 YRASMT 528 (592)
T ss_dssp CBCCTT
T ss_pred CcCCHH
Confidence 998764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.4e-18 Score=191.83 Aligned_cols=173 Identities=20% Similarity=0.227 Sum_probs=118.3
Q ss_pred EEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcC-CCCCCcEEEcccccccCCCCccccCCCCCCEEEccCC
Q 002238 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLN-GLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149 (948)
Q Consensus 72 ~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 149 (948)
.+++++++|+ .+|..+. ..|+.|+|++|+|++..+ .|. ++++|++|+|++|+|+++++..|.++++|++|+|++|
T Consensus 22 ~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 5677788887 5676654 357888888888888766 455 7888888888888888888877888888888888888
Q ss_pred CCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCcc
Q 002238 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKL 229 (948)
Q Consensus 150 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~ 229 (948)
+|+. ..+..|.++++|+.|+|++|+|++..+..|. .+++|++|+|++|+|+
T Consensus 99 ~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~--~l~~L~~L~L~~N~l~-------------------------- 149 (361)
T 2xot_A 99 HLHT-LDEFLFSDLQALEVLLLYNNHIVVVDRNAFE--DMAQLQKLYLSQNQIS-------------------------- 149 (361)
T ss_dssp CCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTT--TCTTCCEEECCSSCCC--------------------------
T ss_pred cCCc-CCHHHhCCCcCCCEEECCCCcccEECHHHhC--CcccCCEEECCCCcCC--------------------------
Confidence 7774 2233455566666666666666655555554 5555555555555555
Q ss_pred CCCccccccCCCccEEEccCCcccccCCC-C---CCCCCCcEEeccCCccccccchhhhCCCC--CcEEEcccCccc
Q 002238 230 GGGIDVIQNMTSLKEIWLHSNAFSGPLPD-F---SGVKQLESLSLRDNFFTGPVPDSLVKLES--LKIVNMTNNLLQ 300 (948)
Q Consensus 230 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~-~---~~l~~L~~L~L~~N~l~~~~p~~l~~l~~--L~~L~Ls~N~l~ 300 (948)
+.++. | ..+++|+.|+|++|+|++..+..+..++. |+.|+|++|++.
T Consensus 150 ------------------------~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 150 ------------------------RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp ------------------------SCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred ------------------------eeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 32222 1 34677778888888887555567777776 478899999886
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.2e-18 Score=184.38 Aligned_cols=138 Identities=20% Similarity=0.186 Sum_probs=106.0
Q ss_pred CcccceecccCceEEEEEEE-cCCcE--EEEEEeecCcCCh----------------------hhHHHHHHHHHHHHhcC
Q 002238 595 FSEENILGRGGFGTVYKGEL-HDGTK--IAVKRMEAGVISG----------------------KGLTEFKSEIAVLTKVR 649 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~-~~g~~--vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l~ 649 (948)
|++.+.||+|+||.||+|.. .+|+. ||||+++...... .....+.+|++++.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67789999999999999987 67999 9999875432110 11236889999999998
Q ss_pred CCce--eeEEeEEEeCCceEEEEEecCC-C----ChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hccCCCee
Q 002238 650 HRHL--VALLGHCLDGNEKLLVFEYMPQ-G----TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH-GLAHQSFI 721 (948)
Q Consensus 650 H~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~iv 721 (948)
|+++ ..++++ +..++||||+.+ | +|.+.... .++..+..++.|++.||+||| + .+|+
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~---~giv 193 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQE---AELV 193 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHT---SCEE
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHH---CCEE
Confidence 8754 344432 356899999942 4 56554321 123456789999999999999 6 8999
Q ss_pred ecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 722 HRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 722 HrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
||||||+|||++. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999754
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.75 E-value=6.1e-21 Score=228.44 Aligned_cols=342 Identities=15% Similarity=0.100 Sum_probs=237.3
Q ss_pred CEEEEEeCCCC-CcC-CCCccccCCCCCcEEEcccCCCCCC----CC-CcCCCCCCcEEEcccccccCCC----CccccC
Q 002238 69 RITRIQIGHQN-LQG-TLPSNLQNLTKLERLELQWNSISGP----LP-SLNGLASLEVVMLSNNQFTSVP----SDFFTG 137 (948)
Q Consensus 69 ~v~~l~l~~~~-l~~-~~p~~l~~l~~L~~L~L~~N~l~~~----~p-~~~~l~~L~~L~L~~N~l~~~~----~~~~~~ 137 (948)
+++.|+|++|. ++. .++....++++|++|+|++|.+++. ++ .+.++++|++|+|++|.++++. +..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 49999999886 221 1223345789999999999998765 22 2456899999999999998544 344678
Q ss_pred CCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCcccc---ccCCCCCCCCCCCCCcEEEcccccccccCCCCccc-c
Q 002238 138 LSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANIT---GQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-S 213 (948)
Q Consensus 138 l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~---~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~ 213 (948)
+++|+.|+|++|.+. .+|..+.++++|+.|+++.+... +..+..+. .+++|+.|+++++.. +.+|..+.. .
T Consensus 219 ~~~L~~L~L~~~~~~--~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~--~~~~L~~L~l~~~~~-~~l~~~~~~~~ 293 (592)
T 3ogk_B 219 CRSLVSVKVGDFEIL--ELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLV--FPRKLCRLGLSYMGP-NEMPILFPFAA 293 (592)
T ss_dssp CTTCCEEECSSCBGG--GGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCC--CCTTCCEEEETTCCT-TTGGGGGGGGG
T ss_pred CCCCcEEeccCccHH--HHHHHHhhhhHHHhhcccccccccchHHHHHHhh--ccccccccCccccch-hHHHHHHhhcC
Confidence 999999999999998 57899999999999999864433 23334444 788999999998643 355655543 5
Q ss_pred cccceeccCCCCCCccCCC-ccccccCCCccEEEccCCcccc-cCCC-CCCCCCCcEEecc-----------CCccccc-
Q 002238 214 QIQSLWVNGQNGNAKLGGG-IDVIQNMTSLKEIWLHSNAFSG-PLPD-FSGVKQLESLSLR-----------DNFFTGP- 278 (948)
Q Consensus 214 ~l~~l~~~~~~~~~~~~~~-~~~l~~l~~L~~L~Ls~N~l~~-~~~~-~~~l~~L~~L~L~-----------~N~l~~~- 278 (948)
+|+.|++.++. ..... ...+.++++|+.|+|+ |.+.. .++. +..+++|+.|+|+ .|.+++.
T Consensus 294 ~L~~L~Ls~~~---l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~ 369 (592)
T 3ogk_B 294 QIRKLDLLYAL---LETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRG 369 (592)
T ss_dssp GCCEEEETTCC---CCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHH
T ss_pred CCcEEecCCCc---CCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHH
Confidence 68888887654 22222 2446889999999999 54443 3333 3457899999999 4677754
Q ss_pred cchhhhCCCCCcEEEcccCcccccCCC-----CCCcccccccccc-CCCCCCCCCCCchhhhhhHHHHHhhCCcchhccc
Q 002238 279 VPDSLVKLESLKIVNMTNNLLQGPVPE-----FDRSVSLDMAKGS-NNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 352 (948)
Q Consensus 279 ~p~~l~~l~~L~~L~Ls~N~l~g~~p~-----~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 352 (948)
++.....+++|+.|+++.|++++..+. +.++..|++.... .+.....|.. ..+.
T Consensus 370 ~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~--~~~~------------------ 429 (592)
T 3ogk_B 370 LIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLD--NGVR------------------ 429 (592)
T ss_dssp HHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCH--HHHH------------------
T ss_pred HHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHH--HHHH------------------
Confidence 334456699999999999999864332 2233333332211 2222211100 0000
Q ss_pred cCCCCCCCCccceeecCCceEEEEccCCc--ccccCCccccC-ccccceEeCccccccc-cCCcCCcCCCCCcEEEccCC
Q 002238 353 WKGNDPCSDWIGVTCTKGNITVINFQKMN--LTGTISPEFAS-FKSLQRLILADNNLSG-MIPEGLSVLGALKELDVSNN 428 (948)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~L~~L~ls~n~--l~g~ip~~~~~-l~~L~~L~Ls~N~l~g-~ip~~l~~l~~L~~L~ls~N 428 (948)
..+..+++|+.|+|++|. +++..+..++. +++|+.|+|++|++++ .++..+..+++|++|+|++|
T Consensus 430 -----------~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n 498 (592)
T 3ogk_B 430 -----------SLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGC 498 (592)
T ss_dssp -----------HHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESC
T ss_pred -----------HHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCC
Confidence 112346789999998644 77776666655 8999999999999987 45666688999999999999
Q ss_pred cccCC-CC----CCCcccccccCCCCC
Q 002238 429 QLYGK-IP----SFKSNAIVNTDGNPD 450 (948)
Q Consensus 429 ~l~g~-ip----~~~~~~~~~~~gnp~ 450 (948)
++++. ++ .+.....+.+++|..
T Consensus 499 ~l~~~~~~~~~~~l~~L~~L~ls~n~i 525 (592)
T 3ogk_B 499 CFSERAIAAAVTKLPSLRYLWVQGYRA 525 (592)
T ss_dssp CCBHHHHHHHHHHCSSCCEEEEESCBC
T ss_pred CCcHHHHHHHHHhcCccCeeECcCCcC
Confidence 98753 22 245677888888873
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.2e-17 Score=172.16 Aligned_cols=150 Identities=25% Similarity=0.363 Sum_probs=130.6
Q ss_pred EEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCC
Q 002238 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNP 150 (948)
Q Consensus 72 ~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 150 (948)
.+++++++++ .+|..+. ++|++|+|++|+|+++.+ .|.++++|++|+|++|+|+++.|..|.++++|++|+|++|+
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 4556677777 6777665 789999999999999877 79999999999999999999999999999999999999999
Q ss_pred CCCCCCCc-cccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCcc
Q 002238 151 FSSWEIPQ-SLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKL 229 (948)
Q Consensus 151 l~~~~~p~-~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~ 229 (948)
|+. +|. .|..+++|++|+|++|+|++..|..|. .+++|++|+|++|++++..+..|
T Consensus 92 l~~--l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~------------------- 148 (220)
T 2v9t_B 92 ITE--LPKSLFEGLFSLQLLLLNANKINCLRVDAFQ--DLHNLNLLSLYDNKLQTIAKGTF------------------- 148 (220)
T ss_dssp CCC--CCTTTTTTCTTCCEEECCSSCCCCCCTTTTT--TCTTCCEEECCSSCCSCCCTTTT-------------------
T ss_pred CCc--cCHhHccCCCCCCEEECCCCCCCEeCHHHcC--CCCCCCEEECCCCcCCEECHHHH-------------------
Confidence 994 554 578899999999999999999999987 89999999999999997666554
Q ss_pred CCCccccccCCCccEEEccCCcccc
Q 002238 230 GGGIDVIQNMTSLKEIWLHSNAFSG 254 (948)
Q Consensus 230 ~~~~~~l~~l~~L~~L~Ls~N~l~~ 254 (948)
..+++|+.|+|++|.+.-
T Consensus 149 -------~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 149 -------SPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp -------TTCTTCCEEECCSSCEEC
T ss_pred -------hCCCCCCEEEeCCCCcCC
Confidence 367888999999988863
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2.4e-18 Score=203.36 Aligned_cols=170 Identities=23% Similarity=0.374 Sum_probs=151.1
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEcc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 147 (948)
.+++.|++++|++.. ++ .+..+++|+.|+|++|.|++.++ +..+++|+.|+|++|.|++++ .|..+++|+.|+|+
T Consensus 43 ~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l~--~l~~l~~L~~L~Ls 117 (605)
T 1m9s_A 43 NSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDENKIKDLS--SLKDLKKLKSLSLE 117 (605)
T ss_dssp TTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCCCT--TSTTCTTCCEEECT
T ss_pred CCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh-hccCCCCCEEECcCCCCCCCh--hhccCCCCCEEEec
Confidence 578899999999984 44 68999999999999999999776 999999999999999999865 59999999999999
Q ss_pred CCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCC
Q 002238 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNA 227 (948)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~ 227 (948)
+|+++. + ..+..+++|+.|+|++|+|++. ..+. .+++|+.|+|++|+|++..| +
T Consensus 118 ~N~l~~--l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~--~l~~L~~L~Ls~N~l~~~~~--l----------------- 171 (605)
T 1m9s_A 118 HNGISD--I-NGLVHLPQLESLYLGNNKITDI--TVLS--RLTKLDTLSLEDNQISDIVP--L----------------- 171 (605)
T ss_dssp TSCCCC--C-GGGGGCTTCSEEECCSSCCCCC--GGGG--SCTTCSEEECCSSCCCCCGG--G-----------------
T ss_pred CCCCCC--C-ccccCCCccCEEECCCCccCCc--hhhc--ccCCCCEEECcCCcCCCchh--h-----------------
Confidence 999995 3 5689999999999999999976 4555 89999999999999987655 3
Q ss_pred ccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccc
Q 002238 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGP 278 (948)
Q Consensus 228 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~ 278 (948)
..+++|+.|+|++|+|++. +.+..+++|+.|+|++|++.+.
T Consensus 172 ---------~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 172 ---------AGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp ---------TTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEECC
T ss_pred ---------ccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCcCC
Confidence 3789999999999999975 6788999999999999999854
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.74 E-value=4.3e-18 Score=183.61 Aligned_cols=169 Identities=24% Similarity=0.380 Sum_probs=149.7
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEcc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 147 (948)
.+++.|++++|++... + .+..+++|++|+|++|++++..+ +.++++|++|+|++|.+++++. +..+++|++|+|+
T Consensus 46 ~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~ 120 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLE 120 (291)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCGGG--GTTCTTCCEEECT
T ss_pred CcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCCChh--hccCCCCCEEECC
Confidence 4789999999999854 4 58899999999999999999777 9999999999999999998643 9999999999999
Q ss_pred CCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCC
Q 002238 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNA 227 (948)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~ 227 (948)
+|+++. + ..+..+++|+.|++++|++++. ..+. .+++|++|+|++|++++..| +
T Consensus 121 ~n~i~~--~-~~l~~l~~L~~L~l~~n~l~~~--~~l~--~l~~L~~L~L~~N~l~~~~~--l----------------- 174 (291)
T 1h6t_A 121 HNGISD--I-NGLVHLPQLESLYLGNNKITDI--TVLS--RLTKLDTLSLEDNQISDIVP--L----------------- 174 (291)
T ss_dssp TSCCCC--C-GGGGGCTTCCEEECCSSCCCCC--GGGG--GCTTCSEEECCSSCCCCCGG--G-----------------
T ss_pred CCcCCC--C-hhhcCCCCCCEEEccCCcCCcc--hhhc--cCCCCCEEEccCCccccchh--h-----------------
Confidence 999995 3 5789999999999999999976 4555 89999999999999986544 3
Q ss_pred ccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCcccc
Q 002238 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTG 277 (948)
Q Consensus 228 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~ 277 (948)
..+++|+.|+|++|++++. +.+..+++|+.|+|++|+++.
T Consensus 175 ---------~~l~~L~~L~L~~N~i~~l-~~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 175 ---------AGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp ---------TTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEEEEEEC
T ss_pred ---------cCCCccCEEECCCCcCCCC-hhhccCCCCCEEECcCCcccC
Confidence 3789999999999999974 568899999999999999984
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.4e-17 Score=171.58 Aligned_cols=152 Identities=24% Similarity=0.307 Sum_probs=88.9
Q ss_pred cEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCC-ccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccC
Q 002238 95 ERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPS-DFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANS 173 (948)
Q Consensus 95 ~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~ 173 (948)
+.|++++|.++.+++.+. ..+++|+|++|+|+++++ ..|..+++|+.|+|++|+|+
T Consensus 14 ~~l~~s~n~l~~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~--------------------- 70 (220)
T 2v70_A 14 TTVDCSNQKLNKIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT--------------------- 70 (220)
T ss_dssp TEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCC---------------------
T ss_pred CEeEeCCCCcccCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCC---------------------
Confidence 366666666665443333 234566666666666533 34555556666665555555
Q ss_pred ccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCccc
Q 002238 174 ANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS 253 (948)
Q Consensus 174 n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 253 (948)
+..+..|. .+++|++|+|++|++++..+..| .++++|++|+|++|+++
T Consensus 71 ----~i~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~--------------------------~~l~~L~~L~Ls~N~l~ 118 (220)
T 2v70_A 71 ----DIEEGAFE--GASGVNEILLTSNRLENVQHKMF--------------------------KGLESLKTLMLRSNRIT 118 (220)
T ss_dssp ----EECTTTTT--TCTTCCEEECCSSCCCCCCGGGG--------------------------TTCSSCCEEECTTSCCC
T ss_pred ----EECHHHhC--CCCCCCEEECCCCccCccCHhHh--------------------------cCCcCCCEEECCCCcCC
Confidence 34444443 45555555555555554333332 24556666666666666
Q ss_pred ccCC-CCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccc
Q 002238 254 GPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG 301 (948)
Q Consensus 254 ~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 301 (948)
+.++ .|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|++.+
T Consensus 119 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 119 CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp CBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred eECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 5544 35566677777777777776667777777777777777777764
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.9e-17 Score=170.55 Aligned_cols=109 Identities=18% Similarity=0.262 Sum_probs=70.5
Q ss_pred cEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCc
Q 002238 95 ERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA 174 (948)
Q Consensus 95 ~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n 174 (948)
+.+++++|.++.++..+. ++|++|+|++|+|+++++..|..+++|+.|+|++|+|+. ..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~-~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLTEIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCSSCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCE-ECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcCcCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCC-cCHHHhhCCcCCCEEECCCC
Confidence 467788888877655444 577888888888888777777777777777777777774 33555666666666666666
Q ss_pred cccccCCCCCCCCCCCCCcEEEcccccccccCCC
Q 002238 175 NITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPA 208 (948)
Q Consensus 175 ~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 208 (948)
+|+...+..|. .+++|++|+|++|++++..|.
T Consensus 91 ~l~~l~~~~f~--~l~~L~~L~L~~N~l~~~~~~ 122 (220)
T 2v9t_B 91 KITELPKSLFE--GLFSLQLLLLNANKINCLRVD 122 (220)
T ss_dssp CCCCCCTTTTT--TCTTCCEEECCSSCCCCCCTT
T ss_pred cCCccCHhHcc--CCCCCCEEECCCCCCCEeCHH
Confidence 66544444443 455555555555555544443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.74 E-value=5.6e-18 Score=188.93 Aligned_cols=147 Identities=20% Similarity=0.283 Sum_probs=127.2
Q ss_pred CCccceEEeCC----------CCEEEEEeCCCCCcCCCCcccc-CCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEccc
Q 002238 57 CKWNHVVCIED----------KRITRIQIGHQNLQGTLPSNLQ-NLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSN 124 (948)
Q Consensus 57 C~w~gv~c~~~----------~~v~~l~l~~~~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~ 124 (948)
|.|..+.|... ..++.|+|++|+|++..+..+. ++++|++|+|++|+|+++.+ .|.++++|++|+|++
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 67788888542 4688999999999988888887 99999999999999999887 699999999999999
Q ss_pred ccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCC-CCCCCCcEEEccccccc
Q 002238 125 NQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGP-DEFPGLTILHLAFNQLI 203 (948)
Q Consensus 125 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~-~~l~~L~~L~Ls~N~l~ 203 (948)
|+|+++++..|..+++|+.|+|++|+|+. ..|..|..+++|+.|+|++|+|++..+..|.. ..+++|++|+|++|+|+
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccE-ECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 99999999999999999999999999996 45788999999999999999999876665521 15788888888888887
Q ss_pred c
Q 002238 204 G 204 (948)
Q Consensus 204 ~ 204 (948)
+
T Consensus 177 ~ 177 (361)
T 2xot_A 177 K 177 (361)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.2e-17 Score=169.06 Aligned_cols=155 Identities=14% Similarity=0.186 Sum_probs=109.9
Q ss_pred CCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCC
Q 002238 112 NGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPG 191 (948)
Q Consensus 112 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~ 191 (948)
..+++|++|+|++|.++.++ .+..+++|++|+|++|.++. +..+..+++|++|++++|++++..+..+. .+++
T Consensus 41 ~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~l~~n~~~~---~~~l~~l~~L~~L~l~~n~l~~~~~~~l~--~l~~ 113 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTDLT--GIEYAHNIKDLTINNIHATN---YNPISGLSNLERLRIMGKDVTSDKIPNLS--GLTS 113 (197)
T ss_dssp HHHHTCCEEEEESSCCSCCT--TGGGCTTCSEEEEESCCCSC---CGGGTTCTTCCEEEEECTTCBGGGSCCCT--TCTT
T ss_pred hhcCCccEEeccCCCccChH--HHhcCCCCCEEEccCCCCCc---chhhhcCCCCCEEEeECCccCcccChhhc--CCCC
Confidence 45666777777777777554 36777777777777776652 34677777777777777777776777776 7788
Q ss_pred CcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEecc
Q 002238 192 LTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLR 271 (948)
Q Consensus 192 L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~ 271 (948)
|++|+|++|++++..|.. +.++++|++|+|++|++.+.++.+..+++|+.|+|+
T Consensus 114 L~~L~Ls~n~i~~~~~~~--------------------------l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~ 167 (197)
T 4ezg_A 114 LTLLDISHSAHDDSILTK--------------------------INTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQ 167 (197)
T ss_dssp CCEEECCSSBCBGGGHHH--------------------------HTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECT
T ss_pred CCEEEecCCccCcHhHHH--------------------------HhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECC
Confidence 888888888877655544 346788888888888733344567778888888888
Q ss_pred CCccccccchhhhCCCCCcEEEcccCcccc
Q 002238 272 DNFFTGPVPDSLVKLESLKIVNMTNNLLQG 301 (948)
Q Consensus 272 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 301 (948)
+|.+++ ++ .+..+++|+.|++++|++.+
T Consensus 168 ~n~i~~-~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 168 FDGVHD-YR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp TBCCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred CCCCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence 888884 44 67888888888888888754
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.72 E-value=6.7e-17 Score=167.69 Aligned_cols=108 Identities=17% Similarity=0.294 Sum_probs=72.9
Q ss_pred CcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCC-ccccCCCCCCEEEcc
Q 002238 94 LERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIP-QSLRNASGLQNFSAN 172 (948)
Q Consensus 94 L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p-~~~~~l~~L~~L~l~ 172 (948)
.+.++++++.++.++..+. ++|++|+|++|+|+++++..|..+++|+.|+|++|+|+. +| ..|..+++|++|+|+
T Consensus 21 ~~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~--i~~~~~~~l~~L~~L~Ls 96 (229)
T 3e6j_A 21 GTTVDCRSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA--LPVGVFDSLTQLTVLDLG 96 (229)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC--CCTTTTTTCTTCCEEECC
T ss_pred CCEeEccCCCcCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCC--cChhhcccCCCcCEEECC
Confidence 4568888888876655443 778888888888888877778888888888888888763 33 345666666666666
Q ss_pred CccccccCCCCCCCCCCCCCcEEEcccccccccCCC
Q 002238 173 SANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPA 208 (948)
Q Consensus 173 ~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 208 (948)
+|+|++..+..|. .+++|++|+|++|+|+ .+|.
T Consensus 97 ~N~l~~l~~~~~~--~l~~L~~L~Ls~N~l~-~lp~ 129 (229)
T 3e6j_A 97 TNQLTVLPSAVFD--RLVHLKELFMCCNKLT-ELPR 129 (229)
T ss_dssp SSCCCCCCTTTTT--TCTTCCEEECCSSCCC-SCCT
T ss_pred CCcCCccChhHhC--cchhhCeEeccCCccc-ccCc
Confidence 6666655555554 5566666666666655 3443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=6.1e-18 Score=179.46 Aligned_cols=172 Identities=18% Similarity=0.251 Sum_probs=134.2
Q ss_pred CCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEE
Q 002238 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNF 169 (948)
Q Consensus 90 ~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 169 (948)
++.+++.|++++|.+++.. .+..+++|++|+|++|.++.++ .+..+++|+.|+|++|++++ ++. +.++++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~-~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~L~~N~i~~--~~~-l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV-SQKELSGVQNFNGDNSNIQSLA--GMQFFTNLKELHLSHNQISD--LSP-LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE-CHHHHTTCSEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC--CGG-GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccccc-chhhcCcCcEEECcCCCcccch--HHhhCCCCCEEECCCCccCC--Chh-hccCCCCCEE
Confidence 4566777888888887654 6777888888888888888765 47888888888888888884 444 8888888888
Q ss_pred EccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccC
Q 002238 170 SANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHS 249 (948)
Q Consensus 170 ~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~ 249 (948)
+|++|++++. |. +. . ++|++|+|++|++++. + . +.++++|+.|+|++
T Consensus 91 ~L~~N~l~~l-~~-~~--~-~~L~~L~L~~N~l~~~-~-~--------------------------l~~l~~L~~L~Ls~ 137 (263)
T 1xeu_A 91 SVNRNRLKNL-NG-IP--S-ACLSRLFLDNNELRDT-D-S--------------------------LIHLKNLEILSIRN 137 (263)
T ss_dssp ECCSSCCSCC-TT-CC--C-SSCCEEECCSSCCSBS-G-G--------------------------GTTCTTCCEEECTT
T ss_pred ECCCCccCCc-Cc-cc--c-CcccEEEccCCccCCC-h-h--------------------------hcCcccccEEECCC
Confidence 8888888764 33 22 3 7888899998888753 2 1 34788899999999
Q ss_pred CcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccC
Q 002238 250 NAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPV 303 (948)
Q Consensus 250 N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~ 303 (948)
|++++. +.+..+++|+.|+|++|++++. ..+..+++|+.|+|++|++++..
T Consensus 138 N~i~~~-~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 138 NKLKSI-VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp SCCCBC-GGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECCC
T ss_pred CcCCCC-hHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCCc
Confidence 988875 4677888999999999999865 66888899999999999988653
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=3.9e-20 Score=217.50 Aligned_cols=122 Identities=16% Similarity=0.184 Sum_probs=75.1
Q ss_pred CccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCC
Q 002238 241 SLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNN 320 (948)
Q Consensus 241 ~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~ 320 (948)
.|+.|+|++|++++. |.+..+++|+.|+|++|+|+ .+|..++++++|+.|+|++|+|++ +|.+.
T Consensus 442 ~L~~L~Ls~n~l~~l-p~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp~l~------------- 505 (567)
T 1dce_A 442 DVRVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVA------------- 505 (567)
T ss_dssp TCSEEECTTSCCSSC-CCGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGGGT-------------
T ss_pred CceEEEecCCCCCCC-cCccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-CcccC-------------
Confidence 466777777777763 34666777777777777777 667777777777777777777664 23211
Q ss_pred CCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccC-CccccCccccceE
Q 002238 321 FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTI-SPEFASFKSLQRL 399 (948)
Q Consensus 321 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~i-p~~~~~l~~L~~L 399 (948)
.+++|+.|+|++|+|++.+ |..|+.+++|+.|
T Consensus 506 -----------------------------------------------~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L 538 (567)
T 1dce_A 506 -----------------------------------------------NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 538 (567)
T ss_dssp -----------------------------------------------TCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred -----------------------------------------------CCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEE
Confidence 2235666666666666655 6666666666666
Q ss_pred eCccccccccCCcC---CcCCCCCcEEEc
Q 002238 400 ILADNNLSGMIPEG---LSVLGALKELDV 425 (948)
Q Consensus 400 ~Ls~N~l~g~ip~~---l~~l~~L~~L~l 425 (948)
+|++|+|++..|.. +..+++|+.||+
T Consensus 539 ~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 539 NLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp ECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred EecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 66666666544321 123566666653
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=2.5e-17 Score=166.66 Aligned_cols=154 Identities=14% Similarity=0.209 Sum_probs=96.5
Q ss_pred cCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCE
Q 002238 89 QNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQN 168 (948)
Q Consensus 89 ~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~ 168 (948)
..+++|++|++++|.|+.. |.+..+++|++|+|++|.++.+. .+..+++|++|+|++|++++ ..|..+..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~l~~n~l~~-~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTDL-TGIEYAHNIKDLTINNIHATNYN--PISGLSNLERLRIMGKDVTS-DKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCSCC-TTGGGCTTCSEEEEESCCCSCCG--GGTTCTTCCEEEEECTTCBG-GGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCccCh-HHHhcCCCCCEEEccCCCCCcch--hhhcCCCCCEEEeECCccCc-ccChhhcCCCCCCE
Confidence 4455666666666666633 35666666666666666554432 46666677777777776664 45666666777777
Q ss_pred EEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEcc
Q 002238 169 FSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLH 248 (948)
Q Consensus 169 L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls 248 (948)
|++++|++++..+..+. .+++|++|+|++|++.+.+| . +.++++|+.|+|+
T Consensus 117 L~Ls~n~i~~~~~~~l~--~l~~L~~L~L~~n~~i~~~~-~--------------------------l~~l~~L~~L~l~ 167 (197)
T 4ezg_A 117 LDISHSAHDDSILTKIN--TLPKVNSIDLSYNGAITDIM-P--------------------------LKTLPELKSLNIQ 167 (197)
T ss_dssp EECCSSBCBGGGHHHHT--TCSSCCEEECCSCTBCCCCG-G--------------------------GGGCSSCCEEECT
T ss_pred EEecCCccCcHhHHHHh--hCCCCCEEEccCCCCccccH-h--------------------------hcCCCCCCEEECC
Confidence 77777777666666665 67777777777776222333 1 3356777777777
Q ss_pred CCcccccCCCCCCCCCCcEEeccCCccc
Q 002238 249 SNAFSGPLPDFSGVKQLESLSLRDNFFT 276 (948)
Q Consensus 249 ~N~l~~~~~~~~~l~~L~~L~L~~N~l~ 276 (948)
+|++++. +.+..+++|+.|++++|+|.
T Consensus 168 ~n~i~~~-~~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 168 FDGVHDY-RGIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp TBCCCCC-TTGGGCSSCCEEEECBC---
T ss_pred CCCCcCh-HHhccCCCCCEEEeeCcccC
Confidence 7777653 35666777777777777765
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.70 E-value=7.6e-20 Score=218.98 Aligned_cols=365 Identities=13% Similarity=0.080 Sum_probs=182.7
Q ss_pred CCEEEEEeCCCCCcCCCCcccc-CCCCCcEEEcccC-CCCCC-CCC-cCCCCCCcEEEcccccccCCCCcccc----CCC
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQ-NLTKLERLELQWN-SISGP-LPS-LNGLASLEVVMLSNNQFTSVPSDFFT----GLS 139 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~-~l~~L~~L~L~~N-~l~~~-~p~-~~~l~~L~~L~L~~N~l~~~~~~~~~----~l~ 139 (948)
.+++.|+|++|.+++..+..+. .+++|++|+|++| .++.. ++. +.++++|++|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 3566677776666655544454 4666777777666 34331 222 23566777777777766654443333 455
Q ss_pred CCCEEEccCCC--CCCCCCCccccCCCCCCEEEccCc-cccccCCCCCCCCCCCCCcEEEcccc-------cccccCCCC
Q 002238 140 SLQSIEIDNNP--FSSWEIPQSLRNASGLQNFSANSA-NITGQIPSFFGPDEFPGLTILHLAFN-------QLIGGLPAS 209 (948)
Q Consensus 140 ~L~~L~Ls~N~--l~~~~~p~~~~~l~~L~~L~l~~n-~l~~~~p~~~~~~~l~~L~~L~Ls~N-------~l~~~~p~~ 209 (948)
+|+.|+|++|. +....++..+.++++|++|++++| .+.+ ++..+. .+++|+.|+++.+ .+.+.. ..
T Consensus 185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~--~~~~L~~L~l~~~~~~~~~~~~~~l~-~~ 260 (594)
T 2p1m_B 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQ--RAPQLEELGTGGYTAEVRPDVYSGLS-VA 260 (594)
T ss_dssp CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHH--HCTTCSEEECSBCCCCCCHHHHHHHH-HH
T ss_pred cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHh--cCCcceEcccccccCccchhhHHHHH-HH
Confidence 67777777665 211011222334567777777766 3333 444444 5666666664433 222211 11
Q ss_pred ccc-ccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCC-C-CCCCCCCcEEeccCCcccc-ccchhhhC
Q 002238 210 FSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-D-FSGVKQLESLSLRDNFFTG-PVPDSLVK 285 (948)
Q Consensus 210 ~~~-~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~-~~~l~~L~~L~L~~N~l~~-~~p~~l~~ 285 (948)
+.. .+++.|. +... ......+..+..+++|++|+|++|.+++... . +..+++|+.|++++| +.. .++.....
T Consensus 261 l~~~~~L~~Ls--~~~~-~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~ 336 (594)
T 2p1m_B 261 LSGCKELRCLS--GFWD-AVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLAST 336 (594)
T ss_dssp HHTCTTCCEEE--CCBT-CCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHH
T ss_pred HhcCCCccccc--CCcc-cchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHh
Confidence 111 1222221 1110 1112223334467788888888888664322 2 345677888888877 432 23333345
Q ss_pred CCCCcEEEccc---------Cccccc-CCCC-CCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccC
Q 002238 286 LESLKIVNMTN---------NLLQGP-VPEF-DRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 354 (948)
Q Consensus 286 l~~L~~L~Ls~---------N~l~g~-~p~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 354 (948)
+++|+.|+|++ |.+++. +..+ ..+.+|+.+....+.... ..+..+.........+...+.
T Consensus 337 ~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~---------~~~~~l~~~~~~L~~L~L~~~ 407 (594)
T 2p1m_B 337 CKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTN---------AALITIARNRPNMTRFRLCII 407 (594)
T ss_dssp CTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCH---------HHHHHHHHHCTTCCEEEEEES
T ss_pred CCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCH---------HHHHHHHhhCCCcceeEeecc
Confidence 77778877732 344321 0000 012222222222221110 011111111111222222211
Q ss_pred CCCCCCCc--------c-ceeecCCceEEEEccCCcccccCCccccC-ccccceEeCccccccccCCcCC-cCCCCCcEE
Q 002238 355 GNDPCSDW--------I-GVTCTKGNITVINFQKMNLTGTISPEFAS-FKSLQRLILADNNLSGMIPEGL-SVLGALKEL 423 (948)
Q Consensus 355 ~~~~~~~~--------~-~~~~~~~~L~~L~ls~n~l~g~ip~~~~~-l~~L~~L~Ls~N~l~g~ip~~l-~~l~~L~~L 423 (948)
+...|... + ..+..+++|+.|+|++ .+++..+..++. +++|+.|+|++|.+++..+..+ ..+++|++|
T Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L 486 (594)
T 2p1m_B 408 EPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKL 486 (594)
T ss_dssp STTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEE
T ss_pred cCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEE
Confidence 10001000 0 1133456788888877 676666666665 7888888888888876555444 567888888
Q ss_pred EccCCcccCCCC-----CCCcccccccCCCCC
Q 002238 424 DVSNNQLYGKIP-----SFKSNAIVNTDGNPD 450 (948)
Q Consensus 424 ~ls~N~l~g~ip-----~~~~~~~~~~~gnp~ 450 (948)
+|++|++++..+ .+.....+.+.+|+.
T Consensus 487 ~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 487 EIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp EEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred ECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 888888854322 234455666666643
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=4e-20 Score=217.41 Aligned_cols=191 Identities=17% Similarity=0.162 Sum_probs=140.9
Q ss_pred cCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCcc-------------ccccCCCCCCCCCCCCCcEEE-ccccc
Q 002238 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN-------------ITGQIPSFFGPDEFPGLTILH-LAFNQ 201 (948)
Q Consensus 136 ~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~-------------l~~~~p~~~~~~~l~~L~~L~-Ls~N~ 201 (948)
..+++|+.|+|++|+++ .+|..++++++|+.|++++|. +.+.+|..++ .+++|+.|+ ++.|.
T Consensus 346 ~~~~~L~~L~Ls~n~L~--~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~--~l~~L~~L~~l~~n~ 421 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST--VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQ--YFSTLKAVDPMRAAY 421 (567)
T ss_dssp STTTTSSSCCCCHHHHH--HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHH--HHHHHHHHCGGGHHH
T ss_pred ccCccceeccCChhhHH--hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHH--HHHhcccCcchhhcc
Confidence 45666666666666665 566666666666666665543 2333333333 334444444 33332
Q ss_pred ccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccch
Q 002238 202 LIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPD 281 (948)
Q Consensus 202 l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 281 (948)
+++|..+.+++|.++...+ ..|+.|+|++|+|++ +|.
T Consensus 422 -------------------------------------~~~L~~l~l~~n~i~~l~~-----~~L~~L~Ls~n~l~~-lp~ 458 (567)
T 1dce_A 422 -------------------------------------LDDLRSKFLLENSVLKMEY-----ADVRVLHLAHKDLTV-LCH 458 (567)
T ss_dssp -------------------------------------HHHHHHHHHHHHHHHHHHH-----TTCSEEECTTSCCSS-CCC
T ss_pred -------------------------------------cchhhhhhhhcccccccCc-----cCceEEEecCCCCCC-CcC
Confidence 2345556667777765433 358999999999995 777
Q ss_pred hhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCC
Q 002238 282 SLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSD 361 (948)
Q Consensus 282 ~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (948)
++.+++|+.|+|++|+|+ .+|.
T Consensus 459 -~~~l~~L~~L~Ls~N~l~-~lp~-------------------------------------------------------- 480 (567)
T 1dce_A 459 -LEQLLLVTHLDLSHNRLR-ALPP-------------------------------------------------------- 480 (567)
T ss_dssp -GGGGTTCCEEECCSSCCC-CCCG--------------------------------------------------------
T ss_pred -ccccccCcEeecCccccc-ccch--------------------------------------------------------
Confidence 999999999999999998 4553
Q ss_pred ccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccC-CcCCcCCCCCcEEEccCCcccCCCCC
Q 002238 362 WIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMI-PEGLSVLGALKELDVSNNQLYGKIPS 436 (948)
Q Consensus 362 ~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~i-p~~l~~l~~L~~L~ls~N~l~g~ip~ 436 (948)
.+..+++|+.|+|++|.|++ +| .|+++++|+.|+|++|+|++.+ |..|..+++|+.|+|++|+|++.+|.
T Consensus 481 ---~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 481 ---ALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp ---GGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred ---hhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 12345689999999999997 67 8999999999999999999887 99999999999999999999998775
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.69 E-value=3.5e-17 Score=173.53 Aligned_cols=168 Identities=14% Similarity=0.248 Sum_probs=142.0
Q ss_pred CEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccC
Q 002238 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148 (948)
Q Consensus 69 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 148 (948)
+++.++++.+++++.. .+..+++|++|++++|.|+.. +.+..+++|++|+|++|+|+++++ |..+++|+.|+|++
T Consensus 20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~ 94 (263)
T 1xeu_A 20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-AGMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNR 94 (263)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCS
T ss_pred HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-hHHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCC
Confidence 3455667778877443 578899999999999999865 478899999999999999999887 99999999999999
Q ss_pred CCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCc
Q 002238 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAK 228 (948)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~ 228 (948)
|++++ +|.... ++|+.|+|++|++++. + .+. .+++|++|+|++|++++. + .
T Consensus 95 N~l~~--l~~~~~--~~L~~L~L~~N~l~~~-~-~l~--~l~~L~~L~Ls~N~i~~~-~-~------------------- 145 (263)
T 1xeu_A 95 NRLKN--LNGIPS--ACLSRLFLDNNELRDT-D-SLI--HLKNLEILSIRNNKLKSI-V-M------------------- 145 (263)
T ss_dssp SCCSC--CTTCCC--SSCCEEECCSSCCSBS-G-GGT--TCTTCCEEECTTSCCCBC-G-G-------------------
T ss_pred CccCC--cCcccc--CcccEEEccCCccCCC-h-hhc--CcccccEEECCCCcCCCC-h-H-------------------
Confidence 99995 554333 9999999999999975 3 455 899999999999999854 2 2
Q ss_pred cCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccc
Q 002238 229 LGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGP 278 (948)
Q Consensus 229 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~ 278 (948)
+..+++|+.|+|++|++++. +.+..+++|+.|+|++|.+++.
T Consensus 146 -------l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 146 -------LGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp -------GGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred -------HccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence 45789999999999999987 7788999999999999999954
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.1e-17 Score=203.05 Aligned_cols=193 Identities=16% Similarity=0.151 Sum_probs=123.1
Q ss_pred EEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCC
Q 002238 73 IQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFS 152 (948)
Q Consensus 73 l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 152 (948)
+++..|.+. ..+..+..++.|+.|+|++|.|..+++.+.++++|++|+|++|.|+. +|..|++|++|++|+|++|+|+
T Consensus 206 ~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~l~~L~~L~Ls~N~l~ 283 (727)
T 4b8c_D 206 DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLTE-LPAEIKNLSNLRVLDLSHNRLT 283 (727)
T ss_dssp -----------------CCCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCSC-CCGGGGGGTTCCEEECTTSCCS
T ss_pred cccccccee-cChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCcc-cChhhhCCCCCCEEeCcCCcCC
Confidence 333333333 45778999999999999999999766678899999999999999994 4567899999999999999999
Q ss_pred CCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCC
Q 002238 153 SWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGG 232 (948)
Q Consensus 153 ~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~ 232 (948)
.+|..+.++++|++|+|++|.|+ .+|..|+ .+++|++|+|++|+|++.+|..+.
T Consensus 284 --~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~--~l~~L~~L~L~~N~l~~~~p~~~~--------------------- 337 (727)
T 4b8c_D 284 --SLPAELGSCFQLKYFYFFDNMVT-TLPWEFG--NLCNLQFLGVEGNPLEKQFLKILT--------------------- 337 (727)
T ss_dssp --SCCSSGGGGTTCSEEECCSSCCC-CCCSSTT--SCTTCCCEECTTSCCCSHHHHHHH---------------------
T ss_pred --ccChhhcCCCCCCEEECCCCCCC-ccChhhh--cCCCccEEeCCCCccCCCChHHHh---------------------
Confidence 68999999999999999999997 6777787 899999999999999998887753
Q ss_pred ccccccC-CCccEEEccCCcccccCCCCCCCCCCcEEeccCC--------ccccccchhhhCCCCCcEEEcccCcccccC
Q 002238 233 IDVIQNM-TSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDN--------FFTGPVPDSLVKLESLKIVNMTNNLLQGPV 303 (948)
Q Consensus 233 ~~~l~~l-~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N--------~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~ 303 (948)
.+ ..+..|+|++|.+++.+| ..|+.|++++| .|.+..+..+.++..+....+++|-+.+..
T Consensus 338 -----~~~~~~~~l~l~~N~l~~~~p-----~~l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~~~ 407 (727)
T 4b8c_D 338 -----EKSVTGLIFYLRDNRPEIPLP-----HERRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQHY 407 (727)
T ss_dssp -----HHHHHHHHHHHHHCCCCCCCC-----CC-----------------------------------------CCCGGG
T ss_pred -----hcchhhhHHhhccCcccCcCc-----cccceeEeecccccccccCCccccccchhhcccccceeeeecccccccc
Confidence 11 122347899999998777 35677777777 444455555667777788888888876543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.65 E-value=5.3e-16 Score=156.10 Aligned_cols=131 Identities=21% Similarity=0.285 Sum_probs=118.4
Q ss_pred EEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCC--cCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccC
Q 002238 71 TRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148 (948)
Q Consensus 71 ~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~--~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 148 (948)
+.+++++++++ .+|..+.. +|++|+|++|+|++.++. |.++++|++|+|++|+|++++|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 45778888886 78877654 899999999999998874 88999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCC
Q 002238 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLP 207 (948)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p 207 (948)
|+|++ ..|..+.++++|++|+|++|+|++.+|..|. .+++|++|+|++|.+.+..+
T Consensus 88 N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFE--HLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCE-ECSSSSTTCTTCCEEECCSSCCCEECTTSST--TCTTCCEEECTTCCBCCSGG
T ss_pred CcCCc-cCHHHhcCCCCCCEEECCCCcCCeeCHHHhh--cCCCCCEEEeCCCCccCcCc
Confidence 99996 4566799999999999999999999999997 89999999999999997655
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.65 E-value=2.8e-16 Score=158.17 Aligned_cols=111 Identities=21% Similarity=0.298 Sum_probs=76.5
Q ss_pred cEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCc-cccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccC
Q 002238 95 ERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSD-FFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANS 173 (948)
Q Consensus 95 ~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~ 173 (948)
+.|++++|+|+.++..+.. +|++|+|++|+|+++++. .|+.+++|++|+|++|+|++ ..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcCcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCC-cCHhHcCCcccCCEEECCC
Confidence 5778888877655444433 777777777777777764 47777777777777777775 4466677777777777777
Q ss_pred ccccccCCCCCCCCCCCCCcEEEcccccccccCCCCc
Q 002238 174 ANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASF 210 (948)
Q Consensus 174 n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 210 (948)
|+|++..+..|. .+++|++|+|++|++++..|..|
T Consensus 88 N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~ 122 (192)
T 1w8a_A 88 NKIKEISNKMFL--GLHQLKTLNLYDNQISCVMPGSF 122 (192)
T ss_dssp CCCCEECSSSST--TCTTCCEEECCSSCCCEECTTSS
T ss_pred CcCCccCHHHhc--CCCCCCEEECCCCcCCeeCHHHh
Confidence 777766666665 66677777777777666655554
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.64 E-value=2.3e-18 Score=206.07 Aligned_cols=321 Identities=14% Similarity=0.132 Sum_probs=208.7
Q ss_pred CCEEEEEeCCC-CCcCC-CCccccCCCCCcEEEcccCCCCCCCC----C-cCCCCCCcEEEcccccccCCCCcc----cc
Q 002238 68 KRITRIQIGHQ-NLQGT-LPSNLQNLTKLERLELQWNSISGPLP----S-LNGLASLEVVMLSNNQFTSVPSDF----FT 136 (948)
Q Consensus 68 ~~v~~l~l~~~-~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~p----~-~~~l~~L~~L~L~~N~l~~~~~~~----~~ 136 (948)
.+++.|+|++| .++.. ++..+.++++|++|+|++|.+++..+ . ...+++|++|+|++|. ..+.... +.
T Consensus 130 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~l~~l~~ 208 (594)
T 2p1m_B 130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSALERLVT 208 (594)
T ss_dssp TTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHHHHHHHH
T ss_pred CCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHHHHHHHH
Confidence 58999999988 55532 44445578999999999998776433 2 3367899999999987 2222222 34
Q ss_pred CCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCcc--------------------------cc----ccCCCCCCC
Q 002238 137 GLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN--------------------------IT----GQIPSFFGP 186 (948)
Q Consensus 137 ~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~--------------------------l~----~~~p~~~~~ 186 (948)
++++|+.|+|++|.... .+|..+.++++|+.|++..+. +. +.++..+.
T Consensus 209 ~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~- 286 (594)
T 2p1m_B 209 RCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYS- 286 (594)
T ss_dssp HCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHH-
T ss_pred hCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHH-
Confidence 56999999999883222 366777777888888755442 11 11222222
Q ss_pred CCCCCCcEEEcccccccccCCCCc-c-cccccceeccCCCCCCccCCCccccccCCCccEEEccC---------Cccccc
Q 002238 187 DEFPGLTILHLAFNQLIGGLPASF-S-GSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHS---------NAFSGP 255 (948)
Q Consensus 187 ~~l~~L~~L~Ls~N~l~~~~p~~~-~-~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~---------N~l~~~ 255 (948)
.+++|++|+|++|.+++.....+ . ..+|+.|++.++. ...+.......+++|++|+|++ |.+++.
T Consensus 287 -~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~~---~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~ 362 (594)
T 2p1m_B 287 -VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYI---EDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQ 362 (594)
T ss_dssp -HHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGGG---HHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHH
T ss_pred -hhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCcc---CHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHH
Confidence 46899999999998765432221 1 1467788777541 1112222334689999999943 455442
Q ss_pred C-CCC-CCCCCCcEEeccCCccccccchhhh-CCCCCcEEEcc--c----CcccccCCC------CCCccccccccccCC
Q 002238 256 L-PDF-SGVKQLESLSLRDNFFTGPVPDSLV-KLESLKIVNMT--N----NLLQGPVPE------FDRSVSLDMAKGSNN 320 (948)
Q Consensus 256 ~-~~~-~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls--~----N~l~g~~p~------~~~~~~l~~~~~~~~ 320 (948)
. ..+ .++++|+.|.+..|++++..+..+. .+++|+.|+|+ + |.+++...+ +..+.+|+.++..++
T Consensus 363 ~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~~ 442 (594)
T 2p1m_B 363 GLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGL 442 (594)
T ss_dssp HHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCSS
T ss_pred HHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecCc
Confidence 1 122 2378999999999999977777776 58999999999 4 455521110 122233333333221
Q ss_pred CCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceee-cCCceEEEEccCCcccccCCccc-cCccccce
Q 002238 321 FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTC-TKGNITVINFQKMNLTGTISPEF-ASFKSLQR 398 (948)
Q Consensus 321 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~L~ls~n~l~g~ip~~~-~~l~~L~~ 398 (948)
. . .. . ...+. .+++|+.|+|++|.+++..+..+ ..+++|+.
T Consensus 443 l----~---~~---~---------------------------~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~ 485 (594)
T 2p1m_B 443 L----T---DK---V---------------------------FEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRK 485 (594)
T ss_dssp C----C---HH---H---------------------------HHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCE
T ss_pred c----c---HH---H---------------------------HHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCE
Confidence 0 0 00 0 00111 25689999999999988766666 67999999
Q ss_pred EeCccccccccCCc-CCcCCCCCcEEEccCCcccC
Q 002238 399 LILADNNLSGMIPE-GLSVLGALKELDVSNNQLYG 432 (948)
Q Consensus 399 L~Ls~N~l~g~ip~-~l~~l~~L~~L~ls~N~l~g 432 (948)
|+|++|.+++..+. .+..+++|++|++++|+++.
T Consensus 486 L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~ 520 (594)
T 2p1m_B 486 LEIRDCPFGDKALLANASKLETMRSLWMSSCSVSF 520 (594)
T ss_dssp EEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred EECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence 99999999765544 44568999999999999853
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=4.2e-16 Score=153.32 Aligned_cols=137 Identities=18% Similarity=0.191 Sum_probs=123.2
Q ss_pred CCEEEEEeCCCCCc-CCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEc
Q 002238 68 KRITRIQIGHQNLQ-GTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (948)
Q Consensus 68 ~~v~~l~l~~~~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (948)
.+++.|++++|+++ +.+|..+..+++|++|+|++|.|++. +.+..+++|++|+|++|++++.+|..+..+++|++|+|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 57999999999998 88999999999999999999999988 88999999999999999999988888889999999999
Q ss_pred cCCCCCCCCCCccccCCCCCCEEEccCccccccCC---CCCCCCCCCCCcEEEcccccccccCCC
Q 002238 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIP---SFFGPDEFPGLTILHLAFNQLIGGLPA 208 (948)
Q Consensus 147 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p---~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 208 (948)
++|+++++..+..+..+++|+.|++++|.+++..+ ..+. .+++|++|++++|.+. .+|.
T Consensus 103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~--~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFK--LLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHT--TCSSCCEETTEETTSC-BCCS
T ss_pred cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHH--hCccCcEecCCCCChh-hccc
Confidence 99999953333789999999999999999997766 4665 8999999999999987 4443
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.1e-16 Score=175.20 Aligned_cols=138 Identities=14% Similarity=0.169 Sum_probs=100.4
Q ss_pred CCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCC------------hhhHH--------HHHHHHHHHHhcCCCce
Q 002238 594 NFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS------------GKGLT--------EFKSEIAVLTKVRHRHL 653 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~------------~~~~~--------~~~~E~~~l~~l~H~ni 653 (948)
-|++.+.||+|+||.||+|...+|+.||||+++..... ..... ...+|...|.++.+..+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 38999999999999999999889999999987543111 00011 12356777777754443
Q ss_pred e--eEEeEEEeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEE
Q 002238 654 V--ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (948)
Q Consensus 654 v--~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nil 731 (948)
. ..+++ ...+|||||++|++|.++.. . .....++.|++.+|.|||. .|||||||||.|||
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~---------~--~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NIL 237 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSS---------V--PDPASLYADLIALILRLAK---HGLIHGDFNEFNIL 237 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCC---------C--SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhcc---------c--HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEE
Confidence 2 22221 23379999999988865431 1 1234678999999999997 89999999999999
Q ss_pred EcCCCC----------eEEeecCCceec
Q 002238 732 LGDDMR----------AKVADFGLVRLA 749 (948)
Q Consensus 732 l~~~~~----------~kl~DfGla~~~ 749 (948)
+++++. +.|+||+-+...
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred EeCCCCcccccccccceEEEEeCCcccC
Confidence 987763 899999976643
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.9e-15 Score=148.59 Aligned_cols=134 Identities=21% Similarity=0.355 Sum_probs=113.9
Q ss_pred CCccceEEeCCCCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccc
Q 002238 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFF 135 (948)
Q Consensus 57 C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~ 135 (948)
|.|.++.|. +++++ .+|..+. ++|++|+|++|++++.++ .|.++++|++|+|++|+|+++++..|
T Consensus 7 C~~~~l~~~-----------~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 72 (177)
T 2o6r_A 7 CSGTEIRCN-----------SKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVF 72 (177)
T ss_dssp EETTEEECC-----------SSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTT
T ss_pred eCCCEEEec-----------CCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHc
Confidence 567766664 45555 4565443 789999999999998777 57899999999999999999999999
Q ss_pred cCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCC
Q 002238 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLP 207 (948)
Q Consensus 136 ~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p 207 (948)
..+++|+.|+|++|++++ ..+..+..+++|++|++++|++++..+..|. .+++|++|+|++|++.+..|
T Consensus 73 ~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 73 DKLTKLTILYLHENKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFD--RLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp TTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTT--TCTTCCEEECCSSCBCCCHH
T ss_pred cCCCccCEEECCCCCccc-cCHHHhhCCcccCEEECcCCcceEeCHHHhc--CCcccCEEEecCCCeeccCc
Confidence 999999999999999995 3455678999999999999999987777776 89999999999999987655
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=6.2e-16 Score=148.74 Aligned_cols=129 Identities=16% Similarity=0.204 Sum_probs=113.6
Q ss_pred CCEEEEEeCCCCCc-CCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEc
Q 002238 68 KRITRIQIGHQNLQ-GTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (948)
Q Consensus 68 ~~v~~l~l~~~~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (948)
.+++.|++++|+++ +.+|..+..+++|++|+|++|.|++. +.+..+++|++|+|++|.+++.+|..+..+++|++|+|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 47889999999998 88999899999999999999999987 78899999999999999999988888888999999999
Q ss_pred cCCCCCCCCCCccccCCCCCCEEEccCccccccCC---CCCCCCCCCCCcEEEccc
Q 002238 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIP---SFFGPDEFPGLTILHLAF 199 (948)
Q Consensus 147 s~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p---~~~~~~~l~~L~~L~Ls~ 199 (948)
++|++++...+..+..+++|++|++++|.+++..+ ..+. .+++|++|++++
T Consensus 96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~--~l~~L~~L~l~d 149 (149)
T 2je0_A 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFK--LLPQLTYLDGYD 149 (149)
T ss_dssp TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHH--HCTTCCEETTBC
T ss_pred CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHH--HCCCcccccCCC
Confidence 99999853234889999999999999999997766 4565 789999998864
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=6.4e-15 Score=148.12 Aligned_cols=128 Identities=19% Similarity=0.312 Sum_probs=114.9
Q ss_pred EEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCC
Q 002238 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPF 151 (948)
Q Consensus 72 ~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 151 (948)
.+++++++++ .+|..+. ++|++|+|++|+|+.+++.|.++++|++|+|++|+|+++++..|.++++|++|+|++|+|
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 5778888888 6777664 689999999999997666899999999999999999999999999999999999999999
Q ss_pred CCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEccccccccc
Q 002238 152 SSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGG 205 (948)
Q Consensus 152 ~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~ 205 (948)
+. ..|..|..+++|++|+|++|+|+...+..|. .+++|++|+|++|.+.+.
T Consensus 91 ~~-i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 91 RC-IPPRTFDGLKSLRLLSLHGNDISVVPEGAFN--DLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CB-CCTTTTTTCTTCCEEECCSSCCCBCCTTTTT--TCTTCCEEECCSSCEECS
T ss_pred CE-eCHHHhCCCCCCCEEECCCCCCCeeChhhhh--cCccccEEEeCCCCeecC
Confidence 96 4466899999999999999999988877887 899999999999999753
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.58 E-value=4.7e-15 Score=145.74 Aligned_cols=134 Identities=19% Similarity=0.186 Sum_probs=87.1
Q ss_pred CCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccce
Q 002238 139 SSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSL 218 (948)
Q Consensus 139 ~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l 218 (948)
++|+.|+|++|+++...+|..+..+++|++|++++|.+++. ..+. .+++|++|+|++|++++.+|..+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~--~l~~L~~L~Ls~N~l~~~~~~~~-------- 91 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLP--KLPKLKKLELSENRIFGGLDMLA-------- 91 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCC--CCSSCCEEEEESCCCCSCCCHHH--------
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhc--cCCCCCEEECcCCcCchHHHHHH--------
Confidence 44555555555554114455555555555555555555544 4444 66777777777777765554432
Q ss_pred eccCCCCCCccCCCccccccCCCccEEEccCCcccccC--CCCCCCCCCcEEeccCCccccccc---hhhhCCCCCcEEE
Q 002238 219 WVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPL--PDFSGVKQLESLSLRDNFFTGPVP---DSLVKLESLKIVN 293 (948)
Q Consensus 219 ~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~--~~~~~l~~L~~L~L~~N~l~~~~p---~~l~~l~~L~~L~ 293 (948)
.++++|++|+|++|++++.. +.+..+++|+.|+|++|.+++..+ ..+..+++|+.|+
T Consensus 92 ------------------~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~ 153 (168)
T 2ell_A 92 ------------------EKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD 153 (168)
T ss_dssp ------------------HHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEET
T ss_pred ------------------hhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEec
Confidence 35677777777777777643 457778888888888888885444 4788888888888
Q ss_pred cccCccccc
Q 002238 294 MTNNLLQGP 302 (948)
Q Consensus 294 Ls~N~l~g~ 302 (948)
+++|.+...
T Consensus 154 l~~n~~~~~ 162 (168)
T 2ell_A 154 GYDREDQEA 162 (168)
T ss_dssp TEETTSCBC
T ss_pred CCCCChhhc
Confidence 888887643
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.55 E-value=3.5e-14 Score=140.78 Aligned_cols=133 Identities=21% Similarity=0.323 Sum_probs=111.0
Q ss_pred CcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccC
Q 002238 94 LERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANS 173 (948)
Q Consensus 94 L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~ 173 (948)
.+.+++++|+++..+..+. ++|++|+|++|+++++++..|..+++|++|+|++|+++. ..+..+..+++|++|+|++
T Consensus 9 ~~~l~~~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCSSCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-CCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCccCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceE-eChhHccCCCccCEEECCC
Confidence 5789999999987665443 789999999999999999999999999999999999995 3345678999999999999
Q ss_pred ccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCccc
Q 002238 174 ANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS 253 (948)
Q Consensus 174 n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 253 (948)
|+|++..+..|. .+++|++|+|++|++++..+..| .++++|++|+|++|.+.
T Consensus 86 N~l~~~~~~~~~--~l~~L~~L~l~~N~l~~~~~~~~--------------------------~~l~~L~~L~l~~N~~~ 137 (177)
T 2o6r_A 86 NKLQSLPNGVFD--KLTQLKELALDTNQLKSVPDGIF--------------------------DRLTSLQKIWLHTNPWD 137 (177)
T ss_dssp SCCCCCCTTTTT--TCTTCCEEECCSSCCSCCCTTTT--------------------------TTCTTCCEEECCSSCBC
T ss_pred CCccccCHHHhh--CCcccCEEECcCCcceEeCHHHh--------------------------cCCcccCEEEecCCCee
Confidence 999988888776 89999999999999985544333 36778888888888777
Q ss_pred ccCC
Q 002238 254 GPLP 257 (948)
Q Consensus 254 ~~~~ 257 (948)
+..+
T Consensus 138 ~~~~ 141 (177)
T 2o6r_A 138 CSCP 141 (177)
T ss_dssp CCHH
T ss_pred ccCc
Confidence 6443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.54 E-value=4e-15 Score=163.56 Aligned_cols=103 Identities=14% Similarity=0.134 Sum_probs=73.6
Q ss_pred CCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHH
Q 002238 262 VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVK 341 (948)
Q Consensus 262 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 341 (948)
+++|+.|+|++|+++...+..|.++++|+.|+|.+| ++. ++.
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~-I~~------------------------------------ 266 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKT-IGQ------------------------------------ 266 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCE-ECT------------------------------------
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cce-ehH------------------------------------
Confidence 567777777777777555566777777777777776 442 221
Q ss_pred hhCCcchhccccCCCCCCCCccceeecCCceE-EEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCC
Q 002238 342 LMGYPQRFAENWKGNDPCSDWIGVTCTKGNIT-VINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGAL 420 (948)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~-~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L 420 (948)
+.|..+.+|+ .|++.+ +++..-+.+|.++++|+.|+|++|+++..-+..|.++++|
T Consensus 267 ----------------------~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L 323 (329)
T 3sb4_A 267 ----------------------RVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPS 323 (329)
T ss_dssp ----------------------TTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCC
T ss_pred ----------------------HHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcch
Confidence 1233445677 788877 6776667788888888888888888886667788888888
Q ss_pred cEEEc
Q 002238 421 KELDV 425 (948)
Q Consensus 421 ~~L~l 425 (948)
+.++.
T Consensus 324 ~~ly~ 328 (329)
T 3sb4_A 324 KLIYK 328 (329)
T ss_dssp CEEEC
T ss_pred hhhcc
Confidence 88763
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=5.8e-14 Score=141.09 Aligned_cols=82 Identities=24% Similarity=0.344 Sum_probs=38.8
Q ss_pred EEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcc
Q 002238 119 VVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLA 198 (948)
Q Consensus 119 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls 198 (948)
++++++|.++.++... .++|++|+|++|+|+ .+|..+.++++|+.|+|++|+|++..+..|. .+++|++|+|+
T Consensus 14 ~l~~~~~~l~~ip~~~---~~~l~~L~L~~n~i~--~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~--~l~~L~~L~Ls 86 (193)
T 2wfh_A 14 VVRCSNKGLKVLPKGI---PRDVTELYLDGNQFT--LVPKELSNYKHLTLIDLSNNRISTLSNQSFS--NMTQLLTLILS 86 (193)
T ss_dssp EEECTTSCCSSCCSCC---CTTCCEEECCSSCCC--SCCGGGGGCTTCCEEECCSSCCCCCCTTTTT--TCTTCCEEECC
T ss_pred EEEcCCCCCCcCCCCC---CCCCCEEECCCCcCc--hhHHHhhcccCCCEEECCCCcCCEeCHhHcc--CCCCCCEEECC
Confidence 3444444444443321 134555555555554 3444455555555555555555544444444 45555555555
Q ss_pred cccccccCC
Q 002238 199 FNQLIGGLP 207 (948)
Q Consensus 199 ~N~l~~~~p 207 (948)
+|+|++..|
T Consensus 87 ~N~l~~i~~ 95 (193)
T 2wfh_A 87 YNRLRCIPP 95 (193)
T ss_dssp SSCCCBCCT
T ss_pred CCccCEeCH
Confidence 555543333
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.53 E-value=9.6e-15 Score=140.35 Aligned_cols=127 Identities=17% Similarity=0.187 Sum_probs=77.0
Q ss_pred CCCcEEEccccccc-CCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCc
Q 002238 115 ASLEVVMLSNNQFT-SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLT 193 (948)
Q Consensus 115 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~ 193 (948)
++|++|+|++|.++ +..|..+..+++|+.|+|++|+++ +. ..+. .+++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~-------------------------~~--~~~~--~l~~L~ 67 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-------------------------SI--ANLP--KLNKLK 67 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCC-------------------------CC--TTCC--CCTTCC
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCC-------------------------Cc--hhhh--cCCCCC
Confidence 44555555555555 333444455555555555555554 33 3333 566666
Q ss_pred EEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccC--CCCCCCCCCcEEecc
Q 002238 194 ILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPL--PDFSGVKQLESLSLR 271 (948)
Q Consensus 194 ~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~--~~~~~l~~L~~L~L~ 271 (948)
+|+|++|++++.+|.. +.++++|++|+|++|++++.. ..+..+++|+.|+++
T Consensus 68 ~L~Ls~n~i~~~~~~~--------------------------~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~ 121 (149)
T 2je0_A 68 KLELSDNRVSGGLEVL--------------------------AEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLF 121 (149)
T ss_dssp EEECCSSCCCSCTHHH--------------------------HHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECT
T ss_pred EEECCCCcccchHHHH--------------------------hhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCc
Confidence 6666666666544433 234667777777777776632 456677778888888
Q ss_pred CCccccccc---hhhhCCCCCcEEEccc
Q 002238 272 DNFFTGPVP---DSLVKLESLKIVNMTN 296 (948)
Q Consensus 272 ~N~l~~~~p---~~l~~l~~L~~L~Ls~ 296 (948)
+|.+++..+ ..+..+++|+.|++++
T Consensus 122 ~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 122 NCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp TCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCcccchHHHHHHHHHHCCCcccccCCC
Confidence 888875554 4677888888887763
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.49 E-value=3.1e-14 Score=141.03 Aligned_cols=131 Identities=15% Similarity=0.241 Sum_probs=114.4
Q ss_pred CCCCEEEEEeCCCCCcCCCCccccCCC-CCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEE
Q 002238 66 EDKRITRIQIGHQNLQGTLPSNLQNLT-KLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSI 144 (948)
Q Consensus 66 ~~~~v~~l~l~~~~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 144 (948)
+..+++.|++++|+++ .+|. +..+. +|++|+|++|.|++. +.|.++++|++|+|++|+|+++++..|..+++|++|
T Consensus 17 ~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 17 NAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 93 (176)
T ss_dssp CTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEE
Confidence 3458999999999999 4554 55555 999999999999987 789999999999999999999998888999999999
Q ss_pred EccCCCCCCCCCCc--cccCCCCCCEEEccCccccccCCCC----CCCCCCCCCcEEEcccccccc
Q 002238 145 EIDNNPFSSWEIPQ--SLRNASGLQNFSANSANITGQIPSF----FGPDEFPGLTILHLAFNQLIG 204 (948)
Q Consensus 145 ~Ls~N~l~~~~~p~--~~~~l~~L~~L~l~~n~l~~~~p~~----~~~~~l~~L~~L~Ls~N~l~~ 204 (948)
+|++|+|+ .+|. .+..+++|+.|++++|.++. +|.. +. .+++|++||+++|.+..
T Consensus 94 ~L~~N~i~--~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~--~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 94 ILTNNSLV--ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIY--KVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp ECCSCCCC--CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHH--HCTTCSEETTEECCHHH
T ss_pred ECCCCcCC--cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHH--HCCccceeCCCcCCHHH
Confidence 99999997 5676 89999999999999999984 4553 65 79999999999998764
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.47 E-value=7.6e-14 Score=138.19 Aligned_cols=134 Identities=14% Similarity=0.134 Sum_probs=91.3
Q ss_pred ccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCccccc
Q 002238 135 FTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQ 214 (948)
Q Consensus 135 ~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 214 (948)
+.++++|+.|+|++|+++ .+|......++|++|++++|.|++. ..+. .+++|++|+|++|++++..+..
T Consensus 15 ~~~~~~L~~L~l~~n~l~--~i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~--~l~~L~~L~Ls~N~l~~~~~~~----- 83 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIP--VIENLGATLDQFDAIDFSDNEIRKL--DGFP--LLRRLKTLLVNNNRICRIGEGL----- 83 (176)
T ss_dssp EECTTSCEEEECTTSCCC--SCCCGGGGTTCCSEEECCSSCCCEE--CCCC--CCSSCCEEECCSSCCCEECSCH-----
T ss_pred cCCcCCceEEEeeCCCCc--hhHHhhhcCCCCCEEECCCCCCCcc--cccc--cCCCCCEEECCCCcccccCcch-----
Confidence 445566666666666665 3343222233666666666666654 3444 6777888888888877443322
Q ss_pred ccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCC--CCCCCCCCcEEeccCCccccccchh----hhCCCC
Q 002238 215 IQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP--DFSGVKQLESLSLRDNFFTGPVPDS----LVKLES 288 (948)
Q Consensus 215 l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~----l~~l~~ 288 (948)
+..+++|++|+|++|+++..++ .+..+++|+.|+|++|.++ .+|.. +..+++
T Consensus 84 ---------------------~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~ 141 (176)
T 1a9n_A 84 ---------------------DQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQ 141 (176)
T ss_dssp ---------------------HHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTT
T ss_pred ---------------------hhcCCCCCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCc
Confidence 2467788888888888865444 5777888999999999988 56664 889999
Q ss_pred CcEEEcccCcccc
Q 002238 289 LKIVNMTNNLLQG 301 (948)
Q Consensus 289 L~~L~Ls~N~l~g 301 (948)
|+.||+++|.+..
T Consensus 142 L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 142 VRVLDFQKVKLKE 154 (176)
T ss_dssp CSEETTEECCHHH
T ss_pred cceeCCCcCCHHH
Confidence 9999999998763
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.47 E-value=1.6e-12 Score=145.98 Aligned_cols=170 Identities=16% Similarity=0.136 Sum_probs=100.4
Q ss_pred CCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEE
Q 002238 92 TKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFS 170 (948)
Q Consensus 92 ~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ 170 (948)
..++.+.+.+ .++.+.+ +|.+. +|+.+.|.+| ++.+...+|.+. +|+.+.|.+ .++. --+.+|.++++|+.++
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~-I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQ-LKEDIFYYCYNLKKAD 186 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCE-ECSSTTTTCTTCCEEE
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccE-ehHHHhhCcccCCeee
Confidence 5566666643 3444333 56653 6777777665 666667777763 577777765 4542 1235667777777777
Q ss_pred ccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCC
Q 002238 171 ANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250 (948)
Q Consensus 171 l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N 250 (948)
+.+|+++......|. ..+|+.+.|..| +...-..+ |.++++|+.|+|..|
T Consensus 187 l~~n~l~~I~~~aF~---~~~L~~l~lp~~-l~~I~~~a--------------------------F~~~~~L~~l~l~~~ 236 (401)
T 4fdw_A 187 LSKTKITKLPASTFV---YAGIEEVLLPVT-LKEIGSQA--------------------------FLKTSQLKTIEIPEN 236 (401)
T ss_dssp CTTSCCSEECTTTTT---TCCCSEEECCTT-CCEECTTT--------------------------TTTCTTCCCEECCTT
T ss_pred cCCCcceEechhhEe---ecccCEEEeCCc-hheehhhH--------------------------hhCCCCCCEEecCCC
Confidence 777777766666663 467777777644 44333333 335666666666654
Q ss_pred cccccCC-CCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCccc
Q 002238 251 AFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ 300 (948)
Q Consensus 251 ~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 300 (948)
++.... .|.+ .+|+.+.| .|.++..-..+|.++++|+.+++.+|.+.
T Consensus 237 -l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~ 284 (401)
T 4fdw_A 237 -VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFN 284 (401)
T ss_dssp -CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCC
T ss_pred -ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCcccc
Confidence 332222 3444 56666666 34455344566666677777776666553
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.45 E-value=6.5e-16 Score=156.38 Aligned_cols=149 Identities=17% Similarity=0.267 Sum_probs=95.1
Q ss_pred CCcEEEcccccccCCCCc------cccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCC
Q 002238 116 SLEVVMLSNNQFTSVPSD------FFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEF 189 (948)
Q Consensus 116 ~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l 189 (948)
.++.++|+.|.+++..|. .|..+++|++|+|++|+++. +| .+.++++|++|++++|+++ .+|..+. .+
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~--l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~ 92 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK--IS-SLSGMENLRILSLGRNLIK-KIENLDA--VA 92 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC--CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH--HH
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc--cc-ccccCCCCCEEECCCCCcc-cccchhh--cC
Confidence 344444444444443333 56666666666666666663 45 6666666666666666666 3454443 45
Q ss_pred CCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCC--CCCCCCCCcE
Q 002238 190 PGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP--DFSGVKQLES 267 (948)
Q Consensus 190 ~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~ 267 (948)
++|++|+|++|++++ +| . +.++++|+.|+|++|++++..+ .+..+++|+.
T Consensus 93 ~~L~~L~L~~N~l~~-l~-~--------------------------~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~ 144 (198)
T 1ds9_A 93 DTLEELWISYNQIAS-LS-G--------------------------IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLED 144 (198)
T ss_dssp HHCSEEEEEEEECCC-HH-H--------------------------HHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSE
T ss_pred CcCCEEECcCCcCCc-CC-c--------------------------cccCCCCCEEECCCCcCCchhHHHHHhcCCCCCE
Confidence 677777777777764 22 1 3356778888888887775332 4667788888
Q ss_pred EeccCCccccccchh----------hhCCCCCcEEEcccCccc
Q 002238 268 LSLRDNFFTGPVPDS----------LVKLESLKIVNMTNNLLQ 300 (948)
Q Consensus 268 L~L~~N~l~~~~p~~----------l~~l~~L~~L~Ls~N~l~ 300 (948)
|++++|.+.+.+|.. +..+++|+.|| +|.++
T Consensus 145 L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 145 LLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp EEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred EEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 888888887666653 78888899886 66665
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.41 E-value=9.4e-13 Score=129.32 Aligned_cols=102 Identities=23% Similarity=0.327 Sum_probs=60.6
Q ss_pred EEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCC
Q 002238 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNP 150 (948)
Q Consensus 72 ~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 150 (948)
.+++++|+++ .+|..+. ++|++|+|++|+|++..| .|.++++|++|+|++|+|+++++..|..+++|++|+|++|+
T Consensus 13 ~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 4666666666 4555543 667777777777776655 46666677777777777766666666666666666666666
Q ss_pred CCCCCCCccccCCCCCCEEEccCcccc
Q 002238 151 FSSWEIPQSLRNASGLQNFSANSANIT 177 (948)
Q Consensus 151 l~~~~~p~~~~~l~~L~~L~l~~n~l~ 177 (948)
|+. ..+..+..+++|++|+|++|.++
T Consensus 90 l~~-~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 90 LKS-IPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CCC-CCTTTTTTCTTCCEEECCSSCBC
T ss_pred cCE-eCHHHhcCCCCCCEEEeCCCCCC
Confidence 663 11223444444444444444443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.40 E-value=1.1e-15 Score=154.64 Aligned_cols=161 Identities=20% Similarity=0.272 Sum_probs=127.4
Q ss_pred CCEEEEEeCCCCCcCCCCc------cccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCC
Q 002238 68 KRITRIQIGHQNLQGTLPS------NLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSL 141 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~------~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 141 (948)
.+++.++++.+++.|.+|. .+.++++|++|+|++|.|++. |.+.++++|++|+|++|.++.++ ..+..+++|
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l-~~~~~l~~L~~L~l~~n~l~~l~-~~~~~~~~L 95 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIKKIE-NLDAVADTL 95 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCC-CCHHHHTTCCEEEEEEEEECSCS-SHHHHHHHC
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCccc-cccccCCCCCEEECCCCCccccc-chhhcCCcC
Confidence 3566677777778777776 899999999999999999984 58999999999999999999764 567888999
Q ss_pred CEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCC-CCCCCCCCCCCcEEEcccccccccCCCCcccccccceec
Q 002238 142 QSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIP-SFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWV 220 (948)
Q Consensus 142 ~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~ 220 (948)
+.|+|++|++++ +| .+..+++|++|++++|++++..+ ..+. .+++|++|+|++|++.+.+|..-.
T Consensus 96 ~~L~L~~N~l~~--l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~--~l~~L~~L~l~~N~l~~~~~~~~~--------- 161 (198)
T 1ds9_A 96 EELWISYNQIAS--LS-GIEKLVNLRVLYMSNNKITNWGEIDKLA--ALDKLEDLLLAGNPLYNDYKENNA--------- 161 (198)
T ss_dssp SEEEEEEEECCC--HH-HHHHHHHSSEEEESEEECCCHHHHHHHT--TTTTCSEEEECSCHHHHHHHTTTT---------
T ss_pred CEEECcCCcCCc--CC-ccccCCCCCEEECCCCcCCchhHHHHHh--cCCCCCEEEecCCccccccccccc---------
Confidence 999999999994 56 68899999999999999986543 4555 799999999999999877664200
Q ss_pred cCCCCCCccCCCccccccCCCccEEEccCCccc
Q 002238 221 NGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS 253 (948)
Q Consensus 221 ~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 253 (948)
........+..+++|+.|| +|.++
T Consensus 162 -------~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 162 -------TSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp -------HHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred -------hHHHHHHHHHhCCCcEEEC--CcccC
Confidence 0000012245788888886 66665
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.39 E-value=8.6e-13 Score=144.85 Aligned_cols=99 Identities=20% Similarity=0.177 Sum_probs=63.4
Q ss_pred CCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCC-CCCCCCCCc-
Q 002238 189 FPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLE- 266 (948)
Q Consensus 189 l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~- 266 (948)
+++|+.|+|++|+++...+..| .++++|+.|+|.+| ++...+ .|.++.+|+
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF--------------------------~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~ 277 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTF--------------------------AQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAG 277 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTT--------------------------TTCTTCCEEECCTT-CCEECTTTTTTCTTCCE
T ss_pred cCCCeEEECCCCCcceecHhhh--------------------------hCCCCCCEEECCcc-cceehHHHhhCChhccE
Confidence 5678888888888774444443 36677777777776 554333 466777777
Q ss_pred EEeccCCccccccchhhhCCCCCcEEEcccCcccccCCC-CCCccccccc
Q 002238 267 SLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMA 315 (948)
Q Consensus 267 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~l~~~ 315 (948)
.|+|.+ .++..-+.+|.++++|+.|++++|+++...+. |.++.+|+.+
T Consensus 278 ~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~l 326 (329)
T 3sb4_A 278 TLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLI 326 (329)
T ss_dssp EEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEE
T ss_pred EEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhh
Confidence 777776 56545556777777777777777777655443 4555555443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.37 E-value=2.5e-12 Score=126.23 Aligned_cols=109 Identities=18% Similarity=0.239 Sum_probs=97.2
Q ss_pred CcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccC
Q 002238 94 LERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANS 173 (948)
Q Consensus 94 L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~ 173 (948)
.+.|++++|.|+.++..+. ++|++|+|++|+|+++++..|.++++|++|+|++|+|+. ..+..|.++++|++|+|++
T Consensus 11 ~~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTV-LPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-CCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCc-cChhhccCCCCCCEEECCC
Confidence 5789999999998665553 889999999999999999999999999999999999995 3345678999999999999
Q ss_pred ccccccCCCCCCCCCCCCCcEEEcccccccccCC
Q 002238 174 ANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLP 207 (948)
Q Consensus 174 n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p 207 (948)
|+|++..+..|. .+++|++|+|++|++++..+
T Consensus 88 N~l~~~~~~~~~--~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFD--NLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTT--TCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhc--CCCCCCEEEeCCCCCCCCch
Confidence 999988888887 89999999999999986554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.37 E-value=2.6e-12 Score=126.57 Aligned_cols=102 Identities=24% Similarity=0.436 Sum_probs=66.5
Q ss_pred EEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCC
Q 002238 71 TRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149 (948)
Q Consensus 71 ~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 149 (948)
+.+++++++++ .+|..+. ++|++|+|++|+|++.+| .|.++++|++|+|++|+|+++++..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 46777777775 6666554 677777777777777666 5667777777777777777777766677777777777777
Q ss_pred CCCCCCCCc-cccCCCCCCEEEccCcccc
Q 002238 150 PFSSWEIPQ-SLRNASGLQNFSANSANIT 177 (948)
Q Consensus 150 ~l~~~~~p~-~~~~l~~L~~L~l~~n~l~ 177 (948)
+|+. +|. .+..+++|++|+|++|.+.
T Consensus 92 ~l~~--l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKS--IPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCC--CCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccce--eCHHHhccccCCCEEEeCCCCcc
Confidence 7663 332 2444444444444444443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.36 E-value=3.2e-12 Score=125.88 Aligned_cols=106 Identities=19% Similarity=0.235 Sum_probs=94.9
Q ss_pred CcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCc-cccCCCCCCEEEcc
Q 002238 94 LERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQ-SLRNASGLQNFSAN 172 (948)
Q Consensus 94 L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~-~~~~l~~L~~L~l~ 172 (948)
-+.+++++|+|+.+++.+. ++|++|+|++|+|++++|..|.++++|+.|+|++|+|++ +|. .|.++++|++|+|+
T Consensus 14 ~~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--i~~~~~~~l~~L~~L~L~ 89 (174)
T 2r9u_A 14 QTLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA--IPTGVFDKLTQLTQLDLN 89 (174)
T ss_dssp SSEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC--CCTTTTTTCTTCCEEECC
T ss_pred CcEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCc--cChhHhCCcchhhEEECC
Confidence 3689999999987666564 899999999999999999999999999999999999995 555 46899999999999
Q ss_pred CccccccCCCCCCCCCCCCCcEEEccccccccc
Q 002238 173 SANITGQIPSFFGPDEFPGLTILHLAFNQLIGG 205 (948)
Q Consensus 173 ~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~ 205 (948)
+|+|++..+..|. .+++|++|+|++|++...
T Consensus 90 ~N~l~~l~~~~~~--~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 90 DNHLKSIPRGAFD--NLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp SSCCCCCCTTTTT--TCTTCSEEECCSSCBCTT
T ss_pred CCccceeCHHHhc--cccCCCEEEeCCCCcccc
Confidence 9999988777787 899999999999999854
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.32 E-value=3.3e-11 Score=135.16 Aligned_cols=253 Identities=10% Similarity=0.146 Sum_probs=186.4
Q ss_pred CCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCC
Q 002238 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIP 157 (948)
Q Consensus 79 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p 157 (948)
+++..-..+|.+ .+|+.++|..| ++.+.. +|.+ .+|+.+.|.+ .++.+...+|.++++|+.++|++|+++ .++
T Consensus 123 ~i~~I~~~aF~~-~~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~--~I~ 196 (401)
T 4fdw_A 123 SVKSIPKDAFRN-SQIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT--KLP 196 (401)
T ss_dssp TCCEECTTTTTT-CCCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS--EEC
T ss_pred ccCEehHhhccc-CCccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce--Eec
Confidence 344333456777 48999999776 666555 6877 4799999996 889999999999999999999999999 577
Q ss_pred ccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccc
Q 002238 158 QSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQ 237 (948)
Q Consensus 158 ~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~ 237 (948)
.......+|+.+.|.+ +++.....+|. .+++|+.++|..| ++..-..+|.
T Consensus 197 ~~aF~~~~L~~l~lp~-~l~~I~~~aF~--~~~~L~~l~l~~~-l~~I~~~aF~-------------------------- 246 (401)
T 4fdw_A 197 ASTFVYAGIEEVLLPV-TLKEIGSQAFL--KTSQLKTIEIPEN-VSTIGQEAFR-------------------------- 246 (401)
T ss_dssp TTTTTTCCCSEEECCT-TCCEECTTTTT--TCTTCCCEECCTT-CCEECTTTTT--------------------------
T ss_pred hhhEeecccCEEEeCC-chheehhhHhh--CCCCCCEEecCCC-ccCccccccc--------------------------
Confidence 6666679999999985 48877778887 8999999999876 5544444443
Q ss_pred cCCCccEEEccCCcccccCC-CCCCCCCCcEEeccCCccc-----cccchhhhCCCCCcEEEcccCcccccCCCCCCccc
Q 002238 238 NMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFT-----GPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVS 311 (948)
Q Consensus 238 ~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~-----~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~ 311 (948)
+ .+|+.+.| .|.++.... .|.++++|+.+.+.+|.+. ...+.+|.++++|+.++|.+ .++. ++.
T Consensus 247 ~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~-I~~------ 316 (401)
T 4fdw_A 247 E-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRI-LGQ------ 316 (401)
T ss_dssp T-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCE-ECT------
T ss_pred c-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEE-Ehh------
Confidence 3 56777777 344554433 5777888888888777664 35567788888888888873 3432 111
Q ss_pred cccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCcccc
Q 002238 312 LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFA 391 (948)
Q Consensus 312 l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~ 391 (948)
+.|..+.+|+.|+|.+| ++..-+.+|.
T Consensus 317 ----------------------------------------------------~aF~~c~~L~~l~lp~~-l~~I~~~aF~ 343 (401)
T 4fdw_A 317 ----------------------------------------------------GLLGGNRKVTQLTIPAN-VTQINFSAFN 343 (401)
T ss_dssp ----------------------------------------------------TTTTTCCSCCEEEECTT-CCEECTTSSS
T ss_pred ----------------------------------------------------hhhcCCCCccEEEECcc-ccEEcHHhCC
Confidence 12334456777888544 6666677888
Q ss_pred CccccceEeCccccccccCCcCCcCCC-CCcEEEccCCccc
Q 002238 392 SFKSLQRLILADNNLSGMIPEGLSVLG-ALKELDVSNNQLY 431 (948)
Q Consensus 392 ~l~~L~~L~Ls~N~l~g~ip~~l~~l~-~L~~L~ls~N~l~ 431 (948)
++ +|+.|++++|.+....+..|.+++ ++..|.+..|.+.
T Consensus 344 ~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 344 NT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp SS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred CC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 88 999999999988866677788884 7888988887654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=3.1e-11 Score=127.78 Aligned_cols=146 Identities=14% Similarity=0.074 Sum_probs=113.7
Q ss_pred HHhhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCceE
Q 002238 589 RNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 589 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 667 (948)
......|+....++.|+++.||++... ++.+++|+...... .....+.+|+++++.+. |..+.++++++.+.+..|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 344567888888999999999999855 78999999865311 22346899999999994 677889999998888899
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcc-------------------------------
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA------------------------------- 716 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------- 716 (948)
+||||++|.+|.+.+. +......++.+++++++.||+..
T Consensus 87 lv~e~i~G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEECCSSEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred EEEEecCCeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 9999999999876531 01123467889999999999721
Q ss_pred -------------------------CCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 717 -------------------------HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 717 -------------------------~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
...++|+|+++.||+++++..+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999876566799998654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.23 E-value=2e-11 Score=135.10 Aligned_cols=84 Identities=19% Similarity=0.256 Sum_probs=62.8
Q ss_pred CCccceEEeCCCCEEEEEeCCC-CCcCCCCccccCCCCCcEEEccc-CCCCCCCC-CcCCCCCCcEEEcccccccCCCCc
Q 002238 57 CKWNHVVCIEDKRITRIQIGHQ-NLQGTLPSNLQNLTKLERLELQW-NSISGPLP-SLNGLASLEVVMLSNNQFTSVPSD 133 (948)
Q Consensus 57 C~w~gv~c~~~~~v~~l~l~~~-~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~ 133 (948)
|.|..|.|. ++ +|+ .+|. |..+++|++|+|++ |.|+++++ .|.+|++|++|+|++|+|++++|.
T Consensus 8 C~~~~v~~~-----------~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 8 HGSSGLRCT-----------RDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp SSSSCEECC-----------SSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred ccCCEEEcC-----------CCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 666666553 34 566 4777 88888888888885 88887766 577788888888888888888777
Q ss_pred cccCCCCCCEEEccCCCCCC
Q 002238 134 FFTGLSSLQSIEIDNNPFSS 153 (948)
Q Consensus 134 ~~~~l~~L~~L~Ls~N~l~~ 153 (948)
.|.+|++|+.|+|++|+|++
T Consensus 75 ~~~~l~~L~~L~l~~N~l~~ 94 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALES 94 (347)
T ss_dssp GGGSCSCCCEEECCSSCCSC
T ss_pred HhcCCcCCCEEeCCCCccce
Confidence 77777777777777777773
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.17 E-value=5.4e-11 Score=131.61 Aligned_cols=106 Identities=15% Similarity=0.168 Sum_probs=94.9
Q ss_pred cEEEcccC-CCCCCCCCcCCCCCCcEEEccc-ccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEcc
Q 002238 95 ERLELQWN-SISGPLPSLNGLASLEVVMLSN-NQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSAN 172 (948)
Q Consensus 95 ~~L~L~~N-~l~~~~p~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~ 172 (948)
..++++++ +|+.+++ +..+++|++|+|++ |+|+++++..|.+|++|+.|+|++|+|++ ..|..|.++++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF-VAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCE-ECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccce-eCHHHhcCCcCCCEEeCC
Confidence 35789888 8998776 99999999999996 99999999999999999999999999997 557789999999999999
Q ss_pred CccccccCCCCCCCCCCCCCcEEEccccccccc
Q 002238 173 SANITGQIPSFFGPDEFPGLTILHLAFNQLIGG 205 (948)
Q Consensus 173 ~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~ 205 (948)
+|+|++..+..|. .++ |+.|+|++|++...
T Consensus 89 ~N~l~~~~~~~~~--~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 89 FNALESLSWKTVQ--GLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp SSCCSCCCSTTTC--SCC-CCEEECCSSCCCCC
T ss_pred CCccceeCHHHcc--cCC-ceEEEeeCCCccCC
Confidence 9999988877775 454 99999999999853
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.17 E-value=3.9e-13 Score=149.43 Aligned_cols=165 Identities=15% Similarity=0.135 Sum_probs=98.1
Q ss_pred CCCcEEEcccccccCCCCccccC-----CCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCC---
Q 002238 115 ASLEVVMLSNNQFTSVPSDFFTG-----LSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGP--- 186 (948)
Q Consensus 115 ~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~--- 186 (948)
+.|++|+|++|.|+......|.. .++|+.|+|++|.++...+..-...+++|+.|+|++|+|+......+..
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 44555666665555433332222 2566666666666653111122223456666777777665443333210
Q ss_pred CCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccC-----CCCCC
Q 002238 187 DEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPL-----PDFSG 261 (948)
Q Consensus 187 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~-----~~~~~ 261 (948)
...++|++|+|++|.|+..-...+ ...+..+++|++|+|++|.++... ..+..
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l----------------------~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~ 209 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVL----------------------MEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDR 209 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHH----------------------HHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGG
T ss_pred hcCCccceeeCCCCCCChHHHHHH----------------------HHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhc
Confidence 134678888888887764222111 122346778888888888887522 23556
Q ss_pred CCCCcEEeccCCcccc----ccchhhhCCCCCcEEEcccCcccc
Q 002238 262 VKQLESLSLRDNFFTG----PVPDSLVKLESLKIVNMTNNLLQG 301 (948)
Q Consensus 262 l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~g 301 (948)
.++|+.|+|++|.|+. .++..+...++|++|+|++|.|+.
T Consensus 210 ~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 210 NRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp CSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred CCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 6789999999998874 344556677899999999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.11 E-value=8.5e-11 Score=124.23 Aligned_cols=137 Identities=18% Similarity=0.149 Sum_probs=100.2
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCc--eeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH--LVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~ 670 (948)
..+....+.+.|..+.||++...+|+.++||+.... ....+.+|+++++.+.+.+ +.+++++...++..++||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 344443333466679999998777888999987542 2245789999999995544 456888888878889999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcc----------------------------------
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA---------------------------------- 716 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------- 716 (948)
||++|.++. .. ..+ ...++.++++.++.||+..
T Consensus 95 e~i~G~~l~--~~--------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 95 GEVPGQDLL--SS--------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp ECCSSEETT--TS--------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred EecCCcccC--cC--------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 999998884 20 111 2256777888888888631
Q ss_pred ---------------------CCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 717 ---------------------HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 717 ---------------------~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
...++|+|++|.||+++.++.+.|+|||.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999877667799999765
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.09 E-value=7.1e-13 Score=147.32 Aligned_cols=161 Identities=14% Similarity=0.109 Sum_probs=78.0
Q ss_pred CCCcEEEcccccccCCCCcc-ccCCCCCCEEEccCCCCCCCCCCccc-----cCCCCCCEEEccCcccccc----CCCCC
Q 002238 115 ASLEVVMLSNNQFTSVPSDF-FTGLSSLQSIEIDNNPFSSWEIPQSL-----RNASGLQNFSANSANITGQ----IPSFF 184 (948)
Q Consensus 115 ~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~p~~~-----~~l~~L~~L~l~~n~l~~~----~p~~~ 184 (948)
++|++|+|++|.|+...... ...+++|+.|+|++|+|+. .-...+ ...++|+.|+|++|.|+.. ++..+
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~-~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L 179 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGP-EACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGL 179 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCH-HHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCH-HHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHH
Confidence 34555555555544321111 1223455555555555542 111111 1234566666666655432 22222
Q ss_pred CCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCC-----CC
Q 002238 185 GPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-----DF 259 (948)
Q Consensus 185 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-----~~ 259 (948)
. ..++|++|+|++|+|...-...+ ...+...++|++|+|++|.++.... .+
T Consensus 180 ~--~~~~L~~L~Ls~N~l~~~g~~~L----------------------~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L 235 (372)
T 3un9_A 180 A--GNTSVTHLSLLHTGLGDEGLELL----------------------AAQLDRNRQLQELNVAYNGAGDTAALALARAA 235 (372)
T ss_dssp H--TCSSCCEEECTTSSCHHHHHHHH----------------------HHHGGGCSCCCEEECCSSCCCHHHHHHHHHHH
T ss_pred h--cCCCcCEEeCCCCCCCcHHHHHH----------------------HHHHhcCCCcCeEECCCCCCCHHHHHHHHHHH
Confidence 2 45667777777776653221111 1223455677777777777764211 23
Q ss_pred CCCCCCcEEeccCCccccccchhhhCCCC-----CcEEE--cccCccc
Q 002238 260 SGVKQLESLSLRDNFFTGPVPDSLVKLES-----LKIVN--MTNNLLQ 300 (948)
Q Consensus 260 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~-----L~~L~--Ls~N~l~ 300 (948)
...++|+.|+|++|.|+......+..+.. |+.+. +..|.+.
T Consensus 236 ~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 236 REHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp HHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred HhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 34567788888888777555555544321 55665 5555554
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.04 E-value=4.4e-09 Score=118.26 Aligned_cols=289 Identities=15% Similarity=0.100 Sum_probs=157.1
Q ss_pred ccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCC--------------
Q 002238 86 SNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNP-------------- 150 (948)
Q Consensus 86 ~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-------------- 150 (948)
.+|.++++|+.+.|.. .++.+.. +|.++++|+.++|.++ ++.+...+|.++++|+.+.+..+-
T Consensus 65 ~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~~~~ 142 (394)
T 4fs7_A 65 AAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAFKGCDFK 142 (394)
T ss_dssp TTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTTCCCS
T ss_pred HHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceeeeccccc
Confidence 3455555555555542 2443333 4555555555555433 444444555555555544443220
Q ss_pred -------CCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCccc-ccccceeccC
Q 002238 151 -------FSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNG 222 (948)
Q Consensus 151 -------l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~~~~ 222 (948)
+.. .-..+|.++++|+.+.+.++ +.......|. .+++|+.+++..| ++......|.. ..|+.+.+..
T Consensus 143 ~~~~~~~~~~-i~~~aF~~c~~L~~i~l~~~-~~~I~~~~F~--~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~ 217 (394)
T 4fs7_A 143 EITIPEGVTV-IGDEAFATCESLEYVSLPDS-METLHNGLFS--GCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPN 217 (394)
T ss_dssp EEECCTTCCE-ECTTTTTTCTTCCEEECCTT-CCEECTTTTT--TCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCT
T ss_pred ccccCccccc-cchhhhcccCCCcEEecCCc-cceecccccc--CCCCceEEEcCCC-ceEeCchhhccccccceeecCC
Confidence 110 01345677788888888654 3334455564 6778888887766 44333444433 2233333221
Q ss_pred CCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCccccc
Q 002238 223 QNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302 (948)
Q Consensus 223 ~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ 302 (948)
. .. ...+.....++|+.+.+..+.-.-....+.+...|+.+.+..+... .....|..+..|+.+.+..+.+..
T Consensus 218 ~---~~--~i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~- 290 (394)
T 4fs7_A 218 S---LY--YLGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPE- 290 (394)
T ss_dssp T---CC--EECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECT-
T ss_pred C---ce--EeehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeecc-
Confidence 1 00 0111223456777777765432211224667778888888777655 556677777888877776554321
Q ss_pred CCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcc
Q 002238 303 VPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNL 382 (948)
Q Consensus 303 ~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l 382 (948)
..+..+.+|..+...++. .. .....|....+|+.++|.++ +
T Consensus 291 -~~F~~~~~L~~i~l~~~i-~~------------------------------------I~~~aF~~c~~L~~i~lp~~-v 331 (394)
T 4fs7_A 291 -KTFYGCSSLTEVKLLDSV-KF------------------------------------IGEEAFESCTSLVSIDLPYL-V 331 (394)
T ss_dssp -TTTTTCTTCCEEEECTTC-CE------------------------------------ECTTTTTTCTTCCEECCCTT-C
T ss_pred -cccccccccccccccccc-ce------------------------------------echhhhcCCCCCCEEEeCCc-c
Confidence 012233333322221110 00 00123444567888888644 6
Q ss_pred cccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCC
Q 002238 383 TGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNN 428 (948)
Q Consensus 383 ~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N 428 (948)
+..-..+|.++++|+.++|..| ++..-...|.++.+|+.+++..|
T Consensus 332 ~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 332 EEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp CEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred cEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 6566677888899999988776 66455678888889998888654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.8e-09 Score=119.88 Aligned_cols=143 Identities=15% Similarity=0.215 Sum_probs=107.3
Q ss_pred ccceecccCceEEEEEEEcCCcEEEEEEee--cCcCChhhHHHHHHHHHHHHhcC--CCceeeEEeEEEeC---CceEEE
Q 002238 597 EENILGRGGFGTVYKGELHDGTKIAVKRME--AGVISGKGLTEFKSEIAVLTKVR--HRHLVALLGHCLDG---NEKLLV 669 (948)
Q Consensus 597 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~--~~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~---~~~~lv 669 (948)
..+.++.|.++.||+.... +..+++|+.. ... .......+.+|+++++.+. +..+.+++.++.+. +..|+|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 4567899999999999876 5788999765 321 1122357889999999996 45678888888776 447999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcc---------------------------------
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA--------------------------------- 716 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------- 716 (948)
|||++|..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 120 me~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 120 MEFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 9999998874321 134677888899999999999999731
Q ss_pred ----------------------CCCeeecCCCCccEEEcCCCC--eEEeecCCcee
Q 002238 717 ----------------------HQSFIHRDLKPSNILLGDDMR--AKVADFGLVRL 748 (948)
Q Consensus 717 ----------------------~~~ivHrDik~~Nill~~~~~--~kl~DfGla~~ 748 (948)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.91 E-value=1.5e-09 Score=117.54 Aligned_cols=186 Identities=18% Similarity=0.241 Sum_probs=121.6
Q ss_pred cceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCc--eeeEEeEEEeCC---ceEEEEE
Q 002238 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRH--LVALLGHCLDGN---EKLLVFE 671 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~~~~~~~~---~~~lv~e 671 (948)
.+.++.|....||+.. +.+++|+... ......+.+|+++++.+. +.. +.+++.....++ ..|+|||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 4568999999999873 5689997542 234577899999999883 332 344554443333 3489999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcc-----------------------------------
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA----------------------------------- 716 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------- 716 (948)
|++|.++.+... ..++..++..++.++++.++.||+..
T Consensus 97 ~i~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 97 KIKGVPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp CCCCEECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred ccCCeECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 999988865431 24566677778888888888888511
Q ss_pred --------------------CCCeeecCCCCccEEEcC--CCCeEEeecCCceecCCCCCcee-------------eeec
Q 002238 717 --------------------HQSFIHRDLKPSNILLGD--DMRAKVADFGLVRLAPEGKGSIE-------------TRIA 761 (948)
Q Consensus 717 --------------------~~~ivHrDik~~Nill~~--~~~~kl~DfGla~~~~~~~~~~~-------------~~~~ 761 (948)
...++|+|+++.||+++. ...+.|+||+.+........-.. ..+.
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHH
Confidence 135899999999999998 45688999998774321100000 0000
Q ss_pred ccccccC-ceecccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 002238 762 GTFGYLA-PEYAVTGRVTTKVDVFSFGVILMELITGRKAL 800 (948)
Q Consensus 762 gt~~y~a-PE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~ 800 (948)
...++.. |+.... .....+.|+++.++|++.+|+.+|
T Consensus 250 ~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1111122 222111 122368999999999999998765
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.85 E-value=3.9e-08 Score=110.50 Aligned_cols=265 Identities=12% Similarity=0.051 Sum_probs=157.8
Q ss_pred CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCC-CccccCCCCCCEEEccCc--------------
Q 002238 110 SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEI-PQSLRNASGLQNFSANSA-------------- 174 (948)
Q Consensus 110 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-p~~~~~l~~L~~L~l~~n-------------- 174 (948)
+|.++.+|+.+.|.. .++.+...+|.++++|+.++|.++ ++ .+ ..+|.++.+|+.+.+..+
T Consensus 66 AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~--~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~~~ 141 (394)
T 4fs7_A 66 AFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VK--MIGRCTFSGCYALKSILLPLMLKSIGVEAFKGCDF 141 (394)
T ss_dssp TTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CC--EECTTTTTTCTTCCCCCCCTTCCEECTTTTTTCCC
T ss_pred HhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ce--EccchhhcccccchhhcccCceeeecceeeecccc
Confidence 799999999999985 488899999999999999999866 54 33 456777777777665433
Q ss_pred -------cccccCCCCCCCCCCCCCcEEEcccccccccCCCCccc-ccccceeccCCCCCCccCCCccccccCCCccEEE
Q 002238 175 -------NITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIW 246 (948)
Q Consensus 175 -------~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~ 246 (948)
.+......+|. .+++|+.+.+..+- .......|.+ ..|+.+.+... ........|.++..|+.+.
T Consensus 142 ~~~~~~~~~~~i~~~aF~--~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~----~~~I~~~~F~~~~~L~~i~ 214 (394)
T 4fs7_A 142 KEITIPEGVTVIGDEAFA--TCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN----LKIIRDYCFAECILLENME 214 (394)
T ss_dssp SEEECCTTCCEECTTTTT--TCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT----CCEECTTTTTTCTTCCBCC
T ss_pred cccccCccccccchhhhc--ccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC----ceEeCchhhccccccceee
Confidence 11111223454 78899999997664 3244444543 23444443211 1222233455666666666
Q ss_pred ccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCC
Q 002238 247 LHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSP 326 (948)
Q Consensus 247 Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~ 326 (948)
+..+...- ...+.....|+.+.+..+. +..-...+.++..|+.+.+..+...-....+.....+.........+
T Consensus 215 ~~~~~~~i-~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i---- 288 (394)
T 4fs7_A 215 FPNSLYYL-GDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIV---- 288 (394)
T ss_dssp CCTTCCEE-CTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEE----
T ss_pred cCCCceEe-ehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcceeeccccccccccceeccCceee----
Confidence 65554331 1222334566666665433 22334556666777777776654431111232322222221111100
Q ss_pred CCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccc
Q 002238 327 GACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNL 406 (948)
Q Consensus 327 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l 406 (948)
....+....+|+.+.+.++ ++..-..+|.++++|+.++|.++ +
T Consensus 289 -----------------------------------~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v 331 (394)
T 4fs7_A 289 -----------------------------------PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-V 331 (394)
T ss_dssp -----------------------------------CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-C
T ss_pred -----------------------------------ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-c
Confidence 0012334557888888755 66566677889999999999754 6
Q ss_pred cccCCcCCcCCCCCcEEEccCC
Q 002238 407 SGMIPEGLSVLGALKELDVSNN 428 (948)
Q Consensus 407 ~g~ip~~l~~l~~L~~L~ls~N 428 (948)
+..-...|.++.+|+.+++..|
T Consensus 332 ~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 332 EEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp CEECTTTTTTCTTCCEECCCTT
T ss_pred cEEhHHhccCCCCCCEEEECcc
Confidence 6444678889999999988765
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.83 E-value=1.1e-09 Score=120.43 Aligned_cols=102 Identities=16% Similarity=0.201 Sum_probs=52.1
Q ss_pred CCCEEEEEeCCCCCcC-CC-------CccccCCCCCcEEEcccCCCCC---------CCC-CcCCCCCCcEEEccccccc
Q 002238 67 DKRITRIQIGHQNLQG-TL-------PSNLQNLTKLERLELQWNSISG---------PLP-SLNGLASLEVVMLSNNQFT 128 (948)
Q Consensus 67 ~~~v~~l~l~~~~l~~-~~-------p~~l~~l~~L~~L~L~~N~l~~---------~~p-~~~~l~~L~~L~L~~N~l~ 128 (948)
..+|+.|.+...+..| .. ..++..+++|+.|.+..+.... .+. -+..+++|+.|+|++|.-.
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l 185 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL 185 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence 3578888888666553 21 2335567788888886653321 111 2344566666666665211
Q ss_pred CCCCccccCCCCCCEEEccCCCCCCCCCCcccc--CCCCCCEEEcc
Q 002238 129 SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLR--NASGLQNFSAN 172 (948)
Q Consensus 129 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~--~l~~L~~L~l~ 172 (948)
.+++ +. +++|+.|+|..|.+.. .....+. .+++|+.|+|+
T Consensus 186 ~l~~--~~-~~~L~~L~L~~~~l~~-~~l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 186 SIGK--KP-RPNLKSLEIISGGLPD-SVVEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp BCCS--CB-CTTCSEEEEECSBCCH-HHHHHHHHSBCTTCCEEEEE
T ss_pred eecc--cc-CCCCcEEEEecCCCCh-HHHHHHHHccCCCCcEEEEe
Confidence 2222 22 5566666666555442 1111222 45555555553
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.78 E-value=1.8e-07 Score=105.07 Aligned_cols=37 Identities=14% Similarity=0.276 Sum_probs=25.6
Q ss_pred CCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcc
Q 002238 258 DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 295 (948)
Q Consensus 258 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 295 (948)
.|.+...|+.+.+.++..+ .-...|.++++|+.+.+.
T Consensus 260 aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~ 296 (394)
T 4gt6_A 260 AFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS 296 (394)
T ss_dssp TTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC
T ss_pred eeeecccccEEecccccce-ecCcccccccccccccCC
Confidence 3666777777777766554 556667777778877774
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.73 E-value=3.7e-09 Score=116.32 Aligned_cols=185 Identities=17% Similarity=0.189 Sum_probs=124.2
Q ss_pred CCCCcEEEcccCCCCC-CC--------CCcCCCCCCcEEEccccccc---------CCCCccccCCCCCCEEEccCCCCC
Q 002238 91 LTKLERLELQWNSISG-PL--------PSLNGLASLEVVMLSNNQFT---------SVPSDFFTGLSSLQSIEIDNNPFS 152 (948)
Q Consensus 91 l~~L~~L~L~~N~l~~-~~--------p~~~~l~~L~~L~L~~N~l~---------~~~~~~~~~l~~L~~L~Ls~N~l~ 152 (948)
+..++.|.+......+ .. .+...+++|+.|.+..+... +.....+..+++|+.|+|++|.-.
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l 185 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL 185 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence 3567888888666552 11 13456889999999765432 123455678899999999988311
Q ss_pred CCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEccc--ccccccC-CCCcccccccceeccCCCCCCcc
Q 002238 153 SWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAF--NQLIGGL-PASFSGSQIQSLWVNGQNGNAKL 229 (948)
Q Consensus 153 ~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~--N~l~~~~-p~~~~~~~l~~l~~~~~~~~~~~ 229 (948)
.++. + .+++|+.|+|..|.+.......+....+|+|++|+|+. |...+.. ...+.
T Consensus 186 --~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~------------------ 243 (362)
T 2ra8_A 186 --SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFR------------------ 243 (362)
T ss_dssp --BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTG------------------
T ss_pred --eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHH------------------
Confidence 3444 3 38899999999998875544333222589999999864 2221110 00000
Q ss_pred CCCcccc--ccCCCccEEEccCCcccccCC-C---CCCCCCCcEEeccCCccccc----cchhhhCCCCCcEEEcccCcc
Q 002238 230 GGGIDVI--QNMTSLKEIWLHSNAFSGPLP-D---FSGVKQLESLSLRDNFFTGP----VPDSLVKLESLKIVNMTNNLL 299 (948)
Q Consensus 230 ~~~~~~l--~~l~~L~~L~Ls~N~l~~~~~-~---~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l 299 (948)
..+ ..+++|+.|+|++|.+.+... . ...+++|++|+|+.|.|.+. ++..+..+++|+.|+|++|.+
T Consensus 244 ----~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i 319 (362)
T 2ra8_A 244 ----PLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319 (362)
T ss_dssp ----GGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBC
T ss_pred ----HHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcC
Confidence 001 257899999999999875332 1 23578999999999999864 444556779999999999988
Q ss_pred cc
Q 002238 300 QG 301 (948)
Q Consensus 300 ~g 301 (948)
+.
T Consensus 320 ~d 321 (362)
T 2ra8_A 320 SD 321 (362)
T ss_dssp CH
T ss_pred CH
Confidence 63
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.72 E-value=4.8e-07 Score=101.49 Aligned_cols=293 Identities=14% Similarity=0.162 Sum_probs=177.1
Q ss_pred ccccCC-CCCcEEEcccCCCCCCCC-CcCCCCCCcEEEccccc---ccCCCCccccCCCCCCEEEccCCCCCCCCC-Ccc
Q 002238 86 SNLQNL-TKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQ---FTSVPSDFFTGLSSLQSIEIDNNPFSSWEI-PQS 159 (948)
Q Consensus 86 ~~l~~l-~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~---l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-p~~ 159 (948)
.+|.+. ..|+.+.+..+ ++.+-. +|.++++|+.+.+..|. ++.+...+|.++.+|+.+.+.++ ++ .+ ...
T Consensus 57 ~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~--~I~~~a 132 (394)
T 4gt6_A 57 RVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VT--EIDSEA 132 (394)
T ss_dssp TTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CS--EECTTT
T ss_pred hhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cc--eehhhh
Confidence 356665 35888888643 555444 68888888888887764 66677778888888888877665 33 23 356
Q ss_pred ccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccC
Q 002238 160 LRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNM 239 (948)
Q Consensus 160 ~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l 239 (948)
|..+.+|+.+.+..+ +.......|. ....|+.+.+..+ ++..-..+|....++++.+... ........|.++
T Consensus 133 F~~c~~L~~i~lp~~-~~~I~~~~F~--~c~~L~~i~~~~~-~~~I~~~aF~~~~l~~i~ip~~----~~~i~~~af~~c 204 (394)
T 4gt6_A 133 FHHCEELDTVTIPEG-VTSVADGMFS--YCYSLHTVTLPDS-VTAIEERAFTGTALTQIHIPAK----VTRIGTNAFSEC 204 (394)
T ss_dssp TTTCTTCCEEECCTT-CCEECTTTTT--TCTTCCEEECCTT-CCEECTTTTTTCCCSEEEECTT----CCEECTTTTTTC
T ss_pred hhhhcccccccccce-eeeeccccee--cccccccccccce-eeEeccccccccceeEEEECCc----ccccccchhhhc
Confidence 777888888888643 4444455554 6778888888655 4444555565556666655321 222233456677
Q ss_pred CCccEEEccCCcccccCCC--------------CCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCC
Q 002238 240 TSLKEIWLHSNAFSGPLPD--------------FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE 305 (948)
Q Consensus 240 ~~L~~L~Ls~N~l~~~~~~--------------~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~ 305 (948)
.++.......+........ +.....+..+.+.+ .++..-..+|.++..|+.+.+..+..+=.--.
T Consensus 205 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~~~I~~~a 283 (394)
T 4gt6_A 205 FALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPDSVVSIGTGA 283 (394)
T ss_dssp TTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTTCCEECTTT
T ss_pred cccceecccccccccccceeecccccccccccccccccccceEEcCC-cceEcccceeeecccccEEecccccceecCcc
Confidence 7777777665544321111 11223344454443 33434466788899999999876654311112
Q ss_pred CCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCccccc
Q 002238 306 FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT 385 (948)
Q Consensus 306 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ 385 (948)
|.++..|........ ...+ ..+.|....+|+.++|.++ ++..
T Consensus 284 F~~c~~L~~i~l~~~-i~~I------------------------------------~~~aF~~c~~L~~i~lp~~-v~~I 325 (394)
T 4gt6_A 284 FMNCPALQDIEFSSR-ITEL------------------------------------PESVFAGCISLKSIDIPEG-ITQI 325 (394)
T ss_dssp TTTCTTCCEEECCTT-CCEE------------------------------------CTTTTTTCTTCCEEECCTT-CCEE
T ss_pred cccccccccccCCCc-cccc------------------------------------CceeecCCCCcCEEEeCCc-ccEe
Confidence 444444443332211 0000 1123445567888888754 5555
Q ss_pred CCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcc
Q 002238 386 ISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430 (948)
Q Consensus 386 ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l 430 (948)
-..+|.++++|+.+.|..+ ++..-...|.++++|+.+++.+|..
T Consensus 326 ~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 326 LDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp CTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred hHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 5677888888888888654 5534456788888888888887754
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.54 E-value=1.6e-09 Score=112.96 Aligned_cols=147 Identities=14% Similarity=0.156 Sum_probs=63.9
Q ss_pred CCCccceEEeCC-CCEEEEEeCC---CCCcCCCCc-cccCCCCCcEEEcccCCCCCCCC--CcCCCCCCcE--EEccccc
Q 002238 56 PCKWNHVVCIED-KRITRIQIGH---QNLQGTLPS-NLQNLTKLERLELQWNSISGPLP--SLNGLASLEV--VMLSNNQ 126 (948)
Q Consensus 56 ~C~w~gv~c~~~-~~v~~l~l~~---~~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~--L~L~~N~ 126 (948)
.|.|.|+.|+.. .+|..+-..+ ..+.+.+.+ .+..++. .|...+|.-++.++ .|...+.|+. ++++.|+
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~ 154 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR 154 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence 589999999864 3665554433 233344432 1111111 12223333333222 2333333333 4444442
Q ss_pred cc---CCCCccccCCCCCCEEEccCCCCCCCC-CCccccCCCCCCEEEccCccccccC-CCCCCCCCCCCCcEEEccccc
Q 002238 127 FT---SVPSDFFTGLSSLQSIEIDNNPFSSWE-IPQSLRNASGLQNFSANSANITGQI-PSFFGPDEFPGLTILHLAFNQ 201 (948)
Q Consensus 127 l~---~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~p~~~~~l~~L~~L~l~~n~l~~~~-p~~~~~~~l~~L~~L~Ls~N~ 201 (948)
.. +.......++++|+.|+|++|+|+++. +|..+..+++|+.|+|++|+|++.. ...+. .+ +|+.|+|++|.
T Consensus 155 ~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~--~l-~L~~L~L~~Np 231 (267)
T 3rw6_A 155 RSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIK--GL-KLEELWLDGNS 231 (267)
T ss_dssp HHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGT--TS-CCSEEECTTST
T ss_pred HHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcc--cC-CcceEEccCCc
Confidence 22 111222234555555555555555321 2334445555555555555555431 01111 12 55555555555
Q ss_pred ccccCC
Q 002238 202 LIGGLP 207 (948)
Q Consensus 202 l~~~~p 207 (948)
+.+.+|
T Consensus 232 l~~~~~ 237 (267)
T 3rw6_A 232 LCDTFR 237 (267)
T ss_dssp TGGGCS
T ss_pred CccccC
Confidence 554443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=2.5e-06 Score=91.87 Aligned_cols=136 Identities=18% Similarity=0.181 Sum_probs=92.4
Q ss_pred cceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCC---ceeeEEeEEE-eCCceEEEEEec
Q 002238 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR---HLVALLGHCL-DGNEKLLVFEYM 673 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~-~~~~~~lv~e~~ 673 (948)
.+.++.|....||+. |+.++||+-. .......+.+|+++++.+.+. .+.+++.++. ..+..++||||+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 456888999999998 6778999742 233456789999999999652 3556666664 445678999999
Q ss_pred CCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 002238 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL-------------------------------------- 715 (948)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------------------------------------- 715 (948)
+|..+.+... ..++..++..++.++++.|+.||+.
T Consensus 96 ~G~~l~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 96 QGQILGEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp CSEECHHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred CCeECchhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9988865321 1123333344444444444444421
Q ss_pred -------------------cCCCeeecCCCCccEEEcC---CCC-eEEeecCCcee
Q 002238 716 -------------------AHQSFIHRDLKPSNILLGD---DMR-AKVADFGLVRL 748 (948)
Q Consensus 716 -------------------~~~~ivHrDik~~Nill~~---~~~-~kl~DfGla~~ 748 (948)
....++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1346799999999999987 455 48999997653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=1.7e-06 Score=91.45 Aligned_cols=134 Identities=16% Similarity=0.160 Sum_probs=96.2
Q ss_pred eecccCce-EEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCceEEEEEecCCC
Q 002238 600 ILGRGGFG-TVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFEYMPQG 676 (948)
Q Consensus 600 ~lg~G~fg-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g 676 (948)
.+..|..| .||+.... ++..++||+-.. .....+.+|++.++.+. +-.+.++++++.+++..++|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 45556555 69998765 467899997543 23467889999999884 334678888999999999999999998
Q ss_pred ChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcc----------------------------------------
Q 002238 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA---------------------------------------- 716 (948)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------- 716 (948)
++.+..... ......++.+++..|+.||+..
T Consensus 106 ~~~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 106 TAFQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp EHHHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred cccccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 887654221 0122345666666677776420
Q ss_pred ---------------CCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 717 ---------------HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 717 ---------------~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
...++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237899999999999987777899999765
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.32 E-value=2.8e-05 Score=86.54 Aligned_cols=61 Identities=13% Similarity=0.120 Sum_probs=40.8
Q ss_pred eecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccC
Q 002238 366 TCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSN 427 (948)
Q Consensus 366 ~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~ 427 (948)
|....+|+.+++.++.++..-...|.++++|+.++|..+ ++-.-...|.++.+|+.+.+..
T Consensus 282 F~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 282 CSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp TTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred cccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence 334456777777777777666677777778888877644 5533355677777777776654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.15 E-value=2.5e-07 Score=91.66 Aligned_cols=67 Identities=16% Similarity=0.187 Sum_probs=39.6
Q ss_pred ccccCCCCCcEEEcccC-CCCCC-----CCCcCCCCCCcEEEcccccccCC----CCccccCCCCCCEEEccCCCCC
Q 002238 86 SNLQNLTKLERLELQWN-SISGP-----LPSLNGLASLEVVMLSNNQFTSV----PSDFFTGLSSLQSIEIDNNPFS 152 (948)
Q Consensus 86 ~~l~~l~~L~~L~L~~N-~l~~~-----~p~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~ 152 (948)
..+...+.|++|+|++| .|... ...+...++|++|+|++|.|+.. ....+...++|++|+|++|.|.
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 44566677777777777 77541 11345556677777777766542 2233444556666666666665
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.14 E-value=3e-07 Score=91.06 Aligned_cols=64 Identities=17% Similarity=0.168 Sum_probs=44.6
Q ss_pred ccCCCccEEEccCCccccc-----CCCCCCCCCCcEEec--cCCccccc----cchhhhCCCCCcEEEcccCccc
Q 002238 237 QNMTSLKEIWLHSNAFSGP-----LPDFSGVKQLESLSL--RDNFFTGP----VPDSLVKLESLKIVNMTNNLLQ 300 (948)
Q Consensus 237 ~~l~~L~~L~Ls~N~l~~~-----~~~~~~l~~L~~L~L--~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~ 300 (948)
...++|++|+|++|.|... ...+...+.|+.|+| ++|.|... +...+...++|++|+|++|.+.
T Consensus 90 ~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 90 KVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3456777777777777652 223555677888888 77888743 3455666688999999998875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=5.6e-06 Score=91.40 Aligned_cols=82 Identities=10% Similarity=-0.013 Sum_probs=56.6
Q ss_pred ccee-cccCceEEEEEEEc-------CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcC-C--CceeeEEeEEEeC--
Q 002238 598 ENIL-GRGGFGTVYKGELH-------DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVR-H--RHLVALLGHCLDG-- 663 (948)
Q Consensus 598 ~~~l-g~G~fg~Vy~~~~~-------~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~-- 663 (948)
.+.| +.|....+|+.... +++.+++|+...... .......+.+|+++++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88999999998764 267899997643210 0001245788999998884 2 3567788777655
Q ss_pred -CceEEEEEecCCCChh
Q 002238 664 -NEKLLVFEYMPQGTLS 679 (948)
Q Consensus 664 -~~~~lv~e~~~~gsL~ 679 (948)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.00 E-value=2.9e-06 Score=88.30 Aligned_cols=66 Identities=21% Similarity=0.234 Sum_probs=57.2
Q ss_pred cCCceEEEEccCCcccc--cCCccccCccccceEeCccccccccCCcCCcCCC--CCcEEEccCCcccCCCC
Q 002238 368 TKGNITVINFQKMNLTG--TISPEFASFKSLQRLILADNNLSGMIPEGLSVLG--ALKELDVSNNQLYGKIP 435 (948)
Q Consensus 368 ~~~~L~~L~ls~n~l~g--~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~--~L~~L~ls~N~l~g~ip 435 (948)
.+++|+.|+||+|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|++++.+|
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 46789999999999998 6778888999999999999999965 3455555 99999999999998776
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.98 E-value=4.3e-05 Score=83.61 Aligned_cols=142 Identities=15% Similarity=0.180 Sum_probs=81.5
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-----CCceeeEE-e--EEEeCCceEEEE
Q 002238 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-----HRHLVALL-G--HCLDGNEKLLVF 670 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~-~--~~~~~~~~~lv~ 670 (948)
+.|+.|..+.||+....+ ..+++|+.... ..++..|+++++.+. .|.++... | +...++..++||
T Consensus 38 ~~l~gG~~n~~~~v~~~~-~~~vlk~~~~~------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDS-GAVCLKRIHRP------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EECC----CEEEEEEETT-EEEEEEEECSC------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeccccccCcEEEEEeCC-CCEEEEecCCC------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 456667789999998764 45999987642 133445666666553 24443311 1 123456779999
Q ss_pred EecCCCChh--------------HHHHhhhhcC--C-------CCCCHHHHH----------------------------
Q 002238 671 EYMPQGTLS--------------RHIFNWAEEG--L-------KPLEWNRRL---------------------------- 699 (948)
Q Consensus 671 e~~~~gsL~--------------~~l~~~~~~~--~-------~~l~~~~~~---------------------------- 699 (948)
||++|..+. ..+|.....- . ..-.|...+
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986542 1122211100 0 012343211
Q ss_pred ---HHHHHHHHHHHHHHh----------ccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 700 ---TIALDVARGVEYLHG----------LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 700 ---~i~~~i~~~l~~LH~----------~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
.+...+..++++|+. .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223445666653 125789999999999999888899999999654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.84 E-value=0.00062 Score=75.51 Aligned_cols=59 Identities=8% Similarity=0.146 Sum_probs=46.9
Q ss_pred CCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCC
Q 002238 369 KGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNN 428 (948)
Q Consensus 369 ~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N 428 (948)
..+|+.+.+..+ +...-...|.++++|+.+.+.++.++..-...|.++.+|+.++|..+
T Consensus 262 ~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~ 320 (379)
T 4h09_A 262 CTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA 320 (379)
T ss_dssp CTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT
T ss_pred eehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc
Confidence 346777777543 55555667899999999999999998666788999999999999754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.81 E-value=9.1e-05 Score=82.91 Aligned_cols=77 Identities=13% Similarity=0.128 Sum_probs=50.9
Q ss_pred cceecccCceEEEEEEEc-CCcEEEEEEeecCcC--C---hhhHHHHHHHHHHHHhcCC--Cc-eeeEEeEEEeCCceEE
Q 002238 598 ENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI--S---GKGLTEFKSEIAVLTKVRH--RH-LVALLGHCLDGNEKLL 668 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~---~~~~~~~~~E~~~l~~l~H--~n-iv~l~~~~~~~~~~~l 668 (948)
.+.||.|.++.||++... +++.|+||....... . ......+..|+++++.+.. |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999754 468999998653211 0 1123457789999988742 33 3455543 4556789
Q ss_pred EEEecCCC
Q 002238 669 VFEYMPQG 676 (948)
Q Consensus 669 v~e~~~~g 676 (948)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00021 Score=76.42 Aligned_cols=141 Identities=15% Similarity=0.151 Sum_probs=93.9
Q ss_pred ccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC---CCceeeEEeEEEeCCceEEEEEec
Q 002238 597 EENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR---HRHLVALLGHCLDGNEKLLVFEYM 673 (948)
Q Consensus 597 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~ 673 (948)
..+.|+.|....+|+.... +..++||+.... ....+.+|++.|+.+. ...+.++++++...+..++||||+
T Consensus 40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEEECCSSSSEEEEEESS-SCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeEEeCCccceeeeEEEEC-CCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 3567899999999999864 788999986532 3567899999999883 366788888888888899999999
Q ss_pred CCCChh--------H---HHHhhhh-cCC----------------CCCCHHHHH---HHHH----------------HHH
Q 002238 674 PQGTLS--------R---HIFNWAE-EGL----------------KPLEWNRRL---TIAL----------------DVA 706 (948)
Q Consensus 674 ~~gsL~--------~---~l~~~~~-~~~----------------~~l~~~~~~---~i~~----------------~i~ 706 (948)
++..+. + .+|.... ... -.-+|.... ++.. .++
T Consensus 114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~ 193 (312)
T 3jr1_A 114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV 193 (312)
T ss_dssp CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence 987652 1 1222111 000 012465432 1111 111
Q ss_pred HH-HHHHHh-ccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 707 RG-VEYLHG-LAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 707 ~~-l~~LH~-~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
.. ...|.. ..+..+||+|+.+.|++++.++ +.|.|+.
T Consensus 194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11 223421 1246899999999999999887 8898874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.0001 Score=78.40 Aligned_cols=79 Identities=19% Similarity=0.203 Sum_probs=57.4
Q ss_pred CCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCC---CceeeEEeEEEeCCceEEEE
Q 002238 594 NFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH---RHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~~~~~~lv~ 670 (948)
.....+.+|.|..+.||+.++.||+.|+||+-... .......|.+|++.|+.+.- -.+.+++++. ..++||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~--~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDD--APALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTT--CCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCC--CcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 45556789999999999999999999999986543 22223468899999998842 2244555432 348999
Q ss_pred EecCCCCh
Q 002238 671 EYMPQGTL 678 (948)
Q Consensus 671 e~~~~gsL 678 (948)
||++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.70 E-value=9.7e-05 Score=83.31 Aligned_cols=77 Identities=22% Similarity=0.262 Sum_probs=48.3
Q ss_pred CCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCceeeeecc--cccccCceecccC---CCCchhhHHHHHHHHH
Q 002238 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG--TFGYLAPEYAVTG---RVTTKVDVFSFGVILM 791 (948)
Q Consensus 717 ~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~Dv~s~Gv~l~ 791 (948)
...++|+|+++.||+++.++ ++++||+.+..-..... . ....+ ...|++|+..... .-....++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-l-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-I-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-H-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-H-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 47899999999999998776 99999998774321110 0 00011 1346666655321 1123456667788888
Q ss_pred HHHhC
Q 002238 792 ELITG 796 (948)
Q Consensus 792 elltg 796 (948)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.40 E-value=0.0013 Score=71.13 Aligned_cols=159 Identities=12% Similarity=0.130 Sum_probs=88.8
Q ss_pred eHHHHHHhhcCCcc-----cceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCc--eeeE
Q 002238 584 SIQVLRNVTNNFSE-----ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH--LVAL 656 (948)
Q Consensus 584 ~~~~l~~~~~~~~~-----~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l 656 (948)
+.+++..+...|.. .+.|+.|....+|+....+| .+++|+.... .....+..|+++++.+.... +.++
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 34555555555654 24567788899999987655 6889987642 11235667888887773212 2333
Q ss_pred EeE------EEeCCceEEEEEecCCCChhH--------------HHHhhhhc-CC------CCCCHHHHHH---------
Q 002238 657 LGH------CLDGNEKLLVFEYMPQGTLSR--------------HIFNWAEE-GL------KPLEWNRRLT--------- 700 (948)
Q Consensus 657 ~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~-~~------~~l~~~~~~~--------- 700 (948)
+.. ....+..++||+|++|..+.. .+|..... .. ....|...+.
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 122356789999999865421 12211100 00 0012333111
Q ss_pred ---HHHHHHHHHHHHHhc----cCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 701 ---IALDVARGVEYLHGL----AHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 701 ---i~~~i~~~l~~LH~~----~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+...+.+.+++++.. ...+++|+|+.+.||+++.+..+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244455666532 13579999999999999987666899998654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.40 E-value=4e-05 Score=73.80 Aligned_cols=58 Identities=17% Similarity=0.217 Sum_probs=29.0
Q ss_pred CCCcEEEcccCCCCC-CCCCcCCCCCCcEEEccccc-ccCCCCccccCC----CCCCEEEccCC
Q 002238 92 TKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQ-FTSVPSDFFTGL----SSLQSIEIDNN 149 (948)
Q Consensus 92 ~~L~~L~L~~N~l~~-~~p~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~Ls~N 149 (948)
.+|++|||+++.|+. .+..+.++++|++|+|++|. |+..--..++.+ ++|++|+|++|
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C 124 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISC 124 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESC
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCC
Confidence 356666666666543 12234555556666666553 443222233333 24555555555
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0018 Score=70.08 Aligned_cols=143 Identities=14% Similarity=0.071 Sum_probs=83.0
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCC--ceeeEEeE-----EEeCCceEEEEE
Q 002238 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR--HLVALLGH-----CLDGNEKLLVFE 671 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~-----~~~~~~~~lv~e 671 (948)
..++ |....||+....+|+.+++|+...... ....+..|..+++.+... .+++++.. ...++..++|||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4576 888999998877788899998864321 235677788888887422 23444432 122455688999
Q ss_pred ecCCCChh-----------HH---HHhhhhcC----CCCCCHHHH----HHH---------------HHHHHHHHHHHHh
Q 002238 672 YMPQGTLS-----------RH---IFNWAEEG----LKPLEWNRR----LTI---------------ALDVARGVEYLHG 714 (948)
Q Consensus 672 ~~~~gsL~-----------~~---l~~~~~~~----~~~l~~~~~----~~i---------------~~~i~~~l~~LH~ 714 (948)
|++|..+. +. +|...... ....++... ..+ ...+.+.++.+..
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 99885542 11 12111100 112222211 000 1111122333322
Q ss_pred c----cCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 715 L----AHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 715 ~----~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
. ....++|+|+++.||+++ + .+.|+||+.+.
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 1 235689999999999999 4 89999998765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0011 Score=71.95 Aligned_cols=143 Identities=15% Similarity=0.131 Sum_probs=73.9
Q ss_pred ceecccCceE-EEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCC--CceeeEEeEEEeCCceEEEEEecCC
Q 002238 599 NILGRGGFGT-VYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH--RHLVALLGHCLDGNEKLLVFEYMPQ 675 (948)
Q Consensus 599 ~~lg~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~ 675 (948)
+.|+.|+... +|+....+|+.+++|...... ...+..|+++++.+.. -.+.+++.+..+. -++|||++.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~-----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~ 96 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE-----GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGD 96 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT-----TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCS
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC-----CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCC
Confidence 4566665554 678765447788888654321 1334567777777632 2345666654333 3789999977
Q ss_pred CChhHHHHhhh------------------hc---CCCCCCHHHHH-------H-------------HHHHHHHHHHHHHh
Q 002238 676 GTLSRHIFNWA------------------EE---GLKPLEWNRRL-------T-------------IALDVARGVEYLHG 714 (948)
Q Consensus 676 gsL~~~l~~~~------------------~~---~~~~l~~~~~~-------~-------------i~~~i~~~l~~LH~ 714 (948)
..+.+.+.... .. ....++..... . ....+...++.+..
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 66654332100 00 01112111100 0 00111122222211
Q ss_pred ---ccCCCeeecCCCCccEEEcCC----CCeEEeecCCcee
Q 002238 715 ---LAHQSFIHRDLKPSNILLGDD----MRAKVADFGLVRL 748 (948)
Q Consensus 715 ---~~~~~ivHrDik~~Nill~~~----~~~kl~DfGla~~ 748 (948)
.....++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 124679999999999999874 6799999998764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.19 E-value=8.4e-05 Score=71.54 Aligned_cols=85 Identities=14% Similarity=0.150 Sum_probs=67.0
Q ss_pred CCCCcEEEcccccccCCCCccccCCCCCCEEEccCCC-CCCCCCCccccCC----CCCCEEEccCcc-ccccCCCCCCCC
Q 002238 114 LASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNP-FSSWEIPQSLRNA----SGLQNFSANSAN-ITGQIPSFFGPD 187 (948)
Q Consensus 114 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~p~~~~~l----~~L~~L~l~~n~-l~~~~p~~~~~~ 187 (948)
-.+|+.|||+++.|+..--..+.++++|+.|+|++|. |+. .--..+..+ ++|++|+|++|. ||...-..+.
T Consensus 60 ~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD-~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~-- 136 (176)
T 3e4g_A 60 KYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIED-GCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALH-- 136 (176)
T ss_dssp CCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCH-HHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGG--
T ss_pred CceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCH-HHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHh--
Confidence 3579999999999887666668899999999999996 664 222334444 369999999985 8866555665
Q ss_pred CCCCCcEEEccccc
Q 002238 188 EFPGLTILHLAFNQ 201 (948)
Q Consensus 188 ~l~~L~~L~Ls~N~ 201 (948)
.+++|++|+|+++.
T Consensus 137 ~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 137 HFRNLKYLFLSDLP 150 (176)
T ss_dssp GCTTCCEEEEESCT
T ss_pred cCCCCCEEECCCCC
Confidence 78999999999985
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00098 Score=71.26 Aligned_cols=74 Identities=12% Similarity=0.148 Sum_probs=46.8
Q ss_pred CcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCce-eeEEeEEEeCCceEEEEEec
Q 002238 595 FSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL-VALLGHCLDGNEKLLVFEYM 673 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~ 673 (948)
+.-.+.|+.|....+|+. +.+++|+..... .......+|+.+++.+....+ .+++++ +.+.-++|+||+
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i 89 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYI 89 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECC
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeec
Confidence 333678999999999998 568999875421 111223568888877742222 355543 344457999999
Q ss_pred -CCCCh
Q 002238 674 -PQGTL 678 (948)
Q Consensus 674 -~~gsL 678 (948)
++.++
T Consensus 90 ~~g~~l 95 (301)
T 3dxq_A 90 AGAQTM 95 (301)
T ss_dssp TTCEEC
T ss_pred CCCccC
Confidence 66555
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.002 Score=70.84 Aligned_cols=143 Identities=15% Similarity=0.155 Sum_probs=83.7
Q ss_pred cceecccCceEEEEEEEc--------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCceEE
Q 002238 598 ENILGRGGFGTVYKGELH--------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~l 668 (948)
.+.+..|-...+|+.... +++.|++|+... .......+.+|.++++.+. +.-..++++++.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~---~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA---ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC---ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 356777888999999864 247899998532 1123456779999998884 3333566666543 39
Q ss_pred EEEecCCCChhH--------------HH---HhhhhcCCCCCC--HHHHHHHHHHHHH-------------------HHH
Q 002238 669 VFEYMPQGTLSR--------------HI---FNWAEEGLKPLE--WNRRLTIALDVAR-------------------GVE 710 (948)
Q Consensus 669 v~e~~~~gsL~~--------------~l---~~~~~~~~~~l~--~~~~~~i~~~i~~-------------------~l~ 710 (948)
||||++|.+|.. .+ |.......+... |.++.++..++.. .++
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 999999866531 11 110001112222 4555555544322 233
Q ss_pred HHHh-----ccCCCeeecCCCCccEEEcCC----CCeEEeecCCce
Q 002238 711 YLHG-----LAHQSFIHRDLKPSNILLGDD----MRAKVADFGLVR 747 (948)
Q Consensus 711 ~LH~-----~~~~~ivHrDik~~Nill~~~----~~~kl~DfGla~ 747 (948)
.|.. .....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3321 123468999999999999876 689999998654
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0013 Score=60.16 Aligned_cols=55 Identities=15% Similarity=0.376 Sum_probs=38.6
Q ss_pred EEEcccCCCC--CCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCC
Q 002238 96 RLELQWNSIS--GPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFS 152 (948)
Q Consensus 96 ~L~L~~N~l~--~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 152 (948)
.++.++++|+ .++..+. .+|++|+|++|+|+.++++.|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4555555555 3322222 35778888888888888888888888888888888775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.90 E-value=0.002 Score=72.37 Aligned_cols=73 Identities=19% Similarity=0.235 Sum_probs=50.0
Q ss_pred cceecccCceEEEEEEEcC--------CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCce-eeEEeEEEeCCceEE
Q 002238 598 ENILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL-VALLGHCLDGNEKLL 668 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~l 668 (948)
.+.|+.|....||++...+ ++.+++|+.... .....+.+|..+++.+...++ .++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 4568888899999998753 578999987431 111455679999988843333 566665532 38
Q ss_pred EEEecCCCCh
Q 002238 669 VFEYMPQGTL 678 (948)
Q Consensus 669 v~e~~~~gsL 678 (948)
||||++|.++
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999987444
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.80 E-value=0.00032 Score=68.88 Aligned_cols=91 Identities=13% Similarity=0.132 Sum_probs=59.1
Q ss_pred CCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccC-----CCCCCC
Q 002238 188 EFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPL-----PDFSGV 262 (948)
Q Consensus 188 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~-----~~~~~l 262 (948)
.-+.|+.|+|++|+|...-...++ +.+..-+.|+.|+|++|.|.... ..+...
T Consensus 68 ~N~~L~~L~L~~n~igd~ga~alA----------------------~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N 125 (197)
T 1pgv_A 68 NSKHIEKFSLANTAISDSEARGLI----------------------ELIETSPSLRVLNVESNFLTPELLARLLRSTLVT 125 (197)
T ss_dssp TCSCCCEEECTTSCCBHHHHTTHH----------------------HHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTT
T ss_pred hCCCcCEEEccCCCCChHHHHHHH----------------------HHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhC
Confidence 345677777777777643333322 33445677888888888887522 235566
Q ss_pred CCCcEEeccCC---cccc----ccchhhhCCCCCcEEEcccCccc
Q 002238 263 KQLESLSLRDN---FFTG----PVPDSLVKLESLKIVNMTNNLLQ 300 (948)
Q Consensus 263 ~~L~~L~L~~N---~l~~----~~p~~l~~l~~L~~L~Ls~N~l~ 300 (948)
+.|+.|+|++| .+.. .+...+..-+.|+.|+++.|.+.
T Consensus 126 ~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 126 QSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp CCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred CceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 77999999865 3332 24456667788999999887654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0041 Score=70.23 Aligned_cols=74 Identities=12% Similarity=0.067 Sum_probs=48.5
Q ss_pred cceecccCceEEEEEEEcC-CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCce-eeEEeEEEeCCceEEEEEecCC
Q 002238 598 ENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL-VALLGHCLDGNEKLLVFEYMPQ 675 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~ 675 (948)
.+.|+.|-...+|+....+ +..+++|+..... ...-...+|..+++.+...++ .++++++. + .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 4568888899999998764 4789999864321 111123689999999965444 46776652 2 359999987
Q ss_pred CCh
Q 002238 676 GTL 678 (948)
Q Consensus 676 gsL 678 (948)
.+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0048 Score=67.98 Aligned_cols=74 Identities=15% Similarity=0.108 Sum_probs=44.9
Q ss_pred cceecccCceEEEEEEEcC---------CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCc-eeeEEeEEEeCCceE
Q 002238 598 ENILGRGGFGTVYKGELHD---------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH-LVALLGHCLDGNEKL 667 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~ 667 (948)
.+.++.|....+|+....+ ++.+++|+.... .........|.++++.+.... ..++++.. . -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH---VDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT---GGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC---ccceecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence 3567888889999998754 268899976542 111123467888888884323 34566443 2 37
Q ss_pred EEEEecCCCCh
Q 002238 668 LVFEYMPQGTL 678 (948)
Q Consensus 668 lv~e~~~~gsL 678 (948)
+||||++|..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.49 E-value=0.0092 Score=64.76 Aligned_cols=32 Identities=22% Similarity=0.427 Sum_probs=27.9
Q ss_pred CCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 717 ~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35799999999999999888899999987653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.45 E-value=0.00035 Score=68.56 Aligned_cols=66 Identities=14% Similarity=0.188 Sum_probs=38.2
Q ss_pred cccCCCCCcEEEcccC-CCCCC-----CCCcCCCCCCcEEEcccccccC----CCCccccCCCCCCEEEccCCCCC
Q 002238 87 NLQNLTKLERLELQWN-SISGP-----LPSLNGLASLEVVMLSNNQFTS----VPSDFFTGLSSLQSIEIDNNPFS 152 (948)
Q Consensus 87 ~l~~l~~L~~L~L~~N-~l~~~-----~p~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~ 152 (948)
.+.+-+.|++|+|++| .|... ...+..-+.|+.|+|++|+|.. .+.+++..-+.|+.|+|++|+|.
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 3455667788888774 66431 1134455667777777777663 22333445566666666666665
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.22 E-value=0.0069 Score=55.35 Aligned_cols=56 Identities=18% Similarity=0.168 Sum_probs=46.5
Q ss_pred cEEEccCCccc--ccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCccc
Q 002238 243 KEIWLHSNAFS--GPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ 300 (948)
Q Consensus 243 ~~L~Ls~N~l~--~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 300 (948)
..++.+++.++ ..+..+. .+|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 47899999998 5443443 57999999999999766778899999999999999885
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.85 E-value=0.067 Score=52.64 Aligned_cols=101 Identities=14% Similarity=0.115 Sum_probs=65.5
Q ss_pred ChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCce
Q 002238 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI 756 (948)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 756 (948)
+|.++|..+ ..++++.++|.++.|.+.+|.-+-... .+ ..+=+.|..|++..+|.|...+ +.+.
T Consensus 34 SL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 34 SLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc---------
Confidence 788888543 368999999999999999987762111 11 1333457899999999998863 1110
Q ss_pred eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCC
Q 002238 757 ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRK 798 (948)
Q Consensus 757 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~ 798 (948)
.....+.|||... ...+.+.=|||+|+++|.-+--..
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 0123466888753 455788899999999999986433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.38 E-value=0.051 Score=60.44 Aligned_cols=142 Identities=12% Similarity=0.154 Sum_probs=84.9
Q ss_pred cceecccCceEEEEEEEcC--------CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCceEE
Q 002238 598 ENILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~l 668 (948)
.+.+..|-...+|+....+ ++.|++|+.... . ...-+..+|.++++.+. +.-..++++.+ . -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~--t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH--V-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC--C--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC--c-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCE
Confidence 4567778889999998763 588999986432 1 11223467888888884 32234555433 2 378
Q ss_pred EEEecCCCChhH-----------------HHHhhhh-----c---CCCCCCHHHHHHHHHHH------------------
Q 002238 669 VFEYMPQGTLSR-----------------HIFNWAE-----E---GLKPLEWNRRLTIALDV------------------ 705 (948)
Q Consensus 669 v~e~~~~gsL~~-----------------~l~~~~~-----~---~~~~l~~~~~~~i~~~i------------------ 705 (948)
||||++|..|.. .+|.... . ...+.-|.++.++..++
T Consensus 148 I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~ 227 (424)
T 3mes_A 148 IEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSK 227 (424)
T ss_dssp EEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHH
T ss_pred EEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHH
Confidence 999999876421 1111111 0 11222344444443322
Q ss_pred -HHHHHHHHh---------------------ccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 706 -ARGVEYLHG---------------------LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 706 -~~~l~~LH~---------------------~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
...++.|.. ..+..++|+|+.+.||+ +.++.+.++||..+.
T Consensus 228 l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 228 ILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 222333321 11346889999999999 778899999998764
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.63 E-value=0.25 Score=34.74 Aligned_cols=25 Identities=8% Similarity=0.219 Sum_probs=13.1
Q ss_pred hhhHhHhHHHHHHHHHHhhhhhhhc
Q 002238 492 ILFCVIGGAFVISLTGVLVFCLCKK 516 (948)
Q Consensus 492 ~~~~v~~~~~~~~~~~~l~~~~~~~ 516 (948)
++.++++++++++++++.++++.|+
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RR 37 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRR 37 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhh
Confidence 5566666666555554444444333
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.31 E-value=0.29 Score=34.27 Aligned_cols=27 Identities=30% Similarity=0.592 Sum_probs=14.7
Q ss_pred ehhhHhHhHHHHHHHHHHhhhhhhhcc
Q 002238 491 VILFCVIGGAFVISLTGVLVFCLCKKK 517 (948)
Q Consensus 491 ~~~~~v~~~~~~~~~~~~l~~~~~~~~ 517 (948)
.++.+++++++++++++..++++.|++
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~~~RRR 37 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAVYVRRK 37 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEeehHHHHHHHHHHHHHHHHhhhh
Confidence 356667766666555554444444433
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.81 E-value=1.5 Score=48.31 Aligned_cols=29 Identities=31% Similarity=0.518 Sum_probs=24.0
Q ss_pred CeeecCCCCccEEE------cCCCCeEEeecCCce
Q 002238 719 SFIHRDLKPSNILL------GDDMRAKVADFGLVR 747 (948)
Q Consensus 719 ~ivHrDik~~Nill------~~~~~~kl~DfGla~ 747 (948)
.++|+|+.+.||++ +++..++++||-.|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 36799999999999 445679999998765
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.12 E-value=0.097 Score=59.09 Aligned_cols=63 Identities=10% Similarity=0.054 Sum_probs=18.1
Q ss_pred ccceecccCceEEEEEEEcC-CcEEEE------EEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe
Q 002238 597 EENILGRGGFGTVYKGELHD-GTKIAV------KRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD 662 (948)
Q Consensus 597 ~~~~lg~G~fg~Vy~~~~~~-g~~vav------K~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 662 (948)
..+.|| ||.||+|.+.. ..+||| |..+...........+.+|..+++.++|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345666 99999998863 367888 7766544445555678999999999999999998877653
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=81.30 E-value=0.95 Score=31.63 Aligned_cols=26 Identities=23% Similarity=0.526 Sum_probs=10.9
Q ss_pred hhhHhHhHHHHHHHHH-Hhhhhhhhccc
Q 002238 492 ILFCVIGGAFVISLTG-VLVFCLCKKKQ 518 (948)
Q Consensus 492 ~~~~v~~~~~~~~~~~-~l~~~~~~~~~ 518 (948)
++.++++ ++++++++ +++++++|+++
T Consensus 14 Ia~~vVG-vll~vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 14 IISAVVG-ILLVVVLGVVFGILIKRRQQ 40 (44)
T ss_dssp HHHHHHH-HHHHHHHHHHHHHHHHHHCS
T ss_pred hHHHHHH-HHHHHHHHHHHHhheehhhh
Confidence 4445555 33333333 33444444443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 948 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-69 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-64 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-58 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-51 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-47 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-47 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-43 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-37 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-25 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-22 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-11 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 7e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 1e-69
Identities = 70/288 (24%), Positives = 126/288 (43%), Gaps = 27/288 (9%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+ +G G FGTVYKG+ H +AVK + + + L FK+E+ VL K RH +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
++ +G+ + +V ++ +L H+ E + + IA A+G++YL
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYL 120
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE-TRIAGTFGYLAPEY 771
H +S IHRDLK +NI L +D+ K+ DFGL + GS + +++G+ ++APE
Sbjct: 121 H---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 772 AVT---GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828
+ + DV++FG++L EL+TG+ + + + +
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237
Query: 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876
+ L C ++ +RP + + L
Sbjct: 238 CPK-------------AMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 8e-65
Identities = 76/284 (26%), Positives = 121/284 (42%), Gaps = 27/284 (9%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+ + +G G FG V+ G + K+A+K + G +S + +F E V+ K+ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPK 61
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
LV L G CL+ LVFE+M G LS ++ L + LDV G+ YL
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYL 117
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
IHRDL N L+G++ KV+DFG+ R + + + T + +PE
Sbjct: 118 E---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 773 VTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832
R ++K DV+SFGV++ E+ + K P E+ I + + P
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGK-----IPYENRSNSEVVEDI----STGFRLYKPR 225
Query: 833 IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876
+ V ++ HC P RP + L+ + E
Sbjct: 226 LASTH--------VYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 6e-64
Identities = 71/279 (25%), Positives = 120/279 (43%), Gaps = 27/279 (9%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
LG G FG V+ G + TK+AVK ++ G +S F +E ++ +++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQR 69
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
LV L ++ EYM G+L + L N+ L +A +A G+ ++
Sbjct: 70 LVRLYAVVTQEP-IYIITEYMENGSLVDFLKT---PSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
+++IHRDL+ +NIL+ D + K+ADFGL RL + + + + APE
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 773 VTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832
G T K DV+SFG++L E++T + P M + + + +
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGR-----IPYPGMTNPEVIQNL---ERGYRMVRPDN 234
Query: 833 IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871
+ +L C P RP + +VL
Sbjct: 235 CP---------EELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 6e-63
Identities = 82/296 (27%), Positives = 136/296 (45%), Gaps = 27/296 (9%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+ E LG+G FG V+ G + T++A+K ++ G +S + F E V+ K+RH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 73
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
LV L +V EYM +G+L + E K L + + +A +A G+ Y+
Sbjct: 74 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
+++HRDL+ +NIL+G+++ KVADFGL RL + + + + APE A
Sbjct: 130 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 773 VTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832
+ GR T K DV+SFG++L EL T + P M ++ + + P
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRV-----PYPGMVNREVLDQV---ERGYRMPCPPE 238
Query: 833 IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDQNSEDI 888
++ +L C +EP +RP + L +P Q E++
Sbjct: 239 CP---------ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 285
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 5e-62
Identities = 64/286 (22%), Positives = 117/286 (40%), Gaps = 32/286 (11%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+ + LG G FG V G+ +A+K ++ G +S EF E V+ + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEK 60
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
LV L G C ++ EYM G L ++ + + L + DV +EYL
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYL 116
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
+ F+HRDL N L+ D KV+DFGL R + + + + PE
Sbjct: 117 E---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 773 VTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831
+ + ++K D+++FGV++ E+ + G+ + E+ + R++ + K
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT- 232
Query: 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877
+ C + +RP +LS+++++
Sbjct: 233 -----------------IMYSCWHEKADERPTFKI---LLSNILDV 258
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 2e-61
Identities = 76/283 (26%), Positives = 126/283 (44%), Gaps = 33/283 (11%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+G+G FG V G+ + G K+AVK ++ + F +E +V+T++RH +
Sbjct: 7 KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSN 61
Query: 653 LVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
LV LLG ++ L +V EYM +G+L ++ + G L + L +LDV +EY
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
L +F+HRDL N+L+ +D AKV+DFGL + A S + + APE
Sbjct: 119 LE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEA 171
Query: 772 AVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831
+ +TK DV+SFG++L E+ + + P + L R+ + +
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVVPRV---EKGYKMDAPD 223
Query: 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874
V E+ +C + RP L +
Sbjct: 224 GCP---------PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 6e-61
Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 12/217 (5%)
Query: 592 TNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 650
++F + + LG G G V+K G +A K + I + E+ VL +
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNS 63
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
++V G E + E+M G+L + + + +++ V +G+
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLT 118
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
YL +HRD+KPSNIL+ K+ DFG+ + S+ GT Y++PE
Sbjct: 119 YLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPE 173
Query: 771 YAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEE 807
+ + D++S G+ L+E+ GR + +E
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 2e-60
Identities = 71/279 (25%), Positives = 114/279 (40%), Gaps = 32/279 (11%)
Query: 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRH 650
+F LG+G FG VY +A+K + + G+ + E+ + + +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
+++ L G+ D L+ EY P GT+ R + + R T ++A +
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALS 120
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
Y H + IHRD+KP N+LLG K+ADFG AP + T + GT YL PE
Sbjct: 121 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPE 174
Query: 771 YAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830
KVD++S GV+ E + G+ P E+ ++RI + +F +
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKP------PFEANTYQETYKRISRVEFTFPDFVT 228
Query: 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869
+L P QRP + +
Sbjct: 229 E-------------GARDLISRLLKHNPSQRPMLREVLE 254
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-59
Identities = 56/281 (19%), Positives = 102/281 (36%), Gaps = 25/281 (8%)
Query: 594 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
++ +G G +G K DG + K ++ G ++ SE+ +L +++H +
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 653 LVALLGHCLDGNEKLL--VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
+V +D L V EY G L+ I +E + L+ L + + ++
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLALK 123
Query: 711 YLH--GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 768
H + +HRDLKP+N+ L K+ DFGL R+ S GT Y++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMS 182
Query: 769 PEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828
PE K D++S G +L EL +E + + + +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 242
Query: 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869
+ + + Y RP + +
Sbjct: 243 NE------------------IITRMLNLKDYHRPSVEEILE 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 3e-59
Identities = 63/283 (22%), Positives = 115/283 (40%), Gaps = 33/283 (11%)
Query: 597 EENILGRGGFGTVYKGELHD---GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
E+ LG G FGTV KG +AVK ++ E +E V+ ++ + ++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
V ++G C + +LV E G L++++ + ++ + + V+ G++YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE 124
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFGYLAPEY 771
+F+HRDL N+LL AK++DFGL + + + + + APE
Sbjct: 125 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 772 AVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830
+ ++K DV+SFGV++ E + G+K + E ++ R+ + D
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 241
Query: 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873
L C + RP L +
Sbjct: 242 ------------------LMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 4e-59
Identities = 62/278 (22%), Positives = 111/278 (39%), Gaps = 32/278 (11%)
Query: 598 ENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
+ +GRG F TVYKG + ++A ++ ++ FK E +L ++H ++V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 657 LGHCLD----GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+LV E M GTL ++ + K ++ + + +G+++L
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFL 128
Query: 713 HGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
H IHRDLK NI + G K+ D GL L + S + GT ++APE
Sbjct: 129 H-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEM 184
Query: 772 AVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831
+ VDV++FG+ ++E+ T E Q ++ ++ + D
Sbjct: 185 -YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR-------RVTSGVKPASFDK 236
Query: 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869
V E+ C + +R + +N
Sbjct: 237 VAI---------PEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (513), Expect = 6e-59
Identities = 80/310 (25%), Positives = 124/310 (40%), Gaps = 47/310 (15%)
Query: 593 NNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLT 646
NN +G G FG V++ T +AVK ++ S +F+ E A++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMA 71
Query: 647 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFN-------------------WAE 687
+ + ++V LLG C G L+FEYM G L+ + + +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 688 EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
G PL +L IA VA G+ YL + F+HRDL N L+G++M K+ADFGL R
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR 188
Query: 748 LAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPE 806
+ A ++ PE R TT+ DV+++GV+L E+ + QP
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL-----QPY 243
Query: 807 ESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGH 866
M + +D A L + L C ++ P RP
Sbjct: 244 YGMAHEEVIYYV---RDGNILACPENCPLE---------LYNLMRLCWSKLPADRPSFCS 291
Query: 867 AVNVLSSLVE 876
+L + E
Sbjct: 292 IHRILQRMCE 301
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 201 bits (511), Expect = 8e-59
Identities = 75/297 (25%), Positives = 128/297 (43%), Gaps = 27/297 (9%)
Query: 593 NNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
+ + ++ LG G +G VY+G +AVK ++ + + EF E AV+ +++H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHP 73
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
+LV LLG C ++ E+M G L ++ E + + L +A ++ +EY
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLR---ECNRQEVSAVVLLYMATQISSAMEY 130
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
L ++FIHRDL N L+G++ KVADFGL RL + + APE
Sbjct: 131 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187
Query: 772 AVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831
+ + K DV++FGV+L E+ T P + L + + D
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGM-----SPYPGIDLSQVYELLE---------KDY 233
Query: 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDQNSEDI 888
++ EG V EL C P RP ++ + +D+ +++
Sbjct: 234 RMERPEGCPEK---VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 287
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 201 bits (511), Expect = 1e-58
Identities = 62/311 (19%), Positives = 125/311 (40%), Gaps = 44/311 (14%)
Query: 584 SIQVLRNVTNNFSEE---------NILGRGGFGTVYKGELHDGTK----IAVKRMEAGVI 630
+ + F++E ++G G FG V G L K +A+K +++G
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY- 66
Query: 631 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL 690
+ K +F SE +++ + H +++ L G +++ E+M G+L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND---- 122
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750
+ + + +A G++YL +++HRDL NIL+ ++ KV+DFGL R
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 751 EGKGSIETR----IAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQP 805
+ + APE + T+ DV+S+G+++ E+++ G + +
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239
Query: 806 EESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMG 865
++ ++ + R+ D L C ++ RP G
Sbjct: 240 QDVINAIEQDYRLPPPMDCPSALHQ------------------LMLDCWQKDRNHRPKFG 281
Query: 866 HAVNVLSSLVE 876
VN L ++
Sbjct: 282 QIVNTLDKMIR 292
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 1e-58
Identities = 59/301 (19%), Positives = 109/301 (36%), Gaps = 33/301 (10%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+ +G+G FG V++G+ G ++AVK + + ++EI +RH +++ +
Sbjct: 8 QESIGKGRFGEVWRGK-WRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 63
Query: 658 GHCLDGNEKL----LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
N LV +Y G+L ++ + + +AL A G+ +LH
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLH 117
Query: 714 -----GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE---TRIAGTFG 765
+ HRDLK NIL+ + +AD GL +I+ GT
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 766 YLAPEYAVT------GRVTTKVDVFSFGVILMELITGRK----ALDESQPEESMHLVTWF 815
Y+APE + D+++ G++ E+ D P +
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 816 RRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875
+ K + + P I ++ +A++ C R LS L
Sbjct: 238 VE-EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
Query: 876 E 876
+
Sbjct: 297 Q 297
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 8e-58
Identities = 68/293 (23%), Positives = 124/293 (42%), Gaps = 34/293 (11%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGT-----KIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
+ + + ++G G FG VYKG L + +A+K ++AG K +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIMGQ 65
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
H +++ L G +++ EYM G L + + + + + +A
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAA 121
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA--GTFG 765
G++YL + +++HRDL NIL+ ++ KV+DFGL R+ + + T
Sbjct: 122 GMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 766 YLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDS 824
+ APE + T+ DV+SFG+++ E++T G + E E M + R+ D
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC 238
Query: 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877
L C +E +RP V++L L+
Sbjct: 239 PSAIYQ------------------LMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 9e-58
Identities = 61/290 (21%), Positives = 116/290 (40%), Gaps = 34/290 (11%)
Query: 592 TNNFSEENI-LGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
+N +I LG G FG+V +G +A+K ++ G E E ++ +
Sbjct: 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQ 65
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+ + ++V L+G C +LV E G L + + + + + + V+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSM 120
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFG 765
G++YL ++F+HRDL N+LL + AK++DFGL + R
Sbjct: 121 GMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 766 YLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDS 824
+ APE + +++ DV+S+GV + E ++ G+K + + E M + +R+ +
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC 237
Query: 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874
+ L C + RPD + +
Sbjct: 238 PPELYA------------------LMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 9e-58
Identities = 83/303 (27%), Positives = 125/303 (41%), Gaps = 38/303 (12%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKV- 648
N+ ++++G G FG V K + A+KRM+ S +F E+ VL K+
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLG 68
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI-----------FNWAEEGLKPLEWNR 697
H +++ LLG C L EY P G L + F A L +
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE 757
L A DVARG++YL + FIHRDL NIL+G++ AK+ADFGL R
Sbjct: 129 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK-- 183
Query: 758 TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRR 817
T ++A E TT DV+S+GV+L E+++ P M + +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYEK 238
Query: 818 IHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877
+ + D V +L C +PY+RP + L+ ++E
Sbjct: 239 L---PQGYRLEKPLNCD---------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286
Query: 878 WKP 880
K
Sbjct: 287 RKT 289
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (505), Expect = 1e-57
Identities = 64/285 (22%), Positives = 106/285 (37%), Gaps = 35/285 (12%)
Query: 590 NVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTK 647
+ FS+ +G G FG VY + + +A+K+M +G S + + E+ L K
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+RH + + G L + LV EY + KPL+ + +
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQ 126
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
G+ YLH + IHRD+K NILL + K+ DFG + GT ++
Sbjct: 127 GLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWM 178
Query: 768 APEYAVT---GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDS 824
APE + G+ KVDV+S G+ +EL + L +++ + L
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238
Query: 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869
+ + C + P RP +
Sbjct: 239 WSEYF-----------------RNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 7e-57
Identities = 72/307 (23%), Positives = 121/307 (39%), Gaps = 46/307 (14%)
Query: 593 NNFSEENILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLT 646
N +LG G FG V + ++AVK ++ S + SE+ ++T
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE-REALMSELKMMT 95
Query: 647 KV-RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFN------------------WAE 687
++ H ++V LLG C L+FEY G L ++ + E
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 688 EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
E L L + L A VA+G+E+L +S +HRDL N+L+ K+ DFGL R
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 748 LAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPE 806
+ ++APE G T K DV+S+G++L E+ + P
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 807 ESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGH 866
++ F+K I +++ A+ + + C A + +RP +
Sbjct: 273 DAN---------------FYKLIQNGFKMDQPFYAT-EEIYIIMQSCWAFDSRKRPSFPN 316
Query: 867 AVNVLSS 873
+ L
Sbjct: 317 LTSFLGC 323
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 3e-56
Identities = 71/305 (23%), Positives = 117/305 (38%), Gaps = 41/305 (13%)
Query: 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLT 646
N S LG G FG V + + +AVK ++ + SE+ VL+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-REALMSELKVLS 81
Query: 647 KV-RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFN-------------WAEEGLKP 692
+ H ++V LLG C G L++ EY G L + E+
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 693 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752
L+ L+ + VA+G+ +L ++ IHRDL NILL K+ DFGL R
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 753 KGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHL 811
++ ++APE T + DV+S+G+ L EL + + P +S
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256
Query: 812 VTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871
F+K I + A + + ++ C +P +RP V ++
Sbjct: 257 -------------FYKMIKEGFRMLSPEHAP-AEMYDIMKTCWDADPLKRPTFKQIVQLI 302
Query: 872 SSLVE 876
+
Sbjct: 303 EKQIS 307
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 8e-56
Identities = 77/313 (24%), Positives = 133/313 (42%), Gaps = 35/313 (11%)
Query: 590 NVTNNFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVL 645
++ +F+E ++GRG FG VY G L D AVK + G+ +++F +E ++
Sbjct: 26 SLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIM 82
Query: 646 TKVRHRHLVALLGHCLDG-NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALD 704
H ++++LLG CL L+V YM G L I N + L
Sbjct: 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQ 138
Query: 705 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG---SIETRIA 761
VA+G+++L + F+HRDL N +L + KVADFGL R + + +T
Sbjct: 139 VAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195
Query: 762 GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS 821
++A E T + TTK DV+SFGV+L EL+T P ++ +
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLL-- 248
Query: 822 KDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPT 881
+ + P + + E+ C + RP V+ +S++ +
Sbjct: 249 --QGRRLLQPEYCPDP--------LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298
Query: 882 DQNSEDIYGIDLE 894
+ ++++
Sbjct: 299 HYVHVNATYVNVK 311
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 8e-56
Identities = 62/281 (22%), Positives = 101/281 (35%), Gaps = 32/281 (11%)
Query: 590 NVTNNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
N + + LG G FG VYK + + A K ++ S + L ++ EI +L
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASC 66
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
H ++V LL N ++ E+ G + + +PL ++ +
Sbjct: 67 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE----RPLTESQIQVVCKQTLDA 122
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 768
+ YLH IHRDLK NIL D K+ADFG+ GT ++A
Sbjct: 123 LNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSFIGTPYWMA 178
Query: 769 PEYAVT-----GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD 823
PE + K DV+S G+ L+E+ E P + +
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA---------- 228
Query: 824 SFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDM 864
K+ PT+ ++ + C + R
Sbjct: 229 ---KSEPPTLAQPSRWSSNF---KDFLKKCLEKNVDARWTT 263
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-55
Identities = 62/280 (22%), Positives = 98/280 (35%), Gaps = 28/280 (10%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
++ LG G +G V +AVK ++ K EI + + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHE 63
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
++V GH +GN + L EY G L I + + GV Y
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVY 118
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYLAPE 770
LH HRD+KP N+LL + K++DFGL + + ++ GT Y+APE
Sbjct: 119 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 771 YAVTGRV-TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829
VDV+S G++L ++ G D+ + ++ +L+
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-------P 228
Query: 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869
ID S L P R +
Sbjct: 229 WKKID---------SAPLALLHKILVENPSARITIPDIKK 259
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-55
Identities = 70/319 (21%), Positives = 131/319 (41%), Gaps = 40/319 (12%)
Query: 572 DIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI 630
D ++LE ++S+ + ++ +G+G GTVY ++ G ++A+++M
Sbjct: 2 DEEILEKLRSIVSV---GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-- 56
Query: 631 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL 690
+EI V+ + ++ ++V L L G+E +V EY+ G+L+ +
Sbjct: 57 QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------ 110
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750
++ + + + + +E+LH IHRD+K NILLG D K+ DFG
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI- 166
Query: 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMH 810
+ S + + GT ++APE KVD++S G++ +E+I G P +++
Sbjct: 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226
Query: 811 LVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN- 869
L+ P + E + A + C + +R +
Sbjct: 227 LIA-------------TNGTPELQNPEKLSAIF---RDFLNRCLDMDVEKRGSAKELLQH 270
Query: 870 -------VLSSLVELWKPT 881
LSSL L
Sbjct: 271 QFLKIAKPLSSLTPLIAAA 289
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 7e-54
Identities = 71/302 (23%), Positives = 115/302 (38%), Gaps = 36/302 (11%)
Query: 585 IQVLRNVTNNFSEENILGRGGFGTVYKGELHD-----GTKIAVKRMEAGVISGKGLTEFK 639
+++L+ F + +LG G FGTVYKG +A+K + S K E
Sbjct: 3 LRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEIL 59
Query: 640 SEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL 699
E V+ V + H+ LLG CL +L+ + MP G L ++ E + L
Sbjct: 60 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL----LDYVREHKDNIGSQYLL 114
Query: 700 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIET 758
+ +A+G+ YL + +HRDL N+L+ K+ DFGL + L E K
Sbjct: 115 NWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171
Query: 759 RIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRR 817
++A E + T + DV+S+GV + EL+T G K D E ++ R
Sbjct: 172 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 231
Query: 818 IHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877
+ + C + RP + S +
Sbjct: 232 LPQPPICTIDVYM------------------IMVKCWMIDADSRPKFRELIIEFSKMARD 273
Query: 878 WK 879
+
Sbjct: 274 PQ 275
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-53
Identities = 61/291 (20%), Positives = 110/291 (37%), Gaps = 30/291 (10%)
Query: 593 NNFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
+G G FG V++G +A+K + S +F E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQF 65
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
H H+V L+G + ++ E G L + L+ + A ++
Sbjct: 66 DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTA 120
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 768
+ YL + F+HRD+ N+L+ + K+ DFGL R + ++ ++A
Sbjct: 121 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
Query: 769 PEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828
PE R T+ DV+ FGV + E++ +P + + RI ++
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRI---ENGERLP 229
Query: 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWK 879
+ P T+ L C A +P +RP LS+++E K
Sbjct: 230 MPPNCP---------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 3e-53
Identities = 71/286 (24%), Positives = 113/286 (39%), Gaps = 31/286 (10%)
Query: 593 NNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTK 647
+ LG G FG V +GE +AVK ++ V+S + + +F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+ HR+L+ L G L K+ V E P G+L + + A+ VA
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS--IETRIAGTFG 765
G+ YL + FIHRDL N+LL K+ DFGL+R P+ ++ F
Sbjct: 123 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 766 YLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825
+ APE T + D + FGV L E+ T + +P ++ +I +
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGERL 234
Query: 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVL 871
+ D D+ + C A +P RP + L
Sbjct: 235 PRPEDCPQDI-----------YNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-52
Identities = 70/298 (23%), Positives = 120/298 (40%), Gaps = 33/298 (11%)
Query: 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLT 646
+ LG+G FG VY+G T++A+K + S + EF +E +V+
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMK 78
Query: 647 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-----AEEGLKPLEWNRRLTI 701
+ H+V LLG G L++ E M +G L ++ + L P ++ + +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE-TRI 760
A ++A G + L F+HRDL N ++ +D K+ DFG+ R E + +
Sbjct: 139 AGEIADG---MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 761 AGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL 820
+++PE G TT DV+SFGV+L E+ T + QP + + R +
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----QPYQGLSNEQVLRFV-- 248
Query: 821 SKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELW 878
+ + EL C P RP ++ + +E
Sbjct: 249 -MEGGLLDKPDNCP---------DMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-52
Identities = 64/279 (22%), Positives = 106/279 (37%), Gaps = 30/279 (10%)
Query: 594 NFSEENILGRGGFGTVYKG-ELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKVRHR 651
+F ILG G F TV EL + A+K +E +I + E V++++ H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
V L D + Y G L ++I + ++ +EY
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEY 123
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL-APEGKGSIETRIAGTFGYLAPE 770
LH + IHRDLKP NILL +DM ++ DFG ++ +PE K + GT Y++PE
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 771 YAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830
D+++ G I+ +L+ G P + + F++I + F +
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGL------PPFRAGNEYLIFQKIIKLEYDFPEKFF 234
Query: 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869
P +L + +R
Sbjct: 235 P-------------KARDLVEKLLVLDATKRLGCEEMEG 260
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 5e-52
Identities = 79/307 (25%), Positives = 125/307 (40%), Gaps = 44/307 (14%)
Query: 593 NNFSEENILGRGGFGTVYKGEL--------HDGTKIAVKRMEAGVISGKGLTEFKSEIAV 644
+ LG G FG V E + TK+AVK +++ K L++ SE+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEM 71
Query: 645 LTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL-----------KP 692
+ + +H++++ LLG C ++ EY +G L ++ GL +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 693 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752
L ++ A VARG+EYL + IHRDL N+L+ +D K+ADFGL R
Sbjct: 132 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 753 KGSIET-RIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQP-EESMH 810
+T ++APE T + DV+SFGV+L E+ T + P EE
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248
Query: 811 LVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870
L+ R+ + ++ + C P QRP V
Sbjct: 249 LLKEGHRMDKPSNCTNELYM------------------MMRDCWHAVPSQRPTFKQLVED 290
Query: 871 LSSLVEL 877
L +V L
Sbjct: 291 LDRIVAL 297
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 181 bits (460), Expect = 4e-51
Identities = 61/278 (21%), Positives = 107/278 (38%), Gaps = 29/278 (10%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
+V +++ LG G FG V++ E G A K + S K + EI ++ +
Sbjct: 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVL 80
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
RH LV L D NE ++++E+M G L + + + + + V +G
Sbjct: 81 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKG 136
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDM--RAKVADFGLVRLAPEGKGSIETRIAGTFGY 766
+ ++H +++H DLKP NI+ K+ DFGL + T GT +
Sbjct: 137 LCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEF 191
Query: 767 LAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826
APE A V D++S GV+ L++G +E++ R + +
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL------RNVKSCDWNMD 245
Query: 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDM 864
+ I + +P R +
Sbjct: 246 DSAFSGIS---------EDGKDFIRKLLLADPNTRMTI 274
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 174 bits (441), Expect = 2e-49
Identities = 65/287 (22%), Positives = 109/287 (37%), Gaps = 31/287 (10%)
Query: 590 NVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTK 647
++++ + ILG GG V+ L +AVK + A + F+ E
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 648 VRHRHLVALLGHCLD----GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 703
+ H +VA+ G +V EY+ TL + P+ R + +
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIA 118
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE--TRIA 761
D + + + H IHRD+KP+NI++ KV DFG+ R + S+ +
Sbjct: 119 DACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
Query: 762 GTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS 821
GT YL+PE A V + DV+S G +L E++TG P +
Sbjct: 176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH--------- 226
Query: 822 KDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAV 868
+ P +EG+ A + + A+ P R +
Sbjct: 227 ---VREDPIPPSARHEGLSAD---LDAVVLKALAKNPENRYQTAAEM 267
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 3e-49
Identities = 71/304 (23%), Positives = 116/304 (38%), Gaps = 40/304 (13%)
Query: 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLT 646
+ LGRG FG V + + +AVK ++ G + SE+ +L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-HRALMSELKILI 71
Query: 647 KVRHRHLVALLGHCL--DGNEKLLVFEYMPQGTLSRHIFN-----------WAEEGLKPL 693
+ H V L G +++ E+ G LS ++ + + L
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 694 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753
+ + VA+G+E+L + IHRDL NILL + K+ DFGL R +
Sbjct: 132 TLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 754 GSIE-TRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLV 812
+ ++APE T + DV+SFGV+L E+ + P + +
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKID 243
Query: 813 TWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLS 872
F R L + + +A D T + + C EP QRP V L
Sbjct: 244 EEFCRR-LKEGTRMRAPDYTTP----------EMYQTMLDCWHGEPSQRPTFSELVEHLG 292
Query: 873 SLVE 876
+L++
Sbjct: 293 NLLQ 296
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (441), Expect = 5e-49
Identities = 69/279 (24%), Positives = 113/279 (40%), Gaps = 30/279 (10%)
Query: 590 NVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
++ + + ++LG G F V E +A+K + + GK ++EIAVL K+
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKI 64
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
+H ++VAL G L+ + + G L I + V
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDA 119
Query: 709 VEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFG 765
V+YLH +HRDLKP N+L +D + ++DFGL ++ E GS+ + GT G
Sbjct: 120 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPG 174
Query: 766 YLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825
Y+APE + VD +S GVI L+ G P + F +I ++ F
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP------PFYDENDAKLFEQILKAEYEF 228
Query: 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDM 864
I + + H ++P +R
Sbjct: 229 DSPYWDDIS---------DSAKDFIRHLMEKDPEKRFTC 258
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 170 bits (431), Expect = 4e-48
Identities = 68/286 (23%), Positives = 99/286 (34%), Gaps = 40/286 (13%)
Query: 594 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTE-------FKSEIAVL 645
N+ + ILGRG V + + AVK ++ E E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 646 TKVR-HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALD 704
KV H +++ L LVF+ M +G L ++ L I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRA 118
Query: 705 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF 764
+ + LH + +HRDLKP NILL DDM K+ DFG G+ + GT
Sbjct: 119 LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTP 173
Query: 765 GYLAPEYAVTGRV------TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI 818
YLAPE +VD++S GVI+ L+ G + R I
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRMI 227
Query: 819 HLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDM 864
F TV +L +P +R
Sbjct: 228 MSGNYQFGSPEWDDYS---------DTVKDLVSRFLVVQPQKRYTA 264
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 172 bits (436), Expect = 8e-48
Identities = 58/280 (20%), Positives = 103/280 (36%), Gaps = 31/280 (11%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
+V + + LG G FG V++ E G K + K K+EI+++ +
Sbjct: 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQ 82
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+ H L+ L D E +L+ E++ G L I + +
Sbjct: 83 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI----AAEDYKMSEAEVINYMRQACE 138
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILL--GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFG 765
G++++H S +H D+KP NI+ K+ DFGL I T
Sbjct: 139 GLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAE 193
Query: 766 YLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825
+ APE V D+++ GV+ L++G E++ V
Sbjct: 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV------------- 240
Query: 826 HKAIDPTIDLNEGILASISTVA-ELAGHCCAREPYQRPDM 864
+ +E +S+S A + + +EP +R +
Sbjct: 241 ---KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTV 277
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 170 bits (432), Expect = 3e-47
Identities = 60/276 (21%), Positives = 107/276 (38%), Gaps = 33/276 (11%)
Query: 593 NNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKG----LTEFKSEIAVLTK 647
N+FS I+GRGGFG VY D G A+K ++ I K + +++++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+V + ++ + + M G L H+ A ++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIIL 118
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
G+E++H ++ ++RDLKP+NILL + +++D GL + K GT GY+
Sbjct: 119 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYM 172
Query: 768 APEYAVTGR-VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826
APE G + D FS G +L +L+ G + + ++ + R
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLTMAVELP 229
Query: 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRP 862
+ P + L R+ +R
Sbjct: 230 DSFSP-------------ELRSLLEGLLQRDVNRRL 252
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 167 bits (423), Expect = 6e-47
Identities = 57/287 (19%), Positives = 105/287 (36%), Gaps = 18/287 (6%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+ +G G +G VYK + + G A+K++ + EI++L +++H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+V L +LVFE++ Q LE + L + G+ Y
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYC 116
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
H + +HRDLKP N+L+ + K+ADFGL R I +
Sbjct: 117 H---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 773 VTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLV----------TWFRRIHLSK 822
+ + +T +D++S G I E++ G + + + W L K
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 823 DSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869
+ + + + + +L +P QR A+
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 167 bits (424), Expect = 7e-47
Identities = 49/318 (15%), Positives = 103/318 (32%), Gaps = 41/318 (12%)
Query: 591 VTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 649
V ++ +G G FG +++G L + ++A+K + + E +
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLA 58
Query: 650 HR-HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
+ + +G +LV + + + A +
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-----RKFSVKTVAMAAKQMLAR 113
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMR-----AKVADFGLVRLAPEGKGSIETR---- 759
V+ +H +S ++RD+KP N L+G V DFG+V+ +
Sbjct: 114 VQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 760 --IAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRR 817
++GT Y++ + + + D+ + G + M + G + + + R
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ---KYER 227
Query: 818 IHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877
I K S P +L G + PD + + S ++E
Sbjct: 228 IGEKKQST-----PLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLE- 278
Query: 878 WKPTDQNSEDIYGIDLEM 895
N+ + D +
Sbjct: 279 ----RLNTTEDENFDWNL 292
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 166 bits (422), Expect = 2e-46
Identities = 63/272 (23%), Positives = 111/272 (40%), Gaps = 33/272 (12%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRH 650
+F LG G FG V+ H+G A+K ++ ++ K + E +L+ V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
++ + G D + ++ +Y+ G L + + A +V +E
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALE 118
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
YLH + I+RDLKP NILL + K+ DFG + P+ + + GT Y+APE
Sbjct: 119 YLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPE 171
Query: 771 YAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830
T +D +SFG+++ E++ G P + + + +I ++ F +
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYT------PFYDSNTMKTYEKILNAELRFPPFFN 225
Query: 831 PTIDLNEGILASISTVAELAGHCCAREPYQRP 862
V +L R+ QR
Sbjct: 226 E-------------DVKDLLSRLITRDLSQRL 244
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (420), Expect = 3e-46
Identities = 53/310 (17%), Positives = 103/310 (33%), Gaps = 37/310 (11%)
Query: 591 VTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 649
V N + +G G FG +Y G + G ++A+K + E + ++
Sbjct: 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE----CVKTKHPQLHIESKIYKMMQ 60
Query: 650 HRHLVALLGHCL-DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
+ + C +G+ ++V E + F + L +A +
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-----RKFSLKTVLLLADQMISR 115
Query: 709 VEYLHGLAHQSFIHRDLKPSNIL---LGDDMRAKVADFGLVRLAPEGKGSIE------TR 759
+EY+H ++FIHRD+KP N L + DFGL + + +
Sbjct: 116 IEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 760 IAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH 819
+ GT Y + + + + D+ S G +LM G +
Sbjct: 173 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 232
Query: 820 LSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWK 879
+S P L +G + A C + +PD + + L+
Sbjct: 233 MS--------TPIEVLCKGYPSEF---ATYLNFCRSLRFDDKPDYSYLRQLFR---NLFH 278
Query: 880 PTDQNSEDIY 889
+ + ++
Sbjct: 279 RQGFSYDYVF 288
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-45
Identities = 64/290 (22%), Positives = 110/290 (37%), Gaps = 25/290 (8%)
Query: 592 TNNFSEENILGRGGFGTVYKGE--LHDGTKIAVKRMEAGVISGKGLTEFKSEIAV---LT 646
+ +G G +G V+K + G +A+KR+ E+AV L
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 647 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKP-LEWNRRLTIALDV 705
H ++V L C + + + + + ++ +P + + +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFG 765
RG+++LH +HRDLKP NIL+ + K+ADFGL R+ T + T
Sbjct: 126 LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLW 180
Query: 766 YLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLV----------TWF 815
Y APE + T VD++S G I E+ + S + + + W
Sbjct: 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 816 RRIHLSKDSFHKAIDPTIDLNEGILASISTVA-ELAGHCCAREPYQRPDM 864
R + L + +FH I E + I + +L C P +R
Sbjct: 241 RDVALPRQAFHSKSAQPI---EKFVTDIDELGKDLLLKCLTFNPAKRISA 287
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-45
Identities = 52/279 (18%), Positives = 98/279 (35%), Gaps = 30/279 (10%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
+ + + LGRG FG V++ E K ++ + G K EI++L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNI 57
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
RHR+++ L E +++FE++ + I L ++ V
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQVCE 113
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLAPEGKGSIETRIAGTFG 765
+++LH + H D++P NI+ K+ +FG R G +
Sbjct: 114 ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPE 168
Query: 766 YLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825
Y APE V+T D++S G ++ L++G ++ I ++ +F
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEYTF 222
Query: 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDM 864
+ I + +E R
Sbjct: 223 DEEAFKEIS---------IEAMDFVDRLLVKERKSRMTA 252
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-45
Identities = 66/279 (23%), Positives = 110/279 (39%), Gaps = 31/279 (11%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGK-GLTEFKSEIAVLTKV-R 649
+F +LG+G FG V+ E A+K ++ V+ + E VL+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 650 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
H L + V EY+ G L HI + + +R A ++ G+
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGL 116
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
++LH + ++RDLK NILL D K+ADFG+ + G + GT Y+AP
Sbjct: 117 QFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNTFCGTPDYIAP 172
Query: 770 EYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829
E + + VD +SFGV+L E++ G+ P F I + + + +
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIRMDNPFYPRWL 226
Query: 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAV 868
+ +L REP +R + +
Sbjct: 227 EK-------------EAKDLLVKLFVREPEKRLGVRGDI 252
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 6e-45
Identities = 57/287 (19%), Positives = 105/287 (36%), Gaps = 18/287 (6%)
Query: 594 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
NF + +G G +G VYK G +A+K++ + + EI++L ++ H +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+V LL N+ LVFE++ Q + L + + + +G+ +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA----LTGIPLPLIKSYLFQLLQGLAFC 118
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
H +HRDLKP N+L+ + K+ADFGL R + + +
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 773 VTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLV----------TWFRRIHLSK 822
+T VD++S G I E++T R + + + W +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 823 DSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869
D ++ + L +P +R A+
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 3e-44
Identities = 55/296 (18%), Positives = 112/296 (37%), Gaps = 22/296 (7%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
+V ++ + +G G +G V + + ++A+K++ EI +L +
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLREIKILLRF 63
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
RH +++ + + + Y+ + ++ + L + + RG
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRG 121
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE--TRIAGTFGY 766
++Y+H + +HRDLKPSN+LL K+ DFGL R+A T T Y
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 767 LAPEYAVTGRVTT-KVDVFSFGVILMELITGRKALDESQPEESMHLV------------T 813
APE + + T +D++S G IL E+++ R + ++ +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 814 WFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869
+ + N + S +L P++R ++ A+
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 1e-43
Identities = 69/285 (24%), Positives = 111/285 (38%), Gaps = 23/285 (8%)
Query: 599 NILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKG---LTEFKSEIAVLTKVRHRHLV 654
+ LG G F TVYK + +A+K+++ G S EI +L ++ H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
LL + LVF++M N L + L +G+EYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLH- 117
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT 774
+HRDLKP+N+LL ++ K+ADFGL + + T T Y APE
Sbjct: 118 --QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFG 174
Query: 775 GRV-TTKVDVFSFGVILMELITGRKALDESQPEESMHLVT---------WFRRIHLSKDS 824
R+ VD+++ G IL EL+ L + + + + + D
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869
P I L+ A+ + +L P R A+
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 2e-43
Identities = 60/284 (21%), Positives = 105/284 (36%), Gaps = 34/284 (11%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI----SGKGLTEFKSEIAV 644
NV + + LG G F V K E G + A K ++ G + + E+++
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 645 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALD 704
L +++H +++ L + + +L+ E + G L + + L
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQ 121
Query: 705 VARGVEYLHGLAHQSFIHRDLKPSNILLGDD----MRAKVADFGLVRLAPEGKGSIETRI 760
+ GV YLH H DLKP NI+L D R K+ DFGL G+ I
Sbjct: 122 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNI 176
Query: 761 AGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL 820
GT ++APE + + D++S GVI L++G +E++ +
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ANVSA 230
Query: 821 SKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDM 864
F + + ++P +R +
Sbjct: 231 VNYEFEDEYFSNTS---------ALAKDFIRRLLVKDPKKRMTI 265
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 4e-43
Identities = 54/276 (19%), Positives = 95/276 (34%), Gaps = 35/276 (12%)
Query: 598 ENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVA 655
+LG G G V + K A+K + + + + E+ + + + H+V
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVR 69
Query: 656 LLGHCLDGNEK----LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
++ + L+V E + G L I + G + I + ++Y
Sbjct: 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQY 126
Query: 712 LHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 768
LH + HRD+KP N+L + K+ DFG + T Y+A
Sbjct: 127 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVA 181
Query: 769 PEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828
PE + D++S GVI+ L+ G + + RI + + F
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--KTRIRMGQYEFPNP 239
Query: 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDM 864
+ V L + EP QR +
Sbjct: 240 EWSEVS---------EEVKMLIRNLLKTEPTQRMTI 266
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 9e-43
Identities = 58/299 (19%), Positives = 104/299 (34%), Gaps = 30/299 (10%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
R ++++ ++G G FG VY+ +L D G +A+K++ + E+ ++ K
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRK 69
Query: 648 VRHRHLVALLGHCLDGNEK------LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTI 701
+ H ++V L EK LV +Y+P+ + L
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ--TLPVIYVKLY 127
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPEGKGSIETRI 760
+ R + Y+H HRD+KP N+LL D K+ DFG + G+ + I
Sbjct: 128 MYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYI 183
Query: 761 AGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLV-------- 812
+ T+ +DV+S G +L EL+ G+ + + +
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 813 -TWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVA-ELAGHCCAREPYQRPDMGHAVN 869
R ++ + F + A L P R A
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 3e-41
Identities = 55/289 (19%), Positives = 102/289 (35%), Gaps = 20/289 (6%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
+ + +G G +GTV+K + +A+KR+ + EI +L +++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
++V L + LVFE+ Q L+ + + +G+ +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGF 116
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
H ++ +HRDLKP N+L+ + K+A+FGL R + +
Sbjct: 117 CH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 772 AVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESM-----------HLVTWFRRIHL 820
+T +D++S G I EL + L + W L
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 821 SKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869
+ T L + +T +L + P QR A+
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 5e-41
Identities = 65/286 (22%), Positives = 106/286 (37%), Gaps = 44/286 (15%)
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKG----LTEFKSEIAVLTK 647
+ + +LG GGFG+VY G + D +A+K +E IS G T E+ +L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 648 VRHRH--LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 705
V ++ LL + +L+ E L+ + V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQV 119
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPEGKGSIETRIAGTF 764
V + H + +HRD+K NIL+ + K+ DFG L + ++ T GT
Sbjct: 120 LEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTR 173
Query: 765 GYLAPEYAVTGRVTTK-VDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD 823
Y PE+ R + V+S G++L +++ G + EE + +FR+ +S +
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVFFRQ-RVSSE 230
Query: 824 SFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869
L C A P RP N
Sbjct: 231 ----------------------CQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 6e-41
Identities = 69/277 (24%), Positives = 104/277 (37%), Gaps = 30/277 (10%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGK-GLTEFKSEIAVLTKVRH 650
N+F +LG+G FG V G A+K + VI K + +E VL RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
L AL + V EY G L H+ + R ++ +E
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALE 119
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
YLH + ++RD+K N++L D K+ DFGL + G+ GT YLAPE
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFCGTPEYLAPE 175
Query: 771 YAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830
VD + GV++ E++ GR P + F I + + F + +
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRL------PFYNQDHERLFELILMEEIRFPRTLS 229
Query: 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHA 867
P L ++P QR G +
Sbjct: 230 P-------------EAKSLLAGLLKKDPKQRLGGGPS 253
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 6e-40
Identities = 60/303 (19%), Positives = 105/303 (34%), Gaps = 34/303 (11%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
+ + + +G+G FG V+K G K+A+K++ EI +L ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 652 HLVALLGHCLDGNEK--------LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 703
++V L+ C LVF++ L + +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQ 124
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS---IETRI 760
+ G L+ + +HRD+K +N+L+ D K+ADFGL R K S T
Sbjct: 125 MLLNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 761 AGTFGYLAPEYAVTGR-VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVT------ 813
T Y PE + R +D++ G I+ E+ T + + + + L++
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241
Query: 814 -------WFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGH 866
K K + +L +P QR D
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301
Query: 867 AVN 869
A+N
Sbjct: 302 ALN 304
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-38
Identities = 65/299 (21%), Positives = 117/299 (39%), Gaps = 32/299 (10%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
V + + +G G +G V + G K+A+K++ S E+ +L +
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 649 RHRHLVALLGHCLDGN------EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIA 702
RH +++ LL + LV +M GT + + L +R +
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH-----EKLGEDRIQFLV 127
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG 762
+ +G+ Y+H IHRDLKP N+ + +D K+ DFGL R A + +
Sbjct: 128 YQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---EMTGYVVT 181
Query: 763 TFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLV---------T 813
+ R T VD++S G I+ E+ITG+ S + + +
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241
Query: 814 WFRRIHLSKDSFHKAIDPTIDLNE--GILASISTVA-ELAGHCCAREPYQRPDMGHAVN 869
+ +R+ + + P ++ + IL + S +A L + QR G A+
Sbjct: 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (357), Expect = 2e-37
Identities = 59/272 (21%), Positives = 97/272 (35%), Gaps = 33/272 (12%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKVRH 650
+ F LG G FG V + G A+K ++ V+ K + +E +L V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
LV L D + +V EY+ G + H+ + A + E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFE 155
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
YLH I+RDLKP N+L+ +V DFG + + GT LAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCGTPEALAPE 208
Query: 771 YAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830
++ VD ++ GV++ E+ G P + + + +I K F
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGY------PPFFADQPIQIYEKIVSGKVRFPSHFS 262
Query: 831 PTIDLNEGILASISTVAELAGHCCAREPYQRP 862
+ +L + + +R
Sbjct: 263 SDLK-------------DLLRNLLQVDLTKRF 281
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 4e-37
Identities = 56/251 (22%), Positives = 96/251 (38%), Gaps = 22/251 (8%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
V + +G G G V + +A+K++ + E+ ++ V
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 649 RHRHLVALLGHCL------DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIA 702
H+++++LL + + LV E M E R +
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE--------RMSYLL 125
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG 762
+ G+++LH IHRDLKPSNI++ D K+ DFGL R G + T
Sbjct: 126 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVV 180
Query: 763 TFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK 822
T Y APE + VD++S G I+ E++ + + + V ++
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV--IEQLGTPC 238
Query: 823 DSFHKAIDPTI 833
F K + PT+
Sbjct: 239 PEFMKKLQPTV 249
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-36
Identities = 63/284 (22%), Positives = 105/284 (36%), Gaps = 32/284 (11%)
Query: 593 NNFSEENILGRGGFGTVYKGEL----HDGTKIAVKRMEAGVISG--KGLTEFKSEIAVLT 646
NF +LG G +G V+ G A+K ++ I K ++E VL
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 647 KVRHR-HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 705
+R LV L + L+ +Y+ G L H+ + + ++
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEI 138
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFG 765
+E+LH I+RD+K NILL + + DFGL + + GT
Sbjct: 139 VLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195
Query: 766 YLAPEYAVTGR--VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD 823
Y+AP+ G VD +S GV++ EL+TG + S + RRI S+
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKSEP 253
Query: 824 SFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHA 867
+ + + +L ++P +R G
Sbjct: 254 PYPQEMSA-------------LAKDLIQRLLMKDPKKRLGCGPR 284
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 133 bits (334), Expect = 1e-34
Identities = 46/300 (15%), Positives = 103/300 (34%), Gaps = 43/300 (14%)
Query: 590 NVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
+++ LGRG + V++ + + K+ VK ++ + K EI +L +
Sbjct: 32 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVK-----ILKPVKKKKIKREIKILENL 86
Query: 649 R-HRHLVALLGHCLDGNEKL--LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 705
R +++ L D + LVFE++ + + L ++
Sbjct: 87 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEI 138
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLAPEGKGSIETRIAGTF 764
+ ++Y H +HRD+KP N+++ + + ++ D+GL G+ +
Sbjct: 139 LKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASR 193
Query: 765 GYLAPEYAVTGR-VTTKVDVFSFGVILMELITGRKALDESQPEESM-----------HLV 812
+ PE V + +D++S G +L +I ++ L
Sbjct: 194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253
Query: 813 TWFRRIHLSKDSFHKAIDPTID-------LNEGILASISTVA-ELAGHCCAREPYQRPDM 864
+ + ++ D I ++ +S A + + R
Sbjct: 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 6e-34
Identities = 54/298 (18%), Positives = 112/298 (37%), Gaps = 30/298 (10%)
Query: 590 NVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
V + + +G G +G+V G ++AVK++ S E+ +L +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 649 RHRHLVALLGHCLDGN-----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 703
+H +++ LL + + ++ L+ + + L + +
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIY 128
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT 763
+ RG++Y+H IHRDLKPSN+ + +D K+ DFG LA + +A
Sbjct: 129 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG---LARHTDDEMTGYVATR 182
Query: 764 FGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLV----------T 813
+ VD++S G I+ EL+TGR + + + L+
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242
Query: 814 WFRRIHLSKDSFHKAI--DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869
+ S ++ +++ P ++ + + +L + +R A+
Sbjct: 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (292), Expect = 7e-29
Identities = 43/233 (18%), Positives = 83/233 (35%), Gaps = 19/233 (8%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH--------- 650
LG G F TV+ + + + T +A+K + + + + EI +L +V
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDADNTKEDSM 77
Query: 651 --RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
H++ LL H + + + + + + + I+ + G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 709 VEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPEGK-GSIETRIAGTFGY 766
++Y+H IH D+KP N+L+ D + + L T T Y
Sbjct: 138 LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 767 LAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH 819
+PE + D++S ++ ELITG + + +I
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 101 bits (251), Expect = 5e-25
Identities = 27/161 (16%), Positives = 46/161 (28%), Gaps = 28/161 (17%)
Query: 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK--------GLTEFKSEIAVLTKVRH 650
++G G V+ + VK + G S K G F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 651 RHLVALLG----HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 706
R L L G ++ E + L R +E + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDE------------VLDMIL 113
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
V + H+ +H DL N+L+ + + DF
Sbjct: 114 EEVAKFY---HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 96.7 bits (239), Expect = 2e-22
Identities = 78/314 (24%), Positives = 137/314 (43%), Gaps = 18/314 (5%)
Query: 29 DDGDAAVMLALKKSLNPPESL-GW-SDTDPC--KWNHVVCIED---KRITRIQIGHQNLQ 81
+ D +L +KK L P +L W TD C W V+C D R+ + + NL
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 82 G--TLPSNLQNLTKLERLELQ--WNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTG 137
+PS+L NL L L + N + P++ L L + +++ + DF +
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 138 LSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHL 197
+ +L +++ N S +P S+ + L + + I+G IP +G T + +
Sbjct: 124 IKTLVTLDFSYNALS-GTLPPSISSLPNLVGITFDGNRISGAIPDSYGSF-SKLFTSMTI 181
Query: 198 AFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP 257
+ N+L G +P +F +L + N G + + + ++I L N+ + L
Sbjct: 182 SRNRLTGKIPPTF---ANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
Query: 258 DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKG 317
K L L LR+N G +P L +L+ L +N++ N L G +P+ D++
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298
Query: 318 SNNFCL--PSPGAC 329
+NN CL AC
Sbjct: 299 ANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 65.5 bits (158), Expect = 5e-12
Identities = 56/250 (22%), Positives = 88/250 (35%), Gaps = 14/250 (5%)
Query: 192 LTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSN 250
+ L L+ L P S + + L G L G I I +T L +++
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 251 AFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRS 309
SG +PD S +K L +L N +G +P S+ L +L + N + G +P+
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD---- 167
Query: 310 VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTK 369
S + N L + A + V
Sbjct: 168 --------SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGS 219
Query: 370 GNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQ 429
T N + K+L L L +N + G +P+GL+ L L L+VS N
Sbjct: 220 DKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 430 LYGKIPSFKS 439
L G+IP +
Sbjct: 280 LCGEIPQGGN 289
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.7 bits (135), Expect = 4e-09
Identities = 28/110 (25%), Positives = 46/110 (41%), Gaps = 9/110 (8%)
Query: 329 CDPR-LNALLSVVKLMGYPQRFAENWKGNDPCSD-WIGVTCTKGN----ITVINFQKMNL 382
C+P+ ALL + K +G P + D C+ W+GV C + ++ +NL
Sbjct: 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 383 TG--TISPEFASFKSLQRLILADN-NLSGMIPEGLSVLGALKELDVSNNQ 429
I A+ L L + NL G IP ++ L L L +++
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN 112
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 40.1 bits (92), Expect = 8e-04
Identities = 42/257 (16%), Positives = 71/257 (27%), Gaps = 17/257 (6%)
Query: 168 NFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNA 227
+ S + IPS P L L++ + G +++ L
Sbjct: 56 DLSGLNLPKPYPIPSSLA--NLPYLNFLYIGGINNLVGPIPPAI-AKLTQLHYLYITHTN 112
Query: 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKL 286
G D + + +L + NA SG LP S + L ++ N +G +PDS
Sbjct: 113 VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSF 172
Query: 287 ESLKIVNMT--NNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMG 344
L N L P F + N + N +
Sbjct: 173 SKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS 232
Query: 345 YPQRFAENWKGNDPCSDWIGVTCTKGNI----------TVINFQKMNLTGTISPEFASFK 394
+ + + G + +N NL G I P+ + +
Sbjct: 233 LAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQ 291
Query: 395 SLQRLILADNNLSGMIP 411
A+N P
Sbjct: 292 RFDVSAYANNKCLCGSP 308
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 89.7 bits (221), Expect = 1e-19
Identities = 65/372 (17%), Positives = 112/372 (30%), Gaps = 37/372 (9%)
Query: 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVP 131
+ +G N+ T+ +L ++ L+ I + + L +L + SNNQ T +
Sbjct: 26 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDIT 82
Query: 132 SDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPG 191
L+ L I ++NN + +L N +GL F+ +I
Sbjct: 83 P--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELS 140
Query: 192 LTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLH--- 248
+ S + N I + L
Sbjct: 141 SNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLE 200
Query: 249 -----SNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPV 303
+N S P + L+ LSL N +L L +L +++ NN +
Sbjct: 201 SLIATNNQISDITPLGI-LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA 257
Query: 304 PEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWI 363
P L K N + ++ L G N
Sbjct: 258 P-LSGLTKLTELKLGANQ--------------ISNISPLAGLTALTNLELNENQLEDISP 302
Query: 364 GVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKEL 423
N+T + N++ +S LQRL A+N +S L+ L + L
Sbjct: 303 ISNLK--NLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD--VSSLANLTNINWL 356
Query: 424 DVSNNQLYGKIP 435
+NQ+ P
Sbjct: 357 SAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 63.1 bits (152), Expect = 5e-11
Identities = 41/189 (21%), Positives = 75/189 (39%), Gaps = 20/189 (10%)
Query: 64 CIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLS 123
+ + + L+ L +LT L L+L N IS L L+GL L + L
Sbjct: 215 LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLG 271
Query: 124 NNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSF 183
NQ +++ GL++L ++E++ N +L+N + L N NI+ P
Sbjct: 272 ANQISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYL-TLYFN--NISDISP-- 324
Query: 184 FGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSL 242
L L A N++ +S + + I L + + + N+T +
Sbjct: 325 --VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQIS-----DLTPLANLTRI 375
Query: 243 KEIWLHSNA 251
++ L+ A
Sbjct: 376 TQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 61.9 bits (149), Expect = 1e-10
Identities = 18/99 (18%), Positives = 40/99 (40%), Gaps = 5/99 (5%)
Query: 51 WSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS 110
+ + K +T + + N+ P + +LTKL+RL N +S S
Sbjct: 290 LELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV-SS 346
Query: 111 LNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149
L L ++ + +NQ + + L+ + + +++
Sbjct: 347 LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 48.8 bits (115), Expect = 2e-06
Identities = 36/265 (13%), Positives = 84/265 (31%), Gaps = 11/265 (4%)
Query: 173 SANITGQIP--SFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLG 230
SA IT P F L + + + Q+ +L + G +
Sbjct: 3 SATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQT-DLDQVTTLQADR-LGIKSID 60
Query: 231 GGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLK 290
G ++ + +L +I +N + + + +L + + +N P + + +
Sbjct: 61 G----VEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGL 115
Query: 291 IVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFA 350
+ P+ L+++ + + G + + + V +
Sbjct: 116 TLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLT 175
Query: 351 ENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMI 410
+ + + ++ + + N + +L L L N L
Sbjct: 176 TLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD-- 233
Query: 411 PEGLSVLGALKELDVSNNQLYGKIP 435
L+ L L +LD++NNQ+ P
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP 258
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.9 bits (206), Expect = 4e-18
Identities = 61/283 (21%), Positives = 98/283 (34%), Gaps = 46/283 (16%)
Query: 57 CKWNHVVCIE----------DKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG 106
C V C + + + + + + +NL L L L N IS
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 107 PLP-SLNGLASLEVVMLSNNQFTSVPSDF---------------------FTGLSSLQSI 144
P + L LE + LS NQ +P F GL+ + +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129
Query: 145 EIDNNPF-SSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLI 203
E+ NP SS + + L NIT IP P LT LHL N++
Sbjct: 130 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL----PPSLTELHLDGNKIT 184
Query: 204 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVK 263
AS G + +L G + N+ + N L+E+ L++N + K
Sbjct: 185 KVDAASLKG--LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHK 242
Query: 264 QLESLSLRDNFFTG------PVPDSLVKLESLKIVNMTNNLLQ 300
++ + L +N + P K S V++ +N +Q
Sbjct: 243 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 70.5 bits (171), Expect = 1e-13
Identities = 36/222 (16%), Positives = 64/222 (28%), Gaps = 8/222 (3%)
Query: 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA 174
++ L NN+ T + F L +L ++ + NN S P + L+ +
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI-SPGAFAPLVKLERLYLSKN 89
Query: 175 NITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGID 234
+ + L + N++ + F+G + G N G
Sbjct: 90 QLKELPEKMPKTLQE-----LRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 144
Query: 235 VIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 294
Q M L I + + L L L N T SL L +L + +
Sbjct: 145 AFQGMKKLSYIRIADTNITTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGL 202
Query: 295 TNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL 336
+ N + + NN L +
Sbjct: 203 SFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYI 244
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 59.7 bits (143), Expect = 4e-10
Identities = 31/199 (15%), Positives = 62/199 (31%), Gaps = 16/199 (8%)
Query: 240 TSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 298
+ L +N + DF +K L +L L +N + P + L L+ + ++ N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 299 LQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDP 358
L+ + +++ + + ++ +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVEL------------GTNPLKS 138
Query: 359 CSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLG 418
G ++ I N+T TI SL L L N ++ + L L
Sbjct: 139 SGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLN 195
Query: 419 ALKELDVSNNQLYGKIPSF 437
L +L +S N +
Sbjct: 196 NLAKLGLSFNSISAVDNGS 214
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.0 bits (131), Expect = 1e-08
Identities = 37/232 (15%), Positives = 71/232 (30%), Gaps = 31/232 (13%)
Query: 44 NPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQ--GTLPSNLQNLTKLERLELQW 101
+ L + + K V ++ +++G L+ G Q + KL + +
Sbjct: 100 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 159
Query: 102 NSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLR 161
+I+ L SL + L N+ T V + GL++L + + N S+ SL
Sbjct: 160 TNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV-DNGSLA 216
Query: 162 NASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVN 221
N L+ N+ + + +++L N + F
Sbjct: 217 NTPHLRELHLNNNKLVKVPGGLAD---HKYIQVVYLHNNNISAIGSNDFCPPGY------ 267
Query: 222 GQNGNAKLGGGIDVIQNMTSLKEIWLHSN---AFSGPLPDFSGVKQLESLSL 270
S + L SN + F V ++ L
Sbjct: 268 --------------NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 62.0 bits (149), Expect = 4e-11
Identities = 26/216 (12%), Positives = 68/216 (31%), Gaps = 15/216 (6%)
Query: 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149
L ++ ++++ + + L + + T++ L++L +E+ +N
Sbjct: 17 ALANAIKIAAGKSNVTDTV-TQADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKDN 73
Query: 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDE---------FPGLTILHLAFN 200
+ ++L + L+ N++ L L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 201 QLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFS 260
+ + + + + + N++ L + N S + +
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPLA 192
Query: 261 GVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTN 296
+ L + L++N + P L +L IV +TN
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.3 bits (124), Expect = 6e-08
Identities = 28/195 (14%), Positives = 59/195 (30%), Gaps = 12/195 (6%)
Query: 238 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
++ + + + + + L L L+DN T P L + + ++ N
Sbjct: 39 DLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQITDLAPLK--NLTKITELELSGN 95
Query: 298 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 357
L+ + S +P A L L + + A
Sbjct: 96 PLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQY 155
Query: 358 PCSDWIGVTCT-----KGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE 412
V+ +T + ++ AS +L + L +N +S + P
Sbjct: 156 LSIGNAQVSDLTPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSP- 212
Query: 413 GLSVLGALKELDVSN 427
L+ L + ++N
Sbjct: 213 -LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 2e-06
Identities = 27/201 (13%), Positives = 63/201 (31%), Gaps = 8/201 (3%)
Query: 238 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
+ + +I + + + + + + +LS T + + L +L + + +N
Sbjct: 17 ALANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 298 LLQGPVPE---FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 354
+ P + N + L+ + + + +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 355 GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL 414
+ ++ G + N + A+ L L DN +S + P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 415 SVLGALKELDVSNNQLYGKIP 435
+ L L E+ + NNQ+ P
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 9e-06
Identities = 23/92 (25%), Positives = 35/92 (38%), Gaps = 3/92 (3%)
Query: 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLAS 116
+ + N Q + + L NL+KL L+ N IS + L L +
Sbjct: 138 LNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPLASLPN 196
Query: 117 LEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148
L V L NNQ + V S+L + + N
Sbjct: 197 LIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.1 bits (141), Expect = 6e-10
Identities = 49/226 (21%), Positives = 84/226 (37%), Gaps = 11/226 (4%)
Query: 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA 174
A+ + + L N+ + VP+ F +L + + +N + + A Q +++A
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 175 NITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGID 234
+ P+ F L LHL L P F + +L NA D
Sbjct: 92 QLRSVDPATFHG--LGRLHTLHLDRCGLQELGPGLF--RGLAALQYLYLQDNALQALPDD 147
Query: 235 VIQNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 293
+++ +L ++LH N S P F G+ L+ L L N P + L L +
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207
Query: 294 MTNN-LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLS 338
+ N L P +L + ++N P CD R L +
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDN-----PWVCDCRARPLWA 248
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.9 bits (138), Expect = 2e-09
Identities = 42/316 (13%), Positives = 82/316 (25%), Gaps = 49/316 (15%)
Query: 119 VVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITG 178
+VP + Q I + N S S R L +S +
Sbjct: 15 TTSCPQQGLQAVPVGIPA---ASQRIFLHGNRISHV-PAASFRACRNLTILWLHSNVLAR 70
Query: 179 QIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQ 237
+ F QL PA+F G ++ +L ++ G + +
Sbjct: 71 IDAAAFTGLALLEQLD-LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQEL---GPGLFR 126
Query: 238 NMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTN 296
+ +L+ ++L NA D F + L L L N + + L SL + +
Sbjct: 127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186
Query: 297 NLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGN 356
N + P + N
Sbjct: 187 NRVAHVHPHA-----------------------------------FRDLGRLMTLYLFAN 211
Query: 357 DPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSV 416
+ + + + + LQ+ + + + +P+ L+
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLA- 269
Query: 417 LGALKELDVSNNQLYG 432
++ N L G
Sbjct: 270 --GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.5 bits (137), Expect = 2e-09
Identities = 36/187 (19%), Positives = 63/187 (33%), Gaps = 32/187 (17%)
Query: 43 LNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWN 102
L +L + + + + + LQ ++L L L L N
Sbjct: 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163
Query: 103 SISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLS---------------------- 139
IS P + GL SL+ ++L N+ V F L
Sbjct: 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP 223
Query: 140 --SLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHL 197
+LQ + +++NP+ ++ + LQ F +S+ + +P G + L
Sbjct: 224 LRALQYLRLNDNPWVC--DCRARPLWAWLQKFRGSSSEVPCSLPQ-----RLAGRDLKRL 276
Query: 198 AFNQLIG 204
A N L G
Sbjct: 277 AANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.7 bits (135), Expect = 4e-09
Identities = 53/260 (20%), Positives = 99/260 (38%), Gaps = 10/260 (3%)
Query: 63 VCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVM 121
VC + ++T Q LQ +P + + +R+ L N IS S +L ++
Sbjct: 7 VCYNEPKVT-TSCPQQGLQ-AVPVGIPAAS--QRIFLHGNRISHVPAASFRACRNLTILW 62
Query: 122 LSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIP 181
L +N + + FTGL+ L+ +++ +N P + L + + P
Sbjct: 63 LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP 122
Query: 182 SFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTS 241
F L L+L N L +F + +L +GN + + S
Sbjct: 123 GLF--RGLAALQYLYLQDNALQALPDDTF--RDLGNLTHLFLHGNRISSVPERAFRGLHS 178
Query: 242 LKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ 300
L + LH N + P F + +L +L L N + ++L L +L+ + + +N
Sbjct: 179 LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
Query: 301 GPVPEFDRSVSLDMAKGSNN 320
L +GS++
Sbjct: 239 CDCRARPLWAWLQKFRGSSS 258
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.8 bits (130), Expect = 1e-08
Identities = 38/258 (14%), Positives = 77/258 (29%), Gaps = 34/258 (13%)
Query: 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-------------------- 109
RI + + ++ + L L L N ++
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 110 ------SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNA 163
+ +GL L + L + F GL++LQ + + +N + + R+
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQAL-PDDTFRDL 152
Query: 164 SGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQ 223
L + + I+ F L L L N++ P +F
Sbjct: 153 GNLTHLFLHGNRISSVPERAF--RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 224 NGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSL 283
N + L + + + +L+ + L+ N + L+ + +P
Sbjct: 211 NNLSALP--TEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQR- 267
Query: 284 VKLESLKIVNMTNNLLQG 301
L + + N LQG
Sbjct: 268 --LAGRDLKRLAANDLQG 283
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.4 bits (137), Expect = 2e-09
Identities = 32/205 (15%), Positives = 61/205 (29%), Gaps = 13/205 (6%)
Query: 236 IQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 295
+ + S E+ + PD K L L +N +L+ L +N+
Sbjct: 6 VSKVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 296 NN----------LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGY 345
L + + + + L + L G
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 346 PQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNN 405
+ KGN+ + G+ + ++ NLT + ++L L+L +N+
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 406 LSGMIPEGLSVLGALKELDVSNNQL 430
L IP+G L + N
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 26/208 (12%), Positives = 62/208 (29%), Gaps = 10/208 (4%)
Query: 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149
+ + +++ LP + ++ LS N + + L + +D
Sbjct: 8 KVASHLEVNCDKRNLTA-LPP-DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS 209
+ ++ +L L ++ + ++FN+L +
Sbjct: 66 ELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL------DVSFNRLTSLPLGA 119
Query: 210 FSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLS 269
G N L G+ + ++N P +G++ L++L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA-NNNLTELPAGLLNGLENLDTLL 178
Query: 270 LRDNFFTGPVPDSLVKLESLKIVNMTNN 297
L++N +P L + N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 0.003
Identities = 14/77 (18%), Positives = 25/77 (32%)
Query: 51 WSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS 110
+ + ++ ++ + + NL L L L+ L LQ NS+
Sbjct: 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKG 190
Query: 111 LNGLASLEVVMLSNNQF 127
G L L N +
Sbjct: 191 FFGSHLLPFAFLHGNPW 207
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.1 bits (136), Expect = 4e-09
Identities = 20/113 (17%), Positives = 39/113 (34%), Gaps = 8/113 (7%)
Query: 51 WSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS 110
+ + + + S LE L + N + LP+
Sbjct: 243 PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPA 301
Query: 111 LNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSW-EIPQSLRN 162
L LE ++ S N VP +L+ + ++ NP + +IP+S+ +
Sbjct: 302 L--PPRLERLIASFNHLAEVPEL----PQNLKQLHVEYNPLREFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.4 bits (129), Expect = 3e-08
Identities = 47/325 (14%), Positives = 94/325 (28%), Gaps = 18/325 (5%)
Query: 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175
+ L+N +S+P L+S+ N + E+P+ ++ L + N
Sbjct: 39 QAHELELNNLGLSSLPEL----PPHLESLVASCNSLT--ELPELPQSLKSLLVDNNNLKA 92
Query: 176 ITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDV 235
++ P + ++ L + G +
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 236 IQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 295
+ +L + L S+ L L L +
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 296 NNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 355
NNLL+ +L++ P + + L P +
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNL---YYL 269
Query: 356 NDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLS 415
N ++ + ++ +N L + A L+RLI + N+L+ +PE
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLAE-VPE--- 321
Query: 416 VLGALKELDVSNNQLYGKIPSFKSN 440
+ LK+L V N L + P +
Sbjct: 322 LPQNLKQLHVEYNPLR-EFPDIPES 345
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 2e-04
Identities = 18/108 (16%), Positives = 34/108 (31%), Gaps = 6/108 (5%)
Query: 343 MGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILA 402
Y E + + + + + I SL+ L ++
Sbjct: 233 DNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVS 292
Query: 403 DNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN-AIVNTDGNP 449
+N L +P L+ L S N L ++P N ++ + NP
Sbjct: 293 NNKLIE-LPAL---PPRLERLIASFNHL-AEVPELPQNLKQLHVEYNP 335
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.3 bits (95), Expect = 4e-04
Identities = 19/108 (17%), Positives = 35/108 (32%), Gaps = 38/108 (35%)
Query: 114 LASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANS 173
SLE + +SNN+ +P+ L+ + N + +P+ +N
Sbjct: 283 PPSLEELNVSNNKLIELPA----LPPRLERLIASFNHLAE--VPELPQN----------- 325
Query: 174 ANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVN 221
L LH+ +N L P ++ L +N
Sbjct: 326 ------------------LKQLHVEYNPLR-EFPDIP--ESVEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.003
Identities = 20/69 (28%), Positives = 29/69 (42%), Gaps = 7/69 (10%)
Query: 92 TKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPF 151
+ LEL +S LP L LE ++ S N T +P SL+S+ +DNN
Sbjct: 38 RQAHELELNNLGLSS-LPEL--PPHLESLVASCNSLTELPE----LPQSLKSLLVDNNNL 90
Query: 152 SSWEIPQSL 160
+ L
Sbjct: 91 KALSDLPPL 99
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.6 bits (115), Expect = 2e-07
Identities = 24/104 (23%), Positives = 43/104 (41%), Gaps = 4/104 (3%)
Query: 75 IGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDF 134
+ H++L T+ +L+ L + L+L N + P+L L LEV+ S+N +V
Sbjct: 5 LAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVA 62
Query: 135 FTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITG 178
LQ + + NN Q L + L + ++
Sbjct: 63 NL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.6 bits (84), Expect = 0.003
Identities = 14/103 (13%), Positives = 30/103 (29%), Gaps = 23/103 (22%)
Query: 233 IDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL----------------------ESLSL 270
+ ++ + + + L N P + ++ L + L L
Sbjct: 13 LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLL 72
Query: 271 RDNFFTG-PVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSL 312
+N LV L ++N+ N L +R +
Sbjct: 73 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 3e-07
Identities = 35/247 (14%), Positives = 80/247 (32%), Gaps = 10/247 (4%)
Query: 71 TRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFT-S 129
+ + +NL + L + + + + PL ++ + LSN+ S
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 130 VPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEF 189
+ S LQ++ ++ S I +L S L + + + +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSD-PIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 190 PGLTIL----HLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEI 245
L L F + + + I L ++G N + +++ +L +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 246 WLHSNAFSGPL--PDFSGVKQLESLSLRD-NFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302
L + +F + L+ LSL L ++ +LK + + + G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 303 VPEFDRS 309
+ +
Sbjct: 241 LQLLKEA 247
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (103), Expect = 3e-05
Identities = 23/222 (10%), Positives = 61/222 (27%), Gaps = 8/222 (3%)
Query: 78 QNLQGTLPSNLQNLTKLERLELQWNSIS--GPLPSLNGLASLEVVMLSNNQFTSVPSDFF 135
++ + + +++ ++L + I L+ + L+ + L + + +
Sbjct: 32 RSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTL 91
Query: 136 TGLSSLQSIEIDNNPFSSWEIPQS----LRNASGLQNFSANSANITGQIPSFFGPDEFPG 191
S+L + + S Q+ L + E
Sbjct: 92 AKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETIT 151
Query: 192 LTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA 251
L L ++ + ++ + + L+ + L
Sbjct: 152 QLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 211
Query: 252 FSGP--LPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 291
P L + + L++L + G + L L+I
Sbjct: 212 DIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI 253
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 5e-06
Identities = 17/65 (26%), Positives = 28/65 (43%), Gaps = 5/65 (7%)
Query: 371 NITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGM----IPEGLSVLGALKELDV 425
+I ++ Q L+ E + Q + L D L+ I L V AL EL++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 426 SNNQL 430
+N+L
Sbjct: 63 RSNEL 67
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 6e-04
Identities = 15/80 (18%), Positives = 28/80 (35%), Gaps = 9/80 (11%)
Query: 94 LERLELQWNSIS--GPLPSLNGLASLEVVMLSNNQFTSVP----SDFFTGLSSLQSIEID 147
++ L++Q +S L L +VV L + T S +L + +
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 148 NNPFSS---WEIPQSLRNAS 164
+N + Q L+ S
Sbjct: 64 SNELGDVGVHCVLQGLQTPS 83
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 13/103 (12%), Positives = 34/103 (33%), Gaps = 15/103 (14%)
Query: 347 QRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT----ISPEFASFKSLQRLILA 402
Q + G+ + V+ +++ + ++ + SL+ L L+
Sbjct: 346 QISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLS 405
Query: 403 DNNLSGMIPEGLSVLG--------ALKELDVSNNQLYGKIPSF 437
+N L G+ L L++L + + ++
Sbjct: 406 NNCLG---DAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR 445
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 1e-05
Identities = 27/189 (14%), Positives = 61/189 (32%), Gaps = 15/189 (7%)
Query: 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149
L + + L +++ S L + + S+ L++L I NN
Sbjct: 16 ALAEKMKTVLGKTNVTDT-VSQTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFSNN 72
Query: 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPG----------LTILHLAF 199
+ ++L + + A+IT + +L
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 200 NQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDF 259
+L + S + + ++ + + N+T+L+ + + SN S +
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQV-TDLKPLANLTTLERLDISSNKVSD-ISVL 190
Query: 260 SGVKQLESL 268
+ + LESL
Sbjct: 191 AKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 31/189 (16%), Positives = 65/189 (34%), Gaps = 8/189 (4%)
Query: 238 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
+ + L + + + + Q+ +L D + L +L +N +NN
Sbjct: 16 ALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 72
Query: 298 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 357
L P + + +D+ +N +P A L L + N
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 358 PCSDWIGVTCTKGNITVINFQKMNLTG---TISPEFASFKSLQRLILADNNLSGMIPEGL 414
++ + + Q++N + T A+ +L+RL ++ N +S L
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVL 190
Query: 415 SVLGALKEL 423
+ L L+ L
Sbjct: 191 AKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 7e-04
Identities = 28/186 (15%), Positives = 54/186 (29%), Gaps = 11/186 (5%)
Query: 113 GLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGL---QNF 169
LA +L T S T L + +++ D S + + L N + + N
Sbjct: 16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQ 73
Query: 170 SANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKL 229
+ + + + N F+ + +L
Sbjct: 74 LTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRL 133
Query: 230 GGGIDVIQNMTSLKEIWLHSNAFSGP-----LPDFSGVKQLESLSLRDNFFTG-PVPDSL 283
+ I ++++L + L + + LE L + N + V L
Sbjct: 134 ELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSDISVLAKL 193
Query: 284 VKLESL 289
LESL
Sbjct: 194 TNLESL 199
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (103), Expect = 1e-05
Identities = 18/138 (13%), Positives = 36/138 (26%), Gaps = 4/138 (2%)
Query: 108 LPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ 167
+ L + + + L +I+ +N + LR L+
Sbjct: 11 AAQYTNAVRDRELDLRGYKIPVIE-NLGATLDQFDAIDFSDNEIRKLDGFPLLRR---LK 66
Query: 168 NFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNA 227
N+ I IL +G L S + L +
Sbjct: 67 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN 126
Query: 228 KLGGGIDVIQNMTSLKEI 245
K + VI + ++ +
Sbjct: 127 KKHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.002
Identities = 12/69 (17%), Positives = 26/69 (37%), Gaps = 2/69 (2%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
+ N + L+L+ I L + + S+N+ + F L L+++
Sbjct: 12 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLD--GFPLLRRLKTLL 69
Query: 146 IDNNPFSSW 154
++NN
Sbjct: 70 VNNNRICRI 78
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.003
Identities = 9/55 (16%), Positives = 23/55 (41%), Gaps = 4/55 (7%)
Query: 380 MNLTGTI---SPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY 431
+ LT + + ++ + + L L + +I + L +D S+N++
Sbjct: 1 VKLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR 54
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 22/193 (11%), Positives = 56/193 (29%), Gaps = 8/193 (4%)
Query: 238 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
+ L + + + + + ++ + ++ + L ++ + + N
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQ-NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 298 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 357
L P + + N S +L +L + +
Sbjct: 79 KLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLES 138
Query: 358 PCSDWIGVTCTKGNITVINFQKMNLTGTI---SPEFASFKSLQRLILADNNLSGMIPEGL 414
+T + ++L A LQ L L+ N++S + L
Sbjct: 139 LYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL--RAL 196
Query: 415 SVLGALKELDVSN 427
+ L L L++ +
Sbjct: 197 AGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 33/211 (15%), Positives = 66/211 (31%), Gaps = 23/211 (10%)
Query: 102 NSISGPLP-----SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEI 156
+I+ P P S + A L T + L+S+ I +N+ S +
Sbjct: 6 ETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG 63
Query: 157 PQSLRNASGLQNFSANSANITG--------QIPSFFGPDEFPGLTILHLAFNQLIGGLPA 208
Q L N + N +T + F + +L
Sbjct: 64 IQYLPN---VTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLE 120
Query: 209 SFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMT---SLKEIWLHSNAFSGPLPDFSGVKQL 265
S I L Q + LG + + + + + +G+ +L
Sbjct: 121 HNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKL 180
Query: 266 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTN 296
++L L N + +L L++L ++ + +
Sbjct: 181 QNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 11/49 (22%), Positives = 23/49 (46%), Gaps = 2/49 (4%)
Query: 100 QWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148
++ + L GL L+ + LS N + + + GL +L +E+ +
Sbjct: 163 LEDNQISDIVPLAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFS 209
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (101), Expect = 2e-05
Identities = 16/78 (20%), Positives = 31/78 (39%), Gaps = 3/78 (3%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLP---SLNGLASLEVVMLSNNQFTSVPSDFF 135
++ TL +N+ +L L L N + + +L+++ LS N+ S
Sbjct: 52 SMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDK 111
Query: 136 TGLSSLQSIEIDNNPFSS 153
L+ + +D N S
Sbjct: 112 IKGLKLEELWLDGNSLSD 129
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 43.6 bits (101), Expect = 3e-05
Identities = 27/185 (14%), Positives = 55/185 (29%), Gaps = 12/185 (6%)
Query: 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175
V + +P D + +++N L
Sbjct: 9 EGTTVDCTGRGLKEIPRDIPL---HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65
Query: 176 ITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGID 234
+TG P+ F L + I F G Q+++L + + + G
Sbjct: 66 LTGIEPNAFEGASHIQELQLGENKIKEI--SNKMFLGLHQLKTLNLYDNQISCVMPG--- 120
Query: 235 VIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 294
+++ SL + L SN F+ + L SL P + ++I ++
Sbjct: 121 SFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDL 177
Query: 295 TNNLL 299
++
Sbjct: 178 PHSEF 182
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.1 bits (102), Expect = 4e-05
Identities = 30/242 (12%), Positives = 58/242 (23%), Gaps = 15/242 (6%)
Query: 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLA 115
C +C ++ ++T I PS+L L + + +G
Sbjct: 8 CSNRVFLC-QESKVTEI-----------PSDL--PRNAIELRFVLTKLRVIQKGAFSGFG 53
Query: 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175
LE + +S N V + I + S
Sbjct: 54 DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT 113
Query: 176 ITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDV 235
+P + + + SF G +S+ + +
Sbjct: 114 GIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF 173
Query: 236 IQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 295
+ ++N P F G L + L L+ L+ +
Sbjct: 174 NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
Query: 296 NN 297
N
Sbjct: 234 NL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (96), Expect = 2e-04
Identities = 12/85 (14%), Positives = 22/85 (25%), Gaps = 3/85 (3%)
Query: 352 NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 411
N + NL + F L ++ + +
Sbjct: 159 WLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 218
Query: 412 EGLSVLGALKELDVSNNQLYGKIPS 436
GL L L+ N + K+P+
Sbjct: 219 YGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 5e-04
Identities = 13/84 (15%), Positives = 27/84 (32%), Gaps = 4/84 (4%)
Query: 51 WSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSN-LQNLTKLERLELQWNSISG-PL 108
W + + + H ++ + + N LP++ + L++ I P
Sbjct: 159 WLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 218
Query: 109 PSLNGLASLEVVMLSNNQFTSVPS 132
L L L S +P+
Sbjct: 219 YGLENLKKLRA--RSTYNLKKLPT 240
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.8 bits (96), Expect = 3e-04
Identities = 14/95 (14%), Positives = 32/95 (33%), Gaps = 6/95 (6%)
Query: 65 IEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPL-----PSLNGLASLEV 119
IE K + I ++ + ++ + L ++ + L N+I ++ LE+
Sbjct: 5 IEGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 120 VMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSW 154
S+ V + L L + +
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTV 98
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 38.1 bits (87), Expect = 0.002
Identities = 24/161 (14%), Positives = 50/161 (31%), Gaps = 24/161 (14%)
Query: 58 KWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASL 117
+ VV E +++ G + + L L + L L N+I + SL+G+ +L
Sbjct: 16 ERKSVVATEAEKVELH--GMIPPIEKMDATLSTLKACKHLALSTNNIEK-ISSLSGMENL 72
Query: 118 EVVML---------------------SNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEI 156
++ L + L +L+ + + NN ++W
Sbjct: 73 RILSLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITNWGE 132
Query: 157 PQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHL 197
L L++ + E+ + L
Sbjct: 133 IDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRL 173
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 948 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.89 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.88 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.79 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.72 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.71 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.69 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.66 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.48 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.45 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.45 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.42 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.41 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.4 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.4 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.39 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.37 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.29 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.18 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.17 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.16 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.16 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.44 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.08 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.04 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.03 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.38 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.33 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.95 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.78 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.39 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.26 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.0 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.95 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=425.89 Aligned_cols=256 Identities=28% Similarity=0.468 Sum_probs=201.8
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
++|+..+.||+|+||.||+|++++++.||||+++.. ....++|.+|++++++++|||||+++|+|.+++..++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG---AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC---cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 578889999999999999999988899999998764 33346899999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++|+|.+++.. ....++|..+++++.|||+||+|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~g~L~~~l~~----~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 82 MEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp CTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred cCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCC
Confidence 999999998843 33578999999999999999999997 89999999999999999999999999999876554
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG-RKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
.........||+.|+|||++.+..++.++|||||||++|||+|+ ++|+......+.... +... .....|
T Consensus 155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~---i~~~-------~~~~~p 224 (263)
T d1sm2a_ 155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED---ISTG-------FRLYKP 224 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH---HHHT-------CCCCCC
T ss_pred CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH---HHhc-------CCCCCc
Confidence 44444456799999999999999999999999999999999995 555554433222111 1110 001111
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
. ..+.++.+++.+||+.||++||+|+||++.|+++.+
T Consensus 225 ~--------~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 R--------LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp T--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c--------ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1 123468899999999999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-50 Score=424.91 Aligned_cols=262 Identities=27% Similarity=0.484 Sum_probs=208.8
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.++|++.+.||+|+||+||+|+++ ..||||+++.........+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467899999999999999999865 469999998766566778899999999999999999999998754 56899999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++|+|.++++. ....+++.+++.++.||++||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 84 y~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 84 WCEGSSLYHHLHI----IETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CCCEEEHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred cCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 9999999998843 23569999999999999999999997 8999999999999999999999999999986544
Q ss_pred CCC-ceeeeecccccccCceeccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 752 GKG-SIETRIAGTFGYLAPEYAVT---GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 752 ~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
... .......||+.|||||++.+ ..++.++|||||||++|||+||+.||.+.......... +.+..
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~--~~~~~-------- 226 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM--VGRGY-------- 226 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--HHHTS--------
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH--HhcCC--------
Confidence 322 23345679999999999864 35899999999999999999999999876544322111 11110
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
..+.+ .......+.++.+++.+||+.||++|||++||++.|+.+.+
T Consensus 227 -~~p~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 227 -LSPDL--SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp -CCCCG--GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCcc--hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 01111 11112233568899999999999999999999999998865
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-49 Score=411.96 Aligned_cols=253 Identities=24% Similarity=0.413 Sum_probs=214.2
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
++|+..+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~---~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc---CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 6889999999999999999999888899999998643 3356899999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++|+|.+++.. ....+++..+++++.|+++||+|||+ ++|+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~g~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 81 MANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp CTTEEHHHHHHS----GGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred cCCCcHHHhhhc----cccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 999999988743 23568899999999999999999997 89999999999999999999999999999866554
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
.........||+.|+|||++.+..++.++|||||||++|||+| |+.||......+....+. ... ....|
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~------~~~----~~~~p 223 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA------QGL----RLYRP 223 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH------TTC----CCCCC
T ss_pred CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH------hCC----CCCCc
Confidence 4444455679999999999999999999999999999999998 899998776544322211 100 11111
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHh
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~ 873 (948)
. ..+.++.+++.+||+.||++|||++++++.|.+
T Consensus 224 ~--------~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 H--------LASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp T--------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred c--------cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1 122468899999999999999999999999865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-49 Score=416.91 Aligned_cols=256 Identities=27% Similarity=0.435 Sum_probs=209.3
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
.++|++.+.||+|+||.||+|++++++.||||+++.. ....++|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC---cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 4578889999999999999999988899999999754 2345689999999999999999999998754 56799999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++|+|.+++.... ...++|.++++|+.||++||+|||+ ++|+||||||+|||+++++.+||+|||+|+....
T Consensus 88 y~~~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 88 YMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred eCCCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccC
Confidence 999999998875422 2468999999999999999999997 8999999999999999999999999999998766
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCC-CCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALD-ESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
..........||+.|||||++.++.++.++|||||||++|||+||..|+. .....+. ...+.. . ..
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~---~~~i~~---~-------~~ 228 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQNLER---G-------YR 228 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHHT---T-------CC
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHH---HHHHHh---c-------CC
Confidence 54444455679999999999999999999999999999999999655544 3332221 111111 0 00
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~ 875 (948)
+..+ ...+.++.+++.+||+.||++||||++|++.|++..
T Consensus 229 ~~~p-----~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 229 MVRP-----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCc-----ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 1110 112346889999999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.5e-49 Score=420.37 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=213.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|++.+.||+|+||+||+|+++ +|+.||||+++.. ....++|.+|++++++++|||||+++++|.+++..++||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc---cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 457888999999999999999886 5889999998754 334578999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. .....+++..++.|+.||++||+|||+ ++|+||||||+|||+++++.+||+|||+|+...
T Consensus 93 E~~~~g~l~~~l~~---~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 93 EFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp ECCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred ecccCcchHHHhhh---ccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecC
Confidence 99999999999854 334679999999999999999999997 899999999999999999999999999999766
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
...........||+.|+|||++.+..++.++|||||||++|||++|..|+........ ....+.. . . .
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~~i~~----~--~----~ 234 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEK----D--Y----R 234 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHT----T--C----C
T ss_pred CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--HHHHHhc----C--C----C
Confidence 5554445556789999999999999999999999999999999997766654332221 1111111 0 0 0
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~ 875 (948)
+.. . ...+.++.+++.+||+.||++|||++||++.|+.+.
T Consensus 235 ~~~--~---~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 235 MER--P---EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCC--C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCC--C---ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111 1 122346889999999999999999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.6e-49 Score=421.69 Aligned_cols=258 Identities=23% Similarity=0.454 Sum_probs=201.8
Q ss_pred cCCcccceecccCceEEEEEEEc-CC---cEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
++|++.++||+|+||+||+|+++ ++ ..||||++.... .....++|.+|++++++++|||||+++|+|.+++..++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56788899999999999999875 33 258999886542 45566789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||||+++|+|.+++.. ....++|.++++++.||++||+|||+ ++||||||||+|||++.++.+||+|||+|+.
T Consensus 105 v~Ey~~~g~L~~~~~~----~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp EEECCTTEEHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEecCCCcceeeecc----ccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceE
Confidence 9999999999988743 33579999999999999999999997 8999999999999999999999999999986
Q ss_pred cCCCCCce----eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCcc
Q 002238 749 APEGKGSI----ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKD 823 (948)
Q Consensus 749 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 823 (948)
........ .....||+.|||||++.++.++.++|||||||++|||+| |+.||.+....+....+ .. ..
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i---~~----~~ 250 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI---EQ----DY 250 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---HT----TC
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc----CC
Confidence 65433211 123458999999999999999999999999999999998 89999876654332211 11 00
Q ss_pred ccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 824 SFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
. ++ .....+.++.+++.+||+.||++||+++||++.|+++++
T Consensus 251 ~--------~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 251 R--------LP---PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp C--------CC---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred C--------CC---CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 0 00 011233568899999999999999999999999998865
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=416.89 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=203.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|++.+.||+|+||+||+|+.+ +|+.||||++.... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 357999999999999999999875 79999999997643 2233467899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++. ....+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+...
T Consensus 83 Ey~~gg~L~~~l~-----~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 83 EYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp ECCTTEEGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred eccCCCcHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeec
Confidence 9999999999883 23579999999999999999999997 899999999999999999999999999999654
Q ss_pred CCC-CceeeeecccccccCceecccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 751 EGK-GSIETRIAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 751 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
... ....+..+||+.|||||++.+..+ +.++||||+||++|||++|+.||.......... ..+ .. ....
T Consensus 155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~~~----~~-~~~~--- 225 (271)
T d1nvra_ 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDW----KE-KKTY--- 225 (271)
T ss_dssp ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-HHH----HT-TCTT---
T ss_pred cCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-HHH----hc-CCCC---
Confidence 332 223445689999999999988876 578999999999999999999997654332211 110 00 0000
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.........++.+++.+|++.||++|||++|+++
T Consensus 226 -------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 -------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0001112345789999999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=416.61 Aligned_cols=249 Identities=23% Similarity=0.413 Sum_probs=207.9
Q ss_pred cCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|+..+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc--ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 5799999999999999999986 479999999997642 3345779999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++|+|.+++.. ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 98 y~~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 98 YLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp CCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 9999999987743 468999999999999999999997 8999999999999999999999999999997654
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDP 831 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (948)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+....+ ... . .+
T Consensus 169 ~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~--~~~-~----------~~ 234 (293)
T d1yhwa1 169 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI--ATN-G----------TP 234 (293)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HHH-C----------SC
T ss_pred ccc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH--HhC-C----------CC
Confidence 332 344567999999999999999999999999999999999999999876544322111 110 0 00
Q ss_pred ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 832 TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 832 ~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.+. .......++.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~---~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 235 ELQ---NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CCS---SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCC---CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 01122346889999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=411.88 Aligned_cols=247 Identities=28% Similarity=0.484 Sum_probs=207.8
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|++.+.||+|+||+||+|+.+ +|+.||||++.+.... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57899999999999999999875 6899999998754322 234577899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 86 Ey~~~g~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 86 EYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp ECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred eecCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecC
Confidence 99999999999853 2468999999999999999999997 899999999999999999999999999998665
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
... .....||+.|||||++.+..++.++|||||||++|||++|+.||.+....+.... +......+.
T Consensus 158 ~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~------i~~~~~~~p---- 224 (263)
T d2j4za1 158 SSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR------ISRVEFTFP---- 224 (263)
T ss_dssp CCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHTTCCCCC----
T ss_pred CCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHH------HHcCCCCCC----
Confidence 432 3456799999999999999999999999999999999999999987654433211 111111111
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+ ....++.+++.+|++.||++|||++|+++
T Consensus 225 ~---------~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 225 D---------FVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp T---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c---------cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1 12245889999999999999999999976
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-49 Score=416.10 Aligned_cols=257 Identities=23% Similarity=0.379 Sum_probs=199.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCceEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNEKLLV 669 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv 669 (948)
++|++.+.||+|+||+||+|+.+ +|+.||||++..........+.+.+|++++++++|||||++++++.+ ++..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999875 78999999998766666667889999999999999999999999875 4567999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcc--CCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA--HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
|||+++|+|.+++....+. ...+++..++.++.|++.||+|||+.. ..+||||||||+|||++.++.+||+|||+|+
T Consensus 84 mEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999998654333 367999999999999999999999732 1359999999999999999999999999998
Q ss_pred ecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 748 LAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
....... ......||+.|||||++.+..++.++|||||||++|||+||+.||......+....+ .. .....
T Consensus 163 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i---~~-----~~~~~ 233 (269)
T d2java1 163 ILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI---RE-----GKFRR 233 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HH-----TCCCC
T ss_pred ecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHH---Hc-----CCCCC
Confidence 7654332 334567999999999999999999999999999999999999999876544322111 11 11110
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
++ .....++.+++.+|++.||.+|||++|+++
T Consensus 234 -----~~-----~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 -----IP-----YRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----CC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CC-----cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11 112245889999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-48 Score=411.38 Aligned_cols=257 Identities=23% Similarity=0.390 Sum_probs=209.4
Q ss_pred cCCcccce-ecccCceEEEEEEEc---CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEE
Q 002238 593 NNFSEENI-LGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 593 ~~~~~~~~-lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 668 (948)
++|.+.+. ||+|+||.||+|.++ ++..||||+++.. ......++|.+|++++++++|||||+++|++.+ +..++
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 45666674 999999999999764 3557999999764 245567889999999999999999999999864 56899
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCcee
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~ 748 (948)
||||+++|+|.+++.. ....+++.++++++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+|+.
T Consensus 86 vmE~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhc
Confidence 9999999999998732 33579999999999999999999997 8999999999999999999999999999997
Q ss_pred cCCCCCc--eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 749 APEGKGS--IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 749 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
....... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+....+....+ .. +.
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i---~~-----~~- 229 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI---EQ-----GK- 229 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH---HT-----TC-
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc-----CC-
Confidence 6544322 2234568999999999999999999999999999999998 99999876654332221 11 10
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
.+.++ ...+.++.+++.+||+.+|++||++.+|.+.|+....
T Consensus 230 ----~~~~p-----~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 230 ----RMECP-----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp ----CCCCC-----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCC-----CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 01111 1223568899999999999999999999999987754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=410.99 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=201.6
Q ss_pred ceecccCceEEEEEEEc---CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEecCC
Q 002238 599 NILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (948)
Q Consensus 599 ~~lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 675 (948)
+.||+|+||+||+|.++ .++.||||+++.........++|.+|++++++++|||||+++|+|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999865 34689999997655455556789999999999999999999999864 567899999999
Q ss_pred CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCCCc
Q 002238 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (948)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 755 (948)
|+|.++++. ...++|.++++++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 999998843 2579999999999999999999997 89999999999999999999999999999976554332
Q ss_pred e--eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcc
Q 002238 756 I--ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832 (948)
Q Consensus 756 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (948)
. .....||++|||||++.+..++.++|||||||++|||+| |+.||.+....+....+ .. +. .+.
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i---~~-----~~-----~~~ 230 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---EK-----GE-----RMG 230 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---HT-----TC-----CCC
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH---Hc-----CC-----CCC
Confidence 2 233568999999999999999999999999999999998 89999876654332221 11 10 001
Q ss_pred cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhh
Q 002238 833 IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875 (948)
Q Consensus 833 ~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~ 875 (948)
. . ...+.++.+++.+||+.||++||++++|.+.|+...
T Consensus 231 ~--p---~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 231 C--P---AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp C--C---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred C--C---cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 1 1 122356889999999999999999999999887753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=415.80 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=206.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
+.|++.+.||+|+||+||+|+.+ +|+.||||++... .....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 56899999999999999999875 7899999999764 44556789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++|+|.+++.. ....+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 90 y~~~g~L~~~~~~----~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 90 FCAGGAVDAVMLE----LERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp CCTTEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred cCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 9999999998743 22579999999999999999999997 8999999999999999999999999999975432
Q ss_pred CCCceeeeecccccccCceecc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 752 GKGSIETRIAGTFGYLAPEYAV-----TGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
.. .......||+.|||||++. +..|+.++|||||||++|||+||+.||.+..+.+....+ ....
T Consensus 163 ~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i------~~~~---- 231 (288)
T d2jfla1 163 TI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI------AKSE---- 231 (288)
T ss_dssp HH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH------HHSC----
T ss_pred Cc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH------HcCC----
Confidence 21 1223467999999999984 456899999999999999999999999877654432211 1100
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.+.+. .......++.+++.+||+.||++|||++|+++
T Consensus 232 ---~~~~~---~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 232 ---PPTLA---QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ---CCCCS---SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CCCCC---ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111 11122346889999999999999999999865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-48 Score=412.31 Aligned_cols=259 Identities=24% Similarity=0.427 Sum_probs=202.6
Q ss_pred cCCcccceecccCceEEEEEEEcCC-----cEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 593 NNFSEENILGRGGFGTVYKGELHDG-----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~g-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
+.|+..++||+|+||.||+|.+++. ..||||++.... ......+|.+|++++++++|||||+++|++.+.+..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 5688899999999999999987632 369999987543 4455678999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+||||+.+|++.+.+.. ....++|.++++++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEecccCcchhhhhc----ccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhh
Confidence 99999999999887743 33679999999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCC--ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 748 LAPEGKG--SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 748 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
....... .......||+.|||||++.++.++.++|||||||++|||++|..|+........ ....+.. .
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~~~~i~~----~--- 229 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAIND----G--- 229 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHT----T---
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--HHHHHhc----c---
Confidence 6544322 122345689999999999999999999999999999999996665544332221 1111111 0
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
..+..+ ...+.++.+++.+||+.||++||+|.||++.|+++++
T Consensus 230 ---~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 230 ---FRLPTP-----MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ---CCCCCC-----TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCc-----hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 011111 1233468899999999999999999999999998875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=406.13 Aligned_cols=247 Identities=25% Similarity=0.397 Sum_probs=199.5
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe----CCceEEE
Q 002238 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD----GNEKLLV 669 (948)
Q Consensus 595 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv 669 (948)
|+..+.||+|+||+||+|.+. +++.||||++..........+.|.+|++++++++|||||++++++.+ +...++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 356678999999999999875 68899999998766566667889999999999999999999999865 3457899
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCC--eeecCCCCccEEEc-CCCCeEEeecCCc
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLG-DDMRAKVADFGLV 746 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrDik~~Nill~-~~~~~kl~DfGla 746 (948)
|||+++|+|.+++.. ...+++.++..++.||++||+|||+ ++ |+||||||+|||++ +++.+||+|||+|
T Consensus 91 mE~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp EECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EeCCCCCcHHHHHhc-----cccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 999999999999854 1478999999999999999999997 55 99999999999996 5789999999999
Q ss_pred eecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 747 RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
+..... ......||+.|||||++.+ .++.++|||||||++|||++|+.||.+...... .. ..+.. +...
T Consensus 163 ~~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~---~~i~~--~~~~ 231 (270)
T d1t4ha_ 163 TLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IY---RRVTS--GVKP 231 (270)
T ss_dssp GGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HH---HHHTT--TCCC
T ss_pred eeccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HH---HHHHc--CCCC
Confidence 864332 2345679999999998865 699999999999999999999999976543322 11 11111 1000
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
..+ ......++.+++.+|++.||++|||++|+++
T Consensus 232 ~~~---------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 ASF---------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGG---------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccc---------CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 011 1112245889999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=407.81 Aligned_cols=258 Identities=29% Similarity=0.478 Sum_probs=203.0
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
++|++.+.||+|+||.||+|++++++.||||+++.. ....+.|.+|+.++++++|||||+++|+|. ++..++||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT---SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc---cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEe
Confidence 578999999999999999999988889999999754 233478999999999999999999999985 4568999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++|+|..++.... ...++|.+++.++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+|+.....
T Consensus 93 ~~~g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 93 MSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred cCCCchhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 99999998885422 2469999999999999999999997 89999999999999999999999999999876555
Q ss_pred CCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccCcc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAIDPT 832 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (948)
.........||+.|+|||++..+.++.++|||||||++|||++|..|+........ ....+... ....+.+
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~~i~~~------~~~~~~~- 237 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERG------YRMPCPP- 237 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTT------CCCCCCT-
T ss_pred CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHHHhc------CCCCCCc-
Confidence 44445556799999999999999999999999999999999997666544332211 11111110 0001111
Q ss_pred cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 833 IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 833 ~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
..+.++.+++.+||+.||++||+|++|+++|+.....
T Consensus 238 --------~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 238 --------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp --------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred --------ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 1234688999999999999999999999998886543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-48 Score=410.66 Aligned_cols=251 Identities=23% Similarity=0.367 Sum_probs=206.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|++.+.||+|+||+||+|+.+ +|+.||||++.+... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999874 789999999975432 2334577999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. .+.+++..+..++.|++.||+|||+ ++||||||||+|||+++++.+||+|||+|+...
T Consensus 88 Ey~~gg~L~~~~~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp CCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EccCCCCHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecc
Confidence 99999999998743 2578999999999999999999997 899999999999999999999999999999765
Q ss_pred CCC-CceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 751 EGK-GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 751 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
... .......+||+.|||||++.+..++.++||||+||++|||++|+.||......+... .+......+
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~------~i~~~~~~~---- 229 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ------KIIKLEYDF---- 229 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHTTCCCC----
T ss_pred cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH------HHHcCCCCC----
Confidence 332 223445679999999999999999999999999999999999999998765443221 111111111
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
+. ....++.+++.+|++.||.+|||++|+...
T Consensus 230 p~---------~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 230 PE---------KFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CT---------TCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred Cc---------cCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 11 112358899999999999999999998664
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=414.28 Aligned_cols=261 Identities=26% Similarity=0.413 Sum_probs=207.2
Q ss_pred hcCCcccceecccCceEEEEEEEcC-C-----cEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCC
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHD-G-----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~-g-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 664 (948)
.++|++.+.||+|+||+||+|++.. + ..||||++.... .......+.+|+.++.++ +|||||++++++.+.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 3678999999999999999998752 2 369999986542 344557899999999998 8999999999999999
Q ss_pred ceEEEEEecCCCChhHHHHhhhh------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAE------------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLK 726 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik 726 (948)
..++||||+++|+|.++++.... .....++|..++.++.||++||+|||+ ++|||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCc
Confidence 99999999999999999965221 112458999999999999999999997 899999999
Q ss_pred CccEEEcCCCCeEEeecCCceecCCCCCc-eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 002238 727 PSNILLGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQ 804 (948)
Q Consensus 727 ~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~ 804 (948)
|+|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||.+..
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999865544332 3345678999999999999999999999999999999998 899998765
Q ss_pred chhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHh
Q 002238 805 PEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSS 873 (948)
Q Consensus 805 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~ 873 (948)
..+.. ...+.. .. .+.. . ...+.++.+++.+||+.||++|||++||+++|..
T Consensus 272 ~~~~~--~~~~~~----~~------~~~~--p---~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 272 VDANF--YKLIQN----GF------KMDQ--P---FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CSHHH--HHHHHT----TC------CCCC--C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHH--HHHHhc----CC------CCCC--C---CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 43321 111111 10 0111 1 1123468899999999999999999999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-47 Score=409.32 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=192.5
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
+.+.|++.+.||+|+||+||+|+.+ +|+.||||++...... ...+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4678999999999999999999875 6899999999765332 2346788999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEc---CCCCeEEeecCCc
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKVADFGLV 746 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~---~~~~~kl~DfGla 746 (948)
|||++||+|.+++.. ...+++..+..++.||+.||+|||+ ++||||||||+|||+. +++.+||+|||+|
T Consensus 86 mE~~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp ECCCCSCBHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred EeccCCCcHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEecccee
Confidence 999999999999843 3579999999999999999999997 8999999999999995 5789999999999
Q ss_pred eecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 747 RLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
+...... .....+||+.|||||++.+..++.++|||||||++|||++|+.||.+....+.... +........
T Consensus 158 ~~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~------i~~~~~~~~ 229 (307)
T d1a06a_ 158 KMEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ------ILKAEYEFD 229 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH------HHTTCCCCC
T ss_pred EEccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHH------HhccCCCCC
Confidence 8654432 23456799999999999999999999999999999999999999987654332111 111111111
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
... ......++.+++.+|++.||++|||++|+++
T Consensus 230 ~~~---------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 230 SPY---------WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTT---------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred Ccc---------ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111 1122346889999999999999999999876
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-48 Score=419.53 Aligned_cols=264 Identities=21% Similarity=0.337 Sum_probs=206.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|++.+.||+|+||+||+|+.. +|+.||||+++... .......+.+|+.++++++|||||++++++.++++.++||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 578999999999999999999875 78999999997643 3444678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 Ey~~gg~L~~~l~~-----~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 99999999999854 1468999999999999999999997 2589999999999999999999999999998553
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHH-HHHh--------hcC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTW-FRRI--------HLS 821 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~-~~~~--------~~~ 821 (948)
+. .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||......+....... .... ...
T Consensus 157 ~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 157 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred CC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 32 23456899999999999999999999999999999999999999977543321110000 0000 000
Q ss_pred ccc--------------------cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 822 KDS--------------------FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 822 ~~~--------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
... ......+.++ ......++.+++.+|++.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP----SGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCC----BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000 0000000000 00112458899999999999999999999884
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2e-46 Score=411.37 Aligned_cols=253 Identities=22% Similarity=0.344 Sum_probs=210.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|++.+.||+|+||.||+|+.+ +|+.||||++... .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 468999999999999999999875 7999999999764 3445678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEc--CCCCeEEeecCCcee
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRL 748 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~--~~~~~kl~DfGla~~ 748 (948)
||+++|+|.+++.. ....+++..+..|+.||+.||+|||+ ++||||||||+|||++ .++.+||+|||+|+.
T Consensus 103 E~~~gg~L~~~l~~----~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 103 EFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp CCCCSCBHHHHHTC----TTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EcCCCCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 99999999988842 23569999999999999999999997 8999999999999996 457899999999997
Q ss_pred cCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
..... ......||+.|||||++.+..++.++||||+||++|||++|+.||.+....+....+ .........
T Consensus 176 ~~~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~~~~~~~~- 246 (350)
T d1koaa2 176 LDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV------KSCDWNMDD- 246 (350)
T ss_dssp CCTTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHTCCCSCC-
T ss_pred ccccc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCCCCCc-
Confidence 65433 344567999999999999999999999999999999999999999876544332211 111111110
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
........++.+++.+|++.||++|||++|++++
T Consensus 247 --------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 --------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111223468899999999999999999999773
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-47 Score=408.81 Aligned_cols=248 Identities=25% Similarity=0.374 Sum_probs=203.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
+.|+..+.||+|+||+||+|+.. +|+.||||++...... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45899999999999999999864 7899999999865433 344567999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|..++.. ...+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 95 E~~~~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp ECCSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 99999999765532 2579999999999999999999997 899999999999999999999999999998654
Q ss_pred CCCCceeeeecccccccCceeccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVT---GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
.. ....||+.|||||++.+ +.|+.++|||||||++|||++|+.||.+....+....+ .. .....
T Consensus 167 ~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i------~~--~~~~~ 233 (309)
T d1u5ra_ 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------AQ--NESPA 233 (309)
T ss_dssp SB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HH--SCCCC
T ss_pred CC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH------Hh--CCCCC
Confidence 32 34579999999999864 46899999999999999999999999876543322111 11 00111
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.... ....++.+++.+|++.||.+|||++|++++
T Consensus 234 ~~~~---------~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 234 LQSG---------HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CSCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCC---------CCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 1111 122458899999999999999999999763
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=402.37 Aligned_cols=254 Identities=22% Similarity=0.349 Sum_probs=209.9
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCCh----hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG----KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 665 (948)
+.++|++.+.||+|+||+||+|+.+ +|+.||||++.+..... ...+.+.+|++++++++|||||++++++.+++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4578999999999999999999874 79999999997653322 236789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC----CeEEe
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVA 741 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~----~~kl~ 741 (948)
.++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+||||||||+|||++.++ .+|++
T Consensus 88 ~~iv~E~~~gg~L~~~i~~-----~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCccccchhcc-----ccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEec
Confidence 9999999999999999854 1479999999999999999999997 8999999999999998776 49999
Q ss_pred ecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcC
Q 002238 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS 821 (948)
Q Consensus 742 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 821 (948)
|||+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+.... +...
T Consensus 160 DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~------i~~~ 231 (293)
T d1jksa_ 160 DFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN------VSAV 231 (293)
T ss_dssp CCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHTT
T ss_pred chhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHH------HHhc
Confidence 999998765433 23456799999999999999999999999999999999999999987654433211 1111
Q ss_pred ccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 822 KDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
...+... ........+.+++.+|++.||++|||++|+++
T Consensus 232 ~~~~~~~---------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 232 NYEFEDE---------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCCCCHH---------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCch---------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111 11122345889999999999999999999876
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-46 Score=407.47 Aligned_cols=267 Identities=29% Similarity=0.453 Sum_probs=214.8
Q ss_pred HHHHhhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEE
Q 002238 587 VLRNVTNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660 (948)
Q Consensus 587 ~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 660 (948)
+++...++|++.+.||+|+||+||+|+++ +++.||||+++... .....++|.+|++++++++||||++++++|
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 34445678999999999999999999864 35789999987542 445567899999999999999999999999
Q ss_pred EeCCceEEEEEecCCCChhHHHHhhh-------------------hcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCee
Q 002238 661 LDGNEKLLVFEYMPQGTLSRHIFNWA-------------------EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFI 721 (948)
Q Consensus 661 ~~~~~~~lv~e~~~~gsL~~~l~~~~-------------------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 721 (948)
.+.+..++||||+++|+|.++++... ......+++..++.|+.|++.||+|||+ ++||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeE
Confidence 99999999999999999999986421 1122458999999999999999999997 8999
Q ss_pred ecCCCCccEEEcCCCCeEEeecCCceecCCCC-CceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCC-CC
Q 002238 722 HRDLKPSNILLGDDMRAKVADFGLVRLAPEGK-GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR-KA 799 (948)
Q Consensus 722 HrDik~~Nill~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~-~p 799 (948)
||||||+|||++.++.+||+|||+|+...... ....+...||+.|+|||++.+..++.++|||||||++|||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999998554332 22334567899999999999999999999999999999999985 57
Q ss_pred CCCCCchhhhhHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhh
Q 002238 800 LDESQPEESMHLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLV 875 (948)
Q Consensus 800 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~ 875 (948)
|.+....+....+ . .+.... ++ ...+.++.+++.+||+.+|++||||.||++.|+++.
T Consensus 243 ~~~~~~~e~~~~v---~-----~~~~~~-~p---------~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAHEEVIYYV---R-----DGNILA-CP---------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCHHHHHHHH---H-----TTCCCC-CC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCHHHHHHHH---H-----cCCCCC-CC---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 7766554432221 1 111110 11 122346889999999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=399.44 Aligned_cols=259 Identities=23% Similarity=0.379 Sum_probs=201.2
Q ss_pred hcCCcccceecccCceEEEEEEEcC----CcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
.++|++.+.||+|+||.||+|++.. +..||||+++.. ......+.|.+|++++++++|||||++++++. ++..+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 4679999999999999999998742 356889988653 24555678999999999999999999999985 46789
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+||||+++|+|.+++.. ....+++..++.++.||++||+|||+ ++|+||||||+||+++.++.+||+|||+|+
T Consensus 84 iv~E~~~~g~l~~~~~~----~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEeccCCcHHhhhhc----cCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhhe
Confidence 99999999999988743 33578999999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 748 LAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
..........+...||+.|+|||++.+..++.++|||||||++|||+| |.+||......+....+ .. +..
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i---~~-----~~~- 227 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---EN-----GER- 227 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---HT-----TCC-
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH---Hc-----CCC-
Confidence 765544444555678999999999999999999999999999999998 89999887655432221 11 100
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
..+.+ ..+.++.+++.+||+.||++|||+.||++.|+.+++.
T Consensus 228 ~~~~~---------~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 228 LPMPP---------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC---------CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 01111 2234688999999999999999999999999988653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.9e-46 Score=408.64 Aligned_cols=252 Identities=21% Similarity=0.309 Sum_probs=209.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.. .......+.+|++++++++|||||++++++.+++..|+||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 467999999999999999999874 7999999999764 3445677899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEc--CCCCeEEeecCCcee
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRL 748 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~--~~~~~kl~DfGla~~ 748 (948)
||+++|+|.+++. .....+++.+++.|+.||+.||+|||+ ++||||||||+|||++ .++.+||+|||+|+.
T Consensus 106 E~~~gg~L~~~~~----~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 106 EFLSGGELFDRIA----AEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp ECCCCCBHHHHTT----CTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EcCCCChHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeeccccee
Confidence 9999999988763 233579999999999999999999997 8999999999999998 678999999999997
Q ss_pred cCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccc
Q 002238 749 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKA 828 (948)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (948)
..... ......||+.|+|||++.+..++.++||||+||++|||+||+.||.+....+....+ ......+...
T Consensus 179 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i------~~~~~~~~~~ 250 (352)
T d1koba_ 179 LNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV------KRCDWEFDED 250 (352)
T ss_dssp CCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HHCCCCCCSS
T ss_pred cCCCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCCCCCcc
Confidence 75543 345567999999999999999999999999999999999999999876554332211 1111111111
Q ss_pred cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 829 IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 829 ~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
. ......++.+++.+|++.||.+|||++|+++
T Consensus 251 ~---------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 251 A---------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp T---------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred c---------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 1122346889999999999999999999976
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=394.65 Aligned_cols=251 Identities=29% Similarity=0.460 Sum_probs=200.5
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-CceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-NEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e 671 (948)
++|+..+.||+|+||.||+|+++ |+.||||+++.. ...++|.+|++++++++|||||+++|+|.++ +..++|||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 56888899999999999999986 889999999753 3347799999999999999999999999654 56899999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+++|+|.+++.... ...++|..+++|+.||+.||+|||+ .+|+||||||+|||++.++.+|++|||+++....
T Consensus 82 y~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CCTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCC
Confidence 999999999986532 2358999999999999999999997 8999999999999999999999999999986543
Q ss_pred CCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
. .....+|+.|+|||++.++.++.++|||||||++|||+| |++||......+.. ..+. .+ ..
T Consensus 156 ~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~---~~i~-----~~-----~~ 218 (262)
T d1byga_ 156 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PRVE-----KG-----YK 218 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH---HHHT-----TT-----CC
T ss_pred C----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH---HHHH-----cC-----CC
Confidence 2 233468999999999999999999999999999999998 68888766544322 2111 11 11
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
+.++ .....++.+++.+||+.||++|||+.+++++|+++..
T Consensus 219 ~~~~-----~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 219 MDAP-----DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC-----ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 1111 1122468899999999999999999999999998864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=404.76 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=204.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCc----EEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
.+|++.++||+|+||+||+|.+. +|+ .||||+++.. ......++|.+|++++++++|||||+++|+|.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 46999999999999999999875 444 5888888653 2445568899999999999999999999999865 567
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
++|||+.+|+|.+++.. ....+++..+++++.|||.||+|||+ ++||||||||+|||++.++.+||+|||+|+
T Consensus 87 ~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EEEECCTTCBHHHHHHH----TSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred EEEEeccCCcccccccc----cccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccce
Confidence 88999999999888743 34679999999999999999999997 899999999999999999999999999999
Q ss_pred ecCCCCCc-eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCcccc
Q 002238 748 LAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDSF 825 (948)
Q Consensus 748 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (948)
........ ......||+.|+|||++.++.++.++|||||||++|||+| |++||.+....+....+. ... .
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~---~~~----~- 231 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---KGE----R- 231 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH---HTC----C-
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH---cCC----C-
Confidence 66543322 2334568999999999999999999999999999999999 789998766544322221 100 0
Q ss_pred ccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 826 HKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
+.. . ...+.++.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 232 -----~~~--p---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 232 -----LPQ--P---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -----CCC--C---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCC--C---cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 000 0 1223468899999999999999999999999988764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-45 Score=393.68 Aligned_cols=262 Identities=23% Similarity=0.335 Sum_probs=205.3
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc---
Q 002238 591 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE--- 665 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--- 665 (948)
+.++|++.+.||+|+||.||+|+. .+|+.||||+++..... ....+.+.+|+++++.++|||||++++++...+.
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 357899999999999999999986 47999999999865433 3446789999999999999999999999876543
Q ss_pred -eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 666 -KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 666 -~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
.|+||||++||+|.+++.. .+.+++.+++.++.||+.||+|||+ .+||||||||+|||++.++.++++|||
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~-----~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~ 156 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFG 156 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCT
T ss_pred eEEEEEECCCCCEehhhhcc-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhh
Confidence 7899999999999988743 2578999999999999999999997 899999999999999999999999999
Q ss_pred CceecCCCC--CceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc
Q 002238 745 LVRLAPEGK--GSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK 822 (948)
Q Consensus 745 la~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 822 (948)
.++...... ........||+.|||||++.+..++.++|||||||++|||+||++||....+.+... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~------~~~~~~ 230 (277)
T d1o6ya_ 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------QHVRED 230 (277)
T ss_dssp TCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHCC
T ss_pred hhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH------HHHhcC
Confidence 987543322 223445679999999999999999999999999999999999999998765443211 111111
Q ss_pred cccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCC-ChHHHHHHHHhhh
Q 002238 823 DSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRP-DMGHAVNVLSSLV 875 (948)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RP-t~~ev~~~L~~~~ 875 (948)
........+ ..+.++.+++.+|++.||.+|| +++++.+.|.++.
T Consensus 231 ~~~~~~~~~---------~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 231 PIPPSARHE---------GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCCGGGTSS---------SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCCchhcc---------CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 111111111 1234688999999999999999 8999998887764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=397.51 Aligned_cols=271 Identities=21% Similarity=0.290 Sum_probs=205.8
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC----ceEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----EKLL 668 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~l 668 (948)
+.|...+.||+|+||.||+|+++ |+.||||+++.. ......++.|+..+.+++|||||+++++|.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 56778899999999999999975 899999998643 222222344555566789999999999998654 5789
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcc-----CCCeeecCCCCccEEEcCCCCeEEeec
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA-----HQSFIHRDLKPSNILLGDDMRAKVADF 743 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivHrDik~~Nill~~~~~~kl~Df 743 (948)
||||+++|+|.++++. ..++|..+++++.|+|.||+|||+.+ .++||||||||+|||++.++.+||+||
T Consensus 79 v~Ey~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEecccCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 9999999999999954 46899999999999999999999632 369999999999999999999999999
Q ss_pred CCceecCCCCCc---eeeeecccccccCceecccCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhh-----
Q 002238 744 GLVRLAPEGKGS---IETRIAGTFGYLAPEYAVTGR------VTTKVDVFSFGVILMELITGRKALDESQPEESM----- 809 (948)
Q Consensus 744 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~----- 809 (948)
|+++........ ......||++|+|||++.+.. ++.++|||||||++|||+||..|+.........
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 999966544322 223467999999999987643 677999999999999999999887543321110
Q ss_pred ---hHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhh
Q 002238 810 ---HLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELW 878 (948)
Q Consensus 810 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 878 (948)
.......... ..+..+|.++...........+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus 233 ~~~~~~~~~~~~~-----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 233 PSDPSVEEMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CSSCCHHHHHHHH-----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHH-----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 0111111111 112223333323333445667999999999999999999999999999987643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=401.30 Aligned_cols=249 Identities=26% Similarity=0.376 Sum_probs=207.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|++.+.||+|+||.||+|+.+ +|+.||||++++... .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57999999999999999999874 799999999976432 2334677899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++||||||||+|||++.+|.+||+|||+|+...
T Consensus 85 ey~~gg~L~~~~~~-----~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 85 EYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eccCCCchhhhhhc-----ccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999998854 2468899999999999999999998 899999999999999999999999999998654
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
... ......+||+.|+|||++.+..|+.++||||+||++|||++|++||.+....+.... +......+.
T Consensus 157 ~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~------i~~~~~~~p---- 225 (337)
T d1o6la_ 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL------ILMEEIRFP---- 225 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHCCCCCC----
T ss_pred cCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHH------HhcCCCCCC----
Confidence 332 234457899999999999999999999999999999999999999988665432211 111111111
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRPD-----MGHAVN 869 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt-----~~ev~~ 869 (948)
. ....++.+++.+|++.||.+||+ ++|+++
T Consensus 226 ~---------~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 226 R---------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp T---------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred c---------cCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1 12245789999999999999995 667665
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-45 Score=399.21 Aligned_cols=246 Identities=26% Similarity=0.412 Sum_probs=206.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|++.+.||+|+||+||+|+.+ +|+.||||++++... .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56999999999999999999874 799999999976432 2334678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||++||+|.+++.. ...+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 84 E~~~gg~l~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 84 DYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp CCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eecCCccccccccc-----cccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEec
Confidence 99999999888743 2567888999999999999999997 899999999999999999999999999999765
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
.. .....||+.|||||++.+..++.++||||+||++|||++|+.||.+....+....+ ......+ .
T Consensus 156 ~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~~~~~~----p 221 (316)
T d1fota_ 156 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------LNAELRF----P 221 (316)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHCCCCC----C
T ss_pred cc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH------HcCCCCC----C
Confidence 43 34567999999999999999999999999999999999999999876554332211 1111111 1
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRP-----DMGHAVN 869 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RP-----t~~ev~~ 869 (948)
+. ...++.+++.+|++.||.+|| +++++++
T Consensus 222 ~~---------~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 222 PF---------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp TT---------SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CC---------CCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11 123588999999999999996 8888876
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=392.34 Aligned_cols=257 Identities=27% Similarity=0.435 Sum_probs=197.8
Q ss_pred cCCcccceecccCceEEEEEEEc--CC--cEEEEEEeecCcCC-hhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH--DG--TKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~--~g--~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
++|++.+.||+|+||.||+|+++ ++ ..||||++...... ....++|.+|++++++++|||||+++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56899999999999999999864 22 37899998765332 3445789999999999999999999999965 4678
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+||||+++|++.+.+... ...+++..+++++.|+|+||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 87 lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeeeecCcchhhhhhcc----cCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhh
Confidence 999999999999887542 2469999999999999999999997 899999999999999999999999999999
Q ss_pred ecCCCCCce--eeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHhhcCccc
Q 002238 748 LAPEGKGSI--ETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESMHLVTWFRRIHLSKDS 824 (948)
Q Consensus 748 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (948)
......... .....||..|+|||++.+..++.++|||||||++|||+| |+.||.+....+... + +......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~---~---i~~~~~~ 233 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH---K---IDKEGER 233 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---H---HHTSCCC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH---H---HHhCCCC
Confidence 765443222 233568889999999999999999999999999999998 899998766544321 1 1111110
Q ss_pred cccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhh
Q 002238 825 FHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSL 874 (948)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~ 874 (948)
. +.. ...+.++.+++.+||+.||++|||+.+|.+.|++.
T Consensus 234 ~--------~~~---~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 L--------PRP---EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp C--------CCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C--------CCc---ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 0 001 12234688999999999999999999999998874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-45 Score=396.39 Aligned_cols=253 Identities=20% Similarity=0.296 Sum_probs=209.0
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEE
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 669 (948)
+.++|++.+.||+|+||+||+|..+ +|+.||||+++.. ......+.+|+++++.++|||||++++++.+++..|+|
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4578999999999999999999875 7899999999764 33446788999999999999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCC--CCeEEeecCCce
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD--MRAKVADFGLVR 747 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~--~~~kl~DfGla~ 747 (948)
|||++||+|.+++.. ....+++.++..++.||+.||+|||+ .+|+||||||+|||++.+ ..+||+|||+++
T Consensus 80 mE~~~gg~L~~~i~~----~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 80 FEFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp ECCCCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhh
Confidence 999999999998842 33478999999999999999999997 899999999999999854 479999999998
Q ss_pred ecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccc
Q 002238 748 LAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHK 827 (948)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (948)
...... ......||+.|+|||...+..++.++||||+||++|||++|+.||......+....+ ......+..
T Consensus 153 ~~~~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i------~~~~~~~~~ 224 (321)
T d1tkia_ 153 QLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI------MNAEYTFDE 224 (321)
T ss_dssp ECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHTCCCCCH
T ss_pred ccccCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCCCCCh
Confidence 765433 344567999999999999999999999999999999999999999876654332211 111111111
Q ss_pred ccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 828 AIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
. .......++.+++.+|++.||.+|||+.|++++
T Consensus 225 ~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 225 E---------AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp H---------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred h---------hccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 111123458899999999999999999999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-45 Score=392.94 Aligned_cols=265 Identities=26% Similarity=0.394 Sum_probs=201.2
Q ss_pred hcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeC-
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG- 663 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~- 663 (948)
.++|++.+.||+|+||.||+|++. +++.||||+++... .....+.+.+|+.++.++ +|+|||.+++++.+.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 467999999999999999999864 34689999987543 444567788888888877 789999999998765
Q ss_pred CceEEEEEecCCCChhHHHHhhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEE
Q 002238 664 NEKLLVFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732 (948)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill 732 (948)
...++||||+++|+|.++++..... ....+++.+++.++.||++||+|||+ ++||||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeE
Confidence 4679999999999999999653221 12458999999999999999999997 899999999999999
Q ss_pred cCCCCeEEeecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCchhhhh
Q 002238 733 GDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITG-RKALDESQPEESMH 810 (948)
Q Consensus 733 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg-~~p~~~~~~~~~~~ 810 (948)
++++.+||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+|| .+||......+..
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~- 246 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF- 246 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH-
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence 9999999999999986544332 233456799999999999999999999999999999999997 4577655433221
Q ss_pred HHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhh
Q 002238 811 LVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVEL 877 (948)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~ 877 (948)
...+... . .+..+ ...+.++.+++.+||+.||++|||++||+++|+++++.
T Consensus 247 -~~~~~~~-----~-----~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 247 -CRRLKEG-----T-----RMRAP-----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp -HHHHHHT-----C-----CCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHhcC-----C-----CCCCC-----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1111110 0 01111 11234588999999999999999999999999998753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-45 Score=394.05 Aligned_cols=262 Identities=31% Similarity=0.476 Sum_probs=207.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCc--EEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCceEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 668 (948)
++|++.++||+|+||.||+|+++ +|. .||||+++... .....++|.+|+++++++ +|||||+++|+|.+++..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 67888999999999999999875 444 47888876432 344567899999999999 79999999999999999999
Q ss_pred EEEecCCCChhHHHHhhh-----------hcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCC
Q 002238 669 VFEYMPQGTLSRHIFNWA-----------EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 737 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~ 737 (948)
||||+++|+|.++++... ......++|..+++++.|||+||.|||+ ++|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCc
Confidence 999999999999986421 2334679999999999999999999997 89999999999999999999
Q ss_pred eEEeecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCchhhhhHHHHHH
Q 002238 738 AKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR-KALDESQPEESMHLVTWFR 816 (948)
Q Consensus 738 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~-~p~~~~~~~~~~~~~~~~~ 816 (948)
+||+|||+++....... .....||..|+|||.+.++.++.++|||||||++|||++|. +||.+....+...
T Consensus 166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~------ 237 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE------ 237 (309)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------
T ss_pred eEEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH------
Confidence 99999999985543221 23346899999999999999999999999999999999976 5676654433211
Q ss_pred HhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhh
Q 002238 817 RIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELW 878 (948)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 878 (948)
.+. ++ ..+..+ ...+.++.+++.+||+.||++||+|+||++.|+++.+..
T Consensus 238 ~i~--~~-----~~~~~~-----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 238 KLP--QG-----YRLEKP-----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HGG--GT-----CCCCCC-----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHH--hc-----CCCCCC-----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 111 10 011111 122346889999999999999999999999999987643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-44 Score=383.89 Aligned_cols=253 Identities=26% Similarity=0.326 Sum_probs=206.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCCh-------hhHHHHHHHHHHHHhcC-CCceeeEEeEEEe
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-------KGLTEFKSEIAVLTKVR-HRHLVALLGHCLD 662 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~ 662 (948)
.++|++.+.||+|+||+||+|+.. +|+.||||++....... ...+.+.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999874 78999999997653322 12346889999999997 9999999999999
Q ss_pred CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEee
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~D 742 (948)
++..|+||||+++|+|.+++.. ...+++.++..++.||++||+|||+ ++|+||||||+|||++.++.+||+|
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred CcceEEEEEcCCCchHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEcc
Confidence 9999999999999999999953 1478999999999999999999997 8999999999999999999999999
Q ss_pred cCCceecCCCCCceeeeecccccccCceeccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH
Q 002238 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVT------GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFR 816 (948)
Q Consensus 743 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~ 816 (948)
||+++...... ..+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..+.+....+
T Consensus 154 FG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i---- 227 (277)
T d1phka_ 154 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI---- 227 (277)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----
T ss_pred chheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH----
Confidence 99999765533 3345679999999999853 35788999999999999999999999876654332111
Q ss_pred HhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 817 RIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
........ .........++.+++.+|++.||++||++.||++
T Consensus 228 --~~~~~~~~---------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 228 --MSGNYQFG---------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp --HHTCCCCC---------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --HhCCCCCC---------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111110 0111123356889999999999999999999865
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=391.93 Aligned_cols=258 Identities=28% Similarity=0.447 Sum_probs=204.8
Q ss_pred cceecccCceEEEEEEEcCC----cEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-CceEEEEEe
Q 002238 598 ENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-NEKLLVFEY 672 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~~g----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e~ 672 (948)
.++||+|+||+||+|.+.++ ..||||+++.. ......++|.+|++++++++|||||+++|++.+. ...++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 46899999999999987532 36899998753 3556678899999999999999999999998764 578999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+++|+|.+++.. .....++..+++++.|+++||.|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 111 ~~~g~l~~~~~~----~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 111 MKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp CTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred eecCchhhhhcc----ccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 999999998743 34567899999999999999999997 89999999999999999999999999999865443
Q ss_pred CC---ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 753 KG---SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 753 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
.. .......||+.|+|||++.++.++.++||||||+++|||+||+.||....... ....++. ... ...
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~---~g~----~~~ 254 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLL---QGR----RLL 254 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH---TTC----CCC
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHHH---cCC----CCC
Confidence 22 12234568999999999999999999999999999999999888776533221 1111111 110 001
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCC
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKP 880 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~ 880 (948)
.+ ...+.++.+++.+||+.||++||+|.||++.|+.+...+..
T Consensus 255 ~p--------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 255 QP--------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp CC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred Cc--------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 11 11234588999999999999999999999999999875443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=392.40 Aligned_cols=264 Identities=25% Similarity=0.407 Sum_probs=212.9
Q ss_pred hcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCC
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 664 (948)
.++|++.++||+|+||.||+|++. +++.||||+++... ......+|.+|+.+++++ +|||||+++++|.+++
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 467888999999999999999863 45789999997643 445567899999999999 6999999999999999
Q ss_pred ceEEEEEecCCCChhHHHHhhhh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEE
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAE-------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nil 731 (948)
..++||||+++|+|.++++.... .....+++..+.+++.||++||+|||+ +++|||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccc
Confidence 99999999999999999865321 223468999999999999999999997 89999999999999
Q ss_pred EcCCCCeEEeecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhh
Q 002238 732 LGDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESM 809 (948)
Q Consensus 732 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~ 809 (948)
++.++.+|++|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+| |.+||......+..
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999997655433 23345679999999999999999999999999999999999 55556554433221
Q ss_pred hHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 810 HLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
. ..+... .. +..+ ...+.++.+|+.+||+.||.+|||+++|+++|++.+.
T Consensus 258 ~--~~i~~~------~~----~~~~-----~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 258 Y--KMIKEG------FR----MLSP-----EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp H--HHHHHT------CC----CCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H--HHHhcC------CC----CCCc-----ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 1 111110 00 1100 1123468899999999999999999999999998764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=390.70 Aligned_cols=263 Identities=29% Similarity=0.429 Sum_probs=208.6
Q ss_pred hcCCcccceecccCceEEEEEEEcC--------CcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEe
Q 002238 592 TNNFSEENILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD 662 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 662 (948)
.++|++.+.||+|+||.||+|+... +..||||+++... ......++.+|+..+.++ +|||||+++++|.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 4678889999999999999997532 2479999997643 445567899999999888 89999999999999
Q ss_pred CCceEEEEEecCCCChhHHHHhhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEE
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nil 731 (948)
++..++||||+++|+|.+++..... .....+++.++++++.||+.||+|||+ .+||||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeeccccee
Confidence 9999999999999999999964321 123568999999999999999999998 89999999999999
Q ss_pred EcCCCCeEEeecCCceecCCCCC-ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhh
Q 002238 732 LGDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELIT-GRKALDESQPEESM 809 (948)
Q Consensus 732 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~ellt-g~~p~~~~~~~~~~ 809 (948)
++.++.+||+|||+++....... .......||+.|+|||++.++.|+.++|||||||++|||++ |.+||.+....+..
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 99999999999999986544332 22344678999999999999999999999999999999998 78888776544322
Q ss_pred hHHHHHHHhhcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 810 HLVTWFRRIHLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
.. +.. .. .+..+ ...+.++.+++.+||+.||.+|||+.||++.|+++..
T Consensus 248 ~~---i~~----~~------~~~~p-----~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 248 KL---LKE----GH------RMDKP-----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HH---HHT----TC------CCCCC-----SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH---HHc----CC------CCCCC-----ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 11 111 11 01111 1123458899999999999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.3e-45 Score=398.47 Aligned_cols=246 Identities=24% Similarity=0.335 Sum_probs=206.1
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 670 (948)
++|++.+.||+|+||.||+|+.+ +|+.||||++.+... .....+.+.+|+++++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999875 799999999875432 2344577899999999999999999999999999999999
Q ss_pred EecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecC
Q 002238 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (948)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~ 750 (948)
||+.+|+|.+++.. .+.+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 121 e~~~~g~l~~~l~~-----~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ccccccchhhhHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 99999999998853 1468999999999999999999997 899999999999999999999999999999764
Q ss_pred CCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccccccC
Q 002238 751 EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAID 830 (948)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (948)
.. .....||+.|||||++.+..++.++|||||||++|||+||+.||.+.........+ ....... .
T Consensus 193 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~~~~~~----p 258 (350)
T d1rdqe_ 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI------VSGKVRF----P 258 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCCCC----C
T ss_pred cc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH------hcCCCCC----C
Confidence 42 33467999999999999999999999999999999999999999876543322111 1111111 1
Q ss_pred cccCCccchHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 002238 831 PTIDLNEGILASISTVAELAGHCCAREPYQRP-----DMGHAVN 869 (948)
Q Consensus 831 ~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RP-----t~~ev~~ 869 (948)
+ ....++.+++.+|++.||.+|+ +++++++
T Consensus 259 ~---------~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 259 S---------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp T---------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred c---------cCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1 1224588999999999999994 8888875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=391.31 Aligned_cols=263 Identities=27% Similarity=0.429 Sum_probs=213.2
Q ss_pred hcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 665 (948)
.++|++.+.||+|+||.||+|.++ +++.||||+++.. ........|.+|++++++++|||||+++++|..++.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 467888999999999999999864 3578999999754 245556789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHHhhh-----hcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEE
Q 002238 666 KLLVFEYMPQGTLSRHIFNWA-----EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 740 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~-----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl 740 (948)
.++||||+++|+|.+++.... ......+++..+.+++.|+|+||+|||+ ++|+||||||+|||+++++.+||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEE
Confidence 999999999999999886532 1223467999999999999999999997 79999999999999999999999
Q ss_pred eecCCceecCCCCCc-eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCchhhhhHHHHHHHh
Q 002238 741 ADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGR-KALDESQPEESMHLVTWFRRI 818 (948)
Q Consensus 741 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~ 818 (948)
+|||+|+........ ......||+.|+|||.+.+..++.++||||||+++|||+||. +||.+....+....+
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i------ 248 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV------ 248 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH------
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH------
Confidence 999999865443322 223346899999999999999999999999999999999984 777665544332221
Q ss_pred hcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhh
Q 002238 819 HLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVE 876 (948)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~ 876 (948)
. .+.... . . ...+..+.+++.+||+.+|++||||.+|+++|++.++
T Consensus 249 ~--~~~~~~-----~--p---~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 M--EGGLLD-----K--P---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp H--TTCCCC-----C--C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred H--hCCCCC-----C--c---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1 111100 0 0 1123468999999999999999999999999987654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-44 Score=390.83 Aligned_cols=252 Identities=21% Similarity=0.269 Sum_probs=199.8
Q ss_pred hcCCcccc-eecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhc-CCCceeeEEeEEEe----CC
Q 002238 592 TNNFSEEN-ILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD----GN 664 (948)
Q Consensus 592 ~~~~~~~~-~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~ 664 (948)
.++|++.. .||+|+||.||+|+. .+|+.||||+++.. ..+.+|++++.++ +|||||++++++.+ +.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 46788764 699999999999987 47899999998653 4678899987655 89999999999875 45
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC---CCCeEEe
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVA 741 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~---~~~~kl~ 741 (948)
..|+||||++||+|.+++.. .+...+++.++..|+.||+.||+|||+ .+|+||||||+|||++. ++.+||+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~---~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHS---CSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEEECCCCCcHHHHHHh---cCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccc
Confidence 67999999999999999853 333579999999999999999999997 89999999999999985 4579999
Q ss_pred ecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcC
Q 002238 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS 821 (948)
Q Consensus 742 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 821 (948)
|||+|+...... ......||+.|||||++.+..|+.++|||||||++|||+||+.||.+.......... .
T Consensus 157 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~--~------ 226 (335)
T d2ozaa1 157 DFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--K------ 226 (335)
T ss_dssp CCTTCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------
T ss_pred ccceeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH--H------
Confidence 999999765533 234567999999999999999999999999999999999999999765433221100 0
Q ss_pred ccccccccCcccCCc-cchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 822 KDSFHKAIDPTIDLN-EGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 822 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
........... ........++.+++.+|++.||++|||+.|++++
T Consensus 227 ----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 227 ----TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00111111111 1112334568999999999999999999999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.4e-44 Score=397.38 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=199.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCC-hhhHHHHHH---HHHHHHhcCCCceeeEEeEEEeCCceE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKS---EIAVLTKVRHRHLVALLGHCLDGNEKL 667 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~~ 667 (948)
++|++.+.||+|+||.||+|+.. +|+.||||++.+.... ......+.+ |+++++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999875 7999999998754222 122233444 466777778999999999999999999
Q ss_pred EEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+
T Consensus 84 ivmE~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEECCCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEecCCCcHHHHHHh-----cccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceee
Confidence 99999999999999854 2467899999999999999999997 899999999999999999999999999999
Q ss_pred ecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCccccc
Q 002238 748 LAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFH 826 (948)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (948)
...... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||......+..... ........
T Consensus 156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~---~~~~~~~~--- 226 (364)
T d1omwa3 156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTLTMAV--- 226 (364)
T ss_dssp ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH---HHSSSCCC---
T ss_pred ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhcccCCC---
Confidence 765433 334579999999999875 56899999999999999999999999876543322111 11111000
Q ss_pred cccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 002238 827 KAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPD-----MGHAVN 869 (948)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt-----~~ev~~ 869 (948)
.+.+ ....++.+++.+|++.||.+||+ ++|+++
T Consensus 227 -~~~~---------~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 -ELPD---------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -CCCS---------SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -CCCC---------CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0111 12245889999999999999999 567765
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=391.59 Aligned_cols=249 Identities=27% Similarity=0.440 Sum_probs=204.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcC-ChhhHHHHHHHHHHHH-hcCCCceeeEEeEEEeCCceEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLT-KVRHRHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lv 669 (948)
++|++.+.||+|+||+||+|+.+ +|+.||||++++... .....+.+..|+.++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999875 799999999975422 2334566777777665 68999999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceec
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~ 749 (948)
|||+++|+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++..
T Consensus 82 mEy~~~g~L~~~i~~-----~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EeecCCCcHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhc
Confidence 999999999999854 2468889999999999999999998 89999999999999999999999999999865
Q ss_pred CCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc
Q 002238 750 PEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI 829 (948)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (948)
.... ...+...||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+....+ ......+.
T Consensus 154 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i------~~~~~~~p--- 223 (320)
T d1xjda_ 154 MLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI------RMDNPFYP--- 223 (320)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCCCCC---
T ss_pred cccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH------HcCCCCCC---
Confidence 4432 2344567999999999999999999999999999999999999999876654432221 11111111
Q ss_pred CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChH-HHHH
Q 002238 830 DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMG-HAVN 869 (948)
Q Consensus 830 ~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~-ev~~ 869 (948)
+ ....++.+++.+|++.||++||++. ++++
T Consensus 224 -~---------~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 224 -R---------WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -T---------TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -c---------cCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1 1224588999999999999999985 6643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=389.22 Aligned_cols=262 Identities=25% Similarity=0.289 Sum_probs=196.6
Q ss_pred cceecccCceEEEEEEEc-CCcEEEEEEeecCcCCh---hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEec
Q 002238 598 ENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG---KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 673 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 673 (948)
.++||+|+||+||+|+.+ +|+.||||+++...... ...+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999864 69999999987543221 12356889999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCCC
Q 002238 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (948)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~~ 753 (948)
.++++..+. .....+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~~~~~~~~~-----~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIK-----DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHT-----TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhh-----hcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 888776554 233568888999999999999999997 899999999999999999999999999998655433
Q ss_pred CceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccccccc---
Q 002238 754 GSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSFHKAI--- 829 (948)
Q Consensus 754 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 829 (948)
. .....+||+.|+|||++... .++.++|||||||++|||++|++||......+....+........ ...+....
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~-~~~~~~~~~~~ 232 (299)
T d1ua2a_ 155 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 232 (299)
T ss_dssp C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC-TTTSSSTTSST
T ss_pred c-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCC-hhhccchhccc
Confidence 2 23345799999999998754 579999999999999999999999987665443322211100000 00000000
Q ss_pred -------CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 830 -------DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 830 -------~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.+.............++.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000000111122356889999999999999999999876
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-44 Score=384.99 Aligned_cols=268 Identities=25% Similarity=0.381 Sum_probs=202.5
Q ss_pred cCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|++.+.||+|+||+||+|+. .+|+.||||+++.........+++.+|++++++++|||||++++++.++++.++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999987 479999999997654444456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
|+.++ +.+++.. .....+++..+..++.|++.||+|||+ .+||||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~~~-~~~~~~~---~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 82 FLHQD-LKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp CCSEE-HHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ecCCc-hhhhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccC
Confidence 99754 4444422 234679999999999999999999997 8999999999999999999999999999986544
Q ss_pred CCCceeeeecccccccCceecccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcccc-cc--
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGR-VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKDSF-HK-- 827 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-- 827 (948)
.. .......||+.|+|||++.... ++.++||||+||++|||++|+.||.+....+....+ ........... ..
T Consensus 155 ~~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 155 PV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPDEVVWPGVT 231 (298)
T ss_dssp CS-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCCCCTTTSTTGG
T ss_pred Cc-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHH--HHhcCCCchhhccccc
Confidence 32 2234457999999999887765 588999999999999999999999876544332221 11111101000 00
Q ss_pred -ccC--ccc---C---CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 828 -AID--PTI---D---LNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 828 -~~~--~~~---~---~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
..+ ... . ..........++.+++.+|++.||++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000 000 0 000111223568899999999999999999999763
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1e-43 Score=381.53 Aligned_cols=268 Identities=23% Similarity=0.309 Sum_probs=204.7
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEEe
Q 002238 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 672 (948)
++|++.+.||+|+||+||+|++++|+.||||++..........+.+.+|+.++++++|||||++++++.+++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 58999999999999999999999999999999977544444568899999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCCC
Q 002238 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (948)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~~ 752 (948)
+.++.+..+. ...+.+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+|++|||.+......
T Consensus 82 ~~~~~~~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLD-----VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHH-----TSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHH-----hhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9877666554 233679999999999999999999997 89999999999999999999999999999865443
Q ss_pred CCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcc--cccccc
Q 002238 753 KGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD--SFHKAI 829 (948)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 829 (948)
.. ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+....+........... ......
T Consensus 154 ~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence 22 23345689999999998764 569999999999999999999999987665443222211110000000 000000
Q ss_pred --C------cccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 830 --D------PTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 830 --~------~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
. ...............+.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000001111122356889999999999999999999975
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.3e-43 Score=376.31 Aligned_cols=275 Identities=15% Similarity=0.213 Sum_probs=218.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCC-CceeeEEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH-RHLVALLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv 669 (948)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+|++.++.++| +|++.+++++.++...++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 468999999999999999999865 78999999886542 22457889999999965 8999999999999999999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC-----CCCeEEeecC
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-----DMRAKVADFG 744 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~-----~~~~kl~DfG 744 (948)
|||+ +++|.+++.. ....+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||
T Consensus 80 me~~-~~~l~~~~~~----~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 80 IDLL-GPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEec-CCCHHHHHHh----hccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccc
Confidence 9999 7899888743 23578999999999999999999997 89999999999999974 5689999999
Q ss_pred CceecCCCCC------ceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh
Q 002238 745 LVRLAPEGKG------SIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI 818 (948)
Q Consensus 745 la~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 818 (948)
+|+....... .......||+.|||||++.+..++.++|||||||++|||+||+.||..............+...
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~ 231 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence 9997654322 1233467999999999999999999999999999999999999999866543332222211111
Q ss_pred hcCccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCCCCCCCcccc
Q 002238 819 HLSKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDQNSEDIY 889 (948)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~ 889 (948)
.. .... .+.....+.++.+++..|++.+|++||+++.+.+.|+++.+......+...||.
T Consensus 232 ~~-~~~~----------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~ 291 (293)
T d1csna_ 232 KQ-STPL----------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN 291 (293)
T ss_dssp HH-HSCH----------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred cC-CCCh----------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCC
Confidence 10 0000 011112234688999999999999999999999999999887777666666664
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-44 Score=379.28 Aligned_cols=242 Identities=26% Similarity=0.371 Sum_probs=197.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCCh----hhHHHHHHHHHHHHhcC--CCceeeEEeEEEeCC
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG----KGLTEFKSEIAVLTKVR--HRHLVALLGHCLDGN 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~ 664 (948)
.++|++.+.||+|+||+||+|+.. +|+.||||++....... ....++.+|+.++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 468999999999999999999874 78999999997653322 12244778999999996 899999999999999
Q ss_pred ceEEEEEecCC-CChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcC-CCCeEEee
Q 002238 665 EKLLVFEYMPQ-GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVAD 742 (948)
Q Consensus 665 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~-~~~~kl~D 742 (948)
..++||||+.+ +++.+++.. ...+++.++..++.||++||+|||+ ++|+||||||+|||++. ++.+||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECC
T ss_pred eEEEEEEeccCcchHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECc
Confidence 99999999976 577776643 2578999999999999999999997 89999999999999985 47999999
Q ss_pred cCCceecCCCCCceeeeecccccccCceecccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcC
Q 002238 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRV-TTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS 821 (948)
Q Consensus 743 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 821 (948)
||+|+..... ..+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... +...
T Consensus 155 FG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------i~~~ 219 (273)
T d1xwsa_ 155 FGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRG 219 (273)
T ss_dssp CTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHHC
T ss_pred cccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------------Hhhc
Confidence 9999865443 2345679999999999987765 5779999999999999999999975211 0001
Q ss_pred ccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 822 KDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.. .+.+.+ ..++.+++.+|++.||++|||++|+++
T Consensus 220 ~~----~~~~~~---------s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 QV----FFRQRV---------SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CC----CCSSCC---------CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cc----CCCCCC---------CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11 111111 245889999999999999999999876
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-43 Score=377.62 Aligned_cols=275 Identities=19% Similarity=0.248 Sum_probs=207.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceee-EEeEEEeCCceEEE
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA-LLGHCLDGNEKLLV 669 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~~~~~~lv 669 (948)
.++|++.+.||+|+||.||+|++. +|+.||||++.... ...++..|+++++.++|+|++. +.++..+++..++|
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 367999999999999999999864 68999999987542 2245789999999998776554 45555777888999
Q ss_pred EEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEc---CCCCeEEeecCCc
Q 002238 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKVADFGLV 746 (948)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~---~~~~~kl~DfGla 746 (948)
|||+ ++++.+.+.. ....+++..+..++.|++.||+|||+ ++||||||||+|||++ .+..++++|||+|
T Consensus 82 me~~-~~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 82 MELL-GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp EECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred EEEc-CCchhhhhhh----ccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcc
Confidence 9999 5566665532 33579999999999999999999997 8999999999999986 3457999999999
Q ss_pred eecCCCCCc------eeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhc
Q 002238 747 RLAPEGKGS------IETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHL 820 (948)
Q Consensus 747 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 820 (948)
+........ ......||+.|||||++.+..++.++|||||||++|||+||+.||....................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC
Confidence 976544321 23446799999999999999999999999999999999999999987655443322221111100
Q ss_pred CccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHHHHhhhhhhCCCCCCCcccc
Q 002238 821 SKDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNVLSSLVELWKPTDQNSEDIY 889 (948)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~ 889 (948)
.. +........+.++.+++.+|++.+|++||+++++.+.|+.+........+...||.
T Consensus 234 ~~-----------~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~ 291 (299)
T d1ckia_ 234 ST-----------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 291 (299)
T ss_dssp HS-----------CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHH
T ss_pred CC-----------ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCch
Confidence 00 00011112335688999999999999999999999999988765554444445553
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=382.06 Aligned_cols=268 Identities=23% Similarity=0.320 Sum_probs=202.3
Q ss_pred hcCCcccceecccCceEEEEEEEc-C-CcEEEEEEeecCcCChhhHHHHHHHHHHHHhc---CCCceeeEEeEEEe----
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-D-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV---RHRHLVALLGHCLD---- 662 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~---- 662 (948)
.++|++.+.||+|+||+||+|+.. + ++.||||+++...........+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999873 4 56799999976544443445567888887766 79999999999863
Q ss_pred -CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEe
Q 002238 663 -GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 741 (948)
Q Consensus 663 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~ 741 (948)
....+++|||++++.+.... ......+++..+..++.|++.||+|||+ ++||||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~----~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLD----KVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHH----HSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCceEEEEEEeccCCchhhhh----hccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeec
Confidence 24578999999887775443 2334678999999999999999999997 899999999999999999999999
Q ss_pred ecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcC
Q 002238 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLS 821 (948)
Q Consensus 742 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 821 (948)
|||+++..... .......||+.|+|||++.+..|+.++||||+||++|||++|++||....+.+....+........
T Consensus 159 dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~- 235 (305)
T d1blxa_ 159 DFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG- 235 (305)
T ss_dssp SCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-
T ss_pred chhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCc-
Confidence 99998854332 234456799999999999999999999999999999999999999988765543333221111000
Q ss_pred cccccc-------ccCc--ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 822 KDSFHK-------AIDP--TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 822 ~~~~~~-------~~~~--~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
...+.. .... ..............+.+|+.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 0000 00001111122346789999999999999999999876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-42 Score=377.08 Aligned_cols=264 Identities=25% Similarity=0.374 Sum_probs=199.7
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-----
Q 002238 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----- 664 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 664 (948)
..++|++.+.||+|+||+||+|..+ +|+.||||+++.........+.+.+|+++|++++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4578999999999999999999874 6999999999876555666778999999999999999999999998654
Q ss_pred -ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeec
Q 002238 665 -EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (948)
Q Consensus 665 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~Df 743 (948)
+.++||||+ +.+|.++.+. ..+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+|++||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccc
Confidence 469999999 6677776632 469999999999999999999997 89999999999999999999999999
Q ss_pred CCceecCCCCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc
Q 002238 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK 822 (948)
Q Consensus 744 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 822 (948)
|+|+..... .+...||+.|+|||++.+. .++.++||||+||++|||++|+.||................. ...
T Consensus 166 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~ 239 (346)
T d1cm8a_ 166 GLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG--TPP 239 (346)
T ss_dssp TTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC--CCC
T ss_pred cceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccC--CCc
Confidence 999876442 3446799999999998764 568999999999999999999999987654433222111100 000
Q ss_pred cccc------------cccCc--ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 823 DSFH------------KAIDP--TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 823 ~~~~------------~~~~~--~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
..+. ..... ..............+.+|+.+|++.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00000 000001111223457899999999999999999999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-42 Score=373.30 Aligned_cols=268 Identities=22% Similarity=0.311 Sum_probs=201.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEe--------
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-------- 662 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-------- 662 (948)
.++|++.+.||+|+||+||+|+.. +|+.||||++...........++.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 368999999999999999999874 79999999987665555566789999999999999999999998865
Q ss_pred CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEee
Q 002238 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (948)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~D 742 (948)
....++||||++++.+.... .....++...+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~-----~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS-----NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT-----CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECC
T ss_pred CceEEEEEeccCCCccchhh-----hcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeee
Confidence 34579999999887765443 334678889999999999999999997 8999999999999999999999999
Q ss_pred cCCceecCCCCC---ceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHh
Q 002238 743 FGLVRLAPEGKG---SIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRI 818 (948)
Q Consensus 743 fGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 818 (948)
||+++....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+..+.+....+......
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~ 240 (318)
T d3blha1 161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240 (318)
T ss_dssp CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999986543321 122335799999999998765 6899999999999999999999999876654443333222111
Q ss_pred hcCccccccccC---------cccCCccchH------HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 819 HLSKDSFHKAID---------PTIDLNEGIL------ASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 819 ~~~~~~~~~~~~---------~~~~~~~~~~------~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
.. .......+ .......... .....+.+|+.+|++.||++|||++|+++
T Consensus 241 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 241 IT--PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CC--TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CC--hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 10 00000000 0000000000 11235678999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=375.33 Aligned_cols=268 Identities=21% Similarity=0.315 Sum_probs=199.7
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC----c
Q 002238 591 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----E 665 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~ 665 (948)
+..+|++.+.||+|+||+||+|.. .+|+.||||++.... .....+.+.+|+++|++++||||+++++++.... .
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 356899999999999999999986 489999999997542 3444678899999999999999999999997643 2
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGl 745 (948)
.+++++|+.+|+|.+++.. ..+++..+..++.|+++||+|||+ ++||||||||+|||+++++.+||+|||+
T Consensus 85 ~~~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~ 155 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGL 155 (345)
T ss_dssp CEEEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEeecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCc
Confidence 3555667779999999843 468999999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCC--ceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCc
Q 002238 746 VRLAPEGKG--SIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSK 822 (948)
Q Consensus 746 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 822 (948)
++....... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+......... ....
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~--~~~~ 233 (345)
T d1pmea_ 156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL--GSPS 233 (345)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH--CSCC
T ss_pred eeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhc--cCCC
Confidence 986543221 12344679999999999854 567899999999999999999999998766433322211110 0000
Q ss_pred ccc-cc----------ccCcc---cCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 823 DSF-HK----------AIDPT---IDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 823 ~~~-~~----------~~~~~---~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
... .. ...+. .+..........++.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 00 00000 00000011122468899999999999999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-41 Score=370.97 Aligned_cols=263 Identities=21% Similarity=0.310 Sum_probs=195.1
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC------Cce
Q 002238 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------NEK 666 (948)
Q Consensus 594 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~ 666 (948)
+|+..++||+|+||+||+|+.. +|+.||||++.... ..+.+|++++++++||||+++++++... .+.
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc------hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 5788899999999999999975 79999999997642 1234799999999999999999998643 246
Q ss_pred EEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC-CeEEeecCC
Q 002238 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGL 745 (948)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~-~~kl~DfGl 745 (948)
++||||++++.+. .+... ......+++.++..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 95 ~lv~Ey~~~~~~~-~l~~~-~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 95 NLVLDYVPETVYR-VARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEECCSEEHHH-HHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEeccCCccHH-HHHhh-hhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccc
Confidence 8999999765443 43322 2334679999999999999999999997 8999999999999999775 899999999
Q ss_pred ceecCCCCCceeeeecccccccCceeccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHH---------H
Q 002238 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVT-GRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTW---------F 815 (948)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~---------~ 815 (948)
++...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+.. .
T Consensus 170 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 170 AKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp CEECCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhhccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhh
Confidence 98765433 2334579999999998865 5689999999999999999999999987664433222110 0
Q ss_pred HHhhcC--ccccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 816 RRIHLS--KDSFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 816 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
...... ...+......... .........++.+|+.+|++.||++|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWT-KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGG-GTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccchhhccccccccCchh-hhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 0000000000000 00111223468899999999999999999998863
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-41 Score=363.10 Aligned_cols=267 Identities=21% Similarity=0.288 Sum_probs=206.8
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCceEEEEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 671 (948)
++|++.+.||+|+||+||+|++. +|+.||||+++..........++.+|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999874 78999999998765555667889999999999999999999999999999999999
Q ss_pred ecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCCceecCC
Q 002238 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (948)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~~~~~ 751 (948)
++.++++..++.. .+.+++..+..++.|++.||+|||+ ++||||||||+|||++.++.+||+|||.++....
T Consensus 82 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecccccccccccc-----ccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccC
Confidence 9999888776632 3578899999999999999999997 8999999999999999999999999999997654
Q ss_pred CCCceeeeecccccccCceecccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchh-hhhHHHHHHHhhcCcccc---c
Q 002238 752 GKGSIETRIAGTFGYLAPEYAVTGR-VTTKVDVFSFGVILMELITGRKALDESQPEE-SMHLVTWFRRIHLSKDSF---H 826 (948)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~---~ 826 (948)
... ......+++.|+|||++.... ++.++||||+||++|||++|+.||....... ....+........ .... .
T Consensus 154 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (292)
T d1unla_ 154 PVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT-EEQWPSMT 231 (292)
T ss_dssp CCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCC-TTTCTTGG
T ss_pred CCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCC-hhhhhhhh
Confidence 332 233445788999999987665 6899999999999999999999975544322 2111111111000 0000 0
Q ss_pred cc--------cCcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 827 KA--------IDPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 827 ~~--------~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
+. .................+.+++.+|++.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000011111122346889999999999999999999866
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=4.9e-41 Score=366.26 Aligned_cols=293 Identities=26% Similarity=0.468 Sum_probs=228.7
Q ss_pred CCChHHHHHHHHHHHhcCCCCCC-CCC-CCCCC--CccceEEeCC---CCEEEEEeCCCCCcC--CCCccccCCCCCcEE
Q 002238 27 SGDDGDAAVMLALKKSLNPPESL-GWS-DTDPC--KWNHVVCIED---KRITRIQIGHQNLQG--TLPSNLQNLTKLERL 97 (948)
Q Consensus 27 ~~~~~d~~~l~~~k~~~~~~~~~-~w~-~~~~C--~w~gv~c~~~---~~v~~l~l~~~~l~~--~~p~~l~~l~~L~~L 97 (948)
-|.++|++||++||+++.+|..+ +|. ++||| .|.||+|+.. .||+.|+|++++++| .+|+.+++|++|++|
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L 81 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CCCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccccc
Confidence 48999999999999999987655 885 67999 4999999864 389999999999998 589999999999999
Q ss_pred Eccc-CCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCcc
Q 002238 98 ELQW-NSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175 (948)
Q Consensus 98 ~L~~-N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~ 175 (948)
+|++ |+++|.+| +|.+|++|++|+|++|++.+.++..+..+.+|+.+++++|++.. .+|..+.++++|+.+++++|.
T Consensus 82 ~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~-~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG-TLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEES-CCCGGGGGCTTCCEEECCSSC
T ss_pred ccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccc-cCchhhccCcccceeeccccc
Confidence 9986 88988777 78999999999999999999888888888888888888888776 667777777777777777777
Q ss_pred ccccCCCCCCCCCCCCC-cEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccc
Q 002238 176 ITGQIPSFFGPDEFPGL-TILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG 254 (948)
Q Consensus 176 l~~~~p~~~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~ 254 (948)
+++.+|..+. .+..+ +.+++++|++++..|..+
T Consensus 161 l~~~ip~~~~--~l~~l~~~l~~~~n~l~~~~~~~~-------------------------------------------- 194 (313)
T d1ogqa_ 161 ISGAIPDSYG--SFSKLFTSMTISRNRLTGKIPPTF-------------------------------------------- 194 (313)
T ss_dssp CEEECCGGGG--CCCTTCCEEECCSSEEEEECCGGG--------------------------------------------
T ss_pred cccccccccc--cccccccccccccccccccccccc--------------------------------------------
Confidence 7766666654 44443 556666666655554433
Q ss_pred cCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhh
Q 002238 255 PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLN 334 (948)
Q Consensus 255 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 334 (948)
.. ..+..+++.+|.+.|.+|..+..+++|+.+++++|.+++.+|.+.
T Consensus 195 -----~~-l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~--------------------------- 241 (313)
T d1ogqa_ 195 -----AN-LNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVG--------------------------- 241 (313)
T ss_dssp -----GG-CCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCC---------------------------
T ss_pred -----cc-ccccccccccccccccccccccccccccccccccccccccccccc---------------------------
Confidence 22 233457777777777777777777888888888887776655421
Q ss_pred hhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCC
Q 002238 335 ALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL 414 (948)
Q Consensus 335 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l 414 (948)
..++|+.|+|++|+++|.+|+.|+++++|++|+|++|+|+|.+| ++
T Consensus 242 ---------------------------------~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP-~~ 287 (313)
T d1ogqa_ 242 ---------------------------------LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QG 287 (313)
T ss_dssp ---------------------------------CCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC-CS
T ss_pred ---------------------------------cccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC-Cc
Confidence 12356777888888888888888888889999999999988888 46
Q ss_pred cCCCCCcEEEccCCc-ccCC
Q 002238 415 SVLGALKELDVSNNQ-LYGK 433 (948)
Q Consensus 415 ~~l~~L~~L~ls~N~-l~g~ 433 (948)
+++++|+.+++++|+ ++|.
T Consensus 288 ~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 288 GNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp TTGGGSCGGGTCSSSEEEST
T ss_pred ccCCCCCHHHhCCCccccCC
Confidence 788888888888887 5664
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=367.62 Aligned_cols=254 Identities=24% Similarity=0.334 Sum_probs=202.4
Q ss_pred cCCcccceecccCceEEEEEEEc----CCcEEEEEEeecCcC--ChhhHHHHHHHHHHHHhcCC-CceeeEEeEEEeCCc
Q 002238 593 NNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVI--SGKGLTEFKSEIAVLTKVRH-RHLVALLGHCLDGNE 665 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~ 665 (948)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 57999999999999999999752 589999999865432 22335678899999999976 899999999999999
Q ss_pred eEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecCC
Q 002238 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (948)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfGl 745 (948)
.++||||+.+|+|.+++... ..+....+..++.|++.||+|||+ .+||||||||+|||++.++.+||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccc
Confidence 99999999999999988542 356778889999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCceeeeecccccccCceecccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcc
Q 002238 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVTG--RVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD 823 (948)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 823 (948)
++..............||+.|+|||.+.+. .++.++||||+||++|||++|+.||......+....+.... ....
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--~~~~- 252 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSE- 252 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HHCC-
T ss_pred hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--ccCC-
Confidence 987655544445557799999999998764 46889999999999999999999998765443322221111 0000
Q ss_pred ccccccCcccCCccchHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 002238 824 SFHKAIDPTIDLNEGILASISTVAELAGHCCAREPYQRPD-----MGHAVN 869 (948)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt-----~~ev~~ 869 (948)
+.++ .....++.+++.+|++.||++||+ ++|+++
T Consensus 253 -------~~~~-----~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 -------PPYP-----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -------CCCC-----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------CCCc-----ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0010 122346889999999999999995 667654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=368.25 Aligned_cols=264 Identities=23% Similarity=0.302 Sum_probs=196.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC------C
Q 002238 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------N 664 (948)
Q Consensus 592 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~ 664 (948)
.++|++.++||+|+||+||+|.+. +|+.||||++...........++.+|+.++++++|||||++++++... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 468999999999999999999875 799999999987665666677899999999999999999999999643 5
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
+.|+||||+.++.+ +.+. ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.++++|||
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~-------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp EEEEEEECCSEEHH-HHHT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred eeEEEEeccchHHH-Hhhh-------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechh
Confidence 77999999976544 4331 468899999999999999999997 899999999999999999999999999
Q ss_pred CceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhh-----
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIH----- 819 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~----- 819 (948)
+++...... ..+...||+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+ .....
T Consensus 165 ~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i--~~~~~~~~~~ 240 (355)
T d2b1pa1 165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV--IEQLGTPCPE 240 (355)
T ss_dssp C-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHHHCCCCHH
T ss_pred hhhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHH--HHhccCCCHH
Confidence 988654432 344567999999999999999999999999999999999999999876543322111 11000
Q ss_pred -------------cCcc-----ccccccCcccC--CccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 820 -------------LSKD-----SFHKAIDPTID--LNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 820 -------------~~~~-----~~~~~~~~~~~--~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.... .....+..... ...........+.+|+.+|++.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00111111110 011122345678899999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.4e-40 Score=360.54 Aligned_cols=259 Identities=17% Similarity=0.294 Sum_probs=198.2
Q ss_pred cCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeC--CceEE
Q 002238 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDG--NEKLL 668 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~l 668 (948)
++|++.++||+|+||+||+|+. .+|+.||||+++.. ..+++.+|++++++++ ||||+++++++... ...++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 5799999999999999999987 47899999998643 2467899999999995 99999999998753 56899
Q ss_pred EEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC-CeEEeecCCce
Q 002238 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVR 747 (948)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~-~~kl~DfGla~ 747 (948)
||||+++++|.+.. +.+++..+..++.||+.||+|||+ ++||||||||+|||++.++ .+||+|||+|+
T Consensus 110 v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 110 VFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp EEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred EEeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccce
Confidence 99999999997653 468999999999999999999997 8999999999999998665 59999999998
Q ss_pred ecCCCCCceeeeecccccccCceecccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhh-H----------HHHH
Q 002238 748 LAPEGKGSIETRIAGTFGYLAPEYAVTG-RVTTKVDVFSFGVILMELITGRKALDESQPEESMH-L----------VTWF 815 (948)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~-~----------~~~~ 815 (948)
...... ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.......... . ..+.
T Consensus 179 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 179 FYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp ECCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred eccCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhh
Confidence 765433 23445789999999998775 47999999999999999999999998765432110 0 0111
Q ss_pred HHhhcCcc-ccccccCc-------ccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 002238 816 RRIHLSKD-SFHKAIDP-------TIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVN 869 (948)
Q Consensus 816 ~~~~~~~~-~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~ 869 (948)
........ .+...... .............++.+|+.+|++.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11100000 00000000 00001111222356889999999999999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=366.98 Aligned_cols=265 Identities=22% Similarity=0.363 Sum_probs=201.4
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----C
Q 002238 591 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-----N 664 (948)
Q Consensus 591 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~ 664 (948)
+.++|++.+.||+|+||+||+|+. .+|+.||||++..........+++.+|++++++++|||+|++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 357899999999999999999986 4799999999987655566677899999999999999999999998643 3
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeEEeecC
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~kl~DfG 744 (948)
..++||+|+.+|+|.+++.. +.+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred ceEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccc
Confidence 44677788889999998832 469999999999999999999997 899999999999999999999999999
Q ss_pred CceecCCCCCceeeeecccccccCceecccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHhhcCcc
Q 002238 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR-VTTKVDVFSFGVILMELITGRKALDESQPEESMHLVTWFRRIHLSKD 823 (948)
Q Consensus 745 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 823 (948)
++..... ......||+.|+|||+..+.. ++.++||||+||++|||++|+.||.+.........+... ......
T Consensus 167 ~a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~--~~~~~~ 240 (348)
T d2gfsa1 167 LARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL--VGTPGA 240 (348)
T ss_dssp ---CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH--HCCCCH
T ss_pred hhcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHh--cCCCCh
Confidence 9875432 233457999999999877654 689999999999999999999999876544332222111 000000
Q ss_pred cccc------------cc--CcccCCccchHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 002238 824 SFHK------------AI--DPTIDLNEGILASISTVAELAGHCCAREPYQRPDMGHAVNV 870 (948)
Q Consensus 824 ~~~~------------~~--~~~~~~~~~~~~~~~~l~~li~~c~~~~P~~RPt~~ev~~~ 870 (948)
.... .. .+..............+.+|+.+|++.||.+|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000 00 00000001111223468899999999999999999999873
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-35 Score=328.51 Aligned_cols=266 Identities=21% Similarity=0.270 Sum_probs=190.8
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-----------CCceeeEEeEE
Q 002238 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-----------HRHLVALLGHC 660 (948)
Q Consensus 593 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~ 660 (948)
.+|++.++||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|+.+++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 35999999999999999999874 7999999999753 333467788999988875 57899999887
Q ss_pred Ee--CCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCC--
Q 002238 661 LD--GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-- 736 (948)
Q Consensus 661 ~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~-- 736 (948)
.. ....+++|+++..+........ ......+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETT
T ss_pred eeccccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcc
Confidence 64 3456777777766554433322 2334678889999999999999999997 47899999999999998655
Q ss_pred ----CeEEeecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhh---
Q 002238 737 ----RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVILMELITGRKALDESQPEESM--- 809 (948)
Q Consensus 737 ----~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~elltg~~p~~~~~~~~~~--- 809 (948)
.++++|||.++..... .....||+.|+|||++....++.++||||+||+++||++|+.||.........
T Consensus 166 ~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 3999999999865432 23457999999999999999999999999999999999999999754322111
Q ss_pred -hHHHHHHHhhcC----------------ccccccccCccc---------CCccchHHHHHHHHHHHHHhcccCCCCCCC
Q 002238 810 -HLVTWFRRIHLS----------------KDSFHKAIDPTI---------DLNEGILASISTVAELAGHCCAREPYQRPD 863 (948)
Q Consensus 810 -~~~~~~~~~~~~----------------~~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~c~~~~P~~RPt 863 (948)
.....+...... .......+.... ...........++.+|+.+|+..||.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 111111110000 000000000000 001122345667899999999999999999
Q ss_pred hHHHHH
Q 002238 864 MGHAVN 869 (948)
Q Consensus 864 ~~ev~~ 869 (948)
++|+++
T Consensus 322 a~e~L~ 327 (362)
T d1q8ya_ 322 AGGLVN 327 (362)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 999865
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=7.3e-30 Score=277.24 Aligned_cols=235 Identities=26% Similarity=0.440 Sum_probs=174.2
Q ss_pred CccccCCCCCCEEEccC-CCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCc
Q 002238 132 SDFFTGLSSLQSIEIDN-NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASF 210 (948)
Q Consensus 132 ~~~~~~l~~L~~L~Ls~-N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 210 (948)
|..+++|++|++|+|++ |++++ .+|..++++++|++|+|++|++.+..+..+. .++.|+++++++|++.+.+|..+
T Consensus 69 p~~l~~L~~L~~L~Ls~~N~l~g-~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~--~~~~L~~l~l~~N~~~~~~p~~l 145 (313)
T d1ogqa_ 69 PSSLANLPYLNFLYIGGINNLVG-PIPPAIAKLTQLHYLYITHTNVSGAIPDFLS--QIKTLVTLDFSYNALSGTLPPSI 145 (313)
T ss_dssp CGGGGGCTTCSEEEEEEETTEES-CCCGGGGGCTTCSEEEEEEECCEEECCGGGG--GCTTCCEEECCSSEEESCCCGGG
T ss_pred ChHHhcCcccccccccccccccc-ccccccccccccchhhhcccccccccccccc--chhhhcccccccccccccCchhh
Confidence 34445555555555543 44444 4555555555555555555566555555554 56667777777776666666554
Q ss_pred ccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCCC-CCCCCCC-cEEeccCCccccccchhhhCCCC
Q 002238 211 SGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQL-ESLSLRDNFFTGPVPDSLVKLES 288 (948)
Q Consensus 211 ~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L-~~L~L~~N~l~~~~p~~l~~l~~ 288 (948)
.+++.|+.+++++|.+++.+|. +..+..+ +.+++++|++++..|..+..+..
T Consensus 146 --------------------------~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~ 199 (313)
T d1ogqa_ 146 --------------------------SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL 199 (313)
T ss_dssp --------------------------GGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC
T ss_pred --------------------------ccCcccceeecccccccccccccccccccccccccccccccccccccccccccc
Confidence 3567777777777777766653 5555554 88999999999999999988855
Q ss_pred CcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeec
Q 002238 289 LKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCT 368 (948)
Q Consensus 289 L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (948)
..+++++|.+.|.+|... ..
T Consensus 200 -~~l~l~~~~~~~~~~~~~-----------------------------------------------------------~~ 219 (313)
T d1ogqa_ 200 -AFVDLSRNMLEGDASVLF-----------------------------------------------------------GS 219 (313)
T ss_dssp -SEEECCSSEEEECCGGGC-----------------------------------------------------------CT
T ss_pred -cccccccccccccccccc-----------------------------------------------------------cc
Confidence 479999999998877521 12
Q ss_pred CCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCCCCC---ccccccc
Q 002238 369 KGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFK---SNAIVNT 445 (948)
Q Consensus 369 ~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~~~---~~~~~~~ 445 (948)
+.+++.+++++|.+.+.+| .++.+++|+.|+|++|+|+|.+|..|+.+++|++|||++|+|+|.||++. ....+.+
T Consensus 220 ~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l 298 (313)
T d1ogqa_ 220 DKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298 (313)
T ss_dssp TSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGT
T ss_pred ccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHh
Confidence 3478899999999998766 68999999999999999999999999999999999999999999999853 4557789
Q ss_pred CCCCCCCCccC
Q 002238 446 DGNPDIGKEKS 456 (948)
Q Consensus 446 ~gnp~~~~~~~ 456 (948)
.||+.+|+.|.
T Consensus 299 ~~N~~l~g~pl 309 (313)
T d1ogqa_ 299 ANNKCLCGSPL 309 (313)
T ss_dssp CSSSEEESTTS
T ss_pred CCCccccCCCC
Confidence 99998887653
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=1e-24 Score=235.41 Aligned_cols=269 Identities=20% Similarity=0.286 Sum_probs=212.0
Q ss_pred CCccceEEeCCCCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccc
Q 002238 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFF 135 (948)
Q Consensus 57 C~w~gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~ 135 (948)
|.|.+|.|. +++++ .+|..+. ++|++|+|++|+|+.+++ +|.++++|++|++++|.+..++|..|
T Consensus 10 c~~~~~~C~-----------~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f 75 (305)
T d1xkua_ 10 CHLRVVQCS-----------DLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75 (305)
T ss_dssp EETTEEECT-----------TSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTT
T ss_pred ecCCEEEec-----------CCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhh
Confidence 456666664 45677 7777764 689999999999999887 69999999999999999999999999
Q ss_pred cCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccc
Q 002238 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQI 215 (948)
Q Consensus 136 ~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l 215 (948)
.++++|+.|+|++|+++ .+|..+ ...|..|++.+|.+.+..+..+. ....+..++...|........
T Consensus 76 ~~l~~L~~L~l~~n~l~--~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~--~~~~~~~l~~~~n~~~~~~~~------- 142 (305)
T d1xkua_ 76 APLVKLERLYLSKNQLK--ELPEKM--PKTLQELRVHENEITKVRKSVFN--GLNQMIVVELGTNPLKSSGIE------- 142 (305)
T ss_dssp TTCTTCCEEECCSSCCS--BCCSSC--CTTCCEEECCSSCCCBBCHHHHT--TCTTCCEEECCSSCCCGGGBC-------
T ss_pred hCCCccCEecccCCccC--cCccch--hhhhhhhhccccchhhhhhhhhh--ccccccccccccccccccCCC-------
Confidence 99999999999999998 566543 45788999999999877666665 667788888888765422111
Q ss_pred cceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcc
Q 002238 216 QSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 295 (948)
Q Consensus 216 ~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 295 (948)
...+..+++|+.+++++|.++.....+ +++|+.|++++|.+++..+..+.+++.++.|+++
T Consensus 143 -----------------~~~~~~l~~L~~l~l~~n~l~~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s 203 (305)
T d1xkua_ 143 -----------------NGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 203 (305)
T ss_dssp -----------------TTGGGGCTTCCEEECCSSCCCSCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECC
T ss_pred -----------------ccccccccccCccccccCCccccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccc
Confidence 122557889999999999988543333 5789999999999998889999999999999999
Q ss_pred cCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEE
Q 002238 296 NNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVI 375 (948)
Q Consensus 296 ~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L 375 (948)
+|.+++..+. .+..+++|+.|
T Consensus 204 ~n~l~~~~~~-----------------------------------------------------------~~~~l~~L~~L 224 (305)
T d1xkua_ 204 FNSISAVDNG-----------------------------------------------------------SLANTPHLREL 224 (305)
T ss_dssp SSCCCEECTT-----------------------------------------------------------TGGGSTTCCEE
T ss_pred cccccccccc-----------------------------------------------------------cccccccceee
Confidence 9999876553 11234578889
Q ss_pred EccCCcccccCCccccCccccceEeCccccccccCCcC------CcCCCCCcEEEccCCccc
Q 002238 376 NFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEG------LSVLGALKELDVSNNQLY 431 (948)
Q Consensus 376 ~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~------l~~l~~L~~L~ls~N~l~ 431 (948)
+|++|+|+ .+|..|.++++|++|+|++|+|+..-... +..+.+|+.|+|++|++.
T Consensus 225 ~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 225 HLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp ECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred eccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 99999887 56888888999999999999988432222 345677888888888875
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.93 E-value=6.9e-25 Score=244.90 Aligned_cols=338 Identities=19% Similarity=0.242 Sum_probs=182.3
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEcc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 147 (948)
.++++|++++++++. + +.+..+++|++|+|++|+|++.. .+.++++|++|+|++|+++++++ ++.+++|+.|+++
T Consensus 44 ~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~-~l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~~ 118 (384)
T d2omza2 44 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT-PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 118 (384)
T ss_dssp TTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred CCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCc-cccCCcccccccccccccccccc--ccccccccccccc
Confidence 578999999998884 3 46788899999999999998765 48889999999999999988764 8899999999999
Q ss_pred CCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCC
Q 002238 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNA 227 (948)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~ 227 (948)
+|.+++ + ........+..+....|.+....+.... ..............+...... . .........
T Consensus 119 ~~~~~~--~-~~~~~~~~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~-----~--~~~~~~~~~-- 184 (384)
T d2omza2 119 NNQITD--I-DPLKNLTNLNRLELSSNTISDISALSGL--TSLQQLSFGNQVTDLKPLANL-----T--TLERLDISS-- 184 (384)
T ss_dssp SSCCCC--C-GGGTTCTTCSEEEEEEEEECCCGGGTTC--TTCSEEEEEESCCCCGGGTTC-----T--TCCEEECCS--
T ss_pred cccccc--c-cccccccccccccccccccccccccccc--ccccccccccccchhhhhccc-----c--ccccccccc--
Confidence 998885 2 2344556677777777766544332221 111111111111111100000 0 000000000
Q ss_pred ccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCC
Q 002238 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFD 307 (948)
Q Consensus 228 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~ 307 (948)
........+..++++..+++++|.+++..+ +...++|+.|++++|.++. +| .+..+++|+.|++++|.+++..+ +.
T Consensus 185 ~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~-~~~~~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~-~~ 260 (384)
T d2omza2 185 NKVSDISVLAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKD-IG-TLASLTNLTDLDLANNQISNLAP-LS 260 (384)
T ss_dssp SCCCCCGGGGGCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCGG-GT
T ss_pred cccccccccccccccceeeccCCccCCCCc-ccccCCCCEEECCCCCCCC-cc-hhhcccccchhccccCccCCCCc-cc
Confidence 000111222333444444444444443222 2223344444444444441 21 23344444444444444443221 23
Q ss_pred CccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCC
Q 002238 308 RSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTIS 387 (948)
Q Consensus 308 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip 387 (948)
.+.+|..++..++.+..++.. ..........+..+. -.....+..+++++.|++++|++++..
T Consensus 261 ~~~~L~~L~l~~~~l~~~~~~--------------~~~~~l~~l~~~~n~--l~~~~~~~~~~~l~~L~ls~n~l~~l~- 323 (384)
T d2omza2 261 GLTKLTELKLGANQISNISPL--------------AGLTALTNLELNENQ--LEDISPISNLKNLTYLTLYFNNISDIS- 323 (384)
T ss_dssp TCTTCSEEECCSSCCCCCGGG--------------TTCTTCSEEECCSSC--CSCCGGGGGCTTCSEEECCSSCCSCCG-
T ss_pred ccccCCEeeccCcccCCCCcc--------------ccccccccccccccc--cccccccchhcccCeEECCCCCCCCCc-
Confidence 333333333333322211100 000000000000000 011122445668889999999998753
Q ss_pred ccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCC--CCCcccccccCCC
Q 002238 388 PEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP--SFKSNAIVNTDGN 448 (948)
Q Consensus 388 ~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip--~~~~~~~~~~~gn 448 (948)
.+..+++|++|+|++|+|++ +| .+..+++|++|++++|+|++.+| .+.....+.+++|
T Consensus 324 -~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 324 -PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp -GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred -ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCCCC
Confidence 38888999999999999874 44 68889999999999999987654 3344556666665
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.6e-24 Score=230.98 Aligned_cols=276 Identities=20% Similarity=0.300 Sum_probs=203.5
Q ss_pred ceEEeCCCCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCC
Q 002238 61 HVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLS 139 (948)
Q Consensus 61 gv~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 139 (948)
+-.|..... ..++.++++++ .+|..+. +.+++|+|++|+|+.+++ .|.++++|++|++++|++..+++..+.+++
T Consensus 5 ~C~C~~~~~-~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~ 80 (284)
T d1ozna_ 5 ACVCYNEPK-VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLA 80 (284)
T ss_dssp TCEEECSSS-CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred CCEEcCCCC-eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccc
Confidence 445644333 33467778888 7777664 678999999999998777 689999999999999999999999999999
Q ss_pred CCCEEEcc-CCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccce
Q 002238 140 SLQSIEID-NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSL 218 (948)
Q Consensus 140 ~L~~L~Ls-~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l 218 (948)
.++.++.. .|.++. ..|..+.++++|++|++++|.+....+..+. .+++|+.+++++|++++..+..|
T Consensus 81 ~~~~l~~~~~~~~~~-l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~--~~~~L~~l~l~~N~l~~i~~~~f-------- 149 (284)
T d1ozna_ 81 LLEQLDLSDNAQLRS-VDPATFHGLGRLHTLHLDRCGLQELGPGLFR--GLAALQYLYLQDNALQALPDDTF-------- 149 (284)
T ss_dssp TCCEEECCSCTTCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTT--TCTTCCEEECCSSCCCCCCTTTT--------
T ss_pred ccccccccccccccc-ccchhhcccccCCEEecCCcccccccccccc--hhcccchhhhccccccccChhHh--------
Confidence 99998875 555664 3477788899999999999999877777776 78889999999999986555554
Q ss_pred eccCCCCCCccCCCccccccCCCccEEEccCCcccccCC-CCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccC
Q 002238 219 WVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297 (948)
Q Consensus 219 ~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 297 (948)
..+++|+.|+|++|++++.++ .|.++++|+.+++++|++++..|..|.++++|++|++++|
T Consensus 150 ------------------~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N 211 (284)
T d1ozna_ 150 ------------------RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211 (284)
T ss_dssp ------------------TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred ------------------ccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccc
Confidence 367788888888888887665 4777888888888888888877888888888888888888
Q ss_pred cccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEc
Q 002238 298 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINF 377 (948)
Q Consensus 298 ~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l 377 (948)
++.+.+|. .+..+.+|+.|+|
T Consensus 212 ~i~~~~~~-----------------------------------------------------------~~~~~~~L~~L~l 232 (284)
T d1ozna_ 212 NLSALPTE-----------------------------------------------------------ALAPLRALQYLRL 232 (284)
T ss_dssp CCSCCCHH-----------------------------------------------------------HHTTCTTCCEEEC
T ss_pred cccccccc-----------------------------------------------------------ccccccccCEEEe
Confidence 88765442 1112346677777
Q ss_pred cCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccC
Q 002238 378 QKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYG 432 (948)
Q Consensus 378 s~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g 432 (948)
++|.+...-+. -.-...++.+....+++....|..+.+ +..++++.+.|+|
T Consensus 233 ~~N~l~C~C~~-~~l~~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g 283 (284)
T d1ozna_ 233 NDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283 (284)
T ss_dssp CSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred cCCCCCCCccc-hHHHHHHHhCcCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence 77777653321 111234566666677777667766653 3455566666665
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.91 E-value=2.1e-23 Score=224.86 Aligned_cols=270 Identities=19% Similarity=0.215 Sum_probs=218.0
Q ss_pred CCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEcc
Q 002238 93 KLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSAN 172 (948)
Q Consensus 93 ~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~ 172 (948)
.++.+|-++++++.+++.+. +.|++|+|++|+|+.+++..|.++++|++|++++|.+.. ..|..|.++++|+.|+++
T Consensus 11 ~~~~~~C~~~~L~~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~-i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK-ISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCCSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCCccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccc-cchhhhhCCCccCEeccc
Confidence 56788999999997766664 689999999999999999999999999999999999995 447789999999999999
Q ss_pred CccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcc
Q 002238 173 SANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAF 252 (948)
Q Consensus 173 ~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l 252 (948)
+|+++.. |..+ .+.|..|++++|.+.+..+..+ .....+..++...|..
T Consensus 88 ~n~l~~l-~~~~----~~~l~~L~~~~n~l~~l~~~~~--------------------------~~~~~~~~l~~~~n~~ 136 (305)
T d1xkua_ 88 KNQLKEL-PEKM----PKTLQELRVHENEITKVRKSVF--------------------------NGLNQMIVVELGTNPL 136 (305)
T ss_dssp SSCCSBC-CSSC----CTTCCEEECCSSCCCBBCHHHH--------------------------TTCTTCCEEECCSSCC
T ss_pred CCccCcC-ccch----hhhhhhhhccccchhhhhhhhh--------------------------hccccccccccccccc
Confidence 9999854 4433 4689999999999885444332 3566778888888866
Q ss_pred ccc--CC-CCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCC
Q 002238 253 SGP--LP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGAC 329 (948)
Q Consensus 253 ~~~--~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~ 329 (948)
... .+ .+..+++|+.+++++|.++ .+|..+ +++|+.|++++|..++..+.
T Consensus 137 ~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~------------------------ 189 (305)
T d1xkua_ 137 KSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAA------------------------ 189 (305)
T ss_dssp CGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTG------------------------
T ss_pred cccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChh------------------------
Confidence 542 22 4777899999999999998 677654 68999999999998876553
Q ss_pred chhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCcccccccc
Q 002238 330 DPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGM 409 (948)
Q Consensus 330 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ 409 (948)
.+..+..++.|++++|.+.+..+..|.++++|++|+|++|+|+ .
T Consensus 190 -----------------------------------~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~ 233 (305)
T d1xkua_ 190 -----------------------------------SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-K 233 (305)
T ss_dssp -----------------------------------GGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-S
T ss_pred -----------------------------------Hhhccccccccccccccccccccccccccccceeeeccccccc-c
Confidence 1123347889999999999999999999999999999999998 7
Q ss_pred CCcCCcCCCCCcEEEccCCcccCCCC----------CCCcccccccCCCCCCC-CccCCCC
Q 002238 410 IPEGLSVLGALKELDVSNNQLYGKIP----------SFKSNAIVNTDGNPDIG-KEKSSSF 459 (948)
Q Consensus 410 ip~~l~~l~~L~~L~ls~N~l~g~ip----------~~~~~~~~~~~gnp~~~-~~~~~~~ 459 (948)
+|.+|..+++|++|+|++|+|+..-. .......+.++|||+.+ ..++..|
T Consensus 234 lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f 294 (305)
T d1xkua_ 234 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTF 294 (305)
T ss_dssp CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGG
T ss_pred cccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHh
Confidence 89999999999999999999985321 12345577899999864 3444443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=1.3e-22 Score=213.69 Aligned_cols=202 Identities=17% Similarity=0.196 Sum_probs=178.4
Q ss_pred EEeCCCCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCC
Q 002238 63 VCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSL 141 (948)
Q Consensus 63 ~c~~~~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 141 (948)
.|.......+++.++++|+ .+|+.+. ++|++|+|++|+|+++++ .|.++++|++|+|++|+|+.+++ ++.+++|
T Consensus 5 ~~~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~--~~~l~~L 79 (266)
T d1p9ag_ 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVL 79 (266)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTC
T ss_pred EEcccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc--ccccccc
Confidence 3555566677899999999 6787775 589999999999998776 69999999999999999998754 6789999
Q ss_pred CEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceecc
Q 002238 142 QSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVN 221 (948)
Q Consensus 142 ~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~ 221 (948)
++|+|++|+++ .++..+.++++|+.|++++|.+....+..+. .+.+|++|++++|.++...+..+
T Consensus 80 ~~L~Ls~N~l~--~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~--~l~~l~~L~l~~n~l~~l~~~~~----------- 144 (266)
T d1p9ag_ 80 GTLDLSHNQLQ--SLPLLGQTLPALTVLDVSFNRLTSLPLGALR--GLGELQELYLKGNELKTLPPGLL----------- 144 (266)
T ss_dssp CEEECCSSCCS--SCCCCTTTCTTCCEEECCSSCCCCCCSSTTT--TCTTCCEEECTTSCCCCCCTTTT-----------
T ss_pred ccccccccccc--ccccccccccccccccccccccceeeccccc--cccccccccccccccceeccccc-----------
Confidence 99999999998 5688899999999999999999988888876 89999999999999986555443
Q ss_pred CCCCCCccCCCccccccCCCccEEEccCCcccccCCC-CCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCccc
Q 002238 222 GQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ 300 (948)
Q Consensus 222 ~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 300 (948)
..+++|+.|++++|++++.++. |..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus 145 ---------------~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 145 ---------------TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp ---------------TTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ---------------cccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 4789999999999999987774 788999999999999999 89999999999999999999885
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.89 E-value=2.5e-22 Score=223.85 Aligned_cols=279 Identities=23% Similarity=0.311 Sum_probs=189.4
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEcc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 147 (948)
.++++|+|++|+|++. + .+.++++|++|+|++|.|.+.. .+.++++|+.|++++|.+++..+. .....+..+...
T Consensus 66 ~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i~-~l~~l~~L~~L~~~~~~~~~~~~~--~~~~~~~~~~~~ 140 (384)
T d2omza2 66 NNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADIT-PLANLTNLTGLTLFNNQITDIDPL--KNLTNLNRLELS 140 (384)
T ss_dssp TTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCCGGG--TTCTTCSEEEEE
T ss_pred CCCCEEeCcCCcCCCC-c-cccCCccccccccccccccccc-cccccccccccccccccccccccc--cccccccccccc
Confidence 5899999999999954 4 3999999999999999999754 488999999999999999886653 344556666555
Q ss_pred CCCCCCC----------------------------------------CCCccccCCCCCCEEEccCccccccCCCCCCCC
Q 002238 148 NNPFSSW----------------------------------------EIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187 (948)
Q Consensus 148 ~N~l~~~----------------------------------------~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~ 187 (948)
.|.+... .....+..+++++.+++++|.+++..|..
T Consensus 141 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~~~---- 216 (384)
T d2omza2 141 SNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG---- 216 (384)
T ss_dssp EEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGGGG----
T ss_pred cccccccccccccccccccccccccchhhhhccccccccccccccccccccccccccccceeeccCCccCCCCccc----
Confidence 5544321 11233344445555555555555443321
Q ss_pred CCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcE
Q 002238 188 EFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLES 267 (948)
Q Consensus 188 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~ 267 (948)
.+++|+.|++++|+++. + +.+..+++|+.|++++|.+++.. .+..+++|+.
T Consensus 217 ~~~~L~~L~l~~n~l~~-~---------------------------~~l~~l~~L~~L~l~~n~l~~~~-~~~~~~~L~~ 267 (384)
T d2omza2 217 ILTNLDELSLNGNQLKD-I---------------------------GTLASLTNLTDLDLANNQISNLA-PLSGLTKLTE 267 (384)
T ss_dssp GCTTCCEEECCSSCCCC-C---------------------------GGGGGCTTCSEEECCSSCCCCCG-GGTTCTTCSE
T ss_pred ccCCCCEEECCCCCCCC-c---------------------------chhhcccccchhccccCccCCCC-cccccccCCE
Confidence 23445555555555442 1 22456677777777777776543 3666677777
Q ss_pred EeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcc
Q 002238 268 LSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQ 347 (948)
Q Consensus 268 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 347 (948)
|++++|++++..+ +..++.++.+++++|.+++ ++.+..+..+..++...|.+..++
T Consensus 268 L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~-~~~~~~~~~l~~L~ls~n~l~~l~--------------------- 323 (384)
T d2omza2 268 LKLGANQISNISP--LAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNISDIS--------------------- 323 (384)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEECCSSCCSC-CGGGGGCTTCSEEECCSSCCSCCG---------------------
T ss_pred eeccCcccCCCCc--ccccccccccccccccccc-ccccchhcccCeEECCCCCCCCCc---------------------
Confidence 7777777764332 5667777777777777765 233444445555554444332221
Q ss_pred hhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccC
Q 002238 348 RFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSN 427 (948)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~ 427 (948)
.+..+++|+.|++++|++++ ++ .|+++++|++|+|++|+|++..| +.++++|++|+|++
T Consensus 324 -----------------~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~ 382 (384)
T d2omza2 324 -----------------PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382 (384)
T ss_dssp -----------------GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCC
T ss_pred -----------------ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCC
Confidence 13356799999999999985 44 69999999999999999997655 89999999999999
Q ss_pred Cc
Q 002238 428 NQ 429 (948)
Q Consensus 428 N~ 429 (948)
|.
T Consensus 383 Na 384 (384)
T d2omza2 383 QA 384 (384)
T ss_dssp EE
T ss_pred Cc
Confidence 84
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=2.8e-22 Score=213.51 Aligned_cols=223 Identities=18% Similarity=0.232 Sum_probs=126.5
Q ss_pred EEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEcc-Cc
Q 002238 96 RLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSAN-SA 174 (948)
Q Consensus 96 ~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~-~n 174 (948)
.++.++++++.++..+. +.+++|+|++|+|+++++.+|.++++|++|++++|++.. ..+..+.++..+..+... .|
T Consensus 15 ~v~c~~~~L~~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~-i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR-IDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCSSCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCCccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccc-ccccccccccccccccccccc
Confidence 45666666665433333 456777777777777777777777777777777776664 223344444444444432 33
Q ss_pred cccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcccc
Q 002238 175 NITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG 254 (948)
Q Consensus 175 ~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~ 254 (948)
.++...+..|. . +++|++|+|++|.+..
T Consensus 92 ~~~~l~~~~~~--~--------------------------------------------------l~~L~~L~l~~n~~~~ 119 (284)
T d1ozna_ 92 QLRSVDPATFH--G--------------------------------------------------LGRLHTLHLDRCGLQE 119 (284)
T ss_dssp TCCCCCTTTTT--T--------------------------------------------------CTTCCEEECTTSCCCC
T ss_pred ccccccchhhc--c--------------------------------------------------cccCCEEecCCccccc
Confidence 33333344443 4 4455555555555444
Q ss_pred cCC-CCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhh
Q 002238 255 PLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRL 333 (948)
Q Consensus 255 ~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 333 (948)
..+ .+....+|+.+++++|+|++..+..|..+++|++|+|++|++++..+.
T Consensus 120 ~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~---------------------------- 171 (284)
T d1ozna_ 120 LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER---------------------------- 171 (284)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT----------------------------
T ss_pred ccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh----------------------------
Confidence 333 234455555555555555544445555555566666666655543332
Q ss_pred hhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCCcC
Q 002238 334 NALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEG 413 (948)
Q Consensus 334 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~ 413 (948)
.+..+++|+.+++++|++++..|..|.++++|++|++++|++.+..|..
T Consensus 172 -------------------------------~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~ 220 (284)
T d1ozna_ 172 -------------------------------AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEA 220 (284)
T ss_dssp -------------------------------TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHH
T ss_pred -------------------------------hhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccc
Confidence 1112234555566666666666666777777777777777777666666
Q ss_pred CcCCCCCcEEEccCCcccC
Q 002238 414 LSVLGALKELDVSNNQLYG 432 (948)
Q Consensus 414 l~~l~~L~~L~ls~N~l~g 432 (948)
|..+++|++|+|++|++.+
T Consensus 221 ~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 221 LAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp HTTCTTCCEEECCSSCEEC
T ss_pred cccccccCEEEecCCCCCC
Confidence 7777777777777666654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=5.8e-22 Score=208.60 Aligned_cols=198 Identities=18% Similarity=0.160 Sum_probs=117.0
Q ss_pred CCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccce
Q 002238 139 SSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSL 218 (948)
Q Consensus 139 ~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l 218 (948)
..+.+.+.+++.++ .+|..+. ++|++|+|++|+|++..+..|. .+++|++|+|++|+|+. +|.
T Consensus 10 ~~~~~v~C~~~~L~--~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~--~l~~L~~L~L~~N~l~~-l~~---------- 72 (266)
T d1p9ag_ 10 ASHLEVNCDKRNLT--ALPPDLP--KDTTILHLSENLLYTFSLATLM--PYTRLTQLNLDRAELTK-LQV---------- 72 (266)
T ss_dssp TTCCEEECTTSCCS--SCCSCCC--TTCCEEECTTSCCSEEEGGGGT--TCTTCCEEECTTSCCCE-EEC----------
T ss_pred CCCeEEEccCCCCC--eeCcCcC--cCCCEEECcCCcCCCcCHHHhh--ccccccccccccccccc-ccc----------
Confidence 33444444444444 3343332 2444555555555444444444 55555556665555542 221
Q ss_pred eccCCCCCCccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCc
Q 002238 219 WVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 298 (948)
Q Consensus 219 ~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 298 (948)
++.+++|++|+|++|++++..+.+.++++|+.|++++|.+.+..+..+..+.+++.|++++|.
T Consensus 73 -----------------~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~ 135 (266)
T d1p9ag_ 73 -----------------DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135 (266)
T ss_dssp -----------------CSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSC
T ss_pred -----------------ccccccccccccccccccccccccccccccccccccccccceeeccccccccccccccccccc
Confidence 123556666666666666555556666666666666666665556666666677777777776
Q ss_pred ccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEcc
Q 002238 299 LQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQ 378 (948)
Q Consensus 299 l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls 378 (948)
+++..+.. +..+++++.|+++
T Consensus 136 l~~l~~~~-----------------------------------------------------------~~~l~~l~~l~l~ 156 (266)
T d1p9ag_ 136 LKTLPPGL-----------------------------------------------------------LTPTPKLEKLSLA 156 (266)
T ss_dssp CCCCCTTT-----------------------------------------------------------TTTCTTCCEEECT
T ss_pred cceecccc-----------------------------------------------------------ccccccchhcccc
Confidence 66443321 1122356666666
Q ss_pred CCcccccCCccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcc
Q 002238 379 KMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430 (948)
Q Consensus 379 ~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l 430 (948)
+|++++..+..|..+++|++|+|++|+|+ .+|.++..+++|+.|+|++|++
T Consensus 157 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 157 NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp TSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred cccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence 66666666667778888888888888888 7888887788887777765543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=4.2e-23 Score=205.62 Aligned_cols=171 Identities=15% Similarity=0.114 Sum_probs=121.5
Q ss_pred cccceecccCceEEEEEEEcCCcEEEEEEeecCcCC----------------hhhHHHHHHHHHHHHhcCCCceeeEEeE
Q 002238 596 SEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS----------------GKGLTEFKSEIAVLTKVRHRHLVALLGH 659 (948)
Q Consensus 596 ~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~H~niv~l~~~ 659 (948)
.+.++||+|+||.||+|+..+|+.||||+++..... ........+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 467899999999999999888999999987542111 0112345678999999999999988755
Q ss_pred EEeCCceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCccEEEcCCCCeE
Q 002238 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 739 (948)
Q Consensus 660 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik~~Nill~~~~~~k 739 (948)
. ..++||||++++.+.+ ++......++.|++++++|||+ .+|+||||||+|||++++ .++
T Consensus 83 ~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp E----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEE
T ss_pred c----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEE
Confidence 3 2379999998866532 2223356789999999999997 899999999999999965 589
Q ss_pred EeecCCceecCCCCCceeeeecccccccCceecccCCCCchhhHHHHHHHH
Q 002238 740 VADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVFSFGVIL 790 (948)
Q Consensus 740 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l 790 (948)
|+|||+|+.......... .......+ .| +..+.|+.++|+||..--+
T Consensus 143 liDFG~a~~~~~~~~~~~--l~rd~~~~-~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWREI--LERDVRNI-IT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHHHH--HHHHHHHH-HH-HHHHHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCcHHH--HHHHHHHH-HH-HHcCCCCCcccHHHHHHHH
Confidence 999999986644321100 00000000 01 1246788899999976443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.79 E-value=1.6e-17 Score=181.93 Aligned_cols=303 Identities=20% Similarity=0.254 Sum_probs=165.6
Q ss_pred CEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccC
Q 002238 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148 (948)
Q Consensus 69 ~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 148 (948)
++++|+|++++|+ .+|+. +++|++|+|++|+|+.++.. +.+|+.|++++|+++.+.. -.+.|++|+|++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~l~~n~l~~l~~----lp~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLKALSD----LPPLLEYLGVSN 107 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCSCCCS----CCTTCCEEECCS
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcccccc---hhhhhhhhhhhcccchhhh----hccccccccccc
Confidence 6778999999998 57764 46789999999999865333 4578999999999887542 124699999999
Q ss_pred CCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCccc-ccccceeccCCCCCC
Q 002238 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNA 227 (948)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~~~~~~~~~ 227 (948)
|.++ .+|. +..+++|+.|++++|.+..... ....+..|.+..+..... ..+.. ..++.+.+..+....
T Consensus 108 n~l~--~lp~-~~~l~~L~~L~l~~~~~~~~~~------~~~~l~~l~~~~~~~~~~--~~l~~l~~l~~L~l~~n~~~~ 176 (353)
T d1jl5a_ 108 NQLE--KLPE-LQNSSFLKIIDVDNNSLKKLPD------LPPSLEFIAAGNNQLEEL--PELQNLPFLTAIYADNNSLKK 176 (353)
T ss_dssp SCCS--SCCC-CTTCTTCCEEECCSSCCSCCCC------CCTTCCEEECCSSCCSSC--CCCTTCTTCCEEECCSSCCSS
T ss_pred cccc--cccc-hhhhccceeecccccccccccc------ccccccchhhcccccccc--ccccccccceecccccccccc
Confidence 9998 5664 5788999999999988875432 234566777766654421 11111 122222222211111
Q ss_pred ccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCC
Q 002238 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFD 307 (948)
Q Consensus 228 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~ 307 (948)
.. ........+.+.++.+. .++.+..++.|+.+++++|... .+|.. ..++..+.+.+|.+........
T Consensus 177 ~~-------~~~~~~~~l~~~~~~~~-~~~~~~~l~~L~~l~l~~n~~~-~~~~~---~~~l~~~~~~~~~~~~~~~~~~ 244 (353)
T d1jl5a_ 177 LP-------DLPLSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLK-TLPDL---PPSLEALNVRDNYLTDLPELPQ 244 (353)
T ss_dssp CC-------CCCTTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSSCCS-SCCSC---CTTCCEEECCSSCCSCCCCCCT
T ss_pred cc-------ccccccccccccccccc-cccccccccccccccccccccc-ccccc---cccccccccccccccccccccc
Confidence 00 01112233333333332 2333444555555555555544 23321 2344555555555443222211
Q ss_pred CccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCC
Q 002238 308 RSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTIS 387 (948)
Q Consensus 308 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip 387 (948)
.+..........+.+...+... .... .......+.....++|+.|+|++|+++ .+|
T Consensus 245 ~l~~~~~~~~~~~~l~~l~~~~-------------------~~~~----~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp 300 (353)
T d1jl5a_ 245 SLTFLDVSENIFSGLSELPPNL-------------------YYLN----ASSNEIRSLCDLPPSLEELNVSNNKLI-ELP 300 (353)
T ss_dssp TCCEEECCSSCCSEESCCCTTC-------------------CEEE----CCSSCCSEECCCCTTCCEEECCSSCCS-CCC
T ss_pred cccccccccccccccccccchh-------------------cccc----cccCccccccccCCCCCEEECCCCccC-ccc
Confidence 1111111111000000000000 0000 000111122233567888888888887 566
Q ss_pred ccccCccccceEeCccccccccCCcCCcCCCCCcEEEccCCcccCCCCCC
Q 002238 388 PEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSF 437 (948)
Q Consensus 388 ~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ip~~ 437 (948)
.. +++|+.|+|++|+|+ .+|.. +++|++|+|++|+|+ .+|.+
T Consensus 301 ~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~ 342 (353)
T d1jl5a_ 301 AL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDI 342 (353)
T ss_dssp CC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCC
T ss_pred cc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCcc
Confidence 43 567888888888887 67753 457888888888887 45544
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=5e-18 Score=173.63 Aligned_cols=80 Identities=18% Similarity=0.334 Sum_probs=34.9
Q ss_pred CCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEE
Q 002238 91 LTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFS 170 (948)
Q Consensus 91 l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ 170 (948)
+.+|+.|++.+|+|+.. +.+.++++|++|+|++|+++++.+ +..+++|+.|++++|.++. + ..+..+++|+.++
T Consensus 40 l~~L~~L~l~~~~i~~l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~--i-~~l~~l~~L~~l~ 113 (227)
T d1h6ua2 40 LDGITTLSAFGTGVTTI-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN--V-SAIAGLQSIKTLD 113 (227)
T ss_dssp HHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC--C-GGGTTCTTCCEEE
T ss_pred cCCcCEEECCCCCCCcc-hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc--c-ccccccccccccc
Confidence 44444444444444432 334444444444444444444332 4444444444444444442 1 1233444444444
Q ss_pred ccCccc
Q 002238 171 ANSANI 176 (948)
Q Consensus 171 l~~n~l 176 (948)
+++|..
T Consensus 114 l~~~~~ 119 (227)
T d1h6ua2 114 LTSTQI 119 (227)
T ss_dssp CTTSCC
T ss_pred cccccc
Confidence 444433
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.73 E-value=5.3e-16 Score=169.59 Aligned_cols=299 Identities=20% Similarity=0.199 Sum_probs=198.2
Q ss_pred CCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEc
Q 002238 92 TKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSA 171 (948)
Q Consensus 92 ~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l 171 (948)
.+|++|||++|.|+..+ .+ +++|++|+|++|+|+.++. .+.+|+.|++++|+++. ++.. .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~~lp-~~--~~~L~~L~Ls~N~l~~lp~----~~~~L~~L~l~~n~l~~--l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLSSLP-EL--PPHLESLVASCNSLTELPE----LPQSLKSLLVDNNNLKA--LSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCSCCC-SC--CTTCSEEECCSSCCSSCCC----CCTTCCEEECCSSCCSC--CCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCCCCC-CC--CCCCCEEECCCCCCccccc----chhhhhhhhhhhcccch--hhhh---ccccccccc
Confidence 46899999999998754 32 5789999999999997753 25689999999999984 4431 246999999
Q ss_pred cCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCc
Q 002238 172 NSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA 251 (948)
Q Consensus 172 ~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~ 251 (948)
++|.+.. +|. ++ .+++|++|++++|.+..... .. ..+..+.+...... ....+..++.++.|++++|.
T Consensus 106 ~~n~l~~-lp~-~~--~l~~L~~L~l~~~~~~~~~~-~~--~~l~~l~~~~~~~~-----~~~~l~~l~~l~~L~l~~n~ 173 (353)
T d1jl5a_ 106 SNNQLEK-LPE-LQ--NSSFLKIIDVDNNSLKKLPD-LP--PSLEFIAAGNNQLE-----ELPELQNLPFLTAIYADNNS 173 (353)
T ss_dssp CSSCCSS-CCC-CT--TCTTCCEEECCSSCCSCCCC-CC--TTCCEEECCSSCCS-----SCCCCTTCTTCCEEECCSSC
T ss_pred ccccccc-ccc-hh--hhccceeecccccccccccc-cc--ccccchhhcccccc-----ccccccccccceeccccccc
Confidence 9999985 454 34 78999999999999874433 32 23444444333222 22345678899999999999
Q ss_pred ccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCCCCCCCCCch
Q 002238 252 FSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDP 331 (948)
Q Consensus 252 l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~ 331 (948)
+...... ....+.+.+.++.+. .+|. +..++.|+.+++++|...........+..+.............+....
T Consensus 174 ~~~~~~~---~~~~~~l~~~~~~~~-~~~~-~~~l~~L~~l~l~~n~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~- 247 (353)
T d1jl5a_ 174 LKKLPDL---PLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLT- 247 (353)
T ss_dssp CSSCCCC---CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSSCCSCCTTCCEEECCSSCCSCCCCCCTTCC-
T ss_pred ccccccc---ccccccccccccccc-cccc-cccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence 8854332 234567777777776 5554 678999999999999887544333333333333222211111110000
Q ss_pred hhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEeCccccccccCC
Q 002238 332 RLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 411 (948)
Q Consensus 332 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip 411 (948)
. .....+ ...+...........+++.|.+.+. ...+++|++|+|++|+|+ .+|
T Consensus 248 ---~---------------~~~~~~----~~~~l~~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~lp 300 (353)
T d1jl5a_ 248 ---F---------------LDVSEN----IFSGLSELPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI-ELP 300 (353)
T ss_dssp ---E---------------EECCSS----CCSEESCCCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-CCC
T ss_pred ---c---------------cccccc----cccccccccchhcccccccCccccc----cccCCCCCEEECCCCccC-ccc
Confidence 0 000000 0000111113455667777776643 234678999999999998 788
Q ss_pred cCCcCCCCCcEEEccCCcccCCCCCC-CcccccccCCCCCC
Q 002238 412 EGLSVLGALKELDVSNNQLYGKIPSF-KSNAIVNTDGNPDI 451 (948)
Q Consensus 412 ~~l~~l~~L~~L~ls~N~l~g~ip~~-~~~~~~~~~gnp~~ 451 (948)
.. +++|+.|+|++|+|+ .+|.. .....+.+++|+..
T Consensus 301 ~~---~~~L~~L~L~~N~L~-~l~~~~~~L~~L~L~~N~L~ 337 (353)
T d1jl5a_ 301 AL---PPRLERLIASFNHLA-EVPELPQNLKQLHVEYNPLR 337 (353)
T ss_dssp CC---CTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCCS
T ss_pred cc---cCCCCEEECCCCcCC-ccccccCCCCEEECcCCcCC
Confidence 54 678999999999998 46654 45778999999854
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=1.2e-17 Score=168.29 Aligned_cols=179 Identities=18% Similarity=0.331 Sum_probs=130.2
Q ss_pred eCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCC
Q 002238 75 IGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSW 154 (948)
Q Consensus 75 l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 154 (948)
++.+++++.++. ..+.+|++|++++|.++.. +.+..+++|++|+|++|+|+++++ ++.+++|+.|++++|+++
T Consensus 31 l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~~l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~-- 103 (210)
T d1h6ta2 31 LKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-- 103 (210)
T ss_dssp TTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC--
T ss_pred hCcCccCCccCH--HHhcCccEEECcCCCCCCc-hhHhhCCCCCEEeCCCccccCccc--cccCcccccccccccccc--
Confidence 344444444332 2456778888888887764 347778888888888888887654 677888888888888887
Q ss_pred CCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCcc
Q 002238 155 EIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGID 234 (948)
Q Consensus 155 ~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~ 234 (948)
.+| .+..+++|+.|++++|.+... + .+. .++.|+.+++++|.+++..+
T Consensus 104 ~l~-~l~~l~~L~~L~l~~~~~~~~-~-~l~--~l~~l~~l~~~~n~l~~~~~--------------------------- 151 (210)
T d1h6ta2 104 DLS-SLKDLKKLKSLSLEHNGISDI-N-GLV--HLPQLESLYLGNNKITDITV--------------------------- 151 (210)
T ss_dssp CGG-GGTTCTTCCEEECTTSCCCCC-G-GGG--GCTTCCEEECCSSCCCCCGG---------------------------
T ss_pred ccc-ccccccccccccccccccccc-c-ccc--cccccccccccccccccccc---------------------------
Confidence 344 577788888888888877642 2 343 67888888888888763221
Q ss_pred ccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEccc
Q 002238 235 VIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTN 296 (948)
Q Consensus 235 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 296 (948)
+.++++|+.+++++|++++. +.+.++++|+.|+|++|+|+ .+| .+.++++|++|+|++
T Consensus 152 -~~~l~~L~~l~l~~n~l~~i-~~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 152 -LSRLTKLDTLSLEDNQISDI-VPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp -GGGCTTCSEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred -cccccccccccccccccccc-ccccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEccC
Confidence 33678888999999988864 45788889999999999888 465 588899999998864
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=9.1e-17 Score=165.92 Aligned_cols=220 Identities=15% Similarity=0.149 Sum_probs=165.9
Q ss_pred EEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccC-CCCccccCCCCCCEEEccC-
Q 002238 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTS-VPSDFFTGLSSLQSIEIDN- 148 (948)
Q Consensus 72 ~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~- 148 (948)
.++.++.+++ .+|+.+. +++++|+|++|+|+.+++ .|.++++|++|+|++|.+.. +++.+|.+++++++|.+..
T Consensus 12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 3555667777 7777664 579999999999998776 68999999999999999876 5677899999999999864
Q ss_pred CCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCc
Q 002238 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAK 228 (948)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~ 228 (948)
|++.. ..+..|.++++|+.|++++|++....+..+. ..+..|..+..+++++....+..|.
T Consensus 89 n~l~~-~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~-~~l~~l~~~~~~n~~l~~i~~~~~~----------------- 149 (242)
T d1xwdc1 89 NNLLY-INPEAFQNLPNLQYLLISNTGIKHLPDVHKI-HSLQKVLLDIQDNINIHTIERNSFV----------------- 149 (242)
T ss_dssp TTCCE-ECTTSEECCTTCCEEEEESCCCCSCCCCTTT-CBSSCEEEEEESCTTCCEECTTSST-----------------
T ss_pred ccccc-cccccccccccccccccchhhhccccccccc-ccccccccccccccccccccccccc-----------------
Confidence 66764 4567789999999999999999855443321 2566677777778787755555542
Q ss_pred cCCCccccccC-CCccEEEccCCcccccCCCCCCCCCCcEE-eccCCccccccchhhhCCCCCcEEEcccCcccccCCC-
Q 002238 229 LGGGIDVIQNM-TSLKEIWLHSNAFSGPLPDFSGVKQLESL-SLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE- 305 (948)
Q Consensus 229 ~~~~~~~l~~l-~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L-~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~- 305 (948)
++ ..++.|++++|+++...+......++..+ ++++|+++...+..|.++++|++|+|++|+++...+.
T Consensus 150 ---------~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~ 220 (242)
T d1xwdc1 150 ---------GLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG 220 (242)
T ss_dssp ---------TSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSS
T ss_pred ---------cccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHH
Confidence 33 47889999999999766655555555544 5788889844455688999999999999999865553
Q ss_pred CCCccccccccccCCCC
Q 002238 306 FDRSVSLDMAKGSNNFC 322 (948)
Q Consensus 306 ~~~~~~l~~~~~~~~~~ 322 (948)
+.++..|+.++..+...
T Consensus 221 ~~~l~~L~~l~~~~l~~ 237 (242)
T d1xwdc1 221 LENLKKLRARSTYNLKK 237 (242)
T ss_dssp CTTCCEEESSSEESSSC
T ss_pred HcCCcccccCcCCCCCc
Confidence 67777777776655443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.72 E-value=7.4e-18 Score=167.25 Aligned_cols=129 Identities=20% Similarity=0.284 Sum_probs=109.6
Q ss_pred EEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC--CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCC
Q 002238 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP--SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149 (948)
Q Consensus 72 ~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 149 (948)
.++.++++|+ .+|..+. +++++|+|++|+|++.++ .|.++++|++|+|++|.+..++++.|..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 4666778888 7787764 689999999999987554 6888999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccC
Q 002238 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGL 206 (948)
Q Consensus 150 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~ 206 (948)
+|+. ..|..|.++++|++|+|++|+|++..+..|. .+++|++|+|++|.+.+..
T Consensus 89 ~l~~-l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~--~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 89 KIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFE--HLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCE-ECSSSSTTCTTCCEEECCSSCCCEECTTSST--TCTTCCEEECTTCCBCCSG
T ss_pred cccc-cCHHHHhCCCcccccccCCccccccCHHHhc--CCccccccccccccccccc
Confidence 9995 3356788899999999999999988888886 7888999999999887543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=6e-17 Score=165.47 Aligned_cols=186 Identities=24% Similarity=0.357 Sum_probs=157.2
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEcc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 147 (948)
..++.|++.+|+++. + +.+.++++|++|+|++|.|++..| +..+++|++|++++|.++.+. .|..+++|+.|+++
T Consensus 41 ~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~n~~~~i~--~l~~l~~L~~l~l~ 115 (227)
T d1h6ua2 41 DGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNVS--AIAGLQSIKTLDLT 115 (227)
T ss_dssp HTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCCG--GGTTCTTCCEEECT
T ss_pred CCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc-ccccccccccccccccccccc--cccccccccccccc
Confidence 479999999999984 5 468999999999999999997654 899999999999999998764 48899999999999
Q ss_pred CCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCC
Q 002238 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNA 227 (948)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~ 227 (948)
+|.... ...+...+.+..+.++++.+....+ +. .+++|++|++++|++....+
T Consensus 116 ~~~~~~---~~~~~~~~~~~~l~~~~~~~~~~~~--~~--~~~~L~~L~l~~n~~~~~~~-------------------- 168 (227)
T d1h6ua2 116 STQITD---VTPLAGLSNLQVLYLDLNQITNISP--LA--GLTNLQYLSIGNAQVSDLTP-------------------- 168 (227)
T ss_dssp TSCCCC---CGGGTTCTTCCEEECCSSCCCCCGG--GG--GCTTCCEEECCSSCCCCCGG--------------------
T ss_pred cccccc---cchhccccchhhhhchhhhhchhhh--hc--cccccccccccccccccchh--------------------
Confidence 999875 3457788999999999999876544 32 67899999999998864322
Q ss_pred ccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEccc
Q 002238 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTN 296 (948)
Q Consensus 228 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 296 (948)
+.++++|+.|+|++|++++ ++.+.++++|++|+|++|++++ ++. +.++++|+.|++++
T Consensus 169 --------l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N~lt~-i~~-l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 169 --------LANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISD-VSP-LANTSNLFIVTLTN 226 (227)
T ss_dssp --------GTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTSCCCB-CGG-GTTCTTCCEEEEEE
T ss_pred --------hcccccceecccCCCccCC-ChhhcCCCCCCEEECcCCcCCC-Ccc-cccCCCCCEEEeeC
Confidence 4478999999999999986 4568889999999999999994 543 88999999999974
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=2.8e-17 Score=169.88 Aligned_cols=211 Identities=18% Similarity=0.198 Sum_probs=166.7
Q ss_pred CCccceEEeCC----------CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCC--CcCCCCCCcEEEccc
Q 002238 57 CKWNHVVCIED----------KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP--SLNGLASLEVVMLSN 124 (948)
Q Consensus 57 C~w~gv~c~~~----------~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~L~~ 124 (948)
|.+..|.|... ..+++|+|++|+++...+..|.++++|++|+|++|.+...++ .|.+++++++|++..
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 67778889632 379999999999996556679999999999999999987554 688999999999764
Q ss_pred -ccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCC-CCCcEEEcccccc
Q 002238 125 -NQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEF-PGLTILHLAFNQL 202 (948)
Q Consensus 125 -N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l-~~L~~L~Ls~N~l 202 (948)
|.+...++..|.++++|+.|++++|++........+..+..|..+...++.+....+..|. .+ ..+..|++++|++
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~--~~~~~l~~L~l~~n~l 165 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV--GLSFESVILWLNKNGI 165 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSST--TSBSSCEEEECCSSCC
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccc--cccccceeeecccccc
Confidence 7899999999999999999999999998533344566678888888888899877777765 44 4799999999999
Q ss_pred cccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEE-EccCCcccccCC-CCCCCCCCcEEeccCCccccccc
Q 002238 203 IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEI-WLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVP 280 (948)
Q Consensus 203 ~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L-~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p 280 (948)
+...+..| +.+++..+ ++++|+++...+ .|.++++|+.|+|++|+|+...+
T Consensus 166 ~~i~~~~~---------------------------~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~ 218 (242)
T d1xwdc1 166 QEIHNCAF---------------------------NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 218 (242)
T ss_dssp CEECTTTT---------------------------TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCS
T ss_pred cccccccc---------------------------cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCH
Confidence 86555444 34555444 578888886555 37889999999999999995445
Q ss_pred hhhhCCCCCcEEEccc
Q 002238 281 DSLVKLESLKIVNMTN 296 (948)
Q Consensus 281 ~~l~~l~~L~~L~Ls~ 296 (948)
..|.++++|+.+++.+
T Consensus 219 ~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 219 YGLENLKKLRARSTYN 234 (242)
T ss_dssp SSCTTCCEEESSSEES
T ss_pred HHHcCCcccccCcCCC
Confidence 5677777777666543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=4.6e-17 Score=162.42 Aligned_cols=162 Identities=24% Similarity=0.386 Sum_probs=101.3
Q ss_pred CCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEE
Q 002238 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNF 169 (948)
Q Consensus 90 ~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 169 (948)
.+.+|++|++++|.|+. ++.+..+++|++|+|++|+++++++ |+++++|++|++++|.+.. ++ .+.++++|+.|
T Consensus 38 ~l~~l~~L~l~~~~i~~-l~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~--~~-~l~~l~~L~~L 111 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--IT-PLANLTNLTGL 111 (199)
T ss_dssp HHTTCCEEECTTSCCCC-CTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC--CG-GGTTCTTCSEE
T ss_pred HhcCCCEEECCCCCCCC-ccccccCCCcCcCccccccccCccc--ccCCccccccccccccccc--cc-ccccccccccc
Confidence 45566677777776664 2446666777777777777766554 6677777777777776663 33 36666777777
Q ss_pred EccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccC
Q 002238 170 SANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHS 249 (948)
Q Consensus 170 ~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~ 249 (948)
++++|.+....+ +. .+++|+.|++++|++.. ++ . +..+++|++|++++
T Consensus 112 ~l~~~~~~~~~~--~~--~l~~L~~L~l~~n~l~~-~~-~--------------------------l~~~~~L~~L~l~~ 159 (199)
T d2omxa2 112 TLFNNQITDIDP--LK--NLTNLNRLELSSNTISD-IS-A--------------------------LSGLTSLQQLNFSS 159 (199)
T ss_dssp ECCSSCCCCCGG--GT--TCTTCSEEECCSSCCCC-CG-G--------------------------GTTCTTCSEEECCS
T ss_pred cccccccccccc--cc--hhhhhHHhhhhhhhhcc-cc-c--------------------------cccccccccccccc
Confidence 777666654322 33 56677777777776652 22 1 23566777777777
Q ss_pred CcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEE
Q 002238 250 NAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 292 (948)
Q Consensus 250 N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 292 (948)
|++++. +.+.++++|++|++++|+++ .++ .++++++|+.|
T Consensus 160 n~l~~l-~~l~~l~~L~~L~ls~N~i~-~i~-~l~~L~~L~~L 199 (199)
T d2omxa2 160 NQVTDL-KPLANLTTLERLDISSNKVS-DIS-VLAKLTNLESL 199 (199)
T ss_dssp SCCCCC-GGGTTCTTCCEEECCSSCCC-CCG-GGGGCTTCSEE
T ss_pred ccccCC-ccccCCCCCCEEECCCCCCC-CCc-cccCCCCCCcC
Confidence 777643 34666677777777777776 343 36666666654
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.69 E-value=1.4e-17 Score=165.15 Aligned_cols=173 Identities=18% Similarity=0.230 Sum_probs=131.7
Q ss_pred CcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccC-CCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEcc
Q 002238 94 LERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTS-VPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSAN 172 (948)
Q Consensus 94 L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~ 172 (948)
.+.++.++|+|+.+++.+. +++++|+|++|+|++ +.+..|.++++|+.|+|++|++.. ..+..+..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~-~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcCccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccc-ccccccccccccceeeec
Confidence 3578899999987665554 678999999999986 567778899999999999999886 557788888899999999
Q ss_pred CccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcc
Q 002238 173 SANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAF 252 (948)
Q Consensus 173 ~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l 252 (948)
+|+|+...+..|. .+++|++|+|++|+|++..|..|. ++++|++|+|++|.+
T Consensus 87 ~N~l~~l~~~~F~--~l~~L~~L~L~~N~l~~i~~~~f~--------------------------~l~~L~~l~L~~N~~ 138 (192)
T d1w8aa_ 87 ENKIKEISNKMFL--GLHQLKTLNLYDNQISCVMPGSFE--------------------------HLNSLTSLNLASNPF 138 (192)
T ss_dssp SCCCCEECSSSST--TCTTCCEEECCSSCCCEECTTSST--------------------------TCTTCCEEECTTCCB
T ss_pred cccccccCHHHHh--CCCcccccccCCccccccCHHHhc--------------------------CCccccccccccccc
Confidence 9999888888886 888999999999998876666653 678888888888888
Q ss_pred cccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCccc
Q 002238 253 SGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ 300 (948)
Q Consensus 253 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 300 (948)
....+.......++.+.+..|.++...|.. +..++.++|+.|.|+
T Consensus 139 ~~~~~~~~~~~~l~~~~l~~~~~~c~~p~~---l~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 139 NCNCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFK 183 (192)
T ss_dssp CCSGGGHHHHHHHHHHCCSGGGCBBCSSTT---TTTSBGGGSCTTTCC
T ss_pred ccccchHHHhhhhhhhcccCCCeEeCCChh---hcCCEeeecCHhhCc
Confidence 764432111234566677777777666654 345566677777765
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=3.5e-17 Score=163.35 Aligned_cols=181 Identities=23% Similarity=0.330 Sum_probs=146.9
Q ss_pred CCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEE
Q 002238 91 LTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFS 170 (948)
Q Consensus 91 l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ 170 (948)
+.++..+.++.+.+++.+ ....+.+|++|++++|.++.+. .++.+++|++|+|++|++++ ++ .+.++++|++|+
T Consensus 17 l~~~i~~~l~~~~~~~~~-~~~~l~~l~~L~l~~~~i~~l~--~l~~l~nL~~L~Ls~N~l~~--~~-~l~~l~~L~~L~ 90 (199)
T d2omxa2 17 LAEKMKTVLGKTNVTDTV-SQTDLDQVTTLQADRLGIKSID--GVEYLNNLTQINFSNNQLTD--IT-PLKNLTKLVDIL 90 (199)
T ss_dssp HHHHHHHHTTCSSTTSEE-CHHHHTTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC--CG-GGTTCTTCCEEE
T ss_pred HHHHHHHHhCCCCCCCcc-CHHHhcCCCEEECCCCCCCCcc--ccccCCCcCcCccccccccC--cc-cccCCccccccc
Confidence 445556678888888754 3456789999999999999864 48899999999999999995 44 389999999999
Q ss_pred ccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCC
Q 002238 171 ANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250 (948)
Q Consensus 171 l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N 250 (948)
+++|.+.... .+. .++.|+.|++++|.+....+ +..+++|+.|++++|
T Consensus 91 l~~n~~~~~~--~l~--~l~~L~~L~l~~~~~~~~~~----------------------------~~~l~~L~~L~l~~n 138 (199)
T d2omxa2 91 MNNNQIADIT--PLA--NLTNLTGLTLFNNQITDIDP----------------------------LKNLTNLNRLELSSN 138 (199)
T ss_dssp CCSSCCCCCG--GGT--TCTTCSEEECCSSCCCCCGG----------------------------GTTCTTCSEEECCSS
T ss_pred cccccccccc--ccc--cccccccccccccccccccc----------------------------cchhhhhHHhhhhhh
Confidence 9999987543 254 89999999999998874322 347899999999999
Q ss_pred cccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccc
Q 002238 251 AFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLD 313 (948)
Q Consensus 251 ~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~ 313 (948)
++.. ++.+..+++|+.|++.+|++++ ++ .+.++++|+.|++++|++++ +|.+..+.+|+
T Consensus 139 ~l~~-~~~l~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L~~L~ls~N~i~~-i~~l~~L~~L~ 197 (199)
T d2omxa2 139 TISD-ISALSGLTSLQQLNFSSNQVTD-LK-PLANLTTLERLDISSNKVSD-ISVLAKLTNLE 197 (199)
T ss_dssp CCCC-CGGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-CGGGGGCTTCS
T ss_pred hhcc-cccccccccccccccccccccC-Cc-cccCCCCCCEEECCCCCCCC-CccccCCCCCC
Confidence 9984 4568889999999999999995 44 38999999999999999986 45555555443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.66 E-value=2.8e-16 Score=158.07 Aligned_cols=164 Identities=23% Similarity=0.374 Sum_probs=140.2
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEcc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 147 (948)
..++.|++++|+++.. + .+..+++|++|+|++|+|++.. .+..+++|++|+|++|+|++++ .+..+++|+.|+++
T Consensus 46 ~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKVKDLS--SLKDLKKLKSLSLE 120 (210)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCGG--GGTTCTTCCEEECT
T ss_pred cCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc-ccccCccccccccccccccccc--cccccccccccccc
Confidence 3688999999999854 3 4888999999999999999854 5788999999999999999865 48999999999999
Q ss_pred CCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCC
Q 002238 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNA 227 (948)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~ 227 (948)
+|.+.. ...+.++++|+.+++++|.+++.. .+. .+++|+++++++|++++..+
T Consensus 121 ~~~~~~---~~~l~~l~~l~~l~~~~n~l~~~~--~~~--~l~~L~~l~l~~n~l~~i~~-------------------- 173 (210)
T d1h6ta2 121 HNGISD---INGLVHLPQLESLYLGNNKITDIT--VLS--RLTKLDTLSLEDNQISDIVP-------------------- 173 (210)
T ss_dssp TSCCCC---CGGGGGCTTCCEEECCSSCCCCCG--GGG--GCTTCSEEECCSSCCCCCGG--------------------
T ss_pred cccccc---cccccccccccccccccccccccc--ccc--cccccccccccccccccccc--------------------
Confidence 999874 346889999999999999998543 333 78999999999999985322
Q ss_pred ccCCCccccccCCCccEEEccCCcccccCCCCCCCCCCcEEeccC
Q 002238 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRD 272 (948)
Q Consensus 228 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~ 272 (948)
+.++++|++|+|++|+++. ++.+.++++|++|+|++
T Consensus 174 --------l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 174 --------LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFS 209 (210)
T ss_dssp --------GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEEE
T ss_pred --------ccCCCCCCEEECCCCCCCC-ChhhcCCCCCCEEEccC
Confidence 3478999999999999985 56799999999999874
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=1.6e-16 Score=180.48 Aligned_cols=332 Identities=17% Similarity=0.162 Sum_probs=200.1
Q ss_pred CEEEEEeCCCCCcCC-CCccccCCCCCcEEEcccCCCCCC----CC-CcCCCCCCcEEEcccccccCCC----Ccccc-C
Q 002238 69 RITRIQIGHQNLQGT-LPSNLQNLTKLERLELQWNSISGP----LP-SLNGLASLEVVMLSNNQFTSVP----SDFFT-G 137 (948)
Q Consensus 69 ~v~~l~l~~~~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~----~p-~~~~l~~L~~L~L~~N~l~~~~----~~~~~-~ 137 (948)
++++||++++++++. +...+..+++|+.|+|++|.|+.. +. .+..+++|++|+|++|.|+... ...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 589999999999863 234456678999999999998741 12 4678899999999999986421 22222 3
Q ss_pred CCCCCEEEccCCCCCCCC---CCccccCCCCCCEEEccCccccccCCCCCC-----------------------------
Q 002238 138 LSSLQSIEIDNNPFSSWE---IPQSLRNASGLQNFSANSANITGQIPSFFG----------------------------- 185 (948)
Q Consensus 138 l~~L~~L~Ls~N~l~~~~---~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~----------------------------- 185 (948)
..+|++|+|++|+++... ++..+..+++|++|++++|.++......+.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 458999999999987411 356678899999999999987643111110
Q ss_pred --CCCCCCCcEEEcccccccccCC----CCccc--ccccceeccCCCCCCc-cCCCccccccCCCccEEEccCCccccc-
Q 002238 186 --PDEFPGLTILHLAFNQLIGGLP----ASFSG--SQIQSLWVNGQNGNAK-LGGGIDVIQNMTSLKEIWLHSNAFSGP- 255 (948)
Q Consensus 186 --~~~l~~L~~L~Ls~N~l~~~~p----~~~~~--~~l~~l~~~~~~~~~~-~~~~~~~l~~l~~L~~L~Ls~N~l~~~- 255 (948)
......++.++++++......- ..+.. .....+.......... .......+...+.++.+++++|.+...
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 0122345666666555432100 00000 1122222222111110 001113345678889999999887532
Q ss_pred ----CC-CCCCCCCCcEEeccCCccccc----cchhhhCCCCCcEEEcccCcccccCC-C----C-CCccccccccccCC
Q 002238 256 ----LP-DFSGVKQLESLSLRDNFFTGP----VPDSLVKLESLKIVNMTNNLLQGPVP-E----F-DRSVSLDMAKGSNN 320 (948)
Q Consensus 256 ----~~-~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~g~~p-~----~-~~~~~l~~~~~~~~ 320 (948)
.. .......|+.|++++|.+... ....+...+.++.+++++|.++..-. . + .....|..+...++
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence 11 234467899999999988733 33445678889999999998863110 0 0 01112333333222
Q ss_pred CCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCccccc----CCcccc-Cccc
Q 002238 321 FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT----ISPEFA-SFKS 395 (948)
Q Consensus 321 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~----ip~~~~-~l~~ 395 (948)
..... .. ..+. .......+|+.|+|++|++... ++..+. ..+.
T Consensus 323 ~l~~~------~~---~~l~-----------------------~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~ 370 (460)
T d1z7xw1 323 SFTAA------CC---SHFS-----------------------SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSV 370 (460)
T ss_dssp CCBGG------GH---HHHH-----------------------HHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCC
T ss_pred chhhh------hh---hhcc-----------------------cccccccchhhhheeeecccCcccchhhhhhhcccCC
Confidence 11100 00 0000 0112345789999999998753 444443 4667
Q ss_pred cceEeCcccccccc----CCcCCcCCCCCcEEEccCCcccC
Q 002238 396 LQRLILADNNLSGM----IPEGLSVLGALKELDVSNNQLYG 432 (948)
Q Consensus 396 L~~L~Ls~N~l~g~----ip~~l~~l~~L~~L~ls~N~l~g 432 (948)
|++|+|++|+|+.. ++..+...++|++|||++|+|+.
T Consensus 371 L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp CCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred CCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 99999999999742 45566777899999999999874
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.45 E-value=9e-14 Score=126.00 Aligned_cols=103 Identities=24% Similarity=0.332 Sum_probs=67.1
Q ss_pred EEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCC
Q 002238 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPF 151 (948)
Q Consensus 72 ~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 151 (948)
.|+|++|+++ .++ .+.++++|++|++++|.|+..++.+..+++|++|+|++|+|++++ .|..+++|+.|++++|+|
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~l~--~~~~l~~L~~L~l~~N~i 77 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD--GVANLPRLQELLLCNNRL 77 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCSSCCEEECCSSCC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccccC--ccccccccCeEECCCCcc
Confidence 4667777776 443 366677777777777777665556666777777777777777653 266777777777777777
Q ss_pred CCCCCCccccCCCCCCEEEccCccccc
Q 002238 152 SSWEIPQSLRNASGLQNFSANSANITG 178 (948)
Q Consensus 152 ~~~~~p~~~~~l~~L~~L~l~~n~l~~ 178 (948)
+.+.....+..+++|+.|++++|.++.
T Consensus 78 ~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 78 QQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred CCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 643323456666667777776666653
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=3.7e-14 Score=135.34 Aligned_cols=125 Identities=14% Similarity=0.198 Sum_probs=88.5
Q ss_pred CCEEEEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEcc
Q 002238 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 147 (948)
.++.+|+|++|+|+ .++..+..+++|+.|+|++|.|+.. +.|..+++|++|+|++|+++.+++..+..+++|+.|+|+
T Consensus 18 ~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~ 95 (162)
T d1a9na_ 18 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 95 (162)
T ss_dssp TSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred CcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhcccccccCCCccccccccccccceec
Confidence 46777888888877 4465566777888888888887754 567778888888888888888777777778888888888
Q ss_pred CCCCCCCCCCccccCCCCCCEEEccCccccccCC---CCCCCCCCCCCcEEE
Q 002238 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIP---SFFGPDEFPGLTILH 196 (948)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p---~~~~~~~l~~L~~L~ 196 (948)
+|+|+.+.--..+..+++|++|++++|.++.... ..+. .+|+|++||
T Consensus 96 ~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~--~lp~L~~LD 145 (162)
T d1a9na_ 96 NNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIY--KVPQVRVLD 145 (162)
T ss_dssp SCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHH--HCTTCSEET
T ss_pred cccccccccccccccccccchhhcCCCccccccchHHHHHH--HCCCcCeeC
Confidence 8887742212456777788888888887764321 1233 577777776
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.42 E-value=3.1e-13 Score=122.33 Aligned_cols=103 Identities=19% Similarity=0.275 Sum_probs=90.4
Q ss_pred cEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCc
Q 002238 95 ERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA 174 (948)
Q Consensus 95 ~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n 174 (948)
+.|+|++|+|+.. +.+.++++|++|+|++|+|+.+++ .|+.+++|+.|++++|+|+. +| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~~l-~~l~~l~~L~~L~ls~N~l~~lp~-~~~~l~~L~~L~l~~N~i~~--l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN--VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSSC-CCGGGGTTCCEEECCSSCCCCCCG-GGGGCTTCCEEECCSSCCCC--CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCCC-cccccCCCCCEEECCCCccCcchh-hhhhhhcccccccccccccc--cC-ccccccccCeEECCCC
Confidence 5799999999955 569999999999999999998765 58999999999999999994 55 5899999999999999
Q ss_pred cccccCC-CCCCCCCCCCCcEEEcccccccc
Q 002238 175 NITGQIP-SFFGPDEFPGLTILHLAFNQLIG 204 (948)
Q Consensus 175 ~l~~~~p-~~~~~~~l~~L~~L~Ls~N~l~~ 204 (948)
+|+.... ..+. .+++|++|+|++|+++.
T Consensus 76 ~i~~~~~~~~l~--~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLV--SCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGG--GCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhc--CCCCCCEEECCCCcCCc
Confidence 9986543 4555 79999999999999984
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=1.3e-13 Score=131.55 Aligned_cols=124 Identities=14% Similarity=0.108 Sum_probs=66.9
Q ss_pred CCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCCcEEEcccccccccCCCCccccccc
Q 002238 137 GLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQ 216 (948)
Q Consensus 137 ~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~ 216 (948)
+..+|++|+|++|+|+ .++..+..+++|+.|+|++|+|+.. + .|. .+++|++|+|++|+++...+..
T Consensus 16 n~~~lr~L~L~~n~I~--~i~~~~~~l~~L~~L~Ls~N~i~~l-~-~~~--~l~~L~~L~ls~N~i~~l~~~~------- 82 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIP--VIENLGATLDQFDAIDFSDNEIRKL-D-GFP--LLRRLKTLLVNNNRICRIGEGL------- 82 (162)
T ss_dssp CTTSCEEEECTTSCCC--SCCCGGGGTTCCSEEECCSSCCCEE-C-CCC--CCSSCCEEECCSSCCCEECSCH-------
T ss_pred CcCcCcEEECCCCCCC--ccCccccccccCCEEECCCCCCCcc-C-Ccc--cCcchhhhhcccccccCCCccc-------
Confidence 4444444444444444 2333334444444444444444422 1 233 5566666666666665332221
Q ss_pred ceeccCCCCCCccCCCccccccCCCccEEEccCCcccccC--CCCCCCCCCcEEeccCCccccccc----hhhhCCCCCc
Q 002238 217 SLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPL--PDFSGVKQLESLSLRDNFFTGPVP----DSLVKLESLK 290 (948)
Q Consensus 217 ~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~--~~~~~l~~L~~L~L~~N~l~~~~p----~~l~~l~~L~ 290 (948)
+..+++|+.|+|++|+++... ..+..+++|+.|++++|.++ ..| ..+..+++|+
T Consensus 83 -------------------~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~ 142 (162)
T d1a9na_ 83 -------------------DQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVR 142 (162)
T ss_dssp -------------------HHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCS
T ss_pred -------------------cccccccccceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcC
Confidence 224566666666666665422 24556677777777777776 344 3577788888
Q ss_pred EEE
Q 002238 291 IVN 293 (948)
Q Consensus 291 ~L~ 293 (948)
.||
T Consensus 143 ~LD 145 (162)
T d1a9na_ 143 VLD 145 (162)
T ss_dssp EET
T ss_pred eeC
Confidence 876
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=9.3e-15 Score=165.55 Aligned_cols=310 Identities=19% Similarity=0.209 Sum_probs=187.3
Q ss_pred CCEEEEEeCCCCCcC----CCCccccCCCCCcEEEcccCCCCCC----CC-CcCC-CCCCcEEEcccccccCC----CCc
Q 002238 68 KRITRIQIGHQNLQG----TLPSNLQNLTKLERLELQWNSISGP----LP-SLNG-LASLEVVMLSNNQFTSV----PSD 133 (948)
Q Consensus 68 ~~v~~l~l~~~~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~----~p-~~~~-l~~L~~L~L~~N~l~~~----~~~ 133 (948)
.+++.|+|++|+++. .+...+..+++|++|||++|.|+.. +. .+.. ..+|++|+|++|+++.. .+.
T Consensus 27 ~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~ 106 (460)
T d1z7xw1 27 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 106 (460)
T ss_dssp TTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccc
Confidence 356678888888762 3445567788888888888888531 11 2322 35788888888888753 345
Q ss_pred cccCCCCCCEEEccCCCCCCC------------------------CCC--------ccccCCCCCCEEEccCcccccc--
Q 002238 134 FFTGLSSLQSIEIDNNPFSSW------------------------EIP--------QSLRNASGLQNFSANSANITGQ-- 179 (948)
Q Consensus 134 ~~~~l~~L~~L~Ls~N~l~~~------------------------~~p--------~~~~~l~~L~~L~l~~n~l~~~-- 179 (948)
.+..+++|++|+|++|.+... .+. ..+.....++.++++++.+...
T Consensus 107 ~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~ 186 (460)
T d1z7xw1 107 TLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGV 186 (460)
T ss_dssp HTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHH
T ss_pred hhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccccccccccccccccccccccccccc
Confidence 577788888888888876420 000 0112234455566555443210
Q ss_pred ---------------------------CC----CCCCCCCCCCCcEEEcccccccccC-----CCCcc-cccccceeccC
Q 002238 180 ---------------------------IP----SFFGPDEFPGLTILHLAFNQLIGGL-----PASFS-GSQIQSLWVNG 222 (948)
Q Consensus 180 ---------------------------~p----~~~~~~~l~~L~~L~Ls~N~l~~~~-----p~~~~-~~~l~~l~~~~ 222 (948)
.. ..+ ...+.++.+++++|++.... +.... ...+..+++.+
T Consensus 187 ~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l--~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~ 264 (460)
T d1z7xw1 187 RVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV--ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWE 264 (460)
T ss_dssp HHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHH--HHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred cccccccccccccccccccccccccchhhhcccccc--cccccccccchhhccccccccchhhccccccccccccccccc
Confidence 00 000 13567889999998764321 11111 13455555554
Q ss_pred CCCCCcc-CCCccccccCCCccEEEccCCcccccCC-----C-CCCCCCCcEEeccCCccccccch----hhhCCCCCcE
Q 002238 223 QNGNAKL-GGGIDVIQNMTSLKEIWLHSNAFSGPLP-----D-FSGVKQLESLSLRDNFFTGPVPD----SLVKLESLKI 291 (948)
Q Consensus 223 ~~~~~~~-~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-----~-~~~l~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~ 291 (948)
+...... ......+...+.++.+++++|.++.... . ......|+.+++++|.++..... .+...++|++
T Consensus 265 n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~ 344 (460)
T d1z7xw1 265 CGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLE 344 (460)
T ss_dssp SCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCE
T ss_pred ccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhh
Confidence 4322221 1122345567788888888888864211 1 12345788888888888754333 3345568888
Q ss_pred EEcccCcccccCCCCCCccccccccccCCCCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCc
Q 002238 292 VNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGN 371 (948)
Q Consensus 292 L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (948)
|+|++|++++.- +..+...+ ......
T Consensus 345 L~Ls~N~i~~~g--------------------------------~~~l~~~l----------------------~~~~~~ 370 (460)
T d1z7xw1 345 LQISNNRLEDAG--------------------------------VRELCQGL----------------------GQPGSV 370 (460)
T ss_dssp EECCSSBCHHHH--------------------------------HHHHHHHH----------------------TSTTCC
T ss_pred hheeeecccCcc--------------------------------cchhhhhh----------------------hcccCC
Confidence 888888876310 00111000 011236
Q ss_pred eEEEEccCCcccc----cCCccccCccccceEeCccccccccCCcCC----c-CCCCCcEEEccCCcccCC
Q 002238 372 ITVINFQKMNLTG----TISPEFASFKSLQRLILADNNLSGMIPEGL----S-VLGALKELDVSNNQLYGK 433 (948)
Q Consensus 372 L~~L~ls~n~l~g----~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~l----~-~l~~L~~L~ls~N~l~g~ 433 (948)
|+.|+|++|+|+. .++..+..+++|++|+|++|+|+......| . +...|+.|++++|.+...
T Consensus 371 L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp CCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred CCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence 8999999999985 355667778999999999999975433222 2 345799999999998753
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.40 E-value=3.6e-14 Score=154.38 Aligned_cols=195 Identities=17% Similarity=0.212 Sum_probs=111.0
Q ss_pred CCccccCCCCCcEEEcccCCCCCC-----CCCcCCCCCCcEEEcccccccCCC----------CccccCCCCCCEEEccC
Q 002238 84 LPSNLQNLTKLERLELQWNSISGP-----LPSLNGLASLEVVMLSNNQFTSVP----------SDFFTGLSSLQSIEIDN 148 (948)
Q Consensus 84 ~p~~l~~l~~L~~L~L~~N~l~~~-----~p~~~~l~~L~~L~L~~N~l~~~~----------~~~~~~l~~L~~L~Ls~ 148 (948)
+...+.+...|++|+|++|.|... -..+...++|+.|+|+++.+.... ...+..+++|+.|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 344566677888888888877542 114666778888888876554321 12355677788888888
Q ss_pred CCCCCCC---CCccccCCCCCCEEEccCccccccCCCCCC-----------CCCCCCCcEEEcccccccccCCCCccccc
Q 002238 149 NPFSSWE---IPQSLRNASGLQNFSANSANITGQIPSFFG-----------PDEFPGLTILHLAFNQLIGGLPASFSGSQ 214 (948)
Q Consensus 149 N~l~~~~---~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~-----------~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 214 (948)
|.+.... +...+...++|+.|++++|.+.......++ ....+.|+.|++++|++.......+
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l---- 178 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW---- 178 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHH----
T ss_pred cccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccc----
Confidence 8776421 233445567777777777766422111110 0134566667766666542111111
Q ss_pred ccceeccCCCCCCccCCCccccccCCCccEEEccCCccccc------CCCCCCCCCCcEEeccCCccccc----cchhhh
Q 002238 215 IQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGP------LPDFSGVKQLESLSLRDNFFTGP----VPDSLV 284 (948)
Q Consensus 215 l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~------~~~~~~l~~L~~L~L~~N~l~~~----~p~~l~ 284 (948)
...+...+.|++|+|++|++... ...+...++|+.|+|++|.++.. +...+.
T Consensus 179 ------------------~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~ 240 (344)
T d2ca6a1 179 ------------------AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 240 (344)
T ss_dssp ------------------HHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGG
T ss_pred ------------------cchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccccc
Confidence 11234456677777777766531 12344556666677766666522 334455
Q ss_pred CCCCCcEEEcccCccc
Q 002238 285 KLESLKIVNMTNNLLQ 300 (948)
Q Consensus 285 ~l~~L~~L~Ls~N~l~ 300 (948)
.+++|++|+|++|.++
T Consensus 241 ~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 241 SWPNLRELGLNDCLLS 256 (344)
T ss_dssp GCTTCCEEECTTCCCC
T ss_pred ccccchhhhhhcCccC
Confidence 6666666666666654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=4.4e-15 Score=156.66 Aligned_cols=197 Identities=14% Similarity=0.212 Sum_probs=119.7
Q ss_pred EEEeCCCCCcCCCCccccCCCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccccccCC-CCccccCCCCCCEEEccCCC
Q 002238 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSV-PSDFFTGLSSLQSIEIDNNP 150 (948)
Q Consensus 72 ~l~l~~~~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~ 150 (948)
.|||+++++.......+.. ..+..+.++...+...+.......+|++|||++|.++.. ....+.++++|++|+|++|.
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~ 82 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCB
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccC
Confidence 5788877765332222221 234556666555554444455567888888888887753 34457788888899888888
Q ss_pred CCCCCCCccccCCCCCCEEEccCc-cccccC-CCCCCCCCCCCCcEEEcccc-ccccc-CCCCcccccccceeccCCCCC
Q 002238 151 FSSWEIPQSLRNASGLQNFSANSA-NITGQI-PSFFGPDEFPGLTILHLAFN-QLIGG-LPASFSGSQIQSLWVNGQNGN 226 (948)
Q Consensus 151 l~~~~~p~~~~~l~~L~~L~l~~n-~l~~~~-p~~~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~~~l~~l~~~~~~~~ 226 (948)
++. ..+..+..+++|++|++++| .++... ...+. .+++|++|+|+++ .++.. +...+.
T Consensus 83 l~~-~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~--~~~~L~~L~ls~c~~~~~~~~~~~~~--------------- 144 (284)
T d2astb2 83 LSD-PIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS--SCSRLDELNLSWCFDFTEKHVQVAVA--------------- 144 (284)
T ss_dssp CCH-HHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHH--HCTTCCEEECCCCTTCCHHHHHHHHH---------------
T ss_pred CCc-HHHHHHhcCCCCcCccccccccccccccchhhH--HHHhccccccccccccccccchhhhc---------------
Confidence 876 56677888888888888885 555321 11122 5788888888885 33311 111110
Q ss_pred CccCCCccccccCCCccEEEccCC--cccc-cCCC-CCCCCCCcEEeccCC-ccccccchhhhCCCCCcEEEcccC
Q 002238 227 AKLGGGIDVIQNMTSLKEIWLHSN--AFSG-PLPD-FSGVKQLESLSLRDN-FFTGPVPDSLVKLESLKIVNMTNN 297 (948)
Q Consensus 227 ~~~~~~~~~l~~l~~L~~L~Ls~N--~l~~-~~~~-~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~Ls~N 297 (948)
...++|+.|+++++ .++. .+.. +.++++|++|+|++| .+++.....+.++++|++|+|++|
T Consensus 145 ----------~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C 210 (284)
T d2astb2 145 ----------HVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC 210 (284)
T ss_dssp ----------HSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTC
T ss_pred ----------ccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCC
Confidence 12356777777654 2332 1112 234567777777765 466566666777777777777764
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=2.8e-14 Score=150.42 Aligned_cols=175 Identities=13% Similarity=0.151 Sum_probs=106.6
Q ss_pred cEEEcccCCCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEEEccC
Q 002238 95 ERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANS 173 (948)
Q Consensus 95 ~~L~L~~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~l~~ 173 (948)
++|||+++.+..... .+.. ..+..+.++.+.+...... .....+|++|||++|.++...++..+.++++|++|+|++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~-~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchhh-hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 478888887753211 1111 2356677777666654433 335568899999988877423455677788888888888
Q ss_pred ccccccCCCCCCCCCCCCCcEEEcccc-cccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCC-c
Q 002238 174 ANITGQIPSFFGPDEFPGLTILHLAFN-QLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN-A 251 (948)
Q Consensus 174 n~l~~~~p~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N-~ 251 (948)
|.++...+..++ .+++|++|+|+++ .++... + ...+.++++|++|+|+++ .
T Consensus 81 ~~l~~~~~~~l~--~~~~L~~L~Ls~c~~itd~~---l----------------------~~l~~~~~~L~~L~ls~c~~ 133 (284)
T d2astb2 81 LRLSDPIVNTLA--KNSNLVRLNLSGCSGFSEFA---L----------------------QTLLSSCSRLDELNLSWCFD 133 (284)
T ss_dssp CBCCHHHHHHHT--TCTTCSEEECTTCBSCCHHH---H----------------------HHHHHHCTTCCEEECCCCTT
T ss_pred cCCCcHHHHHHh--cCCCCcCccccccccccccc---c----------------------chhhHHHHhccccccccccc
Confidence 888877777776 6788888888885 343110 0 011235678888888875 3
Q ss_pred cccc-CC-CCC-CCCCCcEEeccCC--cccc-ccchhhhCCCCCcEEEcccCc
Q 002238 252 FSGP-LP-DFS-GVKQLESLSLRDN--FFTG-PVPDSLVKLESLKIVNMTNNL 298 (948)
Q Consensus 252 l~~~-~~-~~~-~l~~L~~L~L~~N--~l~~-~~p~~l~~l~~L~~L~Ls~N~ 298 (948)
++.. +. .+. ..++|+.|+++++ .++. .+...+.++++|++|+|++|.
T Consensus 134 ~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~ 186 (284)
T d2astb2 134 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV 186 (284)
T ss_dssp CCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCT
T ss_pred cccccchhhhcccccccchhhhccccccccccccccccccccccccccccccc
Confidence 4321 11 122 2356777777764 2332 233334567777777777653
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.29 E-value=5.7e-14 Score=152.76 Aligned_cols=254 Identities=17% Similarity=0.150 Sum_probs=170.0
Q ss_pred CcCCCCCCcEEEcccccccCC----CCccccCCCCCCEEEccCCCCCCC--C-------CCccccCCCCCCEEEccCccc
Q 002238 110 SLNGLASLEVVMLSNNQFTSV----PSDFFTGLSSLQSIEIDNNPFSSW--E-------IPQSLRNASGLQNFSANSANI 176 (948)
Q Consensus 110 ~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~--~-------~p~~~~~l~~L~~L~l~~n~l 176 (948)
.+.....|++|+|++|.|+.. ....+...++|+.|+++++.+... . +...+...++|+.|+|++|.+
T Consensus 26 ~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i 105 (344)
T d2ca6a1 26 VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAF 105 (344)
T ss_dssp HHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCC
T ss_pred HHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccc
Confidence 466688999999999998652 334577889999999998876531 1 123355678999999999998
Q ss_pred cccCC----CCCCCCCCCCCcEEEcccccccccCCCCcccccccceeccCCCCCCccCCCccccccCCCccEEEccCCcc
Q 002238 177 TGQIP----SFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAF 252 (948)
Q Consensus 177 ~~~~p----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~~~~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l 252 (948)
+.... ..+. ..++|++|++++|.+.......+.. .+..+... ......+.|+.|++++|++
T Consensus 106 ~~~~~~~l~~~l~--~~~~L~~L~l~~n~l~~~~~~~l~~-~l~~~~~~------------~~~~~~~~L~~l~l~~n~i 170 (344)
T d2ca6a1 106 GPTAQEPLIDFLS--KHTPLEHLYLHNNGLGPQAGAKIAR-ALQELAVN------------KKAKNAPPLRSIICGRNRL 170 (344)
T ss_dssp CTTTHHHHHHHHH--HCTTCCEEECCSSCCHHHHHHHHHH-HHHHHHHH------------HHHHTCCCCCEEECCSSCC
T ss_pred ccccccchhhhhc--ccccchheecccccccccccccccc-cccccccc------------cccccCcccceeecccccc
Confidence 76522 2232 5689999999999875321111110 01111000 0123567899999999988
Q ss_pred cccCC-----CCCCCCCCcEEeccCCccccc-----cchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCCCC
Q 002238 253 SGPLP-----DFSGVKQLESLSLRDNFFTGP-----VPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFC 322 (948)
Q Consensus 253 ~~~~~-----~~~~l~~L~~L~L~~N~l~~~-----~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~~~ 322 (948)
+...- .+...+.|+.|+|++|.|+.. +...+..+++|+.|+|++|.++..-
T Consensus 171 ~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g------------------- 231 (344)
T d2ca6a1 171 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG------------------- 231 (344)
T ss_dssp TGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHH-------------------
T ss_pred cccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccc-------------------
Confidence 74211 234568899999999998732 3455778899999999999886310
Q ss_pred CCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccc----cC--cccc
Q 002238 323 LPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEF----AS--FKSL 396 (948)
Q Consensus 323 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~----~~--l~~L 396 (948)
...+. ..+...++|+.|+|++|.+.+.-...+ .. .+.|
T Consensus 232 -------------~~~L~-----------------------~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L 275 (344)
T d2ca6a1 232 -------------SSALA-----------------------IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGL 275 (344)
T ss_dssp -------------HHHHH-----------------------HHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCC
T ss_pred -------------ccccc-----------------------ccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCC
Confidence 00000 012234589999999999987533333 22 3679
Q ss_pred ceEeCcccccccc----CCcCCc-CCCCCcEEEccCCcccCC
Q 002238 397 QRLILADNNLSGM----IPEGLS-VLGALKELDVSNNQLYGK 433 (948)
Q Consensus 397 ~~L~Ls~N~l~g~----ip~~l~-~l~~L~~L~ls~N~l~g~ 433 (948)
++|+|++|+|+.. +...+. ++++|+.|+|++|++...
T Consensus 276 ~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~ 317 (344)
T d2ca6a1 276 QTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317 (344)
T ss_dssp CEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred CEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCc
Confidence 9999999998743 333342 578899999999999653
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.18 E-value=5.3e-11 Score=112.17 Aligned_cols=75 Identities=16% Similarity=0.192 Sum_probs=47.2
Q ss_pred CCCCcCCCCccccCCCCCcEEEcccC-CCCCCCC-CcCCCCCCcEEEcccccccCCCCccccCCCCCCEEEccCCCCC
Q 002238 77 HQNLQGTLPSNLQNLTKLERLELQWN-SISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFS 152 (948)
Q Consensus 77 ~~~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 152 (948)
++++. .+|..+..+++|++|++++| .|+.+.+ .|.++++|+.|+|++|+|+.+++.+|..+++|++|+|++|+|+
T Consensus 17 ~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~ 93 (156)
T d2ifga3 17 RDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE 93 (156)
T ss_dssp SSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred CCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc
Confidence 33444 44556666677777777544 3665444 4666666666666666666666666666666666666666666
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.17 E-value=1.4e-13 Score=136.09 Aligned_cols=11 Identities=27% Similarity=0.495 Sum_probs=6.7
Q ss_pred hhCCCCCcEEE
Q 002238 283 LVKLESLKIVN 293 (948)
Q Consensus 283 l~~l~~L~~L~ 293 (948)
+..+|+|+.||
T Consensus 170 i~~lp~L~~LD 180 (198)
T d1m9la_ 170 VKRLPNLKKLD 180 (198)
T ss_dssp HHHCSSCCEES
T ss_pred HHHCCCcCEeC
Confidence 45566666665
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.16 E-value=2.5e-13 Score=134.18 Aligned_cols=63 Identities=22% Similarity=0.337 Sum_probs=31.6
Q ss_pred CCccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccc--hhhhCCCCCcEEEcccCcccccCC
Q 002238 240 TSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVP--DSLVKLESLKIVNMTNNLLQGPVP 304 (948)
Q Consensus 240 ~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p--~~l~~l~~L~~L~Ls~N~l~g~~p 304 (948)
++|+.|++++|+++.. +.+..+++|+.|+|++|+|+ .++ ..+..+++|+.|+|++|+++...+
T Consensus 93 ~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 93 DTLEELWISYNQIASL-SGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp HHCCEEECSEEECCCH-HHHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred cccccccccccccccc-ccccccccccccccccchhc-cccccccccCCCccceeecCCCccccCcc
Confidence 3455555555555432 23444455555555555555 222 345555666666666665554333
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.16 E-value=4.1e-11 Score=112.95 Aligned_cols=109 Identities=16% Similarity=0.128 Sum_probs=94.6
Q ss_pred CCCCcEEEcccCCCCCCCCCcCCCCCCcEEEcccc-cccCCCCccccCCCCCCEEEccCCCCCCCCCCccccCCCCCCEE
Q 002238 91 LTKLERLELQWNSISGPLPSLNGLASLEVVMLSNN-QFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNF 169 (948)
Q Consensus 91 l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 169 (948)
....+.++++++++...+..+.++++|++|+|++| .|+.+.++.|.++++|+.|+|++|+|+. .-|.+|..+++|++|
T Consensus 7 c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~-i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF-VAPDAFHFTPRLSRL 85 (156)
T ss_dssp CSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCE-ECTTGGGSCSCCCEE
T ss_pred cCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCC-cccccccccccccce
Confidence 34456789999999887778999999999999876 5999999999999999999999999995 236789999999999
Q ss_pred EccCccccccCCCCCCCCCCCCCcEEEccccccc
Q 002238 170 SANSANITGQIPSFFGPDEFPGLTILHLAFNQLI 203 (948)
Q Consensus 170 ~l~~n~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~ 203 (948)
+|++|+|+...+..|. ..+|+.|+|++|.+.
T Consensus 86 ~Ls~N~l~~l~~~~~~---~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 86 NLSFNALESLSWKTVQ---GLSLQELVLSGNPLH 116 (156)
T ss_dssp ECCSSCCSCCCSTTTC---SCCCCEEECCSSCCC
T ss_pred eccCCCCcccChhhhc---cccccccccCCCccc
Confidence 9999999977777774 457999999999986
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.44 E-value=4.8e-07 Score=92.69 Aligned_cols=149 Identities=15% Similarity=0.080 Sum_probs=101.4
Q ss_pred HHHHHhhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCC
Q 002238 586 QVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGN 664 (948)
Q Consensus 586 ~~l~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 664 (948)
.+++...+.|+..+..+.++.+.||+...+ ++.++||+.... .......+.+|..+++.+. +--+.+++.++.+++
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~--~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~ 83 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSR--YKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGG--GTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCC--cccchhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence 355666677877666555556799998754 677889987543 2222345788999988874 434567788888888
Q ss_pred ceEEEEEecCCCChhHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcc----------------------------
Q 002238 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA---------------------------- 716 (948)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------- 716 (948)
..++||++++|.++.+.... ... ...++.++++.++.||+..
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~-------~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYED-------EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTT-------CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred ceEEEEEecccccccccccc-------ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence 89999999999887543311 011 2234455555566665320
Q ss_pred ----------------------------CCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 717 ----------------------------HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 717 ----------------------------~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
...++|+|+.|.||++++++.+.|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237899999999999987667799998654
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.08 E-value=1.3e-07 Score=89.05 Aligned_cols=123 Identities=19% Similarity=0.140 Sum_probs=72.6
Q ss_pred CccEEEccCCcccccCCCCCCCCCCcEEeccCCccccccchhhhCCCCCcEEEcccCcccccCCCCCCccccccccccCC
Q 002238 241 SLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNN 320 (948)
Q Consensus 241 ~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~l~~~~~~~~ 320 (948)
..+.|+++++... +.+..+..+..+.+.+|... .++..+..+++|++|+|++|+|+..-+-
T Consensus 23 ~~~~Ldls~l~~~---~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~--------------- 83 (162)
T d1koha1 23 SQQALDLKGLRSD---PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDM--------------- 83 (162)
T ss_dssp SSCCBCCCCCSSC---TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGG---------------
T ss_pred hhCeeecccCCCC---chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchh---------------
Confidence 3455666655432 33444555555666665554 5666667788899999999988742110
Q ss_pred CCCCCCCCCchhhhhhHHHHHhhCCcchhccccCCCCCCCCccceeecCCceEEEEccCCcccccCCccccCccccceEe
Q 002238 321 FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLI 400 (948)
Q Consensus 321 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ls~n~l~g~ip~~~~~l~~L~~L~ 400 (948)
...+..+++|+.|+|++|.|+..-+-.+.....|+.|+
T Consensus 84 ------------------------------------------~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~ 121 (162)
T d1koha1 84 ------------------------------------------SSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELW 121 (162)
T ss_dssp ------------------------------------------GTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCC
T ss_pred ------------------------------------------HHHHhhCCcccccccccCccccchhhhhhhccccceee
Confidence 00112345677777777777754433344445677777
Q ss_pred CccccccccCCcC-------CcCCCCCcEEE
Q 002238 401 LADNNLSGMIPEG-------LSVLGALKELD 424 (948)
Q Consensus 401 Ls~N~l~g~ip~~-------l~~l~~L~~L~ 424 (948)
|++|.+....... +..+++|+.||
T Consensus 122 L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 122 LDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 7777776544322 45667777665
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.04 E-value=4.3e-08 Score=92.42 Aligned_cols=81 Identities=17% Similarity=0.243 Sum_probs=46.9
Q ss_pred CCCCCCcEEEcccccccCCC--CccccCCCCCCEEEccCCCCCCCCCCc-cccCCCCCCEEEccCccccccCCCC-----
Q 002238 112 NGLASLEVVMLSNNQFTSVP--SDFFTGLSSLQSIEIDNNPFSSWEIPQ-SLRNASGLQNFSANSANITGQIPSF----- 183 (948)
Q Consensus 112 ~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~p~-~~~~l~~L~~L~l~~n~l~~~~p~~----- 183 (948)
..+++|++|+|++|+|+.+. +..+..+++|+.|+|++|+|+. ++. ......+|+.|++++|.+.......
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~--l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~ 139 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS--ERELDKIKGLKLEELWLDGNSLSDTFRDQSTYIS 139 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC--GGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHH
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc--chhhhhhhccccceeecCCCCcCcCcccchhHHH
Confidence 34666666666666666653 2345566777777777777663 322 2233345666777777666543321
Q ss_pred --CCCCCCCCCcEEE
Q 002238 184 --FGPDEFPGLTILH 196 (948)
Q Consensus 184 --~~~~~l~~L~~L~ 196 (948)
+. .+|+|++||
T Consensus 140 ~i~~--~~P~L~~LD 152 (162)
T d1koha1 140 AIRE--RFPKLLRLD 152 (162)
T ss_dssp HHHT--TSTTCCEET
T ss_pred HHHH--HCCCCCEEC
Confidence 22 567777765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.03 E-value=6e-06 Score=83.75 Aligned_cols=74 Identities=20% Similarity=0.217 Sum_probs=54.6
Q ss_pred eecccCc-eEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCC--CceeeEEeEEEeCCceEEEEEecCCC
Q 002238 600 ILGRGGF-GTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH--RHLVALLGHCLDGNEKLLVFEYMPQG 676 (948)
Q Consensus 600 ~lg~G~f-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~g 676 (948)
.+..|.. +.||+...+++..+++|..... ....+..|++.++.+.. -.+.++++++.+++..++||+|++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc-----CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 3455553 6899999888888999976543 12357788888887732 33567788888888899999999887
Q ss_pred Ch
Q 002238 677 TL 678 (948)
Q Consensus 677 sL 678 (948)
++
T Consensus 92 ~~ 93 (255)
T d1nd4a_ 92 DL 93 (255)
T ss_dssp ET
T ss_pred cc
Confidence 65
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.38 E-value=0.00027 Score=76.02 Aligned_cols=79 Identities=13% Similarity=0.145 Sum_probs=50.7
Q ss_pred cceecccCceEEEEEEEc-CCcEEEEEEeecCc-C----ChhhHHHHHHHHHHHHhc-CC--CceeeEEeEEEeCCceEE
Q 002238 598 ENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-I----SGKGLTEFKSEIAVLTKV-RH--RHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~----~~~~~~~~~~E~~~l~~l-~H--~niv~l~~~~~~~~~~~l 668 (948)
.+.||.|....||++... +++.|+||.-.... . .+....+...|++.++.+ .+ ..+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 356899999999999865 46789999754211 0 112234556788888877 23 345556544 5566789
Q ss_pred EEEecCCCCh
Q 002238 669 VFEYMPQGTL 678 (948)
Q Consensus 669 v~e~~~~gsL 678 (948)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.33 E-value=3.2e-05 Score=72.53 Aligned_cols=64 Identities=16% Similarity=0.102 Sum_probs=41.2
Q ss_pred cccCCCccEEEccCCcccccC-----CCCCCCCCCcEEeccCCcccc-------ccchhhhCCCCCcEEEcccCcc
Q 002238 236 IQNMTSLKEIWLHSNAFSGPL-----PDFSGVKQLESLSLRDNFFTG-------PVPDSLVKLESLKIVNMTNNLL 299 (948)
Q Consensus 236 l~~l~~L~~L~Ls~N~l~~~~-----~~~~~l~~L~~L~L~~N~l~~-------~~p~~l~~l~~L~~L~Ls~N~l 299 (948)
+...+.|++|+|++|.++... ..+...+.|++|+|++|.+.. .+...+...++|+.|+++.+..
T Consensus 68 L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 68 IETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred hhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 344566777777777776421 135556778888887776542 1445566678888888877654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.95 E-value=7.3e-05 Score=69.94 Aligned_cols=110 Identities=14% Similarity=0.160 Sum_probs=52.2
Q ss_pred CCCCcEEEcccC-CCCCC-----CCCcCCCCCCcEEEcccccccC----CCCccccCCCCCCEEEccCCCCCCCC---CC
Q 002238 91 LTKLERLELQWN-SISGP-----LPSLNGLASLEVVMLSNNQFTS----VPSDFFTGLSSLQSIEIDNNPFSSWE---IP 157 (948)
Q Consensus 91 l~~L~~L~L~~N-~l~~~-----~p~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~---~p 157 (948)
.+.|++|+|+++ .++.. ...+...+.|++|+|++|.++. .....+...+.|+.|+|++|.|+.-. +-
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 345555555542 33321 1124444555566666555542 12223444555666666666555310 11
Q ss_pred ccccCCCCCCEEEccCcccccc-------CCCCCCCCCCCCCcEEEcccccc
Q 002238 158 QSLRNASGLQNFSANSANITGQ-------IPSFFGPDEFPGLTILHLAFNQL 202 (948)
Q Consensus 158 ~~~~~l~~L~~L~l~~n~l~~~-------~p~~~~~~~l~~L~~L~Ls~N~l 202 (948)
.++...++|++|++++|.+... +...+. .-++|+.|+++.+..
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~--~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIE--ENESLLRVGISFASM 143 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHH--HCSSCCEEECCCCCH
T ss_pred HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHH--hCCCccEeeCcCCCc
Confidence 2344445566666665544321 122222 345677777766643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.78 E-value=0.0014 Score=68.25 Aligned_cols=137 Identities=13% Similarity=0.068 Sum_probs=78.2
Q ss_pred ceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCCCce--eeEEe-----EEEeCCceEEEEEecCCCCh
Q 002238 606 FGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL--VALLG-----HCLDGNEKLLVFEYMPQGTL 678 (948)
Q Consensus 606 fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL 678 (948)
--.||+++.++|+.|++|+.+.... ..+++..|.+.+..+....+ +..+. ....++..+.+++|++|..+
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 3589999999999999998765422 34678889988888742221 11111 22345567899999987533
Q ss_pred hH--------------HHHhhhh----cCCCCCCHHH-------------------HHHHHHHHHHHHHHHHh----ccC
Q 002238 679 SR--------------HIFNWAE----EGLKPLEWNR-------------------RLTIALDVARGVEYLHG----LAH 717 (948)
Q Consensus 679 ~~--------------~l~~~~~----~~~~~l~~~~-------------------~~~i~~~i~~~l~~LH~----~~~ 717 (948)
.. .+|.... ......++.. +..+...+.+.++.+.. ...
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 10 1111100 0111222211 11112222223333322 124
Q ss_pred CCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 718 ~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
.++||+|+.+.|||++++ ..++||+-+.
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 578999999999999743 5689999765
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.39 E-value=0.01 Score=61.00 Aligned_cols=160 Identities=10% Similarity=-0.010 Sum_probs=85.6
Q ss_pred eeHHHHHHhhcCCccccee-----cccCceEEEEEEEcCCcEEEEEEeecCcCChhhHHHHHHHHHHHHhcCC-----Cc
Q 002238 583 ISIQVLRNVTNNFSEENIL-----GRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH-----RH 652 (948)
Q Consensus 583 ~~~~~l~~~~~~~~~~~~l-----g~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H-----~n 652 (948)
.+.++++.+..+|.++++. ..|---+.|+.+..+| .+++|+.... ...+++..|++++..+.. |.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~----~~~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC----CCHHHHHHHHHHHHhhhhccccccc
Confidence 3557788888888876544 4566678899988755 5899987542 122455667777777732 22
Q ss_pred eeeEE---eEEEeCCceEEEEEecCCCChhH--------------HHHhhhhcC-----CCCC-CH--------------
Q 002238 653 LVALL---GHCLDGNEKLLVFEYMPQGTLSR--------------HIFNWAEEG-----LKPL-EW-------------- 695 (948)
Q Consensus 653 iv~l~---~~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~~-----~~~l-~~-------------- 695 (948)
.+... .+.........++.++.+..... .++...... .... .|
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 22111 01222445567777777653311 011000000 0000 00
Q ss_pred --HHHHHHHHHHHHHHHHHHh-ccCCCeeecCCCCccEEEcCCCCeEEeecCCce
Q 002238 696 --NRRLTIALDVARGVEYLHG-LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (948)
Q Consensus 696 --~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDik~~Nill~~~~~~kl~DfGla~ 747 (948)
......+..+...+...+. ....++||+|+.++||+++.+...-|.||+.+.
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111222222222222221 124689999999999999988777899999754
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.26 E-value=0.00031 Score=65.38 Aligned_cols=65 Identities=17% Similarity=0.181 Sum_probs=41.8
Q ss_pred cccCCCccEEEccCCccccc-----CCCCCCCCCCcEEec--cCCcccc----ccchhhhCCCCCcEEEcccCccc
Q 002238 236 IQNMTSLKEIWLHSNAFSGP-----LPDFSGVKQLESLSL--RDNFFTG----PVPDSLVKLESLKIVNMTNNLLQ 300 (948)
Q Consensus 236 l~~l~~L~~L~Ls~N~l~~~-----~~~~~~l~~L~~L~L--~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~ 300 (948)
+...+.++.|++++|.+... ...+...+.|+.++| ++|.+.. .+...+...+.|+.|+++.|...
T Consensus 70 l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 70 LKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 34556777777777777542 123555677776444 4666653 34555667888999988877653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.00 E-value=0.011 Score=62.89 Aligned_cols=73 Identities=15% Similarity=0.144 Sum_probs=49.8
Q ss_pred cceecccCceEEEEEEEcCC--------cEEEEEEeecCcCChhhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCceEE
Q 002238 598 ENILGRGGFGTVYKGELHDG--------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLL 668 (948)
Q Consensus 598 ~~~lg~G~fg~Vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~l 668 (948)
.+.|+.|-.=.+|++...++ +.|.+++.-. . .......+|..+++.+. +.-..++++++.+ .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~---~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN---P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS---C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC---c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 35788889999999987542 4566666542 1 22345678999999884 4334477776642 68
Q ss_pred EEEecCCCCh
Q 002238 669 VFEYMPQGTL 678 (948)
Q Consensus 669 v~e~~~~gsL 678 (948)
||||++|..+
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.95 E-value=0.00026 Score=65.94 Aligned_cols=112 Identities=16% Similarity=0.224 Sum_probs=66.3
Q ss_pred cCCCCCcEEEccc-CCCCCC-----CCCcCCCCCCcEEEcccccccCC----CCccccCCCCCCEEEccCCCCCCCC---
Q 002238 89 QNLTKLERLELQW-NSISGP-----LPSLNGLASLEVVMLSNNQFTSV----PSDFFTGLSSLQSIEIDNNPFSSWE--- 155 (948)
Q Consensus 89 ~~l~~L~~L~L~~-N~l~~~-----~p~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~--- 155 (948)
.+.+.|++|+|++ +.|+.. ...+...++|++|+|++|.++.. ....+...+.|+.|++++|.+....
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 4556777777776 445431 11355677777777777777642 2234556677888888887776311
Q ss_pred CCccccCCCCCCEEEcc--Ccccccc----CCCCCCCCCCCCCcEEEcccccc
Q 002238 156 IPQSLRNASGLQNFSAN--SANITGQ----IPSFFGPDEFPGLTILHLAFNQL 202 (948)
Q Consensus 156 ~p~~~~~l~~L~~L~l~--~n~l~~~----~p~~~~~~~l~~L~~L~Ls~N~l 202 (948)
+-..+...++|+.++|+ +|.+... +...+. ..++|+.|+++.|..
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~--~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLE--KNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHH--HCSSCCEEECCCSSH
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHH--hCCCcCEEeCcCCCC
Confidence 22455666777765553 4555432 223332 466788888876654
|